PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gardini, AC; Capelli, L; Ulivi, P; Giannini, M; Freier, E; Tamberi, S; Scarpi, E; Passardi, A; Zoli, W; Ragazzini, A; Amadori, D; Frassineti, GL				Gardini, Andrea Casadei; Capelli, Laura; Ulivi, Paola; Giannini, Massimo; Freier, Eva; Tamberi, Stefano; Scarpi, Emanuela; Passardi, Alassandro; Zoli, Wainer; Ragazzini, Angela; Amadori, Dino; Frassineti, Giovanni Luca			KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)	PLOS ONE			English	Article							COLORECTAL-CANCER; MUTATIONAL STATUS; CETUXIMAB; CHEMORADIOTHERAPY; EGFR	Anti-EGFR therapy appears to be a potential treatment option for squamous cell anal carcinoma (SCAC). KRAS mutation is a rare event in SCAC, indicating the absence of the principal mechanism of resistance to this type of therapy. However, no information is available from the literature regarding the status of BRAF or PIK3CA in this cancer type. We analysed KRAS, BRAF and PIK3CA status in SCAC patients in relation to the clinical-pathological characteristics of patients and to the presence of the human papilloma virus (HPV). One hundred and three patients were treated with the Nigro scheme for anal cancer from March 2001 to August 2012. Fifty patients were considered for the study as there was insufficient paraffin-embedded tumour tissue to perform molecular analysis the remaining 53. DNA was extracted from paraffin-embedded sections. KRAS, BRAF and PIK3CA gene status and HPV genotype were evaluated by pyrosequencing. KRAS and BRAF genes were wild-type in all cases. Conversely, PIK3CA gene was found to be mutated in 11 (22%) cases. In particular, 8 mutations occurred in exon 9 and 3 in exon 20 of the PIK3CA gene. These findings suggest that SCAC could potentially respond to an anti-EGFR drug. PIK3CA mutation may be involved in the process of carcinogenesis in some cases of SCAC.	[Gardini, Andrea Casadei; Capelli, Laura; Ulivi, Paola; Scarpi, Emanuela; Passardi, Alassandro; Zoli, Wainer; Ragazzini, Angela; Amadori, Dino; Frassineti, Giovanni Luca] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy; [Giannini, Massimo] Macerata Hosp, Radiotherapy Unit, Macerata, Italy; [Freier, Eva; Tamberi, Stefano] Degli Infermi Hosp, Oncol Unit, Faenza, Italy	IRCCS Meldola (IRST)	Gardini, AC (corresponding author), Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy.	casadeigardini@gmail.com	gardini, Andrea Casadei/L-4859-2019; Gardini, Andrea Casadei/F-1830-2016; Passardi, Alessandro/AAH-4786-2019; Capelli, Laura/AAB-9682-2019; Scarpi, Emanuela/AAD-7036-2019; Gardini, Andrea/AAA-6985-2022	gardini, Andrea Casadei/0000-0001-6289-7202; Gardini, Andrea Casadei/0000-0001-6289-7202; Passardi, Alessandro/0000-0002-7099-240X; Scarpi, Emanuela/0000-0001-7230-9267; Ulivi, Paola/0000-0002-4334-9662; Tamberi, Stefano/0000-0002-7087-9116; Frassineti, Giovanni Luca/0000-0002-0277-5622				Bamba Takeo, 2012, Gan To Kagaku Ryoho, V39, P311; Barmettler H, 2012, CASE REP ONCOL, V5, P428, DOI 10.1159/000341371; Bruckman KC, 2010, ORAL SURG ORAL MED O, V110, P632, DOI 10.1016/j.tripleo.2010.05.002; COX DR, 1972, J R STAT SOC B, V34, P187; Das P, 2007, INT J RADIAT ONCOL, V68, P794, DOI 10.1016/j.ijrobp.2006.12.052; Deutsch E, 2013, ANN ONCOL, V24, P2834, DOI 10.1093/annonc/mdt368; Edge SB, 2010, AJCC CANC STAGING MA; Kaplan EL, 2005, J AM STAT ASSOC, V24, P341; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Lukan N, 2009, ONCOLOGY-BASEL, V77, P293, DOI 10.1159/000259615; Olivatto LO, 2006, J CLIN ONCOL S243; Paliga A, 2012, BRIT J CANCER, V107, P1864, DOI 10.1038/bjc.2012.479; Pochylski T, 2003, EUR J OBSTET GYN R B, V111, P68, DOI 10.1016/S0301-2115(03)00205-7; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Skamperle M, 2013, ACTA DERMATOVEN ALP, V21, P1, DOI 10.2478/v10162-012-0024-1; Ulivi P, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-87; Van Damme N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-189; Yhim HY, 2011, INT J CANCER, V129, P1752, DOI 10.1002/ijc.25825; Zampino MG, 2009, CANCER CHEMOTH PHARM, V65, P197, DOI 10.1007/s00280-009-1117-3	21	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92071	10.1371/journal.pone.0092071	http://dx.doi.org/10.1371/journal.pone.0092071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642661	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900075
J	Narayan, EJ; Hero, JM				Narayan, Edward J.; Hero, Jean-Marc			Acute Thermal Stressor Increases Glucocorticoid Response but Minimizes Testosterone and Locomotor Performance in the Cane Toad (Rhinella marina)	PLOS ONE			English	Article							CORTICOSTERONE METABOLITE RESPONSES; BASE-LINE CORTICOSTERONE; SHORT-TERM CAPTURE; URINARY CORTICOSTERONE; CLIMATE-CHANGE; REPEATABILITY; TEMPERATURE; WILD; ELEVATION; PATTERNS	Climatic warming is a global problem and acute thermal stressor in particular could be considered as a major stressor for wildlife. Cane toads (Rhinella marina) have expanded their range into warmer regions of Australia and they provide a suitable model species to study the sub-lethal impacts of thermal stressor on the endocrine physiology of amphibians. Presently, there is no information to show that exposure to an acute thermal stressor could initiate a physiological stress (glucocorticoid) response and secondly, the possible effects on reproductive hormones and performance. Answering these questions is important for understanding the impacts of extreme temperature on amphibians. In this study, we experimented on cane toads from Queensland, Australia by acclimating them to mildly warm temperature (25 degrees C) and then exposing to acute temperature treatments of 30 degrees, 35 degrees or 40 degrees C (hypothetical acute thermal stressors). We measured acute changes in the stress hormone corticosterone and the reproductive hormone testosterone using standard capture and handling protocol and quantified the metabolites of both hormones non-invasively using urinary enzyme-immunoassays. Furthermore, we measured performance trait (i.e. righting response score) in the control acclimated and the three treatment groups. Corticosterone stress responses increased in all toads during exposure to an acute thermal stressor. Furthermore, exposure to a thermal stressor also decreased testosterone levels in all toads. The duration of the righting response (seconds) was longer for toads that were exposed to 40 degrees C than to 30 degrees, 35 degrees or 25 degrees C. The increased corticosterone stress response with increased intensity of the acute thermal stressor suggests that the toads perceived this treatment as a stressor. Furthermore, the results also highlight a potential trade-off with performance and reproductive hormones. Ultimately, exposure acute thermal stressors due to climatic variability could impact amphibians at multiple ecophysiological levels through impacts on endocrine physiology, performance and potentially fitness traits (e. g. reproductive output).	[Narayan, Edward J.; Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Nathan, Qld 4111, Australia	Griffith University	Narayan, EJ (corresponding author), Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Nathan, Qld 4111, Australia.	e.narayan@ga.griffith.edu.au	Narayan, Edward/E-8238-2016	Narayan, Edward/0000-0003-2719-0900	Griffith University	Griffith University(Griffith University)	This research was supported by funding to EJN provided by the Griffith University New Researcher Grant 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; CALLARD GV, 1975, J COMP PHYSIOL, V99, P271, DOI 10.1007/BF00710367; Coumou D, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034018; Cunningham SJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080036, 10.1371/journal.pone.0082492]; Edenhofer O., 2014, CONTRIBUTION WORKING; GALINA ZH, 1983, PHARMACOL BIOCHEM BE, V19, P251, DOI 10.1016/0091-3057(83)90048-5; Graham CM, 2013, GEN COMP ENDOCR, V191, P24, DOI 10.1016/j.ygcen.2013.05.012; Jessop TS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1444; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kindermann C, 2013, COMP BIOCHEM PHYS A, V165, P223, DOI 10.1016/j.cbpa.2013.03.011; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Laurance WF, 2011, BIOL CONSERV, V144, P1472, DOI 10.1016/j.biocon.2011.01.016; LEBOULENGER F, 1978, GEN COMP ENDOCR, V36, P327, DOI 10.1016/0016-6480(78)90114-4; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Narayan EJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot011; Narayan E, 2011, AUST J ZOOL, V59, P79, DOI 10.1071/ZO11030; Narayan E, 2010, AUST J ZOOL, V58, P189, DOI 10.1071/ZO10010; Narayan EJ, 2014, J THERM BIOL, V41, P72, DOI 10.1016/j.jtherbio.2014.02.011; Narayan EJ, 2013, J EXP ZOOL PART A, V319, P471, DOI 10.1002/jez.1810; Narayan EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073564; Narayan EJ, 2013, GEN COMP ENDOCR, V191, P225, DOI 10.1016/j.ygcen.2013.06.018; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V165, P304, DOI 10.1016/j.cbpa.2013.03.033; Narayan EJ, 2012, GEN COMP ENDOCR, V179, P345, DOI 10.1016/j.ygcen.2012.09.017; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V164, P21, DOI 10.1016/j.cbpa.2012.10.001; Narayan EJ, 2012, GEN COMP ENDOCR, V178, P301, DOI 10.1016/j.ygcen.2012.06.014; Narayan EJ, 2011, AUST J ZOOL, V59, P264, DOI 10.1071/ZO11070; Narayan EJ, 2012, GEN COMP ENDOCR, V175, P284, DOI 10.1016/j.ygcen.2011.11.023; Narayan EJ, 2011, GEN COMP ENDOCR, V174, P238, DOI 10.1016/j.ygcen.2011.09.004; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Narayan EJ, 2010, GEN COMP ENDOCR, V166, P172, DOI 10.1016/j.ygcen.2009.10.003; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Preest MR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P641, DOI 10.1086/590371; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SUMPTER JP, 1985, GEN COMP ENDOCR, V59, P257, DOI 10.1016/0016-6480(85)90377-6; Sutherst RW, 1996, CONSERV BIOL, V10, P294, DOI 10.1046/j.1523-1739.1996.10010294.x; Todd BD, 2011, P ROY SOC B-BIOL SCI, V278, P2191, DOI 10.1098/rspb.2010.1768; Tyler M. J., 1989, AUSTR FROGS; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385	41	24	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92090	10.1371/journal.pone.0092090	http://dx.doi.org/10.1371/journal.pone.0092090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643017	Green Submitted, gold, Green Published			2022-12-27	WOS:000333259900083
J	Arula, T; Groger, J; Ojaveer, H; Simm, M				Arula, Timo; Groeger, Joachim; Ojaveer, Henn; Simm, Mart			Shifts in the Spring Herring (Clupea harengus membras) Larvae and Related Environment in the Eastern Baltic Sea over the Past 50 Years	PLOS ONE			English	Article							REGIME SHIFTS; NORTH-SEA; TROPHIC INTERACTIONS; MARINE ECOSYSTEMS; CLIMATE-CHANGE; MISMATCH; CIRCULATION; MECHANISMS; MANAGEMENT; PREDATION	Because of the high management relevance, commercial fish related aspects have often been central in marine ecosystem investigations. The iterative shiftogram method was applied to detect occurrence, type and timing of shifts in the single and multivariate time series linked to the spring spawning herring larvae in the Gulf of Riga (Baltic Sea). Altogether nineteen larval herring and related environmental variables were utilized during the period of 1957-2010. All the time series investigated, either single or multivariate, exhibited one or more shifts with variable type and timing. Multivariate shiftogram based on all time series identified two distinct states (1957-1983 and 1992-2010) in studied variables, separated by a smooth transition period lasting almost ten years. The observed shift was mainly related to hydroclimate and not to phenology or biota. Significantly increased variability was found in larval herring and recruitment abundances after the shift. While the shift in hydroclimate (1985-1991) was followed by the shift in phenology (1991-1997), the shift in biota occurred remarkably later (2003). It is likely that the dynamics in biota were affected by other drivers than those investigated in the current paper.	[Arula, Timo; Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Groeger, Joachim] Thunen Inst Sea Fisheries, Hamburg, Germany; [Groeger, Joachim] Univ Rostock, Inst Biosci, D-18055 Rostock, Germany; [Simm, Mart] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia	University of Tartu; Estonian Marine Institute; Johann Heinrich von Thunen Institute; University of Rostock; University of Tartu; Estonian Marine Institute	Arula, T (corresponding author), Univ Tartu, Estonian Marine Inst, Parnu, Estonia.	timo.arula@ut.ee	Ojaveer, Henn/K-2160-2016; arula, timo/G-8710-2017	Ojaveer, Henn/0000-0003-2742-6063; arula, timo/0000-0001-9621-1168	Estonian Ministry of Education and Research [SF0180005s10]; Institutional research funding of the Estonian Research Council [IUT02-20]; Estonian Science Foundation [8254, 8747]; European Community [266445]; project on The status of marine biodiversity and its potential futures in the Estonian coastal sea of Environmental protection and - technology programme of European Regional Fund [3.2.0802.11-0029]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Institutional research funding of the Estonian Research Council(Estonian Research Council); Estonian Science Foundation; European Community(European Commission); project on The status of marine biodiversity and its potential futures in the Estonian coastal sea of Environmental protection and - technology programme of European Regional Fund	This work was partially financed by the Estonian Ministry of Education and Research (grantSF0180005s10), Institutional research funding IUT02-20 of the Estonian Research Council and by the Estonian Science Foundation (grants 8254, 8747). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS). The study has been supported by the project on The status of marine biodiversity and its potential futures in the Estonian coastal sea 3.2.0802.11-0029 of Environmental protection and - technology programme of European Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Arula T, 2012, J SEA RES, V68, P33, DOI 10.1016/j.seares.2011.12.003; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Casini M, 2011, POPUL ECOL, V53, P511, DOI 10.1007/s10144-011-0269-2; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Choi JS, 2005, OCEANOGR MAR BIOL, V43, P47; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Diekmann R, 2010, INTEGRATED ECOSYSTEM; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Greve W, 2005, ICES J MAR SCI, V62, P1216, DOI 10.1016/j.icesjms.2005.03.011; Groger JP, 2011, ECOL INDIC, V11, P1084, DOI 10.1016/j.ecolind.2010.12.008; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; HELCOM, 1988, GUID BALT MON PROGR; HELCOM, 2009, BALT SEA ENV P, V116A; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; ICES, 2012, REP ICES HELCOM WORK; ICES, 2011, REP BALT FISH ASS WO; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Kotta J, 2009, ESTUAR COAST SHELF S, V84, P509, DOI 10.1016/j.ecss.2009.07.014; Kraberg AC, 2011, MAR POLLUT BULL, V62, P7, DOI 10.1016/j.marpolbul.2010.09.010; Laur K, 2014, ESTUAR COAST SHELF S, V136, P112, DOI 10.1016/j.ecss.2013.11.011; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Lehtiniemi M, 2008, MAR ECOL PROG SER, V362, P193, DOI 10.3354/meps07441; Lindegren M, 2010, MAR ECOL PROG SER, V402, P239, DOI 10.3354/meps08454; Link JS, 2002, N AM J FISH MANAGE, V22, P550, DOI 10.1577/1548-8675(2002)022<0550:EIBEAG>2.0.CO;2; McQuatters-Gollop A, 2007, LIMNOL OCEANOGR, V52, P635, DOI 10.4319/lo.2007.52.2.0635; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2011, MAR ECOL PROG SER, V431, P293, DOI 10.3354/meps09205; Ojaveer E, 2011, FISH RES, V107, P159, DOI 10.1016/j.fishres.2010.11.001; Ojaveer E, 1988, BALTIC HERRINGS BIOL; Ojaveer H, 1999, ICES J MAR SCI, V56, P33, DOI 10.1006/jmsc.1999.0609; Omstedt A, 2011, GUIDE TO PROCESS BASED MODELING OF LAKES AND COASTAL SEAS, P1, DOI 10.1007/978-3-642-17728-6; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rannak L, 1971, RAPP P VERB REU CONS, P77; Rannak L, 1979, 1979J9 ICES CM, V9; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schlittgen R., 2001, ANGEW ZEITREIHENANAL; Schwing FB, 2009, REGIME SHIFTS PHYS F, P709; Weijerman M, 2005, MAR ECOL PROG SER, V298, P21, DOI 10.3354/meps298021; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106	48	11	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91304	10.1371/journal.pone.0091304	http://dx.doi.org/10.1371/journal.pone.0091304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637830	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100027
J	Chan, SHJ; Norregaard, L; Solem, C; Jensen, PR				Chan, Siu Hung Joshua; Norregaard, Lasse; Solem, Christian; Jensen, Peter Ruhdal			Acetate Kinase Isozymes Confer Robustness in Acetate Metabolism	PLOS ONE			English	Article							PYRUVATE-FORMATE-LYASE; ACETYL-COENZYME-A; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; METHANOSARCINA-THERMOPHILA; BACILLUS-STEAROTHERMOPHILUS; ACTIVE-SITE; GROWTH; PURIFICATION; EXPRESSION	Acetate kinase (ACK) (EC no: 2.7.2.1) interconverts acetyl-phosphate and acetate to either catabolize or synthesize acetyl-CoA dependent on the metabolic requirement. Among all ACK entries available in UniProt, we found that around 45% are multiple ACKs in some organisms including more than 300 species but surprisingly, little work has been done to clarify whether this has any significance. In an attempt to gain further insight we have studied the two ACKs (AckA1, AckA2) encoded by two neighboring genes conserved in Lactococcus lactis (L. lactis) by analyzing protein sequences, characterizing transcription structure, determining enzyme characteristics and effect on growth physiology. The results show that the two ACKs are most likely individually transcribed. AckA1 has a much higher turnover number and AckA2 has a much higher affinity for acetate in vitro. Consistently, growth experiments of mutant strains reveal that AckA1 has a higher capacity for acetate production which allows faster growth in an environment with high acetate concentration. Meanwhile, AckA2 is important for fast acetate-dependent growth at low concentration of acetate. The results demonstrate that the two ACKs have complementary physiological roles in L. lactis to maintain a robust acetate metabolism for fast growth at different extracellular acetate concentrations. The existence of ACK isozymes may reflect a common evolutionary strategy in bacteria in an environment with varying concentrations of acetate.	[Chan, Siu Hung Joshua; Norregaard, Lasse; Solem, Christian; Jensen, Peter Ruhdal] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark	Solem, C (corresponding author), Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark.	cso@food.dtu.dk; perj@food.dtu.dk	jensen, Peter Ruhdal/AAC-4891-2019; Chan, Siu Hung Joshua/N-9777-2016	Jensen, Peter Ruhdal/0000-0003-2080-2070; Solem, Christian/0000-0002-3898-280X; Chan, Siu Hung Joshua/0000-0002-7707-656X	Danish research council for Nature and Universe (FNU) [10-085115]	Danish research council for Nature and Universe (FNU)(Danish Natural Science Research Council)	This work was supported by the Danish research council for Nature and Universe (FNU; Grant #10-085115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACETI DJ, 1988, J BIOL CHEM, V263, P15444; AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; ANDERSCH W, 1983, EUR J APPL MICROBIOL, V18, P327, DOI 10.1007/BF00504740; Andersen HW, 2001, J BACTERIOL, V183, P3458, DOI 10.1128/JB.183.11.3458-3467.2001; BOWMAN CM, 1976, J BIOL CHEM, V251, P3117; Brondsted L, 1999, APPL ENVIRON MICROB, V65, P752; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Buss KA, 2001, J BACTERIOL, V183, P680, DOI 10.1128/JB.183.2.680-686.2001; Buss KA, 1997, PROTEIN SCI, V6, P2659; Chittori S, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-24; Contiero J, 2000, J IND MICROBIOL BIOT, V24, P421, DOI 10.1038/sj.jim.7000014; de Felipe FL, 2009, APPL MICROBIOL BIOT, V82, P1115, DOI 10.1007/s00253-009-1897-8; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; Eckhardt TH, 2013, J BACTERIOL, V195, P1081, DOI 10.1128/JB.02043-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez M, 2002, J BACTERIOL, V184, P82, DOI 10.1128/JB.184.1.82-90.2002; FOX DK, 1986, J BIOL CHEM, V261, P3487; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gerstmeir R, 2003, J BIOTECHNOL, V104, P99, DOI 10.1016/S0168-1656(03)00167-6; Goel A, 2012, APPL ENVIRON MICROB, V78, P134, DOI 10.1128/AEM.05276-11; Gorrell A, 2005, J BIOL CHEM, V280, P10731, DOI 10.1074/jbc.M412118200; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; GRUNDY FJ, 1993, J BACTERIOL, V175, P7348, DOI 10.1128/JB.175.22.7348-7355.1993; HARWOOD CS, 1982, J BACTERIOL, V152, P246; Henriksen CM, 2001, APPL MICROBIOL BIOT, V56, P767, DOI 10.1007/s002530100694; Hertzberger RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057235; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; ISHIKAWA H, 1995, J CHEM ENG JPN, V28, P517, DOI 10.1252/jcej.28.517; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Jensen PR, 1993, APPL ENVIRON MICROB, V59, P4263; JOHANSEN E, 1992, J DAIRY SCI, V75, P1186, DOI 10.3168/jds.S0022-0302(92)77865-5; KAHANE I, 1979, J BACTERIOL, V137, P764, DOI 10.1128/JB.137.2.764-772.1979; KAKUDA H, 1994, BIOSCI BIOTECH BIOCH, V58, P2232, DOI 10.1271/bbb.58.2232; Knorr R, 2001, MICROBIOL RES, V156, P267, DOI 10.1078/0944-5013-00114; Koebmann BJ, 2002, APPL ENVIRON MICROB, V68, P4274, DOI 10.1128/AEM.68.9.4274-4282.2002; Koebmann B, 2008, BIOTECHNOL APPL BIOC, V50, P25, DOI 10.1042/BA20070132; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Lin WLR, 1998, TETRAHEDRON, V54, P15915, DOI 10.1016/S0040-4020(98)01001-1; Melchiorsen CR, 2000, J BACTERIOL, V182, P4783, DOI 10.1128/JB.182.17.4783-4788.2000; Melchiorsen CR, 2002, APPL MICROBIOL BIOT, V58, P338, DOI 10.1007/s00253-001-0892-5; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073907; Miles RD, 2002, J BIOL CHEM, V277, P22547, DOI 10.1074/jbc.M105921200; Miles RD, 2001, J BIOL CHEM, V276, P45059, DOI 10.1074/jbc.M108355200; Miller J.H., 1972, EXPT MOL GENETICS; NAKAJIMA H, 1978, J BIOCHEM, V84, P193, DOI 10.1093/oxfordjournals.jbchem.a132108; Sambrook J., 2002, MOL CLONING LAB MANU; Singh-Wissmann K, 1998, J BACTERIOL, V180, P1129, DOI 10.1128/JB.180.5.1129-1134.1998; SKOOG K, 1992, APPL ENVIRON MICROB, V58, P2552, DOI 10.1128/AEM.58.8.2552-2558.1992; SNOEP JL, 1993, FEMS MICROBIOL LETT, V114, P279, DOI 10.1016/0378-1097(93)90284-9; Solem C, 2008, APPL ENVIRON MICROB, V74, P4772, DOI 10.1128/AEM.00134-08; Solem C, 2007, J BACTERIOL, V189, P6727, DOI 10.1128/JB.00902-07; SPECTOR LB, 1980, P NATL ACAD SCI-BIOL, V77, P2626, DOI 10.1073/pnas.77.5.2626; THOMAS TD, 1979, J BACTERIOL, V138, P109, DOI 10.1128/JB.138.1.109-117.1979; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	56	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92256	10.1371/journal.pone.0092256	http://dx.doi.org/10.1371/journal.pone.0092256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638105	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100135
J	Chen, LH; Advani, SL; Thai, K; Kabir, MG; Sood, MM; Gibson, IW; Yuen, DA; Connelly, KA; Marsden, PA; Kelly, DJ; Gilbert, RE; Advani, A				Chen, Li-Hao; Advani, Suzanne L.; Thai, Kerri; Kabir, M. Golam; Sood, Manish M.; Gibson, Ian W.; Yuen, Darren A.; Connelly, Kim A.; Marsden, Philip A.; Kelly, Darren J.; Gilbert, Richard E.; Advani, Andrew			SDF-1/CXCR4 Signaling Preserves Microvascular Integrity and Renal Function in Chronic Kidney Disease	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL-CELLS; UP-REGULATION; EXPRESSION; GROWTH; VEGF; INJURY; GLOMERULOSCLEROSIS; PATHOGENESIS; ACETYLATION	The progressive decline of renal function in chronic kidney disease (CKD) is characterized by both disruption of the microvascular architecture and the accumulation of fibrotic matrix. One angiogenic pathway recently identified as playing an essential role in renal vascular development is the stromal cell-derived factor-1 alpha (SDF-1)/CXCR4 pathway. Because similar developmental processes may be recapitulated in the disease setting, we hypothesized that the SDF-1/CXCR4 system would regulate microvascular health in CKD. Expression of CXCR4 was observed to be increased in the kidneys of subtotally nephrectomized (SNx) rats and in biopsies from patients with secondary focal segmental glomerulosclerosis (FSGS), a rodent model and human correlate both characterized by aberration of the renal microvessels. A reno-protective role for local SDF-1/CXCR4 signaling was indicated by i) CXCR4-dependent glomerular eNOS activation following acute SDF-1 administration; and ii) acceleration of renal function decline, capillary loss and fibrosis in SNx rats treated with chronic CXCR4 blockade. In contrast to the upregulation of CXCR4, SDF-1 transcript levels were decreased in SNx rat kidneys as well as in renal fibroblasts exposed to the pro-fibrotic cytokine transforming growth factor beta (TGF-beta), the latter effect being attenuated by histone deacetylase inhibition. Increased renal SDF-1 expression was, however, observed following the treatment of SNx rats with the ACE inhibitor, perindopril. Collectively, these observations indicate that local SDF-1/CXCR4 signaling functions to preserve microvascular integrity and prevent renal fibrosis. Augmentation of this pathway, either purposefully or serendipitously with either novel or existing therapies, may attenuate renal decline in CKD.	[Chen, Li-Hao; Advani, Suzanne L.; Thai, Kerri; Kabir, M. Golam; Yuen, Darren A.; Connelly, Kim A.; Marsden, Philip A.; Gilbert, Richard E.; Advani, Andrew] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Chen, Li-Hao; Advani, Suzanne L.; Thai, Kerri; Kabir, M. Golam; Yuen, Darren A.; Connelly, Kim A.; Marsden, Philip A.; Gilbert, Richard E.; Advani, Andrew] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Sood, Manish M.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Gibson, Ian W.] Univ Manitoba, Hlth Sci Ctr, Winnipeg, MB, Canada; [Kelly, Darren J.] St Vincents Hosp, Dept Med, Melbourne, Vic, Australia	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Manitoba; Children's Hospital Research Institute of Manitoba; St Vincent's Hospital Melbourne	Advani, A (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.	advania@smh.ca	Sood, Manish M/H-3134-2019	Sood, Manish M/0000-0002-9146-2344; Kelly, Darren/0000-0003-4850-3929; Gibson, Ian/0000-0003-3505-0262	CIHR [MOP-97791]; Canadian Diabetes Association (CDA) [OG-3-10-2949-AA]; CIHR Frederick Banting and Charles Best Graduate Scholarship; Banting and Best Diabetes Centre Graduate Studentship; Canadian Diabetes Association	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association (CDA); CIHR Frederick Banting and Charles Best Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre Graduate Studentship; Canadian Diabetes Association	These studies were supported by grants from CIHR (grant MOP-97791) and the Canadian Diabetes Association (CDA, OG-3-10-2949-AA) to Dr. Advani. Mr. Chen was supported by a CIHR Frederick Banting and Charles Best Graduate Scholarship and a Banting and Best Diabetes Centre Graduate Studentship. Dr. Advani is a Canadian Diabetes Association Clinician Scientist and this work was supported, in part, by the Canadian Diabetes Association. Dr. Gilbert is a Canada Research Chair in Diabetes Complications. Dr. Yuen is a KRESCENT New Investigator and Canadian Diabetes Association Clinician Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Advani A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024695; Advani A, 2011, AM J PATHOL, V178, P2205, DOI 10.1016/j.ajpath.2011.01.044; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; BURLINGTON H, 1973, P SOC EXP BIOL MED, V142, P143, DOI 10.3181/00379727-142-36977; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chabane N, 2009, J CELL BIOCHEM, V106, P453, DOI 10.1002/jcb.22027; Chu PY, 2011, CIRC-HEART FAIL, V4, P651, DOI 10.1161/CIRCHEARTFAILURE.110.960831; Dai SJ, 2010, J MOL CELL CARDIOL, V49, P587, DOI 10.1016/j.yjmcc.2010.07.010; Daly AJ, 2008, ORAL ONCOL, V44, P646, DOI 10.1016/j.oraloncology.2007.08.012; De Falco V, 2007, CANCER RES, V67, P11821, DOI 10.1158/0008-5472.CAN-07-0899; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fine LG, 1998, KIDNEY INT, pS74; Floege J, 2009, J AM SOC NEPHROL, V20, P1659, DOI 10.1681/ASN.2009060621; Fogo AB, 2005, CURR OPIN NEPHROL HY, V14, P201, DOI 10.1097/01.mnh.0000165883.08675.ab; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gilbert RE, 1999, AM J PATHOL, V155, P429, DOI 10.1016/S0002-9440(10)65139-5; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Johnson RJ, 1997, AM J PATHOL, V151, P1179; Kanda S, 2003, J BIOL CHEM, V278, P257, DOI 10.1074/jbc.M204771200; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; Kelly DJ, 2003, NEPHROL DIAL TRANSPL, V18, P1286, DOI 10.1093/ndt/gfg176; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Remuzzi A, 2006, KIDNEY INT, V69, P1124, DOI 10.1038/sj.ki.5000060; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Sameermahmood Z, 2008, INVEST OPHTH VIS SCI, V49, P3305, DOI 10.1167/iovs.07-0456; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Stokman G, 2010, NEPHROL DIAL TRANSPL, V25, P3852, DOI 10.1093/ndt/gfq311; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Yuen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009543	48	31	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92227	10.1371/journal.pone.0092227	http://dx.doi.org/10.1371/journal.pone.0092227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637920	Green Published, gold			2022-12-27	WOS:000333254100130
J	Feng, J; Zhang, H; Strelkov, SE; Hwang, SF				Feng, Jie; Zhang, Hui; Strelkov, Stephen E.; Hwang, Sheau-Fang			The LmSNF1 Gene Is Required for Pathogenicity in the Canola Blackleg Pathogen Leptosphaeria maculans	PLOS ONE			English	Article							PHOMA STEM CANKER; INDUCED POINT MUTATIONS; CELL-WALL DEGRADATION; SNF1 PROTEIN-KINASE; RICE BLAST FUNGUS; BRASSICA-NAPUS; OILSEED RAPE; FILAMENTOUS FUNGI; SACCHAROMYCES-CEREVISIAE; AVIRULENCE GENE	Leptosphaeria maculans is a fungal pathogen causing blackleg in canola. Its virulence has been attributed, among other factors, to the activity of hydrolytic cell wall degrading enzymes (CWDEs). Studies on the pathogenicity function of CWDEs in plant pathogenic fungi have been difficult due to gene redundancy. In microorganisms many CWDE genes are repressed by glucose and derepressed by the function of the sucrose non-fermenting protein kinase 1 gene (SNF1). To address the molecular function of SNF1 in L. maculans, the ortholog of SNF1 (LmSNF1) was cloned and functionally characterized using a gene knockout strategy. Growth of the LmSNF1 knockout strains was severely disrupted, as was sporulation, spore germination and the ability to attach on the plant surface. When inoculated on canola cotyledons, the LmSNF1 knockout strains could not cause any symptoms, indicating the loss of pathogenicity. The expression of 11 selected CWDE genes and a pathogenicity gene (LopB) was significantly down-regulated in the LmSNF1 knockout strains. In conclusion, knockout of LmSNF1 prevents L. maculans from properly derepressing the production of CWDEs, compromises the utilization of certain carbon sources, and impairs fungal pathogenicity on canola.	[Feng, Jie; Hwang, Sheau-Fang] Alberta Agr & Rural Dev, Crop Diversificat Ctr North, Edmonton, AB, Canada; [Zhang, Hui] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Strelkov, Stephen E.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Alberta	Hwang, SF (corresponding author), Alberta Agr & Rural Dev, Crop Diversificat Ctr North, Edmonton, AB, Canada.	sheau-fang.hwang@gov.ab.ca			SaskCanola; Agriculture and Agri-Food Canada under the Growing Forward 2 Program	SaskCanola; Agriculture and Agri-Food Canada under the Growing Forward 2 Program	Financial support was received from SaskCanola and Agriculture and Agri-Food Canada under the Growing Forward 2 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Both M, 2005, PLANT CELL, V17, P2107, DOI 10.1105/tpc.105.032631; CARLSON M, 1981, GENETICS, V98, P25; Carver TLW, 2006, ANNU PLANT REV, V23, P368; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Cho Y, 2009, MOL MICROBIOL, V72, P1316, DOI 10.1111/j.1365-2958.2009.06689.x; Choi J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S7; DEISING H, 1992, PLANT CELL, V4, P1101, DOI 10.1105/tpc.4.9.1101; Dilmaghani A, 2009, PLANT PATHOL, V58, P1044, DOI 10.1111/j.1365-3059.2009.02149.x; Elliott CE, 2008, MOL PLANT, V1, P471, DOI 10.1093/mp/ssn014; Elliott CE, 2006, MOL PLANT MICROBE IN, V19, P588, DOI 10.1094/MPMI-19-0588; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Fairhead C, 1998, GENE, V223, P33, DOI 10.1016/S0378-1119(98)00171-1; Feng J, 2005, MICROBIOL-SGM, V151, P3911, DOI 10.1099/mic.0.28261-0; Feng J, 2011, PLANT PATHOL, V60, P698, DOI 10.1111/j.1365-3059.2011.02434.x; Feng J, 2010, CAN J PLANT PATHOL, V32, P396, DOI 10.1080/07060661.2010.508620; Feng J, 2011, MICROBIOL RES, V166, P618, DOI 10.1016/j.micres.2010.12.002; Feng J, 2009, MOL PLANT MICROBE IN, V22, P1601, DOI 10.1094/MPMI-22-12-1601; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Fitt BDL, 2008, PLANT PATHOL, V57, P652, DOI 10.1111/j.1365-3059.2008.01841.x; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Fu HT, 2013, FUNGAL BIOL-UK, V117, P673, DOI 10.1016/j.funbio.2013.07.003; Fudal I, 2007, MOL PLANT MICROBE IN, V20, P459, DOI 10.1094/MPMI-20-4-0459; Garcia-Maceira FI, 2000, MOL PLANT MICROBE IN, V13, P359, DOI 10.1094/MPMI.2000.13.4.359; Goodwin PH, 2002, FEMS MICROBIOL LETT, V215, P169, DOI 10.1111/j.1574-6968.2002.tb11387.x; Gout L, 2006, MOL MICROBIOL, V60, P67, DOI 10.1111/j.1365-2958.2006.05076.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Howlett BJ, 2004, CAN J PLANT PATHOL, V26, P245; Idnurm A, 2003, FUNGAL GENET BIOL, V39, P31, DOI 10.1016/S1087-1845(02)00588-1; Idnurm A, 2002, EUKARYOT CELL, V1, P719, DOI 10.1128/EC.1.5.719-724.2002; JOHNSON RD, 1994, PLANT PATHOL, V43, P269, DOI 10.1111/j.1365-3059.1994.tb02685.x; Jonkers W, 2009, MOL MICROBIOL, V74, P1100, DOI 10.1111/j.1365-2958.2009.06922.x; Kuchin S, 2002, MOL CELL BIOL, V22, P3994, DOI 10.1128/MCB.22.12.3994-4000.2002; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Nadal M, 2010, PHYTOPATHOLOGY, V100, P1364, DOI 10.1094/PHYTO-01-10-0011; Osherov N, 2001, FEMS MICROBIOL LETT, V199, P153, DOI 10.1111/j.1574-6968.2001.tb10667.x; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Parlange F, 2009, MOL MICROBIOL, V71, P851, DOI 10.1111/j.1365-2958.2008.06547.x; Remy E, 2009, MOL PLANT MICROBE IN, V22, P725, DOI 10.1094/MPMI-22-6-0725; Remy E, 2008, NEW PHYTOL, V179, P1105, DOI 10.1111/j.1469-8137.2008.02522.x; Remy E, 2008, FUNGAL GENET BIOL, V45, P1122, DOI 10.1016/j.fgb.2008.04.008; RIKKERINK EHA, 1994, CURR GENET, V25, P202, DOI 10.1007/BF00357163; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Sambrook J., 2001, MOL CLONING LAB MANU; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Vacher S, 2003, GENE, V310, P113, DOI 10.1016/S0378-1119(03)00525-0; Van de Wouw AP, 2014, MOL PLANT PATHOL, V15, P523, DOI 10.1111/mpp.12105; Van de Wouw APV, 2009, FUNGAL GENET BIOL, V46, P695, DOI 10.1016/j.fgb.2009.06.004; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; West JS, 2001, PLANT PATHOL, V50, P10, DOI 10.1046/j.1365-3059.2001.00546.x; Wilson LM, 2002, MOL PLANT PATHOL, V3, P487, DOI 10.1046/j.1364-3703.2002.00144.x; Wu SC, 1997, MOL PLANT MICROBE IN, V10, P700, DOI 10.1094/MPMI.1997.10.6.700; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yi M, 2008, FUNGAL GENET BIOL, V45, P1172, DOI 10.1016/j.fgb.2008.05.003; Zhang TY, 2013, APPL MICROBIOL BIOT, V97, P5433, DOI 10.1007/s00253-012-4593-z	65	19	19	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92503	10.1371/journal.pone.0092503	http://dx.doi.org/10.1371/journal.pone.0092503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638039	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100151
J	Kitano, K; Usui, S; Ootsuji, H; Takashima, S; Kobayashi, D; Murai, H; Furusho, H; Nomura, A; Kaneko, S; Takamura, M				Kitano, Katsunori; Usui, Soichiro; Ootsuji, Hiroshi; Takashima, Shin-ichiro; Kobayashi, Daisuke; Murai, Hisayoshi; Furusho, Hiroshi; Nomura, Ayano; Kaneko, Shuichi; Takamura, Masayuki			Rho-Kinase Activation in Leukocytes Plays a Pivotal Role in Myocardial Ischemia/Reperfusion Injury	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CARDIAC-HYPERTROPHY; NEUTROPHIL DEPLETION; ISCHEMIA-REPERFUSION; APOPTOSIS; INHIBITION; EXPRESSION; ALPHA; SUPPRESSION; DYSFUNCTION	The Rho/Rho-kinase pathway plays an important role in many cardiovascular diseases such as hypertension, atherosclerosis, heart failure, and myocardial infarction. Although previous studies have shown that Rho-kinase inhibitors reduce ischemia/reperfusion (I/R) injury and cytokine production, the role of Rho-kinase in leukocytes during I/R injury is not well understood. Mice were subjected to 30-min ischemia and reperfusion. Rho-kinase activity was significantly greater in leukocytes subjected to myocardial I/R compared to the sham-operated mice. Administration of fasudil, a Rho-kinase inhibitor, significantly reduced the I/R-induced expression of the proinflammatory cytokines interleukin (IL)-6, C-C motif chemoattractant ligand 2 (CCL2), and tumor necrosis factor (TNF)-alpha, in leukocytes, compared with saline as the vehicle. Furthermore, fasudil decreased I/R-induced myocardial infarction/area at risk (IA) and I/R-induced leukocyte infiltration in the myocardium. Interestingly, IA in fasudil-administered mice with leukocyte depletion was similar to that in fasudil-administered mice. I/R also resulted in remarkable increases in the mRNA expression levels of the proinflammatory cytokines TNF-alpha, IL-6, and CCL2 in the heart. Inhibition of Rho-kinase activation in leukocytes has an important role in fasudil-induced cardioprotective effects. Hence, inhibition of Rho-kinase may be an additional therapeutic intervention for the treatment of acute coronary syndrome.	[Kitano, Katsunori; Usui, Soichiro; Ootsuji, Hiroshi; Takashima, Shin-ichiro; Kobayashi, Daisuke; Murai, Hisayoshi; Furusho, Hiroshi; Nomura, Ayano; Kaneko, Shuichi; Takamura, Masayuki] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan	Kanazawa University	Usui, S (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan.	usuiso@m-kanazawa.jp; skaneko@m-kanazawa.jp	USUI, Soichiro/GQH-4849-2022; FURUSHO, Hiroshi/L-3710-2015	FURUSHO, Hiroshi/0000-0002-8428-4615; Usui, Soichiro/0000-0003-1752-8082	Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-24591092, C-25461049, B-25860590]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (C-24591092 to SU, C-25461049 to MT), and a Grant-in-aid for Young Scientists (B-25860590 to HO) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, BLOOD, V107, P2004, DOI 10.1182/blood-2005-06-2345; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Bolger AP, 2002, AM J CARDIOL, V90, P384, DOI 10.1016/S0002-9149(02)02494-3; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Coxon A, 1999, J EXP MED, V190, P923, DOI 10.1084/jem.190.7.923; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Feske SK, 2009, BRAIN RES, V1257, P89, DOI 10.1016/j.brainres.2008.12.045; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Hamid SA, 2007, AM J PHYSIOL-HEART C, V292, pH2598, DOI 10.1152/ajpheart.01393.2006; Hasan Z, 2012, SHOCK, V37, P282, DOI 10.1097/SHK.0b013e3182426be4; Kikuchi Y, 2011, J AM COLL CARDIOL, V58, P1231, DOI 10.1016/j.jacc.2011.05.046; Kin H, 2006, J SURG RES, V135, P170, DOI 10.1016/j.jss.2006.02.019; Lawson CA, 1997, J CLIN INVEST, V99, P1729, DOI 10.1172/JCI119337; Liu YH, 2012, J VIROL, V86, P1372, DOI 10.1128/JVI.06245-11; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Nakayama M, 2008, ATHEROSCLEROSIS, V198, P426, DOI 10.1016/j.atherosclerosis.2007.09.006; Nohria A, 2006, CIRC RES, V99, P1426, DOI 10.1161/01.RES.0000251668.39526.c7; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Ohtani K, 2012, HYPERTENS RES, V35, P287, DOI 10.1038/hr.2011.183; Okamoto R, 2013, FASEB J, V27, P1439, DOI 10.1096/fj.12-217018; Ootsuji H, 2010, CIRC-CARDIOVASC GENE, V3, P68, DOI 10.1161/CIRCGENETICS.108.795484; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pfohl M, 1999, ATHEROSCLEROSIS, V142, P389, DOI 10.1016/S0021-9150(98)00242-1; Prasad A, 2009, CIRCULATION, V120, P2105, DOI 10.1161/CIRCULATIONAHA.108.814640; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; Shibata M, 1997, J INTERF CYTOK RES, V17, P145, DOI 10.1089/jir.1997.17.145; Shimokawa H, 2002, J CARDIOVASC PHARM, V40, P749; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Tousoulis D, 2007, INT J CARDIOL, V115, P203, DOI 10.1016/j.ijcard.2006.03.011; Usui S, 2011, CIRC RES, V109, P161, DOI 10.1161/CIRCRESAHA.110.238717; Venkatachalam K, 2009, J BIOL CHEM, V284, P7853, DOI 10.1074/jbc.M808824200; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093	38	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92242	10.1371/journal.pone.0092242	http://dx.doi.org/10.1371/journal.pone.0092242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638037	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100132
J	Owais, M; Kazmi, S; Tufail, S; Zubair, S				Owais, Mohammad; Kazmi, Shadab; Tufail, Saba; Zubair, Swaleha			An Alternative Chemical Redox Method for the Production of Bispecific Antibodies: Implication in Rapid Detection of Food Borne Pathogens	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODIES; LISTERIA-MONOCYTOGENES; MODEL; ERYTHROCYTES; PROTEINS; DISEASE; GHOSTS; BLOOD	Bi-functional antibodies with the ability to bind two unrelated epitopes have remarkable potential in diagnostic and biosensing applications. In the present study, bispecific antibodies that recognize human red blood cell (RBC) and the food borne pathogen Listeria monocytogenes (L. monocytogenes) were engineered. The procedure involves initial reduction of a mixture of anti-RBC and anti-Listeria antibodies followed by gradual re-oxidation of the reduced disulphides. This facilitates association of the separated antibody chains and formation of hybrid immunoglobulins with affinity for the L. monocytogenes and human RBC. The bispecific antibodies caused the agglutination of the RBCs only in the presence of L. monocytogenes cells. The agglutination process necessitated the specific presence of L. monocytogenes and the red colored clumps formed were readily visible with naked eyes. The RBC agglutination assay described here provides a remarkably simple approach for the rapid and highly specific screening of various pathogens in their biological niches.	[Owais, Mohammad; Kazmi, Shadab; Tufail, Saba] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Zubair, S (corresponding author), Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India.	swalehazubair@yahoo.com		Kazmi, Shadab/0000-0002-1860-0624; Mohammad, Owais/0000-0001-7377-7388	Indian Council of Agriculture Research [NF/PHT-3028/2012-13]	Indian Council of Agriculture Research	The financial assistance was provided by Indian Council of Agriculture Research (www.icar.nic.in) against project sanction (NF/PHT-3028/2012-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2004, CLIN INFECT DIS, V38, pS115, DOI 10.1086/381577; Banada Padmapriya P, 2008, PRINCIPLES BACTERIAL, VIII, P567; BHUNIA AK, 2006, SCI HOMELAND SECURIT, P109; BRATCHER RL, 1974, J IMMUNOL, V112, P1337; Carlring J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022533; [CDC Department of Health and Human Services], 2006, E COLI O; Chauhan A, 2011, INT J NANOMED, V6, P2305, DOI 10.2147/IJN.S23195; De Jonge J, 1998, J IMMUNOL, V161, P1454; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Gasanov U, 2005, FEMS MICROBIOL REV, V29, P851, DOI 10.1016/j.femsre.2004.12.002; Guttikonda Sujatha, 2004, J Pharm Pharm Sci, V7, P7; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hussack G, 2009, SENSORS-BASEL, V9, P5351, DOI 10.3390/s90705351; Iglesias BF, 2005, RES VET SCI, V79, P19, DOI 10.1016/j.rvsc.2004.10.004; Kendall PA, 2006, CLIN INFECT DIS, V42, P1298, DOI 10.1086/503262; Likhite Neah, 2011, J Biomol Tech, V22, P37; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Menard S, 1989, Int J Biol Markers, V4, P131; Mujahid S, 2007, ELECTROPHORESIS, V28, P3998, DOI 10.1002/elps.200600858; Muller S, 1998, INFECT IMMUN, V66, P3128; Ohk SH, 2010, J APPL MICROBIOL, V109, P808, DOI 10.1111/j.1365-2672.2010.04709.x; Orcutt KD, 2010, PROTEIN ENG DES SEL, V23, P221, DOI 10.1093/protein/gzp077; PORATH J, 1983, ARCH BIOCHEM BIOPHYS, V225, P543, DOI 10.1016/0003-9861(83)90065-6; Shen JQ, 2006, J BIOL CHEM, V281, P10706, DOI 10.1074/jbc.M513415200; SINGHAL A, 1986, BIOCHIM BIOPHYS ACTA, V880, P72, DOI 10.1016/0304-4165(86)90121-2; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Zhang JB, 2004, J MOL BIOL, V335, P49, DOI 10.1016/j.jmb.2003.09.034	29	10	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91255	10.1371/journal.pone.0091255	http://dx.doi.org/10.1371/journal.pone.0091255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637674	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100023
J	Attout, L; Fias, W; Salmon, E; Majerus, S				Attout, Lucie; Fias, Wim; Salmon, Eric; Majerus, Steve			Common Neural Substrates for Ordinal Representation in Short-Term Memory, Numerical and Alphabetical Cognition	PLOS ONE			English	Article							LEFT INTRAPARIETAL SULCUS; SERIAL-ORDER; WORKING-MEMORY; PARIETAL CIRCUITS; NEURONAL-ACTIVITY; MODEL; ATTENTION; ACTIVATION; MAGNITUDE; DISTANCE	The representation and maintenance of serial order information is one of the main functions of verbal short-term memory (STM) but its neural correlates remain poorly understood. We show here that the neural substrates allowing for coding of order information in STM are shared with those supporting ordinal processing in the numerical and alphabetical domains. We designed an fMRI experiment determining the neural substrates sensitive to ordinal distance effects in numerical judgment, alphabetical judgment and serial order STM tasks. Null conjunction analyses for parametric ordinal distance effects showed a common involvement of the horizontal segment of the left intraparietal sulcus over the three tasks; in addition, right intraparietal sulcus involvement was also observed for ordinal distance effects in the STM and numerical judgment tasks. These findings demonstrate that shared neural correlates in the intraparietal cortex support processing of order information in verbal STM, number and alphabetical domains, and suggest the existence of domain general, potentially ordinal, comparison processes supported by the left intraparietal sulcus.	[Attout, Lucie; Majerus, Steve] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium; [Fias, Wim] Univ Ghent, Dept Expt Psychol, Ghent, Belgium; [Salmon, Eric] Univ Liege, Cyclotron Res Ctr, Liege, Belgium	University of Liege; Ghent University; University of Liege	Attout, L (corresponding author), Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium.	Lucie.attout@ulg.ac.be	Fias, Wim/D-6861-2010; Salmon, Eric/AAE-4901-2020	Fias, Wim/0000-0002-5788-7306; Salmon, Eric/0000-0003-2520-9241; Majerus, Steve/0000-0002-8206-8097	Belgian National Fund for Scientific Research [F.R.S.-FNRS 1.5.056.10]; Belgian Inter-University Attraction Pole [P7/11]; University of Liege	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Belgian Inter-University Attraction Pole(Belgian Federal Science Policy Office); University of Liege(University of Liege)	This research was supported by the Belgian National Fund for Scientific Research (grant F.R.S.-FNRS 1.5.056.10), by a Belgian Inter-University Attraction Pole (P7/11) and by the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Andres M, 2005, COGNITIVE BRAIN RES, V25, P283, DOI 10.1016/j.cogbrainres.2005.06.002; Ansari D, 2007, NEURON, V53, P165, DOI 10.1016/j.neuron.2007.01.001; Ansari D, 2006, J COGNITIVE NEUROSCI, V18, P1820, DOI 10.1162/jocn.2006.18.11.1820; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Attout L, 2012, APHASIOLOGY, V26, P355, DOI 10.1080/02687038.2011.604303; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; Botvinick MM, 2006, PSYCHOL REV, V113, P201, DOI 10.1037/0033-295X.113.2.201; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Bugden S, 2012, DEV COGN NEUROS-NETH, V2, P448, DOI 10.1016/j.dcn.2012.04.001; Burgess N, 1999, PSYCHOL REV, V106, P551, DOI 10.1037/0033-295X.106.3.551; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Farrell S, 2002, PSYCHON B REV, V9, P59, DOI 10.3758/BF03196257; Fias W, 2007, J NEUROSCI, V27, P8952, DOI 10.1523/JNEUROSCI.2076-07.2007; Franklin MS, 2009, J COGNITIVE NEUROSCI, V21, P2114, DOI 10.1162/jocn.2008.21181; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Henson RNA, 1998, COGNITIVE PSYCHOL, V36, P73, DOI 10.1006/cogp.1998.0685; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Ischebeck A, 2008, HUM BRAIN MAPP, V29, P894, DOI 10.1002/hbm.20433; Jacob SN, 2008, TRENDS COGN SCI, V12, P41, DOI 10.1016/j.tics.2007.11.006; Jou J, 1999, J EXP PSYCHOL LEARN, V25, P680, DOI 10.1037/0278-7393.25.3.680; Kadosh RC, 2010, CEREB CORTEX, V20, P2166, DOI 10.1093/cercor/bhp273; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Kaufmann L, 2009, COGNITIVE DEV, V24, P486, DOI 10.1016/j.cogdev.2009.09.001; Knops A, 2014, NEUROIMAGE, V84, P786, DOI 10.1016/j.neuroimage.2013.09.037; LOVELACE EA, 1971, J EXP PSYCHOL, V88, P258, DOI 10.1037/h0030922; Majerus S, 2008, NEUROIMAGE, V42, P1698, DOI 10.1016/j.neuroimage.2008.06.003; Majerus S, 2007, NEUROIMAGE, V35, P353, DOI 10.1016/j.neuroimage.2006.12.008; Majerus S, 2006, NEUROIMAGE, V32, P880, DOI 10.1016/j.neuroimage.2006.03.048; Majerus S, 2012, CEREB CORTEX, V22, P1086, DOI 10.1093/cercor/bhr174; Majerus S, 2009, INTERACTIONS BETWEEN SHORT-TERM AND LONG-TERM MEMORY IN THE VERBAL DOMAIN, P244; Majerus S, 2010, J COGNITIVE NEUROSCI, V22, P2570, DOI 10.1162/jocn.2009.21378; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; Marshuetz C, 2006, NEUROSCIENCE, V139, P311, DOI 10.1016/j.neuroscience.2005.04.071; Marshuetz C, 2005, PSYCHOL BULL, V131, P323, DOI 10.1037/0033-2909.131.3.323; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Reynvoet B, 2009, J EXP CHILD PSYCHOL, V103, P480, DOI 10.1016/j.jecp.2009.01.007; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Szucs D, 2004, NEUROSCI LETT, V360, P65, DOI 10.1016/j.neulet.2004.02.038; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Turconi E, 2004, COGNITIVE BRAIN RES, V21, P22, DOI 10.1016/j.cogbrainres.2004.05.003; van Dijck JP, 2013, PSYCHOL SCI, V24, P1854, DOI 10.1177/0956797613479610; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Zorzi M, 2011, NEUROIMAGE, V56, P674, DOI 10.1016/j.neuroimage.2010.06.035	64	40	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92049	10.1371/journal.pone.0092049	http://dx.doi.org/10.1371/journal.pone.0092049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632823	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400134
J	Gil-Humanes, J; Piston, F; Barro, F; Rosell, CM				Gil-Humanes, Javier; Piston, Fernando; Barro, Francisco; Rosell, Cristina M.			The Shutdown of Celiac Disease-Related Gliadin Epitopes in Bread Wheat by RNAi Provides Flours with Increased Stability and Better Tolerance to Over-Mixing	PLOS ONE			English	Article							SDS-SEDIMENTATION TEST; PROTEIN FRACTIONS; TRANSGENIC WHEAT; GAMMA-GLIADINS; QUALITY; GLUTEN; DOUGH; INTERFERENCE; BREADMAKING; TEMPERATURE	Celiac disease is a food-sensitive enteropathy triggered by the ingestion of wheat gluten proteins and related proteins from barley, rye, and some varieties of oat. There are no interventional therapies and the only solution is a lifelong gluten-free diet. The down-regulation of gliadins by RNAi provides wheat lines with all the gliadin fractions strongly down-regulated (low-gliadin). The technological properties of doughs prepared from the low-gliadin lines indicated a general weakening effect, although some of the lines displayed similar properties to that of the wild-type lines. In contrast, the stability was increased significantly in some of the transgenic lines, indicating better tolerance to over-mixing. Results reported here are the first analyses of the mixing and bread-making quality of the wheat lines with all gliadin fractions strongly down-regulated. Flour from these lines may be an important breakthrough in the development of new products for the celiac community. These lines might be used directly or blended with other non-toxic cereals, as raw material for developing food products that can be safely tolerated by CD patients and others with gluten intolerance or gluten sensitivity, incrementing the range of available food products and enhancing their diet.	[Gil-Humanes, Javier; Piston, Fernando; Barro, Francisco] CSIC, Inst Agr Sostenible, Cordoba, Spain; [Rosell, Cristina M.] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Gil-Humanes, J (corresponding author), CSIC, Inst Agr Sostenible, Cordoba, Spain.	javigil@ias.csic.es	Piston, Fernando/AAD-6975-2020; Gil-Humanes, Javier/AAU-4381-2020; Barro, Francisco/E-8572-2017; Rosell, Cristina M/F-4888-2010; Barro, Francisco/J-3254-2014	Barro, Francisco/0000-0002-7652-229X; Rosell, Cristina M/0000-0001-7197-5874; Gil Humanes, Javier/0000-0002-7283-6945	Spanish Ministry of Economy and Competitiveness [AGL2010-19643-C02-02]; European Regional Development Fund (FEDER); Junta de Andalucia [P09AGR-4783]; Generalitat Valenciana [Prometeo 2012/064]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	The Spanish Ministry of Economy and Competitiveness (Project AGL2010-19643-C02-02), the European Regional Development Fund (FEDER), and Junta de Andalucia (Project P09AGR-4783) supported this work. Authors also acknowledge the financial support of Generalitat Valenciana (Project Prometeo 2012/064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; AYOUB M, 1993, CAN J PLANT SCI, V73, P995, DOI 10.4141/cjps93-130; BRANLARD G, 1985, J CEREAL SCI, V3, P329, DOI 10.1016/S0733-5210(85)80006-0; Carter BP, 1999, CEREAL CHEM, V76, P907, DOI 10.1094/CCHEM.1999.76.6.907; Cato L, 2008, FOOD AUST, V60, P577; Codina GG, 2010, CZECH J FOOD SCI, V28, P185, DOI 10.17221/169/2008-CJFS; Collar C, 2003, EUR FOOD RES TECHNOL, V216, P505, DOI 10.1007/s00217-003-0686-3; Collar C, 2013, MIXOLAB NEW APPROACH, P23; Cornish GB, 2001, AUST J AGR RES, V52, P1339, DOI 10.1071/AR01060; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; ECKERT B, 1993, Z LEBENSM UNTERS FOR, V196, P122, DOI 10.1007/BF01185570; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; Gil-Humanes J, 2011, J EXP BOT IN PRESS; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; Gil-Humanes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045937; Gil-Humanes J, 2012, J CEREAL SCI, V56, P161, DOI 10.1016/j.jcs.2012.02.009; Gil-Humanes J, 2011, J EXP BOT, V62, P4203, DOI 10.1093/jxb/err119; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; Gras PW, 2000, J CEREAL SCI, V31, P1, DOI 10.1006/jcrs.1999.0293; ICC, 1994, 1231 ICC INT ASS CER, V123/1; ICC, 1994, 1052 ICC INT ASS CER, V105/2; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kasarda D.D., 1989, WHEAT UNIQUE, V277, P302; Khatkar BS, 2002, J CEREAL SCI, V35, P299, DOI 10.1006/jcrs.2001.0429; Koksel H, 2009, CEREAL CHEM, V86, P522, DOI 10.1094/CCHEM-86-5-0522; LORENZO A, 1987, CROP SCI, V27, P247, DOI 10.2135/cropsci1987.0011183X002700020025x; MACRITCHIE F, 1987, J CEREAL SCI, V6, P259, DOI 10.1016/S0733-5210(87)80063-2; MacRitchie F., 1992, Advances in Food and Nutrition Research, V36, P1, DOI 10.1016/S1043-4526(08)60104-7; MACRITCHIE F, 1991, CEREAL CHEM, V68, P122; METAKOVSKY EV, 1990, AUST J AGR RES, V41, P289, DOI 10.1071/AR9900289; Molberg O, 2003, GASTROENTEROLOGY, V125, P337, DOI 10.1016/S0016-5085(03)00890-4; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Piston F, 2011, PLOS ONE, V6; Piston F, 2008, EUPHYTICA, V162, P371, DOI 10.1007/s10681-007-9530-3; Piston F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-136; Piston F, 2009, MOL BREEDING, V23, P655, DOI 10.1007/s11032-009-9263-1; Rojas JA, 1999, FOOD HYDROCOLLOID, V13, P27, DOI 10.1016/S0268-005X(98)00066-6; Rosell CM, 2007, FOOD HYDROCOLLOID, V21, P452, DOI 10.1016/j.foodhyd.2006.05.004; Rosell CM, 2013, CEREAL CHEM, V90, P89, DOI 10.1094/CCHEM-05-12-0056-R; Rosell CM, 2010, EUR FOOD RES TECHNOL, V231, P535, DOI 10.1007/s00217-010-1310-y; Rosell CM, 2009, INT J FOOD SCI TECH, V44, P493, DOI 10.1111/j.1365-2621.2008.01758.x; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Trier JS, 1998, GASTROENTEROLOGY, V115, P211, DOI 10.1016/S0016-5085(98)70383-X; van Herpen TWJM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-1; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; West J, 2003, GASTROENTEROLOGY, V125, P429, DOI 10.1016/S0016-5085(03)00891-6; Wieser H, 2008, CEREAL CHEM, V85, P1, DOI 10.1094/CCHEM-85-1-0001; Williams R, 1988, TECHNICAL MANUAL, V4; Xie LH, 2011, CEREAL CHEM, V88, P333, DOI 10.1094/CCHEM-06-10-0090	56	53	54	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91931	10.1371/journal.pone.0091931	http://dx.doi.org/10.1371/journal.pone.0091931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633046	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400122
J	Jin, H; Liang, Q; Chen, TS; Wang, XP				Jin, Hua; Liang, Qian; Chen, Tongsheng; Wang, Xiaoping			Resveratrol Protects Chondrocytes from Apoptosis via Altering the Ultrastructural and Biomechanical Properties: An AFM Study	PLOS ONE			English	Article							OXIDE-INDUCED APOPTOSIS; NITRIC-OXIDE; ARTICULAR CHONDROCYTES; ELASTIC PROPERTIES; KINASE; DEDIFFERENTIATION; INHIBITION; CARTILAGE; SURFACE; DIFFERENTIATION	Osteoarthritis (OA), a degenerative joint disease with high prevalence among older people, occurs from molecular or nanometer level and extends gradually to higher degrees of the ultrastructure of cartilage, finally resulting in irreversible structural and functional damages. This report aims to use atomic force microscopy (AFM) to investigate the protective effects of resveratrol (RV), a drug with good anti-inflammatory properties, on cellular morphology, membrane architecture, cytoskeleton, cell surface adhesion and stiffness at nanometer level in sodium nitroprusside (SNP)-induced apoptotic chondrocytes, a typical cellular OA model. CCK-8 assay showed that 100 mu M RV significantly prevented SNP-induced cytotoxicity. AFM imaging and quantitative analysis showed that SNP potently induced chondrocytes changes including shrunk, round, lamellipodia contraction and decrease in adherent junctions among cells, as well as the destruction of biomechanics: 90% decrease in elasticity and 30% decrease in adhesion. In addition, confocal imaging analysis showed that SNP induced aggregation of the cytoskeleton and decrease in the expression of cytoskeletal proteins. More importantly, these SNP-induced damages to chondrocytes could be potently prevented by RV pretreatment. Interestingly, the biomechanical changes occurred before morphological changes could be clearly observed during SNP-induced apoptosis, indicating that the biomechanics of cellular membrane may be a more robust indicator of cell function. Collectively, our data demonstrate that RV prevents SNP-induced apoptosis of chondrocytes by regulating actin organization, and that AFM-based technology can be developed into a powerful and sensitive method to study the interaction mechanisms between chondrocytes and drugs.	[Jin, Hua; Liang, Qian; Wang, Xiaoping] Jinan Univ, Affiliated Hosp 1, Dept Pain Management, Guangzhou, Guangdong, Peoples R China; [Chen, Tongsheng] S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Chen, Tongsheng] S China Normal Univ, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China	Jinan University; South China Normal University; South China Normal University	Wang, XP (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Pain Management, Guangzhou, Guangdong, Peoples R China.	txp2938@jnu.edu.cn		jin, Hua/0000-0001-5478-4611	National Natural Science Foundation of China [81071491, 61178078]; Department of Education and Finance of Guangdong Province [cxzd115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education and Finance of Guangdong Province	This work was supported by the National Natural Science Foundation of China (Grant No. 81071491 and 61178078), and Key Project of the Department of Education and Finance of Guangdong Province (cxzd115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Cai XF, 2010, J PHYS CHEM B, V114, P3833, DOI 10.1021/jp910682q; Capella B, 1997, IEEE ENG MED BIOL, V16, P58, DOI 10.1109/51.582177; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dave M, 2008, ARTHRITIS RHEUM, V58, P2786, DOI 10.1002/art.23799; de Andres MC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4295; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Del Carlo Marcello Jr, 2008, Curr Rheumatol Rep, V10, P37; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Eo SH, 2013, BIOMOL THER, V21, P364, DOI 10.4062/biomolther.2013.029; Geiger B, 2001, SCIENCE, V294, P1661, DOI 10.1126/science.1066919; Girasole M, 2007, BBA-BIOMEMBRANES, V1768, P1268, DOI 10.1016/j.bbamem.2007.01.014; Hsieh CH, 2008, OSTEOARTHR CARTILAGE, V16, P480, DOI 10.1016/j.joca.2007.08.004; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/nnano.2009.77, 10.1038/NNANO.2009.77]; Kim JS, 2005, CELL DEATH DIFFER, V12, P201, DOI 10.1038/sj.cdd.4401511; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kim SJ, 2003, J BIOL CHEM, V278, P42448, DOI 10.1074/jbc.M304887200; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kim SJ, 2002, J BIOL CHEM, V277, P30375, DOI 10.1074/jbc.M205193200; Laney DE, 1997, BIOPHYS J, V72, P806, DOI 10.1016/S0006-3495(97)78714-9; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Liang XM, 2004, COLLOID SURFACE B, V34, P41, DOI 10.1016/j.colsurfb.2003.10.017; Lim Teck Chwee, 2005, ASIA PACIFIC BIOTECH, V09, P674; Liu FC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3127; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nakagawa S, 2010, J ORTHOP RES, V28, P156, DOI 10.1002/jor.20976; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Radmacher M, 2002, METHOD CELL BIOL, V68, P67; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Tonomura H, 2006, OSTEOARTHR CARTILAGE, V14, P545, DOI 10.1016/j.joca.2005.12.008; Wadsworth TL, 1999, BIOCHEM PHARMACOL, V57, P941, DOI 10.1016/S0006-2952(99)00002-7; Wu GJ, 2007, J CELL BIOCHEM, V101, P1520, DOI 10.1002/jcb.21268; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764; Yoon JB, 2003, J BIOL CHEM, V278, P15319, DOI 10.1074/jbc.M212520200; Zhuang CP, 2013, J INNOV OPT HEAL SCI, V6, DOI 10.1142/S1793545813500223	41	23	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91611	10.1371/journal.pone.0091611	http://dx.doi.org/10.1371/journal.pone.0091611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632762	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400073
J	Yano, CF; Poltronieri, J; Bertollo, LAC; Artoni, RF; Liehr, T; Cioffi, MD				Yano, Cassia Fernanda; Poltronieri, Juliana; Carlos Bertollo, Luiz Antonio; Artoni, Roberto Ferreira; Liehr, Thomas; Cioffi, Marcelo de Bello			Chromosomal Mapping of Repetitive DNAs in Triportheus trifurcatus (Characidae, Characiformes): Insights into the Differentiation of the Z and W Chromosomes	PLOS ONE			English	Article							FISH HOPLIAS-MALABARICUS; SEX-CHROMOSOMES; SYSTEM; ZZ/ZW; EVOLUTION; HETEROCHROMATIN; GENETICS; PISCES	Repetitive DNA sequences play an important role in the structural and functional organization of chromosomes, especially in sex chromosome differentiation. The genus Triportheus represents an interesting model for such studies because all of its species analyzed so far contain a ZZ/ZW sex chromosome system. A close relationship has been found between the differentiation of the W chromosome and heterochromatinization, with the involvement of different types of repetitive DNA in this process. This study investigated several aspects of this association in the W chromosome of Triportheus trifurcatus (2n = 52 chromosomes), including the cytogenetic mapping of repetitive DNAs such as telomeric sequences (TTAGGG)n, microsatellites and retrotransposons. A remarkable heterochromatic segment on the W chromosome was observed with a preferential accumulation of (CAC)(10), (CAG)(10), (CGG)(10), (GAA)(10) and (TA)(15). The retrotransposons Rex1 and Rex3 showed a general distribution pattern in the chromosomes, and Rex6 showed a different distribution on the W chromosome. The telomeric repeat (TTAGGG) n was highly evident in both telomeres of all chromosomes without the occurrence of ITS. Thus, the differentiation of the W chromosome of T. trifurcatus is clearly associated with the formation of heterochromatin and different types of repetitive DNA, suggesting that these elements had a prominent role in this evolutionary process.	[Yano, Cassia Fernanda; Poltronieri, Juliana; Carlos Bertollo, Luiz Antonio; Cioffi, Marcelo de Bello] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Artoni, Roberto Ferreira] Univ Jena, Jena Univ Hosp, Inst Human Genet, Jena, Thuringen, Germany; [Liehr, Thomas] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, PR, Brazil	Universidade Federal de Sao Carlos; Friedrich Schiller University of Jena; Universidade Estadual de Ponta Grossa	Cioffi, MD (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil.	mbcioffi@ufscar.br	Cioffi, Marcelo/AAG-4675-2022; Artoni, Roberto Ferreira/N-1693-2019; Artoni, Roberto F/H-6651-2013; Cioffi, Marcelo/AFK-6402-2022; Liehr, Thomas/H-2852-2019	Cioffi, Marcelo/0000-0003-4340-1464; Artoni, Roberto Ferreira/0000-0002-2528-9846; Artoni, Roberto F/0000-0002-2528-9846; Cioffi, Marcelo/0000-0003-4340-1464; Liehr, Thomas/0000-0003-1672-3054; Yano, Cassia Fernanda/0000-0002-8118-2867	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian agencies CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artoni RF, 2002, HEREDITY, V89, P15, DOI 10.1038/sj.hdy.6800081; Artoni RF, 2001, CHROMOSOME RES, V9, P449, DOI 10.1023/A:1011620226348; Bellafronte E, 2012, GENET MOL BIOL, V35, P770, DOI 10.1590/S1415-47572012005000077; BERTOLLO L A C, 1978, Revista Brasileira de Genetica, V1, P103; BERTOLLO LAC, 1992, CYTOGENET CELL GENET, V60, P60, DOI 10.1159/000133296; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; Cioffi MB, 2012, J FISH BIOL, V80, P2125, DOI 10.1111/j.1095-8649.2012.03272.x; Cioffi MB, 2011, CYTOGENET GENOME RES, V132, P188, DOI 10.1159/000321571; Cioffi MB, 2009, CYTOGENET GENOME RES, V125, P132, DOI 10.1159/000227838; Cioffi MD, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-28; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Diniz D, 2008, CYTOGENET GENOME RES, V122, P163, DOI 10.1159/000163094; Diniz D, 2008, GENETICA, V133, P85, DOI 10.1007/s10709-007-9187-9; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Ezaz T, 2009, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; Falcao JN, 1988, THESIS U SAO PAULO R; FELDBERG E, 1987, GENOME, V29, P1, DOI 10.1139/g87-001; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Malabarba Maria Claudia S. L., 2004, Neotrop. ichthyol., V2, P167, DOI 10.1590/S1679-62252004000400001; Marquioni V, 2013, MICRON, V45, P129, DOI 10.1016/j.micron.2012.11.008; Nirchio M, 2007, GENET MOL BIOL, V30, P25, DOI 10.1590/S1415-47572007000100007; Ohno S., 1967, SEX CHROMOSOMES SEX; Oliveira C, 2009, FISH PHYSIOL BIOCHEM, V35, P81, DOI 10.1007/s10695-008-9250-1; Pokorna M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-90; Poltronieri J, 2014, CYTOGENET GENOME RES, V142, P40, DOI 10.1159/000355908; Sanchez Sebastian, 1999, Cytologia (Tokyo), V64, P395; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Silva DS, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-74; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Vallender EJ, 2004, BIOESSAYS, V26, P159, DOI 10.1002/bies.10393; Venere PC, 2004, GENETICA, V121, P75, DOI 10.1023/B:GENE.0000019936.40970.7a; Volff JN, 1999, MOL BIOL EVOL, V16, P1427, DOI 10.1093/oxfordjournals.molbev.a026055	38	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90946	10.1371/journal.pone.0090946	http://dx.doi.org/10.1371/journal.pone.0090946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632562	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400026
J	Kimura, T; Watanabe, E; Sakamoto, T; Takasu, O; Ikeda, T; Ikeda, K; Kotani, J; Kitamura, N; Sadahiro, T; Tateishi, Y; Shinozaki, K; Oda, S				Kimura, Tomonori; Watanabe, Eizo; Sakamoto, Teruo; Takasu, Osamu; Ikeda, Toshiaki; Ikeda, Kazumi; Kotani, Joji; Kitamura, Nobuya; Sadahiro, Tomohito; Tateishi, Yoshihisa; Shinozaki, Koichiro; Oda, Shigeto			Autophagy-Related IRGM Polymorphism Is Associated with Mortality of Patients with Severe Sepsis	PLOS ONE			English	Article							CROHNS-DISEASE; ORGAN FAILURE; CRITICAL ILLNESS; CELL-DEATH; SOFA SCORE; MULTIPLE; MECHANISMS; IMMUNOSUPPRESSION; SUSCEPTIBILITY; DEFINITIONS	Objective Autophagy is the regulated catabolic process for recycling damaged or unnecessary organelles, which plays crucial roles in cell survival during nutrient deficiency, and innate immune defense against pathogenic microorganisms. Autophagy has been also reported to be involved in various conditions including inflammatory diseases. IRGM (human immunity-related GTPase) has an important function in eliminating Mycobacterium tuberculosis from host cells via autophagy. We examined the association between genetic polymorphism and clinical course/outcome in severely septic patients. Methods: The study included 125 patients with severe sepsis/septic shock (SS) and 104 non-sepsis patients who were admitted to the intensive care unit (ICU) of Chiba University Hospital between October 2001 and September 2008 (discovery cohort) and 268 SS patients and 454 non-sepsis patients who were admitted to ICUs of five Japanese institutions including Chiba University Hospital between October 2008 and September 2012 (multi-center validation cohort). Three hundred forty seven healthy volunteers who consented to this study were also included. Genotyping was performed for a single-nucleotide polymorphism (SNP) within the coding region of IRGM, IRGM(+313) (rs10065172). Lipopolysaccharide challenge of whole blood from randomly selected healthy volunteers (n = 70) was performed for comparison of IRGM mRNA expression among different genotypes. Results: No significant difference in genotypic distributions (CC/CT/TT) at the IRGM(+313) locus was observed among the three subject groups (SS, non-sepsis, and healthy volunteers) in either cohort. When mortality were compared, no significant difference was observed in the non-sepsis group, while TT homozygotes exhibited a significantly higher mortality than the CC+CT genotype category in the SS group for both cohorts (P = 0.043, 0.037). Lipopolysaccharide challenge to whole blood showed a significant suppression of IRGM mRNA expression in TT compared with the CC+CT genotype category (P = 0.019). Conclusions: The data suggest that the IRGM(+313), an autophagy-related polymorphic locus, influences outcome in severely septic patients, with the possible involvement of autophagy in sepsis exacerbation.	[Kimura, Tomonori; Watanabe, Eizo; Sadahiro, Tomohito; Tateishi, Yoshihisa; Shinozaki, Koichiro; Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chu Ku, Chiba, Japan; [Sakamoto, Teruo; Takasu, Osamu] Kurume Univ, Sch Med, Dept Emergency & Crit Care Med, Kurume, Fukuoka 830, Japan; [Ikeda, Toshiaki; Ikeda, Kazumi] Tokyo Med Univ, Hachioji Med Ctr, Div Crit Care & Emergency Med, Hachioji, Tokyo, Japan; [Kotani, Joji] Hyogo Coll Med, Dept Emergency Disaster & Crit Care Med, Nishinomiya, Hyogo 6638501, Japan; [Kitamura, Nobuya] Kimitsu Chuo Hosp, Dept Emergency & Crit Care Med, Kisarazu City, Chiba, Japan	Chiba University; Kurume University; Tokyo Medical University; Hyogo College of Medicine	Watanabe, E (corresponding author), Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chu Ku, 1-8-1 Inohana, Chiba, Japan.	watanabee@faculty.chiba-u.jp	Watanabe, Eizo/AAO-4780-2021	Watanabe, Eizo/0000-0001-6731-909X	Ministry of Education, Culture, Sports Science, and Technology, Japan [23792070]; ZENKYOREN	Ministry of Education, Culture, Sports Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ZENKYOREN	This work was supported by the Grants-in-Aid for Young Scientists (B) of Grants-in-Aid for Scientific Research (#23792070) from the Ministry of Education, Culture, Sports Science, and Technology, Japan (TK). This work was also supported by ZENKYOREN (EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21; Frazier WJ, 2008, PEDIATR CLIN N AM, V55, P647, DOI 10.1016/j.pcl.2008.02.009; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hsieh CH, 2011, ANN SURG, V253, P1190, DOI 10.1097/SLA.0b013e318214b67e; Hsieh YC, 2009, TRENDS MOL MED, V15, P129, DOI 10.1016/j.molmed.2009.01.002; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 2013, IMMUNITY, V39, P799, DOI 10.1016/j.immuni.2013.10.012; Oda S, 2000, INTENS CARE MED, V26, P1786, DOI 10.1007/s001340000710; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Silva E, 2012, MINERVA ANESTESIOL, V78, P1215; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Takahashi W, 2013, CRIT CARE, V17, DOI 10.1186/cc12839; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; Vanhorebeek I, 2011, J CLIN ENDOCR METAB, V96, pE633, DOI 10.1210/jc.2010-2563; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	35	40	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91522	10.1371/journal.pone.0091522	http://dx.doi.org/10.1371/journal.pone.0091522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626347	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300098
J	Ding, PJ; Yang, Y; Cheng, LY; Zhang, XJ; Cheng, LM; Li, CZ; Cai, JH				Ding, Peijian; Yang, Yang; Cheng, Luyang; Zhang, Xuejun; Cheng, Limin; Li, Caizhen; Cai, Jianhui			The Relationship between Seven Common Polymorphisms from Five DNA Repair Genes and the Risk for Breast Cancer in Northern Chinese Women	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; ANGIOTENSIN-ALDOSTERONE SYSTEM; HAN CHINESE; XRCC1 GENE; ASSOCIATION; METAANALYSIS; EPISTASIS; SUSCEPTIBILITY; HYPERTENSION; POPULATION	Background: Converging evidence supports the central role of DNA damage in progression to breast cancer. We therefore in this study aimed to assess the potential interactions of seven common polymorphisms from five DNA repair genes (XRCC1, XRCC2, XRCC3, XPA and APEX1) in association with breast cancer among Han Chinese women. Methodology/Principal Findings: This was a case-control study involving 606 patients diagnosed with sporadic breast cancer and 633 age-and ethnicity-matched cancer-free controls. The polymerase chain reaction - ligase detection reaction method was used to determine genotypes. All seven polymorphisms were in accordance with Hardy-Weinberg equilibrium in controls. Differences in the genotypes and alleles of XRCC1 gene rs25487 and XPA gene rs1800975 were statistically significant between patients and controls, even after the Bonferroni correction (P<0.05/7). Accordingly, the risk for breast cancer was remarkably increased for rs25487 (OR = 1.28; 95% CI: 1.07-1.51; P = 0.006), but decreased for rs1800975 (OR = 0.77; 95% CI: 0.67-0.90; P = 0.001) under an additive model at a Bonferroni corrected alpha of 0.05/7. Allele combination analysis showed higher frequencies of the most common combination C-G-G-C-G-G-G (alleles in order of rs1799782, rs25487, rs3218536, rs861539, rs1800975, rs1760944 and rs1130409) in controls than in patients (P-Sim = 0.002). In further interaction analysis, two-locus model including rs1800975 and rs25487 was deemed as the overall best model with the maximal testing accuracy of 0.654 and the cross-validation consistency of 10 out of 10 (P = 0.001). Conclusion: Our findings provide clear evidence that XRCC1 gene rs25487 and XPA gene rs1800975 might exert both independent and interactive effects on the development of breast cancer among northern Chinese women.	[Ding, Peijian; Cai, Jianhui] Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China; [Ding, Peijian; Cai, Jianhui] Hebei Gen Hosp, Dept Surg, Shijiazhuang, Hebei, Peoples R China; [Ding, Peijian; Cai, Jianhui] Hebei Gen Hosp, Dept Oncol & Immunotherapy, Shijiazhuang, Hebei, Peoples R China; [Ding, Peijian; Yang, Yang; Cheng, Luyang; Zhang, Xuejun; Cheng, Limin] Chengde Med Coll, Affiliated Hosp, Dept Surg, Chengde, Hebei, Peoples R China; [Li, Caizhen] Hebei Eracon Biotech Co Ltd, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Chengde Medical University	Cai, JH (corresponding author), Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China.	jianhuicai2001@163.com			Nature Science Foundation of Hebei Province [C20100118]	Nature Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was financially supported by the Nature Science Foundation of Hebei Province (Grant No. C20100118). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mutairi FM, 2013, ASIAN PAC J CANCER P, V14, P3809, DOI 10.7314/APJCP.2013.14.6.3809; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Gage M, 2012, J SURG ONCOL, V105, P444, DOI 10.1002/jso.21856; Gu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037970; Gui JA, 2010, HUM HERED, V70, P219, DOI 10.1159/000319175; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han W, 2012, CANCER-AM CANCER SOC, V118, P594, DOI 10.1002/cncr.26220; Holmberg E, 2001, BRIT J CANCER, V85, P362, DOI 10.1054/bjoc.2001.1868; Lin WY, 2011, J MED GENET, V48, P477, DOI 10.1136/jmedgenet-2011-100018; Loizidou MA, 2008, BREAST CANCER RES TR, V112, P575, DOI 10.1007/s10549-007-9881-4; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Niu WQ, 2012, MOL CELL ENDOCRINOL, V358, P9, DOI 10.1016/j.mce.2012.02.010; Niu WQ, 2010, CLIN CHIM ACTA, V411, P1491, DOI 10.1016/j.cca.2010.06.004; Niu WQ, 2009, J HYPERTENS, V27, P1384, DOI 10.1097/HJH.0b013e32832b7e0d; Parshad R, 1996, BRIT J CANCER, V74, P1, DOI 10.1038/bjc.1996.307; Pasche Boris, 2008, V141, P1; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Przybylowska-Sygut K, 2013, CLIN BREAST CANCER, V13, P61, DOI 10.1016/j.clbc.2012.09.019; Qi Y, 2008, EUR J EPIDEMIOL, V23, P143, DOI 10.1007/s10654-007-9208-0; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Sangrajrang S, 2008, BREAST CANCER RES TR, V111, P279, DOI 10.1007/s10549-007-9773-7; Sangrajrang S, 2007, BIOMARKERS, V12, P523, DOI 10.1080/13547500701395602; Webb PM, 2005, CANCER EPIDEM BIOMAR, V14, P319, DOI 10.1158/1055-9965.EPI-04-0335; Wu KS, 2011, ASIAN PAC J CANCER P, V12, P2237; Zhou B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-521	28	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92083	10.1371/journal.pone.0092083	http://dx.doi.org/10.1371/journal.pone.0092083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642895	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900080
J	Liu, TG; Sha, KH; Yang, LH; Wang, Y; Zhang, LG; Liu, XX; Yang, F				Liu, Tonggang; Sha, Kaihui; Yang, Luhua; Wang, Yun; Zhang, Liguo; Liu, Xianxian; Yang, Fang			IL-28B Polymorphisms Correlated with Treatment Response in HCV-4 Mono-Infected Patients: A Meta-Analysis	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; PLUS RIBAVIRIN TREATMENT; GENOTYPE 4; PEGYLATED INTERFERON; IL28B POLYMORPHISM; GENETIC-VARIATION; PREDICT RESPONSE; VIRAL CLEARANCE; THERAPY	Background: The role of interleukin 28B (IL-28B) polymorphisms played in hepatitis C virus (HCV) infection has been gradually explicit, especially in HCV genotype 1, 2 and 3. However, no confirmative conclusion was acquired in genotype 4 HCV patients. Thus we conducted this meta-analysis. Methods: We searched the commonly used databases both in English and Chinese. Meta-analysis was performed in fixed/random effects models using STATA 12.0 or R software. Publication bias was examined through Egger's test and Begg's funnel plot. Results: In total, 11 studies were included in this meta-analysis, encompassing 1284 patients who were mono-infected with HCV-4 and received Peg-interferon (Peg-IFN) plus Ribavirin (Rbv). Around 53.0% patients would achieve sustained virologic response (SVR), 36.6% achieve rapid virologic response (RVR) and 62.4% achieve end of treatment response (ETR). Egyptian patients had a higher rate achieving SVR than non-Egyptian patients (56.3% vs. 47.8%). IL-28B rs12979860 CC genotype not only favored SVR (OR = 3.95, 95% CI = 3.03-5.16), regardless of citizenship, but also favored RVR (OR = 3.82, 95% CI = 2.46-5.95) and ETR (OR = 4.22, 95% CI = 2.81-6.34). IL-28B rs8099917 genotype TT also correlated with SVR (OR = 3.41, 95% CI = 1.92-6.07), but might not with RVR. IL-28B rs12980275 might still correlate with SVR, but warrant more studies to validate. Conclusions: The favorable IL-28B rs12979860 genotype is a statistically significant predictor of SVR, RVR and ETR in HCV-4 monoinfected patients treated with Peg-IFN plus Rbv. Rs8099917 might predict SVR but not RVR. Egyptian HCV-4 patients would achieve better outcomes than non-Egyptian patients when treated with standard care.	[Liu, Tonggang; Yang, Luhua; Wang, Yun; Zhang, Liguo; Liu, Xianxian; Yang, Fang] Binzhou Med Univ Hosp, Dept Infect Dis, Binzhou, Shandong, Peoples R China; [Sha, Kaihui] Binzhou Med Univ, Sch Nursing, Binzhou, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University	Liu, TG (corresponding author), Binzhou Med Univ Hosp, Dept Infect Dis, Binzhou, Shandong, Peoples R China.	tonggang_liu@163.com						Abdo AA, 2013, HEPATOL INT, V7, P533, DOI 10.1007/s12072-013-9421-8; Angelico M, 1997, J HEPATOL, V26, P236, DOI 10.1016/S0168-8278(97)80036-0; Antaki N, 2013, J VIRAL HEPATITIS, V20, P59, DOI 10.1111/j.1365-2893.2012.01621.x; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Bortolotti F, 2007, J HEPATOL, V46, P783, DOI 10.1016/j.jhep.2006.12.014; De Nicola S, 2012, HEPATOLOGY, V55, P336, DOI 10.1002/hep.24683; Derbala M, 2013, VIROLOGY, V444, P292, DOI 10.1016/j.virol.2013.06.025; Derbala M, 2012, WORLD J GASTROENTERO, V18, P7003, DOI 10.3748/wjg.v18.i47.7003; El Awady MK, 2013, WORLD J GASTROENTERO, V19, P290, DOI 10.3748/wjg.v19.i2.290; El-Awady MK, 2012, HEPAT MON, V12, P271, DOI 10.5812/hepatmon.835; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Mira JA, 2012, AIDS, V26, P1721, DOI 10.1097/QAD.0b013e3283568884; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Neukam K, 2013, AIDS; Rangnekar AS, 2013, J VIRAL HEPATITIS, V20, P377, DOI 10.1111/jvh.12039; Rangnekar AS, 2012, ALIMENT PHARM THER, V36, P104, DOI 10.1111/j.1365-2036.2012.05145.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Rizk NM, 2013, CLIN RES HEPATOL GAS, V37, P262, DOI 10.1016/j.clinre.2012.09.012; Roulot D, 2007, J VIRAL HEPATITIS, V14, P460, DOI 10.1111/j.1365-2893.2006.00823.x; Shaker OG, 2013, J PEDIATR GASTR NUTR, V57, P155, DOI 10.1097/MPG.0b013e31828febf0; Shaker OG, 2012, J GASTROEN HEPATOL, V27, P1842, DOI 10.1111/j.1440-1746.2012.07273.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Yahia M, 2011, NATURE, V474, pS12, DOI 10.1038/474S12a; Youssef SS, 2013, J INTERFERON CYTOKIN	37	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91316	10.1371/journal.pone.0091316	http://dx.doi.org/10.1371/journal.pone.0091316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642705	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900017
J	Murtagh, N; Gatersleben, B; Uzzell, D				Murtagh, Niamh; Gatersleben, Birgitta; Uzzell, David			20:60:20-Differences in Energy Behaviour and Conservation between and within Households with Electricity Monitors	PLOS ONE			English	Article							FEEDBACK; CONSUMPTION; LABOR	The introduction of electricity monitors (in-home displays; IHDs), which show accurate and up-to-the-minute energy usage, is expected to lead to reduction in consumption. Studies of feedback on domestic electricity use have generally supported this view. However, such studies also demonstrate wide variation between households. Examining the heterogeneity of responses is essential for understanding the actual and potential effectiveness of IHDs and in order to target interventions effectively. To explore differences between households' responses to IHDs, we conducted a qualitative study with 21 households who had an IHD for more than six months. Of the 21, only four households continued to refer to the IHD and the findings suggest that attempts to reduce energy consumption were situated in wider social and physical contexts. Further, the participants demonstrated energy saving behaviour before and outside of IHD usage. The patterns of energy behaviours and attempts at electricity conservation could best be understood by categorising the households into three types: the Monitor Enthusiasts (20%), the Aspiring Energy Savers (60%) and the Energy Non-Engaged (20%). The factors of importance in energy behaviour differed between the categories. Financial savings contributed to efforts to reduce energy use but only up to boundaries which varied considerably between households. Social practices and social relationships appeared to constrain what actions households were prepared to undertake, illuminating aspects of inter-household variation. Within the household, all energy users were not equal and we found that women were particularly influential on energy use through their primary responsibility for domestic labour on behalf of the household. The implications of the findings for environmental campaigning are discussed.	[Murtagh, Niamh; Gatersleben, Birgitta; Uzzell, David] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England	University of Surrey	Murtagh, N (corresponding author), UCL Bartlett Sch Construct & Project Management, London, England.	n.murtagh@ucl.ac.uk	Uzzell, David/G-4097-2011; Gatersleben, Birgitta/AAV-5158-2021	Uzzell, David/0000-0001-7590-0079; Gatersleben, Birgitta/0000-0002-5841-0577	Digital Economy Programme of the Research Councils UK, a cross-council initiative led by EPSRC; AHRC under the REDUCE [EP/I000232/1]; ESRC under the REDUCE [EP/I000232/1]; MRC under the REDUCE [EP/I000232/1]; EPSRC [EP/I000232/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I000232/1] Funding Source: researchfish	Digital Economy Programme of the Research Councils UK, a cross-council initiative led by EPSRC; AHRC under the REDUCE; ESRC under the REDUCE; MRC under the REDUCE; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research was funded by the Digital Economy Programme of the Research Councils UK, a cross-council initiative led by EPSRC (www.epsrc.ac.uk) and contributed to by AHRC, ESRC and MRC, under the REDUCE project grant (no EP/I000232/1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; AECOM, 2011, EN DEM RES PROJ FIN; Aune M, 2007, ENERG POLICY, V35, P5457, DOI 10.1016/j.enpol.2007.05.007; BITTLE RG, 1979, J ENVIRON SYST, V9, P275, DOI 10.2190/91AA-P97G-JF92-T7EJ; Brandon G, 1999, J ENVIRON PSYCHOL, V19, P75, DOI 10.1006/jevp.1998.0105; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brookings JB, 2006, PSYCHOL REP, V98, P407, DOI 10.2466/PRO.98.2.407-413; Bulkeley H, 2000, PUBLIC UNDERST SCI, V9, P313, DOI 10.1088/0963-6625/9/3/307; Burgess J, 2008, ENERG POLICY, V36, P4454, DOI 10.1016/j.enpol.2008.09.039; CapGemini, 2008, DEM RES DEC BREAKTH; Carlsson-Kanyama A, 2007, ENERGY POLICY, V35; Carrico A. R., 2011, J ENERGY ENV LAW, V2, P61; Cockburn C., 1994, BRINGING TECHNOLOGY; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Darby S., 2006, ORTHOD FR, V86, P221, DOI [10.1051/orthodfr/2015025, DOI 10.1051/ORTHODFR/2015025]; Darby S, 2010, BUILD RES INF, V38, P442, DOI 10.1080/09613218.2010.492660; DECC, 2013, EN CONS UK; DECC, 2013, 2012 UK GREENH GAS E; DEFRA, 2007, FREM ENV BEH; Dietz T, 2005, ANNU REV ENV RESOUR, V30, P335, DOI 10.1146/annurev.energy.30.050504.144444; Dietz T, 2013, DAEDALUS-US, V142, P78, DOI 10.1162/DAED_a_00186; Dixon J, 2004, THEOR PSYCHOL, V14, P167, DOI 10.1177/0959354304042015; EEA, 2012, FIN EN CONS SECT MAR; Ehrhardt-Martinez K., 2010, ADV METERING INITIAT; Emmons R. A., 1996, PSYCHOL ACTION LINKI, P313; Evans D, 2011, GEOFORUM, V42, P550, DOI 10.1016/j.geoforum.2011.03.008; Faruqui A, 2010, J REGUL ECON, V38, P193, DOI 10.1007/s11149-010-9127-y; Faruqui A, 2010, ENERGY, V35, P1598, DOI 10.1016/j.energy.2009.07.042; Faulkner W., 1985, SMOTHERED INVENTION; Ferraro PJ, 2013, RESOUR ENERGY ECON, V35, P356, DOI 10.1016/j.reseneeco.2013.04.001; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Frey BS., 1999, J CONSUMER POLICY, V22, P395, DOI [DOI 10.1023/A:1006256117094, 10.1023/A:1006256117094]; Gatersleben B, 2010, ARCHIT SCI REV, V53, P37, DOI 10.3763/asre.2009.0101; Glucksmann M., 2007, EQUAL OPPORTUNITIES, V26, P96, DOI DOI 10.1108/02610150710732186; Gram-Hanssen K, 2011, J CONSUM CULT, V11, P61, DOI 10.1177/1469540510391725; Gronhoj A, 2011, INT J CONSUM STUD, V35, P138, DOI 10.1111/j.1470-6431.2010.00967.x; Hargreaves T, 2013, ENERG POLICY, V52, P126, DOI 10.1016/j.enpol.2012.03.027; Hargreaves T, 2010, ENERG POLICY, V38, P6111, DOI 10.1016/j.enpol.2010.05.068; JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4; Jain RK, 2012, ENERG BUILDINGS, V48, P8, DOI 10.1016/j.enbuild.2011.12.033; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Little B. R., 2017, PERSONAL PROJECT PUR; Marteau TM., 2002, GETTING RES FINDINGS, P68, DOI [10.1002/9780470755891.CH5, DOI 10.1002/9780470755891.CH5]; Murtagh N, 2013, INDIVIDUAL ENERGY US; Murtagh N, 2012, TRANSPORT RES F-TRAF, V15, P514, DOI 10.1016/j.trf.2012.05.002; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schleich J, 2013, ENERG POLICY, V61, P1097, DOI 10.1016/j.enpol.2013.05.012; Schwartz D, 2013, P NATL ACAD SCI; Schwartz-Cowan R., 1983, MORE WORK MOTHER IRO; Shove E, 2008, BUILDING RES INFORM, V36; Shove Elizabeth, 2003, COMFORT CLEANLINESS; Shui B, 2004, REESTIMATION REFLECT; STERN PC, 1994, J SOC ISSUES, V50, P65, DOI 10.1111/j.1540-4560.1994.tb02420.x; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torriti J, 2010, ENERGY, V35, P1575, DOI 10.1016/j.energy.2009.05.021; van Dam SS, 2010, BUILD RES INF, V38, P458, DOI 10.1080/09613218.2010.494832; VANHOUWELINGEN JH, 1989, J CONSUM RES, V16, P98, DOI 10.1086/209197; Wajcman J, 2010, CAMB J ECON, V34, P134; Wallenborn G, 2011, INT J CONSUM STUD, V35, P146, DOI 10.1111/j.1470-6431.2010.00985.x; Warde A., 2005, J CONSUM CULT, V5, P131, DOI DOI 10.1177/1469540505053090; Wilhite H, 1999, ADV CONSUM RES, V26, P281; Wilk R., 2001, J CONSUM CULT, V1, P245, DOI DOI 10.1177/146954050100100211; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302	64	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92019	10.1371/journal.pone.0092019	http://dx.doi.org/10.1371/journal.pone.0092019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642946	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900062
J	Howard, JD; Sarojini, H; Wan, R; Chien, SF				Howard, Jeffrey D.; Sarojini, Harshini; Wan, Rong; Chien, Sufan			Rapid Granulation Tissue Regeneration by Intracellular ATP Delivery-A Comparison with Regranex	PLOS ONE			English	Article							DIABETIC FOOT ULCERS; GROWTH-FACTOR; RABBIT EAR; MACROPHAGE PROLIFERATION; HYPERBARIC-OXYGEN; SKIN WOUNDS; GEL; ANGIOGENESIS; BECAPLERMIN; METABOLISM	This study tests a new intracellular ATP delivery technique for tissue regeneration and compares its efficacy with that of Regranex. Twenty-seven adult New Zealand white rabbits each underwent minimally invasive surgery to render one ear ischemic. Eight wounds were then created: four on the ischemic and four on the normal ear. Two wounds on one side of each ear were treated with Mg-ATP encapsulated lipid vesicles (ATP-vesicles) while the two wounds on the other side were treated with Regranex. Wound healing time was shorter when ATP-vesicles were used. The most striking finding was that new tissue growth started to appear in less than 1 day when ATP-vesicles were used. The growth continued and covered the wound area within a few days, without the formation of a provisional matrix. Regranex-treated wounds did not have this growth pattern. In wounds treated by ATP-vesicles, histologic studies revealed extremely rich macrophage accumulation, along with active proliferating cell nuclear antigen (PCNA) and positive BrdU staining, indicating in situ macrophage proliferation. Human macrophage culture suggested direct collagen production. These results support an entirely new healing process, which seems to have combined the conventional hemostasis, inflammation, and proliferation phases into a single one, thereby eliminating the lag time usually seen during healing process.	[Howard, Jeffrey D.; Sarojini, Harshini; Wan, Rong; Chien, Sufan] Univ Louisville, Dept Surg, Louisville, KY 40292 USA	University of Louisville	Chien, SF (corresponding author), Univ Louisville, Dept Surg, Louisville, KY 40292 USA.	sufanc@aim.com	Sarojini, Harshini/AAD-4870-2019	Sarojini, Harshini/0000-0002-3103-9712	National Institutes of Health [RO1DK74566, R44AR52984, R43HL114235, R43GM106639]; KSTC [KSTC-184-512-12-138]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL114235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R44AR052984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM106639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KSTC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health grants RO1DK74566, R44AR52984, R43HL114235, and R43GM106639, and KSTC match funding KSTC-184-512-12-138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT JP, 1980, LANCET, V1, P1153; Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019; Berendt AR, 2006, CLIN INFECT DIS, V43, P193, DOI 10.1086/505223; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Chan RK, 2006, J BURN CARE RES, V27, P202, DOI 10.1097/01.BCR.0000202898.11277.58; Cheng B, 2007, J DERMATOL SCI, V45, P193, DOI 10.1016/j.jdermsci.2006.11.014; Chiang B, 2007, AM J SURG, V193, P213, DOI 10.1016/j.amjsurg.2006.08.069; Chien, 2006, RECENT RES DEV BIOPH, V5, P1; Chien S, 2012, JOVE-J VIS EXP, V2012, P1; Chien S, 2007, WOUND REPAIR REGEN, V15, P928, DOI 10.1111/j.1524-475X.2007.00285.x; Chien S, 2007, WOUND REPAIR REGEN, V15, pA39; Chien SF, 2010, METHODS MOL BIOL, V605, P377, DOI 10.1007/978-1-60327-360-2_26; Chvapil M, 1988, J Burn Care Rehabil, V9, P279, DOI 10.1097/00004630-198805000-00009; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Cohen MA, 2001, J AM ACAD DERMATOL, V45, P857, DOI 10.1067/mjd.2001.117721; Coleman R, 2011, ACTA HISTOCHEM, V113, P231, DOI 10.1016/j.acthis.2010.02.002; COOPER GM, 1997, CELL MOL APPROACH; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Edwards JS, 2010, KNOWL MAN RES PRACT, V8, P1, DOI 10.1057/kmrp.2009.39; Fang RC, 2008, BIOL-TARGETS THER, V2, P1; Game FL, 2012, DIABETES-METAB RES, V28, P119, DOI 10.1002/dmrr.2246; Greener B, 2005, J Wound Care, V14, P59; Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160; Howes EL, 1943, SURG GYNECOL OBSTET, V76, P738; HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561; IM MJC, 1970, J SURG RES, V10, P459, DOI 10.1016/0022-4804(70)90070-3; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kloeters O, 2007, WOUND REPAIR REGEN, V15, pS40, DOI 10.1111/j.1524-475X.2007.00224.x; Landsman A, 2010, J AM PODIAT MED ASSN, V100, P155, DOI 10.7547/1000155; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lindblad, 1992, WOUND HEALING BIOCH, P248; Lindblad WJ, 2006, WOUND REPAIR REGEN, V14, P515, DOI 10.1111/j.1743-6109.2006.00171.x; Lubkowska A, 2012, J Biol Regul Homeost Agents, V26, p3S; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012; Niinikoski J, 2003, WOUND REPAIR REGEN, V11, P458, DOI 10.1046/j.1524-475X.2003.11610.x; Ovington LG, 2004, CHRONIC WOUND CARE P, P83; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, DOI 10.1038/nri3016; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Peng XY, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-12; PUISIEUX F, 1994, J DRUG TARGET, V2, P443, DOI 10.3109/10611869408996820; Randolph GJ, 2011, SCIENCE, V332, P1268, DOI 10.1126/science.1208480; Roy S, 2011, WOUND REPAIR REGEN, V19, P753, DOI 10.1111/j.1524-475X.2011.00740.x; Saulis AS, 2002, PLAST RECONSTR SURG, V110, P177, DOI 10.1097/00006534-200207000-00029; SAWYER RT, 1982, LAB INVEST, V46, P165; Schaffer Michael, 2002, Int J Low Extrem Wounds, V1, P104, DOI 10.1177/1534734602001002005; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Senet P, 2011, ARCH DERMATOL, V147, P926, DOI 10.1001/archdermatol.2011.84; SILVER IA, 1980, WOUND HEALING WOUND, P11; Simons M, 2005, J AM COLL CARDIOL, V46, P835, DOI 10.1016/j.jacc.2005.06.008; Smith DG, 1999, FOOT ANKLE INT, V20, P258, DOI 10.1177/107110079902000409; Sorensen V, 2006, J CELL SCI, V119, P4332, DOI 10.1242/jcs.03209; Steed DL, 2006, PLAST RECONSTR SURG, V117, p143S, DOI 10.1097/01.prs.0000222526.21512.4c; Tacke Frank, 2011, Hepatology, V54, P2267, DOI 10.1002/hep.24714; Toledo-Pereyra L.H., 2010, ORGAN PROCUREMENT PR, P82; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; VAAGE J, 1991, BRIT J CANCER, V63, P758, DOI 10.1038/bjc.1991.169; VAAGE J, 1990, J LEUKOCYTE BIOL, V48, P274, DOI 10.1002/jlb.48.3.274; Van den BJ, 2012, J LEUKOCYTE BIOL, V91, P1; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Villiers E, 2006, VET CLIN PATH, V35, P55, DOI 10.1111/j.1939-165X.2006.tb00089.x; WANG D, 1990, BIOCHEM BIOPH RES CO, V166, P251, DOI 10.1016/0006-291X(90)91938-O; Wang J, 2008, WOUND REPAIR REGEN, V16, pA56; Wang JP, 2010, AM J SURG, V199, P823, DOI 10.1016/j.amjsurg.2009.05.040; Wang JP, 2009, ANN PLAS SURG, V62, P180, DOI 10.1097/SAP.0b013e31817fe47e; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Werdin F, 2009, EPLASTY, V9, P169; WILLIAMSBOYCE PK, 1986, J ANAT, V149, P55; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Zamora DO, 2013, ANGIOGENESIS, V16, P745, DOI 10.1007/s10456-013-9352-y	71	27	27	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91787	10.1371/journal.pone.0091787	http://dx.doi.org/10.1371/journal.pone.0091787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637626	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100061
J	Lin, IP; Hsu, YS; Kang, SW; Hsieh, MH; Wang, JY				Lin, I-Ping; Hsu, Yu-Shen; Kang, Ssu-Wei; Hsieh, Miao-His; Wang, Jiu-Yao			Escherichia coli Heat-Labile Detoxified Enterotoxin Modulates Dendritic Cell Function and Attenuates	PLOS ONE			English	Article							CHOLERA-TOXIN; DC-SIGN; MUCOSAL ADJUVANTICITY; ALVEOLAR MACROPHAGE; AIRWAY INFLAMMATION; TH2 CELLS; ACTIVATION; ASTHMA; DIFFERENTIATION; IMMUNOGENICITY	Various mutant forms of Escherichia coli heat-labile enterotoxin (LT) have been used as a mucosal adjuvant for vaccines, as it enhances immune responses to specific antigens including antigen-specific IgA antibodies when administrated intranasally or orally. We hypothesized that a detoxified mutant form of LT, LTS61K, could modulate dendritic cell (DC) function and alleviate allergen-induced airway inflammation. Two protocols, preventative and therapeutic, were used to evaluate the effects of LTS61K in a Dermatophagoides pteronyssinus (Der p)-sensitized and challenged murine model of asthma. LTS61K or Der p-primed bone marrow-derived dendritic cells (BMDCs) were also adoptively transferred into Der p-sensitized and challenged mice. Intranasal inoculations with LTS61K or LTS61K/Der p decreased allergen-induced airway inflammation and alleviated systemic T(H)2-type immune responses. Bronchoalveolar lavage fluid (BALF) and sera from LTS61K/Der p-treated mice also had higher concentrations of Der p-specific immunoglobulin (Ig) A than those of other groups. In vitro, BMDCs stimulated with Der p underwent cellular maturation and secreted proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)alpha In contrast, Der p-stimulated BMDCs that were pretreated with LTS61K showed decreased IL-6 and TNF alpha production and were less mature. Intratracheal adoptive transfer of LTS61K- or LTS61K/Der p-primed BMDCs into Der p-sensitized mice reduced inflammatory cell infiltration and T(H)2-type chemokines in BALF and alleviated airway inflammation in treated mice. LTS61K influenced DC maturation and decreased inflammatory cytokine production. Moreover, LTS61K/Der p induced increased Der p-specific IgA production to decrease allergic T(H)2 cytokine responses and alleviated airway inflammation in Der p-sensitized mice. These results suggest that the immunomodulatory effects of LTS61K may have clinical applications for allergy and asthma treatment.	[Lin, I-Ping; Hsieh, Miao-His; Wang, Jiu-Yao] Natl Cheng Kung Univ, Coll Med, Inst Microbiol & Immunol, Tainan 70101, Taiwan; [Lin, I-Ping; Hsu, Yu-Shen; Kang, Ssu-Wei] Dev Ctr Biotechnol, Taipei, Taiwan; [Wang, Jiu-Yao] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 70101, Taiwan; [Wang, Jiu-Yao] China Med Univ, Sch Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan	National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan	Wang, JY (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Microbiol & Immunol, Tainan 70101, Taiwan.	a122@mail.ncku.edu.tw			Development Center for Biotechnology [101AN201]; National Cheng Kung University [98S153, 99S047, 101S082]	Development Center for Biotechnology; National Cheng Kung University	This work was supported by the Development Center for Biotechnology, grant number 101AN201, and research grants No. 98S153, 99S047, 101S082 from National Cheng Kung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Aydogan M, 2007, PEDIAT ALLERG IMM-UK, V18, P320, DOI 10.1111/j.1399-3038.2007.00527.x; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Chen CL, 2006, J ALLERGY CLIN IMMUN, V118, P105, DOI 10.1016/j.jaci.2006.02.047; Chen CL, 2003, J IMMUNOL, V170, P528, DOI 10.4049/jimmunol.170.1.528; Donaldson DS, 2012, MUCOSAL IMMUNOL; Douce G, 1998, VACCINE, V16, P1065, DOI 10.1016/S0264-410X(98)80100-X; ELSON CO, 1984, J IMMUNOL, V132, P2736; Fahlen-Yrlid L, 2009, J IMMUNOL, V183, P5032, DOI 10.4049/jimmunol.0803992; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Gaffin JM, 2009, CURR OPIN ALLERGY CL, V9, P128, DOI 10.1097/ACI.0b013e32832678b0; Giuliani MM, 1998, J EXP MED, V187, P1123, DOI 10.1084/jem.187.7.1123; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Huang HJ, 2011, MUCOSAL IMMUNOL, V4, P519, DOI 10.1038/mi.2011.17; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Liu CF, 2010, CLIN EXP ALLERGY, V40, P111, DOI [10.1111/j.1365-2222.2009.03367.x, 10.1111/j.1365-2222.2010.03549.x]; Liu CF, 2005, CLIN EXP ALLERGY, V35, P1615, DOI 10.1111/j.1365-2222.2005.02387.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MARINARO M, 1995, J IMMUNOL, V155, P4621; Negri DRM, 2009, INFECT IMMUN, V77, P1924, DOI 10.1128/IAI.01559-08; Petrovska L, 2003, VACCINE, V21, P1445, DOI 10.1016/S0264-410X(02)00696-5; Rappuoli R, 1999, IMMUNOL TODAY, V20, P493, DOI 10.1016/S0167-5699(99)01523-6; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; Schwarze J, 1998, AM J RESP CRIT CARE, V158, P519, DOI 10.1164/ajrccm.158.2.9801014; Soriani M, 2002, MICROBIOL-SGM, V148, P667, DOI 10.1099/00221287-148-3-667; Van Rijt LS, 2005, CLIN EXP ALLERGY, V35, P1125, DOI 10.1111/j.1365-2222.2005.02321.x; Wang JY, 2013, ALLERGY ASTHMA IMMUN, V5, P68, DOI 10.4168/aair.2013.5.2.68; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yu CK, 2003, J IMMUNOL, V171, P3808, DOI 10.4049/jimmunol.171.7.3808; Zhou FM, 2009, CLIN VACCINE IMMUNOL, V16, P471, DOI 10.1128/CVI.00311-08	37	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90293	10.1371/journal.pone.0090293	http://dx.doi.org/10.1371/journal.pone.0090293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637787	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100006
J	Navarro-Castilla, A; Mata, C; Ruiz-Capillas, P; Palme, R; Malo, JE; Barja, I				Navarro-Castilla, Alvaro; Mata, Cristina; Ruiz-Capillas, Pablo; Palme, Rupert; Malo, Juan E.; Barja, Isabel			Are Motorways Potential Stressors of Roadside Wood Mice (Apodemus sylvaticus) Populations?	PLOS ONE			English	Article							FECAL CORTICOSTEROID LEVELS; PHYSIOLOGICAL STRESS; HABITAT USE; PEROMYSCUS-MANICULATUS; TOURIST PRESSURE; SEASONAL-CHANGES; WILD POPULATION; SMALL MAMMALS; RESPONSES; ECOLOGY	Linear infrastructures represent one of the most important human impacts on natural habitats and exert several effects on mammal populations. Motorways are recognized as a major cause of habitat fragmentation and degradation and of biodiversity loss. However, it is unknown whether motorways lead to increased physiological stress reactions in wild animal populations. We analysed faecal corticosterone metabolites (FCM) in wild populations of wood mice (Apodemus sylvaticus) living in a well-preserved Mediterranean agro-pastoral woodland at different distances (verge, 500 m and 1000 m) from the AP-51 motorway in Spain. Wood mice were captured with Sherman live traps, and fresh faecal samples from 424 individuals were collected and analyzed in the laboratory. The quantification of FCM was performed by a 5 alpha-pregnane-3 beta, 11 beta, 21-triol-20-one enzyme immunoassay. Results showed that females had higher FCM levels than males, and these levels were higher in breeding females. In addition, FCM levels were positively correlated with body weight of individuals. Wood mice captured where cattle were present showed higher FCM levels than individuals living where cattle were not detected. FCM levels were higher in non-breeding individuals living close to the motorway compared with FCM levels in those individuals captured further from the motorway. This is the first study showing evidence of the motorways' impact on physiological stress reactions in wild wood mice populations. Understanding how free-living animals are influenced by human interventions could help to understand other subtle changes observed in wild animal populations. Since mice are used world-wide as research models these results could open new perspectives testing human influence on the natural environment and trade-offs of species in degraded ecosystems.	[Navarro-Castilla, Alvaro; Barja, Isabel] Univ Autonoma Madrid, Zool Unit, Dept Biol, Madrid, Spain; [Mata, Cristina; Malo, Juan E.] Univ Autonoma Madrid, Terr Ecol Grp, Dept Ecol, Madrid, Spain; [Ruiz-Capillas, Pablo] Obrascon Huarte Lain SA, Direcc Innovac & Sostenibilidad, Madrid, Spain; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci Biochem, Vienna, Austria	Autonomous University of Madrid; Autonomous University of Madrid; University of Veterinary Medicine Vienna	Navarro-Castilla, A (corresponding author), Univ Autonoma Madrid, Zool Unit, Dept Biol, Madrid, Spain.	alvaro.navarrocastilla@uam.es	Malo, Juan E/K-8305-2014; Arrazola, Juan Esteban Malo/Q-4819-2019; Palme, Rupert/A-3499-2008; Mata, Cristina/ABF-1169-2021; Barja, Isabel/B-8303-2016; Navarro-Castilla, Álvaro/M-7315-2018	Malo, Juan E/0000-0002-6033-5035; Arrazola, Juan Esteban Malo/0000-0002-6033-5035; Palme, Rupert/0000-0001-9466-3662; Mata, Cristina/0000-0002-6206-1015; Barja, Isabel/0000-0002-8354-5342; Navarro-Castilla, Álvaro/0000-0003-0928-3978	CENIT-OASIS; CDTI of the Spanish Ministry of Science and Innovation [REMEDINAL-2 S-2009/AMB/1783, CCG10-UAM/AMB-5325]; Comunidad de Madrid; European Social Fund; Universidad Autonoma de Madrid; Ministerio de Educacion y Ciencia of Spain	CENIT-OASIS; CDTI of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Comunidad de Madrid(Comunidad de Madrid); European Social Fund(European Social Fund (ESF)); Universidad Autonoma de Madrid; Ministerio de Educacion y Ciencia of Spain(Spanish Government)	This research has been funded by the projects: CENIT-OASIS supported by CDTI of the Spanish Ministry of Science and Innovation, REMEDINAL-2 S-2009/AMB/1783 and CCG10-UAM/AMB-5325 (Comunidad de Madrid together with the European Social Fund and Universidad Autonoma de Madrid). A. Navarro-Castilla was supported by a FPU grant from the Ministerio de Educacion y Ciencia of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews A., 1990, Australian Zoologist, V52, P130; ANGELSTAM P, 1987, OIKOS, V50, P123, DOI 10.2307/3565408; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Barja I, 2007, J STEROID BIOCHEM, V104, P136, DOI 10.1016/j.jsbmb.2007.03.008; Bauman D. E., 2000, Ruminant physiology: digestion, metabolism, growth and reproduction, P311, DOI 10.1079/9780851994635.0311; BIRNEY EC, 1976, ECOLOGY, V57, P1043, DOI 10.2307/1941069; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Clevenger AP, 2003, BIOL CONSERV, V109, P15, DOI 10.1016/S0006-3207(02)00127-1; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Crist MR, 2005, J APPL ECOL, V42, P181, DOI 10.1111/j.1365-2664.2005.00996.x; Dantzer B, 2010, GEN COMP ENDOCR, V167, P279, DOI 10.1016/j.ygcen.2010.03.024; Eccard JA, 2000, J ARID ENVIRON, V46, P103, DOI 10.1006/jare.2000.0659; ELTON CHARLES, 1939, JOUR WILDLIFE MANAGEMENT, V3, P332, DOI 10.2307/3796305; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frid A, 2002, CONSERV ECOL, V6; Gotz AA, 2007, PHYSIOL BEHAV, V90, P108, DOI 10.1016/j.physbeh.2006.09.014; Good T, 2003, PHYSIOL BEHAV, V80, P405, DOI 10.1016/j.physbeh.2003.09.006; Goosem M, 2002, WILDLIFE RES, V29, P277, DOI 10.1071/WR01058; GORMAN ML, 1993, J ZOOL, V229, P385, DOI 10.1111/j.1469-7998.1993.tb02643.x; Goymann W, 2001, P ROY SOC B-BIOL SCI, V268, P2453, DOI 10.1098/rspb.2001.1828; GREEN R, 1979, J ZOOL, V188, P357; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Harper JM, 2004, AM MIDL NAT, V152, P400, DOI 10.1674/0003-0031(2004)152[0400:FCLIFP]2.0.CO;2; Harper JM, 2001, GEN COMP ENDOCR, V123, P337, DOI 10.1006/gcen.2001.7682; HAUGER RL, 1994, ENDOCRINOLOGY, V134, P1528, DOI 10.1210/en.134.3.1528; HESKE EJ, 1991, SOUTHWEST NAT, V36, P89, DOI 10.2307/3672121; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; KIKKAWA J, 1964, J ANIM ECOL, V33, P259, DOI 10.2307/2631; KLEIN DR, 1971, SCIENCE, V173, P393, DOI 10.1126/science.173.3995.393; Lode T, 2000, AMBIO, V29, P163, DOI 10.1579/0044-7447-29.3.163; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; Moberg G.P., 1985, P27; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; MOEN AN, 1982, NEW YORK FISH GAME J, V29, P176; Monclus R, 2009, OECOLOGIA, V158, P615, DOI 10.1007/s00442-008-1201-0; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Munoz A, 2009, BASIC APPL ECOL, V10, P151, DOI 10.1016/j.baae.2008.01.003; Navarro-Castilla A, 2014, MAMM BIOL, V79, P36, DOI 10.1016/j.mambio.2013.08.004; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Parris KM, 2009, ECOL SOC, V14; Penn DJ, 2007, P NATL ACAD SCI USA, V104, P553, DOI 10.1073/pnas.0609301103; Pineiro A, 2012, WILDLIFE RES, V39, P532, DOI 10.1071/WR10218; POLLARD E, 1970, J APPL ECOL, V7, P549, DOI 10.2307/2401977; PRESTON CR, 1990, CONDOR, V92, P107, DOI 10.2307/1368388; PUTMAN RJ, 1989, BIOL CONSERV, V47, P13, DOI 10.1016/0006-3207(89)90017-7; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reck H, 1993, STRASSEN LEBENSRAUME; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Reijnen R, 1995, THESIS DLO I FOR NAT; Rico A, 2007, FOLIA ZOOL, V56, P1; Roedenbeck IA, 2008, EUR J WILDLIFE RES, V54, P425, DOI 10.1007/s10344-007-0166-3; Roff Derek A., 1992; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Ruiz-Capillas P, 2013, BIOL CONSERV, V158, P223, DOI 10.1016/j.biocon.2012.09.025; Russell ES, 1966, BIOL LAB MOUSE, P685; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Saunders SC, 2002, BIOL CONSERV, V103, P209, DOI 10.1016/S0006-3207(01)00130-6; Schradin C, 2008, HORM BEHAV, V53, P573, DOI 10.1016/j.yhbeh.2008.01.003; Schwabl H, 1999, GEN COMP ENDOCR, V116, P403, DOI 10.1006/gcen.1999.7379; Sheffield LM, 2001, CAN J ZOOL, V79, P380, DOI 10.1139/cjz-79-3-380; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Spellerberg IF, 2002, ECOLOGICAL EFFECTS R, DOI DOI 10.1201/9781482279931; Stewart PM, 2003, WILLIAMS TXB ENDOCRI, P491; Strier KB, 2003, AM J PRIMATOL, V61, P85, DOI 10.1002/ajp.10109; Tataranni PA, 1996, AM J PHYSIOL-ENDOC M, V271, pE317, DOI 10.1152/ajpendo.1996.271.2.E317; Tchabovsky AV, 2001, J ETHOL, V19, P105, DOI 10.1007/s101640170006; Tester JR, 1961, STUDY CERTAIN PLANT; Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x; Thiel D, 2011, IBIS, V153, P122, DOI 10.1111/j.1474-919X.2010.01083.x; THURBER JM, 1994, WILDLIFE SOC B, V22, P61; Torre I, 2007, BASIC APPL ECOL, V8, P565, DOI 10.1016/j.baae.2006.09.016; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; van der Ree R, 2011, ECOL SOC, V16; VICKERY WL, 1992, ECOGRAPHY, V15, P205, DOI 10.1111/j.1600-0587.1992.tb00026.x; Walker BG, 2005, CONSERV BIOL, V19, P1571, DOI 10.1111/j.1523-1739.2005.00104.x; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; WINGFIELD JC, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P520; WINGFIELD JC WINGFIELD JC, 2001, HDB PHYSL AM PHYSL S HDB PHYSL AM PHYSL S, V4 4, p211 211; WINNER WE, 1994, ECOL APPL, V4, P651, DOI 10.2307/1941998; Ylonen H, 2006, BEHAV ECOL SOCIOBIOL, V60, P350, DOI 10.1007/s00265-006-0171-7; [No title captured]	93	32	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91942	10.1371/journal.pone.0091942	http://dx.doi.org/10.1371/journal.pone.0091942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637740	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100085
J	Nogales-Gadea, G; Ramos-Fransi, A; Suarez-Calvet, X; Navas, M; Rojas-Garcia, R; Mosquera, JL; Diaz-Manera, J; Querol, L; Gallardo, E; Illa, I				Nogales-Gadea, Gisela; Ramos-Fransi, Alba; Suarez-Calvet, Xavier; Navas, Miquel; Rojas-Garcia, Ricard; Luis Mosquera, Jose; Diaz-Manera, Jordi; Querol, Luis; Gallardo, Eduard; Illa, Isabel			Analysis of Serum miRNA Profiles of Myasthenia Gravis Patients	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PROGNOSTIC MARKERS; SUBTLE DIFFERENCES; T-CELLS; BIOMARKERS; EXPRESSION; GENERATION; ANTIGEN; CANCER; PLASMA	Myasthenia gravis (MG) is an autoimmune disease characterized by the presence of autoantibodies, mainly against the acetylcholine receptor (AChR). The mechanisms triggering and maintaining this chronic disease are unknown. MiRNAs are regulatory molecules that play a key role in the immune system and are altered in many autoimmune diseases. The aim of this study was to evaluate miRNA profiles in serum of 61 AChR MG patients. We studied serum from patients with early onset MG (n = 22), late onset MG (n = 27) and thymoma (n = 12), to identify alterations in the specific subgroups. In a discovery cohort, we analysed 381 miRNA arrays from 5 patients from each subgroup, and 5 healthy controls. The 15 patients had not received any treatment. We found 32 miRNAs in different levels in MG and analysed 8 of these in a validation cohort that included 46 of the MG patients. MiR15b, miR122, miR-140-3p, miR185, miR192, miR20b and miR-885-5p were in lower levels in MG patients than in controls. Our study suggests that different clinical phenotypes in MG share common altered mechanisms in circulating miRNAs, with no additional contribution of the thymoma. MG treatment intervention does not modify the profile of these miRNAs. Novel insights into the pathogenesis of MG can be reached by the analysis of circulating miRNAs since some of these miRNAs have also been found low in MG peripheral mononuclear cells, and have targets with important roles in B cell survival and antibody production.	[Nogales-Gadea, Gisela; Ramos-Fransi, Alba; Suarez-Calvet, Xavier; Navas, Miquel; Rojas-Garcia, Ricard; Diaz-Manera, Jordi; Querol, Luis; Gallardo, Eduard; Illa, Isabel] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, E-08193 Barcelona, Spain; [Nogales-Gadea, Gisela; Ramos-Fransi, Alba; Suarez-Calvet, Xavier; Navas, Miquel; Rojas-Garcia, Ricard; Diaz-Manera, Jordi; Querol, Luis; Gallardo, Eduard; Illa, Isabel] Inst Salud Carlos III, CIBER Enfermedades Neurodegenerat CIBERNED, Madrid, Spain; [Luis Mosquera, Jose] Univ Barcelona, Dept Stat, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBERNED; Instituto de Salud Carlos III; University of Barcelona	Nogales-Gadea, G (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, E-08193 Barcelona, Spain.	gnogales@santpau.cat; iilla@santpau.cat	Nogales-Gadea, Gisela/N-4004-2014; ILLA, Isabel/AAD-1816-2019; Suárez-Calvet, Xavier/AAF-8273-2021; Querol, Luis/H-2119-2015; Mosquera, Jose Luis/O-9456-2015	Nogales-Gadea, Gisela/0000-0002-7414-212X; Suárez-Calvet, Xavier/0000-0002-5314-6607; Querol, Luis/0000-0002-4289-8264; Mosquera, Jose Luis/0000-0002-7852-4993; RAMOS-FRANSI, ALBA/0000-0002-4114-4575; Gallardo, Eduard/0000-0002-3942-3436; Diaz-Manera, Jordi/0000-0003-2941-7988; Navas Madronal, Miquel/0000-0003-2984-1471	Fondo de Investigaciones Sanitarias (Fondo de Investigaciones [FIS] Intrasalud [09/1964]; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain [FIS CD10/00027, FIS CM09/00017]	Fondo de Investigaciones Sanitarias (Fondo de Investigaciones [FIS] Intrasalud; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This project was supported with a research grant from Fondo de Investigaciones Sanitarias (Fondo de Investigaciones [FIS] Intrasalud; 09/1964; principal investigator, I. I.). GNG and LQ are supported by FIS CD10/00027 and FIS CM09/00017 grants from Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almehmadi M, 2014, IMMUNOLOGY; Aragones JM, 2003, NEUROLOGY, V60, P1024, DOI 10.1212/01.WNL.0000050461.05432.C5; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baj-Krzyworzeka M, 2007, IMMUNOL LETT, V113, P76, DOI 10.1016/j.imlet.2007.07.014; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Berrih-Aknin S., 2014, J AUTOIMMUN; Berrih-Aknin S, 2009, ANN NEUROL, V66, P521, DOI 10.1002/ana.21628; Beveridge NJ, 2009, CELL SIGNAL, V21, P1837, DOI 10.1016/j.cellsig.2009.07.019; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cavalcante P, 2012, CURR OPIN NEUROL, V25, P621, DOI 10.1097/WCO.0b013e328357a829; Chen W, 2014, EUR J HAEMATOL; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng ZA, 2013, J CLIN IMMUNOL, V33, P567, DOI 10.1007/s10875-012-9834-5; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Csuka D, 2012, EUR J NEUROL, V19, P842, DOI 10.1111/j.1468-1331.2011.03636.x; Davis TE, 2013, ARTHRITIS RHEUM-US, V65, P1882, DOI 10.1002/art.37966; Deitiker PR, 2006, AUTOIMMUNITY, V39, P277, DOI 10.1080/08916930600738581; Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; EYMARD B, 1995, REV NEUROL-FRANCE, V151, P6; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Farrugia ME, 2010, CURR OPIN NEUROL, V23, P489, DOI 10.1097/WCO.0b013e32833cc968; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Gertel-Lapter S, 2013, AUTOIMMUN REV, V12, P894, DOI 10.1016/j.autrev.2013.03.009; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Giraud M, 2007, NATURE, V448, P934, DOI 10.1038/nature06066; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hock M, 2013, J IMMUNOL, V190, P2345, DOI 10.4049/jimmunol.1201591; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ionita CM, 2013, PEDIATR NEUROL, V48, P95, DOI 10.1016/j.pediatrneurol.2012.07.008; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jiang L, 2012, INT IMMUNOPHARMACOL, V14, P217, DOI 10.1016/j.intimp.2012.07.003; Khella HWZ, 2013, AM J KIDNEY DIS, V61, P798, DOI 10.1053/j.ajkd.2012.09.018; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; LANIER LL, 1989, J EXP MED, V169, P2233, DOI 10.1084/jem.169.6.2233; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Leite MI, 2007, AM J PATHOL, V171, P893, DOI 10.2353/ajpath.2007.070240; Leuenberger N, 2013, ANAL BIOANAL CHEM, V405, P9617, DOI 10.1007/s00216-013-7340-0; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; Liang H, 2013, WILEY INTERDISCIP RE; Lu J, 2013, NEUROSCI LETT; Macha MA, 2014, CURR PHARM DES; Melms A, 2006, ACTA NEUROL SCAND, V113, P12, DOI 10.1111/j.1600-0404.2006.00636.x; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mo MH, 2012, J CANCER, V3, P432, DOI 10.7150/jca.4919; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Querol L, 2013, CURR OPIN NEUROL, V26, P459, DOI 10.1097/WCO.0b013e328364c079; Rainer J, 2009, LEUKEMIA, V23, P746, DOI 10.1038/leu.2008.370; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sanders DB, 2013, MUSCLE NERVE; Sangokoya C, 2010, METHODS MOL BIOL, V667, P193, DOI 10.1007/978-1-60761-811-9_13; Setzer F, 2006, PLATELETS, V17, P571, DOI 10.1080/09537100600760244; SHIFENG H, 2013, PLOS ONE, V0008; Shiono H, 1997, EUR J IMMUNOL, V27, P805, DOI 10.1002/eji.1830270402; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stacy S, 2010, J IMMUNOL, V184, P6067, DOI 10.4049/jimmunol.0901618; Suzuki S, 2011, J NEUROIMMUNOL, V230, P148, DOI 10.1016/j.jneuroim.2010.10.023; Tackenberg B, 2007, EUR J IMMUNOL, V37, P849, DOI 10.1002/eji.200636449; THORLACIUS S, 1989, ACTA NEUROL SCAND, V80, P290, DOI 10.1111/j.1600-0404.1989.tb03881.x; Toiyama Y, 2013, ANN SURG; Tsai HL, 2013, TRANSL RES, V162, P258, DOI 10.1016/j.trsl.2013.07.009; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang Z, 2013, MOL CELL BIOCH; Xiao JJ, 2014, INT J CLIN EXP MED, V7, P136; Yang BZ, 1998, CLIN IMMUNOL IMMUNOP, V86, P45, DOI 10.1006/clin.1997.4451; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zheng Hong, 2013, Cancer Biology Medicine, V10, P123, DOI 10.7497/j.issn.2095-3941.2013.03.001; Zivkovic SA, 2012, J NEUROL, V259, P2167, DOI 10.1007/s00415-012-6478-6	87	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91927	10.1371/journal.pone.0091927	http://dx.doi.org/10.1371/journal.pone.0091927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637658	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100082
J	Collins, IJ; Cairns, J; Ngo-Giang-Huong, N; Sirirungsi, W; Leechanachai, P; Le Coeur, S; Samleerat, T; Kamonpakorn, N; Mekmullica, J; Jourdain, G; Lallemant, M				Collins, Intira Jeannie; Cairns, John; Ngo-Giang-Huong, Nicole; Sirirungsi, Wasna; Leechanachai, Pranee; Le Coeur, Sophie; Samleerat, Tanawan; Kamonpakorn, Nareerat; Mekmullica, Jutarat; Jourdain, Gonzague; Lallemant, Marc		Programme For Hiv Prevention Treat	Cost-Effectiveness of Early Infant HIV Diagnosis of HIV-Exposed Infants and Immediate Antiretroviral Therapy in HIV-Infected Children under 24 Months in Thailand	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; DRIED BLOOD SPOTS; DISEASE PROGRESSION; NATIONAL GUIDELINES; ECONOMIC-EVALUATION; MORTALITY; TRANSMISSION; OUTCOMES; CARE	Background: HIV-infected infants have high risk of death in the first two years of life if untreated. WHO guidelines recommend early infant HIV diagnosis (EID) of all HIV-exposed infants and immediate antiretroviral therapy (ART) in HIV-infected children under 24-months. We assessed the cost-effectiveness of this strategy in HIV-exposed non-breastfed children in Thailand. Methods: A decision analytic model of HIV diagnosis and disease progression compared: EID using DNA PCR with immediate ART (Early-Early); or EID with deferred ART based on immune/clinical criteria (Early-Late); vs. clinical/serology based diagnosis and deferred ART (Reference). The model was populated with survival and cost data from a Thai observational cohort and the literature. Incremental cost-effectiveness ratio per life-year gained (LYG) was compared against the Reference strategy. Costs and outcomes were discounted at 3%. Results: Mean discounted life expectancy of HIV-infected children increased from 13.3 years in the Reference strategy to 14.3 in the Early-Late and 17.8 years in Early-Early strategies. The mean discounted lifetime cost was $17,335, $22,583 and $29,108, respectively. The cost-effectiveness ratio of Early-Late and Early-Early strategies was $5,149 and $2,615 per LYG, respectively as compared to the Reference strategy. The Early-Early strategy was most cost-effective at approximately half the domestic product per capita per LYG ($4,420 in Thailand 2011). The results were robust in deterministic and probabilistic sensitivity analyses including varying perinatal transmission rates. Conclusion: In Thailand, EID and immediate ART would lead to major survival benefits and is cost-effective. These findings strongly support the adoption of WHO recommendations as routine care.	[Collins, Intira Jeannie] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Collins, Intira Jeannie; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Jourdain, Gonzague; Lallemant, Marc] IRD PHPT, Chiang Mai, Thailand; [Collins, Intira Jeannie; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie; Jourdain, Gonzague; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Cairns, John] London Sch Hyg Trop Med, Fac Publ Hlth & Policy, London, England; [Ngo-Giang-Huong, Nicole; Sirirungsi, Wasna; Leechanachai, Pranee; Le Coeur, Sophie; Samleerat, Tanawan; Jourdain, Gonzague; Lallemant, Marc] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiang Mai, Thailand; [Le Coeur, Sophie] Univ Paris 05, INED IRD, Ctr Francais Populat & Dev, Unite Mixte Rech 196, Paris, France; [Kamonpakorn, Nareerat] Somdej Prapinklao Hosp, Dept Paediat, Bangkok, Thailand; [Mekmullica, Jutarat] Bhumibol Adulyadej Hosp, Dept Paediat, Bangkok, Thailand	University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Chiang Mai University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Collins, IJ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	jeannie.collins@ucl.ac.uk	Jourdain, Gonzague/F-9117-2017; Collins, Intira Jeannie/I-5048-2019; Cairns, John/AAD-1168-2020; Ngo-Giang-Huong, Nicole/G-2860-2017	Jourdain, Gonzague/0000-0002-3365-7020; Collins, Intira Jeannie/0000-0003-2132-6037; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234	Global Fund to fight AIDS, Tuberculosis and Malaria (Thailand Grant Round 1) [PR-A-N-008]; Institut de Recherche pour le Developpement (IRD), France; International Maternal Pediatric Adolescents Aids Clinical Trials Group (IMPAACT); National Institutes of Health, US [R01 HD 33326, R01 HD 39615]; Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; United Kingdom Medical Research Council Doctoral Training Account Studentship for Intira Collins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039615, R01HD033326] Funding Source: NIH RePORTER	Global Fund to fight AIDS, Tuberculosis and Malaria (Thailand Grant Round 1); Institut de Recherche pour le Developpement (IRD), France; International Maternal Pediatric Adolescents Aids Clinical Trials Group (IMPAACT); National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; United Kingdom Medical Research Council Doctoral Training Account Studentship for Intira Collins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Grant support: The Global Fund to fight AIDS, Tuberculosis and Malaria (Thailand Grant Round 1 sub recipient PR-A-N-008); Institut de Recherche pour le Developpement (IRD), France; International Maternal Pediatric Adolescents Aids Clinical Trials Group (IMPAACT); The National Institutes of Health, US (R01 HD 33326; R01 HD 39615); Ministry of Public Health, Thailand; Oxfam Great Britain, Thailand; United Kingdom Medical Research Council Doctoral Training Account Studentship for Intira Collins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2012, 19 INT AIDS C WASH D; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Binagwaho A, 2013, J PUBLIC HEALTH POL, V34, P2, DOI 10.1057/jphp.2012.62; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Briggs A, 2006, DECISION MODELLING H; Chearskul S, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e25; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Clinton Foundation, 2009, HIV AIDS DIAGN PRIC; Collins I, 2013, JAIDS-J ACQ IMM DEF, V64, P95, DOI 10.1097/QAI.0b013e318298a309; Collins IJ, 2012, AIDS, V26, P1943, DOI 10.1097/QAD.0b013e328357f7b9; Collins IJ, 2010, CLIN INFECT DIS, V51, P1449, DOI 10.1086/657401; Deeks SG, 2013, LANCET; Dunn D, 2008, J INFECT DIS, V197, P398, DOI 10.1086/524686; Goetghebuer T, 2012, CLIN INFECT DIS, V54, P878, DOI 10.1093/cid/cir950; Gray L, 2001, PEDIATRICS, V108, P116, DOI 10.1542/peds.108.1.116; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; Hsiao NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055308; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Judd A, 2011, AIDS, V25, P2279, DOI 10.1097/QAD.0b013e32834d614c; Kim M, 2011, 6 IAS C HIV PATH TRE; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Loubiere S, 2010, CURR OPIN HIV AIDS, V5, P225, DOI 10.1097/COH.0b013e3283384a9d; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Meyer-Rath G, 2010, 18 INT AIDS C VIENN; Naiwatanakul T, 2012, 19 INT AIDS C WASH D; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Ngo-Giang-Huong N, 2008, JAIDS-J ACQ IMM DEF, V49, P465, DOI 10.1097/QAI.0b013e31818e2531; Patel K, 2008, CLIN INFECT DIS, V46, P1751, DOI 10.1086/587900; Persaud D, 2013, 20 C RETR OPP INF CR; Phanuphak N, 2010, ASIAN BIOMED, V4, P529, DOI 10.2478/abm-2010-0067; Plipat T, 2007, AIDS, V21, P145, DOI 10.1097/QAD.0b013e328010e02d; Puthanakit T, 2013, PEDIAT INFECT DIS J; Puthanakit T, 2010, ASIAN BIOMED, V4, P505, DOI 10.2478/abm-2010-0065; Ruel TD, 2012, CLIN INFECT DIS, V54, P1001, DOI 10.1093/cid/cir1037; Ryan M, 2008, AIDS, V22, P749, DOI 10.1097/QAD.0b013e3282f43519; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Schneider K, 2011, AIDS, V25, P1143, DOI 10.1097/QAD.0b013e3283466fab; Shapiro D, 2011, 18 INT AIDS C ROM IT; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; Sirirungsi W, 2013, 5 INT WORKSH HIV PED; Smith R, 2012, PEDIATR INFECT DIS J, V31, P592, DOI 10.1097/INF.0b013e318253844b; Sturt AS, 2012, PEDIATR INFECT DIS J, V31, P53, DOI 10.1097/INF.0b013e31823515a2; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Teerawattananon Yot, 2005, Cost Eff Resour Alloc, V3, P7, DOI 10.1186/1478-7547-3-7; Teerawattananon Yot, 2008, J Med Assoc Thai, V91 Suppl 2, pS11; TOVO PA, 1992, LANCET, V339, P1249, DOI 10.1016/0140-6736(92)91592-V; UNAIDS, 2021, PREV HIV INF TIM NEW; UNAIDS, 2012, TOG WE WILL END AIDS; UNITAID, 2012, HIV AIDS DIAGN TECHN; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; *WHO, 2008, WHO TECHN REF GROUP; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization, 2003, MAKING CHOICES HLTH	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91004	10.1371/journal.pone.0091004	http://dx.doi.org/10.1371/journal.pone.0091004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632750	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332858400032
J	de Hoz, L; Nelken, I				de Hoz, Livia; Nelken, Israel			Frequency Tuning in the Behaving Mouse: Different Bandwidths for Discrimination and Generalization	PLOS ONE			English	Article							INFERIOR COLLICULUS NEURONS; HOUSE-MOUSE; AUDITORY FREQUENCY; HEARING-LOSS; AGE; MICE; RAT; EAR	When faced with sensory stimuli, an organism may be required to detect very small differences in a physical parameter (discrimination), while in other situations it may have to generalize over many possible values of the same physical parameter. This decision may be based both on learned information and on sensory aspects of perception. In the present study we describe frequency processing in the behaving mouse using both discrimination and generalization as two key aspects of behaviour. We used a novel naturalistic behavioural apparatus designed for mice, the Audiobox, and paradigm contingencies that were identical for both auditory discrimination and generalization, the latter measured using latent inhibition. Mice learned to discriminate between frequencies that were an octave apart in a single trial. They showed significant discrimination between tone frequencies that were as close as 4-7%, and had d' of about 1 for Delta F of around 10%. In contrast, pre-exposure frequencies that were half an octave or less below the conditioned tone elicited latent inhibition, showing a generalization bandwidth of at least half an octave. Thus, in the same apparatus and using the same general memory paradigm, mice showed generalization gradients that were considerably wider than their discrimination threshold, indicating that environmental requirements and previous experience can determine whether the same two frequencies will be considered same or different. Remarkably, generalization gradients paralleled the typical bandwidths established in the auditory periphery and midbrain, suggesting that frequencies may be considered similar when falling within the same critical band.	[de Hoz, Livia; Nelken, Israel] Hebrew Univ Jerusalem, Dept Neurobiol, Silberman Inst Life Sci, Jerusalem, Israel; [de Hoz, Livia; Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [de Hoz, Livia] Max Planck Inst Expt Med, D-37075 Gottingen, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Max Planck Society	de Hoz, L (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Silberman Inst Life Sci, Jerusalem, Israel.	de_hoz@em.mpg.de	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; de Hoz, Livia/0000-0002-5782-1120	EU (NovelTune consortium) [LSHM-CT-2006-037378]; German-Israeli Foundation (GIF) [1002/2008]; ELSC post-doctoral fellowship	EU (NovelTune consortium)(European Commission); German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); ELSC post-doctoral fellowship	This work was supported by EU grant LSHM-CT-2006-037378 (NovelTune consortium) and grant 1002/2008 from the German-Israeli Foundation (GIF) to IN, and by an ELSC post-doctoral fellowship to LdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clause A, 2011, J NEUROSCI METH, V200, P63, DOI 10.1016/j.jneumeth.2011.05.027; Egorova M, 2006, NEUROREPORT, V17, P1783, DOI 10.1097/01.wnr.0000239966.29308.fb; EHRET G, 1975, J COMP PHYSIOL, V102, P321, DOI 10.1007/BF01464344; EHRET G, 1976, BIOL CYBERN, V24, P35, DOI 10.1007/BF00365592; EHRET G, 1985, SCIENCE, V227, P1245, DOI 10.1126/science.3975613; EHRET G, 1977, NATURWISSENSCHAFTEN, V64, P461, DOI 10.1007/BF00446257; Ehret G, 1976, J Am Audiol Soc, V1, P179; Ehret Guenter, 2006, P85; Fay RR, 2005, HEARING RES, V205, P7, DOI 10.1016/j.heares.2005.02.006; HEFFNER H, 1980, J ACOUST SOC AM, V68, P1584, DOI 10.1121/1.385213; Heffner HF, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P19; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Kittel M, 2002, HEARING RES, V164, P69, DOI 10.1016/S0378-5955(01)00411-7; Klink KB, 2006, BEHAV RES METHODS, V38, P1, DOI 10.3758/BF03192744; Klink KB, 2010, JARO-J ASSOC RES OTO, V11, P79, DOI 10.1007/s10162-009-0186-7; Kurt S, 2010, P NATL ACAD SCI USA, V107, P8481, DOI 10.1073/pnas.0912357107; Lauer AM, 2009, LAB ANIMAL, V38, P154, DOI 10.1038/laban0509-154; LI HS, 1991, ACTA OTO-LARYNGOL, V111, P827, DOI 10.3109/00016489109138418; LUBOW RE, 1973, PSYCHOL BULL, V79, P398, DOI 10.1037/h0034425; Maier JK, 2006, J ACOUST SOC AM, V119, P1029, DOI 10.1121/1.2159429; Prosen CA, 2003, HEARING RES, V183, P44, DOI 10.1016/S0378-5955(03)00211-9; Radziwon KE, 2009, J COMP PHYSIOL A, V195, P961, DOI 10.1007/s00359-009-0472-1; Rodriguez G, 2011, LEARN BEHAV, V39, P79, DOI 10.3758/s13420-011-0022-x; SAUNDERS JC, 1980, BRAIN RES, V187, P69, DOI 10.1016/0006-8993(80)90495-3; Schechtman E, 2010, J NEUROSCI, V30, P10460, DOI 10.1523/JNEUROSCI.2377-10.2010; SIEGEL S, 1969, J COMP PHYSIOL PSYCH, V69, P157, DOI 10.1037/h0027950; Skottun BC, 2001, P NATL ACAD SCI USA, V98, P14050, DOI 10.1073/pnas.241513998; SOLOMON PR, 1975, J COMP PHYSIOL PSYCH, V89, P1192, DOI 10.1037/h0077183; Song L, 2008, J NEUROPHYSIOL, V99, P344, DOI 10.1152/jn.00983.2007; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Syka J, 1996, HEARING RES, V100, P107, DOI 10.1016/0378-5955(96)00101-3; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Talwar SK, 1998, HEARING RES, V126, P135, DOI 10.1016/S0378-5955(98)00162-2; von Markl H, 1973, Z TIERSPSYCHOL, V33, p[274, 286]; Xu JH, 2009, BEHAV BRAIN RES, V196, P49, DOI 10.1016/j.bbr.2008.07.018; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	38	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91676	10.1371/journal.pone.0091676	http://dx.doi.org/10.1371/journal.pone.0091676			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632841	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400078
J	Gerdes, JS; Walther, EU; Jaganjac, S; Makrigeorgi-Butera, M; Meuth, SG; Deppe, M				Gerdes, Jan S.; Walther, Ernst U.; Jaganjac, Suad; Makrigeorgi-Butera, Maria; Meuth, Sven G.; Deppe, Michael			Early Detection of Widespread Progressive Brain Injury after Cardiac Arrest: A Single Case DTI and Post-Mortem Histology Study	PLOS ONE			English	Article							STROKE; COMA	Objective: We tested the hypothesis in sense of a proof of principle that white matter (WM) degeneration after cardiopulmonary arrest (CPA) can be assessed much earlier by diffusion tensor imaging (DTI) than by conventional MRI. Methods: We performed DTI and T2-weighted FLAIR imaging over four serial acquisitions of a 76-year-old man with unresponsive wakefulness syndrome at day 41, 75, 173 and 284 after CPA. DTI was also performed in ten healthy control subjects. Fractional anisotropy (FA) derived from DTI was assessed in eleven regions of interest within the cerebral white matter (WM) and compared with post-mortem neuropathological findings. Results: In contrast to conventional FLAIR images that revealed only circumscribed WM damage, the first DTI demonstrated significant reduction of FA across the whole WM. The following FLAIR images (MRI 2-4) revealed increasing atrophy and leukoaraiosis paralleled by clinical deterioration with reduction of wakefulness and intractable seizures. Neuropathological findings confirmed the widespread and marked brain injury following CPA. Conclusion: DTI may help to evaluate microstructural brain damage following CPA and may have predictive value for further evolution of cerebral degeneration in the chronic phase after CPA.	[Gerdes, Jan S.; Walther, Ernst U.] Schon Klin Hamburg Eilbek, Dept Neurol, Hamburg, Germany; [Jaganjac, Suad] Schon Klin Hamburg Eilbek, Dept Radiol, Hamburg, Germany; [Makrigeorgi-Butera, Maria] MVZ Hanse Histologikum GmbH, Hamburg, Germany; [Meuth, Sven G.; Deppe, Michael] Univ Munster, Dept Neurol, D-48149 Munster, Germany	University of Munster	Deppe, M (corresponding author), Univ Munster, Dept Neurol, D-48149 Munster, Germany.	mail@Michael-Deppe.de	Meuth, Sven G/HHM-8941-2022; Deppe, Michael/C-5780-2017	Meuth, Sven G/0000-0003-2571-3501; Deppe, Michael/0000-0002-8372-9678				Arbelaez A, 1999, AM J NEURORADIOL, V20, P999; Benarroch EE, 2009, NEUROLOGY, V72, P1779, DOI 10.1212/WNL.0b013e3181a6b123; Chalela JA, 2001, NEUROLOGY, V56, P481, DOI 10.1212/WNL.56.4.481; Deppe M, 2008, NEUROLOGY, V71, P1981, DOI 10.1212/01.wnl.0000336969.98241.17; Deppe M, 2007, INVEST RADIOL, V42, P338, DOI 10.1097/01.rli.0000261935.41188.39; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Hohlfeld R, 2012, NAT MED, V18, P1743, DOI 10.1038/nm.3021; Keller SS, 2011, EPILEPSIA, V52, P1715, DOI 10.1111/j.1528-1167.2011.03117.x; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; KRUMHOLZ A, 1988, NEUROLOGY, V38, P401, DOI 10.1212/WNL.38.3.401; Meuth SG, 2009, NEUROBIOL DIS, V33, P1, DOI 10.1016/j.nbd.2008.09.006; Mohammadi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036851; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; PLUM F, 1962, ARCH INTERN MED, V110, P18, DOI 10.1001/archinte.1962.03620190020003; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f	17	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92103	10.1371/journal.pone.0092103	http://dx.doi.org/10.1371/journal.pone.0092103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633135	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400142
J	Halder, K; Banerjee, S; Bose, A; Majumder, S; Majumdar, S				Halder, Kuntal; Banerjee, Sayantan; Bose, Anamika; Majumder, Saikat; Majumdar, Subrata			Overexpressed PKC delta Downregulates the Expression of PKC alpha in B16F10 Melanoma: Induction of Apoptosis by PKC delta via Ceramide Generation	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHOLIPASE-D ACTIVITY; BREAST-CANCER CELLS; AKT DEPHOSPHORYLATION; ACID SPHINGOMYELINASE; SIGNAL-TRANSDUCTION; ISOFORMS; PROLIFERATION; ACTIVATION; PHOSPHORYLATION	In the present study, we observed a marked variation in the expression of PKC alpha and PKC delta isotypes in B16F10 melanoma tumor cells compared to the normal melanocytes. Interestingly, the tumor instructed expression or genetically manipulated overexpression of PKC alpha isotype resulted in enhanced G1 to S transition. This in turn promoted cellular proliferation by activating PLD1 expression and subsequent AKT phosphorylation, which eventually resulted in suppressed ceramide generation and apoptosis. On the other hand, B16F10 melanoma tumors preferentially blocked the expression of PKC delta isotype, which otherwise could exhibit antagonistic effects on PKC alpha-PLD1-AKT signaling and rendered B16F10 cells more sensitive to apoptosis via generating ceramide and subsequently triggering caspase pathway. Hence our data suggested a reciprocal PKC signaling operational in B16F10 melanoma cells, which regulates ceramide generation and provide important clues to target melanoma cancer by manipulating the PKC delta-ceramide axis.	[Halder, Kuntal; Banerjee, Sayantan; Bose, Anamika; Majumder, Saikat; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@bic.boseinst.ernet.in	Majumder, Saikat/ABC-2194-2020; BANERJEE, SAYANTAN/AAD-8420-2019	Majumder, Saikat/0000-0002-6591-9515; 				Bhattacharyya S, 2001, MOL CELL BIOCHEM, V216, P47, DOI 10.1023/A:1011048210691; Bieberich E, 2008, FUTURE LIPIDOL, V3, P273, DOI 10.2217/17460875.3.3.273; Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLEMENS MJ, 1992, J CELL SCI, V103, P881; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; da Rocha AB, 2002, ONCOLOGIST, V7, P17, DOI 10.1634/theoncologist.7-1-17; Dbaibo GS, 1998, APOPTOSIS, V3, P317, DOI 10.1023/A:1009668802718; Dey R, 2007, INFECT IMMUN, V75, P2136, DOI 10.1128/IAI.01589-06; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Foster DA, 2003, MOL CANCER RES, V1, P789; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; GOODNIGHT J, 1994, ADV CANCER RES, V64, P159, DOI 10.1016/S0065-230X(08)60838-6; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Haughian JM, 2006, ENDOCR-RELAT CANCER, V13, P1251, DOI 10.1677/erc.1.01278; Haughian JM, 2009, J CELL PHYSIOL, V220, P112, DOI 10.1002/jcp.21741; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Huang WC, 2011, J LIPIDS, V2011, DOI 10.1155/2011/565316; JONES MJ, 1995, J BIOL CHEM, V270, P5007, DOI 10.1074/jbc.270.10.5007; Kim NH, 2007, J CELL BIOCHEM, V102, P1160, DOI 10.1002/jcb.21344; Kim SW, 2010, J TOXICOL ENV HEAL A, V73, P1465, DOI 10.1080/15287394.2010.511553; Lahn MM, 2004, MELANOMA RES, V14, P85, DOI 10.1097/00008390-200404000-00002; MAJUMDAR S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P276, DOI 10.1016/0167-4889(93)90056-U; Mandil R, 2011, CANCER RES, V61, P4612; Marengo Barbara, 2011, Cancers (Basel), V3, P531, DOI 10.3390/cancers3010531; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Morse-Gaudio M, 1998, INT J ONCOL, V12, P1349; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oka M, 2003, J INVEST DERMATOL, V121, P69, DOI 10.1046/j.1523-1747.2003.12300.x; Osawa Y, 2013, J CLIN INVEST, V123, P834, DOI 10.1172/JCI65188; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Sudan R, 2012, J IMMUNOL, V188, P2328, DOI 10.4049/jimmunol.1101678; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Visnjic D, 1999, BIOCHEM J, V344, P921, DOI 10.1042/0264-6021:3440921; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	48	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91656	10.1371/journal.pone.0091656	http://dx.doi.org/10.1371/journal.pone.0091656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632809	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400075
J	van Hooren, KWEM; Spijkers, LJA; van Breevoort, D; Fernandez-Borja, M; Bierings, R; van Buul, JD; Alewijnse, AE; Peters, SLM; Voorberg, J				van Hooren, Kathinka W. E. M.; Spijkers, Leon J. A.; van Breevoort, Dorothee; Fernandez-Borja, Mar; Bierings, Ruben; van Buul, Jaap D.; Alewijnse, Astrid E.; Peters, Stephan L. M.; Voorberg, Jan			Sphingosine-1-Phosphate Receptor 3 Mediates Sphingosine-1-Phosphate Induced Release of Weibel-Palade Bodies from Endothelial Cells	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; CARDIOVASCULAR-SYSTEM; LYMPHOCYTE EGRESS; BODY EXOCYTOSIS; SECRETION; KINASE; S1P; PERMEABILITY; STIMULATION; VASOPRESSIN	Sphingosine-1-phosphate (S1P) is an agonist for five distinct G-protein coupled receptors, that is released by platelets, mast cells, erythrocytes and endothelial cells. S1P promotes endothelial cell barrier function and induces release of endothelial cell-specific storage-organelles designated Weibel-Palade bodies (WPBs). S1P-mediated enhancement of endothelial cell barrier function is dependent on S1P receptor 1 (S1PR1) mediated signaling events that result in the activation of the small GTPase Rac1. Recently, we have reported that Rac1 regulates epinephrine-induced WPB exocytosis following its activation by phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 1 (PREX1). S1P has also been described to induce WPB exocytosis. Here, we confirm that S1P induces release of WPBs using von Willebrand factor (VWF) as a marker. Using siRNA mediated knockdown of gene expression we show that S1PR1 is not involved in S1P-mediated release of WPBs. In contrast depletion of the S1PR3 greatly reduced S1P-induced release of VWF. S1P-mediated enhancement of endothelial barrier function was not affected by S1PR3-depletion whereas it was greatly impaired in cells lacking S1PR1. The Rho kinase inhibitor Y27632 completely abrogated S1P-mediated release of VWF. Also, the calcium chelator BAPTA-AM significantly reduced S1P-induced release of VWF. Our findings indicate that S1P-induced release of haemostatic, inflammatory and angiogenic components stored within WPBs depends on the S1PR3.	[van Hooren, Kathinka W. E. M.; van Breevoort, Dorothee; Bierings, Ruben; Voorberg, Jan] Sanquin AMC Landsteiner Lab, Dept Plasma Proteins, Amsterdam, Netherlands; [Spijkers, Leon J. A.; Alewijnse, Astrid E.; Peters, Stephan L. M.] Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands; [Fernandez-Borja, Mar; van Buul, Jaap D.] Sanquin AMC Landsteiner Lab, Dept Mol Cell Biol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Voorberg, J (corresponding author), Sanquin AMC Landsteiner Lab, Dept Plasma Proteins, Amsterdam, Netherlands.	j.voorberg@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021; Bierings, Ruben/AAQ-8854-2020	van Buul, Jaap D/0000-0003-0054-7949; Bierings, Ruben/0000-0002-1205-9689; Voorberg, Jan/0000-0003-4585-2621; van Breevoort, Dorothee/0000-0003-3122-0252	Landsteiner Foundation for Blood Transfusion Research [LSBR 08.19, LSBR 12.44]; European Hematology Association Research Fellowship	Landsteiner Foundation for Blood Transfusion Research; European Hematology Association Research Fellowship	This study was supported by grants from the Landsteiner Foundation for Blood Transfusion Research (LSBR 08.19, LSBR 12.44). RB was supported by a European Hematology Association Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewijnse AE, 2008, EUR J PHARMACOL, V585, P292, DOI 10.1016/j.ejphar.2008.02.089; An SZ, 1999, MOL PHARMACOL, V55, P787; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Brinkmann V, 2006, CURR OPIN PHARMACOL, V6, P244, DOI 10.1016/j.coph.2005.12.004; Curry FE, 2012, AM J PHYSIOL-HEART C, V303, pH825, DOI 10.1152/ajpheart.00181.2012; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hsieh HL, 2006, J CELL PHYSIOL, V207, P757, DOI 10.1002/jcp.20621; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Kozasa T, 1998, SEIKAGAKU, V70, P1418; Kumagai A, 2008, ATHEROSCLEROSIS, V200, P45, DOI 10.1016/j.atherosclerosis.2007.12.010; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsushita K, 2004, P NATL ACAD SCI USA, V101, P11483, DOI 10.1073/pnas.0400185101; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Murata N, 2000, ANAL BIOCHEM, V282, P115, DOI 10.1006/abio.2000.4580; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR; Nightingale TD, 2012, TRENDS CELL BIOL, V22, P329, DOI 10.1016/j.tcb.2012.03.003; Ono Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-20; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Ozaka T, 1997, ANAT REC, V247, P388, DOI 10.1002/(SICI)1097-0185(199703)247:3<388::AID-AR10>3.0.CO;2-L; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Russell FD, 1998, CIRC RES, V83, P314, DOI 10.1161/01.RES.83.3.314; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; STEL HV, 1984, BLOOD, V63, P1408; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tanski W, 2002, J SURG RES, V108, P98, DOI 10.1006/jsre.2002.6529; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; van Breevoort D, 2012, J PROTEOME RES, V11, P2925, DOI 10.1021/pr300010r; van Hooren KWEM, 2012, J BIOL CHEM, V287, P24713, DOI 10.1074/jbc.M111.321976; van Hooren KW, 2013, J THROMB HAEMOST; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P1182; Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Zhang L, 2013, BLOOD, V122, P791, DOI 10.1182/blood-2012-12-473884	48	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91346	10.1371/journal.pone.0091346	http://dx.doi.org/10.1371/journal.pone.0091346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632890	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400057
J	Wartolowska, K; Beard, DJ; Carr, AJ				Wartolowska, Karolina; Beard, David J.; Carr, Andrew J.			Attitudes and Beliefs about Placebo Surgery among Orthopedic Shoulder Surgeons in the United Kingdom	PLOS ONE			English	Article							CLINICAL-PRACTICE; SHAM SURGERY; QUESTIONNAIRE SURVEY; CONTROLLED TRIAL; INTERVENTIONS	Objectives: To survey surgeons on their beliefs and attitudes towards the use of placebo in surgery. Methods: British orthopedic shoulder surgeons, attending a national conference in the United Kingdom, were asked to complete a self-report online questionnaire about their beliefs and attitudes towards the use of placebo related to surgical intervention. The survey included questions about ethical issues, the mechanism of placebo effects, and any concerns regarding its use. Results: 100 surgeons who participated in the survey believed that placebo surgery is ethically acceptable (96%), especially as a part of a clinical trial (46%). Respondents thought that a placebo effect in surgery is real i.e. has a scientific basis (92%), that placebo can be therapeutically beneficial (77%), and that it involves psychological mechanisms (96%). Over half of the respondents (58%) have used a surgical procedure with a significant placebo component at least once in their professional career. Their main concern about placebo use in surgery was that it might involve an element of deception. Conclusions and Implications: Surgeons generally agreed that a placebo component to surgical intervention might exist. They also supported placebo use in clinical trials and considered it ethical, providing it does not involve deception of patients. More studies are needed, particularly among other surgical specialties and with larger numbers of participants, to better understand the use of placebo in surgery.	[Wartolowska, Karolina; Beard, David J.; Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Botnar Inst Musculoskeletal Sci, Oxford, England	University of Oxford	Wartolowska, K (corresponding author), Univ Oxford, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Botnar Inst Musculoskeletal Sci, Oxford, England.	karolina.wartolowska@ndorms.ox.ac.uk	Wartolowska, Karolina/D-3968-2015	Beard, David/0000-0001-7884-6389; Wartolowska, Karolina A./0000-0003-4049-2364	NIHR Musculoskeletal Biomedical Research Unit; National Institute for Health Research [NF-SI-0611-10216] Funding Source: researchfish	NIHR Musculoskeletal Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the NIHR Musculoskeletal Biomedical Research Unit. The funder had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.	Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2002, EVAL HEALTH PROF, V25, P369, DOI 10.1177/0163278702238051; Bostick NA, 2008, J CLIN ETHIC, V19, P58; Campbell MK, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-50; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; England TRCoSo, 2011, SURG WORKF CENS REP; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Frank SA, 2008, MOVEMENT DISORD, V23, P63, DOI 10.1002/mds.21775; Gelijns AC, 2009, SURGERY, V145, P581, DOI 10.1016/j.surg.2009.04.003; Horng S, 2003, CRIT CARE MED, V31, pS126, DOI 10.1097/01.CCM.0000054906.49187.67; Howes N, 1997, BRIT J SURG, V84, P1220; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hull SC, 2013, BMJ, V347; Kim SYH, 2012, MOVEMENT DISORD, V27, P1461, DOI 10.1002/mds.25155; Macklin R, 1999, NEW ENGL J MED, V341, P992, DOI 10.1056/NEJM199909233411312; Miller FG, 2003, AM J BIOETHICS, V3, P41, DOI 10.1162/152651603322614580; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Raz A, 2011, CAN J PSYCHIAT, V56, P198, DOI 10.1177/070674371105600403; SHAPIRO AK, 1960, J NERV MENT DIS, V130, P200, DOI 10.1097/00005053-196003000-00003; SHAPIRO AK, 1973, COMPR PSYCHIAT, V14, P107, DOI 10.1016/0010-440X(73)90003-5; Shermon R, 2008, J GEN INTERN MED, V23, P7, DOI 10.1007/s11606-007-0332-z; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; Tenery R, 2002, ANN SURG, V235, P303, DOI 10.1097/00000658-200202000-00021; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Wenner DM, 2012, J AM COLL SURGEONS, V215, P722, DOI 10.1016/j.jamcollsurg.2012.06.018; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wright JG, 2011, J BONE JOINT SURG AM, V93A, P510, DOI 10.2106/JBJS.J.01039	32	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91699	10.1371/journal.pone.0091699	http://dx.doi.org/10.1371/journal.pone.0091699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632880	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400079
J	Yuan, WJ; Xia, CY				Yuan, Wu-Jie; Xia, Cheng-Yi			Role of Investment Heterogeneity in the Cooperation on Spatial Public Goods Game	PLOS ONE			English	Article							PROMOTES COOPERATION; INDIRECT RECIPROCITY; NETWORK RECIPROCITY; EVOLUTIONARY GAMES; EMERGENCE	Public cooperation plays a significant role in the survival and maintenance of biological species, to elucidate its origin thus becomes an interesting question from various disciplines. Through long-term development, the public goods game has proven to be a useful tool, where cooperator making contribution can beat again the free-rides. Differentiating from the traditional homogeneous investment, individual trend of making contribution is more likely affected by the investment level of his neighborhood. Based on this fact, we here investigate the impact of heterogeneous investment on public cooperation, where the investment sum is mapped to the proportion of cooperators determined by parameter a. Interestingly, we find, irrespective of interaction networks, that the increment of a ( increment of heterogeneous investment) is beneficial for promoting cooperation and even guarantees the complete cooperation dominance under weak replication factor. While this promotion effect can be attributed to the formation of more robust cooperator clusters and shortening END period. Moreover, we find that this simple mechanism can change the potential interaction network, which results in the change of phase diagrams. We hope that our work may shed light on the understanding of the cooperative behavior in other social dilemmas.	[Yuan, Wu-Jie] Huaibei Normal Univ, Coll Phys & Elect Informat, Huaibei, Peoples R China; [Xia, Cheng-Yi] Tianjin Univ Technol, Tianjin Key Lab Intelligence Comp & Novel Softwar, Minist Educ, Key Lab Comp Vis & Syst, Tianjin, Peoples R China	Huaibei Normal University; Tianjin University of Technology	Xia, CY (corresponding author), Tianjin Univ Technol, Tianjin Key Lab Intelligence Comp & Novel Softwar, Minist Educ, Key Lab Comp Vis & Syst, Tianjin, Peoples R China.	xialooking@163.com	Xia, Chengyi/A-2752-2012	Xia, Chengyi/0000-0003-2686-5072	National Natural Science Foundation of China (NSFC) [61374169, 11005047]; Young University Teacher's Fund of Anhui Province in China [2008jql071]; Young Fund of Huaibei Normal University [2013xqz17]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Young University Teacher's Fund of Anhui Province in China; Young Fund of Huaibei Normal University	This project is partially supported by the National Natural Science Foundation of China (NSFC) under Grant Nos. 61374169 and 11005047, the Young University Teacher's Fund of Anhui Province in China under Grant No. 2008jql071, and the Young Fund of Huaibei Normal University under Grant No. 2013xqz17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Du WB, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/60004; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2007, ANNU REV SOCIOL, V33, P43, DOI 10.1146/annurev.soc.33.040406.131812; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Jin Q, 2012, CHAOS SOLITON FRACT, V45, P395, DOI 10.1016/j.chaos.2012.01.004; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ostrom E., 1990, GOVERNING COMMONS EV; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Shigaki K, 2012, PLOS ONE, V8; Shigaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076942; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041021; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Wang Z, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/11/110201; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wang Z, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/10/100204; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xu ZJ, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/20001; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zhang GQ, 2013, CHAOS SOLITON FRACT, V51, P31, DOI 10.1016/j.chaos.2013.03.003; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006	54	48	48	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91012	10.1371/journal.pone.0091012	http://dx.doi.org/10.1371/journal.pone.0091012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632779	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400033
J	Kovacik, J; Babula, P; Klejdus, B; Hedbavny, J; Jarosova, M				Kovacik, Jozef; Babula, Petr; Klejdus, Borivoj; Hedbavny, Josef; Jarosova, Marketa			Unexpected Behavior of Some Nitric Oxide Modulators under Cadmium Excess in Plant Tissue	PLOS ONE			English	Article							HEAVY-METALS; CROSS-TALK; COPPER; TOXICITY; OXYGEN; L.; QUANTIFICATION; PHYTOCHELATINS; COUNTERACTS; METABOLISM	Various nitric oxide modulators (NO donors - SNP, GSNO, DEA NONOate and scavengers - PTIO, cPTIO) were tested to highlight the role of NO under Cd excess in various ontogenetic stages of chamomile (Matricaria chamomilla). Surprisingly, compared to Cd alone, SNP and PTIO elevated Cd uptake (confirmed also by PhenGreen staining) but depleted glutathione (partially ascorbic acid) and phytochelatins PC2 and PC3 in both older plants (cultured hydroponically) and seedlings (cultured in deionised water). Despite these anomalous impacts, fluorescence staining of NO and ROS confirmed predictable assumptions and revealed reciprocal changes (decrease in NO but increase in ROS after PTIO addition and the opposite after SNP application). Subsequent tests using alternative modulators and seedlings confirmed changes to NO and ROS after application of GSNO and DEA NONOate as mentioned above for SNP while cPTIO altered only NO level (depletion). On the contrary to SNP and PTIO, GSNO, DEA NONOate and cPTIO did not elevate Cd content and phytochelatins (PC2, PC3) were rather elevated. These data provide evidence that various NO modulators are useful in terms of NO and ROS manipulation but interactions with intact plants affect metal uptake and must therefore be used with caution. In this view, cPTIO and DEA NONOate revealed the less pronounced side impacts and are recommended as suitable NO scavenger/donor in plant physiological studies under Cd excess.	[Kovacik, Jozef; Klejdus, Borivoj; Hedbavny, Josef; Jarosova, Marketa] Mendel Univ Brno, Fac Agron, Inst Chem & Biochem, Brno, Czech Republic; [Kovacik, Jozef; Klejdus, Borivoj] Mendel Univ Brno, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Babula, Petr] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Nat Drugs, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno; University of Veterinary Sciences Brno	Kovacik, J (corresponding author), Mendel Univ Brno, Fac Agron, Inst Chem & Biochem, Brno, Czech Republic.	jozkovacik@yahoo.com	Hedbavny, Josef/AAH-1368-2020; Klejdus, Borivoj/D-8490-2012; Kovacik, Jozef/E-1688-2012; Babula, Petr/AAL-6510-2020	Hedbavny, Josef/0000-0001-6769-3639; Klejdus, Borivoj/0000-0002-5557-5771; Kovacik, Jozef/0000-0002-5701-0598	European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; OP Education for Competitiveness (European Social Fund and the state budget of the Czech Republic) [CZ.1.07/2.3.00/30.0017]; Internal Grant Agency of Faculty of Agronomy, Mendel University [IP 17/2013]	European Regional Development Fund(European Commission); OP Education for Competitiveness (European Social Fund and the state budget of the Czech Republic); Internal Grant Agency of Faculty of Agronomy, Mendel University	This work was realized in CEITEC - Central European Institute of Technology with research infrastructure supported by the project CZ.1.05/1.1.00/02.0068 financed from European Regional Development Fund. The work was also supported by OP Education for Competitiveness (European Social Fund and the state budget of the Czech Republic) CZ.1.07/2.3.00/30.0017 Postdocs in Biological Sciences at MENDELU and partially by Internal Grant Agency of Faculty of Agronomy, Mendel University (project IP 17/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaki M, 2011, PLANT CELL PHYSIOL, V52, P2006, DOI 10.1093/pcp/pcr133; Akhter MF, 2012, J PLANT PHYSIOL, V169, P1821, DOI 10.1016/j.jplph.2012.07.011; Arasimowicz M, 2007, PLANT SCI, V172, P876, DOI 10.1016/j.plantsci.2007.02.005; Brautigam A, 2010, ANAL BIOANAL CHEM, V398, P877, DOI 10.1007/s00216-010-3970-7; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; Gajewska E, 2010, ECOTOX ENVIRON SAFE, V73, P996, DOI 10.1016/j.ecoenv.2010.02.013; Hose E, 2001, J EXP BOT, V52, P2245, DOI 10.1093/jexbot/52.365.2245; Kazemi N, 2010, SCI HORTIC-AMSTERDAM, V126, P402, DOI 10.1016/j.scienta.2010.07.037; Kopyra M, 2003, PLANT PHYSIOL BIOCH, V41, P1011, DOI 10.1016/j.plaphy.2003.09.003; Kovacik J, 2008, ECOTOXICOLOGY, V17, P471, DOI 10.1007/s10646-008-0200-6; Kovacik J, 2014, PLANT SCI, V215, P1, DOI 10.1016/j.plantsci.2013.10.015; Kovacik J, 2013, J AGR FOOD CHEM, V61, P7864, DOI 10.1021/jf401575a; Kovacik J, 2012, J HAZARD MATER, V239, P175, DOI 10.1016/j.jhazmat.2012.08.062; Kovacik J, 2011, J PLANT PHYSIOL, V168, P576, DOI 10.1016/j.jplph.2010.09.011; Kovacik J, 2010, PLANT SCI, V179, P383, DOI 10.1016/j.plantsci.2010.06.014; Kovacik J, 2009, PLANT SOIL, V320, P231, DOI 10.1007/s11104-009-9889-0; Leterrier M, 2011, PLANT SIGNAL BEHAV, V6, P789, DOI 10.4161/psb.6.6.15161; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Ma WW, 2010, PLANTA, V232, P325, DOI 10.1007/s00425-010-1177-y; Murgia I, 2004, J PLANT PHYSIOL, V161, P777, DOI 10.1016/j.jplph.2003.12.004; Najmanova J, 2012, IND CROP PROD, V36, P536, DOI 10.1016/j.indcrop.2011.11.008; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Peng L, 2013, PLANT BIOLOGY, V15, P405, DOI 10.1111/j.1438-8677.2012.00630.x; Qiu ZB, 2013, ACTA PHYSIOL PLANT, V35, P65, DOI 10.1007/s11738-012-1048-1; Rodriguez-Serrano M, 2009, PLANT PHYSIOL, V150, P229, DOI 10.1104/pp.108.131524; Shingles R, 2004, PLANT PHYSIOL, V135, P145, DOI 10.1104/pp.103.037895; Simontacchi M, 2012, PLANT SCI, V183, P159, DOI 10.1016/j.plantsci.2011.08.006; Stork F, 2013, ENVIRON SCI POLLUT R, V20, P5502, DOI 10.1007/s11356-013-1541-0; Verma K, 2013, BIOMETALS, V26, P255, DOI 10.1007/s10534-013-9608-4; Vollenweider P, 2006, ENVIRON EXP BOT, V58, P25, DOI [10.1016/j.envexpbot.2005.06.012, 10.1016/j.envexpbot.2005.06.017]; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017; Zhang L, 2012, J ENVIRON SCI, V24, P940, DOI 10.1016/S1001-0742(11)60978-9; Zhang ZH, 2012, CELL CHEM TECHNOL, V46, P157	33	53	57	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91685	10.1371/journal.pone.0091685	http://dx.doi.org/10.1371/journal.pone.0091685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626462	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300120
J	Zhang, Q; Ran, X; Wang, DW				Zhang, Qin; Ran, Xiao; Wang, Dao Wen			Relation of Plasma Tissue Kallikrein Levels to Presence and Severity of Coronary Artery Disease in a Chinese Population	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; HEART-DISEASE; BLOOD-PRESSURE; KININ SYSTEM; ISCHEMIC-STROKE; RENAL-DISEASES; GENE; DELIVERY; RISK; INFLAMMATION	Objectives: Tissue kallikrein (TK) has been shown to provide cardiovascular and cerebrovascular protective effects in animal models. The aim of this study was to investigate the relationship of plasma TK levels with the presence and severity of coronary artery disease (CAD) in the Chinese. Methods: The study involved 898 consecutive CAD patients and 905 ethnically and geographically matched controls. CAD was angiographically confirmed in all the patients, and the severity of CAD was expressed by the number of affected vessel and coronary artery stenosis scores. Plasma TK levels were measured using an enzyme-linked immunosorbent assay. Results: Plasma TK levels were significantly higher in CAD patients than controls (0.347+/-.082 vs. 0.256+/-0.087 mg/L, P<0.001), and elevated plasma TK levels were directly associated with a higher risk of CAD (OR = 3.49, 95% CI 2.90-4.19). One-way ANOVA and multivariable stepwise linear regression analysis demonstrated that TK levels were negatively associated with the severity of CAD according to vessel scores (P<0.001) and stenosis scores (r = 20.211, p<0.001). Conclusions: Our findings suggest that higher levels of TK in plasma are associated with the presence of CAD and are a predictor of mild coronary arteriosclerosis.	[Zhang, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Anesthesia, Tongji Hosp, Wuhan 430074, Peoples R China; [Ran, Xiao] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Emergency, Tongji Hosp, Wuhan 430074, Peoples R China; [Wang, Dao Wen] Huazhong Univ Sci & Technol, Inst Hypertens, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, DW (corresponding author), Huazhong Univ Sci & Technol, Inst Hypertens, Tongji Med Coll, Wuhan 430074, Peoples R China.	dwwang@tjh.tjmu.edu.cn		Wang, Dao Wen/0000-0002-9774-3980	National "863'' projects [2006AA02A406]; Natural Science Foundation [81100864]; Ministry of Health of the People's Republic of China	National "863'' projects(National High Technology Research and Development Program of China); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Health of the People's Republic of China	This work was supported by grants from National "863'' projects (No. 2006AA02A406), Natural Science Foundation (No. 81100864) and 2010 Clinical Key Disciplines Construction Grant from the Ministry of Health of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson BL, 1999, CIRCULATION, V99, P1810, DOI 10.1161/01.CIR.99.14.1810; Agata J, 2002, HYPERTENSION, V40, P653, DOI 10.1161/01.HYP.0000036035.41122.99; Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Campbell DJ, 2010, DIABETOLOGIA, V53, P779, DOI 10.1007/s00125-009-1645-8; Chao J, 2005, EXP PHYSIOL, V90, P291, DOI 10.1113/expphysiol.2004.028464; Chao J, 2006, BIOL CHEM, V387, P665, DOI 10.1515/BC.2006.085; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Diamandis EP, 2000, CLIN CHEM, V46, P1855; Federico Cacciapuoti, 2010, Heart Views, V11, P10; FEILD DJ, 1987, J AM COLL CARDIOL, V10, P935, DOI 10.1016/S0735-1097(87)80294-2; GOTTO AM, 1986, AM J MED, V80, P48, DOI 10.1016/0002-9343(86)90160-9; Griol-Charhbili V, 2005, FASEB J, V19, P1172, DOI 10.1096/fj.04-3508fje; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HOLMES DR, 1981, CIRCULATION, V63, P293, DOI 10.1161/01.CIR.63.2.293; Kayashima Y, 2012, CURR OPIN NEPHROL HY, V21, P92, DOI 10.1097/MNH.0b013e32834d54b1; Koch M, 2006, EUR J PHARMACOL, V550, P143, DOI 10.1016/j.ejphar.2006.08.054; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Moran Andrew, 2008, BMC Public Health, V8, P394, DOI 10.1186/1471-2458-8-394; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Murakami H, 1999, HYPERTENSION, V34, P164, DOI 10.1161/01.HYP.34.2.164; PETTERSSON A, 1986, EUR HEART J, V7, P693, DOI 10.1093/oxfordjournals.eurheartj.a062124; Poulter N, 1999, AM J HYPERTENS, V12, p92S; Sharma JN, 2004, PHARMACOLOGY, V70, P201, DOI 10.1159/000075549; Smith S C Jr, 2000, Circulation, V101, pE12; SRINIVASAN SR, 1995, CLIN CHEM, V41, P159; Tu L, 2008, HUM GENE THER, V19, P318, DOI 10.1089/hum.2007.138; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; XIONG W, 1995, HYPERTENSION, V25, P715, DOI 10.1161/01.HYP.25.4.715; Xu YJ, 2011, PHARMACOGENET GENOM, V21, P489, DOI 10.1097/FPC.0b013e3283485eb2; Yin H, 2008, LIFE SCI, V82, P156, DOI 10.1016/j.lfs.2007.10.021; Yoshida H, 2000, HYPERTENSION, V35, P25, DOI 10.1161/01.HYP.35.1.25; Yuan G, 2007, ENDOCRINOLOGY, V148, P2016, DOI 10.1210/en.2006-0602; Zhang Q, 2011, ANN NEUROL, V70, P265, DOI 10.1002/ana.22404; ZINNER SH, 1978, CIRCULATION, V58, P908, DOI 10.1161/01.CIR.58.5.908	35	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91780	10.1371/journal.pone.0091780	http://dx.doi.org/10.1371/journal.pone.0091780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626253	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300133
J	El-Mesallamy, HO; Diab, MR; Hamdy, NM; Dardir, SM				El-Mesallamy, Hala O.; Diab, Mohamed R.; Hamdy, Nadia M.; Dardir, Sarah M.			Cell-Based Regenerative Strategies for Treatment of Diabetic Skin Wounds, a Comparative Study between Human Umbilical Cord Blood-Mononuclear Cells and Calves' Blood Haemodialysate	PLOS ONE			English	Article							INOSITOL PHOSPHATE-OLIGOSACCHARIDES; MESENCHYMAL STEM-CELLS; NITRIC-OXIDE; BONE-MARROW; IN-VIVO; ASYMMETRIC DIMETHYLARGININE; OXIDATIVE STRESS; GROWTH-FACTORS; TRANSPLANTATION; GLUTAMINE	Background: Diabetes-related foot problems are bound to increase. However, medical therapies for wound care are limited; therefore, the need for development of new treatment modalities to improve wound healing in diabetic patients is essential and constitutes an emerging field of investigation. Methods: Animals were randomly divided into 8 groups (I-VIII) (32 rats/group), all were streptozotocin (STZ)-induced diabetics except groups III and VIII were non-diabetic controls. The study comprised two experiments; the first included 3 groups. Group I injected with mononuclear cells (MNCs) derived from human umbilical cord blood (HUCB), group II a diabetic control group (PBS i.v). The second experiment included 5 groups, groups IV, V, and VI received topical HUCB-haemodialysate (HD), calves' blood HD, and solcoseryl, respectively. Group VII was the diabetic control group (topical saline). Standard circular wounds were created on the back of rats. A sample of each type of HD was analyzed using the high performance liquid chromatography-electrospray ionization-mass spectrometry (HPLC-ESI-MS) system. Wound area measurement and photography were carried out every 4 days. Plasma glucose, catalase (CAT), malondialdehyde (MDA), nitric oxide (NO) and platelets count were assessed. Wound samples were excised for hydroxyproline (HP) and histopathological study. Results: Treatment with HUCB MNCs or HUCB-HD resulted in wound contraction, increased CAT, NO, platelets count, body weights, and HP content, and decreased MDA and glucose. Conclusion: Systemic administration of HUCB MNCs and topical application of the newly prepared HUCB-HD or calves' blood HD significantly accelerated the rate of diabetic wound healing and would open the possibility of their future use in regenerative medicine.	[El-Mesallamy, Hala O.; Hamdy, Nadia M.] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Diab, Mohamed R.; Dardir, Sarah M.] Holding Co Biol Prod & Vaccines VACSERA, Res Dept, Giza, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University	El-Mesallamy, HO (corresponding author), Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	hala.elmesallamy@hotmail.com	Hamdy, Nadia/AAB-6087-2021	Hamdy, Nadia/0000-0003-2105-107X				AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al Bayaty F, 2010, SCI RES ESSAYS, V5, P2756; Al-Watban FAH, 2001, LASER MED SCI, V16, P267, DOI 10.1007/PL00011363; Badiavas EV, 2003, ARCH DERMATOL, V139, P510, DOI 10.1001/archderm.139.4.510; Banchroft J.D., 1996, THEORY PRACTICE HIST; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Barua CC, 2009, INDIAN J EXP BIOL, V47, P1001; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bloomgarden ZT, 2008, DIABETES CARE, V31, P372, DOI 10.2337/dc08-zb02; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Calder PC, 1999, AMINO ACIDS, V17, P227, DOI 10.1007/BF01366922; Chen HK, 2005, EUR J CLIN INVEST, V35, P677, DOI 10.1111/j.1365-2362.2005.01565.x; Dashti N, 2004, PAK J MED SCI, V20, P211; DRI P, 1989, ARZNEIMITTEL-FORSCH, V39-2, P1565; Ende N, 2004, BIOCHEM BIOPH RES CO, V321, P168, DOI 10.1016/j.bbrc.2004.06.121; ERIKSSON U, 1983, UPSALA J MED SCI, V88, P17, DOI 10.3109/03009738309178434; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102; Ghoneimi IG, 1997, ANN BURNS FIRE DISAS, V10, P219; GOTTSCHALK WK, 1988, ARCH BIOCHEM BIOPHYS, V261, P175, DOI 10.1016/0003-9861(88)90116-6; Grewal SS, 2003, BLOOD, V101, P4233, DOI 10.1182/blood-2002-08-2510; Gu L, 2007, ANAL CHEM, V79, P8067, DOI 10.1021/ac070938b; Gupta R, 2009, AMINO ACIDS, V37, P271, DOI 10.1007/s00726-008-0143-5; Gurdol F, 2010, PHYSIOL RES, V59, P423, DOI 10.33549/physiolres.931702; Hamed S, 2010, J INVEST DERMATOL, V130, P287, DOI 10.1038/jid.2009.219; Hinchliffe RJ, 2008, DIABETES-METAB RES, V24, pS119, DOI 10.1002/dmrr.825; ISLER H, 1991, BURNS, V17, P93, DOI 10.1016/0305-4179(91)90130-9; Kim JY, 2010, CELL TRANSPLANT, V19, P1635, DOI 10.3727/096368910X516637; Koblas Tomas, 2005, Rev Diabet Stud, V2, P228, DOI 10.1900/RDS.2005.2.228; KONTUREK SJ, 1988, HEPATO-GASTROENTEROL, V35, P25; Lavery LA, 2003, DIABETES CARE, V26, P1435, DOI 10.2337/diacare.26.5.1435; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Lu W, 2009, EXPERT REV DERMATOL, V4, P97; MACHICAO F, 1990, BIOCHEM J, V266, P909; Markiel Z, 2002, POL, V4, P167; MONTGOMERY H, 1961, ANALYST, V86, P414; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; Nayak Shivananda, 2006, BMC Complement Altern Med, V6, P12, DOI 10.1186/1472-6882-6-12; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; NIINIKOSKI J, 1979, ACTA CHIR SCAND, V145, P287; Nwanjo HU, 2007, AFR J BIOTECHNOL, V6, P1744; OBERMAIERKUSSER B, 1989, BIOCHEM J, V261, P699, DOI 10.1042/bj2610699; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Peacock Jr EE, 1984, WOUND REPAIR STRUCTU; Pessina A, 2004, BIOCHEM BIOPH RES CO, V323, P315, DOI 10.1016/j.bbrc.2004.08.088; Phuc PV, 2010, IFMBE PROC, V27, P163, DOI 10.1007/978-3-642-12020-6_40; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; SCHONWALD D, 1991, RES EXP MED, V191, P259, DOI 10.1007/BF02576682; Schwentker A, 2003, SURG CLIN N AM, V83, P521, DOI 10.1016/S0039-6109(02)00207-4; Shi CM, 2006, TRENDS BIOTECHNOL, V24, P48, DOI 10.1016/j.tibtech.2005.11.003; Shi CM, 2004, RADIAT RES, V162, P56, DOI 10.1667/RR3189; Shumakov VI, 2003, B EXP BIOL MED+, V136, P192, DOI 10.1023/A:1026387411627; SIMA AAF, 1988, DIABETES, V37, P544, DOI 10.2337/diabetes.37.5.544; Soneja A, 2005, PHARMACOL REP, V57, P108; Sumitra M, 2009, SCHOLARLY RES EXCHAN, V2009; Sur TK, 2003, ACTA PHARMACOL SIN, V24, P187; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Toker S, 2009, AM J MED SCI, V338, P201, DOI 10.1097/MAJ.0b013e3181aaf209; TRINDER P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158; Trousdale RK, 2009, J SURG RES, V151, P100, DOI 10.1016/j.jss.2008.01.023; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wilmink JM, 2000, J VET MED A, V47, P311, DOI 10.1046/j.1439-0442.2000.00287.x; Wilmore DW, 2001, J NUTR, V131, p2543S, DOI 10.1093/jn/131.9.2543S; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yoshikawa T, 2008, PLAST RECONSTR SURG, V121, P860, DOI 10.1097/01.prs.0000299922.96006.24	66	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e89853	10.1371/journal.pone.0089853	http://dx.doi.org/10.1371/journal.pone.0089853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643010	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900004
J	Guimaraes, AMS; Santos, AP; do Nascimento, NC; Timenetsky, J; Messick, JB				Guimaraes, Ana M. S.; Santos, Andrea P.; do Nascimento, Naila C.; Timenetsky, Jorge; Messick, Joanne B.			Comparative Genomics and Phylogenomics of Hemotrophic Mycoplasmas	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; RIBOSOMAL-RNA GENE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HAEMOBARTONELLA-CANIS; SEQUENCE; IDENTIFICATION; STRAIN; EPERYTHROZOON; HAEMOFELIS; EXPRESSION	Hemotrophic mycoplasmas (hemoplasmas) are a group of animal pathogens of the Mollicutes class. Recently, the genomes of 8 hemoplasmas have been completely sequenced. The aim of this study was to gain a better understanding of their genomic features and relationship to other Mycoplasma species. The genome structure and dynamics of hemoplasmas were analyzed by evaluating gene synteny, adaptive evolution of paralogous gene families (PGF) and horizontal gene transfer (HGT). The Mollicutes class was then phylogenetically analyzed by constructing a distance matrix of the 16S rRNA genes and a phylogenetic tree with 32 conserved, concatenated proteins. Our results suggest that the hemoplasmas have dynamic genomes. The genome size variation (from 547 to 1,545 genes) indicates substantial gene gain/loss throughout evolution. Poorly conserved gene syntenies among hemoplasmas, positional shuffling of paralogous genes between strains, HGT, and codons under positive selection in PGFs were also observed. When compared to other Mollicutes species, the hemoplasmas experienced further metabolic reduction, and the 16S rRNA gene distance matrix of the available mollicutes suggests that these organisms presently constitute the most divergent clade within its class. Our phylogenetic tree of concatenated proteins showed some differences when compared to the 16S rRNA gene tree, but non-mycoplasma organisms, such as Ureaplasma spp. and Mesoplasma spp., continue to branch within Mycoplasma clades. In conclusion, while the hemoplasmas experienced further metabolic shrinkage through gene loss, PGFs with positively selected codons are likely beneficial to these species. Phylogeny of the mollicutes based on 16S rRNA genes or concatenated proteins do not obey the current taxonomy. The metabolism and genetic diversity of the mollicutes, the presence of HGT, and lack of standard for genus circumscription are likely to hinder attempts to classify these organisms based on phylogenetic analyses.	[Guimaraes, Ana M. S.; Santos, Andrea P.; do Nascimento, Naila C.; Messick, Joanne B.] Purdue Univ, Sch Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Guimaraes, Ana M. S.] Minist Educ, Fulbright Program, CAPES, Brasilia, DF, Brazil; [Timenetsky, Jorge] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508 Sao Paulo, Brazil	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Universidade de Sao Paulo	Messick, JB (corresponding author), Purdue Univ, Sch Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	jmessic@purdue.edu	dos Santos, Andrea Pires/O-5371-2019; Guimaraes, Ana M. S./N-5603-2016	dos Santos, Andrea Pires/0000-0002-1037-970X; Guimaraes, Ana/0000-0002-8261-5863; Cannes do Nascimento, Naila/0000-0001-6233-2447	Morris Animal Foundation [D10FE-004]; Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fulbright Commission - Fulbright-Capes Scholarship Program; CAPES-Fulbright Program [167307/6]	Morris Animal Foundation; Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fulbright Commission - Fulbright-Capes Scholarship Program; CAPES-Fulbright Program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding support was provided from Morris Animal Foundation, project number D10FE-004. Funding support for PhD studies was provided by the Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fulbright Commission - Fulbright-Capes Scholarship Program. CAPES-Fulbright Program, ID 167307/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andam CP, 2010, P NATL ACAD SCI USA, V107, P10679, DOI 10.1073/pnas.1001418107; [Anonymous], 2006, STOCHCHAR PACKAGE ME; Arutyunov DY, 2003, BIOCHEM BIOPH RES CO, V300, P149, DOI 10.1016/S0006-291X(02)02802-4; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Barker EN, 2012, J BACTERIOL, V194, P905, DOI 10.1128/JB.06560-11; Barker EN, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-83; Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318; Birkenheuer AJ, 2002, AM J VET RES, V63, P1385, DOI 10.2460/ajvr.2002.63.1385; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Bordenstein SR, 2005, NAT REV MICROBIOL, V3, P688, DOI 10.1038/nrmicro1233; BOYD DA, 1995, J BACTERIOL, V177, P2622, DOI 10.1128/jb.177.10.2622-2627.1995; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; Brinson JJ, 2001, J AM VET MED ASSOC, V218, P1943, DOI 10.2460/javma.2001.218.1943; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Coin L, 2004, BIOINFORMATICS, V20, P94, DOI 10.1093/bioinformatics/bth942; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; do Nascimento NC, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-66; dos Santos AP, 2012, J BACTERIOL, V194, P5758, DOI 10.1128/JB.01240-12; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emes RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002295; Garzon-Ospina D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045962; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Guimaraes AMS, 2012, J BACTERIOL, V194, P6312, DOI 10.1128/JB.01557-12; Guimaraes AMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019574; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P285, DOI 10.1099/ijs.0.001792-0; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035698; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Maddison WP, 2009, MESQUITE MODULAR SYS; Messick JB, 2004, VET CLIN PATH, V33, P2, DOI 10.1111/j.1939-165X.2004.tb00342.x; Messick JB, 2011, CLIN VACCINE IMMUNOL, V18, P1275, DOI 10.1128/CVI.05060-11; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Neimark H, 2001, INT J SYST EVOL MICR, V51, P891, DOI 10.1099/00207713-51-3-891; Oehlerking J, 2011, J BACTERIOL, V193, P2369, DOI 10.1128/JB.00187-11; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Le PT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-243; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rikihisa Y, 1997, J CLIN MICROBIOL, V35, P823, DOI 10.1128/JCM.35.4.823-829.1997; Riley DR, 2012, BIOINFORMATICS, V28, P160, DOI 10.1093/bioinformatics/btr652; Ros VID, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-20; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos AP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-102; Schoenfeld TW, 2013, MOL BIOL EVOL, V30, P1653, DOI 10.1093/molbev/mst078; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Takeno S, 2013, APPL MICROBIOL BIOT, V97, P1259, DOI 10.1007/s00253-012-4275-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P16530, DOI 10.1073/pnas.0508532102; Uilenberg G, 2006, INT J SYST EVOL MICR, V56, P13, DOI 10.1099/ijs.0.63998-0; Uilenberg G, 2004, EXP APPL ACAROL, V32, P301, DOI 10.1023/B:APPA.0000023235.23090.a7; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Volokhov DV, 2012, MOL PHYLOGENET EVOL, V62, P515, DOI 10.1016/j.ympev.2011.11.002; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	61	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91445	10.1371/journal.pone.0091445	http://dx.doi.org/10.1371/journal.pone.0091445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642917	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900022
J	Jensvoll, H; Blix, K; Brkkan, SK; Hansen, JB				Jensvoll, Hilde; Blix, Kristine; Brkkan, Sigrid K.; Hansen, John-Bjarne			Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromso Study	PLOS ONE			English	Article							P-SELECTIN; THROMBOSIS; MODEL; CHEMOTHERAPY; METASTASIS; VALIDATION; ACTIVATION; THROMBOCYTOSIS; TROUSSEAU; DISEASE	Background: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease. We investigated whether pre-cancer platelet count alone or together with high leukocyte count was associated with risk of venous thromboembolism in subjects who did and did not develop cancer during follow-up in a population-based cohort study. Methods: Platelet count and other baseline characteristics were measured in 25160 initially cancer-free subjects who participated in the Tromso Study in 1994-1995. Incident cancer and symptomatic venous thromboembolism events were registered up to December 31 st, 2009. Multivariable Cox regression models were used to calculate hazard ratio for venous thromboembolism across categories of platelet count (<40 th, 40-80 th, and >80 th percentile) with 95% confidence interval. Results: During follow-up, 2082 subjects were diagnosed with cancer. Platelet count was measured on average 8.3 years before the cancer diagnosis. There were 129 venous thromboembolism events in the cancer cohort (13.5 per 1000 person-years) and 377 in the non-cancer cohort (1.2 per 1000 person-years). In cancer patients, pre-cancer platelet count above the 80 th percentile (>= 295x10(9) /L) was associated with a 2-fold higher risk of venous thromboembolism (Hazard ratio: 1.98, 95% confidence interval 1.21-3.23) compared to platelet count below the 40 th percentile (<235x10(9) /L). Concomitant high platelet and leukocyte counts showed a synergistic effect on the VTE risk. In cancer-free subjects, no association was found. Comment: In conclusion, pre-cancer platelet count was associated with risk of symptomatic venous thromboembolism in cancer patients, but not in cancer-free subjects. Our findings suggest that platelet count and platelet-leukocyte interactions may play a role in the pathogenesis of cancer-related venous thromboembolism.	[Jensvoll, Hilde; Blix, Kristine; Brkkan, Sigrid K.; Hansen, John-Bjarne] Univ Tromso, Univ Hosp North Norway, Dept Clin Med, Hematol Res Grp,Div Internal Med, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway	Jensvoll, H (corresponding author), Univ Tromso, Univ Hosp North Norway, Dept Clin Med, Hematol Res Grp,Div Internal Med, Tromso, Norway.	hilde.jensvoll@uit.no		Braekkan, Sigrid/0000-0002-9678-9696	Northern Norway Regional Health Authority	Northern Norway Regional Health Authority	All authors are supported by research funding from the Northern Norway Regional Health Authority (URL: http://www.helse-nord.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay C, 2008, BLOOD, V112, P2703, DOI 10.1182/blood-2008-02-142422; Blix K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073447; Braekkan SK, 2010, J THROMB HAEMOST, V8, P157, DOI 10.1111/j.1538-7836.2009.03498.x; Buergy D, 2012, INT J CANCER, V130, P2747, DOI 10.1002/ijc.27441; Cerletti C, 2012, THROMB RES, V129, P263, DOI 10.1016/j.thromres.2011.10.010; Chen M, 2006, ARCH IMMUNOL THER EX, V54, P75, DOI 10.1007/s00005-006-0010-6; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Elting LS, 2004, ARCH INTERN MED, V164, P1653, DOI 10.1001/archinte.164.15.1653; Garner C, 2000, BLOOD, V95, P342; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Ho KM, 2012, J THROMB HAEMOST, V10, P1768, DOI 10.1111/j.1538-7836.2012.04846.x; Horsted F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001275; Kashuk JL, 2010, SURGERY, V148, P667, DOI 10.1016/j.surg.2010.07.013; Khorana AA, 2005, CANCER-AM CANCER SOC, V104, P2822, DOI 10.1002/cncr.21496; Khorana AA, 2003, J THROMB HAEMOST, V1, P2463, DOI 10.1111/j.1538-7836.2003.00501.x; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Kunicki TJ, 2012, CURR OPIN HEMATOL, V19, P371, DOI 10.1097/MOH.0b013e3283567526; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Mandala M, 2010, ANN ONCOL, V21, P871, DOI 10.1093/annonc/mdp354; Merkow RP, 2011, ANN SURG, V254, P131, DOI 10.1097/SLA.0b013e31821b98da; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Ploquin A, 2012, BRIT J CANCER, V107, P1025, DOI 10.1038/bjc.2012.371; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Salim A, 2009, J TRAUMA, V66, P1349, DOI 10.1097/TA.0b013e318191b8af; Santimone I, 2011, HAEMATOL-HEMATOL J, V96, P1180, DOI 10.3324/haematol.2011.043042; Severinsen MT, 2009, J THROMB HAEMOST, V7, P1297, DOI 10.1111/j.1538-7836.2009.03490.x; Severinsen MT, 2010, EUR J INTERN MED, V21, P268, DOI 10.1016/j.ejim.2010.03.013; Shao BJ, 2011, BLOOD, V118, P4015, DOI 10.1182/blood-2011-07-368514; Simanek R, 2010, J THROMB HAEMOST, V8, P114, DOI 10.1111/j.1538-7836.2009.03680.x; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Togna GI, 2000, THROMB RES, V99, P503, DOI 10.1016/S0049-3848(00)00294-2; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; van der Bom JG, 2009, J THROMB HAEMOST, V7, P399, DOI 10.1111/j.1538-7836.2008.03267.x; von Bruhl ML, 2012, J EXP MED; Woller SC, 2011, AM J MED, V124, P947, DOI 10.1016/j.amjmed.2011.06.004	39	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92011	10.1371/journal.pone.0092011	http://dx.doi.org/10.1371/journal.pone.0092011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642868	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900060
J	Lanteri, MC; Diamond, MS; Law, JP; Chew, GM; Wu, SQ; Inglis, HC; Wong, D; Busch, MP; Norris, PJ; Ndhlovu, LC				Lanteri, Marion C.; Diamond, Michael S.; Law, Jacqueline P.; Chew, Glen M.; Wu, Shiquan; Inglis, Heather C.; Wong, Derek; Busch, Michael P.; Norris, Philip J.; Ndhlovu, Lishomwa C.			Increased Frequency of Tim-3 Expressing T Cells Is Associated with Symptomatic West Nile Virus Infection	PLOS ONE			English	Article							BLOCKADE; EXHAUSTION; IMMUNITY; CD4(+)	More than a decade after West Nile virus (WNV) entered North America, and despite a significant increase in reported cases during the 2012 and 2013 seasons, no treatment or vaccine for humans is available. Although antiviral T cells contribute to the control of WNV, little is known about their regulation during acute infection. We analyzed the expression of Tim-3 and PD-1, two recently identified T cell negative immune checkpoint receptors, over the course of WNV infection. Symptomatic WNV+ donors exhibited higher frequencies of Tim-3(+) cells than asymptomatic subjects within naive/early differentiated CD28(+/-)CD57(-)CD4(+) and differentiated CD28(-)CD57(-)CD8(+) T cells. Our study links Tim-3-expression on T cells during acute WNV infection with the development of symptomatic disease, suggesting Tim-3 and its ligands could be targeted therapeutically to alter anti-WNV immunity and improve disease outcome.	[Lanteri, Marion C.; Law, Jacqueline P.; Wu, Shiquan; Inglis, Heather C.; Wong, Derek; Busch, Michael P.; Norris, Philip J.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Chew, Glen M.; Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Busch, Michael P.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Hawaii System; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanteri, MC (corresponding author), Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.	mlanteri@bloodsystems.org; lndhlovu@hawaii.edu	n, l/AAX-3992-2020; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Ndhlovu, Lishomwa/0000-0001-5427-4187	Centers for Disease Control and Prevention [R01 C1000214]; National Heart Lung and Blood Institute [RC2HL101]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Centers for Disease Control and Prevention R01 C1000214 and National Heart Lung and Blood Institute RC2HL101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649; Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313; Cho Josalyn L, 2012, J Immunol, V189, P2879, DOI 10.4049/jimmunol.1102483; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Kim S, 2010, J IMMUNOL, V184, P4423, DOI 10.4049/jimmunol.0903955; Kumar D, 2004, AM J TRANSPLANT, V4, P1883, DOI 10.1111/j.1600-6143.2004.00592.x; Lai L, 2011, TRANSFUSION; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Lanteri MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022948; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mujib S., 2012, J IMMUNOL; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Nett RJ, 2012, TRANSPL INFECT DIS, V14, P268, DOI 10.1111/j.1399-3062.2012.00743.x; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Pfeiffer IA, 2013, IMMUNOBIOLOGY, V218, P1392, DOI 10.1016/j.imbio.2013.07.005; Qiu YQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002984; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Tobler LH, 2008, J INFECT DIS, V198, P979, DOI 10.1086/591466; Wang Y, 2004, IMMUNOL CELL BIOL, V82, P170, DOI 10.1046/j.0818-9641.2004.01227.x; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92134	10.1371/journal.pone.0092134	http://dx.doi.org/10.1371/journal.pone.0092134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642562	Green Submitted, gold, Green Published			2022-12-27	WOS:000333259900092
J	McCann, JC; Wiley, LM; Forbes, TD; Rouquette, FM; Tedeschi, LO				McCann, Joshua C.; Wiley, Leanne M.; Forbes, T. David; Rouquette, Francis M., Jr.; Tedeschi, Luis O.			Relationship between the Rumen Microbiome and Residual Feed Intake-Efficiency of Brahman Bulls Stocked on Bermudagrass Pastures	PLOS ONE			English	Article							PREVOTELLA-RUMINICOLA; BACTERIAL COMMUNITY; GENETIC DIVERSITY; RUMINAL BACTERIA; PURE CULTURES; COWS; SPECIFICITY; SEQUENCES; DIGESTION; DIET	Residual feed intake (RFI) testing has increased selection pressure on biological efficiency in cattle. The objective of this study was to assess the association of the rumen microbiome in inefficient, positive RFI (p-RFI) and efficient, negative RFI (n-RFI) Brahman bulls grazing 'Coastal' bermudagrass [Cynodondactylon (L.) Pers.] under two levels of forage allowance (high and low stocking intensity). Sixteen Brahman bulls were previously fed in confinement for 70 d to determine the RFI phenotype. Bulls were then allotted 60 d stocking on bermudagrass pastures to estimate RFI using the n-alkane technique. At the conclusion of the grazing period, rumen liquid samples were collected from each bull by stomach tube to evaluate the rumen microbiome. Extraction of DNA, amplification of the V4-V6 region of the 16S rRNA gene, and 454 pyrosequencing were performed on each sample. After denoising the sequences, chimera checking, and quality trimming, 4,573 6 1,287 sequences were generated per sample. Sequences were then assigned taxonomy from the Greengenes database using the RDP classifier. Overall, 67.5 and 22.9% of sequences were classified as Bacteroidetes and Firmicutes, respectively. Within the phylum Bacteroidetes, Prevotella was the most predominant genus and was observed in greater relative abundance in p-RFI bulls compared with n-RFI bulls (P = 0.01). In contrast, an unidentified Bacteroidales family was greater in relative abundance for n-RFI bulls than p-RFI (26.7 vs. 19.1%; P = 0.03). Ruminococcaceae was the third most abundant family in our samples, but it was not affected by RFI phenotype. No effect of stocking intensity was observed for bacterial taxa, but there was a tendency for alpha diversity and operational taxonomic unit richness to increase with lower stocking intensity. Results suggested the rumen microbiome of p-RFI Brahman bulls has greater levels of Prevotella, but the bacterial community composition was unaffected by stocking intensity.	[McCann, Joshua C.; Wiley, Leanne M.; Tedeschi, Luis O.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Forbes, T. David] Texas A&M Agrilife Res, Uvalde, TX USA; [Rouquette, Francis M., Jr.] Texas A&M Agrilife Res, Overton, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Tedeschi, LO (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	luis.tedeschi@tamu.edu			Texas A&M AgriLife Research	Texas A&M AgriLife Research	This work was supported by Texas A&M AgriLife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VG, 2011, GRASS FORAGE SCI, V66, P2, DOI 10.1111/j.1365-2494.2010.00780.x; Arthur PF, 2005, AUST J EXP AGR, V45, P985, DOI 10.1071/EA05052; Arthur PF, 2001, J ANIM SCI, V79, P2805; ATTWOOD GT, 1995, J APPL BACTERIOL, V79, P22, DOI 10.1111/j.1365-2672.1995.tb03119.x; Avgustin G, 1997, INT J SYST BACTERIOL, V47, P284, DOI 10.1099/00207713-47-2-284; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; BRYANT MP, 1961, APPL MICROBIOL, V9, P91, DOI 10.1128/AEM.9.2.91-95.1961; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; COTTA MA, 1992, APPL ENVIRON MICROB, V58, P48, DOI 10.1128/AEM.58.1.48-54.1992; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136, DOI 10.3168/jds.S0022-0302(67)87579-9; DEHORITY BA, 1991, P NUTR SOC, V50, P149, DOI 10.1079/PNS19910026; Dove H, 2006, NAT PROTOC, V1, P1680, DOI 10.1038/nprot.2006.225; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Durunna ON, 2011, J ANIM SCI, V89, P158, DOI 10.2527/jas.2009-2514; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Hernandez-Sanabria E, 2010, APPL ENV MICROBIOL; Hernandez-Sanabria E, 2012, APPL ENVIRON MICROB, V78, P1203, DOI 10.1128/AEM.05114-11; HUNTER RA, 1985, BRIT J NUTR, V53, P637, DOI 10.1079/BJN19850073; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lawrence P, 2011, J ANIM SCI, V89, P3248, DOI 10.2527/jas.2010-3774; Matsui H, 2000, CURR MICROBIOL, V41, P45, DOI 10.1007/s002840010089; McCann JC, 2013, THESIS TEXAS A M U C; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer AM, 2008, J ANIM SCI, V86, P2670, DOI 10.2527/jas.2007-0642; Nkrumah JD, 2006, J ANIM SCI, V84, P145; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramsak A, 2000, FEMS MICROBIOL ECOL, V33, P69, DOI 10.1111/j.1574-6941.2000.tb00728.x; Ramsey R., 2005, Journal of Agricultural and Applied Economics, V37, P91, DOI 10.1017/S1074070800007124; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; RUSSELL JB, 1980, APPL ENVIRON MICROB, V39, P604, DOI 10.1128/AEM.39.3.604-610.1980; Shannon C. E., 1949, MATH THEORY COMMUNIC; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Thoetkiattikul H, 2013, CURR MICROBIOL, V67, P130, DOI 10.1007/s00284-013-0336-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; Whitford MF, 1998, ANAEROBE, V4, P153, DOI 10.1006/anae.1998.0155; Wiley LM, 2013, THESIS TEXAS A M U C	47	67	72	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91864	10.1371/journal.pone.0091864	http://dx.doi.org/10.1371/journal.pone.0091864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642871	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900041
J	Mukherjee, K; Edgett, BA; Burrows, HW; Castro, C; Griffin, JL; Schwertani, AG; Gurd, BJ; Funk, CD				Mukherjee, Kamalika; Edgett, Brittany A.; Burrows, Harrison W.; Castro, Cecilia; Griffin, Julian L.; Schwertani, Adel Giaid; Gurd, Brendon J.; Funk, Colin D.			Whole Blood Transcriptomics and Urinary Metabolomics to Define Adaptive Biochemical Pathways of High-Intensity Exercise in 50-60 Year Old Masters Athletes	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; CDNA-MICROARRAY ANALYSIS; GENE-EXPRESSION; SKELETAL-MUSCLE; SYSTEMS BIOLOGY; PHYSICAL-ACTIVITY; ADAPTATIONS; LIPIN-1; METABOLISM; PHYSIOLOGY	Exercise is beneficial for a variety of age-related disorders. However, the molecular mechanisms mediating the beneficial adaptations to exercise in older adults are not well understood. The aim of the current study was to utilize a dual approach to characterize the genetic and metabolic adaptive pathways altered by exercise in veteran athletes and age-matched untrained individuals. Two groups of 50-60 year old males: competitive cyclists (athletes, n = 9; VO2peak 59.1 +/- 5.2 ml.kg(-1).min(-1); peak aerobic power 383 +/- 39 W) and untrained, minimally active individuals (controls, n = 8; VO2peak 35.9 +/- 9.7 ml.kg(-1).min(-1); peak aerobic power 230 +/- 57 W) were examined. All participants completed an acute bout of submaximal endurance exercise, and blood and urine samples pre-and post-exercise were analyzed for gene expression and metabolic changes utilizing genome-wide DNA microarray analysis and NMR spectroscopy-based metabolomics, respectively. Our results indicate distinct differences in gene and metabolite expression involving energy metabolism, lipids, insulin signaling and cardiovascular function between the two groups. These findings may lead to new insights into beneficial signaling pathways of healthy aging and help identify surrogate markers for monitoring exercise and training load.	[Mukherjee, Kamalika; Burrows, Harrison W.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Edgett, Brittany A.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Castro, Cecilia; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Castro, Cecilia; Griffin, Julian L.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Schwertani, Adel Giaid] McGill Univ, Div Cardiol, Ctr Hlth, Montreal, PQ, Canada	Queens University - Canada; Queens University - Canada; University of Cambridge; University of Cambridge; McGill University	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	funkc@queensu.ca	Mukherjee, Kamalika/O-5148-2019; Monleon, Daniel/A-5078-2010	Monleon, Daniel/0000-0002-4803-1573; Edgett, Brittany/0000-0002-8232-0432; Funk, Colin/0000-0001-7029-4233; Mukherjee, Kamalika/0000-0002-0372-830X	Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	CDF holds a Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine and is recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; Besson D, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009712-1, 10.1074/mcp.M111.009712]; Buttner P, 2007, J APPL PHYSIOL, V102, P26, DOI 10.1152/japplphysiol.00066.2006; Burke MF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001188; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; de Jonge XAKJ, 2003, SPORTS MED, V33, P833; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Eggermont L, 2006, NEUROSCI BIOBEHAV R, V30, P562, DOI 10.1016/j.neubiorev.2005.10.004; Enea C, 2010, ANAL BIOANAL CHEM, V396, P1167, DOI 10.1007/s00216-009-3289-4; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Greenhaff PL, 2011, J PHYSIOL-LONDON, V589, P1031, DOI 10.1113/jphysiol.2010.201525; Groussard C, 2003, EUR J APPL PHYSIOL, V89, P14, DOI 10.1007/s00421-002-0767-1; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Higashida K, 2008, BIOCHEM BIOPH RES CO, V374, P587, DOI 10.1016/j.bbrc.2008.07.079; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Jung HJ, 2011, BIOORG MED CHEM LETT, V21, P1052, DOI 10.1016/j.bmcl.2010.12.002; Ka T, 2003, J RHEUMATOL, V30, P1036; Kawai T, 2007, CLIN J SPORT MED, V17, P375, DOI 10.1097/JSM.0b013e31814c3e4f; Kayashima T, 2011, CANCER SCI, V102, P1137, DOI 10.1111/j.1349-7006.2011.01936.x; Keller P, 2007, BIOCHEM SOC T, V35, P1306, DOI 10.1042/BST0351306; Kohut ML, 2004, EXERC IMMUNOL REV, V10, P6; Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032; Kurapati R, 2012, HUM MOL GENET, V21, P1706, DOI 10.1093/hmg/ddr605; Larner Joseph, 2002, Int J Exp Diabetes Res, V3, P47, DOI 10.1080/15604280212528; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li CG, 2008, INT J CANCER, V123, P273, DOI 10.1002/ijc.23510; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Magaudda L, 2004, BASIC APPL MYOL, V14, P17; McGivney BA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-398; Nakamura S, 2010, BIOCHEM BIOPH RES CO, V391, P846, DOI 10.1016/j.bbrc.2009.11.150; Nieratschker V, 2011, EXPERT REV NEUROTHER, V11, P937, DOI [10.1586/ern.11.84, 10.1586/ERN.11.84]; Oue N, 2009, INT J CANCER, V125, P2383, DOI 10.1002/ijc.24624; PARDEE AB, 1949, J BIOL CHEM, V178, P241; Pears MR, 2007, METABOLOMICS, V3, P121, DOI 10.1007/s11306-007-0051-9; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; Pereira CD, 2012, DIABETES OBES METAB, V14, P869, DOI 10.1111/j.1463-1326.2012.01582.x; Prior BM, 2003, EXERC SPORT SCI REV, V31, P26, DOI 10.1097/00003677-200301000-00006; Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024; Rivera-Brown AM, 2012, PM&R, V4, P797, DOI 10.1016/j.pmrj.2012.10.007; Rodriguez S, 2007, HUM GENET, V122, P1, DOI 10.1007/s00439-007-0378-3; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Saltin B, 1998, ACTA PHYSIOL SCAND, V162, P421, DOI 10.1046/j.1365-201X.1998.0293e.x; Sattelmair JR, 2009, CLIN GERIATR MED, V25, P677, DOI 10.1016/j.cger.2009.07.004; Simpson RJ, 2012, AGEING RES REV, V11, P404, DOI 10.1016/j.arr.2012.03.003; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094; Stepto NK, 2009, MED SCI SPORT EXER, V41, P546, DOI 10.1249/MSS.0b013e31818c6be9; Suviolahti E, 2006, HUM MOL GENET, V15, P377, DOI 10.1093/hmg/ddi448; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Van der Borght K, 2009, HIPPOCAMPUS, V19, P928, DOI 10.1002/hipo.20545; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; West GB, 2009, J GERONTOL A-BIOL, V64, P205, DOI 10.1093/gerona/gln066; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wolach B, 2005, MED SCI SPORT EXER, V37, P949, DOI 10.1249/01.mss.0000171614.68897.8a; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Yarasheski KE, 2003, J GERONTOL A-BIOL, V58, P918; Yoshioka M, 2003, FASEB J, V17, P1812, DOI 10.1096/fj.02-1200com; Zeibig J, 2005, EUR J APPL PHYSIOL, V95, P96, DOI 10.1007/s00421-005-1334-3; Zhang YL, 2013, INT J MOL SCI, V14, P11096, DOI 10.3390/ijms140611096; Zieker D, 2005, PHYSIOL GENOMICS, V23, P287, DOI 10.1152/physiolgenomics.00096.2005; Zieker D, 2005, EXERC IMMUNOL REV, V11, P86	68	37	42	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92031	10.1371/journal.pone.0092031	http://dx.doi.org/10.1371/journal.pone.0092031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643011	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900064
J	Boyer, S; Foray, C; Dehecq, JS				Boyer, Sebastien; Foray, Coralie; Dehecq, Jean-Sebastien			Spatial and Temporal Heterogeneities of Aedes albopictus Density in La Reunion Island: Rise and Weakness of Entomological Indices	PLOS ONE			English	Article							CHIKUNGUNYA-VIRUS; ENVIRONMENTAL-FACTORS; SOURCE REDUCTION; EMILIA-ROMAGNA; AEGYPTI; MOSQUITO; DENGUE; DIPTERA; VECTOR; CULICIDAE	Following the 2006 Chikungunya disease in La Reunion, questions were raised concerning the monitoring survey of Aedes albopictus populations and the entomological indexes used to evaluate population abundance. The objectives of the present study were to determine reliable productivity indexes using a quantitative method to improve entomological surveys and mosquito control measures on Aedes albopictus. Between 2007 and 2011, 4 intervention districts, 24 cities, 990 areas and over 850,000 houses were used to fulfil those objectives. Four indexes including the classical Stegomyia index (House Index, Container Index, Breteau Index) plus an Infested Receptacle Index were studied in order to determine whether temporal (year, month, week) and/or spatial (districts, cities, areas) heterogeneities existed. Temporal variations have been observed with an increase of Ae. albopictus population density over the years, and a seasonality effect with a highest population during the hot and wet season. Spatial clustering was observed at several scales with an important autocorrelation at the area scale. Moreover, the combination among these results and the breeding site productivity obtained during these 5 years allowed us to propose recommendations to monitor Aedes albopictus by eliminating not the most finding sites but the most productive ones. As the other strategies failed in La Reunion, this new approach should should work better.	[Boyer, Sebastien] Univ Montpellier I, Ctr Natl Rech Sci CNRS 5290, MIVEGEC, IRD,UMR 224, Montpellier, France; [Boyer, Sebastien] Univ Montpellier 2, Montpellier, France; [Boyer, Sebastien; Foray, Coralie] Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, France; [Boyer, Sebastien] Inst Pasteur Madagascar, Unite Entomol Med, Antananarivo, Madagascar; [Dehecq, Jean-Sebastien] Agence Reg Sante Ocen Indien ARS OI, Serv Lutte Antivecorielle, GIP Serv Prophylaxie Renforcee, St Denis, Reunion, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Boyer, S (corresponding author), Univ Montpellier I, Ctr Natl Rech Sci CNRS 5290, MIVEGEC, IRD,UMR 224, Montpellier, France.	drsebastien.boyer@gmail.com		Boyer, Sebastien/0000-0002-2946-586X	French Ministry of Health; FEDER Convergence Reunion programme	French Ministry of Health; FEDER Convergence Reunion programme	This work was financially supported by the French Ministry of Health and the FEDER Convergence Reunion 2007-2013 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albieri A, 2010, B INSECTOL, V63, P209; Aldstadt J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000940; Alfonzo D, 2005, J MED ENTOMOL, V42, P278, DOI 10.1603/0022-2585(2005)042[0278:ECOTAH]2.0.CO;2; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381; Beketov MA, 2010, J MED ENTOMOL, V47, P129, DOI 10.1603/ME09150; Blaustein L, 2007, ANNU REV ENTOMOL, V52, P489, DOI 10.1146/annurev.ento.52.110405.091431; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Chadee DD, 2007, ANN TROP MED PARASIT, V101, P69, DOI 10.1179/136485907X157059; CHAMBERS DM, 1986, J AM MOSQUITO CONTR, V2, P539; Chase JM, 2003, ECOLOGY, V84, P580, DOI 10.1890/0012-9658(2003)084[0580:CGTAS]2.0.CO;2; D'Ortenzio E, 2011, EMERG INFECT DIS, V17, P309, DOI 10.3201/eid1702.101056; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Focks D, 2006, TDRIRMDEN06156 WHO; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; FOCKS DA, 2003, WHOTDRIDEDEN031; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Hamon J., 1954, Naturaliste Malgache Tananarive, V5, P35; Kumar NP, 2007, CURR SCI INDIA, V93, P1412; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; NILSSON AN, 1995, HYDROBIOLOGIA, V308, P183, DOI 10.1007/BF00006870; Organizacion Mundial de la Salud (OMS), 1995, DENGUE DENGUE HEMORR, V548; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Setbon M, 2008, POPULATION, V63, P555, DOI 10.3917/popu.803.0555; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Yebakima A, 1996, B SOC PATHOL EXOT, V89, P161	41	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91170	10.1371/journal.pone.0091170	http://dx.doi.org/10.1371/journal.pone.0091170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637507	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100019
J	Cereda, A; Hitchcock, A; Symes, MD; Cronin, L; Bibby, TS; Jones, AK				Cereda, Angelo; Hitchcock, Andrew; Symes, Mark D.; Cronin, Leroy; Bibby, Thomas S.; Jones, Anne K.			A Bioelectrochemical Approach to Characterize Extracellular Electron Transfer by Synechocystis sp PCC6803	PLOS ONE			English	Article							PCC 6803; MICROBIAL ELECTROSYNTHESIS; ELECTRICITY PRODUCTION; BACTERIAL NANOWIRES; FUEL-CELLS; BPV SYSTEM; SHEWANELLA; STRAIN; CYANOBACTERIA; SOLAR	Biophotovoltaic devices employ photosynthetic organisms at the anode of a microbial fuel cell to generate electrical power. Although a range of cyanobacteria and algae have been shown to generate photocurrent in devices of a multitude of architectures, mechanistic understanding of extracellular electron transfer by phototrophs remains minimal. Here we describe a mediatorless bioelectrochemical device to measure the electrogenic output of a planktonically grown cyanobacterium, Synechocystis sp. PCC6803. Light dependent production of current is measured, and its magnitude is shown to scale with microbial cell concentration and light intensity. Bioelectrochemical characterization of a Synechocystis mutant lacking Photosystem II demonstrates conclusively that production of the majority of photocurrent requires a functional water splitting aparatus and electrons are likely ultimately derived from water. This shows the potential of the device to rapidly and quantitatively characterize photocurrent production by genetically modified strains, an approach that can be used in future studies to delineate the mechanisms of cyanobacterial extracellular electron transport.	[Cereda, Angelo; Jones, Anne K.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Hitchcock, Andrew; Bibby, Thomas S.] Univ Southampton, Southampton, Hants, England; [Symes, Mark D.; Cronin, Leroy] Univ Glasgow, Sch Chem, Glasgow, Lanark, Scotland	Arizona State University; Arizona State University-Tempe; University of Southampton; University of Glasgow	Jones, AK (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	jonesak@asu.edu	Symes, Mark/L-9810-2015; Hitchcock, Andrew/AAM-2855-2020; Cronin, Leroy/AAW-8067-2020; Cronin, Leroy/B-7752-2008	Symes, Mark/0000-0001-8067-5240; Hitchcock, Andrew/0000-0001-6572-434X; Cronin, Leroy/0000-0001-8035-5757; Cronin, Leroy/0000-0001-8035-5757; Bibby, Thomas/0000-0003-1743-473X	NSF [1105033]; BBSRC [BB/I02447X/1, BB/I024437/1]; BBSRC [BB/M011267/1] Funding Source: UKRI; EPSRC [EP/F016360/1, EP/H024107/1, EP/J00135X/1, EP/K023004/1, EP/J015156/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02447X/1, BB/I024437/1, BB/M011267/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F016360/1, EP/J00135X/1, EP/H024107/1, EP/K023004/1, EP/J015156/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by the NSF (www.nsf.gov) to AKJ (1105033) and the BBSRC (www.bbsrc.ac.uk) to TSB (BB/I02447X/1) and LC (BB/I024437/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombelli P, 2013, APPL MICROBIOL BIOT, V97, P429, DOI 10.1007/s00253-012-4473-6; Bombelli P, 2012, PHYS CHEM CHEM PHYS, V14, P12221, DOI 10.1039/c2cp42526b; Bombelli P, 2011, ENERG ENVIRON SCI, V4, P4690, DOI 10.1039/c1ee02531g; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Bradley RW, 2012, BIOCHEM SOC T, V40, P1302, DOI 10.1042/BST20120118; Bradley RW, 2013, PHYS CHEM CHEM PHYS, DOI [10.1039/C1033CP52438H, DOI 10.1039/C1033CP52438H]; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; de Schamphelaire L, 2008, ENVIRON SCI TECHNOL, V42, P3053, DOI 10.1021/es071938w; Desloover J, 2012, BIOCHEM SOC T, V40, P1233, DOI 10.1042/BST20120111; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Helder M, 2010, BIORESOURCE TECHNOL, V101, P3541, DOI 10.1016/j.biortech.2009.12.124; Howitt CA, 2001, PLANTA, V214, P46, DOI 10.1007/s004250100578; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Liu HA, 2010, ANGEW CHEM INT EDIT, V49, P6596, DOI 10.1002/anie.201000315; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Lovley DR, 2012, ANNU REV MICROBIOL, V66, P391, DOI 10.1146/annurev-micro-092611-150104; Madiraju KS, 2012, BIORESOURCE TECHNOL, V110, P214, DOI 10.1016/j.biortech.2012.01.065; Malvankar NS, 2012, CHEMSUSCHEM, V5, P1039, DOI 10.1002/cssc.201100733; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; McCormick AJ, 2013, ENERG ENVIRON SCI, V6, P2682, DOI 10.1039/c3ee40491a; McCormick AJ, 2011, ENERG ENVIRON SCI, V4, P4699, DOI 10.1039/c1ee01965a; McLean JS, 2010, ENVIRON SCI TECHNOL, V44, P2721, DOI 10.1021/es903043p; Nealson KH, 2011, MRS BULL, V36, P380, DOI 10.1557/mrs.2011.69; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Pirbadian S, 2012, PHYS CHEM CHEM PHYS, V14, P13802, DOI 10.1039/c2cp41185g; Pisciotta JM, 2011, APPL MICROBIOL BIOT, V91, P377, DOI 10.1007/s00253-011-3239-x; Pisciotta JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010821; Pojidaeva E, 2004, J BACTERIOL, V186, P3991, DOI 10.1128/JB.186.12.3991-3999.2004; Rabaey K, 2011, CURR OPIN BIOTECH, V22, P371, DOI 10.1016/j.copbio.2011.01.010; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rosenbaum M, 2010, ELECTROANAL, V22, P844, DOI 10.1002/elan.200800005; Strik DPBTB, 2011, TRENDS BIOTECHNOL, V29, P41, DOI 10.1016/j.tibtech.2010.10.001; Vermaas W, 1996, J APPL PHYCOL, V8, P263, DOI 10.1007/BF02178569; VERMAAS WFJ, 1986, P NATL ACAD SCI USA, V83, P9474, DOI 10.1073/pnas.83.24.9474; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zou YJ, 2009, BIOTECHNOL BIOENG, V104, P939, DOI 10.1002/bit.22466	40	44	44	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91484	10.1371/journal.pone.0091484	http://dx.doi.org/10.1371/journal.pone.0091484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637387	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333254100037
J	Damania, P; Sen, B; Dar, SB; Kumar, S; Kumari, A; Gupta, E; Sarin, SK; Venugopal, SK				Damania, Preeti; Sen, Bijoya; Dar, Sadaf Bashir; Kumar, Satendra; Kumari, Anupama; Gupta, Ekta; Sarin, Shiv Kumar; Venugopal, Senthil Kumar			Hepatitis B Virus Induces Cell Proliferation via HBx-Induced microRNA-21 in Hepatocellular Carcinoma by Targeting Programmed Cell Death Protein4 (PDCD4) and Phosphatase and Tensin Homologue (PTEN)	PLOS ONE			English	Article							X PROTEIN; REGULATES EXPRESSION; DOWN-REGULATION; UP-REGULATION; MIR-21; NUCLEAR; MIGRATION; SUPPRESSES; ACTIVATION; GROWTH	Hepatitis B viral infection-induced hepatocellular carcinoma is one of the major problems in the developing countries. One of the HBV proteins, HBx, modulates the host cell machinery via several mechanisms. In this study we hypothesized that HBV enhances cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma. HBx gene was over-expressed, and miRNA-21 expression and cell proliferation were measured in Huh 7 and Hep G2 cells. miRNA-21 was over-expressed in these cells, cell proliferation and the target proteins were analyzed. To confirm the role of miRNA-21 in HBx-induced proliferation, Hep G 2.2.1.5 cells (a cell line that expresses HBV stably) were used for miRNA-21 inhibition studies. HBx overexpression enhanced proliferation (3.7- and 4.5-fold increase; n = 3; p<0.01) and miRNA-21 expression (24- and 36-fold increase, normalized with 5S rRNA; p<0.001) in Huh 7 and Hep G2 cells respectively. HBx also resulted in the inhibition of miRNA-21 target proteins, PDCD4 and PTEN. miRNA-21 resulted in a significant increase in proliferation (2- and 2.3-fold increase over control cells; p<0.05 in Huh 7 and Hep G2 cells respectively) and decreased target proteins, PDCD4 and PTEN expression. Anti-miR-21 resulted in a significant decrease in proliferation (p<0.05) and increased miRNA-21 target protein expression. We conclude that HBV infection enhances cell proliferation, at least in part, via HBx-induced miRNA-21 expression during hepatocellular carcinoma progression.	[Damania, Preeti; Sen, Bijoya; Dar, Sadaf Bashir; Kumari, Anupama; Gupta, Ekta; Sarin, Shiv Kumar] Inst Liver & Biliary Sci, New Delhi, India; [Kumar, Satendra; Venugopal, Senthil Kumar] South Asian Univ, New Delhi, India	Institute of Liver & Biliary Sciences (ILBS); South Asian University (SAU)	Sarin, SK (corresponding author), Inst Liver & Biliary Sci, New Delhi, India.	shivsarin@gmail.com; drsenthil@sau.ac.in			Ramalingaswamy Fellowship, DBT, Government of Inida; Department of Biotechnology, Government of India	Ramalingaswamy Fellowship, DBT, Government of Inida; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study was supported by the grants from Ramalingaswamy Fellowship, DBT, Government of Inida and Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chen XL, 2011, TRANSPLANTATION, V91, P293, DOI 10.1097/TP.0b013e318204756c; Chung TW, 2003, CANCER RES, V63, P3453; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Gearhart TL, 2011, VIRUS RES, V155, P363, DOI 10.1016/j.virusres.2010.09.023; Huang WC, 2012, J CELL PHYSIOL, V227, P1446, DOI 10.1002/jcp.22860; Kong GY, 2011, ACTA PHARMACOL SIN, V32, P1173, DOI 10.1038/aps.2011.52; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lara-Pezzi E, 2001, J HEPATOL, V34, P409, DOI 10.1016/S0168-8278(00)00090-8; Lee YI, 2001, J BIOL CHEM, V276, P16969, DOI 10.1074/jbc.M011263200; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; PATERLINI P, 1995, HEPATOLOGY, V21, P313, DOI 10.1002/hep.1840210208; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Shih WL, 2000, J BIOL CHEM, V275, P25858, DOI 10.1074/jbc.M003578200; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Varnholt H, 2008, ANN HEPATOL, V7, P104, DOI 10.1016/S1665-2681(19)31864-2; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Wei XF, 2013, CELL SIGNAL, V25, P439, DOI 10.1016/j.cellsig.2012.10.013; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; Xu XJ, 2013, J CLIN INVEST, V123, P630, DOI 10.1172/JCI64265; Yang B, 2012, J VIROL, V86, P313, DOI 10.1128/JVI.06442-11; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Yoon S, 2010, LIVER INT, V30, P376, DOI 10.1111/j.1478-3231.2009.02181.x; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zhang F, 2010, J MED VIROL, V82, P920, DOI 10.1002/jmv.21753; Zhang SH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-71; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	37	62	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91745	10.1371/journal.pone.0091745	http://dx.doi.org/10.1371/journal.pone.0091745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633222	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400085
J	Feng, Y; Wang, Z; Bao, ZS; Yan, W; You, G; Wang, YY; Hu, HM; Zhang, W; Zhang, QG; Jiang, T				Feng, Ying; Wang, Zheng; Bao, Zhaoshi; Yan, Wei; You, Gan; Wang, Yinyan; Hu, Huimin; Zhang, Wei; Zhang, Quangeng; Jiang, Tao			SOCS3 Promoter Hypermethylation Is a Favorable Prognosticator and a Novel Indicator for G-CIMP-Positive GBM Patients	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; DNA METHYLATION; MULTIPLE GENES; SUPPRESSOR; INSTABILITY; CARCINOMAS; BIOMARKER; OVARIAN; GROWTH	Background: Hypermethylation of the suppressor of cytokine signaling 3(SOCS3) promoter has been reported to predict a poor prognosis in several cancers including glioblstoma multiforme (GBM). We explored the function of SOCS3 promoter hypermethylation in GBM cohorts, including analysis of the CpG island methylator phenotype (CIMP), when a large number of gene loci are simultaneously hypermethylated. Methods: A whole genome promoter methylation profile was performed in a cohort of 33 GBM samples, with 13 long-term survivors (LTS; overall survival >= 18 months) and 20 short-term survivors (STS; overall survival <= 9 months). The SOCS3 promoter methylation status was compared between the two groups. In addition, we investigated the relationship of SOCS3 promoter methylation and G-CIMP status. Results: Interestingly, in our present study, we found that SOCS3 promoter methylation was statistically significantly higher in the 13 LTS than that in the 20 STS. Furthermore, high SOCS3 promoter methylation detected via pyro-sequencing predicted a better prognosis in an independent cohort containing 62 GBM patients. This correlation was validated by the dataset from the Cancer Genome Atlas(TCGA) and the Chinese Cancer Genome Atlas(CGGA). In addition, we found that hypermethylation of the SOCS3 promoter was tightly associated with the G-CIMP-positive GBM patients. Conclusions: Using a total of 359 clinical samples, we demonstrate that SOCS3 promoter hypermethylation status has a favorable prognostic value in GBM patients because of whole genome methylation status. Particularly, the hypermethylation of the SOCS3 promoter indicates positive G-CIMP status.	[Feng, Ying; Zhang, Quangeng] Capital Med Univ, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Wang, Zheng; Bao, Zhaoshi; Yan, Wei; You, Gan; Zhang, Wei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Zheng; Bao, Zhaoshi; Yan, Wei; You, Gan; Wang, Yinyan; Hu, Huimin; Zhang, Wei; Jiang, Tao] Beijing Neurosurg Inst, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Beijing Neurosurgical Institute	Zhang, W (corresponding author), Capital Med Univ, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China.	zhangwei_vincent@126.com; quangengzhang@163.com; taojiang1964@163.com	Jiang, Tao/N-8142-2014; Wang, Yinyan/AAJ-1160-2020; jiang, tao/GWC-7108-2022		National High Technology Research and Development Program [2012AA02A508]; National 973 program [2011CB707804]; National Nature Science Foundation of China [81201993, 81272804]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National 973 program(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National High Technology Research and Development Program (No. 2012AA02A508), the National 973 program (No. 2011CB707804) and the National Nature Science Foundation of China (No. 81201993 and No. 81272804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We appreciate the patients' approval and cooperation.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Barreau O, 2013, J CLIN ENDOCR METAB, V98, pE174, DOI 10.1210/jc.2012-2993; Claus R, 2010, FUTURE ONCOL, V6, P1415, DOI 10.2217/FON.10.110; Eads CA, 2000, CANCER RES, V60, P5021; Fourouclas N, 2008, HAEMATOL-HEMATOL J, V93, P1635, DOI 10.3324/haematol.13043; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Isomoto H, 2009, DIGESTION, V79, P2, DOI 10.1159/000167859; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JPJ, 2001, CANCER RES, V61, P3573; Kang GH, 2002, AM J PATHOL, V160, P787, DOI 10.1016/S0002-9440(10)64901-2; Kloten V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3375; Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553; Kusano M, 2006, CANCER-AM CANCER SOC, V106, P1467, DOI 10.1002/cncr.21789; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; Li Y, 2012, CARCINOGENESIS, V33, P1889, DOI 10.1093/carcin/bgs214; Lindemann C, 2011, ACTA NEUROPATHOL, V122, P241, DOI 10.1007/s00401-011-0832-0; Martini M, 2008, INT J CANCER, V123, P2955, DOI 10.1002/ijc.23805; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oue N, 2006, CANCER-AM CANCER SOC, V106, P1250, DOI 10.1002/cncr.21754; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Shen LL, 2002, J NATL CANCER I, V94, P755, DOI 10.1093/jnci/94.10.755; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Strathdee G, 2001, AM J PATHOL, V158, P1121, DOI 10.1016/S0002-9440(10)64059-X; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang P, 2013, J NEUROONCOL; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang W, 2013, CANCER-AM CANCER SOC, V119, P814, DOI 10.1002/cncr.27826; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	37	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91829	10.1371/journal.pone.0091829	http://dx.doi.org/10.1371/journal.pone.0091829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633048	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400102
J	Nardi, F; Lipina, C; Magill, D; Hassan, RH; Hajduch, E; Gray, A; Hundal, HS				Nardi, Francesca; Lipina, Christopher; Magill, David; Hassan, Rima Hage; Hajduch, Eric; Gray, Alexander; Hundal, Harinder S.			Enhanced Insulin Sensitivity Associated with Provision of Mono and Polyunsaturated Fatty Acids in Skeletal Muscle Cells Involves Counter Modulation of PP2A	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; PLECKSTRIN HOMOLOGY DOMAIN; KINASE-C-ZETA; MITOCHONDRIAL-FUNCTION; MONOUNSATURATED-FAT; DEPENDENT MECHANISM; SRC KINASE; PALMITATE; CERAMIDE; RESISTANCE	Aims/Hypothesis: Reduced skeletal muscle insulin sensitivity is a feature associated with sustained exposure to excess saturated fatty acids (SFA), whereas mono and polyunsaturated fatty acids (MUFA and PUFA) not only improve insulin sensitivity but blunt SFA-induced insulin resistance. The mechanisms by which MUFAs and PUFAs institute these favourable changes remain unclear, but may involve stimulating insulin signalling by counter-modulation/repression of protein phosphatase 2A (PP2A). This study investigated the effects of oleic acid (OA; a MUFA), linoleic acid (LOA; a PUFA) and palmitate (PA; a SFA) in cultured myotubes and determined whether changes in insulin signalling can be attributed to PP2A regulation. Principal Findings: We treated cultured skeletal myotubes with unsaturated and saturated fatty acids and evaluated insulin signalling, phosphorylation and methylation status of the catalytic subunit of PP2A. Unlike PA, sustained incubation of rat or human myotubes with OA or LOA significantly enhanced Akt- and ERK1/2-directed insulin signalling. This was not due to heightened upstream IRS1 or PI3K signalling nor to changes in expression of proteins involved in proximal insulin signalling, but was associated with reduced dephosphorylation/inactivation of Akt and ERK1/2. Consistent with this, PA reduced PP2Ac demethylation and tyrosine(307) phosphorylation - events associated with PP2A activation. In contrast, OA and LOA strongly opposed these PA-induced changes in PP2Ac thus exerting a repressive effect on PP2A. Conclusions/Interpretation: Beneficial gains in insulin sensitivity and the ability of unsaturated fatty acids to oppose palmitate-induced insulin resistance in muscle cells may partly be accounted for by counter-modulation of PP2A.	[Nardi, Francesca; Lipina, Christopher; Magill, David; Gray, Alexander; Hundal, Harinder S.] Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee, Scotland; [Hassan, Rima Hage; Hajduch, Eric] INSERM, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Hassan, Rima Hage; Hajduch, Eric] Univ Paris 06, UMR S 872, Paris, France; [Hassan, Rima Hage; Hajduch, Eric] Univ Paris 05, UMR S 872, Paris, France	University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hundal, HS (corresponding author), Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee, Scotland.	h.s.hundal@dundee.ac.uk	Hundal, Hari/A-8990-2008; Hajduch, Eric/B-7332-2008	Hundal, Hari/0000-0002-7621-4932; Hajduch, Eric/0000-0002-0125-7751; Gray, Alexander/0000-0001-9227-0363; Lipina, Christopher/0000-0001-7327-2857	BBSRC; Diabetes UK; Diabetes UK [10/0004146] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); Diabetes UK(Diabetes UK)	This work was supported by grants from BBSRC and Diabetes UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Feng XT, 2012, BIOSCI BIOTECH BIOCH, V76, P1356, DOI 10.1271/bbb.120107; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hage Hassan R, 2012, DIABETOLOGIA, V55, P204, DOI 10.1007/s00125-011-2328-9; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kien CL, 2013, DIABETES, V62, P1054, DOI 10.2337/db12-0363; Kien CL, 2013, AM J CLIN NUTR, V97, P689, DOI 10.3945/ajcn.112.051730; Kien CL, 2011, OBESITY, V19, P305, DOI 10.1038/oby.2010.135; Kowluru A, 1997, FEBS LETT, V418, P179, DOI 10.1016/S0014-5793(97)01379-3; Kowluru A, 2012, BIOCHEM PHARMACOL, V84, P591, DOI 10.1016/j.bcp.2012.05.003; Macrae K, 2013, J LIPID RES, V54, P2366, DOI 10.1194/jlr.M036996; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; PARILLO M, 1992, METABOLISM, V41, P1373, DOI 10.1016/0026-0495(92)90111-M; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Soto-Guzman A, 2008, MOL CELL ENDOCRINOL, V294, P81, DOI 10.1016/j.mce.2008.08.003; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; Vilquin JT, 2005, GENE THER, V12, P1651, DOI 10.1038/sj.gt.3302565; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010	44	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92255	10.1371/journal.pone.0092255	http://dx.doi.org/10.1371/journal.pone.0092255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632852	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400156
J	Palazon-Bru, A; Gil-Guillen, VF; Orozco-Beltran, D; Pallares-Carratala, V; Valls-Roca, F; Sanchis-Domenech, C; Martin-Moreno, JM; Redon, J; Navarro-Perez, J; Fernandez-Gimenez, A; Perez-Navarro, AM; Trillo, JL; Uso, R; Ruiz, E				Palazon-Bru, Antonio; Gil-Guillen, Vicente F.; Orozco-Beltran, Domingo; Pallares-Carratala, Vicente; Valls-Roca, Francisco; Sanchis-Domenech, Carlos; Martin-Moreno, Jose M.; Redon, Josep; Navarro-Perez, Jorge; Fernandez-Gimenez, Antonio; Perez-Navarro, Ana M.; Trillo, Jose L.; Uso, Ruth; Ruiz, Elias			Is the Physician's Behavior in Dyslipidemia Diagnosis in Accordance with Guidelines? Cross-Sectional Escarval Study	PLOS ONE			English	Article							PRIMARY-CARE; RISK; MANAGEMENT; HYPERCHOLESTEROLEMIA; RECOGNITION; DISEASE; HYPERTENSION; ASSOCIATION; KNOWLEDGE	Background: Clinical inertia has been defined as mistakes by the physician in starting or intensifying treatment when indicated. Inertia, therefore, can affect other stages in the healthcare process, like diagnosis. The diagnosis of dyslipidemia requires >= 2 high lipid values, but inappropriate behavior in the diagnosis of dyslipidemia has only previously been analyzed using just total cholesterol (TC). Objectives: To determine clinical inertia in the dyslipidemia diagnosis using both TC and high-density lipoprotein cholesterol (HDL-c) and its associated factors. Design: Cross-sectional. Setting: All health center visits in the second half of 2010 in the Valencian Community (Spain). Patients: 11,386 nondyslipidemic individuals aged >= 20 years with >= 2 lipid determinations. Measurement Variables: Gender, atrial fibrillation, hypertension, diabetes, cardiovascular disease, age, and ESCARVAL training course. Lipid groups: normal (TC<5.17 mmol/L and normal HDL-c [>= 1.03 mmol/L in men and >= 1.29 mmol/L in women], TC inertia (TC >= 5.17 mmol/L and normal HDL-c), HDL-c inertia (TC<5.17 mmol/L and low HDL-c), and combined inertia (TC >= 5.17 mmol/L and low HDL-c). Results: TC inertia: 38.0% (95% CI: 37.2-38.9%); HDL-c inertia: 17.7% (95% CI: 17.0-18.4%); and combined inertia: 9.6% (95% CI: 9.1-10.2%). The profile associated with TC inertia was: female, no cardiovascular risk factors, no cardiovascular disease, middle or advanced age; for HDL-c inertia: female, cardiovascular risk factors and cardiovascular disease; and for combined inertia: female, hypertension and middle age. Limitations: Cross-sectional study, under-reporting, no analysis of some cardiovascular risk factors or other lipid parameters. Conclusions: A more proactive attitude should be adopted, focusing on the full diagnosis of dyslipidemia in clinical practice. Special emphasis should be placed on patients with low HDL-c levels and an increased cardiovascular risk.	[Palazon-Bru, Antonio; Gil-Guillen, Vicente F.; Orozco-Beltran, Domingo; Fernandez-Gimenez, Antonio] Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain; [Pallares-Carratala, Vicente] Mutual Soc Castellon, Hlth Surveillance Dept, Castellon de La Plana, Spain; [Pallares-Carratala, Vicente] Jaume I Univ, Dept Med, Castellon de La Plana, Spain; [Valls-Roca, Francisco] Generalitat Valenciana, Hlth Ctr Beniganim, Valencia, Spain; [Sanchis-Domenech, Carlos] Generalitat Valenciana, Hlth Ctr Algemesi, Valencia, Spain; [Martin-Moreno, Jose M.; Redon, Josep; Navarro-Perez, Jorge] Univ Valencia, Sch Med, Valencia, Spain; [Perez-Navarro, Ana M.] Generalitat Valenciana, Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Valencia, Spain; [Trillo, Jose L.; Uso, Ruth; Ruiz, Elias] Generalitat Valenciana, Conselleria Sanitat, Valencia, Spain	Universidad Miguel Hernandez de Elche; Universitat Jaume I; University of Valencia	Palazon-Bru, A (corresponding author), Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain.	antonio.pb23@gmail.com	REDON, JOSEP/E-1719-2019; CARRATALA, VICENTE PALLARES/AAH-5511-2019; Redon, Josep/L-5997-2019; Martin-Moreno, Jose M./S-7733-2016; Guillén, Vicente Francisco Gil/AAE-8201-2019	CARRATALA, VICENTE PALLARES/0000-0002-2985-6078; Redon, Josep/0000-0001-8777-6773; Martin-Moreno, Jose M./0000-0002-8648-5541; Palazon-Bru, Antonio/0000-0002-5959-9631; Gil-Guillen, Vicente F/0000-0003-3793-9786; Orozco-Beltran, Domingo/0000-0002-8231-2635	Generalitat Valenciana; Boehringer Ingelheim; Merck Sharp Dohme Corp.; Almirall; Bayer; Novo Nordisk; Sanofi-Aventis	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp Dohme Corp.(Merck & Company); Almirall(Almirall); Bayer(Bayer AG); Novo Nordisk(Novo Nordisk); Sanofi-Aventis(Sanofi-Aventis)	This study was partly funded by the Generalitat Valenciana and nonprofit research grants (donations and collaborations with the ESCARVAL study for setting the course up and making conferences about the results) from the pharmaceutical industry (Boehringer Ingelheim, Merck Sharp & Dohme Corp., Almirall, Bayer, Novo Nordisk and Sanofi-Aventis). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2004, AM J MANAG CARE, V10, P481; BELL MM, 1988, J FAM PRACTICE, V26, P507; Bonny A, 2008, J HYPERTENS, V26, P825, DOI 10.1097/HJH.0b013e3282f857e7; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P117; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Generalitat Valenciana: Conselleria de Sanitat, 2010, EST VAL 2 PREV OB HI; Gil-Guillen V, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-717; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; HUDSON JW, 1990, J FAM PRACTICE, V31, P139; HYMAN DJ, 1992, PUBLIC HEALTH REP, V107, P441; LANDZBERG JS, 1989, ARCH INTERN MED, V149, P933, DOI 10.1001/archinte.149.4.933; Leon-Munoz LA, 2009, J AM GERIATR SOC, V57, P2287, DOI 10.1111/j.1532-5415.2009.02556.x; LEVIN SJ, 1990, J FAM PRACTICE, V31, P613; Maiques A, 2007, ATEN PRIMARIA S3, V39, P15; Maiques Galan A, 2009, RECOMMENDACIONES PRE; Marquez Contreras E, 2007, ATEN PRIM, V39, P661; Merkin SS, 2009, INT J PUBLIC HEALTH, V54, P166, DOI 10.1007/s00038-008-7030-4; Ministerio de Sanidad Politica Social e Igualdad, 2011, INFORM TERAPEUTICA S, V35, P124; Ministerio de Sanidad y Politica Social, 2010, SIST NAC SAL; NAUMBURG EH, 1993, J FAM PRACTICE, V36, P425; Pedrera Carbonell V, 2005, Aten Primaria, V35, P82; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Plans-Rubio Pedro, 2006, Am J Cardiovasc Drugs, V6, P177, DOI 10.2165/00129784-200606030-00005; Rubio PP, 1997, PUBLIC HEALTH, V111, P33, DOI 10.1038/sj.ph.1900304; Saturno Hernandez P J, 2000, Aten Primaria, V25, P82; Steinhagen-Thiessen E, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-31; STOCKBRIDGE H, 1989, J LAB CLIN MED, V114, P142; U.S. Preventive Services Task Force, 2008, SCREEN LIP DIS AD; WHITESIDE C, 1989, PREV MED, V18, P526, DOI 10.1016/0091-7435(89)90011-X; WHO Regional Office for Europe, 2008, HLTH AG PROF; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organization (WHO), 2013, TOP 10 CAUS DEATH	35	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91567	10.1371/journal.pone.0091567	http://dx.doi.org/10.1371/journal.pone.0091567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626597	Green Published, gold			2022-12-27	WOS:000332851300105
J	Dominguez, LG; Radhu, N; Farzan, F; Daskalakis, ZJ				Dominguez, Luis Garcia; Radhu, Natasha; Farzan, Faranak; Daskalakis, Zafiris J.			Characterizing Long Interval Cortical Inhibition over the Time-Frequency Domain	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; EEG; STIMULATION; MECHANISMS; DEFICITS; GABA	Objective: Long-interval cortical inhibition (LICI) can be recorded from motor and non-motor regions of the cortex through combined transcranial magnetic stimulation (TMS) with electroencephalography (EEG). This study aimed to evaluate additional dimensions of LICI characteristics over an extended time-frequency and spatial domain. This was done by introducing two alternative measures of LICI signal amplitude: the Discrete Fourier Transform (DFT) and the Hilbert transform (HT). Both approaches estimate signal amplitude not taking into account the phase. In both cases LICI was measured as the difference between the unconditioned and conditioned activity evoked by the test pulse. Finally, we evaluated whether the topographical patterns of single and paired responses differed beyond the expected variations in amplitude. Materials and Methods: LICI was delivered as single and paired pulses to the motor cortex (MC) and dorsolateral prefrontal cortex (DLPFC) in 33 healthy subjects with TMS-EEG. Results: Significant differences (p < 0.0001) between the unconditioned and conditioned evoked activity were found for both the DLPFC and MC using both methods (i.e., DFT and HT) after correcting for multiple comparisons in the time-frequency domain. The influence of inhibition was found to be significantly larger in space and time than previously considered. Single and paired conditions differ in intensity, but also in their topographic pattern (i.e., the specific spatiotemporal configuration of active sources). Conclusion: Similar results were found by both DFT and HT. The effect of inhibition across the cortex was also found to be complex and extended. In particular, it was found that LICI may be measured with high sensitivity in areas that were relatively distant from the stimulation site, which may have important practical applications. The analysis presented in this study overcomes some limitations of previous studies and could serve as a key reference for future studies examining TMS-indices of inhibition/excitation in healthy and diseased states.	[Dominguez, Luis Garcia; Radhu, Natasha; Farzan, Faranak; Daskalakis, Zafiris J.] Univ Toronto, Ctr Addict & Mental Hlth, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Dominguez, LG (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada.	luisgarcia.dominguez@camh.ca		Farzan, Faranak/0000-0001-9249-2994	Temerty family foundation	Temerty family foundation	Funders: The Temerty family foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLAUS D, 1992, J NEUROL SCI, V111, P180, DOI 10.1016/0022-510X(92)90066-T; Daskalakis ZJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2860, DOI 10.1038/npp.2008.22; Daskalakis ZJ, 2012, BIOL PSYCHIAT, V72, P714, DOI 10.1016/j.biopsych.2012.08.010; Daskalakis ZJ, 2012, BRAIN RES, V1463, P93, DOI 10.1016/j.brainres.2012.04.045; Daskalakis ZJ, 2002, J PHYSIOL-LONDON, V543, P317, DOI 10.1113/jphysiol.2002.017673; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Farzan F, 2010, J NEUROPHYSIOL, V104, P1339, DOI 10.1152/jn.00279.2010; Farzan F, 2010, BRAIN, V133, P1505, DOI 10.1093/brain/awq046; Ferrarelli F, 2008, AM J PSYCHIAT, V165, P996, DOI 10.1176/appi.ajp.2008.07111733; Fitzgerald PB, 2009, CLIN NEUROPHYSIOL, V120, P1706, DOI 10.1016/j.clinph.2009.06.019; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Hoppenbrouwers SS, 2013, CORTEX, V49, P1377, DOI 10.1016/j.cortex.2012.06.003; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCCORMICK DA, 1989, J NEUROPHYSIOL, V62, P1018, DOI 10.1152/jn.1989.62.5.1018; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Muller-Dahlhaus JFM, 2008, J PHYSIOL-LONDON, V586, P495, DOI 10.1113/jphysiol.2007.142059; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Rogasch NC, 2013, J NEUROPHYSIOL, V109, P89, DOI 10.1152/jn.00762.2012; Sanger TD, 2001, J PHYSIOL-LONDON, V530, P307, DOI 10.1111/j.1469-7793.2001.0307l.x; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; VALLSSOLE J, 1992, ELECTROEN CLIN NEURO, V85, P355, DOI 10.1016/0168-5597(92)90048-G; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x	24	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92354	10.1371/journal.pone.0092354	http://dx.doi.org/10.1371/journal.pone.0092354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642981	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900123
J	Lin, HY; Li, Y; Li, L; Wang, WJ; Yang, DZ; Zhang, QX				Lin, Haiyan; Li, Yu; Li, Lin; Wang, Wenjun; Yang, Dongzi; Zhang, Qingxue			Is a GnRH Antagonist Protocol Better in PCOS Patients? A Meta-Analysis of RCTs	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; IN-VITRO FERTILIZATION; ASSISTED REPRODUCTION CYCLES; RANDOMIZED CONTROLLED-TRIAL; AGONIST PROTOCOL; HORMONE AGONISTS; LONG PROTOCOL; HYPERSTIMULATION; STIMULATION; WOMEN	Objective: To review published randomized controlled trials (RCTs) evaluating the outcomes of in vitro fertilization/intra-cytoplasmic sperm injection (IVF/ICSI) utilization of gonadotropin-releasing hormone (GnRH) antagonists for ovarian stimulation in polycystic ovarian syndrome (PCOS) patients compared with classic luteal long agonist protocols. Design: A meta-analysis of prospective randomized trials published in English between 2002 and 2013. Patient(s) and Interventions: Nine RCTs examining PCOS patients undergoing IVF/ICSI including 588 women who underwent long agonist protocols and 554 women who underwent GnRH antagonist protocols. Main Outcome Measure(s): Clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR) and ovarian hyperstimulation syndrome (OHSS) rate. Result(s): Nine RCTs were included in this analysis. The CPR-per-embryo transferred was similar in the two groups (relative risk (RR): 0.97, 95% confidence interval (CI): 0.85-1.10). Non-significant estimates comparing the two protocols were found for age, BMI, total dose of gonadotropin administered, number of days of stimulation and number of oocytes retrieved. After meta-analysis of 4 of the RCTs, it was concluded that a GnRH antagonist protocol is better than an agonist long protocol to reduce the rate of severe OHSS (odds ratio (OR): 1.56, 95% CI: 0.29-8.51). Conclusion(s): With respect to CPR, a GnRH antagonist protocol is similar to a GnRH agonist long protocol. However, for severe OHSS, a GnRH antagonist protocol is significantly better in PCOS patients.	[Lin, Haiyan; Li, Yu; Li, Lin; Wang, Wenjun; Yang, Dongzi; Zhang, Qingxue] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gynecol & Obstet, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, QX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gynecol & Obstet, Guangzhou 510275, Guangdong, Peoples R China.	zhangqingxue666@aliyun.com						Al-Inany H, 2002, HUM REPROD, V17, P874, DOI 10.1093/humrep/17.4.874; Ashrafi M., 2005, Iranian Journal of Reproductive Medicine, V3, P14; Bahceci M, 2005, J REPROD MED, V50, P84; Garcia-Velasco JA, 2011, FERTIL STERIL, V96, P590, DOI 10.1016/j.fertnstert.2011.06.022; Haydardedeoglu B, 2012, ARCH GYNECOL OBSTET, V286, P763, DOI 10.1007/s00404-012-2348-9; Hosseini MA, 2010, J OBSTET GYNAECOL RE, V36, P605, DOI 10.1111/j.1447-0756.2010.01247.x; Huirne JAF, 2005, HUM REPROD, V20, P359, DOI 10.1093/humrep/deh601; Hwang JL, 2004, HUM REPROD, V19, P1993, DOI 10.1093/humrep/deh375; Kaur Harpreet, 2012, J Hum Reprod Sci, V5, P181, DOI 10.4103/0974-1208.101017; Kim Chung-Hoon, 2012, Clin Exp Reprod Med, V39, P22, DOI 10.5653/cerm.2012.39.1.22; Kolibianakis EM, 2004, HUM REPROD, V19, P2490, DOI 10.1093/humrep/deh471; Kurzawa R, 2008, J ASSIST REPROD GEN, V25, P365, DOI 10.1007/s10815-008-9249-7; Lainas TG, 2007, HUM REPROD, V22, P1540, DOI 10.1093/humrep/dem033; Lainas TG, 2010, HUM REPROD, V25, P683, DOI 10.1093/humrep/dep436; Mancini F, 2011, GYNECOL ENDOCRINOL, V27, P150, DOI 10.3109/09513590.2010.526667; Olivennes F, 2002, HUM REPROD UPDATE, V8, P279, DOI 10.1093/humupd/8.3.279; Orvieto R, 2012, GYNECOL ENDOCRINOL, V28, P422, DOI 10.3109/09513590.2011.633661; Orvieto R, 2009, FERTIL STERIL, V91, P1466, DOI 10.1016/j.fertnstert.2008.07.1711; Pundir J, 2012, REPROD BIOMED ONLINE, V24, P6, DOI 10.1016/j.rbmo.2011.09.017; Ragni G, 2005, HUM REPROD, V20, P2421, DOI 10.1093/humrep/dei074; SMITZ J, 1992, HUM REPROD, V7, P49, DOI 10.1093/humrep/7.suppl_1.49; Tehraninejad ES, 2010, ARCH GYNECOL OBSTET, V282, P319, DOI 10.1007/s00404-010-1429-x; Tesarik J, 2006, HUM REPROD, V21, P2572, DOI 10.1093/humrep/del173; Vrtacnik-Bokal E, 2009, REPROD BIOMED ONLINE, V18, P21, DOI 10.1016/S1472-6483(10)60420-8; Xiao JS, 2013, GYNECOL ENDOCRINOL, V29, P187, DOI 10.3109/09513590.2012.736561	25	30	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91796	10.1371/journal.pone.0091796	http://dx.doi.org/10.1371/journal.pone.0091796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642641	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900036
J	Wei, Y; Jiang, YZ; Qian, WH				Wei, Yong; Jiang, Ya-Zhi; Qian, Wen-Hui			Prognostic Role of NLR in Urinary Cancers: A Meta-Analysis	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRETREATMENT NEUTROPHIL; BLADDER-CANCER; SYSTEMIC INFLAMMATION; SURVIVAL; ASSOCIATION; MARKER; RISK	Background: Recently, many studies explored the role of inflammation parameters such as neutrophil-to-lymphocyte ratio (NLR) in the prognosis of urinary cancers, but the results were not consistent. Methods: We carried out a meta-analysis of published studies to assess the prognostic value of NLR in patients with urinary cancers. Hazard ratio (OR) with 95% confidence interval (CI) was used to assess the association of NLR and OS and RFS/CSS. Results: The pooled results showed that high NLR was a poor predictor for OS with HR of 1.81 (95% CI: 1.48-2.21; P-heterogeneity = 0.005) and RFS/CSS (HR = 2.07, 95% CI: 1.65-2.6; P-heterogeneity = 0.849). Subgroup analyses revealed that high NLR yielded a worse OS in RCC (HR = 1.9, 95% CI: 1.47-2.45; P-heterogeneity = 0.003) and a poor RFS/CSS in RCC (HR = 1.83, 95% CI: 1.35-2.48; P-heterogeneity = 0.709), bladder cancer (HR = 2.2, 95% CI: 1.27-3.8; P-heterogeneity = 0.447) and urothelial carcinoma (HR = 2.58, 95% CI: 1.66-4.01; P-heterogeneity = 0.784). Conclusion: Our results showed that NLR could act as a significant biomarker in the prognosis of urinary cancers.	[Wei, Yong; Jiang, Ya-Zhi; Qian, Wen-Hui] Gaochun Cty Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China		Qian, WH (corresponding author), Gaochun Cty Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China.	jsnjqwh2008cn@163.com	Wei, Yongyue/GYV-5660-2022	Wei, Yongyue/0000-0002-1132-1796				Alkhouri N, 2012, LIVER INT, V32, P297, DOI 10.1111/j.1478-3231.2011.02639.x; Azab B, 2011, PANCREATOLOGY, V11, P445, DOI 10.1159/000331494; Azuma T, 2013, CLIN GENITOURIN CANC, V11, P337, DOI 10.1016/j.clgc.2013.04.003; Castelao JE, 2000, BRIT J CANCER, V82, P1364; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Cetin B, 2013, CLIN GENITOURIN CANC, V11, P141, DOI 10.1016/j.clgc.2012.09.001; Dalpiaz O, 2013, BJU INT; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Forget P, 2013, ANN SURG ONCOL; Fox P, 2013, BRIT J CANCER, V109, P147, DOI 10.1038/bjc.2013.300; Gondo T, 2012, UROLOGY, V79, P1085, DOI 10.1016/j.urology.2011.11.070; Gueron G, 2012, PROSTATE CANCER P D, V15, P213, DOI 10.1038/pcan.2011.64; Hatakeyama S, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-47; He WZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0439-x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Keizman D, 2012, EUR J CANCER, V48, P202, DOI 10.1016/j.ejca.2011.09.001; Kobayashi M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0556-1; Krane LS, 2013, J ENDOUROL, V27, P1046, DOI 10.1089/end.2012.0606; Kutikov A, 2010, BJU INT, V106, P218, DOI 10.1111/j.1464-410X.2009.09079.x; Linton A, 2013, CLIN GENITOURIN CANC; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Ohno Y, 2013, INT J CLIN ONCOL; Ohno Y, 2012, J UROLOGY, V187, P411, DOI 10.1016/j.juro.2011.10.026; Ohno Y, 2010, J UROLOGY, V184, P873, DOI 10.1016/j.juro.2010.05.028; PETRIE HT, 1985, J IMMUNOL, V134, P230; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Santoni M, 2013, BRIT J CANCER, V109, P1755, DOI 10.1038/bjc.2013.522; Schaider H, 2003, INT J CANCER, V103, P335, DOI 10.1002/ijc.10775; Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042860; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tsai JCR, 2007, DIABETES-METAB RES, V23, P111, DOI 10.1002/dmrr.647	39	102	107	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92079	10.1371/journal.pone.0092079	http://dx.doi.org/10.1371/journal.pone.0092079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642859	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900079
J	Wu, YW; Tseng, PH; Lee, YC; Wang, SY; Chiu, HM; Tu, CH; Wang, HP; Lin, JT; Wu, MS; Yang, WS				Wu, Yen-Wen; Tseng, Ping-Huei; Lee, Yi-Chia; Wang, Shan-Ying; Chiu, Han-Mo; Tu, Chia-Hung; Wang, Hsiu-Po; Lin, Jaw-Town; Wu, Ming-Shiang; Yang, Wei-Shiung			Association of Esophageal Inflammation, Obesity and Gastroesophageal Reflux Disease: From FDG PET/CT Perspective	PLOS ONE			English	Article							EROSIVE ESOPHAGITIS; BARRETTS-ESOPHAGUS; ADIPOSE-TISSUE; ARTERIAL INFLAMMATION; ENDOSCOPIC DIAGNOSIS; NONEROSIVE REFLUX; F-18-FDG UPTAKE; RISK-FACTORS; ADENOCARCINOMA; BENIGN	Objective: Gastroesophageal reflux disease (GERD) is associated with bothersome symptoms and neoplastic progression into Barrett's esophagus and esophageal adenocarcinoma. We aim to determine the correlation between GERD, esophageal inflammation and obesity with F-18-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). Methods: We studied 458 subjects who underwent a comprehensive health check-up, which included an upper gastrointestinal endoscopy, FDG PET/CT and complete anthropometric measures. GERD symptoms were evaluated with Reflux Disease Questionnaire. Endoscopically erosive esophagitis was scored using the Los Angeles classification system. Inflammatory activity, represented by standardized uptake values (SUVmax) of FDG at pre-determined locations of esophagus, stomach and duodenum, were compared. Association between erosive esophagitis, FDG activity and anthropometric evaluation, including body mass index (BMI), waist circumference, visceral and subcutaneous adipose tissue volumes were analyzed. Results: Subjects with erosive esophagitis (n = 178, 38.9%) had significantly higher SUVmax at middle esophagus (2.69 +/- 0.74 vs. 2.41 +/- 0.57, P<.001) and esophagogastric junction (3.10 +/- 0.89 vs. 2.38 +/-.57, P<001), marginally higher at upper esophageal sphincter (2.29 +/- 0.42 vs. 2.21 +/- 0.48, P=.062), but not in stomach or duodenum. The severity of erosive esophagitis correlated with SUVmax and subjects with Barrett's esophagus had the highest SUVmax at middle esophagus and esophagogastric junction. Heartburn positively correlated with higher SUVmax at middle oesophagus (r=.262, P=.003). Using multivariate regression analyses, age (P=.027), total cholesterol level (P=.003), alcohol drinking (P=.03), subcutaneous adipose tissue (P<001), BMI (P<.001) and waist circumference (P<.001) were independently associated with higher SUVmax at respective esophageal locations. Conclusions: Esophageal inflammation demonstrated by FDG PET/CT correlates with endoscopic findings and symptomatology of GERD. Obesity markers, both visceral and general, are independent determinants of esophageal inflammation.	[Wu, Yen-Wen; Tseng, Ping-Huei; Lee, Yi-Chia; Chiu, Han-Mo; Tu, Chia-Hung; Wang, Hsiu-Po; Wu, Ming-Shiang; Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen; Wang, Shan-Ying] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen; Wang, Shan-Ying] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Tseng, Ping-Huei; Yang, Wei-Shiung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Lee, Yi-Chia] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Lin, Jaw-Town] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University; Fu Jen Catholic University; E-Da Hospital	Yang, WS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	wsyang@ntu.edu.tw	Tseng, Ping-Huei/GZA-8772-2022; Chiu, Han-Mo/AAY-6809-2020	YANG, WEI-SHIUNG/0000-0001-5087-373X; WU, YEN-WEN/0000-0003-1520-1166; LEE, YI-CHIA/0000-0002-8160-1216; CHIU, HAN-MO/0000-0003-2786-8056; TSENG, PING-HUEI/0000-0002-7483-7538; Wu, Ming-Shiang/0000-0002-1940-6428	National Taiwan University Hospital [NTUH.100-M1707, NTUH.101-M1991]; National Science Council of Taiwan [NSC 102-2314-B-002-037]	National Taiwan University Hospital(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grants funded by National Taiwan University Hospital (NTUH.100-M1707, NTUH.101-M1991) and National Science Council of Taiwan (NSC 102-2314-B-002-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Andres E, 2010, EUR J RADIOL, V75, P122, DOI 10.1016/j.ejrad.2009.04.067; Bakheet SM, 1999, CLIN NUCL MED, V24, P995, DOI 10.1097/00003072-199912000-00026; Bhargava P, 2003, CLIN NUCL MED, V28, P849, DOI 10.1097/01.rlu.0000090936.30974.e2; Busing KA, 2013, NUCL MED BIOL, V40, P206, DOI 10.1016/j.nucmedbio.2012.10.014; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; El-Serag HB, 2008, GUT, V57, DOI 10.1136/gut.2007.127878; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Erichsen R, 2012, CLIN GASTROENTEROL H, V10, P475, DOI 10.1016/j.cgh.2011.12.038; Fass R, 2007, J CLIN GASTROENTEROL, V41, P131, DOI 10.1097/01.mcg.0000225631.07039.6d; Fock KM, 2009, CLIN GASTROENTEROL H, V7, P54, DOI 10.1016/j.cgh.2008.08.030; Friedenberg FK, 2008, AM J GASTROENTEROL, V103, P2111, DOI 10.1111/j.1572-0241.2008.01946.x; Imperiale A, 2010, CLIN NUCL MED, V35, P86, DOI 10.1097/RLU.0b013e3181c7be8d; Isomoto H, 2007, J CLIN BIOCHEM NUTR, V41, P84, DOI 10.3164/jcbn.2007012; Kamimura K, 2007, EUR J NUCL MED MOL I, V34, P1815, DOI 10.1007/s00259-007-0477-3; Kandulski A, 2012, NAT REV GASTRO HEPAT, V9, P15, DOI 10.1038/nrgastro.2011.210; Lee HL, 2009, J CLIN GASTROENTEROL, V43, P240, DOI 10.1097/MCG.0b013e318167b88a; Lee YC, 2010, ENDOSCOPY, V42, P699, DOI 10.1055/s-0030-1255629; Lee YC, 2009, GUT, V58, P174, DOI 10.1136/gut.2008.162305; Lee YC, 2007, GASTROINTEST ENDOSC, V66, P230, DOI 10.1016/j.gie.2006.10.056; Li Y, 2008, CANCER INVEST, V26, P278, DOI 10.1080/07357900701708401; Lu CL, 2012, J NEUROGASTROENTEROL, V18, P236, DOI 10.5056/jnm.2012.18.3.236; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metser U, 2007, SEMIN NUCL MED, V37, P206, DOI 10.1053/j.semnuclmed.2007.01.001; Mine S, 2008, J GASTROEN HEPATOL, V23, P303, DOI 10.1111/j.1440-1746.2007.05113.x; Nam SY, 2010, GASTROENTEROLOGY, V139, P1902, DOI 10.1053/j.gastro.2010.08.019; Nelsen EM, 2012, CLIN GASTROENTEROL H, V10, P728, DOI 10.1016/j.cgh.2012.03.007; Ott K, 2006, DIS ESOPHAGUS, V19, P433, DOI 10.1111/j.1442-2050.2006.00617.x; Rastogi A, 2008, GASTROINTEST ENDOSC, V67, P394, DOI 10.1016/j.gie.2007.07.019; Roedl JB, 2008, AM J ROENTGENOL, V191, P515, DOI 10.2214/AJR.07.3320; Salaun PY, 2005, J NUCL MED, V46, P48; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Sharma P, 2007, GASTROENTEROLOGY, V133, P454, DOI 10.1053/j.gastro.2007.06.006; Shaw M, 2004, GUT, V53, P25, DOI 10.1136/gut.2003.034280; Spier BJ, 2010, MOL IMAGING BIOL, V12, P85, DOI 10.1007/s11307-009-0232-1; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Tilg H, 2010, GASTROENTEROLOGY, V139, P1823, DOI 10.1053/j.gastro.2010.10.038; Tsai MK, 2012, SCI WORLD J, DOI 10.1100/2012/702803; Tseng PH, 2008, J CLIN GASTROENTEROL, V42, P1074, DOI 10.1097/MCG.0b013e31809e7126; Tseng PH, 2011, J CLIN GASTROENTEROL, V45, P501, DOI 10.1097/MCG.0b013e3181eeb115; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wu YW, 2012, EUR J NUCL MED MOL I, V39, P399, DOI 10.1007/s00259-011-1994-7; Yeung Henry W.D., 1999, Clin Positron Imaging, V2, P255, DOI 10.1016/S1095-0397(99)00035-7	44	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92001	10.1371/journal.pone.0092001	http://dx.doi.org/10.1371/journal.pone.0092001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642729	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900057
J	Keller, KK; Thomsen, JS; Stengaard-Pedersen, K; Hauge, EM				Keller, Kresten Krarup; Thomsen, Jesper Skovhus; Stengaard-Pedersen, Kristian; Hauge, Ellen-Margrethe			Systemic but No Local Effects of Combined Zoledronate and Parathyroid Hormone Treatment in Experimental Autoimmune Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; MICRO-COMPUTED-TOMOGRAPHY; FACTOR-MEDIATED ARTHRITIS; BONE-MINERAL DENSITY; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; NECROSIS-FACTOR; POSTMENOPAUSAL OSTEOPOROSIS; BISPHOSPHONATE THERAPY; STRUCTURAL DAMAGE	Introduction: Local bone erosions and osteoporosis in rheumatoid arthritis (RA) are the result of a more pronounced bone resorption than bone formation. Present treatment strategies for RA inhibit inflammation, but do not directly target bone erosions. The aim of the study was in experimental arthritis to investigate the juxtaarticular and systemic effects of simultaneous osteoclast inhibition with zoledronate (ZLN) and osteoblast stimulation with parathyroid hormone (PTH). Methods: Arthritis was induced in 36 SKG mice. The mice were randomized to three treatment groups and an untreated group: ZLN, PTH, PTH+ZLN, and untreated. Arthritis score and ankle width measurements were performed. Histological sections were cut from the right hind paw, and design-based stereological estimators were used to quantify histological variables of bone volume and bone formation and resorption. The femora were DXA-and mu CT-scanned, and the bone strength was determined at the femoral neck and mid-diaphysis. Results: Locally, we found no differences in arthritis score or ankle width throughout the study. Similarly, none of the treatments inhibited bone erosions or stimulated bone formation in the paw. Systemically, all treatments improved bone mineral density, strength of the femoral neck and mid-diaphysis, and mu CT parameters of both cortical and trabecular bone. In addition, there was an additive effect of combination treatment compared with single treatments for most trabecular parameters including bone mineral density and bone volume fraction. Conclusions: No local effect on bone was found by the combined action of inhibiting bone resorption and stimulating bone formation. However, a clear systemic effect of the combination treatment was demonstrated.	[Keller, Kresten Krarup; Stengaard-Pedersen, Kristian; Hauge, Ellen-Margrethe] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Thomsen, Jesper Skovhus] Aarhus Univ, Dept Biomed Anat, Aarhus, Denmark	Aarhus University; Aarhus University	Keller, KK (corresponding author), Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark.	kresten@ana.au.dk	Keller, Kresten Krarup/S-2067-2019	Keller, Kresten Krarup/0000-0003-2474-3389; Thomsen, Jesper Skovhus/0000-0001-9386-6679	Danish Rheumatism Association; A.P. Moller Foundation for the Advancement of Medical Science; Aase and Ejnar Danielsens Foundation; Horslev Foundation; Clinical Institute Aarhus University; Peter Ryholts Grant; Hede Nielsens Family Foundation	Danish Rheumatism Association; A.P. Moller Foundation for the Advancement of Medical Science; Aase and Ejnar Danielsens Foundation; Horslev Foundation; Clinical Institute Aarhus University; Peter Ryholts Grant; Hede Nielsens Family Foundation	This work was supported by the Danish Rheumatism Association, The A.P. Moller Foundation for the Advancement of Medical Science, Aase and Ejnar Danielsens Foundation, the Horslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant and the Hede Nielsens Family Foundation. The mu CT scanner was donated by the Velux Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Breuil V, 2006, JOINT BONE SPINE, V73, P349, DOI 10.1016/j.jbspin.2005.10.019; Caetano-Lopes J, 2009, CLIN EXP RHEUMATOL, V27, P475; Caetano-Lopes J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2908; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; Cosman F, 2009, J CLIN ENDOCR METAB, V94, P3772, DOI 10.1210/jc.2008-2719; Cosman F, 2008, CURR OPIN ENDOCRINOL, V15, P495, DOI 10.1097/MED.0b013e32831a46d6; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Erben RG, 1996, ANAT REC, V246, P39, DOI 10.1002/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A; Fukata S, 2004, ARTHRITIS RHEUM-US, V50, P4060, DOI 10.1002/art.20728; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Gravallese EM, 1998, AM J PATHOL, V152, P943; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hardy R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4065; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; Hauge E, 1999, BONE, V25, P389, DOI 10.1016/S8756-3282(99)00194-5; Herrak P, 2004, ARTHRITIS RHEUM-US, V50, P2327, DOI 10.1002/art.20384; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Jarrett SJ, 2006, ARTHRITIS RHEUM-US, V54, P1410, DOI 10.1002/art.21824; Keller KK, 2011, CLIN EXP RHEUMATOL, V29, P536; Keller KK, 2013, RHEUMATOL INT, V33, P1127, DOI 10.1007/s00296-012-2500-7; Keller KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053034; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; Kobayashi K, 2006, INFLAMM RES, V55, P335, DOI 10.1007/s00011-006-5208-x; Le Goff B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2877; Mosekilde L, 1999, BONE, V24, P71, DOI 10.1016/S8756-3282(98)00169-0; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Rau R, 2006, CLIN EXP RHEUMAT S43, V24, pS; Recknor C, 2011, EXPERT OPIN PHARMACO, V12, P807, DOI 10.1517/14656566.2011.562201; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; Romas E, 2005, BEST PRACT RES CL RH, V19, P1065, DOI 10.1016/j.berh.2005.06.008; Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schafer AL, 2012, J CLIN ENDOCR METAB, V97, P3522, DOI 10.1210/jc.2012-1844; Schett G, 2005, ARTHRITIS RHEUM-US, V52, P1604, DOI 10.1002/art.21021; Sims NA, 2004, ARTHRITIS RHEUM-US, V50, P2338, DOI 10.1002/art.20382; Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x; Valleala H, 2012, CLIN EXP RHEUMATOL, V30, P114; van Staa TP, 2006, ARTHRITIS RHEUM-US, V54, P3104, DOI 10.1002/art.22117; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]	46	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92359	10.1371/journal.pone.0092359	http://dx.doi.org/10.1371/journal.pone.0092359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637846	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100146
J	Kosciolek, T; Jones, DT				Kosciolek, Tomasz; Jones, David T.			De Novo Structure Prediction of Globular Proteins Aided by Sequence Variation-Derived Contacts	PLOS ONE			English	Article							RESIDUE CONTACTS; CORRELATED MUTATIONS; FOLDS; FAMILIES; GENOMICS	The advent of high accuracy residue-residue intra-protein contact prediction methods enabled a significant boost in the quality of de novo structure predictions. Here, we investigate the potential benefits of combining a well-established fragment-based folding algorithm - FRAGFOLD, with PSICOV, a contact prediction method which uses sparse inverse covariance estimation to identify co-varying sites in multiple sequence alignments. Using a comprehensive set of 150 diverse globular target proteins, up to 266 amino acids in length, we are able to address the effectiveness and some limitations of such approaches to globular proteins in practice. Overall we find that using fragment assembly with both statistical potentials and predicted contacts is significantly better than either statistical potentials or contacts alone. Results show up to nearly 80% of correct predictions (TM-score >= 0.5) within analysed dataset and a mean TM-score of 0.54. Unsuccessful modelling cases emerged either from conformational sampling problems, or insufficient contact prediction accuracy. Nevertheless, a strong dependency of the quality of final models on the fraction of satisfied predicted long-range contacts was observed. This not only highlights the importance of these contacts on determining the protein fold, but also (combined with other ensemble-derived qualities) provides a powerful guide as to the choice of correct models and the global quality of the selected model. A proposed quality assessment scoring function achieves 0.93 precision and 0.77 recall for the discrimination of correct folds on our dataset of decoys. These findings suggest the approach is well-suited for blind predictions on a variety of globular proteins of unknown 3D structure, provided that enough homologous sequences are available to construct a large and accurate multiple sequence alignment for the initial contact prediction step.	[Kosciolek, Tomasz; Jones, David T.] UCL, Dept Comp Sci, Bioinformat Grp, London, England; [Kosciolek, Tomasz; Jones, David T.] UCL, Inst Struct & Mol Biol, London, England	University of London; University College London; University of London; Birkbeck University London; University College London	Jones, DT (corresponding author), UCL, Dept Comp Sci, Bioinformat Grp, London, England.	d.t.jones@ucl.ac.uk	Kosciolek, Tomasz/Y-2805-2019	Kosciolek, Tomasz/0000-0002-9915-7387	Wellcome Trust [096624/Z/11/Z]; Biotechnology and Biological Sciences Research Council [BB/E023533/1] Funding Source: researchfish; BBSRC [BB/E023533/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TK is supported by the Wellcome Trust PhD studentship (096624/Z/11/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, PROTEIN ENG DES SEL, V23, P321, DOI 10.1093/protein/gzp078; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Ezkurdia L, 2009, BRIEF BIOINFORM, V10, P233, DOI 10.1093/bib/bbp021; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Hamilton N, 2004, PROTEINS, V56, P679, DOI 10.1002/prot.20160; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 2005, PROTEINS, V61, P143, DOI 10.1002/prot.20731; Jones DT, 2003, PROTEINS, V53, P480, DOI 10.1002/prot.10542; Jones DT, 2001, PROTEINS, P127; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones DT, 1997, PROTEINS, P185; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kolinski A, 2004, ACTA BIOCHIM POL, V51, P349; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lapedes A.S., 1999, LECT NOTES MONOGR SE, V33, P236, DOI [10.1214/lnms/1215455556, DOI 10.1214/LNMS/1215455556]; Liwo A, 1997, J COMPUT CHEM, V18, P849, DOI 10.1002/(SICI)1096-987X(199705)18:7<849::AID-JCC1>3.0.CO;2-R; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Nair Rajesh, 2009, Journal of Structural and Functional Genomics, V10, P181, DOI 10.1007/s10969-008-9055-6; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Punta M, 2005, BIOINFORMATICS, V21, P2960, DOI 10.1093/bioinformatics/bti454; Simons KT, 1999, PROTEINS, P171; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	43	83	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92197	10.1371/journal.pone.0092197	http://dx.doi.org/10.1371/journal.pone.0092197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637808	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100126
J	Labeyrie, V; Deu, M; Barnaud, A; Calatayud, C; Buiron, M; Wambugu, P; Manel, S; Glaszmann, JC; Leclerc, C				Labeyrie, Vanesse; Deu, Monique; Barnaud, Adeline; Calatayud, Caroline; Buiron, Marylene; Wambugu, Peterson; Manel, Stephanie; Glaszmann, Jean-Christophe; Leclerc, Christian			Influence of Ethnolinguistic Diversity on the Sorghum Genetic Patterns in Subsistence Farming Systems in Eastern Kenya	PLOS ONE			English	Article							POPULATION-STRUCTURE; FARMERS; MAIZE; VARIETIES; SEED; DIFFERENTIATION; INFORMATION; LANDRACES; DYNAMICS; EXCHANGE	Understanding the effects of actions undertaken by human societies on crop evolution processes is a major challenge for the conservation of genetic resources. This study investigated the mechanisms whereby social boundaries associated with patterns of ethnolinguistic diversity have influenced the on-farm distribution of sorghum diversity. Social boundaries limit the diffusion of planting material, practices and knowledge, thus shaping crop diversity in situ. To assess the effect of social boundaries, this study was conducted in the contact zone between the Chuka, Mbeere and Tharaka ethnolinguistic groups in eastern Kenya. Sorghum varieties were inventoried and samples collected in 130 households. In all, 297 individual plants derived from seeds collected under sixteen variety names were characterized using a set of 18 SSR molecular markers and 15 morphological descriptors. The genetic structure was investigated using both a Bayesian assignment method and distance-based clustering. Principal Coordinates Analysis was used to describe the structure of the morphological diversity of the panicles. The distribution of the varieties and the main genetic clusters across ethnolinguistic groups was described using a non-parametric MANOVA and pairwise Fisher tests. The spatial distribution of landrace names and the overall genetic spatial patterns were significantly correlated with ethnolinguistic partition. However, the genetic structure inferred from molecular makers did not discriminate the short-cycle landraces despite their morphological distinctness. The cases of two improved varieties highlighted possible fates of improved materials. The most recent one was often given the name of local landraces. The second one, that was introduced a dozen years ago, displays traces of admixture with local landraces with differential intensity among ethnic groups. The patterns of congruence or discordance between the nomenclature of farmers' varieties and the structure of both genetic and morphological diversity highlight the effects of the social organization of communities on the diffusion of seed, practices, and variety nomenclature.	[Labeyrie, Vanesse; Deu, Monique; Calatayud, Caroline; Buiron, Marylene; Glaszmann, Jean-Christophe; Leclerc, Christian] UMR AGAP, CIRAD, Montpellier, France; [Wambugu, Peterson] Natl Genebank Kenya, KARI, Nairobi, Kenya; [Barnaud, Adeline] UMR DIADE, IRD, Montpellier, France; [Manel, Stephanie] Univ Aix Marseille, IRD, UMR LPED, Marseille, France; [Manel, Stephanie] UMR AMAP, CIRAD, Montpellier, France	CIRAD; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Labeyrie, V (corresponding author), UMR AGAP, CIRAD, Montpellier, France.	vanesse.labeyrie@gmail.com	Labeyrie, Vanesse/AAF-7767-2021	Wambugu, Peterson/0000-0003-4957-9386; barnaud, adeline/0000-0001-9896-1210	Agropolis Fondation [0900-001]; CIRAD	Agropolis Fondation; CIRAD	This study was supported by Agropolis Fondation in the framework of the ARCAD project No.0900-001. V. Labeyrie was supported by Agropolis Fondation through a Ph.D. grant and received financial support from CIRAD for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler C, 1988, KENYAN COMMUNITIES A, P123; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2000, GENES FIELD ON FARM; Baco MN, 2008, CAH AGRIC, V17, P172; Badstue LB, 2007, WORLD DEV, V35, P1579, DOI 10.1016/j.worlddev.2006.05.023; Bandiera O, 2006, ECON J, V116, P869, DOI 10.1111/j.1468-0297.2006.01115.x; Barnaud A, 2007, THEOR APPL GENET, V114, P237, DOI 10.1007/s00122-006-0426-8; Barth F, 1969, ETHNIC GROUPS BOUND; Belkhir K, 2004, GENETIX SOFTWARE WIN; Bellon MR, 2004, WORLD DEV, V32, P159, DOI 10.1016/j.worlddev.2003.04.007; BELLON MR, 1994, ECON BOT, V48, P196, DOI 10.1007/BF02908218; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthouly C, 2009, MOL ECOL, V18, P3980, DOI 10.1111/j.1365-294X.2009.04342.x; Billot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059714; Billot C, 2012, AM J BOT, V99, pE245, DOI 10.3732/ajb.1100548; BOSTER JS, 1986, AM ANTHROPOL, V88, P428, DOI 10.1525/aa.1986.88.2.02a00100; Bowser B.J., 2008, CULTURAL TRANSMISSIO, P223; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Camberlin P, 2012, INT J CLIMATOL, DOI DOI 10.1002/J0C.3427/FULL.ACCESSED; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Chesaina C, 1997, ORAL LIT EMBU MBEERE, P3; David S., 1999, Agriculture and Human Values, V16, P381, DOI 10.1023/A:1007603902380; Deu M, 2008, THEOR APPL GENET, V116, P903, DOI 10.1007/s00122-008-0721-7; DEWET JMJ, 1967, EVOLUTION, V21, P787, DOI 10.1111/j.1558-5646.1967.tb03434.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fadiman Jeffrey A., 1993, WE BEGAN THERE WERE; Gibson RW, 2009, ECON BOT, V63, P242, DOI 10.1007/s12231-009-9086-3; Glazier J, 1970, RITUAL SOCIAL CONFLI; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harlan Jack R., 1976, ORIGINS AFRICAN PLAN, P3, DOI DOI 10.1515/9783110806373.465; International Fund for Agricultural Development (IFAD), 2001, RUR POV REP 2001 CHA; IPGRI, 1993, DESCR SORGH; Jaetzold R, 2007, FARM MANAGEMENT HD C, VII; Labeyrie V, 2013, AGR HUMAN V IN PRESS; Leclerc C., 2011, DIVERSITY, V4, P1, DOI [DOI 10.3390/D4010001, 10.3390/d4010001]; Lewis M., 2013, ETHNOLOGUE LANGUAGES, V17th; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; McGuire SJ, 2008, HUM ECOL, V36, P217, DOI 10.1007/s10745-007-9143-4; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Middleton J, 1953, CENTRAL TRIBES N E B; Moehlig WJG, 1980, DIALECTOLOGIE COMP A, P27; Nakazawa M, 2013, FMSB FUNCTIONS MED S; Nei M., 1987, MOL EVOLUTIONARY GEN; Nuijten E, 2008, ECON BOT, V62, P148, DOI 10.1007/s12231-008-9012-0; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Perrier X., 2006, DARWIN SOFTWARE; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Plucknett D. L., 1970, Advances in Agronomy, V22, P285, DOI 10.1016/S0065-2113(08)60271-0; Pressoir G, 2004, HEREDITY, V92, P95, DOI 10.1038/sj.hdy.6800388; Pritchard JK, 2000, GENETICS, V155, P945; Rabbi IY, 2010, PLANT GENET RESOUR-C, V8, P116, DOI 10.1017/S147926211000002X; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reyes-Garcia V, 2009, EVOL HUM BEHAV, V30, P274, DOI 10.1016/j.evolhumbehav.2009.02.001; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sardos J, 2012, GENET RESOUR CROP EV, V59, P805, DOI 10.1007/s10722-011-9720-7; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Soler C, 2013, PLANT GENET RESOUR-C, V11, P36, DOI 10.1017/S1479262112000342; Van den Broeck K, 2011, J DEV STUD, V47, P231, DOI 10.1080/00220381003599360; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	66	33	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92178	10.1371/journal.pone.0092178	http://dx.doi.org/10.1371/journal.pone.0092178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637745	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100124
J	Puga-Gonzalez, I; Butovskaya, M; Thierry, B; Hemelrijk, CK				Puga-Gonzalez, Ivan; Butovskaya, Marina; Thierry, Bernard; Hemelrijk, Charlotte Korinna			Empathy versus Parsimony in Understanding Post-Conflict Affiliation in Monkeys: Model and Empirical Data	PLOS ONE			English	Article							POSTCONFLICT 3RD-PARTY AFFILIATION; MACAQUE MACACA-MULATTA; CAPTIVE CHIMPANZEES; BARBARY MACAQUES; RHESUS; RECONCILIATION; CONSOLATION; DOMINANCE; RECIPROCITY; MECHANISMS	Post-conflict affiliation between former opponents and bystanders occurs in several species of non-human primates. It is classified in four categories of which affiliation received by the former victim, 'consolation', has received most attention. The hypotheses of cognitive constraint and social constraint are inadequate to explain its occurrence. The cognitive constraint hypothesis is contradicted by recent evidence of 'consolation' in monkeys and the social constraint hypothesis lacks information why 'consolation' actually happens. Here, we combine a computational model and an empirical study to investigate the minimum cognitive requirements for post-conflict affiliation. In the individual-based model, individuals are steered by cognitively simple behavioural rules. Individuals group and when nearby each other they fight if they are likely to win, otherwise, they may groom, especially when anxious. We parameterize the model after empirical data of a tolerant species, the Tonkean macaque (Macaca tonkeana). We find evidence for the four categories of post-conflict affiliation in the model and in the empirical data. We explain how in the model these patterns emerge from the combination of a weak hierarchy, social facilitation, risk-sensitive aggression, interactions with partners close-by and grooming as tension-reduction mechanism. We indicate how this may function as a new explanation for empirical data.	[Puga-Gonzalez, Ivan; Hemelrijk, Charlotte Korinna] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Butovskaya, Marina] Russian Acad Sci, Inst Ethnol & Anthropol, Moscow, Russia; [Thierry, Bernard] Univ Strasbourg, Dept Ecol Physiol & Ethol, Inst Interdisciplinaire Hubert Curien, Ctr Natl Rech Sci, Strasbourg, France	University of Groningen; Russian Academy of Sciences; N.N. Miklukho-Maklai Institute of Ethnology & Anthropology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hemelrijk, CK (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	c.k.hemelrijk@rug.nl	Butovskaya, Marina/E-2368-2016; Hemelrijk, Charlotte/E-4828-2013	Butovskaya, Marina/0000-0002-5528-0519; Puga-Gonzalez, Ivan/0000-0003-2510-6760; Hemelrijk, Charlotte/0000-0001-6160-077X	NWO; University of Groningen	NWO(Netherlands Organization for Scientific Research (NWO)); University of Groningen	A NWO visitor grant was awarded to Prof. Dr. Marina Butovskaya for the realization of this project. The University of Groningen provided financial support to Ivan Puga-Gonzalez during his Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; Aureli F, 2002, BEHAVIOUR, V139, P393, DOI 10.1163/156853902760102726; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barchas P.R., 1984, SOCIAL HIERARCHIES E, P81; Butovskaya M. L., 2004, MACAQUE SOC MODEL ST, P182; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; Clay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055206; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cozzi A, 2010, BEHAV PROCESS, V85, P185, DOI 10.1016/j.beproc.2010.07.007; Das M, 1998, INT J PRIMATOL, V19, P53, DOI 10.1023/A:1020354826422; DAS M, 2000, NATURAL CONFLICT RES; De Marco A, 2011, AM J PHYS ANTHROPOL, V146, P457, DOI 10.1002/ajpa.21606; De Marco A, 2010, ANIM BEHAV, V80, P197, DOI 10.1016/j.anbehav.2010.04.016; De Waal Frans B. M., 1996, P80; Demaria C, 2001, BEHAVIOUR, V138, P397, DOI 10.1163/15685390152032514; DEWAAL FBM, 1988, ETHOL SOCIOBIOL, V9, P101, DOI 10.1016/0162-3095(88)90016-7; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Evers E, 2012, BEHAV ECOL SOCIOBIOL, V66, P931, DOI 10.1007/s00265-012-1342-3; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Graves FC, 2002, BEHAV NEUROSCI, V116, P489, DOI 10.1037//0735-7044.116.3.489; Hemelrijk CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037271; Hemelrijk CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002678; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2005, BEHAVIOUR, V142, P1037, DOI 10.1163/156853905774405290; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hogeweg P, 1988, ARTIFICIAL LIFE SFI, P297; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Judge PG, 2005, ANIM BEHAV, V69, P1345, DOI 10.1016/j.anbehav.2004.08.016; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; McFarland R, 2012, ANIM BEHAV, V84, P583, DOI 10.1016/j.anbehav.2012.06.010; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P105, DOI 10.1002/ajpa.20242; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; Romero T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022173; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2008, INT J PRIMATOL, V29, P1591, DOI 10.1007/s10764-008-9315-0; Romero T, 2009, AM J PRIMATOL, V71, P60, DOI 10.1002/ajp.20619; SCHINO G, 1992, BRAIN RES, V576, P125, DOI 10.1016/0006-8993(92)90617-I; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Setchell JM, 2008, HORM BEHAV, V54, P365, DOI 10.1016/j.yhbeh.2008.05.004; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Silk JB, 2002, ANNU REV ANTHROPOL, V31, P21, DOI 10.1146/annurev.anthro.31.032902.101743; THIERRY B, 1989, FOLIA PRIMATOL, V52, P178, DOI 10.1159/000156396; THIERRY B, 1990, J THEOR BIOL, V145, P511, DOI 10.1016/S0022-5193(05)80485-0; THIERRY B, 1985, AGGRESSIVE BEHAV, V11, P223, DOI 10.1002/1098-2337(1985)11:3<223::AID-AB2480110305>3.0.CO;2-A; Thierry B., 2006, P29; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3	57	22	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91262	10.1371/journal.pone.0091262	http://dx.doi.org/10.1371/journal.pone.0091262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637720	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100024
J	Tang, YC; Xu, XJ; Guo, SX; Zhang, CB; Tang, Y; Tian, Y; Ni, B; Lu, BF; Wang, HZ				Tang, Yichen; Xu, Xuejun; Guo, Shixiang; Zhang, Chaobin; Tang, Yan; Tian, Yi; Ni, Bing; Lu, Binfeng; Wang, Huaizhi			An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; PERIPHERAL-BLOOD; IMMUNE-RESPONSE; HEPATOCELLULAR-CARCINOMA; ANTITUMOR IMMUNITY; MICROENVIRONMENT; RECRUITMENT; SURVIVAL; IMMUNOTHERAPY; LYMPHOCYTES	CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4(+) T cells and CD8(+) T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8(+) T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4(+)CD25(+)Foxp3(+) Tregs and CD8(+) T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3(+) T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3(+) T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8(+) T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.	[Tang, Yichen; Xu, Xuejun; Guo, Shixiang; Zhang, Chaobin; Wang, Huaizhi] Third Mil Med Univ, Southwest Hosp, Inst Hepatopancreatobiliary Surg, Chongqing, Peoples R China; [Tang, Yan; Tian, Yi; Ni, Bing] Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China; [Lu, Binfeng] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA USA	Army Medical University; Army Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ni, B (corresponding author), Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China.	nibingxi@yahoo.com; lumobile@hotmail.com; whuaizhi@gmail.com		Ni, Bing/0000-0002-4297-5346	National Natural Science Foundation of China [81072439, 81372242]; Logistics Research Projects of PLA [CWS11J051]; National High Technology Research and Development Program of China (863 Program) [2012AA021105]; Special Research Fund for Public Welfare for the Health Industry [201202007]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Logistics Research Projects of PLA; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Special Research Fund for Public Welfare for the Health Industry; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the National Natural Science Foundation of China (No. 81072439, 81372242), the Logistics Research Projects of PLA (No. CWS11J051), the National High Technology Research and Development Program of China (863 Program) (No. 2012AA021105), and the Special Research Fund for Public Welfare for the Health Industry (No. 201202007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; Betts G, 2012, GUT, V61, P1163, DOI 10.1136/gutjnl-2011-300970; Cambien B, 2009, BRIT J CANCER, V100, P1755, DOI 10.1038/sj.bjc.6605078; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Clark RA, 2008, J EXP MED, V205, P2221, DOI 10.1084/jem.20071190; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de Rezende LCD, 2010, ARCH IMMUNOL THER EX, V58, P179, DOI 10.1007/s00005-010-0075-0; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Ene-Obong A, 2013, GASTROENTEROLOGY, V145, P1121, DOI 10.1053/j.gastro.2013.07.025; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hiraoka N, 2010, INT J CLIN ONCOL, V15, P544, DOI 10.1007/s10147-010-0130-1; Huang Xin, 2009, V506, P115, DOI 10.1007/978-1-59745-409-4_9; Huang Y, 2012, DIGESTION, V86, P329, DOI 10.1159/000342801; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Kelsen DP, 1997, SURGERY, V122, P53, DOI 10.1016/S0039-6060(97)90264-6; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Labidi-Galy SI, 2011, CANCER RES, V71, P5423, DOI 10.1158/0008-5472.CAN-11-0367; Lin YC, 2013, INT J CANCER, V132, P1341, DOI 10.1002/ijc.27784; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Litzinger MT, 2007, BLOOD, V110, P3192, DOI 10.1182/blood-2007-06-094615; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Loddenkemper C, 2009, CANCER SCI, V100, P1112, DOI 10.1111/j.1349-7006.2009.01153.x; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Okita R, 2005, ONCOL REP, V14, P1269; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Pedroza-Gonzalez A, 2013, HEPATOLOGY, V57, P183, DOI 10.1002/hep.26013; Preston CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080063; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Siddiqui SA, 2007, CLIN CANCER RES, V13, P2075, DOI 10.1158/1078-0432.CCR-06-2139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; van Steenwijk PJD, 2013, INT J CANCER, V133, P2884, DOI 10.1002/ijc.28309; Vizio B, 2012, EXP THER MED, V4, P70, DOI 10.3892/etm.2012.553; Yamamoto T, 2012, PANCREAS, V41, P409, DOI 10.1097/MPA.0b013e3182373a66; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	47	106	109	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91551	10.1371/journal.pone.0091551	http://dx.doi.org/10.1371/journal.pone.0091551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637664	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000333254100042
J	Tatsuke, T; Zhu, L; Li, ZQ; Mitsunobu, H; Yoshimura, K; Mon, H; Lee, JM; Kusakabe, T				Tatsuke, Tsuneyuki; Zhu, Li; Li, Zhiqing; Mitsunobu, Hitoshi; Yoshimura, Kaito; Mon, Hiroaki; Lee, Jae Man; Kusakabe, Takahiro			Roles of Piwi Proteins in Transcriptional Regulation Mediated by HP1s in Cultured Silkworm Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; BOMBYX-MORI; DROSOPHILA; HETEROCHROMATIN; GENE; TRANSPOSONS; LOCALIZATION; BIOGENESIS; MECHANISMS; MACHINERY	Piwi proteins are part of a superfamily of Argonaute proteins, which are one of the core components of the RNA silencing pathway in many eukaryotes. Piwi proteins are thought to repress the transposon expression both transcriptionally and post-transcriptionally. Recently, Drosophila melanogaster Piwi was recently reported to associate with chromatin and to interact directly with the Heterochromatin Protein 1 (HP1a). However, similar interactions have not been reported in other higher eukaryotes. Here we show that silkworm Piwi proteins interact with HP1s in the nucleus. The silkworm, Bombyx mori, has two Piwi proteins, Ago3 and Siwi, and two typical HP1 proteins, HP1a and HP1b. We found that HP1a plays an important role in the interaction between Ago3/Siwi and HP1b in the ovary-derived BmN4 cell line. We also found that Ago3/Siwi regulates the transcription in an HP1-dependent manner. These results suggest that silkworm Piwi proteins function as a chromatin regulator in collaboration with HP1a and HP1b.	[Tatsuke, Tsuneyuki; Zhu, Li; Li, Zhiqing; Yoshimura, Kaito; Mon, Hiroaki; Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan; [Mitsunobu, Hitoshi] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Kyushu University; Harvard University; Harvard Medical School	Kusakabe, T (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan.	kusakabe@agr.kyushu-u.ac.jp	Tatsuke, Tsuneyuki/I-3714-2019; Zhu, Li/S-7517-2018	Tatsuke, Tsuneyuki/0000-0003-2322-4528; Zhu, Li/0000-0002-4919-1894	Japan Society for the Promotion of Science [22248004, 23580077]; Grants-in-Aid for Scientific Research [22248004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) no. 22248004 and 23580077 from the Japan Society for the Promotion of Science to TK and JML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kavi HH, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-15; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Li ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034330; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Maeda Takuji, 2005, Journal of Insect Biotechnology and Sericology, V74, P21; Mitsunobu H, 2012, INSECT MOL BIOL, V21, P9, DOI 10.1111/j.1365-2583.2011.01115.x; Mitsunobu Hitoshi, 2006, Journal of Insect Biotechnology and Sericology, V75, P141; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Mon H, 2009, ANAL BIOCHEM, V392, P180, DOI 10.1016/j.ab.2009.05.033; Nakao H, 1999, DEV GENES EVOL, V209, P312, DOI 10.1007/s004270050257; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Tatsuke T, 2010, CELL MOL BIOL LETT, V15, P118, DOI 10.2478/s11658-009-0038-9; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92313	10.1371/journal.pone.0092313	http://dx.doi.org/10.1371/journal.pone.0092313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637637	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100140
J	Vatanavicharn, T; Prapavorarat, A; Jaree, P; Somboonwiwat, K; Tassanakajon, A				Vatanavicharn, Tipachai; Prapavorarat, Adisak; Jaree, Phattarunda; Somboonwiwat, Kunlaya; Tassanakajon, Anchalee			PmVRP15, a Novel Viral Responsive Protein from the Black Tiger Shrimp, Penaeus monodon, Promoted White Spot Syndrome Virus Replication	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; CDNA MICROARRAY; RT-PCR; BACULOVIRUS; WSSV; INFECTION; IDENTIFICATION; HEMOCYTES; DISCOVERY; JAPONICUS	Suppression subtractive hybridization of Penaeus monodon hemocytes challenged with white spot syndrome virus (WSSV) has identified the viral responsive gene, PmVRP15, as the highest up-regulated gene ever reported in shrimps. Expression analysis by quantitative real time RT-PCR revealed 9410-fold up-regulated level at 48 h post WSSV injection. Tissue distribution analysis showed that PmVRP15 transcript was mainly expressed in the hemocytes of shrimp. The full-length cDNA of PmVRP15 transcript was obtained and showed no significant similarity to any known gene in the GenBank database. The predicted open reading frame of PmVRP15 encodes for a deduced 137 amino acid protein containing a putative transmembrane helix. Immunofluorescent localization of the PmVRP15 protein revealed it accumulated around the nuclear membrane in all three types of shrimp hemocytes and that the protein was highly up-regulated in WSSV-infected shrimps. Double-stranded RNA interference-mediated gene silencing of PmVRP15 in P. monodon significantly decreased WSSV propagation compared to the control shrimps (injected with GFP dsRNA). The significant decrease in cumulative mortality rate of WSSV-infected shrimp following PmVRP15 knockdown was observed. These results suggest that PmVRP15 is likely to be a nuclear membrane protein and that it acts as a part of WSSV propagation pathway.	[Vatanavicharn, Tipachai] King Mongkuts Inst Technol Ladkrabang, Dept Chem, Appl Analyt Chem Res Unit, Fac Sci, Bangkok, Thailand; [Prapavorarat, Adisak; Jaree, Phattarunda; Somboonwiwat, Kunlaya; Tassanakajon, Anchalee] Chulalongkorn Univ, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Bangkok, Thailand	King Mongkuts Institute of Technology Ladkrabang; Chulalongkorn University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Bangkok, Thailand.	anchalee.k@chula.ac.th			Thailand Research Fund (TRF) [RTA5580008]; Chulalongkorn University [RSA5580024]; International Foundation for Science (IFS), Stockholm, Sweden; project "Development of Aquaculture Technology for Food Security and Food Safety in the Next Generation'' under JST-JICA joint program "Science and Technology Research Partnership for Sustainable Development, SATREPS; Royal Golden Jubilee Ph.D. Program, Thailand Research Fund; Chulalongkorn University under the Ratchadaphisek Somphot Endowment	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); International Foundation for Science (IFS), Stockholm, Sweden(International Foundation for Science); project "Development of Aquaculture Technology for Food Security and Food Safety in the Next Generation'' under JST-JICA joint program "Science and Technology Research Partnership for Sustainable Development, SATREPS; Royal Golden Jubilee Ph.D. Program, Thailand Research Fund; Chulalongkorn University under the Ratchadaphisek Somphot Endowment	This work was supported by research grants from the Thailand Research Fund (TRF Senior Scholar number RTA5580008), TRF and Chulalongkorn University (TRF Research Career Development Grant number RSA5580024). This research was also partially support by International Foundation for Science (IFS), Stockholm, Sweden, through a grant to KS and from project "Development of Aquaculture Technology for Food Security and Food Safety in the Next Generation'' under JST-JICA joint program "Science and Technology Research Partnership for Sustainable Development, SATREPS. A Ph.D. student fellowship granted to PJ by the Royal Golden Jubilee Ph.D. Program, Thailand Research Fund is greatly appreciated. The authors also thank Chulalongkorn University for the support under the Ratchadaphisek Somphot Endowment to the Center of Excellence for Molecular Biology and Genomics of Shrimp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2011, MAR BIOTECHNOL, V13, P629, DOI 10.1007/s10126-010-9291-1; Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chai YM, 2012, FISH SHELLFISH IMMUN, V32, P307, DOI 10.1016/j.fsi.2011.11.020; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Du HH, 2007, AQUACULTURE, V262, P532, DOI 10.1016/j.aquaculture.2006.11.002; Durand S, 1997, DIS AQUAT ORGAN, V29, P205, DOI 10.3354/dao029205; Flegel TW, 1997, WORLD J MICROB BIOT, V13, P433, DOI 10.1023/A:1018580301578; He F, 2006, J VIROL, V80, P3884, DOI 10.1128/JVI.80.8.3884-3892.2006; Hutchinson EC, 2012, VACCINE, V30, P7353, DOI 10.1016/j.vaccine.2012.04.085; INOUYE K, 1994, FISH PATHOL, V29, P149, DOI 10.3147/jsfp.29.149; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Karunasagar I, 1997, AQUACULTURE, V153, P9, DOI 10.1016/S0044-8486(97)00011-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Lei KY, 2008, DEV COMP IMMUNOL, V32, P808, DOI 10.1016/j.dci.2007.11.010; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Lightner DV, 1996, REV SCI TECH OIE, V15, P579, DOI 10.20506/rst.15.2.944; Liu WJ, 2005, VIROLOGY, V334, P327, DOI 10.1016/j.virol.2005.01.047; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; MARTIN GG, 1985, J MORPHOL, V185, P339, DOI 10.1002/jmor.1051850306; Mekata T, 2011, MOL CELL PROBE, V25, P94, DOI 10.1016/j.mcp.2011.02.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Ponprateep S, 2012, FISH SHELLFISH IMMUN, V32, P26, DOI 10.1016/j.fsi.2011.10.010; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Sung HH, 1999, FISH SHELLFISH IMMUN, V9, P167, DOI 10.1006/fsim.1998.0185; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Wang HC, 2007, DIS AQUAT ORGAN, V74, P179, DOI 10.3354/dao074179; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wang ZM, 2004, BIOCHEM BIOPH RES CO, V325, P899, DOI 10.1016/j.bbrc.2004.09.224; Wongpanya Ratree, 2007, ScienceAsia, V33, P165, DOI 10.2306/scienceasia1513-1874.2007.33.165; WONGTEERASUPAYA C, 1995, DIS AQUAT ORGAN, V21, P69, DOI 10.3354/dao021069; Woramongkolchai N, 2011, DEV COMP IMMUNOL, V35, P530, DOI 10.1016/j.dci.2010.12.016; Zhan WB, 1998, J AQUAT ANIM HEALTH, V10, P405, DOI 10.1577/1548-8667(1998)010&lt;0405:WSSVIO&gt;2.0.CO;2	43	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91930	10.1371/journal.pone.0091930	http://dx.doi.org/10.1371/journal.pone.0091930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637711	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100083
J	Amraoui, F; Spijkers, L; Lahsinoui, HH; Vogt, L; van der Post, J; Peters, S; Afink, G; Ris-Stalpers, C; van den Born, BJ				Amraoui, Fouad; Spijkers, Leon; Lahsinoui, Hajar Hassani; Vogt, Liffert; van der Post, Joris; Peters, Stephan; Afink, Gijs; Ris-Stalpers, Carrie; van den Born, Bert-Jan			SFlt-1 Elevates Blood Pressure by Augmenting Endothelin-1-Mediated Vasoconstriction in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PREGNANT RATS; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; VASCULAR REACTIVITY; INHIBITOR SUNITINIB; CANCER-PATIENTS; MOUSE MODEL; PREECLAMPSIA; HYPERTENSION	Objective: Scavenging of vascular endothelial growth factor (VEGF) elevates blood pressure (BP) in patients receiving anti-angiogenic therapy. Similarly, inhibition of circulation VEGF by its soluble receptor fms-like tyrosine kinase-1 (sFlt-1) underlies BP elevation in pre-eclampsia. Both phenotypes are characterized by augmented production of endothelin-1 (ET-1), suggesting a role for ET-1 in anti-angiogenic hypertension. We aimed to assess the effect of VEGF inhibition on ET-1-induced contractility and downstream ET-1 signaling. Approach and Results: Male C57BL/6N mice were treated with either sFlt-1 or vehicle and BP was assessed via tail-cuff. Mean arterial pressure of sFlt-1-treated mice markedly increased compared to vehicle-treated controls (N = 11-12, p<0.05). After sacrifice, carotid and mesenteric arteries were isolated for isometric tension measurements. ET-1-induced contractions were similar in mesenteric arteries of vehicle and sFlt-1-treated mice, but augmented in carotid segments of sFlt-1-treated mice compared to controls (N = 9-10, p<0.05). The increased contraction in carotid segments could be completely abrogated by the cyclooxygenase (COX) inhibitor indomethacin (N = 9-10, p<0.05), indicating heightened prostaglandin-mediated vasoconstriction. This was associated with a shift towards procontractile ETB signaling in sFlt-1-treated mice, possibly explaining the increased ET-1-induced prostaglandin-mediated vasoconstriction. In line with the ex vivo findings, sFlt-1-induced BP elevation could be prevented in vivo by oral treatment with either a high-dose of the COX inhibitor aspirin (N = 7) or with picotamide (N = 9), a dual thromboxane A(2) synthase inhibitor and receptor antagonist. Conclusions: VEGF inhibition augments the pressor response to ET-1. The cyclooxygenase-thromboxane signaling route downstream of ET-1 might be a possible target to prevent BP elevation during VEGF inhibition.	[Amraoui, Fouad; Spijkers, Leon; Vogt, Liffert; Peters, Stephan; van den Born, Bert-Jan] Univ Amsterdam, Acad Med Ctr, Dept Internal & Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Lahsinoui, Hajar Hassani; van der Post, Joris; Ris-Stalpers, Carrie] Univ Amsterdam, Acad Med Ctr, Womens & Childrens Clin, NL-1105 AZ Amsterdam, Netherlands; [Lahsinoui, Hajar Hassani; van der Post, Joris; Afink, Gijs; Ris-Stalpers, Carrie] Univ Amsterdam, Acad Med Ctr, Reprod Biol Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van den Born, BJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal & Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.j.vandenborn@amc.uva.nl	van der Post, Joris A M/A-8991-2008; Afink, Gijs/AAB-2832-2021; Vogt, Liffert/C-3168-2018; van den Born, Bert-Jan/E-4263-2017; Afink, Gijs/A-2025-2009	Vogt, Liffert/0000-0002-4585-7505; Afink, Gijs/0000-0002-2155-725X; van der Post, Joris/0000-0003-3311-2116; van den Born, Bert-Jan H. (BJH)/0000-0003-0943-4393	Netherlands Organization for Scientific Research/ZonMw, The Netherlands [90700310]	Netherlands Organization for Scientific Research/ZonMw, The Netherlands	This study was funded by a Clinical Fellowship awarded to B.J.H. van den Born (90700310) from the Netherlands Organization for Scientific Research/ZonMw, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalvand A, 2013, HYPERTENSION, V61, P488, DOI 10.1161/HYPERTENSIONAHA.111.00055; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Bridges JP, 2009, AM J HYPERTENS, V22, P564, DOI 10.1038/ajh.2009.24; Cardillo CM, 2000, HYPERTENSION, V35, P1237, DOI 10.1161/01.HYP.35.6.1237; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; DEKKER GA, 1991, EUR J OBSTET GYN R B, V40, P215, DOI 10.1016/0028-2243(91)90120-A; DORLEANSJUSTE P, 1994, BRIT J PHARMACOL, V113, P1257, DOI 10.1111/j.1476-5381.1994.tb17133.x; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Facemire CS, 2009, HYPERTENSION, V54, P652, DOI 10.1161/HYPERTENSIONAHA.109.129973; Faxen M, 2000, ARCH GYNECOL OBSTET, V264, P143, DOI 10.1007/s004040000111; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; George EM, 2011, AM J HYPERTENS, V24, P964, DOI 10.1038/ajh.2011.99; Hood JD, 1998, AM J PHYSIOL-HEART C, V274, pH1054; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Kandula P, 2011, KIDNEY INT, V80, P1271, DOI 10.1038/ki.2011.288; Kappers MHW, 2011, HYPERTENSION, V58, P295, DOI 10.1161/HYPERTENSIONAHA.111.173559; Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690; KARAKI H, 1994, BIOCHEM BIOPH RES CO, V205, P168, DOI 10.1006/bbrc.1994.2645; Lankhorst S, 2013, J HYPERTENS, V31, P444, DOI 10.1097/HJH.0b013e32835c1d1b; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mills JL, 1999, JAMA-J AM MED ASSOC, V282, P356, DOI 10.1001/jama.282.4.356; Mousa AA, 2012, HYPERTENSION, V59, P1249, DOI 10.1161/HYPERTENSIONAHA.111.188730; Murphy SR, 2012, AM J PHYSIOL-REG I, V302, pR259, DOI 10.1152/ajpregu.00319.2011; Murphy SR, 2010, HYPERTENSION, V55, P394, DOI 10.1161/HYPERTENSIONAHA.109.141473; NOVA A, 1991, AM J OBSTET GYNECOL, V165, P724, DOI 10.1016/0002-9378(91)90317-K; Pereg D, 2008, EUR HEART J, V29, P2325, DOI 10.1093/eurheartj/ehn384; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Ranpura V, 2010, AM J HYPERTENS, V23, P460, DOI 10.1038/ajh.2010.25; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029222; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; TAKAYASUOKISHIO M, 1990, BIOCHEM PHARMACOL, V40, P2713; TAYLOR RN, 1990, J CLIN ENDOCR METAB, V71, P1675, DOI 10.1210/jcem-71-6-1675; White RM, 1996, HYPERTENSION, V27, P1245, DOI 10.1161/01.HYP.27.6.1245; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	39	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91897	10.1371/journal.pone.0091897	http://dx.doi.org/10.1371/journal.pone.0091897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632840	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400118
J	Bertuccio, CA; Lee, SL; Wu, GY; Butterworth, MB; Hamilton, KL; Devor, DC				Bertuccio, Claudia A.; Lee, Shih-Liang; Wu, Guangyu; Butterworth, Michael B.; Hamilton, Kirk L.; Devor, Daniel C.			Anterograde Trafficking of KCa3.1 in Polarized Epithelia Is Rab1-and Rab8-Dependent and Recycling Endosome-Independent	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; CELL-SURFACE EXPRESSION; ANGIOTENSIN-II; PLASMA-MEMBRANE; INTERMEDIATE CONDUCTANCE; ENDOPLASMIC-RETICULUM; CHLORIDE SECRETION; GTP-BINDING; DEPENDENT REGULATION; PROTEIN TRAFFICKING	The intermediate conductance, Ca2+-activated K+ channel (KCa3.1) targets to the basolateral (BL) membrane in polarized epithelia where it plays a key role in transepithelial ion transport. However, there are no studies defining the anterograde and retrograde trafficking of KCa3.1 in polarized epithelia. Herein, we utilize Biotin Ligase Acceptor Peptide (BLAP)-tagged KCa3.1 to address these trafficking steps in polarized epithelia, using MDCK, Caco-2 and FRT cells. We demonstrate that KCa3.1 is exclusively targeted to the BL membrane in these cells when grown on filter supports. Following endocytosis, KCa3.1 degradation is prevented by inhibition of lysosomal/proteosomal pathways. Further, the ubiquitylation of KCa3.1 is increased following endocytosis from the BL membrane and PR-619, a deubiquitylase inhibitor, prevents degradation, indicating KCa3.1 is targeted for degradation by ubiquitylation. We demonstrate that KCa3.1 is targeted to the BL membrane in polarized LLC-PK1 cells which lack the mu 1B subunit of the AP-1 complex, indicating BL targeting of KCa3.1 is independent of mu 1B. As Rabs 1, 2, 6 and 8 play roles in ER/Golgi exit and trafficking of proteins to the BL membrane, we evaluated the role of these Rabs in the trafficking of KCa3.1. In the presence of dominant negative Rab1 or Rab8, KCa3.1 cell surface expression was significantly reduced, whereas Rabs 2 and 6 had no effect. We also co-immunoprecipitated KCa3.1 with both Rab1 and Rab8. These results suggest these Rabs are necessary for the anterograde trafficking of KCa3.1. Finally, we determined whether KCa3.1 traffics directly to the BL membrane or through recycling endosomes in MDCK cells. For these studies, we used either recycling endosome ablation or dominant negative RME-1 constructs and determined that KCa3.1 is trafficked directly to the BL membrane rather than via recycling endosomes. These results are the first to describe the anterograde and retrograde trafficking of KCa3.1 in polarized epithelia cells.	[Bertuccio, Claudia A.; Butterworth, Michael B.; Devor, Daniel C.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Lee, Shih-Liang; Hamilton, Kirk L.] Univ Otago, Otago Sch Med Sci, Dept Physiol, Dunedin, Otago, New Zealand; [Wu, Guangyu] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Otago; University System of Georgia; Augusta University	Hamilton, KL (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Physiol, Dunedin, Otago, New Zealand.	kirk.hamilton@otago.ac.nz; dd2@pitt.edu		Butterworth, Michael/0000-0002-2173-8333; Lee, Shih-Liang/0000-0001-5882-8503	National Institute of Health [HL092157, GM076167, DK078917]; University of Otago (UoO); Department of Physiology; Department of Physiology at UoO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK078917, K99DK078917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076167] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Otago (UoO); Department of Physiology; Department of Physiology at UoO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health to DCD (HL092157), GW(GM076167) and MBB (DK078917). KLH was supported by an University of Otago (UoO) Research Grant and the Department of Physiology. SLL was supported by an MSc scholarship from the Department of Physiology at UoO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hazza A, 2012, J PATHOL, V226, P463, DOI 10.1002/path.2994; Albaqumi M, 2008, KIDNEY INT, V74, P740, DOI 10.1038/ki.2008.246; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; Balut CM, 2010, FUTURE MED CHEM, V2, P707, DOI [10.4155/fmc.10.182, 10.4155/FMC.10.182]; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Cancino J, 2007, MOL BIOL CELL, V18, P4872, DOI 10.1091/mbc.E07-06-0563; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; DEVOR DC, 1993, AM J PHYSIOL, V265, pC1271, DOI 10.1152/ajpcell.1993.265.5.C1271; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; DEVOR DC, 1990, AM J PHYSIOL, V258, pC318, DOI 10.1152/ajpcell.1990.258.2.C318; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Duffield A, 2004, TRAFFIC, V5, P449, DOI 10.1111/j.1398-9219.2004.00192.x; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; FULLER SD, 1985, EMBO J, V4, P297, DOI 10.1002/j.1460-2075.1985.tb03629.x; FUTTER CE, 1995, J BIOL CHEM, V270, P10999, DOI 10.1074/jbc.270.18.10999; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; GalchevaGargova Z, 1995, ONCOGENE, V11, P2649; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; Hammad MM, 2012, BIOL CHEM, V393, P541, DOI 10.1515/hsz-2011-0284; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Joiner WJ, 2003, AM J PHYSIOL-GASTR L, V285, pG185, DOI 10.1152/ajpgi.00337.2002; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Jones HM, 2007, CHANNELS, V1, P80, DOI 10.4161/chan.3999; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Orzech E, 2000, J BIOL CHEM, V275, P15207, DOI 10.1074/jbc.275.20.15207; Pilecka I, 2011, EXP CELL RES, V317, P1093, DOI 10.1016/j.yexcr.2011.02.002; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rufo PA, 1996, J CLIN INVEST, V98, P2066, DOI 10.1172/JCI119012; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Simms LA, 2010, AM J GASTROENTEROL, V105, P2209, DOI 10.1038/ajg.2010.161; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wulf A, 2002, J MEMBRANE BIOL, V187, P71, DOI 10.1007/s00232-001-0149-3; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhuang XL, 2010, ENDOCRINOLOGY, V151, P5114, DOI 10.1210/en.2010-0422	62	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92013	10.1371/journal.pone.0092013	http://dx.doi.org/10.1371/journal.pone.0092013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632741	Green Published, gold, Green Accepted			2022-12-27	WOS:000332858400130
J	Deramaudt, TB; Dujardin, D; Noulet, F; Martin, S; Vauchelles, R; Takeda, K; Ronde, P				Deramaudt, Therese B.; Dujardin, Denis; Noulet, Fanny; Martin, Sophie; Vauchelles, Romain; Takeda, Ken; Ronde, Philippe			Altering FAK-Paxillin Interactions Reduces Adhesion, Migration and Invasion Processes	PLOS ONE			English	Article							C-TERMINAL DOMAIN; TYROSINE PHOSPHORYLATION; CELL MOTILITY; FOCAL ADHESIONS; BINDING-SITE; CALCIUM OSCILLATIONS; P130CAS LOCALIZATION; ASTROCYTOMA-CELLS; KINASE INHIBITOR; IN-VIVO	Focal adhesion kinase (FAK) plays an important role in signal transduction pathways initiated at sites of integrin-mediated cell adhesion to the extracellular matrix. Thus, FAK is involved in many aspects of the metastatic process including adhesion, migration and invasion. Recently, several small molecule inhibitors which target FAK catalytic activity have been developed by pharmaceutical companies. The current study was aimed at addressing whether inhibiting FAK targeting to focal adhesions (FA) represents an efficient alternative strategy to inhibit FAK downstream pathways. Using a mutagenesis approach to alter the targeting domain of FAK, we constructed a FAK mutant that fails to bind paxillin. Inhibiting FAK-paxillin interactions led to a complete loss of FAK localization at FAs together with reduced phosphorylation of FAK and FAK targets such as paxillin and p130Cas. This in turn resulted in altered FA dynamics and inhibition of cell adhesion, migration and invasion. Moreover, the migration properties of cells expressing the FAK mutant were reduced as compared to FAK(-/-) cells. This was correlated with a decrease in both phospho-Src and phospho-p130Cas levels at FAs. We conclude that targeting FAK-paxillin interactions is an efficient strategy to reduce FAK signalling and thus may represent a target for the development of new FAK inhibitors.	[Deramaudt, Therese B.; Dujardin, Denis; Noulet, Fanny; Martin, Sophie; Vauchelles, Romain; Takeda, Ken; Ronde, Philippe] CNRS, UMR 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France; [Deramaudt, Therese B.; Dujardin, Denis; Noulet, Fanny; Martin, Sophie; Vauchelles, Romain; Takeda, Ken; Ronde, Philippe] Univ Strasbourg, Fac Pharm, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ronde, P (corresponding author), CNRS, UMR 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France.	philippe.ronde@unistra.fr	Dujardin, Denis/GYA-0463-2022; martin, sophie/AAP-3498-2021	Dujardin, Denis/0000-0001-6372-5293	Ligue contre le cancer (Comites du Bas-Rhin et Haut-Rhin); ARC; CNRS; Universite de Strasbourg	Ligue contre le cancer (Comites du Bas-Rhin et Haut-Rhin); ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg	Ligue contre le cancer (Comites du Bas-Rhin et Haut-Rhin); ARC; CNRS; Universite de Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Giannone G, 2002, J BIOL CHEM, V277, P26364, DOI 10.1074/jbc.M203952200; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang YT, 2005, ANTICANCER RES, V25, P2017; ILLC D, 1995, NATURE, V377, P539; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Kolli-Bouhafs K, 2012, INVEST NEW DRUG, V30, P2121, DOI 10.1007/s10637-011-9777-3; Kurenova EV, 2009, J MED CHEM, V52, P4716, DOI 10.1021/jm900159g; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mortier E, 2001, CELL SIGNAL, V13, P901, DOI 10.1016/S0898-6568(01)00226-1; Neff L, 2003, J BIOL CHEM, V278, P27721, DOI 10.1074/jbc.M212065200; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Ronde P, 2000, BBA-MOL CELL RES, V1498, P273, DOI 10.1016/S0167-4889(00)00102-6; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Sieg DJ, 1999, J CELL SCI, V112, P2677; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05	51	75	83	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92059	10.1371/journal.pone.0092059	http://dx.doi.org/10.1371/journal.pone.0092059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642576	Green Published, gold			2022-12-27	WOS:000333259900073
J	Iadevaia, S; Nakhleh, LK; Azencott, R; Ram, PT				Iadevaia, Sergio; Nakhleh, Luay K.; Azencott, Robert; Ram, Prahlad T.			Mapping Network Motif Tunability and Robustness in the Design of Synthetic Signaling Circuits	PLOS ONE			English	Article							FEEDBACK LOOPS; BIOLOGY; SYSTEMS	Cellular networks are highly dynamic in their function, yet evolutionarily conserved in their core network motifs or topologies. Understanding functional tunability and robustness of network motifs to small perturbations in function and structure is vital to our ability to synthesize controllable circuits. In establishing core sets of network motifs, we selected topologies that are overrepresented in mammalian networks, including the linear, feedback, feed-forward, and bifan circuits. Static and dynamic tunability of network motifs were defined as the motif ability to respectively attain steady-state or transient outputs in response to pre-defined input stimuli. Detailed computational analysis suggested that static tunability is insensitive to the circuit topology, since all of the motifs displayed similar ability to attain predefined steady-state outputs in response to constant inputs. Dynamic tunability, in contrast, was tightly dependent on circuit topology, with some motifs performing superiorly in achieving observed time-course outputs. Finally, we mapped dynamic tunability onto motif topologies to determine robustness of motif structures to changes in topology and identify design principles for the rational assembly of robust synthetic networks.	[Iadevaia, Sergio; Ram, Prahlad T.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Nakhleh, Luay K.] Rice Univ, Dept Comp Sci, Houston, TX USA; [Azencott, Robert] Univ Houston, Dept Math, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Houston System; University of Houston	Iadevaia, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	siadevai@mdanderson.org; pram@mdanderson.org		Ram, Prahlad/0000-0003-4739-3166	NIH [R01CA125109, U54 CA112970]; NATIONAL CANCER INSTITUTE [U54CA112970, R01CA125109] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NIH R01CA125109 and U54 CA112970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A., 2006, SWARM INTELLIGENT SY; Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arpino JAJ, 2013, MICROBIOL-SGM, V159, P1236, DOI 10.1099/mic.0.067975-0; Barnes CP, 2011, INTERFACE FOCUS, V1, P895, DOI 10.1098/rsfs.2011.0056; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2003, PROG BIOPHYS MOL BIO, V81, P45, DOI 10.1016/S0079-6107(02)00046-9; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Kim D, 2008, BIOESSAYS, V30, P1204, DOI 10.1002/bies.20839; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; MacDonald JT, 2011, INTEGR BIOL-UK, V3, P97, DOI 10.1039/c0ib00077a; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Nicklas D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083531; Oyarzun DA, 2012, J R SOC INTERFACE; Rossger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3825; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Ye HF, 2013, CURR OPIN CHEM BIOL, V17, P910, DOI 10.1016/j.cbpa.2013.10.006	26	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91743	10.1371/journal.pone.0091743	http://dx.doi.org/10.1371/journal.pone.0091743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642504	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900033
J	Kotkamp, K; Kur, E; Wendik, B; Polok, BK; Ben-Dor, S; Onichtchouk, D; Driever, W				Kotkamp, Kay; Kur, Esther; Wendik, Bjoern; Polok, Bozena K.; Ben-Dor, Shifra; Onichtchouk, Daria; Driever, Wolfgang			Pou5f1/Oct4 Promotes Cell Survival via Direct Activation of mych Expression during Zebrafish Gastrulation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; C-MYC; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL EXPRESSION; ONCOGENE EXPRESSION; OCT4 PROMOTES; DNA-BINDING; APOPTOSIS; MOUSE; GENES	Myc proteins control cell proliferation, cell cycle progression, and apoptosis, and play important roles in cancer as well in establishment of pluripotency. Here we investigated the control of myc gene expression by the Pou5f1/Oct4 pluripotency factor in the early zebrafish embryo. We analyzed the expression of all known zebrafish Myc family members, myca, mycb, mych, mycl1a, mycl1b, and mycn, by whole mount in situ hybridization during blastula and gastrula stages in wildtype and maternal plus zygotic pou5f1 mutant (MZspg) embryos, as well as by quantitative PCR and in time series microarray data. We found that the broad blastula and gastrula stage mych expression, as well as late gastrula stage mycl1b expression, both depend on Pou5f1 activity. We analyzed ChIP-Seq data and found that both Pou5f1 and Sox2 bind to mych and mycl1b control regions. The regulation of mych by Pou5f1 appears to be direct transcriptional activation, as overexpression of a Pou5f1 activator fusion protein in MZspg embryos induced strong mych expression even when translation of zygotically expressed mRNAs was suppressed. We further showed that MZspg embryos develop enhanced apoptosis already during early gastrula stages, when apoptosis was not be detected in wildtype embryos. However, Mych knockdown alone did not induce early apoptosis, suggesting potentially redundant action of several early expressed myc genes, or combination of several pathways affected in MZspg. Experimental mych overexpression in MZspg embryos did significantly, but not completely suppress the apoptosis phenotype. Similarly, p53 knockdown only partially suppressed apoptosis in MZspg gastrula embryos. However, combined knockdown of p53 and overexpression of Mych completely rescued the MZspg apoptosis phenotype. These results reveal that Mych has anti-apoptotic activity in the early zebrafish embryo, and that p53-dependent and Myc pathways are likely to act in parallel to control apoptosis at these stages.	[Kotkamp, Kay; Kur, Esther; Wendik, Bjoern; Polok, Bozena K.; Onichtchouk, Daria; Driever, Wolfgang] Univ Freiburg, Inst Biol 1, Fac Biol, Freiburg, Germany; [Ben-Dor, Shifra] Weizmann Inst Sci, Biol Serv, IL-76100 Rehovot, Israel; [Onichtchouk, Daria; Driever, Wolfgang] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; Weizmann Institute of Science	Driever, W (corresponding author), Univ Freiburg, Inst Biol 1, Fac Biol, Albertstr 21A, Freiburg, Germany.	driever@biologie.uni-freiburg.de	Onichtchouk, Daria/E-1741-2012; BEN-DOR, SHIFRA/M-6718-2019	Onichtchouk, Daria/0000-0001-6497-1445; BEN-DOR, SHIFRA/0000-0001-9604-1939; Driever, Wolfgang/0000-0002-9551-9141	BMBF FORSYS center FRISYS; Excellence Initiative of the German Federal Government (BIOSS Centre for Biological Signalling Studies) [EXC 294]; Excellence Initiative of the German State Government (BIOSS Centre for Biological Signalling Studies) [EXC 294]; German Research Foundation [DFG-SFB592-A3, SFB850-A1]	BMBF FORSYS center FRISYS(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Federal Government (BIOSS Centre for Biological Signalling Studies); Excellence Initiative of the German State Government (BIOSS Centre for Biological Signalling Studies); German Research Foundation(German Research Foundation (DFG))	This work was supported by BMBF FORSYS center FRISYS, the Excellence Initiative of the German Federal and State Governments (BIOSS Centre for Biological Signalling Studies EXC 294), and German Research Foundation (DFG-SFB592-A3 & SFB850-A1, WD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; AMIN C, 1993, MOL CELL BIOL, V13, P383, DOI 10.1128/MCB.13.1.383; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Belting HG, 2001, DEVELOPMENT, V128, P4165; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Chen TJ, 2012, MOL BIOL REP, V39, P1855, DOI 10.1007/s11033-011-0928-6; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Domashenko AD, 1997, MOL REPROD DEV, V47, P57, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;57::AID-MRD8&gt;3.0.CO;2-P; DOWNS KM, 1989, GENE DEV, V3, P860, DOI 10.1101/gad.3.6.860; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hauptmann G, 2000, METH MOL B, V137, P139; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Hong SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002029; HOURDRY J, 1988, DEVELOPMENT, V104, P631; Inohara N, 2000, CELL DEATH DIFFER, V7, P509, DOI 10.1038/sj.cdd.4400679; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kotkamp K, 2013, POU5F1 OCT4 DEPENDEN, DOI DOI 10.1016/J.YDBI0.2013.10.025I; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Krumschnabel G, 2009, APOPTOSIS, V14, P1, DOI 10.1007/s10495-008-0281-y; Lachnit M, 2008, DEV BIOL, V315, P1, DOI 10.1016/j.ydbio.2007.10.008; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Leung TC, 2003, DEVELOPMENT, V130, P3639, DOI 10.1242/dev.00558; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Loeb-Hennard C, 2005, GENE EXPR PATTERNS, V5, P341, DOI 10.1016/j.modgep.2004.10.003; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; MINER JH, 1991, MOL CELL BIOL, V11, P2842, DOI 10.1128/MCB.11.5.2842; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Penaloza C, 2006, HISTOCHEM CELL BIOL, V126, P149, DOI 10.1007/s00418-006-0214-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; SCHREIBERAGUS N, 1993, MOL CELL BIOL, V13, P2765, DOI 10.1128/MCB.13.5.2765; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Song SM, 2013, DEV CELL, V24, P486, DOI 10.1016/j.devcel.2013.01.016; Storer NY, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001123; Swartling FJ, 2012, UPSALA J MED SCI, V117, P122, DOI 10.3109/03009734.2012.658975; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thisse B, 2004, ZFIN DIRECT DATA SUB; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; VIZE PD, 1990, DEVELOPMENT, V110, P885; Wang YD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.272; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	74	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92356	10.1371/journal.pone.0092356	http://dx.doi.org/10.1371/journal.pone.0092356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643012	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900124
J	Kwak, Y; Lee, HE; Kim, WH; Kim, DW; Kang, SB; Lee, HS				Kwak, Yoonjin; Lee, Hee Eun; Kim, Woo Ho; Kim, Duck-Woo; Kang, Sung-Bum; Lee, Hye Seung			The Clinical Implication of Cancer-Associated Microvasculature and Fibroblast in Advanced Colorectal Cancer Patients with Synchronous or Metachronous Metastases	PLOS ONE			English	Article							LYMPHATIC VESSEL DENSITY; MICROVESSEL DENSITY; TUMOR-GROWTH; CARCINOMA; HETEROGENEITY; EXPRESSION; PTEN; KRAS; ANGIOGENESIS; METAANALYSIS	Background: We aimed to evaluate the clinical significance of microvessel density (MVD), lymphatic vessel density (LVD), and cancer-associated fibroblasts (CAFs) in relation to tumor location in advanced colorectal cancer (CRC). Methods: Using immunohistochemistry, we examined 181 advanced CRC patients for CD31 and D2-40 to measure MVD and LVD, respectively, a-smooth muscle actin (SMA) and desmin to identify CAFs, and PTEN to examine genetic changes of CAFs. To evaluate the regional heterogeneity of these properties, we examined tissue from four sites (the center and periphery of the primary cancer, a distant metastasis, and a lymph node metastasis) in each patient. Results: MVD, LVD, and CAFs showed significant heterogeneity with respect to the tumor location. LVD was the greatest in the center of the primary cancers and the amount of CAFs was the lowest in distant metastases. In distant metastases, those from the lung had higher LVD and MVD, but fewer CAFs than those from the liver, peritoneum, or ovary. Patients with low MVD and LVD in the center of the primary cancer had worse outcomes and patients with few CAFs in distant metastases and in the primary tumor had a lower survival rate. PTEN expression in CAFs in distant metastases was lost in 11 of 181 CRC patients (6.1%), which was associated with a worse prognosis. Conclusions: The microenvironment, including cancer-associated microvasculature and fibroblasts, is heterogeneous with respect to the tumor location in CRC patients. Therefore, heterogeneity of microenvironments should be taken into account when managing CRC patients.	[Kwak, Yoonjin; Lee, Hee Eun; Kim, Woo Ho] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Kwak, Yoonjin; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Duck-Woo; Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, Gyeonggi Do, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi Do, South Korea.	hye2@snu.ac.kr	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986	Seoul National University Bundang Hospital Research Fund [03-2011-012]	Seoul National University Bundang Hospital Research Fund	This study was supported by grant number 03-2011-012 from the Seoul National University Bundang Hospital Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese I, 2004, BIOCHEM BIOPH RES CO, V325, P784, DOI 10.1016/j.bbrc.2004.10.111; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Barresi V, 2010, VIRCHOWS ARCH, V457, P11, DOI 10.1007/s00428-010-0933-5; BARSKY SH, 1987, CANCER RES, V47, P1663; Bosman F. T., 2010, WHO CLASSIFICATION T; Campbell I, 2011, J PATHOL, V223, P450, DOI 10.1002/path.2842; Chen Y, 2013, LYMPHOLOGY, V46, P42; Des Guetz G, 2006, BRIT J CANCER, V94, P1823, DOI 10.1038/sj.bjc.6603176; Duff SE, 2007, COLORECTAL DIS, V9, P793, DOI 10.1111/j.1463-1318.2006.01199.x; Edge S B, 2010, AJCC CANC STAGING MA; Gombos Z, 2005, CLIN CANCER RES, V11, P8364, DOI 10.1158/1078-0432.CCR-05-1238; Jain RK, 2002, J NATL CANCER I, V94, P417; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kim MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-347; Kitadai Y, 2005, INT J CANCER, V115, P388, DOI 10.1002/ijc.20859; Knijn N, 2010, DISCOV MED, V9, P328; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lee Hye Seung, 2006, Cancer Res Treat, V38, P1, DOI 10.4143/crt.2006.38.1.1; Lindmark G, 1996, J CLIN ONCOL, V14, P461, DOI 10.1200/JCO.1996.14.2.461; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Matsumoto N, 2003, BRIT J CANCER, V89, P707, DOI 10.1038/sj.bjc.6601141; Mekenkamp LJM, 2010, BRIT J CANCER, V103, P159, DOI 10.1038/sj.bjc.6605737; Moreira LR, 2011, TUMOR BIOL, V32, P527, DOI 10.1007/s13277-010-0147-0; Muller-Hubenthal B, 2009, ANTICANCER RES, V29, P4795; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; PAGET S, 1989, CANCER METAST REV, V8, P98; Park JH, 2011, CANCER CHEMOTH PHARM, V68, P1045, DOI 10.1007/s00280-011-1586-z; Prall F, 2003, HISTOPATHOLOGY, V42, P482, DOI 10.1046/j.1365-2559.2003.01610.x; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Ryu HS, 2012, HUM PATHOL, V43, P520, DOI 10.1016/j.humpath.2011.07.003; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Van Cutsem E, 2007, CLIN COLORECTAL CANC, V6, pS60, DOI 10.3816/CCC.2007.s.004; VERMEULEN PB, 1995, BRIT J CANCER, V71, P340, DOI 10.1038/bjc.1995.68; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	41	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91811	10.1371/journal.pone.0091811	http://dx.doi.org/10.1371/journal.pone.0091811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642707	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900038
J	Paredes, JL; Orabi, AI; Ahmad, T; Benbourenane, I; Tobita, K; Tadros, S; Bae, KT; Husain, SZ				Paredes, Jose L.; Orabi, Abrahim I.; Ahmad, Taimur; Benbourenane, Iman; Tobita, Kimimasa; Tadros, Sameh; Bae, Kyongtae T.; Husain, Sohail Z.			A Non-Invasive Method of Quantifying Pancreatic Volume in Mice Using Micro-MRI	PLOS ONE			English	Article							ORTHOTOPIC MODEL; ENDOCRINE; CELLS; REGENERATION; EXOCRINE	In experimental models of pancreatic growth and recovery, changes in pancreatic size are assessed by euthanizing a large cohort of animals at varying time points and measuring organ mass. However, to ascertain this information in clinical practice, patients with pancreatic disorders routinely undergo non-invasive cross-sectional imaging of the pancreas using magnetic resonance imaging (MRI) or computed tomography (CT). The aim of the current study was to develop a thin-sliced, optimized sequence protocol using a high field MRI to accurately calculate pancreatic volumes in the most common experimental animal, the mouse. Using a 7 Telsa Bruker micro-MRI system, we performed abdominal imaging in whole-fixed mice in three standard planes: axial, sagittal, and coronal. The contour of the pancreas was traced using Vitrea software and then transformed into a 3-dimensional (3D) reconstruction, from which volumetric measurements were calculated. Images were optimized using heart perfusion-fixation, T1 sequence analysis, and 0.2 to 0.4 mm thick slices. As proof of principle, increases in pancreatic volume among mice of different ages correlated tightly with increasing body weight. In summary, this is the first study to measure pancreatic volumes in mice, using a high field 7 Tesla micro-MRI and a thin-sliced, optimized sequence protocol. We anticipate that micro-MRI will improve the ability to non-invasively quantify changes in pancreatic size and will dramatically reduce the number of animals required to serially assess pancreatic growth and recovery.	[Paredes, Jose L.; Orabi, Abrahim I.; Ahmad, Taimur; Benbourenane, Iman; Husain, Sohail Z.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15219 USA; [Paredes, Jose L.; Orabi, Abrahim I.; Ahmad, Taimur; Benbourenane, Iman; Tobita, Kimimasa; Tadros, Sameh; Bae, Kyongtae T.; Husain, Sohail Z.] Univ Pittsburgh, Pittsburgh, PA USA; [Tobita, Kimimasa] UPMC, Childrens Hosp Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Tadros, Sameh; Bae, Kyongtae T.] UPMC, Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Husain, SZ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15219 USA.	sohail.husain@chp.edu		Tobita, Kimimasa/0000-0001-5435-8436; Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health [R01 DK083327, DK093491]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083327, T32DK007017, R01DK093491, R01DK103002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health Grant R01 DK083327, and DK093491 (to SZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili AK, 2010, INT J CARDIOVAS IMAG, V26, P27, DOI 10.1007/s10554-009-9571-x; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Flurkey K., 2007, MOUSE BIOMEDICAL RES; Foster JR, 2013, TOXICOL PATHOL; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Geraghty EM, 2004, ABDOM IMAGING, V29, P482, DOI 10.1007/s00261-003-0139-2; Grimm J, 2003, INT J CANCER, V106, P806, DOI 10.1002/ijc.11281; Grippo PJ, 2011, AM J PATHOL, V179, P610, DOI 10.1016/j.ajpath.2011.04.007; Gurda GT, 2010, GASTROENTEROLOGY, V139, P609, DOI 10.1053/j.gastro.2010.04.050; He ZQ, 2000, PANCREAS, V21, P69, DOI 10.1097/00006676-200007000-00054; HEUCK A, 1987, GASTROINTEST RADIOL, V12, P18, DOI 10.1007/BF01885094; Kaufman MH, 1995, ATLAS MOUSE DEV; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Low MJ, 2012, GASTROENTEROLOGY, V143, P1410, DOI 10.1053/j.gastro.2012.10.011; Moore A, 2004, DIABETES, V53, P1459, DOI 10.2337/diabetes.53.6.1459; Nakamura Y, 2005, PANCREATOLOGY, V5, P422, DOI 10.1159/000086543; Orabi AI, 2013, JOVE-J VIS EXP, DOI 10.3791/50391; Prodhomme O, 2012, ARCH DIS CHILD-FETAL, V97, pF434, DOI 10.1136/fetalneonatal-2011-301309; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Saluja AK, 2013, GASTROENTEROLOGY, V144, P1194, DOI 10.1053/j.gastro.2013.01.070; Sequeiros IM, 2010, BRIT J RADIOL, V83, P921, DOI 10.1259/bjr/24009651; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Suetens P., 2009, FUNDAMENTALS MED IMA, V2nd, DOI DOI 10.1017/CBO9780511596803; Szczepaniak EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055991; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Williams AJK, 2007, DIABETIC MED, V24, P35, DOI 10.1111/j.1464-5491.2007.02027.x; Williams JA, 2010, CURR OPIN GASTROEN, V26, P478, DOI 10.1097/MOG.0b013e32833d11c6	29	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92263	10.1371/journal.pone.0092263	http://dx.doi.org/10.1371/journal.pone.0092263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642611	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333259900113
J	Zhao, X; Wang, JX; Feng, YF; Wu, ZX; Zhang, Y; Shi, L; Tan, QC; Yan, YB; Lei, W				Zhao, Xiong; Wang, Jia-xing; Feng, Ya-fei; Wu, Zi-xiang; Zhang, Yang; Shi, Lei; Tan, Quan-chang; Yan, Ya-bo; Lei, Wei			Systemic Treatment with Telmisartan Improves Femur Fracture Healing in Mice	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; CONVERTING ENZYME; BONE; RISK; CALCIFICATION; OSTEOPOROSIS; RECEPTOR; CELLS; HYPERTENSION; INHIBITORS	Recent clinical studies indicated that angiotensin receptor blockers (ARBs) would decrease the risk of bone fractures in the elderly populations. There is little known about the role of the ARBs in the process of fracture healing. The purpose of the present study was to verify the hypothesis that systemic treatment with telmisartan has the ability to promote fracture healing. In this study, femur fractures were produced in 96 mature male BALB/c mice. Animals were treated with the ARBs telmisartan or vehicle. Fracture healing was analysed after 2, 5 and 10 weeks postoperatively using X-ray, biomechanical testing, histomorphometry, immunohistochemistry and micro-computed tomography (micro-CT). Radiological analysis showed the diameter of the callus in the telmisartan treated animals was significantly increased when compared with that of vehicle treated controls after two weeks of fracture healing. The radiologically observed promotion of callus formation was confirmed by histomorphometric analyses, which revealed a significantly increased amount of bone formation when compared with vehicle-treated controls. Biomechanical testing further showed a significantly greater peak torque at failure, and a higher torsional stiffness in telmisartan-treated animals compared with controls. There was an increased fraction of PCNA-positive cells and VEGF-positive cells in telmisartan-treated group compared with vehicle-treated controls. From the three-dimensional reconstruction of the bony callus, telmisartan-treated group significantly increased the values of BV/TV by 21.7% and CsAr by 26.0% compared to the vehicle-treated controls at 5 weeks post-fracture. In summary, we demonstrate in the current study that telmisartan could promote fracture healing in a mice model via increasing mechanical strength and improving microstructure. The most mechanism is probably by an increase of cell proliferation and neovascularization associated with a decreased VEGF expression in hypertrophic chondrocytes.	[Zhao, Xiong; Feng, Ya-fei; Wu, Zi-xiang; Zhang, Yang; Shi, Lei; Tan, Quan-chang; Yan, Ya-bo; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopead, Xian 710032, Peoples R China; [Wang, Jia-xing] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Wang, Jia-xing] PLA, Hosp 309, ICU, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Yan, YB (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopead, Xian 710032, Peoples R China.	yaboyan@fmmu.edu.cn; wlspine@163.com		Lei, Wei/0000-0002-7346-6915	National Natural Science Foundation of China [81300710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 81300710). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI [10.1359/jbmr.081006, 10.1359/JBMR.081006]; Bagger YZ, 2006, J INTERN MED, V259, P598, DOI 10.1111/j.1365-2796.2006.01640.x; Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Danilevicius CF, 2007, BRAZ J MED BIOL RES, V40, P435, DOI 10.1590/S0100-879X2007000400001; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Fu LJ, 2009, BONE, V44, P893, DOI 10.1016/j.bone.2009.01.378; Garcia P, 2008, J BIOMECH, V41, P1689, DOI 10.1016/j.jbiomech.2008.03.010; Garcia P, 2010, BRIT J PHARMACOL, V159, P1672, DOI 10.1111/j.1476-5381.2010.00651.x; Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI 10.1359/JBMR.081113; Hagiwara H, 1998, J ENDOCRINOL, V156, P543, DOI 10.1677/joe.0.1560543; Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005; Hayashi Y, 1998, PSYCHIAT CLIN NEUROS, V52, P621; Hiruma Y, 1997, BIOCHEM BIOPH RES CO, V230, P176, DOI 10.1006/bbrc.1996.5914; Holstein JH, 2007, J BIOMECH, V40, P215, DOI 10.1016/j.jbiomech.2005.10.034; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; Muller R, 1997, ST HEAL T, V40, P61; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Sakai K, 2007, J CLIN INVEST, V117, P1088, DOI 10.1172/JCI31242; Sanada M, 2004, ATHEROSCLEROSIS, V176, P387, DOI 10.1016/j.atherosclerosis.2004.05.021; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Schurman SJ, 2004, PEDIATR NEPHROL, V19, P33, DOI 10.1007/s00467-003-1361-4; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Solomon DH, 2011, J BONE MINER RES, V26, P1561, DOI 10.1002/jbmr.356; Song HJ, 2012, BONE, V51, P1008, DOI 10.1016/j.bone.2012.08.126; Stojanovic OL, 2011, ARCH MED SCI, V7, P179, DOI 10.5114/aoms.2011.22066; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006	35	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92085	10.1371/journal.pone.0092085	http://dx.doi.org/10.1371/journal.pone.0092085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642982	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900081
J	Berrabah, F; Bourcy, M; Cayrel, A; Eschstruth, A; Mondy, S; Ratet, P; Gourion, B				Berrabah, Fathi; Bourcy, Marie; Cayrel, Anne; Eschstruth, Alexis; Mondy, Samuel; Ratet, Pascal; Gourion, Benjamin			Growth Conditions Determine the DNF2 Requirement for Symbiosis	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; RHIZOBIUM-MELILOTI; ARABIDOPSIS-THALIANA; PHOSPHOLIPASE-C; SALICYLIC-ACID; PLANT; RESISTANCE; NODULATION; EXPRESSION; INFECTION	Rhizobia and legumes are able to interact in a symbiotic way leading to the development of root nodules. Within nodules, rhizobia fix nitrogen for the benefit of the plant. These interactions are efficient because spectacularly high densities of nitrogen fixing rhizobia are maintained in the plant cells. DNF2, a Medicago truncatula gene has been described as required for nitrogen fixation, bacteroid's persistence and to prevent defense-like reactions in the nodules. This manuscript shows that a Rhizobium mutant unable to differentiate is not sufficient to trigger defense-like reactions in this organ. Furthermore, we show that the requirement of DNF2 for effective symbiosis can be overcome by permissive growth conditions. The dnf2 knockout mutants grown in vitro on agarose or Phytagel as gelling agents are able to produce nodules fixing nitrogen with the same efficiency as the wild-type. However, when agarose medium is supplemented with the plant defense elicitor ulvan, the dnf2 mutant recovers the fix(-) phenotype. Together, our data show that plant growth conditions impact the gene requirement for symbiotic nitrogen fixation and suggest that they influence the symbiotic suppression of defense reactions in nodules.	[Berrabah, Fathi; Bourcy, Marie; Cayrel, Anne; Eschstruth, Alexis; Mondy, Samuel; Ratet, Pascal; Gourion, Benjamin] CNRS, Inst Sci Vegetal, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ratet, P (corresponding author), CNRS, Inst Sci Vegetal, Gif Sur Yvette, France.	pascal.ratet@isv.cnrs-gif.fr	Mondy, Samuel/AAG-8805-2019; Cayrel, Anne/A-5257-2016; Ratet, Pascal/GPP-3654-2022; Gourion, Benjamin/AAG-9063-2019	Mondy, Samuel/0000-0002-9203-6398; Ratet, Pascal/0000-0002-8621-1495; Gourion, Benjamin/0000-0001-5768-6961; Fathi, Berrabah/0000-0002-5710-8421	French State grant [ANR-10-LABX-0040-SPS]; French National Research Agency under an Investments for the Future program [ANR-11-IDEX-0003-02]; Centre National de la Recherche Scientifique (CNRS); grant Agence Nationale de la Recherche (ANR) Blanc International SVSE [6.2010.1]; French Ministry of Research	French State grant; French National Research Agency under an Investments for the Future program(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); grant Agence Nationale de la Recherche (ANR) Blanc International SVSE(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work has benefited from a French State grant (reference ANR-10-LABX-0040-SPS) managed by the French National Research Agency under an Investments for the Future program (reference noANR-11-IDEX-0003-02). This work was supported by the Centre National de la Recherche Scientifique (CNRS) and the grant Agence Nationale de la Recherche (ANR) Blanc International SVSE 6.2010.1 (LEGUMICS) to PR. MB was supported by a PhD fellowship from the French Ministry of Research. This work has benefited from the facilities and expertise of the Imagif Cell Biology Unit of the Gif campus (www.imagif.cnrs.fr) which is supported by the Conseil General de l'Essonne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bourcy M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23915; Bourcy M, 2013, NEW PHYTOL, V197, P1250, DOI 10.1111/nph.12091; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Cluzet S, 2004, PLANT CELL ENVIRON, V27, P917, DOI 10.1111/j.1365-3040.2004.01197.x; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Ferguson GP, 2002, J BACTERIOL, V184, P5625, DOI 10.1128/JB.184.20.5625-5632.2002; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Gellatly SA, 2012, BIOCHEM BIOPH RES CO, V424, P651, DOI 10.1016/j.bbrc.2012.06.079; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Gough C, 2013, TRENDS PLANT SCI; Haag AF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001169; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; Hoffmann B, 1997, MOL PLANT MICROBE IN, V10, P307, DOI 10.1094/MPMI.1997.10.3.307; HOWIESON JG, 1986, AUST J AGR RES, V37, P55, DOI 10.1071/AR9860055; Jaulneau V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525291; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KING EO, 1954, J LAB CLIN MED, V44, P301; KOCH B, 1966, PLANT PHYSIOL, V41, P1748, DOI 10.1104/pp.41.10.1748; KONDOROSI E, 1984, MOL GEN GENET, V193, P445, DOI 10.1007/BF00382082; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Limpens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064377; Lopez-Gomez M, 2012, J EXP BOT, V63, P393, DOI 10.1093/jxb/err291; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Menard R, 2004, PLANT CELL, V16, P3020, DOI 10.1105/tpc.104.024968; Mithofer A, 2002, TRENDS PLANT SCI, V7, P440, DOI 10.1016/S1360-1385(02)02336-1; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Molouba F, 1999, APPL ENVIRON MICROB, V65, P3084; Nars A, 2013, PLANT CELL REP, V32, P489, DOI 10.1007/s00299-012-1380-3; Paulert R, 2010, PLANT PATHOL, V59, P634, DOI 10.1111/j.1365-3059.2010.02300.x; Peleg-Grossman S, 2012, PLANT SIGNAL BEHAV, V7, P409, DOI 10.4161/psb.19217; Peleg-Grossman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008399; Pislariu CI, 2007, PLANT PHYSIOL, V144, P682, DOI 10.1104/pp.106.092494; Pislariu CI, 2012, PLANT PHYSIOL, V159, P1686, DOI 10.1104/pp.112.197061; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Reguera M, 2010, J PLANT PHYSIOL, V167, P625, DOI 10.1016/j.jplph.2009.11.017; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Rupwate SD, 2012, PLANT SIGNAL BEHAV, V7, P1281, DOI 10.4161/psb.21436; Samac DA, 2011, MOL PLANT PATHOL, V12, P786, DOI [10.1111/j.1364-3703.2011.00712.x, 10.1111/J.1364-3703.2011.00712.X]; Stacey G, 2006, PLANT PHYSIOL, V141, P1473, DOI 10.1104/pp.106.080986; Starker CG, 2006, PLANT PHYSIOL, V140, P671, DOI 10.1104/pp.105.072132; Tadege M, 2008, PLANT J, V54, P335, DOI 10.1111/j.1365-313X.2008.03418.x; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; Welchen E, 2005, PLANT PHYSIOL, V139, P88, DOI 10.1104/pp.105.065920; Weller DM, 2012, PHYTOPATHOLOGY, V102, P403, DOI 10.1094/PHYTO-08-11-0222; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	56	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91866	10.1371/journal.pone.0091866	http://dx.doi.org/10.1371/journal.pone.0091866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632747	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400111
J	Li, XY; Zhang, LS; Wang, GJ				Li, Xiangyang; Zhang, Linshuang; Wang, Gejiao			Genomic Evidence Reveals the Extreme Diversity and Wide Distribution of the Arsenic-Related Genes in Burkholderiales	PLOS ONE			English	Article							HERMINIIMONAS-ARSENICOXYDANS; ALCALIGENES-FAECALIS; OXIDIZING BACTERIA; RICH ENVIRONMENTS; SEQUENCE; RESISTANCE; IDENTIFICATION; OXIDASE; METABOLISM; REDUCTASE	So far, numerous genes have been found to associate with various strategies to resist and transform the toxic metalloid arsenic (here, we denote these genes as "arsenic-related genes"). However, our knowledge of the distribution, redundancies and organization of these genes in bacteria is still limited. In this study, we analyzed the 188 Burkholderiales genomes and found that 95% genomes harbored arsenic-related genes, with an average of 6.6 genes per genome. The results indicated: a) compared to a low frequency of distribution for aio (arsenite oxidase) (12 strains), arr (arsenate respiratory reductase) (1 strain) and arsM (arsenite methytransferase)-like genes (4 strains), the ars (arsenic resistance system)-like genes were identified in 174 strains including 1,051 genes; b) 2/3 ars-like genes were clustered as ars operon and displayed a high diversity of gene organizations (68 forms) which may suggest the rapid movement and evolution for ars-like genes in bacterial genomes; c) the arsenite efflux system was dominant with ACR3 form rather than ArsB in Burkholderiales; d) only a few numbers of arsM and arrAB are found indicating neither As III biomethylation nor AsV respiration is the primary mechanism in Burkholderiales members; (e) the aio-like gene is mostly flanked with ars-like genes and phosphate transport system, implying the close functional relatedness between arsenic and phosphorus metabolisms. On average, the number of arsenic-related genes per genome of strains isolated from arsenic-rich environments is more than four times higher than the strains from other environments. Compared with human, plant and animal pathogens, the environmental strains possess a larger average number of arsenic-related genes, which indicates that habitat is likely a key driver for bacterial arsenic resistance.	[Li, Xiangyang; Zhang, Linshuang; Wang, Gejiao] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Wang, GJ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	gejiao@mail.hzau.edu.cn	Li, Xiangyang/AAJ-3142-2020	Li, Xiangyang/0000-0003-1313-633X	National Natural Science Foundation of China [31010103903, 31170106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China 31010103903 and 31170106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; Arsene-Ploetze F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000859; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bertin PN, 2011, ISME J, V5, P1735, DOI 10.1038/ismej.2011.51; Cai L, 2013, APPL MICROBIOL BIOT, V97, P9579, DOI 10.1007/s00253-012-4678-8; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Cavalca L, 2013, FUTURE MICROBIOL, V8, P753, DOI [10.2217/FMB.13.38, 10.2217/fmb.13.38]; Cleiss-Arnold J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-709; Dhuldhaj UP, 2013, REV ENVIRON CONTAM T, V224, P1, DOI 10.1007/978-1-4614-5882-1_1; Elias M, 2012, NATURE, V491, P134, DOI 10.1038/nature11517; Escudero LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078890; Fan H, 2008, J APPL MICROBIOL, V105, P529, DOI 10.1111/j.1365-2672.2008.03790.x; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Heinrich-Salmeron A, 2011, APPL ENVIRON MICROB, V77, P4685, DOI 10.1128/AEM.02884-10; Huang YY, 2012, J BACTERIOL, V194, P1635, DOI 10.1128/JB.06814-11; Jackson CR, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-18; Jia Y, 2013, ENVIRON SCI TECHNOL, V47, P3141, DOI 10.1021/es303649v; Kang YS, 2012, ENVIRON MICROBIOL, V14, P3097, DOI 10.1111/j.1462-2920.2012.02881.x; Koechler S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-53; Kruger MC, 2013, APPL MICROBIOL BIOT, V97, P3827, DOI 10.1007/s00253-013-4838-5; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li XY, 2013, APPL MICROBIOL BIOT, V97, P6413, DOI 10.1007/s00253-013-5018-3; Li XY, 2012, J BACTERIOL, V194, P4473, DOI 10.1128/JB.00907-12; Li XY, 2012, J BACTERIOL, V194, P1243, DOI 10.1128/JB.06667-11; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Muller D, 2003, J BACTERIOL, V185, P135, DOI 10.1128/JB.185.1.135-141.2003; Muller D, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030053; Nagai F, 2009, INT J SYST EVOL MICR, V59, P1793, DOI 10.1099/ijs.0.002519-0; Oremland RS, 2009, GEOMICROBIOL J, V26, P522, DOI 10.1080/01490450903102525; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Phung LT, 2012, J BACTERIOL, V194, P5153, DOI 10.1128/JB.01185-12; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Plewniak F, 2013, MOL ECOL, V22, P4870, DOI 10.1111/mec.12432; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Quemeneur M, 2008, APPL ENVIRON MICROB, V74, P4567, DOI 10.1128/AEM.02851-07; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Shen ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058894; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trimble WL, 2012, J BACTERIOL, V194, P6355, DOI 10.1128/JB.01660-12; Villegas-Torres MF, 2011, INT BIODETER BIODEGR, V65, P147, DOI 10.1016/j.ibiod.2010.10.007; Wang LR, 2006, APPL ENVIRON MICROB, V72, P3738, DOI 10.1128/AEM.72.5.3738-3742.2006; Wang LP, 2009, APPL ENVIRON MICROB, V75, P5064, DOI 10.1128/AEM.00149-09; Weiss S, 2009, BIOCHIMIE, V91, P192, DOI 10.1016/j.biochi.2008.07.013; Yang HC, 2005, J BACTERIOL, V187, P6991, DOI 10.1128/JB.187.20.6991-6997.2005; Yin XX, 2011, PLANT PHYSIOL, V156, P1631, DOI 10.1104/pp.111.178947; Zargar K, 2012, ENVIRON MICROBIOL, V14, P1635, DOI 10.1111/j.1462-2920.2012.02722.x	54	39	40	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92236	10.1371/journal.pone.0092236	http://dx.doi.org/10.1371/journal.pone.0092236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632831	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400155
J	Skorheim, S; Lonjers, P; Bazhenov, M				Skorheim, Steven; Lonjers, Peter; Bazhenov, Maxim			A Spiking Network Model of Decision Making Employing Rewarded STDP	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; TOTAL SYNAPTIC WEIGHT; DENDRITIC SPINES; DOPAMINE; MODULATION; SPECIFICITY; NORMALIZATION; OSCILLATIONS	Reward-modulated spike timing dependent plasticity (STDP) combines unsupervised STDP with a reinforcement signal that modulates synaptic changes. It was proposed as a learning rule capable of solving the distal reward problem in reinforcement learning. Nonetheless, performance and limitations of this learning mechanism have yet to be tested for its ability to solve biological problems. In our work, rewarded STDP was implemented to model foraging behavior in a simulated environment. Over the course of training the network of spiking neurons developed the capability of producing highly successful decision-making. The network performance remained stable even after significant perturbations of synaptic structure. Rewarded STDP alone was insufficient to learn effective decision making due to the difficulty maintaining homeostatic equilibrium of synaptic weights and the development of local performance maxima. Our study predicts that successful learning requires stabilizing mechanisms that allow neurons to balance their input and output synapses as well as synaptic noise.	[Skorheim, Steven; Lonjers, Peter; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	maksim.bazhenov@ucr.edu			National Institutes of Health [R01 MH087631]; ONR [N00014-13-1-0672]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding from National Institutes of Health (R01 MH087631) and ONR (N00014-13-1-0672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Babadi B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000961; Baker DA, 1998, PHARMACOL BIOCHEM BE, V61, P107, DOI 10.1016/S0091-3057(98)00070-7; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; Bazhenov M, 2013, J NEUROSCI, V33, P5686, DOI 10.1523/JNEUROSCI.4145-12.2013; Bazhenov M, 2010, NEURON, V67, P357, DOI 10.1016/j.neuron.2010.07.023; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Chadderdon GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047251; Chen JY, 2013, J NEUROSCI, V33, P15915, DOI 10.1523/JNEUROSCI.5088-12.2013; CHENG B, 1994, STAT SCI, V9, P2, DOI 10.1214/ss/1177010638; Chistiakova M, 2009, EXP BRAIN RES, V199, P377, DOI 10.1007/s00221-009-1859-5; Ciresan DC, 2010, NEURAL COMPUT, V22, P3207, DOI 10.1162/NECO_a_00052; Delgado JY, 2010, J NEUROSCI, V30, P15713, DOI 10.1523/JNEUROSCI.3068-10.2010; Elliott T, 2002, NEURAL COMPUT, V14, P1311, DOI 10.1162/089976602753712954; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Finelli LA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000062; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Fremaux N, 2010, J NEUROSCI, V30, P13326, DOI 10.1523/JNEUROSCI.6249-09.2010; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Gutig R, 2003, J NEUROSCI, V23, P3697; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hardingham NR, 2007, J NEUROPHYSIOL, V97, P2965, DOI 10.1152/jn.01352.2006; Hebb D.O., 1961, BRAIN MECH LEARNING, P37, DOI DOI 10.5962/BHL.TITLE.7220; Huerta R, 2004, NEURAL COMPUT, V16, P1601, DOI 10.1162/089976604774201613; Huerta R, 2009, NEURAL COMPUT, V21, P2123, DOI 10.1162/neco.2009.03-08-733; Hull C., 1943, PRINCIPLES BEHAV; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jain AK, 1996, COMPUTER, V29, P31, DOI 10.1109/2.485891; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kawato M, 2011, CURR OPIN NEUROBIOL, V21, P791, DOI 10.1016/j.conb.2011.05.014; Kempter R, 2001, NEURAL COMPUT, V13, P2709, DOI 10.1162/089976601317098501; Kossel A, 1990, Neuroreport, V1, P115, DOI 10.1097/00001756-199010000-00008; Lee K, 2008, NEUROCOMPUTING, V71, P3037, DOI 10.1016/j.neucom.2007.09.009; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lotfi A, 2011, J ARTIFICIAL INTELLI, P288; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Miller P, 2010, J NEUROSCI, V30, P2559, DOI 10.1523/JNEUROSCI.3047-09.2010; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nitz DA, 2007, NEUROREPORT, V18, P1833, DOI 10.1097/WNR.0b013e3282f16d86; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rao RPN, 2001, NEURAL COMPUT, V13, P2221, DOI 10.1162/089976601750541787; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Rulkov NF, 2008, J BIOL PHYS, V34, P279, DOI 10.1007/s10867-008-9079-y; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schultz W, 1999, NEWS PHYSIOL SCI, V14, P249; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; SEGAL DS, 1974, PHARMACOL BIOCHEM BE, V2, P249, DOI 10.1016/0091-3057(74)90060-4; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Timofeev I, 2005, TRENDS CHRONOBIOLOGY, P1; Turing A.M, 1948, TECH REP; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; White H, 1989, NEURAL COMPUT, V1, P425, DOI 10.1162/neco.1989.1.4.425; Wu ZH, 2006, NEURAL NETWORKS, V19, P547, DOI 10.1016/j.neunet.2005.06.048; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhang GQ, 1999, EUR J OPER RES, V116, P16, DOI 10.1016/S0377-2217(98)00051-4; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; Zhou YD, 2005, P NATL ACAD SCI USA, V102, P19121, DOI 10.1073/pnas.0509856103	85	14	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90821	10.1371/journal.pone.0090821	http://dx.doi.org/10.1371/journal.pone.0090821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632858	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400018
J	Speyer, CL; Hachem, AH; Assi, AA; Johnson, JS; DeVries, JA; Gorski, DH				Speyer, Cecilia L.; Hachem, Ali H.; Assi, Ali A.; Johnson, Jennifer S.; DeVries, John A.; Gorski, David H.			Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-COUPLED RECEPTORS; FACTOR-KAPPA-B; TUMORAL VASCULARITY; PROGNOSTIC-FACTOR; GENE-EXPRESSION; KINASE-C; ANGIOGENESIS; RILUZOLE; ACTIVATION	Metabotropic glutamate receptors (mGluRs) are normally expressed in the central nervous system, where they mediate neuronal excitability and neurotransmitter release. Certain cancers, including melanoma and gliomas, express various mGluR subtypes that have been implicated as playing a role in disease progression. Recently, we detected metabotropic glutamate receptor-1 (gene: GRM1; protein: mGluR1) in breast cancer and found that it plays a role in the regulation of cell proliferation and tumor growth. In addition to cancer cells, brain endothelial cells express mGluR1. In light of these studies, and because angiogenesis is both a prognostic indicator in cancer correlating with a poorer prognosis and a potential therapeutic target, we explored a potential role for mGluR1 in mediating endothelial cell (EC) proliferation and tumor-induced angiogenesis. GRM1 and mGluR1 were detected in various types of human ECs and, using mGluR1-specific inhibitors or shRNA silencing, we demonstrated that EC growth and Matrigel tube formation are dependent on mGluR1 signaling. In addition, loss of mGluR1 activity leads to reduced angiogenesis in a murine Matrigel sponge implant model as well as a murine tumor model. These results suggest a role for mGluR1 in breast cancer as a pro-angiogenic factor as well as a mediator of tumor progression. They also suggest mGluR1 as a potential new molecular target for the anti-angiogenic therapy of breast cancer.	[Speyer, Cecilia L.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Tumor Microenvironm Program, Detroit, MI USA; [Gorski, David H.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48202 USA; [Speyer, Cecilia L.; DeVries, John A.; Gorski, David H.] Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA; [Hachem, Ali H.; Assi, Ali A.] Univ Michigan, Dearborn, MI USA; [Johnson, Jennifer S.] Van Andel Res Inst, Grand Rapids, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of Michigan System; University of Michigan; Van Andel Institute	Gorski, DH (corresponding author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48202 USA.	gorskid@med.wayne.edu	Gorski, David/AAE-6399-2022	Gorski, David/0000-0002-9805-6699	NIH [P30CA22453]; Wayne State University; Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University; Conquer Cancer Foundation of ASCO; Bayer Healthcare; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University; Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University; Conquer Cancer Foundation of ASCO; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The MICR Core is supported, in part, by NIH Center grant P30CA22453 to The Karmanos Cancer Institute, Wayne State University and the Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University. This work was also supported by in part by grants from the Conquer Cancer Foundation of ASCO as well as a Grants-4Targets grant from Bayer Healthcare, as well as institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bonsi P, 2005, NEUROPHARMACOLOGY, V49, P104, DOI 10.1016/j.neuropharm.2005.05.012; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Chu ZG, 2000, BRAIN RES, V879, P88, DOI 10.1016/S0006-8993(00)02752-9; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Endoh T, 2004, BRAIN RES, V1024, P212, DOI 10.1016/j.brainres.2004.07.074; Festoff BW, 1996, DRUGS, V51, P28, DOI 10.2165/00003495-199651010-00004; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2001, SEMIN ONCOL, V28, P536, DOI 10.1053/sonc.2001.29543; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Gorski DH, 1998, CANCER RES, V58, P5686; Greenberg JI, 2009, EXPERT OPIN BIOL TH, V9, P1347, DOI 10.1517/14712590903208883; Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris SL, 2004, MOL CELL NEUROSCI, V25, P275, DOI 10.1016/j.mcn.2003.10.018; HEBERT T, 1994, MOL PHARMACOL, V45, P1055; Higa GM, 2009, EXPERT REV ANTICANC, V9, P999, DOI 10.1586/ERA.09.68; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hsu JY, 2009, BIODRUGS, V23, P289, DOI 10.2165/11317600-000000000-00000; Kohara A, 2005, J PHARMACOL EXP THER, V315, P163, DOI 10.1124/jpet.105.087171; Le MN, 2010, J INVEST DERMATOL, V130, P2240, DOI 10.1038/jid.2010.126; Lin SH, 2001, NEUROSCI LETT, V298, P207, DOI 10.1016/S0304-3940(00)01766-3; Liu F, 2002, J BIOL CHEM, V277, P45393, DOI 10.1074/jbc.M204499200; Mabire D, 2005, J MED CHEM, V48, P2134, DOI 10.1021/jm049499o; Mao LM, 2003, EUR J NEUROSCI, V17, P741, DOI 10.1046/j.1460-9568.2003.02495.x; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MILLER FR, 1983, INVAS METAST, V3, P22; MILLER FR, 1983, INVAS METAST, V3, P234; Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191; Mills CD, 2002, J NEUROTRAUM, V19, P23, DOI 10.1089/089771502753460213; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Noh KM, 2000, NEUROBIOL DIS, V7, P375, DOI 10.1006/nbdi.2000.0297; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; Patel S, 2005, CANCER RES, V65, P1414, DOI 10.1158/0008-5472.CAN-04-3431; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Ribeiro FM, 2011, MOL NEUROBIOL, V43, P1, DOI 10.1007/s12035-010-8153-1; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; TEICHER BA, 1992, CANCER RES, V52, P6702; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Weidner Noel, 1996, P167; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Yoo MH, 2005, INVEST OPHTH VIS SCI, V46, P4780, DOI 10.1167/iovs.05-0376; Zona C, 1998, NEUROSCIENCE, V85, P931, DOI 10.1016/S0306-4522(97)00604-0	55	39	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e88830	10.1371/journal.pone.0088830	http://dx.doi.org/10.1371/journal.pone.0088830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633367	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400004
J	Hertz, R; Ben Lulu, S; Shahi, P; Trebicz-Geffen, M; Benhar, M; Ankri, S				Hertz, Rivka; Ben Lulu, Shani; Shahi, Preeti; Trebicz-Geffen, Meirav; Benhar, Moran; Ankri, Serge			Proteomic Identification of S-Nitrosylated Proteins in the Parasite Entamoeba histolytica by Resin-Assisted Capture: Insights into the Regulation of the Gal/GalNAc Lectin by Nitric Oxide	PLOS ONE			English	Article							UNIQUE RAB GTPASE; CYSTEINE PROTEINASES; IN-VITRO; ALCOHOL-DEHYDROGENASE-2 EHADH2; ANTISENSE INHIBITION; AMEBICIDAL ACTIVITY; LIVER-ABSCESS; EXPRESSION; GENES; OVEREXPRESSION	Entamoeba histolytica is a gastrointestinal protozoan parasite that causes amebiasis, a disease which has a worldwide distribution with substantial morbidity and mortality. Nitrosative stress, which is generated by innate immune cells, is one of the various environmental challenges that E. histolytica encounters during its life cycle. Although the effects of nitric oxide (NO) on the regulation of gene expression in this parasite have been previously investigated, our knowledge on S-nitrosylated proteins in E. histolytica is lacking. In order to fill this knowledge gap, we performed a large-scale detection of S-nitrosylated (SNO) proteins in E. histolytica trophozoites that were treated with the NO donor, S-nitrosocysteine by resin-assisted capture (RAC). We found that proteins involved in glycolysis, gluconeogenesis, translation, protein transport, and adherence to target cells such as the heavy subunit of Gal/GalNac lectin are among the S-nitrosylated proteins that were enriched by SNO-RAC. We also found that the S-nitrosylated cysteine residues in the carbohydrate recognition domain (CRD) of Gal/GalNAc lectin impairs its function and contributes to the inhibition of E. histolytica adherence to host cells. Collectively, these results advance our understanding of the mechanism of reduced E. histolytica adherence to mammalian cells by NO and emphasize the importance of NO as a regulator of key physiological functions in E. histolytica.	[Hertz, Rivka; Shahi, Preeti; Trebicz-Geffen, Meirav; Ankri, Serge] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel; [Ben Lulu, Shani; Benhar, Moran] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ankri, S (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Mol Microbiol, POB 9649, IL-31096 Haifa, Israel.	sankri@tx.technion.ac.il	Shahi, Preeti/S-8197-2019; Benhar, Moran/AAV-5764-2020	Benhar, Moran/0000-0002-7094-3456	Israel Science Foundation [1218/10]; German Research Foundation [784/1-2]	Israel Science Foundation(Israel Science Foundation); German Research Foundation(German Research Foundation (DFG))	This study was supported by The Israel Science Foundation (grant number 1218/10) and The German Research Foundation (grant number 784/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MA, 2004, MOL BIOCHEM PARASIT, V133, P187, DOI 10.1016/j.molbiopara.2003.10.006; Ankri S, 1999, MOL MICROBIOL, V33, P327, DOI 10.1046/j.1365-2958.1999.01476.x; Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; [Anonymous], 1997, Epidemiol Bull, V18, P13; ARROYO R, 1987, MOL BIOCHEM PARASIT, V23, P151, DOI 10.1016/0166-6851(87)90150-2; Biller L, 2014, MOL CELL PROTEOMICS, V13, P132, DOI 10.1074/mcp.M113.031393; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Dodson JM, 1999, J INFECT DIS, V179, P460, DOI 10.1086/314610; Elnekave K, 2003, PARASITE IMMUNOL, V25, P597, DOI 10.1111/j.0141-9838.2004.00669.x; Espinosa A, 2004, J ANTIMICROB CHEMOTH, V54, P56, DOI 10.1093/jac/dkh280; Espinosa A, 2001, J BIOL CHEM, V276, P20136, DOI 10.1074/jbc.M101349200; Fares A, 2011, BIOCHEM BIOPH RES CO, V416, P331, DOI 10.1016/j.bbrc.2011.11.036; Faust DM, 2012, MICROBES INFECT, V14, P1428, DOI 10.1016/j.micinf.2012.05.013; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Hara MR, 2005, NATURE CELL BIOL, V7; Hellberg A, 2001, CELL MICROBIOL, V3, P13, DOI 10.1046/j.1462-5822.2001.00086.x; Holzmuller P, 2006, INFECT GENET EVOL, V6, P187, DOI 10.1016/j.meegid.2005.03.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Illi B, 2009, PHARMACOL THERAPEUT, V123, P344, DOI 10.1016/j.pharmthera.2009.05.003; Irmer H, 2009, MOL MICROBIOL, V72, P658, DOI 10.1111/j.1365-2958.2009.06672.x; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Kim YM, 1998, MOL MED, V4, P179, DOI 10.1007/BF03401915; Lam YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009075; Lavi T, 2006, MOL MICROBIOL, V62, P1373, DOI 10.1111/j.1365-2958.2006.05464.x; LIN JY, 1992, J IMMUNOL, V148, P3999; Makioka A, 2005, EXP PARASITOL, V109, P27, DOI 10.1016/j.exppara.2004.10.003; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Matthiesen J, 2013, MBIO, V4, DOI 10.1128/mBio.00072-13; Nakada-Tsukui K, 2012, CELL MICROBIOL, V14, P1299, DOI 10.1111/j.1462-5822.2012.01800.x; Nakada-Tsukui K, 2010, EXP PARASITOL, V126, P337, DOI 10.1016/j.exppara.2010.04.014; NUNOSHIBA T, 1995, INFECT IMMUN, V63, P794, DOI 10.1128/IAI.63.3.794-798.1995; Petri WA, 1996, J INVEST MED, V44, P24; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Petri William A. Jr, 1993, Seminars in Cell Biology, V4, P305, DOI 10.1006/scel.1993.1037; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; RAVDIN JI, 1980, J EXP MED, V152, P377, DOI 10.1084/jem.152.2.377; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Saito-Nakano Y, 2007, CELL MICROBIOL, V9, P1796, DOI 10.1111/j.1462-5822.2007.00915.x; Santi-Rocca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031777; Seguin R, 1995, P NATL ACAD SCI USA, V92, P12175, DOI 10.1073/pnas.92.26.12175; Seguin R, 1997, INFECT IMMUN, V65, P2522; Siman-Tov R, 2003, PARASITOL RES, V89, P146, DOI 10.1007/s00436-002-0716-2; Stuart MK, 2003, ARCH INSECT BIOCHEM, V52, P17, DOI 10.1002/arch.10061; Teixeira JE, 2008, INFECT IMMUN, V76, P959, DOI 10.1128/IAI.01455-07; Tillack M, 2006, MOL BIOCHEM PARASIT, V149, P58, DOI 10.1016/j.molbiopara.2006.04.009; Venturini G, 2000, BIOCHEM BIOPH RES CO, V267, P190, DOI 10.1006/bbrc.1999.1922; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Wang L, 2013, ANTIOXID REDOX SIGNA; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Welter BH, 2005, MOL BIOCHEM PARASIT, V140, P161, DOI 10.1016/j.molbiopara.2004.12.011; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550	53	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91518	10.1371/journal.pone.0091518	http://dx.doi.org/10.1371/journal.pone.0091518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626316	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300096
J	Akrawinthawong, K; Park, JW; Piknova, B; Sibmooh, N; Fucharoen, S; Schechter, AN				Akrawinthawong, Krittapoom; Park, Ji Won; Piknova, Barbora; Sibmooh, Nathawut; Fucharoen, Suthat; Schechter, Alan N.			A Flow Cytometric Analysis of the Inhibition of Platelet Reactivity Due to Nitrite Reduction by Deoxygenated Erythrocytes	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; HYPOXIC CONDITIONS; DIETARY NITRATE; RELAXING FACTOR; OXIDE; ENDOTHELIUM; AGGREGATION; ACTIVATION; ASPIRIN; HUMANS	Nitric oxide (NO), a small gas molecule, has long been known to be a potent inhibitor of platelet function but the physiological and pathological implications of platelet inhibition by NO have not been well clarified. We recently showed that the addition of nitrite to platelet-rich plasma in the presence of erythrocytes could inhibit platelet aggregation and this inhibitory effect of nitrite + erythrocytes was enhanced by deoxygenation of erythrocytes as measured by P-selectin expression and cGMP production. In order to study the nitrite effect on platelets at different oxygen levels, we used the flow cytometric assays to detect platelet membrane surface markers upon activation. The P-selectin and activated gpIIb/IIIa expression on platelet membranes in response to ADP, collagen and thrombin stimulation was measured at various hematocrit and oxygen levels. Nitrite (0.1 to 1.0 mu M) significantly decreased the percentage of these surface markers on the platelet membrane at the hematocrit values above 23% and oxygen levels lower than 49 mmHg. The inhibitory effect of nitrite was augmented by increasing hematocrit values and decreasing oxygen saturation. C-PTIO (an NO scavenger) prevented the platelet inhibition by nitrite + erythrocytes whereas the inhibitors of NO synthase and xanthine oxidoreductase had no effect. These results support the proposal that circulating nitrite decreases platelet reactivity in the presence of partially deoxygenated erythrocytes through its reduction to NO, which may also explain certain differences between arterial and venous thrombosis and support directly the role of deoxyhemoglobin in this process. We believe that our flow cytometric assays offer a possibility to identify the individual molecular process involved in these effects.	[Akrawinthawong, Krittapoom; Park, Ji Won; Piknova, Barbora; Schechter, Alan N.] Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Sibmooh, Nathawut] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Akrawinthawong, Krittapoom] Mahidol Univ, Dept Biochem, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Fucharoen, Suthat] Mahidol Univ, Thalassemia Res Ctr, Inst Sci & Technol Res & Dev, Nakhon Pathom, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Mahidol University; Mahidol University; Mahidol University	Schechter, AN (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	alans@intra.niddk.nih.gov		Schechter, Alan N/0000-0002-5235-9408	intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025104] Funding Source: NIH RePORTER	intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID U, 1987, THROMB RES, V47, P561, DOI 10.1016/0049-3848(87)90361-6; AZUMA H, 1986, BRIT J PHARMACOL, V88, P411, DOI 10.1111/j.1476-5381.1986.tb10218.x; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Becker RC, 2012, NEW ENGL J MED, V366, P2028, DOI 10.1056/NEJMe1201911; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; BULT H, 1988, BRIT J PHARMACOL, V95, P1308, DOI 10.1111/j.1476-5381.1988.tb11769.x; Carlsson S, 2001, NITRIC OXIDE-BIOL CH, V5, P580, DOI 10.1006/niox.2001.0371; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Govoni M, 2008, NITRIC OXIDE-BIOL CH, V19, P333, DOI 10.1016/j.niox.2008.08.003; Keszler A, 2008, J BIOL CHEM, V283, P9615, DOI 10.1074/jbc.M705630200; LAUSTIOLA KE, 1991, PHARMACOL TOXICOL, V68, P60, DOI 10.1111/j.1600-0773.1991.tb01209.x; LUNDBERG JON, 1994, GUT, V35, P1543, DOI 10.1136/gut.35.11.1543; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Machha A, 2011, EUR J NUTR, V50, P293, DOI 10.1007/s00394-011-0192-5; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Naseem KM, 2011, PLATELETS, V22, P148, DOI 10.3109/09537104.2010.522629; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055699; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Richardson G, 2002, NITRIC OXIDE-BIOL CH, V7, P24, DOI 10.1016/S1089-8603(02)00010-1; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Sibmooh N, 2008, BIOCHEMISTRY-US, V47, P2989, DOI 10.1021/bi702158d; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Velmurugan S, 2013, FREE RADIC BIOL MED, DOI [10.1016/j.freeradbiomed.2013.06.031, DOI 10.1016/J.FREERADBI0MED.2013.06.031.[]; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Zhang Zhi, 1997, Biochemical Society Transactions, V25, p524S	32	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92435	10.1371/journal.pone.0092435	http://dx.doi.org/10.1371/journal.pone.0092435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642865	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900139
J	Broca, C; Varin, E; Armanet, M; Tourrel-Cuzin, C; Bosco, D; Dalle, S; Wojtusciszyn, A				Broca, Christophe; Varin, Elodie; Armanet, Mathieu; Tourrel-Cuzin, Cecile; Bosco, Domenico; Dalle, Stephane; Wojtusciszyn, Anne			Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN PANCREATIC-ISLETS; INSULIN-SECRETION; OXIDATIVE STRESS; AMYLOID POLYPEPTIDE; ER STRESS; RAT MODEL; UBIQUITIN; PROTEIN; SYSTEM	The ubiquitin/proteasome system (UPS), a major cellular protein degradation machinery, plays key roles in the regulation of many cell functions. Glucotoxicity mediated by chronic hyperglycaemia is detrimental to the function and survival of pancreatic beta cells. The aim of our study was to determine whether proteasome dysfunction could be involved in beta cell apoptosis in glucotoxic conditions, and to evaluate whether such a dysfunction might be pharmacologically corrected. Therefore, UPS activity was measured in GK rats islets, INS-1E beta cells or human islets after high glucose and/or UPS inhibitor exposure. Immunoblotting was used to quantify polyubiquitinated proteins, endoplasmic reticulum (ER) stress through CHOP expression, and apoptosis through the cleavage of PARP and caspase-3, whereas total cell death was detected through histone-associated DNA fragments measurement. In vitro, we found that chronic exposure of INS-1E cells to high glucose concentrations significantly decreases the three proteasome activities by 20% and leads to caspase-3-dependent apoptosis. We showed that pharmacological blockade of UPS activity by 20% leads to apoptosis in a same way. Indeed, ER stress was involved in both conditions. These results were confirmed in human islets, and proteasome activities were also decreased in hyperglycemic GK rats islets. Moreover, we observed that a high glucose treatment hypersensitized beta cells to the apoptotic effect of proteasome inhibitors. Noteworthily, the decreased proteasome activity can be corrected with Exendin-4, which also protected against glucotoxicity-induced apoptosis. Taken together, our findings reveal an important role of proteasome activity in high glucose-induced beta cell apoptosis, potentially linking ER stress and glucotoxicity. These proteasome dysfunctions can be reversed by a GLP-1 analog. Thus, UPS may be a potent target to treat deleterious metabolic conditions leading to type 2 diabetes.	[Broca, Christophe; Varin, Elodie; Dalle, Stephane; Wojtusciszyn, Anne] CNRS, INSERM, UMR 5203, U661, Montpellier, France; [Broca, Christophe; Varin, Elodie; Dalle, Stephane; Wojtusciszyn, Anne] Montpellier 1&2 Univ, Inst Funct Genom, Montpellier, France; [Broca, Christophe; Varin, Elodie; Armanet, Mathieu; Dalle, Stephane; Wojtusciszyn, Anne] Univ Hosp St Eloi, Inst Res Biotherapy, Lab Diabet Cell Therapy, Montpellier, France; [Tourrel-Cuzin, Cecile] Univ Paris Diderot, CNRS, EAC4413, B2PE Lab Biol & Pathol Endocrine Pancreas,BFA Uni, Paris, France; [Bosco, Domenico] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Bosco, Domenico] Univ Geneva, Geneva, Switzerland; [Wojtusciszyn, Anne] Univ Hosp Lapeyronie, Dept Endocrinol Diabet Nutr, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Geneva; University of Geneva; Universite de Montpellier; CHU de Montpellier	Wojtusciszyn, A (corresponding author), CNRS, INSERM, UMR 5203, U661, Montpellier, France.	a-wojtusciszyn@chu-montpellier.fr		Wojtusciszyn, Anne/0000-0002-9410-9909; Tourrel-Cuzin, Cecile/0000-0002-5368-4018; Broca, Christophe/0000-0002-7715-8231; Bosco, Domenico/0000-0003-3453-9613	Societe Francophone du Diabete (SFD) bourse ALFEDIAM-Industrie; Agence de Biomedecine bourse AOR Recherche et Greffe; Institut National de la Sante et de la Recherche Medicale (INSERM, Paris, France); Region Languedoc-Roussillon, France	Societe Francophone du Diabete (SFD) bourse ALFEDIAM-Industrie; Agence de Biomedecine bourse AOR Recherche et Greffe; Institut National de la Sante et de la Recherche Medicale (INSERM, Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Languedoc-Roussillon, France(Region Occitanie)	This work was supported by grants obtained from the following: the Societe Francophone du Diabete (SFD) bourse ALFEDIAM-Industrie; the Agence de Biomedecine bourse AOR Recherche et Greffe; the Institut National de la Sante et de la Recherche Medicale (INSERM, Paris, France); and the Region Languedoc-Roussillon, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An B, 1998, CELL DEATH DIFFER, V5, P1062, DOI 10.1038/sj.cdd.4400436; Asai M, 2009, J MOL CELL CARDIOL, V46, P452, DOI 10.1016/j.yjmcc.2008.11.001; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Chang TL, 2009, METABOLISM, V58, P1643, DOI 10.1016/j.metabol.2009.05.020; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Costes S, 2011, DIABETES, V60, P227, DOI 10.2337/db10-0522; Costes S, 2009, DIABETES, V58, P1105, DOI 10.2337/db08-0926; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; Kalbe L, 2005, BRIT J NUTR, V93, P309, DOI 10.1079/BJN20041313; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kawaguchi M, 2006, J BIOL CHEM, V281, P13015, DOI 10.1074/jbc.M601228200; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Kitagawa H, 1999, FEBS LETT, V443, P181, DOI 10.1016/S0014-5793(98)01709-8; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Kloss A, 2010, CARDIOVASC RES, V85, P367, DOI 10.1093/cvr/cvp217; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Miralles F, 2001, DIABETES, V50, pS84, DOI 10.2337/diabetes.50.2007.S84; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Portha B, 2005, METHOD MOL BIOL, V933, P125; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Roccaro AM, 2008, BLOOD, V111, P4752, DOI 10.1182/blood-2007-11-120972; Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890; Schmidt N, 2012, TRANSPLANTATION, V94, P352, DOI 10.1097/TP.0b013e318257acf6; Storling J, 2005, ENDOCRINOLOGY, V146, P1718, DOI 10.1210/en.2004-0963; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tourrel C, 2002, DIABETES, V51, P1443, DOI 10.2337/diabetes.51.5.1443; Uhal BD, 2013, AM J PHYSIOL-LUNG C, V305, pL33, DOI 10.1152/ajplung.00001.2013; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Wojcik C, 1999, CELL MOL LIFE SCI, V56, P908, DOI 10.1007/s000180050483; Wu LW, 1999, BLOOD CELL MOL DIS, V25, P20, DOI 10.1006/bcmd.1999.0223; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200	49	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92066	10.1371/journal.pone.0092066	http://dx.doi.org/10.1371/journal.pone.0092066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642635	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900074
J	Opena, JL; Chauhan, BS; Baltazar, AM				Opena, Jhoana L.; Chauhan, Bhagirath S.; Baltazar, Aurora M.			Seed Germination Ecology of Echinochloa glabrescens and Its Implication for Management in Rice (Oryza sativa L.)	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; WEED MANAGEMENT; LOWLAND RICE; GROWTH; WATER; PHILIPPINES; EMERGENCE; LIGHT	Echinochloa glabrescens is a C-4 grass weed that is very competitive with rice when left uncontrolled. The competitive ability of weeds is intensified in direct-seeded rice production systems. A better understanding is needed of factors affecting weed seed germination, which can be used as a component of integrated weed management in direct-seeded rice. This study was conducted to determine the effects of temperature, light, salt and osmotic stress, burial depth, crop residue, time and depth of flooding, and herbicide application on the emergence, survival, and growth of two populations [Nueva Ecija (NE) and Los Banos (IR)] of E. glabrescens. Seeds from both populations germinated at all temperatures. The NE population had a higher germination rate (88%) from light stimulation than did the IR population (34%). The salt concentration and osmotic potential required to inhibit 50% of germination were 313 mM and -0.24 MPa, respectively, for the NE population and 254 mM and -0.33 MPa, respectively, for the IR population. Emergence in the NE population was totally inhibited at 4-cm burial depth in the soil, whereas that of the IR population was inhibited at 8 cm. Compared with zero residue, the addition of 5 t ha(-1) of rice residue reduced emergence in the NE and IR populations by 38% and 9%, respectively. Early flooding (within 2 days after sowing) at 2-cm depth reduced shoot growth by 50% compared with non-flooded conditions. Pretilachlor applied at 0.075 kg ai ha(-1) followed by shallow flooding (2-cm depth) reduced seedling emergence by 94-96% compared with the nontreated flooded treatment. Application of postemergence herbicides at 4-leaf stage provided 85-100% control in both populations. Results suggest that integration of different strategies may enable sustainable management of this weed and of weeds with similar germination responses.	[Opena, Jhoana L.; Chauhan, Bhagirath S.] Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Laguna, Philippines; [Baltazar, Aurora M.] Univ Philippines, Los Banos, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Chauhan, BS (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Laguna, Philippines.	b.chauhan@irri.org	Chauhan, Bhagirath/G-8892-2014; Opena, Jhoana/AFD-9723-2022; Opena, Jhoana/AAE-9487-2022	Chauhan, Bhagirath/0000-0003-1540-4668; Opena, Jhoana/0000-0002-6043-3663; Opena, Jhoana/0000-0002-6043-3663				Abilay WP, 1984, IRRI RES PAPER SERIE, V100; [Anonymous], 1991, WORLDS WORST WEEDS D; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BENVENUTI S, 1995, WEED RES, V35, P343, DOI 10.1111/j.1365-3180.1995.tb01629.x; Bolfrey-Arku GEK, 2011, WEED SCI, V59, P182, DOI 10.1614/WS-D-10-00095.1; Boyd N, 2004, WEED SCI, V52, P589, DOI 10.1614/WS-03-15R2; Bureau of Agricultural Statistics, 2011, MONTHL AGR SIT REP 2; Chauhan B. S., 2012, The Scientific World Journal, V2012, P123071; Chauhan BS, 2011, CROP PROT, V30, P1385, DOI 10.1016/j.cropro.2011.07.013; Chauhan BS, 2010, WEED RES, V50, P553, DOI 10.1111/j.1365-3180.2010.00807.x; Chauhan BS, 2009, CROP PROT, V28, P887, DOI 10.1016/j.cropro.2009.05.005; Chauhan BS, 2008, WEED SCI, V56, P699, DOI 10.1614/WS-08-048.1; Chauhan BS, 2008, WEED SCI, V56, P383, DOI 10.1614/WS-07-154.1; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Chauhan BS, 2008, WEED SCI, V56, P820, DOI 10.1614/WS-08-070.1; Chauhan BS, 2012, WEED SCI, V60, P199, DOI 10.1614/WS-D-11-00137.1; Chauhan BS, 2009, SOIL TILL RES, V106, P15, DOI 10.1016/j.still.2009.10.004; Chauhan BS, 2014, ADV AGRON, V123, P65; CRUTCHFIELD DA, 1986, WEED SCI, V34, P110, DOI 10.1017/S0043174500026564; DIOP AM, 1984, PHIL J WEED SCI, V11, P65; Dorji S., 2013, CAN J PLANT PROT, V1, P43; EGLEY G H, 1986, Reviews of Weed Science, V2, P67; Erguiza A., 1990, IRRI RES PAPER SERIE; Eslami SV, 2011, WEED SCI, V59, P90, DOI 10.1614/WS-D-10-00059.1; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Gadde B, 2009, ENVIRON POLLUT, V157, P1554, DOI 10.1016/j.envpol.2009.01.004; Kent RJ, 2001, CROP PROT, V20, P691, DOI 10.1016/S0261-2194(01)00034-5; Lee J, 2011, WEED SCI, V59, P495, DOI 10.1614/WS-D-11-00002.1; Mandac AM, 1982, IRRI RES PAPER SERIE, V80; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Pablico PP, 1993, PHILIPPINE J WEED SC, V20, P56; PONS TL, 1982, WEED RES, V22, P155, DOI 10.1111/j.1365-3180.1982.tb00159.x; Rao A. N, 1987, INT RICE RES NEWSL, V12, P51; RAO AN, 1992, TROP PEST MANAGE, V38, P25; Schutz W, 2002, ANN BOT-LONDON, V90, P707, DOI 10.1093/aob/mcf250; Singh S, 2004, WEED TECHNOL, V18, P1031, DOI 10.1614/WT-03-209R2; SMITH RJ, 1973, WEED SCI, V21, P61, DOI 10.1017/S0043174500031702; Sushil Pandey, 2005, Rice is life: scientific perspectives for the 21st century. Proceedings of the World Rice Research Conference held in Tsukuba, Japan, 4-7 November 2004, P178; Tuong TP, 2005, PLANT PROD SCI, V8, P231, DOI 10.1626/pps.8.231	41	26	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92261	10.1371/journal.pone.0092261	http://dx.doi.org/10.1371/journal.pone.0092261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642568	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900112
J	Biggs, AT; Stey, PC; Davoli, CC; Lapsley, D; Brockmole, JR				Biggs, Adam T.; Stey, Paul C.; Davoli, Christopher C.; Lapsley, Daniel; Brockmole, James R.			Knowing Where to Draw the Line: Perceptual Differences between Risk-takers and Non-Risk-Takers	PLOS ONE			English	Article							FUTURE LIFE EVENTS; TOOL-USE; SUBJECTIVE INVULNERABILITY; PERCEIVED DISTANCE; SENSATION SEEKING; OPTIMISM; BIAS; ADJUSTMENT; WORLD; TASK	There are a variety of reasons someone might engage in risky behaviors, such as perceived invulnerability to harm or a belief that negative outcomes are more likely for others than for oneself. However, these risk-taking biases are often measured at a decision-making level or from the developmental perspective. Here we assessed whether or not risk-taking influenced perceptual judgments associated with risk. Participants were provided an objective task to measure individual differences in the perception of physical dimensions (i.e., actual size of a balloon) versus the perception of risk (i.e., size at which the balloon would explode). Our results show that specific differences in risk-taking personalities produce specific differences in perceptual judgments about risk, but do not affect perception of the actual dimensions. Thus, risk-takers differ from non-risk-takers in the perceptual estimations they make about risks, and therefore may be more likely to engage in dangerous or uncertain behaviors because they perceive risks differently.	[Biggs, Adam T.] Duke Univ, Durham, NC 27706 USA; [Stey, Paul C.; Lapsley, Daniel; Brockmole, James R.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Davoli, Christopher C.] Cent Michigan Univ, Mt Pleasant, MI 48859 USA	Duke University; University of Notre Dame; Central Michigan University	Biggs, AT (corresponding author), Duke Univ, Durham, NC 27706 USA.	adam.biggs@duke.edu		Brockmole, James/0000-0003-3227-1078				Biggs AT, 2013, ATTEN PERCEPT PSYCHO, V75, P1715, DOI 10.3758/s13414-013-0538-6; Brockmole JR, 2013, CURR DIR PSYCHOL SCI, V22, P38, DOI 10.1177/0963721412465065; Chan DCN, 2010, ACCIDENT ANAL PREV, V42, P1549, DOI 10.1016/j.aap.2010.03.011; Chang EC, 2001, J PERS SOC PSYCHOL, V81, P476, DOI 10.1037/0022-3514.81.3.476; Davoli CC, 2012, J EXP PSYCHOL HUMAN, V38, P80, DOI 10.1037/a0024981; Duggan P.M., 2000, 8 BIENN M SOC RES AD; Gibson J.J., 1986, ECOLOGICAL APPROACH; Hill PL, 2012, J EARLY ADOLESCENCE, V32, P489, DOI 10.1177/0272431611400304; Hill PL, 2009, IMPLICATIONS NARCISS; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Jacobs-Quadrel M, 1993, AM PSYCHOL, V48, P102; Klaczynski PA, 1996, J YOUTH ADOLESCENCE, V25, P755, DOI 10.1007/BF01537452; Lapsley D., 1988, SELF EGO IDENTITY IN, P109; Lapsley DK, 2010, J YOUTH ADOLESCENCE, V39, P847, DOI 10.1007/s10964-009-9409-9; LAPSLEY DK, 1993, AM J ORTHOPSYCHIAT, V63, P562, DOI 10.1037/h0079470; Lauriola M, 2014, J BEHAV DECIS MAKING, V27, P20, DOI 10.1002/bdm.1784; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lopez-Bonilla JM, 2010, SOC SCI COMPUT REV, V28, P177, DOI 10.1177/0894439309341229; Millstein SG, 2002, J ADOLESCENT HEALTH, V31, P10, DOI 10.1016/S1054-139X(02)00412-3; PYSZCZYNSKI T, 1987, J PERS SOC PSYCHOL, V52, P994, DOI 10.1037/0022-3514.52.5.994; QUADREL MJ, 1993, AM PSYCHOL, V48, P102, DOI 10.1037/0003-066X.48.2.102; Stefanucci JK, 2009, PERCEPTION, V38, P1782, DOI 10.1068/p6437; Wann JP, 2011, PSYCHOL SCI, V22, P429, DOI 10.1177/0956797611400917; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; Witt JK, 2011, CURR DIR PSYCHOL SCI, V20, P201, DOI 10.1177/0963721411408770; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880; Zuckerman M, 2009, HDB INDIVIDUAL DIFFE, P455, DOI DOI 10.1037/H0030478	27	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91880	10.1371/journal.pone.0091880	http://dx.doi.org/10.1371/journal.pone.0091880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637945	gold, Green Published			2022-12-27	WOS:000333254100073
J	Ebner, OA; Selbach, M				Ebner, Olivia A.; Selbach, Matthias			Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CELL-CYCLE; TRANSLATIONAL REPRESSION; GROWTH-INHIBITION; DOWN-REGULATION; P53 TARGET; MICRORNA; EXPRESSION; FAMILY; APOPTOSIS	microRNAs (miRNAs) repress target genes by destabilizing mRNAs and/or by inhibiting translation. The best known factor for target recognition is the so called seed - a short continuous region of Watson-Crick base pairing between nucleotides 2-7 of the miRNA and complementary sequences in 3' untranslated regions of target mRNAs. The miR-34 family consists of three conserved members with important tumor suppressor functions linked to the p53 pathway. The family members share the same seed, raising the question if they also have the same targets. Here, we analyse the effect of miR-34a and miR-34c on protein synthesis by pSILAC. Despite significant overlap, we observe that the impact of both family members on protein synthesis differs. The ability to identify specific targets of a family member is complicated by the occurrence of * strand mediated repression. Transfection of miR-34 chimeras indicates that the 3' end of the miRNA might be responsible for differential regulation in case of targets without a perfect seed site. Pathway analysis of regulated proteins indicates overlapping functions related to cell cycle and the p53 pathway and preferential targeting of several anti-apoptotic proteins by miR-34a. We used luciferase assays to confirm that Vcl and Fkbp8, an important anti-apoptotic protein, are specifically repressed by miR-34a. In summary, we find that miR-34a and miR-34c down-regulate distinct subsets of targets which might mediate different cellular outcomes. Our data provides a rich resource of miR-34 targets that might be relevant for clinical trials that want to implement the miR-34 family in cancer therapy.	[Ebner, Olivia A.; Selbach, Matthias] Max Delbrueck Ctr Mol Med, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ebner, OA (corresponding author), Max Delbrueck Ctr Mol Med, Berlin, Germany.	oliviaaebner@gmail.com			Helmholtz Association	Helmholtz Association(Helmholtz Association)	This work was supported by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba M, 2012, ANTICANCER AGENTS ME; [Anonymous], 2006, ENCY STAT SCI; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartonicek N, 2010, BIOINFORMATICS, V26, P2900, DOI 10.1093/bioinformatics/btq545; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Choi BH, 2011, CURR OPIN PHARMACOL, V11, P354, DOI 10.1016/j.coph.2011.04.013; CIARDIELLO F, 1993, INT J CANCER, V53, P438, DOI 10.1002/ijc.2910530315; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Jain AK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002859; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kang CB, 2005, BIOCHEM BIOPH RES CO, V337, P30, DOI 10.1016/j.bbrc.2005.09.023; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim SN, 2000, J CELL PHYSIOL, V182, P421, DOI 10.1002/(SICI)1097-4652(200003)182:3<421::AID-JCP13>3.0.CO;2-2; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landau DA, 2011, SEMIN ONCOL, V38, P743, DOI 10.1053/j.seminoncol.2011.08.003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Preall JB, 2005, CELL, V123, P543, DOI 10.1016/j.cell.2005.11.006; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; WEISS J, 1992, BIOCHIM BIOPHYS ACTA, V1136, P208, DOI 10.1016/0167-4889(92)90259-E; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wong MY, 2010, INT J ONCOL, V38, P1189; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	70	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92166	10.1371/journal.pone.0092166	http://dx.doi.org/10.1371/journal.pone.0092166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637697	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000333254100122
J	Gustafson, DJ; Major, C; Jones, D; Synovec, J; Baer, SG; Gibson, DJ				Gustafson, Danny J.; Major, Charles; Jones, Dewitt; Synovec, John; Baer, Sara G.; Gibson, David J.			Genetic Sorting of Subordinate Species in Grassland Modulated by Intraspecific Variation in Dominant Species	PLOS ONE			English	Article							GENOTYPIC DIVERSITY; BIG BLUESTEM; COMMUNITY STRUCTURE; ECOSYSTEM GENETICS; ECOTYPIC VARIATION; LOCAL ADAPTATION; PLANT; POPULATIONS; EVOLUTION; DIFFERENTIATION	Genetic variation in a single species can have predictable and heritable effects on associated communities and ecosystem processes, however little is known about how genetic variation of a dominant species affects plant community assembly. We characterized the genetic structure of a dominant grass (Sorghastrum nutans) and two subordinate species (Chamaecrista fasciculata, Silphium integrifolium), during the third growing season in grassland communities established with genetically distinct (cultivated varieties or local ecotypes) seed sources of the dominant grasses. There were genetic differences between subordinate species growing in the cultivar versus local ecotype communities, indicating that intraspecific genetic variation in the dominant grasses affected the genetic composition of subordinate species during community assembly. A positive association between genetic diversity of S. nutans, C. fasciculata, and S. integrifolium and species diversity established the role of an intraspecific biotic filter during community assembly. Our results show that intraspecific variation in dominant species can significantly modulate the genetic composition of subordinate species.	[Gustafson, Danny J.; Major, Charles; Jones, Dewitt; Synovec, John] The Citadel, Dept Biol, Charleston, SC 29409 USA; [Baer, Sara G.; Gibson, David J.] Southern Illinois Univ Carbondale, Dept Plant Biol, Carbondale, IL USA; [Baer, Sara G.; Gibson, David J.] Southern Illinois Univ Carbondale, Ctr Ecol, Carbondale, IL USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Gustafson, DJ (corresponding author), The Citadel, Dept Biol, Charleston, SC 29409 USA.	danny.gustafson@citadel.edu	Gustafson, Danny J./H-7075-2019	Synovec, John/0000-0003-4003-5681; Gibson, David/0000-0002-0308-7506	National Science Foundation (NSF) [DEB 0516429]; National Science Foundation supplemental Research Opportunity Award (NSF ROA) [DEB 0516429]; The Citadel Foundation (TCF)	National Science Foundation (NSF)(National Science Foundation (NSF)); National Science Foundation supplemental Research Opportunity Award (NSF ROA)(National Science Foundation (NSF)); The Citadel Foundation (TCF)	This research has been made possible by funding from National Science Foundation (NSF (DEB 0516429), www.nsf.gov) to S. G. Baer and D. J. Gibson, National Science Foundation supplemental Research Opportunity Award (NSF ROA through DEB 0516429, http://www.nsf.gov/bio/deb/suppopp.jsp) to D. J. Gustafson and The Citadel Foundation (TCF, http://foundation.citadel.edu/) to D. J. Gustafson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P605, DOI 10.2307/2260497; Avolio ML, 2013, OECOLOGIA, V171, P571, DOI 10.1007/s00442-012-2427-4; Baer SG, 2014, EVOL APPL, V7, P323, DOI 10.1111/eva.12124; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bangert RK, 2008, HEREDITY, V100, P121, DOI 10.1038/sj.hdy.6800914; Bangert RK, 2007, EVOL ECOL, V21, P549, DOI 10.1007/s10682-006-9135-7; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Carter DL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00223.1; CLAUSEN J, 1947, AM NAT, V81, P114, DOI 10.1086/281507; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Coulson T, 2006, EVOL ECOL RES, V8, P1155; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Crawford KM, 2012, J ECOL, V100, P1512, DOI 10.1111/j.1365-2745.2012.02016.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Fehr W.R., 1987, PRINCIPLES CULTIVAR, V2; Genung MA, 2012, ECOL LETT, V15, P65, DOI 10.1111/j.1461-0248.2011.01710.x; Genung MA, 2011, FUNCT ECOL, V25, P408, DOI 10.1111/j.1365-2435.2010.01797.x; Gibson DJ, 2013, J VEG SCI, V24, P429, DOI 10.1111/j.1654-1103.2012.01475.x; Gibson DJ, 2012, OIKOS, V121, P496, DOI 10.1111/j.1600-0706.2011.19447.x; GIBSON DJ, 1987, VEGETATIO, V72, P175; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Gustafson DJ, 2004, J APPL ECOL, V41, P389, DOI 10.1111/j.0021-8901.2004.00904.x; Gustafson DJ, 1999, MOL ECOL, V8, P1693, DOI 10.1046/j.1365-294x.1999.00756.x; Gustafson DJ, 2004, FUNCT ECOL, V18, P451, DOI 10.1111/j.0269-8463.2004.00850.x; Gustafson DJ., 2001, P 17 N AM PRAIRIE C, P118; Gustafson DJ, 2014, DRYAD DIGITAL REPOSI, DOI DOI 10.5061/DRYAD.CQ8BH; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Huff DR, 1998, MOL ECOL, V7, P1591, DOI 10.1046/j.1365-294x.1998.00473.x; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Johnson MTJ, 2009, PHILOS T R SOC B, V364, P1593, DOI 10.1098/rstb.2008.0334; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klopf RP, 2011, RESTOR ECOL, V19, P112, DOI 10.1111/j.1526-100X.2009.00539.x; Lambert AM, 2011, RESTOR ECOL, V19, P43, DOI 10.1111/j.1526-100X.2010.00673.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Liancourt P, 2013, ECOLOGY, V94, P444, DOI 10.1890/12-0780.1; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; MCMILLAN C, 1959, ECOL MONOGR, V29, P285, DOI 10.2307/1942132; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Price DL, 2012, CROP SCI, V52, P189, DOI 10.2135/cropsci2011.05.0280; Rouse MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017641; Schroder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071066; Seliskar DM, 2002, J ECOL, V90, P1, DOI 10.1046/j.0022-0477.2001.00632.x; SNAYDON RW, 1982, EVOLUTION, V36, P289, DOI [10.2307/2408047, 10.1111/j.1558-5646.1982.tb05044.x]; Taberlet P, 2012, ECOL LETT, V15, P1439, DOI 10.1111/ele.12004; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Turesson G, 1925, HEREDITAS, V6, P147; United States Department of Agriculture (USDA), 1995, GRASS VAR US; *USDA NRCS, 2002, PLANTS DAT VER 3 5; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitlock R, 2007, J ECOL, V95, P895, DOI 10.1111/j.1365-2745.2007.01275.x; Whitlock R, 2010, ECOLOGY, V91, P1344, DOI 10.1890/08-2098.1; Wolfe AD, 1998, P NATL ACAD SCI USA, V95, P5112, DOI 10.1073/pnas.95.9.5112	56	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91511	10.1371/journal.pone.0091511	http://dx.doi.org/10.1371/journal.pone.0091511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637462	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100038
J	Hervy, M; Weber, JL; Pecheul, M; Dolley-Sonneville, P; Henry, D; Zhou, Y; Melkoumian, Z				Hervy, Martial; Weber, Jennifer L.; Pecheul, Marylene; Dolley-Sonneville, Paula; Henry, David; Zhou, Yue; Melkoumian, Zara			Long Term Expansion of Bone Marrow-Derived hMSCs on Novel Synthetic Microcarriers in Xeno-Free, Defined Conditions	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SIGNALING PATHWAYS; CULTURE	Human mesenchymal stem cells (hMSCs) present an attractive target for cell therapy given their wide availability, immunomodulatory properties, and multipotent nature for differentiation into chondrocytes, osteocytes, and adipocytes. With the progression of hMSC clinical studies, there is an increasing demand for development of technologies that enable efficient cell scale-up into clinically relevant quantities. Commercial scale manufacturing of hMSCs will require a large surface area which is not cost effective with available two-dimensional culture vessels. Recent studies showed that microcarriers provide a three-dimensional culture environment suitable for hMSC expansion. Traditionally, biological coatings and/or serum-containing medium are required to facilitate hMSC attachment and expansion in dynamic conditions. These limitations may hinder the use of microcarriers as a scale-up technology for hMSC therapeutics, where cell products, and therefore patient safety, are more controlled with the use of xeno-free, defined culture conditions. Here we report the long term culture of hMSCs on novel synthetic Synthemax II microcarriers in two different xeno-free media. Cells were maintained over 40 days on sterile, ready-to-use microcarriers in spinner flasks with programmed agitation. hMSC expansion was obtained by addition of fresh beads without the need for enzymatic dissociation. We achieved a cumulative cell expansion of >10,000 fold, and cells retained normal hMSC phenotype, karyotype, and tri-lineage differentiation potential. To our knowledge, this report is the first example of long term culture of hMSCs on synthetic microcarriers in xeno-free, defined conditions.	[Weber, Jennifer L.; Dolley-Sonneville, Paula; Zhou, Yue; Melkoumian, Zara] Corning Inc, Corning Life Sci Dev, Corning, NY 14831 USA; [Hervy, Martial; Pecheul, Marylene; Henry, David] Corning Inc, Corning European Technol Ctr, Avon, France	Corning Inc; State University of New York (SUNY) System; SUNY Community College; Corning Inc	Hervy, M (corresponding author), Corning Inc, Corning European Technol Ctr, Avon, France.	hervym@corning.com			Corning Incorporated	Corning Incorporated	This work was supported by Corning Incorporated. The funder played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bulj Z, 2013, INT J ONCOL, V42, P118, DOI 10.3892/ijo.2012.1700; Chase LG, 2012, STEM CELL TRANSL MED, V1, P750, DOI 10.5966/sctm.2012-0072; Choi SH, 2012, CIRC J, V76, P1307, DOI 10.1253/circj.CJ-11-1479; Dander E, 2012, LEUKEMIA, V26, P1681, DOI 10.1038/leu.2011.384; Delaine-Smith RM, 2012, EUR CELLS MATER, V24, P162, DOI 10.22203/eCM.v024a12; Dolley-Sonneville PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070263; dos Santos DCM, 2012, LIVER INT, V32, P147, DOI 10.1111/j.1478-3231.2011.02654.x; dos Santos F, 2011, METHODS MOL BIOL, V698, P189, DOI 10.1007/978-1-60761-999-4_15; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Ferrari C, 2012, BIOTECHNOL PROGR, V28, P780, DOI 10.1002/btpr.1527; Hewitt CJ, 2011, BIOTECHNOL LETT, V33, P2325, DOI 10.1007/s10529-011-0695-4; Jung S, 2012, J TISSUE ENG REGEN M, V6, P391, DOI 10.1002/term.441; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Matthay MA, 2010, CRIT CARE MED, V38, pS569, DOI 10.1097/CCM.0b013e3181f1ff1d; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Sart S, 2009, J BIOTECHNOL, V139, P291, DOI 10.1016/j.jbiotec.2008.12.011; Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73; Stagg J, 2008, STEM CELL REV, V4, P119, DOI 10.1007/s12015-008-9030-4; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; Wang YS, 1999, CYTOTECHNOLOGY, V31, P221, DOI 10.1023/A:1008079013375; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Yang ZJ, 2010, CARDIOVASC THER, V28, P380, DOI 10.1111/j.1755-5922.2009.00116.x; Yeatts AB, 2013, BBA-GEN SUBJECTS, V1830, P2470, DOI 10.1016/j.bbagen.2012.06.007; Yuan Y, 2012, J TISSUE ENG REGEN M; Zheng LS, 2012, J BIOMECH, V45, P2368, DOI 10.1016/j.jbiomech.2012.07.013	27	55	58	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92120	10.1371/journal.pone.0092120	http://dx.doi.org/10.1371/journal.pone.0092120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638103	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100116
J	Kong, XZ; Yin, RH; Ning, HM; Zheng, WW; Dong, XM; Yang, Y; Xu, FF; Li, JJ; Zhan, YQ; Yu, M; Ge, CH; Zhang, JH; Chen, H; Li, CY; Yang, XM				Kong, Xiang-Zhen; Yin, Rong-Hua; Ning, Hong-Mei; Zheng, Wei-Wei; Dong, Xiao-Ming; Yang, Yang; Xu, Fei-Fei; Li, Jian-Jie; Zhan, Yi-Qun; Yu, Miao; Ge, Chang-Hui; Zhang, Jian-Hong; Chen, Hui; Li, Chang-Yan; Yang, Xiao-Ming			Effects of THAP11 on Erythroid Differentiation and Megakaryocytic Differentiation of K562 Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-2; EMBRYONIC STEM-CELLS; C-MYC; HEMATOPOIETIC-CELLS; ZINC-FINGER; GENE-EXPRESSION; DOWN-REGULATION; PROLIFERATION; TESCALCIN; ELEMENT	Hematopoiesis is a complex process regulated by sets of transcription factors in a stage-specific and context-dependent manner. THAP11 is a transcription factor involved in cell growth, ES cell pluripotency, and embryogenesis. Here we showed that THAP11 was down-regulated during erythroid differentiation but up-regulated during megakaryocytic differentiation of cord blood CD34(+) cells. Overexpression of THAP11 in K562 cells inhibited the erythroid differentiation induced by hemin with decreased numbers of benzidine-positive cells and decreased mRNA levels of alpha-globin (HBA) and glycophorin A (GPA), and knockdown of THAP11 enhanced the erythroid differentiation. Conversely, THAP11 overexpression accelerated the megakaryocytic differentiation induced by phorbol myristate acetate (PMA) with increased percentage of CD41(+) cells, increased numbers of 4N cells, and elevated CD61 mRNA levels, and THAP11 knockdown attenuated the megakaryocytic differentiation. The expression levels of transcription factors such as c-Myc, c-Myb, GATA-2, and Fli1 were changed by THAP11 overexpression. In this way, our results suggested that THAP11 reversibly regulated erythroid and megakaryocytic differentiation.	[Kong, Xiang-Zhen; Dong, Xiao-Ming; Yang, Xiao-Ming] Tianjin Univ, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China; [Kong, Xiang-Zhen; Yin, Rong-Hua; Zheng, Wei-Wei; Xu, Fei-Fei; Zhan, Yi-Qun; Yu, Miao; Ge, Chang-Hui; Zhang, Jian-Hong; Chen, Hui; Li, Chang-Yan; Yang, Xiao-Ming] Beijing Inst Radiat Med, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Yin, Rong-Hua; Li, Chang-Yan; Yang, Xiao-Ming] State Key Lab Prote, Beijing, Peoples R China; [Ning, Hong-Mei] Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China; [Yang, Yang] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Li, Jian-Jie] Acad Mil Med Sci, Affiliated Hosp, Dept Pulm Neoplasms Internal Med, Beijing, Peoples R China	Tianjin University; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Academy of Military Medical Sciences - China	Li, CY (corresponding author), Beijing Inst Radiat Med, Dept Biochem & Mol Biol, Beijing, Peoples R China.	fmmli@163.com; xiaomingyang@sina.com		Dong, xiao-ming/0000-0003-2413-8541	Chinese National Natural Science Foundation [81222005, 81070435]; Major State Basic Research of China [2012AA020206, 2013CB910800]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major State Basic Research of China	This study is partly supported by Chinese National Natural Science Foundation Projects (81222005, 81070435); and Major State Basic Research of China (2012AA020206, 2013CB910800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou M, 2000, LEUKEMIA, V14, P439, DOI 10.1038/sj.leu.2401689; Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Brewer G, 2000, J BIOL CHEM, V275, P33336, DOI 10.1074/jbc.M006145200; Campagne S, 2010, NUCLEIC ACIDS RES, V38, P3466, DOI 10.1093/nar/gkq053; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Ikonomi P, 2000, EXP HEMATOL, V28, P1423, DOI 10.1016/S0301-472X(00)00553-1; Jayapal S, 2010, J BIOL CHEM, V285, P40252, DOI 10.1074/jbc.M110.181073; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Li CY, 2004, CELL DEATH DIFFER, V11, P1299, DOI 10.1038/sj.cdd.4401490; Nakamura S, 2012, INT J CANCER, V130, P1046, DOI 10.1002/ijc.26065; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parker JB, 2012, MOL CELL BIOL, V32, P1654, DOI 10.1128/MCB.06033-11; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Rubin CI, 2003, EXP HEMATOL, V31, P389, DOI 10.1016/S0301-472X(03)00043-2; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Ukarapong S, 2012, EXP CELL RES, V318, P662, DOI 10.1016/j.yexcr.2012.01.009; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Zhu CY, 2009, CELL DEATH DIFFER, V16, P395, DOI 10.1038/cdd.2008.160	30	6	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91557	10.1371/journal.pone.0091557	http://dx.doi.org/10.1371/journal.pone.0091557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637716	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100043
J	Koorem, K; Gazol, A; Opik, M; Moora, M; Saks, U; Uibopuu, A; Sober, V; Zobel, M				Koorem, Kadri; Gazol, Antonio; Oepik, Maarja; Moora, Mari; Saks, Uelle; Uibopuu, Annika; Sober, Virve; Zobel, Martin			Soil Nutrient Content Influences the Abundance of Soil Microbes but Not Plant Biomass at the Small-Scale	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY COMPOSITION; SPECIES RICHNESS; FATTY-ACIDS; ECTOMYCORRHIZAL MYCELIA; SAPROTROPHIC FUNGI; CARBON ALLOCATION; SPATIAL-PATTERN; GROWTH; BACTERIA	Small-scale heterogeneity of abiotic and biotic factors is expected to play a crucial role in species coexistence. It is known that plants are able to concentrate their root biomass into areas with high nutrient content and also acquire nutrients via symbiotic microorganisms such as arbuscular mycorrhizal (AM) fungi. At the same time, little is known about the small-scale distribution of soil nutrients, microbes and plant biomass occurring in the same area. We examined small-scale temporal and spatial variation as well as covariation of soil nutrients, microbial biomass (using soil fatty acid biomarker content) and above-and belowground biomass of herbaceous plants in a natural herb-rich boreonemoral spruce forest. The abundance of AM fungi and bacteria decreased during the plant growing season while soil nutrient content rather increased. The abundance of all microbes studied also varied in space and was affected by soil nutrient content. In particular, the abundance of AM fungi was negatively related to soil phosphorus and positively influenced by soil nitrogen content. Neither shoot nor root biomass of herbaceous plants showed any significant relationship with variation in soil nutrient content or the abundance of soil microbes. Our study suggests that plants can compensate for low soil phosphorus concentration via interactions with soil microbes, most probably due to a more efficient symbiosis with AM fungi. This compensation results in relatively constant plant biomass despite variation in soil phosphorous content and in the abundance of AM fungi. Hence, it is crucial to consider both soil nutrient content and the abundance of soil microbes when exploring the mechanisms driving vegetation patterns.	[Koorem, Kadri; Gazol, Antonio; Oepik, Maarja; Moora, Mari; Saks, Uelle; Uibopuu, Annika; Zobel, Martin] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Sober, Virve] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Koorem, K (corresponding author), NIOO KNAW, Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.	kadri.koorem@ut.ee	Zobel, Martin/H-1336-2015; Öpik, Maarja/A-1765-2008; Moora, Mari/D-1961-2009; Gazol, Antonio/B-7322-2015; KNAW, NIOO-KNAW/A-4320-2012	Zobel, Martin/0000-0001-7957-6704; Öpik, Maarja/0000-0001-8025-7460; Moora, Mari/0000-0002-4819-7506; Gazol, Antonio/0000-0001-5902-9543; Koorem, Kadri/0000-0002-3376-9372; KNAW, NIOO-KNAW/0000-0002-3835-159X	Estonian Science Foundation [9050, 9157]; European Union [GA-2010-267243-PLANT FELLOWS]; ERMOS programme grant [14]; Marie Curie Actions; European Regional Development Fund (Centre of Excellence FIBIR);  [IUT 20-28]	Estonian Science Foundation; European Union(European Commission); ERMOS programme grant; Marie Curie Actions(European Commission); European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); 	This research was funded by grants from the Estonian Science Foundation (9050, 9157), targeted financing (IUT 20-28), European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no GA-2010-267243-PLANT FELLOWS, ERMOS programme grant 14 (co-funded by Marie Curie Actions), and the European Regional Development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atul-Nayyar, 2008, APPL SOIL ECOL, V40, P30, DOI 10.1016/j.apsoil.2008.03.004; Baldrian P, 2012, APPL ENVIRON MICROB, V78, P3473, DOI 10.1128/AEM.07953-11; Baldrian P, 2010, BIOL FERT SOILS, V46, P717, DOI 10.1007/s00374-010-0478-4; Beauregard MS, 2010, MICROB ECOL, V59, P379, DOI 10.1007/s00248-009-9583-z; Birkhofer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043292; Bjornstad O. N, 2012, NCF SPATIAL NONPARAM; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; Calvaruso C, 2006, APPL ENVIRON MICROB, V72, P1258, DOI 10.1128/AEM.72.2.1258-1266.2006; Campbell CD, 2008, SOIL BIOL BIOCHEM, V40, P2246, DOI 10.1016/j.soilbio.2008.04.020; Chagnon PL, 2013, FUNGAL ECOL, V6, P557, DOI 10.1016/j.funeco.2013.09.005; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Day KJ, 2003, J ECOL, V91, P541, DOI 10.1046/j.1365-2745.2003.00799.x; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Franklin RB, 2009, SOIL BIOL BIOCHEM, V41, P1833, DOI 10.1016/j.soilbio.2009.06.003; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Gazol A, 2013, OECOLOGIA, V173, P545, DOI 10.1007/s00442-013-2623-x; GRAHAM JH, 1995, APPL ENVIRON MICROB, V61, P58, DOI 10.1128/AEM.61.1.58-64.1995; Groffman PM, 2011, SOIL BIOL BIOCHEM, V43, P2441, DOI 10.1016/j.soilbio.2011.08.011; Hamel C, 2006, SOIL BIOL BIOCHEM, V38, P2104, DOI 10.1016/j.soilbio.2006.01.011; Hinojosa MB, 2005, J ENVIRON QUAL, V34, P1789, DOI 10.2134/jeq2004.0470; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hoffland E, 2003, ECOSYSTEMS, V6, P739, DOI 10.1007/s10021-003-0191-3; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kabir Z, 1998, AGR ECOSYST ENVIRON, V68, P151, DOI 10.1016/S0167-8809(97)00155-2; Kaiser C, 2010, NEW PHYTOL, V187, P843, DOI 10.1111/j.1469-8137.2010.03321.x; Kikuchi K, 2007, MYCORRHIZA, V17, P563, DOI 10.1007/s00572-007-0131-8; Klironomos JN, 1999, APPL SOIL ECOL, V12, P227, DOI 10.1016/S0929-1393(99)00014-1; Koorem K, 2012, BASIC APPL ECOL, V13, P663, DOI 10.1016/j.baae.2012.09.008; Koorem K, 2010, FOREST ECOL MANAG, V260, P1407, DOI 10.1016/j.foreco.2010.07.043; Lecomte J, 2011, FEMS MICROBIOL LETT, V317, P43, DOI 10.1111/j.1574-6968.2011.02209.x; Legendre P., 2012, NUMERICAL ECOLOGY; Leigh J, 2011, FEMS MICROBIOL ECOL, V76, P428, DOI 10.1111/j.1574-6941.2011.01066.x; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; MCNAUGHTON SJ, 1990, OIKOS, V59, P92, DOI 10.2307/3545127; Moora M, 2007, FOREST ECOL MANAG, V250, P64, DOI 10.1016/j.foreco.2007.03.010; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; NICHOLS P, 1986, ARCH MICROBIOL, V146, P1, DOI 10.1007/BF00690149; Nilsson LO, 2007, OECOLOGIA, V153, P375, DOI 10.1007/s00442-007-0735-x; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Olsson PA, 1996, FEMS MICROBIOL ECOL, V21, P77, DOI 10.1111/j.1574-6941.1996.tb00335.x; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Olsson PA, 1997, APPL ENVIRON MICROB, V63, P3531, DOI 10.1128/AEM.63.9.3531-3538.1997; Olsson PA, 1998, PLANT SOIL, V201, P9, DOI 10.1023/A:1004379404220; Osorio F., 2012, R PACKAGE VERSION 02, V3, P4; Paul E. A., 1989, Soil microbiology and biochemistry.; Pausas JG, 2003, J VEG SCI, V14, P661, DOI 10.1111/j.1654-1103.2003.tb02198.x; Pereira E, 2012, MYCORRHIZA, V22, P41, DOI 10.1007/s00572-011-0379-x; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Potila H, 2009, PLANT SOIL, V316, P139, DOI 10.1007/s11104-008-9766-2; R Core Team, 2016, R FDN STAT COMP; Ranneklev SB, 2003, APPL ENVIRON MICROB, V69, P3532, DOI 10.1128/AEM.69.6.3532-3539.2003; Roesti D, 2005, APPL ENVIRON MICROB, V71, P6673, DOI 10.1128/AEM.71.11.6673-6679.2005; Rousk J, 2011, FEMS MICROBIOL ECOL, V78, P17, DOI 10.1111/j.1574-6941.2011.01106.x; Schnoor TK, 2011, OECOLOGIA, V167, P809, DOI 10.1007/s00442-011-2020-2; Schutter ME, 2000, SOIL SCI SOC AM J, V64, P1659, DOI 10.2136/sssaj2000.6451659x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Staddon PL, 2003, GLOBAL CHANGE BIOL, V9, P186, DOI 10.1046/j.1365-2486.2003.00593.x; Thoms C, 2010, SOIL BIOL BIOCHEM, V42, P1558, DOI 10.1016/j.soilbio.2010.05.030; Tran T.S., 1993, SOIL SAMPL METHODS A, V43, P49; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Walder F, 2013, SOIL BIOL BIOCHEM, V58, P341, DOI 10.1016/j.soilbio.2012.12.008; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zobel M, 2007, FOREST ECOL MANAG, V250, P71, DOI 10.1016/j.foreco.2007.03.011; Zuur Alain F., 2009, P1	76	49	50	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91998	10.1371/journal.pone.0091998	http://dx.doi.org/10.1371/journal.pone.0091998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637633	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100100
J	Chaves, LD; Bao, L; Wang, Y; Chang, A; Haas, M; Quigg, RJ				Chaves, Lee Daniel; Bao, Lihua; Wang, Ying; Chang, Anthony; Haas, Mark; Quigg, Richard John			Loss of CD11b Exacerbates Murine Complement-Mediated Tubulointerstitial Nephritis	PLOS ONE			English	Article							TISSUE-RESIDENT MACROPHAGES; ACUTE-RENAL-FAILURE; DENDRITIC CELLS; ALTERNATIVE PATHWAY; MONOCLONAL-ANTIBODY; ACTIVATION; GLOMERULONEPHRITIS; INFLAMMATION; KIDNEY; MICE	Acute complement activation occurs in the tubulointerstitium (TI) of kidneys transplanted from Crry(-/-)C3(-/-) mice into complement-sufficient wildtype mice, followed by marked inflammatory cell infiltration, tubular damage and interstitial fibrosis. We postulated iC3b-CD11b interactions were critical in this TI nephritis model. We transplanted Crry(-/-)C3(-/-) mouse kidneys into CD11b(-/-) and wildtype C57BL/6 mice. Surprisingly, there was greater inflammation in Crry(-/-)C3(-/-) kidneys in CD11b(-/-) recipients compared to those in wildtype hosts. Kidneys in CD11b(-/-) recipients had large numbers of CD11b(-)Ly6C(hi)CCR2(hi)F4/80(+) cells consistent with inflammatory (M1) macrophages recruited from circulating monocytes of the host CD11b(-/-) animal. There was also an expanded population of CD11b(+)CD11c(+)Ly6C(-)F4/80(hi) cells. Since these cells were CD11b(+), they must have originated from the transplanted kidney; their surface protein expression and appearance within the kidney were consistent with the intrinsic renal mononuclear cellular population. These cells were markedly expanded relative to all relevant controls, including the contralateral donor kidney and Crry(-/-)C3(-/-) mouse kidneys in CD11b(+/+) wildtype recipients. Direct evidence for their in situ proliferation was the presence of nuclear Ki67 and PCNA in CD11b(+)F4/80(+) cells. Thus, in this experimental model in which there is unrestricted C3 activation, CD11b(+) monocytes limit their own infiltration into the kidney and prevent proliferation of endogenous mononuclear cells. This suggests a role for outside-in iC3b-CD11b signals in limiting intrinsic organ inflammation.	[Chaves, Lee Daniel; Quigg, Richard John] SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Div Nephrol, Buffalo, NY 14260 USA; [Bao, Lihua; Wang, Ying] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Chang, Anthony] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Haas, Mark] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Chicago; University of Chicago; Cedars Sinai Medical Center	Quigg, RJ (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Div Nephrol, Buffalo, NY 14260 USA.	rquigg@buffalo.edu		Chang, Anthony/0000-0002-6877-5510	National Institutes of Health (NIH) [R01DK041873]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041873] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grant R01DK041873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2012, KIDNEY INT, V82, P961, DOI 10.1038/ki.2012.249; Bao LH, 2007, J AM SOC NEPHROL, V18, P811, DOI 10.1681/ASN.2006101176; Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Barbour TD, 2013, NEPHROL DIAL TRANSPL, V28, P1685, DOI 10.1093/ndt/gfs430; Berger M, 2002, J LEUKOCYTE BIOL, V71, P798; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; FUNABASHI K, 1994, IMMUNOLOGY, V81, P444; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gottschalk C, 2013, J AM SOC NEPHROL, V24, P543, DOI 10.1681/ASN.2012101022; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; ICHIDA S, 1994, KIDNEY INT, V46, P89, DOI 10.1038/ki.1994.247; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Kawakami T, 2013, J IMMUNOL, V191, P3358, DOI 10.4049/jimmunol.1300342; KIM YU, 1995, J EXP MED, V181, P151, DOI 10.1084/jem.181.1.151; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; LI B, 1993, J IMMUNOL, V151, P4295; Lukacs-Kornek V, 2008, J IMMUNOL, V180, P706, DOI 10.4049/jimmunol.180.2.706; Mao DL, 2003, IMMUNITY, V19, P813, DOI 10.1016/S1074-7613(03)00321-2; Means TK, 2010, NAT IMMUNOL, V11, P691, DOI 10.1038/ni0810-691; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naik A, 2013, SEMIN NEPHROL, V33, P575, DOI 10.1016/j.semnephrol.2013.08.008; NATH KA, 1985, J CLIN INVEST, V76, P667, DOI 10.1172/JCI112020; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; NOMURA A, 1995, J CLIN INVEST, V96, P2348, DOI 10.1172/JCI118291; Quigg RJ, 1998, KIDNEY INT, V53, P320, DOI 10.1046/j.1523-1755.1998.00723.x; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Shah SN, 2009, AM J KIDNEY DIS, V54, P270, DOI 10.1053/j.ajkd.2009.02.014; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Thurman JM, 2005, KIDNEY INT, V67, P524, DOI 10.1111/j.1523-1755.2005.67109.x; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Thurman JM, 2006, J AM SOC NEPHROL, V17, P707, DOI 10.1681/ASN.2005070698; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498	45	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92051	10.1371/journal.pone.0092051	http://dx.doi.org/10.1371/journal.pone.0092051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632830	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400135
J	Ghorbaniaghdam, A; Chen, JK; Henry, O; Jolicoeur, M				Ghorbaniaghdam, Atefeh; Chen, Jingkui; Henry, Olivier; Jolicoeur, Mario			Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform	PLOS ONE			English	Article							RECOMBINANT PROTEIN-PRODUCTION; YEAST PYRUVATE-CARBOXYLASE; HAMSTER OVARY CELLS; PROTEOMIC ANALYSIS; FLUX ANALYSIS; HIGH PRODUCTIVITY; MYELOMA CELLS; ENERGY-CHARGE; EXPRESSION; CULTURE	Monoclonal antibody producing Chinese hamster ovary (CHO) cells have been shown to undergo metabolic changes when engineered to produce high titers of recombinant proteins. In this work, we have studied the distinct metabolism of CHO cell clones harboring an efficient inducible expression system, based on the cumate gene switch, and displaying different expression levels, high and low productivities, compared to that of the parental cells from which they were derived. A kinetic model for CHO cell metabolism was further developed to include metabolic regulation. Model calibration was performed using intracellular and extracellular metabolite profiles obtained from shake flask batch cultures. Model simulations of intracellular fluxes and ratios known as biomarkers revealed significant changes correlated with clonal variation but not to the recombinant protein expression level. Metabolic flux distribution mostly differs in the reactions involving pyruvate metabolism, with an increased net flux of pyruvate into the tricarboxylic acid (TCA) cycle in the high-producer clone, either being induced or non-induced with cumate. More specifically, CHO cell metabolism in this clone was characterized by an efficient utilization of glucose and a high pyruvate dehydrogenase flux. Moreover, the high-producer clone shows a high rate of anaplerosis from pyruvate to oxaloacetate, through pyruvate carboxylase and from glutamate to a-ketoglutarate, through glutamate dehydrogenase, and a reduced rate of cataplerosis from malate to pyruvate, through malic enzyme. Indeed, the increase of flux through pyruvate carboxylase was not driven by an increased anabolic demand. It is in fact linked to an increase of the TCA cycle global flux, which allows better regulation of higher redox and more efficient metabolic states. To the best of our knowledge, this is the first time a dynamic in silico platform is proposed to analyze and compare the metabolomic behavior of different CHO clones.	[Ghorbaniaghdam, Atefeh; Chen, Jingkui; Jolicoeur, Mario] Ecole Polytech, Canada Res Chair Appl Metab Engn, Montreal, PQ H3C 3A7, Canada; [Ghorbaniaghdam, Atefeh; Chen, Jingkui; Henry, Olivier; Jolicoeur, Mario] Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Polytechnique Montreal	Jolicoeur, M (corresponding author), Ecole Polytech, Canada Res Chair Appl Metab Engn, Montreal, PQ H3C 3A7, Canada.	mario.jolicoeur@polymtl.ca			National Sciences and Engineering Research Council of Canada (NSERC) through the Canadian Monoclonal Antibody Network (MabNet); Canadian Foundation for Innovation (CFI)	National Sciences and Engineering Research Council of Canada (NSERC) through the Canadian Monoclonal Antibody Network (MabNet); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	The National Sciences and Engineering Research Council of Canada (NSERC) funded this research project through the Canadian Monoclonal Antibody Network (MabNet), in which MJ is a member. The Canadian Foundation for Innovation (CFI) has funded the analytical equipments used in this work as well as their operation. Viropro International Inc. (Montreal, Quebec, Canada) has only provided the cell lines used in this study. The funders, as well as Viropro International Inc., had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Alete DE, 2005, PROTEOMICS, V5, P4689, DOI 10.1002/pmic.200500019; Altamirano C, 2001, BIOTECHNOL PROGR, V17, P1032, DOI 10.1021/bp0100981; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; BEBBINGTON CR, 1992, BIO-TECHNOL, V10, P169, DOI 10.1038/nbt0292-169; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Bonarius HPJ, 1998, BIOTECHNOL BIOENG, V57, P447, DOI 10.1002/(SICI)1097-0290(19980220)57:4<447::AID-BIT8>3.3.CO;2-C; Chong WPK, 2012, BIOTECHNOL BIOENG, V109, P3103, DOI 10.1002/bit.24580; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; CLARKE GD, 1965, BRIT J CANCER, V19, P840, DOI 10.1038/bjc.1965.97; Dahodwala H, 2012, CYTOTECHNOLOGY, V64, P27, DOI 10.1007/s10616-011-9388-z; Dash RK, 2008, IEEE T BIO-MED ENG, V55, P1298, DOI 10.1109/TBME.2007.913422; Davies SL, 2013, BIOTECHNOL BIOENG, V110, P260, DOI 10.1002/bit.24621; Dean J, 2013, BIOTECHNOL BIOENG, V110, P1735, DOI 10.1002/bit.24826; Dell'mour M, 2010, J SEP SCI, V33, P911, DOI 10.1002/jssc.200900743; Dinnis DM, 2006, BIOTECHNOL BIOENG, V94, P830, DOI 10.1002/bit.20899; Dorka P, 2009, BIOPROC BIOSYST ENG, V32, P183, DOI 10.1007/s00449-008-0236-2; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Eppink MHM, 2009, BIOPHARM INT, P32; Europa AF, 2006, BIOTECHNOL BIOENG, V67, P25; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Gaillet B, 2010, BIOTECHNOL BIOENG, V106, P203, DOI 10.1002/bit.22698; GARREAU H, 1972, BIOCHIMIE, V54, P1103, DOI 10.1016/S0300-9084(72)80013-0; Ghorbaniaghdam A, 2013, BIOPROC BIOSYST ENG, V36, P469, DOI 10.1007/s00449-012-0804-3; Goudar C, 2010, METAB ENG, V12, P138, DOI 10.1016/j.ymben.2009.10.007; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Harper ME, 2002, J ANIM SCI, V80, P90; Hayduk EJ, 2005, BIOTECHNOL BIOENG, V90, P354, DOI 10.1002/bit.20438; Hayduk EJ, 2004, ELECTROPHORESIS, V25, P2545, DOI 10.1002/elps.200406010; HEINRICH R, 1977, PROG BIOPHYS MOL BIO, V32, P1; Heyland J, 2011, J BIOTECHNOL, V155, P178, DOI 10.1016/j.jbiotec.2011.06.016; Heyland J, 2011, BIOTECHNOL BIOENG, V108, P1942, DOI 10.1002/bit.23114; HUNDAL HS, 1989, J PHYSIOL-LONDON, V408, P93, DOI 10.1113/jphysiol.1989.sp017449; Irani N, 2002, J BIOTECHNOL, V93, P269, DOI 10.1016/S0168-1656(01)00409-6; Kim NS, 2001, BIOTECHNOL PROGR, V17, P69, DOI 10.1021/bp000144h; KONRAD MW, 1977, CELL, V10, P305, DOI 10.1016/0092-8674(77)90224-0; Lamboursain L, 2002, BIOTECHNOL PROGR, V18, P1377, DOI 10.1021/bp015511j; Lee YY, 2009, J BIOTECHNOL, V143, P34, DOI 10.1016/j.jbiotec.2009.05.013; Lehninger A. L., 1977, BIOCHEMISTRY; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Liebermeister W, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-41; Link T, 2004, J BIOTECHNOL, V110, P51, DOI 10.1016/j.jbiotec.2003.12.008; Mailier J, 2011, BIOTECHNOL BIOENG, V108, P1108, DOI 10.1002/bit.23030; Martens D. E., 2007, SYSTEMS BIOL, P275; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mo ML, 2009, BMC SYSTEMS BIOL, V25, P3; Mullick A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-43; Naderi S, 2011, BIOTECHNOL PROGR, V27, P1197, DOI 10.1002/btpr.647; Niklas J, 2011, BIOPROC BIOSYST ENG, V34, P533, DOI 10.1007/s00449-010-0502-y; Nissom PM, 2006, MOL BIOTECHNOL, V34, P125, DOI 10.1385/MB:34:2:125; Nolan RP, 2011, METAB ENG, V13, P108, DOI 10.1016/j.ymben.2010.09.003; Oh MK, 2003, J CELL BIOCHEM, V90, P1068, DOI 10.1002/jcb.10712; Pavlou AK, 2005, EUR J PHARM BIOPHARM, V59, P389, DOI 10.1016/j.ejpb.2004.11.007; PETERSON JA, 1976, P NATL ACAD SCI USA, V73, P2056, DOI 10.1073/pnas.73.6.2056; Pincetich CA, 2005, COMP BIOCHEM PHYS C, V140, P103, DOI 10.1016/j.cca.2005.01.010; Preinerstorfer B, 2010, J CHROMATOGR A, V1217, P312, DOI 10.1016/j.chroma.2009.11.051; Pugin A, 1997, PLANT CELL, V9, P2077, DOI 10.1105/tpc.9.11.2077; Qian TX, 2004, ANAL BIOCHEM, V325, P77, DOI 10.1016/j.ab.2003.10.028; REICH JG, 1981, ENERGY METABOLISM CE; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Segel IH., 1993, ENZYME KINETICS BEHA; Sengupta N, 2011, BIOTECHNOL BIOENG, V108, P82, DOI 10.1002/bit.22890; Seth G, 2007, BIOTECHNOL BIOENG, V97, P933, DOI 10.1002/bit.21234; Sheikholeslami Z, 2013, J BIOTECHNOL, V164, P469, DOI 10.1016/j.jbiotec.2013.01.025; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Stephanopoulos G., 1998, METAB ENG; Templeton N, 2013, BIOTECHNOL BIOENG, V110, P2013, DOI 10.1002/bit.24858; WANG CS, 1977, EUR J BIOCHEM, V78, P569, DOI 10.1111/j.1432-1033.1977.tb11770.x; Yoon SK, 2004, BIOTECHNOL PROGR, V20, P1683, DOI 10.1021/bp049847f; Zagari F, 2013, NEW BIOTECHNOL, V30, P238, DOI 10.1016/j.nbt.2012.05.021; Zamorano F., 2012, J BIOTECHNOL, P409; ZDZIENICKA MZ, 1985, SOMAT CELL MOLEC GEN, V11, P127, DOI 10.1007/BF01534701; Zomorrodi AR, 2012, METAB ENG, V14, P672, DOI 10.1016/j.ymben.2012.09.005	76	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90832	10.1371/journal.pone.0090832	http://dx.doi.org/10.1371/journal.pone.0090832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632968	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000332858400020
J	Taskinen, B; Airenne, TT; Janis, J; Rahikainen, R; Johnson, MS; Kulomaa, MS; Hytonen, VP				Taskinen, Barbara; Airenne, Tomi T.; Janis, Janne; Rahikainen, Rolle; Johnson, Mark S.; Kulomaa, Markku S.; Hytonen, Vesa P.			A Novel Chimeric Avidin with Increased Thermal Stability Using DNA Shuffling	PLOS ONE			English	Article							BIOTIN-BINDING PROTEIN; HIGH-AFFINITY; FAMILY; REFINEMENT; GENES	Avidins are a family of proteins widely employed in biotechnology. We have previously shown that functional chimeric mutant proteins can be created from avidin and avidin-related protein 2 using a methodology combining random mutagenesis by recombination and selection by a tailored biopanning protocol (phage display). Here, we report the crystal structure of one of the previously selected and characterized chimeric avidin forms, A/A2-1. The structure was solved at 1.8 angstrom resolution and revealed that the protein fold was not affected by the shuffled sequences. The structure also supports the previously observed physicochemical properties of the mutant. Furthermore, we improved the selection and screening methodology to select for chimeric avidins with slower dissociation rate from biotin than were selected earlier. This resulted in the chimeric mutant A/A2-B, which showed increased thermal stability as compared to A/A2-1 and the parental proteins. The increased stability was especially evident at conditions of extreme pH as characterized using differential scanning calorimetry. In addition, amino acid sequence and structural comparison of the chimeric mutants and the parental proteins led to the rational design of A/A2-B I109K. This mutation further decreased the dissociation rate from biotin and yielded an increase in the thermal stability.	[Taskinen, Barbara; Rahikainen, Rolle; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Taskinen, Barbara; Rahikainen, Rolle; Hytonen, Vesa P.] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland; [Airenne, Tomi T.; Johnson, Mark S.] Abo Akad Univ, Dept Biosci, Turku, Finland; [Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Kulomaa, Markku S.] Tampere Univ Hosp, Tampere, Finland	Tampere University; Pirkanmaa Hospital District; Abo Akademi University; University of Eastern Finland; Tampere University; Tampere University Hospital	Hytonen, VP (corresponding author), Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland.	vesa.hytonen@uta.fi	Jänis, Janne/B-7326-2014; Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480; Taskinen, Barbara/0000-0003-2989-7563; Rahikainen, Rolle/0000-0003-1265-862X	Academy of Finland [136288, 257814, 272283, 273192]; National Doctoral Programme in Informational and Structural Biology (ISB); Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Pirkanmaa Hospital District, Tampere University Hospital	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology (ISB); Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Pirkanmaa Hospital District, Tampere University Hospital	This work was funded by the Academy of Finland [projects 136288, 257814, 272283, 273192], the National Doctoral Programme in Informational and Structural Biology (ISB), the Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging), the Sigrid Juselius Foundation, and the Joe, Pentti and Tor Borg Memorial Fund. This study was financially supported by the Competitive Research Funding of the Pirkanmaa Hospital District, Tampere University Hospital. The authors acknowledge the FIRI infrastructure support for structural biology from the Academy of Finland. Biocenter Finland is acknowledged for the infrastructure support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Humbert N, 2005, ELECTROPHORESIS, V26, P47, DOI 10.1002/elps.200406148; Hytonen VP, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-8; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEINANEN RA, 1994, EUR J BIOCHEM, V220, P615, DOI 10.1111/j.1432-1033.1994.tb18663.x; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leppiniemi J, 2013, PROTEIN SCI; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meir A, 2012, J BIOL CHEM, V287, P17951, DOI 10.1074/jbc.M112.357186; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholas K.B., 1997, GENEDOC ANAL VISUALI; Niederhauser B, 2012, J BIOTECHNOL, V157, P38, DOI 10.1016/j.jbiotec.2011.10.014; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reznik GO, 1998, P NATL ACAD SCI USA, V95, P13525, DOI 10.1073/pnas.95.23.13525; Riihimaki TA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-64; Sidhu SS, 2000, J MOL BIOL, V296, P487, DOI 10.1006/jmbi.1999.3465; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Taskinen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077207; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	47	8	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92058	10.1371/journal.pone.0092058	http://dx.doi.org/10.1371/journal.pone.0092058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632863	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400137
J	Allen, DK; Evans, BS; Libourel, IGL				Allen, Doug K.; Evans, Bradley S.; Libourel, Igor G. L.			Analysis of Isotopic Labeling in Peptide Fragments by Tandem Mass Spectrometry	PLOS ONE			English	Article							METABOLIC FLUX ANALYSIS; HIGHER-PLANT CELLS; CODED AFFINITY TAGS; AMINO-ACIDS; NONAQUEOUS FRACTIONATION; ARABIDOPSIS CELLS; HIGH-RESOLUTION; SOYBEAN SEEDS; ROOT-TIPS; C-13	Phenotype in multicellular organisms is the consequence of dynamic metabolic events that occur in a spatially dependent fashion. This spatial and temporal complexity presents challenges for investigating metabolism; creating a need for improved methods that effectively probe biochemical events such as amino acid biosynthesis. Isotopic labeling can provide a temporal-spatial recording of metabolic events through, for example, the description of enriched amino acids in the protein pool. Proteins are therefore an important readout of metabolism and can be assessed with modern mass spectrometers. We compared the measurement of isotopic labeling in MS2 spectra obtained from tandem mass spectrometry under either higher energy collision dissociation (HCD) or collision induced dissociation (CID) at varied energy levels. Developing soybean embryos cultured with or without C-13-labeled substrates, and Escherichia coli MG1655 enriched by feeding 7% uniformly labeled glucose served as a source of biological material for protein evaluation. CID with low energies resulted in a disproportionate amount of heavier isotopologues remaining in the precursor isotopic distribution. HCD resulted in fewer quantifiable products; however deviation from predicted distributions were small relative to the CID-based comparisons. Fragment ions have the potential to provide information on the labeling of amino acids in peptides, but our results indicate that without further development the use of this readout in quantitative methods such as metabolic flux analysis is limited.	[Allen, Doug K.] ARS, USDA, Plant Genet Res Unit, St Louis, MO USA; [Allen, Doug K.; Evans, Bradley S.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Libourel, Igor G. L.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA	United States Department of Agriculture (USDA); Donald Danforth Plant Science Center; University of Minnesota System; University of Minnesota Twin Cities	Allen, DK (corresponding author), ARS, USDA, Plant Genet Res Unit, St Louis, MO USA.	doug.allen@ars.usda.gov	Evans, Bradley S/M-2842-2013; Allen, Doug K/M-2836-2013	Evans, Bradley S/0000-0002-1207-9006; Allen, Doug K/0000-0001-8599-8946	NSF [DBI-0922879]	NSF(National Science Foundation (NSF))	The authors acknowledge USDA facilities and resources, and technical expertise of Jim Gierse and Christine Diepenbrock along with the Donald Danforth Plant Science Center Proteomics and Mass Spectrometry Facility where the Orbitrap mass spectrometer was located (funded by NSF: DBI-0922879). Technical advice from Drs. Alisha Roberts and Jae Schwartz, Thermo-Fisher Scientific was also greatly appreciated.	Allen DK, 2009, PLANT METABOLIC NETWORKS, P105, DOI 10.1007/978-0-387-78745-9_5; Allen DK, 2007, PHYTOCHEMISTRY, V68, P2197, DOI 10.1016/j.phytochem.2007.04.010; Allen DK, 2014, ANAL CHEM, V86, P1894, DOI 10.1021/ac403985w; Allen DK, 2013, PLANT PHYSIOL, V161, P1458, DOI 10.1104/pp.112.203299; Allen DK, 2012, PLANT CELL ENVIRON, V35, P1232, DOI 10.1111/j.1365-3040.2012.02485.x; Allen DK, 2009, PLANT CELL ENVIRON, V32, P1241, DOI 10.1111/j.1365-3040.2009.01992.x; Allen DK, 2009, PLANT J, V58, P220, DOI 10.1111/j.1365-313X.2008.03771.x; Alonso AP, 2007, METAB ENG, V9, P419, DOI 10.1016/j.ymben.2007.06.002; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Aubert S, 1999, PLANT CELL ENVIRON, V22, P255, DOI 10.1046/j.1365-3040.1999.00421.x; Aubert S, 1998, PLANT PHYSIOL, V116, P547, DOI 10.1104/pp.116.2.547; Balbuena TS, 2011, J PROTEOME RES, V10, P2330, DOI 10.1021/pr101137q; Benkeblia N, 2007, METABOLOMICS, V3, P297, DOI 10.1007/s11306-007-0078-y; Blank LM, 2012, ANAL BIOANAL CHEM, V403, P2291, DOI 10.1007/s00216-012-6009-4; Borisjuk L, 2005, NEW PHYTOL, V167, P761, DOI 10.1111/j.1469-8137.2005.01474.x; Borisjuk L, 2013, PLANT CELL, V25, P1625, DOI 10.1105/tpc.113.111740; Chen XW, 2013, METAB ENG, V18, P78, DOI 10.1016/j.ymben.2013.04.006; Chen XW, 2012, J EXP BOT, V63, P2343, DOI 10.1093/jxb/ers057; Cheung CY, 2013, PLANT J; Colangelo Christopher M., 2006, V328, P151; Demartini DR, 2011, J PROTEOME RES, V10, P2226, DOI 10.1021/pr101047y; Ebert B, 2010, J EXP BOT, V61, P1321, DOI 10.1093/jxb/erq002; Fernie AR, 2013, PLANT CELL ENV; Geigenberger P, 2011, METHODS MOL BIOL, V775, P135, DOI 10.1007/978-1-61779-237-3_8; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; GERHARDT R, 1987, PLANT PHYSIOL, V83, P399, DOI 10.1104/pp.83.2.399; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; GOUT E, 1992, J BIOL CHEM, V267, P13903; GOUT E, 1993, J BIOL CHEM, V268, P3986; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Herbst FA, 2013, MOL CELL PROTEOMICS, V12, P2060, DOI 10.1074/mcp.M112.025627; HOOKS MA, 1989, PLANT PHYSIOL, V89, P963, DOI 10.1104/pp.89.3.963; Horn PJ, 2012, PLANT CELL, V24, P622, DOI 10.1105/tpc.111.094581; Horn PJ, 2011, J BIOL CHEM, V286, P3298, DOI 10.1074/jbc.M110.186353; HSU FC, 1982, PLANT SCI LETT, V27, P129, DOI 10.1016/0304-4211(82)90141-9; Huege J, 2012, MOL BIOSYST, V8, P2466, DOI 10.1039/c2mb25068c; Hughes C, 2012, TRENDS BIOTECHNOL, V30, P668, DOI 10.1016/j.tibtech.2012.09.007; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; Jehmlich N, 2010, NAT PROTOC, V5, P1957, DOI 10.1038/nprot.2010.166; JOHNSON RS, 1988, INT J MASS SPECTROM, V86, P137, DOI 10.1016/0168-1176(88)80060-0; Koubaa M, 2012, ANAL BIOCHEM, V425, P183, DOI 10.1016/j.ab.2012.03.020; Kruger NJ, 2012, J EXP BOT, V63, P2309, DOI 10.1093/jxb/err382; Lee CP, 2012, J PROTEOME RES, V11, P3326, DOI 10.1021/pr3001157; Libourel IGL, 2006, PLANT PHYSIOL, V142, P1710, DOI 10.1104/pp.106.088898; Lonien J, 2009, PLANT PHYSIOL, V151, P1617, DOI 10.1104/pp.109.144121; Mandy DE, 2014, PLANT J, V77, P476, DOI 10.1111/tpj.12390; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Marco-Urrea E, 2012, J BACTERIOL, V194, P4169, DOI 10.1128/JB.00049-12; Martin SF, 2012, J PROTEOME RES, V11, P476, DOI 10.1021/pr2009302; Masakapalli SK, 2013, PLANT J, V74, P569, DOI 10.1111/tpj.12142; Nelson CJ, 2013, J PROTEOME RES, V12, P3449, DOI 10.1021/pr400304r; Oikawa A, 2011, PLANT PHYSIOL, V157, P544, DOI 10.1104/pp.111.183772; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PATTERSON BW, 1993, BIOL MASS SPECTROM, V22, P518, DOI 10.1002/bms.1200220905; Truong Q, 2013, J EXP BOT, V64, P2985, DOI 10.1093/jxb/ert138; RATCLIFFE RG, 1994, ADV BOT RES, V20, P43, DOI 10.1016/S0065-2296(08)60215-3; Rolletschek H, 2011, PLANT CELL, V23, P3041, DOI 10.1105/tpc.111.087015; Rosman KJR, 1998, PURE APPL CHEM, V70, P217, DOI 10.1351/pac199870010217; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shachar-Hill Y, 2013, CURR OPIN BIOTECH, V24, P247, DOI 10.1016/j.copbio.2013.01.004; Sobott F, 2009, J AM SOC MASS SPECTR, V20, P1652, DOI 10.1016/j.jasms.2009.04.023; Sriram G, 2007, METAB ENG, V9, P442, DOI 10.1016/j.ymben.2007.07.003; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Stitt M, 2013, CURR OPIN PLANT BIOL, V16, P381, DOI 10.1016/j.pbi.2013.02.012; STOCKING CR, 1959, PLANT PHYSIOL, V34, P56, DOI 10.1104/pp.34.1.56; Sweetlove LJ, 2013, ANNU REV PLANT BIOL, V64, P723, DOI 10.1146/annurev-arplant-050312-120233; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Taubert M, 2011, PROTEOMICS, V11, P2265, DOI 10.1002/pmic.201000788; THOMPSON JF, 1977, ANN BOT-LONDON, V41, P29, DOI 10.1093/oxfordjournals.aob.a085281; Verboven P, 2013, NEW PHYTOL, V199, P936, DOI 10.1111/nph.12342; Yoon JM, 2013, ANNU REV CHEM BIOMOL, V4, P211, DOI 10.1146/annurev-chembioeng-061312-103320; Zhang Y, 2010, MOL CELL PROTEOMICS, V9, P780, DOI 10.1074/mcp.M900452-MCP200	74	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91537	10.1371/journal.pone.0091537	http://dx.doi.org/10.1371/journal.pone.0091537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626471	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300101
J	Kerr, JE; Abramian, JR; Dao, DHV; Rigney, TW; Fritz, J; Pham, T; Gay, I; Parthasarathy, K; Wang, BY; Zhang, WJ; Tribble, GD				Kerr, Jennifer E.; Abramian, Jared R.; Dao, Doan-Hieu V.; Rigney, Todd W.; Fritz, Jamie; Tan Pham; Gay, Isabel; Parthasarathy, Kavitha; Wang, Bing-yan; Zhang, Wenjian; Tribble, Gena D.			Genetic Exchange of Fimbrial Alleles Exemplifies the Adaptive Virulence Strategy of Porphyromonas gingivalis	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; FIMA GENOTYPES; MEMBRANE-VESICLES; EPITHELIAL-CELLS; PERIODONTITIS; INVOLVEMENT; INVASION; PREVALENCE; COMPONENTS; EXPRESSION	Porphyromonas gingivalis is a gram-negative anaerobic bacterium, a member of the human oral microbiome, and a proposed "keystone" pathogen in the development of chronic periodontitis, an inflammatory disease of the gingiva. P. gingivalis is a genetically diverse species, and is able to exchange chromosomal DNA between strains by natural competence and conjugation. In this study, we investigate the role of horizontal DNA transfer as an adaptive process to modify behavior, using the major fimbriae as our model system, due to their critical role in mediating interactions with the host environment. We show that P. gingivalis is able to exchange fimbrial allele types I and IV into four distinct strain backgrounds via natural competence. In all recombinants, we detected a complete exchange of the entire fimA allele, and the rate of exchange varies between the different strain backgrounds. In addition, gene exchange within other regions of the fimbrial genetic locus was identified. To measure the biological implications of these allele swaps we compared three genotypes of fimA in an isogenic background, strain ATCC 33277. We demonstrate that exchange of fimbrial allele type results in profound phenotypic changes, including the quantity of fimbriae elaborated, membrane blebbing, auto-aggregation and other virulence-associated phenotypes. Replacement of the type I allele with either the type III or IV allele resulted in increased invasion of gingival fibroblast cells relative to the isogenic parent strain. While genetic variability is known to impact host-microbiome interactions, this is the first study to quantitatively assess the adaptive effect of exchanging genes within the pan genome cloud. This is significant as it presents a potential mechanism by which opportunistic pathogens may acquire the traits necessary to modify host-microbial interactions.	[Kerr, Jennifer E.; Abramian, Jared R.; Dao, Doan-Hieu V.; Rigney, Todd W.; Fritz, Jamie; Tan Pham; Gay, Isabel; Parthasarathy, Kavitha; Wang, Bing-yan; Tribble, Gena D.] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont & Dent Hyg, Houston, TX 77030 USA; [Zhang, Wenjian] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Tribble, GD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont & Dent Hyg, Houston, TX 77030 USA.	gena.d.tribble@uth.tmc.edu	Tribble, Gena/A-8755-2011	Tribble, Gena/0000-0002-6468-2851; Kerr, Jennifer/0000-0002-3946-449X	Public Health Service from the National Institute for Dental and Craniofacial Research [DE-019634]; High Resolution Electron Microscopy Facility, UTMDACC [CA16672]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019634] Funding Source: NIH RePORTER	Public Health Service from the National Institute for Dental and Craniofacial Research; High Resolution Electron Microscopy Facility, UTMDACC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Public Health Service grant DE-019634 from the National Institute for Dental and Craniofacial Research to G.D.T., http://www.nidcr.nih.gov, and Institutional Core Grant #CA16672 High Resolution Electron Microscopy Facility, UTMDACC, http://www.mdanderson.org/education-andresearch/resources-for-professionals/scientific-resources/core-facilities-and-services/high-resolution-electron-microscopy-facility/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; Beikler T, 2003, EUR J ORAL SCI, V111, P390, DOI 10.1034/j.1600-0722.2003.00065.x; Bentley S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/nrmicro2123; Choi YS, 2012, FEMS IMMUNOL MED MIC, V65, P497, DOI 10.1111/j.1574-695X.2012.00955.x; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Davila-Perez C, 2007, J CLIN PERIODONTOL, V34, P25, DOI 10.1111/j.1600-051X.2006.01011.x; Enersen M., 2011, J ORAL MICROBIOL, V3, P8487, DOI [10.3402/jom.v3i0.8487, DOI 10.3402/J0M.V3I0.8487]; Enersen M, 2008, J CLIN MICROBIOL, V46, P31, DOI 10.1128/JCM.00986-07; Frandsen EVG, 2001, INFECT IMMUN, V69, P4479, DOI 10.1128/IAI.69.7.4479-4485.2001; Fujise O, 2005, J PERIODONTOL, V76, P1661, DOI 10.1902/jop.2005.76.10.1661; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Handfield M, 2008, J DENT RES, V87, P203, DOI 10.1177/154405910808700302; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; Perez-Chaparro PJ, 2009, BIOMEDICA, V29, P298; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kato T, 2007, CELL MICROBIOL, V9, P753, DOI 10.1111/j.1462-5822.2006.00825.x; Koehler A, 2003, MICROBIOL-SGM, V149, P2407, DOI 10.1099/mic.0.26267-0; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; LEE JY, 1991, INFECT IMMUN, V59, P383, DOI 10.1128/IAI.59.1.383-389.1991; Lo A, 2010, J BACTERIOL, V192, P1332, DOI 10.1128/JB.01211-09; LOOS BG, 1993, INFECT IMMUN, V61, P204, DOI 10.1128/IAI.61.1.204-212.1993; Love RM, 2000, INFECT IMMUN, V68, P1359, DOI 10.1128/IAI.68.3.1359-1365.2000; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Missailidis CG, 2004, ORAL MICROBIOL IMMUN, V19, P224, DOI 10.1111/j.1399-302X.2004.00140.x; Miura M, 2005, J PERIODONTAL RES, V40, P147, DOI 10.1111/j.1600-0765.2005.00779.x; Nagano K, 2013, MOL ORAL MICROBIOL, V28, P392, DOI 10.1111/omi.12032; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Naito M, 2011, MICROBIOL-SGM, V157, P2022, DOI 10.1099/mic.0.047803-0; Nakano K, 2008, ORAL MICROBIOL IMMUN, V23, P170, DOI 10.1111/j.1399-302X.2007.00406.x; Nakano K, 2004, ORAL MICROBIOL IMMUN, V19, P205, DOI 10.1111/j.0902-0055.2004.00133.x; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishikawa K, 2004, MOL MICROBIOL, V54, P546, DOI 10.1111/j.1365-2958.2004.04291.x; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Onoe T, 1995, MICROB PATHOGENESIS, V19, P351, DOI 10.1016/S0882-4010(96)80006-4; Pierce DL, 2009, INFECT IMMUN, V77, P3294, DOI 10.1128/IAI.00262-09; Rocas IN, 2010, ORAL SURG ORAL MED O, V109, P474, DOI 10.1016/j.tripleo.2009.11.009; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; TAKAHASHI Y, 1992, J PERIODONTAL RES, V27, P599, DOI 10.1111/j.1600-0765.1992.tb01742.x; Teixeira SRL, 2009, J CLIN PERIODONTOL, V36, P482, DOI 10.1111/j.1600-051X.2009.01411.x; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Tribble GD, 2007, J BACTERIOL, V189, P6382, DOI 10.1128/JB.00460-07; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; van der Ploeg JR, 2004, FEMS MICROBIOL LETT, V232, P31, DOI 10.1016/S0378-1097(04)00064-3; Wang QA, 2010, J ENDODONT, V36, P1790, DOI 10.1016/j.joen.2010.08.018; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; Wong C, 2012, MBIO, DOI [10.1128/mBio.00231-11, DOI 10.1128/MBI0.00231-11]; Xia QW, 2007, PROTEOMICS, V7, P4323, DOI 10.1002/pmic.200700543; Xie H, 2000, INFECT IMMUN, V68, P6574, DOI 10.1128/IAI.68.12.6574-6579.2000; Xie HA, 1997, INFECT IMMUN, V65, P2265, DOI 10.1128/IAI.65.6.2265-2271.1997; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; YOSHIMURA F, 1993, INFECT IMMUN, V61, P5181, DOI 10.1128/IAI.61.12.5181-5189.1993; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; Zhang W, 2011, J PERIODONTOL, V82, P909, DOI 10.1902/jop.2010.100501; Zhang WJ, 2010, MICROBES INFECT, V12, P838, DOI 10.1016/j.micinf.2010.05.011; Zhao L, 2007, J PERIODONTAL RES, V42, P511, DOI 10.1111/j.1600-0765.2007.00975.x; Zhou L, 1998, FEMS MICROBIOL LETT, V163, P223, DOI 10.1111/j.1574-6968.1998.tb13049.x	74	17	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91696	10.1371/journal.pone.0091696	http://dx.doi.org/10.1371/journal.pone.0091696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626479	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300123
J	Ekert, JE; Johnson, K; Strake, B; Pardinas, J; Jarantow, S; Perkinson, R; Colter, DC				Ekert, Jason E.; Johnson, Kjell; Strake, Brandy; Pardinas, Jose; Jarantow, Stephen; Perkinson, Robert; Colter, David C.			Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro - Implication for Drug Development	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; C-MET ANTIBODY; CANCER-CELLS; MULTICELLULAR SPHEROIDS; ERLOTINIB RESISTANCE; KINASE INHIBITORS; ANTICANCER DRUGS; PROSTATE-CANCER; CARCINOMA-CELLS; CROSS-TALK	Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular models that better mimic physiologic tissues. Spheroids are one such 3D model where clusters of cells will undergo self-assembly to form viable, 3D tumor-like structures. However, to date little is known about how spheroid biology compares to that of the more traditional and widely utilized 2D monolayer cultures. Therefore, the goal of this study was to characterize the phenotypic and functional differences between lung tumor cells grown as 2D monolayer cultures, versus cells grown as 3D spheroids. Eight lung tumor cell lines, displaying varying levels of epidermal growth factor receptor (EGFR) and cMET protein expression, were used to develop a 3D spheroid cell culture model using low attachment U-bottom plates. The 3D spheroids were compared with cells grown in monolayer for 1) EGFR and cMET receptor expression, as determined by flow cytometry, 2) EGFR and cMET phosphorylation by MSD assay, and 3) cell proliferation in response to epidermal growth factor (EGF) and hepatocyte growth factor (HGF). In addition, drug responsiveness to EGFR and cMET inhibitors (Erlotinib, Crizotinib, Cetuximab [Erbitux] and Onartuzumab [MetMab]) was evaluated by measuring the extent of cell proliferation and migration. Data showed that EGFR and cMET expression is reduced at day four of untreated spheroid culture compared to monolayer. Basal phosphorylation of EGFR and cMET was higher in spheroids compared to monolayer cultures. Spheroids showed reduced EGFR and cMET phosphorylation when stimulated with ligand compared to 2D cultures. Spheroids showed an altered cell proliferation response to HGF, as well as to EGFR and cMET inhibitors, compared to monolayer cultures. Finally, spheroid cultures showed exceptional utility in a cell migration assay. Overall, the 3D spheroid culture changed the cellular response to drugs and growth factors and may more accurately mimic the natural tumor microenvironment.	[Ekert, Jason E.; Pardinas, Jose; Jarantow, Stephen; Perkinson, Robert; Colter, David C.] Janssen R&D LLC, Biotechnol Ctr Excellence, Biol Res, Spring House, PA USA; [Johnson, Kjell] Arbor Analyt LLC, Ann Arbor, MI USA	Johnson & Johnson; Janssen Pharmaceuticals	Ekert, JE (corresponding author), Janssen R&D LLC, Biotechnol Ctr Excellence, Biol Res, Spring House, PA USA.	jekert@its.jnj.com			Janssen RD	Janssen RD	This research was supported by Janssen R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Albrecht C, 2009, INT J MOL MED, V23, P347, DOI 10.3892/ijmm_00000138; Arrondeau J, 2010, DISCOV MED, V10, P355; BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Burga LN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2850; Castoldi R, 2013, ONCOGENE; Catros S, 2012, TISSUE ENG PART C-ME, V18, P62, DOI [10.1089/ten.tec.2011.0382, 10.1089/ten.TEC.2011.0382]; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; David L, 2008, ACTA BIOMATER, V4, P256, DOI 10.1016/j.actbio.2007.08.012; de Castro DG, 2013, CLIN PHARMACOL THER, V93, P252, DOI 10.1038/clpt.2012.237; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Garay T, 2013, EXP CELL RES, V319, P3094, DOI 10.1016/j.yexcr.2013.08.018; Graveel CR, 2013, COLD SPRING HARB PER, V5; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ho WJ, 2010, CANCER SCI, V101, P2637, DOI 10.1111/j.1349-7006.2010.01723.x; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kim SH, 2009, ARCH PHARM RES, V32, P915, DOI 10.1007/s12272-009-1614-2; Kiss DL, 2013, CYTOKINE, V64, P122, DOI 10.1016/j.cyto.2013.07.012; Kola I, 2008, CLIN PHARMACOL THER, V83, P227, DOI 10.1038/sj.clpt.6100479; Kurtze I, 2011, ONCOL REP, V25, P1021, DOI 10.3892/or.2011.1160; Lama R, 2013, BIOORGAN MED CHEM, V21, P922, DOI 10.1016/j.bmc.2012.12.007; Li QW, 2010, J PHARMACOL EXP THER, V332, P821, DOI 10.1124/jpet.109.160390; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Liu TF, 2003, CANCER RES, V63, P1834; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0; Miyamoto M, 2011, BRIT J CANCER, V105, P131, DOI 10.1038/bjc.2011.199; Moritz W, 2011, EFFECTIVE DETERMINAT; Nakagawa T, 2012, MOL CANCER THER, V11, P2149, DOI 10.1158/1535-7163.MCT-12-0195; Nedergaard MK, 2012, BIODRUGS, V26, P83, DOI 10.2165/11599760-000000000-00000; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Phung YT, 2011, J CANCER, V2, P507, DOI 10.7150/jca.2.507; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Puri Neelu, 2008, J Carcinog, V7, P9; Schulte A, 2013, NEUROONCOL; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Spigel DR, 2011, J CLIN ONCOL, V29, P2582, DOI 10.1200/JCO.2010.30.7678; Sun R, 2012, ONCOL LETT, V3, P1124, DOI 10.3892/ol.2012.613; Sundstrom L, 2012, EXPERT OPIN DRUG DIS, V7, P525, DOI 10.1517/17460441.2012.686488; Surati M, 2011, EXPERT OPIN BIOL TH, V11, P1655, DOI 10.1517/14712598.2011.626762; Takata M, 2012, CANCER BIOL THER, V13, P369, DOI 10.4161/cbt.19238; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Vinci Maria, 2013, Methods Mol Biol, V986, P253, DOI 10.1007/978-1-62703-311-4_16; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Windus LCE, 2012, EXP CELL RES, V318, P2507, DOI 10.1016/j.yexcr.2012.07.013; Workman P, 2011, CANCER CELL, V19, P437, DOI 10.1016/j.ccr.2011.03.020; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; Yamada T, 2012, CLIN CANCER RES, V18, P3592, DOI 10.1158/1078-0432.CCR-11-2972; Yamada T, 2012, J THORAC ONCOL, V7, P272, DOI 10.1097/JTO.0b013e3182398e69; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	70	104	105	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92248	10.1371/journal.pone.0092248	http://dx.doi.org/10.1371/journal.pone.0092248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638075	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100133
J	Gramer, BM; Martinez, PD; Chin, AS; Sylvestre, MP; Larrivee, S; Stevens, LM; Noiseux, N; Soulez, G; Rummeny, EJ; Chartrand-Lefebvre, C				Gramer, Bettina M.; Martinez, Patricia Diez; Chin, Anne S.; Sylvestre, Marie-Pierre; Larrivee, Sandra; Stevens, Louis-Mathieu; Noiseux, Nicolas; Soulez, Gilles; Rummeny, Ernst J.; Chartrand-Lefebvre, Carl			256-Slice CT Angiographic Evaluation of Coronary Artery Bypass Grafts: Effect of Heart Rate, Heart Rate Variability and Z-Axis Location on Image Quality	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; DIAGNOSTIC-ACCURACY; NONINVASIVE ASSESSMENT; MAGNETIC-RESONANCE; AMERICAN-COLLEGE; TASK-FORCE; PERFORMANCE; PATENCY; SURGERY; INTERVENTIONS	Purpose: The objective of this study is to assess the effect of heart rate, heart rate variability and z-axis location on coronary artery bypass graft (CABG) image quality using a 256-slice computed tomography (CT) scanner. Methods: A total of 78 patients with 254 CABG (762 graft segments) were recruited to undergo CABG assessment with 256-slice CT and prospective ECG-gating. Two observers rated graft segments for image quality on a 5-point scale. Quantitative measurements were also made. Logistic and cumulative link mixed models were used to assess the predictors of graft image quality. Results: Graft image quality was judged as diagnostic (scores 5 (excellent), 4 (good) and 3 (moderate)) in 96.6% of the 762 segments. Interobserver agreement was excellent (kappa >= 0.90). Graft image quality was not affected by heart rate level. However, high heart rate variability was associated with an important and significant image quality deterioration (odds ratio 4.31; p = 0.036). Distal graft segments had significantly lower image quality scores than proximal segments (p <= 0.02). Significantly higher noise was noted at the origin of the mammary grafts (p = 0.001), owing to streak artifacts from the shoulders. Conclusion: CABG imaging with 270-msec rotation 256-slice CT and prospective ECG-gating showed an adequate image quality in 96.6% of graft segments, and an excellent interobserver agreement. Graft image quality was not influenced by heart rate level. Image quality scores were however significantly decreased in patients with high heart rate variability, as well as in distal graft segments, which are closer to the heart.	[Gramer, Bettina M.; Martinez, Patricia Diez; Chin, Anne S.; Soulez, Gilles; Chartrand-Lefebvre, Carl] Univ Montreal Med Ctr CHUM, Montreal, PQ, Canada; [Gramer, Bettina M.; Sylvestre, Marie-Pierre; Larrivee, Sandra; Stevens, Louis-Mathieu; Noiseux, Nicolas; Soulez, Gilles; Chartrand-Lefebvre, Carl] Univ Montreal Med Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada; [Gramer, Bettina M.; Rummeny, Ernst J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany; [Sylvestre, Marie-Pierre] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Stevens, Louis-Mathieu; Noiseux, Nicolas] Univ Montreal, CHUM, Montreal, PQ, Canada; [Stevens, Louis-Mathieu; Noiseux, Nicolas] CRCHUM, Montreal, PQ, Canada	Universite de Montreal; Technical University of Munich; Universite de Montreal; Universite de Montreal; Universite de Montreal	Chartrand-Lefebvre, C (corresponding author), Univ Montreal Med Ctr CHUM, Montreal, PQ, Canada.	chartrandlef@videotron.ca	Stevens, Louis-Mathieu/E-6453-2016; Chartrand-Lefebvre, Carl/G-1260-2015; Soulez, Gilles/F-2834-2013; Sylvestre, Marie-Pierre/CAF-5219-2022	Stevens, Louis-Mathieu/0000-0003-3372-3419; Chartrand-Lefebvre, Carl/0000-0002-2299-7855; Sylvestre, Marie-Pierre/0000-0001-5803-4615; soulez, gilles/0000-0002-5566-3552	state of Bavaria, Germany; University of Montreal, Department of Radiology	state of Bavaria, Germany; University of Montreal, Department of Radiology	This work was supported by an academic grant from the state of Bavaria, Germany, and a grant from the University of Montreal, Department of Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders K, 2006, EUR J RADIOL, V57, P336, DOI 10.1016/j.ejrad.2005.12.018; BOURASSA MG, 1985, CIRCULATION, V72, P71; Brodoefel H, 2008, RADIOLOGY, V247, P346, DOI 10.1148/radiol.2472070906; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; de Graaf FR, 2011, EUR RADIOL, V21, P2285, DOI 10.1007/s00330-011-2192-5; Dewey M, 2006, ANN INTERN MED, V145, P407, DOI 10.7326/0003-4819-145-6-200609190-00004; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Feuchtner GM, 2007, AM J ROENTGENOL, V189, P574, DOI 10.2214/AJR.07.2174; Goetti R, 2010, INVEST RADIOL, V45, P324, DOI 10.1097/RLI.0b013e3181dfa47e; Hamon M, 2008, RADIOLOGY, V247, P679, DOI 10.1148/radiol.2473071132; Lee JH, 2011, INT J CARDIOVAS IMAG, V27, P657, DOI 10.1007/s10554-011-9904-4; Lee YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049212; Leschka S, 2008, AM J ROENTGENOL, V190, P1583, DOI 10.2214/AJR.07.2000; Leschka S, 2006, RADIOLOGY, V241, P378, DOI 10.1148/radiol.2412051384; Marano R, 2004, EUR RADIOL, V14, P1353, DOI 10.1007/s00330-004-2323-3; Meyer TS, 2007, J AM COLL CARDIOL, V49, P946, DOI 10.1016/j.jacc.2006.10.066; Moller CH, 2010, SCAND CARDIOVASC J, V44, P161, DOI 10.3109/14017430903556286; Muenzel D, 2011, EUR RADIOL, V21, P2277, DOI 10.1007/s00330-011-2185-4; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; R Development Core Team, 2012, R LANG ENV STAT COMP; Ropers D, 2006, CIRCULATION, V114, P2334, DOI 10.1161/CIRCULATIONAHA.106.631051; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Schlosser T, 2004, J AM COLL CARDIOL, V44, P1224, DOI 10.1016/j.jacc.2003.09.075; Schonenberger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000246; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Tremblay JA, 2013, EUR J CARDIO-THORAC, V44, pE302, DOI 10.1093/ejcts/ezt388; Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6; Viera AJ, 2005, FAM MED, V37, P360; Weustink AC, 2009, JACC-CARDIOVASC IMAG, V2, P816, DOI 10.1016/j.jcmg.2009.02.010; Willmann JK, 2004, RADIOLOGY, V232, P568, DOI 10.1148/radiol.2322030788; Wintersperger BJ, 2006, INVEST RADIOL, V41, P436, DOI 10.1097/01.rli.0000202639.99949.c6; Yee TW, 2010, J STAT SOFTW, V32, P1	32	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91861	10.1371/journal.pone.0091861	http://dx.doi.org/10.1371/journal.pone.0091861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637891	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100071
J	Kotilainen, H; Lokki, ML; Paakkanen, R; Seppanen, M; Tukiainen, P; Meri, S; Poussa, T; Eskola, J; Valtonen, V; Jarvinen, A				Kotilainen, Hannele; Lokki, Marja-Liisa; Paakkanen, Riitta; Seppanen, Mikko; Tukiainen, Pentti; Meri, Seppo; Poussa, Tuija; Eskola, Jussi; Valtonen, Ville; Jarvinen, Asko			Complement C4 Deficiency - A Plausible Risk Factor for Non-Tuberculous Mycobacteria (NTM) Infection in Apparently Immunocompetent Patients	PLOS ONE			English	Article							PULMONARY-DISEASE; INTERFERON-GAMMA; AVIUM-COMPLEX; SUSCEPTIBILITY; IMMUNITY; DEFECTS; BODY	Background: Non-tuberculous mycobacteria (NTM) are ubiquitous in the environment and they infect mainly persons with underlying pulmonary diseases but also previously healthy elderly women. Defects in host resistance that lead to pulmonary infections by NTM are relatively unknown. A few genetic defects have been associated with both pulmonary and disseminated mycobacterial infections. Rare disseminated NTM infections have been associated with genetic defects in T-cell mediated immunity and in cytokine signaling in families. We investigated whether there was an association between NTM infections and deficiencies of complement components C4A or C4B that are encoded by major histocompatibility complex (MHC). Methods: 50 adult patients with a positive NTM culture with symptoms and findings of a NTM disease were recruited. Patients' clinical history was collected and symptoms and clinical findings were categorized according to 2007 diagnostic criteria of The American Thoracic Society (ATS). To investigate the deficiencies of complement, C4A and C4B gene copy numbers and phenotype frequencies of the C4 allotypes were analyzed. Unselected, healthy, 149 Finnish adults were used as controls. Results: NTM patients had more often C4 deficiencies (C4A or C4B) than controls (36/50 [72%] vs 83/149 [56%], OR = 2.05, 95%CI = 1.019-4.105, p = 0.042). C4 deficiencies for female NTM patients were more common than for controls (29/36 [81%] vs 55/100 [55%], OR = 3.39, 95% CI = 1.358-8.460, p = 0.007). C4 deficiences seemed not to be related to any specific underlying disease or C4 phenotype. Conclusions: C4 deficiency may be a risk factor for NTM infection in especially elderly female patients.	[Kotilainen, Hannele; Seppanen, Mikko; Valtonen, Ville; Jarvinen, Asko] Univ Helsinki, Cent Hosp, Div Infect Dis, Dept Med, Helsinki, Finland; [Lokki, Marja-Liisa; Paakkanen, Riitta] Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; [Paakkanen, Riitta] Univ Helsinki, Cent Hosp, Div Cardiol, Dept Med, Helsinki, Finland; [Tukiainen, Pentti] Univ Helsinki, Cent Hosp, Div Lung Dis, Dept Med, Helsinki, Finland; [Meri, Seppo] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Eskola, Jussi] Univ Helsinki, Cent Hosp Lab, Mycobacteriol Unit, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Kotilainen, H (corresponding author), Univ Helsinki, Cent Hosp, Div Infect Dis, Dept Med, Helsinki, Finland.	hannele.kotilainen@hus.fi		Seppanen, Mikko/0000-0001-9733-3650; Meri, Seppo/0000-0001-9142-501X	Finnish Lung Health Association (FILHA)	Finnish Lung Health Association (FILHA)	This study was financially supported by a research grant from the Finnish Lung Health Association (FILHA), which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Colombo RE, 2010, CHEST, V137, P629, DOI 10.1378/chest.09-1173; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Fernando SL, 2006, IMMUNOL CELL BIOL, V84, P125, DOI 10.1111/j.1440-1711.2006.01420.x; Field SK, 2004, CHEST, V126, P566, DOI 10.1378/chest.126.2.566; Fowler CJ, 2013, AM J RESP CRIT CARE, V187, P1374, DOI 10.1164/rccm.201212-2197OC; Guide SV, 2002, INFECT DIS CLIN N AM, V16, P163, DOI 10.1016/S0891-5520(03)00051-5; Haverkamp MH, 2006, MICROBES INFECT, V8, P1157, DOI 10.1016/j.micinf.2005.10.029; Holland SM, 2001, AM J MED SCI, V321, P49, DOI 10.1097/00000441-200101000-00008; ISEMAN MD, 1991, AM REV RESPIR DIS, V144, P914, DOI 10.1164/ajrccm/144.4.914; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Kartalija M, 2013, AM J RESP CRIT CARE, V187, P197, DOI 10.1164/rccm.201206-1035OC; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; Koh WJ, 2005, CHEST, V128, P94, DOI 10.1378/chest.128.1.94; Kotilainen H, 2011, SCAND J INFECT DIS, V43, P188, DOI 10.3109/00365548.2010.535558; Maliwan N, 2005, POSTGRAD MED J, V81, P530, DOI 10.1136/pgmj.2004.026229; Piersimoni C, 2008, LANCET INFECT DIS, V8, P323, DOI 10.1016/S1473-3099(08)70100-2; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; Senbagavalli P, 2011, HUM IMMUNOL, V72, P173, DOI 10.1016/j.humimm.2010.11.002; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; Yuliwulandari R, 2010, HUM IMMUNOL, V71, P697, DOI 10.1016/j.humimm.2010.04.005	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91450	10.1371/journal.pone.0091450	http://dx.doi.org/10.1371/journal.pone.0091450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638111	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100035
J	Lo, YL; Liu, Y				Lo, Yu-Li; Liu, Yu			Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides	PLOS ONE			English	Article							INDUCED APOPTOSIS; P-GLYCOPROTEIN; DRUG-DELIVERY; IN-VITRO; CANCER; EXPRESSION; CELLS; BCL-2; EPIRUBICIN; INDUCTION	Multidrug resistance (MDR) is a major impediment to chemotherapy. In the present study, we designed antisense oligonucleotides (ASOs) against MDR1, MDR-associated protein (MRP)1, MRP2, and/or BCL-2/BCL-xL to reverse MDR transporters and induce apoptosis, respectively. The cationic liposomes (100 nm) composed of N-[1-(2,3-dioleyloxy) propyl]-n, n, n-trimethylammonium chloride and dioleoyl phosphotidylethanolamine core surrounded by a polyethylene glycol (PEG) shell were prepared to carry ASOs and/or epirubicin, an antineoplastic agent. We aimed to simultaneously suppress efflux pumps, provoke apoptosis, and enhance the chemosensitivity of human colon adenocarcinoma Caco-2 cells to epirubicin. We evaluated encapsulation efficiency, particle size, cytotoxicity, intracellular accumulation, mRNA levels, cell cycle distribution, and caspase activity of these formulations. We found that PEGylated liposomal ASOs significantly reduced Caco-2 cell viability and thus intensified epirubicin-mediated apoptosis. These formulations also decreased the MDR1 promoter activity levels and enhanced the intracellular retention of epirubicin in Caco-2 cells. Epirubicin and ASOs in PEGylated liposomes remarkably decreased mRNA expression levels of human MDR1, MRP1, MRP2, and BCL-2. The combined treatments all significantly increased the mRNA expressions of p53 and BAX, and activity levels of caspase-3, -8, and -9. The formulation of epirubicin and ASOs targeting both pump resistance of MDR1, MRP1, and MRP2 and nonpump resistance of BCL-2/BCL-xL demonstrated more superior effect to all the other formulations used in this study. Our results provide a novel insight into the mechanisms by which PEGylated liposomal ASOs against both resistance types act as activators to epirubicin-induced apoptosis through suppressing MDR1, MRP1, and MRP2, as well as triggering intrinsic mitochondrial and extrinsic death receptor pathways. The complicated regulation of MDR highlights the necessity for a multifunctional approach using an effective delivery system, such as PEGylated liposomes, to carry epirubicin and ASOs as a potent nanomedicine for improving the clinical efficacy of chemotherapy.	[Lo, Yu-Li; Liu, Yu] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan	National University Tainan	Lo, YL (corresponding author), Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan.	yulilo@mail.nutn.edu.tw		Lo, Yu-Li/0000-0002-6548-3280	National Science Council of Taiwan [NSC 96-2320-B-024-002, NSC 102-2320-B-024-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The National Science Council of Taiwan (Grant No. NSC 96-2320-B-024-002 and NSC 102-2320-B-024-002) is gratefully acknowledged for financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altundag K, 2004, MED HYPOTHESES, V63, P823, DOI 10.1016/j.mehy.2004.03.026; Balcerczak E, 2010, INT J COLORECTAL DIS, V25, P1167, DOI 10.1007/s00384-010-0961-2; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Campone M, 2001, LEUKEMIA, V15, P1377, DOI 10.1038/sj.leu.2402222; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Dean NM, 2003, ONCOGENE, V22, P9087, DOI 10.1038/sj.onc.1207231; Falkson G., 1984, ADV ANTHRACYCLINE CH, P105; Haley B, 2008, UROL ONCOL-SEMIN ORI, V26, P57, DOI 10.1016/j.urolonc.2007.03.015; Harada T, 2003, CANCER SCI, V94, P394, DOI 10.1111/j.1349-7006.2003.tb01453.x; He T, 2013, COLORECTAL DIS, V15, P12, DOI 10.1111/j.1463-1318.2012.02919.x; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Liu D, 1995, BBA-BIOMEMBRANES, V1240, P277, DOI 10.1016/0005-2736(95)00184-0; Lo YL, 2008, EUR J PHARM SCI, V35, P52, DOI 10.1016/j.ejps.2008.06.003; Lo YI, 2003, J CONTROL RELEASE, V90, P37, DOI 10.1016/S0168-3659(03)00163-9; Lo YL, 2013, BIOMED PHARMACOTHER, V67, P261, DOI 10.1016/j.biopha.2012.12.002; Lo YL, 2013, INT J MOL SCI, V14, P158, DOI 10.3390/ijms14010158; Lo YL, 2012, TOXICOLOGY, V302, P221, DOI 10.1016/j.tox.2012.08.003; Makhey VD, 1998, PHARMACEUT RES, V15, P1160, DOI 10.1023/A:1011971303880; Marbeuf-Gueye C, 2000, EUR J PHARMACOL, V391, P207, DOI 10.1016/S0014-2999(00)00047-9; Marwick C, 1998, JAMA-J AM MED ASSOC, V280, P871, DOI 10.1001/jama.280.10.871; Men Y, 2011, INT J NANOMED, V6, P3125, DOI 10.2147/IJN.S24847; Miao ZH, 2003, INT J CANCER, V106, P108, DOI 10.1002/ijc.11174; Minko T, 2005, J CONTROL RELEASE, V105, P269, DOI 10.1016/j.jconrel.2005.03.019; Minko T, 2004, CURR DRUG TARGETS, V5, P389, DOI 10.2174/1389450043345443; Nakagawa O, 2010, J AM CHEM SOC, V132, P8848, DOI 10.1021/ja102635c; Pakunlu RI, 2006, J CONTROL RELEASE, V114, P153, DOI 10.1016/j.jconrel.2006.06.010; Perouzel E, 2003, BIOCONJUGATE CHEM, V14, P884, DOI 10.1021/bc034068q; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Ray RM, 2011, APOPTOSIS, V16, P35, DOI 10.1007/s10495-010-0538-0; Rayburn Elizabeth Rose, 2006, Expert Opin Emerg Drugs, V11, P337, DOI 10.1517/14728214.11.2.337; Ruefli A, 2002, CELL DEATH DIFFER, V9, P1266, DOI 10.1038/sj.cdd.4401081; Shabbits JA, 2003, MOL CANCER THER, V2, P805; Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164; Takane H, 2004, J PHARMACOL EXP THER, V311, P1179, DOI 10.1124/jpet.104.069724; Wang XF, 2007, LEUKEMIA RES, V31, P989, DOI 10.1016/j.leukres.2006.09.001; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; Yamanaka K, 2005, MOL CANCER THER, V4, P1689, DOI 10.1158/1535-7163.MCT-05-0064; Yamanaka K, 2006, BJU INT, V97, P1300, DOI 10.1111/j.1464-410X.2006.06147.x; Zhang W, 2011, BIOMATERIALS, V32, P5934, DOI 10.1016/j.biomaterials.2011.04.075; Zhou L, 2011, SURGERY, V150, P25, DOI 10.1016/j.surg.2010.12.010	43	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90180	10.1371/journal.pone.0090180	http://dx.doi.org/10.1371/journal.pone.0090180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637737	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100004
J	Mennella, JA; Finkbeiner, S; Lipchock, SV; Hwang, LD; Reed, DR				Mennella, Julie A.; Finkbeiner, Susana; Lipchock, Sarah V.; Hwang, Liang-Dar; Reed, Danielle R.			Preferences for Salty and Sweet Tastes Are Elevated and Related to Each Other during Childhood	PLOS ONE			English	Article							ORAL SENSORY PHENOTYPE; UNITED-STATES; BODY-FAT; SUGAR; CHILDREN; CONSUMPTION; ADOLESCENTS; REDUCTION; SENSATION; MARKER	Background: The present study aimed to determine if salty and sweet taste preferences in children are related to each other, to markers of growth, and to genetic differences. Methods: We conducted a 2-day, single-blind experimental study using the Monell two-series, forced-choice, pairedcomparison tracking method to determine taste preferences. The volunteer sample consisted of a racially/ethnically diverse group of children, 5-10 years of age (n = 108), and their mothers (n = 83). After excluding those mothers who did not meet eligibility and children who did not understand or comply with study procedures, the final sample was 101 children and 76 adults. The main outcome measures were most preferred concentration of salt in broth and crackers; most preferred concentration of sucrose in water and jelly; reported dietary intake of salty and sweet foods; levels of a bone growth marker; anthropometric measurements such as height, weight, and percent body fat; and TAS1R3 (sweet taste receptor) genotype. Results: Children preferred higher concentrations of salt in broth and sucrose in water than did adults, and for both groups, salty and sweet taste preferences were significantly and positively correlated. In children, preference measures were related to reported intake of sodium but not of added sugars. Children who were tall for their age preferred sweeter solutions than did those that were shorter and percent body fat was correlated with salt preference. In mothers but not in children, sweet preference correlated with TAS1R3 genotype. Conclusions and Relevance: For children, sweet and salty taste preferences were positively correlated and related to some aspects of real-world food intake. Complying with recommendations to reduce added sugars and salt may be more difficult for some children, which emphasizes the need for new strategies to improve children's diets.	[Mennella, Julie A.; Finkbeiner, Susana; Lipchock, Sarah V.; Hwang, Liang-Dar; Reed, Danielle R.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Mennella, JA (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	mennella@monell.org	Hwang, Liang-Dar/P-2722-2014	Hwang, Liang-Dar/0000-0002-5535-2199; Reed, Danielle/0000-0002-4374-6107; Mennella, Julie/0000-0002-8855-0204	Pennsylvania Tobacco Research Settlement Fund; Pennsylvania Department of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD37119]; National Institute on Deafness and Other Communication Disorders [R01DC011287, P30DC011735, T32DC000014, F32DC011975]; Institute for Translational Medicine and Therapeutics of the University of Pennsylvania (National Center for Research Resources grant) [UL1RR024134]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037119] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC011975, P30DC011735, R01DC011287, T32DC000014] Funding Source: NIH RePORTER	Pennsylvania Tobacco Research Settlement Fund; Pennsylvania Department of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Institute for Translational Medicine and Therapeutics of the University of Pennsylvania (National Center for Research Resources grant); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was funded by the the Pennsylvania Tobacco Research Settlement Fund, the Pennsylvania Department of Health, by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD37119), and by the National Institute on Deafness and Other Communication Disorders (R01DC011287, P30DC011735) awarded to JAM. SVL was supported by the National Institute on Deafness and Other Communication Disorders (T32DC000014, F32DC011975). The creatinine analysis was supported in part by the Institute for Translational Medicine and Therapeutics of the University of Pennsylvania (National Center for Research Resources grant number UL1RR024134 awarded to Garret A. Fitzgerald). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Institutes of Health, or the Pennsylvania Department of Health. The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	[Anonymous], CIT TRANSF RAC ETHN; Beauchamp GK, 1991, HEDONICS TASTE, P159; BERTINO M, 1982, AM J CLIN NUTR, V36, P1134, DOI 10.1093/ajcn/36.6.1134; BOLLEN AM, 1994, BONE, V15, P31, DOI 10.1016/8756-3282(94)90888-5; Bollen AM, 2000, ANN HUM BIOL, V27, P199, DOI 10.1080/030144600282307; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Cohen J., 2003, APPL MULTIPLE REGRES; Coldwell SE, 2009, PHYSIOL BEHAV, V96, P574, DOI 10.1016/j.physbeh.2008.12.010; Cowart BJ, 1990, PSYCHOL BASIS SENSOR, P1; DESOR JA, 1975, SCIENCE, V190, P686, DOI 10.1126/science.1188365; DESOR JA, 1987, PHYSIOL BEHAV, V39, P639, DOI 10.1016/0031-9384(87)90166-1; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; Ervin R Bethene, 2012, NCHS Data Brief, P1; Fushan AA, 2009, CURR BIOL, V19, P1288, DOI 10.1016/j.cub.2009.06.015; Green BG, 2013, CHEM SENSES, V38, P289, DOI 10.1093/chemse/bjt007; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; Hayes JE, 2008, PHYSIOL BEHAV, V95, P77, DOI 10.1016/j.physbeh.2008.04.023; Hayes JE, 2010, PHYSIOL BEHAV, V100, P369, DOI 10.1016/j.physbeh.2010.03.017; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; Henney JE, 2010, STRATEGIES TO REDUCE SODIUM INTAKE IN THE UNITED STATES, P1; Herman-Giddens ME, 2006, INT J ANDROL, V29, P241, DOI 10.1111/j.1365-2605.2005.00575.x; Jacobson MF, 2013, JAMA INTERN MED, V173, P1285, DOI 10.1001/jamainternmed.2013.6154; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Lapillonne A, 1996, J BONE MINER RES, V11, pS419; Mattes RD, 1997, AM J CLIN NUTR, V65, P692; Mattes RD, 2009, AM J CLIN NUTR, V89, P1, DOI 10.3945/ajcn.2008.26792; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; Mennella JA, 2012, INT J OBESITY, V36, P1285, DOI 10.1038/ijo.2012.51; Mennella JA, 2011, CHEM SENSES, V36, P345, DOI 10.1093/chemse/bjq134; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; National Cancer Institute Applied Research Program, 2010, US INT ADD SUG; OLIVERIA SA, 1992, AM J CLIN NUTR, V56, P593, DOI 10.1093/ajcn/56.3.593; Panel on Dietary Reference Intakes for Electrolytes and Water, 2005, DIET REF INT WAT POT; SCHULKIN J, 1991, PSYCHOBIOLOGY, V19, P116; STONE LJ, 1990, APPETITE, V15, P63, DOI 10.1016/0195-6663(90)90100-M; USDA, 2010, FOOD NUTR DAT DIET S; USDA Agricultural Research Service, 2012, SOD INT REASS 2007 2; Van Horn L, 2010, J AM DIET ASSOC, V110, P1638, DOI 10.1016/j.jada.2010.08.018; Yang LJ, 2006, CLIN BIOCHEM, V39, P561, DOI 10.1016/j.clinbiochem.2005.11.015; Zimmerman TP, 2009, J FOOD COMPOS ANAL, V22, pS48, DOI 10.1016/j.jfca.2009.02.003	44	88	88	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92201	10.1371/journal.pone.0092201	http://dx.doi.org/10.1371/journal.pone.0092201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637844	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100127
J	Morita, K; Shiraishi, S; Motoyama, N; Kitayama, T; Kanematsu, T; Uezono, Y; Dohi, T				Morita, Katsuya; Shiraishi, Seiji; Motoyama, Naoyo; Kitayama, Tomoya; Kanematsu, Takashi; Uezono, Yasuhito; Dohi, Toshihiro			Palliation of Bone Cancer Pain by Antagonists of Platelet-Activating Factor Receptors	PLOS ONE			English	Article							NEUROPATHIC PAIN; FACTOR PAF; SPINAL-CORD; TACTILE ALLODYNIA; MICE; METASTASIS; MORPHINE; OXYCODONE; GROWTH; CELLS	Bone cancer pain is the most severe among cancer pain and is often resistant to current analgesics. Thus, the development of novel analgesics effective at treating bone cancer pain are desired. Platelet-activating factor (PAF) receptor antagonists were recently demonstrated to have effective pain relieving effects on neuropathic pain in several animal models. The present study examined the pain relieving effect of PAF receptor antagonists on bone cancer pain using the femur bone cancer (FBC) model in mice. Animals were injected with osteolytic NCTC2472 cells into the tibia, and subsequently the effects of PAF receptor antagonists on pain behaviors were evaluated. Chemical structurally different type of antagonists, TCV-309, BN 50739 and WEB 2086 ameliorated the allodynia and improved pain behaviors such as guarding behavior and limb-use abnormalities in FBC model mice. The pain relieving effects of these antagonists were achieved with low doses and were long lasting. Blockade of spinal PAF receptors by intrathecal injection of TCV-309 and WEB 2086 or knockdown of the expression of spinal PAF receptor protein by intrathecal transfer of PAF receptor siRNA also produced a pain relieving effect. The amount of an inducible PAF synthesis enzyme, lysophosphatidylcholine acyltransferase 2 (LPCAT2) protein significantly increased in the spinal cord after transplantation of NCTC 2472 tumor cells into mouse tibia. The combination of morphine with PAF receptor antagonists develops marked enhancement of the analgesic effect against bone cancer pain without affecting morphine-induced constipation. Repeated administration of TCV-309 suppressed the appearance of pain behaviors and prolonged survival of FBC mice. The present results suggest that PAF receptor antagonists in combination with, or without, opioids may represent a new strategy for the treatment of persistent bone cancer pain and improve the quality of life of patients.	[Morita, Katsuya] Hiroshima Bunka Gakuen Univ, Fac Nursing, Dept Pharmacol, Hiroshima, Japan; [Morita, Katsuya; Shiraishi, Seiji; Motoyama, Naoyo; Uezono, Yasuhito] Div Natl Canc Ctr Res Inst, Tokyo, Japan; [Motoyama, Naoyo] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Integrated Hlth Sci, Dept Dent Sci Hlth Promot, Hiroshima, Japan; [Morita, Katsuya; Kitayama, Tomoya; Kanematsu, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cell & Mol Pharmacol, Div Basic Life Sci, Hiroshima, Japan; [Dohi, Toshihiro] Nihon Pharmaceut Univ, Dept Pharmacotherapy, Saitama, Japan	Hiroshima University; Hiroshima University	Dohi, T (corresponding author), Nihon Pharmaceut Univ, Dept Pharmacotherapy, Saitama, Japan.	t-dohi@nichiyaku.ac.jp	Shiraishi, Seiji/GPX-5566-2022		Japanese Society for Promotion of Sciences [22390349, 21592421, 24592798]; National Cancer Center Research and Development Fund [23-A-30]; Grants-in-Aid for Scientific Research [26670809] Funding Source: KAKEN	Japanese Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in Aid for Scientific Research (B) 22390349, (C) 21592421 and (C) 24592798 from the Japanese Society for Promotion of Sciences and by the National Cancer Center Research and Development Fund (23-A-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil H, 1998, DRUG ALCOHOL DEPEN, V51, P127, DOI 10.1016/S0376-8716(98)00071-4; Becker R, 2000, STEREOT FUNCT NEUROS, V75, P16, DOI 10.1159/000048379; Biancone L, 1999, AM J PATHOL, V155, P1731, DOI 10.1016/S0002-9440(10)65488-0; Bussolati B, 2002, INT J CANCER, V100, P654, DOI 10.1002/ijc.10545; Bussolati B, 2000, AM J PATHOL, V157, P1713, DOI 10.1016/S0002-9440(10)64808-0; BUSSOLINO F, 1995, J CLIN INVEST, V96, P940, DOI 10.1172/JCI118142; de Oliveira SI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-200; de Wit R, 2001, PAIN, V91, P339, DOI 10.1016/S0304-3959(00)00455-3; Dohi T, 2009, PHARMACOL THERAPEUT, V123, P54, DOI 10.1016/j.pharmthera.2009.03.018; Fallani A, 2002, PROSTAG OTH LIPID M, V70, P209, DOI 10.1016/S0090-6980(02)00109-0; Hasegawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010467; Honda Z, 2002, J BIOCHEM, V131, P773, DOI 10.1093/oxfordjournals.jbchem.a003164; Honore P, 2000, PAIN MED, V1, P303, DOI 10.1046/j.1526-4637.2000.00047.x; Im SY, 1996, CANCER RES, V56, P2662; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Li X, 2013, J PHYSIOL SCI, DOI [10.1007/s12576-D12-0244-5, DOI 10.1007/S12576-D12-0244-5]; LILLEMOE KD, 1993, ANN SURG, V217, P447, DOI 10.1097/00000658-199305010-00004; Luger NM, 2002, PAIN, V99, P397, DOI 10.1016/S0304-3959(02)00102-1; MAGGI M, 1994, CANCER RES, V54, P4777; Melnikova V, 2007, CANCER METAST REV, V26, P359, DOI 10.1007/s10555-007-9092-9; Minami K, 2009, J PHARMACOL SCI, V111, P60, DOI 10.1254/jphs.09139FP; MINAMI T, 1995, PAIN, V61, P285, DOI 10.1016/0304-3959(94)00183-F; Morita K, 2004, PAIN, V111, P351, DOI 10.1016/j.pain.2004.07.016; Morita K, 2008, PAIN, V138, P525, DOI 10.1016/j.pain.2008.01.030; Motoyama N, 2013, EUR J PAIN, V17, P1156, DOI 10.1002/j.1532-2149.2013.00289.x; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakamura A, 2013, BRIT J PHARMACOL, V168, P375, DOI 10.1111/j.1476-5381.2012.02139.x; Narita M, 2008, NEUROPSYCHOPHARMACOL, V33, P1097, DOI 10.1038/sj.npp.1301471; Okubo M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-8; Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8; Portenoy RK, 1999, LANCET, V353, P1695, DOI 10.1016/S0140-6736(99)01310-0; TERASHITA ZI, 1992, J PHARMACOL EXP THER, V260, P748; Tsoupras A. B., 2009, Infectious Disorders - Drug Targets, V9, P390; Yanagisawa Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-38; Yuan C-S, 2005, HDB OPIOID BOWEL SYN; Yuan CS, 2000, REGION ANESTH PAIN M, V25, P639, DOI 10.1053/rapm.2000.8658	36	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91746	10.1371/journal.pone.0091746	http://dx.doi.org/10.1371/journal.pone.0091746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637403	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100057
J	van Wouwe, JP; van Gameren-Oosterom, HBM; Verkerk, PH; van Dommelen, P; Fekkes, M				van Wouwe, Jacobus P.; van Gameren-Oosterom, Helma B. M.; Verkerk, Paul H.; van Dommelen, Paula; Fekkes, Minne			Mainstream and Special School Attendance among a Dutch Cohort of Children with Down Syndrome	PLOS ONE			English	Article							SKILLS	Object: To determine the level of mainstream education in a nationwide cohort of adolescents with Down Syndrome (DS), and to find characteristics related to mainstream or special school attendance. Method: Dutch children with DS born in 1992, 1993 or 1994, were assessed when 16-19 years old. Parents scored school enrolment between the age of 4-18 years, general characteristics and the levels of intellectual disability using the Dutch Social Competence Rating Scale. Associations between disability and years in mainstream school were assessed by ordinal logistic regression, adjusting for sex and parental education. Results: We collected data from 170 boys and 152 girls (response 63%); mean age 18.3 years (ranges 16.8-19.9). Intellectual disability was mostly moderate (43%). Most children (74%) entered mainstream education between 4 and 6 years of age. At 13 years 17% was in mainstream school and 7% stayed in up to 16 years. From the age of 8 years onwards the majority was in special education, while 6% never attended school. Girls were more often in mainstream school and stayed in longer. Level of disability was significantly associated with number of years in mainstream education. Conclusion: Three out of four Dutch children with DS entered mainstream primary education, however late entry and high dropout are common.	[van Wouwe, Jacobus P.; van Gameren-Oosterom, Helma B. M.; Verkerk, Paul H.; Fekkes, Minne] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands; [van Dommelen, Paula] Netherlands Org Appl Sci Res TNO, Dept Life Style, Leiden, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research	van Wouwe, JP (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands.	ko.vanwouwe@tno.nl	Van Wouwe, Jacobus P/D-5549-2018	Van Wouwe, Jacobus P/0000-0001-9273-6258	Nederlandse Stichting voor het Gehandicapte Kind (NSGK, Dutch Foundation for Disabled Children)	Nederlandse Stichting voor het Gehandicapte Kind (NSGK, Dutch Foundation for Disabled Children)	This study is financed by the Nederlandse Stichting voor het Gehandicapte Kind (NSGK, Dutch Foundation for Disabled Children). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley S, 2006, DOWN SYNDROME RES PR, V89, P54; Coppus AMW, 2008, NEUROBIOL AGING, V29, P828, DOI 10.1016/j.neurobiolaging.2006.12.013; Crombie MP, 1994, THESIS U QUEENSLAND; Cuckle P, 1999, Downs Syndr Res Pract, V6, P95, DOI 10.3104/reviews.100; De Bildt A., 2004, SOCIAL INDEPENDENCE; de Graaf G, 2013, J INTELL DISABIL RES, V57, P21, DOI 10.1111/j.1365-2788.2011.01512.x; De Graaf G, 2013, J INTELL DISABIL RES, DOI [10.1111/jir.12060, DOI 10.1111/JIR.12060.ACCESSED]; Dolva AS, 2007, AM J OCCUP THER, V61, P414, DOI 10.5014/ajot.61.4.414; Lightfoota L, 2013, EDUC PSYCHOL PRACT, V29, P163, DOI 10.1080/02667363.2013.800024; Turner S, 2008, J INTELL DISABIL RES, V52, P380, DOI 10.1111/j.1365-2788.2007.01038.x; van Gameren-Oosterom HBM, 2013, J PEDIATR-US, V163, P1396, DOI 10.1016/j.jpeds.2013.06.054; van Gameren-Oosterom HBM, 2012, PRENATAL DIAG, V32, P1035, DOI 10.1002/pd.3951; Van Gamereri-Oosterom HBM, 2013, RES DEV DISABIL, V34, P4599, DOI 10.1016/j.ridd.2013.09.041; Weijerman ME, 2010, EUR J PEDIATR, V169, P1445, DOI 10.1007/s00431-010-1253-0	14	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91737	10.1371/journal.pone.0091737	http://dx.doi.org/10.1371/journal.pone.0091737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24638156	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100056
J	Bartoszewski, R; Hering, A; Marszall, M; Hajduk, JS; Bartoszewska, S; Kapoor, N; Kochan, K; Ochocka, R				Bartoszewski, Rafal; Hering, Anna; Marszall, Marcin; Hajduk, Justyna Stefanowicz; Bartoszewska, Sylwia; Kapoor, Niren; Kochan, Kinga; Ochocka, Renata			Mangiferin Has an Additive Effect on the Apoptotic Properties of Hesperidin in Cyclopia sp. Tea Extracts	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; TIME PCR DATA; REAL-TIME; XCELLIGENCE SYSTEM; PROTEIN TRADD; RECEPTOR 1; ACTIVATION; PATHWAYS; GENE	A variety of biological pro-health activities have been reported for mangiferin and hesperidin, two major phenolic compounds of Honeybush (Cyclopia sp.) tea extracts. Given their increasing popularity, there is a need for understanding the mechanisms underlying the biological effects of these compounds. In this study, we used real-time cytotoxicity cellular analysis of the Cyclopia sp. extracts on HeLa cells and found that the higher hesperidin content in non-fermented "green" extracts correlated with their higher cytotoxicity compared to the fermented extracts. We also found that mangiferin had a modulatory effect on the apoptotic effects of hesperidin. Quantitative PCR analysis of hesperidin-induced changes in apoptotic gene expression profile indicated that two death receptor pathway members, TRADD and TRAMP, were up regulated. The results of this study suggest that hesperidin mediates apoptosis in HeLa cells through extrinsic pathway for programmed cell death.	[Bartoszewski, Rafal; Hering, Anna; Hajduk, Justyna Stefanowicz; Kochan, Kinga; Ochocka, Renata] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Bartoszewska, Sylwia] Med Univ Gdansk, Dept Inorgan Chem, Gdansk, Poland; [Kapoor, Niren] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Marszall, Marcin] Med Univ Gdansk, Dept Toxicol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Alabama System; University of Alabama Birmingham; Fahrenheit Universities; Medical University Gdansk	Bartoszewski, R (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland.	rafalbar@gumed.edu.pl	Bartoszewski, Rafal A/D-6311-2011; Bartoszewska, Sylwia/L-3922-2019	Bartoszewski, Rafal A/0000-0002-2864-6757; Bartoszewska, Sylwia/0000-0001-8063-1272; hering, anna/0000-0003-1060-5380	National Science Center KBN Programme [66991/B/P01/2011/40]	National Science Center KBN Programme	This work has been supported by National Science Center KBN Programme under contract 66991/B/P01/2011/40 (to RO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang E, 2011, J CELL BIOCHEM, V112, P89, DOI 10.1002/jcb.22800; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Crnkovic-Mertens I, 2003, ONCOGENE, V22, P8330, DOI 10.1038/sj.onc.1206973; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; du Plessis-Stoman D, 2011, AFR J TRADIT COMPLEM, V8, P177; Erskine CL, 2012, JOVE-J VIS EXP, DOI 10.3791/3683; Garg A, 2001, PHYTOTHER RES, V15, P655, DOI 10.1002/ptr.1074; Ghorbani A, 2012, EUR J NUTR, V51, P39, DOI 10.1007/s00394-011-0187-2; Ghosh M, 2012, FREE RADICAL RES, V46, P116, DOI 10.3109/10715762.2011.644240; Golke A, 2012, POL J VET SCI, V15, P151, DOI 10.2478/v10181-011-0126-4; Gong X, 2013, J NUTR BIOCHEM, V24, P1173, DOI 10.1016/j.jnutbio.2012.09.003; Guan N, 2013, MOL BIOSYST, V9, P1035, DOI 10.1039/c3mb25421f; Guha S, 1996, CHEMOTHERAPY, V42, P443, DOI 10.1159/000239478; Hellevik T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-59; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Joubert E, 2012, S AFR J BOT, V82, P113, DOI 10.1016/j.sajb.2012.07.019; Joubert E, 2003, EUR FOOD RES TECHNOL, V216, P270, DOI 10.1007/s00217-002-0644-5; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kamara BI, 2003, J AGR FOOD CHEM, V51, P3874, DOI 10.1021/jf0210730; KO FN, 1991, EUR J PHARMACOL, V192, P133; Kokotkiewicz A, 2012, Z NATURFORSCH C, V67, P65, DOI 10.5560/ZNC.2012.67c0065; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Leatherbarrow RJ, 2009, GRAFIT VERSION 7 7 0; Lee CJ, 2010, PHYTOTHER RES, V24, pS15, DOI 10.1002/ptr.2856; Lee KH, 2010, TOXICOL LETT, V194, P42, DOI 10.1016/j.toxlet.2010.01.021; Li HZ, 2013, TOXICOL APPL PHARM, V272, P180, DOI 10.1016/j.taap.2013.05.011; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Menkovic N, 2010, PHYTOTHER RES, V24, P1693, DOI 10.1002/ptr.3225; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Nandakumar N, 2011, BIOMED PREV NUTR, V1, P207; Nazari M, 2011, EUR J PHARMACOL, V650, P526, DOI 10.1016/j.ejphar.2010.10.053; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Pal PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056894; Park HJ, 2008, PHYTOMEDICINE, V15, P147, DOI 10.1016/j.phymed.2007.07.061; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Rajendran Peramaiyan, 2013, Int J Biomed Sci, V9, P68; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scrace S, 2013, METHODS MOL BIOL, V1046, P295, DOI 10.1007/978-1-62703-538-5_17; Shoji K, 2011, ARCH PHARM RES, V34, P469, DOI 10.1007/s12272-011-0316-8; TENG CM, 1989, BIOCHEM PHARMACOL, V38, P3791, DOI 10.1016/0006-2952(89)90587-X; Vanden Heuvel JP, 1999, TOXICOL SCI, V47, P1, DOI 10.1093/toxsci/47.1.1; Wang H, 2007, ACTA PHARMACOL SIN, V28, P1968, DOI 10.1111/j.1745-7254.2007.00724.x; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; Xia J, 2006, J PHARMACEUT BIOMED, V41, P1401, DOI 10.1016/j.jpba.2006.02.030; ZHENG MS, 1990, CHINESE MED J-PEKING, V103, P160	48	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92128	10.1371/journal.pone.0092128	http://dx.doi.org/10.1371/journal.pone.0092128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633329	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400145
J	Chernyavsky, IL; Croisier, H; Chapman, LAC; Kimpton, LS; Hiorns, JE; Brook, BS; Jensen, OE; Billington, CK; Hall, IP; Johnson, SR				Chernyavsky, Igor L.; Croisier, Huguette; Chapman, Lloyd A. C.; Kimpton, Laura S.; Hiorns, Jonathan E.; Brook, Bindi S.; Jensen, Oliver E.; Billington, Charlotte K.; Hall, Ian P.; Johnson, Simon R.			The Role of Inflammation Resolution Speed in Airway Smooth Muscle Mass Accumulation in Asthma: Insight from a Theoretical Model	PLOS ONE			English	Article							CELL-PROLIFERATION; GROWTH; HYPERRESPONSIVENESS; EXACERBATIONS; HYPERTROPHY; PHENOTYPE	Despite a large amount of in vitro data, the dynamics of airway smooth muscle (ASM) mass increase in the airways of patients with asthma is not well understood. Here, we present a novel mathematical model that describes qualitatively the growth dynamics of ASM cells over short and long terms in the normal and inflammatory environments typically observed in asthma. The degree of ASM accumulation can be explained by an increase in the rate at which ASM cells switch between non-proliferative and proliferative states, driven by episodic inflammatory events. Our model explores the idea that remodelling due to ASM hyperplasia increases with the frequency and magnitude of these inflammatory events, relative to certain sensitivity thresholds. It highlights the importance of inflammation resolution speed by showing that when resolution is slow, even a series of small exacerbation events can result in significant remodelling, which persists after the inflammatory episodes. In addition, we demonstrate how the uncertainty in long-term outcome may be quantified and used to design an optimal low-risk individual anti-proliferative treatment strategy. The model shows that the rate of clearance of ASM proliferation and recruitment factors after an acute inflammatory event is a potentially important, and hitherto unrecognised, target for anti-remodelling therapy in asthma. It also suggests new ways of quantifying inflammation severity that could improve prediction of the extent of ASM accumulation. This ASM growth model should prove useful for designing new experiments or as a building block of more detailed multi-cellular tissue-level models.	[Chernyavsky, Igor L.; Croisier, Huguette; Hiorns, Jonathan E.; Brook, Bindi S.] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England; [Chapman, Lloyd A. C.; Kimpton, Laura S.] Univ Oxford, Inst Math, Oxford OX1 3LB, England; [Jensen, Oliver E.] Univ Manchester, Sch Math, Manchester, Lancs, England; [Billington, Charlotte K.; Hall, Ian P.; Johnson, Simon R.] Univ Nottingham, Dept Therapeut & Mol Med, Nottingham NG7 2RD, England	University of Nottingham; University of Oxford; University of Manchester; University of Nottingham	Chernyavsky, IL (corresponding author), Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England.	Igor.Chernyavsky@nottingham.ac.uk	Brook, Bindi/O-6704-2016; Jensen, Oliver/B-5880-2008	Brook, Bindi/0000-0001-9883-4131; Jensen, Oliver/0000-0003-0172-6578; Hall, Ian/0000-0001-9933-3216; Johnson, Simon/0000-0002-9837-2763; Chernyavsky, Igor L./0000-0003-0284-9318; Chapman, Lloyd/0000-0001-7727-7102	AirPROM 7th European Framework Programme; Medical Research Council [G0901174]; National Centre for the Replacement, Refinement and Reduction of Animals in Research & EPSRC UK Research Council; MRC [G0400910, G0701390, G0901174] Funding Source: UKRI; Medical Research Council [G0400910, G0701390] Funding Source: researchfish; Asthma UK [05/007] Funding Source: researchfish	AirPROM 7th European Framework Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement, Refinement and Reduction of Animals in Research & EPSRC UK Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	AirPROM 7th European Framework Programme (www.airprom.eu; ILC), Medical Research Council New Investigator Grant G0901174 (www.mrc.ac.uk; BSB & HC), National Centre for the Replacement, Refinement and Reduction of Animals in Research & EPSRC UK Research Council (www.maths-in-medicine.org; all authors). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alkhouri H, 2011, ALLERGY, V66, P1231, DOI 10.1111/j.1398-9995.2011.02616.x; Allen JE, 2009, PULM PHARMACOL THER, V22, P455, DOI 10.1016/j.pupt.2009.04.001; Alrifai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085839; Baker M, 2011, MATH MODELLING AIRWA; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Bergeron C, 2005, J ALLERGY CLIN IMMUN, V116, P983, DOI 10.1016/j.jaci.2005.07.029; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brook BS, 2010, RESP PHYSIOL NEUROBI, V170, P44, DOI 10.1016/j.resp.2009.11.006; Byrne H, 2003, MATH MED BIOL, V20, P341; Contoli M, 2010, ALLERGY, V65, P141, DOI 10.1111/j.1398-9995.2009.02242.x; Dekkers BGJ, 2012, BRIT J PHARMACOL, V166, P359, DOI 10.1111/j.1476-5381.2011.01773.x; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Halayko AJ, 1999, AM J PHYSIOL-LUNG C, V276, pL197, DOI 10.1152/ajplung.1999.276.1.L197; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Kariyawasam HH, 2007, AM J RESP CRIT CARE, V175, P896, DOI 10.1164/rccm.200609-1260OC; Kaur D, 2010, CLIN EXP ALLERGY, V40, P279, DOI 10.1111/j.1365-2222.2009.03423.x; Leclere M, 2012, AM J RESP CELL MOL, V47, P589, DOI 10.1165/rcmb.2011-0363OC; Louis R, 2002, ALLERGY, V57, P907, DOI 10.1034/j.1398-9995.2002.23608.x; Markwick LJ, 2012, CLIN EXP ALLERGY, V42, P1040, DOI 10.1111/j.1365-2222.2012.04019.x; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; Moulton DE, 2011, J APPL PHYSIOL, V110, P1003, DOI 10.1152/japplphysiol.00991.2010; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Tattersfield AE, 1999, AM J RESP CRIT CARE, V160, P594, DOI 10.1164/ajrccm.160.2.9811100; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; Wegmann M, 2005, CLIN EXP ALLERGY, V35, P1263, DOI 10.1111/j.1365-2222.2005.02306.x	32	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90162	10.1371/journal.pone.0090162	http://dx.doi.org/10.1371/journal.pone.0090162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632688	Green Published, Green Accepted, gold			2022-12-27	WOS:000332858400010
J	Mi, H; Ho, SL; Lim, WK; Wong, EPY; Teoh, SC				Mi, Helen; Ho, Su L.; Lim, Wee K.; Wong, Elizabeth P. Y.; Teoh, Stephen C.			Trends in Patterns of Intermediate Uveitis in a Tertiary Institution in Singapore	PLOS ONE			English	Article							INTRAOCULAR INFLAMMATORY DISEASE; CLINICAL-FEATURES; REFERRAL CENTER; PARS PLANITIS; MULTIPLE-SCLEROSIS; CHANGING PATTERNS; TUBERCULOSIS; COMPLICATIONS	Purpose: The study aims to describe the characteristics and etiologic causes of intermediate uveitis (IU) patients seen by a tertiary eye center in Singapore over 8 years. Methods: This was a retrospective analysis of the clinical records of consecutive new cases of IU that presented to the uveitis subspecialty clinic from 2004-2011 at Tan Tock Seng Hospital. Data collected included demographics, clinical and laboratory findings. Diagnoses were based on standardized clinical history, ophthalmological examination and investigations. Results: There were 66 new cases of IU, comprising 5.7% of 1168 new uveitis patients. The median age of diagnosis was 40 years (mean 39.4 +/- 15.9), with largest subgroup of the patients in the age group of 41-60 years (36.4%). The majority was Chinese (57.6%), followed by Asian Indians (18.2%) and Malays (16.7%). The ethnicity distribution was dissimilar to our ethnic distribution in Singapore (p<0.001) with an increased incidence of IU in the Asian Indian population. Most were idiopathic (59.1%) in etiology, followed by tuberculosis (TB) (15.2%). Ocular complications developed in 21 patients (31.8%), with cystoid macular edema (CME) being the commonest (28.8%). Severe vitritis occurred in 9.1% of patients, and was significantly associated with TB-associated IU (p<0.001). There was a downward trend for the incidence of the proportion of IU patients over the total uveitis patients (p = 0.021), with Spearman's rho of -0.786. Conclusions: Despite the downward trend, TB-associated IU was still of higher prevalence compared to less endemic areas, emphasizing the need for increased TB surveillance. A high index of suspicion for TB-associated IU is required in patients with severe vitritis. Comparisons with other countries revealed disparities in the IU etiologies, indicating possible geographical differences. Prevalence of known immune-mediated etiologies of IU is less compared to the western population. Our study also suggests a probable predisposition of the Singapore local Indian population for IU.	[Mi, Helen] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Ho, Su L.; Lim, Wee K.; Wong, Elizabeth P. Y.; Teoh, Stephen C.] Tan Tock Seng Hosp, Natl Healthcare Grp, Inst Eye, Singapore, Singapore; [Lim, Wee K.; Teoh, Stephen C.] Eagle Eye Ctr, Singapore, Singapore	National University of Singapore; Tan Tock Seng Hospital	Teoh, SC (corresponding author), Tan Tock Seng Hosp, Natl Healthcare Grp, Inst Eye, Singapore, Singapore.	Stephen_Teoh@ttsh.com.sg		Wong, Elizabeth/0000-0001-5288-0546; Teoh, Stephen/0000-0002-9359-9694				Aguirre-Cruz L, 2011, AUTOIMMUNITY, V44, P571, DOI 10.3109/08916934.2011.592887; Al-Mezaine HS, 2010, OCUL IMMUNOL INFLAMM, V18, P424, DOI 10.3109/09273948.2010.502284; Ang M, 2012, CLIN EXP OPHTHALMOL, V40, P689, DOI 10.1111/j.1442-9071.2012.02766.x; Anonymous, 2005, International Ophthalmology Clinics, V45, P1, DOI 10.1097/01.iio.0000155938.83083.94; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Bodaghi B, 2000, Curr Opin Ophthalmol, V11, P443, DOI 10.1097/00055735-200012000-00010; Chang JHM, 2002, OCUL IMMUNOL INFLAMM, V10, P263, DOI 10.1076/ocii.10.4.263.15592; Chong HT, 2008, NEUROL ASIA, V13, P145; Cimino L., 2010, International Ophthalmology, V30, P521, DOI 10.1007/s10792-010-9359-y; Cimino Luca, 2009, International Ophthalmology, V29, P67, DOI 10.1007/s10792-007-9071-8; Communicable Disease Center Tan Tock Seng Hospital, 2002, TRENDS SEL INF DIS S; Cunningham ET, 2000, OCUL IMMUNOL INFLAMM, V8, P251; Davis EJ, 2012, J OPHTHALMIC INFLAMM, V2, P183, DOI 10.1007/s12348-012-0079-5; Department of Statistics Singapore, 2011, SING RES AG GROUP ET; Donaldson MJ, 2007, AM J OPHTHALMOL, V144, P812, DOI 10.1016/j.ajo.2007.08.023; Gupta V, 2007, SURV OPHTHALMOL, V52, P561, DOI 10.1016/j.survophthal.2007.08.015; Hamade IH, 2010, ACTA OPHTHALMOL, V88, P905, DOI 10.1111/j.1755-3768.2009.01579.x; Hamade IH, 2009, OCUL IMMUNOL INFLAMM, V17, P11, DOI 10.1080/09273940802491850; HENDERLY DE, 1987, AM J OPHTHALMOL, V103, P131, DOI 10.1016/S0002-9394(14)74217-5; Huang JJ., 2010, OCULAR INFLAMMATORY; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Keino H, 2009, CLIN EXP OPHTHALMOL, V37, P595, DOI 10.1111/j.1442-9071.2009.02102.x; Kempen JH, 2010, AM J OPHTHALMOL, V149, P550, DOI 10.1016/j.ajo.2009.11.019; Khairallah M, 2007, EYE, V21, P33, DOI 10.1038/sj.eye.6702111; MALINOWSKI SM, 1993, OPHTHALMOLOGY, V100, P818; Parchand S, 2011, J OPHTHALMIC INFLAMM, V1, P65, DOI 10.1007/s12348-011-0020-3; PERKINS ES, 1984, OPHTHALMOLOGICA, V189, P36, DOI 10.1159/000309382; Raja SC, 1999, OPHTHALMOLOGY, V106, P594, DOI 10.1016/S0161-6420(99)90122-7; ROTHOVA A, 1992, BRIT J OPHTHALMOL, V76, P137, DOI 10.1136/bjo.76.3.137; Sengun A, 2005, OCUL IMMUNOL INFLAMM, V13, P45, DOI 10.1080/09273940590909121; Smit R L, 1995, Curr Opin Ophthalmol, V6, P57; SMIT RLMJ, 1993, INT OPHTHALMOL, V17, P71, DOI 10.1007/BF00942778; Soheilian M, 2004, OCUL IMMUNOL INFLAMM, V12, P297, DOI 10.1080/092739490500174; Tan WJ, 2013, OCUL IMMUNOL INFLAMM, V21, P270, DOI 10.3109/09273948.2013.779725; Wakabayashi T, 2003, OCUL IMMUNOL INFLAMM, V11, P277, DOI 10.1076/ocii.11.4.277.18260; ZIERHUT M, 1992, DEV OPHTHALMOL, V23, P41	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91533	10.1371/journal.pone.0091533	http://dx.doi.org/10.1371/journal.pone.0091533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626440	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300100
J	Cheng, XR; Schafer, G; Riddell, PM				Cheng, Xiaorong; Schafer, Graham; Riddell, Patricia M.			Immediate Auditory Repetition of Words and Nonwords: An ERP Study of Lexical and Sublexical Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SHORT-TERM-MEMORY; NEIGHBORHOOD ACTIVATION; PHONOTACTIC PROBABILITY; SERIAL-RECALL; SPOKEN WORDS; TIME-COURSE; TREE MODEL; RECOGNITION; DECISION	ERPs were elicited to (1) words, (2) pseudowords derived from these words, and (3) nonwords with no lexical neighbors, in a task involving listening to immediately repeated auditory stimuli. There was a significant early (P200) effect of phonotactic probability in the first auditory presentation, which discriminated words and pseudowords from nonwords; and a significant somewhat later (N400) effect of lexicality, which discriminated words from pseudowords and nonwords. There was no reliable effect of lexicality in the ERPs to the second auditory presentation. We conclude that early sublexical phonological processing differed according to phonotactic probability of the stimuli, and that lexically-based redintegration occurred for words but did not occur for pseudowords or nonwords. Thus, in online word recognition and immediate retrieval, phonological and/or sublexical processing plays a more important role than lexical level redintegration.	[Cheng, Xiaorong] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [Cheng, Xiaorong] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Cheng, Xiaorong; Schafer, Graham; Riddell, Patricia M.] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England	Central China Normal University; University of Reading	Schafer, G (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	g.w.schafer@reading.ac.uk	Schafer, Graham/ABB-4360-2020; Riddell, Patricia/S-3724-2019	Riddell, Patricia/0000-0002-4916-2057	University of Reading; SRF for ROCS, SEM; China Postdoctoral Science Foundation [20110491179]; Humanities and Social Sciences Foundation of the Ministry of Education of China [11YJC190006]; National Natural Science Foundation of China [31170979]; Economic and Social Research Council [RES-474-25-0014] Funding Source: researchfish	University of Reading; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Humanities and Social Sciences Foundation of the Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was conducted at the University of Reading, UK, by the first author with the support of an Overseas PhD Studentship from the University of Reading. Additional data analyses and writing up were funded by SRF for ROCS, SEM, the China Postdoctoral Science Foundation (Grant No. 20110491179), the Humanities and Social Sciences Foundation of the Ministry of Education of China (Grant No. 11YJC190006) and the National Natural Science Foundation of China (Grant No. 31170979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev YG, 1998, NEUROIMAGE, V7, P1, DOI 10.1006/nimg.1997.0309; Barber H, 2004, NEUROREPORT, V15, P545, DOI 10.1097/00001756-200403010-00032; BENTIN S, 1993, PSYCHOPHYSIOLOGY, V30, P161, DOI 10.1111/j.1469-8986.1993.tb01729.x; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; BENTIN S, 1994, J EXP PSYCHOL LEARN, V20, P130, DOI 10.1037/0278-7393.20.1.130; Bonte ML, 2007, NEUROPSYCHOLOGIA, V45, P1427, DOI 10.1016/j.neuropsychologia.2006.11.009; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Carreiras M, 2005, J COGNITIVE NEUROSCI, V17, P1803, DOI 10.1162/089892905774589217; Chauncey K, 2008, LANG COGNITIVE PROC, V23, P183, DOI 10.1080/01690960701579839; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; DANNENBRING GL, 1982, CAN J PSYCHOL, V36, P435, DOI 10.1037/h0080650; Deacon D, 2000, COGNITIVE BRAIN RES, V9, P137, DOI 10.1016/S0926-6410(99)00050-6; Deacon D, 2004, PSYCHOPHYSIOLOGY, V41, P60, DOI 10.1111/1469-8986.00120; Dhond RP, 2005, NEUROIMAGE, V28, P293, DOI 10.1016/j.neuroimage.2005.06.027; Dienes Z., 2008, UNDERSTANDING PSYCHO; Donchin E, 1984, COGNITIVE PSYCHOPHYS; Doyle MC, 1996, PSYCHOPHYSIOLOGY, V33, P132, DOI 10.1111/j.1469-8986.1996.tb02117.x; Edwards J, 2004, J SPEECH LANG HEAR R, V47, P421, DOI 10.1044/1092-4388(2004/034); Embick D, 2001, COGNITIVE BRAIN RES, V10, P345, DOI 10.1016/S0926-6410(00)00053-7; Gathercole SE, 1999, J EXP PSYCHOL LEARN, V25, P84, DOI 10.1037/0278-7393.25.1.84; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; GERKEN L, 1995, PERCEPT PSYCHOPHYS, V57, P475, DOI 10.3758/BF03213073; Gupta P, 2009, J MEM LANG, V61, P481, DOI 10.1016/j.jml.2009.08.001; Herzmann G, 2007, PSYCHOPHYSIOLOGY, V44, P262, DOI 10.1111/j.1469-8986.2007.00505.x; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; Holcomb PJ, 2009, J NEUROLINGUIST, V22, P301, DOI 10.1016/j.jneuroling.2008.06.004; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Huber DE, 2008, J EXP PSYCHOL HUMAN, V34, P1389, DOI 10.1037/a0013625; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Hutzler F, 2004, NEUROSCI LETT, V372, P179, DOI 10.1016/j.neulet.2004.07.050; Jefferies E, 2006, J MEM LANG, V54, P81, DOI 10.1016/j.jml.2005.08.001; Jones G, 2011, MEM COGNITION, V39, P588, DOI 10.3758/s13421-010-0045-0; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; KARAYANIDIS F, 1991, PSYCHOPHYSIOLOGY, V28, P307, DOI 10.1111/j.1469-8986.1991.tb02200.x; Kim MS, 2008, BRAIN RES, V1240, P132, DOI 10.1016/j.brainres.2008.08.061; Kucera H., 1967, COMPUTATIONAL ANAL P; Leech G, 2001, WORD FREQUENCIES WRI; Lewandowsky S, 2000, PSYCHOL RES-PSYCH FO, V63, P163, DOI 10.1007/PL00008175; MacGregor LJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1715; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Metsala JL, 1999, J EDUC PSYCHOL, V91, P3, DOI 10.1037/0022-0663.91.1.3; MICHAS IC, 1994, BRIT J DEV PSYCHOL, V12, P147, DOI 10.1111/j.2044-835X.1994.tb00625.x; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Munson B, 2001, J SPEECH LANG HEAR R, V44, P778, DOI 10.1044/1092-4388(2001/061); Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Norris D, 2000, BEHAV BRAIN SCI, V23, P299, DOI 10.1017/S0140525X00003241; Page M. P., 2008, INTERACTIONS SHORT T, P136; PAPAGNO C, 1992, Q J EXP PSYCHOL-A, V44, P47, DOI 10.1080/14640749208401283; Pickering S., 2001, WORKING MEMORY TEST; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Roodenrys S, 2002, J EXP PSYCHOL LEARN, V28, P29, DOI 10.1037//0278-7393.28.1.29; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rossi S, 2010, J COGNITIVE IN PRESS; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Ruchkin DS, 1999, J MEM LANG, V41, P345, DOI 10.1006/jmla.1999.2644; RUGG MD, 1987, Q J EXP PSYCHOL-A, V39, P123, DOI 10.1080/02724988743000060; RUGG MD, 1995, J COGNITIVE NEUROSCI, V7, P209, DOI 10.1162/jocn.1995.7.2.209; RUGG MD, 1995, NEUROPSYCHOLOGIA, V33, P471, DOI 10.1016/0028-3932(94)00132-9; RUGG MD, 1987, MEM COGNITION, V15, P473, DOI 10.3758/BF03198381; Rugg MD., 1994, COGNITIVE ELECTROPHY, P124, DOI [10.1007/978-1-4612-0283-7%5F5, DOI 10.1007/978-1-4612-0283-7_5]; Samuel AG, 2011, ANNU REV PSYCHOL, V62, P49, DOI 10.1146/annurev.psych.121208.131643; SCHWEICKERT R, 1993, MEM COGNITION, V21, P168, DOI 10.3758/BF03202729; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; Stark CEL, 2000, J EXP PSYCHOL LEARN, V26, P945, DOI 10.1037//0278-7393.26.4.945; Steinberg J, 2010, J COGNITIVE NEUROSCI, V22, P2174, DOI 10.1162/jocn.2009.21408; Swick D, 1997, J EXP PSYCHOL LEARN, V23, P123, DOI 10.1037/0278-7393.23.1.123; Thorn ASC, 2005, COGNITIVE PSYCHOL, V50, P133, DOI 10.1016/j.cogpsych.2004.07.001; Vitevitch MS, 1999, J MEM LANG, V40, P374, DOI 10.1006/jmla.1998.2618; Vitevitch MS, 2004, BEHAV RES METH INS C, V36, P481, DOI 10.3758/BF03195594; Vitevitch MS, 1999, BRAIN LANG, V68, P306, DOI 10.1006/brln.1999.2116; Wagenmakers EJM, 2004, Q J EXP PSYCHOL-A, V57, P1191, DOI 10.1080/02724980343000729; Zangl R, 2005, J COGN DEV, V6, P179, DOI 10.1207/s15327647jcd0602_2; Zeelenberg R, 2004, J EXP PSYCHOL LEARN, V30, P270, DOI 10.1037/0278-7393.30.1.270	78	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91988	10.1371/journal.pone.0091988	http://dx.doi.org/10.1371/journal.pone.0091988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642662	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900055
J	Reuland, EA; Hays, JP; de Jongh, DMC; Abdelrehim, E; Willemsen, I; Kluytmans, JAJW; Savelkoul, PHM; Vandenbroucke-Grauls, CMJE; al Naiemi, N				Reuland, E. Ascelijn; Hays, John P.; de Jongh, Denise M. C.; Abdelrehim, Eman; Willemsen, Ina; Kluytmans, Jan A. J. W.; Savelkoul, Paul H. M.; Vandenbroucke-Grauls, Christina M. J. E.; al Naiemi, Nashwan			Detection and Occurrence of Plasmid-Mediated AmpC in Highly Resistant Gram-Negative Rods	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; NOSOCOMIAL TRANSMISSION; PROTEUS-MIRABILIS; ENTEROBACTERIACEAE; IDENTIFICATION; EPIDEMIOLOGY; SURVEILLANCE; HOSPITALS	Objectives: The aim of this study was to compare the current screening methods and to evaluate confirmation tests for phenotypic plasmidal AmpC (pAmpC) detection. Methods: For this evaluation we used 503 Enterobacteriaceae from 18 Dutch hospitals and 21 isolates previously confirmed to be pAmpC positive. All isolates were divided into three groups: isolates with 1) reduced susceptibility to ceftazidime and/or cefotaxime; 2) reduced susceptibility to cefoxitin; 3) reduced susceptibility to ceftazidime and/or cefotaxime combined with reduced susceptibility to cefoxitin. Two disk-based tests, with cloxacillin or boronic acid as inhibitor, and Etest with cefotetan-cefotetan/cloxacillin were used for phenotypic AmpC confirmation. Finally, presence of pAmpC genes was tested by multiplex and singleplex PCR. Results: We identified 13 pAmpC producing Enterobacteriaceae isolates among the 503 isolates (2.6%): 9 CMY-2, 3 DHA-1 and 1 ACC-1 type in E. coli isolates. The sensitivity and specificity of reduced susceptibility to ceftazidime and/or cefotaxime in combination with cefoxitin was 97% (33/34) and 90% (289/322) respectively. The disk-based test with cloxacillin showed the best performance as phenotypic confirmation method for AmpC production. Conclusions: For routine phenotypic detection of pAmpC the screening for reduced susceptibility to third generation cephalosporins combined with reduced susceptibility to cefoxitin is recommended. Confirmation via a combination disk diffusion test using cloxacillin is the best phenotypic option. The prevalence found is worrisome, since, due to their plasmidal location, pAmpC genes may spread further and increase in prevalence.	[Reuland, E. Ascelijn; Abdelrehim, Eman; Kluytmans, Jan A. J. W.; Savelkoul, Paul H. M.; Vandenbroucke-Grauls, Christina M. J. E.; al Naiemi, Nashwan] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Hays, John P.; de Jongh, Denise M. C.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Willemsen, Ina; Kluytmans, Jan A. J. W.] Amphia Hosp, Dept Med Microbiol & Infect Control, Breda, Netherlands; [al Naiemi, Nashwan] Lab Med Microbiol & Publ Hlth, Hengelo, Netherlands; [al Naiemi, Nashwan] Ziekenhuisgrp Twente, Almelo, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Amphia Hospital	Reuland, EA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.	e.reuland@vumc.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020; Hays, J/I-9007-2017	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Hays, J/0000-0001-9183-4497	ZonMw [125020011]	ZonMw(Netherlands Organization for Health Research and Development)	This research was funded by ZonMw, project number 125020011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Naiemi N, 2005, J CLIN MICROBIOL, V43, P4862, DOI 10.1128/JCM.43.9.4862-4864.2005; Al Naiemi N, 2009, EUR J CLIN MICROBIOL, V28, P989, DOI 10.1007/s10096-009-0714-8; al Naiemi N, 2008, NVMM GUIDELINE DUTCH; [Anonymous], EUCAST EUR COMM ANT; BEESLEY T, 1983, BIOCHEM J, V209, P229, DOI 10.1042/bj2090229; Black JA, 2005, J CLIN MICROBIOL, V43, P3110, DOI 10.1128/JCM.43.7.3110-3113.2005; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cohen Stuart J, 2012, NVMM GUIDELINE LAB D; Dahmen S, 2012, MICROB DRUG RESIST, V18, P479, DOI 10.1089/mdr.2011.0214; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Doi Y, 2007, INT J INFECT DIS, V11, P191, DOI 10.1016/j.ijid.2006.07.008; Gude MJ, 2012, EUR J CLIN MICROBIOL, V31, P2037, DOI 10.1007/s10096-011-1537-y; Gude MJ, 2013, INT J MED MICROBIOL; Hernandez-Alles S, 2000, J ANTIMICROB CHEMOTH, V46, P273, DOI 10.1093/jac/46.2.273; Huang IF, 2005, J CLIN MICROBIOL, V43, P2608, DOI 10.1128/JCM.43.6.2608-2612.2005; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kluytmans-VandenBergh MFQ, 2005, INFECTION, V33, P309, DOI 10.1007/s15010-005-5079-z; Mata C, 2010, CLIN MICROBIOL INFEC, V16, P473, DOI 10.1111/j.1469-0691.2009.02864.x; Miro E, 2013, EUR J CLIN MICROBIOL, V32, P253, DOI 10.1007/s10096-012-1737-0; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Nadjar D, 2000, FEMS MICROBIOL LETT, V187, P35, DOI 10.1016/S0378-1097(00)00166-X; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; Ohana S, 2005, ANTIMICROB AGENTS CH, V49, P2095, DOI 10.1128/AAC.49.5.2095-2097.2005; Pai H, 2004, ANTIMICROB AGENTS CH, V48, P3720, DOI 10.1128/AAC.48.10.3720-3728.2004; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pitout JDD, 2007, EMERG INFECT DIS, V13, P443, DOI 10.3201/eid1303.060447; Pitout JDD, 2013, CURR PHARM DESIGN, V19, P257, DOI 10.2174/138161213804070348; Pitout JDD, 2012, EXPERT REV ANTI-INFE, V10, P1165, DOI [10.1586/ERI.12.110, 10.1586/eri.12.110]; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P891, DOI 10.1128/AAC.44.4.891-897.2000; Rodriguez-Bano J, 2012, J INFECTION, V64, P176, DOI 10.1016/j.jinf.2011.11.016; Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999; Seiffert SN, 2013, J ANTIMICROB CHEMOTH, V68, P2249, DOI 10.1093/jac/dkt208; Tan TY, 2008, J CLIN PATHOL, V61, P642, DOI 10.1136/jcp.2007.053470; Tan TY, 2009, ANTIMICROB AGENTS CH, V53, P146, DOI 10.1128/AAC.00862-08; Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102; Willemsen I, 2011, INFECT CONT HOSP EP, V32, P333, DOI 10.1086/658941; Willemsen I, 2011, J CLIN MICROBIOL, V49, P2985, DOI 10.1128/JCM.02087-10; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456; Yagi T, 2005, J CLIN MICROBIOL, V43, P2551, DOI 10.1128/JCM.43.6.2551-2558.2005	39	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91396	10.1371/journal.pone.0091396	http://dx.doi.org/10.1371/journal.pone.0091396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642853	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900020
J	Hatazawa, Y; Tadaishi, M; Nagaike, Y; Morita, A; Ogawa, Y; Ezaki, O; Takai-Igarashi, T; Kitaura, Y; Shimomura, Y; Kamei, Y; Miura, S				Hatazawa, Yukino; Tadaishi, Miki; Nagaike, Yuta; Morita, Akihito; Ogawa, Yoshihiro; Ezaki, Osamu; Takai-Igarashi, Takako; Kitaura, Yasuyuki; Shimomura, Yoshiharu; Kamei, Yasutomi; Miura, Shinji			PGC-1 alpha-Mediated Branched-Chain Amino Acid Metabolism in the Skeletal Muscle	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR; MESSENGER-RNA; DEHYDROGENASE COMPLEX; EXERCISE; RECEPTOR; EXPRESSION; OVEREXPRESSION; CATABOLISM; ANGIOGENESIS; INCREASES	Peroxisome proliferator-activated receptor (PPAR) c coactivator 1 alpha (PGC-1 alpha) is a coactivator of various nuclear receptors and other transcription factors, which is involved in the regulation of energy metabolism, thermogenesis, and other biological processes that control phenotypic characteristics of various organ systems including skeletal muscle. PGC-1 alpha in skeletal muscle is considered to be involved in contractile protein function, mitochondrial function, metabolic regulation, intracellular signaling, and transcriptional responses. Branched-chain amino acid (BCAA) metabolism mainly occurs in skeletal muscle mitochondria, and enzymes related to BCAA metabolism are increased by exercise. Using murine skeletal muscle overexpressing PGC-1 alpha and cultured cells, we investigated whether PGC-1 alpha stimulates BCAA metabolism by increasing the expression of enzymes involved in BCAA metabolism. Transgenic mice overexpressing PGC-1 alpha specifically in the skeletal muscle had increased the expression of branched-chain aminotransferase (BCAT) 2, branched-chain a-keto acid dehydrogenase (BCKDH), which catabolize BCAA. The expression of BCKDH kinase (BCKDK), which phosphorylates BCKDH and suppresses its enzymatic activity, was unchanged. The amount of BCAA in the skeletal muscle was significantly decreased in the transgenic mice compared with that in the wild-type mice. The amount of glutamic acid, a metabolite of BCAA catabolism, was increased in the transgenic mice, suggesting the activation of muscle BCAA metabolism by PGC-1 alpha. In C2C12 cells, the overexpression of PGC-1 alpha significantly increased the expression of BCAT2 and BCKDH but not BCKDK. Thus, PGC-1 alpha in the skeletal muscle is considered to significantly contribute to BCAA metabolism.	[Hatazawa, Yukino; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Grad Sch Med & Dent Sci, Tokyo, Japan; [Hatazawa, Yukino; Kamei, Yasutomi] Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Environm & Life Sci, Kyoto 606, Japan; [Tadaishi, Miki] Natl Inst Hlth & Nutr, Dept Food Funct & Labeling, Tokyo 162, Japan; [Nagaike, Yuta; Morita, Akihito; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Shizuoka 4228526, Japan; [Ezaki, Osamu] Showa Womens Univ, Dept Human Hlth & Design, Tokyo, Japan; [Takai-Igarashi, Takako] Tohoku Univ, Dept Hlth Record Informat, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kitaura, Yasuyuki; Shimomura, Yoshiharu] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan	Tokyo Medical & Dental University (TMDU); Kyoto Prefectural University; National Institute of Health & Nutrition - Japan; University of Shizuoka; Tohoku University; Nagoya University	Kamei, Y (corresponding author), Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Environm & Life Sci, Kyoto 606, Japan.	kamei@kpu.ac.jp; miura@u-shizuoka-ken.ac.jp	Miura, Shinji/K-6516-2013	Miura, Shinji/0000-0001-8806-9763; Ogawa, Yoshihiro/0000-0002-0834-2836; xing zhi, shi zhi/0000-0003-3289-5681	Fuji Foundation for Protein Research; Sapporo Bioscience Foundation; Kieikai Research Foundation; Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Sapporo Bioscience Foundation; Kieikai Research Foundation(Kieikai Research Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Fuji Foundation for Protein Research, Sapporo Bioscience Foundation, The Kieikai Research Foundation, The Uehara Memorial Foundation, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kobayashi R, 2000, ARCH BIOCHEM BIOPHYS, V375, P55, DOI 10.1006/abbi.1999.1635; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Misawa K, 2000, P NATL ACAD SCI USA, V97, P3062, DOI 10.1073/pnas.060489597; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; SHIMOMURA Y, 1995, J NUTR, V125, pS1762; Shimomura Y, 2006, J NUTR, V136, p250S, DOI 10.1093/jn/136.1.250S; Shimomura Y, 2004, J NUTR, V134, p1583S, DOI 10.1093/jn/134.6.1583S; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Takahashi M, 2013, BIOCHEM BIOPH RES CO, V434, P873, DOI 10.1016/j.bbrc.2013.04.041; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Yoshioka T, 2009, J MATER CYCLES WASTE, V11, P1, DOI 10.1007/s10163-008-0223-3	32	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91006	10.1371/journal.pone.0091006	http://dx.doi.org/10.1371/journal.pone.0091006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638054	Green Published, gold			2022-12-27	WOS:000333254100015
J	Jaligot, E; Hooi, WY; Debladis, E; Richaud, F; Beule, T; Collin, M; Agbessi, MDT; Sabot, F; Garsmeur, O; D'Hont, A; Alwee, SSRS; Rival, A				Jaligot, Estelle; Hooi, Wei Yeng; Debladis, Emilie; Richaud, Frederique; Beule, Thierry; Collin, Myriam; Agbessi, Mawusse D. T.; Sabot, Francois; Garsmeur, Olivier; D'Hont, Angelique; Alwee, Sharifah Shahrul Rabiah Syed; Rival, Alain			DNA Methylation and Expression of the EgDEF1 Gene and Neighboring Retrotransposons in mantled Somaclonal Variants of Oil Palm	PLOS ONE			English	Article							ELAEIS-GUINEENSIS JACQ.; MADS BOX GENES; TRANSPOSABLE ELEMENTS; EPIGENETIC CONTROL; FLOWER STRUCTURE; TISSUE-CULTURE; ARABIDOPSIS; PLANTS; EVOLUTION; APETALA3	The mantled floral phenotype of oil palm (Elaeis guineensis) affects somatic embryogenesis-derived individuals and is morphologically similar to mutants defective in the B-class MADS-box genes. This somaclonal variation has been previously demonstrated to be associated to a significant deficit in genome-wide DNA methylation. In order to elucidate the possible role of DNA methylation in the transcriptional regulation of EgDEF1, the APETALA3 ortholog of oil palm, we studied this epigenetic mark within the gene in parallel with transcript accumulation in both normal and mantled developing inflorescences. We also examined the methylation and expression of two neighboring retrotransposons that might interfere with EgDEF1 regulation. We show that the EgDEF1 gene is essentially unmethylated and that its methylation pattern does not change with the floral phenotype whereas expression is dramatically different, ruling out a direct implication of DNA methylation in the regulation of this gene. Also, we find that both the gypsy element inserted within an intron of the EgDEF1 gene and the copia element located upstream from the promoter are heavily methylated and show little or no expression. Interestingly, we identify a shorter, alternative transcript produced by EgDEF1 and characterize its accumulation with respect to its full-length counterpart. We demonstrate that, depending on the floral phenotype, the respective proportions of these two transcripts change differently during inflorescence development. We discuss the possible phenotypical consequences of this alternative splicing and the new questions it raises in the search for the molecular mechanisms underlying the mantled phenotype in the oil palm.	[Jaligot, Estelle; Hooi, Wei Yeng; Debladis, Emilie; Richaud, Frederique; Beule, Thierry; Agbessi, Mawusse D. T.; Rival, Alain] CIRAD, UMR DIADE, Montpellier, France; [Collin, Myriam; Sabot, Francois] IRD, UMR DIADE, Montpellier, France; [Garsmeur, Olivier; D'Hont, Angelique] CIRAD, UMR AGAP, Montpellier, France; [Hooi, Wei Yeng; Alwee, Sharifah Shahrul Rabiah Syed] FASSB, FELDA Biotechnol Ctr, Bandar Enstek, Malaysia	CIRAD; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Universite de Montpellier	Jaligot, E (corresponding author), CIRAD, UMR DIADE, Montpellier, France.	estelle.jaligot@cirad.fr	Sabot, Francois/B-7820-2010; RIVAL, Alain/A-9064-2011; DHONT, Angélique/AAL-8074-2021	Sabot, Francois/0000-0002-8522-7583; Debladis, Emilie/0000-0003-4734-7426; Jaligot, Estelle/0000-0002-9252-5271	PalmElit SAS; CIRAD (Centre de cooperation internationale en recherche agronomique pour le developpement); CIRAD; FELDA/FASSB (Federal Land Development Authority/Agricultural Services Sdn Bdh); Genoscope [AAP2007/8]; AIRD (Agence inter-etablissements de recherche pour le developpement)	PalmElit SAS; CIRAD (Centre de cooperation internationale en recherche agronomique pour le developpement); CIRAD; FELDA/FASSB (Federal Land Development Authority/Agricultural Services Sdn Bdh); Genoscope; AIRD (Agence inter-etablissements de recherche pour le developpement)	This work was partly funded through the RnaPalm (between PalmElit SAS and CIRAD (Centre de cooperation internationale en recherche agronomique pour le developpement) and FloriPalm projects (between CIRAD and FELDA/FASSB (Federal Land Development Authority/Agricultural Services Sdn Bdh). BAC sequencing was funded by Genoscope (AAP2007/8). WYH is the recipient of a PhD grant from CIRAD and AIRD (Agence inter-etablissements de recherche pour le developpement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam H, 2006, J MOL EVOL, V62, P15, DOI 10.1007/s00239-005-0333-7; Adam H, 2005, AM J BOT, V92, P1836, DOI 10.3732/ajb.92.11.1836; Adam H, 2007, ANN BOT-LONDON, V100, P1, DOI 10.1093/aob/mcm027; Adam H, 2007, J EXP BOT, V58, P1245, DOI 10.1093/jxb/erl263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausin I, 2012, EPIGENETICS-US, V7, P29, DOI 10.4161/epi.7.1.18782; Cegan R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-180; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Galimba KD, 2012, P NATL ACAD SCI USA, V109, pE2267, DOI 10.1073/pnas.1203686109; Grafi G, 2011, PLANTA, V233, P433, DOI 10.1007/s00425-011-1366-3; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Hands P, 2011, ANN BOT-LONDON, V107, P1557, DOI 10.1093/aob/mcr045; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jaligot E, 2004, GENOME, V47, P224, DOI 10.1139/G03-085; Jaligot E, 2002, THEOR APPL GENET, V104, P1263, DOI 10.1007/s00122-002-0906-4; Jaligot E, 2000, PLANT CELL REP, V19, P684, DOI 10.1007/s002999900177; Jaligot E, 2011, ANN BOT, V108, P1463; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; KAEPPLER SM, 1993, IN VITRO CELL DEV-PL, V29P, P125, DOI 10.1007/BF02632283; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li-Byarlay H, 2013, P NATL ACAD SCI USA, V110, P12750, DOI 10.1073/pnas.1310735110; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Liu ZX, 2013, PLANT CELL REP, V32, P227, DOI 10.1007/s00299-012-1357-2; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Melzer R, 2009, NUCLEIC ACIDS RES, V37, P2723, DOI 10.1093/nar/gkp129; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Morcillo F, 2006, TREE PHYSIOL, V26, P585, DOI 10.1093/treephys/26.5.585; Nuthikattu S, 2013, PLANT PHYSIOL, V162, P116, DOI 10.1104/pp.113.216481; PANNETIER C, 1981, OLEAGINEUX, V36, P119; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Pelissier T, 2012, TOPICS CURRENT GENET, P125; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piffanelli P, 2002, PLANT AN MICR GEN 10; Piwarzyk E, 2007, PLANT PHYSIOL, V145, P1495, DOI 10.1104/pp.107.105346; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Rigal M, 2011, BBA-GENE REGUL MECH, V1809, P452, DOI 10.1016/j.bbagrm.2011.04.001; Rival A, 2008, J EXP BOT, V59, P3271, DOI 10.1093/jxb/ern178; Salemme M, 2013, MOL BIOL REP, P1; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Schor IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048084; Seo PJ, 2012, PLANT J, V72, P162, DOI 10.1111/j.1365-313X.2012.05069.x; Severing EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030524; Shearman JR, 2013, GENOMICS, V101, P306, DOI 10.1016/j.ygeno.2013.02.012; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Stellari GM, 2004, MOL BIOL EVOL, V21, P506, DOI 10.1093/molbev/msh044; Tregear JW, 2002, J EXP BOT, V53, P1387, DOI 10.1093/jexbot/53.373.1387; Tsaftaris AS, 2005, BIOL PLANTARUM, V49, P499, DOI 10.1007/s10535-005-0041-6; Tsuchiya T, 2013, P NATL ACAD SCI USA, V110, pE3535, DOI 10.1073/pnas.1312545110; Wang XG, 2013, P NATL ACAD SCI USA, V110, P15467, DOI 10.1073/pnas.1315399110; Weil C, 2008, CURR OPIN GENET DEV, V18, P188, DOI 10.1016/j.gde.2008.01.015; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zhang CJ, 2013, EMBO J, V32, P1128, DOI 10.1038/emboj.2013.49; Zhang JQ, 2011, GENE, V473, P82, DOI 10.1016/j.gene.2010.11.005; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	66	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91896	10.1371/journal.pone.0091896	http://dx.doi.org/10.1371/journal.pone.0091896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638102	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100076
J	Niu, JW; Vysochan, A; Luo, WQ				Niu, Jingwen; Vysochan, Anna; Luo, Wenqin			Dual Innervation of Neonatal Merkel Cells in Mouse Touch Domes	PLOS ONE			English	Article							SENSORY NEURONS; CUTANEOUS MECHANORECEPTORS; DIFFERENTIAL DEPENDENCY; TRK RECEPTORS; OVEREXPRESSION; NEUROTROPHINS; SPECIFICATION; CORPUSCLE; SUBTYPES; RAT	Merkel cell-neurite complexes are specialized mechanosensory end organs that mediate discriminative touch sensation. It is well established that type I slowly adapting (SAI) mechanoreceptors, which express neural filament heavy chain (NFH), innervate Merkel cells. It was previously shown that neurotrophic factor NT3 and its receptor TrkC play crucial roles in controlling touch dome Merkel cell innervation of NFH+ fibers. In addition, nerve fibers expressing another neurotrophic tyrosine receptor kinase (NTRK), Ret, innervate touch dome Merkel cells as well. However, the relationship between afferents responsive to NT3/TrkC signaling and those expressing Ret is unclear. It is also controversial if these Ret(+) fibers belong to the early or late Ret(+) DRG neurons, which are defined based on the co-expression and developmental dependence of TrkA. To address these questions, we genetically traced Ret(+) and TrkC(+) fibers and analyzed their developmental dependence on TrkA. We found that Merkel cells in neonatal mouse touch domes receive innervation of two types of fibers: one group is Ret(+), while the other subset expresses TrkC and NFH. In addition, Ret(+) fibers depend on TrkA for their survival and normal innervation whereas NFH+ Merkel cell innervating fibers are almost unaltered in TrkA mutant mice, supporting that Ret(+) and NFH+/TrkC(+) afferents are two distinct groups. Ret signaling, on the other hand, plays a minor role for the innervation of neonatal touch domes. In contrast, Merkel cells in the glabrous skin are mainly contacted by NFH+/TrkC(+) afferents. Taken together, our results suggest that neonatal Merkel cells around hair follicles receive dual innervation while Merkel cells in the glabrous skin are mainly innervated by only SAI mechanoreceptors. In addition, our results suggest that neonatal Ret(+) Merkel cell innervating fibers most likely belong to the late but not early Ret(+) DRG neurons.	[Niu, Jingwen; Vysochan, Anna; Luo, Wenqin] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Luo, WQ (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	luow@mail.med.upenn.edu		Niu, Jingwen/0000-0001-5456-1485	National Institutes of Health (NIH) [R00NS069799, 1R01NS083702]; Basil O'Connor Starter Scholar Research Award; Thomas B. McCabe and Jeanette E. Laws McCabe Pilot Award; Institute of Regenerative Medicine Pilot Grant from UPenn; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS069799, R01NS083702] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basil O'Connor Starter Scholar Research Award(March of Dimes); Thomas B. McCabe and Jeanette E. Laws McCabe Pilot Award; Institute of Regenerative Medicine Pilot Grant from UPenn; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health (NIH, R00NS069799 and 1R01NS083702), Basil O'Connor Starter Scholar Research Award, Thomas B. McCabe and Jeanette E. Laws McCabe Pilot Award, and the Institute of Regenerative Medicine Pilot Grant from UPenn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo H, 2011, EUR J NEUROSCI, V34, P1529, DOI 10.1111/j.1460-9568.2011.07883.x; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; Boulais N, 2007, J AM ACAD DERMATOL, V57, P147, DOI 10.1016/j.jaad.2007.02.009; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Cronk KM, 2002, DEVELOPMENT, V129, P3739; Fleming Michael S, 2013, Front Biol (Beijing), V8, DOI 10.1007/s11515-013-1271-1; Fleming MS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-52; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Funfschilling U, 2004, J COMP NEUROL, V480, P392, DOI 10.1002/cne.20359; Gong SC, 2010, NAT PROTOC, V5, P1678, DOI 10.1038/nprot.2010.131; Halata Z, 2005, ANAT EMBRYOL, V209, P335, DOI 10.1007/s00429-005-0455-0; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; Krimm RF, 2004, J COMP NEUROL, V471, P352, DOI 10.1002/cne.20041; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045551; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; McIlwrath SL, 2007, EUR J NEUROSCI, V26, P1801, DOI 10.1111/j.1460-9568.2007.05821.x; MILLS LR, 1989, DEV BIOL, V136, P61, DOI 10.1016/0012-1606(89)90130-9; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Niu JW, 2013, J NEUROSCI, V33, P17691, DOI 10.1523/JNEUROSCI.3429-13.2013; Pare M, 2001, J NEUROSCI, V21, P7236, DOI 10.1523/JNEUROSCI.21-18-07236.2001; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Rice FL, 2008, SENSES COMPREHENSIVE, P1, DOI 10.1016/B978-0-12-805408-6.00340-7; Senzaki K, 2010, MOL CELL NEUROSCI, V43, P296, DOI 10.1016/j.mcn.2009.12.003; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Zelena J, 1994, NERVES MECHANORECEPT	35	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92027	10.1371/journal.pone.0092027	http://dx.doi.org/10.1371/journal.pone.0092027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637732	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100103
J	Ohlsson, C; Engdahl, C; Fak, F; Andersson, A; Windahl, SH; Farman, HH; Moverare-Skrtic, S; Islander, U; Sjogren, K				Ohlsson, Claes; Engdahl, Cecilia; Fak, Frida; Andersson, Annica; Windahl, Sara H.; Farman, Helen H.; Moverare-Skrtic, Sofia; Islander, Ulrika; Sjogren, Klara			Probiotics Protect Mice from Ovariectomy-Induced Cortical Bone Loss	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; C-REACTIVE PROTEIN; T-CELLS; MINERAL DENSITY; TRABECULAR BONE; GUT MICROBIOTA; IMMUNE-SYSTEM; TNF-ALPHA; OSTEOPROTEGERIN; WOMEN	The gut microbiota (GM) modulates the hosts metabolism and immune system. Probiotic bacteria are defined as live microorganisms which when administered in adequate amounts confer a health benefit on the host and can alter the composition of the GM. Germ-free mice have increased bone mass associated with reduced bone resorption indicating that the GM also regulates bone mass. Ovariectomy (ovx) results in bone loss associated with altered immune status. The purpose of this study was to determine if probiotic treatment protects mice from ovx-induced bone loss. Mice were treated with either a single Lactobacillus (L) strain, L. paracasei DSM13434 (L. para) or a mixture of three strains, L. paracasei DSM13434, L. plantarum DSM 15312 and DSM 15313 (L. mix) given in the drinking water during 6 weeks, starting two weeks before ovx. Both the L. para and the L. mix treatment protected mice from ovx-induced cortical bone loss and bone resorption. Cortical bone mineral content was higher in both L. para and L. mix treated ovx mice compared to vehicle (veh) treated ovx mice. Serum levels of the resorption marker C-terminal telopeptides and the urinary fractional excretion of calcium were increased by ovx in the veh treated but not in the L. para or the L. mix treated mice. Probiotic treatment reduced the expression of the two inflammatory cytokines, TNF alpha and IL-1 beta, and increased the expression of OPG, a potent inhibitor of osteoclastogenesis, in cortical bone of ovx mice. In addition, ovx decreased the frequency of regulatory T cells in bone marrow of veh treated but not probiotic treated mice. In conclusion, treatment with L. para or the L. mix prevents ovxinduced cortical bone loss. Our findings indicate that these probiotic treatments alter the immune status in bone resulting in attenuated bone resorption in ovx mice.	[Ohlsson, Claes; Engdahl, Cecilia; Andersson, Annica; Windahl, Sara H.; Farman, Helen H.; Moverare-Skrtic, Sofia; Islander, Ulrika; Sjogren, Klara] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Engdahl, Cecilia; Andersson, Annica; Islander, Ulrika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Fak, Frida] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden	University of Gothenburg; University of Gothenburg; Lund University	Sjogren, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden.	Klara.Sjogren@medic.gu.se	Skrtic, Sofia/AAQ-1585-2020; Islander, Ulrika/S-4824-2019; Ohlsson, Claes/AGP-3544-2022; Andersson, Annica/B-4424-2015	Islander, Ulrika/0000-0002-8493-1739; Ohlsson, Claes/0000-0002-9633-2805; Andersson, Annica/0000-0002-3333-8687; Engdahl, Cecilia/0000-0002-8914-0178; Windahl, Sara/0000-0002-6611-6001; Sjogren, Klara/0000-0001-5776-7278	Swedish Research Council; Swedish Foundation for Strategic Research; COMBINE; Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet research grant in Gothenburg; Lundberg Foundation; Torsten and Ragnar Soderberg Foundation; Novo Nordisk Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Inga-Britt and Arne Lundberg Foundation; Novo Nordisk Fonden [NNF13OC0005785, NNF14OC0010513] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); COMBINE; Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet research grant in Gothenburg; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Magnus Bergvall Foundation; Ake Wiberg Foundation; Inga-Britt and Arne Lundberg Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Swedish Research Council, Swedish Foundation for Strategic Research, COMBINE, Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet research grant in Gothenburg, Lundberg Foundation, Torsten and Ragnar Soderberg Foundation, Novo Nordisk Foundation, Magnus Bergvall Foundation and Ake Wiberg Foundation. The BD FACS Canto II was bought thanks to generous support from the Inga-Britt and Arne Lundberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal N, 2013, J CLIN ENDOCRINOL ME; Bouladoux N, 2012, MUCOSAL IMMUNOL, V5, P623, DOI 10.1038/mi.2012.36; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Buchwald ZS, 2013, BONE, V56, P163, DOI 10.1016/j.bone.2013.05.024; Charatcharoenwitthaya N, 2007, J BONE MINER RES, V22, P724, DOI 10.1359/JBMR.070207; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Ding C, 2008, J CLIN ENDOCR METAB, V93, P1952, DOI 10.1210/jc.2007-2325; Eriksson AL, 2013, J BONE MINER RES; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; Kim YG, 2007, BIOCHEM BIOPH RES CO, V357, P1046, DOI 10.1016/j.bbrc.2007.04.042; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Luo CY, 2011, CELL MOL IMMUNOL, V8, P50, DOI 10.1038/cmi.2010.54; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; MCKANE WR, 1995, J CLIN ENDOCR METAB, V80, P3458, DOI 10.1210/jc.80.12.3458; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Pasco JA, 2006, JAMA-J AM MED ASSOC, V296, P1353, DOI 10.1001/jama.296.11.1353; Pytlik M, 2004, CALCIFIED TISSUE INT, V75, P225, DOI 10.1007/s00223-004-0097-x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schett G, 2006, ARCH INTERN MED, V166, P2495, DOI 10.1001/archinte.166.22.2495; Scholz-Ahrens KE, 2007, J NUTR, V137, p838S, DOI 10.1093/jn/137.3.838S; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Williams S, 1996, BONE, V19, P637, DOI 10.1016/S8756-3282(96)00302-X; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Zaiss MM, 2007, ARTHRITIS RHEUM, V56, P4104, DOI 10.1002/art.23138; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	43	184	205	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92368	10.1371/journal.pone.0092368	http://dx.doi.org/10.1371/journal.pone.0092368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637895	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100148
J	Samuelson, EM; Laird, RM; Papillion, AM; Tatum, AH; Princiotta, MF; Hayes, SM				Samuelson, Elizabeth M.; Laird, Renee M.; Papillion, Amber M.; Tatum, Arthur H.; Princiotta, Michael F.; Hayes, Sandra M.			Reduced B Lymphoid Kinase (Blk) Expression Enhances Proinflammatory Cytokine Production and Induces Nephrosis in C57BL/6-lpr/lpr Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; FOLLICULAR HELPER-CELL; TUMOR-NECROSIS-FACTOR; T-CELLS; INDUCIBLE COSTIMULATOR; SUSCEPTIBILITY LOCI; RHEUMATOID-ARTHRITIS; IL-21 RECEPTOR; SERUM-LEVELS	BLK, which encodes B lymphoid kinase, was recently identified in genome wide association studies as a susceptibility gene for systemic lupus erythematosus (SLE), and risk alleles mapping to the BLK locus result in reduced gene expression. To determine whether BLK is indeed a bona fide susceptibility gene, we developed an experimental mouse model, namely the Blk(+/-). lpr/lpr (Blk(+/-). lpr) mouse, in which Blk expression levels are reduced to levels comparable to those in individuals carrying a risk allele. Here, we report that Blk is expressed not only in B cells, but also in IL-17-producing gamma delta and DN alpha beta T cells and in plasmacytoid dendritic cells (pDCs). Moreover, we found that solely reducing Blk expression in C57BL/6-lpr/lpr mice enhanced proinflammatory cytokine production and accelerated the onset of lymphoproliferation, proteinuria, and kidney disease. Together, these findings suggest that BLK risk alleles confer susceptibility to SLE through the dysregulation of a proinflammatory cytokine network.	[Samuelson, Elizabeth M.; Laird, Renee M.; Papillion, Amber M.; Princiotta, Michael F.; Hayes, Sandra M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Tatum, Arthur H.] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Hayes, SM (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	HayesSa@upstate.edu			National Institutes of Health [R21 AI097694, R56 AI091908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097694, R56AI091908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (R21 AI097694 and R56 AI091908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Bae YJ, 2012, ALLERGY ASTHMA IMMUN, pe125; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Blaho VA, 2009, J IMMUNOL, V183, P5644, DOI 10.4049/jimmunol.0901499; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; Brennan F, 2007, CURR OPIN RHEUMATOL, V19, P296, DOI 10.1097/BOR.0b013e32805e87f1; Brunskill EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024640; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Calvani N, 2005, AUTOIMMUN REV, V4, P542, DOI 10.1016/j.autrev.2005.04.009; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cash H, 2010, J RHEUMATOL, V37, P60, DOI 10.3899/jrheum.090194; Cay HF, 2012, CLIN EXP RHEUMATOL, V30, P843; Chan OTM, 1999, IMMUNOL REV, V169, P107, DOI 10.1111/j.1600-065X.1999.tb01310.x; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Delgado-Vega AM, 2012, ANN RHEUM DIS, V71, P1219, DOI 10.1136/annrheumdis-2011-200987; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; ESPERSEN GT, 1991, CLIN RHEUMATOL, V10, P374, DOI 10.1007/BF02206655; Fairhurst AM, 2006, ADV IMMUNOL, V92, P1, DOI 10.1016/S0065-2776(06)92001-X; Fina Daniele, 2007, Inflammation & Allergy Drug Targets, V6, P63, DOI 10.2174/187152807780077246; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Gourh P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2821; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gutierrez S, 2012, NEFROLOGIA, V32, P245, DOI 10.3265/Nefrologia.pre2011.Nov.11138; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hu HB, 2011, P NATL ACAD SCI USA, V108, P12827, DOI 10.1073/pnas.1105774108; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; ISLAM KB, 1995, J IMMUNOL, V154, P1265; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwai H, 2003, J IMMUNOL, V171, P2848, DOI 10.4049/jimmunol.171.6.2848; IZUI S, 1984, J IMMUNOL, V133, P227; Jacob N, 2010, AUTOIMMUNITY, V43, P84, DOI 10.3109/08916930903374600; Jarvinen TM, 2012, RHEUMATOLOGY, V51, P87, DOI 10.1093/rheumatology/ker263; Jia S, 2010, CLIN EXP IMMUNOL, V162, P131, DOI 10.1111/j.1365-2249.2010.04236.x; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Kang KY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3504; Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319; Koca SS, 2008, RHEUMATOLOGY, V47, P172, DOI 10.1093/rheumatology/kem344; Koga M, 2011, J HUM GENET, V56, P503, DOI 10.1038/jhg.2011.49; Korn T, 2012, ANN NY ACAD SCI, V1247, P34, DOI 10.1111/j.1749-6632.2011.06355.x; Kraft SW, 2005, J AM SOC NEPHROL, V16, P175, DOI 10.1681/ASN.2004050350; Krishnan S, 2006, SEMIN IMMUNOL, V18, P230, DOI 10.1016/j.smim.2006.03.011; Kyttaris VC, 2010, J IMMUNOL, V184, P4605, DOI 10.4049/jimmunol.0903595; Laird RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063178; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Li H, 2001, IMMUNITY; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Lopes-Carvalho Thiago, 2005, V8, P91; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Ma CY, 2012, RHEUMATOL INT, V32, P395, DOI 10.1007/s00296-010-1636-6; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; METSARINNE KP, 1992, RHEUMATOL INT, V12, P93, DOI 10.1007/BF00290261; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; Navarro JF, 1999, AM J KIDNEY DIS, V33, P458, DOI 10.1016/S0272-6386(99)70182-4; Nordmark G, 2011, GENES IMMUN, V12, P100, DOI 10.1038/gene.2010.44; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Orozco G, 2011, ANN RHEUM DIS, V70, P463, DOI 10.1136/ard.2010.137174; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036761; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; Quiroga MF, 2006, J IMMUNOL, V176, P5965, DOI 10.4049/jimmunol.176.10.5965; Rai E, 2011, SEMIN IMMUNOL, V23, P67, DOI 10.1016/j.smim.2011.01.015; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Rankin AL, 2012, J IMMUNOL, V188, P1656, DOI 10.4049/jimmunol.1003871; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Samuelson EM, 2012, IMMUNOL CELL BIOL, V90, P620, DOI 10.1038/icb.2011.76; Sanchez E, 2011, ARTHRITIS RHEUM-US, V63, P3493, DOI 10.1002/art.30563; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; Segal R, 2001, LUPUS, V10, P23, DOI 10.1191/096120301675275538; Seshan SV, 2009, ARCH PATHOL LAB MED, V133, P233, DOI 10.1043/1543-2165-133.2.233; Sille FCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029632; Simons DM, 2013, J IMMUNOL, V190, P3134, DOI 10.4049/jimmunol.1203212; Simpfendorfer KR, 2012, HUM MOL GENET, V21, P3918, DOI 10.1093/hmg/dds220; Suarez-Gestal M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2698; Tai GP, 2013, BIOL OPEN, V2, P416, DOI 10.1242/bio.20133780; Texido G, 2000, MOL CELL BIOL, V20, P1227, DOI 10.1128/MCB.20.4.1227-1233.2000; Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wassink L, 2004, J IMMUNOL, V173, P1779, DOI 10.4049/jimmunol.173.3.1779; Watanabe M, 2008, J IMMUNOL, V180, P5222, DOI 10.4049/jimmunol.180.8.5222; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zhang Z, 2010, J IMMUNOL, V183, P3160; Zhang Z, 2010, ARCH DERMATOL RES, V302, P619, DOI 10.1007/s00403-010-1029-4	102	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92054	10.1371/journal.pone.0092054	http://dx.doi.org/10.1371/journal.pone.0092054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637841	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100108
J	Subic-Wrana, C; Beutel, ME; Brahler, E; Stobel-Richter, Y; Knebel, A; Lane, RD; Wiltink, J				Subic-Wrana, Claudia; Beutel, Manfred E.; Braehler, Elmar; Stoebel-Richter, Yve; Knebel, Achim; Lane, Richard D.; Wiltink, Joerg			How Is Emotional Awareness Related to Emotion Regulation Strategies and Self-Reported Negative Affect in the General Population?	PLOS ONE			English	Article							TORONTO-ALEXITHYMIA-SCALE; COGNITIVE REAPPRAISAL; HOSPITAL ANXIETY; GERMAN VERSION; DEPRESSION; SUPPRESSION; VALIDATION; ACCEPTANCE; INPATIENTS; DISORDERS	Objective: The Levels of Emotional Awareness Scale (LEAS) as a performance task discriminates between implicit or subconscious and explicit or conscious levels of emotional awareness. An impaired awareness of one's feeling states may influence emotion regulation strategies and self-reports of negative emotions. To determine this influence, we applied the LEAS and self-report measures for emotion regulation strategies and negative affect in a representative sample of the German general population. Sample and Methods: A short version of the LEAS, the Hospital Anxiety and Depression Scale (HADS) and the Emotion Regulation Questionnaire (ERQ), assessing reappraisal and suppression as emotion regulation strategies, were presented to N = 2524 participants of a representative German community study. The questionnaire data were analyzed with regard to the level of emotional awareness. Results: LEAS scores were independent from depression, but related to self-reported anxiety. Although of small or medium effect size, different correlational patters between emotion regulation strategies and negative affectivity were related to implict and explict levels of emotional awareness. In participants with implicit emotional awareness, suppression was related to higher anxiety and depression, whereas in participants with explicit emotional awareness, in addition to a positive relationship of suppression and depression, we found a negative relationship of reappraisal to depression. These findings were independent of age. In women high use of suppression and little use of reappraisal were more strongly related to negative affect than in men. Discussion: Our first findings suggest that conscious awareness of emotions may be a precondition for the use of reappraisal as an adaptive emotion regulation strategy. They encourage further research in the relation between subconsious and conscious emotional awareness and the prefarance of adaptive or maladaptive emotion regulation strategies The correlational trends found in a representative sample of the general population may become more pronounced in clinical samples.	[Subic-Wrana, Claudia; Beutel, Manfred E.; Knebel, Achim; Wiltink, Joerg] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Rhinland Palati, Germany; [Braehler, Elmar; Stoebel-Richter, Yve] Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Saxony, Germany; [Lane, Richard D.] Univ Arizona, Coll Social & Behav Sci, Dept Neurosci, Tucson, AZ USA	Johannes Gutenberg University of Mainz; Leipzig University; University of Arizona	Subic-Wrana, C (corresponding author), Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Rhinland Palati, Germany.	Claudia.Subic-Wrana@unimedizin-mainz.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728				Abler B, 2009, DIAGNOSTICA, V55, P144, DOI 10.1026/0012-1924.55.3.144; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Amstadter Ananda B, 2008, J Aggress Maltreat Trauma, V17, P279, DOI 10.1080/10926770802403236; Bach M, 1996, PSYCHOTHER PSYCH MED, V46, P23; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Betts J, 2009, BRIT J DEV PSYCHOL, V27, P473, DOI 10.1348/026151008X314900; Bochand L, 2010, ENCEPHALE, V36, P334, DOI 10.1016/j.encep.2009.12.013; Bydlowski S, 2005, INT J EAT DISORDER, V37, P321, DOI 10.1002/eat.20132; Campbell-Sills L, 2006, BEHAV RES THER, V44, P1251, DOI 10.1016/j.brat.2005.10.001; Chong SA, 2012, ANN ACAD MED SINGAP, V41, P49; Consoli SM, 2010, AM J HYPERTENS, V23, P515, DOI 10.1038/ajh.2010.9; Consoli SM, 2006, DERMATOLOGY, V212, P128, DOI 10.1159/000090653; Danner UN, 2012, EUR EAT DISORD REV, V20, P490, DOI 10.1002/erv.2184; Derogatis LR., 1977, SCL 90 ADM SCORING P; Donges US, 2005, J NERV MENT DIS, V193, P331, DOI 10.1097/01.nmd.0000161683.02482.19; Egloff B, 2006, EMOTION, V6, P356, DOI 10.1037/1528-3542.6.3.356; Ehring T, 2010, EMOTION, V10, P563, DOI 10.1037/a0019010; Franke G., 1995, SYMPTOM CHECK LISTE; Gillanders S, 2008, AM J KIDNEY DIS, V51, P651, DOI 10.1053/j.ajkd.2007.12.023; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Herrmann C., 1995, HADS D HOSP ANXIETY; Hinz A, 2001, PSYCHOTHER PSYCH MED, V51, P193, DOI 10.1055/s-2001-13279; Hinz A, 2011, J PSYCHOSOM RES, V71, P74, DOI 10.1016/j.jpsychores.2011.01.005; Hofmann W, 2009, J EXP SOC PSYCHOL, V45, P431, DOI 10.1016/j.jesp.2008.09.013; Igarashi T, 2011, BIOPSYCHOSOC MED, V5, DOI 10.1186/1751-0759-5-2; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kraaij V, 2002, AGING MENT HEALTH, V6, P275, DOI 10.1080/13607860220142387; Kraaij V, 2008, AIDS PATIENT CARE ST, V22, P395, DOI 10.1089/apc.2007.0145; Kurth BM, 2012, BUNDESGESUNDHEITSBLA, V55, P980, DOI 10.1007/s00103-012-1504-5; LANE RD, 1990, J PERS ASSESS, V55, P124, DOI 10.1207/s15327752jpa5501&2_12; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 1998, COMPR PSYCHIAT, V39, P377, DOI 10.1016/S0010-440X(98)90051-7; LANE RD, 1987, AM J PSYCHIAT, V144, P133; Laux L., 1981, STATE TRAIT ANGSTINV; Liverant GI, 2008, BEHAV RES THER, V46, P1201, DOI 10.1016/j.brat.2008.08.001; Meng XF, 2012, CAN J PSYCHIAT, V57, P479, DOI 10.1177/070674371205700806; Moore SA, 2008, BEHAV RES THER, V46, P993, DOI 10.1016/j.brat.2008.05.001; Pasquier A, 2010, ENCEPHALE, V36, pD97, DOI 10.1016/j.encep.2009.01.007; Piaget J, 1972, PSYCHOL KINDES; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Subic-Wrana C, 2005, PSYCHOSOM MED, V67, P483, DOI 10.1097/01.psy.0000160461.19239.13; Subic-Wrana C, 2002, PSYCHOTHER PSYCH MED, V52, P454, DOI 10.1055/s-2002-35281; Subic-Wrana C, 2011, UEXKULL PSYCHOSOMATI, P241; Subic-Wrana C, 2010, PSYCHOSOM MED, V72, P404, DOI 10.1097/PSY.0b013e3181d35e83; Wiltink J., 2011, GMS PSYCHOSOCIAL MED, V8, DOI [https://doi.org/10.3205/psm000078, 10.3205/psm000078, DOI 10.3205/PSM000078]	47	41	44	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91846	10.1371/journal.pone.0091846	http://dx.doi.org/10.1371/journal.pone.0091846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637792	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100067
J	Groeneweg, FL; van Royen, ME; Fenz, S; Keizer, VIP; Geverts, B; Prins, J; de Kloet, ER; Houtsmuller, AB; Schmidt, TS; Schaaf, MJM				Groeneweg, Femke L.; van Royen, Martin E.; Fenz, Susanne; Keizer, Veer I. P.; Geverts, Bart; Prins, Jurrien; de Kloet, E. Ron; Houtsmuller, Adriaan B.; Schmidt, Thomas S.; Schaaf, Marcel J. M.			Quantitation of Glucocorticoid Receptor DNA-Binding Dynamics by Single-Molecule Microscopy and FRAP	PLOS ONE			English	Article							NF-KAPPA-B; MINERALOCORTICOID RECEPTOR; CORRELATION SPECTROSCOPY; IN-VIVO; TRANSCRIPTION; REVEALS; PROTEIN; MOBILITY; CHROMATIN; MEMBRANE	Recent advances in live cell imaging have provided a wealth of data on the dynamics of transcription factors. However, a consistent quantitative description of these dynamics, explaining how transcription factors find their target sequences in the vast amount of DNA inside the nucleus, is still lacking. In the present study, we have combined two quantitative imaging methods, single-molecule microscopy and fluorescence recovery after photobleaching, to determine the mobility pattern of the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR), two ligand-activated transcription factors. For dexamethasone-activated GR, both techniques showed that approximately half of the population is freely diffusing, while the remaining population is bound to DNA. Of this DNA-bound population about half the GRs appeared to be bound for short periods of time (similar to 0.7 s) and the other half for longer time periods (similar to 2.3 s). A similar pattern of mobility was seen for the MR activated by aldosterone. Inactive receptors (mutant or antagonist-bound receptors) show a decreased DNA binding frequency and duration, but also a higher mobility for the diffusing population. Likely, very brief (<= 1 ms) interactions with DNA induced by the agonists underlie this difference in diffusion behavior. Surprisingly, different agonists also induce different mobilities of both receptors, presumably due to differences in ligand-induced conformational changes and receptor complex formation. In summary, our data provide a consistent quantitative model of the dynamics of GR and MR, indicating three types of interactions with DNA, which fit into a model in which frequent low-affinity DNA binding facilitates the search for high-affinity target sequences.	[Groeneweg, Femke L.; Prins, Jurrien; de Kloet, E. Ron] Leiden Univ, LUMC, Dept Med Pharmacol, Leiden, Netherlands; [van Royen, Martin E.; Geverts, Bart; Houtsmuller, Adriaan B.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Fenz, Susanne; Schmidt, Thomas S.] Leiden Univ, LION, Inst Phys, Leiden, Netherlands; [Fenz, Susanne] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany; [Keizer, Veer I. P.; Prins, Jurrien; Schaaf, Marcel J. M.] Leiden Univ, Inst Biol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University - Excl LUMC; University of Wurzburg; Leiden University; Leiden University - Excl LUMC	Schaaf, MJM (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	m.j.m.schaaf@biology.leidenuniv.nl	Fenz, Susanne F/B-7969-2012; Schmidt, Thomas/B-6296-2009; prins, jurrien/AAK-9350-2020	Fenz, Susanne F/0000-0002-8395-0727; Schmidt, Thomas/0000-0002-0045-1851; prins, jurrien/0000-0001-6499-5076; Schaaf, Marcel/0000-0002-5859-8936; van Royen, Martin/0000-0002-6814-0996; de Kloet, Ron/0000-0001-9176-1830	Royal Netherlands Academy for Arts and Sciences; Netherlands Organization for Scientific Research (NWO-STW); Foundation for Fundamental Research on Matter (FOM); SmartMix Program of The Netherlands Ministry of Economic Affairs; Ministry of Education, Culture and Science	Royal Netherlands Academy for Arts and Sciences; Netherlands Organization for Scientific Research (NWO-STW)(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); SmartMix Program of The Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	FLG and ERdK are supported by the Royal Netherlands Academy for Arts and Sciences, MvR by the Netherlands Organization for Scientific Research (NWO-STW), VIPK by the Foundation for Fundamental Research on Matter (FOM), and MJMS by the SmartMix Program of The Netherlands Ministry of Economic Affairs and the Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER TK, 1994, MOL ENDOCRINOL, V8, P568, DOI 10.1210/me.8.5.568; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Biddie SC, 2009, STRESS, V12, P193, DOI 10.1080/10253890802506409; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; DEKLOET ER, 1994, ANN NY ACAD SCI, V746, P8; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/NMETH.2411, 10.1038/nmeth.2411]; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Gomez-Sanchez EP, 2010, EXP PHYSIOL, V95, P13, DOI 10.1113/expphysiol.2008.045914; Gorski SA, 2006, CURR OPIN CELL BIOL, V18, P284, DOI 10.1016/j.ceb.2006.03.002; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Grossmann C, 2004, EUR J ENDOCRINOL, V151, P397, DOI 10.1530/eje.0.1510397; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Harms GS, 2001, BIOPHYS J, V80, P2396, DOI 10.1016/S0006-3495(01)76209-1; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Li GW, 2009, FEBS LETT, V583, P3979, DOI 10.1016/j.febslet.2009.11.035; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Lind U, 2000, J BIOL CHEM, V275, P19041, DOI 10.1074/jbc.M000228200; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; Lord SJ, 2010, ANAL CHEM, V82, P2192, DOI 10.1021/ac9024889; Mazza D, 2012, METHODS MOL BIOL, V833, P177, DOI 10.1007/978-1-61779-477-3_12; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2007, MOL CELL BIOL, V27, P2442, DOI 10.1128/MCB.01570-06; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; MUNCK A, 1976, J STEROID BIOCHEM, V7, P1117, DOI 10.1016/0022-4731(76)90042-X; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Polman JAE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-118; Quinkler M, 2002, EUR J ENDOCRINOL, V146, P789, DOI 10.1530/eje.0.1460789; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RUPPRECHT R, 1993, EUR J PHARM-MOLEC PH, V247, P145, DOI 10.1016/0922-4106(93)90072-H; Saxton Michael J., 2007, V400, P295; Schaaf MJM, 2006, J BIOL CHEM, V281, P22409, DOI 10.1074/jbc.M511086200; Schaaf MJM, 2009, BIOPHYS J, V97, P1206, DOI 10.1016/j.bpj.2009.05.044; Schaaf MJM, 2005, MOL ENDOCRINOL, V19, P1501, DOI 10.1210/me.2005-0050; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Semrau S, 2007, BIOPHYS J, V92, P613, DOI 10.1529/biophysj.106.092577; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Speil J, 2011, BIOPHYS J, V101, P2592, DOI 10.1016/j.bpj.2011.10.006; Stasevich TJ, 2010, BIOPHYS J, V99, P3093, DOI 10.1016/j.bpj.2010.08.059; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; van den Broek B, 2008, P NATL ACAD SCI USA, V105, P15738, DOI 10.1073/pnas.0804248105; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; van Royen Martin E., 2009, V505, P69, DOI 10.1007/978-1-60327-575-0_5; van Royen Martin E., 2008, V464, P363, DOI 10.1007/978-1-60327-461-6_20; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, METHODS, V39, P316, DOI 10.1016/j.ymeth.2006.06.002	62	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90532	10.1371/journal.pone.0090532	http://dx.doi.org/10.1371/journal.pone.0090532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632838	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400016
J	Liao, KL; Bai, XF; Friedman, A				Liao, Kang-Ling; Bai, Xue-Feng; Friedman, Avner			Mathematical Modeling of Interleukin-27 Induction of Anti-Tumor T Cells Response	PLOS ONE			English	Article							COMPLETE REGRESSION; TUMOR-DEVELOPMENT; CANCER INVASION; IFN-GAMMA; IL-27; IL-10; GROWTH; EXPRESSION; EFFECTOR; PROMOTES	Interleukin-12 is a pro-inflammatory cytokine which promotes Th1 and cytotoxic T lymphocyte activities, such as Interferon-gamma secretion. For this reason Interleukin-12 could be a powerful therapeutic agent for cancer treatment. However, Interleukin-12 is also excessively toxic. Interleukin-27 is an immunoregulatory cytokine from the Interleukin-12 family, but it is not as toxic as Interleukin-12. In recent years, Interleukin-27 has been considered as a potential anti-tumor agent. Recent experiments in vitro and in vivo have shown that cancer cells transfected with IL-27 activate CD8(+) T cells to promote the secretion of anti-tumor cytokines Interleukin-10, although, at the same time, IL-27 inhibits the secretion of Interferon-gamma by CD8(+) T cells. In the present paper we develop a mathematical model based on these experimental results. The model involves a dynamic network which includes tumor cells, CD8(+) T cells and cytokines Interleukin-27, Interleukin-10 and Interferon-gamma. Simulations of the model show how Interleukin-27 promotes CD8(+) T cells to secrete Interleukin-10 to inhibit tumor growth. On the other hand Interleukin-27 inhibits the secretion of Interferon-gamma by CD8(+) T cells which somewhat diminishes the inhibition of tumor growth. Our numerical results are in qualitative agreement with experimental data. We use the model to design protocols of IL-27 injections for the treatment of cancer and find that, for some special types of cancer, with a fixed total amount of drug, within a certain range, continuous injection has better efficacy than intermittent injections in reducing the tumor load while the treatment is ongoing, although the decrease in tumor load is only temporary.	[Liao, Kang-Ling; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Bai, Xue-Feng] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Bai, Xue-Feng] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liao, KL (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	liao.92@mbi.osu.edu	Bai, Xue-feng/E-2681-2011; Bai, Xue-Feng/H-5164-2013	Bai, Xue-Feng/0000-0001-9476-8376	National Science Council of Taiwan, R.O.C [NSC 101-2917-I-564-062]; National Science Foundation [DMS 0931642]; National Cancer Institute [R01CA138427]; American Cancer Society [RSG-09-188-01-LIB]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA138427] Funding Source: NIH RePORTER	National Science Council of Taiwan, R.O.C(Ministry of Science and Technology, Taiwan); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in part, by the National Science Council of Taiwan, R.O.C (http://web1.nsc.gov.tw/) under No. NSC 101-2917-I-564-062; the National Science Foundation (http://www.nsf.gov/) under Agreement DMS 0931642; the National Cancer Institute (http://www.cancer.gov/) under R01CA138427; and the American Cancer Society (http://www.cancer.org/) under RSG-09-188-01-LIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Bresch D, 2010, SIAM J SCI COMPUT, V32, P2321, DOI 10.1137/070708895; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; BYRNE HM, 1995, MATH BIOSCI, V130, P151, DOI 10.1016/0025-5564(94)00117-3; Car BD, 1999, TOXICOL PATHOL, V27, P58, DOI 10.1177/019262339902700112; Cavallo F, 1997, J NATL CANCER I, V89, P1049, DOI 10.1093/jnci/89.14.1049; Chaplain MAJ, 2006, NETW HETEROG MEDIA, V1, P399; Chiyo M, 2004, ANTICANCER RES, V24, P3763; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; Deakin NE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00070; Fujii S, 2001, BLOOD, V98, P2143, DOI 10.1182/blood.V98.7.2143; Groux H, 1999, J IMMUNOL, V162, P1723; Groux H, 1998, J IMMUNOL, V160, P3188; Hall AO, 2012, ADV IMMUNOL, V115, P1, DOI 10.1016/B978-0-12-394299-9.00001-1; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Itakura E, 2011, MODERN PATHOL, V24, P801, DOI 10.1038/modpathol.2011.5; Lemech C, 2012, CLIN MED INSIGHTS-ON, V6, DOI 10.4137/CMO.S5855; Liao KL, 2013, J THEOR BIOL, V328, P65, DOI 10.1016/j.jtbi.2013.03.017; Liu ZZ, 2013, EUR J IMMUNOL, V43, P468, DOI 10.1002/eji.201242930; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marshall E, 1995, SCIENCE, V268, P1555; McGillen JB, 2013, J MATH BIOL; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Morishima N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/605483; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Rakhmilevich AL, 1997, HUM GENE THER, V8, P1303, DOI 10.1089/hum.1997.8.11-1303; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; ROTH AD, 1991, CLIN EXP IMMUNOL, V86, P163; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Shinozaki Y, 2009, INT J CANCER, V124, P1372, DOI 10.1002/ijc.24107; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Swarbrick A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25409; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Szymanska Z, 2009, MATH MOD METH APPL S, V19, P257, DOI 10.1142/S0218202509003425; Tanikawa T, 2012, CANCER RES, V72, P420, DOI 10.1158/0008-5472.CAN-10-4627; Wang R, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-62; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Zhu SG, 2010, J IMMUNOL, V184, P2348, DOI 10.4049/jimmunol.0902371; Zolochevska O, 2013, J CELL PHYSIOL, V228, P1127, DOI 10.1002/jcp.24265	49	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91844	10.1371/journal.pone.0091844	http://dx.doi.org/10.1371/journal.pone.0091844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633175	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400105
J	Mwafongo, AA; Rosenberg, NE; Ng'ambi, W; Werner, AB; Garneau, WM; Gumulira, J; Phiri, S; Hosseinipour, MC				Mwafongo, Albert A.; Rosenberg, Nora E.; Ng'ambi, Wingston; Werner, Alexandra B.; Garneau, William M.; Gumulira, Joe; Phiri, Sam; Hosseinipour, Mina C.			Treatment Outcomes of AIDS-Associated Kaposi's Sarcoma under a Routine Antiretroviral Therapy Program in Lilongwe, Malawi: Bleomycin/Vincristine Compared to Vincristine Monotherapy	PLOS ONE			English	Article							IMMUNE-DEFICIENCY-SYNDROME; SUB-SAHARAN AFRICA; FOLLOW-UP; RISK-FACTORS; LOST; MORTALITY; CHEMOTHERAPY; COMBINATION; SETTINGS	Purpose: Despite Kaposi's sarcoma (KS) being the most prevalent AIDS-associated cancer in resource limited settings, optimal treatment options remain unknown. We assessed whether bleomycin/vincristine compared to vincristine monotherapy was associated with improved treatment outcomes for AIDS-associated KS among patients initiating combination antiretroviral therapy (cART) in Malawi. Methods: All patients initiating cART and chemotherapy for AIDS-related KS were identified from an electronic data system from the HIV Lighthouse Clinic from 2002 to 2011. Treatment responses were compared between patients receiving vincristine monotherapy and vincristine/bleomycin. Binomial regression models were implemented to assess probability of tumor improvement for patients receiving vincristine/bleomycin compared to vincristine monotherapy after a complete cycle of chemotherapy (9-10 months). A chi-squared test was used to compare changes in CD4 count after six months of chemotherapy. Results: Of 449 patients with AIDS-associated KS on chemotherapy, 94% received vincristine monotherapy and 6% received bleomycin/vincristine. Distribution of treatment outcomes was different: 29% of patients on vincristine experienced tumor improvement compared to 53% of patients on bleomycin/vincristine. Patients receiving bleomycin/vincristine were 2.25 (95% CI: 1.47, 3.44) times as likely to experience tumor improvement as to those on vincristine monotherapy. This value changed little after adjustment for age and baseline CD4 count: 2.46 (95% CI: 1.57, 3.86). Change in CD4 count was similar for patients receiving vincristine monotherapy and bleomycin/vincristine (p = 0.6). Conclusion: Bleomycin/vincristine for the treatment of AIDS-associated KS was associated with better tumor response compared to vincristine monotherapy without impairing CD4 count recovery. Replication in larger datasets and randomized controlled trials is necessary.	[Mwafongo, Albert A.; Rosenberg, Nora E.; Hosseinipour, Mina C.] Univ North Carolina Project, Lilongwe, Malawi; [Rosenberg, Nora E.; Werner, Alexandra B.; Garneau, William M.; Hosseinipour, Mina C.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Ng'ambi, Wingston; Gumulira, Joe; Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mwafongo, AA (corresponding author), Univ North Carolina Project, Lilongwe, Malawi.	amwafongo@gmail.com	Garneau, William/GXV-3378-2022	Garneau, William/0000-0002-1849-1640	National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; NCC; NEI; NHBLI; NIDCR; NIDA; NIMH; NIAID; NIHOWH; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; American Relief and Recovery Act; University of North Carolina Center for AIDS Research [P30AI50410]; UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program [R25TW009340]; UNC Center for AIDS Research [P30 AI50410]; American Society of Tropical Medicine and Hygiene; FOGARTY INTERNATIONAL CENTER [R25TW009340, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCC; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHBLI; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIHOWH; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; American Relief and Recovery Act; University of North Carolina Center for AIDS Research; UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program; UNC Center for AIDS Research; American Society of Tropical Medicine and Hygiene; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AM was supported by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, NCC, NEI, NHBLI, NIDCR, NIDA, NIMH, NIAID, NIHOWH, Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988), the American Relief and Recovery Act, and the University of North Carolina Center for AIDS Research (P30AI50410). NR was supported by the UNC Hopkins Morehouse Tulane Fogarty Global Health Fellows Program (R25TW009340), and the UNC Center for AIDS Research (P30 AI50410). WG was supported by the Benjamin H. Kean Traveling Fellowship in Tropical Medicine from the American Society of Tropical Medicine and Hygiene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bihl F, 2007, AIDS, V21, P1245, DOI 10.1097/QAD.0b013e328182df03; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chu K, 2010, INT HEALTH, V2, P99, DOI 10.1016/j.inhe.2010.04.001; Chu KM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-23; Cottrill C P, 1997, Clin Oncol (R Coll Radiol), V9, P365, DOI 10.1016/S0936-6555(97)80129-X; Dittmer DP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00141; Francis H, 2012, PROSPECTIVE STUDY AS, V2012; GILL P, 1990, AM J CLIN ONCOL-CANC, V13, P315, DOI 10.1097/00000421-199008000-00010; GILL PS, 1990, CANCER, V65, P1074, DOI 10.1002/1097-0142(19900301)65:5<1074::AID-CNCR2820650505>3.0.CO;2-1; GILL PS, 1991, AM J MED, V90, P427, DOI 10.1016/0002-9343(91)80081-V; GOMPELS MM, 1992, AIDS, V6, P1175, DOI 10.1097/00002030-199210000-00018; HIV unit, 2003, TREATM AIDS GUID US; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Krown SE, 2004, J CLIN ONCOL, V22, P399, DOI 10.1200/JCO.2004.08.064; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Krown SE, 2011, CURR OPIN ONCOL, V23, P463, DOI 10.1097/CCO.0b013e328349428d; Makombe SD, 2008, TROP DOCT, V38, P5, DOI 10.1258/td.2007.060023; MINTZER DM, 1985, ANN INTERN MED, V102, P200, DOI 10.7326/0003-4819-102-2-200; Mlombe Y, 2008, MALAWI MED J, V20, P129; Mosam A, 2010, CURR OPIN INFECT DIS, V23, P119, DOI 10.1097/QCO.0b013e328335b01a; Mosam A, 2012, JAIDS-J ACQ IMM DEF, V60, P150, DOI 10.1097/QAI.0b013e318251aedd; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sissolak G, 2005, TROP MED INT HEALTH, V10, P981, DOI 10.1111/j.1365-3156.2005.01491.x; Stebbing J, 2006, LANCET, V367, P1495, DOI 10.1016/S0140-6736(06)68649-2; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Uldrick TS, 2011, CANCER LETT, V305, P150, DOI 10.1016/j.canlet.2011.02.006; Vanni T, 2006, HIV CLIN TRIALS, V7, P194, DOI 10.1310/hct0704-194; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	31	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91020	10.1371/journal.pone.0091020	http://dx.doi.org/10.1371/journal.pone.0091020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632813	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400035
J	Olderoy, MO; Lilledahl, MB; Beckwith, MS; Melvik, JE; Reinholt, F; Sikorski, P; Brinchmann, JE				Olderoy, Magnus O.; Lilledahl, Magnus B.; Beckwith, Marianne Sandvold; Melvik, Jan Egil; Reinholt, Finn; Sikorski, Pawel; Brinchmann, Jan E.			Biochemical and Structural Characterization of Neocartilage Formed by Mesenchymal Stem Cells in Alginate Hydrogels	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; HYALURONIC-ACID HYDROGELS; PROCOLLAGEN C-PROTEINASE; ARTICULAR-CARTILAGE; ENGINEERED CARTILAGE; DEGRADATION; COLLAGEN; BONE; FIBRILLOGENESIS	A popular approach to make neocartilage in vitro is to immobilize cells with chondrogenic potential in hydrogels. However, functional cartilage cannot be obtained by control of cells only, as function of cartilage is largely dictated by architecture of extracellular matrix (ECM). Therefore, characterization of the cells, coupled with structural and biochemical characterization of ECM, is essential in understanding neocartilage assembly to create functional implants in vitro. We focused on mesenchymal stem cells (MSC) immobilized in alginate hydrogels, and used immunohistochemistry (IHC) and gene expression analysis combined with advanced microscopy techniques to describe properties of cells and distribution and organization of the forming ECM. In particular, we used second harmonic generation (SHG) microscopy and focused ion beam/scanning electron microscopy (FIB/SEM) to study distribution and assembly of collagen. Samples with low cell seeding density (1e7 MSC/ml) showed type II collagen molecules distributed evenly through the hydrogel. However, SHG microscopy clearly indicated only pericellular localization of assembled fibrils. Their distribution was improved in hydrogels seeded with 5e7 MSC/ml. In those samples, FIB/SEM with nm resolution was used to visualize distribution of collagen fibrils in a three dimensional network extending from the pericellular region into the ECM. In addition, distribution of enzymes involved in procollagen processing were investigated in the alginate hydrogel by IHC. It was discovered that, at high cell seeding density, procollagen processing and fibril assembly was also occurring far away from the cell surface, indicating sufficient transport of procollagen and enzymes in the intercellular space. At lower cell seeding density, the concentration of enzymes involved in procollagen processing was presumably too low. FIB/SEM and SHG microscopy combined with IHC localization of specific proteins were shown to provide meaningful insight into ECM assembly of neocartilage, which will lead to better understanding of cartilage formation and development of new tissue engineering strategies.	[Olderoy, Magnus O.; Brinchmann, Jan E.] Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Lilledahl, Magnus B.; Beckwith, Marianne Sandvold; Sikorski, Pawel] Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway; [Melvik, Jan Egil] NovaMatrix FMC Biopolymer, Sandvika, Norway; [Reinholt, Finn] Univ Oslo, Dept Pathol, Oslo, Norway; [Reinholt, Finn] Oslo Univ Hosp, Oslo, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo	Olderoy, MO (corresponding author), Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Oslo, Norway.	magnus.ostgard.olderoy@rr-research.no	Sikorski, Pawel/A-2304-2009	Sikorski, Pawel/0000-0001-9413-1623; Beckwith, Marianne Sandvold/0000-0001-8235-3755	South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p; Bushby AJ, 2011, NAT PROTOC, V6, P845, DOI 10.1038/nprot.2011.332; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040; Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Fernandes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062994; Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024; Guo Y, 2012, J MATER SCI-MATER M, V23, P2267, DOI 10.1007/s10856-012-4684-5; Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.TEA.2010.0499, 10.1089/ten.tea.2010.0499]; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Kadler KE, 1996, BIOCHEM J, V316, P1; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Klein TJ, 2010, SOFT MATTER, V6, P5175, DOI 10.1039/c0sm00229a; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kundu J, 2015, J TISSUE ENG REGEN M, V9, P1286, DOI 10.1002/term.1682; Leal-Egana A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-24; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Melvik JE, 2011, US Patent Application, Patent No. 20110053886; Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d; Ng KW, 2009, OSTEOARTHR CARTILAGE, V17, P220, DOI 10.1016/j.joca.2008.06.013; Nicodemus GD, 2011, ACTA BIOMATER, V7, P492, DOI 10.1016/j.actbio.2010.08.021; Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0; Rice MA, 2007, TISSUE ENG, V13, P683, DOI 10.1089/ten.2006.0142; Roberts JJ, 2011, CLIN ORTHOP RELAT R, V469, P2725, DOI 10.1007/s11999-011-1823-0; Smith AM, 2012, BIOMACROMOLECULES, V13, P4032, DOI 10.1021/bm301321d; Trewenack AJ, 2009, MATH MED BIOL, V26, P241, DOI 10.1093/imammb/dqp013; Wong M, 2001, J ORTHOPAED RES, V19, P493, DOI 10.1016/S0736-0266(00)90023-8; Zehbe R, 2012, MICRON, V43, P1060, DOI 10.1016/j.micron.2012.05.001	33	29	30	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91662	10.1371/journal.pone.0091662	http://dx.doi.org/10.1371/journal.pone.0091662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626259	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300115
J	Rosjo, H; Dahl, MB; Bye, A; Andreassen, J; Jorgensen, M; Wisloff, U; Christensen, G; Edvardsen, T; Omland, T				Rosjo, Helge; Dahl, Mai Britt; Bye, Anja; Andreassen, Johanna; Jorgensen, Marit; Wisloff, Ulrik; Christensen, Geir; Edvardsen, Thor; Omland, Torbjorn			Prognostic Value of Circulating MicroRNA-210 Levels in Patients with Moderate to Severe Aortic Stenosis	PLOS ONE			English	Article							HEART-FAILURE; MYOCARDIAL-INFARCTION; BIOMARKERS; QUANTIFICATION; MIR-210; DISEASE; PLASMA; ISCHEMIA; RISK	Background: Circulating micro-RNAs have been proposed as a novel class of cardiovascular (CV) biomarkers, but whether they meet analytical requirements and provide additional information to establish risk indices have not been established. miR-210 levels are increased in subjects with low VO2 max, which is a recognized risk factor in patients with aortic stenosis (AS), and we hypothesized that circulating miR-210 levels may be increased in patients with AS and associated with a poor prognosis. Methods: We measured circulating miR-210 levels by real-time PCR in 57 patients with moderate to severe AS and in 10 age-and gender-matched healthy controls. The merit of miR-210 as a biomarker was assessed according to established criteria, including by comparing miR-210 levels with NT-proBNP and miR-22 levels, which is another miRNA biomarker candidate. Results: All patients and control subjects had miR-210 levels within the range of detection (Cq<35) and the analytical variability was low. Circulating miR-210 levels were 2.0+/-0.2 [mean+/-SEM] fold increased in AS patients compared to controls (p = 0.002), whereas miR-22 levels were not differently expressed in the AS patients (0.12+/-0.06 fold increase, p = 0.45). The increase in miR-210 levels in AS patients was comparable to the increment in NT-proBNP levels: [AUC] 0.82 (95% CI 0.70-0.90) vs. 0.85 (0.75-0.93), respectively, p = 0.71. During a median follow-up of 1287 days, 15 patients (26%) died. There was a significant association between higher circulating levels of miR-210 and increased mortality during follow-up: hazard ratio [supra- vs. inframedian levels] 3.3 (95% CI 1.1-10.5), p = 0.039. Adjusting for other risk indices in multivariate analysis did not attenuate the prognostic merit of circulating miR-210 levels. Conclusion: Circulating miR-210 levels are increased in patients with AS and provide independent prognostic information to established risk indices. Analytical characteristics were also excellent supporting the potential of micro-RNAs as novel CV biomarkers.	[Rosjo, Helge; Dahl, Mai Britt; Jorgensen, Marit; Omland, Torbjorn] Akershus Univ Hosp, Div Med, Lorenskog, Norway; [Rosjo, Helge; Dahl, Mai Britt; Jorgensen, Marit; Christensen, Geir; Edvardsen, Thor; Omland, Torbjorn] Univ Oslo, Inst Clin Med, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Rosjo, Helge; Dahl, Mai Britt; Jorgensen, Marit; Christensen, Geir; Edvardsen, Thor; Omland, Torbjorn] Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, Norway; [Dahl, Mai Britt; Jorgensen, Marit] Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, UiO, Lorenskog, Norway; [Bye, Anja; Wisloff, Ulrik] Norwegian Inst Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Fac Med, Trondheim, Norway; [Andreassen, Johanna; Edvardsen, Thor] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; National Hospital Norway; University of Oslo	Rosjo, H (corresponding author), Akershus Univ Hosp, Div Med, Lorenskog, Norway.	helge.rosjo@medisin.uio.no	Edvardsen, Thor/F-4079-2012; Bye, Anja/K-8041-2019; Wisloff, Ulrik/K-2899-2012	Edvardsen, Thor/0000-0002-3800-765X; Bye, Anja/0000-0003-1259-5542; Wisloff, Ulrik/0000-0002-7211-3587	Akershus University Hospital; University of Oslo	Akershus University Hospital; University of Oslo	This study was supported by Akershus University Hospital and the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; Coglianese EE, 2009, CIRCULATION, V120, P9, DOI 10.1161/CIRCULATIONAHA.109.875591; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Endo K, 2013, BIOL PHARM BULL, V36, P48, DOI 10.1248/bpb.b12-00578; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Kaudewitz D, 2013, THROMB HAEMOSTASIS, V110, P609, DOI 10.1160/TH13-05-0368; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; McManus DD, 2011, CIRCULATION, V124, P1908, DOI 10.1161/CIRCULATIONAHA.111.062117; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Omland Torbjorn, 2008, Crit Care Med, V36, pS17, DOI 10.1097/01.CCM.0000296266.74913.85; Otto CM, 2006, J AM COLL CARDIOL, V47, P2141, DOI 10.1016/j.jacc.2006.03.002; Rosjo H, 2012, CLIN CHEM, V58, P1565, DOI 10.1373/clinchem.2012.190868; Rosjo H, 2011, AM J CARDIOL, V108, P88, DOI 10.1016/j.amjcard.2011.02.346; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Vahanian A, 2010, EUR HEART J, V31, P416, DOI 10.1093/eurheartj/ehp575; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; VINCENT WR, 1974, CIRCULATION, V49, P326, DOI 10.1161/01.CIR.49.2.326; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Zampetaki A, 2012, THROMB HAEMOSTASIS, V108, P592, DOI 10.1160/TH12-02-0097; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhao DS, 2013, CARDIOVASC PATHOL, V22, P444, DOI 10.1016/j.carpath.2013.04.001	32	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91812	10.1371/journal.pone.0091812	http://dx.doi.org/10.1371/journal.pone.0091812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626394	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300138
J	Serang, O				Serang, Oliver			The Probabilistic Convolution Tree: Efficient Exact Bayesian Inference for Faster LC-MS/MS Protein Inference	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CAUSAL INDEPENDENCE; SHOTGUN PROTEOMICS; MARGINALIZATION	Exact Bayesian inference can sometimes be performed efficiently for special cases where a function has commutative and associative symmetry of its inputs (called "causal independence''). For this reason, it is desirable to exploit such symmetry on big data sets. Here we present a method to exploit a general form of this symmetry on probabilistic adder nodes by transforming those probabilistic adder nodes into a probabilistic convolution tree with which dynamic programming computes exact probabilities. A substantial speedup is demonstrated using an illustration example that can arise when identifying splice forms with bottom-up mass spectrometry-based proteomics. On this example, even state-of-the-art exact inference algorithms require a runtime more than exponential in the number of splice forms considered. By using the probabilistic convolution tree, we reduce the runtime to O(k log(k)(2)) and the space to O(k log(k)) where k is the number of variables joined by an additive or cardinal operator. This approach, which can also be used with junction tree inference, is applicable to graphs with arbitrary dependency on counting variables or cardinalities and can be used on diverse problems and fields like forward error correcting codes, elemental decomposition, and spectral demixing. The approach also trivially generalizes to multiple dimensions.	Thermo Fisher Sci, Bremen, Germany	Thermo Fisher Scientific	Serang, O (corresponding author), Thermo Fisher Sci, Bremen, Germany.	orserang@uw.edu			Thermo Fisher Scientific	Thermo Fisher Scientific	This work was created as an employee of Thermo Fisher Scientific (http://www.thermofisher.com/) with no external funding. The funder provided support in the form of salaries for author OS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Andersen SK, 1990, HUGIN SHELL BUILDING, P332; Andrews G., 1998, THEORY PARTITIONS, V2; BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Heckerman D, 1996, IEEE T SYST MAN CY A, V26, P826, DOI 10.1109/3468.541341; Heckerman D, 1993, P 9 C UNC ART INT, P122; Heckerman D, 1994, P 10 C UNC ART INT, P286, DOI DOI 10.1016/B978-1-55860-332-5.50041-9; Huang T, 2012, BRIEF BIOINFORM, V13, P586, DOI 10.1093/bib/bbs004; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Kelchtermans P, 2013, PROTEOMICS; KOLLER D., 2009, PROBABILISTIC GRAPHI; Li YF, 2008, LECT N BIOINFORMAT, V4955, P167; Li YF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S4; Li YF, 2012, STAT INTERFACE, V5, P21; McDowell GS, 2013, J PROTEOME RES, V12, P3809, DOI 10.1021/pr400032m; Minka T. P., 2001, PROC 17 C UNCERTAINT, P362; Murphy K, 1999, P 15 C UNC ART INT, P4067; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009; NUSSBAUMER HJ, 1978, IBM J RES DEV, V22, P134, DOI 10.1147/rd.222.0134; Pearl J., 1982, P AM ASS ART INT NAT, P133; POTTIER L, 1991, LECT NOTES COMPUT SC, V488, P162; Rappsilber J, 2002, TRENDS BIOCHEM SCI, V27, P74, DOI 10.1016/S0968-0004(01)02021-7; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; ROBERTSON N, 1984, J COMB THEORY B, V36, P49, DOI 10.1016/0095-8956(84)90013-3; Serang O, 2012, J PROTEOME RES, V11, P5586, DOI 10.1021/pr300426s; Serang O, 2012, IEEE ACM T COMPUT BI, V9, P809, DOI 10.1109/TCBB.2012.26; Serang O, 2012, STAT INTERFACE, V5, P3; Serang O, 2010, J PROTEOME RES, V9, P5346, DOI 10.1021/pr100594k; Shokrollahi A, 2004, PROG COM SC, V23, P85; Zhang NL, 1996, J ARTIF INTELL RES, V5, P301, DOI 10.1613/jair.305	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91507	10.1371/journal.pone.0091507	http://dx.doi.org/10.1371/journal.pone.0091507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626234	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300093
J	Zhu, JW; Loos, RJF; Lu, L; Zong, G; Gan, W; Ye, XW; Sun, L; Li, HX; Lin, X				Zhu, Jingwen; Loos, Ruth J. F.; Lu, Ling; Zong, Geng; Gan, Wei; Ye, Xingwang; Sun, Liang; Li, Huaixing; Lin, Xu			Associations of Genetic Risk Score with Obesity and Related Traits and the Modifying Effect of Physical Activity in a Chinese Han Population	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; FTO RS9939609 POLYMORPHISM; COMMON VARIANTS; LOCI; FAT; PREDISPOSITION; CHILDHOOD; CHILDREN	Background/Objectives: Recent large-scale genome-wide association studies have identified multiple loci robustly associated with BMI, predominantly in European ancestry (EA) populations. However, associations of these loci with obesity and related traits have not been well described in Chinese Hans. This study aimed to investigate whether BMI-associated loci are, individually and collectively, associated with adiposity-related traits and obesity in Chinese Hans and whether these associations are modified by physical activity (PA). Subjects/Methods: We genotyped 28 BMI-associated single nucleotide polymorphisms (SNPs) in a population-based cohort including 2,894 unrelated Han Chinese. Genetic risk score (GRS), EA and East Asian ancestry (EAA) GRSs were calculated by adding BMI-increasing alleles based on all, EA and EAA identified SNPs, respectively. Interactions of GRS and PA were examined by including the interaction-term in the regression model. Results: Individually, 26 of 28 SNPs showed directionally consistent effects on BMI, and associations of four loci (TMEM18, PCSK1, BDNF and MAP2K5) reached nominal significance(P<0.05). The GRS was associated with increased BMI, trunk fat and body fat percentages; and increased risk of obesity and overweight (all P<0.05). Effect sizes (0.11 vs. 0.17 kg/m(2)) and explained variance (0.90% vs. 1.45%) of GRS for BMI tended to be lower in Chinese Hans than in Europeans. The EA GRS and EAA GRS were associated with 0.11 and 0.13 kg/m(2) higher BMI, respectively. In addition, we found that PA attenuated the effect of the GRS on BMI (P-interaction = 0.022). Conclusions: Our observations suggest that the combined effect of obesity-susceptibility loci on BMI tended to be lower in Han Chinese than in EA. The overall, EA and EAA GRSs exert similar effects on adiposity traits. Genetic predisposition to increased BMI is attenuated by PA in this population of Han Chinese.	[Zhu, Jingwen; Lu, Ling; Zong, Geng; Gan, Wei; Ye, Xingwang; Sun, Liang; Li, Huaixing; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Zhu, Jingwen; Lu, Ling; Zong, Geng; Gan, Wei; Ye, Xingwang; Sun, Liang; Li, Huaixing; Lin, Xu] Chinese Acad Sci, Grad Univ, Shanghai, Peoples R China; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, Charles Bronfman Inst Personalized Med, Mindich Child Hlth & Dev Inst,Dept Prevent Med, New York, NY USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Icahn School of Medicine at Mount Sinai	Li, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	lihx@sibs.ac.cn; xlin@sibs.ac.cn	Loos, Ruth J F/Q-2862-2016; Zong, Geng/ABG-6946-2021; Loos, Ruth/GON-5877-2022	Loos, Ruth J F/0000-0002-8532-5087; 	National High Technology Research and Development Program (863 Program) [2009AA022704]; National Basic Research Program of China (973 Program) [2012CB524900]; National Natural Science Foundation of China [30930081, 81170734, 81021002]; Chinese Academy of Sciences [KSCX2-EW-R-10, SIBS2008006]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the National High Technology Research and Development Program (863 Program 2009AA022704), the National Basic Research Program of China (973 Program 2012CB524900), the National Natural Science Foundation of China (30930081, 81170734 and 81021002), and the Chinese Academy of Sciences (KSCX2-EW-R-10 and SIBS2008006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Browne W.J., 2009, GUIDE SAMPLE SIZE CA; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hong J, 2013, INT J OBESITY, V37, P673, DOI 10.1038/ijo.2012.87; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Ruiz JR, 2010, ARCH PEDIAT ADOL MED, V164, P328, DOI 10.1001/archpediatrics.2010.29; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tews D, 2011, HORM METAB RES, V43, P17, DOI 10.1055/s-0030-1265130; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi B, 2013, BIOMED ENVIRON SCI, V26, P787, DOI 10.3967/bes2013.001; Xi B, 2013, CLIN ENDOCRINOL, V79, P523, DOI 10.1111/cen.12091; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	39	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91442	10.1371/journal.pone.0091442	http://dx.doi.org/10.1371/journal.pone.0091442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626232	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300085
J	Hewitt, SK; Donaldson, IJ; Lovell, SC; Delneri, D				Hewitt, Sarah K.; Donaldson, Ian J.; Lovell, Simon C.; Delneri, Daniela			Sequencing and Characterisation of Rearrangements in Three S. pastorianus Strains Reveals the Presence of Chimeric Genes and Gives Evidence of Breakpoint Reuse	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ADAPTIVE EVOLUTION; NATURAL HYBRIDS; YEAST; GENOME; RECOMBINATION; DIVERGENCE; ALLELES; ORIGINS; REGIONS	Gross chromosomal rearrangements have the potential to be evolutionarily advantageous to an adapting organism. The generation of a hybrid species increases opportunity for recombination by bringing together two homologous genomes. We sought to define the location of genomic rearrangements in three strains of Saccharomyces pastorianus, a natural lager-brewing yeast hybrid of Saccharomyces cerevisiae and Saccharomyces eubayanus, using whole genome shotgun sequencing. Each strain of S. pastorianus has lost species-specific portions of its genome and has undergone extensive recombination, producing chimeric chromosomes. We predicted 30 breakpoints that we confirmed at the single nucleotide level by designing species-specific primers that flank each breakpoint, and then sequencing the PCR product. These rearrangements are the result of recombination between areas of homology between the two subgenomes, rather than repetitive elements such as transposons or tRNAs. Interestingly, 28/30 S. cerevisiae- S. eubayanus recombination breakpoints are located within genic regions, generating chimeric genes. Furthermore we show evidence for the reuse of two breakpoints, located in HSP82 and KEM1, in strains of proposed independent origin.	[Hewitt, Sarah K.; Donaldson, Ian J.; Lovell, Simon C.; Delneri, Daniela] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Delneri, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	d.delneri@manchester.ac.uk		Delneri, Daniela/0000-0001-8070-411X; Lovell, Simon/0000-0002-4092-8458; Hewitt, Sarah/0000-0002-7220-9300; Donaldson, Ian/0000-0002-0032-0931	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F007620/1]; BBSRC [BB/D009901/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007620/1, BB/D009901/1] Funding Source: researchfish; Natural Environment Research Council [NE/B500190/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SKH was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship. This work was also supported by a BBSRC grant to SCL and DD (BB/F007620/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Bond U, 2004, CURR GENET, V45, P360, DOI 10.1007/s00294-004-0504-x; Bond U, 2009, GENOMES LAGER YEASTS, P159; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; de Barros Lopes Miguel, 2002, FEMS Yeast Res, V1, P323, DOI 10.1016/S1567-1356(01)00051-4; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Di Rienzi SC, 2009, GENOME BIOL EVOL, V1, P350, DOI 10.1093/gbe/evp034; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; HANSEN J, 1994, GENE, V140, P33, DOI 10.1016/0378-1119(94)90727-7; Hao Weilong, 2011, Mob Genet Elements, V1, P256; Hoang ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001228; Infante JJ, 2003, GENETICS, V165, P1745; James TC, 2008, CURR GENET, V53, P139, DOI 10.1007/s00294-007-0172-8; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Libkind D, 2011, P NATL ACAD SCI; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; MARTINI AV, 1987, A VAN LEEUW J MICROB, V53, P77, DOI 10.1007/BF00419503; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; Rainieri S, 2008, FEMS YEAST RES, V8, P586, DOI 10.1111/j.1567-1364.2008.00363.x; Rainieri S, 2006, APPL ENVIRON MICROB, V72, P3968, DOI 10.1128/AEM.02769-05; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sato M, 2002, J BIOSCI BIOENG, V93, P395, DOI 10.1263/jbb.93.395; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Usher J, 2009, APPL ENVIRON MICROB, V75, P4573, DOI 10.1128/AEM.00351-09; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000	46	53	52	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92203	10.1371/journal.pone.0092203	http://dx.doi.org/10.1371/journal.pone.0092203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643015	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900103
J	Ho, ECY; Eubanks, JH; Zhang, L; Skinner, FK				Ho, Ernest C. Y.; Eubanks, James H.; Zhang, Liang; Skinner, Frances K.			Network Models Predict that Reduced Excitatory Fluctuations Can Give Rise to Hippocampal Network Hyper-Excitability in MeCP2-Null Mice	PLOS ONE			English	Article							SYNAPTIC CIRCUIT ABNORMALITIES; 2/3 PYRAMIDAL NEURONS; MOUSE MODEL; RETT-SYNDROME; BRAIN; CONDUCTANCES; DYSFUNCTION; INHIBITION; INITIATION; THRESHOLD	Rett syndrome is a severe pediatric neurological disorder caused by loss of function mutations within the gene encoding methyl CpG-binding protein 2 (MeCP2). Although MeCP2 is expressed near ubiquitously, the primary pathophysiology of Rett syndrome stems from impairments of nervous system function. One alteration within different regions of the MeCP2-deficient brain is the presence of hyper-excitable network responses. In the hippocampus, such responses exist despite there being an overall decrease in spontaneous excitatory drive within the network. In this study, we generated and used mathematical, neuronal network models to resolve this apparent paradox. We did this by taking advantage of previous mathematical modelling insights that indicated that decreased excitatory fluctuations, but not mean excitatory drive, more critically explain observed changes in hippocampal network oscillations from MeCP2-null mouse slices. Importantly, reduced excitatory fluctuations could also bring about hyper-excitable responses in our network models. Therefore, these results indicate that diminished excitatory fluctuations may be responsible for the hyper-excitable state of MeCP2-deficient hippocampal circuitry.	[Ho, Ernest C. Y.; Eubanks, James H.; Zhang, Liang; Skinner, Frances K.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Ho, Ernest C. Y.; Skinner, Frances K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Eubanks, James H.] Univ Toronto, Dept Surg Neurosurg, Toronto, ON, Canada; [Zhang, Liang; Skinner, Frances K.] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Skinner, FK (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	frances.skinner@utoronto.ca		Skinner, Frances/0000-0001-7819-4202; Zhang, Liang/0000-0002-7888-5043; Eubanks, James/0000-0001-8595-2024	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; Canadian Institutes of Health Research (CIHR) [MOP-106481]; Ontario Brain Institute; Canada Foundation for Innovation under the auspices of Compute Canada; Government of Ontario; Ontario Research Fund - Research Excellence; University of Toronto	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute; Canada Foundation for Innovation under the auspices of Compute Canada; Government of Ontario; Ontario Research Fund - Research Excellence; University of Toronto(University of Toronto)	Funders: Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (FKS, LZ); Canadian Institutes of Health Research (CIHR) MOP-106481 (JHE, LZ), and Ontario Brain Institute (LZ). Computations were performed on the GPC supercomputer at the SciNet HPC Consortium. SciNet is funded by: the Canada Foundation for Innovation under the auspices of Compute Canada; the Government of Ontario; Ontario Research Fund - Research Excellence; and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2010, P NATL ACAD SCI USA, V107, P18208, DOI 10.1073/pnas.1012104107; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Chapleau CA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/976164; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Dur-e-Ahmad M, 2012, J COMPUT NEUROSCI, V33, P21, DOI 10.1007/s10827-011-0372-6; Glaze DG, 2005, J CHILD NEUROL, V20, P740; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Ho ECY, 2011, THESIS U TORONTO; Ho ECY, 2012, J NEUROSCI, V32, P9931, DOI 10.1523/JNEUROSCI.5446-11.2012; Ho ECY, 2009, HIPPOCAMPUS, V19, P152, DOI 10.1002/hipo.20493; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Johnston MV, 2003, J CHILD NEUROL, V18, P688, DOI 10.1177/08830738030180100501; Jugloff DGM, 2006, J NEUROSCI METH, V154, P89, DOI 10.1016/j.jneumeth.2005.12.002; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Lane JB, 2011, NEUROLOGY, V77, P1812, DOI 10.1212/WNL.0b013e3182377dd2; Loken Chris, 2010, Journal of Physics: Conference Series, V256, DOI 10.1088/1742-6596/256/1/012026; McLeod F, 2013, NEUROSCIENCE, V231, P195, DOI 10.1016/j.neuroscience.2012.11.058; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Moser SJ, 2007, PEDIATR NEUROL, V36, P95, DOI 10.1016/j.pediatrneurol.2006.10.003; Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253; Nomura Y, 2005, J CHILD NEUROL, V20, P764, DOI 10.1177/08830738050200091201; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Schreiber S, 2009, J NEUROPHYSIOL, V101, P2239, DOI 10.1152/jn.90711.2008; Stauder JEA, 2006, BRAIN DEV-JPN, V28, P487, DOI 10.1016/j.braindev.2006.02.011; Stettner GM, 2007, J PHYSIOL-LONDON, V579, P863, DOI 10.1113/jphysiol.2006.119966; Takano H, 2012, J NEUROSCI, V32, P4743, DOI 10.1523/JNEUROSCI.4277-11.2012; Taneja P, 2009, J NEUROSCI, V29, P12187, DOI 10.1523/JNEUROSCI.3156-09.2009; Taxidis J, 2012, HIPPOCAMPUS, V22, P995, DOI 10.1002/hipo.20930; Wood L, 2010, NEUROBIOL DIS, V38, P281, DOI 10.1016/j.nbd.2010.01.018; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Wu CP, 2005, J NEUROPHYSIOL, V94, P741, DOI 10.1152/jn.00086.2005; Wu CP, 2005, J NEUROPHYSIOL, V93, P2302, DOI 10.1152/jn.00806.2004; Wu CP, 2002, J PHYSIOL-LONDON, V540, P509, DOI 10.1113/jphysiol.2001.013441; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91148	10.1371/journal.pone.0091148	http://dx.doi.org/10.1371/journal.pone.0091148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642514	Green Published, gold			2022-12-27	WOS:000333259900013
J	Naveau, E; Pinson, A; Gerard, A; Nguyen, L; Charlier, C; Thome, JP; Zoeller, RT; Bourguignon, JP; Parent, AS				Naveau, Elise; Pinson, Anneline; Gerard, Arlette; Nguyen, Laurent; Charlier, Corinne; Thome, Jean-Pierre; Zoeller, R. Thomas; Bourguignon, Jean-Pierre; Parent, Anne-Simone			Alteration of Rat Fetal Cerebral Cortex Development after Prenatal Exposure to Polychlorinated Biphenyls	PLOS ONE			English	Article							THYROID-HORMONE RECEPTORS; CELL-PROLIFERATION; PURKINJE-CELL; PCB EXPOSURE; BRAIN; EXPRESSION; DIFFERENTIATION; MIGRATION; HYPOTHALAMUS; AROCLOR-1254	Polychlorinated biphenyls (PCBs) are environmental contaminants that persist in environment and human tissues. Perinatal exposure to these endocrine disruptors causes cognitive deficits and learning disabilities in children. These effects may involve their ability to interfere with thyroid hormone (TH) action. We tested the hypothesis that developmental exposure to PCBs can concomitantly alter TH levels and TH-regulated events during cerebral cortex development: progenitor proliferation, cell cycle exit and neuron migration. Pregnant rats exposed to the commercial PCB mixture Aroclor 1254 ended gestation with reduced total and free serum thyroxine levels. Exposure to Aroclor 1254 increased cell cycle exit of the neuronal progenitors and delayed radial neuronal migration in the fetal cortex. Progenitor cell proliferation, cell death and differentiation rate were not altered by prenatal exposure to PCBs. Given that PCBs remain ubiquitous, though diminishing, contaminants in human systems, it is important that we further understand their deleterious effects in the brain.	[Naveau, Elise; Pinson, Anneline; Gerard, Arlette; Bourguignon, Jean-Pierre; Parent, Anne-Simone] Univ Liege, CHU, GIGA Neurosci, Dev Neuroendocrinol Unit, Liege, Belgium; [Nguyen, Laurent] Univ Liege, CHU, GIGA Neurosci, Dev Neurobiol Unit, Liege, Belgium; [Charlier, Corinne] Univ Liege, CHU, Lab Clin Forens & Environm Toxicol, Liege, Belgium; [Thome, Jean-Pierre] Univ Liege, Lab Anim Ecol & Ecotoxicol LEAE CART, Liege, Belgium; [Zoeller, R. Thomas] Univ Massachusetts, Dept Biol, Morrill Sci Ctr, Amherst, MA 01003 USA	University of Liege; University of Liege; University of Liege; University of Liege; University of Massachusetts System; University of Massachusetts Amherst	Parent, AS (corresponding author), Univ Liege, CHU, GIGA Neurosci, Dev Neuroendocrinol Unit, Liege, Belgium.	asparent@ulg.ac.be	Nguyen, Laurent/E-9882-2016; Parent, Anne-Simone/ABC-1458-2021	Nguyen, Laurent/0000-0002-8560-3008	Fonds National de la Recherche Scientifique (FNRS, National Foundation for Research) [3.4567.09]; Belgian Study Group for Pediatric Endocrinology	Fonds National de la Recherche Scientifique (FNRS, National Foundation for Research)(Fonds de la Recherche Scientifique - FNRS); Belgian Study Group for Pediatric Endocrinology	This work was supported by the Fonds National de la Recherche Scientifique (FNRS, National Foundation for Research) grant 3.4567.09 and the Belgian Study Group for Pediatric Endocrinology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2009, ENVIRON RES, V109, P620, DOI 10.1016/j.envres.2009.03.009; Ahmed OM, 2008, INT J DEV NEUROSCI, V26, P147, DOI 10.1016/j.ijdevneu.2007.09.011; [Anonymous], 1999, ORTHO SIDE PCBS OCCU; Baas D, 1997, GLIA, V19, P324, DOI 10.1002/(SICI)1098-1136(199704)19:4<324::AID-GLIA5>3.0.CO;2-X; Bansal R, 2005, DEV BRAIN RES, V156, P13, DOI 10.1016/j.devbrainres.2005.01.007; Bansal R, 2008, ENDOCRINOLOGY, V149, P4001, DOI 10.1210/en.2007-1774; Boix J, 2010, NEUROSCIENCE, V167, P994, DOI 10.1016/j.neuroscience.2010.02.068; Boucher O, 2009, ENVIRON HEALTH PERSP, V117, P7, DOI 10.1289/ehp.11294; BYRNE JJ, 1987, ENDOCRINOLOGY, V121, P520, DOI 10.1210/endo-121-2-520; Charlier C, 2003, J ANAL TOXICOL, V27, P74, DOI 10.1093/jat/27.2.74; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Colciago A, 2009, TOXICOL APPL PHARM; Cuevas E, 2005, EUR J NEUROSCI, V22, P541, DOI 10.1111/j.1460-9568.2005.04243.x; de Nijs L, 2009, NAT NEUROSCI, V12, P1266, DOI 10.1038/nn.2390; Debier C, 2003, MAR ECOL PROG SER, V247, P237, DOI 10.3354/meps247237; Dugas JC, 2012, MOL CELL NEUROSCI, V50, P45, DOI 10.1016/j.mcn.2012.03.007; Erickson M.D., 2001, PCBS RECENT ADV ENV, P11; Farwell AP, 2005, DEV BRAIN RES, V154, P121, DOI 10.1016/j.devbrainres.2004.07.016; Farwell AP, 1999, ENDOCRINOLOGY, V140, P5014, DOI 10.1210/en.140.11.5014; Fritsche E, 2005, ENVIRON HEALTH PERSP, V113, P871, DOI 10.1289/ehp.7793; Gauger KJ, 2004, ENVIRON HEALTH PERSP, V112, P516, DOI 10.1289/ehp.6672; Giera S, 2011, ENDOCRINOLOGY, V152, P2909, DOI 10.1210/en.2010-1490; Gilbert ME, 2012, NEUROTOXICOLOGY, V33, P842, DOI 10.1016/j.neuro.2011.11.005; Gilbert ME, 2011, NEUROTOXICOLOGY; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; Iskaros J, 2000, J CLIN ENDOCR METAB, V85, P2620, DOI 10.1210/jc.85.7.2620; Kimura-Kuroda J, 2005, DEV BRAIN RES, V154, P259, DOI 10.1016/j.devbrainres.2004.11.004; Kimura-Kuroda J, 2002, DEV BRAIN RES, V137, P55, DOI 10.1016/S0165-3806(02)00408-X; Kobayashi K, 2009, BRAIN RES, V1264, P24, DOI 10.1016/j.brainres.2008.12.029; KOOPMANESSEBOOM C, 1994, PEDIATR RES, V36, P468, DOI 10.1203/00006450-199410000-00009; Lackmann GM, 2004, SCI TOTAL ENVIRON, V329, P289, DOI 10.1016/j.scitotenv.2004.03.014; Lanting CI, 1998, PEDIATR RES, V44, P222, DOI 10.1203/00006450-199808000-00014; Lein PJ, 2007, ENVIRON HEALTH PERSP, V115, P556, DOI 10.1289/ehp.9773; Morse DC, 1996, TOXICOL APPL PHARM, V136, P269, DOI 10.1006/taap.1996.0034; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Parent AS, 2011, J TOXICOL ENV HEAL B, V14, P328, DOI 10.1080/10937404.2011.578556; Pravettoni A, 2005, REPROD TOXICOL, V20, P521, DOI 10.1016/j.reprotox.2005.03.008; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641, DOI 10.18388/abp.2006_3292; Roegge CS, 2006, NEUROTOXICOL TERATOL, V28, P74, DOI 10.1016/j.ntt.2005.10.001; Sanchez-Alonso JA, 2004, TOXICOL LETT, V153, P311, DOI 10.1016/j.toxlet.2004.05.012; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schnitzler JG, 2008, MAR POLLUT BULL, V56, P1755, DOI 10.1016/j.marpolbul.2008.06.011; Sessa A, 2010, GENE DEV, V24, P1816, DOI 10.1101/gad.575410; Sharlin DS, 2006, ENDOCRINOLOGY, V147, P846, DOI 10.1210/en.2005-0778; Stewart PW, 2008, ENVIRON HEALTH PERSP, V116, P1416, DOI 10.1289/ehp.11058; Thompson CC, 2000, CEREB CORTEX, V10, P939, DOI 10.1093/cercor/10.10.939; Uchida K, 2005, NEUROREPORT, V16, P103, DOI 10.1097/00001756-200502080-00005; Yang D, 2009, ENVIRON HEALTH PERSP, V117, P426, DOI 10.1289/ehp.11771; Zhang LQ, 2009, NEUROBIOL DIS, V34, P366, DOI 10.1016/j.nbd.2009.02.006; Zoeller R. Thomas, 2001, P265; Zoeller RT, 2000, ENDOCRINOLOGY, V141, P181, DOI 10.1210/en.141.1.181; Zoeller RT, 2002, ENVIRON HEALTH PERSP, V110, P355, DOI 10.1289/ehp.02110s3355	52	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91903	10.1371/journal.pone.0091903	http://dx.doi.org/10.1371/journal.pone.0091903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642964	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900043
J	O'Malley, G; Asrat, L; Sharma, A; Hamunime, N; Stephanus, Y; Brandt, L; Ali, D; Kaindjee-Tjituka, F; Natanael, S; Gweshe, J; Feldacker, C; Shihepo, E				O'Malley, Gabrielle; Asrat, Lily; Sharma, Anjali; Hamunime, Ndapewa; Stephanus, Yvonne; Brandt, Laura; Ali, Deqa; Kaindjee-Tjituka, Francina; Natanael, Salomo; Gweshe, Justice; Feldacker, Caryl; Shihepo, Ella			Nurse Task Shifting for Antiretroviral Treatment Services in Namibia: Implementation Research to Move Evidence into Action	PLOS ONE			English	Article							OPERATIONAL-RESEARCH; SOUTH-AFRICA; SCALE-UP; CARE; THERAPY; OUTCOMES; TRIAL; MODEL; INFECTION; STRETCH	Background: Evidence from several sub-Saharan countries support nurse-initiated antiretroviral treatment as a feasible alternative to doctor-led models characteristic of early responses to the HIV epidemic. However, service delivery models shown to be effective in one country may not be readily adopted in another. This study used an implementation research approach to assist policy makers and other stakeholders to assess the acceptability and feasibility of task shifting in the Namibian context. Methods: The Namibian Ministry of Health and Social Services implemented a Task Shifting Demonstration Project (TSDP) at 9 sites at different levels of the health system. Six months after implementation, a mixed methods evaluation was conducted. Seventy semi-structured interviews were conducted with patients, managers, doctors and nurses directly involved with the TSDP. Physician-evaluators observed and compared health service provision between doctors and nurses for 40 patients (80 observations), documenting performance in agreement with the national guidelines on 13 clinical care indicators. Results: Doctors, nurses, and patients interviewed believed task shifting would improve access to and quality of HIV services. Doctors and nurses both reported an increase in nurses' skills as a result of the project. Observation data showed doctors and nurses were in considerable agreement (>80%) with each other on all dimensions of HIV care and >= 90% on eight dimensions. To ensure success of national scale-up of the task shifting model, challenges involving infrastructure, ongoing mentoring, and nursing scope of practice should be anticipated and addressed. Conclusion: In combination with findings from other studies in the region, data from the TSDP provided critical and timely information to the Namibian Ministry of Health and Social Services, thus helping to move evidence into action. Small-scale implementation research projects enable stakeholders to learn by doing, and provide an opportunity to test and modify the intervention before expansion.	[O'Malley, Gabrielle; Sharma, Anjali; Feldacker, Caryl] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA; [Asrat, Lily; Stephanus, Yvonne; Brandt, Laura; Ali, Deqa] Univ Washington, Int Training & Educ Ctr Hlth, Windhoek, Namibia; [Hamunime, Ndapewa; Kaindjee-Tjituka, Francina; Natanael, Salomo; Gweshe, Justice; Shihepo, Ella] Namibia Minist Hlth & Social Serv, Windhoek, Namibia	University of Washington; University of Washington Seattle	O'Malley, G (corresponding author), Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA.	gomalley@uw.edu		O&apos;Malley, Gabrielle/0000-0002-7514-8240; Feldacker, Caryl/0000-0002-8152-6754	US Department of Health and Human Services, Health Resources and Services Administration (HRSA) [U91HA06801]	US Department of Health and Human Services, Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	This study and the activities detailed were developed and conducted by the Namibian Ministry of Health and Social Services and the University of Washington International Training and Education Center for Health (I-TECH) with funding from Cooperative Agreement U91HA06801 from the US Department of Health and Human Services, Health Resources and Services Administration (HRSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi SB, 2008, INDIAN J PEDIATR, V75, P1115, DOI [10.1007/s12098-008-0185-4, 10.1007/S12098-008-0185-4]; ASSEFA Y, 2011, J HLTH SERVICES RES; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Boyer S, 2011, CURR OPIN HIV AIDS, V6, P239, DOI 10.1097/COH.0b013e3283478757; Brentlinger PE, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-23; Chang Larry William, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P130, DOI 10.1177/1545109708318525; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Curran GM, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-17; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Davidoff F, 2008, ANN INTERN MED, V149, P670, DOI 10.7326/0003-4819-149-9-200811040-00009; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Feldstein AC, 2008, JT COMM J QUAL PATIE, V34, P228, DOI 10.1016/S1553-7250(08)34030-6; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Georgeu D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-66; GIMBELSHERR K, 2008, 17 ANN INT AIDS C ME; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; HULELA E, 2008, 17 ANN INT AIDS C ME; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; KAMWI R, 2012, 19 ANN INT AIDS C WA; Katzenstein D, 2010, AIDS, V24, pS1, DOI 10.1097/01.aids.0000366077.37827.0a; KOSGEI R, 2008, 17 ANN INT AIDS C ME; Leeman J, 2007, J ADV NURS, V58, P191, DOI 10.1111/j.1365-2648.2006.04207.x; MCGUIRE M, 2008, 17 ANN INT AIDS C ME; MCGUIRE M, 2013, 6 INT AIDS SOC C HIV; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; *MIN HLTH SOC SERV, WINDH DIR SPEC PROGR; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; *NAM HLTH FAC CENS, 2009, KEY FIND HIV AIDS TB; *NAM MIN HLTH SOC, 2010, REP 2010 NAT HIV SEN; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Remme JHF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001000; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; Vasan A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-75; *WHO, GLOB ATL WORLDS WORK; *WHO PEPFAR UNAIDS, 2008, TREAT TRAIN RET TASK; World Health Organization, 2008, TASK SHIFT RAT RED T; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92014	10.1371/journal.pone.0092014	http://dx.doi.org/10.1371/journal.pone.0092014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642894	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900061
J	Fan, SH; Hu, YA; Li, C; Liu, YR				Fan, Sanhong; Hu, Yanan; Li, Chen; Liu, Yanrong			Optimization of Preparation of Antioxidative Peptides from Pumpkin Seeds Using Response Surface Method	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; PROTEIN; HYDROLYSIS; OIL	Protein isolates of pumpkin (Cucurbita pepo L) seeds were hydrolyzed by acid protease to prepare antioxidative peptides. The hydrolysis conditions were optimized through Box-Behnken experimental design combined with response surface method (RSM). The second-order model, developed for the DPPH radical scavenging activity of pumpkin seed hydrolysates, showed good fit with the experiment data with a high value of coefficient of determination (0.9918). The optimal hydrolysis conditions were determined as follows: hydrolyzing temperature 50 degrees C, pH 2.5, enzyme amount 6000 U/g, substrate concentration 0.05 g/ml and hydrolyzing time 5 h. Under the above conditions, the scavenging activity of DPPH radical was as high as 92.82%.	[Fan, Sanhong; Hu, Yanan; Li, Chen; Liu, Yanrong] Shanxi Univ, Coll Life Sci, Taiyuan, Peoples R China	Shanxi University	Fan, SH (corresponding author), Shanxi Univ, Coll Life Sci, Taiyuan, Peoples R China.	fsh729@sxu.edu.cn			Natural Science Foundation of Shanxi [2012011031-4]	Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province)	This work was supported by the Natural Science Foundation of Shanxi (2012011031-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1995, OFFICIAL METHODS ANA, V16th; Chalamaiah M, 2010, FOOD CHEM, V120, P652, DOI 10.1016/j.foodchem.2009.10.057; Chen HM, 1998, J AGR FOOD CHEM, V46, P49, DOI 10.1021/jf970649w; Cumby N, 2008, FOOD CHEM, V109, P144, DOI 10.1016/j.foodchem.2007.12.039; Darmawan R, 2010, PLANT FOOD HUM NUTR, V65, P233, DOI 10.1007/s11130-010-0185-1; El-Adawy TA, 2001, FOOD CHEM, V74, P47, DOI 10.1016/S0308-8146(00)00337-X; El-Soukkary FAH, 2001, PLANT FOOD HUM NUTR, V56, P365, DOI 10.1023/A:1011802014770; Fu CL, 2006, PLANT FOOD HUM NUTR, V61, P73, DOI 10.1007/s11130-006-0016-6; Gao DD, 2010, J SCI FOOD AGR, V90, P1855, DOI 10.1002/jsfa.4024; Giami SY, 2004, J SCI FOOD AGR, V84, P1901, DOI 10.1002/jsfa.1881; Girish TK, 2012, FOOD CHEM TOXICOL, V50, P1690, DOI 10.1016/j.fct.2012.01.043; Hwang JY, 2010, LWT-FOOD SCI TECHNOL, V43, P285, DOI 10.1016/j.lwt.2009.08.020; Jamdar SN, 2010, FOOD CHEM, V121, P178, DOI 10.1016/j.foodchem.2009.12.027; Jao CL, 2002, FISHERIES SCI, V68, P430, DOI 10.1046/j.1444-2906.2002.00442.x; Kong BH, 2012, FOOD CHEM, V135, P540, DOI 10.1016/j.foodchem.2012.04.122; Li YH, 2008, FOOD CHEM, V106, P444, DOI 10.1016/j.foodchem.2007.04.067; Liu Y, 2013, IND CROP PROD, V49, P837, DOI 10.1016/j.indcrop.2013.07.023; Rezig L, 2012, IND CROP PROD, V37, P82, DOI 10.1016/j.indcrop.2011.12.004; Sailaja RP, 2011, FREE RADICALS ANTIOX, V1, P1, DOI [10.5530/ax.2011.4.2, DOI 10.5530/AX.2011.4.2]; SATHE SK, 1984, CRC CR REV FOOD SCI, V20, P1; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Suetsuna K, 2002, FOOD SCI TECHNOL RES, V8, P227, DOI 10.3136/fstr.8.227; Triveni R, 2001, PROCESS BIOCHEM, V36, P787, DOI 10.1016/S0032-9592(00)00279-X; Vastag Z, 2010, FOOD BIOPROD PROCESS, V88, P277, DOI 10.1016/j.fbp.2009.12.003; Zielinski H, 2012, FOOD CHEM, V135, P2965, DOI 10.1016/j.foodchem.2012.07.009	25	10	11	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92335	10.1371/journal.pone.0092335	http://dx.doi.org/10.1371/journal.pone.0092335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637721	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100142
J	Farag, IF; Davis, JP; Youssef, NH; Elshahed, MS				Farag, Ibrahim F.; Davis, James P.; Youssef, Noha H.; Elshahed, Mostafa S.			Global Patterns of Abundance, Diversity and Community Structure of the Aminicenantes (Candidate Phylum OP8)	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; MICROBIAL DIVERSITY; MOLECULAR ANALYSIS; SOIL; GENOME; RARE; SEDIMENTS; INSIGHTS; VERRUCOMICROBIA; METAGENOMICS	We investigated the global patterns of abundance, diversity, and community structure of members of the Aminicenantes (candidate phylum OP8). Our aim was to identify the putative ecological role(s) played by members of this poorly characterized bacterial lineages in various ecosystems. Analysis of near full-length 16S rRNA genes identified four classes and eight orders within the Aminicenantes. Within 3,134 datasets comprising similar to 1.8 billion high throughput-generated partial 16S rRNA genes, 47,351 Aminicenantes-affiliated sequences were identified in 913 datasets. The Aminicenantes exhibited the highest relative abundance in hydrocarbon-impacted environments, followed by marine habitats (especially hydrothermal vents and coral-associated microbiome samples), and aquatic, non-marine habitats (especially in terrestrial springs and groundwater samples). While the overall abundance of the Aminicenantes was higher in low oxygen tension as well as non-saline and low salinity habitats, it was encountered in a wide range of oxygen tension, salinities, and temperatures. Analysis of the community structure of the Aminicenantes showed distinct patterns across various datasets that appear to be, mostly, driven by habitat variations rather than prevalent environmental parameters. We argue that the detection of the Aminicenantes across environmental extremes and the observed distinct community structure patterns reflect a high level of intraphylum metabolic diversity and adaptive capabilities that enable its survival and growth in a wide range of habitats and environmental conditions.	[Farag, Ibrahim F.; Davis, James P.; Youssef, Noha H.; Elshahed, Mostafa S.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Elshahed, MS (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	Mostafa@okstate.edu	Youssef, Noha H./T-5198-2019	Youssef, Noha H./0000-0001-9159-3785; Farag, Ibrahim/0000-0002-5732-4108	National Science Foundation Microbial Observatories Program [EF0801858]; Emerging Frontiers [0801858] Funding Source: National Science Foundation	National Science Foundation Microbial Observatories Program(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation Microbial Observatories Program (grant EF0801858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Benson DA, 2008, NUCLEIC ACIDS RES, V36, pD25, DOI 10.1093/nar/gkm929; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Buckley DH, 2006, APPL ENVIRON MICROB, V72, P4522, DOI 10.1128/AEM.00149-06; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Dalevi D, 2001, INT J SYST EVOL MICR, V51, P385, DOI 10.1099/00207713-51-2-385; Davis JP, 2012, MICROB ECOL, V64, P942, DOI 10.1007/s00248-012-0073-3; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; Elshahed MS, 2005, APPL ENVIRON MICROB, V71, P7598, DOI 10.1128/AEM.71.11.7598-7602.2005; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Girguis PR, 2005, APPL ENVIRON MICROB, V71, P3725, DOI 10.1128/AEM.71.7.3725-3733.2005; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hugenholtz P, 2002, GENOME BIOL, V3; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Joynt J, 2006, MICROB ECOL, V51, P209, DOI 10.1007/s00248-005-0205-0; Kielak AM, 2010, APPL ENVIRON MICROB, V76, P6769, DOI 10.1128/AEM.00343-10; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legg TM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00082; Li H, 2006, FEMS MICROBIOL LETT, V257, P92, DOI 10.1111/j.1574-6968.2006.00149.x; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McLean JS, 2013, P NATL ACAD SCI USA, V110, pE2390, DOI 10.1073/pnas.1219809110; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Pol A, 2007, NATURE, V450, P874, DOI 10.1038/nature06222; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Saidi-Mehrabad A, 2013, ISME J, V7, P908, DOI 10.1038/ismej.2012.163; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stevenson BS, 2011, ENVIRON MICROBIOL, V13, P1078, DOI 10.1111/j.1462-2920.2010.02413.x; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team R. D. C, 2011, R LANG ENV STAT COMP; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2004, ENVIRON MICROBIOL, V6, P970, DOI 10.1111/j.1462-2920.2004.00663.x; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Youssef N, 2012, APPL ENVIRON MICROB, V78, P2677, DOI 10.1128/AEM.00002-12; Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11; Youssef NH, 2009, ISME J, V3, P305, DOI 10.1038/ismej.2008.106; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	64	66	71	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92139	10.1371/journal.pone.0092139	http://dx.doi.org/10.1371/journal.pone.0092139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637619	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100120
J	Gao, WN; Fu, YC; Yu, C; Wang, SK; Zhang, YC; Zong, C; Xu, TF; Liu, Y; Li, X; Wang, XD				Gao, Weina; Fu, Yuchang; Yu, Cong; Wang, Shunke; Zhang, Yuchao; Zong, Chen; Xu, Tongfu; Liu, Yong; Li, Xia; Wang, Xiangdong			Elevation of NR4A3 Expression and Its Possible Role in Modulating Insulin Expression in the Pancreatic Beta Cell	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NUCLEAR RECEPTOR NOR-1; ORPHAN RECEPTOR; ENDOPLASMIC-RETICULUM; TRANSCRIPTIONAL ACTIVITY; METABOLIC DISEASE; INDUCED APOPTOSIS; GENE-EXPRESSION; ER STRESS; NGFI-B	Background: NR4A3/NOR-1 is a member of the NR4A orphan nuclear receptor subfamily, which contains early response genes that sense and respond to a variety of stimuli in the cellular environment. The role of NR4A3 in insulin expression in pancreatic beta cells remains unknown. Methods: Dynamic changes in NR4A3 were examined in a pancreatic beta-cell line, MIN6, treated with thapsigargin (TG), palmitate (PA), tunicamycin (TM), and dithiothreitol (DTT), chemicals that produce cell stress and even apoptosis. We exploited virus infection techniques to induce expression of NR4A3 or three deletion mutants, and determined expression of insulin and insulin regulatory genes in MIN6 cells. Results: TG and PA, two endoplasmic reticulum (ER) stress inducers, were able to induce unfolded protein response (UPR) activation and elevation of NR4A3 expression in MIN6 cells, whereas TM and DTT, two other ER stress inducers, were able to induce UPR activation but not NR4A3 elevation. MIN6 cells over-expressing NR4A3 protein after adenoviral infection exhibited reduced transcription of the insulin genes Ins1 and Ins2, and reduced insulin protein secretion, which were negatively correlated with NR4A3 expression levels. Functional analysis of different deletion mutants of NR4A3 showed that deleting the activation domain AF1 or the DNA-binding domain abolished the down-regulation of insulin transcription by NR4A3 in MIN6 cells, indicating that this down-regulative role was closely related to the NR4A3 trans-activation activity. Over-expression of NR4A3 in MIN6 cells resulted in reduced mRNA transcription of the insulin positive-regulation genes, Pdx1 and NeuroD1. Conclusion: Some ER stress inducers, such as TG or PA, are able to elevate NR4A3 expression in MIN6 cells, while others, such as TM or DTT, are not. Over-expression of NR4A3 in MIN6 cells results in down-regulation of insulin gene transcription and insulin secretion. NR4A3 reduces insulin gene expression by modulating the expression of Pdx1 and NeuroD1.	[Gao, Weina; Yu, Cong; Wang, Shunke; Zhang, Yuchao; Zong, Chen; Xu, Tongfu; Li, Xia; Wang, Xiangdong] Shandong Univ, Dept Cell Biol, Sch Med, Jinan 250100, Peoples R China; [Gao, Weina] Henan Univ Sci & Technol, Sch Med Technol & Engn, Luoyang, Peoples R China; [Fu, Yuchang] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Liu, Yong] Chinese Acad Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Wang, Xiangdong] Shandong Univ, Key Lab Prot Sci Chron Degenerat Dis, Jinan 250100, Peoples R China	Shandong University; Henan University of Science & Technology; University of Alabama System; University of Alabama Birmingham; Chinese Academy of Sciences; Shandong University	Li, X (corresponding author), Shandong Univ, Dept Cell Biol, Sch Med, Jinan 250100, Peoples R China.	lixia1666@sdu.edu.cn; xdongw@sdu.edu.cn			National Natural Science Foundation of China (NSFC) [81170814, 81370881]; Education Ministry of China for PhD program [20100131110037]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Education Ministry of China for PhD program	This work was supported by National Natural Science Foundation of China (NSFC, funding numbers are 81170814, 81370881) and the Education Ministry of China for PhD program (funding number is 20100131110037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerx J, 1999, CELL, V97, P161; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Bandoh S, 1995, MOL CELL ENDOCRINOL, V115, P227, DOI 10.1016/0303-7207(95)03685-7; Briand O, 2012, MOL ENDOCRINOL, V26, P399, DOI 10.1210/me.2011-1317; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Chen HZ, 2013, INT J BIOCHEM CELL B, V45, P1600, DOI 10.1016/j.biocel.2013.04.026; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Crespo J, 2005, CARDIOVASC RES, V67, P333, DOI 10.1016/j.cardiores.2005.03.016; de Leseleuc L, 2006, CELL DEATH DIFFER, V13, P293, DOI 10.1038/sj.cdd.4401737; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Evans R, 2004, NAT MED, V10, P1022, DOI 10.1038/nm1004-1022; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Guo QS, 2012, EXP DIABETES RES, DOI 10.1155/2012/672013; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hummasti S, 2008, MOL ENDOCRINOL, V22, P1743, DOI 10.1210/me.2007-0566; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu WF, 2001, EUR J IMMUNOL, V31, P1757, DOI 10.1002/1521-4141(200106)31:6<1757::AID-IMMU1757>3.0.CO;2-J; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; Ordelheide AM, 2013, MOL METAB, V2, P243, DOI 10.1016/j.molmet.2013.06.003; PAULSEN RE, 1992, J BIOL CHEM, V267, P16491; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Roche E, 1999, DIABETES, V48, P2007, DOI 10.2337/diabetes.48.10.2007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; Weyrich P, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-77; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Yang YS, 2013, EMBO MOL MED, V5, P92, DOI 10.1002/emmm.201201398; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; ZeRuth GT, 2013, MOL ENDOCRINOL, V27, P1692, DOI 10.1210/me.2013-1117; Zhang T, 2009, MOL CANCER RES, V7, P1408, DOI 10.1158/1541-7786.MCR-08-0533; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	46	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91462	10.1371/journal.pone.0091462	http://dx.doi.org/10.1371/journal.pone.0091462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638142	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100036
J	Paoloni, M; Webb, C; Mazcko, C; Cherba, D; Hendricks, W; Lana, S; Ehrhart, EJ; Charles, B; Fehling, H; Kumar, L; Vail, D; Henson, M; Childress, M; Kitchell, B; Kingsley, C; Kim, S; Neff, M; Davis, B; Chand, K; Trent, J				Paoloni, Melissa; Webb, Craig; Mazcko, Christina; Cherba, David; Hendricks, William; Lana, Susan; Ehrhart, E. J.; Charles, Brad; Fehling, Heather; Kumar, Leena; Vail, David; Henson, Michael; Childress, Michael; Kitchell, Barbara; Kingsley, Christopher; Kim, Seungchan; Neff, Mark; Davis, Barbara; Khanna, Chand; Trent, Jeffrey			Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials	PLOS ONE			English	Article							GENOME; CHEMOSENSITIVITY; ONCOLOGY; TARGETS; TUMORS; GENES	Background: Molecularly-guided trials (i.e. PMed) now seek to aid clinical decision-making by matching cancer targets with therapeutic options. Progress has been hampered by the lack of cancer models that account for individual-to-individual heterogeneity within and across cancer types. Naturally occurring cancers in pet animals are heterogeneous and thus provide an opportunity to answer questions about these PMed strategies and optimize translation to human patients. In order to realize this opportunity, it is now necessary to demonstrate the feasibility of conducting molecularly-guided analysis of tumors from dogs with naturally occurring cancer in a clinically relevant setting. Methodology: A proof-of-concept study was conducted by the Comparative Oncology Trials Consortium (COTC) to determine if tumor collection, prospective molecular profiling, and PMed report generation within 1 week was feasible in dogs. Thirty-one dogs with cancers of varying histologies were enrolled. Twenty-four of 31 samples (77%) successfully met all predefined QA/QC criteria and were analyzed via Affymetrix gene expression profiling. A subsequent bioinformatics workflow transformed genomic data into a personalized drug report. Average turnaround from biopsy to report generation was 116 hours (4.8 days). Unsupervised clustering of canine tumor expression data clustered by cancer type, but supervised clustering of tumors based on the personalized drug report clustered by drug class rather than cancer type. Conclusions: Collection and turnaround of high quality canine tumor samples, centralized pathology, analyte generation, array hybridization, and bioinformatic analyses matching gene expression to therapeutic options is achievable in a practical clinical window (<1 week). Clustering data show robust signatures by cancer type but also showed patient-to-patient heterogeneity in drug predictions. This lends further support to the inclusion of a heterogeneous population of dogs with cancer into the preclinical modeling of personalized medicine. Future comparative oncology studies optimizing the delivery of PMed strategies may aid cancer drug development.	[Paoloni, Melissa; Mazcko, Christina; Khanna, Chand] NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Webb, Craig; Cherba, David; Neff, Mark; Trent, Jeffrey] Van Andel Res Inst, Grand Rapids, MI USA; [Hendricks, William; Kingsley, Christopher; Kim, Seungchan; Davis, Barbara; Trent, Jeffrey] Translat Genom Res Inst TGen, Phoenix, AZ USA; [Lana, Susan; Ehrhart, E. J.; Charles, Brad] Colorado State Univ, Coll Vet Med, Ft Collins, CO 80523 USA; [Fehling, Heather; Kumar, Leena] Clin Reference Lab, Lenexa, KS USA; [Vail, David] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; [Henson, Michael] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Childress, Michael] Purdue Univ, Sch Vet Med, W Lafayette, IN 47907 USA; [Kitchell, Barbara] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Van Andel Institute; Translational Genomics Research Institute; Colorado State University; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Michigan State University	Chand, K (corresponding author), NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA.	khannac@mail.nih.gov; jtrent@tgen.org		, William/0000-0001-7192-8699; Childress, Michael/0000-0001-6127-4679; Kim, Seungchan/0000-0003-4183-4338	National Institutes of Health [UC2 CA148149]; NATIONAL CANCER INSTITUTE [ZIGBC010569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support: National Institutes of Health UC2 CA148149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrechek ER, 2010, J MOL MED, V88, P1095, DOI 10.1007/s00109-010-0644-z; Beijnen JH, 2010, CURR CLIN PHARMACOL, V5, P141, DOI 10.2174/157488410791498789; Briggs JW, 2011, TLS-TIMES LIT SUPPL, P6; Collisson EA, 2012, NAT REV CLIN ONCOL; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gheeya JS, 2009, CANCER BIOL THER, V8, P2386, DOI 10.4161/cbt.8.24.10184; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; McKeage K, 2002, DRUGS, V62, P209, DOI 10.2165/00003495-200262010-00008; Monks NR, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-158; NCI, 2002, NCI BIOINF OR 2002 F; Normanno N, 2012, J CELL BIOCH; Ofiara LM, 2012, CURR ONCOL, V19, pS16, DOI 10.3747/co.19.1062; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Paoloni MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011013; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Ramsey SD, 2011, HEALTH AFFAIR, V30, P2259, DOI 10.1377/hlthaff.2010.0637; Richards KL, 2013, CANC RES; Roukos DH, 2012, ANN SURG ONCOL, V19, P3646, DOI 10.1245/s10434-012-2542-9; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Sholler G., 2012, J CANC THER, V3, P602, DOI [DOI 10.4236/JCT.2012.35077, 10.4236/jct.2012.35077]; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stricker T, 2011, SEMIN ONCOL, V38, P173, DOI 10.1053/j.seminoncol.2011.01.013; Tian Q, 2012, J INTERN MED, V271, P111, DOI 10.1111/j.1365-2796.2011.02498.x; Tsimberidou AM, 2012, CLIN CANC RES; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Veterinary cooperative oncology group D common terminology criteria for adverse events (VCOG-CTCAE), 2011, VET COMP ONCOL, DOI [10.1111/j.1476-5829.2011.00283.x, DOI 10.1111/J.1476-5829.2011.00283.X]; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Xian W, 2011, GENOME MED, V3, DOI 10.1186/gm236; Zhang L, 2011, CURR DRUG METAB, V12, P455, DOI 10.2174/138920011795495303	38	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90028	10.1371/journal.pone.0090028	http://dx.doi.org/10.1371/journal.pone.0090028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637659	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100002
J	Rivera, MF; Chukkapalli, SS; Velsko, IM; Lee, JY; Bhattacharyya, I; Dolce, C; Toro, EJ; Holliday, LS; Kesavalu, L				Rivera, Mercedes F.; Chukkapalli, Sasanka S.; Velsko, Irina M.; Lee, Ju-Youn; Bhattacharyya, Indraneel; Dolce, Calogero; Toro, Edgardo J.; Holliday, L. Shannon; Kesavalu, Lakshmyya			Bis-Enoxacin Blocks Rat Alveolar Bone Resorption from Experimental Periodontitis	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; OSTEOCLAST FORMATION; ALZHEIMERS-DISEASE; ALENDRONATE; IDENTIFICATION; INFLAMMATION; PHOSPHATASE; INHIBITOR; PATHOGENS; VIRULENCE	Periodontal diseases are multifactorial, caused by polymicrobial subgingival pathogens, including Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Chronic periodontal infection results in inflammation, destruction of connective tissues, periodontal ligament, and alveolar bone resorption, and ultimately tooth loss. Enoxacin and a bisphosphonate derivative of enoxacin (bis-enoxacin) inhibit osteoclast formation and bone resorption and also contain antibiotic properties. Our study proposes that enoxacin and/or bis-enoxacin may be useful in reducing alveolar bone resorption and possibly bacterial colonization. Rats were infected with 10(9) cells of polymicrobial inoculum consisting of P. gingivalis, T. denticola, and T. forsythia, as an oral lavage every other week for twelve weeks. Daily subcutaneous injections of enoxacin (5 mg/kg/day), bis-enoxacin (5, 25 mg/kg/day), alendronate (1, 10 mg/kg/day), or doxycycline (5 mg/day) were administered after 6 weeks of polymicrobial infection. Periodontal disease parameters, including bacterial colonization/infection, immune response, inflammation, alveolar bone resorption, and systemic spread, were assessed post-euthanasia. All three periodontal pathogens colonized the rat oral cavity during polymicrobial infection. Polymicrobial infection induced an increase in total alveolar bone resorption, intrabony defects, and gingival inflammation. Treatment with bis-enoxacin significantly decreased alveolar bone resorption more effectively than either alendronate or doxycycline. Histologic examination revealed that treatment with bis-enoxacin and enoxacin reduced gingival inflammation and decreased apical migration of junctional epithelium. These data support the hypothesis that bis-enoxacin and enoxacin may be useful for the treatment of periodontal disease.	[Rivera, Mercedes F.; Chukkapalli, Sasanka S.; Velsko, Irina M.; Lee, Ju-Youn; Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA; [Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Bhattacharyya, Indraneel] Univ Florida, Coll Dent, Dept Oral Diagnost Sci, Gainesville, FL USA; [Dolce, Calogero; Toro, Edgardo J.; Holliday, L. Shannon] Univ Florida, Coll Dent, Dept Orthodont, Gainesville, FL USA; [Holliday, L. Shannon] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kesavalu, L (corresponding author), Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA.	Kesavalu@dental.ufl.edu	Holliday, Lexie/GYQ-4972-2022; Bhattacharyya, Indraneel/U-7752-2019	Holliday, Lexie/0000-0002-0844-1965	USPHS from National Institute of Dental and Craniofacial Research, NIH [R21 DE019862]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019862] Funding Source: NIH RePORTER	USPHS from National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by USPHS research grant R21 DE019862 (LSH) from National Institute of Dental and Craniofacial Research, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2010, ORAL DIS, V16, P674, DOI 10.1111/j.1601-0825.2010.01677.x; [Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Herczegh P, 2002, J MED CHEM, V45, P2338, DOI 10.1021/jm0105326; Herrera BS, 2013, J PERIODONTOL, V84; Hoff AO, 2011, ANN NY ACAD SCI, V1218, P47, DOI 10.1111/j.1749-6632.2010.05771.x; Inoue K, 2004, J PERIODONTAL RES, V39, P50, DOI 10.1111/j.1600-0765.2004.00704.x; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Karimbux NY, 1998, J PERIODONTOL, V69, P34, DOI 10.1902/jop.1998.69.1.34; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee JJ, 2013, HEAD NECK-J SCI SPEC, V35, P1787, DOI 10.1002/hed.23235; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Melo S, 2011, P NATL ACAD SCI USA, V108, P4394, DOI 10.1073/pnas.1014720108; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Nahid MA, 2011, INFECT IMMUN, V79, P1597, DOI 10.1128/IAI.01062-10; Ostrov DA, 2009, J MED CHEM, V52, P5144, DOI 10.1021/jm900277z; Poole S, 2013, J ALZHEIMERS DIS, V36, P665, DOI 10.3233/JAD-121918; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Scannapieco Frank A, 2003, Ann Periodontol, V8, P70, DOI 10.1902/annals.2003.8.1.70; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sousa EJ, 2013, EPIGENETICS-US, V8, P548, DOI 10.4161/epi.24519; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Toro EJ, 2013, J DENT RES, V92, P925, DOI 10.1177/0022034513501876; Toro EJ, 2012, J BIOL CHEM, V287, P17894, DOI 10.1074/jbc.M111.280511; Toro EJ, 2012, CURR PROTEIN PEPT SC, V13, P180; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Verma RK, 2010, INTERDISCIPLINARY PE, V2010, P1; WOLFSON JS, 1991, AM J MED, V91, pS153, DOI 10.1016/0002-9343(91)90330-Z; Zubery Y, 1998, INFECT IMMUN, V66, P4158; Zuo J, 2006, J BONE MINER RES, V21, P714, DOI 10.1359/JBMR.060201	41	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92119	10.1371/journal.pone.0092119	http://dx.doi.org/10.1371/journal.pone.0092119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638087	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100115
J	Wang, JH; Lin, RY; Zhang, WB; Li, L; Gottstein, B; Blagosklonov, O; Lu, GD; Zhang, CS; Lu, XM; Vuitton, DA; Wen, H				Wang, Junhua; Lin, Renyong; Zhang, Wenbao; Li, Liang; Gottstein, Bruno; Blagosklonov, Oleg; Lu, Guodong; Zhang, Chuangshan; Lu, Xiaomei; Vuitton, Dominique A.; Wen, Hao			Transcriptional Profiles of Cytokine/Chemokine Factors of Immune Cell-Homing to the Parasitic Lesions: A Comprehensive One-Year Course Study in the Liver of E. multilocularis-Infected Mice	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; IN-VIVO TREATMENT; ECHINOCOCCUS-MULTILOCULARIS; SCHISTOSOMA-MANSONI; IFN-GAMMA; PERIPARASITIC GRANULOMA; ALVEOLAR ECHINOCOCCOSIS; HELMINTH INFECTION; CHEMOKINE RELEASE; CYTOKINE	Pathogenesis of chronically developing alveolar echinococcosis (AE) is characterized by a continuous, granulomatous, periparasitic infiltration of immune cells surrounding the metacestode of Echinococcus multilocularis (E. multilocularis) in the affected liver. A detailed cytokine and chemokine profile analysis of the periparasitic infiltrate in the liver has, however, not yet been carried out in a comprehensive way all along the whole course of infection in E. multilocularis intermediate hosts. We thus assessed the hepatic gene expression profiles of 18 selected cytokine and chemokine genes using qRT-PCR in the periparasitic immune reaction and the subsequent adjacent, not directly affected, liver tissue of mice from day 2 to day 360 post intra-hepatic injection of metacestode. DNA microarray analysis was also used to get a more complete picture of the transcriptional changes occurring in the liver surrounding the parasitic lesions. Profiles of mRNA expression levels in the hepatic parasitic lesions showed that a mixed Th1/Th2 immune response, characterized by the concomitant presence of IL-12 alpha, IFN-gamma and IL-4, was established very early in the development of E. multilocularis. Subsequently, the profile extended to a combined tolerogenic profile associating IL-5, IL-10 and TGF-beta. IL-17 was permanently expressed in the liver, mostly in the periparasitic infiltrate; this was confirmed by the increased mRNA expression of both IL-17A and IL-17F from a very early stage, with a subsequent decrease of IL-17A after this first initial rise. All measured chemokines were significantly expressed at a given stage of infection; their expression paralleled that of the corresponding Th1, Th2 or Th17 cytokines. In addition to giving a comprehensive insight in the time course of cytokines and chemokines in E. multilocularis lesion, this study contributes to identify new targets for possible immune therapy to minimize E. multilocularis-related pathology and to complement the only parasitostatic effect of benzimidazoles in AE.	[Wang, Junhua; Lin, Renyong; Zhang, Wenbao; Li, Liang; Lu, Guodong; Zhang, Chuangshan; Lu, Xiaomei; Wen, Hao] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Incubat Base Xinjiang Major Dis Res, Urumqi, Xinjiang, Peoples R China; [Wang, Junhua; Lin, Renyong; Zhang, Wenbao; Li, Liang; Lu, Guodong; Zhang, Chuangshan; Lu, Xiaomei; Wen, Hao] Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Echinococcosis, Urumqi, Xinjiang, Peoples R China; [Wang, Junhua] Univ Franche Comte, Dept Nucl Med, F-25030 Besancon, Franche Comte, France; [Wang, Junhua] Jean Minjoz Univ Hosp, Besancon, Franche Comte, France; [Wang, Junhua; Gottstein, Bruno; Blagosklonov, Oleg] Univ Bern, Inst Parasitol, Bern, Switzerland; [Vuitton, Dominique A.] Univ Franche Comte, WHO Collaborating Ctr Prevent & Treatment Human E, F-25030 Besancon, Franche Comte, France; [Vuitton, Dominique A.] Univ Hosp, Besancon, Franche Comte, France	Xinjiang Medical University; Xinjiang Medical University; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; University of Bern; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Vuitton, DA (corresponding author), Univ Franche Comte, WHO Collaborating Ctr Prevent & Treatment Human E, F-25030 Besancon, Franche Comte, France.	dvuitton@univ-fcomte.fr; Dr.wenhao@163.com	Wang, Junhua/ABB-6324-2021	Wang, Junhua/0000-0002-6110-3711	NSFC [81260452, 81260252]; Swiss National Science Foundation [31003A_141039/1]; Program for Changjiang Scholars and Innovative Research Team in Universities [IRT1181]; Xinjiang Key-Lab Projects [SKLIB-XJMDR-2012-Y1]	NSFC(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Program for Changjiang Scholars and Innovative Research Team in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Xinjiang Key-Lab Projects	This work was supported by NSFC Grant Projects (81260452, 81260252), the Swiss National Science Foundation (31003A_141039/1), the Program for Changjiang Scholars and Innovative Research Team in Universities (IRT1181), and Xinjiang Key-Lab Projects (SKLIB-XJMDR-2012-Y1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot F, 1999, PARASITE IMMUNOL, V21, P475, DOI 10.1046/j.1365-3024.1999.00245.x; Amri M, 2009, EUR CYTOKINE NETW, V20, P63, DOI 10.1684/ecn.2009.0154; Aumuller E, 2004, PARASITE IMMUNOL, V26, P387, DOI 10.1111/j.0141-9838.2004.00724.x; BRESSONHADNI S, 1990, CLIN EXP IMMUNOL, V82, P378, DOI 10.1111/j.1365-2249.1990.tb05457.x; Brunet LR, 1999, J PARASITOL, V85, P734, DOI 10.2307/3285752; Caoduro C, 2013, J NUCL MED, V54, P358, DOI 10.2967/jnumed.112.109942; Correa-Oliveira R, 1998, BRAZ J MED BIOL RES, V31, P171, DOI 10.1590/S0100-879X1998000100024; Dai WJ, 1999, IMMUNOLOGY, V97, P107, DOI 10.1046/j.1365-2567.1999.00723.x; Dai WJ, 2004, IMMUNOLOGY, V112, P481, DOI 10.1111/j.1365-2567.2004.01885.x; Dreweck CM, 1999, PARASITE IMMUNOL, V21, P433, DOI 10.1046/j.1365-3024.1999.00243.x; Eger A, 2003, PARASITE IMMUNOL, V25, P103, DOI 10.1046/j.1365-3024.2003.00601.x; Emery I, 1998, PARASITE IMMUNOL, V20, P81, DOI 10.1046/j.1365-3024.1998.00131.x; Emery I, 1996, PARASITE IMMUNOL, V18, P463, DOI 10.1111/j.1365-3024.1996.tb01030.x; Godot V, 2003, GASTROENTEROLOGY, V124, P1441, DOI 10.1016/S0016-5085(03)00273-7; Godot V, 2000, CLIN EXP IMMUNOL, V121, P484, DOI 10.1046/j.1365-2249.2000.01308.x; Gottstein B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009779; Harraga S, 2003, ACTA TROP, V85, P231, DOI 10.1016/S0001-706X(02)00218-8; Hicks DJ, 2013, J COMP PATHOL; Hubner MP, 2006, CLIN EXP IMMUNOL, V145, P243, DOI 10.1111/j.1365-2249.2006.03142.x; Jenne L, 1997, CLIN EXP IMMUNOL, V109, P90, DOI 10.1046/j.1365-2249.1997.4031299.x; Kocherscheidt L, 2008, EXP PARASITOL, V119, P467, DOI 10.1016/j.exppara.2008.04.006; Lechner CJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/735342; Liance M, 1998, PARASITE, V5, P231, DOI 10.1051/parasite/1998053231; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Manfras BJ, 2004, INT IMMUNOL, V16, P43, DOI 10.1093/intimm/dxh005; Manfras BJ, 2002, INFECT IMMUN, V70, P1168, DOI 10.1128/IAI.70.3.1168-1174.2002; Mejri N, 2010, PARASITOLOGY, V137, P557, DOI 10.1017/S0031182009991533; Mejri N, 2011, PARASITOL INT, V60, P45, DOI 10.1016/j.parint.2010.10.002; Mourglia-Ettlin G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001293; Mutapi F, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-139; Pak-Wittel MA, 2013, P NATL ACAD SCI USA, V110, pE50, DOI 10.1073/pnas.1220456110; Rigano R, 2001, INFECT IMMUN, V69, P288, DOI 10.1128/IAI.69.1.288-296.2001; Rigano R, 1996, CLIN EXP IMMUNOL, V105, P456, DOI 10.1046/j.1365-2249.1996.d01-796.x; Rutitzky LI, 2005, J IMMUNOL, V175, P3920, DOI 10.4049/jimmunol.175.6.3920; SABIN EA, 1995, J IMMUNOL, V155, P4844; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Shi DZ, 2004, WORLD J GASTROENTERO, V10, P3674, DOI 10.3748/wjg.v10.i24.3674; Vuitton DA, 2006, PARASITOL INT, V55, pS51, DOI 10.1016/j.parint.2005.11.007; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1989, CLIN EXP IMMUNOL, V78, P67; Wang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055379; Zhang CS, 2012, PLOS ONE, V7, P436, DOI 10.1371/journal.pone.0030127; ZHAO H, 2012, LAS DIAGN OPT MEAS, P1	44	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91638	10.1371/journal.pone.0091638	http://dx.doi.org/10.1371/journal.pone.0091638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637903	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100050
J	Wei, L; Zhu, SS; She, RP; Hu, FJ; Wang, J; Yan, X; Zhang, CY; Liu, SH; Quan, R; Li, ZX; Du, F; Wei, T; Liu, J				Wei, Li; Zhu, Shanshan; She, Ruiping; Hu, Fengjiao; Wang, Jing; Yan, Xu; Zhang, Chunyan; Liu, Shuhang; Quan, Rong; Li, Zixuan; Du, Fang; Wei, Ting; Liu, Jue			Viral Replication and Lung Lesions in BALB/c Mice Experimentally Inoculated with Avian Metapneumovirus Subgroup C Isolated from Chickens	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; AIRWAY-OBSTRUCTION; IMMUNE-RESPONSE; INFECTION; PNEUMOVIRUS; HYPERRESPONSIVENESS; PATHOGENESIS; SEQUENCE; PROTEIN; HMPV	Avian metapneumovirus (aMPV) emerged as an important respiratory pathogen causing acute respiratory tract infection in avian species. Here we used a chicken aMPV subgroup C (aMPV/C) isolate to inoculate experimentally BALB/c mice and found that the aMPV/C can efficiently replicate and persist in the lungs of mice for at least 21 days with a peak viral load at day 6 postinoculation. Lung pathological changes were characterized by increased inflammatory cells. Immunochemical assay showed the presence of viral antigens in the lungs and significant upregulation of pulmonary inflammatory cytokines and chemokines including MCP-1, MIP-1 alpha, RANTES, IL-1 beta, IFN-gamma, and TNF-alpha were detected following inoculation. These results indicate for the first time that chicken aMPV/C may replicate in the lung of mice. Whether aMPV/C has potential as zoonotic pathogen, further investigation will be required.	[Wei, Li; Zhu, Shanshan; Wang, Jing; Yan, Xu; Zhang, Chunyan; Liu, Shuhang; Quan, Rong; Li, Zixuan; Liu, Jue] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing, Peoples R China; [She, Ruiping; Hu, Fengjiao; Du, Fang] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Wei, Ting] QIMR Berghofer Med Res Inst, Mol Virol Lab, Brisbane, Qld, Australia	Beijing Academy of Agriculture & Forestry; China Agricultural University; QIMR Berghofer Medical Research Institute	Liu, J (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing, Peoples R China.	liujue23@yahoo.com			China Agriculture Research System [CARS-42]	China Agriculture Research System	This work was supported by a grant from China Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2005, J VIROL, V79, P5971, DOI 10.1128/JVI.79.10.5971-5978.2005; Alvarez R, 2004, J VIROL, V78, P14003, DOI 10.1128/JVI.78.24.14003-14011.2004; Alvarez R, 2004, CLIN DIAGN LAB IMMUN, V11, P245, DOI 10.1128/CDLI.11.2.245-249.2004; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Buys S.B., 1980, TURKEYS, P36; Cha RM, 2011, VET IMMUNOL IMMUNOP, V140, P30, DOI 10.1016/j.vetimm.2010.11.006; Chakraborty K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037173; Cook JKA, 1999, AVIAN PATHOL, V28, P607, DOI 10.1080/03079459994407; Darniot M, 2005, VACCINE, V23, P4473, DOI 10.1016/j.vaccine.2005.04.027; Darniot M, 2009, J VIROL, V83, P3323, DOI 10.1128/JVI.02198-08; Durbin JE, 2002, J IMMUNOL, V168, P2944, DOI 10.4049/jimmunol.168.6.2944; Easton AJ, 2004, CLIN MICROBIOL REV, V17, P390, DOI 10.1128/CMR.17.2.390-412.2004; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Hamelin ME, 2005, J VIROL, V79, P8894, DOI 10.1128/JVI.79.14.8894-8903.2005; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Jirjis FF, 2002, VET PATHOL, V39, P300, DOI 10.1354/vp.39-3-300; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Kukavica-Ibrulj I, 2009, J VIROL, V83, P1341, DOI 10.1128/JVI.01123-08; Lee EH, 2007, VIRUS RES, V128, P18, DOI 10.1016/j.virusres.2007.03.029; MacPhail M, 2004, J GEN VIROL, V85, P1655, DOI 10.1099/vir.0.79805-0; MCDOUGALL JS, 1986, VET REC, V118, P206, DOI 10.1136/vr.118.8.206; Njenga MK, 2003, VIRUS RES, V91, P163, DOI 10.1016/S0168-1702(02)00256-3; Schwarze J, 2004, AM J RESP CRIT CARE, V169, P801, DOI 10.1164/rccm.200308-1203OC; Skiadopoulos MH, 2004, J VIROL, V78, P6927, DOI 10.1128/JVI.78.13.6927-6937.2004; Toquin D, 2006, VIRUS GENES, V32, P97, DOI 10.1007/s11262-005-5850-3; Turpin EA, 2008, AVIAN PATHOL, V37, P343, DOI 10.1080/03079450802068566; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; Velayudhan BT, 2006, EMERG INFECT DIS, V12, P1853; Wei L, 2013, EMERG INFECT DIS, V19, P1092, DOI 10.3201/eid1907.121126; World Organization for Animal Health, 2011, TERR AN HLTH COD; Yunus AS, 2003, VIRUS RES, V93, P91, DOI 10.1016/S0168-1702(03)00074-1	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92136	10.1371/journal.pone.0092136	http://dx.doi.org/10.1371/journal.pone.0092136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637582	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100119
J	Wu, ZJ; Lin, Y; Xiao, J; Wu, LC; Liu, JG				Wu, Zhen-Jie; Lin, Yuan; Xiao, Jun; Wu, Liu-Cheng; Liu, Jun-Gang			Clinical Significance of Colonoscopy in Patients with Upper Gastrointestinal Polyps and Neoplasms: A Meta-Analysis	PLOS ONE			English	Article							SPORADIC DUODENAL ADENOMA; INDEPENDENT RISK-FACTOR; FUNDIC GLAND POLYPS; COLORECTAL-CANCER; GASTRIC-CANCER; AMERICAN-COLLEGE; COLONIC POLYPS; PREVALENCE; SURVEILLANCE; ASSOCIATION	Background: Some authors have studied the relationship between the presence of polyps, adenomas and cancers of upper gastrointestinal tract (stomach and duodenum) and risk of colorectal polyps and neoplasms; however, the results are controversial, which may be due to study sample size, populations, design, clinical features, and so on. No meta-analysis, which can be generalized to a larger population and could provide a quantitative pooled risk estimate of the relationship, of this issue existed so far. Methods: We performed a meta-analysis to evaluate risk of colorectal polyps or neoplasms in patients with polyps, adenomas or cancers in upper gastrointestinal tract comparing with controls. A search was conducted through PubMed, EMBASE, reference lists of potentially relevant papers, and practice guidelines up to 27 November 2013 without languages restriction. Odd ratios (ORs) were pooled using random-effects models. Results: The search yielded 3 prospective and 21 retrospective case-control studies (n = 37152 participants). The principal findings included: (1) OR for colorectal polyps was 1.15 (95% CI, 1.04-1.26) in the gastric polyps group comparing with control groups; (2) Patients with gastric polyps and neoplasms have higher risk (OR, 1.31 [95% CI, 1.06-1.62], and 1.72 [95% CI, 1.42-2.09], respectively) of colorectal neoplasms comparing with their controls; and (3) Positive association was found between the presence of colorectal neoplasms and sporadic duodenal neoplasms (OR, 2.59; 95% CI, 1.64-4.11). Conclusions: Findings from present meta-analysis of 24 case-control studies suggest that the prevalence of colorectal polyps was higher in patients with gastric polyps than in those without gastric polyps, and the risk of colorectal neoplasms increases significantly in patients with gastric polyps, neoplasms, and duodenal neoplasms. Therefore, screening colonoscopy should be considered for patients with upper gastrointestinal polyps and neoplasms.	[Wu, Zhen-Jie; Lin, Yuan; Xiao, Jun; Wu, Liu-Cheng; Liu, Jun-Gang] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gastrointestinal Surg, Nanning, Peoples R China	Guangxi Medical University	Lin, Y (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gastrointestinal Surg, Nanning, Peoples R China.	linyuannanning@163.com		Xiao, Jun/0000-0003-1562-3342				Arai T, 2001, J GASTROENTEROL, V36, P748, DOI 10.1007/s005350170016; Attard TM, 2004, AM J GASTROENTEROL, V99, P681, DOI 10.1111/j.1572-0241.2004.04115.x; Bae RC, 2009, WORLD J GASTROENTERO, V15, P5722, DOI 10.3748/wjg.15.5722; Brink D., 2012, COLORECTAL CANC SCRE; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; CAPPELL MS, 1995, J CLIN GASTROENTEROL, V21, P198, DOI 10.1097/00004836-199510000-00006; Card TR, 2006, J EPIDEMIOL COMMUN H, V60, P819, DOI 10.1136/jech.2005.041202; Chung WC, 2011, GUT LIVER, V5, P432, DOI 10.5009/gnl.2011.5.4.432; Dariusz A, 2009, EUR J GASTROEN HEPAT, V21, P816, DOI 10.1097/MEG.0b013e328306c7cc; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eom BW, 2008, J SURG ONCOL, V98, P106, DOI 10.1002/jso.21027; GALANDIUK S, 1988, ANN SURG, V207, P234, DOI 10.1097/00000658-198803000-00002; Genta RM, 2009, CLIN GASTROENTEROL H, V7, P849, DOI 10.1016/j.cgh.2009.05.015; Georgopoulos SD, 2006, DIGESTION, V74, P42, DOI 10.1159/000096593; Gonzalez-Ortiz Dilka I, 2010, Bol Asoc Med P R, V102, P5; Grady WM, 2003, GASTROENTEROLOGY, V124, P1574, DOI 10.1016/S0016-5085(03)00376-7; Gu GL, 2008, WORLD J GASTROENTERO, V14, P2121, DOI 10.3748/wjg.14.2121; Cimmino DG, 2013, WORLD J GASTRO ENDOS, V5, P240, DOI 10.4253/wjge.v5.i5.240; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hwang Sun-Mee, 2011, Korean J Gastroenterol, V58, P20; JEPSEN JM, 1994, SCAND J GASTROENTERO, V29, P483, DOI 10.3109/00365529409092458; Joo MK, 2010, ENDOSCOPY, V42, P114, DOI 10.1055/s-0029-1243875; Jung A, 2002, PATHOL RES PRACT, V198, P731, DOI 10.1078/0344-0338-00328; Kim SY, 2013, DIG DIS SCI; Lagarde S, 2009, GASTROEN CLIN BIOL, V33, P441, DOI 10.1016/j.gcb.2008.10.018; Lee JH, 2006, WORLD J GASTROENTERO, V12, P2588, DOI 10.3748/wjg.v12.i16.2588; Lee KJ, 2011, SCAND J GASTROENTERO, V46, P1349, DOI 10.3109/00365521.2011.613948; Lee Sang Su, 2011, J Korean Soc Coloproctol, V27, P246, DOI 10.3393/jksc.2011.27.5.246; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Meucci G, 1997, J CLIN GASTROENTEROL, V25, P605, DOI 10.1097/00004836-199712000-00011; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Murray MA, 2004, GUT, V53, P261, DOI 10.1136/gut.2003.025320; Oh Se Yong, 2006, Korean J Gastroenterol, V47, P191; Ohtani H, 2000, INT J CANCER, V86, P678, DOI 10.1002/(SICI)1097-0215(20000601)86:5<678::AID-IJC12>3.0.CO;2-O; Park DI, 2010, J CLIN GASTROENTEROL, V44, P102, DOI 10.1097/MCG.0b013e3181a15849; Park Seon Young, 2009, Korean J Gastroenterol, V54, P220; Park W, 2012, J GASTROEN HEPATOL, V27, P1490, DOI 10.1111/j.1440-1746.2012.07128.x; Pequin P, 2007, ALIMENT PHARM THER, V26, P277, DOI 10.1111/j.1365-2036.2007.03359.x; Ramsoekh D, 2008, AM J GASTROENTEROL, V103, P1505, DOI 10.1111/j.1572-0241.2007.01775.x; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Schneider ARJ, 2005, Z GASTROENTEROL, V43, P1123, DOI 10.1055/s-2005-858628; Schulmann K, 2002, BEST PRACT RES CL GA, V16, P91, DOI 10.1053/bega.2002.0268; Shmuely H, 2001, AM J GASTROENTEROL, V96, P3406; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Teichmann J, 2008, EUR J MED RES, V13, P192; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Winawer SJ, 2011, J CLIN GASTROENTEROL, V45, P297, DOI 10.1097/MCG.0b013e3182098e07; Yamamoto S, 2006, DIS COLON RECTUM, V49, pS30, DOI 10.1007/s10350-006-0600-8; Yang MH, 2010, GASTROINTEST ENDOSC, V71, P774, DOI 10.1016/j.gie.2009.11.042; Yoo HM, 2013, ANN SURG ONCOL, V20, P1614, DOI 10.1245/s10434-012-2737-0	54	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91810	10.1371/journal.pone.0091810	http://dx.doi.org/10.1371/journal.pone.0091810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637723	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100064
J	Zhang, R; Gong, H; Zhu, D; Gao, JZ; Fang, J; Fan, YB				Zhang, Rui; Gong, He; Zhu, Dong; Gao, Jiazi; Fang, Juan; Fan, Yubo			Seven Day Insertion Rest in Whole Body Vibration Improves Multi-Level Bone Quality in Tail Suspension Rats	PLOS ONE			English	Article							LOW-MAGNITUDE; HIGH-FREQUENCY; TRABECULAR BONE; MECHANICAL-PROPERTIES; RESISTANCE EXERCISE; MINERAL DENSITY; DAILY EXPOSURE; FEMORAL BONE; SINGLE; HETEROGENEITY	Objective: This study aimed to investigate the effects of low-magnitude, high-frequency vibration with rest days on bone quality at multiple levels. Methods: Forty-nine three-month-old male Wistar rats were randomly divided into seven groups, namely, vibrational loading for X day followed by X day rest (VLXR, X= 1, 3, 5, 7), vibrational loading every day (VLNR), tail suspension (SPD), and baseline control (BCL). One week after tail suspension, rats were loaded by vibrational loading (35 Hz, 0.25 g, 15 min/day) except SPD and BCL. Fluorescence markers were used in all rats. Eight weeks later, femora were harvested to investigate macromechanical properties, and micro-computed tomography scanning and fluorescence test were used to evaluate microarchitecture and bone growth rate. Atomic force microscopy analyses and nanoindentation test were used to analyze the nanostructure and mechanical properties of bone material, respectively. Inductively coupled plasma optical emission spectroscopy was used for quantitative chemical analyses. Results: Microarchitecture, mineral apposition rate and bone formation rate and macromechanical properties were improved in VL7R. Grain size and roughness were significantly different among all groups. No statistical difference was found for the mechanical properties of the bone material, and the chemical composition of all groups was almost similar. Conclusions: Low-magnitude, high-frequency vibration with rest days altered bone microarchitecture and macrobiomechanical properties, and VL7R was more efficacious in improving bone loss caused by mechanical disuse, which provided theoretical basis and explored the mechanisms of vibration for improving bone quality in clinics.	[Zhang, Rui; Gong, He; Gao, Jiazi; Fang, Juan] Jilin Univ, Dept Engn Mech, Changchun 130023, Jilin, Peoples R China; [Zhu, Dong] Jilin Univ, Hosp 1, Dept Orthoped Surg, Changchun 130023, Jilin, Peoples R China; [Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China	Jilin University; Jilin University; Beihang University	Gong, H (corresponding author), Jilin Univ, Dept Engn Mech, Changchun 130023, Jilin, Peoples R China.	gonghe1976@yahoo.com; swyxgc@126.com			National Natural Science Foundation of China [11322223, 11272134]; 973 Program [2012CB821202]; Program for New Century Excellent Talents in University [NCET-12-0024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work is supported by the National Natural Science Foundation of China (Nos. 11322223 and 11272134), the 973 Program (No. 2012CB821202), and the Program for New Century Excellent Talents in University (NCET-12-0024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCENZI A, 1990, J BIOMECH, V23, P763, DOI 10.1016/0021-9290(90)90023-V; BOSKEY AL, 2001, BONE MECH HDB; Brisceno CE, 2009, AM J ORTHOD DENTOFAC, V135, P292, DOI 10.1016/j.ajodo.2008.06.023; Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6; Chen PY, 2011, CALCIFIED TISSUE INT, V88, P351, DOI 10.1007/s00223-011-9462-8; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601; Fan ZF, 2007, COMPOS PART B-ENG, V38, P411, DOI 10.1016/j.compositesb.2006.08.006; FAULKNER KG, 1995, CALCIFIED TISSUE INT, V56, P26, DOI 10.1007/BF00298740; Feng LA, 2011, J BIOMECH, V44, P313, DOI 10.1016/j.jbiomech.2010.10.011; Flieger J, 1998, CALCIFIED TISSUE INT, V63, P510, DOI 10.1007/s002239900566; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Gong H, 2006, J BONE MINER METAB, V24, P386, DOI 10.1007/s00774-006-0698-8; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Hassenkam T, 2005, MICRON, V36, P681, DOI 10.1016/j.micron.2005.06.007; Hassenkam T, 2006, ANAT REC PART A, V288A, P1087, DOI 10.1002/ar.a.20376; Hembree M, 2009, AM J ORTHOD DENTOFAC, V135, DOI 10.1016/j.ajodo.2008.06.022; Hoffler CE, 2000, J ORTHOPAED RES, V18, P432, DOI 10.1002/jor.1100180315; Hoffler CE, 2000, BONE, V26, P603, DOI 10.1016/S8756-3282(00)00268-4; Lafage V, 2002, Stud Health Technol Inform, V91, P428; Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; LeBlanc A, 1998, BONE, V22, p113S, DOI 10.1016/S8756-3282(98)00013-1; LI XJ, 1990, ANAT RECORD, V227, P12, DOI 10.1002/ar.1092270103; Li ZL, 2012, EUR J APPL PHYSIOL, V112, P3743, DOI 10.1007/s00421-012-2355-3; LOTZ JC, 1991, J BIOMECH, V24, P317, DOI 10.1016/0021-9290(91)90350-V; Luu YK, 2010, INT J OBESITY, V34, P401, DOI 10.1038/ijo.2009.240; Ma RS, 2012, HIP INT, V22, P218, DOI 10.5301/HIP.2012.9033; Manske SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036486; Matsuda J, 2009, IFMBE PROC, V23, P1766; Milovanovic P, 2011, ACTA BIOMATER, V7, P3446, DOI 10.1016/j.actbio.2011.05.028; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; PHARR GM, 1992, MRS BULL, V17, P28, DOI 10.1557/S0883769400041634; Rahmani P, 2009, CAN MED ASSOC J, V181, P815, DOI 10.1503/cmaj.080709; Rankovic D, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/33/335202; Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Robling AG, 2002, MED SCI SPORT EXER, V34, P196, DOI 10.1097/00005768-200202000-00003; Rubin C, 2002, J BONE MINER RES, V17, P349, DOI 10.1359/jbmr.2002.17.2.349; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Rubin CT, 2001, DRUG DISCOV TODAY, V6, P848, DOI 10.1016/S1359-6446(01)01872-4; Ruff C, 1999, 1 BIENN SPAC BIOM IN, V1, P86; Ruimerman R, 2001, COMPUT METHOD BIOMEC, V4, P433; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6; Sun LW, 2009, ACTA BIOMATER, V5, P3506, DOI 10.1016/j.actbio.2009.04.042; Tezval M, 2011, CALCIFIED TISSUE INT, V88, P33, DOI 10.1007/s00223-010-9423-7; Thurner J., 2007, MODERN RES ED TOPICS, P37; Thurner P. J., 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5746, P515, DOI 10.1117/12.595799; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Ward K, 2004, J BONE MINER RES, V19, P360, DOI 10.1359/JBMR.040129; Yamauchi H, 2003, JPN J PHYS FIT SPORT, V52, P119, DOI 10.7600/jspfsm1949.52.1_119; Yang P, 2009, AVIAT SPACE ENVIR MD, V80, P88, DOI 10.3357/ASEM.2368.2009	58	26	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92312	10.1371/journal.pone.0092312	http://dx.doi.org/10.1371/journal.pone.0092312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637608	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100139
J	Bartholomew, AJ; Cirulli, ET				Bartholomew, Alex J.; Cirulli, Elizabeth T.			Individual Variation in Contagious Yawning Susceptibility Is Highly Stable and Largely Unexplained by Empathy or Other Known Factors	PLOS ONE			English	Article							COGNITIVE TESTS; CHIMPANZEES; SCALE; PERFORMANCE; SLEEPINESS; IMITATION; AGE	The contagious aspect of yawning is a well-known phenomenon that exhibits variation in the human population. Despite the observed variation, few studies have addressed its intra-individual reliability or the factors modulating differences in the susceptibility of healthy volunteers. Due to its obvious biological basis and impairment in diseases like autism and schizophrenia, a better understanding of this trait could lead to novel insights into these conditions and the general biological functioning of humans. We administered 328 participants a 3-minute yawning video stimulus, a cognitive battery, and a comprehensive questionnaire that included measures of empathy, emotional contagion, circadian energy rhythms, and sleepiness. Individual contagious yawning measurements were found to be highly stable across testing sessions, both in a lab setting and if administered remotely online, confirming that certain healthy individuals are less susceptible to contagious yawns than are others. Additionally, most individuals who failed to contagiously yawn in our study were not simply suppressing their reaction, as they reported not even feeling like yawning in response to the stimulus. In contrast to previous studies indicating that empathy, time of day, or intelligence may influence contagious yawning susceptibility, we found no influence of these variables once accounting for the age of the participant. Participants were less likely to show contagious yawning as their age increased, even when restricting to ages of less than 40 years. However, age was only able to explain 8% of the variability in the contagious yawn response. The vast majority of the variability in this extremely stable trait remained unexplained, suggesting that studies of its inheritance are warranted.	[Bartholomew, Alex J.; Cirulli, Elizabeth T.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27706 USA	Duke University	Cirulli, ET (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27706 USA.	etc3@duke.edu		Cirulli Rogers, Liz/0000-0001-7808-2809	National Institute of Mental Health of the National Institutes of Health [K01MH098126]; Ellison Medical Foundation [AG-NS-0441-08]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098126] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under award number K01MH098126 and the Ellison Medical Foundation New Scholar award AG-NS-0441-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Arnott SR, 2009, COGN AFFECT BEHAV NE, V9, P335, DOI 10.3758/CABN.9.3.335; BAENNINGER R, 1991, PSYCHOL REC, V41, P453; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cirulli ET, 2011, CLIN NEUROPSYCHOL, V25, P778, DOI 10.1080/13854046.2011.578587; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Cooper NR, 2012, COGN AFFECT BEHAV NE, V12, P393, DOI 10.3758/s13415-011-0081-7; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Gallup AC, 2011, FRONTIERS EVOLUTIONA, V3; Gallup AC, 2008, PHYSIOL BEHAV, V95, P10, DOI 10.1016/j.physbeh.2008.05.003; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Giganti F., 2009, CURRENT PSYCHOL LETT, V25; Giganti F, 2011, J ETHOL, V29, P215, DOI 10.1007/s10164-010-0242-0; Gilet AL, 2013, CAN J BEHAV SCI, V45, P42, DOI 10.1037/a0030425; Greco M, 1989, B PSYCHONOMIC SOC; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; Haker H, 2013, BRAIN IMAGING BEHAV, V7, P28, DOI 10.1007/s11682-012-9189-9; Haker H, 2009, EUR ARCH PSY CLIN N, V259, P352, DOI 10.1007/s00406-009-0007-3; HEUSNER AP, 1946, PHYSIOL REV, V26, P156, DOI 10.1152/physrev.1946.26.1.156; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Madsen EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076266; Meno P, 2003, CURR PSYCHOL LETT, V11, P1; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Monk TH, 2007, J BIOL RHYTHM, V22, P278, DOI 10.1177/0748730407301054; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; OCONNELL SM, 1995, PRIMATES, V36, P397, DOI 10.1007/BF02382862; Ottoni GL, 2011, CHRONOBIOL INT, V28, P229, DOI 10.3109/07420528.2011.553696; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Platek SM, 2010, YAWN YAWN YAWN YAWN; Preacher K. J., 2002, CALCULATION TEST DIF; Provine RR, 2005, AM SCI, V93, P532, DOI 10.1511/2005.56.980; PROVINE RR, 1986, ETHOLOGY, V72, P109, DOI 10.1111/j.1439-0310.1986.tb00611.x; Provine RR, 1989, B PSYCHONOMIC SOC; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schoner J, 2013, EMPHATHY MEMORY GENE; Schurmann M, 2005, NEUROIMAGE, V24, P1260, DOI 10.1016/j.neuroimage.2004.10.022; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; SHERER DM, 1991, J ULTRAS MED, V10, P68; StataCorp, 2011, STAT STAT SOFTW REL, P173; Zilli I, 2008, J SLEEP RES, V17, P303, DOI 10.1111/j.1365-2869.2008.00666.x; Zilli I, 2007, PHYSIOL BEHAV, V91, P218, DOI 10.1016/j.physbeh.2007.02.015	48	39	39	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91773	10.1371/journal.pone.0091773	http://dx.doi.org/10.1371/journal.pone.0091773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632594	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400088
J	Zhang, JL; Zhang, CY; Chu, TG; Weissing, FJ				Zhang, Jianlei; Zhang, Chunyan; Chu, Tianguang; Weissing, Franz J.			Cooperation in Networks Where the Learning Environment Differs from the Interaction Environment	PLOS ONE			English	Article							PRISONERS-DILEMMA; SNOWDRIFT GAME; EVOLUTION; REPLACEMENT	We study the evolution of cooperation in a structured population, combining insights from evolutionary game theory and the study of interaction networks. In earlier studies it has been shown that cooperation is difficult to achieve in homogeneous networks, but that cooperation can get established relatively easily when individuals differ largely concerning the number of their interaction partners, such as in scale-free networks. Most of these studies do, however, assume that individuals change their behaviour in response to information they receive on the payoffs of their interaction partners. In real-world situations, subjects do not only learn from their interaction partners, but also from other individuals (e.g. teachers, parents, or friends). Here we investigate the implications of such incongruences between the 'interaction network' and the 'learning network' for the evolution of cooperation in two paradigm examples, the Prisoner's Dilemma game (PDG) and the Snowdrift game (SDG). Individual-based simulations and an analysis based on pair approximation both reveal that cooperation will be severely inhibited if the learning network is very different from the interaction network. If the two networks overlap, however, cooperation can get established even in case of considerable incongruence between the networks. The simulations confirm that cooperation gets established much more easily if the interaction network is scale-free rather than random-regular. The structure of the learning network has a similar but much weaker effect. Overall we conclude that the distinction between interaction and learning networks deserves more attention since incongruences between these networks can strongly affect both the course and outcome of the evolution of cooperation.	[Zhang, Jianlei; Chu, Tianguang] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Zhang, Jianlei; Zhang, Chunyan] Univ Groningen, Inst Ind Engn, Network Anal & Control Grp, Groningen, Netherlands; [Zhang, Jianlei; Zhang, Chunyan; Weissing, Franz J.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Theoret Biol Grp, Groningen, Netherlands	Peking University; University of Groningen; University of Groningen	Chu, TG (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.	chutg@pku.edu.cn; f.j.weissing@rug.nl	Chu, Tianguang/C-3521-2012	Zhang, Jianlei/0000-0002-9932-9265; Weissing, Franz J./0000-0003-3281-663X	National Basic Research Program of China (973 Program) [2012CB821200]; National Natural Science Foundation of China (NSFC) [61273111, 60974064]; Erasmus Mundus Action (EMA2 Lotus Grant); Organization for Scientific Research (NWO) [82301006]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Erasmus Mundus Action (EMA2 Lotus Grant); Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by National Basic Research Program of China (973 Program, No. 2012CB821200), and the National Natural Science Foundation of China (NSFC, Nos. 61273111, 60974064). In addition, JZ, CZ, and FJW acknowledge support from the Erasmus Mundus Action (EMA2 Lotus Grant), and Organization for Scientific Research (NWO, No. 82301006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollobas B., 2001, RANDOM GRAPHS, V73; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Heckathorn DD, 1996, AM SOCIOL REV, V61, P250, DOI 10.2307/2096334; Ifti M, 2004, J THEOR BIOL, V231, P97, DOI 10.1016/j.jtbi.2004.06.003; McNamara JM, 2010, SOCIAL BEHAV GENES E, P109; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Suzuki R, 2011, INT J BIO-INSPIR COM, V3, P151, DOI 10.1504/IJBIC.2011.040313; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; Wu ZX, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041114; Zhang CY, 2011, THEOR POPUL BIOL, V80, P226, DOI 10.1016/j.tpb.2011.06.007; Zhang JL, 2011, CHAOS SOLITON FRACT, V44, P131, DOI 10.1016/j.chaos.2011.01.002	29	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90288	10.1371/journal.pone.0090288	http://dx.doi.org/10.1371/journal.pone.0090288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632774	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400012
J	Alberti, G				Alberti, Gianmarco			Modeling Group Size and Scalar Stress by Logistic Regression from an Archaeological Perspective	PLOS ONE			English	Article							FAUNAL REMAINS; ORGANIZATION; POTTERY; ARCHITECTURE; TRANSITION; COMPLEXITY; DEMOGRAPHY; SOCIETIES; POLITICS; QUALITY	Johnson's scalar stress theory, describing the mechanics of (and the remedies to) the increase in in-group conflictuality that parallels the increase in groups' size, provides scholars with a useful theoretical framework for the understanding of different aspects of the material culture of past communities (i.e., social organization, communal food consumption, ceramic style, architecture and settlement layout). Due to its relevance in archaeology and anthropology, the article aims at proposing a predictive model of critical level of scalar stress on the basis of community size. Drawing upon Johnson's theory and on Dunbar's findings on the cognitive constrains to human group size, a model is built by means of Logistic Regression on the basis of the data on colony fissioning among the Hutterites of North America. On the grounds of the theoretical framework sketched in the first part of the article, the absence or presence of colony fissioning is considered expression of not critical vs. critical level of scalar stress for the sake of the model building. The model, which is also tested against a sample of archaeological and ethnographic cases: a) confirms the existence of a significant relationship between critical scalar stress and group size, setting the issue on firmer statistical grounds; b) allows calculating the intercept and slope of the logistic regression model, which can be used in any time to estimate the probability that a community experienced a critical level of scalar stress; c) allows locating a critical scalar stress threshold at community size 127 (95% CI: 122-132), while the maximum probability of critical scale stress is predicted at size 158 (95% CI: 147-170). The model ultimately provides grounds to assess, for the sake of any further archaeological/anthropological interpretation, the probability that a group reached a hot spot of size development critical for its internal cohesion.				gianmarcoalberti@tin.it	Alberti, Gianmarco/N-1537-2014	Alberti, Gianmarco/0000-0003-2916-1767				ADLER M, 1993, J ANTHROPOL RES, V49, P319, DOI 10.1086/jar.49.4.3630153; ADLER MA, 1990, WORLD ARCHAEOL, V22, P133, DOI 10.1080/00438243.1990.9980136; Adler MA, 2002, INT MONOGRAPHS PREHI, P155; Adler MichaelA., 1989, ARCHITECTURE SOCIAL, P35; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Alberti G, 2012, THESIS U UDINE; Ames K.M., 2009, HDB ARCHAEOLOGICAL T, P487; [Anonymous], [No title captured]; [Anonymous], 2010, MANY FRIENDS DOES ON; Bandy MS, 2006, ANDEAN ARCHAEOLOGY III: NORTH AND SOUTH, P210, DOI 10.1007/0-387-28940-2_10; Bandy MS, 2004, AM ANTHROPOL, V106, P322, DOI 10.1525/aa.2004.106.2.322; Bernard HR, 1984, SOC SCI RES, V2, P145; Bernardini W, 1996, J ANTHROPOL ARCHAEOL, V15, P372, DOI 10.1006/jaar.1996.0014; BONACICH P, 1976, J CONFLICT RESOLUT, V20, P687, DOI 10.1177/002200277602000406; Bowser BJ, 2004, J ARCHAEOL METHOD TH, V11, P157, DOI 10.1023/B:JARM.0000038065.43689.75; Bowser BJ, 2000, J ARCHAEOL METHOD TH, V7, P219, DOI 10.1023/A:1026510620824; Brown B. M., 1987, CROSS-CULT RES, V21, P1, DOI DOI 10.1177/106939718702100101; Byrd B., 2002, LIFE NEOLITHIC FARMI, P63; BYRD BF, 1994, AM ANTIQUITY, V59, P639, DOI 10.2307/282338; Cameron CM, 1999, J ANTHROPOL ARCHAEOL, V18, P201, DOI 10.1006/jaar.1999.0336; Carneiro RL, 2000, P NATL ACAD SCI USA, V97, P12926, DOI 10.1073/pnas.240462397; Cavalier, 1980, MELIGUNIS LIPARA; Chagnon NA, 1980, EVOLUTIONARY BIOL HU, P86; Chamberlain A.T., 2006, DEMOGRAPHY ARCHAEOLO; Chao-Ying Joanne Peng, 2002, Understanding Statistics, V1, P31, DOI 10.1207/S15328031US0101_04; CUMMINGS LL, 1974, ACAD MANAGE J, V17, P460, DOI 10.2307/254650; de Ruiter J, 2011, AM ANTHROPOL, V113, P557, DOI 10.1111/j.1548-1433.2011.01369.x; Dobres MA, 2000, AGENCY IN ARCHAEOLOGY, P3; Dubreuil Benoit, 2010, HUMAN EVOLUTION ORIG; Duff Andrew I., 2002, W PUEBLO IDENTITIES; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; DUNBAR RIM, 2002, SO NEUROSCI SER, P69; During B., 2006, CONSTRUCTING COMMUNI; Feinman G. M., 2013, COOPERATION COLLECTI, P35; Feinman GM, 2011, CROSS-CULT RES, V45, P37, DOI 10.1177/1069397110383658; Finlayson B, 2011, P NATL ACAD SCI USA, V108, P8183, DOI 10.1073/pnas.1017642108; Forsyth D.R., 2009, GROUP DYNAMICS; Friesen TM, 1999, WORLD ARCHAEOL, V31, P21, DOI 10.1080/00438243.1999.9980430; Fry D. P, 2004, WAR HUMAN POTENTIAL; Fry DP, 2011, DEV PRIMATOL-PROG PR, P227, DOI 10.1007/978-1-4419-9520-9_13; Gladwell M., 2006, TIPPING POINT LITTLE; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; HACKMAN JR, 1970, SOCIOMETRY, V33, P37, DOI 10.2307/2786271; Hally D., 2008, KING SOCIAL ARCHAEOL; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; Hare AP, 1952, AM SOCIOL REV, V17, P261, DOI 10.2307/2088071; Hassan FA, 1978, ADV ARCHAEOLOGICAL M, V1, P49; Hayden Brian, 2004, COMPLEX HUNTER GATHE, P84; Hegmon M, 1989, ARCHITECTURE SOCIAL, P125; Hegmon Michelle., 1995, SOCIAL DYNAMICS POTT; HILL JN, 1970, BROKEN K PUEBLO PREH; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Hockett BS, 1998, AM ANTIQUITY, V63, P289, DOI 10.2307/2694699; Holmberg AR, 1950, NOMADS LONG BOW SIRI; Hostetler J. A., 1997, HUTTERITE SOC; Houle J.-L, 2009, SOCIAL COMPLEXITY PR, P358, DOI [10.1017/CBO9780511605376, DOI 10.1017/CBO9780511605376]; Janzen Rod, 2010, HUTTERITES N AM; Johnson G. A., 1982, THEORY EXPLANATION A, P389; JOHNSON GA, 1983, HUM ECOL, V11, P175, DOI 10.1007/BF00891742; KOSSE K, 1990, J ANTHROPOL ARCHAEOL, V9, P275, DOI 10.1016/0278-4165(90)90009-3; Kosse K., 2001, COMPLEXITY, V6, P60; Lee Lyman R, 2009, PREHISTORY OREGON CO; Lee YK, 2007, J ANTHROPOL ARCHAEOL, V26, P630, DOI 10.1016/j.jaa.2007.03.001; LEVINE JM, 1990, ANNU REV PSYCHOL, V41, P585, DOI 10.1146/annurev.psych.41.1.585; MANNERS GE, 1975, ACAD MANAGE J, V18, P715, DOI 10.2307/255374; McDonald JH., 2008, HDB BIOL STAT; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; MCGRATH JE, 1982, ANNU REV PSYCHOL, V33, P195, DOI 10.1146/annurev.ps.33.020182.001211; Means BK, 2007, CIRCULAR VILLAGES MO; Nelson MC, 2011, ECOL SOC, V16; OLSEN CL, 1987, AM ANTHROPOL, V89, P823, DOI 10.1525/aa.1987.89.4.02a00040; Pampel FC., 2021, LOGISTIC REGRESSION, DOI 10.4135/9781071878729; Parkinson WA, 2006, J ANTHROPOL ARCHAEOL, V25, P33, DOI 10.1016/j.jaa.2005.06.002; Peter K., 1987, DYNAMICS HUTTERITE S; Peterson CE, 2012, J ANTHROPOL ARCHAEOL, V31, P265, DOI 10.1016/j.jaa.2012.01.007; Porcic M, 2011, DOC PRAEHIST, V38, P323, DOI 10.4312/dp.38.25; Porcic M, 2012, CROSS-CULT RES, V46, P72, DOI 10.1177/1069397111423889; Porcic M, 2010, CROSS-CULT RES, V44, P405, DOI 10.1177/1069397110378839; Potter JM, 1997, J FIELD ARCHAEOL, V24, P353, DOI 10.1179/009346997792208140; R Core Team, 2021, R LANGUAGE ENV STAT; Rakita Gordon F. M., 2009, ANCESTORS ELITES EME; Rappaport Roy A., 1979, ECOLOGY MEANING RELI; Rappaport Roy A., 1968, PIGS ANCESTORS RITUA; REYNOLDS RG, 1984, J ANTHROPOL ARCHAEOL, V3, P159, DOI 10.1016/0278-4165(84)90001-1; Robb J, 2010, WORLD ARCHAEOL, V42, P493, DOI 10.1080/00438243.2010.520856; Rosemberg M, 2002, LIFE NEOLITHC FARMIN, P39; Rumsey D, 2009, STATISTICS; Satterlee JL, 1993, HUTTERITES STUDY CUL; Schachner G, 2001, J ANTHROPOL ARCHAEOL, V20, P168, DOI 10.1006/jaar.2001.0379; SCHACHT RM, 1981, ANNU REV ANTHROPOL, V10, P119, DOI 10.1146/annurev.an.10.100181.001003; Shelach G, 2006, J ANTHROPOL ARCHAEOL, V25, P318, DOI 10.1016/j.jaa.2005.11.007; SLATER PE, 1958, SOCIOMETRY, V21, P129, DOI 10.2307/2785897; Souvatzi SG, 2008, SOCIAL ARCHAEOLOGY OF HOUSEHOLDS IN NEOLITHIC GREECE: AN ANTHROPOLOGICAL APPROACH; Stordeur D., 2000, PALE ORIENT, V26, P29, DOI DOI 10.3406/paleo.2000.4696; THOMAS EJ, 1963, PSYCHOL BULL, V60, P371, DOI 10.1037/h0047169; Turner Victor, 1969, RITUAL PROCESS; Twiss KC, 2008, J ANTHROPOL ARCHAEOL, V27, P418, DOI 10.1016/j.jaa.2008.06.002; Verhagen P, 2012, J ARCHAEOL METHOD TH, V19, P49, DOI 10.1007/s10816-011-9102-7; Warren R.E., 2000, PRACTICAL APPL GIS A, P6; Whitelaw T, 2004, BR SCH ATHENS STUD, V12, P147; ZILLER RC, 1957, SOCIOMETRY, V20, P165, DOI 10.2307/2785643	102	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91510	10.1371/journal.pone.0091510	http://dx.doi.org/10.1371/journal.pone.0091510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AC9JS	24626241	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300094
J	Hill, WD; de Leeuw, C; Davies, G; Liewald, DCM; Payton, A; Craig, LCA; Whalley, LJ; Horan, M; Ollier, W; Starr, JM; Pendleton, N; Posthuma, D; Bates, TC; Deary, IJ				Hill, W. David; de Leeuw, Christiaan; Davies, Gail; Liewald, David Cherry McLachlan; Payton, Anthony; Craig, Leone C. A.; Whalley, Lawrence J.; Horan, Mike; Ollier, William; Starr, John M.; Pendleton, Neil; Posthuma, Danielle; Bates, Timothy C.; Deary, Ian J.			Functional Gene Group Analysis Indicates No Role for Heterotrimeric G Proteins in Cognitive Ability	PLOS ONE			English	Article							COMMON SNPS EXPLAIN; LARGE PROPORTION; NMDA RECEPTORS; MENTAL SURVEYS; HERITABILITY; INTELLIGENCE; METAANALYSIS; ASSOCIATION; COMPONENTS; COMPLEXES	Previous functional gene group analyses implicated common single nucleotide polymorphisms (SNPs) in heterotrimeric G protein coding genes as being associated with differences in human intelligence. Here, we sought to replicate this finding using five independent cohorts of older adults including current IQ and childhood IQ, and using both gene- and SNP-based analytic strategies. No significant associations were found between variation in heterotrimeric G protein genes and intelligence in any cohort at either of the two time points. These results indicate that, whereas G protein systems are important in cognition, common genetic variation in these genes is unlikely to be a substantial influence on human intelligence differences.	[Hill, W. David; Davies, Gail; Liewald, David Cherry McLachlan; Starr, John M.; Bates, Timothy C.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Hill, W. David; Bates, Timothy C.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [de Leeuw, Christiaan; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [de Leeuw, Christiaan] Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 ED Nijmegen, Netherlands; [Payton, Anthony; Ollier, William; Pendleton, Neil] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England; [Craig, Leone C. A.] Univ Aberdeen, Inst Appl Hlth Sci, Publ Hlth Nutr Grp, Aberdeen, Scotland; [Whalley, Lawrence J.] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Horan, Mike] Univ Manchester, Inst Brain Behav & Mental Hlth, Ctr Clin & Cognit Neurosci, Manchester, Lancs, England; [Posthuma, Danielle] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Posthuma, Danielle] Erasmus Univ, Sophia Child Hosp, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	University of Edinburgh; University of Edinburgh; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Manchester; University of Aberdeen; University of Aberdeen; University of Manchester; Vrije Universiteit Amsterdam; Erasmus University Rotterdam	Deary, IJ (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	iand@staffmail.ed.ac.uk	Deary, Ian J/C-6297-2009; whalley, lawrence j/E-9019-2011; Bates, Timothy C/C-9637-2010; Pendleton, Neil/F-2333-2015	Deary, Ian J/0000-0002-1733-263X; Bates, Timothy C/0000-0002-1153-9007; Pendleton, Neil/0000-0003-0794-2386; Posthuma, Danielle/0000-0001-7582-2365; de Leeuw, Christiaan/0000-0003-1076-9828; Payton, Antony/0000-0003-0335-152X	Engineering and Physical research council (EPSRC); Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Wellcome Trust; Economic and Social Research Council (ESRC); Netherlands Organization of Scientific Research NWO [645-000-003]; Biotechnology and Biological Sciences Research Council [BB/F022441/1, BB/F019394/1] Funding Source: researchfish; Medical Research Council [MC_PC_15018, MR/K026992/1, G0700704] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish; BBSRC [BB/F019394/1, BB/F022441/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI	Engineering and Physical research council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Engineering and Physical research council (EPSRC), the Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), the Wellcome Trust, the Economic and Social Research Council (ESRC), and Netherlands Organization of Scientific Research NWO 645-000-003. The work was undertaken in The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1960, INDIVIDUAL GROUP CUL; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary I.J., 2009, LIFETIME INTELLIGENC; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Guildford JP, 1978, ALTERNATE USES MANUA; Heim A.W., 1970, AH 4 GROUP TEST GEN; Hill WD, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.114; Horn JL, 1994, ENCY HUMAN INTELLIGE; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lips E, 2012, JAG TOOL EVALUATE RO; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Nelson H., 1991, NATL ADULT READING T; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Rabbitt PMA, 2004, AGING NEUROPSYCHOL C, V11, P245, DOI 10.1080/13825580490511116; Raven JC, 1977, MANUAL RAVENS PROGR; Raven JC, 1965, MILL HILL VOCABULARY; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trzaskowski M, 2013, MOL PSYCHIAT; Tucker-Drob EA, 2008, PSYCHOL AGING, V23, P453, DOI 10.1037/0882-7974.23.2.453; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1998, WECHSLER ADULT INTEL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Whalley LJ, 2011, MATURITAS, V69, P365, DOI 10.1016/j.maturitas.2011.05.010; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zorumski CF, 2012, NEUROSCI BIOBEHAV R, V36, P989, DOI 10.1016/j.neubiorev.2011.12.011	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91690	10.1371/journal.pone.0091690	http://dx.doi.org/10.1371/journal.pone.0091690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626473	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300122
J	de Oliveira, MPA; Ferreira, RL				Alves de Oliveira, Marcus Paulo; Ferreira, Rodrigo Lopes			Aspects of the Behavior and Activity Rhythms of Rowlandius potiguar (Schizomida: Hubbardiidae)	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; ARACHNIDA; PATTERNS	Although organisms of the order Schizomida are not widely distributed in caves throughout the world, they can, eventually, be abundant in certain regions, becoming a major faunal element in some caves. The majority of works on this order includes species descriptions, with rare references to behavioral aspects. As such, the present study describes the behavioral repertoire, and the activity and feeding periods of Rowlandius potiguar (Schizomida: Hubbardiidae) in the laboratory. The specimens were maintained in a terrarium, in an aphotic room, with temperature and humidity levels similar to the cave of origin. We used the focal-animal and ad libitum methods to describe behavior with qualitative and quantitative evaluations of behavioral acts. We witnessed nineteen behavioral acts, which is considered representative for observations in captivity. Two activity periods were observed: between 10 a. m. and 4 p. m. and between 10 p. m. and 4 a. m., characterizing an ultradian rhythm. In adaptive terms, this condition may be important for population maintenance in oligotrophic environments such as caverns. Necrophagy and cannibalism were also registered and could have been selected in the subterranean environment due to oligotrophy. The observation of rare and unprecedented behavior in this group, as well as the presence of rhythmicity in activity patterns, contribute to a better understanding of the ecological aspects of the species of this still little known Order.	[Alves de Oliveira, Marcus Paulo; Ferreira, Rodrigo Lopes] Univ Fed Lavras, Dept Biol Setor Zool, Lab Ecol Subterranea, Lavras, Brazil	Universidade Federal de Lavras	de Oliveira, MPA (corresponding author), Univ Fed Lavras, Dept Biol Setor Zool, Lab Ecol Subterranea, Lavras, Brazil.	marcuspbr@gmail.com	Ferreira, RL/L-8419-2014	Ferreira, RL/0000-0003-3288-4405	Conselho Nacional de Pesquisa (CNPq) [477712/2006-1]	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Conselho Nacional de Pesquisa (CNPq), process No. 477712/2006-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adis J, 1999, J ARACHNOL, V27, P205; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Armas LF, 2004, ESPECIAL MONOGRAFICO, V2, P3; Ayres M., 2007, BIOESTAT 5 0 APL EST; BECK L, 1968, Amazoniana, V1, P247; Bonaldo A, 2007, REV BRAS ZOOL, V24, P323, DOI 10.1590/S0101-81752007000200009; Cokendolpher JC, 2000, AMAZONIANA, V16, P187; Culver DC, 1982, CAVE LIFE EVOLUTION; EICKSTEDT VRD, 1994, VENENOS ANIMAIS VISA, P151; Elpino-Campos Abner, 2001, Bulletin of the British Arachnological Society, V12, P144; Ferreira R.L., 2010, REV BRASILEIRA ESPEL, V1, P25; Gerkema M, 1985, EXP BRAIN RES S, V12, P321, DOI DOI 10.1007/978-3-642-70483-3; HAMILTON WD, 1978, DIVERSITY INSECT FAU, P154; Harvey MS, 2007, ZOOTAXA, P363; Hoenen S, 2005, EUR J ENTOMOL, V102, P663, DOI 10.14411/eje.2005.094; Hoenen S, 1999, J ARACHNOL, V27, P159; HUMPHREYS WF, 1989, J ZOOL, V217, P177, DOI 10.1111/j.1469-7998.1989.tb02481.x; Idema - Instituto de Desenvolvimento Sustentavel e Meio Ambiente do Rio Grande do Norte, 2008, PERF MUN FELIP GUERR; KRAUS O, 1967, Senckenbergiana Biologica, V48, P401; LAMPRECHT G, 1986, NSS B, V47, P147; Lehner PN, 1996, HDB ETHOLOGICAL METH; Marques N, 1997, CRONOBIOLOGIA; Martin P., 2007, MEASURING BEHAV INTR, V3; Medeiros WE, 2001, RELATORIO TECNICO; Mineo Marina Farcic, 2003, Revista Brasileira de Zoociencias, V5, P23; ORTEGA J, 1992, J INTERDISCIPL CYCLE, V23, P295, DOI 10.1080/09291019209360188; PAGE TL, 1980, PHYSIOL ENTOMOL, V5, P271, DOI 10.1111/j.1365-3032.1980.tb00235.x; Page TL, 1985, COMPREHENSIVE INSECT, P577; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; R Development Core Team, 2012, R LANG ENV STAT COMP; Reddell J.R., 2002, P387; Reddell James R., 1995, Texas Memorial Museum Speleological Monograph, V4, P1; ROWLAND J M, 1972, Entomological News, V83, P69; Sandidge JS, 2003, NATURE, V426, P30, DOI 10.1038/426030a; Santoro AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065813, 10.1371/journal.pone.0066932]; Santos AJ, 2008, ZOOTAXA, P53; Saunders DS, 1982, INSECT CLOCKS; STURM H, 1973, Zeitschrift fuer Tierpsychologie, V33, P113; Tizo-Pedroso E, 2011, ETHOLOGY, V117, P498, DOI 10.1111/j.1439-0310.2011.01906.x; Tourinho Ana Lucia M., 1999, Boletim do Museu Nacional Rio de Janeiro Zoologia, V405, P1; TRAJANO E, 1995, BIOL RHYTHM RES, V26, P341, DOI 10.1080/09291019509360347	41	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91913	10.1371/journal.pone.0091913	http://dx.doi.org/10.1371/journal.pone.0091913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643024	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900045
J	Bishi, DK; Mathapati, S; Cherian, KM; Guhathakurta, S; Verma, RS				Bishi, Dillip Kumar; Mathapati, Santosh; Cherian, Kotturathu Mammen; Guhathakurta, Soma; Verma, Rama Shanker			In Vitro Hepatic Trans-Differentiation of Human Mesenchymal Stem Cells Using Sera from Congestive/Ischemic Liver during Cardiac Failure	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BONE-MARROW; HEART-FAILURE; CULTURE-SYSTEM; TRANSPLANTATION; PROLIFERATION; DYSFUNCTION; EXPRESSION; CHALLENGES; BILIRUBIN	Cellular therapy for end-stage liver failures using human mesenchymal stem cells (hMSCs)-derived hepatocytes is a potential alternative to liver transplantation. Hepatic trans-differentiation of hMSCs is routinely accomplished by induction with commercially available recombinant growth factors, which is of limited clinical applications. In the present study, we have evaluated the potential of sera from cardiac-failure-associated congestive/ischemic liver patients for hepatic trans-differentiation of hMSCs. Results from such experiments were confirmed through morphological changes and expression of hepatocyte-specific markers at molecular and cellular level. Furthermore, the process of mesenchymal-to-epithelial transition during hepatic trans-differentiation of hMSCs was confirmed by elevated expression of E-Cadherin and downregulation of Snail. The functionality of hMSCs-derived hepatocytes was validated by various liver function tests such as albumin synthesis, urea release, glycogen accumulation and presence of a drug inducible cytochrome P450 system. Based on these findings, we conclude that sera from congestive/ischemic liver during cardiac failure support a liver specific microenvironment for effective hepatic trans-differentiation of hMSCs in vitro.	[Bishi, Dillip Kumar; Mathapati, Santosh; Verma, Rama Shanker] Indian Inst Technol, Dept Biotechnol, Stem Cells & Mol Biol Lab, Madras 600036, Tamil Nadu, India; [Bishi, Dillip Kumar; Mathapati, Santosh; Cherian, Kotturathu Mammen] Frontier Lifeline, Stem Cells & Tissue Engn Lab, Int Ctr Cardiothorac & Vasc Dis, Madras, Tamil Nadu, India; [Guhathakurta, Soma] Indian Inst Technol, Dept Engn Design, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Guhathakurta, S (corresponding author), Indian Inst Technol, Dept Engn Design, Madras 600036, Tamil Nadu, India.	husun1971@gmail.com; vermars@iitm.ac.in	Mathapati, Santosh/O-9151-2017; BISHI, DILLIP KUMAR/N-9758-2014	Mathapati, Santosh/0000-0001-9448-6889; BISHI, DILLIP KUMAR/0000-0003-4025-979X; Verma, Rama/0000-0001-7287-7803				Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Asgari S, 2010, J HEPATOL, V53, P738, DOI 10.1016/j.jhep.2010.05.009; Avital L, 2001, BIOCHEM BIOPH RES CO, V288, P156; Cai YF, 2004, WORLD J GASTROENTERO, V10, P3308, DOI 10.3748/wjg.v10.i22.3308; Chang CY, 2007, ALIMENT PHARM THER, V25, P1135, DOI 10.1111/j.1365-2036.2007.03307.x; Czyz J, 2003, BIOL CHEM, V384, P1391, DOI 10.1515/BC.2003.155; Dalgetty DM, 2009, AM J PHYSIOL-GASTR L, V297, pG241, DOI 10.1152/ajpgi.00138.2009; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; Gallegos-Orozco JF, 2009, MED CLIN N AM, V93, P931, DOI 10.1016/j.mcna.2009.03.010; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; JANES CH, 1995, J CLIN INVEST, V95, P2581, DOI 10.1172/JCI117959; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Lamblin N, 2005, AM HEART J, V150, P137, DOI 10.1016/j.ahj.2005.03.047; Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Li ZD, 2007, AM J PHYSIOL-GASTR L, V292, pG639, DOI 10.1152/ajpgi.00292.2006; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Maleki M, 2011, HEART ASIA, V3, P143, DOI 10.1136/heartasia-2011-010023; Matsumori A, 1996, BIOCHEM BIOPH RES CO, V221, P391, DOI 10.1006/bbrc.1996.0606; Min J, 2007, ACTA PHARMACOL SIN, V28, P1931, DOI 10.1111/j.1745-7254.2007.00715.x; Mohamadnejad M, 2007, ARCH IRAN MED, V10, P459; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura Y, 1996, HYPERTENSION, V28, P409, DOI 10.1161/01.HYP.28.3.409; Ochiya T, 2010, DIFFERENTIATION, V79, P65, DOI 10.1016/j.diff.2009.10.002; Ong SY, 2006, TISSUE ENG, V12, P3477, DOI 10.1089/ten.2006.12.3477; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Poelzl G, 2012, EUR J CLIN INVEST, V42, P153, DOI 10.1111/j.1365-2362.2011.02573.x; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rius C, 1998, BLOOD, V92, P4677; Ruiz-Gaspa S, 2011, HEPATOLOGY, V54, P2104, DOI 10.1002/hep.24605; Rychli K, 2011, HEART, V97, P1158, DOI 10.1136/hrt.2010.220228; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; SHERLOCK S, 1951, BRIT HEART J, V13, P273; SHIOTA G, 1995, HEPATOLOGY, V21, P106, DOI 10.1002/hep.1840210119; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sivasubramaniyan K, 2008, REGEN MED, V3, P23, DOI 10.2217/17460751.3.1.23; Snykers S, 2006, TOXICOL SCI, V94, P330, DOI 10.1093/toxsci/kfl058; Snykers S, 2011, METHODS MOL BIOL, V698, P305, DOI 10.1007/978-1-60761-999-4_23; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; Szygula-Jurkiewicz Bozena, 2007, Pol Arch Med Wewn, V117, P227; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Ueno S, 2001, J CARD FAIL, V7, P329, DOI 10.1054/jcaf.2001.27686; Ueno S, 1997, INT HEPATOL COMMUN, V6, P294, DOI 10.1016/S0928-4346(97)00359-9; Van Deursen VM, 2010, J CARD FAIL, V16, P84, DOI 10.1016/j.cardfail.2009.08.002; Wang PP, 2004, BIOCHEM BIOPH RES CO, V320, P712, DOI 10.1016/j.bbrc.2004.05.213; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xu J, 2008, STEM CELLS DEV, V17, P143, DOI 10.1089/scd.2007.0094; Yamagamim H, 2002, CANCER, V95, P824, DOI 10.1002/cncr.10732; Yamazaki S, 2003, J HEPATOL, V39, P17, DOI 10.1016/S0168-8278(03)00150-8; Yang Y, 2009, J SURG RES, V155, P18, DOI 10.1016/j.jss.2009.01.006; Zhao QJ, 2009, BIOL CELL, V101, P557, DOI 10.1042/BC20080105; Zhao YS, 2010, TISSUE ENG PART C-ME, V16, P653, DOI 10.1089/ten.TEC.2009.0053; Zhu Y, 2000, HEART, V83, P450, DOI 10.1136/heart.83.4.450	57	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92397	10.1371/journal.pone.0092397	http://dx.doi.org/10.1371/journal.pone.0092397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642599	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900132
J	Juhasz, T; Matta, C; Katona, E; Somogyi, C; Takacs, R; Gergely, P; Csernoch, L; Panyi, G; Toth, G; Reglodi, D; Tamas, A; Zakany, R				Juhasz, Tamas; Matta, Csaba; Katona, Eva; Somogyi, Csilla; Takacs, Roland; Gergely, Pal; Csernoch, Laszlo; Panyi, Gyorgy; Toth, Gabor; Regloedi, Dora; Tamas, Andrea; Zakany, Roza			Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Signalling Exerts Chondrogenesis Promoting and Protecting Effects: Implication of Calcineurin as a Downstream Target	PLOS ONE			English	Article							STRESS-INDUCED APOPTOSIS; INDUCED CELL-DEATH; HYDROGEN-PEROXIDE; CYCLIC-AMP; IN-VITRO; CARTILAGE DIFFERENTIATION; EXTRACELLULAR DOMAIN; CHICKEN PINEALOCYTES; CORTICAL-NEURONS; PROGENITOR CELLS	Pituitary adenylate cyclase activating polypeptide (PACAP) is an important neurotrophic factor influencing differentiation of neuronal elements and exerting protecting role during traumatic injuries or inflammatory processes of the central nervous system. Although increasing evidence is available on its presence and protecting function in various peripheral tissues, little is known about the role of PACAP in formation of skeletal components. To this end, we aimed to map elements of PACAP signalling in developing cartilage under physiological conditions and during oxidative stress. mRNAs of PACAP and its receptors (PAC1, VPAC1, VPAC2) were detectable during differentiation of chicken limb bud-derived chondrogenic cells in micromass cell cultures. Expression of PAC1 protein showed a peak on days of final commitment of chondrogenic cells. Administration of either the PAC1 receptor agonist PACAP 1-38, or PACAP 6-38 that is generally used as a PAC1 antagonist, augmented cartilage formation, stimulated cell proliferation and enhanced PAC1 and Sox9 protein expression. Both variants of PACAP elevated the protein expression and activity of the Ca-calmodulin dependent Ser/Thr protein phosphatase calcineurin. Application of PACAPs failed to rescue cartilage formation when the activity of calcineurin was pharmacologically inhibited with cyclosporine A. Moreover, exogenous PACAPs prevented diminishing of cartilage formation and decrease of calcineurin activity during oxidative stress. As an unexpected phenomenon, PACAP 6-38 elicited similar effects to those of PACAP 1-38, although to a different extent. On the basis of the above results, we propose calcineurin as a downstream target of PACAP signalling in differentiating chondrocytes either in normal or pathophysiological conditions. Our observations imply the therapeutical perspective that PACAP can be applied as a natural agent that may have protecting effect during joint inflammation and/or may promote cartilage regeneration during degenerative diseases of articular cartilage.	[Juhasz, Tamas; Matta, Csaba; Katona, Eva; Somogyi, Csilla; Takacs, Roland; Zakany, Roza] Univ Debrecen, Fac Med, Dept Anat Histol & Embryol, H-4012 Debrecen, Hungary; [Gergely, Pal] Univ Debrecen, Cell Biol & Signalling Res Grp, Hungarian Acad Sci, Dept Med Chem,Res Ctr Mol Med,Fac Med, H-4012 Debrecen, Hungary; [Csernoch, Laszlo] Univ Debrecen, Dept Physiol, Fac Med, H-4012 Debrecen, Hungary; [Panyi, Gyorgy] Univ Debrecen, Dept Biophys & Cell Biol, Fac Med, H-4012 Debrecen, Hungary; [Toth, Gabor] Univ Szeged, Fac Med, Dept Med Chem, Szeged, Hungary; [Regloedi, Dora; Tamas, Andrea] Univ Pecs, Sch Med, Dept Anat PTE MTA Lendulet PACAP Res Team, Pecs, Hungary	University of Debrecen; Hungarian Academy of Sciences; University of Debrecen; University of Debrecen; University of Debrecen; Szeged University; University of Pecs	Zakany, R (corresponding author), Univ Debrecen, Fac Med, Dept Anat Histol & Embryol, H-4012 Debrecen, Hungary.	roza@anat.med.unideb.hu	Panyi, Gyorgy/H-4406-2013; Matta, Csaba/C-7066-2017; Juhasz, Tamas/M-6878-2019; Gergely, Pál/A-5547-2008	Matta, Csaba/0000-0002-9678-7420; Juhasz, Tamas/0000-0003-0489-5676; Katona, Eva/0000-0002-8166-1438; Csernoch, Laszlo/0000-0002-2446-1456; Panyi, Gyorgy/0000-0001-6227-3301; Takacs, Roland Adam/0000-0002-1598-3922	Akira Arimura Foundation Research Grant; Hungarian Science Research Fund [OTKA CNK80709]; Bolyai Scholarship; Hungarian Ministry of Education [TAMOP 4.2.1.B-10/2/KONV-2010-002]; New Szechenyi Plan [TAMOP-4.2.2.A-11/1/KONV-2012-0025]; European Union; European Social Fund; Medical and Health Science Center, University of Debrecen, Hungary [DEOEC Mec-9/2011]; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]	Akira Arimura Foundation Research Grant; Hungarian Science Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Scholarship(Hungarian Academy of Sciences); Hungarian Ministry of Education; New Szechenyi Plan; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Medical and Health Science Center, University of Debrecen, Hungary; European Social Fund(European Social Fund (ESF))	This work was supported by grants from Akira Arimura Foundation Research Grant, the Hungarian Science Research Fund (OTKA CNK80709), Bolyai Scholarship and the Hungarian Ministry of Education (TAMOP 4.2.1.B-10/2/KONV-2010-002, PTE-MTA "Lendulet'') and from the New Szechenyi Plan (TAMOP-4.2.2.A-11/1/KONV-2012-0025; The project is co-financed by the European Union and the European Social Fund). C. M. is supported by a Mecenatura grant (DEOEC Mec-9/2011) from the Medical and Health Science Center, University of Debrecen, Hungary. Research activity of T.J. was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 'National Excellence Program'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Bergstrom AL, 2003, EUR J NEUROSCI, V18, P2552, DOI 10.1046/j.1460-9568.2003.03000.x; Borzsei R, 2009, EUR J ENDOCRINOL, V160, P561, DOI 10.1530/EJE-08-0911; Brandl A, 2011, J ORTHOP RES, V29, P1114, DOI 10.1002/jor.21348; Cochaud S, 2010, NEUROPEPTIDES, V44, P373, DOI 10.1016/j.npep.2010.06.003; Cohen JR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-676; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Di Michele M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.007625; Fodor J, 2009, CELL CALCIUM, V45, P421, DOI 10.1016/j.ceca.2009.02.004; Gasz B, 2006, PEPTIDES, V27, P87, DOI 10.1016/j.peptides.2005.06.022; Gourlet P, 1997, PEPTIDES, V18, P1539, DOI 10.1016/S0196-9781(97)00228-3; HADHAZY C, 1982, ACTA MORPHOL HUNG, V30, P65; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Holighaus Y, 2011, PEPTIDES, V32, P1647, DOI 10.1016/j.peptides.2011.06.004; Horvath G, 2011, J MOL NEUROSCI, V43, P67, DOI 10.1007/s12031-010-9428-8; Horvath G, 2010, NEUROSCI LETT, V484, P148, DOI 10.1016/j.neulet.2010.08.039; Horvath G, 2010, NEUROSCI LETT, V469, P70, DOI 10.1016/j.neulet.2009.11.046; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Jolivel V, 2009, NEUROSCIENCE, V160, P434, DOI 10.1016/j.neuroscience.2009.02.028; Jovanovic DV, 2002, J RHEUMATOL, V29, P2165; Juhasz T, 2010, CENT EUR J BIOL, V5, P572, DOI 10.2478/s11535-010-0053-x; Kano M, 2011, ANN ANAT, V193, P494, DOI 10.1016/j.aanat.2011.08.005; Khan AM, 2011, J INVEST MED, V59, P793, DOI 10.2310/JIM.0b013e31821452a2; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Kovacs CS, 1996, J ENDOCRINOL, V149, P287, DOI 10.1677/joe.0.1490287; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Lacombe A, 2006, P NATL ACAD SCI USA, V103, P3793, DOI 10.1073/pnas.0505827103; Lam SY, 2012, ADV EXP MED BIOL, V758, P301, DOI 10.1007/978-94-007-4584-1_41; Lee VA, 2007, MOL CELLS, V24, P9; Masmoudi-Kouki O, 2011, J NEUROCHEM, V117, P403, DOI 10.1111/j.1471-4159.2011.07185.x; Matta C, 2008, CELL CALCIUM, V44, P310, DOI 10.1016/j.ceca.2007.12.010; Matta C, 2011, BIOCHIMIE, V93, P149, DOI 10.1016/j.biochi.2010.09.005; McIlvain HB, 2006, BRAIN RES, V1077, P16, DOI 10.1016/j.brainres.2005.12.130; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Moody TW, 2012, J MOL NEUROSCI, V46, P68, DOI 10.1007/s12031-011-9639-7; Nagata A, 2009, J CELL PHYSIOL, V221, P75, DOI 10.1002/jcp.21831; Nakamachi T, 2012, J MOL NEUROSCI, V48, P518, DOI 10.1007/s12031-012-9819-0; Nakamachi T, 2011, CURR PHARM DESIGN, V17, P973, DOI 10.2174/138161211795589346; Njaine B, 2010, EUR J NEUROSCI, V32, P311, DOI 10.1111/j.1460-9568.2010.07286.x; Payet MD, 2003, J BIOL CHEM, V278, P1663, DOI 10.1074/jbc.M206470200; Persson E, 2011, J CELL BIOCHEM, V112, P3732, DOI 10.1002/jcb.23304; Pirone A, 2011, ACTA HISTOCHEM, V113, P477, DOI 10.1016/j.acthis.2010.04.008; Racz B, 2007, GEN COMP ENDOCR, V153, P115, DOI 10.1016/j.ygcen.2006.12.006; Racz B, 2008, J MOL NEUROSCI, V36, P220, DOI 10.1007/s12031-008-9112-4; Reglodi D, 2010, J ENDOCRINOL INVEST, V33, P443, DOI 10.1007/BF03346621; Reglodi D, 2008, J MOL NEUROSCI, V36, P270, DOI 10.1007/s12031-008-9089-z; Reglodi D, 2012, NEUROPEPTIDES, V46, P61, DOI 10.1016/j.npep.2011.05.001; Reinhold MI, 2004, J BIOL CHEM, V279, P38209, DOI 10.1074/jbc.M404855200; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sanchez A, 2009, REGUL PEPTIDES, V152, P33, DOI 10.1016/j.regpep.2008.07.004; Sanchez A, 2008, NEUROSCI LETT, V448, P52, DOI 10.1016/j.neulet.2008.10.021; Sherwood NM, 2007, PEPTIDES, V28, P1680, DOI 10.1016/j.peptides.2007.03.008; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Shpakov A O, 2011, Zh Evol Biokhim Fiziol, V47, P40; St Hilaire RC, 2010, PEPTIDES, V31, P1517, DOI 10.1016/j.peptides.2010.04.024; StrangeVognsen HH, 1997, NEUROPEPTIDES, V31, P137, DOI 10.1016/S0143-4179(97)90082-2; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; TIKU ML, 1990, J IMMUNOL, V145, P690; Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6; Tomita M, 2002, J BIOL CHEM, V277, P42214, DOI 10.1074/jbc.C200504200; Tsuji G, 2006, FREE RADICAL BIO MED, V40, P1721, DOI 10.1016/j.freeradbiomed.2006.01.006; Ushiyama M, 2007, MOL PHARMACOL, V72, P103, DOI 10.1124/mol.107.035477; VANDERMEERS A, 1992, EUR J BIOCHEM, V208, P815, DOI 10.1111/j.1432-1033.1992.tb17252.x; Varga Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027957; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vincze A, 2011, INT J DEV NEUROSCI, V29, P923, DOI 10.1016/j.ijdevneu.2011.06.008; Walker CS, 2014, BRIT J PHARMACOL, V171, P1521, DOI 10.1111/bph.12541; Zakany R, 2005, EXP CELL RES, V305, P190, DOI 10.1016/j.yexcr.2004.12.016; Zakany R, 2002, EXP CELL RES, V275, P1, DOI 10.1006/excr.2002.5487; Zhao L, 2009, J BONE MINER RES, V24, P826, DOI [10.1359/JBMR.081236, 10.1359/jbmr.081236]; Zhou CJ, 2001, PEPTIDES, V22, P1111, DOI 10.1016/S0196-9781(01)00437-5	75	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91541	10.1371/journal.pone.0091541	http://dx.doi.org/10.1371/journal.pone.0091541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643018	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900025
J	Kranz, K; Warnecke, A; Lenarz, T; Durisin, M; Scheper, V				Kranz, Katharina; Warnecke, Athanasia; Lenarz, Thomas; Durisin, Martin; Scheper, Verena			Phosphodiesterase Type 4 Inhibitor Rolipram Improves Survival of Spiral Ganglion Neurons In Vitro	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; INNER HAIR-CELLS; NEUROTROPHIC FACTOR; AXONAL REGENERATION; FUNCTIONAL RECOVERY; INDUCED APOPTOSIS; AUDITORY NEURONS; OPTIC-NERVE; CAMP; GROWTH	Sensorineural deafness is caused by damage of hair cells followed by degeneration of the spiral ganglion neurons and can be moderated by cochlear implants. However, the benefit of the cochlear implant depends on the excitability of the spiral ganglion neurons. Therefore, current research focuses on the identification of agents that will preserve their degeneration. In this project we investigated the neuroprotective effect of Rolipram as a promising agent to improve the viability of the auditory neurons. It is a pharmaceutical agent that acts by selective inhibition of the phosphodiesterase 4 leading to an increase in cyclic AMP. Different studies reported a neuroprotective effect of Rolipram. However, its significance for the survival of SGN has not been reported so far. Thus, we isolated spiral ganglion cells of neonatal rats for cultivation with different Rolipram concentrations and determined the neuronal survival rate. Furthermore, we examined immunocytologically distinct proteins that might be involved in the neuroprotective signalling pathway of Rolipram and determined endogenous BDNF by ELISA. When applied at a concentration of 0.1 nM, Rolipram improved the survival of SGN in vitro. According to previous studies, our immunocytological data showed that Rolipram application induces the phosphorylation and thereby activation of the transcription factor CREB. This activation can be mediated by the cAMP-PKA-signalling pathway as well as via ERK as a part of the MAP-kinase pathway. However, only in cultures pre-treated with BDNF, an endogenous increase of BDNF was detected. We conclude that Rolipram has the potential to improve the vitality of neonatal auditory nerve cells in vitro. Further investigations are necessary to prove the effect of Rolipram in vivo in the adult organism after lesion of the hair cells and insertion of cochlear implants.	[Kranz, Katharina; Warnecke, Athanasia; Lenarz, Thomas; Durisin, Martin; Scheper, Verena] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany	Hannover Medical School	Warnecke, A (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Warnecke.Athanasia@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022; Scheper, Verena/J-4298-2019	Scheper, Verena/0000-0001-8618-8793	cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft") "Hearing4all"; EC project	cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft") "Hearing4all"(German Research Foundation (DFG)); EC project	Work was supported by the cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft") "Hearing4all" and by the EC project NeuEar: Neurotrophic Cochlear Implant for Severe Hearing Loss. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletsee C, 2003, LARYNGOSCOPE, V113, P791, DOI 10.1097/00005537-200305000-00005; Beghe B, 2013, AM J RESP CRIT CARE, V188, P271, DOI 10.1164/rccm.201301-0021PP; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bok J, 2003, J NEUROSCI, V23, P777; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Carreno FR, 2013, INT J NEUROPSYCHOPH, V8, P1; Costa LM, 2013, BEHAV BRAIN RES, V243, P66, DOI 10.1016/j.bbr.2012.12.056; Cui Qi, 2004, Anatomical Science International, V79, P209, DOI 10.1111/j.1447-073x.2004.00089.x; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Drescher MJ, 2002, MOL BRAIN RES, V98, P1, DOI 10.1016/S0169-328X(01)00289-3; Flora G, 2012, CELL TRANSPLANT, V8, P8; Garcia-Hernandez S, 2013, BRAIN RES, V1529, P39, DOI 10.1016/j.brainres.2013.07.030; Gillespie LN, 2004, NEUROREPORT, V15, P1121, DOI 10.1097/00001756-200405190-00008; Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x; Green SH, 2012, ANAT REC, V295, P1877, DOI 10.1002/ar.22587; Gudasheva TA, 2013, DOKL BIOCHEM BIOPHYS, V451, P212, DOI 10.1134/S1607672913040121; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hegarty JL, 1997, J NEUROSCI, V17, P1959; Hu ZQ, 2013, REGEN MED, V8, P309, DOI [10.2217/RME.13.32, 10.2217/rme.13.32]; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Incesulu A, 1998, ANN OTO RHINOL LARYN, V107, P906, DOI 10.1177/000348949810701102; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; Kajana S, 2009, J SPINAL CORD MED, V32, P175, DOI 10.1080/10790268.2009.11760769; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Korhonen R, 2013, BRIT J PHARMACOL, V169, P1525, DOI 10.1111/bph.12189; Kraft P, 2013, EXP NEUROL, V247, P80, DOI 10.1016/j.expneurol.2013.03.026; Lee HT, 2004, ANN NEUROL, V56, P611, DOI 10.1002/ana.20259; Lin CH, 2005, EXP NEUROL, V194, P384, DOI 10.1016/j.expneurol.2005.02.016; Linthicum FH, 2009, OTOL NEUROTOL, V30, P418, DOI 10.1097/MAO.0b013e31819a8827; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; Meyer H, 2012, INT J NANOMED, V7, P2449, DOI 10.2147/IJN.S29712; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Paintlia AS, 2009, GLIA, V57, P182, DOI 10.1002/glia.20745; Park JW, 2013, EUR J PHARMACOL, V706, P76, DOI 10.1016/j.ejphar.2013.02.049; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Reddy CS, 2005, HUM EXP TOXICOL, V24, P235, DOI 10.1191/0960327105ht514oa; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rodger J, 2005, MOL CELL NEUROSCI, V30, P452, DOI 10.1016/j.mcn.2005.08.009; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sasaki T, 2007, STROKE, V38, P1597, DOI 10.1161/STROKEAHA.106.476754; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Song BN, 2009, ACTA OTO-LARYNGOL, V129, P142, DOI 10.1080/00016480802043949; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Sun XJ, 2012, EXP NEUROL, V237, P304, DOI 10.1016/j.expneurol.2012.07.011; Teixeira MM, 1997, TRENDS PHARMACOL SCI, V18, P164, DOI 10.1016/S0165-6147(97)90613-1; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Udina E, 2010, EXP NEUROL, V223, P143, DOI 10.1016/j.expneurol.2009.08.026; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Wang Q, 2011, J NEUROSCI, V31, P7938, DOI 10.1523/JNEUROSCI.1434-10.2011; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; Warnecke A, 2010, NEUROREPORT, V21, P517, DOI 10.1097/WNR.0b013e328339045b; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Wirtz-Brugger F, 2000, NEUROSCIENCE, V99, P737, DOI 10.1016/S0306-4522(00)00243-8; Xu HX, 2012, ACTA OTO-LARYNGOL, V132, P482, DOI 10.3109/00016489.2011.647361; Xu NY, 2012, HEARING RES, V283, P33, DOI 10.1016/j.heares.2011.11.010; Yan Y, 2013, DEV NEUROBIOL, V73, P559, DOI 10.1002/dneu.22080; Yang L, 2008, EXP NEUROL, V211, P311, DOI 10.1016/j.expneurol.2007.02.010; Yao H, 2009, CELL DEATH DIFFER, V16, P1681, DOI 10.1038/cdd.2009.108; Yin Y, 2013, NEUROCHEM INT, V62, P903, DOI 10.1016/j.neuint.2013.03.005; Yossifoff M, 2008, EUR J NEUROSCI, V28, P2267, DOI 10.1111/j.1460-9568.2008.06532.x; Zha XM, 2001, HEARING RES, V156, P53, DOI 10.1016/S0378-5955(01)00267-2; Zhai SQ, 2004, ACTA OTO-LARYNGOL, V124, P124, DOI 10.1080/00016480310015939; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012	75	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92157	10.1371/journal.pone.0092157	http://dx.doi.org/10.1371/journal.pone.0092157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642701	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900096
J	Ogawa, N; Kawai, H; Terashima, T; Kojima, H; Oka, K; Chan, L; Maegawa, H				Ogawa, Nobuhiro; Kawai, Hiromichi; Terashima, Tomoya; Kojima, Hideto; Oka, Kazuhiro; Chan, Lawrence; Maegawa, Hiroshi			Gene Therapy for Neuropathic Pain by Silencing of TNF-alpha Expression with Lentiviral Vectors Targeting the Dorsal Root Ganglion in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SPINAL NERVE LIGATION; NEUTRALIZING ANTIBODIES; MECHANICAL HYPERALGESIA; DIABETIC-NEUROPATHY; SODIUM-CHANNELS; SENSORY NEURONS; IMMUNE-SYSTEM; UP-REGULATION; RAT	Neuropathic pain can be a debilitating condition. Many types of drugs that have been used to treat neuropathic pain have only limited efficacy. Recent studies indicate that pro-inflammatory mediators including tumor necrosis factor alpha (TNF-alpha) are involved in the pathogenesis of neuropathic pain. In the present study, we engineered a gene therapy strategy to relieve neuropathic pain by silencing TNF-alpha expression in the dorsal root ganglion (DRG) using lentiviral vectors expressing TNF short hairpin RNA1-4 (LV-TNF-shRNA1-4) in mice. First, based on its efficacy in silencing TNF-alpha in vitro, we selected shRNA3 to construct LV-TNF-shRNA3 for in vivo study. We used L5 spinal nerve transection (SNT) mice as a neuropathic pain model. These animals were found to display up-regulated mRNA expression of activating transcription factor 3 (ATF3) and neuropeptide Y (NPY), injury markers, and interleukin (IL)-6, an inflammatory cytokine in the ipsilateral L5 DRG. Injection of LV-TNF-shRNA3 onto the proximal transected site suppressed significantly the mRNA levels of ATF3, NPY and IL-6, reduced mechanical allodynia and neuronal cell death of DRG neurons. These results suggest that lentiviral-mediated silencing of TNF-alpha in DRG relieves neuropathic pain and reduces neuronal cell death, and may constitute a novel therapeutic option for neuropathic pain.	[Ogawa, Nobuhiro; Kawai, Hiromichi; Terashima, Tomoya; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Kojima, Hideto] Shiga Univ Med Sci, Dept Mol Genet Med, Otsu, Shiga 52021, Japan; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Shiga University of Medical Science; Shiga University of Medical Science; Baylor College of Medicine; Baylor College of Medicine	Terashima, T (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan.	tom@belle.shiga-med.ac.jp		Maegawa, Hiroshi/0000-0002-4611-8149	Ministry of Education, Culture, Sports, Science and Technology, Japan [23590378]; US National Institutes of Health [R01-HL051586]; Shiga University of Medical Science [1515503L, 1515503F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shiga University of Medical Science(Shiga University of Medical Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Grant-in-Aid (#23590378 to H. Kojima) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grants from the US National Institutes of Health (R01-HL051586 (to L. Chan), and the President's Discretionary Fund from Shiga University of Medical Science (no. 1515503L and no. 1515503F to H. Kojima). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade P, 2011, NEUROL SCI, V32, P757, DOI 10.1007/s10072-011-0599-z; Andre N, 2002, FEBS LETT, V532, P256, DOI 10.1016/S0014-5793(02)03691-8; Arruda JL, 1998, MOL BRAIN RES, V62, P228, DOI 10.1016/S0169-328X(98)00257-5; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blomer U, 1997, J VIROL, V71, P6641; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Camussi G, 1998, DRUGS, V55, P613, DOI 10.2165/00003495-199855050-00001; Caroyer JM, 2002, NEUROLOGY, V59, P1113, DOI 10.1212/WNL.59.7.1113; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Czeschik JC, 2008, NEUROSCI LETT, V434, P293, DOI 10.1016/j.neulet.2008.01.070; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Desmaris N, 2001, MOL THER, V4, P149, DOI 10.1006/mthe.2001.0431; Drory VE, 1998, J NEUROL SCI, V158, P1, DOI 10.1016/S0022-510X(98)00098-7; El Maarouf A, 2005, P NATL ACAD SCI USA, V102, P11516, DOI 10.1073/pnas.0504718102; Empl M, 2001, NEUROLOGY, V56, P1371, DOI 10.1212/WNL.56.10.1371; Fukuoka T, 1998, PAIN, V78, P13, DOI 10.1016/S0304-3959(98)00111-0; Fukuoka T, 2012, PAIN, V153, P68, DOI 10.1016/j.pain.2011.09.009; Ghosh AK, 1999, BIOCHEM BIOPH RES CO, V264, P601, DOI 10.1006/bbrc.1999.1568; Glatzel W, 2000, P NATL ACAD SCI USA, V97, P442, DOI 10.1073/pnas.97.1.442; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; HANSSON PT, 2001, NEUROPATHIC PAIN PAT; Hao S, 2007, GENE THER, V14, P1010, DOI 10.1038/sj.gt.3302950; Homma Y, 2002, PAIN, V95, P239, DOI 10.1016/S0304-3959(01)00404-3; Hotta Y, 2003, DEV BRAIN RES, V143, P1, DOI 10.1016/S0165-3806(03)00035-X; Huang Y, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/968218; Jaggi AS, 2011, FUND CLIN PHARMACOL, V25, P1, DOI 10.1111/j.1472-8206.2009.00801.x; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Karppinen J, 2003, SPINE, V28, P750, DOI 10.1097/00007632-200304150-00004; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kuntzer T, 2004, MUSCLE NERVE, V30, P255, DOI 10.1002/mus.20100; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Latha M, 2013, J MOL NEUROSCI, V46, P497; Lee KM, 2009, EUR J PAIN, V13, P794, DOI 10.1016/j.ejpain.2008.09.009; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li YB, 2000, PAIN, V85, P493, DOI 10.1016/S0304-3959(00)00250-5; Lindenlaub T, 2000, BRAIN RES, V866, P15, DOI 10.1016/S0006-8993(00)02190-9; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; Merskey HE, 1994, TASK FORCE TAXONOMY, P209; Miao PH, 2008, NEUROL RES, V30, P623, DOI 10.1179/174313208X289606; Mitchell S. Weir, 1872, INJURIES NERVES THEI; Murata Y, 2006, SPINE, V31, P530, DOI 10.1097/01.brs.0000201260.10082.23; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Ohtori S, 2012, SPINE, V37, P439, DOI 10.1097/BRS.0b013e318238af83; Ossipov MH, 2002, J NEUROSCI, V22, P9858; Puljak L, 2009, ANESTH ANALG, V108, P1021, DOI 10.1213/ane.0b013e318193873e; Saito H, 2009, NEUROSCI LETT, V456, P30, DOI 10.1016/j.neulet.2009.03.075; Schafers M, 2003, J NEUROSCI, V23, P2517; Sommer C, 2001, BRAIN RES, V913, P86, DOI 10.1016/S0006-8993(01)02743-3; Sommer C, 2001, J PERIPHER NERV SYST, V6, P67, DOI 10.1046/j.1529-8027.2001.01010.x; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Sorkin LS, 2000, J PERIPHER NERV SYST, V5, P96, DOI 10.1046/j.1529-8027.2000.00012.x; Terashima T, 2012, FASEB J, V26, P295, DOI 10.1096/fj.11-186262; Terashima T, 2009, J CLIN INVEST, V119, P2100, DOI 10.1172/JCI39038; Tonini G, 2002, J BIOL REG HOMEOS AG, V16, P105; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Wagner R, 1996, NEUROREPORT, V7, P2897, DOI 10.1097/00001756-199611250-00018; Wei XH, 2013, EXP NEUROL, V241, P159, DOI 10.1016/j.expneurol.2012.12.007; WELLS MR, 1992, J NEUROIMMUNOL, V39, P261, DOI 10.1016/0165-5728(92)90260-R; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Xu JT, 2006, PAIN, V123, P306, DOI 10.1016/j.pain.2006.03.011; Xu Y, 2003, HUM GENE THER, V14, P897, DOI 10.1089/104303403765701187; Yamakawa I, 2011, AM J PHYSIOL-ENDOC M, V301, pE844, DOI 10.1152/ajpendo.00029.2011; Yang P, 2012, J MOL NEUROSCI, V47, P173, DOI 10.1007/s12031-012-9710-z; Yu HW, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-63; Zhang JM, 2002, J NEUROPHYSIOL, V88, P1387, DOI 10.1152/jn.2002.88.3.1387; Zhang YH, 2002, J PHYSIOL-LONDON, V544, P385, DOI 10.1113/jphysiol.2002.024265	71	39	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92073	10.1371/journal.pone.0092073	http://dx.doi.org/10.1371/journal.pone.0092073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642694	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900076
J	Alzoghaibi, MA; Pandi-Perumal, SR; Sharif, MM; BaHammam, AS				Alzoghaibi, Mohammed A.; Pandi-Perumal, Seithikurippu R.; Sharif, Munir M.; BaHammam, Ahmed S.			Diurnal Intermittent Fasting during Ramadan: The Effects on Leptin and Ghrelin Levels	PLOS ONE			English	Article							EPWORTH SLEEPINESS SCALE; PLASMA LEPTIN; HEALTHY-SUBJECTS; FOOD-INTAKE; INSULIN; OBESE; HUMANS; ADIPOSITY; SECRETION; RESPONSES	We aimed to assess the effect of Islamic intermittent fasting, during and outside of Ramadan, on plasma levels of leptin and ghrelin while controlling for several potential confounding variables. Eight healthy male volunteers with a mean age of 26.6 +/- 4.9 years reported to the sleep disorders center (SDC) at King Saud University on four occasions: 1) adaptation; 2) 4 weeks before Ramadan while performing Islamic fasting for 1 week (baseline fasting) (BLF); 3) 1 week before Ramadan (non-fasting baseline) (BL); and 4) during the second week of Ramadan while fasting. Plasma leptin and ghrelin levels were measured using enzyme- linked immunoassays at 22: 00, 02: 00, 04: 00, 06: 00, and 11: 00. During BLF, there were significant reductions in plasma leptin concentrations at 22: 00 and 02: 00 compared with the baseline concentrations (at 22: 00: 194.2 +/- 177.2 vs. 146.7 +/- 174.5; at 02: 00: 203.8 +/- 189.5 vs. 168.1 +/- 178.1; p<0.05). During Ramadan, there was a significant reduction in plasma leptin levels at 22: 00 (194.2 +/- 177.2 vs. 132.6 +/- 130.4, p<0.05). No significant difference in plasma ghrelin concentrations was detected during the BL, BLF, or Ramadan periods. Cosinor analyses of leptin and ghrelin plasma levels revealed no significant changes in the acrophases of the hormones during the three periods. The nocturnal reduction in plasma leptin levels during fasting may be the result of the changes in meal times during fasting.	[Alzoghaibi, Mohammed A.] King Saud Univ, Coll Med, Dept Physiol, Riyadh 11461, Saudi Arabia; [Pandi-Perumal, Seithikurippu R.] NYU, Clin & Translat Res Inst, Ctr Healthful Behav Change,Langone Med Ctr, Div Hlth & Behav,Dept Populat Hlth, New York, NY USA; [Pandi-Perumal, Seithikurippu R.] Somnogen Canada Inc, Toronto, ON, Canada; [Sharif, Munir M.; BaHammam, Ahmed S.] King Saud Univ, Coll Med, Dept Med, Univ Sleep Disorders Ctr, Riyadh 11461, Saudi Arabia; [Alzoghaibi, Mohammed A.; Sharif, Munir M.; BaHammam, Ahmed S.] King Saud Univ, Riyadh, Saudi Arabia	King Saud University; New York University; NYU Langone Medical Center; King Saud University; King Saud University	BaHammam, AS (corresponding author), King Saud Univ, Coll Med, Dept Med, Univ Sleep Disorders Ctr, Riyadh 11461, Saudi Arabia.	ashammam2@gmail.com	BaHammam, Ahmed Salem/B-9037-2008; Pandi-Perumal, Seithikurippu R./Q-8281-2016; Pandi-Perumal, Seithikurippu R/HDM-2070-2022; BaHammam, Ahmed S/D-7521-2011	BaHammam, Ahmed Salem/0000-0002-1706-6167; Pandi-Perumal, Seithikurippu R./0000-0002-8686-7259; BaHammam, Ahmed S/0000-0002-1706-6167	National Plan for Science and Technology, King Saud University; King Abdulaziz City for Science and Technology, Saudi Arabia	National Plan for Science and Technology, King Saud University(King Saud University); King Abdulaziz City for Science and Technology, Saudi Arabia	This study was supported by a grant from the National Plan for Science and Technology, King Saud University, and King Abdulaziz City for Science and Technology, Saudi Arabia (http://npst.ksu.edu.sa/index.php?page_id=101). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid Alfonso, 2012, Indian J Endocrinol Metab, V16, pS617, DOI 10.4103/2230-8210.105580; Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; Al-Abri Mohammed, 2013, Oman Med J, V28, P454, DOI 10.5001/omj.2013.126; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Azizi F, 2002, ANN SAUDI MED, V22, P186, DOI 10.5144/0256-4947.2002.186; Bahammam A, 2006, INT J CLIN PRACT, V60, P1631, DOI 10.1111/j.1742-1241.2005.00811.x; BaHammam A, 2010, APPETITE, V54, P426, DOI 10.1016/j.appet.2010.01.011; Bahammam AS, 2013, J SLEEP RES; Bogdan A, 2005, BRIT J NUTR, V93, P515, DOI 10.1079/BJN20041380; Caixas A, 2002, J CLIN ENDOCR METAB, V87, P1902, DOI 10.1210/jc.87.4.1902; Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Chan JL, 2004, J CLIN ENDOCR METAB, V89, P335, DOI 10.1210/jc.2003-031412; Cinti S, 2000, INT J OBESITY, V24, P789, DOI 10.1038/sj.ijo.0801228; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Dorwny CA, 2008, MED SCI SPORT EXER, V40, P699, DOI 10.1249/MSS.0b013e318161ea8f; Elimam A, 2002, EUR J ENDOCRINOL, V147, P181, DOI 10.1530/eje.0.1470181; Figueiro MG, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/530726; Flanagan DE, 2003, AM J PHYSIOL-ENDOC M, V284, pE313, DOI 10.1152/ajpendo.00569.2001; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kolaczynski JW, 1996, DIABETES, V45, P1511, DOI 10.2337/diabetes.45.11.1511; Malavolti M, 2007, NUTR METAB CARDIOVAS, V17, P338, DOI 10.1016/j.numecd.2005.12.009; Mantzoros CS, 1998, CLIN ENDOCRINOL, V49, P551, DOI 10.1046/j.1365-2265.1998.00571.x; Mignault D, 2005, DIABETES CARE, V28, P225, DOI 10.2337/diacare.28.1.225-a; Morris CJ, 2010, CHRONOBIOL INT, V27, P590, DOI 10.3109/07420521003663819; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Natalucci G, 2005, EUR J ENDOCRINOL, V152, P845, DOI 10.1530/eje.1.01919; Nedvidkova J, 2003, J CLIN ENDOCR METAB, V88, P1678, DOI 10.1210/jc.2002-021669; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Nicklas BJ, 1997, OBES RES, V5, P62, DOI 10.1002/j.1550-8528.1997.tb00284.x; Radic R, 2003, COLLEGIUM ANTROPOL, V27, P555; Roky R, 2001, J SLEEP RES, V10, P319, DOI 10.1046/j.1365-2869.2001.00269.x; Saad MF, 1998, J CLIN ENDOCR METAB, V83, P453, DOI 10.1210/jc.83.2.453; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Sadiya A, 2011, DIABETES METAB SYNDR, V4, P409, DOI 10.2147/DMSO.S24221; Schaller G, 2003, DIABETES, V52, P16, DOI 10.2337/diabetes.52.1.16; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Ueno H, 2005, REGUL PEPTIDES, V126, P11, DOI 10.1016/j.regpep.2004.08.007; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	43	34	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92214	10.1371/journal.pone.0092214	http://dx.doi.org/10.1371/journal.pone.0092214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637892	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100129
J	Austdal, M; Skrastad, RB; Gundersen, AS; Austgulen, R; Iversen, AC; Bathen, TF				Austdal, Marie; Skrastad, Ragnhild Bergene; Gundersen, Astrid Solberg; Austgulen, Rigmor; Iversen, Ann-Charlotte; Bathen, Tone Frost			Metabolomic Biomarkers in Serum and Urine in Women with Preeclampsia	PLOS ONE			English	Article							NMR-SPECTROSCOPY; PLASMA; METABONOMICS; PREGNANCY; LIPIDS	Objective: To explore the potential of magnetic resonance (MR) metabolomics for study of preeclampsia, for improved phenotyping and elucidating potential clues to etiology and pathogenesis. Methods: Urine and serum samples from pregnant women with preeclampsia (n = 10), normal pregnancies (n = 10) and non-pregnant women (n = 10) matched by age and gestational age were analyzed with MR spectroscopy and subjected to multivariate analysis. Metabolites were then quantified and compared between groups. Results: Urine and serum samples revealed clear differences between women with preeclampsia and both control groups (normal pregnant and non-pregnant women). Nine urine metabolites were significantly different between preeclampsia and the normal pregnant group. Urine samples from women with early onset preeclampsia clustered together in the multivariate analysis. The preeclampsia serum spectra showed higher levels of low and very-low density lipoproteins and lower levels of high-density lipoproteins when compared to both non-pregnant and normal pregnant women. Conclusion: The MR determined metabolic profiles in urine and serum from women with preeclampsia are clearly different from normal pregnant women. The observed differences represent a potential to examine mechanisms underlying different preeclampsia phenotypes in urine and serum samples in larger studies. In addition, similarities between preeclampsia and cardiovascular disease in metabolomics are demonstrated.	[Austdal, Marie; Bathen, Tone Frost] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Fac Med, Trondheim, Norway; [Austdal, Marie] Liaison Comm Cent Norway Reg Hlth Author RHA & No, Trondheim, Norway; [Austdal, Marie; Bathen, Tone Frost] Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway; [Skrastad, Ragnhild Bergene] Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Fac Med, Trondheim, Norway; [Skrastad, Ragnhild Bergene] St Olavs Hosp, Natl Ctr Fetal Med, Trondheim, Norway; [Gundersen, Astrid Solberg; Austgulen, Rigmor; Iversen, Ann-Charlotte] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, Trondheim, Norway; [Austgulen, Rigmor; Iversen, Ann-Charlotte] NTNU, Ctr Mol Inflammat Res CEMIR, Fac Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Austdal, M (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Fac Med, Trondheim, Norway.	marie.austdal@ntnu.no	Iversen, Ann-Charlotte/C-6920-2011	Iversen, Ann-Charlotte/0000-0001-7726-7684; Skrastad, Ragnhild Bergene/0000-0003-3810-0413	Central Norway Regional Health Authority (RHA) [46052200]; Norwegian University of Science and Technology (NTNU), Trondheim, Norway [46052200]	Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU), Trondheim, Norway	The work is funded by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and Norwegian University of Science and Technology (NTNU), Trondheim, Norway, project number 46052200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahado-Sing RO, 2012, J MATERN FETAL NEO M; Bahado-Singh RO, 2012, AM J OBSTET GYNECOL, V208, pe10; Bathen TF, 2000, NMR BIOMED, V13, P271, DOI 10.1002/1099-1492(200008)13:5<271::AID-NBM646>3.0.CO;2-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Bergsjo P, 2001, PREEKLAMPSI EKLAMPSI; Bolin M, 2011, AM J HYPERTENS, V24, P496, DOI 10.1038/ajh.2010.264; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Braekke K, 2007, PEDIATR RES, V62, P319, DOI 10.1203/PDR.0b013e318123fba2; Craici Iasmina, 2008, Ther Adv Cardiovasc Dis, V2, P249, DOI 10.1177/1753944708094227; Demirci O, 2011, J OBSTET GYNAECOL RE, V37, P1427, DOI 10.1111/j.1447-0756.2011.01562.x; Diaz SO, 2013, J PROTEOME RES, V12, P969, DOI 10.1021/pr301022e; Diaz SO, 2011, J PROTEOME RES, V10, P3732, DOI 10.1021/pr200352m; Dreier L, 2006, MAGN RESON CHEM, V44, pS206, DOI 10.1002/mrc.1838; Friesen RW, 2007, J NUTR, V137, P2641; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Lorentzen B, 2008, HYPERTENSIVE SVANGER; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Sachse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052399; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Schott Susanne, 2012, Int J Biomed Sci, V8, P258; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Turner E, 2008, HYPERTENS PREGNANCY, V27, P225, DOI 10.1080/10641950801955725; Turner E, 2007, HYPERTENS PREGNANCY, V26, P329, DOI 10.1080/10641950701436073; Uzan J, 2011, VASC HEALTH RISK MAN, V7, P467, DOI 10.2147/VHRM.S20181; Watanabe H, 2013, KIDNEY INT; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	28	48	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91923	10.1371/journal.pone.0091923	http://dx.doi.org/10.1371/journal.pone.0091923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637620	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100081
J	Jaschinski, K; Babski, J; Lehr, M; Burmester, A; Benz, J; Heyer, R; Dorr, M; Marchfelder, A; Soppa, J				Jaschinski, Katharina; Babski, Julia; Lehr, Matthias; Burmester, Anna; Benz, Juliane; Heyer, Ruth; Doerr, Marcella; Marchfelder, Anita; Soppa, Joerg			Generation and Phenotyping of a Collection of sRNA Gene Deletion Mutants of the Haloarchaeon Haloferax volcanii	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; SMALL NONCODING RNAS; MESSENGER-RNAS; ARCHAEA; IDENTIFICATION; TRANSCRIPTOME; AVAILABILITY; CONSTRUCTION; EXPRESSION; MICRORNAS	The haloarchaeon Haloferax volcanii was shown to contain 145 intergenic and 45 antisense sRNAs. In a comprehensive approach to unravel various biological roles of haloarchaeal sRNAs in vivo, 27 sRNA genes were selected and deletion mutants were generated. The phenotypes of these mutants were compared to that of the parent strain under ten different conditions, i.e. growth on four different carbon sources, growth at three different salt concentrations, and application of four different stress conditions. In addition, cell morphologies in exponential and stationary phase were observed. Furthermore, swarming of 17 mutants was analyzed. 24 of the 27 mutants exhibited a difference from the parent strain under at least one condition, revealing that haloarchaeal sRNAs are involved in metabolic regulation, growth under extreme conditions, regulation of morphology and behavior, and stress adaptation. Notably, 7 deletion mutants showed a gain of function phenotype, which has not yet been described for any other prokaryotic sRNA gene deletion mutant. Comparison of the transcriptomes of one sRNA gene deletion mutant and the parent strain led to the identification of differentially expressed genes. Genes for flagellins and chemotaxis were up-regulated in the mutant, in accordance with its gain of function swarming phenotype. While the deletion mutant analysis underscored that haloarchaeal sRNAs are involved in many biological functions, the degree of conservation is extremely low. Only 3 of the 27 genes are conserved in more than 10 haloarchaeal species. 22 of the 27 genes are confined to H. volcanii, indicating a fast evolution of haloarchaeal sRNA genes.	[Jaschinski, Katharina; Babski, Julia; Lehr, Matthias; Burmester, Anna; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, D-60054 Frankfurt, Germany; [Benz, Juliane; Heyer, Ruth; Doerr, Marcella; Marchfelder, Anita] Univ Ulm, D-89069 Ulm, Germany	Goethe University Frankfurt; Ulm University	Soppa, J (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, D-60054 Frankfurt, Germany.	soppa@bio.uni-frankfurt.de		Soppa, Jorg/0000-0002-6132-5840; Marchfelder, Anita/0000-0002-1382-1794	German Research Council (Deutsche Forschungsgemeinschaft) [SPP1258, DFG Ma1238/11-2, So264/14-2]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was funded by the German Research Council (Deutsche Forschungsgemeinschaft) through the Priority Program SPP1258 "Sensory and regulatory RNAs in prokaryotes" (grants DFG Ma1238/11-2 and So264/14-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Babski J, 2011, RNA BIOL, V8, P806, DOI 10.4161/rna.8.5.16039; Baumann A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-21; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon RA, 2011, TRENDS CARDIOVAS MED, V21, P172, DOI 10.1016/j.tcm.2012.05.005; Brantl S, 2012, FUTURE MICROBIOL, V7, P853, DOI [10.2217/FMB.12.59, 10.2217/fmb.12.59]; Dennis PP, 2005, CURR OPIN MICROBIOL, V8, P685, DOI 10.1016/j.mib.2005.10.013; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Ehlers C, 2011, ARCHAEA, V2011, DOI 10.1155/2011/439608; Fischer S, 2010, J BIOL CHEM, V285, P34429, DOI 10.1074/jbc.M110.118950; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Gomez-Lozano M, 2012, ENVIRON MICROBIOL, V14, P2006, DOI 10.1111/j.1462-2920.2012.02759.x; Gottesman S, 2011, COLD SPRING HARB PER, V3, DOI 10.1101; Hammelmann M, 2008, J MICROBIOL METH, V75, P201, DOI 10.1016/j.mimet.2008.05.029; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Heyer R, 2012, RNA BIOL, V9, P1011, DOI 10.4161/rna.20826; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Huang Y, 2013, BIOCHEMISTRY-MOSCOW+, V78, P221, DOI 10.1134/S0006297913030024; Jager D, 2012, NUCLEIC ACIDS RES, V40, P10964, DOI 10.1093/nar/gks847; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; Jantzer K, 2011, FEMS MICROBIOL LETT, V322, P123, DOI 10.1111/j.1574-6968.2011.02341.x; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Marchfelder A, 2012, EXTREMOPHILES, V16, P685, DOI 10.1007/s00792-012-0469-5; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Prasse D, 2013, BIOCHEM SOC T, V41, P344, DOI 10.1042/BST20120280; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Sambrook J., 2001, MOL CLONING LAB MANU; Schattner P, 2002, NUCLEIC ACIDS RES, V30, P2076, DOI 10.1093/nar/30.9.2076; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Soppa J, 2009, BIOCHEM SOC T, V37, P133, DOI 10.1042/BST0370133; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Straub J, 2009, RNA BIOL, V6, P281, DOI 10.4161/rna.6.3.8357; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Wanner C, 2002, J BACTERIOL, V184, P3114, DOI 10.1128/JB.184.11.3114-3121.2002; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x	49	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90763	10.1371/journal.pone.0090763	http://dx.doi.org/10.1371/journal.pone.0090763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637842	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100009
J	Zhao, Q; Xiao, JZ; He, J; Zhang, XL; Hong, J; Kong, XM; Mills, KT; Weng, JP; Jia, WP; Yang, WY				Zhao, Qi; Xiao, Jianzhong; He, Jiang; Zhang, Xuelian; Hong, Jing; Kong, Xiaomu; Mills, Katherine T.; Weng, Jianping; Jia, Weiping; Yang, Wenying			Cross-Sectional and Longitudinal Replication Analyses of Genome-Wide Association Loci of Type 2 Diabetes in Han Chinese	PLOS ONE			English	Article							COMMON VARIANTS; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; RISK LOCI; GLUCOSE; TCF7L2; CDKAL1; GENES; METAANALYSIS; POPULATIONS	This study aimed to examine genomic loci of type 2 diabetes (T2D) initially identified by genome-wide association studies in populations of European ancestry for their associations with T2D and quantitative glycemic traits, as well as their effects on longitudinal change in fasting plasma glucose (FPG) and T2D development, in the Chinese population. Single nucleotide polymorphisms (SNP) from 25 loci were genotyped in a large case-control sample of 10,001 subjects (5,338 T2D cases and 4,663 controls) and a prospective cohort of 1,881 Chinese. In the case-control sample, 8 SNPs in or near WFS1, CDKAL1, CDKN2A/2B, CDC123, HHEX, TCF7L2, KCNQ1, and MTNR1B were significantly associated with T2D (P<0.05). Thirteen SNPs were associated with quantitative glycemic traits. For example, the most significant SNP, rs10811661 near CDKN2A/2B (P = 1.11x10(-8) for T2D), was also associated with 2-h glucose level of an oral glucose tolerance test (P = 9.11x10(-3)) and insulinogenic index (P = 2.71x10(-2)). In the cohort study, individuals carrying more risk alleles of the replicated SNPs had greater FPG increase and T2D incidence in a 7.5-year follow-up period, with each quartile increase in the number of risk alleles being associated with a 0.06 mmol/l greater increase in FPG (P = 0.03) and 19% higher odds of developing T2D (P = 0.058). Our study identified the associations of several established T2D-loci in Europeans with T2D and quantitative glycemic traits in the Chinese population. The prospective data also suggest their potential role in the risk prediction of T2D in the Chinese population.	[Zhao, Qi; He, Jiang; Mills, Katherine T.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Xiao, Jianzhong; Zhang, Xuelian; Hong, Jing; Kong, Xiaomu; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Weng, Jianping] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai, Peoples R China	Tulane University; China-Japan Friendship Hospital; Tulane University; Sun Yat Sen University; Shanghai Jiao Tong University	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	ywying_1010@163.com	Zhao, Qi/Y-9866-2019; He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Kong, Xiaomu/0000-0002-5920-4759; Weng, Jianping/0000-0002-7889-1697	Chinese Medical Association Foundation; sanofi (China) Investment Co., Ltd.; National 973 Program [2011CB504001]; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. [R01HL087263]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K12HD043451]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087263] Funding Source: NIH RePORTER	Chinese Medical Association Foundation; sanofi (China) Investment Co., Ltd.; National 973 Program(National Basic Research Program of China); National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The DMS study was supported by grants from the Chinese Medical Association Foundation, sanofi (China) Investment Co., Ltd. and the National 973 Program (2011CB504001). The GenSalt study is supported by the research grant (R01HL087263) from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. Dr. Qi Zhao was supported by Award Number K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chang YC, 2012, CLIN ENDOCRINOL, V76, P365, DOI 10.1111/j.1365-2265.2011.04175.x; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; Das Swapan Kumar, 2006, Cellscience, V2, P100; Gloyn AL, 2009, DIABETES, V58, P800, DOI 10.2337/db09-0099; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kota SK, 2012, DIABETES METAB SYND, V6, P54, DOI 10.1016/j.dsx.2012.05.014; Liu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021464; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Savic D, 2013, DIABETOLOGIA, V56, P121, DOI 10.1007/s00125-012-2730-y; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031093; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xi B, 2011, OBESITY, V19, P236, DOI 10.1038/oby.2010.139; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	37	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91790	10.1371/journal.pone.0091790	http://dx.doi.org/10.1371/journal.pone.0091790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637646	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100062
J	Chen, J; Li, CH; Wang, SH				Chen, Jing; Li, Chenghai; Wang, Sihong			Periodic Heat Shock Accelerated the Chondrogenic Differentiation of Human Mesenchymal Stem Cells in Pellet Culture	PLOS ONE			English	Article							SELF-ASSEMBLING PEPTIDE; PROTECTS ARTICULAR CHONDROCYTES; MARROW STROMAL CELLS; IN-VITRO CULTURE; BONE-MARROW; CARTILAGE TISSUE; HEAT-SHOCK-PROTEIN-70 HSP70; CLINICAL-APPLICATIONS; KNEE OSTEOARTHRITIS; INDUCED APOPTOSIS	Osteoarthritis (OA) is one of diseases that seriously affect elderly people's quality of life. Human mesenchymal stem cells (hMSCs) offer a potential promise for the joint repair in OA patients. However, chondrogenic differentiation from hMSCs in vitro takes a long time (similar to 6 weeks) and differentiated cells are still not as functionally mature as primary isolated chondrocytes, though chemical stimulations and mechanical loading have been intensively studied to enhance the hMSC differentiation. On the other hand, thermal stimulations of hMSC chondrogenesis have not been well explored. In this study, the direct effects of mild heat shock (HS) on the differentiation of hMSCs into chondrocytes in 3D pellet culture were investigated. Periodic HS at 41 degrees C for 1 hr significantly increased sulfated glycosaminoglycan in 3D pellet culture at Day 10 of chondrogenesis. Immunohistochemical and Western Blot analyses revealed an increased expression of collagen type II and aggrecan in heat-shocked pellets than non heat-shocked pellets on Day 17 of chondrogenesis. In addition, HS also upregulated the expression of collagen type I and X as well as heat shock protein 70 on Day 17 and 24 of differentiation. These results demonstrate that HS accelerated the chondrogenic differentiation of hMSCs and induced an early maturation of chondrocytes differentiated from hMSCs. The results of this study will guide the design of future protocols using thermal treatments to facilitate cartilage regeneration with human mesenchymal stem cells.	[Chen, Jing; Li, Chenghai; Wang, Sihong] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Wang, SH (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	shwang@ccny.cuny.edu			National Institutes of Health/National Institute on Aging (NIH/NIA) [SC2AG036823]; NATIONAL INSTITUTE ON AGING [SC2AG036823] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project is partially funded by National Institutes of Health/National Institute on Aging (NIH/NIA) SC2AG036823 (http://www.nia.nih.gov/research). NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]; Arai Y, 1997, J RHEUMATOL, V24, P1787; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; Chen J, 2013, TISSUE ENG PT A, V19, P716, DOI [10.1089/ten.tea.2012.0070, 10.1089/ten.TEA.2012.0070]; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Cucchiarini M, 2012, BIO-MED MATER ENG, V22, P197, DOI 10.3233/BME-2012-0709; Dickhut A, 2008, FRONT BIOSCI-LANDMRK, V13, P4517, DOI 10.2741/3020; DOYLE JR, 1963, J BONE JOINT SURG AM, V45, P15, DOI 10.2106/00004623-196345010-00002; Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099; Etienne S, 2008, BIO-MED MATER ENG, V18, P253, DOI 10.3233/BME-2008-0534; Grossin L, 2006, FASEB J, V20, P65, DOI 10.1096/fj.04-2889com; Grossin L, 2004, BIORHEOLOGY, V41, P521; Guo XD, 2006, BIOMED MATER, V1, P206, DOI 10.1088/1748-6041/1/4/006; Hojo Tatsuya, 2003, J Orthop Sci, V8, P396, DOI 10.1007/s10776-002-0643-2; Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073; Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]; Kubo T, 2001, J RHEUMATOL, V28, P330; Lim CL, 2008, ANN ACAD MED SINGAP, V37, P347; Lin WQ, 1997, J HISTOCHEM CYTOCHEM, V45, P1157, DOI 10.1177/002215549704500813; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1; Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002; Miller RE, 2010, OSTEOARTHR CARTILAGE, V18, P1608, DOI 10.1016/j.joca.2010.09.004; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Mwale F, 2006, J ORTHOP RES, V24, P1791, DOI 10.1002/jor.20200; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329; Raghunath J, 2005, CURR OPIN BIOTECH, V16, P503, DOI 10.1016/j.copbio.2005.08.004; RICHARDS V, 1959, SURGERY, V46, P84; Shereif WI, 2011, LIFE SCI J, V8, P388; Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515; Steinert AF, 2009, ARTHRITIS RES THER, V11; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Takahashi KA, 2009, INT J HYPERTHER, V25, P661, DOI 10.3109/02656730903107519; Terauchi R, 2003, ARTHRITIS RHEUM-US, V48, P1562, DOI 10.1002/art.11040; Tonomura H, 2006, OSTEOARTHR CARTILAGE, V14, P545, DOI 10.1016/j.joca.2005.12.008; Tonomura H, 2008, J ORTHOP RES, V26, P34, DOI 10.1002/jor.20421; van Osch GJVM, 2009, J CELL MOL MED, V13, P792, DOI 10.1111/j.1582-4934.2009.00789.x; Vinatier C, 2006, BIO-MED MATER ENG, V16, pS107; Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747; Yildirim N, 2010, J CLIN NURS, V19, P1113, DOI 10.1111/j.1365-2702.2009.03070.x; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zhou XZ, 2008, INT J ARTIF ORGANS, V31, P480, DOI 10.1177/039139880803100603; Zou L, 2013, SCI REPORTS	53	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91561	10.1371/journal.pone.0091561	http://dx.doi.org/10.1371/journal.pone.0091561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632670	Green Published, gold			2022-12-27	WOS:000332858400069
J	Jo, A; Park, H; Lee, SH; Ahn, SH; Kim, HJ; Park, EM; Choi, YH				Jo, Ara; Park, Hyunju; Lee, Sung-Hee; Ahn, So-Hee; Kim, Hee Ja; Park, Eun-Mi; Choi, Youn-Hee			SHP-2 Binds to Caveolin-1 and Regulates Src Activity via Competitive Inhibition of CSK in Response to H2O2 in Astrocytes	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FOCAL ADHESION KINASE; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; EPIDERMAL-GROWTH; C-SRC; ACTIVATION; CELLS; PHOSPHORYLATION; EXPRESSION	Reactive oxygen species (ROS) regulate diverse cellular functions by triggering signal transduction events, such as Src and mitogen-activated protein (MAP) kinases. Here, we report the role of caveolin-1 and Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP-2) in H2O2-induced signaling pathway in brain astrocytes. H2O2-mediated oxidative stress induced phosphorylation of caveolin-1 and association between p-caveolin-1 and SHP-2. SHP-2 specifically bound to wild-type caveolin-1 similarly to c-Src tyrosine kinase (CSK), but not to phosphorylation-deficient mutant of caveolin-1 (Y14A), and interfered with complex formation between caveolin-1 and CSK. In the presence of CSK siRNA, binding between caveolin-1 and SHP-2 was enhanced by H2O2 treatment, which led to reduced Src phosphorylation at tyrosine (Tyr) 530 and enhanced Src phosphorylation at Tyr 419. In contrast, siRNA targeting of SHP-2 facilitated H2O2-mediated interaction between caveolin-1 and CSK and enhanced Src phosphorylation at Tyr 530, leading to subsequent decrease in Src downstream signaling, such as focal adhesion kinase (FAK) and extracellular signal-related kinase (ERK). Our results collectively indicate that SHP-2 alters Src kinase activity by interfering with the complex formation between CSK and phosphotyrosine caveolin-1 in the presence of H2O2, thus functions as a positive regulator in Src signaling under oxidative stress in brain astrocytes.	[Jo, Ara; Park, Hyunju; Lee, Sung-Hee; Ahn, So-Hee; Kim, Hee Ja; Choi, Youn-Hee] Ewha Womans Univ, Tissue Injury Def Res Ctr, Sch Med, Dept Physiol, Seoul, South Korea; [Park, Eun-Mi] Ewha Womans Univ, Tissue Injury Def Res Ctr, Sch Med, Dept Pharmacol, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Choi, YH (corresponding author), Ewha Womans Univ, Tissue Injury Def Res Ctr, Sch Med, Dept Physiol, Seoul, South Korea.	yc@ewha.ac.kr	LEE, Sunghee/HCH-4510-2022	PARK, EUN-MI/0000-0003-2414-3789	National Research Foundation of Korea (NRF); Korea government (MSIP) [2012R1A5A2A32671866]; Korea government (MEST) [2010-0029352]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) [grant 2012R1A5A2A32671866] and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) 2010-0029352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2000, FASEB J, V14, P1965, DOI 10.1096/fj.00-0105com; Arnaud M, 2004, BIOCHEM J, V382, P545, DOI 10.1042/BJ20040103; Biagini RE, 2003, CLIN DIAGN LAB IMMUN, V10, P744, DOI 10.1128/CDLI.10.5.744-750.2003; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Cameron PL, 1997, J NEUROSCI, V17, P9520; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Chong ZZ, 2003, CELL MOL NEUROBIOL, V23, P561, DOI 10.1023/A:1025158314016; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Gadoth N, 2011, OXIDATIVE STRESS FRE, Vviii; Gee CE, 2005, CELL MOL LIFE SCI, V62, P1120, DOI 10.1007/s00018-005-5008-4; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Gupta VK, 2012, BBA-MOL BASIS DIS, V1822, P1643, DOI 10.1016/j.bbadis.2012.07.016; Ha CH, 2008, J BIOL CHEM, V283, P7261, DOI 10.1074/jbc.M702881200; Hirrlinger J, 2010, BRAIN RES REV, V63, P177, DOI 10.1016/j.brainresrev.2009.10.003; Ilic D, 1997, J CELL SCI, V110, P401; Kim BW, 2010, EXPERT REV PROTEOMIC, V7, P849, DOI 10.1586/EPR.10.87; Kim YN, 2002, EXP CELL RES, V280, P134, DOI 10.1006/excr.2002.5623; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; OKADA M, 1989, J BIOL CHEM, V264, P20886; Park SJ, 2012, J IMMUNOL, V188, P5132, DOI 10.4049/jimmunol.1101600; Park SJ, 2009, FREE RADICAL BIO MED, V46, P1694, DOI 10.1016/j.freeradbiomed.2009.03.026; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Place AT, 2011, MOL PHARMACOL, V80, P665, DOI 10.1124/mol.111.073957; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; SABE H, 1992, MOL CELL BIOL, V12, P4706, DOI 10.1128/MCB.12.10.4706; Salmond RJ, 2006, TRENDS IMMUNOL, V27, P154, DOI 10.1016/j.it.2006.01.007; Servidei T, 1998, NEUROSCIENCE, V82, P529; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sun SY, 2010, CANCER BIOL THER, V9, P109, DOI 10.4161/cbt.9.2.10583; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V211, P950, DOI 10.1006/bbrc.1995.1904; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tiffany-Castiglioni E, 2011, INT J DEV NEUROSCI, V29, P811, DOI 10.1016/j.ijdevneu.2011.09.004; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vepa S, 1997, FREE RADICAL BIO MED, V22, P25, DOI 10.1016/S0891-5849(96)00241-9; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Yun JH, 2011, EXP MOL MED, V43, P660, DOI 10.3858/emm.2011.43.12.075; Zheng J, 2005, BIOL REPROD, V72, P1421, DOI 10.1095/biolreprod.104.039172	46	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91582	10.1371/journal.pone.0091582	http://dx.doi.org/10.1371/journal.pone.0091582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632723	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400071
J	Lacerda, RB; Sales, NM; da Silva, LL; Tesch, R; Miranda, ALP; Barreiro, EJ; Fernandes, PD; Fraga, CAM				Lacerda, Renata B.; Sales, Natalia M.; da Silva, Leandro L.; Tesch, Roberta; Miranda, Ana Luisa P.; Barreiro, Eliezer J.; Fernandes, Patricia D.; Fraga, Carlos A. M.			Novel Potent Imidazo[1,2-a]pyridine-N-Glycinyl-Hydrazone Inhibitors of TNF-alpha Production: In Vitro and In Vivo Studies	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; MAP KINASE; INFLAMMATION; ASSAY	In this work, we describe the design, synthesis and pharmacological evaluation of novel imidazo[1,2-a]pyridine-N-glycinylhydrazone derivatives (1a-k) intended for use as inhibitors of tumor necrosis factor alpha (TNF-alpha) production. The compounds were designed based on the orally active anti-inflammatory prototype LASSBio-1504 (2), which decreases the levels of the pro-inflammatory cytokine TNF-alpha in vitro and in vivo. The in vitro pharmacological evaluation of the imidazo[1,2-a] pyridine compounds (1) showed that substitution of the N-phenylpyrazole core present in prototype 2 by a bioisosteric imidazo[1,2-a]pyridine scaffold generated anti-TNF-alpha compounds that were more potent than the previously described N-phenylpyrazole derivative 2 and as potent as SB-203580, a p38 MAPK inhibitor. The most active derivative (E)-2-( 2-tert-butylimidazo[1,2-a]pyridin-3-ylamino)-N'-(4-chlorobenzylidene) acetohydrazide, or LASSBio-1749 (1i) was orally active as an anti-inflammatory agent in a subcutaneous air pouch model, reducing expressively the levels in vivo of TNF-alpha and other pro-inflammatory cytokines at all of the tested doses.	[Lacerda, Renata B.; Barreiro, Eliezer J.; Fraga, Carlos A. M.] Univ Fed Rio de Janeiro, Lab Avaliacao & Sintese Substancias Bioat LASSBio, Rio De Janeiro, Brazil; [Lacerda, Renata B.; Barreiro, Eliezer J.; Fraga, Carlos A. M.] Univ Fed Rio de Janeiro, Inst Quim, Programa Posgrad Quim, Rio De Janeiro, Brazil; [Sales, Natalia M.; da Silva, Leandro L.; Tesch, Roberta; Miranda, Ana Luisa P.; Barreiro, Eliezer J.; Fernandes, Patricia D.; Fraga, Carlos A. M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Farmacol & Quim Med, Rio De Janeiro, Brazil; [da Silva, Leandro L.; Miranda, Ana Luisa P.] Univ Fed Rio de Janeiro, Fac Farm, Lab Estudos Farmacol Expt, Rio De Janeiro, Brazil; [Sales, Natalia M.; Fernandes, Patricia D.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Fraga, CAM (corresponding author), Univ Fed Rio de Janeiro, Lab Avaliacao & Sintese Substancias Bioat LASSBio, Rio De Janeiro, Brazil.	cmfraga@ccsdecania.ufrj.br	Fernandes, Patricia Dias/C-4489-2013; Fernandes, Patricia Dias/W-1565-2019; lacerda, renata/V-4003-2019; Fraga, Carlos/G-3495-2012; da Silva, Leandro Louback/AAQ-7573-2020; Barreiro, Eliezer J/B-1131-2011	Fernandes, Patricia Dias/0000-0001-6870-6745; Fernandes, Patricia Dias/0000-0001-6870-6745; Fraga, Carlos/0000-0001-6733-7079; Barreiro, Eliezer J/0000-0003-1759-0038	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil); Programa de Apoio a Nucleos de Excelencia (PRONEX, Brazil); Instituto Nacional de Ciencia e Tecnologia de Farmacos e Medicamentos (INCT-INOFAR, Brazil) [573.564/2008-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Apoio a Nucleos de Excelencia (PRONEX, Brazil); Instituto Nacional de Ciencia e Tecnologia de Farmacos e Medicamentos (INCT-INOFAR, Brazil)	The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil), Programa de Apoio a Nucleos de Excelencia (PRONEX, Brazil) and Instituto Nacional de Ciencia e Tecnologia de Farmacos e Medicamentos (INCT-INOFAR, Brazil, Grant #573.564/2008-6) for financial support and fellowships (to RBL, CKFdL, LLdS, ALPM, EJB, CAMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzeni F, 2012, AUTOIMMUN REV, V12, P225, DOI 10.1016/j.autrev.2012.06.008; Campbell IK, 2003, IMMUNOL CELL BIOL, V81, P354; DiMauro EF, 2006, J ORG CHEM, V71, P3959, DOI 10.1021/jo060218p; Domling A, 2000, ANGEW CHEM INT EDIT, V39, P3168, DOI 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U; Domling A, 2012, CHEM REV, V112, P3083, DOI 10.1021/cr100233r; Gallily R, 1997, J PHARMACOL EXP THER, V283, P918; Goettert M, 2010, ANAL BIOCHEM, V406, P233, DOI 10.1016/j.ab.2010.07.007; Groebke K, 1998, SYNLETT, P661, DOI 10.1055/s-1998-1721; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ismail MA, 2004, J MED CHEM, V47, P3658, DOI 10.1021/jm0400092; Lacerda RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046925; Lacerda RB, 2009, BIOORGAN MED CHEM, V17, P74, DOI 10.1016/j.bmc.2008.11.018; Lopes AB, 2013, MOLECULES, V18, P11683, DOI 10.3390/molecules181011683; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PALLA G, 1986, TETRAHEDRON, V42, P3649, DOI 10.1016/S0040-4020(01)87332-4; PALLA G, 1982, GAZZ CHIM ITAL, V112, P339; Patel HS, 2003, TETRAHEDRON LETT, V44, P4077, DOI 10.1016/S0040-4039(03)00875-X; Raymundo LJRP, 2011, J ETHNOPHARMACOL, V134, P725, DOI 10.1016/j.jep.2011.01.027; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Regan J, 2003, J MED CHEM, V46, P4676, DOI 10.1021/jm030121k; Romano M, 1997, MEDIAT INFLAMM, V6, P32, DOI 10.1080/09629359791901; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; Slobbe P, 2012, MEDCHEMCOMM, V3, P1189, DOI 10.1039/c2md20089a; Toussirot E, 2004, EXPERT OPIN PHARMACO, V5, P581, DOI 10.1517/14656566.5.3.581; Wong SH, 2004, ARCH IMMUNOL THER EX, V52, P379; Wyrzykiewicz E, 2000, J HETEROCYCLIC CHEM, V37, P975, DOI 10.1002/jhet.5570370448; Zhu DJ, 2009, J BRAZIL CHEM SOC, V20, P482, DOI 10.1590/S0103-50532009000300012	28	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91660	10.1371/journal.pone.0091660	http://dx.doi.org/10.1371/journal.pone.0091660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632827	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400076
J	Luan, MD; Xu, MY; Lu, YM; Zhang, QX; Zhang, L; Zhang, CY; Fan, YL; Lang, ZH; Wang, L				Luan, Mingda; Xu, Miaoyun; Lu, Yunming; Zhang, Qiuxue; Zhang, Lan; Zhang, Chunyi; Fan, Yunliu; Lang, Zhihong; Wang, Lei			Family-Wide Survey of miR169s and NF-YAs and Their Expression Profiles Response to Abiotic Stress in Maize Roots	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DNA-BINDING; SMALL RNAS; MICRORNAS; ARABIDOPSIS; PLANT; GENES; IDENTIFICATION; REGULATOR; ROLES	Previous studies have identified miR169/NF-YA modules are important regulators of plant development and stress responses. Currently, reported genome sequence data offers an opportunity for global characterization of miR169 and NF-YA genes, which may provide insights into the molecular mechanisms of the miR169/NF-YA modules in maize. In our study, fourteen NF-YA transcription factors with conserved domains were identified based on maize genome loci. The miR169 gene family has 18 members that generate 10 mature products, and 8 of these mature miR169 members could target 7 of 14 ZmNF-YA genes in maize. The seven ZmNF-YA proteins were localized to the nucleus while lacked transcriptional activity. We investigated the expression patterns of the zma-miR169 members and their targeted ZmNF-YA genes in maize roots treated by drought stress (polyethylene glycol, PEG), hormone stress (abscisic acid, ABA), and salt stress (NaCl). The zma-miR169 family members were downregulated in short term (0,48 h) and generally upregulated over the long term (15 days) in response to the three abiotic stress conditions. Most of the targeted ZmNF-YA genes exhibited a reverse correlation with zma-miR169 gene expression over both the short term and long term. Maize root elongation was promoted by PEG and ABA but repressed by NaCl over the long term. Apparently, ZmNF-YA14 expression perfectly matched the zma-miR169 expression and corresponded to root growth reversely.	[Luan, Mingda; Lang, Zhihong; Wang, Lei] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China; [Luan, Mingda; Xu, Miaoyun; Zhang, Qiuxue; Zhang, Lan; Zhang, Chunyi; Fan, Yunliu; Lang, Zhihong; Wang, Lei] Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Lu, Yunming] Shenzhen Nongke Grp CO LTD, Shenzhen, Peoples R China	Southwest University of Science & Technology - China; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Lang, ZH (corresponding author), Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China.	langzhihong@caas.cn; wanglei01@caas.cn	xu, miaoyun/AAF-3676-2021; Luan, Mingda/GSD-6582-2022	Luan, Mingda/0000-0001-8772-6733	National High-Tech RD Program [2012AA10A306]; National Key Basic Research Program [2014CB138200]; National Special Program for Transgenic Research [2010ZX08010-002]	National High-Tech RD Program(National High Technology Research and Development Program of China); National Key Basic Research Program(National Basic Research Program of China); National Special Program for Transgenic Research	This work was supported by the National High-Tech R&D Program (Grant No. 2012AA10A306), the National Key Basic Research Program (Grant No. 2014CB138200), and the National Special Program for Transgenic Research (2010ZX08010-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Jia WS, 2002, J EXP BOT, V53, P2201, DOI 10.1093/jxb/erf079; Jin DF, 2013, J GENET GENOMICS, V40, P161, DOI 10.1016/j.jgg.2013.02.003; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Warpeha KM, 2007, PLANT SIGNAL BEHAV, V2, P480, DOI 10.4161/psb.2.6.4497; Xu M. Y., 2013, J EXPT BOT; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	33	51	59	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91369	10.1371/journal.pone.0091369	http://dx.doi.org/10.1371/journal.pone.0091369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633051	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400059
J	Moiane, I; Machado, A; Santos, N; Nhambir, A; Inlamea, O; Hattendorf, J; Kallenius, G; Zinsstag, J; Correia-Neves, M				Moiane, Ivania; Machado, Adelina; Santos, Nuno; Nhambir, Andre; Inlamea, Osvaldo; Hattendorf, Jan; Kallenius, Gunilla; Zinsstag, Jakob; Correia-Neves, Margarida			Prevalence of Bovine Tuberculosis and Risk Factor Assessment in Cattle in Rural Livestock Areas of Govuro District in the Southeast of Mozambique	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; SUSCEPTIBILITY; INFECTION; HUSBANDRY; DIAGNOSIS; PATHOLOGY; TANZANIA; DISEASE; TESTS	Background: Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is an infectious disease of cattle that also affects other domestic animals, free-ranging and farmed wildlife, and also humans. In Mozambique, scattered surveys have reported a wide variation of bTB prevalence rates in cattle from different regions. Due to direct economic repercussions on livestock and indirect consequences for human health and wildlife, knowing the prevalence rates of the disease is essential to define an effective control strategy. Methodology/Principal findings: A cross-sectional study was conducted in Govuro district to determine bTB prevalence in cattle and identify associated risk factors. A representative sample of the cattle population was defined, stratified by livestock areas (n = 14). A total of 1136 cattle from 289 farmers were tested using the single comparative intradermal tuberculin test. The overall apparent prevalence was estimated at 39.6% (95% CI 36.8-42.5) using a diagnostic threshold cutoff according to the World Organization for Animal Health. bTB reactors were found in 13 livestock areas, with prevalence rates ranging from 8.1 to 65.8%. Age was the main risk factor; animals older than 4 years were more likely to be positive reactors (OR = 3.2, 95% CI: 2.2-4.7). Landim local breed showed a lower prevalence than crossbred animals (Landim 6 Brahman) (OR = 0.6, 95% CI: 0.4-0.8). Conclusions/Significance: The findings reveal an urgent need for intervention with effective, area-based, control measures in order to reduce bTB prevalence and prevent its spread to the human population. In addition to the high prevalence, population habits in Govuro, particularly the consumption of raw milk, clearly may potentiate the transmission to humans. Thus, further studies on human tuberculosis and the molecular characterization of the predominant strain lineages that cause bTB in cattle and humans are urgently required to evaluate the impact on human health in the region.	[Moiane, Ivania; Santos, Nuno; Correia-Neves, Margarida] Univ Minho, ICVS, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Moiane, Ivania; Santos, Nuno; Correia-Neves, Margarida] PT Govt Associate Lab, Braga, Portugal; [Machado, Adelina; Nhambir, Andre; Inlamea, Osvaldo] Eduardo Mondlane Univ, Fac Vet, Paraclin Dept, Maputo, Mozambique; [Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Hattendorf, Jan; Zinsstag, Jakob] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Universidade do Minho; Eduardo Mondlane University; Karolinska Institutet; University of Basel; Swiss Tropical & Public Health Institute	Correia-Neves, M (corresponding author), Univ Minho, ICVS, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal.	mcorreianeves@ecsaude.uminho.pt	Zinsstag, Jakob/A-8317-2008; Santos, Nuno/D-6742-2016; Källenius, Gunilla/AGZ-3956-2022; Correia-Neves, Margarida/C-9122-2009; Correia-Neves, Margarida/AAH-4636-2020; Hattendorf, Jan/F-5371-2010	Zinsstag, Jakob/0000-0002-8899-6097; Santos, Nuno/0000-0002-1676-107X; Correia-Neves, Margarida/0000-0002-2202-5431; Correia-Neves, Margarida/0000-0002-2202-5431; Hattendorf, Jan/0000-0002-1176-401X; Kallenius, Gunilla/0000-0002-8921-0551	European Union [221948]	European Union(European Commission)	The research leading to these results has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated Control of Neglected Zoonoses). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Awah-Ndukum J, 2012, Vet Med Int, V2012, P798502, DOI 10.1155/2012/798502; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Boukary AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024629; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Cook AJC, 1996, BRIT VET J, V152, P37, DOI 10.1016/S0007-1935(96)80084-4; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Dinka H, 2011, AFR J AGR RES, V6, P3853; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Dvorska L, 2007, VET MICROBIOL, V119, P366, DOI 10.1016/j.vetmic.2006.09.010; Etter E, 2006, ANN NY ACAD SCI, V1081, P61, DOI 10.1196/annals.1373.006; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Humblet MF, 2010, J CLIN MICROBIOL, V48, P2802, DOI 10.1128/JCM.00293-10; Ibrahim S, 2012, Vet Med Int, V2012, P865924, DOI 10.1155/2012/865924; Inangolet FO, 2008, TROP ANIM HEALTH PRO, V40, P501, DOI 10.1007/s11250-007-9126-x; Kazwala RR, 2001, INT J TUBERC LUNG D, V5, P87; Kennedy HE, 2001, INF IMM, V70, P1488; Macucule B, 2008, THESIS U PRETORIA S; Ministerio da Administracao Estatal, 2005, PERF DISTR GOV PROV; Muller B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008215; Nega M, 2012, INT J MED MED SCI, V2, P188; Nicholson M.J., 1986, GUIDE CONDITION SCOR; OIE, 2009, MANUAL DIAGNOSTIC TE; Okuni JB, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-99; Ozygit MO, 2007, VET REC, V160, P307, DOI 10.1136/vr.160.9.307; Pavlik I, 2005, VET MED-CZECH, V50, P281, DOI 10.17221/5625-VETMED; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Sun LP, 2012, VET IMMUNOL IMMUNOP, V147, P195, DOI 10.1016/j.vetimm.2012.04.016; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006; Vordermeier M, 2012, COMP IMMUNOL MICROB, V35, P227, DOI 10.1016/j.cimid.2012.01.003; Zanini MS, 1998, J VET MED B, V45, P473, DOI 10.1111/j.1439-0450.1998.tb00818.x	36	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91527	10.1371/journal.pone.0091527	http://dx.doi.org/10.1371/journal.pone.0091527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632593	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000332858400068
J	Peng, LS; Zhuang, Y; Li, WH; Zhou, YY; Wang, TT; Chen, N; Cheng, P; Li, BS; Guo, H; Yang, SM; Chen, WS; Zou, QM				Peng, Liu-sheng; Zhuang, Yuan; Li, Wen-hua; Zhou, Yuan-yuan; Wang, Ting-ting; Chen, Na; Cheng, Ping; Li, Bo-sheng; Guo, Hong; Yang, Shi-ming; Chen, Wei-san; Zou, Quan-ming			Elevated Interleukin-32 Expression Is Associated with Helicobacter pylori-Related Gastritis	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE; CHRONIC RHINOSINUSITIS; SYDNEY SYSTEM; CELL RESPONSE; IL-32; INFLAMMATION; DISEASE; MUCOSA; LIVER	Background: Interleukin-32 (IL-32) is a recently discovered proinflammatory cytokine involved in inflammatory diseases. We investigated the expression of IL-32 and its regulation mechanism in the inflammatory response of patients with Helicobacter pylori (H. pylori) infection. Design and Methods: IL-32 mRNA and protein expression in gastric tissues was detected by quantitative real-time PCR and immunohistochemistry. The regulation of IL-32 in human gastric epithelia cell line AGS was investigated by different cytokine stimulation and different H. pylori strain infection. Results: Gastric IL-32 mRNA and protein expression were elevated in patients with H. pylori infection and positively correlated with gastritis. In H. pylori-infected patients, the mRNA level of IL-32 was also correlated with that of proinflammatory cytokines IL-1 beta and TNF-alpha. In vitro IL-1 beta and TNF-alpha could upregulate IL-32 mRNA and protein level in AGS cells, which was dependent on NF-kappa B signal pathway. The regulation of IL-32 expression in response to H. pylori-infection could be weakened by using neutralizing antibodies to block IL-1 beta and TNF-alpha. Moreover, H. pylori-infected AGS cells also induced IL-32 mRNA and protein expression, which was dependent on CagA. Conclusions: IL-32 level is elevated in patients with H. pylori infection and its expression is regulated by proinflammatory stimuli, suggesting that IL-32 may play a role in the pathogenesis of H. pylori-related gastritis.	[Peng, Liu-sheng; Zhuang, Yuan; Li, Wen-hua; Wang, Ting-ting; Chen, Na; Cheng, Ping; Li, Bo-sheng; Zou, Quan-ming] Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China; [Zhou, Yuan-yuan; Guo, Hong; Yang, Shi-ming] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Chen, Wei-san] La Trobe Univ, Sch Mol Sci, Bundoora, Vic, Australia	Army Medical University; Army Medical University; La Trobe University	Zhuang, Y (corresponding author), Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China.	yuanzhuang1983@yahoo.com; qmzou@tmmu.edu.cn	wang, tingting/AAK-2640-2020; Chen, Weisan/E-7828-2012	Chen, Weisan/0000-0002-5221-9771	Medical Science Youth Training Project of Chinese People's Liberation Army [13QNP108]; National Basic Research Program of China (973 Program) [2009CB522606]	Medical Science Youth Training Project of Chinese People's Liberation Army; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the Medical Science Youth Training Project of Chinese People's Liberation Army (13QNP108) and National Basic Research Program of China (973 Program, No. 2009CB522606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Andersen LP, 2007, HELICOBACTER, V12, P12, DOI 10.1111/j.1523-5378.2007.00574.x; ANDREW A, 1994, HISTOPATHOLOGY, V25, P317, DOI 10.1111/j.1365-2559.1994.tb01349.x; Bai XY, 2010, J IMMUNOL, V184, P3830, DOI 10.4049/jimmunol.0901913; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; DAHL CA, 1992, J IMMUNOL, V148, P597; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jung MY, 2011, J IMMUNOL, V186, P6848, DOI 10.4049/jimmunol.1003996; Keswani A, 2012, ALLERGY, V67, P25, DOI 10.1111/j.1398-9995.2011.02706.x; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Meyer N, 2012, J ALLERGY CLIN IMMUN, V129, P964, DOI 10.1016/j.jaci.2011.12.1002; Meyer N, 2010, J ALLERGY CLIN IMMUN, V125, P858, DOI 10.1016/j.jaci.2010.01.016; Moschen AR, 2011, HEPATOLOGY, V53, P1819, DOI 10.1002/hep.24285; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Sakitani K, 2012, INFECT IMMUN, V80, P3795, DOI 10.1128/IAI.00637-12; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Soyka MB, 2012, ALLERGY, V67, P790, DOI 10.1111/j.1398-9995.2012.02820.x; Tan SM, 2004, J BACTERIOL, V186, P885, DOI 10.1128/JB.186.3.885-888.2004; Wroblewski LE, 2009, GASTROENTEROLOGY, V136, P236, DOI 10.1053/j.gastro.2008.10.011; Xu QH, 2012, J INFECTION, V65, P336, DOI 10.1016/j.jinf.2012.05.009; Zhang JY, 2011, IMMUNOBIOLOGY, V216, P803, DOI 10.1016/j.imbio.2010.12.006	27	21	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e88270	10.1371/journal.pone.0088270	http://dx.doi.org/10.1371/journal.pone.0088270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633341	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400002
J	Sun, MY; Wang, S; Song, QW; Wang, ZY; Wang, HQ; Ning, DX; Wei, Q; Liu, AL				Sun, Meiyu; Wang, Sheng; Song, Qingwei; Wang, Zhiyuan; Wang, Heqing; Ning, Dianxiu; Wei, Qiang; Liu, Ailian			Utility of R-2* Obtained from T-2*-Weighted Imaging in Differentiating Hepatocellular Carcinomas from Cavernous Hemangiomas of the Liver	PLOS ONE			English	Article							TUMOR; MRI; DISCRIMINATION; CONTRAST; HYPOXIA; LESIONS; BENIGN; TIMES; CT	Purpose: To evaluate the feasibility of applying R-2* values to differentiate hepatocellular carcinomas (HCC) from cavernous hemangiomas of the liver (CHL). Materials and Methods: This retrospective study was approved by the participating Institutional Review Board and written informed consent for all subjects were obtained. Seventy-three patients with 79 pathologically identified HCCs and 65 patients with 91 clinically or pathologically identified CHLs were enrolled in this study. All subjects underwent a breath-hold multi-echo T-2* weighted MR imaging on a 1.5T clinical MR scanner. R2* values from HCC and CHL groups were compared using the Mann-Whitney non-parametric U test. A cut-off value of R2* was evaluated with receiver operator characteristic (ROC) analysis. Results: The mean R-2* value was 23.32 +/- 12.23 Hz (95% confidence interval [CI]: 20.58 Hz, 26.06 Hz) for the HCC group, and 3.66 +/- 2.37 Hz (95% CI: 3.17 Hz, 4.15 Hz) for the CHL group. The mean R-2* value for HCC was significantly higher than that of CHL (p<0.001). A threshold of 9.48 Hz for the minimum R-2* value in the diagnosis of HCC resulted in a sensitivity of 96.20% (76 out of 79 patients), and a specificity of 97.80% (89 out of 91 patients). The positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy for HCC were 97.44% (76 out of 78 patients), 96.74% (89 out of 92 patients) and 97.06% (165 out of 170 patients), respectively. The AUC for differentiation between these two groups was 0.994 (95% CI: 0.980, 1.000). Conclusions: R-2* is a significant MRI biomarker to differentiate HCC from CHL with satisfying sensitivity and specificity.	[Sun, Meiyu; Wang, Sheng; Wang, Heqing; Ning, Dianxiu; Wei, Qiang; Liu, Ailian] Dalian Med Univ, Affiliated Hosp 1, Dept Radiol, Dalian, Liaoning, Peoples R China; [Wang, Sheng] Fuxin Mineral Hosp, Dept CT & MRI, Fuxing, Liaoning, Peoples R China; [Wang, Zhiyuan] Cent S Univ, Hunan Prov Tumor Hosp, Dept Ultrasound, Changsha, Hunan, Peoples R China; [Wang, Zhiyuan] Cent S Univ, Tumor Hosp, Xiangya Med Sch, Changsha, Hunan, Peoples R China	Dalian Medical University; Central South University; Central South University	Liu, AL (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Radiol, Dalian, Liaoning, Peoples R China.	liuailian_dalianmu@126.com						Chan YL, 2002, CLIN RADIOL, V57, P250, DOI 10.1053/crad.2001.0763; Cieszanowski A, 2002, EUR RADIOL, V12, P2273, DOI 10.1007/s00330-002-1366-6; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Farraher SW, 2006, J MAGN RESON IMAGING, V24, P1333, DOI 10.1002/jmri.20758; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo LF, 2013, CLIN NEURORADIOL, V23, P121, DOI 10.1007/s00062-012-0185-7; Hamilton SR, 2000, WHO CLASSIFICATION T; Hardie AD, 2011, EUR J RADIOL, V80, pE249, DOI 10.1016/j.ejrad.2010.10.027; Hardie AD, 2010, MAGN RESON IMAGING, V28, P281, DOI 10.1016/j.mri.2009.12.010; Ito K, 1997, RADIOLOGY, V204, P729, DOI 10.1148/radiology.204.3.9280251; Jhaveri KS, 2013, J MAGN RESON IMAGING, V37, P692, DOI 10.1002/jmri.23858; Lee JH, 2012, BRIT J RADIOL, V85, pE573, DOI 10.1259/bjr/86767895; LESLIE DF, 1995, AM J ROENTGENOL, V164, P625, DOI 10.2214/ajr.164.3.7863883; Li Guo-Wei, 2003, Hepatobiliary Pancreat Dis Int, V2, P367; Li RK, 2012, J MAGN RESON IMAGING, V36, P900, DOI 10.1002/jmri.23734; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; QUINN SF, 1992, RADIOLOGY, V182, P545, DOI 10.1148/radiology.182.2.1732978; Santoro L, 2009, J MAGN RESON IMAGING, V30, P1012, DOI 10.1002/jmri.21937; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; SEMELKA RC, 1994, RADIOLOGY, V192, P401, DOI 10.1148/radiology.192.2.8029404; Song TJ, 2004, GASTROENTEROLOGY, V127, pS248, DOI 10.1053/j.gastro.2004.09.039; Soyer P, 2011, EUR J RADIOL, V80, P316, DOI 10.1016/j.ejrad.2010.08.011; Sun XL, 2006, SHIJIE HUA REN XIAO, V14, P3107; Tao R, 2012, CLIN RADIOL, V67, pE91, DOI 10.1016/j.crad.2012.08.015; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vilgrain V, 2000, RADIOGRAPHICS, V20, P379, DOI 10.1148/radiographics.20.2.g00mc01379; Yu De-xin, 2010, Zhonghua Yi Xue Za Zhi, V90, P1463	27	7	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91751	10.1371/journal.pone.0091751	http://dx.doi.org/10.1371/journal.pone.0091751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632579	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400087
J	Wang, CH; Liu, XJ; Peng, ST; Xu, Q; Yuan, XP; Feng, Y; Yu, HY; Wang, YP; Wei, XH				Wang, Caihong; Liu, Xiaojiao; Peng, Suotang; Xu, Qun; Yuan, Xiaoping; Feng, Yue; Yu, Hanyong; Wang, Yiping; Wei, Xinghua			Development of Novel Microsatellite Markers for the BBCC Oryza Genome (Poaceae) Using High-Throughput Sequencing Technology	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GENUS ORYZA; CROSS-AMPLIFICATION; CHLOROPLAST DNA; SSR MARKERS; RICE GENUS; DIVERSITY; IDENTIFICATION; MITOCHONDRIAL; CHROMOSOMES	Wild species of Oryza are extremely valuable sources of genetic material that can be used to broaden the genetic background of cultivated rice, and to increase its resistance to abiotic and biotic stresses. Until recently, there was no sequence information for the BBCC Oryza genome; therefore, no special markers had been developed for this genome type. The lack of suitable markers made it difficult to search for valuable genes in the BBCC genome. The aim of this study was to develop microsatellite markers for the BBCC genome. We obtained 13,991 SSR-containing sequences and designed 14,508 primer pairs. The most abundant was hexanuclelotide (31.39%), followed by trinucleotide (27.67%) and dinucleotide (19.04%). 600 markers were selected for validation in 23 accessions of Oryza species with the BBCC genome. A set of 495 markers produced clear amplified fragments of the expected sizes. The average number of alleles per locus (Na) was 2.5, ranging from 1 to 9. The genetic diversity per locus (He) ranged from 0 to 0.844 with a mean of 0.333. The mean polymorphism information content (PIC) was 0.290, and ranged from 0 to 0.825. Of the 495 markers, 12 were only found in the BB genome, 173 were unique to the CC genome, and 198 were also present in the AA genome. These microsatellite markers could be used to evaluate the phylogenetic relationships among different Oryza genomes, and to construct a genetic linkage map for locating and identifying valuable genes in the BBCC genome, and would also for marker-assisted breeding programs that included accessions with the AA genome, especially Oryza sativa.	[Wang, Caihong; Xu, Qun; Yuan, Xiaoping; Feng, Yue; Yu, Hanyong; Wang, Yiping; Wei, Xinghua] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Liu, Xiaojiao; Peng, Suotang] Shanxi Agr Univ, Coll Agr Sci, Taigu, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Shanxi Agricultural University	Wei, XH (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	hzxwei@gmail.com	wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; wang, yi/GVT-8516-2022		National Key Technology R&D Program in China [2013BAD01B02-14]	National Key Technology R&D Program in China(National Key Technology R&D Program)	This work was supported by the National Key Technology R&D Program in China (2013BAD01B02-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1999, GENES GENET SYST, V74, P23, DOI 10.1266/ggs.74.23; Akagi H, 1996, THEOR APPL GENET, V93, P1071, DOI 10.1007/BF00230127; AMANTEBORDEOS A, 1992, THEOR APPL GENET, V84, P345, DOI 10.1007/BF00229493; Bastide M, 2007, CURRENT PROTOCOLS BI; DALLY AM, 1990, THEOR APPL GENET, V80, P209, DOI 10.1007/BF00224389; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fukui K, 1997, THEOR APPL GENET, V95, P1239, DOI 10.1007/s001220050687; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; GUPTA PK, 1985, CAN J GENET CYTOL, V27, P515, DOI 10.1139/g85-077; Harushima Y, 1998, GENETICS, V148, P479; Heinrichs E., 1985, GENETIC EVALUATION I; Ho KC, 1961, CYTOGENETICAL STUDIE; Jauhar P, 1996, METHODS GENOME ANAL, P21; Joshi SP, 2000, THEOR APPL GENET, V100, P1311, DOI 10.1007/s001220051440; KANNO A, 1992, THEOR APPL GENET, V83, P791, DOI 10.1007/BF00226699; KATAYAMA T, 1977, JPN J GENET, V52, P301, DOI 10.1266/jjg.52.301; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; KRISHNASWAMY N., 1957, SCI AND CULTURE, V23, P308; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Li CB, 2001, THEOR APPL GENET, V103, P204, DOI 10.1007/s001220100563; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nishikawa T, 2005, THEOR APPL GENET, V110, P696, DOI 10.1007/s00122-004-1895-2; Page RD, 2001, TREEVIEW; Simon VI, 2010, AM J BOT, V97, pE10, DOI 10.3732/ajb.1000023; SITCH LA, 1989, RICE GENET NEWSL, V6, P58; TATEOKA T., 1962, Shokubutsugaku Zasshi = Bot. Mag., V75, P455; TATEOKA T., 1963, Bot. Mag., V76, P165; TATEOKA T., 1962, Shokubutsugaku Zasshi = Bot. Mag., V75, P418; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang ZY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-139; Yang T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-602; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490; Zhou HF, 2011, AM J BOT, V98, pE195, DOI 10.3732/ajb.1100040; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	39	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91826	10.1371/journal.pone.0091826	http://dx.doi.org/10.1371/journal.pone.0091826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632997	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400101
J	Wormer, DB; Davis, KA; Henderson, JH; Turner, CE				Wormer, Duncan B.; Davis, Kevin A.; Henderson, James H.; Turner, Christopher E.			The Focal Adhesion-Localized CdGAP Regulates Matrix Rigidity Sensing and Durotaxis	PLOS ONE			English	Article							MYOSIN-II; CELL MORPHOLOGY; SIMULTANEOUS QUANTIFICATION; RHO-GTPASES; PAXILLIN; ACTIN; ACTOPAXIN; MEMBRANE; RAC; ACTIVATION	Motile cells are capable of sensing the stiffness of the surrounding extracellular matrix through integrin-mediated focal adhesions and migrate towards regions of higher rigidity in a process known as durotaxis. Durotaxis plays an important role in normal development and disease progression, including tumor invasion and metastasis. However, the signaling mechanisms underlying focal adhesion-mediated rigidity sensing and durotaxis are poorly understood. Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that cdGAP, an adhesion-localized Rac1 and Cdc42 specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness. CdGAP regulated rigidity-dependent motility by controlling membrane protrusion and adhesion dynamics, as well as by modulating Rac1 activity. CdGAP was also found to be necessary for U2OS cell durotaxis. Taken together, these data identify cdGAP as an important component of an integrin-mediated signaling pathway that senses and responds to mechanical cues in the extracellular matrix in order to coordinate directed cell motility.	[Wormer, Duncan B.; Turner, Christopher E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [Davis, Kevin A.; Henderson, James H.] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University	Turner, CE (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	turnerce@upstate.edu		Henderson, James/0000-0003-3355-5953	National Institutes of Health [GM47607, CA163296]; National Science Foundation [1334493]; NATIONAL CANCER INSTITUTE [R01CA163296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institutes of Health (http://grants.nih.gov/grants/oer.htm) Grants GM47607 and CA163296 to CET, and the National Science Foundation (http://www.nsf.gov/funding/) 1334493 to CET and JHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Bosgraaf L, 2010, CELL ADHES MIGR, V4, P46, DOI 10.4161/cam.4.1.9953; Bosgraaf L, 2009, CELL MOTIL CYTOSKEL, V66, P156, DOI 10.1002/cm.20338; Breckenridge M, 2013, CELL MOL BIOENGINEER; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Chan KT, 2007, METHOD ENZYMOL, V426, P47, DOI 10.1016/S0076-6879(07)26003-3; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Clark AG, 2009, CURR BIOL, V19, P1389, DOI 10.1016/j.cub.2009.06.044; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; Endris V, 2011, J CELL SCI, V124, P3941, DOI 10.1242/jcs.077081; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He Y, 2011, ONCOGENE, V30, P1032, DOI 10.1038/onc.2010.477; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Khyrul WAKM, 2004, J BIOL CHEM, V279, P54131, DOI 10.1074/jbc.M410051200; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lee K, 2012, MOL BIOL CELL, V23, P4097, DOI 10.1091/mbc.E12-02-0166; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin B, 2012, P NATL ACAD SCI USA, V109, pE3668, DOI 10.1073/pnas.1210295109; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pignatelli J, 2012, J BIOL CHEM, V287, P37309, DOI 10.1074/jbc.M112.385229; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Plotnikov SV, 2013, CURR OPIN CELL BIOL; Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saraiva N, 2013, J CELL BIOL, V202, P699, DOI 10.1083/jcb.201301016; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Tcherkezian J, 2005, MOL CELL BIOL, V25, P6314, DOI 10.1128/MCB.25.15.6314-6329.2005; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Tyson RA, 2010, MATH MODEL NAT PHENO, V5, P34, DOI 10.1051/mmnp/20105102; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wormer D, 2012, CYTOSKELETON, V69, P644, DOI 10.1002/cm.21057; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765	70	34	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91815	10.1371/journal.pone.0091815	http://dx.doi.org/10.1371/journal.pone.0091815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632816	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400095
J	Garcia-Alvarez, A; Egan, B; de Klein, S; Dima, L; Maggi, FM; Isoniemi, M; Ribas-Barba, L; Raats, MM; Meissner, EM; Badea, M; Bruno, F; Salmenhaara, M; Mila-Villarroel, R; Knaze, V; Hodgkins, C; Marculescu, A; Uusitalo, L; Restani, P; Serra-Majem, L				Garcia-Alvarez, Alicia; Egan, Bernadette; de Klein, Simone; Dima, Lorena; Maggi, Franco M.; Isoniemi, Merja; Ribas-Barba, Lourdes; Raats, Monique M.; Meissner, Eva Melanie; Badea, Mihaela; Bruno, Flavia; Salmenhaara, Maija; Mila-Villarroel, Raimon; Knaze, Viktoria; Hodgkins, Charo; Marculescu, Angela; Uusitalo, Liisa; Restani, Patrizia; Serra-Majem, Lluis			Usage of Plant Food Supplements across Six European Countries: Findings from the PlantLIBRA Consumer Survey	PLOS ONE			English	Article							NATIONAL-HEALTH; ALTERNATIVE MEDICINE; DIETARY-SUPPLEMENTS; UNITED-STATES; HERBAL SUPPLEMENTS; ADULT-POPULATION; US ADULTS; COMPLEMENTARY; PATTERNS; PREVALENCE	Background: The popularity of botanical products is on the rise in Europe, with consumers using them to complement their diets or to maintain health, and products are taken in many different forms (e. g. teas, juices, herbal medicinal products, plant food supplements (PFS)). However there is a scarcity of data on the usage of such products at European level. Objective: To provide an overview of the characteristics and usage patterns of PFS consumers in six European countries. Design: Data on PFS usage were collected in a cross-sectional, retrospective survey of PFS consumers using a bespoke frequency of PFS usage questionnaire. Subjects/setting: A total sample of 2359 adult PFS consumers from Finland, Germany, Italy, Romania, Spain and the United Kingdom. Data analyses: Descriptive analyses were conducted, with all data stratified by gender, age, and country. Absolute frequencies, percentages and 95% confidence intervals are reported. Results: Overall, an estimated 18.8% of screened survey respondents used at least one PFS. Characteristics of PFS consumers included being older, well-educated, never having smoked and self-reporting health status as "good or very good". Across countries, 491 different botanicals were identified in the PFS products used, with Ginkgo biloba (Ginkgo), Oenothera biennis (Evening primrose) and Cynara scolymus (Artichoke) being most frequently reported; the most popular dose forms were capsules and pills/tablets. Most consumers used one product and half of all users took single-botanical products. Some results varied across countries. Conclusions: The PlantLIBRA consumer survey is unique in reporting on usage patterns of PFS consumers in six European countries. The survey highlights the complexity of measuring the intake of such products, particularly at pan-European level. Incorporating measures of the intake of botanicals in national dietary surveys would provide much-needed data for comprehensive risk and benefit assessments at the European level.	[Garcia-Alvarez, Alicia; Ribas-Barba, Lourdes; Mila-Villarroel, Raimon; Knaze, Viktoria; Serra-Majem, Lluis] Univ Barcelona, Fdn Invest Nutr, Barcelona, Spain; [Egan, Bernadette; Raats, Monique M.; Hodgkins, Charo] Univ Surrey, Food Consumer Behav & Hlth Res Ctr, Guildford GU2 5XH, Surrey, England; [de Klein, Simone; Meissner, Eva Melanie] PhytoLab GmbH & Co KG, Vestenbergsgreuth, Germany; [Dima, Lorena; Badea, Mihaela; Marculescu, Angela] Transilvania Univ Brasov, Brasov, Romania; [Maggi, Franco M.; Bruno, Flavia; Restani, Patrizia] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Isoniemi, Merja; Salmenhaara, Maija; Uusitalo, Liisa] Finnish Food Safety Author Evira, Helsinki, Finland; [Ribas-Barba, Lourdes; Serra-Majem, Lluis] Inst Salud Carlos III, Ciber Obn Fisiopatol Obesidad & Nutr, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Inst Biomed & Hlth Res Las Palmas, Las Palmas Gran Canaria, Spain	University of Barcelona; University of Surrey; Transylvania University of Brasov; University of Milan; Finnish Food Authority; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Las Palmas de Gran Canaria	Serra-Majem, L (corresponding author), Univ Barcelona, Fdn Invest Nutr, Barcelona Sci Pk, Barcelona, Spain.	lserra@dcc.ulpgc.es	Badea, Mihaela/B-8240-2012; Garcia-Alvarez, Alicia/AAV-9762-2020; Badea, Mihaela/Z-1490-2018; Milà Villarroel, Raimon/AGR-2823-2022; Raats, Monique/G-5348-2012; Serra-Majem, Lluis/I-6708-2019	Badea, Mihaela/0000-0003-4824-2175; Raats, Monique/0000-0002-8057-2783; Serra-Majem, Lluis/0000-0002-9658-9061; Egan, Bernadette/0000-0002-5767-0457; Hodgkins, Charo/0000-0003-4775-0338; Dima, Lorena/0000-0002-4406-9304	European Community [245199]; European Commission	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245199. It has been carried out within the PlantLIBRA project (www.plantlibra.eu). This report does not necessarily reflect the Commission's views or its future policy on this area. The European Commission had no direct say in the project methods or outcome beyond providing funding for materials and personnel, and did not directly contribute to the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, BIRTH-ISS PERINAT C, V36, P237, DOI 10.1111/j.1523-536X.2009.00328.x; [Anonymous], 2002, OFF J EUR COMMUNIT L, VL183, P51; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Bardia A, 2007, MAYO CLIN PROC, V82, P561, DOI 10.4065/82.5.561; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; Bundesinstitut fur Risikobewertung, 2013, TARG GROUP OR RISK C; Centro de Investigacion sobre Fitoterapia, 2007, EST INFITO CONS PLAN; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dwyer J, 2013, AM J CLIN NUTR, V97, P1331, DOI 10.3945/ajcn.112.052373; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.225r; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; European Advisory Service (EAS), 2007, US SUBST NUTR PHYS E; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2663; Federal Office of Consumer Protection and Food Safety (BVL), 2010, SUBST LIST DRAFT LIS; Finger JD, 2013, BUNDESGESUNDHEITSBLA, V56, P607; Foote JA, 2003, AM J EPIDEMIOL, V157, P888, DOI 10.1093/aje/kwg072; Harrison RA, 2004, INT J VITAM NUTR RES, V74, P183, DOI 10.1024/0300-9831.74.3.183; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kelly JP, 2005, ARCH INTERN MED, V165, P281, DOI 10.1001/archinte.165.3.281; Larranaga-Guetaria A, 2012, AGRO FOOD IND HI TEC, V23, P20; Max Rubner Institut, 2008, GERM NAT NUTR SURV N; Menniti-Ippolito F, 2002, EUR J CLIN PHARMACOL, V58, P61, DOI 10.1007/s00228-002-0435-8; Messerer M, 2001, J INTERN MED, V250, P160, DOI 10.1046/j.1365-2796.2001.00872.x; National Center for Health Statistics, 2009, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2003, 2002 NAT HLTH INT SU; Nielsen MW, 2005, ANN PHARMACOTHER, V39, P1534, DOI 10.1345/aph.1G119; Nilsson M, 2001, J INTERN MED, V250, P225, DOI 10.1046/j.1365-2796.2001.00882.x; Picciano MF, 2007, ARCH PEDIAT ADOL MED, V161, P978, DOI 10.1001/archpedi.161.10.978; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Ritchie MR, 2007, P NUTR SOC, V66, P479, DOI 10.1017/S0029665107005794; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; Rovira MA, 2013, J NUTR EDUC BEHAV, V45, P386, DOI 10.1016/j.jneb.2012.03.007; Schaffer DM, 2003, J AM DIET ASSOC, V103, P1500, DOI 10.1016/j.jada.2003.08.026; Silano V, 2011, FOOD FUNCT, V2, P710, DOI 10.1039/c1fo10105f; Skeie G, 2009, EUR J CLIN NUTR, V63, pS226, DOI 10.1038/ejcn.2009.83; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002; Touvier M, 2009, EUR J CLIN NUTR, V63, P39, DOI 10.1038/sj.ejcn.1602907; Vargas-Murga L, 2011, FOOD FUNCT, V2, P731, DOI 10.1039/c1fo10075k; World Health Organization (WHO), 2013, BMI CLASS; Wu CH, 2011, CLIN THER, V33, P1749, DOI 10.1016/j.clinthera.2011.09.024	42	81	81	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92265	10.1371/journal.pone.0092265	http://dx.doi.org/10.1371/journal.pone.0092265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642692	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900115
J	Li, XY; Tao, H; Xie, KW; Ni, ZH; Yan, YC; Wei, K; Chuang, PY; He, JC; Gu, LY				Li, Xiaoying; Tao, Hua; Xie, Kewei; Ni, Zhaohui; Yan, Yucheng; Wei, Kai; Chuang, Peter Y.; He, John Cijiang; Gu, Leyi			cAMP Signaling Prevents Podocyte Apoptosis via Activation of Protein Kinase A and Mitochondrial Fusion	PLOS ONE			English	Article							GLOMERULAR PODOCYTES; EPITHELIAL-CELLS; MOUSE MODEL; IN-VITRO; PATHWAY; EXPRESSION; RECEPTOR; NEPHROPATHY; DAMAGE; STRESS	Our previous in vitro studies suggested that cyclic AMP (cAMP) signaling prevents adriamycin (ADR) and puromycin aminonucleoside (PAN)-induced apoptosis in podocytes. As cAMP is an important second messenger and plays a key role in cell proliferation, differentiation and cytoskeleton formation via protein kinase A (PKA) or exchange protein directly activated by cAMP (Epac) pathways, we sought to determine the role of PKA or Epac signaling in cAMP-mediated protection of podocytes. In the ADR nephrosis model, we found that forskolin, a selective activator of adenylate cyclase, attenuated albuminuria and improved the expression of podocyte marker WT-1. When podocytes were treated with pCPT-cAMP (a selective cAMP/PKA activator), PKA activation was increased in a time-dependent manner and prevented PAN-induced podocyte loss and caspase 3 activation, as well as a reduction in mitochondrial membrane potential. We found that PAN and ADR resulted in a decrease in Mfn1 expression and mitochondrial fission in podocytes. pCPT-cAMP restored Mfn1 expression in puromycin or ADR-treated podocytes and induced Drp1 phosphorylation, as well as mitochondrial fusion. Treating podocytes with arachidonic acid resulted in mitochondrial fission, podocyte loss and cleaved caspase 3 production. Arachidonic acid abolished the protective effects of pCPT-cAMP on PAN-treated podocytes. Mdivi, a mitochondrial division inhibitor, prevented PAN-induced cleaved caspase 3 production in podocytes. We conclude that activation of cAMP alleviated murine podocyte caused by ADR. PKA signaling resulted in mitochondrial fusion in podocytes, which at least partially mediated the effects of cAMP.	[Li, Xiaoying; Tao, Hua; Xie, Kewei; Ni, Zhaohui; Yan, Yucheng; Wei, Kai; Gu, Leyi] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Renal, Shanghai 200030, Peoples R China; [Li, Xiaoying; Tao, Hua; Xie, Kewei; Ni, Zhaohui; Yan, Yucheng; Wei, Kai; Gu, Leyi] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Mol Cell Lab Kidney Dis, Shanghai 200030, Peoples R China; [Chuang, Peter Y.; He, John Cijiang] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY USA; [He, John Cijiang] James J Peter Vet Affairs Med Ctr, Renal Sect, Bronx, NY USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Gu, LY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Renal, Shanghai 200030, Peoples R China.	guleyi@aliyun.com			National Nature Science Foundation Grant of China [30971363, 81270781]; Nature Science Foundation Grant of Shanghai [08ZR1413200]; National Basic Research Program of China 973 Program [2012CB517602]; Nature Science Foundation of Shanghai [10JC1410200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078897] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000345] Funding Source: NIH RePORTER	National Nature Science Foundation Grant of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation Grant of Shanghai; National Basic Research Program of China 973 Program(National Basic Research Program of China); Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Nature Science Foundation Grant of China (30971363 and 81270781, http://www.nsfc.gov.cn) and Nature Science Foundation Grant of Shanghai (08ZR1413200, http://www.stcsm.gov.cn) to Dr Gu. National Basic Research Program of China 973 Program (2012CB517602,http://program.most.gov.cn) to Dr Ni as well as by a grant (10JC1410200,http://www.stcsm.gov.cn) from the Nature Science Foundation of Shanghai to Dr Yan. The funders had no role in study design, data collection and analysis, decision to publish, or preparaton of the manuscript.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bek M, 1999, NEPHROL DIAL TRANSPL, V14, P581, DOI 10.1093/ndt/14.3.581; Bridgewater DJ, 2005, KIDNEY INT, V67, P1308, DOI 10.1111/j.1523-1755.2005.00208.x; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Cowell RM, 2008, NEUROSCI LETT, V439, P269, DOI 10.1016/j.neulet.2008.04.104; Ding GH, 2002, AM J PHYSIOL-RENAL, V283, pF173, DOI 10.1152/ajprenal.00240.2001; Endlich N, 2002, MICROSC RES TECHNIQ, V57, P228, DOI 10.1002/jemt.10079; Faour WH, 2008, CELL SIGNAL, V20, P2156, DOI 10.1016/j.cellsig.2008.08.007; Gao SY, 2007, CELL TISSUE RES, V328, P391, DOI 10.1007/s00441-006-0365-3; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gu LY, 2013, AIDS, V27, P1091, DOI 10.1097/QAD.0b013e32835f1ea1; Gu LY, 2012, KIDNEY INT, V81, P458, DOI 10.1038/ki.2011.406; He JCJ, 2007, J AM SOC NEPHROL, V18, P93, DOI 10.1681/ASN.2006070727; Huber TB, 1998, J AM SOC NEPHROL, V9, P335; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Keravis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028899; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Li Y, 2008, AM J PHYSIOL-RENAL, V295, pF525, DOI 10.1152/ajprenal.00448.2007; Marshall CB, 2006, KIDNEY INT, V70, P1962, DOI 10.1038/sj.ki.5001965; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Oba S, 2008, NEPHROL DIAL TRANSPL, V23, P510, DOI 10.1093/ndt/gfm600; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; Qin Y, 2012, BRIT J PHARMACOL, V165, P1137, DOI 10.1111/j.1476-5381.2011.01594.x; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Ruster C, 2011, AM J NEPHROL, V34, P309, DOI 10.1159/000329321; Saito Y, 2010, AM J PHYSIOL-RENAL, V298, pF1436, DOI 10.1152/ajprenal.00512.2009; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Stokman G, 2011, J AM SOC NEPHROL, V22, P859, DOI 10.1681/ASN.2010040423; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Wada T, 2005, KIDNEY INT, V68, P1618, DOI 10.1111/j.1523-1755.2005.00574.x; Xiao HQ, 2009, AM J NEPHROL, V30, P34, DOI 10.1159/000200769; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhong YF, 2012, KIDNEY INT, V81, P856, DOI 10.1038/ki.2011.467; Zhu CH, 2011, AM J PATHOL, V178, P2020, DOI 10.1016/j.ajpath.2011.01.029	43	23	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92003	10.1371/journal.pone.0092003	http://dx.doi.org/10.1371/journal.pone.0092003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642777	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900058
J	Chen, ZZ; Shin, D; Chen, SY; Mikhail, K; Hadass, O; Tomlison, BN; Korkin, D; Shyu, CR; Cui, JK; Anthony, DC; Gu, ZZ				Chen, Zhenzhou; Shin, Dmitriy; Chen, Shanyan; Mikhail, Kovalenko; Hadass, Orr; Tomlison, Brittany N.; Korkin, Dmitry; Shyu, Chi-Ren; Cui, Jiankun; Anthony, Douglas C.; Gu, Zezong			Histological Quantitation of Brain Injury Using Whole Slide Imaging: A Pilot Validation Study in Mice	PLOS ONE			English	Article							DIGITAL PATHOLOGY; NEUROPROTECTION; QUANTIFICATION; INHIBITION; PROTEIN; STAINS	Quantitative assessment of serial brain sections provides an objective measure of neurological events at cellular and molecular levels but is difficult to implement in experimental neuroscience laboratories because of variation from person-to-person and the time required for analysis. Whole slide imaging (WSI) technology, recently introduced for pathological diagnoses, offers an electronic environment and a variety of computational tools for performing high-throughput histological analysis and managing the associated information. In our study, we applied various algorithms to quantify histologic changes associated with brain injury and compared the results to manual assessment. WSI showed a high degree of concordance with manual quantitation by Pearson correlation and strong agreement using Bland-Altman plots in: (i) cortical necrosis in cresyl-violet-stained brain sections of mice after focal cerebral ischemia; (ii) intracerebral hemorrhage in ischemic mouse brains for automated annotation of the small regions, rather than whole hemisphere of the tissue sections; (iii) Iba1-immunoreactive cell density in the adjacent and remote brain regions of mice subject to controlled cortical impact (CCI); and (iv) neuronal degeneration by silver staining after CCI. These results show that WSI, when appropriately applied and carefully validated, is a highly efficient and unbiased tool to locate and identify neuropathological features, delineate affected regions and histologically quantify these events.	[Chen, Zhenzhou; Shin, Dmitriy; Chen, Shanyan; Mikhail, Kovalenko; Hadass, Orr; Tomlison, Brittany N.; Cui, Jiankun; Anthony, Douglas C.; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Chen, Zhenzhou; Chen, Shanyan; Hadass, Orr; Tomlison, Brittany N.; Cui, Jiankun; Anthony, Douglas C.; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Chen, Shanyan] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA; [Korkin, Dmitry; Shyu, Chi-Ren] Univ Missouri, Inst Informat, Columbia, MO USA; [Korkin, Dmitry; Shyu, Chi-Ren] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Anthony, Douglas C.] Brown Univ, Dept Pathol & Lab Med, Alpert Med Sch, Providence, RI 02912 USA; [Chen, Zhenzhou] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Brown University; Southern Medical University - China	Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	guze@missouri.edu		Shin, Dmitriy/0000-0002-5571-9384; Anthony, Douglas/0000-0002-3815-2240	Dana Foundation; American Heart Association National Scientist Development award [09SDG2260983]; Western States Affiliate Beginning [0665051Y]; University of Missouri Department of Pathology and Anatomical Sciences research fund; Div Of Biological Infrastructure [0845196] Funding Source: National Science Foundation	Dana Foundation; American Heart Association National Scientist Development award(American Heart Association); Western States Affiliate Beginning; University of Missouri Department of Pathology and Anatomical Sciences research fund; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grants from Dana Foundation, American Heart Association National Scientist Development award (09SDG2260983) and Western States Affiliate Beginning Grant-in-Aid (0665051Y) and the University of Missouri Department of Pathology and Anatomical Sciences research fund (ZG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barisoni L, 2013, CLIN J AM SOC NEPHRO, V8, P1449, DOI 10.2215/CJN.08370812; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cornish TC, 2012, ADV ANAT PATHOL, V19, P152, DOI 10.1097/PAP.0b013e318253459e; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Garrido R, 2013, J HISTOCHEM CYTOCHEM, V61, P362, DOI 10.1369/0022155413482926; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Guzman M, 2009, BRAIN PATHOL, V19, P305, DOI 10.1111/j.1750-3639.2009.00264.x; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Harvey NR, 2002, IEEE T GEOSCI REMOTE, V40, P393, DOI 10.1109/36.992801; Hipp JD, 2011, AM J SURG PATHOL, V35, P783, DOI 10.1097/PAS.0b013e31821946b6; Ho J, 2006, HUM PATHOL, V37, P322, DOI 10.1016/j.humpath.2005.11.005; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jaraj SJ, 2009, VIRCHOWS ARCH, V455, P375, DOI 10.1007/s00428-009-0833-8; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Krajewska M, 2009, J HISTOCHEM CYTOCHEM, V57, P649, DOI 10.1369/jhc.2009.952812; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Pantanowitz Liron, 2010, J Pathol Inform, V1, DOI [10.4103/2153-3539.68332, 10.4103/2153-3539.63821]; Pantanowitz L, 2013, ARCH PATHOL LAB MED, V137, P1710, DOI 10.5858/arpa.2013-0093-CP; Rizzardi AE, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-42; Rojo MG, 2013, J ONCOPATHOLOGY, V1, P83; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Tenkova Tatyana I., 2007, V399, P31, DOI 10.1007/978-1-59745-504-6_3; Titus K, 2012, CAP TODAY, V26, P56; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Weinstein RS, 2009, HUM PATHOL, V40, P1057, DOI 10.1016/j.humpath.2009.04.006; Wilbur DC, 2009, ARCH PATHOL LAB MED, V133, P1949, DOI 10.1043/1543-2165-133.12.1949; Xiang ZH, 2006, J NEUROSCI RES, V83, P91, DOI 10.1002/jnr.20709; Yagi Yukako, 2012, J Pathol Inform, V3, P14; Yagi Y, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S15	38	12	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92133	10.1371/journal.pone.0092133	http://dx.doi.org/10.1371/journal.pone.0092133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637518	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100118
J	Cillo, AR; Krishnan, S; McMahon, DK; Mitsuyasu, RT; Para, MF; Mellors, JW				Cillo, Anthony R.; Krishnan, Supriya; McMahon, Deborah K.; Mitsuyasu, Ronald T.; Para, Michael F.; Mellors, John W.			Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LATENT RESERVOIR; PCR ASSAY; TRANSPLANTATION; BLOOD; CELLS; QUANTIFICATION; RESISTANCE; COFACTOR; DEFENSE	The first cure of HIV-1 infection was achieved through complex, multimodal therapy including myeloablative chemotherapy, total body irradiation, anti-thymocyte globulin, and allogeneic stem cell transplantation with a CCR5 delta32 homozygous donor. The contributions of each component of this therapy to HIV-1 eradication are unclear. To assess the impact of cytotoxic chemotherapy alone on HIV-1 persistence, we longitudinally evaluated low-level plasma viremia and HIV-1 DNA in PBMC from patients in the ACTG A5001/ALLRT cohort on suppressive antiretroviral therapy (ART) who underwent chemotherapy for HIV-1 related lymphoma without interrupting ART. Plasma HIV-1 RNA, total HIV-1 DNA and 2-LTR circles (2-LTRs) in PBMC were measured using sensitive qPCR assays. In the 9 patients who received moderately intensive chemotherapy for HIV-1 related lymphoma with uninterrupted ART, low-level plasma HIV-1 RNA did not change significantly with chemotherapy: median HIV-1 RNA was 1 copy/mL (interquartile range: 1.0 to 20) pre-chemotherapy versus 4 copies/mL (interquartile range: 1.0 to 7.0) post-chemotherapy. HIV-1 DNA levels also did not change significantly, with median pre-chemotherapy HIV-1 DNA of 355 copies/10(6) CD4+ cells versus 228 copies/10(6) CD4+ cells post-chemotherapy. 2-LTRs were detectable in 2 of 9 patients pre-chemotherapy and in 3 of 9 patients post-chemotherapy. In summary, moderately intensive chemotherapy for HIV-1 related lymphoma in the context of continuous ART did not have a prolonged impact on HIV-1 persistence.	[Cillo, Anthony R.; McMahon, Deborah K.; Mellors, John W.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Krishnan, Supriya] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Mitsuyasu, Ronald T.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Para, Michael F.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Los Angeles; University System of Ohio; Ohio State University	Cillo, AR (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	arc85@pitt.edu; jwm1@pitt.edu			National Institute of Allergy and Infectious Diseases [U01AI068636]; National Institute of Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); AIDS Clinical Trials Group to the Pittsburgh Virology Specialty Laboratory [AI068636]; Statistical and Data Management Center [UM1 AI068634]; Clinical Trials Units at the University of Pittsburgh [AI069494]; Ohio State University [AI069474]; University of California Los Angeles Clinical Research Core [AI28697]; Pitt AIDS Research Training Grant [5 T32 AI065380-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069474, UM1AI106701, UM1AI069494, UM1AI068636, UM1AI069474, P30AI028697, UM1AI069424, UM1AI068634, T32AI065380, U01AI068636, U01AI069494] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); AIDS Clinical Trials Group to the Pittsburgh Virology Specialty Laboratory; Statistical and Data Management Center; Clinical Trials Units at the University of Pittsburgh; Ohio State University(Ohio State University); University of California Los Angeles Clinical Research Core; Pitt AIDS Research Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award number U01AI068636 from the National Institute of Allergy and Infectious Diseases and supported by National Institute of Mental Health (NIMH) and the National Institute of Dental and Craniofacial Research (NIDCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. This work was also supported by grants from the AIDS Clinical Trials Group to the Pittsburgh Virology Specialty Laboratory (AI068636), the Statistical and Data Management Center (UM1 AI068634), the Clinical Trials Units at the University of Pittsburgh (AI069494), Ohio State University (AI069474), and the University of California Los Angeles Clinical Research Core (AI28697). ARC also received support from the Pitt AIDS Research Training Grant (#5 T32 AI065380-08). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Casorati G, 2005, EXP HEMATOL, V33, P212, DOI 10.1016/j.exphem.2004.10.008; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cillo AR, 2013, JAIDS-J ACQ IMM DEF, V63, P438, DOI 10.1097/QAI.0b013e31828e6163; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Henrich TJ, 6 INT WORKSH HIV PER; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Lehrnbecher T, 1997, J PEDIAT HEMATOL ONC, V19, P399, DOI 10.1097/00043426-199709000-00001; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; MACKALL CL, 1994, BLOOD, V84, P2221; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Malnati MS, 2008, NAT PROTOC, V3, P1240, DOI 10.1038/nprot.2008.108; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Petz LD, 2013, BIOL BLOOD MARROW TR, V19, P393, DOI 10.1016/j.bbmt.2012.10.017; Sanchez G, 1997, J VIROL, V71, P2233, DOI 10.1128/JVI.71.3.2233-2240.1997; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smurzynski M, 2008, HIV CLIN TRIALS, V9, P269, DOI 10.1310/hct0904-269; Tebas P, 2013, BLOOD, V121, P1524, DOI 10.1182/blood-2012-07-447250; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zou SM, 2013, BLOOD, V122, P3111, DOI 10.1182/blood-2013-07-518316	32	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92118	10.1371/journal.pone.0092118	http://dx.doi.org/10.1371/journal.pone.0092118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638072	Green Published, Green Accepted, gold			2022-12-27	WOS:000333254100114
J	Poormasjedi-Meibod, MS; Hartwell, R; Kilani, RT; Ghahary, A				Poormasjedi-Meibod, Malihe-Sadat; Hartwell, Ryan; Kilani, Ruhangiz Taghi; Ghahary, Aziz			Anti-Scarring Properties of Different Tryptophan Derivatives	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; HYPERTROPHIC SCAR; INDOLEAMINE 2,3-DIOXYGENASE; SKIN SUBSTITUTE; MATRIX METALLOPROTEINASES; ONCOFETAL FIBRONECTIN; EXTRACELLULAR-MATRIX; LOCAL EXPRESSION	Hypertrophic scars are associated with prolonged extracellular matrix (ECM) production, aberrant ECM degradation and high tissue cellularity. Routinely used antifibrotic strategies aim to reduce ECM deposition and enhance matrix remodeling. Our previous study investigating the antifibrotic effects of indoleamine2, 3 dioxygenase (IDO) led to the identification of kynurenine (Kyn) as an antiscarring agent. A topical antifibrogenic therapy using Kyn is very attractive; however, it is well established that Kyn passes the blood brain barrier (BBB) which causes complications including excitatory neuronal death. Here we investigated the antiscarring properties of kynurenic acid (KynA), a downstream end product of Kyn that is unlikely to pass the BBB, as an effective and safe replacement for Kyn. Our results indicated that while not having any adverse effect on dermal cell viability, KynA significantly increases the expression of matrix metalloproteinases (MMP1 and MMP3) and suppresses the production of type-I collagen and fibronectin by fibroblasts. Topical application of cream containing KynA in fibrotic rabbit ear significantly decreased scar elevation index (1.13 +/- 0.13 vs. 1.61 +/- 0.12) and tissue cellularity (221.38 +/- 21.7 vs. 314.5 +/- 68.66 cells/hpf) in KynA treated wounds compared to controls. KynA treated wounds exhibited lower levels of collagen deposition which is accompanied with a significant decrease in type-I collagen and fibronectin expression, as well as an increase in MMP1 expression compared to untreated wounds or wounds treated with cream only. The results of this study provided evidence for the first time that KynA is promising candidate antifibrogenic agent to improve healing outcome in patients at risk of hypertrophic scarring.	[Poormasjedi-Meibod, Malihe-Sadat; Hartwell, Ryan; Kilani, Ruhangiz Taghi; Ghahary, Aziz] Univ British Columbia, Dept Surg, Div Plast Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Ghahary, A (corresponding author), Univ British Columbia, Dept Surg, Div Plast Surg, Vancouver, BC V6T 1W5, Canada.	aghahary@mail.ubc.ca			Collaborative Health Research Projects (CHRP); Vanier Canada Graduate Scholarship (Vanier CGS), Transplantation Scholarship Training awards; CIHR Skin Research Training Centre	Collaborative Health Research Projects (CHRP)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier Canada Graduate Scholarship (Vanier CGS), Transplantation Scholarship Training awards; CIHR Skin Research Training Centre(Canadian Institutes of Health Research (CIHR))	This study was supported by the Collaborative Health Research Projects (CHRP). M. P. was supported by Vanier Canada Graduate Scholarship (Vanier CGS), Transplantation Scholarship Training awards and CIHR Skin Research Training Centre awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Montilla N, 2013, BLOOD, V121, pE108, DOI 10.1182/blood-2012-07-445106; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12; BALDWIN D, 1995, INT CLIN PSYCHOPHARM, V9, P41, DOI 10.1097/00004850-199501004-00006; Baumann P, 2002, EUR NEUROPSYCHOPHARM, V12, P433, DOI 10.1016/S0924-977X(02)00051-2; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BENDER DA, 1982, BIOCHIM BIOPHYS ACTA, V717, P56, DOI 10.1016/0304-4165(82)90379-8; BORDEN JH, 1976, SCIENCE, V192, P894, DOI 10.1126/science.1273573; Chavez-Munoz C, 2012, J INVEST DERMATOL, V132, P1501, DOI 10.1038/jid.2011.467; COOPER SM, 1979, ARTHRITIS RHEUM, V22, P983, DOI 10.1002/art.1780220906; Dasu MRK, 2004, J PATHOL, V202, P476, DOI 10.1002/path.1539; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Ding Y, 2012, FEBS LETT, V586, P1813, DOI 10.1016/j.febslet.2012.05.020; Forouzandeh F, 2010, WOUND REPAIR REGEN, V18, P614, DOI 10.1111/j.1524-475X.2010.00635.x; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Ghahary A, 1996, J INVEST DERMATOL, V106, P476, DOI 10.1111/1523-1747.ep12343658; GHAHARY A, 1993, J LAB CLIN MED, V122, P465; Ghahary Aziz, 1993, Wound Repair and Regeneration, V1, P166, DOI 10.1046/j.1524-475X.1993.10306.x; Hayashi S, 2012, J DERMATOL SCI, V67, P20, DOI 10.1016/j.jdermsci.2012.02.013; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Huang JS, 2002, FASEB J, V16, P1269, DOI 10.1096/fj.02-0103fje; Iimuro Y, 2003, GASTROENTEROLOGY, V124, P445, DOI 10.1053/gast.2003.50063; Ishida M, 2010, CARCINOGENESIS, V31, P287, DOI 10.1093/carcin/bgp222; KISCHER CW, 1983, CELL TISSUE RES, V231, P29; KISCHER CW, 1989, CONNECT TISSUE RES, V23, P279, DOI 10.3109/03008208909005627; Kohan M, 2010, FASEB J, V24, P4503, DOI 10.1096/fj.10-154435; Kung T, 2009, BIOCHEM PHARMACOL, V77, P536, DOI 10.1016/j.bcp.2008.09.031; Li M, 2009, MOL CELL BIOCHEM, V332, P1, DOI 10.1007/s11010-009-0167-5; Li Y, 2013, J INVEST DERMATOL; Li YY, 2006, J INVEST DERMATOL, V126, P128, DOI 10.1038/sj.jid.5700022; McDonald GA, 2003, AM J PHYSIOL-RENAL, V285, pF59, DOI 10.1152/ajprenal.00157.2002; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; MURPHY G, 1987, BIOCHEM J, V248, P265, DOI 10.1042/bj2480265; Murphy KA, 2004, J BIOL CHEM, V279, P25284, DOI 10.1074/jbc.M402168200; Nakagami Y, 1996, JPN J PHARMACOL, V71, P183, DOI 10.1254/jjp.71.183; Okuda S, 1998, J NEUROCHEM, V70, P299; Olivier B, 2004, ANN NY ACAD SCI, V1036, P382, DOI 10.1196/annals.1330.022; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; RAFFA RB, 1993, J PHARMACOL EXP THER, V267, P331; Rahmani-Neishaboor E, 2010, WOUND REPAIR REGEN, V18, P401, DOI 10.1111/j.1524-475X.2010.00598.x; RENNARD SI, 1981, P NATL ACAD SCI-BIOL, V78, P7147, DOI 10.1073/pnas.78.11.7147; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; Singer AJ, 2009, J BURN CARE RES, V30, P329, DOI 10.1097/BCR.0b013e31819a6369; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Tredget EE, 1999, ANN NY ACAD SCI, V888, P165, DOI 10.1111/j.1749-6632.1999.tb07955.x; Tuan TL, 1998, MOL MED TODAY, V4, P19, DOI 10.1016/S1357-4310(97)80541-2; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; WELCH MP, 1990, J CELL BIOL, V110, P133, DOI 10.1083/jcb.110.1.133; YOUNAI S, 1994, ANN PLAS SURG, V33, P148, DOI 10.1097/00000637-199408000-00005	58	31	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91955	10.1371/journal.pone.0091955	http://dx.doi.org/10.1371/journal.pone.0091955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637853	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100089
J	Ramon-Laca, A; Gleeson, D; Yockney, I; Perry, M; Nugent, G; Forsyth, DM				Ramon-Laca, Ana; Gleeson, Dianne; Yockney, Ivor; Perry, Michael; Nugent, Graham; Forsyth, David M.			Reliable Discrimination of 10 Ungulate Species Using High Resolution Melting Analysis of Faecal DNA	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; 12S RIBOSOMAL-RNA; REAL-TIME PCR; RED-DEER; NEW-ZEALAND; SIKA-DEER; CAPREOLUS-CAPREOLUS; MULTIPLEX ASSAY; CYTOCHROME-B; DAMA-DAMA	Identifying species occupying an area is essential for many ecological and conservation studies. Faecal DNA is a potentially powerful method for identifying cryptic mammalian species. In New Zealand, 10 species of ungulate (Order: Artiodactyla) have established wild populations and are managed as pests because of their impacts on native ecosystems. However, identifying the ungulate species present within a management area based on pellet morphology is unreliable. We present a method that enables reliable identification of 10 ungulate species (red deer, sika deer, rusa deer, fallow deer, sambar deer, white-tailed deer, Himalayan tahr, Alpine chamois, feral sheep, and feral goat) from swabs of faecal pellets. A high resolution melting (HRM) assay, targeting a fragment of the 12S rRNA gene, was developed. Species-specific primers were designed and combined in a multiplex PCR resulting in fragments of different length and therefore different melting behaviour for each species. The method was developed using tissue from each of the 10 species, and was validated in blind trials. Our protocol enabled species to be determined for 94% of faecal pellet swabs collected during routine monitoring by the New Zealand Department of Conservation. Our HRM method enables high-throughput and cost-effective species identification from low DNA template samples, and could readily be adapted to discriminate other mammalian species from faecal DNA.	[Ramon-Laca, Ana] EcoGene, Landcare Res, Auckland, New Zealand; [Gleeson, Dianne] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Yockney, Ivor; Nugent, Graham] Landcare Res, Canterbury, New Zealand; [Perry, Michael] Landcare Res, Palmerston North, Manawatu, New Zealand; [Forsyth, David M.] Arthur Rylah Inst Environm Res, Dept Environm & Primary Ind, Heidelberg, Vic, Australia	Landcare Research - New Zealand; University of Canberra; Landcare Research - New Zealand; Landcare Research - New Zealand; Arthur Rylah Institute for Environmental Research (ARI)	Ramon-Laca, A (corresponding author), EcoGene, Landcare Res, Auckland, New Zealand.	ramon-lacaa@landcareresearch.co.nz		Ramon-Laca, Ana/0000-0002-9204-6932; Nugent, Graham/0000-0001-6223-8450; Gleeson, Dianne/0000-0002-5093-4405; Forsyth, David/0000-0001-5356-9573	New Zealand Department of Conservation as part of Biodiversity Monitoring and Reporting System	New Zealand Department of Conservation as part of Biodiversity Monitoring and Reporting System	Funding was provided by the New Zealand Department of Conservation as part of their Biodiversity Monitoring and Reporting System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RB, 2009, DESIGNING INVENTORY; Berry O, 2007, MOL ECOL NOTES, V7, P1, DOI 10.1111/j.1471-8286.2006.01541.x; Bowkett AE, 2013, CONSERV GENET RESOUR, V5, P1095, DOI 10.1007/s12686-013-9935-3; Brinkman TJ, 2010, CONSERV GENET, V11, P1547, DOI 10.1007/s10592-009-9928-7; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caughley G, 1983, DEER WARS STORY DEER; Challies C. N., 1985, BIOL DEER PRODUCTION, V22, P23; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Conover MR, 1997, WILDLIFE SOC B, V25, P298; Coomes DA, 2003, CONSERV BIOL, V17, P450, DOI 10.1046/j.1523-1739.2003.15099.x; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DAVIDSON M M, 1973, New Zealand Journal of Forestry Science, V3, P153; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Demay SM, 2013, MOL ECOL RESOUR, V13, P654, DOI 10.1111/1755-0998.12104; Diaz A, 2006, J ZOOL, V270, P227, DOI 10.1111/j.1469-7998.2006.00130.x; DOUZERY E, 1995, J MOL EVOL, V41, P622; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; Fajardo V, 2006, J AGR FOOD CHEM, V54, P1144, DOI 10.1021/jf051766r; Fajardo V, 2008, MEAT SCI, V79, P289, DOI 10.1016/j.meatsci.2007.09.013; Fajardo V, 2010, TRENDS FOOD SCI TECH, V21, P408, DOI 10.1016/j.tifs.2010.06.002; Faria PJ, 2011, CONSERV GENET, V12, P745, DOI 10.1007/s10592-011-0181-5; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forsyth DM, 2011, NEW ZEAL J ZOOL, V38, P237, DOI 10.1080/03014223.2011.592200; Forsyth DM, 2007, J WILDLIFE MANAGE, V71, P964, DOI 10.2193/2005-695; Forsyth DM, 2013, WILDLIFE RES, V40, P447, DOI 10.1071/WR13016; Forsyth DM, 2001, AM NAT, V157, P583, DOI 10.1086/320626; Forsyth DM, 2005, PROTOCOL ESTIMATING; Fraser KW, 2000, J ROY SOC NEW ZEAL, V30, P419, DOI 10.1080/03014223.2000.9517633; Girish PS, 2005, MEAT SCI, V70, P107, DOI 10.1016/j.meatsci.2004.12.004; Goodman SJ, 1999, GENETICS, V152, P355; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Granados-Cifuentes C, 2011, MOL ECOL RESOUR, V11, P394, DOI 10.1111/j.1755-0998.2010.02933.x; Groves C.P., 1987, P21; Harris LH., 2002, DEER MENACE HIST GOV; King CM., 2005, HDB NZ MAMMALS; Kuwayama R, 2000, MOL PHYLOGENET EVOL, V15, P115, DOI 10.1006/mpev.1999.0731; Li Bo, 2006, Journal of Forestry Research (Harbin), V17, P160, DOI 10.1007/s11676-006-0038-9; Longmire JL, 1997, OCCASIONAL PAPERS MU; Lorenzini R, 2005, FORENSIC SCI INT, V153, P218, DOI 10.1016/j.forsciint.2005.04.032; Mayle B.A, 1999, MANY DEER FIELD GUID; McDevitt AD, 2009, MAMM BIOL, V74, P263, DOI 10.1016/j.mambio.2009.03.015; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Morgan JAT, 2011, MOL ECOL RESOUR, V11, P813, DOI 10.1111/j.1755-0998.2011.03023.x; Murphy MA, 2007, CONSERV GENET, V8, P1219, DOI 10.1007/s10592-006-9264-0; Nichols RV, 2012, MOL ECOL RESOUR, V12, P983, DOI 10.1111/j.1755-0998.2012.03172.x; Nugent G, 2005, HDB NZ MAMMALS, P420; Perry GH, 2010, MOL ECOL, V19, P5332, DOI 10.1111/j.1365-294X.2010.04888.x; Ramon-Laca A, 2013, ELECTROPHORESIS, V34, P3370, DOI 10.1002/elps.201300324; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; RINEY THANE, 1957, NEW ZEALAND JOUR SCI AND TECHNOL SER B, V38, P507; Roques S, 2011, MOL ECOL RESOUR, V11, P171, DOI 10.1111/j.1755-0998.2010.02878.x; Rutledge LY, 2009, J WILDLIFE MANAGE, V73, P1430, DOI 10.2193/2008-492; Sakaridis I, 2013, MEAT SCI, V94, P84, DOI 10.1016/j.meatsci.2012.12.017; Senn HV, 2009, MOL ECOL, V18, P862, DOI 10.1111/j.1365-294X.2008.04051.x; Shackell GH, 2008, INT J FOOD SCI TECH, V43, P2134, DOI 10.1111/j.1365-2621.2008.01812.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; STEWART GH, 1989, BIOL CONSERV, V49, P275, DOI 10.1016/0006-3207(89)90048-7; Thompson W.L., 1998, MONITORING VERTEBRAT; Thompson WL, 2004, SAMPLING RARE ELUSIV; Tobe SS, 2008, ELECTROPHORESIS, V29, P340, DOI 10.1002/elps.200700706; van Vliet N, 2008, AFR J ECOL, V46, P411, DOI 10.1111/j.1365-2028.2007.00879.x; VEBLEN TT, 1982, ANN ASSOC AM GEOGR, V72, P372, DOI 10.1111/j.1467-8306.1982.tb01832.x; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wada K, 2010, ANIM SCI J, V81, P551, DOI 10.1111/j.1740-0929.2010.00799.x; Wadley JJ, 2013, WILDLIFE RES, V40, P241, DOI 10.1071/WR13005; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Yamashiro A, 2010, CONSERV GENET RESOUR, V2, P409, DOI 10.1007/s12686-010-9281-7	69	35	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92043	10.1371/journal.pone.0092043	http://dx.doi.org/10.1371/journal.pone.0092043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637802	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100107
J	Zhai, R; Liu, XT; Feng, WT; Chen, SS; Xu, LF; Wang, ZG; Zhang, JL; Li, PM; Ma, FW				Zhai, Rui; Liu, Xiao-Ting; Feng, Wen-Ting; Chen, Sha-Sha; Xu, Ling-Fei; Wang, Zhi-Gang; Zhang, Jiang-Li; Li, Peng-Min; Ma, Feng-Wang			Different Biosynthesis Patterns among Flavonoid 3-glycosides with Distinct Effects on Accumulation of Other Flavonoid Metabolites in Pears (Pyrus bretschneideri Rehd.)	PLOS ONE			English	Article							PYRIFOLIA NAKAI; ANTHOCYANIN ACCUMULATION; PHENOLIC-COMPOUNDS; GENE-EXPRESSION; RED; LIGHT; SKIN	Flavonoid biosynthesis profile was clarified by fruit bagging and re-exposure treatments in the green Chinese pear 'Zaosu' (Pyrus bretschneideri Rehd.) and its red mutant 'Red Zaosu'. Two distinct biosynthesis patterns of flavonoid 3-glycosides were found in 'Zaosu' pear. By comparison with 'Red Zaosu', the biosynthesis of flavonoid 3-galactosides and flavonoid 3-arabinosides were inhibited by bagging and these compounds only re-accumulated to a small degree in the fruit peel of 'Zaosu' after the bags were removed. In contrast, the biosynthesis of flavonoid 3-gluctosides and flavonoid 3-rutinosides was reduced by bagging and then increased when the fruits were re-exposed to sunlight. A combination of correlation, multicollinearity test and partial-correlation analyses among major flavonoid metabolites indicated that biosynthesis of each phenolic compound was independent in 'Zaosu' pear, except for the positive correlation between flavonoid 3-rutincosides and flavanols. In contrast with the green pear cultivar, almost all phenolic compounds in the red mutant had similar biosynthesis patterns except for arbutin. However, only the biosynthesis of flavonoid 3-galactosides was relatively independent and strongly affected the synthesis of the other phenolic compounds. Therefore, we propose a hypothesis that the strong accumulation of flavonoid 3-galactosides stimulated the biosynthesis of other flavonoid compounds in the red mutant and, therefore, caused systemic variation of flavonoid biosynthesis profiles between 'Zaosu' and its red mutant. This hypothesis had been further demonstrated by the enzyme activity of UFGT, and transcript levels of flavonoid biosynthetic genes and been well tested by a stepwise linear regression forecasting model. The gene that encodes flavonoid 3-galacosyltransferase was also identified and isolated from the pear genome.	[Zhai, Rui; Liu, Xiao-Ting; Feng, Wen-Ting; Chen, Sha-Sha; Xu, Ling-Fei; Wang, Zhi-Gang; Zhang, Jiang-Li; Li, Peng-Min; Ma, Feng-Wang] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Xu, LF (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	lingfxu2013@sina.com		Li, Pengmin/0000-0003-3514-0153	National Natural Science Foundation of China [31171925]; Fundamental Research Funds for the Central Universities [ZD201300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 31171925)326 and the Fundamental Research Funds for the Central Universities (No. ZD201300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad MA, 2001, SCI HORTIC-AMSTERDAM, V90, P69, DOI 10.1016/S0304-4238(00)00255-7; Chen CS, 2012, SCI HORTIC-AMSTERDAM, V142, P68, DOI 10.1016/j.scienta.2012.05.001; Feng ShouQian, 2008, Agricultural Sciences in China, V7, P1318, DOI 10.1016/S1671-2927(08)60180-7; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Fonseca S, 2004, PLANT SCI, V167, P457, DOI 10.1016/j.plantsci.2004.03.033; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Huang CH, 2009, SCI HORTIC-AMSTERDAM, V121, P149, DOI 10.1016/j.scienta.2009.01.031; Jakopic J, 2009, SCI HORTIC-AMSTERDAM, V123, P234, DOI 10.1016/j.scienta.2009.09.004; JU ZG, 1995, SCI HORTIC-AMSTERDAM, V61, P215, DOI 10.1016/0304-4238(94)00739-3; Ju ZG, 1998, SCI HORTIC-AMSTERDAM, V77, P155, DOI 10.1016/S0304-4238(98)00161-7; Kim SH, 2003, PLANT SCI, V165, P403, DOI 10.1016/S0168-9452(03)00201-2; Li MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033055; Li PM, 2008, PHYSIOL PLANTARUM, V134, P486, DOI 10.1111/j.1399-3054.2008.01155.x; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Liu YJ, 2012, NEW ZEAL J CROP HORT, V40, P87, DOI 10.1080/01140671.2011.610325; MCGUIRE RG, 1992, HORTSCIENCE, V27, P1254, DOI 10.21273/HORTSCI.27.12.1254; Neill SO, 2003, FUNCT PLANT BIOL, V30, P865, DOI 10.1071/FP03118; Qian MJ, 2013, SCI HORTIC-AMSTERDAM, V151, P75, DOI 10.1016/j.scienta.2012.12.020; RITENOUR M, 1997, HORTSCIENCE, V32, P272; Ryan KG, 2001, Z NATURFORSCH C, V56, P745; Szankowski I, 2009, PLANTA, V229, P681, DOI 10.1007/s00425-008-0864-4; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Wang ZG, 2013, PLANT PHYSIOL, V162, P885, DOI 10.1104/pp.113.214700; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yang YN, 2013, TREE GENET GENOMES, V9, P75; Yu B, 2012, SCI HORTIC-AMSTERDAM, V136, P29, DOI 10.1016/j.scienta.2011.12.026; Zhang D, 2012, SCI HORTIC-AMSTERDAM, V134, P53, DOI 10.1016/j.scienta.2011.10.025; Zhang YZ, 2010, FOOD CHEM, V123, P1013, DOI 10.1016/j.foodchem.2010.05.053	30	16	16	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91945	10.1371/journal.pone.0091945	http://dx.doi.org/10.1371/journal.pone.0091945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637788	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100087
J	Zhu, HD; Zhou, JM; Ni, YX; Yu, ZY; Mao, AH; Hu, YY; Wang, W; Zhang, XH; Wen, LB; Li, B; Wang, XM; Yu, Y; Lv, LX; Guo, RL; Lu, CP; He, KW				Zhu, Haodan; Zhou, Junming; Ni, Yanxiu; Yu, Zhengyu; Mao, Aihua; Hu, Yiyi; Wang, Wei; Zhang, Xuehan; Wen, Libin; Li, Bin; Wang, Xiaomin; Yu, Yang; Lv, Lixin; Guo, Rongli; Lu, Chengping; He, Kongwang			Contribution of Eukaryotic-Type Serine/Threonine Kinase to Stress Response and Virulence of Streptococcus suis	PLOS ONE			English	Article							PROTEIN-KINASE; MYCOBACTERIUM-TUBERCULOSIS; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; FULL VIRULENCE; SER/THR KINASE; IDENTIFICATION; SEROTYPE-2; PATHOGENESIS; PHOSPHATASE	Streptococcus suis serotype 2 (SS2) is an important swine and human pathogen responsible for septicemia and meningitis. The bacterial homologues of eukaryotic-type serine/threonine kinases (ESTKs) have been reported to play critical roles in various cellular processes. To investigate the role of STK in SS2, an isogenic stk mutant strain (Dstk) and a complemented strain (CDstk) were constructed. The Dstk showed a significant decrease in adherence to HEp-2 cells, compared with the wild-type strain, and a reduced survival ratio in whole blood. In addition, the Dstk exhibited a notable reduced tolerance of environmental stresses including high temperature, acidic pH, oxidative stress, and high osmolarity. More importantly, the Dstk was attenuated in both the CD1 mouse and piglet models of infection. The results of quantitative reverse transcription-PCR (qRT-PCR) analysis indicated that the expressions of a few genes involving in adherence, stress response and virulence were clearly decreased in the Dstk mutant strain. Our data suggest that SsSTK is required for virulence and stress response in SS2.	[Zhu, Haodan; Zhou, Junming; Ni, Yanxiu; Yu, Zhengyu; Mao, Aihua; Hu, Yiyi; Wang, Wei; Zhang, Xuehan; Wen, Libin; Li, Bin; Wang, Xiaomin; Yu, Yang; Lv, Lixin; Guo, Rongli; He, Kongwang] Natl Ctr Engn Res Vet Bioprod, Jiangsu Acad Agr Sci, Inst Vet Med, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing, Jiangsu, Peoples R China; [Zhu, Haodan; Zhou, Junming; Ni, Yanxiu; Yu, Zhengyu; Mao, Aihua; Hu, Yiyi; Wang, Wei; Zhang, Xuehan; Wen, Libin; Li, Bin; Wang, Xiaomin; Yu, Yang; Lv, Lixin; Guo, Rongli; He, Kongwang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China; [Lu, Chengping] Nanjing Agr Univ, Key Lab Anim Bacteriol, Minist Agr, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	He, KW (corresponding author), Natl Ctr Engn Res Vet Bioprod, Jiangsu Acad Agr Sci, Inst Vet Med, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing, Jiangsu, Peoples R China.	kwh2003@263.net			National Natural Science Foundation of China [31302114, 31072155]; China Postdoctoral Science Foundation [2012M521026]; Innovation of Agricultural Sciences in Jiangsu province [CX(11)2060]; Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture [201303041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovation of Agricultural Sciences in Jiangsu province; Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture	This work was supported by National Natural Science Foundation of China (31302114 and 31072155), China Postdoctoral Science Foundation Grant (2012M521026), Innovation of Agricultural Sciences in Jiangsu province (CX(11)2060), and Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture (201303041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Banu LD, 2010, INFECT IMMUN, V78, P2209, DOI 10.1128/IAI.01167-09; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Bonifait L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-42; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Bugrysheva J, 2011, INFECT IMMUN, V79, P4201, DOI 10.1128/IAI.05360-11; Burnside K, 2011, FUTURE MICROBIOL, V6, P747, DOI [10.2217/FMB.11.62, 10.2217/fmb.11.62]; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Espinoza JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051306; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Garibaldi M, 2010, VACCINE, V28, P3609, DOI 10.1016/j.vaccine.2010.01.009; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hill JE, 2005, VET MICROBIOL, V107, P63, DOI 10.1016/j.vetmic.2005.01.003; Hussain H, 2006, J BACTERIOL, V188, P1628, DOI 10.1128/JB.188.4.1628-1632.2006; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Jang J, 2010, MICROBIOL-SGM, V156, P1619, DOI 10.1099/mic.0.038133-0; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Ju CX, 2012, J BACTERIOL, V194, P1464, DOI 10.1128/JB.06231-11; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Lalonde M, 2000, MICROBIOL-SGM, V146, P1913, DOI 10.1099/00221287-146-8-1913; Lapointe L, 2002, CAN J VET RES, V66, P8; Li J, VET MICROBIOL, V148, P99; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Misra SK, 2011, PROTEOMICS, V11, P4155, DOI 10.1002/pmic.201100259; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Osaki M, 2009, J BACTERIOL, V191, P4943, DOI 10.1128/JB.00196-09; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Tang YL, 2012, VET MICROBIOL, V158, P360, DOI 10.1016/j.vetmic.2012.02.028; Tran LSP, 1999, APPL MICROBIOL BIOT, V52, P845, DOI 10.1007/s002530051602; Vanier G, 2004, INFECT IMMUN, V72, P1441, DOI 10.1128/IAI.72.3.1441-1449.2004; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Wu T, 2011, MICROB PATHOGENESIS, V51, P69, DOI 10.1016/j.micpath.2010.10.001; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zhang XH, 2009, MICROB PATHOGENESIS, V47, P267, DOI 10.1016/j.micpath.2009.09.001; Zhu HD, 2011, MICROB PATHOGENESIS, V51, P442, DOI 10.1016/j.micpath.2011.08.002	59	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91971	10.1371/journal.pone.0091971	http://dx.doi.org/10.1371/journal.pone.0091971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637959	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100092
J	Feng, QQ; Ma, YX; Mu, SH; Wu, JJ; Chen, S; OuYang, LS; Lei, WL				Feng, Qiqi; Ma, Yuxin; Mu, Shuhua; Wu, Jiajia; Chen, Si; OuYang, Lisi; Lei, Wanlong			Specific Reactions of Different Striatal Neuron Types in Morphology Induced by Quinolinic Acid in Rats	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; CELL-DEATH; INTRASTRIATAL INJECTIONS; 3-NITROPROPIONIC ACID; NADPH-DIAPHORASE; INTERNEURONS; SURVIVAL; MODELS; EXCITOTOXICITY; VULNERABILITY	Huntington's disease (HD) is a neurological degenerative disease and quinolinic acid (QA) has been used to establish HD model in animals through the mechanism of excitotoxicity. Yet the specific pathological changes and the underlying mechanisms are not fully elucidated. We aimed to reveal the specific morphological changes of different striatal neurons in the HD model. Sprague-Dawley (SD) rats were subjected to unilaterally intrastriatal injections of QA to mimic the HD model. Behavioral tests, histochemical and immunhistochemical stainings as well as Western blots were applied in the present study. The results showed that QA-treated rats had obvious motor and cognitive impairments when compared with the control group. Immunohistochemical detection showed a great loss of NeuN+ neurons and Darpp32+ projection neurons in the transition zone in the QA group when compared with the control group. The numbers of parvalbumin (Parv)+ and neuropeptide Y (NPY)+ interneurons were both significantly reduced while those of calretinin (Cr)+ and choline acetyltransferase (ChAT)+ were not changed notably in the transition zone in the QA group when compared to the controls. Parv+, NPY+ and ChAT+ interneurons were not significantly increased in fiber density while Cr+ neurons displayed an obvious increase in fiber density in the transition zone in QA-treated rats. The varicosity densities of Parv+, Cr+ and NPY+ interneurons were all raised in the transition zone after QA treatment. In conclusion, the present study revealed that QA induced obvious behavioral changes as well as a general loss of striatal projection neurons and specific morphological changes in different striatal interneurons, which may help further explain the underlying mechanisms and the specific functions of various striatal neurons in the pathological process of HD.	[Feng, Qiqi; Ma, Yuxin; Mu, Shuhua; Wu, Jiajia; Chen, Si; OuYang, Lisi; Lei, Wanlong] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China; [Feng, Qiqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Yuxin] Guangdong Pharmaceut Univ, Sch Basic Med, Dept Anat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Pharmaceutical University	Lei, WL (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China.	leiwl@mail.sysu.edu.cn	MU, shuhua/CAG-2304-2022	mu, shuhua/0000-0002-4457-6795; Chen, Si/0000-0002-4196-0740	National Science Foundations of China [31070941, 30770679]; Major State Basic Research Development Program of China (973 Program) [2010CB530004]	National Science Foundations of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Science Foundations of China (No. 31070941, No. 30770679) and the Major State Basic Research Development Program of China (973 Program, No. 2010CB530004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; Bates GP, 1997, HUM MOL GENET, V6, P1633, DOI 10.1093/hmg/6.10.1633; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bithell A, 2009, BIOCHEM SOC T, V37, P1270, DOI 10.1042/BST0371270; BOEGMAN RJ, 1988, BRAIN RES, V445, P358, DOI 10.1016/0006-8993(88)91199-7; Braidy N, 2009, INT J TRYPTOPHAN RES, V2, P61; Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; BRUYN RPM, 1990, J NEUROL SCI, V95, P29, DOI 10.1016/0022-510X(90)90114-3; Cicchetti F, 1996, BRAIN RES, V730, P232; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; CLAES S, 1995, ARCH NEUROL-CHICAGO, V52, P749, DOI 10.1001/archneur.1995.00540320021009; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; DAVIES SW, 1988, NEUROSCIENCE, V26, P387, DOI 10.1016/0306-4522(88)90156-X; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; Durieux PF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00040; FERRANTE RJ, 1987, J NEUROPATH EXP NEUR, V46, P12, DOI 10.1097/00005072-198701000-00002; Figueredo-Cardenas G, 1998, EXP NEUROL, V149, P356, DOI 10.1006/exnr.1997.6724; FigueredoCardenas G, 1997, EXP NEUROL, V146, P444, DOI 10.1006/exnr.1997.6549; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2003, ADV EXP MED BIOL, V527, P137; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guyot MC, 1997, NEUROSCIENCE, V79, P45, DOI 10.1016/S0306-4522(96)00602-1; Haik KL, 2000, EXP NEUROL, V163, P430, DOI 10.1006/exnr.2000.7384; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; HUANG Q, 1995, NEUROSCIENCE, V65, P397, DOI 10.1016/0306-4522(94)00494-P; Kalonia H, 2011, BEHAV BRAIN RES, V216, P220, DOI 10.1016/j.bbr.2010.07.040; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kim SH, 2011, ASN NEURO, V3, DOI 10.1042/AN20110009; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACKENZIE GM, 1995, NEUROSCIENCE, V67, P357, DOI 10.1016/0306-4522(94)00621-B; Massouh M, 2008, NEUROSCI RES, V62, P216, DOI 10.1016/j.neures.2008.08.007; Meade CA, 2000, EXP NEUROL, V166, P307, DOI 10.1006/exnr.2000.7530; Mejia ROS, 2001, NEUROSCIENTIST, V7, P480, DOI 10.1177/107385840100700604; Mu SH, 2011, J NEUROSCI RES, V89, P744, DOI 10.1002/jnr.22591; Ngai LY, 2005, J NEUROENDOCRINOL, V17, P424, DOI 10.1111/j.1365-2826.2005.01321.x; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Perez-De La Cruz V, 2012, INT J TRYPTOPHAN RES, V5, P1, DOI 10.4137/IJTR.S8158; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; ROBERTS RC, 1993, EXP NEUROL, V124, P274, DOI 10.1006/exnr.1993.1197; Sawa A, 2003, CYTOGENET GENOME RES, V100, P287, DOI 10.1159/000072864; Schwarcz R, 2010, PROG NEUROBIOL, V90, P230, DOI 10.1016/j.pneurobio.2009.04.005; Shear DA, 1998, PROG NEURO-PSYCHOPH, V22, P1217, DOI 10.1016/S0278-5846(98)00070-0; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tarawneh R, 2010, CLIN GERIATR MED, V26, P125, DOI 10.1016/j.cger.2009.12.003; Tasset I, 2010, NEUROSIGNALS, V18, P24, DOI 10.1159/000243650; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; Voogd J, 1981, METHODS NEUROBIOLOGY, V2, P301; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Watson C, 2006, RAT BRAIN STEREOTAXI; WOLFENSBERGER M, 1983, NEUROSCI LETT, V41, P247, DOI 10.1016/0304-3940(83)90458-5	58	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91512	10.1371/journal.pone.0091512	http://dx.doi.org/10.1371/journal.pone.0091512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632560	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400066
J	Gao, XX; Liu, ZM; Cui, WJ; Zhou, L; Tian, YP; Zhou, ZM				Gao, Xinxing; Liu, Zhongmei; Cui, Wenjing; Zhou, Li; Tian, Yaping; Zhou, Zhemin			Enhanced Thermal Stability and Hydrolytic Ability of Bacillus subtilis Aminopeptidase by Removing the Thermal Sensitive Domain in the Non-Catalytic Region	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; DOUBLE-ZINC AMINOPEPTIDASE; PROTEASE-ASSOCIATED DOMAIN; STREPTOMYCES-GRISEUS; AEROMONAS-PROTEOLYTICA; PEPTIDE HYDROLYSIS; LEUCINE AMINOPEPTIDASE; MECHANISM; ENZYME; THERMOSTABILITY	Besides the catalytic ability, many enzymes contain conserved domains to perform some other physiological functions. However, sometimes these conserved domains were unnecessary or even detrimental to the catalytic process for industrial application of the enzymes. In this study, based on homology modeling and molecular dynamics simulations, we found that Bacillus subtilis aminopeptidase contained a thermal sensitive domain (protease-associated domain) in the non-catalytic region, and predicted that deletion of this flexible domain can enhance the structure stability. This prediction was then verified by the deletion of protease-associated domain from the wild-type enzyme. The thermal stability analysis showed that deletion of this domain improved the T-50 (the temperature required to reduce initial activity by 50% in 30 min) of the enzyme from 71 degrees C to 77 degrees C. The melting temperature (T-m) of the enzyme also increased, which was measured by thermal denaturation experiments using circular dichroism spectroscopy. Further studies indicated that this deletion did not affect the activity and specificity of the enzyme toward aminoacyl-p-nitroanilines, but improved its hydrolytic ability toward a 12aa-long peptide (LKRLKRFLKRLK) and soybean protein. These findings suggested the possibility of a simple technique for enzyme modification and the artificial enzyme obtained here was more suitable for the protein hydrolysis in food industry than the wild-type enzyme.	[Gao, Xinxing; Liu, Zhongmei; Cui, Wenjing; Zhou, Li; Tian, Yaping; Zhou, Zhemin] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Zhou, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	zhmzhou@jiangnan.edu.cn	Cui, Wenjing/HIR-1471-2022	Zhou, Li/0000-0001-8448-2040	National High Technology Research and Development Program of China (863 Program) [2011AA100905]; Program for New Century Excellent Talents in University [NCET-10-0461]; Key project of Chinese Ministry of Education [NCET-10-0461]; Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education [KLIB-KF201107, KLIB-KF201203]; Fundamental Research Funds for the Central Universities [JUSRP1001]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key project of Chinese Ministry of Education(Ministry of Education, China); Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National High Technology Research and Development Program of China (863 Program, 2011AA100905), the Program for New Century Excellent Talents in University (NCET-10-0461), the Key project of Chinese Ministry of Education (311023), the Public Project for Key Laboratory of Industrial Biotechnology, Ministry of Education (KLIB-KF201107 and KLIB-KF201203) and the Fundamental Research Funds for the Central Universities JUSRP1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SU, 2000, J CELL BIOL, V149, P1335, DOI 10.1083/jcb.149.7.1335; Arima J, 2006, APPL MICROBIOL BIOT, V70, P541, DOI 10.1007/s00253-005-0105-8; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Chebaro Y, 2009, J PHYS CHEM B, V113, P7668, DOI 10.1021/jp900425e; Chen GJ, 1997, BIOCHEMISTRY-US, V36, P4278, DOI 10.1021/bi9618676; Chen SL, 2008, J PHYS CHEM B, V112, P2494, DOI 10.1021/jp710035j; Du LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062306; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Fundoiano-Hershcovitz Y, 2004, FEBS LETT, V571, P192, DOI 10.1016/j.febslet.2004.07.001; Gao XX, 2013, PRION, V7, P328, DOI 10.4161/pri.25147; Gao XX, 2013, J SCI FOOD AGR, V93, P2810, DOI 10.1002/jsfa.6105; Gilboa R, 2001, PROTEINS, V44, P490, DOI 10.1002/prot.1115; Guo YX, 2009, FOOD CHEM, V114, P328, DOI 10.1016/j.foodchem.2008.09.041; Hershcovitz YF, 2007, FEBS J, V274, P3864, DOI 10.1111/j.1742-4658.2007.05912.x; Holz RC, 2003, CURR OPIN CHEM BIOL, V7, P197, DOI 10.1016/S1367-5931(03)00033-4; Jiang LW, 2000, J CELL BIOL, V150, P755, DOI 10.1083/jcb.150.4.755; Kato GJ, 1999, HUM MUTAT, V13, P87, DOI 10.1002/(SICI)1098-1004(1999)13:2<87::AID-HUMU1>3.0.CO;2-K; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; Liu J, 2008, J MOL GRAPH MODEL, V27, P529, DOI 10.1016/j.jmgm.2008.09.004; Liu XT, 2013, J MOL CATAL B-ENZYM, V93, P44, DOI 10.1016/j.molcatb.2013.04.002; Lu X, 2013, APPL MICROBIOL BIOT, P1; Luo XM, 2001, TRENDS BIOCHEM SCI, V26, P147, DOI 10.1016/S0968-0004(00)01768-0; Mahadevan D, 1999, PROTEIN SCI, V8, P2546; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; MILLER J, 1977, J AGR FOOD CHEM, V25, P653, DOI 10.1021/jf60211a051; Munih P, 2007, J INORG BIOCHEM, V101, P1099, DOI 10.1016/j.jinorgbio.2007.03.010; Nilsang S, 2005, J FOOD ENG, V70, P571, DOI 10.1016/j.jfoodeng.2004.10.011; Pulido-Cejudo G, 1997, ANTIVIR RES, V36, P167, DOI 10.1016/S0166-3542(97)00052-1; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Su GW, 2011, FOOD CHEM, V126, P1306, DOI 10.1016/j.foodchem.2010.11.083; TAYLOR A, 1993, TRENDS BIOCHEM SCI, V18, P167; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; Wang FH, 2012, J AGR FOOD CHEM, V60, P165, DOI 10.1021/jf204002e; Wang YJ, 2009, BIORESOURCE TECHNOL, V100, P345, DOI 10.1016/j.biortech.2008.06.001; WU XC, 1991, J BACTERIOL, V173, P4952, DOI 10.1128/jb.173.16.4952-4958.1991; Yan MC, 2008, PROTEINS, V70, P731, DOI 10.1002/prot.21539; Zhou C, 2010, J BIOSCI BIOENG, V110, P12, DOI 10.1016/j.jbiosc.2009.12.002	38	20	24	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92357	10.1371/journal.pone.0092357	http://dx.doi.org/10.1371/journal.pone.0092357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633010	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400158
J	Huang, XY; Du, YH; Hu, XN; Ma, HX; Wang, HF; You, AG; Kang, K; Chen, HM; Zhang, L; Liu, GH; Xu, BL				Huang, Xueyong; Du, Yanhua; Hu, Xiaoning; Ma, Hongxia; Wang, Haifeng; You, Aiguo; Kang, Kai; Chen, Haomin; Zhang, Li; Liu, Guohua; Xu, Bianli			Epidemiological and Etiological Characteristics of Fever, Thrombocytopenia and Leukopenia Syndrome in Henan Province, China, 2011-2012	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; BUNYAVIRUS; INFECTION; VIRUS; DIAGNOSIS	The Fever, Thrombocytopenia and Leukopenia Syndrome (FTLS) is caused by a bunyavirus known as the FTLS virus (FTLSV), which was recently discovered in China. We examined the epidemiological and etiological features of 637 laboratory-confirmed cases of FTLS with onset from January 2011 to December 2012 in Henan Province, China. The highest incidence of FTLS occurred between May and August: 76.5% of all laboratory-confirmed cases occurred during those four months. Of the laboratory-confirmed cases, 60.9% were in the 46-69 years old age groups; 96.1% (612/637) occurred in farmers; 98.1% (625/637) were reported from Xinyang Prefecture. During the same time period, 2047 cases were reported in China. The nucleotide and amino acid sequences of FTLSV strains identified during 2011-2012 in Henan Province were >= 96% identical. This findings provides insight for developing public-health interventions for the control and prevention of FTLS in epidemic area.	[Huang, Xueyong; Du, Yanhua; Hu, Xiaoning; Ma, Hongxia; Wang, Haifeng; You, Aiguo; Kang, Kai; Chen, Haomin; Liu, Guohua; Xu, Bianli] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Hu, Xiaoning] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou 450052, Peoples R China; [Zhang, Li] Xinyang Ctr Dis Control & Prevent, Xinyang, Peoples R China	Zhengzhou University	Xu, BL (corresponding author), Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China.	bianlixu@163.com			Henan Medical Science Project [200702016]; Henan Province Health Department [201101017]; National Health and Fimaly Planning Commission of the People's Republic of China [201101017]; China-Australia Health and HIV/AIDS Facility [EID35]	Henan Medical Science Project; Henan Province Health Department; National Health and Fimaly Planning Commission of the People's Republic of China; China-Australia Health and HIV/AIDS Facility	This research was supported by Henan Medical Science Project (200702016), Henan Province Health Department and National Health and Fimaly Planning Commission of the People's Republic of China Co-build Project (201101017), and China-Australia Health and HIV/AIDS Facility (EID35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman BR, 2013, J WILDLIFE DIS, V49, P132, DOI 10.7589/2012-02-041; [Anonymous], 2010, NAT GUID PREV CONTR; Chang MS, 2013, J KOREAN MED SCI, V28, P795, DOI 10.3346/jkms.2013.28.6.795; Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100; DU Yan-Hua, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P169; Huang Xue-Yong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P165; Huang XY, 2013, J MED MICROBIOL, V62, P1060, DOI 10.1099/jmm.0.049577-0; Jiang Xiao-lin, 2012, Chinese Journal of Virology, V28, P252; Lam TTY, 2013, EPIDEMICS-NETH, V5, P1, DOI 10.1016/j.epidem.2012.09.002; Lam WY, 2010, J MED VIROL, V82, P675, DOI 10.1002/jmv.21725; Lihoradova OA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002181; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Liu Yang, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P500; Martin RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046752; Neeraja M, 2013, J CLIN DIAGN RES, V7, P457, DOI 10.7860/JCDR/2013/4786.2798; Ojogun N, 2012, INFECT IMMUN, V80, P3748, DOI 10.1128/IAI.00654-12; Pan H, 2013, VIROL J, V10, P1; Reddy V, 2012, J MED VIROL, V84, P1771, DOI 10.1002/jmv.23406; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Xiao H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002260; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu L, 2011, PLOS ONE, V7; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, J VIROL, V86, P2864, DOI 10.1128/JVI.06192-11; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	26	13	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91166	10.1371/journal.pone.0091166	http://dx.doi.org/10.1371/journal.pone.0091166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633131	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400044
J	Kaufman, J; Johnston, PJ				Kaufman, Jordy; Johnston, Patrick J.			Facial Motion Engages Predictive Visual Mechanisms	PLOS ONE			English	Article							EXPRESSIONS; EMOTION; RECOGNITION; PERCEPTION; RESPONSES; SYSTEM	We employed a novel cuing paradigm to assess whether dynamically versus statically presented facial expressions differentially engaged predictive visual mechanisms. Participants were presented with a cueing stimulus that was either the static depiction of a low intensity expressed emotion; or a dynamic sequence evolving from a neutral expression to the low intensity expressed emotion. Following this cue and a backwards mask, participants were presented with a probe face that displayed either the same emotion (congruent) or a different emotion (incongruent) with respect to that displayed by the cue although expressed at a high intensity. The probe face had either the same or different identity from the cued face. The participants' task was to indicate whether or not the probe face showed the same emotion as the cue. Dynamic cues and same identity cues both led to a greater tendency towards congruent responding, although these factors did not interact. Facial motion also led to faster responding when the probe face was emotionally congruent to the cue. We interpret these results as indicating that dynamic facial displays preferentially invoke predictive visual mechanisms, and suggest that motoric simulation may provide an important basis for the generation of predictions in the visual system.	[Kaufman, Jordy] Swinburne Univ Technol, Hawthorn, Vic 3122, Australia; [Johnston, Patrick J.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	Swinburne University of Technology; University of York - UK	Johnston, PJ (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	jkaufman@swin.edu.au	Johnston, Patrick/P-3158-2014; Kaufman, Jordy/A-5742-2008	Johnston, Patrick/0000-0001-7703-1073; Kaufman, Jordy/0000-0001-9881-371X	Australian Research Council [DP110101598]	Australian Research Council(Australian Research Council)	We would like to thank Dr. Angela Mayes for her contribution to the generation of stimuli that were used in this experiment. We also extend our thanks to Mr. Gage Milecki and Mr. Peter Goodin for conducting valuable pilot work with an early version of the experimental paradigm, to Mr. Tian Wu for his aid in data collection for the current study, and to Ms. Meredith Allen and Prof. Denny Meyer for their helpful comments and editing. Dr. Kaufman's contribution to the project was supported under Australian Research Council's Discovery Projects funding scheme (project number DP110101598).	BERRY DS, 1990, J PERS SOC PSYCHOL, V58, P1004, DOI 10.1037/0022-3514.58.6.1004; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; De Houwer J, 2002, COGNITION EMOTION, V16, P643, DOI 10.1080/02699930143000419; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; Ekman P., 2002, FACIAL ACTION CODING; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Fiorentini C, 2012, PERCEPTION, V41, P532, DOI 10.1068/p7052; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jellema T, 2011, VIS COGN, V19, P616, DOI 10.1080/13506285.2011.569775; Johnston P, 2013, CORTEX, V30, P1; Johnston PJ, 2010, SCHIZOPHRENIA BULL, V36, P680, DOI 10.1093/schbul/sbn136; Johnston PJ, 2005, EUR J NEUROSCI, V22, P1221, DOI 10.1111/j.1460-9568.2005.04294.x; Katsyri J, 2008, INT J HUM-COMPUT ST, V66, P233, DOI 10.1016/j.ijhcs.2007.10.001; Kessler HL, 2011, SPECULUM, V86, P1, DOI 10.1017/S0038713410003477; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Klauer K.C., 1998, EUR REV SOC PSYCHOL, V8, P67, DOI [10.1080/14792779643000083, DOI 10.1080/14792779643000083]; Lander K, 1999, MEM COGNITION, V27, P974, DOI 10.3758/BF03201228; Macmillan N. A., 1993, HDB DATA ANAL BEHAV, P21; Mayes AK, 2009, BRAIN TOPOGR, V22, P145, DOI 10.1007/s10548-009-0106-5; Nomura M, 2003, NEUROSCI LETT, V348, P113, DOI 10.1016/S0304-3940(03)00768-7; Rahko J, 2010, BRAIN IMAGING BEHAV, V4, P164, DOI 10.1007/s11682-010-9096-x; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Yoshikawa S, 2008, COGN AFFECT BEHAV NE, V8, P25, DOI 10.3758/CABN.8.1.25; Yu H, 2012, COMPUT GRAPH-UK, V36, P152, DOI 10.1016/j.cag.2011.12.002	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91038	10.1371/journal.pone.0091038	http://dx.doi.org/10.1371/journal.pone.0091038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632821	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400036
J	Kotani, Y; Kunisawa, J; Suzuki, Y; Sato, I; Saito, T; Toba, M; Kohda, N; Kiyono, H				Kotani, Yoshifumi; Kunisawa, Jun; Suzuki, Yuji; Sato, Ikutaro; Saito, Takao; Toba, Masamichi; Kohda, Noriyuki; Kiyono, Hiroshi			Role of Lactobacillus pentosus Strain b240 and the Toll-Like Receptor 2 Axis in Peyer's Patch Dendritic Cell-Mediated Immunoglobulin A Enhancement	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; B-CELLS; IGA PRODUCTION; IMMUNE-SYSTEM; IN-VIVO; GUT; PROBIOTICS; MECHANISMS; RESPONSES; IMMUNOSTIMULATION	Lactic acid bacteria are well known to possess immune-modulating effects, but the mechanisms underlying their modulation of the gut immune system are not fully understood. Here, we examined the localization of heat-killed Lactobacillus pentosus strain b240 (b240) in intestinal tissues and the effect of b240 on adaptive immune cascades in the gut. Histological analysis showed that b240 co-localized with dendritic cells (DCs) in the subepithelial dome region of Peyer's patches (PPs). In a PP cell culture system, b240 promoted the production of immunoglobulin A (IgA), interleukin (IL)6, IL-10, interferon (IFN)-gamma, and tumor necrosis factor, but not IL-4, IL-5, B-cell activating factors, IFN-alpha, IFN-beta, and transforming growth factor-beta 1. The enhanced IgA production by b240 was attenuated by neutralizing IL-6, a potent IgA-enhancing cytokine. b240 stimulated DCs to produce an elevated amount of IL-6 in a Toll-like receptor (TLR) 2-, but not TLR4- or TLR9-dependent manner. Finally, we demonstrated that TLR2-mediated IL-6 production from PP DCs in response to b240 activated B cells to produce a large amount of IgA in a DC-B cell co-culture system. Our findings open up the possibility that the heat-killed form of Lactobacillus pentosus strain b240 can be used as a TLR2-mediated DC-activating biologic for enhancing IgA production in the intestine.	[Kotani, Yoshifumi; Sato, Ikutaro; Saito, Takao; Toba, Masamichi; Kohda, Noriyuki] Otsuka Pharmaceut Co Ltd, Otsu Nutraceut Res Inst, Shiga, Japan; [Kotani, Yoshifumi; Kunisawa, Jun; Suzuki, Yuji; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kotani, Yoshifumi; Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Osaka, Japan	Otsuka Pharmaceutical; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); National Institute of Health Sciences - Japan	Kunisawa, J (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan.	kunisawa@nibio.go.jp; Kohda.Noriyuki@otsuka.jp; kiyono@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health and Welfare of Japan; Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Yakult Bio-Science Foundation; Kowa Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; CREST	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Yakult Bio-Science Foundation; Kowa Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Young Scientists A [to J.K.], for Scientific Research on Innovative Areas [to J.K.], for Scientific Research S [to H.K.], for Scientific Research on Priority Area [to H.K.], Leading-edge Research Infrastructure Program [J.K. and H.K.]); the Ministry of Health and Welfare of Japan (to J.K. and H.K.); the Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine (to H.K.); the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN; to J.K.); the Yakult Bio-Science Foundation (to J.K.); Kowa Life Science Foundation (to J.K.); Mochida Memorial Foundation for Medical and Pharmaceutical Research (to J.K.); and CREST (to H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Clancy R, 2003, FEMS IMMUNOL MED MIC, V38, P9, DOI 10.1016/S0928-8244(03)00147-0; Forsythe P, 2010, IMMUNOL INVEST, V39, P429, DOI 10.3109/08820131003667978; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Harata G, 2009, MICROBIOL IMMUNOL, V53, P475, DOI 10.1111/j.1348-0421.2009.00146.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Jin HK, 2010, BIOL PHARM BULL, V33, P289, DOI 10.1248/bpb.33.289; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kishi K, 2006, JPN J LACTIC ACID BA, V17, P132; Kotani Yoshifumi, 2010, Immun Ageing, V7, P11, DOI 10.1186/1742-4933-7-11; Kotzamanidis C, 2010, INT J FOOD MICROBIOL, V140, P154, DOI 10.1016/j.ijfoodmicro.2010.04.004; Kunisawa J, 2005, CELL MOL LIFE SCI, V62, P1308, DOI 10.1007/s00018-005-5035-1; Kunisawa J, 2007, BLOOD, V109, P3749, DOI 10.1182/blood-2006-08-041582; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Galdeano CM, 2009, J DAIRY RES, V76, P446, DOI 10.1017/S0022029909990021; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P300, DOI 10.1002/ibd.20602; OKADA S, 1986, J GEN APPL MICROBIOL, V32, P57, DOI 10.2323/jgam.32.57; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Perdigon G, 2000, INT J IMMUNOPATH PH, V13, P141; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Salminen S, 1999, TRENDS FOOD SCI TECH, V10, P107, DOI 10.1016/S0924-2244(99)00027-8; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Shida K, 2006, J DAIRY SCI, V89, P3306, DOI 10.3168/jds.S0022-0302(06)72367-0; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Tsai YT, 2010, INT IMMUNOPHARMACOL, V10, P791, DOI 10.1016/j.intimp.2010.04.012; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Yamahira S, 2006, JPN J LACTIC ACID BA, V17, P57	42	26	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91857	10.1371/journal.pone.0091857	http://dx.doi.org/10.1371/journal.pone.0091857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632732	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400110
J	Siboni, N; Abrego, D; Motti, CA; Tebben, J; Harder, T				Siboni, Nachshon; Abrego, David; Motti, Cherie A.; Tebben, Jan; Harder, Tilmann			Gene Expression Patterns during the Early Stages of Chemically Induced Larval Metamorphosis and Settlement of the Coral Acropora millepora	PLOS ONE			English	Article							PROTEIN	The morphogenetic transition of motile coral larvae into sessile primary polyps is triggered and genetically programmed upon exposure to environmental biomaterials, such as crustose coralline algae (CCA) and bacterial biofilms. Although the specific chemical cues that trigger coral larval morphogenesis are poorly understood there is much more information available on the genes that play a role in this early life phase. Putative chemical cues from natural biomaterials yielded defined chemical samples that triggered different morphogenetic outcomes: an extract derived from a CCA-associated Pseudoalteromonas bacterium that induced metamorphosis, characterized by non-attached metamorphosed juveniles; and two fractions of the CCA Hydrolithon onkodes (Heydrich) that induced settlement, characterized by attached metamorphosed juveniles. In an effort to distinguish the genes involved in these two morphogenetic transitions, competent larvae of the coral Acropora millepora were exposed to these predictable cues and the expression profiles of 47 coral genes of interest (GOI) were investigated after only 1 hour of exposure using multiplex RT-qPCR. Thirty-two GOI were differentially expressed, indicating a putative role during the early regulation of morphogenesis. The most striking differences were observed for immunity-related genes, hypothesized to be involved in cell recognition and adhesion, and for fluorescent protein genes. Principal component analysis of gene expression profiles resulted in separation between the different morphogenetic cues and exposure times, and not only identified those genes involved in the early response but also those which influenced downstream biological changes leading to larval metamorphosis or settlement.	[Siboni, Nachshon; Abrego, David; Motti, Cherie A.; Harder, Tilmann] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Tebben, Jan; Harder, Tilmann] Univ New S Wales, Ctr Marine Bioinnovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Australian Institute of Marine Science; University of New South Wales Sydney	Siboni, N (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	N.Siboni@aims.gov.au	Abrego, David/AAT-8120-2020; Siboni, Nachshon/K-4202-2012; Tebben, Jan/ABD-2247-2020; Motti, Cherie/A-2588-2012; Harder, Tilmann/B-6861-2008	Abrego, David/0000-0003-3311-2730; Siboni, Nachshon/0000-0001-6082-0949; Tebben, Jan/0000-0002-2780-2236; Harder, Tilmann/0000-0003-3173-6806; Motti, Cherie/0000-0002-3292-2785	Australian Institute of Marine Science [2233]; German Research Foundation [HA 3496/5-1]	Australian Institute of Marine Science; German Research Foundation(German Research Foundation (DFG))	Funding was provided by the Australian Institute of Marine Science, Futures Project, Appropriation Fund 2233. TH was partially supported by a Research Fellowship awarded by the German Research Foundation (HA 3496/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball EE, 2002, INT J DEV BIOL, V46, P671; Beltran-Ramirez V, 2010, THESIS J COOK U TOWN; Cheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038650; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; Harrington L, 2004, THESIS J COOK U TOWN; Hayward DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026411; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Li HL, 2008, J EXP ZOOL PART B, V310B, P417, DOI 10.1002/jez.b.21214; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; MORSE DE, 1991, BIOL BULL, V181, P104, DOI 10.2307/1542493; Muller WA, 2002, CAN J ZOOL, V80, P1755, DOI 10.1139/Z02-130; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Orhan IE, 2012, REC NAT PROD, V6, P356; Palmer CV, 2012, DEV COMP IMMUNOL, V38, P395, DOI 10.1016/j.dci.2012.07.008; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Siboni N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037774; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Tebben J, 2013, THESIS U NEW S WALES; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Webster NS, 2011, ISME J, V5, P759, DOI 10.1038/ismej.2010.152	32	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91082	10.1371/journal.pone.0091082	http://dx.doi.org/10.1371/journal.pone.0091082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632854	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400039
J	Xu, QB; Wu, YM; Liu, HY; Xie, YM; Huang, XB; Liu, JX				Xu, Qingbiao; Wu, Yueming; Liu, Hongyun; Xie, Yingming; Huang, Xinbei; Liu, Jianxin			Establishment and Characterization of an Omasal Epithelial Cell Model Derived from Dairy Calves for the Study of Small Peptide Absorption	PLOS ONE			English	Article							PRIMARY CULTURES; INCUBATION TECHNIQUES; AMINO-ACIDS; SHEEP RUMEN; METABOLISM; FLUX; COWS; FORESTOMACH; EXPRESSION; CARNOSINE	The objective of this study was to establish a primary culture of omasal epithelial cells (OECs) derived from dairy calves and to characterize its function in small peptide absorption. Bovine omasal tissues were obtained from newborn Chinese Holstein calves and digested with a 2.5% trypsin solution to obtain OECs. The isolated cells were later cultured in DMEM containing 10% fetal bovine serum, 5 mg/ml insulin, 10 ng/ml epidermal growth factor, 100 U/ml penicillin, 100 mg/ml streptomycin, 50 mg/ml gentamycin and 2.5 mg/ml amphotericin B. Hematoxylin and eosin staining of omasal tissue after digestion indicated that the cultured cells originated from the epithelial strata. Pure epithelial cells displayed an epithelial cell-like morphology, similar to cobblestone, with few visible fibroblasts and were cytokeratin 18-positive according to immunocytochemical analyses. The OECs were morphologically characterized with desmosomes, tight junctions and microvilli. These cells exhibited normal growth properties, as assessed using a cell growth curve, and were stably cultured for 10 passages. The OECs expressed the peptide transporter 1 (PEPT1) mRNA and absorbed intact glycylsarcosine (Gly-Sar). The uptake of Gly-Sar by OECs was pH-dependent with an optimal pH of 5.5-6.5. Furthermore, the uptake of Gly-Sar was also time-dependent, concentration-dependent and temperature-dependent. Moreover, PEPT1 was saturated with Gly-Sar at a concentration of 2.5 mM. The uptake via PEPT1 was higher compared with that via passive route at low substrate concentrations (<1.5 mM). This result suggested that PEPT1 contributed more to total small peptide absorption at low concentrations. In addition, this uptake could be competitively inhibited by methionine-glycine. Taken together, these data suggested that PEPT1 contributes to small peptide absorption in OECs. Thus, OECs may serve as a useful culture model for the study of the absorption of small peptides in bovine omasum.	[Xu, Qingbiao; Wu, Yueming; Liu, Hongyun; Xie, Yingming; Huang, Xinbei; Liu, Jianxin] Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Inst Dairy Sci,Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wu, YM (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Inst Dairy Sci,Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	ymwu@zju.edu.cn; liujx@zju.edu.cn	Xu, Qingbiao/AAZ-3477-2021	Xu, Qingbiao/0000-0001-8461-9924	National Key Basic Research Program of China Ministry of Science and Technology [2011CB100801]	National Key Basic Research Program of China Ministry of Science and Technology	This research was supported by the grant from the National Key Basic Research Program of China Ministry of Science and Technology (Grant No. 2011CB100801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2006, J COMP PHYSIOL B, V176, P477, DOI 10.1007/s00360-006-0069-8; Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; BALDWIN RL, 1991, J ANIM SCI, V69, P3603, DOI 10.2527/1991.6993603x; Chen H, 2002, J NUTR, V132, P38, DOI 10.1093/jn/132.1.38; Chen H, 2002, J NUTR, V132, P387, DOI 10.1093/jn/132.3.387; Choi CW, 2002, ANIM FEED SCI TECH, V102, P15, DOI 10.1016/S0377-8401(02)00251-1; CHOPRA DP, 1991, IN VITRO CELL DEV B, V27, P13, DOI 10.1007/BF02630889; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; EVANS GS, 1992, J CELL SCI, V101, P219; Fell B., 1975, DIGESTION METABOLISM, P101; Follmann W, 2000, TOXICOL IN VITRO, V14, P435, DOI 10.1016/S0887-2333(00)00033-3; GALFI P, 1981, VET RES COMMUN, V4, P295; Garcia A, 2013, HISTOL HISTOPATHOL, V28, P737, DOI 10.14670/HH-28.737; Gilbert ER, 2008, J ANIM SCI, V86, P2135, DOI 10.2527/jas.2007-0826; Gillis RC, 2002, SMALL RUMINANT RES, V45, P291, DOI 10.1016/S0921-4488(02)00117-7; Hidalgo I J, 1996, Pharm Biotechnol, V8, P35; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Huhtanen P, 1997, J ANIM SCI, V75, P1380; Jayawardena VP, 2000, OBERVATIONS RUMINAL; JESSE BW, 1992, J ANIM SCI, V70, P2235, DOI 10.2527/1992.7072235x; Kaushik RS, 2008, J VIROL METHODS, V148, P182, DOI 10.1016/j.jviromet.2007.11.006; Klotz JL, 2001, J DAIRY SCI, V84, P183, DOI 10.3168/jds.S0022-0302(01)74468-2; Liu ZH, 2011, PEPTIDES, V32, P747, DOI 10.1016/j.peptides.2011.01.019; Loret S, 2009, RES VET SCI, V87, P123, DOI 10.1016/j.rvsc.2008.12.002; MATTHEWS JC, 1995, J ANIM SCI, V73, P3464, DOI 10.2527/1995.73113464x; McCollum MQ, 1998, J ANIM SCI, V76, P2706; Miyazawa K, 2010, HISTOCHEM CELL BIOL, V133, P125, DOI 10.1007/s00418-009-0648-3; PICKETT PB, 1975, J CELL BIOL, V66, P316, DOI 10.1083/jcb.66.2.316; Remond D, 2000, J ANIM SCI, V78, P158; Remond D, 2000, J ANIM SCI, V78, P1960; Ren HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027010; Rusu D, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-42; Scow JS, 2011, J SURG RES, V170, P17, DOI 10.1016/j.jss.2011.02.018; Shimizu R, 2008, INT J PHARMACEUT, V354, P104, DOI 10.1016/j.ijpharm.2007.12.045; Stumpff F, 2011, J EXP BIOL, V214, P2871, DOI 10.1242/jeb.055582; Tagari H, 2008, J DAIRY SCI, V91, P679, DOI 10.3168/jds.2007-0629; Waldron MR, 2002, J ANIM SCI, V80, P270; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023; Zhou MM, 2011, J ANIM PHYSIOL AN N, V95, P781, DOI 10.1111/j.1439-0396.2010.01110.x	39	13	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e88993	10.1371/journal.pone.0088993	http://dx.doi.org/10.1371/journal.pone.0088993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633419	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400005
J	Xiao, Q; Hu, YT; Liu, Y; Wang, ZH; Geng, HT; Hu, LF; Xu, DY; Wang, K; Zheng, L; Zheng, S; Ding, KF				Xiao, Qian; Hu, Yeting; Liu, Yue; Wang, Zhanhuai; Geng, Haitao; Hu, Lifeng; Xu, Dengyong; Wang, Ke; Zheng, Lei; Zheng, Shu; Ding, Kefeng			BEX1 Promotes Imatinib-Induced Apoptosis by Binding to and Antagonizing BCL-2	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BREAST-CANCER; MALIGNANT GLIOMA; GENE FAMILY; CELL-CYCLE; RESISTANCE; THERAPY; INHIBITION; ACTIVATION; PHOSPHORYLATION	An enhanced anti-apoptotic capacity of tumor cells plays an important role in the process of breakpoint cluster region/Abelson tyrosine kinase gene (BCR/ABL)-independent imatinib resistance. We have previously demonstrated that brain expressed X-linked 1 (BEX1) was silenced in secondary imatinib-resistant K562 cells and that re-expression of BEX1 can restore imatinib sensitivity resulting in the induction of apoptosis. However, the mechanism by which BEX1 executes its proapoptotic function remains unknown. We identified B-cell lymphoma 2 (BCL-2) as a BEX1-interacting protein using a yeast two-hybrid screen. The interaction between BEX1 and BCL-2 was subsequently confirmed by co-immunoprecipitation assays. Like BCL-2, BEX1 was localized to the mitochondria. The region between 33K and 64Q on BEX1 is important for its localization to the mitochondria and its ability to interact with BCL-2. Additionally, we found that this region is essential for BEX1-regulated imatinib-induced apoptosis. Furthermore, we demonstrated that the interaction between BCL-2 and BEX1 promotes imatinib-induced apoptosis by suppressing the formation of anti-apoptotic BCL-2/BCL-2-associated X protein (BAX) heterodimers. Our results revealed an interaction between BEX1 and BCL-2 and a novel mechanism of imatinib resistance mediated by the BEX1/BCL-2 pathway.	[Xiao, Qian; Hu, Yeting; Liu, Yue; Wang, Zhanhuai; Geng, Haitao; Hu, Lifeng; Xu, Dengyong; Wang, Ke; Zheng, Shu; Ding, Kefeng] Inst Canc Res, China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Mol Biol Med Sci Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Xiao, Qian; Hu, Yeting; Liu, Yue; Wang, Zhanhuai; Geng, Haitao; Hu, Lifeng; Xu, Dengyong; Wang, Ke; Zheng, Lei; Zheng, Shu; Ding, Kefeng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Surg, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA	Zhejiang University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Zheng, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	lzheng6@jhmi.edu; zhengshu@zju.edu.cn; Dingkefeng@zju.edu.cn			National Natural Science Foundation of China [30772473, 81071801, 81272455]; Zhejiang Provincial Natural Science Foundation of China [R2100071]; US NIH [K23 CA148964-01]; Johns Hopkins University School of Medicine Clinician Scientist Award; NATIONAL CANCER INSTITUTE [P50CA062924, K23CA148964, R01CA169702] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine Clinician Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in Cancer Institute of Zhejiang University School of Medicine was supported by grants from the National Natural Science Foundation of China (No. 30772473, 81071801, 81272455) and Zhejiang Provincial Natural Science Foundation of China (No. R2100071). Lei Zheng is supported by a US NIH K23 CA148964-01 and a Johns Hopkins University School of Medicine Clinician Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012; Behrens M, 2003, J NEUROCHEM, V86, P1289, DOI 10.1046/j.1471-4159.2003.01940.x; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Burke SP, 2010, J BIOL CHEM, V285, P30061, DOI 10.1074/jbc.M110.125955; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; Ding KF, 2009, CARCINOGENESIS, V30, P35, DOI 10.1093/carcin/bgn251; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Giuliani F, 2012, EXPERT OPIN THER TAR, V16, pS35, DOI 10.1517/14728222.2012.657627; Gordon PM, 2010, J BIOL CHEM, V285, P14109, DOI 10.1074/jbc.M109.078592; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Juan WC, 2012, PROG MOL BIOL TRANSL, V106, P107, DOI 10.1016/B978-0-12-396456-4.00007-9; Karvela M, 2012, EXPERT REV ANTICANC, V12, P381, DOI [10.1586/ERA.12.10, 10.1586/era.12.10]; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Lee F, 2008, INT J BIOCHEM CELL B, V40, P334, DOI 10.1016/j.biocel.2007.10.001; Melarangi T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.102; Milojkovic D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Naderi A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-111; Naderi A, 2010, INT J CANCER, V126, P1596, DOI 10.1002/ijc.24866; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Ohanian M, 2012, EXPERT OPIN PHARMACO, V13, P927, DOI 10.1517/14656566.2012.672974; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pratesi G, 2001, BIOCHEM PHARMACOL, V61, P381, DOI 10.1016/S0006-2952(00)00538-4; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Thomadaki H, 2006, CRIT REV CL LAB SCI, V43, P1, DOI 10.1080/10408360500295626; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; WELLER M, 1995, J CLIN INVEST, V95, P2633, DOI 10.1172/JCI117965; Wendel HG, 2006, P NATL ACAD SCI USA, V103, P7444, DOI 10.1073/pnas.0602402103; Yang QS, 2002, BIOCHEM GENET, V40, P1, DOI 10.1023/A:1014565320998	32	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91782	10.1371/journal.pone.0091782	http://dx.doi.org/10.1371/journal.pone.0091782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626299	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300135
J	Christidis, L; Goodman, SM; Naughton, K; Appleton, B				Christidis, Les; Goodman, Steven M.; Naughton, Kate; Appleton, Belinda			Insights into the Evolution of a Cryptic Radiation of Bats: Dispersal and Ecological Radiation of Malagasy Miniopterus (Chiroptera: Miniopteridae)	PLOS ONE			English	Article							LONG-FINGERED BATS; ADAPTIVE RADIATION; MITOCHONDRIAL-DNA; MOLECULAR SYSTEMATICS; MADAGASCAR; COMORO; SCHREIBERSII; BIOGEOGRAPHY; PHYLOGENY; ALGORITHM	The past decade has seen a proliferation of new species of Miniopterus bats (family Miniopteridae) recognized from Madagascar and the neighboring Comoros archipelago. The interspecific relationships of these taxa, their colonization history, and the evolution of this presumed adaptive radiation have not been sufficiently explored. Using the mitochondrial cytochrome-b gene, we present a phylogeny of the Malagasy members of this widespread Old World genus, based on 218 sequences, of which 82 are new and 136 derived from previous studies. Phylogenetic analyses recovered 18 clades, which divide into five primary lineages: (1) M. griveaudi; (2) M. mahafaliensis, M. sororculus and X3; (3) M. majori, M. gleni and M. griffithsi; (4) M. brachytragos; M. aelleniA, and M. aelleniB; and (5) M. manavi and M. petersoni recovered as sister species, which were in turn linked to a group comprising M. egeri and five genetically distinct populations referred to herein as P3, P4, P5, P6 and P7. Beast analysis indicated that the initial divergence within the Malagasy Miniopterus radiation took place 4.5 Myr; most species diverged between 4 and 2.5 Myr, and a secondary period was between 1.25 and 1 Myr. DNA K2P-distances between recognized taxa ranged from 12.9% to 2.5% and intraspecific variation was less than 1.8%. Of the 18 identified clades, Latin binomials are only associated with 11, which indicates much greater differentiation than currently recognized for Malagasy Miniopterus. These data are placed in a context of the dispersal history of this genus on the island and patterns of ecological diversity.	[Christidis, Les] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Christidis, Les; Naughton, Kate; Appleton, Belinda] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar; [Appleton, Belinda] Deakin Univ, Geelong, Vic 3217, Australia	Southern Cross University; University of Melbourne; Field Museum of Natural History (Chicago); Deakin University	Christidis, L (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	les.christidis@gmail.com			CABS of Conservation International; John D. and Catherine T. MacArthur Foundation; Volkswagen Foundation	CABS of Conservation International; John D. and Catherine T. MacArthur Foundation; Volkswagen Foundation(Volkswagen)	Financial support for the fieldwork associated with this project was graciously given by CABS of Conservation International, The John D. and Catherine T. MacArthur Foundation and Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Appleton BR, 2004, MOL PHYLOGENET EVOL, V31, P431, DOI 10.1016/j.ympev.2003.08.017; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; BERMINGHAM E, 1993, P NATL ACAD SCI USA, V90, P2734, DOI 10.1073/pnas.90.7.2734; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Burney David A., 1999, P145; Cardinal BR, 2000, AUST J ZOOL, V48, P1, DOI 10.1071/ZO99067; Carleton Michael D., 1998, Fieldiana Zoology, V90, P163; Cibois A, 2001, EVOLUTION, V55, P1198; Cibois A, 2010, ZOOTAXA, P65, DOI 10.11646/zootaxa.2554.1.6; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eagles G, 2008, GEOPHYS J INT, V173, P703, DOI [10.1111/j.1365-246X.2008.03753.x, 10.1111/J.1365-246X.2008.03753.X]; Gaffney ES, 2003, AM MUS NOVIT, P1; Goodman SM, 2007, J MAMMAL, V88, P1216, DOI 10.1644/06-MAMM-A-285R1.1; Goodman SM, 2010, J ZOOL SYST EVOL RES, V48, P75, DOI 10.1111/j.1439-0469.2009.00524.x; Goodman S. M., WINDOWS EXT IN PRESS; Goodman S. M., 2011, CHAUVES SOURIS MADAG; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2008, MAMM BIOL, V73, P199, DOI 10.1016/j.mambio.2007.12.003; Goodman SM, 2011, ZOOTAXA, P1; Goodman SM, 2012, J MAMMAL, V93, P1440, DOI 10.1644/11-MAMM-A-271.1; Goodman SM, 2009, AM MUS NOVIT, P1, DOI 10.1206/652.1; Goodman SM, 2010, ACTA CHIROPTEROL, V12, P117, DOI 10.3161/150811010X504635; Goodman SM, 2009, ZOOL SCR, V38, P339, DOI 10.1111/j.1463-6409.2008.00377.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jonsson KA, 2008, MOL PHYLOGENET EVOL, V47, P221, DOI 10.1016/j.ympev.2008.01.017; Jonsson KA, 2012, P NATL ACAD SCI USA, V109, P6620, DOI 10.1073/pnas.1115835109; Juste J, 2007, ACTA CHIROPTEROL, V9, P27, DOI 10.3161/1733-5329(2007)9[27:TOLBBM]2.0.CO;2; KERTH G, 2006, FUNCTIONAL EVOLUTION, P199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kundu S, 2012, MOL PHYLOGENET EVOL, V62, P296, DOI 10.1016/j.ympev.2011.09.025; MARCK C, 1990, DNA STRIDER A C PROG; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Miller-Butterworth CM, 2005, J MAMMAL, V86, P1121, DOI 10.1644/05-MAMM-A-021R1.1; Monadjem A, ZOOTAXA IN PRESS; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Peterson R., 1995, FAUNE MADAGASCAR, V84; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Poux C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-102; Rambaut A., 2007, TRACER V1 5; Raxworthy Christopher J., 1997, P124; Reddy S, 2012, P ROY SOC B-BIOL SCI, V279, P2062, DOI 10.1098/rspb.2011.2380; Redondo RAF, 2008, MOL PHYLOGENET EVOL, V49, P44, DOI 10.1016/j.ympev.2008.07.001; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell AL, 2008, J MAMMAL, V89, P209, DOI 10.1644/07-MAMM-A-044.1; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Weyeneth N, 2011, J EVOLUTION BIOL, V24, P1298, DOI 10.1111/j.1420-9101.2011.02262.x; Weyeneth N, 2008, MOL ECOL, V17, P5205, DOI 10.1111/j.1365-294X.2008.03994.x; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303	63	20	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92440	10.1371/journal.pone.0092440	http://dx.doi.org/10.1371/journal.pone.0092440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642892	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900140
J	Herberg, M; Kalkan, T; Glauche, I; Smith, A; Roeder, I				Herberg, Maria; Kalkan, Tuezer; Glauche, Ingmar; Smith, Austin; Roeder, Ingo			nA Model-Based Analysis of Culture-Dependent Phenotypes of mESCs	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MOUSE ES CELLS; GROUND-STATE PLURIPOTENCY; NANOG GENE-EXPRESSION; SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; DIFFERENTIATION; OCT4; SOX2; ESRRB	Mouse embryonic stem cells (mESCs) can be maintained in a proliferative and undifferentiated state over many passages (self-renewal) while retaining the potential to give rise to every cell type of the organism (pluripotency). Autocrine FGF4/Erk signalling has been identified as a major stimulus for fate decisions and lineage commitment in these cells. Recent findings on serum-free culture conditions with specific inhibitors (known as 2i) demonstrate that the inhibition of this pathway reduces transcription factor heterogeneity and is vital to maintain ground state pluripotency of mESCs. We suggest a novel mathematical model to explicitly integrate FGF4/Erk signalling into an interaction network of key pluripotency factors (namely Oct4, Sox2, Nanog and Rex1). The envisaged model allows to explore whether and how proposed mechanisms and feedback regulations can account for different expression patterns in mESC cultures. We demonstrate that an FGF4/Erk-mediated negative feedback is sufficient to induce molecular heterogeneity with respect to Nanog and Rex1 expression and thus critically regulates the propensity for differentiation and the loss of pluripotency. Furthermore, we compare simulation results on the transcription factor dynamics in different self-renewing states and during differentiation with experimental data on a Rex1GFPd2 reporter cell line using flow cytometry and qRT-PCR measurements. Concluding from our results we argue that interaction between FGF4/Erk signalling and Nanog expression qualifies as a key mechanism to manipulate mESC pluripotency. In particular, we infer that ground state pluripotency under 2i is achieved by shifting stable expression pattern of Nanog from a bistable into a monostable regulation impeding stochastic state transitions. Furthermore, we derive testable predictions on altering the degree of Nanog heterogeneity and on the frequency of state transitions in LIF/serum conditions to challenge our model assumptions.	[Herberg, Maria; Glauche, Ingmar; Roeder, Ingo] Tech Univ Dresden, Inst Med Informat & Biometry, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany; [Kalkan, Tuezer; Smith, Austin] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council, Cambridge, England	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Cambridge	Herberg, M (corresponding author), Tech Univ Dresden, Inst Med Informat & Biometry, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany.	maria.herberg@tu-dresden.de		Smith, Austin/0000-0002-3029-4682	European Commission project EuroSyStem [200270]; DFG Priority Program: SPP 1356 Pluripotency and Cellular Reprogramming [RO35002-1]; German Research Foundation; Open Access Publication Funds of the TU Dresden; Medical Research Council [G1100526, MC_PC_12009] Funding Source: researchfish	European Commission project EuroSyStem; DFG Priority Program: SPP 1356 Pluripotency and Cellular Reprogramming; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the European Commission project EuroSyStem (200270) and the DFG Priority Program: SPP 1356 Pluripotency and Cellular Reprogramming (RO35002-1). We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-98; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo Y, 2012, J ROYAL SOC INTERFAC; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	60	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92496	10.1371/journal.pone.0092496	http://dx.doi.org/10.1371/journal.pone.0092496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643025	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900144
J	Wientzek, A; Vigl, M; Steindorf, K; Bruhmann, B; Bergmann, MM; Harttig, U; Katzke, V; Kaaks, R; Boeing, H				Wientzek, Angelika; Vigl, Matthaeus; Steindorf, Karen; Bruehmann, Boris; Bergmann, Manuela M.; Harttig, Ulrich; Katzke, Verena; Kaaks, Rudolf; Boeing, Heiner			The Improved Physical Activity Index for Measuring Physical Activity in EPIC Germany	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; HEART-RATE; VALIDITY; RELIABILITY; REPEATABILITY; ACCELEROMETERS; NUTRITION; CANCER; ADULTS; RISK	In the European Investigation into Cancer and Nutrition study (EPIC), physical activity (PA) has been indexed as a cross-tabulation between PA at work and recreational activity. As the proportion of non-working participants increases, other categorization strategies are needed. Therefore, our aim was to develop a valid PA index for this population, which will also be able to express PA continuously. In the German EPIC centers Potsdam and Heidelberg, a clustered sample of 3,766 participants was re-invited to the study center. 1,615 participants agreed to participate and 1,344 participants were finally included in this study. PA was measured by questionnaires on defined activities and a 7-day combined heart rate and acceleration sensor. In a training sample of 433 participants, the Improved Physical Activity Index (IPAI) was developed. Its performance was evaluated in a validation sample of 911 participants and compared with the Cambridge Index and the Total PA Index. The IPAI consists of items covering five areas including PA at work, sport, cycling, television viewing, and computer use. The correlations of the IPAI with accelerometer counts in the training and validation sample ranged r = 0.40-0.43 and with physical activity energy expenditure (PAEE) r = 0.33-0.40 and were higher than for the Cambridge Index and the Total PA Index previously applied in EPIC. In non-working participants the IPAI showed higher correlations than the Cambridge Index and the Total PA Index, with r = 0.34 for accelerometer counts and r = 0.29 for PAEE. In conclusion, we developed a valid physical activity index which is able to express PA continuously as well as to categorize participants according to their PA level. In populations with increasing rates of non-working people the performance of the IPAI is better than the established indices used in EPIC.	[Wientzek, Angelika; Vigl, Matthaeus; Bergmann, Manuela M.; Harttig, Ulrich; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Steindorf, Karen; Bruehmann, Boris] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Div Prevent Oncol G110, Heidelberg, Germany; [Katzke, Verena; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol C020, Heidelberg, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Wientzek, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	angelika.wientzek@dife.de	Wientzek, Angelika/F-4851-2013	Wientzek, Angelika/0000-0002-9068-3022	German Federal Ministry of Education and Research [BMBF FKZ: 01ER0808]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant from the German Federal Ministry of Education and Research (BMBF FKZ: 01ER0808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Buchowski MS, 2009, J PHYS ACT HEALTH, V6, P252, DOI 10.1123/jpah.6.2.252; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Dorner TE, 2013, WIEN KLIN WOCHENSCHR; Friedenreich C, 2006, CANCER EPIDEM BIOMAR, V15, P2398, DOI 10.1158/1055-9965.EPI-06-0595; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Seefeldt V, 2002, SPORTS MED, V32, P143, DOI 10.2165/00007256-200232030-00001; Spittaels H, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-48; Straker LM, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-54; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Tooze JA, 2013, AM J EPIDEMIOL, V177, P1199, DOI 10.1093/aje/kws379; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875	23	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92005	10.1371/journal.pone.0092005	http://dx.doi.org/10.1371/journal.pone.0092005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642812	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900059
J	Gonzalez-Tokman, D; Ruch, J; Pulpitel, T; Ponton, F				Gonzalez-Tokman, Daniel; Ruch, Jasmin; Pulpitel, Tamara; Ponton, Fleur			Cuticular Antifungals in Spiders: Density- and Condition Dependence	PLOS ONE			English	Article							DISEASE RESISTANCE; TRADE-OFFS; GROUP-SIZE; ANTIPREDATOR BENEFITS; PREDATION RISK; INSECT; DEFENSES; RECOGNITION; RELATEDNESS; PROPHYLAXIS	Animals living in groups face a high risk of disease contagion. In many arthropod species, cuticular antimicrobials constitute the first protective barrier that prevents infections. Here we report that group-living spiders produce cuticular chemicals which inhibit fungal growth. Given that cuticular antifungals may be costly to produce, we explored whether they can be modulated according to the risk of contagion (i.e. under high densities). For this purpose, we quantified cuticular antifungal activity in the subsocial crab spider Diaea ergandros in both natural nests and experimentally manipulated nests of varying density. We quantified the body-condition of spiders to test whether antifungal activity is condition dependent, as well as the effect of spider density on body-condition. We predicted cuticular antifungal activity to increase and body-condition to decrease with high spider densities, and that antifungal activity would be inversely related to body-condition. Contrary to our predictions, antifungal activity was neither density-nor condition-dependent. However, body-condition decreased with density in natural nests, but increased in experimental nests. We suggest that pathogen pressure is so important in nature that it maintains high levels of cuticular antifungal activity in spiders, impacting negatively on individual energetic condition. Future studies should identify the chemical structure of the isolated antifungal compounds in order to understand the physiological basis of a trade-off between disease prevention and energetic condition caused by group living, and its consequences in the evolution of sociality in spiders.	[Gonzalez-Tokman, Daniel] Univ Nacl Autonoma Mexico, Inst Fis, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Ruch, Jasmin] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Ruch, Jasmin] Univ Hamburg, Zool Museum, Hamburg, Germany; [Ruch, Jasmin] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Pulpitel, Tamara; Ponton, Fleur] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Ponton, Fleur] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	Universidad Nacional Autonoma de Mexico; University of Hamburg; University of Hamburg; Macquarie University; University of Sydney; University of Sydney	Gonzalez-Tokman, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	danigt@gmail.com	Gonzalez-Tokman, Daniel/Q-6833-2018	Gonzalez-Tokman, Daniel/0000-0001-7251-5773; Ponton, Fleur/0000-0001-7156-3896	Consejo Nacional de Ciencia y Tecnologia (Beca Mixta); Posgrado en Ciencias Biologicas (Programa de Apoyo a Estudiantes de Posgrado); University of Sydney; Macquarie University	Consejo Nacional de Ciencia y Tecnologia (Beca Mixta); Posgrado en Ciencias Biologicas (Programa de Apoyo a Estudiantes de Posgrado); University of Sydney(University of Sydney); Macquarie University	Daniel Gonzalez-Tokman was supported by the Consejo Nacional de Ciencia y Tecnologia (Beca Mixta) and by the Posgrado en Ciencias Biologicas (Programa de Apoyo a Estudiantes de Posgrado). Fleur Ponton was supported by the University of Sydney. The study was funded by a scholarship of Jasmin Ruch from Macquarie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2010, ANIM BEHAV, V79, P3, DOI 10.1016/j.anbehav.2009.10.012; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Aviles Leticia, 1997, P476; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Bilde T, 2001, J EVOLUTION BIOL, V14, P959, DOI 10.1046/j.1420-9101.2001.00346.x; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Crawley M.J., 2007, R BOOK; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; ERWIN RM, 1978, CONDOR, V80, P211, DOI 10.2307/1367920; Evans TA, 1998, P ROY SOC B-BIOL SCI, V265, P129, DOI 10.1098/rspb.1998.0273; Evans TA, 2002, MOL ECOL, V11, P2307, DOI 10.1046/j.1365-294X.2002.01623.x; Evans Theodore A., 1995, Records of the Western Australian Museum Supplement, V52, P151; FREELAND WJ, 1983, AM NAT, V121, P223, DOI 10.1086/284052; Fritz H, 1996, J ANIM ECOL, V65, P736, DOI 10.2307/5672; Godfrey SS, 2006, PARASITOL RES, V99, P223, DOI 10.1007/s00436-005-0120-9; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gonzalez-Tokman D, 2011, ANIM BEHAV, V81, P1185, DOI 10.1016/j.anbehav.2011.02.027; Gross J, 1998, J INVERTEBR PATHOL, V72, P296, DOI 10.1006/jipa.1998.4781; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hass CC, 2002, BEHAV ECOL SOCIOBIOL, V51, P570, DOI 10.1007/s00265-002-0463-5; JAKOB EM, 1991, ANIM BEHAV, V41, P711, DOI 10.1016/S0003-3472(05)80908-X; James RR, 2003, J INVERTEBR PATHOL, V84, P67, DOI 10.1016/j.jip.2003.08.006; KOIDSUMI K, 1957, J INSECT PHYSIOL, V1, P40, DOI 10.1016/0022-1910(57)90022-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Machado G, 2002, INSECT SOC, V49, P388, DOI 10.1007/PL00012663; Ortiz-Urquiza Almudena, 2013, Insects, V4, P357, DOI 10.3390/insects4030357; POIANI A, 1992, OECOLOGIA, V92, P429, DOI 10.1007/BF00317470; R Core Team, 2020, R LANG ENV STAT COMP; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Rifkin JL, 2012, AM NAT, V180, P70, DOI 10.1086/666081; Ruch J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-257; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmid-Hempel P., 1998, Parasites in social insects.; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHYKOFF JA, 1991, P ROY SOC B-BIOL SCI, V243, P55, DOI 10.1098/rspb.1991.0009; SMITH RJ, 1982, J INVERTEBR PATHOL, V39, P15, DOI 10.1016/0022-2011(82)90153-7; Stow A, 2008, BRAIN BEHAV IMMUN, V22, P1009, DOI 10.1016/j.bbi.2008.03.008; Stow A, 2007, BIOL LETTERS, V3, P422, DOI 10.1098/rsbl.2007.0178; Uetz GW, 2002, ANIM BEHAV, V63, P445, DOI 10.1006/anbe.2001.1918; Unglaub B, 2013, BEHAV ECOL SOCIOBIOL, V67, P785, DOI 10.1007/s00265-013-1502-0; Whitehouse MEA, 2005, BIOL REV, V80, P347, DOI 10.1017/S1464793104006694; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson K, 1998, ECOL ENTOMOL, V23, P100, DOI 10.1046/j.1365-2311.1998.00107.x; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Wise DH, 2006, ANNU REV ENTOMOL, V51, P441, DOI 10.1146/annurev.ento.51.110104.150947; WRONA FJ, 1991, AM NAT, V137, P186, DOI 10.1086/285153; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	52	5	5	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91785	10.1371/journal.pone.0091785	http://dx.doi.org/10.1371/journal.pone.0091785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637563	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100060
J	Jiao, SP; Wu, MQ; Ye, F; Tang, HL; Xie, XH; Xie, XM				Jiao, Shiping; Wu, Minqing; Ye, Feng; Tang, Hailin; Xie, Xinhua; Xie, Xiaoming			BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer	PLOS ONE			English	Article							NONINVASIVE IMAGING MODELS; MALIGNANT-TRANSFORMATION; TARGETED EXPRESSION; DRUG-RESISTANCE; POOR-PROGNOSIS; CELL-DEATH; BCL-2; APOPTOSIS; PROMOTES; PATHWAY	Our previous studies showed that BikDD, a constitutively active mutant form of Bik, exhibited powerful antitumor effects in preclinical pancreatic, lung and breast cancer models. Howerver, the antitumor activity of BikDD in triple-negative breast cancer (TNBC) is unknown. Here we show that aberrant expression of p-ERK1/2 was a meaningful molecular phenotype in TNBC patients, and can be an obstacle for treatment because of the converse correlation with Bik. A novel mutant, BikDDA, in which Ser(124) was changed to Alanine to block BikDD phosphorylation by p-ERK1/2 prevented subsequent ubiquitin-proteasome degradation. BikDDA showed a prolonged half-life and enhanced pro-apoptotic ability in TNBC cells compared with BikDD. Moreover, aberrant expression of p-ERK1/2 was associated with 5-fluorouracil resistance in breast cancer patients and BikDDA enhanced the therapeutic effects of 5-fluorouracil in vitro.	[Jiao, Shiping; Wu, Minqing; Ye, Feng; Tang, Hailin; Xie, Xinhua; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Jiao, Shiping; Ye, Feng; Tang, Hailin; Xie, Xinhua; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Minqing] Sun Yat Sen Univ, Ctr Canc, Dept Canc Prevent Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Jiao, Shiping] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xie, XM (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn		Jiao, Shiping/0000-0001-6546-9369	National Natural Science Foundation of China [81272514, 31100935, 81302318, 31030061]; China Postdoctoral Science Foundation [2012M520075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funds from the National Natural Science Foundation of China (81272514, 31100935, 81302318), the Key Programme of the National Natural Science Foundation of China (31030061), and the China Postdoctoral Science Foundation (2012M520075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2011, CELL, V144, P638, DOI 10.1016/j.cell.2011.02.030; Bartholomeusz C, 2012, ONCOLOGIST, V17, P766, DOI 10.1634/theoncologist.2011-0377; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Elangovan B, 1997, J BIOL CHEM, V272, P24494, DOI 10.1074/jbc.272.39.24494; Eralp Y, 2008, ANN ONCOL, V19, P669, DOI 10.1093/annonc/mdm522; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065138; Hamilton A, 2000, ANN ONCOL, V11, P647, DOI 10.1023/A:1008390429428; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li YM, 2003, CANCER RES, V63, P7630; Lopez J, 2012, CELL DEATH DIFFER, V19, P1459, DOI 10.1038/cdd.2012.21; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mebratu YA, 2008, J CELL BIOL, V183, P429, DOI 10.1083/jcb.200801186; Sher YP, 2011, MOL CANCER THER, V10, P637, DOI 10.1158/1535-7163.MCT-10-0827; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Xie XM, 2007, CANCER CELL, V12, P52, DOI 10.1016/j.ccr.2007.05.009; Xie XH, 2012, MOL CANCER THER, V11, P1915, DOI 10.1158/1535-7163.MCT-12-0191; Yoon H, 2011, BIOCHEM BIOPH RES CO, V405, P333, DOI 10.1016/j.bbrc.2010.11.130; Zou YY, 2002, CANCER RES, V62, P8	30	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92172	10.1371/journal.pone.0092172	http://dx.doi.org/10.1371/journal.pone.0092172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637719	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100123
J	Su, YF; Wu, TF; Ko, JL; Tsai, HT; Tee, YT; Chien, MH; Chou, CH; Lin, WL; Low, HY; Chou, MY; Yang, SF; Wang, PH				Su, Ying-Fang; Wu, Tzu-Fan; Ko, Jiunn-Liang; Tsai, Hsiu-Ting; Tee, Yi-Torng; Chien, Ming-Hsien; Chou, Chi-Hung; Lin, Wea-Lung; Low, Hui-Ying; Chou, Ming-Yung; Yang, Shun-Fa; Wang, Po-Hui			The Expression of Ribonucleotide Reductase M2 in the Carcinogenesis of Uterine Cervix and Its Relationship with Clinicopathological Characteristics and Prognosis of Cancer Patients	PLOS ONE			English	Article							DNA-DAMAGE; CELL-PROLIFERATION; EARLY-STAGE; SUBUNIT M2; IN-VITRO; REPAIR; RRM2; R2; INHIBITORS; CARCINOMA	Background: To investigate the implication of ribonucleotide reductase M2 (RRM2) in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients. Methodology and Principal Findings: The impact of RRM2 on cell viability was investigated in SiHa cervical cancer cells after RRM2 knockdown and the addition of cisplatin, which induces inter-and intra-strand DNA crosslinks. RRM2 immunoreactivity was evaluated by semi-quantitative H score among 29 normal, 30 low-grade dysplasia, 30 high-grade dysplasia and 103 invasive cancer tissue specimens of the uterine cervix, using tissue microarrays. RRM2 was then correlated with the clinicopathological variables of cervical cancer and patient survival. A greater toxic effect on cell viability using cisplatin was reflected by the greater reduction in RRM2 protein expression in SiHa cells. The RRM2 expression in cancer tissues was higher than that in high-grade dysplasia, low-grade dysplasia or normal cervical tissues. RRM2 upregulation was correlated with deep stromal invasion, large tumors and parametrial invasion and predicted poor survival. Conclusions: RRM2 is a new molecular marker for the diagnosis and clinical outcomes of cervical cancer. It is involved in cervical carcinogenesis and predicts poor survival, and may be a potential therapeutic target including in cisplatin treatment.	[Su, Ying-Fang; Wu, Tzu-Fan; Ko, Jiunn-Liang; Tee, Yi-Torng; Chou, Chi-Hung; Yang, Shun-Fa; Wang, Po-Hui] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Su, Ying-Fang; Chou, Ming-Yung] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Su, Ying-Fang] Chung Shan Med Univ Hosp, Dept Stomatol, Taichung, Taiwan; [Tsai, Hsiu-Ting] Chung Shan Med Univ, Sch Nursing, Taichung, Taiwan; [Tsai, Hsiu-Ting] Chung Shan Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Tee, Yi-Torng; Lin, Wea-Lung; Wang, Po-Hui] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Tee, Yi-Torng; Low, Hui-Ying; Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fan Hosp, Taipei, Taiwan; [Chou, Chi-Hung] Yuan Sheng Hosp, Dept Internal Med, Div Cardiol, Yuanlin, Taiwan; [Chou, Chi-Hung] Changhua Christian Hosp, Yuanlin Branch, Yuanlin, Taiwan; [Lin, Wea-Lung] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Wang, PH (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ginhow84921344@yahoo.com.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Ko, Jiunn-Liang/0000-0001-6855-9239; Tsai, Hsiu Ting/0000-0003-1137-9274	Chung Shan Medical University Hospital [CSH-2013-D-001]; Taiwan National Science Council [NSC 102-2314-B-040-014-MY3]	Chung Shan Medical University Hospital; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by research grants from Chung Shan Medical University Hospital, (CSH-2013-D-001) and Taiwan National Science Council (NSC 102-2314-B-040-014-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MF, 2013, PROG MOL BIOL TRANSL, V117, P389, DOI 10.1016/B978-0-12-386931-9.00014-3; Altaha R, 2004, INT J MOL MED, V14, P959; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Burton TR, 2003, INT J ONCOL, V22, P21; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; DELGADO G, 1990, GYNECOL ONCOL, V38, P352, DOI 10.1016/0090-8258(90)90072-S; Duxbury MS, 2007, BIOCHEM BIOPH RES CO, V354, P190, DOI 10.1016/j.bbrc.2006.12.177; Fan HZ, 1998, CANCER RES, V58, P1650; FULLER AF, 1989, GYNECOL ONCOL, V33, P34, DOI 10.1016/0090-8258(89)90598-2; Grisaru DA, 2003, CANCER, V97, P1904, DOI 10.1002/cncr.11269; Heidel JD, 2007, CLIN CANCER RES, V13, P2207, DOI 10.1158/1078-0432.CCR-06-2218; Kristensen GB, 1999, GYNECOL ONCOL, V74, P245, DOI 10.1006/gyno.1999.5420; Kurman RJ, 2008, AM J OBSTET GYNECOL, V198, P351, DOI 10.1016/j.ajog.2008.01.005; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Lien E J, 1987, Prog Drug Res, V31, P101; Lin ZP, 2011, MOL PHARMACOL, V80, P1000, DOI 10.1124/mol.111.074708; Liu XY, 2007, CLIN COLORECTAL CANC, V6, P374, DOI 10.3816/CCC.2007.n.007; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Morikawa T, 2010, HISTOPATHOLOGY, V57, P885, DOI 10.1111/j.1365-2559.2010.03725.x; Morikawa T, 2010, HUM PATHOL, V41, P1742, DOI 10.1016/j.humpath.2010.06.001; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nocentini G, 1996, CRIT REV ONCOL HEMAT, V22, P89, DOI 10.1016/1040-8428(95)00187-5; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Sapp H, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.028; SEVIN BU, 1995, CANCER-AM CANCER SOC, V76, P1978, DOI 10.1002/1097-0142(19951115)76:10+<1978::AID-CNCR2820761313>3.0.CO;2-K; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Wang LM, 2012, CHINESE MED J-PEKING, V125, P2151, DOI 10.3760/cma.j.issn.0366-6999.2012.12.013; Wang PH, 2011, INT J CANCER, V129, P2380, DOI 10.1002/ijc.25936; Yen Y, 2003, CLIN CANCER RES, V9, P4304; Zhang KQ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-11; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020	40	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91644	10.1371/journal.pone.0091644	http://dx.doi.org/10.1371/journal.pone.0091644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637958	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100051
J	Yu, H; Waddell, JN; Kuang, SH; Bidwell, CA				Yu, Hui; Waddell, Jolena N.; Kuang, Shihuan; Bidwell, Christopher A.			Park7 Expression Influences Myotube Size and Myosin Expression in Muscle	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; SKELETAL-MUSCLE; GENE-EXPRESSION; CALLIPYGE GENE; PHENOTYPIC CHARACTERIZATION; PARKINSONS-DISEASE; FIBER-TYPE; DJ-1; GROWTH; HYPERTROPHY	Callipyge sheep exhibit postnatal muscle hypertrophy due to the up-regulation of DLK1 and/or RTL1. The up-regulation of PARK7 was identified in hypertrophied muscles by microarray analysis and further validated by quantitative PCR. The expression of PARK7 in hypertrophied muscle of callipyge lambs was confirmed to be up-regulated at the protein level. PARK7 was previously identified to positively regulate PI3K/AKT pathway by suppressing the phosphatase activity of PTEN in mouse fibroblasts. The purpose of this study was to investigate the effects of PARK7 in muscle growth and protein accretion in response to IGF1. Primary myoblasts isolated from Park7 (+/+) and Park7 (-/-) mice were used to examine the effect of differential expression of Park7. The Park7 (+/+) myotubes had significantly larger diameters and more total sarcomeric myosin expression than Park7 (-/-) myotubes. IGF1 treatment increased the mRNA abundance of Myh4, Myh7 and Myh8 between 20-40% in Park7 (+/+) myotubes relative to Park7 (-/-). The level of AKT phosphorylation was increased in Park7 (+/+) myotubes at all levels of IGF1 supplementation. After removal of IGF1, the Park7 (+/+) myotubes maintained higher AKT phosphorylation through 3 hours. PARK7 positively regulates the PI3K/AKT pathway by inhibition of PTEN phosphatase activity in skeletal muscle. The increased PARK7 expression can increase protein synthesis and result in myotube hypertrophy. These results support the hypothesis that elevated expression of PARK7 in callipyge muscle would increase levels of AKT activity to cause hypertrophy in response to the normal IGF1 signaling in rapidly growing lambs. Increasing expression of PARK7 could be a novel mechanism to increase protein accretion and muscle growth in livestock or help improve muscle mass with disease or aging.	[Yu, Hui; Waddell, Jolena N.; Kuang, Shihuan; Bidwell, Christopher A.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bidwell, CA (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	cbidwell@purdue.edu	Yu, Hui/AAR-3692-2021; yu, hui/K-3222-2017	Kuang, Shihuan/0000-0001-9180-3180	Chinese Scholarship Council; Purdue University Department of Animal Sciences; Purdue University Agricultural Research Programs; Purdue University Department of Animal Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	Chinese Scholarship Council(China Scholarship Council); Purdue University Department of Animal Sciences; Purdue University Agricultural Research Programs; Purdue University Department of Animal Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	HY was partially supported by the Chinese Scholarship Council and the Purdue University Department of Animal Sciences. The work was supported by the Purdue University Agricultural Research Programs and gift funds through the Purdue University Department of Animal Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Carpenter CE, 2000, CAN J ANIM SCI, V80, P511, DOI 10.4141/A00-009; Carpenter E, 1996, J ANIM SCI, V74, P388; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Chelh I, 2011, ANIMAL, V5, P278, DOI 10.1017/S1751731110001862; Chelh I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-196; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Duckett SK, 2000, J ANIM SCI, V78, P2836; Eltoweissy M, 2011, MOL BIOSYST, V7, P1277, DOI 10.1039/c0mb00116c; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Freking BA, 1998, J ANIM SCI, V76, P2062; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; He XY, 2011, J DIGEST DIS, V12, P131, DOI 10.1111/j.1751-2980.2011.00488.x; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jackson SP, 1997, J ANIM SCI, V75, P125; Jackson SP, 1997, J ANIM SCI, V75, P133; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Liu H, 2008, BIOCHEM BIOPH RES CO, V375, P477, DOI 10.1016/j.bbrc.2008.08.046; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; Mcnally RS, 2011, J BIOL CHEM, V286, P4098, DOI 10.1074/jbc.M110.147371; Meng ZX, 2013, NAT MED, V19, P640, DOI 10.1038/nm.3144; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Miyajima Y, 2010, ANTICANCER RES, V30, P265; Murphy SK, 2006, GENOME RES, V16, P340, DOI 10.1101/gr.4389306; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Perkins AC, 2006, ANIM GENET, V37, P535, DOI 10.1111/j.1365-2052.2006.01518.x; Pucci-Minafra I, 2008, J PROTEOME RES, V7, P1412, DOI 10.1021/pr700748m; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sandirasegarane L, 2001, BIOCHEM BIOPH RES CO, V283, P158, DOI 10.1006/bbrc.2001.4739; Shinbo YM, 2005, INT J ONCOL, V26, P641; Smit M, 2003, GENETICS, V163, P453; STAVAUX D, 1994, J VET MED A, V41, P229, DOI 10.1111/j.1439-0442.1994.tb00089.x; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	58	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92030	10.1371/journal.pone.0092030	http://dx.doi.org/10.1371/journal.pone.0092030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637782	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100105
J	Dazzi, L; Talani, G; Biggio, F; Utzeri, C; Lallai, V; Licheri, V; Lutzu, S; Mostallino, MC; Secci, PP; Biggio, G; Sanna, E				Dazzi, Laura; Talani, Giuseppe; Biggio, Francesca; Utzeri, Cinzia; Lallai, Valeria; Licheri, Valentina; Lutzu, Stefano; Mostallino, Maria Cristina; Secci, Pietro Paolo; Biggio, Giovanni; Sanna, Enrico			Involvement of the Cannabinoid CB1 Receptor in Modulation of Dopamine Output in the Prefrontal Cortex Associated with Food Restriction in Rats	PLOS ONE			English	Article							GABA RELEASE; EXTRACELLULAR DOPAMINE; BEHAVIOR; ANTAGONIST; INHIBITION; EXPRESSION; NEURONS; ENDOCANNABINOIDS; BRAIN; TRANSMISSION	Increase in dopamine output on corticolimbic structures, such as medial prefrontal cortex (mPFC) and nucleus accumbens, has been related to reward effects associated with palatable food or food presentation after a fasting period. The endocannabinoid system regulates feeding behavior through a modulatory action on different neurotransmitter systems, including the dopaminergic system. To elucidate the involvement of type 1 cannabinoid receptors in the regulation of dopamine output in the mPFC associated with feeding in hungry rats, we restricted the food availability to a 2-h period daily for 3 weeks. In food-restricted rats the extracellular dopamine concentration in the mPFC increased starting 80 min before food presentation and returned to baseline after food removal. These changes were attenuated in animals treated with the CB1 receptor antagonist SR141716. To better understand how food restriction can change the response of mesocortical dopaminergic neurons, we studied several components of the neuronal circuit that regulates dopamine output in the mPFC. Patch-clamp experiments revealed that the inhibitory effect of the CB1 receptor agonist WIN 55,212-2 on GABAergic sIPSC frequency was diminished in mPFC neurons of FR compared to fed ad libitum rats. The basal sIPSC frequency resulted reduced in mPFC neurons of food-restricted rats, suggestive of an altered regulation of presynaptic GABA release; these changes were accompanied by an enhanced excitability of mPFC and ventral tegmental area neurons. Finally, type 1 cannabinoid receptor expression in the mPFC was reduced in food-restricted rats. Together, our data support an involvement of the endocannabinoid system in regulation of dopamine release in the mPFC through changes in GABA inhibitory synapses and suggest that the emphasized feeding-associated increase in dopamine output in the mPFC of food-restricted rats might be correlated with an altered expression and function of type 1 cannabinoid receptor in this brain region.	[Dazzi, Laura; Biggio, Francesca; Utzeri, Cinzia; Lallai, Valeria; Licheri, Valentina; Lutzu, Stefano; Secci, Pietro Paolo; Biggio, Giovanni; Sanna, Enrico] Univ Cagliari, Ctr Excellence Neurobiol Dependence, Sect Neurosci & Anthropol, Dept Life & Environm Sci, Cagliari, Italy; [Talani, Giuseppe; Mostallino, Maria Cristina; Biggio, Giovanni; Sanna, Enrico] CNR, Inst Neurosci, Cagliari, Italy	University of Cagliari; Consiglio Nazionale delle Ricerche (CNR)	Dazzi, L (corresponding author), Univ Cagliari, Ctr Excellence Neurobiol Dependence, Sect Neurosci & Anthropol, Dept Life & Environm Sci, Cagliari, Italy.	dazzi@unica.it	lallai, valeria/AHE-2859-2022; sanna, enrico/HHY-8509-2022	Dazzi, Laura/0000-0002-7102-0530	Regione Autonoma della Sardegna (RAS)	Regione Autonoma della Sardegna (RAS)(Russian Academy of SciencesRegione Sardegna)	Funding for this study was provided by grants from Regione Autonoma della Sardegna (RAS). RAS had no further role in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the paper for publication.	Abood ME, 2005, HANDB EXP PHARMACOL, V168, P81; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Bassareo V, 1997, J NEUROSCI, V17, P851; Beaufour CC, 2001, PHARMACOL BIOCHEM BE, V69, P133, DOI 10.1016/S0091-3057(01)00492-0; Bello NT, 2012, PHYSIOL BEHAV, V105, P720, DOI 10.1016/j.physbeh.2011.09.021; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Carr TP, 2008, NUTR RES, V28, P641, DOI 10.1016/j.nutres.2008.08.003; Chiu CQ, 2010, J NEUROSCI, V30, P7236, DOI 10.1523/JNEUROSCI.0736-10.2010; Dazzi L, 1997, SYNAPSE, V26, P351; De Luca MA, 2012, NEUROPHARMACOLOGY, V63, P161, DOI 10.1016/j.neuropharm.2011.10.018; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; Egerton A, 2006, NEUROSCI BIOBEHAV R, V30, P680, DOI 10.1016/j.neubiorev.2005.12.002; EVANS KR, 1987, PHARMACOL BIOCHEM BE, V27, P649, DOI 10.1016/0091-3057(87)90189-4; FIBIGER HC, 1973, BRAIN RES, V55, P135, DOI 10.1016/0006-8993(73)90493-9; FUKUDA A, 1993, J NEUROPHYSIOL, V70, P448, DOI 10.1152/jn.1993.70.1.448; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Ghiani CA, 1998, PHARMACOL BIOCHEM BE, V59, P657, DOI 10.1016/S0091-3057(97)00426-7; GRACE AA, 1989, J NEUROSCI, V9, P3463; Ito R, 2000, J NEUROSCI, V20, P7489; Jentsch JD, 1997, NEUROPSYCHOPHARMACOL, V16, P426, DOI 10.1016/S0893-133X(97)00018-3; Katona I, 1999, J NEUROSCI, V19, P4544; Kiritoshi T, 2013, NEUROPHARMACOLOGY, V66, P170, DOI 10.1016/j.neuropharm.2012.03.024; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kirkham TC, 2001, NUTR RES REV, V14, P65, DOI 10.1079/NRR200118; Kobayashi M, 2012, J NEUROPHYSIOL, V107, P1431, DOI 10.1152/jn.00813.2011; Koch JE, 2001, NUTR NEUROSCI, V4, P179, DOI 10.1080/1028415X.2001.11747361; Lovinger David M., 2008, V184, P435; Maccioni P, 2008, BEHAV PHARMACOL, V19, P197, DOI 10.1097/FBP.0b013e3282fe8888; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Marongiu MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035013; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; McLaughlin PJ, 2003, BEHAV PHARMACOL, V14, P583, DOI 10.1097/00008877-200312000-00002; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Melis T, 2007, NEUROSCI LETT, V419, P231, DOI 10.1016/j.neulet.2007.04.012; Monteleone P, 2012, J CLIN ENDOCR METAB, V97, pE917, DOI 10.1210/jc.2011-3018; Oleson EB, 2012, NEURON, V73, P360, DOI 10.1016/j.neuron.2011.11.018; Paxinos G., 2004, J CHEM INF MODEL, V5th; Pistis M, 2002, BRAIN RES, V948, P155, DOI 10.1016/S0006-8993(02)03055-X; RETAUX S, 1991, NEUROSCIENCE, V43, P323, DOI 10.1016/0306-4522(91)90296-Z; Ross HE, 1999, INT J EAT DISORDER, V26, P245, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;245::AID-EAT2&gt;3.0.CO;2-R; Rubino T, 2000, SYNAPSE, V35, P8, DOI 10.1002/(SICI)1098-2396(200001)35:1<8::AID-SYN2>3.0.CO;2-Y; Sanna E, 2011, FRONT NEUROSCI, V10, P5; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Talani G, 2011, FRONT ENDOCRINOL, V2, P1; Thompson SE, 2006, NEUROSIGNALS, V15, P202, DOI 10.1159/000098515; Timofeeva E, 2009, J NEUROENDOCRINOL, V21, P982, DOI 10.1111/j.1365-2826.2009.01921.x; Trettel J, 2002, J NEUROPHYSIOL, V88, P534, DOI 10.1152/jn.2002.88.1.534; Tzavara ET, 2003, BRIT J PHARMACOL, V138, P544, DOI 10.1038/sj.bjp.0705100; Verrico CD, 2003, SYNAPSE, V48, P178, DOI 10.1002/syn.10202; Weed JL, 1997, PHYSIOL BEHAV, V62, P97, DOI 10.1016/S0031-9384(97)00147-9; Williams CM, 2002, PHARMACOL BIOCHEM BE, V71, P333, DOI 10.1016/S0091-3057(01)00694-3	53	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92224	10.1371/journal.pone.0092224	http://dx.doi.org/10.1371/journal.pone.0092224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632810	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400153
J	Egarter, S; Andenmatten, N; Jackson, AJ; Whitelaw, JA; Pall, G; Black, JA; Ferguson, DJP; Tardieux, I; Mogilner, A; Meissner, M				Egarter, Saskia; Andenmatten, Nicole; Jackson, Allison J.; Whitelaw, Jamie A.; Pall, Gurman; Black, Jennifer Ann; Ferguson, David J. P.; Tardieux, Isabelle; Mogilner, Alex; Meissner, Markus			The Toxoplasma Acto-MyoA Motor Complex Is Important but Not Essential for Gliding Motility and Host Cell Invasion	PLOS ONE			English	Article							GONDII MYOSIN-A; APICOMPLEXAN PARASITES; RHOPTRY ORGANELLES; MOVING JUNCTION; DYNAMICS; GENE; CYTOSKELETON; MECHANISM; MEMBRANE; ADHESION	Apicomplexan parasites are thought to actively invade the host cell by gliding motility. This movement is powered by the parasite's own actomyosin system, and depends on the regulated polymerisation and depolymerisation of actin to generate the force for gliding and host cell penetration. Recent studies demonstrated that Toxoplasma gondii can invade the host cell in the absence of several core components of the invasion machinery, such as the motor protein myosin A (MyoA), the microneme proteins MIC2 and AMA1 and actin, indicating the presence of alternative invasion mechanisms. Here the roles of MyoA, MLC1, GAP45 and Act1, core components of the gliding machinery, are re-dissected in detail. Although important roles of these components for gliding motility and host cell invasion are verified, mutant parasites remain invasive and do not show a block of gliding motility, suggesting that other mechanisms must be in place to enable the parasite to move and invade the host cell. A novel, hypothetical model for parasite gliding motility and invasion is presented based on osmotic forces generated in the cytosol of the parasite that are converted into motility.	[Egarter, Saskia; Andenmatten, Nicole; Jackson, Allison J.; Whitelaw, Jamie A.; Pall, Gurman; Black, Jennifer Ann; Meissner, Markus] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Ferguson, David J. P.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Tardieux, Isabelle] Univ Paris 05, Inst Cochin, INSERM U 1016, CNRS UMR 8104, Paris, France; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of Glasgow; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Davis; University of California System; University of California Davis	Meissner, M (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	markus.meissner@glasgow.ac.uk	Whitelaw, Jamie/HHZ-1062-2022; Tardieux, Isabelle/G-4733-2014	Whitelaw, Jamie/0000-0001-6739-1032; Tardieux, Isabelle/0000-0002-5677-7463; Black, Jennifer Ann/0000-0001-5219-3172; Ferguson, David/0000-0001-5045-819X; Egarter, Saskia/0000-0003-2577-9228; Meissner, Markus/0000-0002-5341-5969	Wellcome Trust; Wellcome Trust Senior Fellowship [087582/Z/08/Z]; ERC Starting Grant [ERC-2012-StG 309255]; EviMalaR PhD fellowship [242095]; Wellcome Trust [085349]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Senior Fellowship(Wellcome Trust); ERC Starting Grant(European Research Council (ERC)); EviMalaR PhD fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Wellcome Trust. M.M. is funded by a Wellcome Trust Senior Fellowship (087582/Z/08/Z) and an ERC Starting Grant (ERC-2012-StG 309255). N.A. is supported by an EviMalaR (European FP7/2007-2013, grant number 242095) PhD fellowship. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Atzberger PJ, 2009, PHYSICA D, V238, P1168, DOI 10.1016/j.physd.2009.03.018; Bargieri DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3552; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Charras GT, 2009, J CELL SCI, V122, P3233, DOI 10.1242/jcs.049262; Daher W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001132; Delbac F, 2001, J CELL BIOL, V155, P613, DOI 10.1083/jcb.200012116; Delorme-Walker V, 2012, J CELL SCI, V125, P4333, DOI 10.1242/jcs.103648; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700; Hellmann JK, 2013, ADV HEALTHC MATER, V2, P1162, DOI 10.1002/adhm.201200426; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kenthirapalan S, 2012, INT J PARASITOL, V42, P1185, DOI 10.1016/j.ijpara.2012.10.006; Kessler H, 2008, J CELL SCI, V121, P947, DOI 10.1242/jcs.022350; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Meissner M, 2013, CURR OPIN MICROBIOL, V16, P438, DOI 10.1016/j.mib.2013.05.002; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Mueller C, 2013, CELL HOST MICROBE, V13, P289, DOI 10.1016/j.chom.2013.02.001; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Nardi J, 1999, PHYS REV LETT, V82, P5168, DOI 10.1103/PhysRevLett.82.5168; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; OSTER GF, 1987, J CELL SCI, P35; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Polonais V, 2011, TRAFFIC, V12, P287, DOI 10.1111/j.1600-0854.2010.01148.x; RYNING FW, 1978, INFECT IMMUN, V20, P739, DOI 10.1128/IAI.20.3.739-743.1978; Sebastian S, 2012, CELL HOST MICROBE, V12, P9, DOI 10.1016/j.chom.2012.05.014; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Sibley LD, 2010, CURR OPIN BIOTECH, V21, P592, DOI 10.1016/j.copbio.2010.05.009; Skillman KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3285; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Starnes GL, 2009, CELL HOST MICROBE, V5, P353, DOI 10.1016/j.chom.2009.03.005; STEINBERG IZ, 1966, NATURE, V210, P568, DOI 10.1038/210568a0; Venit T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061406; Volkmann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041409; Xian WJ, 1999, BIOCHEMISTRY-US, V38, P7219, DOI 10.1021/bi982301f	56	79	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91819	10.1371/journal.pone.0091819	http://dx.doi.org/10.1371/journal.pone.0091819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632839	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332858400098
J	Sievert, W; Tapio, S; Breuninger, S; Gaipl, U; Andratschke, N; Trott, KR; Multhoff, G				Sievert, Wolfgang; Tapio, Soile; Breuninger, Stephanie; Gaipl, Udo; Andratschke, Nicolaus; Trott, Klaus-Ruediger; Multhoff, Gabriele			Adhesion Molecule Expression and Function of Primary Endothelial Cells in Benign and Malignant Tissues Correlates with Proliferation	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; VE-CADHERIN; MONOCLONAL-ANTIBODY; ENDOGLIN CD105; MELANOMA CELLS; ANGIOGENESIS; CD34; GENE; VASCULATURE; MODULATION	Background: Comparative analysis of the cellular biology of the microvasculature in different tissues requires the availability of viable primary endothelial cells (ECs). This study describes a novel method to isolate primary ECs from healthy organs, repair blastemas and tumors as examples of non-proliferating and proliferating benign and malignant tissues and their functional characterization. Methodology/Principal Findings: Single cell suspensions from hearts, lungs, repair blastemas and tumors were incubated consecutively with an anti-CD31 antibody and magnetic micro-beads, coupled to a derivative of biotin and streptavidin, respectively. Following magnetic bead separation, CD31-positive ECs were released by biotin-streptavidin competition. In the absence of micro-beads, ECs became adherent to plastic surfaces. ECs from proliferating repair blastemas and tumors were larger and exhibited higher expression densities of CD31, CD105 and CD102 compared to those from non-proliferating normal tissues such as heart and lung. The expression density of CD34 was particularly high in tumor-derived ECs, and that of CD54 and CD144 in ECs of repair blastemas. Functionally, ECs of non-proliferating and proliferating tissues differed in their capacity to form tubes in matrigel and to align under flow conditions. Conclusions/Significance: This method provides a powerful tool to generate high yields of viable, primary ECs of different origins. The results suggest that an altered expression of adhesion molecules on ECs in proliferating tissues contribute to loss of EC function that might cause a chaotic tumor vasculature.	[Sievert, Wolfgang; Breuninger, Stephanie; Andratschke, Nicolaus; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-80290 Munich, Germany; [Sievert, Wolfgang; Breuninger, Stephanie; Andratschke, Nicolaus; Multhoff, Gabriele] Helmholtz Zentrum Munchen HMGU, German Res Ctr Environm Hlth Munich, Clin Cooperat Grp CCG Innate Immun Tumor Biol, Neuherberg, Germany; [Tapio, Soile] Helmholtz Zentrum Munchen HMGU, German Res Ctr Environm Hlth Munich, Dept Radiat Biol, Neuherberg, Germany; [Gaipl, Udo] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Trott, Klaus-Ruediger] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London, England	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Imperial College London	Multhoff, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-80290 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Multhoff, Gabriele/AAW-9796-2021; Tapio, Soile/CAJ-5871-2022; Gaipl, Udo/AAE-1060-2020; Tapio, Soile/M-7358-2014	Multhoff, Gabriele/0000-0002-2616-3137; Tapio, Soile/0000-0001-9860-3683	Deutsche Forschungsgemeinschaft (DFG) [SFB814, (DFG) INST95/980-1 FUGG]; DFG- Cluster of Excellence: MunichAdvanced Photonics (MAP); BMBF; m4 - Cluster of Excellence [01EX1021C]; Kompetenzverbund Strahlenforschung [03NUK007E]; European Union (EU CARDIORISK) [FP7-2114033]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG- Cluster of Excellence: MunichAdvanced Photonics (MAP)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); m4 - Cluster of Excellence; Kompetenzverbund Strahlenforschung; European Union (EU CARDIORISK)	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB814, (DFG) INST95/980-1 FUGG, DFG- Cluster of Excellence: MunichAdvanced Photonics (MAP), BMBF, m4 - Cluster of Excellence (01EX1021C), Kompetenzverbund Strahlenforschung (03NUK007E), and the European Union (EU CARDIORISK, FP7-2114033). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; DENEKAMP J, 1991, RADIOTHER ONCOL, V20, P103, DOI 10.1016/0167-8140(91)90196-N; DUSTIN ML, 1986, J IMMUNOL, V137, P245; FIDLER IJ, 1975, CANCER RES, V35, P218; Fiedler U, 2006, AM J PATHOL, V168, P1045, DOI 10.2353/ajpath.2006.050554; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fonsatti Ester, 2004, J Transl Med, V2, P18, DOI 10.1186/1479-5876-2-18; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Haveman J, 2007, J RADIAT RES, V48, P107, DOI 10.1269/jrr.0631; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hendry JH, 2008, RADIAT ENVIRON BIOPH, V47, P189, DOI 10.1007/s00411-007-0155-7; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Ikubo A, 1999, CLIN EXP METASTAS, V17, P849, DOI 10.1023/A:1006730320248; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Liao F, 2002, CANCER RES, V62, P2567; Liao F, 2000, CANCER RES, V60, P6805; LIN GS, 1995, EUR J IMMUNOL, V25, P1508, DOI 10.1002/eji.1830250606; Maltby S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018160; MIELE ME, 1994, EXP CELL RES, V214, P231, DOI 10.1006/excr.1994.1253; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Park S, 2010, AM J PHYSIOL-CELL PH, V299, pC1468, DOI 10.1152/ajpcell.00246.2010; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; Postiglione L, 2005, INT J ONCOL, V26, P1193; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Scholz D, 1997, CELL TISSUE RES, V290, P623, DOI 10.1007/s004410050968; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; Solowiej A, 2003, AM J PATHOL, V162, P953, DOI 10.1016/S0002-9440(10)63890-4; Steri V, 2014, CIRC RES, V114, P79, DOI 10.1161/CIRCRESAHA.114.301591; STOCKINGER H, 1990, J IMMUNOL, V145, P3889; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; Wood HB, 1997, BLOOD, V90, P2300; Xu H, 1996, J IMMUNOL, V156, P4909; Zhou Z, 1999, Angiogenesis, V3, P181, DOI 10.1023/A:1009092107382	45	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91808	10.1371/journal.pone.0091808	http://dx.doi.org/10.1371/journal.pone.0091808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632811	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000332858400094
J	Zhang, B; Shen, CY; Bealmear, B; Ragheb, S; Xiong, WC; Lewis, RA; Lisak, RP; Mei, L				Zhang, Bin; Shen, Chengyong; Bealmear, Beverly; Ragheb, Samia; Xiong, Wen-Cheng; Lewis, Richard A.; Lisak, Robert P.; Mei, Lin			Autoantibodies to Agrin in Myasthenia Gravis Patients	PLOS ONE			English	Article							TYROSINE KINASE MUSK; ACETYLCHOLINE-RECEPTOR; PROTEIN 4; DISTINCT ROLES; MUSCLE; ANTIBODY; LRP4; DIFFERENTIATION; LOCALIZATION; AGGREGATION	To determine if patients with myasthenia gravis (MG) have antibodies to agrin, a proteoglycan released by motor neurons and is critical for neuromuscular junction (NMJ) formation, we collected serum samples from 93 patients with MG with known status of antibodies to acetylcholine receptor (AChR), muscle specific kinase (MuSK) and lipoprotein-related 4 (LRP4) and samples from control subjects (healthy individuals and individuals with other diseases). Sera were assayed for antibodies to agrin. We found antibodies to agrin in 7 serum samples of MG patients. None of the 25 healthy controls and none of the 55 control neurological patients had agrin antibodies. Two of the four triple negative MG patients (i.e., no detectable AChR, MuSK or LRP4 antibodies, AChR-/MuSK-/LRP4-) had antibodies against agrin. In addition, agrin antibodies were detected in 5 out of 83 AChR+/MuSK-/LRP4- patients but were not found in the 6 patients with MuSK antibodies (AChR-/MuSK+/LRP4-). Sera from MG patients with agrin antibodies were able to recognize recombinant agrin in conditioned media and in transfected HEK293 cells. These sera also inhibited the agrin-induced MuSK phosphorylation and AChR clustering in muscle cells. Together, these observations indicate that agrin is another autoantigen in patients with MG and agrin autoantibodies may be pathogenic through inhibition of agrin/LRP4/MuSK signaling at the NMJ.	[Zhang, Bin; Shen, Chengyong; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA; [Zhang, Bin] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Zhang, Bin] Huazhong Univ Sci & Technol, Tongji Med Coll, Basic Med Sch, Dept Physiol, Wuhan, Hubei Province, Peoples R China; [Bealmear, Beverly; Ragheb, Samia; Lewis, Richard A.; Lisak, Robert P.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Ragheb, Samia] Oakland Univ, William Beaumont Sch Med, Dept Biomed Sci, Rochester, MI 48063 USA; [Lewis, Richard A.] Cedars Sinai Med Ctr, Dept Neurol, West Hollywood, CA USA; [Lisak, Robert P.] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI USA; [Shen, Chengyong; Xiong, Wen-Cheng; Mei, Lin] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Huazhong University of Science & Technology; Wayne State University; Oakland University; Cedars Sinai Medical Center; Wayne State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mei, L (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA.	lmei@gru.edu		Xiong, Wen-Cheng/0000-0001-9071-7598; Zhang, Bin/0000-0003-1323-8678	National Institutes of Health; Parker Webber Chair in Neurology Endowment; Mary Parker Neuroscience Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Webber Chair in Neurology Endowment; Mary Parker Neuroscience Fund	This work was supported in part by grants from National Institutes of Health (WCX, LM), and by Parker Webber Chair in Neurology Endowment and the Mary Parker Neuroscience Fund (SR, RPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONOV A, 1975, P NATL ACAD SCI USA, V72, P1456, DOI 10.1073/pnas.72.4.1456; Alshekhlee A, 2009, NEUROLOGY, V72, P1548, DOI 10.1212/WNL.0b013e3181a41211; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; CHRISTADOSS P, 1981, J IMMUNOL, V126, P1646; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Cossins J, 2012, ANN NY ACAD SCI, V1275, P123, DOI 10.1111/j.1749-6632.2012.06833.x; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; ENGEL AG, 1977, MAYO CLIN PROC, V52, P267; ENGEL AG, 1987, ANN NY ACAD SCI, V505, P326, DOI 10.1111/j.1749-6632.1987.tb51301.x; ENGEL AG, 1976, J NEUROPATH EXP NEUR, V35, P569, DOI 10.1097/00005072-197609000-00008; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GOMEZ CM, 1983, P NATL ACAD SCI-BIOL, V80, P4089, DOI 10.1073/pnas.80.13.4089; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; KAO I, 1977, SCIENCE, V196, P527, DOI 10.1126/science.850793; Kim JY, 2011, J CLIN NEUROL, V7, P173, DOI 10.3988/jcn.2011.7.4.173; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kumar V, 2011, CURR NEUROL NEUROSCI, V11, P89, DOI 10.1007/s11910-010-0151-1; Lavrnic D, 2005, J NEUROL NEUROSUR PS, V76, P1099, DOI 10.1136/jnnp.2004.052415; Leite MI, 2005, ANN NEUROL, V57, P444, DOI 10.1002/ana.20386; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LINDSTROM JM, 1976, ANN NY ACAD SCI, V274, P254, DOI 10.1111/j.1749-6632.1976.tb47691.x; Lindstrom JM, 2000, MUSCLE NERVE, V23, P453, DOI 10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; Luo SW, 2008, NEURON, V60, P97, DOI 10.1016/j.neuron.2008.08.013; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; Phillips LH, 2003, ANN NY ACAD SCI, V998, P407, DOI 10.1196/annals.1254.053; Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018; Richman DP, 2003, NEUROLOGY, V61, P1652, DOI 10.1212/01.WNL.0000098887.24618.A0; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; Saka E, 2005, NEUROLOGY, V65, P782, DOI 10.1212/WNL.65.5.782; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shen CY, 2013, J CLIN INVEST, V123, P5190, DOI 10.1172/JCI66039; Shigemoto K, 2008, ANN NY ACAD SCI, V1132, P93, DOI 10.1196/annals.1405.002; Suhail H, 2010, INT J NEUROSCI, V120, P115, DOI 10.3109/00207450903389131; ter Beek WP, 2009, AM J PATHOL, V175, P1536, DOI 10.2353/ajpath.2009.090040; Tsiamalos P, 2009, EUR J NEUROL, V16, P925, DOI 10.1111/j.1468-1331.2009.02624.x; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393; Zhou L, 2004, MUSCLE NERVE, V30, P55, DOI 10.1002/mus.20069; Zisimopoulou P, 2013, J AUTOIMMUNITY	69	97	101	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91816	10.1371/journal.pone.0091816	http://dx.doi.org/10.1371/journal.pone.0091816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632822	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400096
J	Zhang, Y; Liu, B; Yang, S; An, JB; Chen, CH; Zhang, XL; Ren, HZ				Zhang, Yan; Liu, Bin; Yang, Sen; An, Jingbo; Chen, Chunhua; Zhang, Xiaolan; Ren, Huazhong			A Cucumber DELLA Homolog CsGAIP May Inhibit Staminate Development through Transcriptional Repression of B Class Floral Homeotic Genes	PLOS ONE			English	Article							GAMYB-LIKE GENES; GIBBERELLIN RECEPTOR; ARABIDOPSIS-THALIANA; MOLECULAR-MECHANISM; SEX DETERMINATION; SYNTHASE GENE; FEMALE FLOWER; GAI GENE; SATIVUS; EXPRESSION	In hermaphroditic Arabidopsis, the phytohormone gibberellin (GA) stimulates stamen development by opposing the DELLA repression of B and C classes of floral homeotic genes. GA can promote male flower formation in cucumber (Cucumis sativus L.), a typical monoecious vegetable with unisexual flowers, and the molecular mechanism remains unknown. Here we characterized a DELLA homolog CsGAIP in cucumber, and we found that CsGAIP is highly expressed in stem and male flower buds. In situ hybridization showed that CsGAIP is greatly enriched in the stamen primordia, especially during the hermaphrodite stage of flower development. Further, CsGAIP protein is located in nucleus. CsGAIP can partially rescue the plant height, stamen development and fertility phenotypes of Arabidopsis rga-24/gai-t6 mutant, and ectopic expression of CsGAIP in wide-type Arabidopsis results in reduced number of stamens and decreased transcription of B class floral homeotic genes APETALA3 (AP3) and PISTILLATA (PI). Our data suggest that monoecious CsGAIP may inhibit staminate development through transcriptional repression of B class floral homeotic genes in Arabidopsis.	[Zhang, Xiaolan] China Agr Univ, Coll Agron & Biotechnol, Dept Vegetable Sci, Beijing 100094, Peoples R China; China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Zhang, XL (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Dept Vegetable Sci, Beijing 100094, Peoples R China.	zhxiaolan@cau.edu.cn; renhuazhong@cau.edu.cn	Liu, Bin/B-4768-2018	Liu, Bin/0000-0002-0855-0213	National Basic Research Program of China [2009CB119000]; Research Projects for the Areas of Public Interest (Agriculture) [201203003]; National Key Research Program of China [2011BAD12B03, 2013BAD20B01]; Key Project of Scientific & Technological Research of Beijing [D131100000713001]; national basic research of China 973 program [2012CB113900]	National Basic Research Program of China(National Basic Research Program of China); Research Projects for the Areas of Public Interest (Agriculture); National Key Research Program of China; Key Project of Scientific & Technological Research of Beijing; national basic research of China 973 program(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (2009CB119000); Research Projects for the Areas of Public Interest (Agriculture, 201203003); National Key Research Program of China (2011BAD12B03 and 2013BAD20B01); Key Project of Scientific & Technological Research of Beijing (D131100000713001) to HR; and by the national basic research of China 973 program (2012CB113900) to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; Borner A, 1996, EUPHYTICA, V89, P69, DOI 10.1007/BF00015721; Chen XueHao, 2003, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V24, P68; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dill A, 2001, GENETICS, V159, P777; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Gubler F, 1999, PLANT J, V17, P1, DOI 10.1046/j.1365-313X.1999.00346.x; Hao YJ, 2003, PLANTA, V217, P888, DOI 10.1007/s00425-003-1064-x; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; HARBERD NP, 1989, GENETICS, V121, P827; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Helliwell CA, 1998, P NATL ACAD SCI USA, V95, P9019, DOI 10.1073/pnas.95.15.9019; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; Huang HY, 2013, SCI HORTIC-AMSTERDAM, V150, P206, DOI 10.1016/j.scienta.2012.11.011; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; King KE, 2001, GENETICS, V159, P767; King RW, 2003, ANNU REV PLANT BIOL, V54, P307, DOI 10.1146/annurev.arplant.54.031902.135029; Knopf RR, 2006, PLANT CELL PHYSIOL, V47, P1217, DOI 10.1093/pcp/pcj092; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; MALEPSZY S, 1991, PLANT SCI, V80, P39, DOI 10.1016/0168-9452(91)90271-9; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PHARIS RP, 1985, ANNU REV PLANT PHYS, V36, P517, DOI 10.1146/annurev.pp.36.060185.002505; PIKE LM, 1969, EUPHYTICA, V18, P106; ROOD SB, 1980, PLANT PHYSIOL, V66, P793, DOI 10.1104/pp.66.5.793; Saito S, 2007, J EXP BOT, V58, P2897, DOI 10.1093/jxb/erm141; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwechheimer C, 2008, CURR OPIN PLANT BIOL, V11, P9, DOI 10.1016/j.pbi.2007.10.011; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Silverstone AL, 1997, PLANT J, V12, P9, DOI 10.1046/j.1365-313X.1997.12010009.x; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Sun TP, 2010, PLANT PHYSIOL, V154, P567, DOI 10.1104/pp.110.161554; Swain SM, 2004, PLANT PHYSIOL, V134, P694, DOI 10.1104/pp.103.031666; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trebitsh T, 1997, PLANT PHYSIOL, V113, P987, DOI 10.1104/pp.113.3.987; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Wang DH, 2010, PLANT J, V61, P862, DOI 10.1111/j.1365-313X.2009.04114.x; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; WITTWER SH, 1962, NATURWISSENSCHAFTEN, V49, P305, DOI 10.1007/BF00622719; Wu J, 2011, PLANT PHYSIOL, V157, P2120, DOI 10.1104/pp.111.185272; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yamasaki S, 2003, SEX PLANT REPROD, V16, P103, DOI 10.1007/s00497-003-0183-7; Yamasaki S, 2003, PLANT CELL ENVIRON, V26, P537, DOI 10.1046/j.1365-3040.2003.00984.x; Yamasaki S, 2001, PLANT CELL PHYSIOL, V42, P608, DOI 10.1093/pcp/pce076; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; Zhang XL, 2013, PLANT CELL, V25, P83, DOI 10.1105/tpc.112.107854	64	19	22	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91804	10.1371/journal.pone.0091804	http://dx.doi.org/10.1371/journal.pone.0091804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632777	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400092
J	Kotagal, M; Agarwal-Harding, KJ; Mock, C; Quansah, R; Arreola-Risa, C; Meara, JG				Kotagal, Meera; Agarwal-Harding, Kiran J.; Mock, Charles; Quansah, Robert; Arreola-Risa, Carlos; Meara, John G.			Health and Economic Benefits of Improved Injury Prevention and Trauma Care Worldwide	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; COST-EFFECTIVENESS; STATISTICAL LIFE; GLOBAL BURDEN; MORTALITY; SURGERY; LIVES; DISEASES	Objectives: Injury is a significant source of morbidity and mortality worldwide, and often disproportionately affects younger, more productive members of society. While many have made the case for improved injury prevention and trauma care, health system development in low-and middle-income countries is often limited by resources. This study aims to determine the economic benefit of improved injury prevention and trauma care in low-and middle-income countries. Methods: This study uses existing data on injury mortality worldwide from the 2010 Global Burden of Disease Study to estimate the number of lives that could be saved if injury mortality rates in low-and middle-income countries could be reduced to rates in high-income countries. Using economic modeling - through the human capital approach and the value of a statistical life approach - the study then demonstrates the associated economic benefit of these lives saved. Results: 88 percent of injury-related deaths occur in low-and middle-income countries. If injury mortality rates in low-and middle-income countries were reduced to rates in high-income countries, 2,117,500 lives could be saved per year. This would result in between 49 million and 52 million disability adjusted life years averted per year, with discounting and age weighting. Using the human capital approach, the associated economic benefit of reducing mortality rates ranges from $245 to $261 billion with discounting and age weighting. Using the value of a statistical life approach, the benefit is between 758 and 786 billion dollars per year. Conclusions: Reducing injury mortality in low-and middle-income countries could save over 2 million lives per year and provide significant economic benefit globally. Further investments in trauma care and injury prevention are needed.	[Kotagal, Meera] Harvard Univ, Sch Med, Dept Surg, Univ Washington,Program Global Surg & Social Chan, Seattle, WA 98122 USA; [Agarwal-Harding, Kiran J.; Meara, John G.] Harvard Univ, Sch Med, Dept Plast & Oral Surg, Boston Childrens Hosp,Program Global Surg & Socia, Boston, MA USA; [Mock, Charles] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Quansah, Robert] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Surg, Kumasi, Ghana; [Arreola-Risa, Carlos] Tecnol Monterrey, Sch Med, Dept Emergency Med, Monterrey, Mexico	Harvard University; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard Medical School; Harborview Medical Center; University of Washington; University of Washington Seattle; Kwame Nkrumah University Science & Technology; Tecnologico de Monterrey	Kotagal, M (corresponding author), Harvard Univ, Sch Med, Dept Surg, Univ Washington,Program Global Surg & Social Chan, Seattle, WA 98122 USA.	mkotagal@uw.edu		Meara, John G./0000-0003-4369-3209; Mock, Charles/0000-0002-0564-568X	University of Washington Department of Surgery T32 training fellowship grant from the National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK070555-03]; Doris Duke Clinical Research Fellowship; Program in Global Surgery and Social Change (PGSSC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK070555] Funding Source: NIH RePORTER	University of Washington Department of Surgery T32 training fellowship grant from the National Institute of Diabetes and Digestive and Kidney Diseases; Doris Duke Clinical Research Fellowship(Doris Duke Charitable Foundation (DDCF)); Program in Global Surgery and Social Change (PGSSC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Kotagal is supported by a University of Washington Department of Surgery T32 training fellowship grant from the National Institute of Diabetes and Digestive and Kidney Diseases (grant 5T32DK070555-03). Mr. Agarwal-Harding was supported by the Doris Duke Clinical Research Fellowship and The Program in Global Surgery and Social Change (PGSSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldy JE, 2008, REV ECON STAT, V90, P573, DOI 10.1162/rest.90.3.573; Alkire B, 2011, WORLD J SURG, V35, P1194, DOI 10.1007/s00268-011-1055-1; Alkire BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034595; [Anonymous], 2012, GLOBAL BURDEN DIS IN; [Anonymous], 2010, FREQUENTLY ASKED QUE; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Fieno JV, 2008, AIDS CARE, V20, P515, DOI 10.1080/09540120701867149; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; Hammitt JK, 2007, REV ENV ECON POLICY, V1, P228, DOI 10.1093/reep/rem015; Jamison D.T., 1993, DIS CONTROL PRIORITI; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marseille E, 1996, B WORLD HEALTH ORGAN, V74, P319; McCord C, 2003, INT J GYNECOL OBSTET, V81, P83, DOI 10.1016/S0020-7292(03)00072-9; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Rivara FP, 2005, INJURY PREV, V11, P321, DOI 10.1136/ip.2005.009928; Sachs J.D., 2001, MACROECONOMICS HLTH; Tiska MA, 2004, EMERG MED J, V21, P237, DOI 10.1136/emj.2002.002097; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; World Bank, 2011, WORLD BANK OP DAT	30	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91862	10.1371/journal.pone.0091862	http://dx.doi.org/10.1371/journal.pone.0091862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626472	Green Published, gold			2022-12-27	WOS:000332851300141
J	Beaudry, JL; Dunford, EC; Teich, T; Zaharieva, D; Hunt, H; Belanoff, JK; Riddell, MC				Beaudry, Jacqueline L.; Dunford, Emily C.; Teich, Trevor; Zaharieva, Dessi; Hunt, Hazel; Belanoff, Joseph K.; Riddell, Michael C.			Effects of Selective and Non-Selective Glucocorticoid Receptor II Antagonists on Rapid-Onset Diabetes in Young Rats	PLOS ONE			English	Article							INSULIN SENSITIVITY; MIFEPRISTONE RU-486; FASTING GLUCOSE; WEIGHT-GAIN; RU 486; FAT; MECHANISMS; OLANZAPINE; STRESS; RESISTANCE	The blockade of glucocorticoid (GC) action through antagonism of the glucocorticoid receptor II (GRII) has been used to minimize the undesirable effects of chronically elevated GC levels. Mifepristone (RU486) is known to competitively block GRII action, but not exclusively, as it antagonizes the progesterone receptor. A number of new selective GRII antagonists have been developed, but limited testing has been completed in animal models of overt type 2 diabetes mellitus. Therefore, two selective GRII antagonists (C113176 and C108297) were tested to determine their effects in our model of GC-induced rapid-onset diabetes (ROD). Male Sprague-Dawley rats (similar to six weeks of age) were placed on a high-fat diet (60%), surgically implanted with pellets containing corticosterone (CORT) or wax (control) and divided into five treatment groups. Each group was treated with either a GRII antagonist or vehicle for 14 days after surgery: CORT pellets (400 mg/rat) + antagonists (80 mg/kg/day); CORT pellets + drug vehicle; and wax pellets (control) + drug vehicle. After 10 days of CORT treatment, body mass gain was increased with RU486 (by similar to 20% from baseline) and maintained with C113176 administration, whereas rats given C108297 had similar body mass loss (similar to 15%) to ROD animals. Fasting glycemia was elevated in the ROD animals (> 20 mM), normalized completely in animals treated with RU486 (6.2 +/- 0.1 mM, p < 0.05) and improved in animals treated with C108297 and C113176 (14.0 +/- 1.6 and 8.8 +/- 1.6 mM, p < 0.05 respectively). Glucose intolerance was normalized with RU486 treatment, whereas acute insulin response was improved with RU486 and C113176 treatment. Also, peripheral insulin resistance was attenuated with C113176 treatment along with improved levels of beta-cell function while C108297 antagonism only provided modest improvements. In summary, C113176 is an effective agent that minimized some GC-induced detrimental metabolic effects and may provide an alternative to the effective, but non-selective, GRII antagonist RU486.	[Beaudry, Jacqueline L.; Dunford, Emily C.; Teich, Trevor; Zaharieva, Dessi; Riddell, Michael C.] York Univ, Sch Kinesiol & Hlth Sci, Fac Hlth, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Beaudry, Jacqueline L.; Dunford, Emily C.; Teich, Trevor; Zaharieva, Dessi; Riddell, Michael C.] York Univ, Phys Act & Chron Dis Unit, Toronto, ON M3J 2R7, Canada; [Hunt, Hazel; Belanoff, Joseph K.] Corcept Therapeut, Menlo Pk, CA USA	York University - Canada; York University - Canada	Riddell, MC (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Fac Hlth, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada.	mriddell@yorku.ca		Zaharieva, Dessi/0000-0002-9374-8469	Corcept Therapuetics; Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC-Canadian Graduate Scholarship Doctoral Award	Corcept Therapuetics; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-Canadian Graduate Scholarship Doctoral Award	This study was funded by Corcept Therapuetics and the Natural Sciences and Engineering Research Council of Canada (NSERC) grant to MCR. JLB is a recipient of an NSERC-Canadian Graduate Scholarship Doctoral Award. The funders had no role in data collection or analysis. The funders did help to prepare the manuscript for submission.	Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; [Anonymous], 2012, MED LETT DRUGS THER, V54, P46; Asagami T, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/235389; Beaudry JL, 2013, ENDOCRINOLOGY, V154, P3197, DOI 10.1210/en.2012-2114; Beebe KL, 2006, BEHAV BRAIN RES, V171, P225, DOI 10.1016/j.bbr.2006.03.039; Belanoff JK, 2010, DIABETES OBES METAB, V12, P545, DOI 10.1111/j.1463-1326.2009.01185.x; Belanoff JK, 2011, EUR J PHARMACOL, V655, P117, DOI 10.1016/j.ejphar.2011.01.019; Belavic Jennifer M, 2013, Nurse Pract, V38, P24, DOI 10.1097/01.NPR.0000425824.44694.e8; BOURGEOIS S, 1984, EMBO J, V3, P751, DOI 10.1002/j.1460-2075.1984.tb01879.x; Bujalska IJ, 2005, J MOL ENDOCRINOL, V34, P675, DOI 10.1677/jme.1.01718; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Chan O, 2003, Minerva Endocrinol, V28, P87; Chrousos GP, 2004, P NATL ACAD SCI USA, V101, P6329, DOI 10.1073/pnas.0401671101; D'souza AM, 2012, AM J PHYSIOL-GASTR L, V302, pG850, DOI 10.1152/ajpgi.00378.2011; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Dallman MF, 2003, TRENDS ENDOCRIN MET, V14, P394, DOI 10.1016/j.tem.2003.09.005; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Debono M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060984; deSchoolmeester J, 2013, DIABETES OBES METAB, V15, P1056, DOI 10.1111/dom.12137; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; FRIEDMAN JE, 1993, J BIOL CHEM, V268, P12952; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Goldberg JR, 1998, ARCH FAM MED, V7, P219, DOI 10.1001/archfami.7.3.219; Gross C, 2009, ADV THER, V26, P959, DOI 10.1007/s12325-009-0070-1; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; HEIKINHEIMO O, 1987, J STEROID BIOCHEM, V26, P279; Hoes JN, 2011, ANN RHEUM DIS, V70, P1887, DOI 10.1136/ard.2011.151464; Hoffman RP, 2008, PEDIATR DIABETES, V9, P57, DOI 10.1111/j.1399-5448.2007.00350.x; Holness MJ, 2005, DIABETOLOGIA, V48, P2062, DOI 10.1007/s00125-005-1894-0; Johanssen S, 2007, EUR J ENDOCRINOL, V157, P561, DOI 10.1530/EJE-07-0458; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Koizumi M, 2008, J ENDOCRINOL, V197, P221, DOI 10.1677/JOE-07-0462; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; LANGLEY SC, 1990, AM J PHYSIOL, V259, pR539, DOI 10.1152/ajpregu.1990.259.3.R539; Lansang MC, 2011, CLEV CLIN J MED, V78, P748, DOI 10.3949/ccjm.78a.10180; Linssen MML, 2011, CELL SIGNAL, V23, P1708, DOI 10.1016/j.cellsig.2011.06.002; Matthews LC, 2011, DIABETOLOGIA, V54, P223, DOI 10.1007/s00125-010-1963-x; MCMAHON M, 1988, DIABETES METAB REV, V4, P17, DOI 10.1002/dmr.5610040105; Mohler ML, 2007, EXPERT OPIN THER PAT, V17, P59, DOI 10.1517/13543776.17.1.59; Nielsen MF, 2004, AM J PHYSIOL-ENDOC M, V286, pE102, DOI 10.1152/ajpendo.00566.2002; OKADA S, 1992, AM J PHYSIOL, V262, pR1106, DOI 10.1152/ajpregu.1992.262.6.R1106; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007; ROY RR, 1983, ARCH ORAL BIOL, V28, P639, DOI 10.1016/0003-9969(83)90012-2; Sartor O, 1996, CLIN OBSTET GYNECOL, V39, P506, DOI 10.1097/00003081-199606000-00024; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Shibli-Rahhal A, 2006, CLIN DERMATOL, V24, P260, DOI 10.1016/j.clindermatol.2006.04.012; Shpilberg Y, 2012, DIS MODEL MECH, V5, P671, DOI 10.1242/dmm.008912; Simmons LR, 2012, ISRN ENDOCRINOL, V2012, DOI DOI 10.5402/2012/910905.PMID:22830041; Spiga F, 2007, J NEUROENDOCRINOL, V19, P891, DOI 10.1111/j.1365-2826.2007.01605.x; Stewart PM, 1996, CLIN ENDOCRINOL, V44, P493, DOI 10.1046/j.1365-2265.1996.716535.x; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Taylor AI, 2009, HORM METAB RES, V41, P899, DOI 10.1055/s-0029-1234071; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang Y, 2011, DIABETOLOGIA, V54, P440, DOI 10.1007/s00125-010-1956-9; Zalachoras I, 2013, P NATL ACAD SCI USA, V110, P7910, DOI 10.1073/pnas.1219411110; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	61	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91248	10.1371/journal.pone.0091248	http://dx.doi.org/10.1371/journal.pone.0091248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642683	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900016
J	Ivanisenko, NV; Mishchenko, EL; Akberdin, IR; Demenkov, PS; Likhoshvai, VA; Kozlov, KN; Todorov, DI; Gursky, VV; Samsonova, MG; Samsonov, AM; Clausznitzer, D; Kaderali, L; Kolchanov, NA; Ivanisenko, VA				Ivanisenko, Nikita V.; Mishchenko, Elena L.; Akberdin, Ilya R.; Demenkov, Pavel S.; Likhoshvai, Vitaly A.; Kozlov, Konstantin N.; Todorov, Dmitry I.; Gursky, Vitaly V.; Samsonova, Maria G.; Samsonov, Alexander M.; Clausznitzer, Diana; Kaderali, Lars; Kolchanov, Nikolay A.; Ivanisenko, Vladimir A.			A New Stochastic Model for Subgenomic Hepatitis C Virus Replication Considers Drug Resistant Mutants	PLOS ONE			English	Article							HCV PROTEASE INHIBITOR; IN-VITRO RESISTANCE; RNA REPLICATION; ANTIVIRAL ACTIVITY; NS3 PROTEASE; CYCLOPHILIN INHIBITOR; POLYMERASE INHIBITORS; VIROLOGICAL RESPONSE; REPLICON VARIANTS; CROSS-RESISTANCE	As an RNA virus, hepatitis C virus (HCV) is able to rapidly acquire drug resistance, and for this reason the design of effective anti-HCV drugs is a real challenge. The HCV subgenomic replicon-containing cells are widely used for experimental studies of the HCV genome replication mechanisms, for drug testing in vitro and in studies of HCV drug resistance. The NS3/4A protease is essential for virus replication and, therefore, it is one of the most attractive targets for developing specific antiviral agents against HCV. We have developed a stochastic model of subgenomic HCV replicon replication, in which the emergence and selection of drug resistant mutant viral RNAs in replicon cells is taken into account. Incorporation into the model of key NS3 protease mutations leading to resistance to BILN-2061 (A156T, D168V, R155Q), VX-950 (A156S, A156T, T54A) and SCH 503034 (A156T, A156S, T54A) inhibitors allows us to describe the long term dynamics of the viral RNA suppression for various inhibitor concentrations. We theoretically showed that the observable difference between the viral RNA kinetics for different inhibitor concentrations can be explained by differences in the replication rate and inhibitor sensitivity of the mutant RNAs. The pre-existing mutants of the NS3 protease contribute more significantly to appearance of new resistant mutants during treatment with inhibitors than wild-type replicon. The model can be used to interpret the results of anti-HCV drug testing on replicon systems, as well as to estimate the efficacy of potential drugs and predict optimal schemes of their usage.	[Ivanisenko, Nikita V.; Mishchenko, Elena L.; Akberdin, Ilya R.; Demenkov, Pavel S.; Likhoshvai, Vitaly A.; Kolchanov, Nikolay A.; Ivanisenko, Vladimir A.] Inst Cytol & Genet SB RAS, Dept Syst Biol, Novosibirsk, Russia; [Kozlov, Konstantin N.; Todorov, Dmitry I.; Gursky, Vitaly V.; Samsonova, Maria G.; Samsonov, Alexander M.] St Petersburg State Polytech Univ, Dept Computat Biol, St Petersburg, Russia; [Clausznitzer, Diana; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, D-01062 Dresden, Germany; [Ivanisenko, Vladimir A.] PB Soft Llc, Novosibirsk, Russia; [Todorov, Dmitry I.] St Petersburg State Univ, Chebyshev Lab, St Petersburg 199034, Russia; [Gursky, Vitaly V.; Samsonov, Alexander M.] Russian Acad Sci, Ioffe Phys Tech Inst, Dept Theoret, St Petersburg 196140, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Peter the Great St. Petersburg Polytechnic University; Technische Universitat Dresden; Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute	Ivanisenko, VA (corresponding author), Inst Cytol & Genet SB RAS, Dept Syst Biol, Novosibirsk, Russia.	salix@bionet.nsc.ru	Akberdin, Ilya R/J-3172-2018; Todorov, Dmitry I/H-1856-2013; Kolchanov, Nikolay/A-9916-2014; Ivanisenko, Nikita/AAO-1621-2020; Gursky, Vitaly V/A-9187-2014; Ivanisenko, Vladimir/J-7832-2018; Kozlov, Konstantin/N-6748-2013; Demenkov, Pavel/AAC-8708-2020	Akberdin, Ilya R/0000-0003-0010-8620; Todorov, Dmitry I/0000-0002-6155-5865; Gursky, Vitaly V/0000-0003-4094-1983; Kozlov, Konstantin/0000-0001-6765-236X; Demenkov, Pavel/0000-0001-9433-8341; Ivanisenko, Vladimir/0000-0002-1859-4631; Kaderali, Lars/0000-0002-2359-2294; Kolchanov, Nikolay/0000-0001-6800-8787	EU [260429]	EU(European Commission)	This work is supported by the FP7 EU grant SysPatho No260429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiwijaya BS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000745; Ali S, 2008, ANTIMICROB AGENTS CH, V52, P4356, DOI 10.1128/AAC.00444-08; Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bartenschlager R, 2003, ANTIVIR RES, V60, P91, DOI 10.1016/j.antiviral.2003.08.016; Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018; Berenguer M, 2011, VIRUS ADAPTATION TRE, V3, P7; Berger Kristi L, 2009, Commun Integr Biol, V2, P471; Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Dahari H, 2007, J VIROL, V81, P750, DOI 10.1128/JVI.01304-06; Dahari H, 2009, J VIROL, V83, P6383, DOI 10.1128/JVI.02612-08; de Bruijne J, 2012, ANTIMICROB AGENTS CH, V56, P4525, DOI 10.1128/AAC.00451-12; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Flores MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1441, DOI 10.1016/j.bbapap.2009.06.004; Forestier N, 2011, J HEPATOL, V54, P1130, DOI 10.1016/j.jhep.2010.11.001; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fridell RA, 2011, J VIROL, V85, P7312, DOI 10.1128/JVI.00253-11; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Habersetzer F, 2012, PHARMACOGEN PERS MED, V5, P125, DOI 10.2147/PGPM.S24259; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Herrmann E, 2006, ANTIVIR THER, V11, P371; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Hotho DM, 2013, J VIRAL HEPATITIS, V20, pe78, DOI 10.1111/jvh.12012; Hotho DM, 2012, ANTIVIR THER, V17, P365, DOI 10.3851/IMP1989; Johnson CL, 2007, J BIOL CHEM, V282, P10792, DOI 10.1074/jbc.M610361200; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Kozlov K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002635; Kozlov K, 2011, J SUPERCOMPUT, V57, P172, DOI 10.1007/s11227-010-0390-6; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lam AM, 2011, ANTIMICROB AGENTS CH, V55, P2566, DOI 10.1128/AAC.00032-11; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lenz O, 2013, J HEPATOL, V58, P445, DOI 10.1016/j.jhep.2012.10.028; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Liang YQ, 2008, GASTROENTEROLOGY, V135, P1710, DOI 10.1053/j.gastro.2008.07.023; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lu LJ, 2007, ANTIMICROB AGENTS CH, V51, P1889, DOI 10.1128/AAC.01004-06; Lu LJ, 2004, ANTIMICROB AGENTS CH, V48, P2260, DOI 10.1128/AAC.48.6.2260-2266.2004; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2012, LIVER INT, V32, P27, DOI 10.1111/j.1478-3231.2011.02725.x; Mathy JE, 2008, ANTIMICROB AGENTS CH, V52, P3267, DOI 10.1128/AAC.00498-08; Matthews SJ, 2012, CLIN THER, V34, P1857, DOI 10.1016/j.clinthera.2012.07.011; McCown MF, 2009, ANTIMICROB AGENTS CH, V53, P2129, DOI 10.1128/AAC.01598-08; McLean AK, 2010, J THEOR BIOL, V267, P565, DOI 10.1016/j.jtbi.2010.09.031; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mishchenko EL, 2007, J BIOINF COMPUT BIOL, V5, P593, DOI 10.1142/S0219720007002849; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nag A, 2012, J VIROL, V86, P12616, DOI 10.1128/JVI.01351-12; Nakabayashi J, 2012, J THEOR BIOL, V300, P110, DOI 10.1016/j.jtbi.2012.01.023; O'Leary Jacqueline G, 2010, Therap Adv Gastroenterol, V3, P43, DOI 10.1177/1756283X09353353; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rajagopalan R, 2009, BIOCHEMISTRY-US, V48, P2559, DOI 10.1021/bi900038p; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Reiser M, 2005, HEPATOLOGY, V41, P832, DOI 10.1002/hep.20612; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Robinson M, 2011, P NATL ACAD SCI USA, V108, P10290, DOI 10.1073/pnas.1101515108; Rong LB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002959; Rong LB, 2012, B MATH BIOL, V74, P1789, DOI 10.1007/s11538-012-9736-y; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Soriano V, 2008, J ANTIMICROB CHEMOTH, V62, P1, DOI 10.1093/jac/dkn175; Svarovskaia ES, 2012, J CLIN MICROBIOL, V50, P3267, DOI 10.1128/JCM.00838-12; Tong X, 2006, VIRUS RES, V115, P122, DOI 10.1016/j.virusres.2005.07.012; Tong X, 2010, ANTIMICROB AGENTS CH, V54, P2365, DOI 10.1128/AAC.00135-10; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Tong X, 2008, ANTIVIR RES, V77, P177, DOI 10.1016/j.antiviral.2007.11.010; Upadhyay A, 2013, MOL CELL PROTEOMICS, V12, P1539, DOI 10.1074/mcp.M112.017020; Verbinnen T, 2012, J ANTIMICROB CHEMOTH, V67, P2327, DOI 10.1093/jac/dks234; Verbinnen T, 2010, J VIROL, V84, P11124, DOI 10.1128/JVI.01217-10; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	89	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91502	10.1371/journal.pone.0091502	http://dx.doi.org/10.1371/journal.pone.0091502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643004	Green Submitted, gold, Green Published			2022-12-27	WOS:000333259900024
J	Wilson, TJ; Garner, LI; Metcalfe, C; King, E; Margraf, S; Brown, MH				Wilson, Timothy J.; Garner, Lee I.; Metcalfe, Clive; King, Elliott; Margraf, Stefanie; Brown, Marion H.			Fine Specificity and Molecular Competition in SLAM Family Receptor Signalling	PLOS ONE			English	Article							PHOSPHOLIPASE C-GAMMA; PROTEIN-TYROSINE-PHOSPHATASE; NK CELL ACTIVATION; GENE-PRODUCT SAP; SH2 DOMAIN; T-CELLS; CUTTING EDGE; B-CELLS; EAT-2; 2B4	SLAM family receptors regulate activation and inhibition in immunity through recruitment of activating and inhibitory SH2 domain containing proteins to immunoreceptor tyrosine based switch motifs (ITSMs). Binding of the adaptors, SAP and EAT2 to ITSMs in the cytoplasmic regions of SLAM family receptors is important for activation. We analysed the fine specificity of SLAM family receptor phosphorylated ITSMs and the conserved tyrosine motif in EAT-2 for SH2 domain containing signalling proteins. Consistent with the literature describing dependence of CRACC (SLAMF7) on EAT-2, CRACC bound EAT-2 (K-D = 0.003 mu M) with approximately 2 orders of magnitude greater affinity than SAP (K-D = 0.44 mu M). RNA interference in cytotoxicity assays in NK92 cells showed dependence of CRACC on SAP in addition to EAT-2, indicating selectivity of SAP and EAT-2 may depend on the relative concentrations of the two adaptors. The concentration of SAP was four fold higher than EAT-2 in NK92 cells. Compared with SAP, the significance of EAT-2 recruitment and its downstream effectors are not well characterised. We identified PLC gamma 1 and PLC gamma 2 as principal binding partners for the EAT-2 tail. Both PLC gamma 1 and PLC gamma 2 are functionally important for cytotoxicity in NK92 cells through CD244 (SLAMF4), NTB-A (SLAMF6) and CRACC. Comparison of the specificity of SH2 domains from activating and inhibitory signalling mediators revealed a hierarchy of affinities for CD244 (SLAMF4) ITSMs. While binding of phosphatase SH2 domains to individual ITSMs of CD244 was weak compared with SAP or EAT-2, binding of tandem SH2 domains of SHP-2 to longer peptides containing tandem phosphorylated ITSMs in human CD244 increased the affinity ten fold. The concentration of the tyrosine phosphatase, SHP-2 was in the order of a magnitude higher than the adaptors, SAP and EAT-2. These data demonstrate a mechanism for direct recruitment of phosphatases in inhibitory signalling by ITSMs, while explaining competitive dominance of SAP and EAT-2.	[Wilson, Timothy J.; Garner, Lee I.; Metcalfe, Clive; King, Elliott; Margraf, Stefanie; Brown, Marion H.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Brown, MH (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	Marion.Brown@path.ox.ac.uk		Wilson, Timothy/0000-0001-8403-9401; Metcalfe, Clive/0000-0002-7856-8574	European Commission [PIIF-GA-2009-235224]; Medical Research Council, UK [G0400808]; Cancer Research UK [C29938/A13236]; Cancer Research UK [13236] Funding Source: researchfish; Medical Research Council [G0400808] Funding Source: researchfish; MRC [G0400808] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Marie Curie International Incoming Fellowship, European Commission 7th Framework Programme (PIIF-GA-2009-235224) awarded to TJW, the Medical Research Council, UK (G0400808) and Cancer Research UK (C29938/A13236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOV S, 1986, CELL IMMUNOL, V100, P1, DOI 10.1016/0008-8749(86)90001-8; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Benoit L, 2000, J IMMUNOL, V165, P3549, DOI 10.4049/jimmunol.165.7.3549; Bida AT, 2011, MOL IMMUNOL, V48, P1149, DOI 10.1016/j.molimm.2011.02.008; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bunney TD, 2012, STRUCTURE, V20, P2062, DOI 10.1016/j.str.2012.09.005; Calpe S, 2006, IMMUNOGENETICS, V58, P15, DOI 10.1007/s00251-005-0056-3; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Clarkson NG, 2007, J BIOL CHEM, V282, P25385, DOI 10.1074/jbc.M704483200; Clarkson NG, 2009, J BIOL CHEM, V284, P24725, DOI 10.1074/jbc.M109.028209; Coxon CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049543; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Dushek O, 2012, IMMUNOL REV, V250, P258, DOI 10.1111/imr.12008; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; HARADA S, 1982, INT J CANCER, V30, P739, DOI 10.1002/ijc.2910300610; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Klem J, 2002, J IMMUNOL, V169, P55, DOI 10.4049/jimmunol.169.1.55; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Lewis J, 2001, CLIN IMMUNOL, V100, P15, DOI 10.1006/clim.2001.5035; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Li CJ, 2003, J BIOL CHEM, V278, P3852, DOI 10.1074/jbc.M206649200; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Mukhopadhyay H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003004; Norman PJ, 2009, GENOME RES, V19, P757, DOI 10.1101/gr.085738.108; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Sayos J, 2001, BLOOD, V97, P3867, DOI 10.1182/blood.V97.12.3867; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Sharifi R, 2004, BLOOD, V103, P3821, DOI 10.1182/blood-2003-09-3359; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Thompson AD, 1996, ONCOGENE, V13, P2649; Tovar V, 2002, IMMUNOGENETICS, V54, P394, DOI 10.1007/s00251-002-0483-3; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	56	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92184	10.1371/journal.pone.0092184	http://dx.doi.org/10.1371/journal.pone.0092184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642916	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900100
J	Wuren, T; Simonson, TS; Qin, G; Xing, JC; Huff, CD; Witherspoon, DJ; Jorde, LB; Ge, RL				Wuren, Tana; Simonson, Tatum S.; Qin, Ga; Xing, Jinchuan; Huff, Chad D.; Witherspoon, David J.; Jorde, Lynn B.; Ge, Ri-Li			Shared and Unique Signals of High-Altitude Adaptation in Geographically Distinct Tibetan Populations	PLOS ONE			English	Article							POSITIVE SELECTION; BLOOD-PRESSURE; GENETIC-EVIDENCE; PLATEAU; HYPERTENSION; ASSOCIATION; EGLN1; LOCI	Recent studies have used a variety of analytical methods to identify genes targeted by selection in high-altitude populations located throughout the Tibetan Plateau. Despite differences in analytic strategies and sample location, hypoxia-related genes, including EPAS1 and EGLN1, were identified in multiple studies. By applying the same analytic methods to genome-wide SNP information used in our previous study of a Tibetan population (n = 31) from the township of Maduo, located in the northeastern corner of the Qinghai-Tibetan Plateau (4200 m), we have identified common targets of natural selection in a second geographically and linguistically distinct Tibetan population (n = 46) in the Tuo Tuo River township (4500 m). Our analyses provide evidence for natural selection based on iHS and XP-EHH signals in both populations at the p < 0.02 significance level for EPAS1, EGLN1, HMOX2, and CYP17A1 and for PKLR, HFE, and HBB and HBG2, which have also been reported in other studies. We highlight differences (i.e., stratification and admixture) in the two distinct Tibetan groups examined here and report selection candidate genes common to both groups. These findings should be considered in the prioritization of selection candidate genes in future genetic studies in Tibet.	[Wuren, Tana; Qin, Ga; Ge, Ri-Li] Qinghai Univ, Sch Med, Res Ctr High Altitude Med, Xining, Qinghai, Peoples R China; [Simonson, Tatum S.] Univ Calif San Diego, Dept Med, Div Physiol, La Jolla, CA 92093 USA; [Simonson, Tatum S.; Xing, Jinchuan; Huff, Chad D.; Witherspoon, David J.; Jorde, Lynn B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA	Qinghai University; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah	Ge, RL (corresponding author), Qinghai Univ, Sch Med, Res Ctr High Altitude Med, Xining, Qinghai, Peoples R China.	geriligao@hotmail.com			National Basic Research Program of China [2012CB518200]; Program of International S&T Cooperation of China [0S2012GR0195]; National Natural Science Foundation of China [30393133]; National Institutes of Health [NIH GM-59290]; National Institute of Health [NIH T32 GM-007464]; National Human Genome Research Institute, National Institute of Health [K99HG005846]	National Basic Research Program of China(National Basic Research Program of China); Program of International S&T Cooperation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by The National Basic Research Program of China (No. 2012CB518200, L-RG), Program of International S&T Cooperation of China (No: 0S2012GR0195, L-RG) and National Natural Science Foundation of China (No. 30393133, L-RG), and the National Institutes of Health (NIH GM-59290). T. S. S. was supported by the National Institute of Health (NIH T32 GM-007464). J.X. is supported by the National Human Genome Research Institute, National Institute of Health (K99HG005846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Aldenderfer M, 2011, HIGH ALT MED BIOL, V12, P141, DOI 10.1089/ham.2010.1094; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Beall CM, 2011, HIGH ALT MED BIOL, V12, P101, DOI 10.1089/ham.2011.1007; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham Abigail W., 2009, Human Genomics, V4, P79; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge RL, 2012, MOL GENET METAB, V106, P244, DOI 10.1016/j.ymgme.2012.03.003; Hong KW, 2010, J HUM GENET, V55, P336, DOI 10.1038/jhg.2010.31; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lorenzo F, 2011, TIBETAN PHD2 POLYMOR; MacInnis MJ, 2011, HIGH ALT MED BIOL, V12, P133, DOI 10.1089/ham.2010.1090; Pagani L, 2012, HUM GENET, V131, P423, DOI 10.1007/s00439-011-1084-8; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Qin ZD, 2010, AM J PHYS ANTHROPOL, V143, P555, DOI 10.1002/ajpa.21350; Qingying C, 1990, TIBETAN TRIBE CHINA; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Simonson TS, 2012, HUM GENET, V131, P527, DOI 10.1007/s00439-011-1109-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Xiang K, 2013, MOL BIOL EVOL, V30, P1889, DOI 10.1093/molbev/mst090; Xing JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003634; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	37	33	35	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e88252	10.1371/journal.pone.0088252	http://dx.doi.org/10.1371/journal.pone.0088252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642866	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900001
J	Zhang, QB; Matzke, M; Schepmoes, AA; Moore, RJ; Webb-Robertson, BJ; Hu, ZP; Monroe, ME; Qian, WJ; Smith, RD; Morgan, WF				Zhang, Qibin; Matzke, Melissa; Schepmoes, Athena A.; Moore, Ronald J.; Webb-Robertson, Bobbie-Jo; Hu, Zeping; Monroe, Matthew E.; Qian, Wei-Jun; Smith, Richard D.; Morgan, William F.			High and Low Doses of Ionizing Radiation Induce Different Secretome Profiles in a Human Skin Model	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; SOFTWARE PACKAGE; GENE-EXPRESSION; GAMMA-RADIATION; PROTEOMICS DATA; MS; IDENTIFICATION; BIOMARKERS; PROTEINS; TISSUE	It is postulated that secreted soluble factors are important contributors of bystander effect and adaptive responses observed in low dose ionizing radiation. Using multidimensional liquid chromatography-mass spectrometry based proteomics, we quantified the changes of skin tissue secretome - the proteins secreted from a full thickness, reconstituted 3-dimensional skin tissue model 48 hr after exposure to 3, 10 and 200 cGy of X-rays. Overall, 135 proteins showed statistical significant difference between the sham (0 cGy) and any of the irradiated groups (3, 10 or 200 cGy) on the basis of Dunnett adjusted t-test; among these, 97 proteins showed a trend of downregulation and 9 proteins showed a trend of upregulation with increasing radiation dose. In addition, there were 21 and 8 proteins observed to have irregular trends with the 10 cGy irradiated group either having the highest or the lowest level among all three radiated doses. Moreover, two proteins, carboxypeptidase E and ubiquitin carboxyl-terminal hydrolase isozyme L1 were sensitive to ionizing radiation, but relatively independent of radiation dose. Conversely, proteasome activator complex subunit 2 protein appeared to be sensitive to the dose of radiation, as rapid upregulation of this protein was observed when radiation doses were increased from 3, to 10 or 200 cGy. These results suggest that different mechanisms of action exist at the secretome level for low and high doses of ionizing radiation.	[Zhang, Qibin; Schepmoes, Athena A.; Moore, Ronald J.; Hu, Zeping; Monroe, Matthew E.; Qian, Wei-Jun; Smith, Richard D.; Morgan, William F.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Matzke, Melissa; Webb-Robertson, Bobbie-Jo] Pacific NW Natl Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Zhang, QB (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	qibin.zhang@pnnl.gov	Webb-Robertson, Bobbie-Jo/K-8230-2019; Monroe, Matthew/L-1157-2019; Smith, Richard D/J-3664-2012; QIAN, Wei-Jun/AAC-1907-2021; Hu, Zeping/F-6205-2010; Qian, Wei-Jun/C-6167-2011; Zhang, Qibin/L-6283-2017	Smith, Richard D/0000-0002-2381-2349; QIAN, Wei-Jun/0000-0002-5393-2827; Hu, Zeping/0000-0003-4146-7750; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397; Zhang, Qibin/0000-0002-6135-8706	Office of Science, U.S. Department of Energy, under the Low Dose Radiation Science Focus Area Program; NIH [5P41RR018522-10]; National Institute of General Medical Sciences [8P41 GM103493-10]; DOE by Battelle [DE-AC05-76RLO-1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER	Office of Science, U.S. Department of Energy, under the Low Dose Radiation Science Focus Area Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE by Battelle(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Office of Science, U.S. Department of Energy, under the Low Dose Radiation Science Focus Area Program. This work used instrumentation and capabilities developed with support from the NIH grant 5P41RR018522-10, the National Institute of General Medical Sciences grant 8P41 GM103493-10, and the U.S. Department of Energy Office of Biological and Environmental Research (DOE/BER). Significant portions of this work were performed in the Environmental Molecular Science Laboratory, a DOE/BER national scientific user facility at Pacific Northwest National Laboratory (PNNL) in Richland, Washington. PNNL is operated for the DOE by Battelle under contract DE-AC05-76RLO-1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht H, 2012, RADIAT RES, V177, P69, DOI 10.1667/RR2524.1; Amundson S A, 2001, Expert Rev Mol Diagn, V1, P211, DOI 10.1586/14737159.1.2.211; Barjaktarovic Z, 2013, RADIAT ENVIRON BIOPH, V52, P87, DOI 10.1007/s00411-012-0439-4; BIER V, 2006, PHASE 2 HLTH RISKS E; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Chaker S, 2013, PROTEOMICS, V13, P771, DOI 10.1002/pmic.201200356; Chaudhry MA, 2012, MOL BIOL REP, V39, P7549, DOI 10.1007/s11033-012-1589-9; Datta K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-205; Dauer LT, 2010, RADIAT PROT DOSIM, V140, P103, DOI 10.1093/rpd/ncq141; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Hu ZP, 2012, MOL BIOSYST, V8, P1979, DOI 10.1039/c2mb25061f; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Knops K, 2012, RADIAT RES, V178, P304, DOI 10.1667/RR2913.1; Laiakis EC, 2012, RADIAT RES, V177, P187, DOI 10.1667/RR2771.1; Liu Y, 2004, J PROTEOME RES, V3, P728, DOI 10.1021/pr034127+; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Matzke MM, 2011, BIOINFORMATICS; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Mothersill C, 2012, INT J RADIAT BIOL, V88, P763, DOI 10.3109/09553002.2012.715795; Nanashima N, 2012, INT J MOL MED, V30, P579, DOI 10.3892/ijmm.2012.1018; Petritis K, 2006, ANAL CHEM, V78, P5026, DOI 10.1021/ac060143p; Piehowski PD, 2013, J PROTEOME RES, V12, P2128, DOI 10.1021/pr301146m; Pluder F, 2011, RADIAT ENVIRON BIOPH, V50, P155, DOI 10.1007/s00411-010-0342-9; Royal HD, 2008, SEMIN NUCL MED, V38, P392, DOI 10.1053/j.semnuclmed.2008.05.006; Shi TJ, 2012, METHODS, V56, P246, DOI 10.1016/j.ymeth.2011.09.001; Snijders AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045394; Varnum SM, 2012, RADIAT RES, V178, P591, DOI 10.1667/RR2976.1; Wang FL, 2013, J RADIAT RES, V54, P649, DOI 10.1093/jrr/rrt010; Wang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024843; Webb-Robertson BJM, 2011, PROTEOMICS, V11, P4736, DOI 10.1002/pmic.201100078; Webb-Robertson BJM, 2010, J PROTEOME RES, V9, P5748, DOI 10.1021/pr1005247; Yang F, 2012, EXP DERMATOL, V21, P352, DOI 10.1111/j.1600-0625.2012.01470.x; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	38	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92332	10.1371/journal.pone.0092332	http://dx.doi.org/10.1371/journal.pone.0092332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642900	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900121
J	Awad, WA; Hess, C; Khayal, B; Aschenbach, JR; Hess, M				Awad, Wageha A.; Hess, Claudia; Khayal, Basel; Aschenbach, Joerg R.; Hess, Michael			In Vitro Exposure to Escherichia coli Decreases Ion Conductance in the Jejunal Epithelium of Broiler Chickens	PLOS ONE			English	Article							BARRIER FUNCTION; SECRETION; TRANSPORT; CHLORIDE; EXPRESSION; PATHOGEN; DIARRHEA; PROTEIN; PERMEABILITY; MONOLAYERS	Escherichia coli (E. coli) infections are very widespread in poultry. However, little is known about the interaction between the intestinal epithelium and E. coli in chickens. Therefore, the effects of avian non-pathogenic and avian pathogenic Escherichia coli (APEC) on the intestinal function of broiler chickens were investigated by measuring the electrogenic ion transport across the isolated jejunal mucosa. In addition, the intestinal epithelial responses to cholera toxin, histamine and carbamoylcholine (carbachol) were evaluated following an E. coli exposure. Jejunal tissues from 5-week-old broilers were exposed to 6 x 10(8) CFU/mL of either avian non-pathogenic E. coli IMT11322 (Ont:H16) or avian pathogenic E. coli IMT4529 (O24:H4) in Ussing chambers and electrophysiological variables were monitored for 1 h. After incubation with E. coli for 1 h, either cholera toxin (1 mg/L), histamine (100 mu M) or carbachol (100 mu M) were added to the incubation medium. Both strains of avian E. coli (non-pathogenic and pathogenic) reduced epithelial ion conductance (G(t)) and short-circuit current (I-sc). The decrease in ion conductance after exposure to avian pathogenic E. coli was, at least, partly reversed by the histamine or carbachol treatment. Serosal histamine application produced no significant changes in the I-sc in any tissues. Only the uninfected control tissues responded significantly to carbachol with an increase of I-sc, while the response to carbachol was blunted to non-significant values in infected tissues. Together, these data may explain why chickens rarely respond to intestinal infections with overt secretory diarrhea. Instead, the immediate response to intestinal E. coli infections appears to be a tightening of the epithelial barrier.	[Awad, Wageha A.; Hess, Claudia; Khayal, Basel; Hess, Michael] Univ Vet Med, Clin Poultry & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Fac Vet Med, Berlin, Germany	University of Veterinary Medicine Vienna; Free University of Berlin	Awad, WA (corresponding author), Univ Vet Med, Clin Poultry & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	wageha.awad@vetmeduni.ac.at	Aschenbach, Joerg R/R-7572-2016; Awad, Wageha/R-1705-2016	Aschenbach, Joerg R/0000-0001-5080-1007; Awad, Wageha/0000-0003-0843-2089; Hess, Claudia/0000-0002-3535-5157; Hess, Michael/0000-0002-6991-0120				Ahrens F, 2003, INFLAMM RES, V52, P79; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Awad WA, 2007, J ANIM PHYSIOL AN N, V91, P175, DOI 10.1111/j.1439-0396.2007.00689.x; Awad WA, 2012, POULTRY SCI, V91, P2949, DOI 10.3382/ps.2012-02448; Awad WA, 2015, INNATE IMMUN-LONDON, V21, P151, DOI 10.1177/1753425914521648; Barnes H.J., 2008, DIS POULTRY, P691; Borenshtein D, 2009, INFECT IMMUN, V77, P3639, DOI 10.1128/IAI.00225-09; Caldwell DJ, 2004, POULTRY SCI, V83, P591, DOI 10.1093/ps/83.4.591; Caldwell DJ, 2001, DEV COMP IMMUNOL, V25, P169, DOI 10.1016/S0145-305X(00)00055-0; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Chausse AM, 2011, INFECT IMMUN, V79, P3445, DOI 10.1128/IAI.00025-11; Collington GK, 1998, GUT, V42, P200, DOI 10.1136/gut.42.2.200; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Dho-Moulin M, 1999, VET RES, V30, P299; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Fraser SA, 2003, INFECT IMMUN, V71, P1527, DOI 10.1128/IAI.71.3.1527-1537.2003; Ginns CA, 1998, AVIAN PATHOL, V27, P505, DOI 10.1080/03079459808419375; GRUBB BR, 1987, J COMP PHYSIOL B, V157, P181, DOI 10.1007/BF00692362; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Guttman JA, 2007, CELL MICROBIOL, V9, P131, DOI 10.1111/j.1462-5822.2006.00773.x; Guttman JA, 2008, TRENDS MICROBIOL, V16, P535, DOI 10.1016/j.tim.2008.08.004; Hanson PJ, 2011, INNATE IMMUN-LONDON, V17, P269, DOI 10.1177/1753425910367813; Hecht G, 2004, AM J PHYSIOL-GASTR L, V287, pG370, DOI 10.1152/ajpgi.00432.2003; Hering NA, 2014, MUCOSAL IMMUNOL, V7, P369, DOI 10.1038/mi.2013.55; HOLMGREN J, 1973, INFECT IMMUN, V8, P851, DOI 10.1128/IAI.8.6.851-859.1973; Huff GR, 2013, POULTRY SCI, V92, P655, DOI 10.3382/ps.2012-02787; Iizumi Y, 2007, CELL HOST MICROBE, V2, P383, DOI 10.1016/j.chom.2007.09.012; Kock J, 2007, LIVEST SCI, V109, P42, DOI 10.1016/j.livsci.2007.01.044; Kuldeep Dhama, 2013, Research Opinions in Animal and Veterinary Sciences, V3, P179; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lucas ML, 2008, J PHYSIOL BIOCHEM, V64, P69, DOI 10.1007/BF03168236; Matsuzawa T, 2005, INFECT IMMUN, V73, P6283, DOI 10.1128/IAI.73.10.6283-6289.2005; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; McPeake SJM, 2005, VET MICROBIOL, V110, P245, DOI 10.1016/j.vetmic.2005.08.001; Murek M, 2010, EXP PHYSIOL, V95, P471, DOI 10.1113/expphysiol.2009.049445; PAL SC, 1968, INDIAN J MED RES, V56, P1482; PARRY SH, 1977, IMMUNOLOGY, V32, P731; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Roxas JL, 2010, LAB INVEST, V90, P1152, DOI 10.1038/labinvest.2010.91; Ruhnke I, 2013, ARCH ANIM NUTR, V67, P161, DOI 10.1080/1745039X.2013.776328; Sanni Saka, 2005, Veterinarski Arhiv, V75, P423; Schultheiss G, 2006, EUR J PHARMACOL, V546, P161, DOI 10.1016/j.ejphar.2006.07.047; Schwarz A, 2011, DEV COMP IMMUNOL, V35, P774, DOI 10.1016/j.dci.2011.02.012; Singh SD, 2011, POULTRY WORLD    OCT, P14; Sklan D, 2003, BRIT J NUTR, V89, P747, DOI 10.1079/BJN2003853; SPITZ J, 1995, AM J PHYSIOL-GASTR L, V268, pG374, DOI 10.1152/ajpgi.1995.268.2.G374; Stordeur P, 2002, VET MICROBIOL, V84, P231, DOI 10.1016/S0378-1135(01)00464-3; Vandekerchove D, 2005, VET MICROBIOL, V108, P75, DOI 10.1016/j.vetmic.2005.02.009; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; Wilking H, 2009, THESIS U BERLIN BERL; Yunus AW, 2010, POULTRY SCI, V89, P1372, DOI 10.3382/ps.2009-00617; Zareie M, 2005, CELL MICROBIOL, V7, P1782, DOI 10.1111/j.1462-5822.2005.00595.x; Zhu HL, 2013, INNATE IMMUN-LONDON, V19, P242, DOI 10.1177/1753425912456223	57	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92156	10.1371/journal.pone.0092156	http://dx.doi.org/10.1371/journal.pone.0092156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637645	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100121
J	Gras, B; Jacqueroud, L; Wierinckx, A; Lamblot, C; Fauvet, F; Lachuer, J; Puisieux, A; Ansieau, S				Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane			Snail Family Members Unequally Trigger EMT and Thereby Differ in Their Ability to Promote the Neoplastic Transformation of Mammary Epithelial Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; TO-MESENCHYMAL TRANSITION; E-CADHERIN; BREAST-CARCINOMA; ANOIKIS RESISTANCE; GENE-EXPRESSION; POOR-PROGNOSIS; SLUG; CANCER; TWIST	By fostering cell commitment to the epithelial-to-mesenchymal transition (EMT), SNAIL proteins endow cells with motility, thereby favoring the metastatic spread of tumor cells. Whether the phenotypic change additionally facilitates tumor initiation has never been addressed. Here we demonstrate that when a SNAIL protein is ectopically produced in non-transformed mammary epithelial cells, the cells are protected from anoikis and proliferate under low-adherence conditions: a hallmark of cancer cells. The three SNAIL proteins show unequal oncogenic potential, strictly correlating with their ability to promote EMT. SNAIL3 especially behaves as a poor EMT-inducer comforting the concept that the transcription factor functionally diverges from its two related proteins.	[Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] Ctr Rech Cancerol Lyon, INSERM, UMR S1052, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] Ctr Rech Cancerol Lyon, CNRS, UMR5286, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] LabEx DEVweCAN, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] UNIV, UMR1052, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] Univ Lyon, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] Ctr Leon Berard, F-69373 Lyon, France; [Wierinckx, Anne; Lachuer, Joel] ProfileXpert, Bron, France; [Puisieux, Alain] Inst Univ France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; Institut Universitaire de France	Puisieux, A (corresponding author), Ctr Rech Cancerol Lyon, INSERM, UMR S1052, Lyon, France.	alain.puisieux@lyon.unicancer.fr; stephane.ansieau@lyon.unicancer.fr	Ansieau, Stephane/I-6195-2016; Wierinckx, Anne/AAF-5233-2021	Wierinckx, Anne/0000-0002-0186-6645; lachuer, joel/0000-0002-5209-5094; PUISIEUX, Alain/0000-0002-9938-3798; ANSIEAU, Stephane/0000-0003-0989-2108	Association pour la Recherche contre le Cancer; French National Agency (ANR) [ANR-10-LABX-0061, ANR-11-IDEX 0007]; Ministere de la Recherche and the Fondation des Treilles; Ligue Nationale Contre le Cancer	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); French National Agency (ANR)(French National Research Agency (ANR)); Ministere de la Recherche and the Fondation des Treilles; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was financially supported by the Association pour la Recherche contre le Cancer and was performed within the framework of the LABEX DEVweCAN (ANR-10-LABX-0061 of Lyon University, within the program "Investissements d'Avenir (ANR-11-IDEX 0007) operated by the French National Agency (ANR). BG received support from the Ministere de la Recherche and the Fondation des Treilles. LJ is a recipient of fellowships from the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; ALBERGA A, 1991, DEVELOPMENT, V111, P983; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Ansieau S, 2008, CELL CYCLE, V7, P3659, DOI 10.4161/cc.7.23.7049; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bradley CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065344; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Dahlem T, 2012, EUR J IMMUNOL, V42, P1038, DOI 10.1002/eji.201142193; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Geradts J, 2011, HUM PATHOL, V42, P1125, DOI 10.1016/j.humpath.2010.11.004; HAMMERSCHMIDT M, 1993, DEVELOPMENT, V119, P1107; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hugo HJ, 2011, CELLS TISSUES ORGANS, V193, P23, DOI 10.1159/000320174; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Kataoka H, 2000, NUCLEIC ACIDS RES, V28, P626, DOI 10.1093/nar/28.2.626; Katoh M, 2003, INT J MOL MED, V11, P383; Kobayashi M, 2013, ANN THORAC SURG, V95, P1181, DOI 10.1016/j.athoracsur.2013.01.012; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mayor R, 2000, MECH DEVELOP, V97, P47, DOI 10.1016/S0925-4773(00)00412-3; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Natsugoe S, 2007, ONCOL REP, V17, P517; NIETO MA, 1992, DEVELOPMENT, V116, P227; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pioli PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069216; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Shin NR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-521; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; SMITH DE, 1992, DEVELOPMENT, V116, P1033; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Wada S, 1999, DEV GROWTH DIFFER, V41, P9; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhuge X, 2005, INT J MOL MED, V15, P945	52	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92254	10.1371/journal.pone.0092254	http://dx.doi.org/10.1371/journal.pone.0092254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638100	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100134
J	Kjaergaard, AG; Rodgaard-Hansen, S; Dige, A; Krog, J; Moller, HJ; Tonnesen, E				Kjaergaard, Anders G.; Rodgaard-Hansen, Sidsel; Dige, Anders; Krog, Jan; Moller, Holger J.; Tonnesen, Else			Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients	PLOS ONE			English	Article							SERUM MARKERS; ORGAN FAILURE; CD163; SEPSIS; BACTEREMIA; RESPONSES; PROTEIN; DISEASE	Background: The diagnosis of sepsis is challenging and there is an unmet need for sensitive and specific diagnostic and prognostic biomarkers. Following activation of macrophages and monocytes, the haptoglobin-haemoglobin receptor (CD163) and the mannose receptor (MR) are shed into the circulation (sCD163 and sMR). Objective: We investigated monocyte expression of CD163 and MR, and levels of sCD163 and sMR in septic and non-septic patients, and in healthy controls. We hypothesised that these receptors are elevated during sepsis and can be used diagnostic and prognostic. Methods: Twenty-one patients with severe sepsis or septic shock and 15 critically ill non-septic patients were included in this prospective observational study at three ICUs at Aarhus University Hospital and Randers Regional Hospital, Denmark. Fifteen age-and gender-matched healthy volunteers served as controls. Levels of sCD163 and sMR were measured using a sandwich ELISA and monocyte expression of CD163 and MR was evaluated by flow cytometry during the first four days of ICU stay. The diagnostic and prognostic values of the receptors were assessed using AUROC curves. Results: At ICU admission and during the observation period, monocyte expression of CD163 and levels of sCD163 and sMR were significantly higher in septic patients compared with non-septic patients and healthy controls (p<0.01 for all comparisons). Monocytes did not express MR. The diagnostic values estimated by AUROC were 1.00 for sMR, 0.95 for sCD163, 0.87 for CRP, and 0.75 for monocyte-bound CD163. Among the septic patients, monocyte expression of CD163 was higher in non-survivors compared with survivors at ICU admission (p = 0.02) and during the observation period (p = 0.006). The prognostic value of monocyte-bound CD163 estimated by AUROC at ICU admission was 0.82. Conclusion: The macrophage-specific markers CD163, sCD163, and sMR are increased in septic patients. Particularly sMR is a promising new biomarker of sepsis.	[Kjaergaard, Anders G.; Krog, Jan; Tonnesen, Else] Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care, DK-8000 Aarhus C, Denmark; [Kjaergaard, Anders G.; Krog, Jan] Randers Reg Hosp, Dept Anaesthesiol & Intens Care, Randers, Denmark; [Dige, Anders] Aarhus Univ Hosp, Dept Med Hepatol & Gastroenterol 5, GIRL, DK-8000 Aarhus C, Denmark; [Rodgaard-Hansen, Sidsel; Moller, Holger J.] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Kjaergaard, AG (corresponding author), Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care, DK-8000 Aarhus C, Denmark.	ajk@dadlnet.dk	Krog, Jan/ABD-2700-2021	Moller, Holger Jon/0000-0001-7687-5995	A.P. Moller Foundation for the Advancement of Medical Science; Aase and Ejnar Danielsens Foundation; Danish Society of Anaesthesiology and Intensive Care Medicines Foundation; Danish council for strategic research [TRAIN 10-092797]	A.P. Moller Foundation for the Advancement of Medical Science; Aase and Ejnar Danielsens Foundation; Danish Society of Anaesthesiology and Intensive Care Medicines Foundation; Danish council for strategic research(Danske Strategiske Forskningsrad (DSF))	The A.P. Moller Foundation for the Advancement of Medical Science, The Aase and Ejnar Danielsens Foundation, The Danish Society of Anaesthesiology and Intensive Care Medicines Foundation and the Danish council for strategic research for funding (TRAIN 10-092797, HJM) supported the study. University of Aarhus holds patent applications for the use of sCD163 and sMR as biomarkers. HJM has received royalties from IQ-Products, NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P9; Brunialti MK, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0037393; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gaini S, 2008, CLIN EXP IMMUNOL, V151, P423, DOI 10.1111/j.1365-2249.2007.03586.x; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Holland-Fischer P, 2011, GUT, V60, P1389, DOI 10.1136/gut.2010.234542; Ingels C, 2012, J CLIN IMMUNOL; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Parkner T, 2012, DIABETOLOGIA, V55, P1856, DOI 10.1007/s00125-012-2533-1; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Rodgaard-Hansen S, 2013, CLIN CHEM LAB MED, P1; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Smeekens SP, 2011, EUR J IMMUNOL, V41, P2915, DOI 10.1002/eji.201141418; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weiss M, 2006, CRIT CARE MED, V34, P2682, DOI 10.1097/01.CCM.0000240242.10583.86; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3	24	36	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92331	10.1371/journal.pone.0092331	http://dx.doi.org/10.1371/journal.pone.0092331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637679	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100141
J	Pazos, M; Casanova, M; Palacios, P; Margolin, W; Natale, P; Vicente, M				Pazos, Manuel; Casanova, Mercedes; Palacios, Pilar; Margolin, William; Natale, Paolo; Vicente, Miguel			FtsZ Placement in Nucleoid-Free Bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-DIVISION; RING FORMATION; MIN PROTEINS; LOCALIZATION; SYSTEM; SITE; TOPOREGULATION; OSCILLATION; REQUIRES	We describe the placement of the cytoplasmic FtsZ protein, an essential component of the division septum, in nucleoid-free Escherichia coli maxicells. The absence of the nucleoid is accompanied in maxicells by degradation of the SlmA protein. This protein, together with the nucleoid, prevents the placement of the septum in the regions occupied by the chromosome by a mechanism called nucleoid occlusion (NO). A second septum placement mechanism, the MinCDE system (Min) involving a pole-to-pole oscillation of three proteins, nonetheless remains active in maxicells. Both Min and NO act on the polymerization of FtsZ, preventing its assembly into an FtsZ-ring except at midcell. Our results show that even in the total absence of NO, Min oscillations can direct placement of FtsZ in maxicells. Deletion of the FtsZ carboxyl terminal domain (FtsZ*), a central hub that receives signals from a variety of proteins including MinC, FtsA and ZipA, produces a Min-insensitive form of FtsZ unable to interact with the membrane-anchoring FtsA and ZipA proteins. This protein produces a totally disorganized pattern of FtsZ localization inside the maxicell cytoplasm. In contrast, FtsZ*-VM, an artificially cytoplasmic membrane-anchored variant of FtsZ*, forms helical or repetitive ring structures distributed along the entire length of maxicells even in the absence of NO. These results show that membrane anchoring is needed to organize FtsZ into rings and underscore the role of the C-terminal hub of FtsZ for their correct placement.	[Pazos, Manuel; Casanova, Mercedes; Palacios, Pilar; Natale, Paolo; Vicente, Miguel] CSIC, CNB, Madrid, Spain; [Margolin, William] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Texas System; University of Texas Health Science Center Houston	Vicente, M (corresponding author), CSIC, CNB, Madrid, Spain.	mvicente@cnb.csic.es	Pazos, Manuel/AAH-7922-2019; Natale, Paolo/E-9326-2012	Pazos, Manuel/0000-0002-8774-4453; Natale, Paolo/0000-0002-4759-0816	European Commission [HEALTH-F3-2009-223431]; Ministerio de Ciencia e Innovacion [BIO2011-28941-C03-01]; Human Frontier Science Program [RGP0050/2010]; Programa Juan de la Cierva Ministerio de Educacion y Ciencia; Programa de Formacion de Personal Investigador Ministerio de Educacion y Ciencia	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Human Frontier Science Program(Human Frontier Science Program); Programa Juan de la Cierva Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); Programa de Formacion de Personal Investigador Ministerio de Educacion y Ciencia	This work was supported through grants from European Commission HEALTH-F3-2009-223431 (DIVINOCELL) (http://ec.europa.eu/research/index.cfm) to MV, Ministerio de Ciencia e Innovacion BIO2011-28941-C03-01 (http://www.idi.mineco.gob.es/) to MV, and Human Frontier Science Program RGP0050/2010 (http://www.hfsp.org/) to MV and WM. PN acknowledges a fellowship from Programa Juan de la Cierva Ministerio de Educacion y Ciencia. MP acknowledges a fellowship from Programa de Formacion de Personal Investigador Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Cambridge J, 2013, J BACTERIOL; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cho H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003304; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; JAFFE A, 1990, J BACTERIOL, V172, P3500, DOI 10.1128/jb.172.6.3500-3502.1990; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Osawa M, 2005, MICROBIOL-SGM, V151, P4033, DOI 10.1099/mic.0.28219-0; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; PLA J, 1991, MOL MICROBIOL, V5, P1681, DOI 10.1111/j.1365-2958.1991.tb01915.x; PLA J, 1993, FEMS SYMP, P363; Potluri LP, 2012, MOL MICROBIOL, V84, P203, DOI 10.1111/j.1365-2958.2012.08023.x; Rasband W., 2006, IMAGEJ; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rodrigues CDA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002561; Sambrook J., 2001, MOL CLONING LAB MANU; SANCAR A, 1979, J BACTERIOL, V137, P692, DOI 10.1128/JB.137.1.692-693.1979; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shih YL, 2013, ENVIRON MICROBIOL, V15, P3229, DOI 10.1111/1462-2920.12119; Si FW, 2013, BIOPHYS J, V105, P1976, DOI 10.1016/j.bpj.2013.09.030; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Sun Q, 2004, J BACTERIOL, V186, P3951, DOI 10.1128/JB.186.12.3951-3959.2004; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vischer N, NONDESTRUCTIVE MARKI; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; WOLDRINGH CL, 1991, RES MICROBIOL, V142, P309, DOI 10.1016/0923-2508(91)90046-D; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	49	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91984	10.1371/journal.pone.0091984	http://dx.doi.org/10.1371/journal.pone.0091984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638110	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100096
J	Saye, M; Miranda, MR; di Girolamo, F; Camara, MD; Pereira, CA				Saye, Melisa; Miranda, Mariana R.; di Girolamo, Fabio; de los Milagros Camara, Maria; Pereira, Claudio A.			Proline Modulates the Trypanosoma cruzi Resistance to Reactive Oxygen Species and Drugs through a Novel D, L-Proline Transporter	PLOS ONE			English	Article							OXIDATIVE STRESS; LEISHMANIA-DONOVANI; ARGININE UPTAKE; EXPRESSION; PERMEASE; RACEMASES; INFECTION; FAMILY	Trypanosoma cruzi, the etiological agent of Chagas' disease, has a metabolism largely based on the consumption of glucose and proline. This amino acid is essential for host cells infection and intracellular differentiation. In this work we identified a proline transporter (TcAAAP069) by yeasts complementation assays and overexpression in Trypanosoma cruzi epimastigotes. TcAAAP069 is mono-specific for proline but presents an unusual feature; the lack of stereospecificity, because it is competitively inhibited by the D-enantiomer. Parasites overexpressing TcAAAP069 have an increased intracellular proline concentration, 2.6-fold higher than controls, as a consequence of a higher proline transport rate. Furthermore, augmented proline concentration correlates with an improved resistance to trypanocidal drugs and also to reactive oxygen species including hydrogen peroxide and nitric oxide, emulating natural physiological situations. The IC(50)s for nifurtimox, benznidazole, H2O2 and NO. were 125%, 68%, 44% and 112% higher than controls, respectively. Finally, proline metabolism generates a higher concentration (48%) of ATP in TcAAAP069 parasites. Since proline participates on essential energy pathways, stress and drug resistance responses, these results provide a novel target for the development of new drugs for the treatments for Chagas' disease.	[Pereira, Claudio A.] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Pereira, CA (corresponding author), Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina.	cpereira@retina.ar	Pereira, Claudio A/F-5382-2012	Pereira, Claudio A/0000-0001-7874-1894; SAYE, MELISA/0000-0003-0246-1356; Miranda, Mariana/0000-0002-0692-5675	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2010-0685, 2011-0263]; Agencia Nacional de Promocion Cientifica y Tecnologica [FONCYT PICT 2008-1209, 2010-0289, 2012-0559]; Fundacion Bunge y Born [2012]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Bunge y Born	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2010-0685 and 2011-0263), Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT 2008-1209, 2010-0289 and 2012-0559), and Fundacion Bunge y Born (grant 2012). CAP and MRM are members of the career of scientific investigator and MdMC and MS are research fellows from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman M, 2004, BIOCHEM BIOPH RES CO, V325, P353, DOI 10.1016/j.bbrc.2004.09.212; Bouvier LA, 2004, BIOCHEM BIOPH RES CO, V321, P547, DOI 10.1016/j.bbrc.2004.07.002; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Carrillo C, 2010, FEMS MICROBIOL LETT, V306, P97, DOI 10.1111/j.1574-6968.2010.01936.x; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Coatnoan N, 2009, MEM I OSWALDO CRUZ, V104, P295, DOI 10.1590/S0074-02762009000900039; Coutinho L, 2009, MEM I OSWALDO CRUZ, V104, P1055, DOI 10.1590/S0074-02762009000800001; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Inbar E, 2013, BIOCHEM J, V449, P555, DOI 10.1042/BJ20121262; Inbar E, 2012, AMINO ACIDS, V42, P347, DOI 10.1007/s00726-010-0812-z; Kaul S, 2008, AMINO ACIDS, V34, P315, DOI 10.1007/s00726-006-0407-x; Kollien AH, 2001, J INSECT PHYSIOL, V47, P739, DOI 10.1016/S0022-1910(00)00170-0; Krishnan N, 2006, J BACTERIOL, V188, P1227, DOI 10.1128/JB.188.4.1227-1235.2006; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Magdaleno A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004534; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Miranda MR, 2006, EXP PARASITOL, V114, P341, DOI 10.1016/j.exppara.2006.04.004; Miranda MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032760; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Natarajan SK, 2012, FREE RADICAL BIO MED, V53, P1181, DOI 10.1016/j.freeradbiomed.2012.07.002; Paes LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069419; Pereira CA, 1999, J EUKARYOT MICROBIOL, V46, P566, DOI 10.1111/j.1550-7408.1999.tb05132.x; Pereira CA, 2003, FEBS LETT, V554, P201, DOI 10.1016/S0014-5793(03)01171-2; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Saeftel M, 2001, INFECT IMMUN, V69, P2252, DOI 10.1128/IAI.69.4.2252-2259.2001; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Shao HB, 2008, CR BIOL, V331, P433, DOI 10.1016/j.crvi.2008.03.011; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; TROLL W, 1955, J BIOL CHEM, V215, P655; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; VISSERS S, 1989, EUR J BIOCHEM, V181, P357, DOI 10.1111/j.1432-1033.1989.tb14732.x; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5	42	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92028	10.1371/journal.pone.0092028	http://dx.doi.org/10.1371/journal.pone.0092028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637744	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100104
J	Thomson, V; Aplin, KP; Cooper, A; Hisheh, S; Suzuki, H; Maryanto, I; Yap, G; Donnellan, SC				Thomson, Vicki; Aplin, Ken P.; Cooper, Alan; Hisheh, Susan; Suzuki, Hitoshi; Maryanto, Ibnu; Yap, Grace; Donnellan, Stephen C.			Molecular Genetic Evidence for the Place of Origin of the Pacific Rat, Rattus exulans	PLOS ONE			English	Article							PHYLOGENIES; NETWORKS; MTDNA	Commensal plants and animals have long been used to track human migrations, with Rattus exulans (the Pacific rat) a common organism for reconstructing Polynesian dispersal in the Pacific. However, with no knowledge of the homeland of R. exulans, the place of origin of this human-commensal relationship is unknown. We conducted a mitochondrial DNA phylogeographic survey of R. exulans diversity across the potential natural range in mainland and Island Southeast Asia in order to establish the origin of this human-commensal dyad. We also conducted allozyme electrophoresis on samples from ISEA to obtain a perspective on patterns of genetic diversity in this critical region. Finally, we compared molecular genetic evidence with knowledge of prehistoric rodent faunas in mainland and ISEA. We find that ISEA populations of R. exulans contain the highest mtDNA lineage diversity including significant haplotype diversity not represented elsewhere in the species range. Within ISEA, the island of Flores in the Lesser Sunda group contains the highest diversity in ISEA (across all loci) and also has a deep fossil record of small mammals that appears to include R. exulans. Therefore, in addition to Flores harboring unusual diversity in the form of Homo floresiensis, dwarfed stegodons and giant rats, this island appears to be the homeland of R. exulans.	[Thomson, Vicki; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Aplin, Ken P.] Smithsonian Inst, Div Mammals, US Natl Museum, Washington, DC 20560 USA; [Aplin, Ken P.] Australian Natl Univ, Dept Archaeol & Nat Hist, Coll Asia & Pacific, Canberra, ACT, Australia; [Hisheh, Susan] Univ Melbourne, Austin Acad Ctr, Melbourne, Vic, Australia; [Suzuki, Hitoshi] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 060, Japan; [Maryanto, Ibnu] Indonesian Inst Sci, Biol Res Ctr, Div Zool, Bogor, Indonesia; [Yap, Grace] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore; [Donnellan, Stephen C.] S Australian Museum, Adelaide, SA 5000, Australia; [Donnellan, Stephen C.] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia	University of Adelaide; Smithsonian Institution; Smithsonian National Museum of Natural History; Australian National University; University of Melbourne; Hokkaido University; Indonesian Institute of Sciences; University of Adelaide	Thomson, V (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia.	vicki.thomson@adelaide.edu.au	Thomson, Vicki A./B-9971-2014; Suzuki, Hitoshi/F-8539-2012; Donnellan, Stephen/F-2442-2013	Thomson, Vicki A./0000-0001-8368-9664; Suzuki, Hitoshi/0000-0003-4426-385X; Donnellan, Stephen/0000-0002-5448-3226; Cooper, Alan/0000-0002-7738-7851	National Geographic Society Exploration Grant; Australian Centre for International Agricultural Research; AUSAid; Australian Research Council [DP0988863]; Australian post-graduate award	National Geographic Society Exploration Grant(National Geographic Society); Australian Centre for International Agricultural Research; AUSAid(Australian Aid (AusAID)); Australian Research Council(Australian Research Council); Australian post-graduate award(Australian Government)	A National Geographic Society Exploration Grant provided funding for the vertebrate fauna survey in eastern Indonesia, and the Australian Centre for International Agricultural Research and AUSAid provided funding for fieldwork in the agricultural landscapes of Southeast Asia. The study was partially funded from Australian Research Council grant DP0988863 to SCD and KPA. VT was supported by an Australian post-graduate award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin K, 2008, QUATERNARY MURID R 1, P160; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chaimanee Y, 1998, PLIO PLEISTOCENE ROD; Chasen F N, 1940, B RAFFLES MUSEUM, V15; Cooper A, 2000, SCIENCE, V289, P1139; Drummond A., 2011, GENEIOUS V5 5; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrison JL, 1966, INTRO MAMMALS SINGAP; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kitchener D. J., 1991, RECORDS W AUSTR MUSE, V15, P611; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Matisoo-Smith E, 1994, AM J PHYS ANTHROPOL, V0, P141; Murphy Robert W., 1996, P51; Musser G.G., 1984, Modern Quaternary Research in Southeast Asia, V8, P61; MUSSER GG, 1983, B AM MUS NAT HIST, V174, P327; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RICHARDSON BJ, 1986, ALLOZYME ELECTROPHOR; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; SCHWARZ E., 1967, AN ESC NAC CIENC BIOL MEX, V14, P79; TATE G. H. H., 1935, BULL ARNER MUS NAT HIST, V68, P145; van den Bergh GD, 2009, J HUM EVOL, V57, P527, DOI 10.1016/j.jhevol.2008.08.015; van der Meulen A.J., 1999, Deinsea, V7, P361; Waite E, 1897, P ZOOLOGICAL SOC, V1897, P857; Yom-Tov Y, 1999, J BIOGEOGR, V26, P947, DOI 10.1046/j.1365-2699.1999.00338.x; Zhang RZ., 1997, DISTRIBUTION MAMMALI	30	31	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91356	10.1371/journal.pone.0091356	http://dx.doi.org/10.1371/journal.pone.0091356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637896	gold, Green Published			2022-12-27	WOS:000333254100030
J	Duan, F; Chapeau-Blondeau, F; Abbott, D				Duan, Fabing; Chapeau-Blondeau, Francois; Abbott, Derek			Stochastic Resonance with Colored Noise for Neural Signal Detection	PLOS ONE			English	Article							WEAKLY DEPENDENT NOISE; SYSTEM; TRANSDUCTION; ENHANCEMENT; THRESHOLD	We analyze signal detection with nonlinear test statistics in the presence of colored noise. In the limits of small signal and weak noise correlation, the optimal test statistic and its performance are derived under general conditions, especially concerning the type of noise. We also analyze, for a threshold nonlinearity-a key component of a neural model, the conditions for noise-enhanced performance, establishing that colored noise is superior to white noise for detection. For a parallel array of nonlinear elements, approximating neurons, we demonstrate even broader conditions allowing noise-enhanced detection, via a form of suprathreshold stochastic resonance.	[Duan, Fabing] Qingdao Univ, Inst Complex Sci, Qingdao 266071, Peoples R China; [Chapeau-Blondeau, Francois] Univ Angers, Lab Ingn Syst Automatises, Angers, France; [Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Qingdao University; Universite d'Angers; University of Adelaide; University of Adelaide	Duan, F (corresponding author), Qingdao Univ, Inst Complex Sci, Qingdao 266071, Peoples R China.	fabing.duan@gmail.com	Abbott, Derek/E-8352-2011	Abbott, Derek/0000-0002-0945-2674; CHAPEAU-BLONDEAU, Francois/0000-0003-0536-7146	NSF of Shandong Province [ZR2010FM006]	NSF of Shandong Province	This work is sponsored by the NSF of Shandong Province (No. ZR2010FM006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Benzi R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01052; Bezrukov SM, 1997, NATURE, V385, P319, DOI 10.1038/385319a0; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Blanchard S, 2007, NEUROCOMPUTING, V71, P333, DOI 10.1016/j.neucom.2006.12.014; BULSARA AR, 1993, PHYS REV E, V47, P3734, DOI 10.1103/PhysRevE.47.3734; Chapeau-Blondeau F, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.060101; Chapeau-Blondeau F, 2009, J STAT MECH-THEORY E, V1; Chapeau-Blondeau F, 2007, PHYS REV E, V81; ChapeauBlondeau F, 1997, PHYS REV E, V55, P1478, DOI 10.1103/PhysRevE.55.1478; Chen H, 2008, IEEE T SIGNAL PROCES, V56, P5031, DOI 10.1109/TSP.2008.928509; Chen HO, 2007, IEEE T SIGNAL PROCES, V55, P3172, DOI 10.1109/TSP.2007.893757; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Collins JJ, 2003, IEEE ENG MED BIOL, V22, P76, DOI 10.1109/MEMB.2003.1195700; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Duan FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034282; Duan FB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051107; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gan CB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/4/040508; Gosak M, 2011, EUR PHYS J B, V80, P519, DOI 10.1140/epjb/e2011-10573-8; Gosak M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013012; Hanggi P, 2000, PHYS REV E, V62, P6155, DOI 10.1103/PhysRevE.62.6155; HANGGI P, 1993, J STAT PHYS, V70, P25, DOI 10.1007/BF01053952; Inchiosa ME, 1996, PHYS REV E, V53, pR2021, DOI 10.1103/PhysRevE.53.R2021; Kassam S. A., 1988, SIGNAL DETECTION NON; Kay S, 2000, IEEE SIGNAL PROC LET, V7, P8, DOI 10.1109/97.809511; Kay S. M., 1998, FUNDAMENTALS STAT SI; Kitajo K, 2006, EUROPHYS LETT, V76, P1029, DOI 10.1209/epl/i2006-10377-0; Kosko B, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051110; Kurita Y, 2013, IEEE T HUM-MACH SYST, V43, P333, DOI 10.1109/TSMC.2013.2242886; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; LINDNER JF, 1995, PHYS REV LETT, V75, P3, DOI 10.1103/PhysRevLett.75.3; LONGTIN A, 1993, J STAT PHYS, V70, P309, DOI 10.1007/BF01053970; Makra P, 2003, PHYS LETT A, V317, P228, DOI 10.1016/j.physleta.2003.08.042; MARTINEZ AB, 1984, IEEE T INFORM THEORY, V30, P815, DOI 10.1109/TIT.1984.1056981; McDonnell M.D., 2008, STOCH RES SUPR, DOI DOI 10.1017/CBO9780511535239; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Neiman A, 1996, PHYS LETT A, V223, P341, DOI 10.1016/S0375-9601(96)00742-6; Nikitin A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021121; Nozaki D, 1999, PHYS REV LETT, V82, P2402, DOI 10.1103/PhysRevLett.82.2402; Patel A, 2011, IEEE T SIGNAL PROCES, V59, P488, DOI 10.1109/TSP.2010.2091409; Patel A, 2009, NEURAL NETWORKS, V22, P697, DOI 10.1016/j.neunet.2009.06.044; Perc M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066203; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036105; POOR HV, 1982, IEEE T INFORM THEORY, V28, P735, DOI 10.1109/TIT.1982.1056545; POOR HV, 1982, IEEE T INFORM THEORY, V28, P744, DOI 10.1109/TIT.1982.1056546; PORTNOY SL, 1977, ANN STAT, V5, P22, DOI 10.1214/aos/1176343738; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Rousseau D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021102; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Simonotto E, 1997, PHYS REV LETT, V78, P1186, DOI 10.1103/PhysRevLett.78.1186; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stocks NG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041114; Teramae J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00485; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Xu BH, 2003, CHAOS SOLITON FRACT, V16, P93, DOI 10.1016/S0960-0779(02)00201-1; Zeng LZ, 2012, CHAOS SOLITON FRACT, V45, P378, DOI 10.1016/j.chaos.2011.10.012; Zozor S, 2003, IEEE T SIGNAL PROCES, V51, P3177, DOI 10.1109/TSP.2003.818905	63	19	19	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91345	10.1371/journal.pone.0091345	http://dx.doi.org/10.1371/journal.pone.0091345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632853	gold, Green Published			2022-12-27	WOS:000332858400056
J	Goeldner, I; Skare, T; Boldt, ABW; Nass, FR; Messias-Reason, IJ; Utiyama, SR				Goeldner, Isabela; Skare, Thelma; Boldt, Angelica B. W.; Nass, Flavia R.; Messias-Reason, Iara J.; Utiyama, Shirley R.			Association of MASP-2 Levels and MASP2 Gene Polymorphisms with Rheumatoid Arthritis in Patients and Their Relatives	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; PATTERN-RECOGNITION MOLECULES; SERINE PROTEASE-2 MASP-2; PATHWAY COMPONENTS; COMPLEMENT; SERUM; DEFICIENCY; ACTIVATION; DISEASE; RISK	Background: Mannan-binding lectin-associated serine protease 2 (MASP-2) is a key protein of the lectin pathway of complement. MASP-2 levels have been associated with different polymorphisms within MASP2 gene as well as with the risk for inflammatory disorders and infections. Despite its clinical importance, MASP-2 remains poorly investigated in rheumatoid arthritis (RA). Methods: In this case-control study, we measured MASP-2 serum levels in 156 RA patients, 44 patient relatives, and 100 controls from Southern Brazil, associating the results with nine MASP2 polymorphisms in all patients, 111 relatives, and 230 controls genotyped with multiplex SSP-PCR. Results: MASP-2 levels were lower in patients than in controls and relatives (medians 181 vs. 340 or 285 ng/ml, respectively, P<0.0001). Conversely, high MASP-2 levels were associated with lower susceptibility to RA and to articular symptoms independently of age, gender, ethnicity, smoking habit, anti-CCP and rheumatoid factor positivity (OR = 0.05 [95% CI = 0.019-0.13], P<0.0001 between patients and controls; OR = 0.12, [95% CI = 0.03-0.45], P = 0.002 between patients and relatives; OR = 0.06, [95% CI = 0.004-0.73], P = 0.03 between relatives with and without articular symptoms). MASP2 haplotypes *2A1 and *2B1-i were associated with increased susceptibility to RA (OR = 3.32 [95% CI = 1.48-7.45], P = 0.004). Deficiency-causing p.120G and p.439H substitutions were associated with five times increased susceptibility to articular symptoms in relatives (OR = 5.13 [95% CI = 1.36-20.84], P = 0.02). There was no association of MASP-2 levels or MASP2 polymorphisms with autoantibodies, Sjogren's syndrome, nodules and functional class. Conclusions: In this study, we found the first evidence that MASP-2 deficiency might play an important role in the development of RA and articular symptoms among relatives of RA patients.	[Goeldner, Isabela; Boldt, Angelica B. W.; Nass, Flavia R.; Messias-Reason, Iara J.] Univ Fed Parana, Dept Med Pathol, BR-80060000 Curitiba, Parana, Brazil; [Skare, Thelma] Evangel Univ Hosp, Rheumatol Unit, Curitiba, Parana, Brazil; [Utiyama, Shirley R.] Univ Fed Parana, Dept Clin Anal, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Goeldner, I (corresponding author), Univ Fed Parana, Dept Med Pathol, BR-80060000 Curitiba, Parana, Brazil.	igoeldner@gmail.com.br	Boldt, Angelica/G-3630-2012; Eibofner, Isabela/D-1884-2014	Boldt, Angelica/0000-0002-0902-9622; Eibofner, Isabela/0000-0002-9850-6231; Jose de Messias Reason, Iara/0000-0002-5573-260X	Araucaria Foundation [412/2009, 5103]; National Counsel of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES)	Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was partially supported by grants from the Araucaria Foundation (no. 412/2009, protocol 5103, http://www.fundacaoaraucaria.org.br/), as well as by fellowships from the National Counsel of Technological and Scientific Development (CNPq) and Coordination for the Improvement of Higher Level Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammitzboll CG, 2012, RHEUMATOL INT, V32, P1457, DOI 10.1007/s00296-011-1879-x; Arlestig L, 2012, ANN RHEUM DIS, V71, P825, DOI 10.1136/annrheumdis-2011-200668; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Banda NK, 2010, J IMMUNOL, V185, P5598, DOI 10.4049/jimmunol.1001564; Bergstrom U, 2011, RHEUMATOLOGY, V50, P2005, DOI 10.1093/rheumatology/ker258; Boldt ABW, 2011, HUM IMMUNOL, V72, P753, DOI 10.1016/j.humimm.2011.05.015; Boldt ABW, 2013, PLOS ONE IN PRESS; Boldt ABW, 2012, ADV CLIN CHEM, V56, P105, DOI 10.1016/B978-0-12-394317-0.00012-1; Boldt ABW, 2011, CLIN IMMUNOL, V140, P63, DOI 10.1016/j.clim.2011.03.008; Braun-Prado K, 2000, TISSUE ANTIGENS, V56, P417, DOI 10.1034/j.1399-0039.2000.560504.x; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Dolman KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2386; Eleftherohorinou H, 2011, HUM MOL GENET, V20, P3494, DOI 10.1093/hmg/ddr248; Endo Y, 2002, INT IMMUNOL, V14, P1193, DOI 10.1093/intimm/dxf085; Gabriel SE, 1999, J RHEUMATOL, V26, P2529; Goeldner I, 2010, RHEUMATOLOGY, V49, P1590, DOI 10.1093/rheumatology/keq134; Guthrie KA, 2009, ANN RHEUM DIS, V68, P107, DOI 10.1136/ard.2008.092312; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Ip WK, 2000, ARTHRITIS RHEUM, V43, P1679, DOI 10.1002/1529-0131(200008)43:8<1679::AID-ANR3>3.3.CO;2-4; Jacobsen S, 2009, J RHEUMATOL, V36, P731, DOI 10.3899/jrheum.080846; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Herraez DL, 2013, ARTHRITIS RHEUM-US, V65, P1457, DOI 10.1002/art.37923; Martiny FL, 2012, J RHEUMATOL, V39, P6, DOI 10.3899/jrheum.110052; Messias-Reason I, 2008, CLIN EXP DERMATOL, V33, P495, DOI 10.1111/j.1365-2230.2008.02743.x; Michou L, 2008, J RHEUMATOL, V35, P790; Myouzen K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002949; Nebert DW, 2002, HUM MUTAT, V20, P463, DOI 10.1002/humu.10143; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Probst CM, 2000, HUM BIOL, V72, P597; Rojas-Villarraga A, 2009, J AUTOIMMUN, V32, P64, DOI 10.1016/j.jaut.2008.11.004; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schafranski MD, 2008, HUM IMMUNOL, V69, P41, DOI 10.1016/j.humimm.2007.11.003; Schlapbach LJ, 2009, PEDIATR INFECT DIS J, V26, P989; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Sorensen CM, 2006, CLIN EXP IMMUNOL, V145, P173, DOI 10.1111/j.1365-2249.2006.03101.x; Srirangan S, 2010, THER ADV MUSCULOSKEL, V2, P247, DOI 10.1177/1759720X10378372; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Stover C, 2001, GENES IMMUN, V2, P119, DOI 10.1038/sj.gene.6363745; Thiel S, 2007, GENES IMMUN, V8, P154, DOI 10.1038/sj.gene.6364373; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Troelsen LN, 2010, MOL IMMUNOL, V47, P713, DOI 10.1016/j.molimm.2009.10.021; Unterberger C, 2007, BIOCHEM BIOPH RES CO, V364, P1022, DOI 10.1016/j.bbrc.2007.10.114; Valles X, 2009, TISSUE ANTIGENS, V74, P298, DOI 10.1111/j.1399-0039.2009.01328.x; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Zhang M, 2013, INT J CARDIOL, V166, P499, DOI 10.1016/j.ijcard.2011.11.032	48	11	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90979	10.1371/journal.pone.0090979	http://dx.doi.org/10.1371/journal.pone.0090979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632598	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400028
J	Manea, A; Leishman, MR				Manea, Anthony; Leishman, Michelle R.			Leaf Area Index Drives Soil Water Availability and Extreme Drought-Related Mortality under Elevated CO2 in a Temperate Grassland Model System	PLOS ONE			English	Article							CLIMATE-CHANGE; C-4 GRASSES; SPECIES COMPOSITION; SEMIARID GRASSLAND; ATMOSPHERIC CO2; GLOBAL CHANGE; GAS-EXCHANGE; RESPONSES; ECOSYSTEM; PLANTS	The magnitude and frequency of climatic extremes, such as drought, are predicted to increase under future climate change conditions. However, little is known about how other factors such as CO2 concentration will modify plant community responses to these extreme climatic events, even though such modifications are highly likely. We asked whether the response of grasslands to repeat extreme drought events is modified by elevated CO2, and if so, what are the underlying mechanisms? We grew grassland mesocosms consisting of 10 co-occurring grass species common to the Cumberland Plain Woodland of western Sydney under ambient and elevated CO2 and subjected them to repeated extreme drought treatments. The 10 species included a mix of C-3, C-4, native and exotic species. We hypothesized that a reduction in the stomatal conductance of the grasses under elevated CO2 would be offset by increases in the leaf area index thus the retention of soil water and the consequent vulnerability of the grasses to extreme drought would not differ between the CO2 treatments. Our results did not support this hypothesis: soil water content was significantly lower in the mesocosms grown under elevated CO2 and extreme drought-related mortality of the grasses was greater. The C-4 and native grasses had significantly higher leaf area index under elevated CO2 levels. This offset the reduction in the stomatal conductance of the exotic grasses as well as increased rainfall interception, resulting in reduced soil water content in the elevated CO2 mesocosms. Our results suggest that projected increases in net primary productivity globally of grasslands in a high CO2 world may be limited by reduced soil water availability in the future.	[Manea, Anthony; Leishman, Michelle R.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Manea, A (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	anthony.manea@students.mq.edu.au	Leishman, Michelle M/G-9726-2012; Leishman, Michelle/AAU-4102-2020	Leishman, Michelle M/0000-0003-4830-5797; Leishman, Michelle/0000-0003-4830-5797; Manea, Anthony/0000-0002-0956-4529	Macquarie University Research Excellence; National Climate Change Adaptation Research Flagship scholarship	Macquarie University Research Excellence; National Climate Change Adaptation Research Flagship scholarship	This research was funded by a Macquarie University Research Excellence and National Climate Change Adaptation Research Flagship scholarship to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson LJ, 2001, GLOBAL CHANGE BIOL, V7, P693, DOI 10.1046/j.1354-1013.2001.00438.x; [Anonymous], 2004, ANNU REV ENV RESOUR; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Cavaleri MA, 2010, ECOLOGY, V91, P2705, DOI 10.1890/09-0582.1; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Dijkstra FA, 2010, FUNCT ECOL, V24, P1152, DOI 10.1111/j.1365-2435.2010.01717.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; ETCCDI/CRD, 2012, CC1 CLIVAR JCOMM EXP; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Field C. B, 2011, MANAGING RISKS EXTRE; Funk JL, 2010, BIOL INVASIONS, V12, P1685, DOI 10.1007/s10530-009-9581-6; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Joussaume S, 2013, WORKING GROUP 1 CONT; Lecain DR, 2003, ANN BOT-LONDON, V92, P41, DOI 10.1093/aob/mcg109; Little D, 2003, BRINGING BUSH BACK W, P47; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2001, GLOBAL CHANGE BIOL, V7, P451, DOI 10.1046/j.1365-2486.2001.00415.x; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Newingham BA, 2013, GLOBAL CHANGE BIOL, V19, P2168, DOI 10.1111/gcb.12177; Niklaus PA, 2001, ECOL MONOGR, V71, P341, DOI 10.1890/0012-9615(2001)071[0341:ALTFSO]2.0.CO;2; PARTON WJ, 1995, GLOBAL CHANGE BIOL, V1, P13, DOI 10.1111/j.1365-2486.1995.tb00002.x; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Polley HW, 2012, GLOBAL CHANGE BIOL, V18, P700, DOI 10.1111/j.1365-2486.2011.02529.x; Polley HW, 2003, NEW PHYTOL, V160, P319, DOI 10.1046/j.1469-8137.2003.00897.x; Schiermeier Q, 2008, NATURE, V452, P270, DOI 10.1038/452270a; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; WOODWARD FI, 1990, TRENDS ECOL EVOL, V5, P308, DOI 10.1016/0169-5347(90)90087-T	30	20	20	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91046	10.1371/journal.pone.0091046	http://dx.doi.org/10.1371/journal.pone.0091046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632832	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400038
J	Manso, R; Rodriguez-Pinilla, SM; Lombardia, L; de Garibay, GR; Lopez, MD; Requena, L; Sanchez, L; Sanchez-Beato, M; Piris, MA				Manso, Rebeca; Maria Rodriguez-Pinilla, Socorro; Lombardia, Luis; Ruiz de Garibay, Gorka; del Mar Lopez, Maria; Requena, Luis; Sanchez, Lydia; Sanchez-Beato, Margarita; Angel Piris, Miguel			An A91V SNP in the Perforin Gene Is Frequently Found in NK/T-Cell Lymphomas	PLOS ONE			English	Article							NATURAL-KILLER-CELL; BARR-VIRUS INFECTION; NASAL-TYPE; T-CELL; CLINICAL-FEATURES; K-RAS; PROGNOSTIC-FACTORS; C-KIT; MUTATIONS; P53	NK/T-cell lymphoma (NKTCL) is the most frequent EBV-related NK/T-cell disease. Its clinical manifestations overlap with those of familial haemophagocytic lymphohistiocytosis (FHLH). Since PERFORIN (PRF1) mutations are present in FHLH, we analysed its role in a series of 12 nasal and 12 extranasal-NKTCLs. 12.5% of the tumours and 25% of the nasal-origin cases had the well-known g.272C>T(p.Ala91Val) pathogenic SNP, which confers a poor prognosis. Two of these cases had a double-CD4/CD8-positive immunophenotype, although no correlation was found with perforin protein expression. p53 was overexpressed in 20% of the tumoral samples, 80% of which were of extranasal origin, while none showed PRF1 SNVs. These results suggest that nasal and extranasal NKTCLs have different biological backgrounds, although this requires validation.	[Manso, Rebeca; Maria Rodriguez-Pinilla, Socorro] Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain; [Maria Rodriguez-Pinilla, Socorro; Ruiz de Garibay, Gorka; del Mar Lopez, Maria; Sanchez-Beato, Margarita; Angel Piris, Miguel] CNIO, Lymphoma Grp, Mol Pathol Programme, Madrid, Spain; [Lombardia, Luis] CNIO, Diagnost Clin Res Unit, Clin Res Programme, Madrid, Spain; [Ruiz de Garibay, Gorka] Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain; [del Mar Lopez, Maria] CNIO, Monoclonal Antibodies Unit, Biotechnol Programme, Madrid, Spain; [Requena, Luis] Fdn Jimenez Diaz, Dept Dermatol, Madrid, Spain; [Sanchez, Lydia] CNIO, Immunohistochem Unit, Biotechnol Programme, Madrid, Spain; [Sanchez-Beato, Margarita] Hosp Univ Puerta Hierro Majadahonda, Inst Invest Sanitaria, Oncol Haematol Area, Madrid, Spain; [Angel Piris, Miguel] Univ Cantabria, Hosp Univ Marques Valdecilla, IFIMAV, Dept Pathol, E-39005 Santander, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Clinico San Carlos; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Puerta de Hierro-Majadahonda; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Rodriguez-Pinilla, SM (corresponding author), Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain.	smrodriguez@fjd.es	de Garibay, Gorka Ruiz/AAB-6579-2020; Piris, Miguel A/B-7067-2008; Piris, Miguel A/AAP-1445-2020; Sanchez-Beato, Margarita/G-8753-2012	de Garibay, Gorka Ruiz/0000-0001-9936-8419; Piris, Miguel A/0000-0001-5839-3634; Piris, Miguel A/0000-0001-5839-3634; Sanchez-Beato, Margarita/0000-0002-0058-7599	Ministerio de Ciencia e Innovacion, Spain (RETICC) [SAF2008-03871, FIS 08/0856]; Spanish Association Against Cancer (AECC); Fondo de Investigaciones Sanitarias [CP11/00018]; Conchita Rabago Foundation	Ministerio de Ciencia e Innovacion, Spain (RETICC); Spanish Association Against Cancer (AECC); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Conchita Rabago Foundation	This study was supported by grants from the Ministerio de Ciencia e Innovacion, Spain (RETICC, SAF2008-03871, FIS 08/0856) and the Spanish Association Against Cancer (AECC). MSB is supported by a Miguel Servet Contract (CP11/00018) from the Fondo de Investigaciones Sanitarias. RM is supported by the Conchita Rabago Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aozasa K, 2008, INT J HEMATOL, V87, P110, DOI 10.1007/s12185-008-0021-7; Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Berti E, 2010, BLOOD, V116, P165, DOI 10.1182/blood-2009-11-252957; Brennan AJ, 2010, CELL DEATH DIFFER, V17, P607, DOI 10.1038/cdd.2009.212; Cannella S, 2007, CANCER-AM CANCER SOC, V109, P2566, DOI 10.1002/cncr.22718; Chan KC Q-ML, 2008, WHO CLASSIFICATION T; Chen RL, 2007, J CLIN PATHOL, V60, P1168, DOI 10.1136/jcp.2007.049551; Chia J, 2009, P NATL ACAD SCI USA, V106, P9809, DOI 10.1073/pnas.0903815106; Clementi R, 2005, BLOOD, V105, P4424, DOI 10.1182/blood-2004-04-1477; Elenitoba-Johnson KSJ, 1998, MODERN PATHOL, V11, P905; Gaal K, 2000, AM J SURG PATHOL, V24, P1511, DOI 10.1097/00000478-200011000-00006; Garcia JF, 2003, BLOOD, V101, P681, DOI 10.1182/blood-2002-04-1128; Hongyo T, 2005, ONCOL REP, V13, P265; Hoshida Y, 2003, CANCER SCI, V94, P297, DOI 10.1111/j.1349-7006.2003.tb01436.x; Huang YL, 2010, BLOOD, V115, P1226, DOI 10.1182/blood-2009-05-221275; Isobe Y, 2012, J CLIN PATHOL, V65, P278, DOI 10.1136/jclinpath-2011-200523; Jo JC, 2012, EUR J HAEMATOL, V89, P103, DOI 10.1111/j.1600-0609.2012.01796.x; KANAVAROS P, 1993, BLOOD, V81, P2688; Katano H, 2004, BLOOD, V103, P1244, DOI 10.1182/blood-2003-06-2171; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Kurniawan AN, 2006, ONCOL REP, V15, P1257; Lee J, 2005, BRIT J CANCER, V92, P1226, DOI 10.1038/sj.bjc.6602502; Lee SM, 2004, J MED GENET, V41, P137, DOI 10.1136/jmg.2003.011528; Li SY, 2013, AM J SURG PATHOL, V37, P14, DOI 10.1097/PAS.0b013e31826731b5; Li T, 2000, LAB INVEST, V80, P493, DOI 10.1038/labinvest.3780055; Li YX, 2008, BLOOD, V112, P3057, DOI 10.1182/blood-2008-05-160176; Li YX, 2011, CANCER-AM CANCER SOC, V117, P5203, DOI 10.1002/cncr.26167; Li YX, 2009, CLIN CANCER RES, V15, P2905, DOI 10.1158/1078-0432.CCR-08-2914; Lu G, 2009, CHINESE MED J-PEKING, V122, P262, DOI 10.3760/cma.j.issn.0366-6999.2009.03.005; Ng SB, 2004, MODERN PATHOL, V17, P1097, DOI 10.1038/modpathol.3800157; Petit B, 2001, HUM PATHOL, V32, P196, DOI 10.1053/hupa.2001.21569; Pipkin ME, 2010, IMMUNOL REV, V235, P55, DOI 10.1111/j.0105-2896.2010.00905.x; Pongpruttipan T, 2012, AM J SURG PATHOL, V36, P481, DOI 10.1097/PAS.0b013e31824433d8; Pongpruttipan T, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-79; Quintanilla-Martinez L, 1999, HUM PATHOL, V30, P849, DOI 10.1016/S0046-8177(99)90147-8; Quintanilla-Martinez L, 2001, AM J PATHOL, V159, P2095, DOI 10.1016/S0002-9440(10)63061-1; Risma KA, 2006, J CLIN INVEST, V116, P182, DOI 10.1172/JCI26217; Santoro A, 2005, HAEMATOLOGICA, V90, P697; Schwartz EJ, 2008, AM J CLIN PATHOL, V130, P343, DOI 10.1309/V561QTM6854W4WAV; Stadt UZ, 2004, BLOOD, V104, P1909, DOI 10.1182/blood-2004-02-0733; Suzuki R, 2009, BLOOD, V113, P6260, DOI 10.1182/blood-2009-03-211011; Swerdlow SH, 2008, WHO CLASSIFICATION T; Takahara M, 2004, HUM PATHOL, V35, P86, DOI 10.1016/j.humpath.2003.08.025; Trambas C, 2005, BLOOD, V106, P932, DOI 10.1182/blood-2004-09-3713; Voskoboinik I, 2006, IMMUNOL CELL BIOL, V84, P66, DOI 10.1111/j.1440-1711.2005.01409.x; Voskoboinik I, 2005, BLOOD, V105, P4700, DOI 10.1182/blood-2004-12-4935; Willemze R, 2008, BLOOD, V111, P838, DOI 10.1182/blood-2007-04-087288; Yang LY, 2011, LEUKEMIA RES, V35, P196, DOI 10.1016/j.leukres.2010.06.016; Ye ZY, 2013, J CLIN PATHOL, V66, P676, DOI 10.1136/jclinpath-2013-201454	49	11	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91521	10.1371/journal.pone.0091521	http://dx.doi.org/10.1371/journal.pone.0091521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632576	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400067
J	Ruser, A; Dahne, M; Sundermeyer, J; Lucke, K; Houser, DS; Finneran, JJ; Driver, J; Pawliczka, I; Rosenberger, T; Siebert, U				Ruser, Andreas; Daehne, Michael; Sundermeyer, Janne; Lucke, Klaus; Houser, Dorian S.; Finneran, James J.; Driver, Joerg; Pawliczka, Iwona; Rosenberger, Tanja; Siebert, Ursula			In-Air Evoked Potential Audiometry of Grey Seals (Halichoerus grypus) from the North and Baltic Seas	PLOS ONE			English	Article							TEMPORARY THRESHOLD SHIFT; HEARING SENSITIVITY; AMPHIBIOUS HEARING; HARBOR SEALS; NOISE; VOCALIZATIONS; PINNIPEDS; EXPOSURE; SINGLE	In-air anthropogenic sound has the potential to affect grey seal (Halichoerus grypus) behaviour and interfere with acoustic communication. In this study, a new method was used to deliver acoustic signals to grey seals as part of an in-air hearing assessment. Using in-ear headphones with adapted ear inserts allowed for the measurement of auditory brainstem responses (ABR) on sedated grey seals exposed to 5-cycle (2-1-2) tone pips. Thresholds were measured at 10 frequencies between 1-20 kHz. Measurements were made using subcutaneous electrodes on wild seals from the Baltic and North Seas. Thresholds were determined by both visual and statistical approaches (single point F-test) and good agreement was obtained between the results using both methods. The mean auditory thresholds were <= 40 dB re 20 mu Pa peak equivalent sound pressure level (peSPL) between 4-20 kHz and showed similar patterns to in-air behavioural hearing tests of other phocid seals between 3 and 20 kHz. Below 3 kHz, a steep reduction in hearing sensitivity was observed, which differed from the rate of decline in sensitivity obtained in behavioural studies on other phocids. Differences in the rate of decline may reflect influence of the ear inserts on the ability to reliably transmit lower frequencies or interference from the structure of the distal end of the ear canal.	[Ruser, Andreas; Daehne, Michael; Sundermeyer, Janne; Siebert, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Fdn, Busum, Schleswig Holst, Germany; [Lucke, Klaus] Wageningen UR, Imares, Inst Marine Resources & Ecosyst Studies, Den Burg, North Holland, Netherlands; [Houser, Dorian S.] Natl Marine Mammal Fdn, San Diego, CA USA; [Finneran, James J.] US Navy Marine Mammal Program, Space & Naval Warfare Syst Ctr Pacific, San Diego, CA USA; [Driver, Joerg] Vet Clin, Reinsbuttel, Schleswig Holst, Germany; [Pawliczka, Iwona] Univ Gdansk, Hel Marine Stn, Hel, Pomerania, Poland; [Rosenberger, Tanja] Seal Ctr Friedrichskoog, Schleswig Holstein, Germany	University of Veterinary Medicine Hannover, Foundation; Wageningen University & Research; Naval Information Warfare Center Pacific; United States Department of Defense; United States Navy; Fahrenheit Universities; University of Gdansk	Ruser, A (corresponding author), Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Fdn, Busum, Schleswig Holst, Germany.	andreas.ruser@tiho-hannover.de	Lucke, Klaus/B-9349-2015; Houser, Dorian/AAG-6359-2020	Lucke, Klaus/0000-0002-5414-3715; Houser, Dorian/0000-0002-0960-8528; Pawliczka, Iwona/0000-0001-9235-9456	Federal Agency for Nature Conservation, Germany [Z1.2-5330/2010/14]; Wehrtechnische Dienststelle of the German Bundeswehr [71]	Federal Agency for Nature Conservation, Germany; Wehrtechnische Dienststelle of the German Bundeswehr	This study was funded by the Federal Agency for Nature Conservation, Germany (http://www.bfn.de/index+M52087573ab0.html) under the contract Z1.2-5330/2010/14. The data acquisition hardware was purchased by means of funding by the Wehrtechnische Dienststelle 71 of the German Bundeswehr (http://www.baain.de/portal/a/baain/!ut/p/c4/04_SB8K8xLLM9MSSzPy8xBz9CP3I5EyrpHK9pMTEzDy9lMzUvOKSYr3ykhRzQ_1wkPKcdP3I1Dz9gtxcRwConM6j/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSELIN S, 1993, CAN J ZOOL, V71, P2211, DOI 10.1139/z93-310; BfN - Bundesamt fur Naturschutz, 2007, NAT BER 2007 BEW FFH; BMWI - Bundesministerium fur Wirtschaft und Technologie, 2011, RES ENV SOUND REL AF; Breton SP, 2009, RENEW ENERG, V34, P646, DOI 10.1016/j.renene.2008.05.040; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; Dudzinski KM, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P260; ELBERLING C, 1984, SCAND AUDIOL, V13, P187, DOI 10.3109/01050398409043059; Finneran JJ, 2006, J ACOUST SOC AM, V119, P3181, DOI 10.1121/1.2180208; Finneran JJ, 2009, J ACOUST SOC AM, V126, P491, DOI 10.1121/1.3148214; Finneran JJ, 2002, J ACOUST SOC AM, V111, P2929, DOI 10.1121/1.1479150; Finneran JJ, 2008, 3226 SSC SAN DIEG; Harkonen Tero, 2007, NAMMCO Scientific Publications, V6, P57; Herrmann C, 2007, NATURSCHUTZARBEIT MV, V50, P56; Houser Dorian S., 2007, Aquatic Mammals, V33, P110, DOI 10.1578/AM.33.1.2007.110; Houser DS, 2006, J ACOUST SOC AM, V120, P4090, DOI 10.1121/1.2357993; JEWETT DL, 1971, BRAIN, V94, P681, DOI 10.1093/brain/94.4.681; Kastak D, 2005, J ACOUST SOC AM, V118, P3154, DOI 10.1121/1.2047128; Kastak D, 1999, CAN J ZOOL, V77, P1751, DOI 10.1139/cjz-77-11-1751; Kastak D, 1998, J ACOUST SOC AM, V103, P2216, DOI 10.1121/1.421367; Kastak D, 2007, J ACOUST SOC AM, V122, P2916, DOI 10.1121/1.2783111; King J. E., 1991, SEALS WORLD; Lucke K., 2008, AUDITORY STUDIES MAR; MOHL B, 1968, Journal of Auditory Research, V8, P27; Mulsow J, 2011, J ACOUST SOC AM, V129, P2298, DOI 10.1121/1.3552882; Nachtigall PE, 2004, MAR MAMMAL SCI, V20, P673, DOI 10.1111/j.1748-7692.2004.tb01187.x; National Research Council, 2005, MAR MAMM POP OC NOIS; OLIVER GW, 1978, BEHAVIOUR, V67, P97, DOI 10.1163/156853978X00279; OSPAR Commission, 2000, QUAL STAT REP 2000; RALLS K, 1985, CAN J ZOOL, V63, P1050, DOI 10.1139/z85-157; Reichmuth C, 2013, J COMP PHYSIOL A, V199, P491, DOI 10.1007/s00359-013-0813-y; Reijnders Peter J.H., 2009, Wadden Sea Ecosystem, V25, P1; RIDGWAY S H, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P81; SCHEVILL WE, 1963, SCIENCE, V141, P50, DOI 10.1126/science.141.3575.50; Siebert U., 2012, THREATENED BIODIVERS, P488; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Sundermeyer J, 2006, UNTERSUCHUNGEN OPTIM; TERHUNE JM, 1971, CAN J ZOOLOG, V49, P385, DOI 10.1139/z71-057; Thomas J. A., 1983, ANTARCT J, V17, P186; Thomson D.H., 1995, MARINE MAMMALS NOISE, P159, DOI [10.1016/B978-0-08-057303-8.50010-0., DOI 10.1016/B978-0-08-057303-8.50010-0]; TURNBULL SD, 1990, CAN J ZOOL, V68, P2090, DOI 10.1139/z90-291; Wolski LF, 2003, J ACOUST SOC AM, V113, P629, DOI 10.1121/1.1527961	41	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90824	10.1371/journal.pone.0090824	http://dx.doi.org/10.1371/journal.pone.0090824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632891	Green Published, gold			2022-12-27	WOS:000332858400019
J	Tan, T; Chen, Z; Lei, Y; Zhu, Y; Liang, QJ				Tan, Tan; Chen, Zhe; Lei, Yan; Zhu, Yan; Liang, Qianjin			A Regulatory Effect of INMAP on Centromere Proteins: Antisense INMAP Induces CENP-B Variation and Centromeric Halo	PLOS ONE			English	Article							KINETOCHORE PROTEINS; CELL-DIVISION; DNA-BINDING; HELA-CELLS; NULL MICE; SATELLITE; COMPLEX; LOCALIZATION; MICROTUBULES; CHECKPOINT	CENP-B is a highly conserved protein that facilitates the assembly of specific centromere structures both in interphase nuclei and on mitotic chromosomes. INMAP is a conserved protein that localizes at nucleus in interphase cells and at mitotic apparatus in mitotic cells. Our previous results showed that INMAP over-expression leads to spindle defects, mitotic arrest and formation of polycentrosomal and multinuclear cells, indicating that INMAP may modulate the function of (a) key protein(s) in mitotic apparatus. In this study, we demonstrate that INMAP interacts with CENP-B and promotes cleavage of the N-terminal DNA binding domain from CENP-B. The cleaved CENP-B cannot associate with centromeres and thus lose its centromere-related functions. Consistent with these results, CENP-B in INMAP knockdown cells becomes more diffused around kinetochores. Although INMAP knockdown cells do not exhibit gross defects in mitotic spindle formation, these cells go through mitosis, especially prophase and metaphase, with different relative timing, indicating subtle abnormality. These results identify INMAP as a model regulator of CENP-B and support the notion that INMAP regulates mitosis through modulating CENP-B-mediated centromere organization.	[Tan, Tan; Lei, Yan; Zhu, Yan; Liang, Qianjin] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Chen, Zhe; Liang, Qianjin] Beijing Normal Univ, Beijing Key Lab Gene Engn Drugs & Biol Technol, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Liang, QJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China.	lqj@bnu.edu.cn			National Natural Science Foundation of China [30971470]; Beijing Natural Science Foundation [5122017]; Key Laboratory of Cell Proliferation and Regulation Biology, the Ministry of Education [201001]; Beijing Key Laboratory of Gene Resource and Molecular Development [201102, 201204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Key Laboratory of Cell Proliferation and Regulation Biology, the Ministry of Education; Beijing Key Laboratory of Gene Resource and Molecular Development	This study was supported by the National Natural Science Foundation of China (no. 30971470 to QL), the Beijing Natural Science Foundation (no. 5122017 to QL), the open fund of Key Laboratory of Cell Proliferation and Regulation Biology, the Ministry of Education (no. 201001 to YZ) and the open fund of Beijing Key Laboratory of Gene Resource and Molecular Development (no. 201102 to YZ and no. 201204 YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Baum M, 2000, MOL CELL BIOL, V20, P2852, DOI 10.1128/MCB.20.8.2852-2864.2000; Burrack LS, 2011, CURR BIOL, V21, P889, DOI 10.1016/j.cub.2011.04.002; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Fowler KJ, 2000, GENOME RES, V10, P30; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; He DC, 1997, P 14 INT S MORPH SCI, V3; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; Hudson M, 2012, J RHEUMATOL, V39, P787, DOI 10.3899/rheum.111133; KIPLING D, 1995, MOL CELL BIOL, V15, P4009; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Masumoto H, 2004, CHROMOSOME RES, V12, P543, DOI 10.1023/B:CHRO.0000036593.72788.99; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; Orthaus S, 2008, CHEMBIOCHEM, V9, P77, DOI 10.1002/cbic.200700358; Orthaus S, 2006, BIOCHEM BIOPH RES CO, V348, P36, DOI 10.1016/j.bbrc.2006.06.187; Ortiz-Lombardia M, 1998, J MOL BIOL, V277, P757, DOI 10.1006/jmbi.1998.1646; Perez-Castro AV, 1998, DEV BIOL, V201, P135, DOI 10.1006/dbio.1998.9005; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Shen EZ, 2009, EXP CELL RES, V315, P1100, DOI 10.1016/j.yexcr.2009.01.022; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suzuki N, 2004, J BIOL CHEM, V279, P5934, DOI 10.1074/jbc.M306477200; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036; Yang CH, 1996, MOL CELL BIOL, V16, P3576; Yang ZY, 2003, CELL RES, V13, P275, DOI 10.1038/sj.cr.7290172; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yoda K, 1998, GENES CELLS, V3, P533, DOI 10.1046/j.1365-2443.1998.00210.x; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413; Zhou YL, 2013, MOL CELL BIOCHEM, V374, P81, DOI 10.1007/s11010-012-1507-4; ZHU XL, 1995, J BIOL CHEM, V270, P19545, DOI 10.1074/jbc.270.33.19545; Zhu XL, 1999, MOL CELL BIOL, V19, P1016; Zhu XL, 1997, J CELL BIOCHEM, V66, P441, DOI 10.1002/(SICI)1097-4644(19970915)66:4<441::AID-JCB3>3.0.CO;2-L	52	6	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91937	10.1371/journal.pone.0091937	http://dx.doi.org/10.1371/journal.pone.0091937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633075	Green Published, gold			2022-12-27	WOS:000332858400123
J	Viorica, D; Jemna, D; Pintilescu, C; Asandului, M				Viorica, Daniela; Jemna, Danut; Pintilescu, Carmen; Asandului, Mircea			The Relationship between Inflation and Inflation Uncertainty. Empirical Evidence for the Newest EU Countries	PLOS ONE			English	Article							OUTPUT GROWTH; LINK	The objective of this paper is to verify the hypotheses presented in the literature on the causal relationship between inflation and its uncertainty, for the newest EU countries. To ensure the robustness of the results, in the study four models for inflation uncertainty are estimated in parallel: ARCH (1), GARCH (1,1), EGARCH (1,1,1) and PARCH (1,1,1). The Granger method is used to test the causality between two variables. The working hypothesis is that groups of countries with a similar political and economic background in 1990 and are likely to be characterized by the same causal relationship between inflation and inflation uncertainty. Empirical results partially confirm this hypothesis.	[Viorica, Daniela; Jemna, Danut; Pintilescu, Carmen; Asandului, Mircea] Alexandru Ioan Cuza Univ, Fac Econ & Business Adm, Iasi, Romania	Alexandru Ioan Cuza University	Asandului, M (corresponding author), Alexandru Ioan Cuza Univ, Fac Econ & Business Adm, Iasi, Romania.	asmircea@yahoo.com	Asandului, Mircea/A-2845-2017; Viorica, Daniela/AAE-9954-2019	Asandului, Mircea/0000-0002-6182-7103; Viorica, Elena-Daniela/0000-0002-5301-7776				Ajevskis V, 2007, WORKING PAPERS LATVI; BALL L, 1992, J MONETARY ECON, V29, P371, DOI 10.1016/0304-3932(92)90032-W; Berument H, 2005, SCOT J POLIT ECON, V52, P222, DOI 10.1111/j.0036-9292.2005.00342.x; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Conrad C, 2005, STUD NONLINEAR DYN E, V9; CUKIERMAN A, 1986, ECONOMETRICA, V54, P1099, DOI 10.2307/1912324; Ding Z, 1993, J EMPIR FINANC, V1, P83, DOI [10.1016/0927-5398(93)90006-D, DOI 10.1016/0927-5398(93)90006-D]; EVANS M, 1991, J MONEY CREDIT BANK, V23, P169, DOI 10.2307/1992775; Fountas S, 2004, MANCH SCH, V72, P221, DOI 10.1111/j.1467-9957.2004.00390.x; Fountas S, 2001, ECON LETT, V74, P77, DOI 10.1016/S0165-1765(01)00522-5; Fountas S, 2007, J INT MONEY FINANC, V26, P229, DOI 10.1016/j.jimonfin.2006.10.006; FRIEDMAN M, 1977, J POLIT ECON, V85, P451, DOI 10.1086/260579; Grier KB, 1998, J INT MONEY FINANC, V17, P671, DOI 10.1016/S0261-5606(98)00023-0; Hasanov M, 2011, EMERG MARK FINANC TR, V47, P5, DOI 10.2753/REE1540-496X4704S301; HOLLAND AS, 1995, J MONEY CREDIT BANK, V27, P827, DOI 10.2307/2077753; Karanasos M, 2008, GER ECON REV, V9, P265, DOI 10.1111/j.1468-0475.2008.00433.x; Khan M, 2013, WORKING PAPERS SERIE; Kontonikas A, 2004, ECON MODEL, V21, P525, DOI 10.1016/j.econmod.2003.08.001; McKenzie M, 2002, APPL FINANCIAL EC, V12, P555; Mladenovic Z, 2009, YUGOSLAV J OPERATION, V19, P171; Neanidis K, 2010, CTR GROWTH BUSINESS, V145; NELSON DB, 1992, J BUS ECON STAT, V10, P229, DOI 10.2307/1391681; OKUN AM, 1971, BROOKINGS PAP ECO AC, P485; Paesani P., 2010, 2720 CESIFO; POURGERAMI A, 1987, WORLD DEV, V15, P287, DOI 10.1016/0305-750X(87)90083-0; SCHWERT GW, 1989, J FINANC, V44, P1115, DOI 10.2307/2328636; Tas BKO, 2012, SCOT J POLIT ECON, V59, P283, DOI 10.1111/j.1467-9485.2012.00581.x; Taylor S., 1986, MODELLING FINANCIAL; Thornton J, 2007, SOUTH ECON J, V73, P858, DOI 10.2307/20111932; UNGAR M, 1993, J MONEY CREDIT BANK, V25, P709, DOI 10.2307/2077800	30	5	5	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91164	10.1371/journal.pone.0091164	http://dx.doi.org/10.1371/journal.pone.0091164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24633073	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400043
J	Zhou, C; Dobrinsky, J; Tsoi, S; Foxcroft, GR; Dixon, WT; Stothard, P; Verstegen, J; Dyck, MK				Zhou, Chi; Dobrinsky, John; Tsoi, Stephen; Foxcroft, George R.; Dixon, Walter T.; Stothard, Paul; Verstegen, John; Dyck, Michael K.			Characterization of the Altered Gene Expression Profile in Early Porcine Embryos Generated from Parthenogenesis and Somatic Cell Chromatin Transfer	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; MICE LACKING; TIME; RNA; DIFFERENTIATION; TROPHECTODERM; DEGRADATION; EFFECTORS; SOFTWARE; PROTEINS	The in vitro production of early porcine embryos is of particular scientific and economic interest. In general, embryos produced from in vitro Assisted Reproductive Technologies (ART) manipulations, such as somatic cell chromatin transfer (CT) and parthenogenetic activation (PA), are less developmentally competent than in vivo-derived embryos. The mechanisms underlying the deficiencies of embryos generated from PA and CT have not been completely understood. To characterize the altered genes and gene networks in embryos generated from CT and PA, comparative transcriptomic analyses of in vivo (IVV) expanded blastocysts (XB), IVV hatched blastocyst (HB), PA XB, PA HB, and CT HB were performed using a custom microarray platform enriched for genes expressed during early embryonic development. Differential expressions of 1492 and 103 genes were identified in PA and CT HB, respectively, in comparison with IVV HB. The "eIF2 signalling", "mitochondrial dysfunction", "regulation of eIF4 and p70S6K signalling", "protein ubiquitination", and "mTOR signalling" pathways were down-regulated in PA HB. Dysregulation of notch signalling-associated genes were observed in both PA and CT HB. TP53 was predicted to be activated in both PA and CT HB, as 136 and 23 regulation targets of TP53 showed significant differential expression in PA and CT HB, respectively, in comparison with IVV HB. In addition, dysregulations of several critical pluripotency, trophoblast development, and implantation-associated genes (NANOG, GATA2, KRT8, LGMN, and DPP4) were observed in PA HB during the blastocyst hatching process. The critical genes that were observed to be dysregulated in CT and PA embryos could be indicative of underlying developmental deficiencies of embryos produced from these technologies.	[Zhou, Chi; Tsoi, Stephen; Foxcroft, George R.; Dixon, Walter T.; Stothard, Paul; Dyck, Michael K.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Dobrinsky, John; Verstegen, John] Minitube Amer, Int Ctr Biotechnol, Mt Horeb, WI USA	University of Alberta	Dyck, MK (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	michael.dyck@ualberta.ca	Zhou, Chi/R-4277-2019	Zhou, Chi/0000-0002-3349-9069	Natural Science and Engineering Research Council of Canada (NSERC) [NETPG 340825-06]	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by funding from the Natural Science and Engineering Research Council of Canada (NSERC, Grant number: NETPG 340825-06). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027767; Assou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039306; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brevini IAL, 2008, CELL PROLIFERAT, V41, P20, DOI 10.1111/j.1365-2184.2008.00485.x; Carlson DF, 2011, TRANSGENIC RES, V20, P1125, DOI 10.1007/s11248-010-9481-7; Castro FO, 2010, THERIOGENOLOGY, V73, P71, DOI 10.1016/j.theriogenology.2009.08.003; Collas P, 2007, Methods for cloning nonhuman mammals using reprogrammed donor chromatin or donor cells US Patent, Patent No. [7,253,334, 7253334]; Degenstein KL, 2008, THERIOGENOLOGY, V70, P1075, DOI 10.1016/j.theriogenology.2008.06.027; Degrelle SA, 2009, PROTEOMICS, V9, P2678, DOI 10.1002/pmic.200800776; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dudek EJ, 2010, INVEST OPHTH VIS SCI, V51, P4164, DOI 10.1167/iovs.09-4087; Duranthon V, 2008, REPRODUCTION, V135, P141, DOI 10.1530/REP-07-0324; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Foltz M, 2004, FASEB J, V18, P1758, DOI 10.1096/fj.03-1387fje; Fujiwara H, 2005, BBA-PROTEINS PROTEOM, V1751, P26, DOI 10.1016/j.bbapap.2005.04.007; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert I, 2009, MOL REPROD DEV, V76, P762, DOI 10.1002/mrd.21030; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Glujovsky D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002118.pub4, 10.1002/14651858.CD002118.pub5]; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Hao YH, 2004, BIOL REPROD, V70, P1644, DOI 10.1095/biolreprod.103.026005; Hata H, 2014, MOL CARCINOGEN, V53, P181, DOI 10.1002/mc.21961; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Isom SC, 2013, PHYSIOL GENOMICS, V45, P577, DOI 10.1152/physiolgenomics.00094.2012; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Klein C, 2010, BIOL REPROD, V83, P102, DOI 10.1095/biolreprod.109.081612; Konig R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh027; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ledgard AM, 2009, MOL REPROD DEV, V76, P65, DOI 10.1002/mrd.20931; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Lonergan P, 2007, Soc Reprod Fertil Suppl, V64, P315; Ma GT, 1997, DEVELOPMENT, V124, P907; Mesquita FS, 2013, ANIM REPROD SCI, V136, P231, DOI 10.1016/j.anireprosci.2012.10.030; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Nanassy L, 2008, ANIM REPROD SCI, V104, P264, DOI 10.1016/j.anireprosci.2007.01.019; Naturil-Alfonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051271; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Oestrup O, 2009, REPROD DOMEST ANIM, V44, P39, DOI 10.1111/j.1439-0531.2009.01482.x; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Robert C, 2011, MOL REPROD DEV, V78, P651, DOI 10.1002/mrd.21364; Rodriguez-Osorio N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-190; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Seshagiri PB, 2009, J REPROD IMMUNOL, V83, P79, DOI 10.1016/j.jri.2009.06.264; Shepherd AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008063; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sullivan EJ, 2004, BIOL REPROD, V70, P146, DOI 10.1095/biolreprod.103.021220; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Tsoi S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-370; Vejlsted M, 2006, THERIOGENOLOGY, V65, P153, DOI 10.1016/j.theriogenology.2005.09.021; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; Whitworth KM, 2005, BIOL REPROD, V72, P1437, DOI 10.1095/biolreprod.104.037952; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yoshioka K, 2012, ANIM REPROD SCI, V131, P23, DOI 10.1016/j.anireprosci.2012.01.018; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	70	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91728	10.1371/journal.pone.0091728	http://dx.doi.org/10.1371/journal.pone.0091728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633136	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400083
J	Pisapia, C; Anderson, K; Pratchett, MS				Pisapia, Chiara; Anderson, Kristen; Pratchett, Morgan S.			Intraspecific Variation in Physiological Condition of Reef-Building Corals Associated with Differential Levels of Chronic Disturbance	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; CLIMATE-CHANGE; POCILLOPORA-DAMICORNIS; ARTIFICIAL INJURIES; ACROPORA-HYACINTHUS; POPULATION-DYNAMICS; PARTIAL MORTALITY; TISSUE BIOMASS; LONG-TERM	Even in the absence of major disturbances (e.g., cyclones, bleaching), corals are subject to high levels of partial or whole-colony mortality, often caused by chronic and small-scale disturbances. Depending on levels of background mortality, these chronic disturbances may undermine individual fitness and have significant consequences on the ability of colonies to withstand subsequent acute disturbances or environmental change. This study quantified intraspecific variations in physiological condition (measured based on total lipid content and zooxanthellae density) through time in adult colonies of two common and widespread coral species (Acropora spathulata and Pocillopora damicornis), subject to different levels of biological and physical disturbances along the most disturbed reef habitat, the crest. Marked intraspecific variation in the physiological condition of A. spathulata was clearly linked to differences in local disturbance regimes and habitat. Specifically, zooxanthellae density decreased (r(2) = 26, df = 5,42, p<0.02, B = -2121255, p = 0.03) and total lipid content increased (r(2) = 14, df = 5,42, p = 0.01, B = 0.9, p = 0.01) with increasing distance from exposed crests. Moreover, zooxanthellae density was strongly and negatively correlated with the individual level of partial mortality (r(2) = 26, df = 5,42, p<0.02, B = -7386077, p = 0.01). Conversely, P. damicornis exhibited very limited intraspecific variation in physiological condition, despite marked differences in levels of partial mortality. This is the first study to relate intraspecific variation in the condition of corals to localized differences in chronic disturbance regimes. The next step is to ascertain whether these differences have further ramifications for susceptibility to periodic acute disturbances, such as climate-induced coral bleaching.	[Pisapia, Chiara; Anderson, Kristen; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Pisapia, Chiara] James Cook Univ, AIMS JCU Australian Inst Marine Sci, Sch Marine Biol, Townsville, Qld 4811, Australia	James Cook University; Australian Institute of Marine Science; James Cook University	Pisapia, C (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	chiara.pisapia@my.jcu.edu.au	Pratchett, Morgan/AAW-5179-2020; Pratchett, Morgan S/A-9256-2010	Pratchett, Morgan/0000-0002-1862-8459; Pratchett, Morgan S/0000-0002-1862-8459; Anderson, Kristen/0000-0002-1576-6979	ARC Centre of Excellence for Coral Reef Studies, Townsville; AIMS@JCU, Townsville	ARC Centre of Excellence for Coral Reef Studies, Townsville(Australian Research Council); AIMS@JCU, Townsville	This project was supported by the ARC Centre of Excellence for Coral Reef Studies, Townsville, and AIMS@JCU, Townsville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Bachok Z, 2006, CORAL REEFS, V25, P545, DOI 10.1007/s00338-006-0130-9; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bak R. P. M, 1977, Proceedings int Coral Reef Symp, V3, P143; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; BAK RPM, 1980, OECOLOGIA, V47, P145, DOI 10.1007/BF00346812; Baker Andrew C., 1997, P1301; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BARNES H, 1973, Journal of Experimental Marine Biology and Ecology, V12, P103, DOI 10.1016/0022-0981(73)90040-3; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; Bonaldo RM, 2012, CORAL REEFS, V31, P263, DOI 10.1007/s00338-011-0846-z; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; Cole AJ, 2011, CORAL REEFS, V30, P85, DOI 10.1007/s00338-010-0674-6; Cole AJ, 2009, J EXP MAR BIOL ECOL, V373, P11, DOI 10.1016/j.jembe.2009.02.016; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Cooper TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020434; Cooper TF, 2009, ESTUAR COAST SHELF S, V83, P186, DOI 10.1016/j.ecss.2009.03.015; COX EF, 1986, J EXP MAR BIOL ECOL, V101, P161, DOI 10.1016/0022-0981(86)90047-X; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; Cumming RL, 2002, MAR ECOL PROG SER, V242, P131, DOI 10.3354/meps242131; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DONE TJ, 1988, MAR BIOL, V100, P51, DOI 10.1007/BF00392954; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; Ferrier-Pages C, 2001, J EXP MAR BIOL ECOL, V259, P249, DOI 10.1016/S0022-0981(01)00241-6; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Graham JE, 2013, MAR BIOL, V160, P2561, DOI 10.1007/s00227-013-2248-y; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Gurney WSC, 1996, THEOR POPUL BIOL, V49, P344, DOI 10.1006/tpbi.1996.0017; GUZMAN HM, 1994, MAR ECOL PROG SER, V105, P231, DOI 10.3354/meps105231; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hall VR, 1997, J EXP MAR BIOL ECOL, V212, P9, DOI 10.1016/S0022-0981(96)02760-8; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; HARLAND AD, 1993, MAR BIOL, V117, P113, DOI 10.1007/BF00346432; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Hourigan T.F., 1988, P107; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Jones RJ, 1997, MAR ECOL PROG SER, V149, P163, DOI 10.3354/meps149163; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; Knowlton N, 1990, CASE STUDY NATURAL P; Kojis B.L., 1985, P 5 INT COR REEF C, V4, P289; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; Madin JS, 2013, CORAL REEFS, V32, P173, DOI 10.1007/s00338-012-0958-0; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mass T, 2011, LIMNOL OCEANOGR, V56, P2176, DOI 10.4319/lo.2011.56.6.2176; McCowan D.M., 2011, GALAXEA J CORAL REEF, V13, P29, DOI [10.3755/galaxea.13.29, DOI 10.3755/GALAXEA.13.29]; Meesters E.H., 1992, P 7 INT COR REEF S, V2, P681; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; MOTTA PJ, 1988, ENVIRON BIOL FISH, V22, P39, DOI 10.1007/BF00000543; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; Oku H, 2003, CORAL REEFS, V22, P83, DOI 10.1007/s00338-003-0279-4; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; Pernet V, 2002, J COMP PHYSIOL B, V172, P455, DOI 10.1007/s00360-002-0268-x; PETERS EC, 1985, J EXP MAR BIOL ECOL, V92, P215, DOI 10.1016/0022-0981(85)90096-6; Pisapia C, 2012, P 12 INT COR REEF S, V13, P1; Pratchett MS, 2013, MAR ENVIRON RES, V86, P29, DOI 10.1016/j.marenvres.2013.02.007; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rotjan RD, 2006, CORAL REEFS, V25, P361, DOI 10.1007/s00338-006-0120-y; Rotjan RD, 2009, MAR BIOL, V156, P569, DOI 10.1007/s00227-008-1108-7; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; STIMSON J, 1985, ECOLOGY, V66, P40, DOI 10.2307/1941305; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; STIMSON JS, 1987, B MAR SCI, V41, P889; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Strickland D, 2010, THESIS U W AUSTR; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tanner JE, 1997, J EXP MAR BIOL ECOL, V214, P19, DOI 10.1016/S0022-0981(97)00024-5; Titlyanov EA, 2005, J EXP MAR BIOL ECOL, V323, P27, DOI 10.1016/j.jembe.2005.02.015; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; WARD S, 1995, CORAL REEFS, V14, P87, DOI 10.1007/BF00303428; Yamashiro H, 2001, J EXP MAR BIOL ECOL, V265, P171, DOI 10.1016/S0022-0981(01)00333-1	92	15	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91529	10.1371/journal.pone.0091529	http://dx.doi.org/10.1371/journal.pone.0091529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626395	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300099
J	Badaoui, B; Rutigliano, T; Anselmo, A; Vanhee, M; Nauwynck, H; Giuffra, E; Botti, S				Badaoui, Bouabid; Rutigliano, Teresa; Anselmo, Anna; Vanhee, Merijn; Nauwynck, Hans; Giuffra, Elisabetta; Botti, Sara			RNA-Sequence Analysis of Primary Alveolar Macrophages after In Vitro Infection with Porcine Reproductive and Respiratory Syndrome Virus Strains of Differing Virulence	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; SIGNALING PATHWAYS; IMMUNE-RESPONSES; TYROSINE KINASE; ACTIVATION; CELLS; DISEASE; GENOME; SWINE	Porcine reproductive and respiratory syndrome virus (PRRSV) mainly infects porcine alveolar macrophages (PAMs), resulting in porcine reproductive and respiratory syndrome (PRRS) in pigs. Most of the transcriptomic studies on PAMs infected with PRRSV conducted thus far have made use of microarray technology. Here, we investigated the transcriptome of PAMs in vitro at 12 h post-infection with two European PRRSV strains characterized by low (Lelystad, LV) and high (Lena) virulence through RNA-Seq. The expression levels of genes, isoforms, alternative transcription start sites (TSS) and differential promoter usage revealed a complex pattern of transcriptional and post-transcriptional gene regulation upon infection with the two strains. Gene ontology analysis confirmed that infection of PAMs with both the Lena and LV strains affected signaling pathways directly linked to the innate immune response, including interferon regulatory factors (IRF), RIG1-like receptors, TLRs and PKR pathways. The results confirmed that interferon signaling is crucial for transcriptional regulation during PAM infection. IFN-beta 1 and IFN-alpha omega, but not IFN-alpha, were up-regulated following infection with either the LV or Lena strain. The down-regulation of canonical pathways, such as the interplay between the innate and adaptive immune responses, cell death and TLR3/TLR7 signaling, was observed for both strains, but Lena triggered a stronger down-regulation than LV. This analysis contributes to a better understanding of the interactions between PRRSV and PAMs and outlines the differences in the responses of PAMs to strains with different levels of virulence, which may lead to the development of new PRRSV control strategies.	[Badaoui, Bouabid; Rutigliano, Teresa; Anselmo, Anna; Giuffra, Elisabetta; Botti, Sara] Parco Tecnol Padano, Lodi, Italy; [Vanhee, Merijn; Nauwynck, Hans] Univ Ghent, Fac Vet Med, Virol Lab, B-9000 Ghent, Belgium	Ghent University	Badaoui, B (corresponding author), Parco Tecnol Padano, Via Einstein, Lodi, Italy.	bouabid.badaoui@tecnoparco.org	Giuffra, Elisabetta/J-8080-2014; Badaoui, Bouabid/AAV-8968-2021	Nauwynck, Hans/0000-0001-5470-0713; Giuffra, Elisabetta/0000-0001-9568-2056; Anselmo, Anna/0000-0002-5279-8670	EC project FP7-PoRRSCon [245141]; "Progetto AGER" Cariplo Foundation, Italy [2011-0279]	EC project FP7-PoRRSCon; "Progetto AGER" Cariplo Foundation, Italy	This project was funded by EC project FP7-PoRRSCon (grant no. 245141) and "Progetto AGER" (grant no. 2011-0279) Cariplo Foundation, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, J MOL BIOL, V367, P25, DOI 10.1016/j.jmb.2006.12.060; Ait-Ali T, 2008, DEV BIOLOGICALS, V132, P239, DOI 10.1159/000317166; Badaoui B, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-58; Badaoui B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-220; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; BLOMSTROM DC, 1986, J BIOL CHEM, V261, P8811; Carter-Su C, 2000, PEDIATR NEPHROL, V14, P550, DOI 10.1007/s004670000366; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Delputte PL, 2004, J VIROL, V78, P8094, DOI 10.1128/JVI.78.15.8094-8101.2004; Diaz I, 2006, VIROLOGY, V351, P249, DOI 10.1016/j.virol.2006.03.046; Eskildsen S, 2003, NUCLEIC ACIDS RES, V31, P3166, DOI 10.1093/nar/gkg427; Flores-Mendoza L, 2008, CLIN VACCINE IMMUNOL, V15, P720, DOI 10.1128/CVI.00224-07; Fortin CF, 2007, INT IMMUNOL, V19, P41, DOI 10.1093/intimm/dxl119; Frydas IS, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-73; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gimeno M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-9; Gomez-Laguna J, 2013, TRANSBOUND EMERG DIS, V60, P273, DOI 10.1111/j.1865-1682.2012.01338.x; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; HALLER O, 1980, NATURE, V283, P660, DOI 10.1038/283660a0; Hou J, 2012, VIRUS RES, V167, P106, DOI 10.1016/j.virusres.2012.03.017; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059229; Johnson W, 2004, VET IMMUNOL IMMUNOP, V102, P233, DOI 10.1016/j.vetimm.2004.09.010; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kim TS, 2002, VIRUS RES, V85, P133, DOI 10.1016/S0168-1702(02)00029-1; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CH, 2004, VET IMMUNOL IMMUNOP, V102, P189, DOI 10.1016/j.vetimm.2004.09.020; Lee SM, 2004, VET IMMUNOL IMMUNOP, V102, P217, DOI 10.1016/j.vetimm.2004.09.009; Liu CH, 2009, VET MICROBIOL, V136, P266, DOI 10.1016/j.vetmic.2008.11.016; Loving CL, 2008, VIRAL IMMUNOL, V21, P315, DOI 10.1089/vim.2008.0038; Loving CL, 2007, IMMUNOLOGY, V120, P217, DOI 10.1111/j.1365-2567.2006.02493.x; Luo R, 2008, MOL IMMUNOL, V45, P2839, DOI 10.1016/j.molimm.2008.01.028; MARDASSI H, 1994, J CLIN MICROBIOL, V32, P2197, DOI 10.1128/JCM.32.9.2197-2203.1994; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; Miller LC, 2004, VET IMMUNOL IMMUNOP, V102, P131, DOI 10.1016/j.vetimm.2004.09.004; Moretta L, 2002, EUR J IMMUNOL, V32, P1205, DOI 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y; Morgan SB, 2013, VET MICROBIOL, V163, P13, DOI 10.1016/j.vetmic.2012.11.024; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nieuwenhuis N, 2012, VET REC, V170, P225, DOI 10.1136/vr.100101; Onomoto K, 2007, CURR TOP MICROBIOL, V316, P193; Pitkin A, 2009, VET MICROBIOL, V136, P1, DOI 10.1016/j.vetmic.2008.10.013; Prieto C, 2009, VET J, V180, P363, DOI 10.1016/j.tvjl.2008.01.005; Reiner G, 2009, APPL ANIM BEHAV SCI, V118, P217, DOI 10.1016/j.applanim.2009.02.011; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schmit F, 2009, FEBS J, V276, P5703, DOI 10.1111/j.1742-4658.2009.07261.x; Schwickart M, 2004, SWML APCL3 EVOLUTION; Stadejek T, 2008, ARCH VIROL, V153, P1479, DOI 10.1007/s00705-008-0146-2; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun Y, 2012, VIRUSES-BASEL, V4, P424, DOI 10.3390/v4040424; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tessarz AS, 2007, J IMMUNOL, V178, P1991, DOI 10.4049/jimmunol.178.4.1991; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zhang XX, 1999, VIROLOGY, V262, P152, DOI 10.1006/viro.1999.9914; Zhou A, 2012, CELL SIGNAL, V24, P973, DOI 10.1016/j.cellsig.2012.01.004; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947; Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003	72	33	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91918	10.1371/journal.pone.0091918	http://dx.doi.org/10.1371/journal.pone.0091918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643046	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900046
J	Gocek, E; Marchwicka, A; Bujko, K; Marcinkowska, E				Gocek, Elzbieta; Marchwicka, Aleksandra; Bujko, Kamila; Marcinkowska, Ewa			NADPH-Cytochrome P450 Reductase Is Regulated by All-Trans Retinoic Acid and by 1,25-Dihydroxyvitamin D-3 in Human Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							OXIDOREDUCTASE DEFICIENCY; DIFFERENTIATION; VASCULOGENESIS; PROLIFERATION; HOMEOSTASIS; MEMBRANE; PROMOTER; RESCUE; SYSTEM; CYP26	Acute myeloid leukemia (AML) cell lines can be driven to differentiate to monocyte-like cells by 1,25-dihydroxyvitamin D-3 (1,25D) and to granulocyte-like cells by all-trans-retinoic acid (ATRA). Both compounds activate their specific intracellular receptors, vitamin D receptor (VDR) and retinoic acid receptors (RARs) respectively. Inside the cells 1,25D is degraded to calcitrioic acid by a mitochondrial enzyme CYP24A1, while ATRA is degraded to several polar metabolites by CYP26. NADPH-cytochrome P450 oxidoreductase (POR) is a membrane-bound enzyme required for electron transfer to cytochrome P450 (CYP), vital in the processes of the metabolism of drugs and steroid production in humans. In this paper we report that POR in AML cells, from both cell lines and patients, is upregulated by ATRA and by 1,25D at the level of mRNA and protein. Partial silencing of POR in HL60 cells resulted in augmented differentiation response to 1,25D.	[Gocek, Elzbieta; Marchwicka, Aleksandra; Bujko, Kamila; Marcinkowska, Ewa] Univ Wroclaw, Dept Biotechnol, PL-50138 Wroclaw, Poland	University of Wroclaw	Marcinkowska, E (corresponding author), Univ Wroclaw, Dept Biotechnol, PL-50138 Wroclaw, Poland.	ema@cs.uni.wroc.pl	Bujko, Kamila/ABE-3627-2020; Marcinkowska, Ewa/AAE-1272-2019; Marcinkowska, Ewa/F-5979-2014	Bujko, Kamila/0000-0002-2205-1154; Marcinkowska, Ewa/0000-0002-6808-5464; Marcinkowska, Ewa/0000-0002-6808-5464; Marchwicka, Aleksandra/0000-0003-3707-4997; Gocek, Elzbieta/0000-0002-1941-0275	National Science Centre [0351/B/P01/2011/40]; Wroclaw Research Center EIT+ within the Project "Biotechnologies and advanced medical Technologies-BioMed" [POIG 01.01.02-02-003/08-00]; European Regional Development Fund (Operational Program Innovative Economy) [1.1.2]	National Science Centre(National Science Centre, Poland); Wroclaw Research Center EIT+ within the Project "Biotechnologies and advanced medical Technologies-BioMed"; European Regional Development Fund (Operational Program Innovative Economy)	The research was financed by the National Science Centre grant No. 0351/B/P01/2011/40 and by the Wroclaw Research Center EIT+ within the Project "Biotechnologies and advanced medical Technologies-BioMed" (POIG 01.01.02-02-003/08-00) financed by the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baurska H, 2011, J STEROID BIOCHEM, V126, P46, DOI 10.1016/j.jsbmb.2011.04.006; BRACKMAN D, 1995, LEUKEMIA RES, V19, P57, DOI 10.1016/0145-2126(94)00061-E; Eichelbaum M, 2004, ENCY REFERENCE MOL P, P705; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Gocek E, 2012, LEUK RES TREATMENT, V2012; Gocek E, 2012, J STEROID BIOCHEM, V132, P220, DOI 10.1016/j.jsbmb.2012.07.001; Gocek E, 2010, LEUKEMIA RES, V34, P649, DOI 10.1016/j.leukres.2009.10.004; LANOTTE M, 1991, BLOOD, V77, P1080; LOEPER J, 1993, GASTROENTEROLOGY, V104, P203, DOI 10.1016/0016-5085(93)90853-5; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Marohnic CC, 2010, DRUG METAB DISPOS, V38, P332, DOI 10.1124/dmd.109.030445; Merla G, 2006, AM J HUM GENET; MUNKER R, 1986, J CLIN INVEST, V78, P424, DOI 10.1172/JCI112593; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Pike W, 2011, VITAMIN D, P97; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; Robin MA, 2000, J PHARMACOL EXP THER, V294, P1063; Ross AC, 2003, J NUTR, V133, p291S, DOI 10.1093/jn/133.1.291S; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; SIMMONS DL, 1989, BLOOD, V73, P284; STEWART M, 1995, CURR OPIN CELL BIOL, V7, P690, DOI 10.1016/0955-0674(95)80111-1; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91752	10.1371/journal.pone.0091752	http://dx.doi.org/10.1371/journal.pone.0091752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642534	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900034
J	Shahid, MA; Markham, PF; Marenda, MS; Agnew-Crumpton, R; Noormohammadi, AH				Shahid, Muhammad A.; Markham, Philip F.; Marenda, Marc S.; Agnew-Crumpton, Rebecca; Noormohammadi, Amir H.			High-Resolution Melting-Curve Analysis of obg Gene to Differentiate the Temperature-Sensitive Mycoplasma synoviae Vaccine Strain MS-H from Non-Temperature-Sensitive Strains	PLOS ONE			English	Article							REAL-TIME PCR; SINGLE-NUCLEOTIDE POLYMORPHISMS; EGGSHELL APEX ABNORMALITIES; INFECTIOUS SYNOVITIS; BACILLUS-ANTHRACIS; LIVE VACCINE; FIELD; HEMAGGLUTININ; VLHA; IDENTIFICATION	Temperature-sensitive (ts(+)) vaccine strain MS-H is the only live attenuated M. synoviae vaccine commercially available for use in poultry. With increasing use of this vaccine to control M. synoviae infections, differentiation of MS-H from field M. synoviae strains and from rarely occurring non-temperature-sensitive (ts(-)) MS-H revertants has become important, especially in countries where local strains are indistinguishable from MS-H by sequence analysis of variable lipoprotein haemagglutinin (vlhA) gene. Single nucleotide polymorphisms (SNPs) in the obg of MS-H have been found to associate with ts phenotype. In this study, four PCRs followed by high-resolution melting (HRM)-curve analysis of the regions encompassing these SNPs were developed and evaluated for their potential to differentiate MS-H from 36 M. synoviae strains/isolates. The nested-obg PCR-HRM differentiated ts(+) MS-H vaccine not only from field M. synoviae strains/isolates but also from ts(-) MS-H revertants. The mean genotype confidence percentages, 96.9 +/- 3.4 and 8.8 +/- 11.2 for ts(+) and ts(-) strains, respectively, demonstrated high differentiating power of the nested-obg PCR-HRM. Using a combination of nested-obg and obg-F3R3 PCR-HRM, 97% of the isolates/strains were typed according to their ts phenotype with all MS-H isolates typed as MS-H. A set of respiratory swabs from MS-H vaccinated specific pathogen free chickens and M. synoviae infected commercial chicken flocks were tested using obg PCR-HRM system and results were consistent with those of vlhA genotyping. The PCR-HRM system developed in this study, proved to be a rapid and reliable tool using pure M. synoviae cultures as well as direct clinical specimens.	[Shahid, Muhammad A.; Marenda, Marc S.; Agnew-Crumpton, Rebecca; Noormohammadi, Amir H.] Univ Melbourne, Fac Vet Sci, Werribee, Vic, Australia; [Markham, Philip F.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Werribee, Vic, Australia	University of Melbourne; University of Melbourne	Shahid, MA (corresponding author), Univ Melbourne, Fac Vet Sci, Werribee, Vic, Australia.	m.shahid@student.unimelb.edu.au	Shahid, Muhammad Akbar/M-7608-2019	Shahid, Muhammad Akbar/0000-0003-2554-5990; MARENDA, MARC/0000-0001-6778-1110; NOORMOHAMMADI, AMIR/0000-0003-3459-2692	University of Melbourne; Higher Education Commission of Pakistan	University of Melbourne(University of Melbourne); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Financial support to conduct this study was provided jointly by the University of Melbourne and the Higher Education Commission of Pakistan. The senior author was supported by the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2001, BIOTECHNIQUES, V30, P358, DOI 10.2144/01302tt05; Bencina D, 2001, FEMS MICROBIOL LETT, V203, P115, DOI 10.1111/j.1574-6968.2001.tb10829.x; BRUNNER H, 1973, ANN NY ACAD SCI, V225, P436, DOI 10.1111/j.1749-6632.1973.tb45668.x; Buim MR, 2010, COMP IMMUNOL MICROB, V33, P15, DOI 10.1016/j.cimid.2008.07.005; Easterday WR, 2005, J CLIN MICROBIOL, V43, P1995, DOI 10.1128/JCM.43.4.1995-1997.2005; Edenberg HJ, 2009, COLD SPRING HARB PRO, V2009, P1; Feberwee A, 2010, AVIAN PATHOL, V39, P133, DOI 10.1080/03079451003657637; Feberwee A, 2009, AVIAN PATHOL, V38, P77, DOI 10.1080/03079450802662772; Foster JT, 2008, J CLIN MICROBIOL, V46, P296, DOI 10.1128/JCM.01496-07; GREENBERG H, 1974, P NATL ACAD SCI USA, V71, P4015, DOI 10.1073/pnas.71.10.4015; Hammond PP, 2009, VET MICROBIOL, V136, P61, DOI 10.1016/j.vetmic.2008.10.011; Harada K, 2009, AVIAN DIS, V53, P538, DOI 10.1637/8934-052309-Reg.1; Hong Y, 2004, AVIAN DIS, V48, P606, DOI 10.1637/7156-011504R; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; KLEVEN SH, 2008, DIS POULTRY, P845; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Lopes VC, 2002, AVIAN DIS, V46, P162, DOI 10.1637/0005-2086(2002)046[0162:DCAPEO]2.0.CO;2; Markham JF, 1998, AVIAN DIS, V42, P682, DOI 10.2307/1592703; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; MORROW CJ, 1990, AUST VET J, V67, P121, DOI 10.1111/j.1751-0813.1990.tb07726.x; Noormohammadi AH, 1997, INFECT IMMUN, V65, P2542, DOI 10.1128/IAI.65.7.2542-2547.1997; Noormohammadi AH, 2003, AVIAN DIS, V47, P355, DOI 10.1637/0005-2086(2003)047[0355:EOTNFC]2.0.CO;2; Ogino S, 2011, AVIAN DIS, V55, P187, DOI 10.1637/9461-071310-Reg.1; OLSON NO, 1956, AM J VET RES, V17, P747; Ramirez AS, 2011, AVIAN PATHOL, V40, P79, DOI 10.1080/03079457.2010.537305; Raviv Z, 2009, AVIAN DIS, V53, P103, DOI 10.1637/8469-091508-Reg.1; Shahid MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073954; Shahid MA, 2013, AVIAN PATHOL, V42, P185, DOI 10.1080/03079457.2013.779363; Stephens AJ, 2006, J MED MICROBIOL, V55, P43, DOI 10.1099/jmm.0.46157-0; Twyman R., 2005, ENCY DIAGNOSTIC GENO, V6, P1202; U'Ren JM, 2005, J CLIN MICROBIOL, V43, P5771, DOI 10.1128/JCM.43.11.5771-5774.2005; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Wetzel AN, 2010, AVIAN DIS, V54, P1292, DOI 10.1637/9349-033010-ResNote.1; Whithear K., 1993, AUSTR STANDARD DIAGN, P1; WHITHEAR KG, 1990, AUST VET J, V67, P159, DOI 10.1111/j.1751-0813.1990.tb07745.x	37	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92215	10.1371/journal.pone.0092215	http://dx.doi.org/10.1371/journal.pone.0092215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643035	gold, Green Published			2022-12-27	WOS:000333259900104
J	Shetty, A; Hickey, WJ				Shetty, Ameesha; Hickey, William J.			Effects of Outer Membrane Vesicle Formation, Surface-Layer Production and Nanopod Development on the Metabolism of Phenanthrene by Delftia acidovorans Cs1-4	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; LIPOPOLYSACCHARIDE; VIRULENCE; BACTERIA; RELEASE; PROTEIN; ARCHAEA; PQS	Nanopods are extracellular structures arising from the convergence of two widely distributed bacterial characteristics: production of outer membrane vesicles (OMV) and formation of surface layers (S-layers). Nanopod production is driven by OMV formation, and in Delftia acidovorans Cs1-4 growth on phenanthrene induces OMV/nanopod formation. While OMV production has been associated with many functions, particularly with pathogens, linkage to biodegradation has been limited to a membrane stress response to lipophilic compounds. The objectives of this study were to determine: 1.) Whether induction of nanopod formation was linked to phenanthrene metabolism or a non-specific membrane stress response, and 2.) The relative importance of OMV/nanopod formation vs. formation of the S-layer alone to phenanthrene utilization. Membrane stress response was investigated by quantifying nanopod formation following exposure to compounds that exceeded phenanthrene in membrane stress-inducing potential. Naphthalene did not induce nanopod formation, and toluene was a weak inducer compared to phenanthrene (two-vs. six-fold increase, respectively). Induction of nanopod formation by growth on phenanthrene was therefore linked to phenanthrene metabolism and not a membrane stress response. Impacts on phenanthrene biodegradation of OMV/nanopod production vs. S-layer formation were assessed with D. acidovorans Cs1-4 mutants deficient in S-layer formation or OMV/nanopod production. Both mutants had impaired growth on phenanthrene, but the loss of OMV/nanopod production was more significant than loss of the S-layer. The Slayer of D. acidovorans Cs1-4 did not affect phenanthrene uptake, and its primary role in phenanthrene biodegradation process appeared to be enabling nanopod development. Nanopods appeared to benefit phenanthrene biodegradation by enhancing cellular retention of metabolites. Collectively, these studies established that nanopod/OMV formation was an essential characteristic of the D. acidovorans Cs1-4 phenanthrene degradation process. This report thus established a new dimension in the area of biodegradation, namely, the involvement of extracellular structures as elements supporting metabolic processes underlying biodegradation.	[Shetty, Ameesha; Hickey, William J.] Univ Wisconsin, Dept Soil Sci, ON Allen Lab Soil Microbiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Hickey, WJ (corresponding author), Univ Wisconsin, Dept Soil Sci, ON Allen Lab Soil Microbiol, Madison, WI 53706 USA.	wjhickey@wisc.edu	Hickey, William/HGC-5490-2022		National Science Foundation [NSF MCB0920664]; O. N. Allen Professorship endowment	National Science Foundation(National Science Foundation (NSF)); O. N. Allen Professorship endowment	This study was funded by National Science Foundation grant NSF MCB0920664 (WJH) and by the O. N. Allen Professorship endowment (WJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasnezhad H, 2011, APPL MICROBIOL BIOT, V92, P653, DOI 10.1007/s00253-011-3589-4; Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; Baumgarten T, 2012, APPL ENVIRON MICROB, V78, P6217, DOI 10.1128/AEM.01525-12; Berleman J, 2013, ENVIRON MICROBIOL, V15, P347, DOI 10.1111/1462-2920.12048; Bredenbruch F, 2006, ENVIRON MICROBIOL, V8, P1318, DOI 10.1111/j.1462-2920.2006.01025.x; Chen SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00187; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hickey WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00125; HICKEY WJ, 1990, APPL ENVIRON MICROB, V56, P3842, DOI 10.1128/AEM.56.12.3842-3850.1990; KAY WW, 1981, J BACTERIOL, V147, P1077, DOI 10.1128/JB.147.3.1077-1084.1981; KAY WW, 1985, J BACTERIOL, V164, P1332, DOI 10.1128/JB.164.3.1332-1336.1985; Marguet E, 2013, BIOCHEM SOC T, V41, P436, DOI 10.1042/BST20120293; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1985, PHARMACOL THERAPEUT, V27, P197, DOI 10.1016/0163-7258(85)90069-5; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Rengstl B, 2013, PLANTA, V237, P471, DOI 10.1007/s00425-012-1720-0; Rengstl B, 2011, J BIOL CHEM, V286, P21944, DOI 10.1074/jbc.M111.237867; Schwechheimer C, 2013, BIOCHEMISTRY-US, V52, P3031, DOI 10.1021/bi400164t; Shetty A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020725; Tashiro Y, 2012, ENVIRON MICROBIOL, V14, P1349, DOI 10.1111/j.1462-2920.2011.02632.x; Toyofuku M, 2013, ENVIRON MICROBIOL; Yokota S, 2007, COMP IMMUNOL MICROB, V30, P97, DOI 10.1016/j.cimid.2006.11.002; Yuroff AS, 2003, APPL ENVIRON MICROB, V69, P7401, DOI 10.1128/AEM.69.12.7401-7408.2003	27	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92143	10.1371/journal.pone.0092143	http://dx.doi.org/10.1371/journal.pone.0092143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642639	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900094
J	Barresi, S; Tomaselli, S; Athanasiadis, A; Galeano, F; Locatelli, F; Bertini, E; Zanni, G; Gallo, A				Barresi, Sabina; Tomaselli, Sara; Athanasiadis, Alekos; Galeano, Federica; Locatelli, Franco; Bertini, Enrico; Zanni, Ginevra; Gallo, Angela			Oligophrenin-1 (OPHN1), a Gene Involved in X-Linked Intellectual Disability, Undergoes RNA Editing and Alternative Splicing during Human Brain Development	PLOS ONE			English	Article							MENTAL-RETARDATION; MESSENGER-RNA; VENTRICULAR ENLARGEMENT; CEREBELLAR HYPOPLASIA; BAR DOMAIN; RECEPTOR; PROTEIN; INOSINE; DROSOPHILA; MUTATIONS	Oligophrenin-1 (OPHN1) encodes for a Rho-GTPase-activating protein, important for dendritic morphogenesis and synaptic function. Mutations in this gene have been identified in patients with X-linked intellectual disability associated with cerebellar hypoplasia. ADAR enzymes are responsible for A-to-I RNA editing, an essential post-transcriptional RNA modification contributing to transcriptome and proteome diversification. Specifically, ADAR2 activity is essential for brain development and function. Herein, we show that the OPHN1 transcript undergoes post-transcriptional modifications such as A-to-I RNA editing and alternative splicing in human brain and other tissues. We found that OPHN1 editing is detectable already at the 18th week of gestation in human brain with a boost of editing at weeks 20 to 33, concomitantly with OPHN1 expression increase and the appearance of a novel OPHN1 splicing isoform. Our results demonstrate that multiple post-transcriptional events occur on OPHN1, a gene playing an important role in brain function and development.	[Barresi, Sabina; Bertini, Enrico; Zanni, Ginevra] Bambino Gesu Childrens Hosp IRCCS, Mol Med Lab, Dept Neurosci, Rome, Italy; [Tomaselli, Sara; Galeano, Federica; Locatelli, Franco; Gallo, Angela] Bambino Gesu Childrens Hosp IRCCS, Oncohaematol Dept, RNA Editing Lab, Rome, Italy; [Athanasiadis, Alekos] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; Instituto Gulbenkian de Ciencia; University of Pavia	Zanni, G (corresponding author), Bambino Gesu Childrens Hosp IRCCS, Mol Med Lab, Dept Neurosci, Rome, Italy.	ginevra.zanni@opbg.net; angela.gallo@opbg.net	Gallo, Angela/E-7837-2011; Gallo, Angela/AAA-5003-2020; Athanasiadis, Alekos/F-2038-2011; Zanni, Ginevra/L-2869-2015; Bertini, Enrico/ABG-1278-2020; Bertini, Enrico/A-2284-2014	Gallo, Angela/0000-0003-0297-1807; Gallo, Angela/0000-0003-0297-1807; Athanasiadis, Alekos/0000-0003-1526-0000; Zanni, Ginevra/0000-0002-6367-1843; Bertini, Enrico/0000-0001-9276-4590; BARRESI, SABINA/0000-0002-7307-388X	IG grant from AIRC (Associazione Italiana Ricerca sul cancro) [13202]; special project 5x1000 AIRC	IG grant from AIRC (Associazione Italiana Ricerca sul cancro)(Fondazione AIRC per la ricerca sul cancro); special project 5x1000 AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by an IG grant (n. 13202) to A. G. from AIRC (Associazione Italiana Ricerca sul cancro) and by the special project 5x1000 AIRC to F. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Owain M, 2011, CLIN GENET, V79, P363, DOI 10.1111/j.1399-0004.2010.01462.x; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Ba W, 2013, EXP CELL RES, V319, P2368, DOI 10.1016/j.yexcr.2013.05.033; Bedeschi MF, 2008, AM J MED GENET A, V146A, P1718, DOI 10.1002/ajmg.a.32365; Beghini A, 2000, HUM MOL GENET, V9, P2297, DOI 10.1093/oxfordjournals.hmg.a018921; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen LL, 2008, CELL CYCLE, V7, P3294, DOI 10.4161/cc.7.21.6927; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Gallo A, 2011, BIOL REV CAMB PHILOS, V87, P95, DOI DOI 10.1111/J.1469-185X.2011.00186.X; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Greenberger S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-608; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grohmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008956; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Ljubimova JY, 2001, INT J ONCOL, V18, P287; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mallela A, 2012, CRIT REV BIOCHEM MOL, V47, P493, DOI 10.3109/10409238.2012.714350; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Pirozzi F, 2011, HUM MUTAT, V32, pE2294, DOI 10.1002/humu.21567; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rocas D, 2013, EUR J MED GENET, V56, P270, DOI 10.1016/j.ejmg.2013.01.014; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI 10.1038/nchembio.434; Santos-Reboucas CB, 2014, EUR J HUM GENET, V22, P644, DOI 10.1038/ejhg.2013.216; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tojo K, 2006, MOVEMENT DISORD, V21, P1510, DOI 10.1002/mds.21011; Valnegri P, 2011, NAT NEUROSCI, V14, P1293, DOI 10.1038/nn.2911; Veno MT, 2012, RNA BIOL, V9, P1054, DOI 10.4161/rna.21082; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang QQ, 2005, CURR BIOL, V15, P384, DOI 10.1016/j.cub.2005.01.046; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Yang L, 2010, FASEB J; Zanni G, 2005, NEUROLOGY, V65, P1364, DOI 10.1212/01.wnl.0000182813.94713.ee; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91351	10.1371/journal.pone.0091351	http://dx.doi.org/10.1371/journal.pone.0091351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637888	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100029
J	Huang, Y; Caputo, CR; Noordmans, GA; Yazdani, S; Monteiro, LH; van den Born, J; van Goor, H; Heeringa, P; Korstanje, R; Hillebrands, JL				Huang, Yuan; Caputo, Christina R.; Noordmans, Gerda A.; Yazdani, Saleh; Monteiro, Luiz Henrique; van den Born, Jaap; van Goor, Harry; Heeringa, Peter; Korstanje, Ron; Hillebrands, Jan-Luuk			Identification of Novel Genes Associated with Renal Tertiary Lymphoid Organ Formation in Aging Mice	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; CHRONIC REJECTION; IMMUNE-RESPONSE; HUMAN KIDNEY; NEOGENESIS; DISEASE; EXPRESSION; CD30; FAMILY; TISSUE	A hallmark of aging-related organ deterioration is a dysregulated immune response characterized by pathologic leukocyte infiltration of affected tissues. Mechanisms and genes involved are as yet unknown. To identify genes associated with aging-related renal infiltration, we analyzed kidneys from aged mice (>= 20 strains) for infiltrating leukocytes followed by Haplotype Association Mapping (HAM) analysis. Immunohistochemistry revealed CD45(+) cell clusters (predominantly T and B cells) in perivascular areas coinciding with PNAd(+) high endothelial venules and podoplanin(+) lymph vessels indicative of tertiary lymphoid organs. Cumulative cluster size increased with age (analyzed at 6, 12 and 20 months). Based on the presence or absence of clusters in male and female mice at 20 months, HAM analysis revealed significant associations with loci on Chr1, Chr2, Chr8 and Chr14 in male mice, and with loci on Chr4, Chr7, Chr13 and Chr14 in female mice. Wisp2 (Chr2) showed the strongest association (P = 5.00x10(-137)) in male mice; Ctnnbip1 (P = 6.42x10(-267)) and Tnfrsf8 (P = 5.42x10(-245)) (both on Chr4) showed the strongest association in female mice. Both Wisp2 and Ctnnbip1 are part of the Wnt-signaling pathway and the encoded proteins were expressed within the tertiary lymphoid organs. In conclusion, this study revealed differential lymphocytic infiltration and tertiary lymphoid organ formation in aged mouse kidneys across different inbred mouse strains. HAM analysis identified candidate genes involved in the Wnt-signaling pathway that may be causally linked to tertiary lymphoid organ formation.	[Huang, Yuan; Noordmans, Gerda A.; Monteiro, Luiz Henrique; van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol Pathol, Groningen, Netherlands; [Huang, Yuan] Fudan Univ, Sch Basic Med Sci, Dept Pathol, Shanghai 200433, Peoples R China; [Caputo, Christina R.; Korstanje, Ron] Jackson Lab, Bar Harbor, ME 04609 USA; [Yazdani, Saleh; van den Born, Jaap] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Nephrol, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol Med Biol, Groningen, Netherlands	University of Groningen; Fudan University; Jackson Laboratory; University of Groningen; University of Groningen	Hillebrands, JL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol Pathol, Groningen, Netherlands.	j.l.hillebrands@umcg.nl	Yazdani, Saleh/K-9640-2015; van+Goor, Harry/AAS-7712-2020; Heeringa, Peter/A-6008-2009	Yazdani, Saleh/0000-0002-5162-9904; Heeringa, Peter/0000-0001-8684-763X; Hillebrands, Jan-Luuk/0000-0003-3135-3274; van Goor, Harry/0000-0002-6670-1577	University of Groningen Graduate School of Medical Sciences; NIGMS [GM076468]; NIA [AG038070]; National Cancer Institute Cancer Core grant [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038070] Funding Source: NIH RePORTER	University of Groningen Graduate School of Medical Sciences; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute Cancer Core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the University of Groningen Graduate School of Medical Sciences (YH [Bernoulli Bursary], GAN and SY), GM076468 from the NIGMS (RK), AG038070 from NIA (RK), and the National Cancer Institute Cancer Core grant (CA034196) to The Jackson Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bowen MA, 1996, J IMMUNOL, V156, P442; Brink TC, 2009, BIOGERONTOLOGY, V10, P721, DOI 10.1007/s10522-009-9219-1; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Gaspal FM, 2011, J EXP MED, V208, P1579, DOI 10.1084/jem.20101484; Hjelmstrom P, 2001, J LEUKOCYTE BIOL, V69, P331; Hoang K, 2003, KIDNEY INT, V64, P1417, DOI 10.1046/j.1523-1755.2003.00207.x; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kelly FM, 2009, AM J PHYSIOL-RENAL, V296, pF512, DOI 10.1152/ajprenal.90629.2008; Lee AS, 2013, KIDNEY INT, V83, P50, DOI 10.1038/ki.2012.312; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027496; Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111; Matsui K, 2003, J AM SOC NEPHROL, V14, P1981, DOI 10.1097/01.ASN.0000076078.50889.43; Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Nasr IW, 2007, AM J TRANSPLANT, V7, P1071, DOI 10.1111/j.1600-6143.2007.01756.x; Pablos JL, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-6; Pabst R, 2007, IMMUNOL LETT, V112, P1, DOI 10.1016/j.imlet.2007.06.009; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0; Segerer S, 2008, KIDNEY INT, V73, P533, DOI 10.1038/sj.ki.5002734; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; Tago K, 2000, GENE DEV, V14, P1741; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Thaunat O, 2010, J IMMUNOL, V185, P717, DOI 10.4049/jimmunol.0903589; Tsaih SW, 2010, KIDNEY INT, V77, P201, DOI 10.1038/ki.2009.434; Tsaih SW, 2009, METHODS MOL BIOL, V573, P213, DOI 10.1007/978-1-60761-247-6_12; Tullius SG, 2011, NEW ENGL J MED, V364, P1369, DOI 10.1056/NEJMc1103007; van Goor H, 2009, KIDNEY INT, V75, P767, DOI 10.1038/ki.2009.45; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; WATANABE Y, 1991, NEPHRON, V58, P210, DOI 10.1159/000186417; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	41	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91850	10.1371/journal.pone.0091850	http://dx.doi.org/10.1371/journal.pone.0091850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637805	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100068
J	Machado, VS; Bicalho, MLD; Junior, EBDM; Rossi, R; Ribeiro, BL; Lima, S; Santos, T; Kussler, A; Foditsch, C; Ganda, EK; Oikonomou, G; Cheong, SH; Gilbert, RO; Bicalho, RC				Machado, Vinicius Silva; Bicalho, Marcela Luccas de Souza; Junior, Enoch Brandao de Souza Meira; Rossi, Rodolfo; Ribeiro, Bruno Leonardo; Lima, Svetlana; Santos, Thiago; Kussler, Arieli; Foditsch, Carla; Ganda, Erika Korzune; Oikonomou, Georgios; Cheong, Soon Hon; Gilbert, Robert Owen; Bicalho, Rodrigo Carvalho			Subcutaneous Immunization with Inactivated Bacterial Components and Purified Protein of Escherichia coli, Fusobacterium necrophorum and Trueperella pyogenes Prevents Puerperal Metritis in Holstein Dairy Cows	PLOS ONE			English	Article							POSTPARTUM UTERINE DISEASE; ARCANOBACTERIUM-PYOGENES; FIMH-ADHESIN; NEUTROPHIL FUNCTION; REPRODUCTIVE-TRACT; RETAINED PLACENTA; PERIPARTUM PERIOD; LIVER-ABSCESSES; FEEDLOT CATTLE; CLINICAL-TRIAL	In this study we evaluate the efficacy of five vaccine formulations containing different combinations of proteins (FimH; leukotoxin, LKT; and pyolysin, PLO) and/or inactivated whole cells (Escherichia coli, Fusobacterium necrophorum, and Trueperella pyogenes) in preventing postpartum uterine diseases. Inactivated whole cells were produced using two genetically distinct strains of each bacterial species (E. coli, F. necrophorum, and T. pyogenes). FimH and PLO subunits were produced using recombinant protein expression, and LKT was recovered from culturing a wild F. necrophorum strain. Three subcutaneous vaccines were formulated: Vaccine 1 was composed of inactivated bacterial whole cells and proteins; Vaccine 2 was composed of proteins only; and Vaccine 3 was composed of inactivated bacterial whole cells only. Two intravaginal vaccines were formulated: Vaccine 4 was composed of inactivated bacterial whole cells and proteins; and Vaccine 5 was composed of PLO and LKT. To evaluate vaccine efficacy, a randomized clinical trial was conducted at a commercial dairy farm; 371 spring heifers were allocated randomly into one of six different treatments groups: control, Vaccine 1, Vaccine 2, Vaccine 3, Vaccine 4 and Vaccine 5. Late pregnant heifers assigned to one of the vaccine groups were each vaccinated twice: at 230 and 260 days of pregnancy. When vaccines were evaluated grouped as subcutaneous and intravaginal, the subcutaneous ones were found to significantly reduce the incidence of puerperal metritis. Additionally, subcutaneous vaccination significantly reduced rectal temperature at 661 days in milk. Reproduction was improved for cows that received subcutaneous vaccines. In general, vaccination induced a significant increase in serum IgG titers against all antigens, with subcutaneous vaccination again being more effective. In conclusion, subcutaneous vaccination with inactivated bacterial components and/or protein subunits of E. coli, F. necrophorum and T. pyogenes can prevent puerperal metritis during the first lactation of dairy cows, leading to improved reproduction.	[Machado, Vinicius Silva; Bicalho, Marcela Luccas de Souza; Junior, Enoch Brandao de Souza Meira; Rossi, Rodolfo; Ribeiro, Bruno Leonardo; Lima, Svetlana; Santos, Thiago; Kussler, Arieli; Foditsch, Carla; Ganda, Erika Korzune; Oikonomou, Georgios; Cheong, Soon Hon; Gilbert, Robert Owen; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Ganda, Erika/AAD-6286-2020; Ribeiro, Bruno Leonardo Mendonça/W-2138-2019; Gilbert, Robert/J-9107-2012	Ganda, Erika/0000-0002-8735-0753; Ribeiro, Bruno Leonardo Mendonça/0000-0002-4303-0504; Gilbert, Robert/0000-0002-1528-243X; Monteiro Araujo dos Santos, Thiago/0000-0002-0648-6078; Cheong, Soon Hon/0000-0001-9002-7589; Rossi, Rodolfo/0000-0002-4776-1232	Merck Animal Health	Merck Animal Health(Merck & Company)	This study was funded by a grant from Merck Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Bannerman DD, 2003, J DAIRY SCI, V86, P3128, DOI 10.3168/jds.S0022-0302(03)73914-9; Bicalho MLS, 2012, VET MICROBIOL, V157, P125, DOI 10.1016/j.vetmic.2011.11.034; Bicalho RC, 2010, J DAIRY SCI, V93, P5818, DOI 10.3168/jds.2010-3550; Billington SJ, 1997, J BACTERIOL, V179, P6100, DOI 10.1128/jb.179.19.6100-6106.1997; Bondurant RH, 1999, J ANIM SCI, V77, P101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTT BM, 1993, INFECT IMMUN, V61, P2558, DOI 10.1128/IAI.61.6.2558-2562.1993; CAI TQ, 1994, AM J VET RES, V55, P934; Cheong SH, 2012, THERIOGENOLOGY, V77, P858, DOI 10.1016/j.theriogenology.2011.09.009; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CORBEIL LB, 1974, INFECT IMMUN, V10, P422, DOI 10.1128/IAI.10.3.422-429.1974; Dohmen MJW, 2000, THERIOGENOLOGY, V54, P1019, DOI 10.1016/S0093-691X(00)00410-6; Dolejska M, 2011, VET MICROBIOL, V149, P513, DOI 10.1016/j.vetmic.2010.11.032; Dubuc J, 2010, J DAIRY SCI, V93, P5764, DOI 10.3168/jds.2010-3429; Dubuc J, 2010, J DAIRY SCI, V93, P5225, DOI 10.3168/jds.2010-3428; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Fricke PM, 2003, J DAIRY SCI, V86, P3941, DOI 10.3168/jds.S0022-0302(03)74003-X; Galvao KN, 2010, J DAIRY SCI, V93, P2926, DOI 10.3168/jds.2009-2551; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Jones G, 2004, BOVINE PR, V38, P36; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kelton DF, 1998, J DAIRY SCI, V81, P2502, DOI 10.3168/jds.S0022-0302(98)70142-0; Kim IH, 2005, J REPROD DEVELOP, V51, P757, DOI 10.1262/jrd.17036; Kimura K, 2002, J DAIRY SCI, V85, P544, DOI 10.3168/jds.S0022-0302(02)74107-6; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; LeBlanc SJ, 2008, VET J, V176, P102, DOI 10.1016/j.tvjl.2007.12.019; LeBlanc SJ, 2011, THERIOGENOLOGY, V76, P1610, DOI 10.1016/j.theriogenology.2011.07.017; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; Machado VS, 2012, J DAIRY SCI, V95, P3100, DOI 10.3168/jds.2011-5063; Machado VS, 2012, J DAIRY SCI, V95, P1349, DOI 10.3168/jds.2011-4867; Miller ANA, 2007, THERIOGENOLOGY, V68, P972, DOI 10.1016/j.theriogenology.2007.07.013; MOOI FR, 1985, CURR TOP MICROBIOL, V118, P119; Moreira F, 2001, J DAIRY SCI, V84, P1646, DOI 10.3168/jds.S0022-0302(01)74600-0; Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P351, DOI 10.1016/j.cvfa.2007.05.002; Narayanan S, 2002, INFECT IMMUN, V70, P4609, DOI 10.1128/IAI.70.8.4609-4620.2002; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Oliveira LJ, 2012, REPROD DOMEST ANIM, V47, P384, DOI 10.1111/j.1439-0531.2012.02102.x; Overton M., 2008, DAIRY CATTLE REPROD, P39; PURSLEY JR, 1995, THERIOGENOLOGY, V44, P915, DOI 10.1016/0093-691X(95)00279-H; Sannmann I, 2013, J DAIRY SCI, V96, P5773, DOI 10.3168/jds.2013-6813; Santos TMA, 2011, J DAIRY SCI, V94, P291, DOI 10.3168/jds.2010-3668; Santos TMA, 2010, VET MICROBIOL, V145, P84, DOI 10.1016/j.vetmic.2010.03.001; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Singh J, 2008, VET J, V175, P301, DOI 10.1016/j.tvjl.2007.02.003; TAN ZL, 1994, AM J VET RES, V55, P515; TAN ZL, 1992, VET MICROBIOL, V32, P15, DOI 10.1016/0378-1135(92)90003-C; TAN ZL, 1994, VET MICROBIOL, V42, P121, DOI 10.1016/0378-1135(94)90012-4; UEHLING DT, 1994, J UROLOGY, V152, P2308, DOI 10.1016/S0022-5347(17)31664-6; Uehling DT, 2003, J UROLOGY, V170, P867, DOI 10.1097/01.ju.0000075094.54767.6e; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017	54	59	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91734	10.1371/journal.pone.0091734	http://dx.doi.org/10.1371/journal.pone.0091734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638139	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100055
J	Yoo, SH; Lee, BH; Moon, Y; Spalding, MH; Jane, JL				Yoo, Sang-Ho; Lee, Byung-Hoo; Moon, Youyoun; Spalding, Martin H.; Jane, Jay-Lin			Glycogen Synthase Isoforms in Synechocystis sp PCC6803: Identification of Different Roles to Produce Glycogen by Targeted Mutagenesis	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; SP PCC 6803; STARCH SYNTHASE; BACTERIAL GLYCOGEN; AMYLOPECTIN; ENZYME; POTATO; CYANOBACTERIA; BIOSYNTHESIS; BIOGENESIS	Synechocystis sp. PCC6803 belongs to cyanobacteria which carry out photosynthesis and has recently become of interest due to the evolutionary link between bacteria and plant species. Similar to other bacteria, the primary carbohydrate storage source of Synechocystis sp. PCC6803 is glycogen. While most bacteria are not known to have any isoforms of glycogen synthase, analysis of the genomic DNA sequence of Synechocystis sp. PCC6803 predicts that this strain encodes two isoforms of glycogen synthase (GS) for synthesizing glycogen structure. To examine the functions of the putative GS genes, each gene (sll1393 or sll0945) was disrupted by double cross-over homologous recombination. Zymogram analysis of the two GS disruption mutants allowed the identification of a protein band corresponding to each GS isoform. Results showed that two GS isoforms (GSI and GSII) are present in Synechocystis sp. PCC6803, and both are involved in glycogen biosynthesis with different elongation properties: GSI is processive and GSII is distributive. Total GS activities in the mutant strains were not affected and were compensated by the remaining isoform. Analysis of the branch-structure of glycogen revealed that the sll1393 2 mutant (GSI 2) produced glycogen containing more intermediate-length chains (DP 8-18) at the expense of shorter and longer chains compared with the wild-type strain. The sll0945 2 mutant (GSII 2) produced glycogen similar to the wildtype, with only a slightly higher proportion of short chains (DP 4-11). The current study suggests that GS isoforms in Synechocystis sp. PCC6803 have different elongation specificities in the biosynthesis of glycogen, combined with ADPglucose pyrophosphorylase and glycogen branching enzyme.	[Yoo, Sang-Ho] Sejong Univ, Dept Food Sci & Technol, Seoul, South Korea; [Yoo, Sang-Ho] Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul, South Korea; [Lee, Byung-Hoo] Purdue Univ, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [Lee, Byung-Hoo] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Moon, Youyoun; Spalding, Martin H.] Iowa State Univ, Dept Bot, Ames, IA USA; [Jane, Jay-Lin] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA USA	Sejong University; Sejong University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; Iowa State University	Yoo, SH (corresponding author), Sejong Univ, Dept Food Sci & Technol, Seoul, South Korea.	shyoo@sejong.ac.kr	Yoo, Sang-Ho/AAI-4446-2020		National Research Foundation of Korea (NRF); Korea government (MEST) [2012R1A2A2A01047497]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012R1A2A2A01047497, http://www.nrf.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GJW, 1996, PLANT J, V10, P981, DOI 10.1046/j.1365-313X.1996.10060981.x; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BOYER CD, 1981, PLANT PHYSIOL, V67, P1141, DOI 10.1104/pp.67.6.1141; Buleon A, 1997, PLANT PHYSIOL, V115, P949, DOI 10.1104/pp.115.3.949; CHAO L, 1971, J BACTERIOL, V105, P331, DOI 10.1128/JB.105.1.331-338.1971; Cid E, 2002, FEBS LETT, V528, P5, DOI 10.1016/S0014-5793(02)03313-6; Craig J, 1998, PLANT CELL, V10, P413, DOI 10.1105/tpc.10.3.413; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; EDWARDS A, 1995, PLANT J, V8, P283, DOI 10.1046/j.1365-313X.1995.08020283.x; Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x; Edwards A, 1999, EUR J BIOCHEM, V266, P724, DOI 10.1046/j.1432-1327.1999.00861.x; Ermakova-Gerdes S, 1999, J BIOL CHEM, V274, P30540, DOI 10.1074/jbc.274.43.30540; FARKAS I, 1991, J BIOL CHEM, V266, P15602; FONTAINE T, 1993, J BIOL CHEM, V268, P16223; Fujimori K, 1995, FISHERIES SCI, V61, P951, DOI 10.2331/fishsci.61.951; Gao M, 1998, PLANT CELL, V10, P399, DOI 10.1105/tpc.10.3.399; Grundel M, 2012, MICROBIOL-SGM, V158, P3032, DOI 10.1099/mic.0.062950-0; GUAN HP, 1995, P NATL ACAD SCI USA, V92, P964, DOI 10.1073/pnas.92.4.964; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8; Iglesias AA, 2006, PLANT CELL PHYSIOL, V47, P523, DOI 10.1093/pcp/pcj021; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; Kaneko T, 1996, DNA Res, V3, P109; Kossmann J, 2000, CRIT REV BIOCHEM MOL, V35, P141; Li L, 2006, THESIS IOWA STATE U; MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J; McFadden GI, 2001, PLANT PHYSIOL, V125, P50, DOI 10.1104/pp.125.1.50; Miao XL, 2003, FEMS MICROBIOL LETT, V218, P71, DOI 10.1111/j.1574-6968.2003.tb11500.x; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; Preiss J, 1991, OXFORD SURVEYS PLANT, V7, P59; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Sivak MN, 1998, STARCH BASIC SCI BIO; STEINER KE, 1977, J BACTERIOL, V129, P246, DOI 10.1128/JB.129.1.246-253.1977; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; TYYNELA J, 1993, PHYSIOL PLANTARUM, V89, P835, DOI [10.1111/j.1399-3054.1993.tb05293.x, 10.1034/j.1399-3054.1993.890422.x]; Vasanthan T, 2001, CURRENT PROTOCOLS FO; Wang CX, 2007, MICROBIOL-SGM, V153, P388, DOI 10.1099/mic.0.29214-0; WANG YJ, 1993, CEREAL CHEM, V70, P171; Wong KS, 1997, J LIQ CHROMATOGR R T, V20, P297, DOI 10.1080/10826079708010654; Yoo SH, 2007, INT J BIOL MACROMOL, V40, P498, DOI 10.1016/j.ijbiomac.2006.11.009	44	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91524	10.1371/journal.pone.0091524	http://dx.doi.org/10.1371/journal.pone.0091524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637565	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100040
J	Jiao, F; Bai, SY; Ma, Y; Yan, ZH; Yue, Z; Yu, Y; Wang, X; Wang, J				Jiao, Fei; Bai, Shi-yu; Ma, Ying; Yan, Zhong-hai; Yue, Zhen; Yu, Yuan; Wang, Xin; Wang, Juan			DNA Methylation of Heparanase Promoter Influences Its Expression and Associated with the Progression of Human Breast Cancer	PLOS ONE			English	Article							CELLS IN-VITRO; GENE-EXPRESSION; DOWN-REGULATION; MAMMALIAN HEPARANASE; MDA-MB-435 CELLS; PROSTATE-CANCER; M14 MELANOMA; METASTASIS; INVASION; LINES	Heparanase promotes tumor invasion and metastasis in several malignancies including breast cancer. However, the roles and regulation mechanisms of heparanase during breast cancer progression are still not fully understood. The aim of this study is to determine the differential regulation of heparanase gene expression in specific stages of breast cancer by DNA methylation. We detected levels of heparanase expression and DNA methylation patterns of its promoter in breast cancer cell lines (MCF-7 and MDA-MB-435) and clinical tissues, respectively. It has been observed that heparanase is highly expressed in the invasive MDA-MB-435 cells with low methylation modification in the heparanase promoter. In contrast, lower expression of heparanase in MCF-7 cells is accompanied by higher methylation in the promoter. Treatment of MCF-7 cells with 5-aza-2'-deoxycytidine (5-aza-dC), a potent demethylating agent, results in induction of heparanase expression and higher invasion potential in vitro and leads to an advantage of tumor formation in vivo. In 54 tissue samples, cancer samples at late stages (stage IV) showed the highest heparanase expression accomplished by little DNA methylation. On the contrary, methylation prevalence is highest in normal tissue and inversely correlated with heparanase expression. A significant correlation between DNA methylation and clinical stage was demonstrated (p = 0.012). Collectively, these results demonstrate that DNA methylation play the regulation role in heparanase gene in different stages of breast cancer and present a direct effect on tumor progression.	[Jiao, Fei; Ma, Ying; Yue, Zhen; Yu, Yuan] Binzhou Med Coll, Dept Biochem & Mol Biol, Yantai, Shandong, Peoples R China; [Bai, Shi-yu] Taian City Cent Hosp, Dept Clin Lab, Tai An, Shandong, Peoples R China; [Yan, Zhong-hai] Columbia Univ, Dept Med, New York, NY USA; [Wang, Xin] Jinan Mil Area Command, Binzhou Med Coll Yantai, PLA 107th Hosp, Dept Clin Lab, Jinan, Peoples R China; [Wang, Juan] Binzhou Med Coll, Dept Biotechnol, Yantai, Shandong, Peoples R China	Binzhou Medical University; Columbia University; Binzhou Medical University; Binzhou Medical University	Wang, X (corresponding author), Jinan Mil Area Command, Binzhou Med Coll Yantai, PLA 107th Hosp, Dept Clin Lab, Jinan, Peoples R China.	wang3j@gmail.com; lamei050109@126.com	Yan, Zhonghai/B-9228-2017	Yan, Zhonghai/0000-0003-2456-4284	National Natural Science Foundation of China [31000564]; Natural Science Foundation of Shandong Province [ZR2012BM006]; Foundation of Shandong Educational Committee [J10LF12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation of Shandong Educational Committee	This work was partly supported by grants from the National Natural Science Foundation of China (No. 31000564), the Natural Science Foundation of Shandong Province (No. ZR2012BM006) and the Foundation of Shandong Educational Committee (No. J10LF12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2006, CANCER-AM CANCER SOC, V106, P2514, DOI 10.1002/cncr.21905; Arvatz G, 2010, FASEB J, V24, P4969, DOI 10.1096/fj.10-156372; BAO L, 1994, BRIT J CANCER, V70, P228, DOI 10.1038/bjc.1994.284; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Baraz L, 2006, ONCOGENE, V25, P3939, DOI 10.1038/sj.onc.1209425; Bertolesi GE, 2011, DEV DYNAM, V240, P2657, DOI 10.1002/dvdy.22770; Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057697; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chen ZT, 2013, ACTA BIOCH BIOPH SIN, V45, P188, DOI 10.1093/abbs/gms109; Chik F, 2011, CARCINOGENESIS, V32, P224, DOI 10.1093/carcin/bgq221; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Elkin M, 2003, CANCER RES, V63, P8821; Guo YJ, 2002, J BIOL CHEM, V277, P41571, DOI 10.1074/jbc.M201864200; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Hong X, 2012, INT J ONCOL, V40, P494, DOI 10.3892/ijo.2011.1229; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Jiang GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031379; Klajic J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-456; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li Y, 2013, INT J MOL MED, V31, P1234, DOI 10.3892/ijmm.2013.1292; Lu WC, 2003, ONCOGENE, V22, P919, DOI 10.1038/sj.onc.1206201; Meirovitz A, 2011, CANCER RES, V71, P2772, DOI 10.1158/0008-5472.CAN-10-3402; Montel V, 2009, DIFFERENTIATION, V78, P283, DOI 10.1016/j.diff.2009.07.007; Nerlich AG, 2013, ONCOL LETT, V5, P1370, DOI 10.3892/ol.2013.1157; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Pakneshan P, 2003, FASEB J, V17, P1081, DOI 10.1096/fj.02-0973com; Peerless Y, 2013, EXP MOL PATHOL, V94, P309, DOI 10.1016/j.yexmp.2013.01.001; PRICE JE, 1990, CANCER RES, V50, P717; Rabbani SA, 2008, NEOPLASIA, V10, P266, DOI 10.1593/neo.07947; Radpour R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027355; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Ridgway LD, 2011, EXP THER MED, V2, P229, DOI 10.3892/etm.2010.189; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Szyf M, 2008, CURR ONCOL, V15, P72; Szyf M, 2012, GENOME MED, V4, DOI 10.1186/gm325; Tost J, 2011, EPIGENETICS-US, V6, P1035, DOI 10.4161/epi.6.8.16077; Veronesi U, 2006, BREAST, V15, P3, DOI 10.1016/j.breast.2005.11.011; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 2001, BIOCHIMIE, V83, P831, DOI 10.1016/S0300-9084(01)01318-9; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Xiong Z, 2012, INT J ONCOL, V40, P1601, DOI 10.3892/ijo.2012.1338; Zeng C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0403-9; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910; Zhang QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009712; Zhang ZH, 2007, CANCER BIOL THER, V6, P587, DOI 10.4161/cbt.6.4.3888; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	54	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92190	10.1371/journal.pone.0092190	http://dx.doi.org/10.1371/journal.pone.0092190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632672	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400148
J	Koyio, LN; van der Sanden, WJM; Dimba, E; Mulder, J; Creugers, NHJ; Merkx, MAW; van der Ven, A; Frencken, JE				Koyio, Lucina N.; van der Sanden, Wil J. M.; Dimba, Elizabeth; Mulder, Jan; Creugers, Nico H. J.; Merkx, Matthias A. W.; van der Ven, Andre; Frencken, Jo E.			Oral Health Training Programs for Community and Professional Health Care Workers in Nairobi East District Increases Identification of HIV-Infected Patients	PLOS ONE			English	Article							LESIONS	Background: Better knowledge and skills for diagnosis and management of human immunodeficiency virus (HIV) related oral lesions by primary healthcare workers (PHWs) may increase recognition of HIV-related oral lesions (HROLs) and may improve implementation of HIV testing in Kenya. For this purpose training programs at health facility and community level were evaluated. Design and Methods: A pre-post control-test group design in two administrative divisions of Nairobi East District was used. Clinical competencies of PHWs (n = 32 intervention, and n = 27 control) at health facility level were assessed 9 months after training, and after 6 months for community health workers, (CHWs) (n = 411 intervention and n = 404 control) using written questionnaires, clinical data and patient interviews. Effects on referral for HIV testing and actual HIV testing were assessed by comparing laboratory registries pre- and post training. Results: PHWs in intervention (n = 27; 84%) and control (n = 15; 60%) divisions, and CHWs in intervention (n = 330; 80%) and control (189; 47%) divisions, completed all questionnaires. Trained PHWs significantly increased their knowledge of HROLs (p<0.02), frequency of oral examinations, diagnosis of HROLs and referral of patients with HROLs for HIV testing. Trained CHWs significantly gained knowledge about HROLs (p<0.02) and referred more patients with HROLs to health facilities. Overall percentage of HIV-positive test results was three-fold for HROLs compared to non-HROLs. Specifically, 70% of patients with oro pharyngeal candidiasis (OPC), the most commonly diagnosed HROL, were confirmed as being HIV-positive. Increase in overall HIV testing rates (1.6% pre-, 1.2% post training) and overall percentage of HIV-positive results (13% pre-, 16% post-intervention) was not significant. Conclusion: Training programs significantly increased PHW and CHW knowledge, recognition and management of HROLs but increased neither overall HIV testing rates nor overall percentage of positive tests. Speculation is that the health system and patient-related barriers seriously limit HIV testing.	[Koyio, Lucina N.] Minist Publ Hlth & Sanitat, Dept Primary Hlth Care Serv, Nairobi, Kenya; [van der Sanden, Wil J. M.; Mulder, Jan; Frencken, Jo E.] Radboud Univ Nijmegen, Coll Oral Sci, Med Ctr, Dept Global Oral Hlth, NL-6525 ED Nijmegen, Netherlands; [Dimba, Elizabeth] Univ Nairobi, Dent Teaching Hosp, Dept Oral & Maxillofacial Surg, Nairobi, Kenya; [Creugers, Nico H. J.] Radboud Univ Nijmegen, Coll Oral Sci, Med Ctr, Dept Oral Rehabil, NL-6525 ED Nijmegen, Netherlands; [Merkx, Matthias A. W.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [van der Ven, Andre] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, Dept Gen Internal Med, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Nairobi; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van der Sanden, WJM (corresponding author), Radboud Univ Nijmegen, Coll Oral Sci, Med Ctr, Dept Global Oral Hlth, NL-6525 ED Nijmegen, Netherlands.	wil.vanderSanden@radboudumc.nl	Creugers, N.H.J./H-8022-2014; x, x/M-4834-2017; Merkx, Matthias AW/H-8074-2014; van der Ven, A.J.A.M./H-8102-2014; Sanden, W.J.M. van der/L-4621-2015	x, x/0000-0002-7739-6723; Merkx, Matthias AW/0000-0002-0687-9760; van der Ven, A.J.A.M./0000-0003-1833-3391; Sanden, W.J.M. van der/0000-0003-0720-1983	Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Hague, The Netherlands [C&B-NFP-PHD.10/110]	Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Hague, The Netherlands	This study is funded by a research grant from The Netherlands Organization for International Cooperation in Higher Education (NUFFIC, Grant nr: C&B-NFP-PHD.10/110, The Hague, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbelusi GA, 2005, ORAL DIS, V11, P370, DOI 10.1111/j.1601-0825.2005.01132.x; Anver M., 2010, J KENYA DENT ASS, V1, P93; Bhayat A, 2010, ORAL SURG ORAL MED O, V109, P720, DOI 10.1016/j.tripleo.2009.11.019; Ferrinho P, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-34; Hamza Omar J M, 2006, BMC Oral Health, V6, P12; KDHS, 2008, KEN DEM HLTH SURV 20; Kenya, 2011, KEN SIN SLUM FIR TRA; Koyio LN, 2014, OROPHARYNGEAL CANDID, P59; Koyio LN, 2014, OROPHARYNGEAL CANDID, P135; Koyio Lucina N, 2013, J Public Health Res, V2, P22, DOI 10.4081/jphr.2013.e5; Koyio LN, 2012, J PUBLIC HEALTH RES, V1, P137, DOI 10.4081/jphr.2012.e20; Koyio LN, 2013, J PUBLIC HEALTH DENT, V73, P127, DOI 10.1111/j.1752-7325.2012.00353.x; Ministry of Health (MOH) [Kenya], 2006, TAK KEN ESS PACK HLT; Miziara ID, 2008, J ORAL PATHOL MED, V37, P99, DOI 10.1111/j.1600-0714.2007.00598.x; MoH, 2007, KEN AIDS IND SURV 20; Ranganathan K, 2006, Adv Dent Res, V19, P63; Robinson PG, 1998, SEX TRANSM INFECT, V74, P345, DOI 10.1136/sti.74.5.345; WILLIAMS DM, 1993, J ORAL PATHOL MED, V22, P289, DOI 10.1111/j.1600-0714.1993.tb01074.x; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	20	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90927	10.1371/journal.pone.0090927	http://dx.doi.org/10.1371/journal.pone.0090927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633223	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400025
J	Westrate, LM; Sayfie, AD; Burgenske, DM; MacKeigan, JP				Westrate, Laura M.; Sayfie, Aaron D.; Burgenske, Danielle M.; MacKeigan, Jeffrey P.			Persistent Mitochondrial Hyperfusion Promotes G2/M Accumulation and Caspase-Dependent Cell Death	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; MAMMALIAN-CELLS; FISSION; APOPTOSIS; FUSION; DRP1; MITOSIS; STRESS; GTPASE; ARREST	Cancer cells have several hallmarks that define their neoplastic behavior. One is their unabated replicative potential that allows cells to continually proliferate, and thereby contribute to increasing tumor burden. The progression of a cell through the cell cycle is regulated by a series of checkpoints that ensures successful transmission of genetic information, as well as various cellular components, including organelles and protein complexes to the two resulting daughter cells. The mitochondrial reticulum undergoes coordinated changes in shape to correspond with specific stages of the cell cycle, the most dramatic being complete mitochondrial fragmentation prior to cytokinesis. To determine whether mitochondrial fission is a required step to ensure proper mitochondrial segregation into two daughter cells, we investigated the importance of mitochondrial dynamics to cell cycle progression. We found that mitochondrial hyperfusion promotes a defect in cell cycle progression characterized by an inability for cells to exit G2/M. Additionally, extended periods of persistent mitochondrial fusion led to robust caspase-dependent cell death. The cell death signals were coordinated through activation and cleavage of caspase-8, promoting a potent death response. These results demonstrate the importance of mitochondrial dynamics in cell cycle progression, and that inhibiting mitochondrial fission regulators may provide a therapeutic strategy to target the replicative potential of cancer cells.	[Westrate, Laura M.; Sayfie, Aaron D.; Burgenske, Danielle M.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA; Grad Sch, Van Andel Inst, Grand Rapids, MI USA	Van Andel Institute; Van Andel Institute	MacKeigan, JP (corresponding author), Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA.	jeff.mackeigan@vai.org		MacKeigan, Jeffrey/0000-0002-0198-5679	National Cancer Institute [RO1CA138651]; Van Andel Institute Graduate School; NATIONAL CANCER INSTITUTE [R01CA138651] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Van Andel Institute Graduate School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by award number RO1CA138651 from the National Cancer Institute to J.P. MacKeigan and a fellowship from the Van Andel Institute Graduate School to L.M. Westrate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Harper Jane V., 2004, V296, P157; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Masuda A, 2003, AM J PATHOL, V163, P1109, DOI 10.1016/S0002-9440(10)63470-0; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Niemi NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053803; Philpott NJ, 1996, BLOOD, V87, P2244, DOI 10.1182/blood.V87.6.2244.bloodjournal8762244; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2001, J CELL SCI, V114, P867; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	30	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91911	10.1371/journal.pone.0091911	http://dx.doi.org/10.1371/journal.pone.0091911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632851	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400119
J	Qiao, Y; Zhao, YL; Wu, QL; Sun, LM; Ruan, QL; Chen, YY; Wang, M; Duan, JN; Wang, DY				Qiao, Yan; Zhao, Yunli; Wu, Qiuli; Sun, Lingmei; Ruan, Qinli; Chen, Yanyan; Wang, Meng; Duan, Jinao; Wang, Dayong			Full Toxicity Assessment of Genkwa Flos and the Underlying Mechanism in Nematode Caenorhabditis elegans	PLOS ONE			English	Article							ENVIRONMENTAL RELEVANT CONCENTRATIONS; POTENT INHIBITORY-ACTIVITY; MICROCYSTIN-LR EXPOSURE; WALLED CARBON NANOTUBES; LUNG-CANCER CELLS; DAPHNE-GENKWA; OXIDATIVE STRESS; DITERPENE ESTERS; FLOWER BUDS; REPRODUCTIVE TOXICITY	Genkwa Flos (GF), the dried flower bud from Daphne genkwa Sieb. et Zucc. (Thymelaeaceae), is a well-known and widely used traditional Chinese medicine. However, we know little about the in vivo mechanism of GF toxicity. Nematode Caenorhabditis elegans has been considered as a useful toxicity assay system by offering a system best suited for asking the in vivo questions. In the present study, we employed the prolonged exposure assay system of C. elegans to perform the full in vivo toxicity assessment of raw-processed GF. Our data show that GF exposure could induce the toxicity on lifespan, development, reproduction, and locomotion behavior. GF exposure not only decreased body length but also induced the formation of abnormal vulva. The decrease in brood size in GF exposed nematodes appeared mainly at day-1 during the development of adult nematodes. The decrease of locomotion behavior in GF exposed nematodes might be due to the damage on development of D-type GABAergic motor neurons. Moreover, we observed the induction of intestinal reactive oxygen species (ROS) production and alteration of expression patterns of genes required for development of apical domain, microvilli, and apical junction of intestine in GF exposed nematodes, implying the possible dysfunction of the primary targeted organ. In addition, GF exposure induced increase in defecation cycle length and deficits in development of AVL and DVB neurons controlling the defecation behavior. Therefore, our study implies the usefulness of C. elegans assay system for toxicity assessment from a certain Chinese medicine or plant extract. The observed toxicity of GF might be the combinational effects of oxidative stress, dysfunction of intestine, and altered defecation behavior in nematodes.	[Qiao, Yan; Ruan, Qinli; Chen, Yanyan; Wang, Meng; Duan, Jinao] Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing, Jiangsu, Peoples R China; [Qiao, Yan; Zhao, Yunli; Wu, Qiuli; Sun, Lingmei; Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Southeast University - China	Wang, M (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing, Jiangsu, Peoples R China.	mengwang.drug@hotmail.com; dja@njutcm.edu.cn; dayongw@seu.edu.cn	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Basic Research Program of China (973 Program) [2011CB505303]; National Natural Science Foundation of China [81172698, 81202233, 81302814]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (973 Program) (No. 2011CB505303), and National Natural Science Foundation of China (No. 81172698, 81202233, 81302814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Bang KK, 2013, BIOORG MED CHEM LETT, V23, P3334, DOI 10.1016/j.bmcl.2013.03.096; Boyd WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007024; BRENNER S, 1974, GENETICS, V77, P71; Chang CW, 2012, VIRUSES-BASEL, V4, P539, DOI 10.3390/v4040539; Chen YY, 2013, PHYTOMEDICINE, V21, P82, DOI 10.1016/j.phymed.2013.06.012; Dharmalingam K, 2012, J ETHNOPHARMACOL, V139, P657, DOI 10.1016/j.jep.2011.12.016; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Dostal V, 2010, GENETICS, V186, P857, DOI 10.1534/genetics.110.120436; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Fan D, 2011, FOOD CHEM, V124, P195, DOI 10.1016/j.foodchem.2010.06.008; Geng LL, 2013, PHYTOTHER RES, V27, P521, DOI 10.1002/ptr.4748; Goh GY, 2013, AGING CELL, DOI [10.1111/acel.12, DOI 10.1111/ACEL.12]; Helmcke KJ, 2009, TOXICOL APPL PHARM, V240, P265, DOI 10.1016/j.taap.2009.03.013; Hong JY, 2011, J NAT PROD, V74, P2102, DOI 10.1021/np2003512; Hong JY, 2010, CHEM PHARM BULL, V58, P234, DOI 10.1248/cpb.58.234; Hu YO, 2008, BIOMED ENVIRON SCI, V21, P467, DOI 10.1016/S0895-3988(09)60004-0; Jiang B, 2011, J BIOL INORG CHEM, V16, P267, DOI 10.1007/s00775-010-0723-1; Jiangsu New Medical College, 1985, ENC TRAD CHIN MED; Ju JJ, 2013, ENVIRON SCI POLLUT R, V20, P1823, DOI 10.1007/s11356-012-1151-2; Kandasamy S, 2012, MAR DRUGS, V10, P84, DOI 10.3390/md10010084; Kumar S, 2010, REPROD TOXICOL, V29, P415, DOI 10.1016/j.reprotox.2010.02.006; Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007; Lee MY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/728196; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li FF, 2013, BIOORG MED CHEM LETT, V23, P2500, DOI 10.1016/j.bmcl.2013.03.025; Li YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044688; Li YX, 2013, NANOTOXICOLOGY, V7, P1004, DOI 10.3109/17435390.2012.689884; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071180; Li YH, 2009, J ENVIRON SCI, V21, P971, DOI 10.1016/S1001-0742(08)62370-0; Li ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067451; Liu PD, 2012, ECOTOX ENVIRON SAFE, V79, P90, DOI 10.1016/j.ecoenv.2011.12.007; Lublin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027762; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1324, DOI 10.1897/08-262.1; MCGHEE JD, 2007, C ELEGANS INTESTINE, DOI DOI 10.1895/W0RMB00K.1.133.1; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mohan N, 2010, NANO LETT, V10, P3692, DOI 10.1021/nl1021909; Mukai D, 2008, J NAT MED, V62, P155, DOI 10.1007/s11418-007-0201-4; Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park BY, 2008, INT IMMUNOPHARMACOL, V8, P967, DOI 10.1016/j.intimp.2008.02.012; Park BY, 2006, PHYTOTHER RES, V20, P610, DOI 10.1002/ptr.1915; Pluskota A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006622; Qu Y, 2011, NANO LETT, V11, P3174, DOI 10.1021/nl201391e; Ruan QL, 2012, J APPL TOXICOL, V32, P527, DOI 10.1002/jat.1783; Ruan QL, 2009, J TOXICOL ENV HEAL A, V72, P746, DOI 10.1080/15287390902841532; Rui Q, 2009, FRONT MED-PRC, V3, P76; Rui Q, 2013, CHEMOSPHERE, V93, P2289, DOI 10.1016/j.chemosphere.2013.08.007; Sangha JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043990; Tullet JM, 2008, CELL, V132; Wang DY, 2008, ARCH ENVIRON CON TOX, V54, P447, DOI 10.1007/s00244-007-9050-0; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P1221, DOI 10.1016/j.ecoenv.2010.05.002; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P423, DOI 10.1016/j.ecoenv.2009.12.014; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; Wang R, 2013, J ASIAN NAT PROD RES, V15, P502, DOI 10.1080/10286020.2013.786703; Wang SC, 2009, CHEM-BIOL INTERACT, V180, P151, DOI 10.1016/j.cbi.2009.03.012; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Wu QL, 2013, NANOSCALE, V5, P11166, DOI 10.1039/c3nr03917j; Wu QL, 2013, NANOSCALE, V5, P9934, DOI 10.1039/c3nr02084c; Wu QL, 2012, J HAZARD MATER, V243, P161, DOI 10.1016/j.jhazmat.2012.10.013; Wu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043729; Wu QL, 2011, ENVIRON TOXICOL PHAR, V32, P175, DOI 10.1016/j.etap.2011.04.009; Wu QL, 2012, CHEMOSPHERE, V87, P1281, DOI 10.1016/j.chemosphere.2012.01.035; Wu S, 2011, ENVIRON TOXICOL PHAR, V31, P179, DOI 10.1016/j.etap.2010.10.005; Xie HC, 2011, J LIQ CHROMATOGR R T, V34, P2360, DOI 10.1080/10826076.2011.589094; Xing X, 2009, B ENVIRON CONTAM TOX, V83, P530, DOI 10.1007/s00128-009-9816-3; Xing XJ, 2009, J ENVIRON SCI, V21, P1684, DOI 10.1016/S1001-0742(08)62474-2; Yang CL, 1993, TOXIC HERBAL MED; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Ye HY, 2008, NEUROBIOL LEARN MEM, V90, P10, DOI 10.1016/j.nlm.2007.12.001; Yu SH, 2011, ENVIRON TOXICOL PHAR, V32, P233, DOI 10.1016/j.etap.2011.05.008; Zeitoun-Ghandour S, 2010, FEBS J, V277, P2531, DOI 10.1111/j.1742-4658.2010.07667.x; Zhan ZJ, 2005, BIOORGAN MED CHEM, V13, P645, DOI 10.1016/j.bmc.2004.10.054; Zhang HF, 2010, METALLOMICS, V2, P806, DOI 10.1039/c0mt00059k; Zhang SX, 2006, BIOORGAN MED CHEM, V14, P3888, DOI 10.1016/j.bmc.2006.01.055; Zhang WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074553; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093; Zhao YL, 2014, NANOMED-NANOTECHNOL, V10, P89, DOI 10.1016/j.nano.2013.07.004; Zhao YL, 2013, RSC ADV, V3, P5741, DOI 10.1039/c2ra22798c; Zheng WF, 2007, INT IMMUNOPHARMACOL, V7, P117, DOI 10.1016/j.intimp.2006.07.010; Zheng WF, 2007, INT IMMUNOPHARMACOL, V7, P128, DOI 10.1016/j.intimp.2006.07.011	82	33	36	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91825	10.1371/journal.pone.0091825	http://dx.doi.org/10.1371/journal.pone.0091825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626436	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300139
J	Theriault, BL; Basavarajappa, HD; Lim, H; Pajovic, S; Gallie, BL; Corson, TW				Theriault, Brigitte L.; Basavarajappa, Halesha D.; Lim, Harvey; Pajovic, Sanja; Gallie, Brenda L.; Corson, Timothy W.			Transcriptional and Epigenetic Regulation of KIF14 Overexpression in Ovarian Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FAMILY-MEMBER 14; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC MARKER; SIGNALING PATHWAY; GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; FACTORS SP1; PROGRESSION	KIF14 (kinesin family member 14) is a mitotic kinesin and an important oncogene in several cancers. Tumor KIF14 expression levels are independently predictive of poor outcome, and in cancer cells KIF14 can modulate metastatic behavior by maintaining appropriate levels of cell adhesion and migration proteins at the cell membrane. Thus KIF14 is an exciting potential therapeutic target. Understanding KIF14's regulation in cancer cells is crucial to the development of effective and selective therapies to block its tumorigenic function(s). We previously determined that close to 30% of serous ovarian cancers (OvCa tumors) exhibit low-level genomic gain, indicating one mechanism of KIF14 overexpression in tumors. We now report on transcriptional and epigenetic regulation of KIF14. Through promoter deletion analyses, we identified one cis-regulatory region containing binding sites for Sp1, HSF1 and YY1. siRNA-mediated knockdown of these transcription factors demonstrated endogenous regulation of KIF14 overexpression by Sp1 and YY1, but not HSF1. ChIP experiments confirmed an enrichment of both Sp1 and YY1 binding to the endogenous KIF14 promoter in OvCa cell lines with high KIF14 expression. A strong correlation was seen in primary serous OvCa tumors between Sp1, YY1 and KIF14 expression, further evidence that these transcription factors are important players in KIF14 overexpression. Hypomethylation patterns were observed in primary serous OvCa tumors, suggesting a minor role for promoter methylation in the control of KIF14 gene expression. miRNA expression analysis determined that miR-93, miR-144 and miR-382 had significantly lower levels of expression in primary serous OvCa tumors than normal tissues; treatment of an OvCa cell line with miRNA mimics and inhibitors specifically modulated KIF14 mRNA levels, pointing to potential novel mechanisms of KIF14 overexpression in primary tumors. Our findings reveal multiple mechanisms of KIF14 upregulation in cancer cells, offering new targets for therapeutic interventions to reduce KIF14 in tumors, aiming at improved prognosis.	[Theriault, Brigitte L.; Lim, Harvey; Pajovic, Sanja; Gallie, Brenda L.] Princess Margaret Canc Ctr, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Basavarajappa, Halesha D.; Corson, Timothy W.] Indiana Univ Sch Med, Dept Ophthalmol, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Basavarajappa, Halesha D.; Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Lim, Harvey; Gallie, Brenda L.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Gallie, Brenda L.] Toronto Western Hosp, Res Inst, Div Visual Sci, Toronto, ON M5T 2S8, Canada; [Gallie, Brenda L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Gallie, Brenda L.] Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; [Corson, Timothy W.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis	Gallie, BL (corresponding author), Princess Margaret Canc Ctr, Campbell Family Canc Res Inst, Toronto, ON, Canada.	brenda@gallie.ca; tcorson@iupui.edu	Corson, Timothy W./B-6851-2009; Basavarajappa, Halesha Dhurvigere/V-2038-2019	Corson, Timothy W./0000-0002-1402-7875; Basavarajappa, Halesha Dhurvigere/0000-0002-2840-5937; Gallie, Brenda/0000-0002-9697-9211	U.S. Department of Defence [OC080083]; Marsha Rivkin Ovarian Cancer Center Scientific Scholar Award; Indiana Clinical and Translational Sciences Institute; United States National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TR000163]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	U.S. Department of Defence(United States Department of Defense); Marsha Rivkin Ovarian Cancer Center Scientific Scholar Award; Indiana Clinical and Translational Sciences Institute; United States National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the U.S. Department of Defence Career Development Award; grant #OC080083, and the Marsha Rivkin Ovarian Cancer Center Scientific Scholar Award. This work was also supported in part by the Indiana Clinical and Translational Sciences Institute funded, in part by the United States National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (TR000163; TWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2012, J CELL BIOL, V199, P951, DOI 10.1083/jcb.201206051; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Bijron Jonathan G, 2012, Expert Opin Med Diagn, V6, P421, DOI 10.1517/17530059.2012.702105; Bowles E, 2007, GENE CHROMOSOME CANC, V46, P118, DOI 10.1002/gcc.20383; Campbell MJ, 2013, ADV EXP MED BIOL, V754, P81, DOI 10.1007/978-1-4419-9967-2_4; Carleton M, 2006, MOL CELL BIOL, V26, P3853, DOI 10.1128/MCB.26.10.3853-3863.2006; Chiang YC, 2013, ENDOCR-RELAT CANCER, V20, P213, DOI 10.1530/ERC-12-0117; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Davie JR, 2008, ADV ENZYME REGUL, V48, P189, DOI 10.1016/j.advenzreg.2007.11.016; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Ehrlichova M, 2013, GENOMICS, V102, P96, DOI 10.1016/j.ygeno.2013.03.005; Filges I, 2013, CLIN GENET; Fu X, 2012, FEBS LETT, V586, P1279, DOI 10.1016/j.febslet.2012.03.006; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Healy NA, 2012, INT J CANCER, V131, P2215, DOI 10.1002/ijc.27642; Heichman KA, 2012, CLIN CHEM LAB MED, V50, P1707, DOI 10.1515/cclm-2011-0935; Ho CM, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-53; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Joung JG, 2013, J AM MED INFORM ASS; Jun DY, 2008, BBA-GENE REGUL MECH, V1779, P356, DOI 10.1016/j.bbagrm.2008.03.013; Kim SW, 2007, GENE CHROMOSOME CANC, V46, P1, DOI 10.1002/gcc.20384; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Kong LM, 2010, CANCER SCI, V101, P1463, DOI 10.1111/j.1349-7006.2010.01554.x; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Madhavan J, 2009, MOL VIS, V15, P235; Malek A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035130; Markowski J, 2009, J PHYSIOL PHARMACOL, V60, P57; Markowski J, 2009, EUR ARCH OTO-RHINO-L, V266, P1501, DOI 10.1007/s00405-009-1019-3; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Renna M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703778200; Sarver AL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-7; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sriraksa R, 2010, CLIN BIOCHEM, V43, P528, DOI 10.1016/j.clinbiochem.2009.11.005; Stefansson OA, 2012, EPIGENETICS-US, V7, P1225, DOI 10.4161/epi.22561; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Szponar A, 2009, INT J CANCER, V124, P2071, DOI 10.1002/ijc.24180; Theriault BL, 2012, ATLAS GENETICS CYTOG; Theriault BL, 2012, INT J CANCER, V130, P1844, DOI 10.1002/ijc.26189; Thorsen SB, 2012, CANCER J, V18, P275, DOI 10.1097/PPO.0b013e318258b5d6; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; Wang Q, 2013, CANCER EPIDEMIOL, V37, P79, DOI 10.1016/j.canep.2012.08.011; Wang YQ, 2013, J OBSTET GYNAECOL RE, V39, P549, DOI 10.1111/j.1447-0756.2012.01979.x; Yang T, 2013, CANCER SCI, V104, P552, DOI 10.1111/cas.12128; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Zaman MS, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-44; Zhang Qiang, 2011, Critical Reviews in Oncogenesis, V16, P163; ZHOU QJ, 1995, J VIROL, V69, P4323, DOI 10.1128/JVI.69.7.4323-4330.1995	54	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91540	10.1371/journal.pone.0091540	http://dx.doi.org/10.1371/journal.pone.0091540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626475	gold, Green Published			2022-12-27	WOS:000332851300102
J	Carey, AL; Vorlander, C; Reddy-Luthmoodoo, M; Natoli, AK; Formosa, MF; Bertovic, DA; Anderson, MJ; Duffy, SJ; Kingwell, BA				Carey, Andrew L.; Vorlander, Camilla; Reddy-Luthmoodoo, Medini; Natoli, Alaina K.; Formosa, Melissa F.; Bertovic, David A.; Anderson, Mitchell J.; Duffy, Stephen J.; Kingwell, Bronwyn A.			Reduced UCP-1 Content in In Vitro Differentiated Beige/Brite Adipocytes Derived from Preadipocytes of Human Subcutaneous White Adipose Tissues in Obesity	PLOS ONE			English	Article							BROWN FAT; ADULT HUMANS; MESSENGER-RNA; COLD-EXPOSURE; EXPRESSION; THERMOGENESIS; ADIPOGENESIS; METABOLISM; ACTIVATION; INCREASES	Introduction: Brown adipose tissue (BAT) is a potential therapeutic target to reverse obesity. The purpose of this study was to determine whether primary precursor cells isolated from human adult subcutaneous white adipose tissue (WAT) can be induced to differentiate in-vitro into adipocytes that express key markers of brown or beige adipose, and whether the expression level of such markers differs between lean and obese young adult males. Methods: Adipogenic precursor cells were isolated from lean and obese individuals from subcutaneous abdominal WAT biopsies. Cells were grown to confluence, differentiated for 2.5 weeks then harvested for measurement of gene expression and UCP1 protein. Results: There was no difference between groups with respect to differentiation into adipocytes, as indicated by oil red-O staining, rates of lipolysis, and expression of adipogenic genes (FABP4, PPARG). WAT genes (HOXC9, RB1) were expressed equally in the two groups. Post differentiation, the beige adipose specific genes CITED1 and CD137 were significantly increased in both groups, but classic BAT markers ZIC1 and LHX8 decreased significantly. Cell lines from both groups also equally increased post-differentiation expression of the thermogenic-responsive gene PPARGC1A (PGC-1 alpha). UCP1 gene expression was undetectable prior to differentiation, however after differentiation both gene expression and protein content were increased in both groups and were significantly greater in cultures from lean compared with obese individuals (p < 0.05). Conclusion: Human subcutaneous WAT cells can be induced to attain BAT characteristics, but this capacity is reduced in WAT cells from obese individuals.	[Carey, Andrew L.; Vorlander, Camilla; Reddy-Luthmoodoo, Medini; Natoli, Alaina K.; Formosa, Melissa F.; Bertovic, David A.; Anderson, Mitchell J.; Duffy, Stephen J.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia; [Duffy, Stephen J.; Kingwell, Bronwyn A.] Alfred Hosp, Dept Cardiol, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health	Carey, AL (corresponding author), Baker IDI Heart & Diabet Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia.	andrew.carey@bakeridi.edu.au	Kingwell, Bronwyn A/B-1183-2009	Formosa, Melissa Frances/0000-0002-9837-7476; Carey, Andrew/0000-0003-3452-1501; Anderson, Mitchell/0000-0003-1458-1689	National Health and Medical Research Council of Australia; Operational Infrastructure Support (OIS) Scheme of the Victorian State Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support (OIS) Scheme of the Victorian State Government	This study was supported by the National Health and Medical Research Council of Australia and the Operational Infrastructure Support (OIS) Scheme of the Victorian State Government. BAK is a Senior Research Fellow of the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondin DP, 2014, J CLIN ENDOCR METAB; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Camera DM, 2010, EUR J APPL PHYSIOL, V109, P307, DOI 10.1007/s00421-010-1356-3; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Carey AL, 2013, PHARMACOL THERAPEUT, V140, P26, DOI 10.1016/j.pharmthera.2013.05.009; Cinti S, 2009, AM J PHYSL ENDOCRINO; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Corpeleijn E, 2010, AM J PHYSIOL-ENDOC M, V299, pE14, DOI 10.1152/ajpendo.00187.2010; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Esposito F, 2009, J BIOL CHEM, V284, P25993, DOI 10.1074/jbc.M109.034280; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Frontini A, 2013, BIOCH BIOPHYS ACTA; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; HIMMSHAGEN J, 1979, CAN MED ASSOC J, V121, P1361; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jo SJ, 2011, LIPIDS, V46, P487, DOI 10.1007/s11745-011-3525-5; Kozak L. P., 2011, PROG MOL BIOL TRANSL, V94, P75; KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191; Lee P, 2011, ENDOCRINOLOGY, V152, P3597, DOI 10.1210/en.2011-1349; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Oberkofler H, 1997, J LIPID RES, V38, P2125; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Orava J, 2013, OBESITY SILVER SPRIN; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pisani Didier F, 2011, Front Endocrinol (Lausanne), V2, P87, DOI 10.3389/fendo.2011.00087; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Silva FJ, 2014, STEM CELLS, V32, P572, DOI 10.1002/stem.1595; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	50	57	63	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91997	10.1371/journal.pone.0091997	http://dx.doi.org/10.1371/journal.pone.0091997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642703	Green Published, gold			2022-12-27	WOS:000333259900056
J	Schule, SA; Clowes, P; Kroidl, I; Kowuor, DO; Nsojo, A; Mangu, C; Riess, H; Geldmacher, C; Laubender, RP; Mhina, S; Maboko, L; Loscher, T; Hoelscher, M; Saathoff, E				Schuele, Steffen Andreas; Clowes, Petra; Kroidl, Inge; Kowuor, Dickens O.; Nsojo, Anthony; Mangu, Chacha; Riess, Helene; Geldmacher, Christof; Laubender, Ruediger Paul; Mhina, Seif; Maboko, Leonard; Loescher, Thomas; Hoelscher, Michael; Saathoff, Elmar			Ascaris lumbricoides Infection and Its Relation to Environmental Factors in the Mbeya Region of Tanzania, a Cross-Sectional, Population-Based Study	PLOS ONE			English	Article							GEOGRAPHICAL INFORMATION-SYSTEMS; TRANSMITTED HELMINTH INFECTIONS; FRACTIONAL POLYNOMIALS; RISK-FACTORS; EPIDEMIOLOGY; TRICHURIS; VARIABLES; CHILDREN; MOISTURE; PROGRAM	Background: With one quarter of the world population infected, the intestinal nematode Ascaris lumbricoides is one of the most common infectious agents, especially in the tropics and sub-tropics. Infection is caused by oral intake of eggs and can cause respiratory and gastrointestinal problems. To identify high risk areas for intervention, it is necessary to understand the effects of climatic, environmental and socio-demographic conditions on A. lumbricoides infection. Methodology: Cross-sectional survey data of 6,366 study participants in the Mbeya region of South-Western Tanzania were used to analyze associations between remotely sensed environmental data and A. lumbricoides infection. Non-linear associations were accounted for by using fractional polynomial regression, and socio-demographic and sanitary data were included as potential confounders. Principal Findings: The overall prevalence of A. lumbricoides infection was 6.8%. Our final multivariable model revealed a significant non-linear association between rainfall and A. lumbricoides infection with peak prevalences at 1740 mm of mean annual rainfall. Mean annual land surface temperature during the day was linearly modeled and negatively associated with A. lumbricoides infection (odds ratio (OR) = 0.87, 95% confidence interval (CI) = 0.78-0.97). Furthermore, age, which also showed a significant non-linear association (infection maximum at 7.7 years), socio-economic status (OR = 0.82, CI = 0.68-0.97), and latrine coverage around the house (OR = 0.80, CI = 0.67-0.96) remained in the final model. Conclusions: A. lumbricoides infection was associated with environmental, socio-demographic and sanitary factors both in uni-and multivariable analysis. Non-linear analysis with fractional polynomials can improve model fit, resulting in a better understanding of the relationship between environmental conditions and helminth infection, and more precise predictions of high prevalence areas. However, socio-demographic determinants and sanitary conditions should also be considered, especially when planning public health interventions on a smaller scale, such as the community level.	[Schuele, Steffen Andreas; Kroidl, Inge; Riess, Helene; Geldmacher, Christof; Loescher, Thomas; Hoelscher, Michael; Saathoff, Elmar] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Schuele, Steffen Andreas; Riess, Helene; Laubender, Ruediger Paul] Univ Munich, Inst Med Bioinformat Biometry & Epidemiol, Munich, Germany; [Schuele, Steffen Andreas] Univ Bremen, Inst Publ Hlth & Nursing Res, Dept Social Epidemiol, D-28359 Bremen, Germany; [Clowes, Petra; Kroidl, Inge; Kowuor, Dickens O.; Nsojo, Anthony; Mangu, Chacha; Maboko, Leonard; Hoelscher, Michael] NIMR Mbeya Med Res Ctr MMRC, Mbeya, Tanzania; [Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] German Ctr Infect Res DZIF, Munich, Germany; [Mhina, Seif] Mbeya Reg Med Off, Mbeya, Tanzania	University of Munich; University of Munich; University of Bremen; German Center for Infection Research	Schule, SA (corresponding author), Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.	steffenschuele@t-online.de	Löscher, Thomas/AAA-8399-2020; Hoelscher, Michael/D-3436-2012		European Commission [SANTE/2004/078-545/130, SANTE/2006/129-931]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The EMINI study was funded by the European Commission (SANTE/2004/078-545/130 & SANTE/2006/129-931). Helminth data collection was supported by the German Science foundation DFG (SA 1878/1-1) and the German Federal Ministry of Education and Research BMBF (01 KA 0904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin SAN, 2003, CONTROLLING DISEASE DUE TO HELMINTH INFECTIONS, P67; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alin A, 2010, WIRES COMPUT STAT, V2, P370, DOI 10.1002/wics.84; Ambler G, 2001, J STAT COMPUT SIM, V69, P89, DOI 10.1080/00949650108812083; Anderson RM, 1982, POPULATION DYNAMICS, P68; BEAVER PC, 1975, HEALTH LAB SCI, V12, P116; BEAVER PC, 1952, J PARASITOL, V38, P445, DOI 10.2307/3273923; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2002, TRENDS PARASITOL, V18, P70, DOI 10.1016/S1471-4922(01)02223-1; Brooker S, 2000, PARASITOL TODAY, V16, P303, DOI 10.1016/S0169-4758(00)01687-2; Brooker S, 2004, EPIDEMIOL INFECT, V132, P1065, DOI 10.1017/S0950268804003024; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2002, PHOTOGRAMM ENG REM S, V68, P175; Brooker S., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P24; Brooker S, 2002, B WORLD HEALTH ORGAN, V80, P783; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; Brooker S, 2009, INT J PARASITOL, V39, P591, DOI 10.1016/j.ijpara.2008.10.014; Carneiro FF, 2002, B WORLD HEALTH ORGAN, V80, P40; Crompton D.W.T., 1985, P9; Crompton DWT, 2001, ADV PARASIT, V48, P285, DOI 10.1016/S0065-308X(01)48008-0; Crompton DWT, 2007, HDB HELMINTHIASISI P; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; deSilva NR, 1997, TROP MED INT HEALTH, V2, P189, DOI 10.1046/j.1365-3156.1997.d01-241.x; deSilva NR, 1997, TROP MED INT HEALTH, V2, P519; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Drake LJ., 2000, SEMIN PEDIAT INFECT, V11, P245, DOI [10.1053/spid.2000.9638, DOI 10.1053/SPID.2000.9638]; ELKINS DB, 1986, T ROY SOC TROP MED H, V80, P774, DOI 10.1016/0035-9203(86)90384-6; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FORRESTER JE, 1988, T ROY SOC TROP MED H, V82, P282, DOI 10.1016/0035-9203(88)90448-8; Gunawardena GSA, 2004, J HELMINTHOL, V78, P305, DOI 10.1079/JOH2004252; Harrell FE, 2001, REGRESSION MODELING, pxxii; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kan S. P., 1985, Ascariasis and its public health significance, P69; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; Menard SW, 2002, APPL LOGISTIC REGRES, pviii; Montresor A., 1998, WORLD HLTH ORG; NASA Land Processes Distributed Active Archive Center (LP DAAC), 2001, 11A2 LA DAAC MODIS; NASA Land Processes Distributed Active Archive Center (LP DAAC), 2001, 13Q1 MODIS; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; Otto GF, 1929, AM J HYG, V10, P0497, DOI 10.1093/oxfordjournals.aje.a112765; Pisati M., 2001, STATA TECHNICAL B, V60, P21; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; Riess H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002408; Rogers WH, 1993, STATA TECHN B, V13, P19; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Royston P, 1997, J ROY STAT SOC D-STA, V46, P411; Royston P, 2008, MULTIVARIABLE MODEL, pxvii; Saathoff E, 2005, TROP MED INT HEALTH, V10, P412, DOI 10.1111/j.1365-3156.2005.01406.x; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott ME., 2008, ANN NESTLE, V66, P7, DOI DOI 10.1159/000113305; Spindler LA, 1929, AM J HYG, V10, P0476, DOI 10.1093/oxfordjournals.aje.a112764; Stephenson L. S., 1985, Ascariasis and its public health significance, P113; STOREY GW, 1985, PARASITOLOGY, V91, P585, DOI 10.1017/S003118200006282X; Tarafder MR, 2010, INT J PARASITOL, V40, P399, DOI 10.1016/j.ijpara.2009.09.003; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; TSHIKUKA JG, 1995, ANN TROP MED PARASIT, V89, P505, DOI 10.1080/00034983.1995.11812983; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001047; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; World Health Organization, 1991, BAS LAB METH MED PAR	67	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92032	10.1371/journal.pone.0092032	http://dx.doi.org/10.1371/journal.pone.0092032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643023	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900065
J	Antonsson, A; Cornford, M; Perry, S; Davis, M; Dunne, MP; Whiteman, DC				Antonsson, Annika; Cornford, Michelle; Perry, Susan; Davis, Marcia; Dunne, Michael P.; Whiteman, David C.			Prevalence and Risk Factors for Oral HPV Infection in Young Australians	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS-CELL CARCINOMA; GAMMAPAPILLOMAVIRUS GENERA; OROPHARYNGEAL CANCER; NUCLEOTIDE-SEQUENCE; UNITED-STATES; NECK CANCERS; SWEDEN; HEAD; MEN	The prevalence of human papillomavirus (HPV)-associated head and neck cancers is increasing, but the prevalence of oral HPV infection in the wider community remains unknown. We sought to determine the prevalence of, and identify risk factors for, oral HPV infection in a sample of young, healthy Australians. For this study, we recruited 307 Australian university students (18-35 years). Participants reported anonymously about basic characteristics, sexual behaviour, and alcohol, tobacco and illicit drugs use. We collected oral rinse samples from all participants for HPV testing and typing. Seven of 307 (2.3%) students tested positive for oral HPV infection (3 HPV-18, one each of HPV-16, -67, -69, -90), and six of them were males (p = 0.008). Compared to HPV negative students, those with oral HPV infection were more likely to have received oral sex from more partners in their lifetime (p = 0.0004) and in the last year (p = 0.008). We found no statistically significant associations with alcohol consumption, smoking or numbers of partners for passionate kissing or sexual intercourse. In conclusion, oral HPV infection was associated with male gender and receiving oral sex in our sample of young Australians.	[Antonsson, Annika; Perry, Susan; Davis, Marcia; Whiteman, David C.] QIMR Berghofer Med Res Inst, Dept Populat Hlth, Brisbane, Qld, Australia; [Cornford, Michelle; Dunne, Michael P.] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia	QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT)	Antonsson, A (corresponding author), QIMR Berghofer Med Res Inst, Dept Populat Hlth, Brisbane, Qld, Australia.	Annika.Antonsson@qimrberghofer.edu.au	Antonsson, Annika/A-2725-2015; Whiteman, David C/P-2728-2014	Antonsson, Annika/0000-0002-7383-8416; Whiteman, David C/0000-0003-2563-9559; Dunne, Michael/0000-0001-9041-4802	NHMRC [552429]; Garnett Passe and Rodney Williams Memorial Foundation; Australian Research Council [FT0990987]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Garnett Passe and Rodney Williams Memorial Foundation; Australian Research Council(Australian Research Council)	This project was funded by NHMRC program grant 552429. Annika Antonsson is funded by a Research Fellowship from the Garnett Passe and Rodney Williams Memorial Foundation. David C. Whiteman is funded by a Future Fellowship (FT0990987) from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding bodies.	Attner P, 2012, INT J CANCER, V131, P1124, DOI 10.1002/ijc.26490; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; De Roda Husman A. M., 1995, Journal of Medical Virology, V46, P97, DOI 10.1002/jmv.1890460203; De Roda Husman Ana-Maria, 1995, Journal of General Virology, V76, P1057, DOI 10.1099/0022-1317-76-4-1057; Du J, 2012, EMERG INFECT DIS, V18, P1468, DOI 10.3201/eid1809.111731; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hansson BG, 2005, ACTA OTO-LARYNGOL, V125, P1337, DOI 10.1080/00016480510043945; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; Kino N, 2000, CLIN DIAGN LAB IMMUN, V7, P91, DOI 10.1128/CDLI.7.1.91-95.2000; Kirii Y, 1998, VIRUS GENES, V17, P117, DOI 10.1023/A:1008002905588; Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kurose K, 2004, ORAL SURG ORAL MED O, V98, P91, DOI 10.1016/j.tripleo.2003.12.029; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nordfors C, 2013, SCAND J INFECT DIS; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Terai M, 2002, J INFECT DIS, V185, P1794, DOI 10.1086/340824	26	64	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91761	10.1371/journal.pone.0091761	http://dx.doi.org/10.1371/journal.pone.0091761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637512	Green Published, gold			2022-12-27	WOS:000333254100059
J	Cox, GN; Chlipala, EA; Smith, DJ; Carlson, SJ; Bell, SJ; Doherty, DH				Cox, George N.; Chlipala, Elizabeth A.; Smith, Darin J.; Carlson, Sharon J.; Bell, Stacie J.; Doherty, Daniel H.			Hematopoietic Properties of Granulocyte Colony-Stimulating Factor/Immunoglobulin (G-CSF/IgG-Fc) Fusion Proteins in Normal and Neutropenic Rodents	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; POLYETHYLENE-GLYCOL; GROWTH-FACTORS; CSF; GENE; FILGRASTIM; ANTIBODIES; DURATION; RATS; MICE	Previously we showed that granulocyte colony-stimulating factor (G-CSF) in vitro bioactivity is preserved when the protein is joined via a flexible 7 amino acid linker to an immunoglobulin-1 (IgG1)-Fc domain and that the G-CSF/IgG1-Fc fusion protein possessed a longer circulating half-life and improved hematopoietic properties compared to G-CSF in normal rats. We have extended this analysis by comparing the relative hematopoietic potencies of G-CSF/IgG1-Fc to G-CSF in normal mice and to G-CSF and polyethylene glycol (PEG) - modified G-CSF in neutropenic rats. Mice were treated for 5 days using different doses and dosing regimens of G-CSF/IgG1-Fc or G-CSF and circulating neutrophil levels in the animals measured on Day 6. G-CSF/IgG1-Fc stimulated greater increases in blood neutrophils than comparable doses of G-CSF when administered using daily, every other day or every third day dosing regimens. In rats made neutropenic with cyclophosphamide, G-CSF/IgG1-Fc accelerated recovery of blood neutrophils to normal levels (from Day 9 to Day 5) when administered as 5 daily injections or as a single injection on Day 1. By contrast, G-CSF accelerated neutrophil recovery when administered as 5 daily injections, but not when administered as a single injection. G-CSF/IgG1-Fc was as effective as PEG-G-CSF at accelerating neutrophil recovery following a single injection in neutropenic rats. G-CSF/IgG1-Fc and G-CSF/IgG4-Fc fusion proteins in which the 7 amino acid linker was deleted also were effective at accelerating neutrophil recovery following a single injection in neutropenic rats. These studies confirm the enhanced in vivo hematopoietic properties of G-CSF/IgG-Fc fusion proteins.	[Cox, George N.; Smith, Darin J.; Carlson, Sharon J.; Bell, Stacie J.; Doherty, Daniel H.] Bolder BioTechnol Inc, Boulder, CO USA; [Chlipala, Elizabeth A.] Univ Colorado, BolderPATH Inc, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Cox, GN (corresponding author), Bolder BioTechnol Inc, Boulder, CO USA.	jcox@bolderbio.com			National Institutes of Diabetes, Digestive, and Kidney Diseases of The National Institutes of Health [1 R43 DK054561, 2R44 DK054561]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK054561, R43DK054561] Funding Source: NIH RePORTER	National Institutes of Diabetes, Digestive, and Kidney Diseases of The National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants 1 R43 DK054561 and 2R44 DK054561 to G. C. from the National Institutes of Diabetes, Digestive, and Kidney Diseases of The National Institutes of Health. The publication contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlini P, 1996, BLOOD, V88, P2819, DOI 10.1182/blood.V88.8.2819.bloodjournal8882819; Bowen S, 1999, EXP HEMATOL, V27, P425, DOI 10.1016/S0301-472X(98)00051-4; Cox GN, 2004, EXP HEMATOL, V32, P441, DOI 10.1016/j.exphem.2004.01.012; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; ELLISON J, 1981, DNA-J MOLEC CELL BIO, V1, P11, DOI 10.1089/dna.1.1981.1.11; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; Gaertner HF, 1996, BIOCONJUGATE CHEM, V7, P38, DOI 10.1021/bc950074d; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; HILL CP, 1993, P NATL ACAD SCI USA, V90, P5167, DOI 10.1073/pnas.90.11.5167; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Kinstler OB, 1996, PHARMACEUT RES, V13, P996, DOI 10.1023/A:1016042220817; KUBOTA N, 1990, J BIOCHEM, V107, P486, DOI 10.1093/oxfordjournals.jbchem.a123072; KUGA T, 1989, BIOCHEM BIOPH RES CO, V159, P103, DOI 10.1016/0006-291X(89)92410-8; LAYTON JE, 1991, J BIOL CHEM, V266, P23815; Molineux G, 2004, CURR PHARM DESIGN, V10, P1235, DOI 10.2174/1381612043452613; Molineux G, 1999, EXP HEMATOL, V27, P1724, DOI 10.1016/S0301-472X(99)00112-5; MOTT HR, 1995, CURR OPIN STRUC BIOL, V5, P114, DOI 10.1016/0959-440X(95)80016-T; NAGATA S, 1986, EMBO J, V5, P575, DOI 10.1002/j.1460-2075.1986.tb04249.x; Nohynek GJ, 1997, CANCER CHEMOTH PHARM, V39, P259; Paige AG, 1995, PHARMACEUT RES, V12, P1883, DOI 10.1023/A:1016227519561; Rosendahl Mary S, 2005, Bioprocess Int, V3, P52; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; TANAKA H, 1991, CANCER RES, V51, P3710; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; Young DC, 1997, PROTEIN SCI, V6, P1228, DOI 10.1002/pro.5560060611	26	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91990	10.1371/journal.pone.0091990	http://dx.doi.org/10.1371/journal.pone.0091990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637521	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100098
J	Jonason, D; Franzen, M; Ranius, T				Jonason, Dennis; Franzen, Markus; Ranius, Thomas			Surveying Moths Using Light Traps: Effects of Weather and Time of Year	PLOS ONE			English	Article							ABUNDANCE; DIVERSITY; RICHNESS; CONSERVATION; BIODIVERSITY; LEPIDOPTERA; TEMPERATURE; BUTTERFLIES; MANAGEMENT; MOONLIGHT	Light trapping is an ideal method for surveying nocturnal moths, but in the absence of standardised survey methods effects of confounding factors may impede interpretation of the acquired data. We explored the influence of weather, time of year, and light source on nightly catches of macro moths in light traps, and compared four strategies for sampling by estimating observed species richness using rarefaction. We operated two traps with different light sources for 225 consecutive nights from mid-March to the end of October in eastern Germany in 2011. In total, 49 472 individuals of 372 species were recorded. Species richness and abundance per night were mainly influenced by night temperature, humidity and lamp type. With a limited sample size (<10 nights) it was slightly better to concentrate sampling on the warmest summer nights, but with more sampling nights it was slightly better to sample during the warmest nights in each month (March to October). By exploiting the higher moth activity during warm nights and an understanding of the species' phenology, it is possible to increase the number of species caught and reduce effects of confounding abiotic factors.	[Jonason, Dennis] Linkoping Univ, IFM Biol, Div Ecol, Linkoping, Sweden; [Jonason, Dennis; Ranius, Thomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Franzen, Markus] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany	Linkoping University; Swedish University of Agricultural Sciences; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Jonason, D (corresponding author), Linkoping Univ, IFM Biol, Div Ecol, Linkoping, Sweden.	dennis.jonason@liu.se			Marie-Claire Cronstedts Stiftelse; Stiftelsen Langmanska kulturfonden	Marie-Claire Cronstedts Stiftelse; Stiftelsen Langmanska kulturfonden	This work was supported by Marie-Claire Cronstedts Stiftelse and Stiftelsen Langmanska kulturfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RR, 1978, NATURE, V276, P818, DOI 10.1038/276818a0; Barton K., 2012, MUMIN MULTIMODEL INF; Bates AJ, 2013, ENTOMOL EXP APPL, V146, P386, DOI 10.1111/eea.12038; Bates D, 2012, LME4 LINEAR MIXED EF; Butler L, 1999, ENVIRON ENTOMOL, V28, P795, DOI 10.1093/ee/28.5.795; EASAC, 2004, US GUID BIOD IND; Ehnstrom B, 2011, SALG LIVETS VIKTIGAS; Elmquist H., 2011, SVERIGES FJARILAR FA; Fayle Tom M., 2007, British Journal of Entomology and Natural History, V20, P221; Fowler J., 2013, PRACTICAL STAT FIELD; Fox R., 2013, REPORT BUTTERFLY CON, DOI [DOI 10.23637/ROTHAM-STED.898Z8, 10.23637/rotham-sted.898z8]; Franzen M, 2007, J INSECT CONSERV, V11, P367, DOI 10.1007/s10841-006-9053-6; Franzen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037359; Fuentes-Montemayor E, 2012, BIOL CONSERV, V153, P265, DOI 10.1016/j.biocon.2012.04.019; Fuentes-Montemayor E, 2011, J APPL ECOL, V48, P532, DOI 10.1111/j.1365-2664.2010.01927.x; GELMAN A., 2013, PACKAGE ARM; Grant BS, 1998, J HERED, V89, P465, DOI 10.1093/jhered/89.5.465; Groenendijk D, 2011, J INSECT CONSERV, V15, P95, DOI 10.1007/s10841-010-9326-y; Groombridge B., 1992, GLOBAL BIODIVERSITY; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Holyoak M, 1997, ENTOMOL EXP APPL, V83, P329, DOI 10.1023/A:1003015401648; Intachat J, 1999, B ENTOMOL RES, V89, P153, DOI 10.1017/S0007485399000243; Jonason D, 2013, BASIC APPL ECOL, V14, P515, DOI [10.1016/j.baae.2013.07.002, 10.1016/j.baae.2013.07.003]; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Leinonen R, 1998, ENTOMOL FENNICA, V9, P37, DOI 10.33338/ef.83965; Leraut P, 2009, MOTHS EUROPE GEOMETR; Littlewood NA, 2008, INSECT CONSERV DIVER, V1, P151, DOI 10.1111/j.1752-4598.2008.00021.x; MANLEY C, 2008, BRIT MOTHS BUTTERFLI; MCGEACHIE WJ, 1989, B ENTOMOL RES, V79, P185, DOI 10.1017/S0007485300018162; Mellanby K, 1939, PROC R SOC SER B-BIO, V127, P473, DOI 10.1098/rspb.1939.0035; Merckx T, 2009, AGR ECOSYST ENVIRON, V129, P302, DOI 10.1016/j.agee.2008.10.004; Merckx T, 2014, INSECT CONSERV DIVER, V7, P453, DOI 10.1111/icad.12068; Merckx T, 2009, AGR ECOSYST ENVIRON, V130, P177, DOI 10.1016/j.agee.2009.01.006; New TR, 2004, J INSECT CONSERV, V8, P79, DOI 10.1023/B:JICO.0000045807.04047.bd; Nowacki J., 1998, NOCTUIDS LEPIDOPTERA; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; Rakosy L, 2011, ECOL INDIC, V11, P1040, DOI 10.1016/j.ecolind.2010.10.010; Schowalter TD, 2011, INSECT ECOLOGY: AN ECOSYSTEM APPROACH, 3RD EDITION, P1; Shapiro A.M., 1975, P181; Skinner B., 2009, COLOUR IDENTIFICATIO, V3rd; Skou, 1991, NORDENS UGLER HANDBO; Skou P., 1984, NORDENS MALERE HANDB; Slade EM, 2013, ECOLOGY, V94, P1519, DOI 10.1890/12-1366.1; Somers-Yeates R, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0376; Summerville KS, 2004, BIOL CONSERV, V116, P9, DOI 10.1016/S0006-3207(03)00168-X; Summerville KS, 2003, OIKOS, V100, P134, DOI 10.1034/j.1600-0706.2003.11992.x; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Truxa C, 2012, INSECT CONSERV DIVER, V5, P389, DOI 10.1111/j.1752-4598.2011.00177.x; van Langevelde F, 2011, BIOL CONSERV, V144, P2274, DOI 10.1016/j.biocon.2011.06.004; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Wickramasinghe LP, 2004, CONSERV BIOL, V18, P1283, DOI 10.1111/j.1523-1739.2004.00152.x; Yela JL, 1997, ENVIRON ENTOMOL, V26, P1283, DOI 10.1093/ee/26.6.1283	55	47	49	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92453	10.1371/journal.pone.0092453	http://dx.doi.org/10.1371/journal.pone.0092453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637926	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000333254100149
J	Monge, S; Guillot, V; Alvarez, M; Chueca, N; Stella, N; Pena, A; Delgado, R; Cordoba, J; Aguilera, A; Vidal, C; Garcia, F				Monge, Susana; Guillot, Vicente; Alvarez, Marta; Chueca, Natalia; Stella, Natalia; Pena, Alejandro; Delgado, Rafael; Cordoba, Juan; Aguilera, Antonio; Vidal, Carmen; Garcia, Federico		CoRIS	Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SPANISH COHORT; MUTATIONS; PREVALENCE; CORIS	Background: The aim was to analyse trends in clinically relevant resistance to first-line antiretroviral drugs in Spain, applying the Stanford algorithm, and to compare these results with reported Transmitted Drug Resistance (TDR) defined by the 2009 update of the WHO SDRM list. Methods: We analysed 2781 sequences from ARV naive patients of the CoRIS cohort (Spain) between 2007-2011. Using the Stanford algorithm "Low-level resistance", "Intermediate resistance" and "High-level resistance" categories were considered as "Resistant". Results: 70% of the TDR found using the WHO list were relevant for first-line treatment according to the Stanford algorithm. A total of 188 patients showed clinically relevant resistance to first-line ARVs [6.8% (95% Confidence Interval: 5.8-7.7)], and 221 harbored TDR using the WHO list [7.9% (6.9-9.0)]. Differences were due to a lower prevalence in clinically relevant resistance for NRTIs [2.3% (1.8-2.9) vs. 3.6% (2.9-4.3) by the WHO list] and PIs [0.8% (0.4-1.1) vs. 1.7% (1.2-2.2)], while it was higher for NNRTIs [4.6% (3.8-5.3) vs. 3.7% (3.0-4.7)]. While TDR remained stable throughout the study period, clinically relevant resistance to first line drugs showed a significant trend to a decline (p = 0.02). Conclusions: Prevalence of clinically relevant resistance to first line ARVs in Spain is decreasing, and lower than the one expected looking at TDR using the WHO list. Resistance to first-line PIs falls below 1%, so the recommendation of screening for TDR in the protease gene should be questioned in our setting. Cost-effectiveness studies need to be carried out to inform evidence-based recommendations.	[Monge, Susana] Natl Ctr Epidemiol, Madrid, Spain; [Guillot, Vicente; Alvarez, Marta; Chueca, Natalia; Pena, Alejandro; Garcia, Federico] San Cecilio Univ Hosp, Dept Microbiol, Inst Biosanitario Invest IBIG, Granada, Spain; [Stella, Natalia] La Paz Univ Hosp, IdiPAZ, Infect Dis Unit, Madrid, Spain; [Delgado, Rafael] Doce Octubre Univ Hosp, Dept Microbiol, Madrid, Spain; [Cordoba, Juan] La Fe Univ Hosp, Dept Microbiol, Valencia, Spain; [Aguilera, Antonio] Univ Hosp Santiago, Dept Microbiol, Santiago De Compostela, Spain; [Vidal, Carmen] Son Espases Univ Hosp, Dept Microbiol, Palma De Mallorca, Spain	Hospital Universitario San Cecilio; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari Son Espases	Garcia, F (corresponding author), San Cecilio Univ Hosp, Dept Microbiol, Inst Biosanitario Invest IBIG, Granada, Spain.	fegarcia@ugr.es	Garcia, Federico/AAA-3175-2020; Chueca, Natalia/K-5225-2014; Muga, Roberto/AAY-8655-2021; Valle-Garay, Eulalia/AAG-6664-2020; Delgado, Rafael/C-4910-2016; Perez, Laura/AAC-8394-2020; Melón, Santiago/AAY-1466-2021; Pulido, Federico/B-8417-2009; DELGADO, RAFAEL/A-2938-2012; Alvarez-del Arco, Debora/E-1744-2015; Berenguer, Juan/A-1347-2009; Mingorance, Jesus/B-7562-2009; DEL AMO VALERO, JULIA/M-7020-2015; Monge, Susana/H-9210-2017; Padilla, Sergio/U-7682-2017; Valero, Ignacio Pérez/G-5909-2016; , Felipe/F-4242-2014; Aguilera, Antonio/L-6586-2018; Masiá, Mar/U-7510-2017; Oteo, Jose A./AAB-3134-2020; Valero, Ignacio Pérez/AAD-6566-2020; Chueca, Natalia/T-9734-2019; Cuellar, Sandra/I-3069-2015; Soriano, Vicente/O-5730-2018; Lopez.Cortes, Luis Fernando/S-5625-2018	Garcia, Federico/0000-0001-7611-781X; Chueca, Natalia/0000-0002-3420-3290; Muga, Roberto/0000-0001-6301-431X; Valle-Garay, Eulalia/0000-0002-5998-699X; Delgado, Rafael/0000-0002-6912-4736; Melón, Santiago/0000-0001-5770-7902; Pulido, Federico/0000-0002-7414-8812; Alvarez-del Arco, Debora/0000-0003-4079-9219; Berenguer, Juan/0000-0001-8541-8200; Mingorance, Jesus/0000-0001-6173-5711; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Valero, Ignacio Pérez/0000-0002-3488-7135; , Felipe/0000-0001-7658-5832; Aguilera, Antonio/0000-0001-6940-241X; Masiá, Mar/0000-0001-9878-2458; Oteo, Jose A./0000-0001-7080-6542; Valero, Ignacio Pérez/0000-0002-3488-7135; Chueca, Natalia/0000-0002-3420-3290; Soriano, Vicente/0000-0002-4624-5199; Estebanez, Miriam/0000-0003-4509-9123; JARRIN, INMA/0000-0002-7485-2252; Monge, Susana/0000-0003-1412-3012; MARTIN CARBONERO, LUZ/0000-0001-8102-4079; Perez Elias/0000-0001-5700-5257; POVEDA, EVA/0000-0003-4835-9875; SIRVENT, JUAN JOSE/0000-0002-7486-8916; Munoz-Fernandez/0000-0002-0813-4500; Sanvisens, Arantza/0000-0001-6269-5491; Calabuig, Eva/0000-0002-0177-0037; Amengual, Maria Jose/0000-0002-5385-3061; Stella-Ascariz, Natalia/0000-0002-8937-5911; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458	Instituto de Salud Carlos III through the Red Tematica de Investigacion Cooperativa en Sida [ISCIII-RETIC RD06/006, RD12/0017];  [PI12/01053]	Instituto de Salud Carlos III through the Red Tematica de Investigacion Cooperativa en Sida; 	This work was supported by the Instituto de Salud Carlos III through the Red Tematica de Investigacion Cooperativa en Sida [ISCIII-RETIC RD06/006 and RD12/0017], and through Grant no PI12/01053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Beerenwinkel N, 2005, J INFECT DIS, V191, P1953, DOI 10.1086/430005; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Caro-Murillo AM, 2007, ENFERM INFEC MICR CL, V25, P23, DOI 10.1157/13096749; De Gascun CF, 2012, AIDS RES HUM RETROV, V28, P276, DOI 10.1089/aid.2011.0166; Descamps D, 2010, J ANTIMICROB CHEMOTH, V65, P2620, DOI 10.1093/jac/dkq380; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents - A Working Group of the Office of AIDS Research Advisory Council (OARAC), GUIDELINES USE ANTIR; Dolling D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5253; European AIDS clinical Society, EACS GUID V6 1; Frentz D, 2011, JAIDS-J ACQ IMM DEF, V58, pE135, DOI 10.1097/QAI.0b013e3182364c80; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Grupo de Estudio de SIDA, 2013, DOC CONS GES PLAN NA; Hurt CB, 2009, ANTIVIR THER, V14, P673; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Li JZ, 2013, J INFECT DIS, V207, P893, DOI 10.1093/infdis/jis925; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Monge S, 2012, CLIN MICROBIOL INFEC, V18, pE485, DOI 10.1111/1469-0691.12011; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Sobrino-Vegas P, 2011, ENFERM INFEC MICR CL, V29, P645, DOI 10.1016/j.eimc.2011.06.002; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9	24	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90710	10.1371/journal.pone.0090710	http://dx.doi.org/10.1371/journal.pone.0090710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637804	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100008
J	Ogata, T; Niihori, T; Tanaka, N; Kawai, M; Nagashima, T; Funayama, R; Nakayama, K; Nakashima, S; Kato, F; Fukami, M; Aoki, Y; Matsubara, Y				Ogata, Tsutomu; Niihori, Tetsuya; Tanaka, Noriko; Kawai, Masahiko; Nagashima, Takeshi; Funayama, Ryo; Nakayama, Keiko; Nakashima, Shinichi; Kato, Fumiko; Fukami, Maki; Aoki, Yoko; Matsubara, Yoichi			TBX1 Mutation Identified by Exome Sequencing in a Japanese Family with 22q11.2 Deletion Syndrome-Like Craniofacial Features and Hypocalcemia	PLOS ONE			English	Article							CYCLIN D1; HAPLOINSUFFICIENCY; POLYMORPHISM; VARIANTS; DIGEORGE; DISEASE; GAIN; GENE	Background: Although TBX1 mutations have been identified in patients with 22q11.2 deletion syndrome (22q11.2DS)-like phenotypes including characteristic craniofacial features, cardiovascular anomalies, hypoparathyroidism, and thymic hypoplasia, the frequency of TBX1 mutations remains rare in deletion-negative patients. Thus, it would be reasonable to perform a comprehensive genetic analysis in deletion-negative patients with 22q11.2DS-like phenotypes. Methodology/Principal Findings: We studied three subjects with craniofacial features and hypocalcemia (group 1), two subjects with craniofacial features alone (group 2), and three subjects with normal phenotype within a single Japanese family. Fluorescence in situ hybridization analysis excluded chromosome 22q11.2 deletion, and genomewide array comparative genomic hybridization analysis revealed no copy number change specific to group 1 or groups 1+2. However, exome sequencing identified a heterozygous TBX1 frameshift mutation (c.1253delA, p.Y418fsX459) specific to groups 1+2, as well as six missense variants and two in-frame microdeletions specific to groups 1+2 and two missense variants specific to group 1. The TBX1 mutation resided at exon 9C and was predicted to produce a non-functional truncated protein missing the nuclear localization signal and most of the transactivation domain. Conclusions/Significance: Clinical features in groups 1+2 are well explained by the TBX1 mutation, while the clinical effects of the remaining variants are largely unknown. Thus, the results exemplify the usefulness of exome sequencing in the identification of disease-causing mutations in familial disorders. Furthermore, the results, in conjunction with the previous data, imply that TBX1 isoform C is the biologically essential variant and that TBX1 mutations are associated with a wide phenotypic spectrum, including most of 22q11.2DS phenotypes.	[Ogata, Tsutomu; Nakashima, Shinichi; Kato, Fumiko] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan; [Niihori, Tetsuya; Aoki, Yoko; Matsubara, Yoichi] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 980, Japan; [Tanaka, Noriko] Kurashiki Cent Hosp, Dept Pediat, Kurashiki, Okayama, Japan; [Kawai, Masahiko] Kyoto Univ, Sch Med, Dept Pediat, Kyoto 606, Japan; [Nagashima, Takeshi; Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Div Cell Proliferat, United Ctr Adv Res & Translat Med, Sendai, Miyagi 980, Japan; [Fukami, Maki; Matsubara, Yoichi] Natl Res Inst Child Hlth & Dev, Tokyo, Japan	Hamamatsu University School of Medicine; Tohoku University; Kurashiki Central Hospital; Kyoto University; Tohoku University; National Center for Child Health & Development - Japan	Ogata, T (corresponding author), Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan.	tomogata@hama-med.ac.jp	Niihori, Tetsuya/ABE-2350-2021; Fukami, Maki/ABE-4694-2020	Niihori, Tetsuya/0000-0002-2118-9776; Fukami, Maki/0000-0001-9971-4035; Ogata, Tsutomu/0000-0001-7178-9991	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science and Technology; National Center for Child Health and Development; Grants-in-Aid for Scientific Research [22227002, 23390268] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Health, Labor, and Welfare, from the Ministry of Education, Culture, Sports, Science and Technology, and from the National Center for Child Health and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldini A, 2005, CURR OPIN GENET DEV, V15, P279, DOI 10.1016/j.gde.2005.03.001; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Griffin HR, 2010, HEART, V96, P1651, DOI 10.1136/hrt.2010.200121; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Kawame H, 2001, J PEDIATR-US, V139, P892, DOI 10.1067/mpd.2001.119448; Kong SM, 2000, CANCER RES, V60, P249; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McDonnell SK, 2013, CYTOGENET GENOME RES, V139, P250, DOI 10.1159/000348815; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; OHTANI I, 1984, ANN OTO RHINOL LARYN, V93, P220, DOI 10.1177/000348948409300306; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Rauch R, 2010, J MED GENET, V47, P321, DOI 10.1136/jmg.2009.070391; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Stoller JZ, 2005, HUM MOL GENET, V14, P885, DOI 10.1093/hmg/ddi081; Vezzoli G, 2007, KIDNEY INT, V71, P1155, DOI 10.1038/sj.ki.5002156; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Zuoheng, 2013, Frontiers in Genetics, V4, P160, DOI 10.3389/fgene.2013.00160; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zatyka M, 2002, CANCER RES, V62, P3803; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	22	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91598	10.1371/journal.pone.0091598	http://dx.doi.org/10.1371/journal.pone.0091598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637876	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100048
J	Popovic, J; Stanisavljevic, D; Schwirtlich, M; Klajn, A; Marjanovic, J; Stevanovic, M				Popovic, Jelena; Stanisavljevic, Danijela; Schwirtlich, Marija; Klajn, Andrijana; Marjanovic, Jelena; Stevanovic, Milena			Expression Analysis of SOX14 during Retinoic Acid Induced Neural Differentiation of Embryonal Carcinoma Cells and Assessment of the Effect of Its Ectopic Expression on SOXB Members in HeLa Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; STEM-CELLS; VERTEBRATE NEUROGENESIS; GENOMIC ORGANIZATION; CERVICAL-CANCER; GLIAL-CELLS; TRANSCRIPTION; NEURONS; MOUSE	SOX14 is a member of the SOXB2 subgroup of transcription factors implicated in neural development. Although the first SOX14 gene in vertebrates was cloned and characterized more than a decade ago and its expression profile during development was revealed in various animal model systems, the role of this gene during neural development is largely unknown. In the present study we analyzed the expression of SOX14 in human NT2/D1 and mouse P19 pluripotent embryonal carcinoma cells. We demonstrated that it is expressed in both cell lines and upregulated during retinoic acid induced neural differentiation. We showed that SOX14 was expressed in both neuronal and non-neuronal differentiated derivatives, as revealed by immunocytochemistry. Since it was previously proposed that increased SOXB2 proteins level interfere with the activity of SOXB1 counteracting partners, we compared expression patterns of SOXB members during retinoic acid induction of embryonal carcinoma cells. We revealed that upregulation of SOX14 expression is accompanied by alterations in the expression patterns of SOXB1 members. In order to analyze the potential cross-talk between them, we generated SOX14 expression construct. The ectopic expression of SOX14 was demonstrated at the mRNA level in NT2/D1, P19 and HeLa cells, while an increased level of SOX14 protein was detected in HeLa cells only. By transient transfection experiments in HeLa cells we showed for the first time that ectopic expression of SOX14 repressed SOX1 expression, whereas no significant effect on SOX2, SOX3 and SOX21 was observed. Data presented here provide an insight into SOX14 expression during in vitro neural differentiation of embryonal carcinoma cells and demonstrate the effect of its ectopic expression on protein levels of SOXB members in HeLa cells. Obtained results contribute to better understanding the role of one of the most conserved SOX proteins.	[Popovic, Jelena; Stanisavljevic, Danijela; Schwirtlich, Marija; Klajn, Andrijana; Marjanovic, Jelena; Stevanovic, Milena] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Human Mol Genet, Belgrade, Serbia	University of Belgrade	Popovic, J (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Human Mol Genet, Belgrade, Serbia.	jpopovic@imgge.bg.ac.rs	Popovic, Jelena/S-6304-2017	Popovic, Jelena/0000-0001-8565-1555; Lazic, Andrijana/0000-0003-4433-7695; Stevanovic, Milena/0000-0003-4286-7334; Stanisavljevic Ninkovic, Danijela/0000-0003-0481-4004; Schwirtlich, Marija/0000-0002-2183-0164	Ministry of Education, Science and Technological Development, Republic of Serbia [173051]	Ministry of Education, Science and Technological Development, Republic of Serbia	This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No 173051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Arsic N, 1998, CYTOGENET CELL GENET, V83, P139, DOI 10.1159/000015149; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Buescher M, 2002, DEVELOPMENT, V129, P4193; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cnaani A, 2007, SEX DEV, V1, P207, DOI 10.1159/000102109; Collignon J, 1996, DEVELOPMENT, V122, P509; Cunningham DD, 2008, INT J DEV BIOL, V52, P999, DOI 10.1387/ijdb.082586dc; Delogu A, 2012, NEURON, V75, P648, DOI 10.1016/j.neuron.2012.06.013; Djurovic J, 2004, BBA-GENE STRUCT EXPR, V1680, P53, DOI 10.1016/j.bbaexp.2004.08.011; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guillemain I, 2000, J COMP NEUROL, V422, P380, DOI 10.1002/1096-9861(20000703)422:3<380::AID-CNE5>3.0.CO;2-C; Hargrave M, 2000, HUM GENET, V106, P432, DOI 10.1007/s004390000266; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kirby PJ, 2002, CYTOGENET GENOME RES, V98, P96, DOI 10.1159/000068539; Kishi M, 2000, DEVELOPMENT, V127, P791; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kuzmichev AN, 2012, CURR BIOL, V22, P1705, DOI 10.1016/j.cub.2012.07.013; Lai HC, 2008, INT J CANCER, V123, P161, DOI 10.1002/ijc.23519; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lin YW, 2013, GYNECOL ONCOL, V131, P174, DOI 10.1016/j.ygyno.2013.07.111; Malas S, 1999, MAMM GENOME, V10, P934, DOI 10.1007/s003359901118; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; Mazzuchelli J, 2011, CHROMOSOME RES, V19, P657, DOI 10.1007/s10577-011-9225-4; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McKimmie C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-26; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Popovic J, 2010, BBA-GENE REGUL MECH, V1799, P411, DOI 10.1016/j.bbagrm.2010.01.002; Popovic J, 2009, J GENET, V88, P15, DOI 10.1007/s12041-009-0003-4; Rex M, 1997, MECH DEVELOP, V66, P39, DOI 10.1016/S0925-4773(97)00086-5; RUDNICKI MA, 1988, MOL CELL BIOL, V8, P406, DOI 10.1128/MCB.8.1.406; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shih YH, 2010, DEVELOPMENT, V137, P2671, DOI 10.1242/dev.054130; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STAINES WA, 1994, NEUROSCIENCE, V58, P735, DOI 10.1016/0306-4522(94)90451-0; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Uchikawa M, 2011, DEV GROWTH DIFFER, V53, P761, DOI 10.1111/j.1440-169X.2011.01286.x; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1	58	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91852	10.1371/journal.pone.0091852	http://dx.doi.org/10.1371/journal.pone.0091852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637840	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100069
J	Radlowski, EC; Conrad, MS; Lezmi, S; Dilger, RN; Sutton, B; Larsen, R; Johnson, RW				Radlowski, Emily C.; Conrad, Matthew S.; Lezmi, Stephane; Dilger, Ryan N.; Sutton, Brad; Larsen, Ryan; Johnson, Rodney W.			A Neonatal Piglet Model for Investigating Brain and Cognitive Development in Small for Gestational Age Human Infants	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; INTRAUTERINE GROWTH-RETARDATION; MAGNETIC-RESONANCE SPECTROSCOPY; ADULTS BORN PRETERM; N-ACETYL-ASPARTATE; CATCH-UP GROWTH; T-MAZE TASK; DEVELOPING-COUNTRIES; IN-VIVO; CHILDREN	The piglet was investigated as a potential model for studying brain and cognitive deficits associated with being born small for gestational age (SGA). Naturally farrowed SGA (0.7-1.0 kg BW) and average for gestational age (AGA, 1.3-1.6 kg BW) piglets were obtained on postnatal day (PD) 2, placed in individual cages, and provided a nutritionally adequate milk replacer diet (285 ml/kg/d). Beginning at PD14, performance in a spatial T-maze task was assessed. At PD28, piglets were anesthetized for magnetic resonance (MR) imaging to assess brain structure (voxel-based morphometry), connectivity (diffusion-tensor imaging) and metabolites in the hippocampus and corpus callosum (proton MR spectroscopy). Piglets born SGA showed compensatory growth such that BW of SGA and AGA piglets was similar (P>0.05), by PD15. Birth weight lffected maze performance, with SGA piglets taking longer to reach criterion than AGA piglets (p<0.01). Total brain volume of SGA and AGA piglets was similar (P<0.05), but overall, SGA piglets had less gray matter than AGA piglets (p<0.01) and tended to have a smaller internal capsule (p = 0.07). Group comparisons between SGA and AGA piglets defined 9 areas (>= 20 clusters) where SGA piglets had less white matter (p<0.01); 2 areas where SGA piglets had more white matter (p<0.01); and 3 areas where SGA piglets had more gray matter (p<0.01). The impact of being born SGA on white matter was supported by a lower (p<0.04) fractional anisotropy value for SGA piglets, suggesting reduced white matter development and connectivity. None of the metabolites measured were different between groups. Collectively, the results show that SGA piglets have spatial learning deficits and abnormal development of white matter. As learning deficits and abnormalities in white matter are common in SGA human infants, the piglet is a tractable translational model that can be used to investigate SGA-associated cognitive deficits and potential interventions.	[Radlowski, Emily C.; Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Radlowski, Emily C.; Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Conrad, Matthew S.; Dilger, Ryan N.; Sutton, Brad; Johnson, Rodney W.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Lezmi, Stephane] Univ Illinois, Dept Vet Pathobiol, Urbana, IL 61801 USA; [Sutton, Brad] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Larsen, Ryan] Univ Illinois, Beckman Inst, Biomed Imaging Ctr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Johnson, RW (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	rwjohn@illinois.edu	Sutton, Bradley P./A-4801-2008	Sutton, Bradley P./0000-0002-8443-0408; Johnson, Rodney/0000-0002-2376-1852; /0000-0003-0661-4321; Dilger, Ryan/0000-0003-2538-2845; Lezmi, Stephane/0000-0002-3412-4058	University of Illinois Center for Nutrition, Learning, and Memory; National Institutes of Health [R01 HD069899]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069899] Funding Source: NIH RePORTER	University of Illinois Center for Nutrition, Learning, and Memory; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the University of Illinois Center for Nutrition, Learning, and Memory, and the National Institutes of Health (R01 HD069899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Abernethy LJ, 2002, ARCH DIS CHILD, V87, P279, DOI 10.1136/adc.87.4.279; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baker-Henningham H, 2009, J NUTR, V139, P1765, DOI 10.3945/jn.109.106294; Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Bhakoo KK, 2000, J NEUROCHEM, V74, P254, DOI 10.1046/j.1471-4159.2000.0740254.x; Bluml S., 2013, MR SPECTROSCOPY PEDI; braham H, 2010, INT J DEV NEUROSCI, V28, P401; BUEKENS P, 1984, J EPIDEMIOL COMMUN H, V38, P79, DOI 10.1136/jech.38.1.79; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; COOPER J E, 1975, Laboratory Animals (London), V9, P329, DOI 10.1258/002367775780957188; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Easton A, 2000, AMYGDALA FUNCTIONAL, P569; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Elmore MRP, 2012, ANIM COGN, V15, P667, DOI 10.1007/s10071-012-0495-9; Fang MR, 2005, NEUROSIGNALS, V14, P222, DOI 10.1159/000088638; Fields RD, 2008, SCI AM, V298, P54; Fitz NF, 2008, BRAIN RES BULL, V77, P356, DOI 10.1016/j.brainresbull.2008.08.016; Ghetti S, 2012, DEV COGN NEUROS-NETH, V2, P381, DOI 10.1016/j.dcn.2012.05.002; Gieling ET, 2011, PEDIAT RES; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gutbrod T, 2000, ARCH DIS CHILD-FETAL, V82, pF208, DOI 10.1136/fn.82.3.F208; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; Ishizu K, 2000, SYNAPSE, V38, P87, DOI 10.1002/1098-2396(200010)38:1<87::AID-SYN10>3.0.CO;2-C; Jakobsen S, 2006, J NUCL MED, V47, P2008; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P4498, DOI 10.1210/jc.2012-1716; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lepomaki V, 2013, PEDIATR RADIOL, V43, P80, DOI 10.1007/s00247-012-2509-9; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Lundgren EM, 2001, PEDIATR RES, V50, P91, DOI 10.1203/00006450-200107000-00017; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Martin E, 2001, ANN NEUROL, V49, P518, DOI 10.1002/ana.102; Mathews T J, 2010, Natl Vital Stat Rep, V58, P1; MATTHEWS PM, 1991, NEUROLOGY, V41, P1251, DOI 10.1212/WNL.41.8.1251; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; Mirandola C, 2011, LEARN INDIVID DIFFER, V21, P206, DOI 10.1016/j.lindif.2010.12.001; Nakagawa H, 1998, AM J NEURORADIOL, V19, P1129; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Provencher SW, 2011, LCMODEL LCMGUI USERS; Roelants-Van Rijn AM, 2004, PEDIATR RES, V56, P285, DOI 10.1203/01.PDR.0000132751.09067.3F; Rosen Y, 2007, NEUROTHERAPEUTICS, V4, P330, DOI 10.1016/j.nurt.2007.04.009; Rosenberg Melanie, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P338, DOI 10.1016/j.cppeds.2007.07.003; SANDSON J, 1984, NEUROPSYCHOLOGIA, V22, P715, DOI 10.1016/0028-3932(84)90098-8; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Sommerfelt K, 2000, ARCH DIS CHILD, V83, P25, DOI 10.1136/adc.83.1.25; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; Stringer KG, 2005, BEHAV NEUROSCI, V119, P946, DOI 10.1037/0735-7044.119.4.946; Thelen E, 2001, BEHAV BRAIN SCI, V24, P1, DOI 10.1017/S0140525X01003910; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Watanabe H, 2001, NEUROIMAGE, V14, P1089, DOI 10.1006/nimg.2001.0910; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Widdowson E, 1971, NEONATOLOGY, V19, P329; Winter JD, 2007, MAGN RESON IMAGING, V25, P1283, DOI 10.1016/j.mri.2007.03.010; Woodcock R. W., 1989, WJ R TESTS ACHIEVEME; WOOTTON R, 1983, J REPROD FERTIL, V69, P659, DOI 10.1530/jrf.0.0690659; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yang PC, 2010, PSYCHIAT RES-NEUROIM, V181, P199, DOI 10.1016/j.pscychresns.2009.10.001	75	60	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91951	10.1371/journal.pone.0091951	http://dx.doi.org/10.1371/journal.pone.0091951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637829	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100088
J	Sivaji, M; Sadasivam, V; Narayanasamy, J; Samuel, S; Fan, CZ				Sivaji, Manigandan; Sadasivam, Vinoth; Narayanasamy, Jayabalan; Samuel, Selvaraj; Fan, Chuanzhu			Detection, Characterization and Evolution of Internal Repeats in Chitinases of Known 3-D Structure	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TANDEM REPEATS; PROTEINS; TOOL	Chitinase proteins have evolved and diversified almost in all organisms ranging from prokaryotes to eukaryotes. During evolution, internal repeats may appear in amino acid sequences of proteins which alter the structural and functional features. Here we deciphered the internal repeats from Chitinase and characterized the structural similarities between them. Out of 24 diverse Chitinase sequences selected, six sequences (2CJL, 2DSK, 2XVP, 2Z37, 3EBV and 3HBE) did not contain any internal repeats of amino acid sequences. Ten sequences contained repeats of length,50, and the remaining 8 sequences contained repeat length between 50 and 100 residues. Two Chitinase sequences, 1ITX and 3SIM, were found to be structurally similar when analyzed using secondary structure of Chitinase from secondary and 3-Dimensional structure database of Protein Data Bank. Internal repeats of 3N17 and 1O6I were also involved in the ligand-binding site of those Chitinase proteins, respectively. Our analyses enhance our understanding towards the identification of structural characteristics of internal repeats in Chitinase proteins.	[Sivaji, Manigandan; Sadasivam, Vinoth; Narayanasamy, Jayabalan] Bharathidasan Univ, Dept Plant Sci, Tiruchirappalli, Tamil Nadu, India; [Narayanasamy, Jayabalan; Fan, Chuanzhu] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Samuel, Selvaraj] Bharathidasan Univ, Dept Bioinformat, Tiruchirappalli, Tamil Nadu, India	Bharathidasan University; Wayne State University; Bharathidasan University	Samuel, S (corresponding author), Bharathidasan Univ, Dept Bioinformat, Tiruchirappalli, Tamil Nadu, India.	selvarajsamuel@gmail.com; cfan@wayne.edu	Samuel, Selvaraj/AAU-2166-2021; Narayanasamy, Jayabalan/J-3133-2016	Narayanasamy, Jayabalan/0000-0001-6358-5470	Wayne State University; Bharathidasan University	Wayne State University; Bharathidasan University	C.F. was supported by start-up fund from Wayne State University. J.N. and S. S. were supported by fund from Bharathidasan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AL, 2008, BIOINFORMATICS, V24, P1536, DOI 10.1093/bioinformatics/btn234; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Fukamizo T, 2003, FOODS FOOD INGREDIEN, V208, P6; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Heringa J, 1998, CURR OPIN STRUC BIOL, V8, P338, DOI 10.1016/S0959-440X(98)80068-7; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Kajava AV, 2012, J STRUCT BIOL, V179, P279, DOI 10.1016/j.jsb.2011.08.009; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; MCLACHLAN AD, 1983, J MOL BIOL, V169, P15, DOI 10.1016/S0022-2836(83)80173-9; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0	24	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91915	10.1371/journal.pone.0091915	http://dx.doi.org/10.1371/journal.pone.0091915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637574	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100080
J	Gould, FDH				Gould, Francois D. H.			To 3D or Not to 3D, That Is the Question: Do 3D Surface Analyses Improve the Ecomorphological Power of the Distal Femur in Placental Mammals?	PLOS ONE			English	Article							DISCRIMINANT FUNCTION-ANALYSIS; FUNCTIONAL-MORPHOLOGY; LOCOMOTOR BEHAVIOR; HINDLIMB; CARNIVORANS; EVOLUTION; ANATOMY; RATIOS; CORPUS; SIZE	Improvements in three-dimensional imaging technologies have renewed interest in the study of functional and ecological morphology. Quantitative approaches to shape analysis are used increasingly to study form-function relationships. These methods are computationally intensive, technically demanding, and time-consuming, which may limit sampling potential. There have been few side-by-side comparisons of the effectiveness of such approaches relative to more traditional analyses using linear measurements and ratios. Morphological variation in the distal femur of mammals has been shown to reflect differences in locomotor modes across clades. Thus I tested whether a geometric morphometric analysis of surface shape was superior to a multivariate analysis of ratios for describing ecomorphological patterns in distal femoral variation. A sample of 164 mammalian specimens from 44 genera was assembled. Each genus was assigned to one of six locomotor categories. The same hypotheses were tested using two methods. Six linear measurements of the distal femur were taken with calipers, from which four ratios were calculated. A 3D model was generated with a laser scanner, and analyzed using three dimensional geometric morphometrics. Locomotor category significantly predicted variation in distal femoral morphology in both analyses. Effect size was larger in the geometric morphometric analysis than in the analysis of ratios. Ordination reveals a similar pattern with arboreal and cursorial taxa as extremes on a continuum of morphologies in both analyses. Discriminant functions calculated from the geometric morphometric analysis were more accurate than those calculated from ratios. Both analysis of ratios and geometric morphometric surface analysis reveal similar, biologically meaningful relationships between distal femoral shape and locomotor mode. The functional signal from the morphology is slightly higher in the geometric morphometric analysis. The practical costs of conducting these sorts of analyses should be weighed against potentially slight increases in power when designing protocols for ecomorphological studies.	[Gould, Francois D. H.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD USA	Johns Hopkins University	Gould, FDH (corresponding author), Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA.	fgould@neomed.edu			Center for Functional Anatomy and Evolution at Johns Hopkins University	Center for Functional Anatomy and Evolution at Johns Hopkins University	Funding for this work was provided by the Center for Functional Anatomy and Evolution at Johns Hopkins University while the author was a graduate student there. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1984, ORDERS FAMILIES RECE; Andersson K, 2004, ZOOL J LINN SOC-LOND, V142, P91, DOI 10.1111/j.1096-3642.2004.00129.x; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; ATCHLEY WR, 1976, SYST ZOOL, V25, P137, DOI 10.2307/2412740; BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; BANFIELD A W F, 1974, P438; Beisiegel Beatriz de Mello, 2005, Mammalian Species, P1, DOI 10.1644/783.1; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; BIKNEVICIUS AR, 1993, J MAMMAL, V74, P95, DOI 10.2307/1381908; Bonnan MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075216; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Curran SC, 2012, J ARCHAEOL SCI, V39, P1172, DOI 10.1016/j.jas.2011.12.028; De Groote I, 2011, AM J PHYS ANTHROPOL, V144, P498, DOI 10.1002/ajpa.21467; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Dunn RH, 2007, J VERTEBR PALEONTOL, V27, P987, DOI 10.1671/0272-4634(2007)27[987:SMALBO]2.0.CO;2; Eisenberg J., 1989, MAMMALS NEOTROPICS; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Fabre AC, 2013, J EVOLUTION BIOL, V26, P1521, DOI 10.1111/jeb.12161; FLETCHER JM, 1978, CORTEX, V14, P564, DOI 10.1016/S0010-9452(78)80031-8; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; GARLAND T, 1993, J ZOOL, V229, P133, DOI 10.1111/j.1469-7998.1993.tb02626.x; Gittleman JL., 1989, SPRINGER, DOI [10.1007/978-1-4757-4716-4, DOI 10.1007/978-1-4757-4716-4]; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Harcourt-Smith William E. H., 2008, P373, DOI 10.1007/978-1-4020-6997-0_17; Janis CM, 2012, J VERTEBR PALEONTOL, V32, P433, DOI 10.1080/02724634.2012.635737; KAPPELMAN J, 1988, J MORPHOL, V198, P119, DOI 10.1002/jmor.1051980111; Kingdon J, 1971, E AFRICAN MAMMALS AT; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kovarovic K, 2011, J ARCHAEOL SCI, V38, P3006, DOI 10.1016/j.jas.2011.06.028; Lariviere Serge, 2002, Mammalian Species, P1; Leopold AS., 1959, WILDLIFE MEXICO GAME, DOI 10.1525/9780520326422; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; MacLeod N, 2009, NEW SYSTEMATICS; Malda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057683; POGLAYEN-NEUWALL I, 1988, Mammalian Species, P1, DOI 10.2307/3504321; Polly PD, 2011, J VERTEBR PALEONTOL, V31, P175; Polly P. David, 2008, P167, DOI 10.1007/978-1-4020-6997-0_9; Prater S.H., 1965, BOOK INDIAN ANIMALS; Presley S.J., 2000, MAMM SPECIES, V636, P1, DOI [DOI 10.1644/1545-1410(2000)6362.0.CO;2, 10.2307/0.636.1, DOI 10.1644/1545-1410(2000)636<0001:EB>2.0.CO;2]; R Core Team, 2021, R LANGUAGE ENV STAT; Ricklefs R. E., 1994, ECOLOGICAL MORPHOLOG; Roberts MS, 1984, MAMMALIAN SPECIES; Salton Justine A., 2008, P51, DOI 10.1007/978-1-4020-6997-0_4; Sargis EJ, 2002, J MORPHOL, V254, P149, DOI 10.1002/jmor.10025; Smith RJ, 2005, CURR ANTHROPOL, V46, P249, DOI 10.1086/427117; SMYTHE N, 1970, AM NAT, V104, P491, DOI 10.1086/282684; Stein BR, 1997, J ZOOL, V242, P185, DOI 10.1111/j.1469-7998.1997.tb02939.x; Stroganov S.U., 1969, CARNIVOROUS MAMMALS; TAYLOR ME, 1976, J MORPHOL, V148, P227, DOI 10.1002/jmor.1051480208; Tocheri MW, 2005, J HUM EVOL, V49, P570, DOI 10.1016/j.jhevol.2005.06.005; Tocheri MW, 2009, ADV IMAGING BIOL MED, P85, DOI DOI 10.1007/978-3-540-68993-5_4; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Walker E. P., 1991, MAMMALS OF THE WORLD; Weber Gerhard W., 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P69, DOI 10.2114/jpa.20.69; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; White JW, 2007, MAR ECOL PROG SER, V329, P301, DOI 10.3354/meps329301; White Jennifer L., 1993, Journal of Vertebrate Paleontology, V13, P230; Wood AR, 2011, J MAMM EVOL, V18, P1, DOI 10.1007/s10914-010-9145-7	62	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91719	10.1371/journal.pone.0091719	http://dx.doi.org/10.1371/journal.pone.0091719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633081	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400082
J	Jones, DL; Simfukwe, P; Hill, PW; Mills, RTE; Emmett, BA				Jones, David L.; Simfukwe, Paul; Hill, Paul W.; Mills, Robert T. E.; Emmett, Bridget A.			Evaluation of Dissolved Organic Carbon as a Soil Quality Indicator in National Monitoring Schemes	PLOS ONE			English	Article							ULTRAVIOLET ABSORBENCY; UV-ABSORBENCY; MATTER; WATER; DOC; COUNTRYSIDE; ABSORPTION; FOLIN	Background: Monitoring the properties of dissolved organic carbon (DOC) in soil water is frequently used to evaluate changes in soil quality and to explain shifts in freshwater ecosystem functioning. Methods: Using >700 individual soils (0-15 cm) collected from a 209,331 km(2) area we evaluated the relationship between soil classification (7 major soil types) or vegetation cover (8 dominant classes, e. g. cropland, grassland, forest) and the absorbance properties (254 and 400 nm), DOC quantity and quality (SUVA, total soluble phenolics) of soil water. Results: Overall, a good correlation (r(2) = 0.58) was apparent between soil water absorbance and DOC concentration across the diverse range of soil types tested. In contrast, both DOC and the absorbance properties of soil water provided a poor predictor of SUVA or soluble phenolics which we used as a measure of humic substance concentration. Significant overlap in the measured ranges for UV absorbance, DOC, phenolic content and especially SUVA of soil water were apparent between the 8 vegetation and 7 soil classes. A number of significant differences, however, were apparent within these populations with total soluble phenolics giving the greatest statistical separation between both soil and vegetation groups. Conclusions: We conclude that the quality of DOC rather than its quantity provides a more useful measure of soil quality in large scale surveys.	[Jones, David L.; Simfukwe, Paul; Hill, Paul W.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Mills, Robert T. E.] Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, Lab Ecol Syst ECOS, Lausanne, Switzerland; [Emmett, Bridget A.] Environm Ctr Wales, Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales	Bangor University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institute for Forest, Snow & Landscape Research; UK Centre for Ecology & Hydrology (UKCEH)	Jones, DL (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	d.jones@bangor.ac.uk	Jones, Davey/AAD-6037-2020; Jones, Davey L/C-7411-2011; jones, davey/AAN-5606-2020; Emmett, Bridget A/D-6199-2011	Jones, Davey/0000-0002-1482-4209; Jones, Davey L/0000-0002-1482-4209; Emmett, Bridget A/0000-0002-2713-4389	United Kingdom Department for Environment, Food and Rural Affairs; Natural Environment Research Council [ceh010010] Funding Source: researchfish	United Kingdom Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the United Kingdom Department for Environment, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amery F, 2008, EUR J SOIL SCI, V59, P1087, DOI 10.1111/j.1365-2389.2008.01078.x; [Anonymous], 2006, GUID SOIL DESCR; Avery B.W., 1990, SOILS BRIT ISLES; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Brandstetter A, 1996, Z PFLANZ BODENKUNDE, V159, P605, DOI 10.1002/jpln.1996.3581590612; Bunce R. G. H., 1999, VEGETATION BRIT COUN; Camarero L, 2009, FRESHWATER BIOL, V54, P2452, DOI 10.1111/j.1365-2427.2009.02296.x; Clutterbuck B, 2010, SCI TOTAL ENVIRON, V408, P6179, DOI 10.1016/j.scitotenv.2010.08.038; Dilling J, 2002, WATER RES, V36, P5037, DOI 10.1016/S0043-1354(02)00365-2; Dittman JA, 2009, ENVIRON POLLUT, V157, P1953, DOI 10.1016/j.envpol.2009.01.031; DOUGAN WK, 1974, ANALYST, V99, P413, DOI 10.1039/an9749900413; EDWARDS AC, 1987, WATER RES, V21, P49, DOI 10.1016/0043-1354(87)90098-4; Emmett B.A., 2010, 907 CS CTR EC HYDR; Emmett BA, 2008, 307 NERC CS CTR EC H; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Filep T, 2008, CEREAL RES COMMUN, V36, P667; Hansson K, 2010, SOIL BIOL BIOCHEM, V42, P178, DOI 10.1016/j.soilbio.2009.10.013; Izbicki JA, 2007, ENVIRON CHEM, V4, P35, DOI 10.1071/EN06046; Jaffrain J, 2007, SOIL SCI SOC AM J, V71, P1851, DOI 10.2136/sssaj2006.0202; Lawrence GB, 2013, J ENVIRON QUAL, V42, P623, DOI 10.2134/jeq2012.0378; Matilainen A, 2011, CHEMOSPHERE, V83, P1431, DOI 10.1016/j.chemosphere.2011.01.018; MATTSON JS, 1974, LIMNOL OCEANOGR, V19, P530, DOI 10.4319/lo.1974.19.3.0530; Norton LR, 2012, J ENVIRON MANAGE, V113, P117, DOI 10.1016/j.jenvman.2012.07.030; O'Neill KP, 2005, ENVIRON MONIT ASSESS, V107, P59, DOI 10.1007/s10661-005-2144-0; Ohno T, 1998, J ENVIRON QUAL, V27, P776, DOI 10.2134/jeq1998.00472425002700040008x; Osborne DM, 2013, RAPID COMMUN MASS SP, V27, P851, DOI 10.1002/rcm.6521; Reynolds B, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0114; Rowe EC, 2012, SCI TOTAL ENVIRON, V434, P62, DOI 10.1016/j.scitotenv.2011.12.027; SHARMA OK, 1966, ANAL BIOCHEM, V14, P11, DOI 10.1016/0003-2697(66)90050-9; Smart SM, 2003, J ENVIRON MANAGE, V67, P239, DOI 10.1016/S0301-4797(02)00177-9; Steinberg CEW, 2004, ENVIRON TOXICOL, V19, P409, DOI 10.1002/tox.20019; THORN KA, 1989, 894196 US GEOL SURV; Tipping E, 2009, ENVIRON CHEM, V6, P472, DOI 10.1071/EN09090; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; WHEELER JR, 1977, LIMNOL OCEANOGR, V22, P573, DOI 10.4319/lo.1977.22.3.0573; Zhang Q, 2009, J HAZARD MATER, V172, P880, DOI 10.1016/j.jhazmat.2009.07.068	37	27	32	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90882	10.1371/journal.pone.0090882	http://dx.doi.org/10.1371/journal.pone.0090882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633085	Green Published, Green Accepted, gold			2022-12-27	WOS:000332858400023
J	Ketabchi, A; Komm, K; Miles-Rossouw, M; Cassani, DAD; Variola, F				Ketabchi, Amirhossein; Komm, Kristopher; Miles-Rossouw, Malaika; Cassani, Davide A. D.; Variola, Fabio			Nanoporous Titanium Surfaces for Sustained Elution of Proteins and Antibiotics	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; CONTROLLED DRUG-DELIVERY; DELAYED RELEASE; TIO2 NANOTUBES; ADSORPTION; TOPOGRAPHY; VANCOMYCIN; ATTACHMENT; VIBRATIONS; DIFFUSION	Current medically relevant metals for prosthetic reconstructions enjoy a relatively good success rate, but their performance drops significantly in patients with compromised health status, and post-surgical infections still remain an important challenge. To address these problems, different nanotechnology-based strategies have been exploited to create implantable metals with an enhanced bioactivity and antibacterial capacities. Among these, oxidative nanopatterning has emerged as a very effective approach to engender nanoporous surfaces that stimulate and guide the activity of adhering cells. The resulting nanoporosity is also attractive because it offers nanoconfined volumes that can be exploited to load bioactive compounds and modulate their release over time. Such extended elution is needed since a single exposure to growth factors and/or antibiotics, for instance, may not be adequate to further sustain bone regeneration and/or to counteract bacterial colonization. In this article, we assessed the capacities of nanoporous titanium surfaces generated by oxidative nanopatterning to provide controlled and sustained elution of proteins and antibiotic molecules. To this end, we have selected bovine serum albumin (BSA) and vancomycin to reflect commonly used compounds, and investigated their adsorption and elution by Fourier-transform infrared (FT-IR) and ultraviolet-visible (UV-VIS) spectroscopy. Our results demonstrate that while the elution of albumin is not significantly affected by the nanoporosity, in the case of vancomycin, nanoporous surfaces provided an extended release. These findings were successively correlated to the establishment of interactions with the surface and physical-entrapment effects exerted by the nanopores, ultimately highlighting their synergistic contribution to the release profiles and thus their importance in the design of nanostructured eluting platforms for applications in medicine.	[Ketabchi, Amirhossein; Komm, Kristopher; Miles-Rossouw, Malaika; Cassani, Davide A. D.; Variola, Fabio] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada; [Komm, Kristopher; Miles-Rossouw, Malaika] Univ Ottawa, Dept Chem & Biol Engn, Ottawa, ON K1N 6N5, Canada; [Cassani, Davide A. D.] Politecn Milan, Dept Chem Mat & Chem Engn, I-20133 Milan, Italy; [Variola, Fabio] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa; Polytechnic University of Milan; University of Ottawa	Variola, F (corresponding author), Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.	fabio.variola@uottawa.ca		Variola, Fabio/0000-0002-5519-6915	uOttawa Faculty of Engineering start up funds; Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI); Ontario Ministry of Research and Innovation (MRI)	uOttawa Faculty of Engineering start up funds; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Research and Innovation (MRI)(Ministry of Research and Innovation, Ontario)	uOttawa Faculty of Engineering start up funds; Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC); Leaders Opportunity Fund from the Canada Foundation for Innovation (CFI); and the Ontario Ministry of Research and Innovation (MRI). The funding agencies did not participate in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They provided money used to pay for materials, students, and equipment.	Aucoin HR, 2013, POLYMERS-BASEL, V5, P1241, DOI 10.3390/polym5041241; Aw MS, 2012, CHEM COMMUN, V48, P3348, DOI 10.1039/c2cc17690d; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Ben Jazia D, 2011, COLLOID SURFACE A, V384, P643, DOI 10.1016/j.colsurfa.2011.05.033; Bouhekka A, 2012, ACTA CHIM SLOV, V59, P841; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Cauda V, 2008, J MATER CHEM, V18, P5888, DOI 10.1039/b805395b; Dash S, 2010, ACTA POL PHARM, V67, P217; de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955; Ferrer ML, 2001, BIOPHYS J, V80, P2422, DOI 10.1016/S0006-3495(01)76211-X; Frutos P, 2002, BIOMATERIALS, V23, P3787, DOI 10.1016/S0142-9612(02)00028-5; Gonzalez B, 2008, CHEM MATER, V20, P4826, DOI 10.1021/cm703568k; Grdadolink J, 2001, BIOPOLYMERS, V62, P40, DOI 10.1002/1097-0282(2001)62:1<40::AID-BIP60>3.0.CO;2-C; Gulati K, 2012, ACTA BIOMATER, V8, P449, DOI 10.1016/j.actbio.2011.09.004; Gultepe E, 2010, SMALL, V6, P213, DOI 10.1002/smll.200901736; Gurzawska K, 2012, J BIOMED NANOTECHNOL, V8, P1012, DOI 10.1166/jbn.2012.1457; Haris PI, 2010, BIOCHEM SOC T, V38, P940, DOI 10.1042/BST0380940; Huang BX, 2004, J AM SOC MASS SPECTR, V15, P1237, DOI 10.1016/j.jasms.2004.05.004; Ketonis C, 2009, CLIN ORTHOP RELAT R, V467, P1678, DOI 10.1007/s11999-009-0828-4; Kim MH, 2011, J NANOSCI NANOTECHNO, V11, P1656, DOI 10.1166/jnn.2011.3303; Kupser P, 2010, J AM CHEM SOC, V132, P2085, DOI 10.1021/ja909842j; LENK TJ, 1989, J BIOMED MATER RES, V23, P549, DOI 10.1002/jbm.820230603; Lin Y, 2013, LUMINESCENC IN PRESS; Mavropoulos E, 2011, COLLOID SURFACE B, V83, P1, DOI 10.1016/j.colsurfb.2010.10.025; Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d; Peng LL, 2009, NANO LETT, V9, P1932, DOI 10.1021/nl9001052; Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412; Poully JC, 2010, PHYS CHEM CHEM PHYS, V12, P3606, DOI 10.1039/b923787a; Richert L, 2008, ADV MATER, V15, P1; Richert L, 2010, SURF SCI, V604, P1445, DOI 10.1016/j.susc.2010.05.007; RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6; RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4; Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601; Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374; Sahoo S., 2012, J CHEM PHARM RES, V4, P2268; SALTER CJ, 1995, J CHEM SOC PERK T 2, P2203, DOI 10.1039/p29950002203; Swanson TE, 2011, J BIOMED MATER RES A, V97A, P167, DOI 10.1002/jbm.a.33043; Tao CH, 2011, J NANOSCI NANOTECHNO, V11, P5068, DOI 10.1166/jnn.2011.4144; Temenoff J. S., 2008, BIOMATERIALS INTERSE, V1st; Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040; Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e; Variola F, 2009, APPL SPECTROSC, V63, P1187, DOI 10.1366/000370209789553129; Variola F, 2009, ADV ENG MATER, V11, pB227, DOI 10.1002/adem.200900122; Vetrone F, 2008, NANO LETT; Wan ACA, 2010, ADV DRUG DELIVER REV, V62, P731, DOI 10.1016/j.addr.2010.02.002; Yang L, 2009, EXPERT OPIN DRUG DEL, V6, P851, DOI 10.1517/17425240903044935; Yi JH, 2006, SURF SCI, V600, P4613, DOI 10.1016/j.susc.2006.07.053; Yoshikawa H, 2012, INT J BIOL MACROMOL, V50, P1286, DOI 10.1016/j.ijbiomac.2012.03.014; Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7; Zhou J, 2012, J BIOMED MATER RES A, V100A, P2295, DOI 10.1002/jbm.a.34170; Zhou JA, 2011, J MICROENCAPSUL, V28, P99, DOI 10.3109/02652048.2010.534824	53	21	22	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92080	10.1371/journal.pone.0092080	http://dx.doi.org/10.1371/journal.pone.0092080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633020	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400140
J	Sagulenko, E; Morgan, GP; Webb, RI; Yee, B; Lee, KC; Fuerst, JA				Sagulenko, Evgeny; Morgan, Garry P.; Webb, Richard I.; Yee, Benjamin; Lee, Kuo-Chang; Fuerst, John A.			Structural Studies of Planctomycete Gemmata obscuriglobus Support Cell Compartmentalisation in a Bacterium	PLOS ONE			English	Article							ESCHERICHIA-COLI; IGNICOCCUS-HOSPITALIS; BACILLUS-SUBTILIS; OUTER-MEMBRANE; RIBOSOMAL-RNA; SURFACE-LAYER; PROTEIN; DIVISION; EVOLUTION; FTSK	Members of phylum Planctomycetes have been proposed to possess atypical cell organisation for the Bacteria, having a structure of sectioned cells consistent with internal compartments surrounded by membranes. Here via electron tomography we confirm the presence of compartments in the planctomycete Gemmata obscuriglobus cells. Resulting 3-D models for the most prominent structures, nuclear body and riboplasm, demonstrate their entirely membrane - enclosed nature. Immunogold localization of the FtsK protein also supports the internal organisation of G. obscuriglobus cells and their unique mechanism of cell division. We discuss how these new data expand our knowledge on bacterial cell biology and suggest evolutionary consequences of the findings.	[Sagulenko, Evgeny; Yee, Benjamin; Lee, Kuo-Chang; Fuerst, John A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Morgan, Garry P.; Webb, Richard I.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Sagulenko, E (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	e.sagulenko@uq.edu.au; j.fuerst@uq.edu.au	Fuerst, John/I-8649-2012	Fuerst, John/0000-0002-6451-8533	Australian Research Council (ARC) [DP0881485]; Dow Agrosciences; University of Queensland	Australian Research Council (ARC)(Australian Research Council); Dow Agrosciences; University of Queensland(University of Queensland)	The work was supported by the Australian Research Council (ARC) discovery grant number DP0881485. A PhD scholarship of B.Y. was supported by Dow Agrosciences, and that of K-C.L. by the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2013, J CELL SCI; Acehan D, 2014, J CELL SCI, V127, P277, DOI 10.1242/jcs.137596; Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Amat F, 2010, J BACTERIOL, V192, P5855, DOI 10.1128/JB.00747-10; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bernander R, 2010, CURR OPIN MICROBIOL, V13, P747, DOI 10.1016/j.mib.2010.10.005; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bisicchia P, 2013, MBIO, V4; Dacks JB, 2008, P NATL ACAD SCI USA, V105, P588, DOI 10.1073/pnas.0707318105; Devos DP, 2014, ANTON LEEUW INT J G, V105, P271, DOI 10.1007/s10482-013-0087-y; Devos DP, 2014, TRENDS MICROBIOL, V22, P14, DOI 10.1016/j.tim.2013.10.008; Devos DP, 2013, TRENDS MICROBIOL; Devos DP, 2013, A VANLEEUWENHOEK; Dubarry N, 2010, EMBO J, V29, P597, DOI 10.1038/emboj.2009.381; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; Forterre P, 2010, P NATL ACAD SCI USA, V107, P12739, DOI 10.1073/pnas.1007720107; Fuerst JA, 2005, ANNU REV MICROBIOL, V59, P299, DOI 10.1146/annurev.micro.59.030804.121258; FUERST JA, 1991, P NATL ACAD SCI USA, V88, P8184, DOI 10.1073/pnas.88.18.8184; Fuerst JA, 2014, BBA-MOL CELL RES, V1843, P1732, DOI 10.1016/j.bbamcr.2013.10.002; Fuerst JA, 2013, ANTON LEEUW INT J G, V104, P451, DOI 10.1007/s10482-013-9986-1; Fuerst JA, 2013, J MOL MICROB BIOTECH, V23, P95, DOI 10.1159/000346544; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Fuerst John A, 2010, Commun Integr Biol, V3, P572, DOI 10.4161/cib.3.6.13061; GIOVANNONI SJ, 1987, J BACTERIOL, V169, P2702, DOI 10.1128/jb.169.6.2702-2707.1987; Goley ED, 2011, MOL MICROBIOL, V80, P1680, DOI 10.1111/j.1365-2958.2011.07677.x; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; HOBOT JA, 1984, J BACTERIOL, V160, P143, DOI 10.1128/JB.160.1.143-152.1984; Huber H, 2012, ANTON LEEUW INT J G, V102, P203, DOI 10.1007/s10482-012-9748-5; Jogler C, 2011, APPL ENVIRON MICROB, V77, P5826, DOI 10.1128/AEM.05132-11; Kuper U, 2010, P NATL ACAD SCI USA, V107, P3152, DOI 10.1073/pnas.0911711107; Kuznetsov YG, 2013, J VIROL, V87, P11200, DOI 10.1128/JVI.01372-13; Lee KC, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-4; LIESACK W, 1986, ARCH MICROBIOL, V145, P361, DOI 10.1007/BF00470872; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lindsay MR, 1997, MICROBIOL-UK, V143, P739, DOI 10.1099/00221287-143-3-739; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Neumann N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013241; Pilhofer M, 2008, J BACTERIOL, V190, P3192, DOI 10.1128/JB.01797-07; Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480; Santarella-Mellwig R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001565; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; SCHLESNER H, 1994, SYST APPL MICROBIOL, V17, P135, DOI 10.1016/S0723-2020(11)80042-1; Sherratt D, 2013, EMBO J, V32, P1208, DOI 10.1038/emboj.2013.84; Speth DR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00304; STACKEBRANDT E, 1986, FEMS MICROBIOL LETT, V37, P289, DOI 10.1016/0378-1097(86)90421-0; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; van Teeseling MCF, 2014, J BACTERIOL, V196, P80, DOI 10.1128/JB.00988-13; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Wang SCE, 2006, J BACTERIOL, V188, P1497, DOI 10.1128/JB.188.4.1497-1508.2006; Yee B, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00326	53	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91344	10.1371/journal.pone.0091344	http://dx.doi.org/10.1371/journal.pone.0091344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632833	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400055
J	Sun, L; Jin, YQ; Shen, C; Qi, H; Chu, P; Yin, QQ; Li, JQ; Tian, JL; Jiao, WW; Xiao, J; Shen, AD				Sun, Lin; Jin, Ya-qiong; Shen, Chen; Qi, Hui; Chu, Ping; Yin, Qing-qin; Li, Jie-qiong; Tian, Jian-ling; Jiao, Wei-wei; Xiao, Jing; Shen, A-dong			Genetic Contribution of CISH Promoter Polymorphisms to Susceptibility to Tuberculosis in Chinese Children	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; T-CELLS; SH2-CONTAINING PROTEIN; SOUTHEAST IRAN; SOCS PROTEINS; CYTOKINE; INTERLEUKIN-10; ASSOCIATION; INFLAMMATION; EXPRESSION	Tuberculosis (TB) is the leading cause of death due to an infectious disease worldwide, particularly in developing countries. A series of candidate genes have been suggested to be associated with development of TB disease. Among them, the human Cytokine-inducible Src homology 2(SH2) domain protein (CISH) gene has been very recently reported to be involved in T cell activation and differentiation in response to Mycobacterium tuberculosis infection. Here, we studied the association between CISH promoter polymorphisms and pediatric TB. A case-control study enrolled 352 TB patients and 527 healthy controls, who were of Han Chinese ethnicity and aged from 0.2 to 18 years. CISH gene promoter SNPs rs414171, rs622502 and rs809451 were genotyped in all subjects and transcriptional activity, mRNA level, and plasma cytokine level of subjects with different genotypes were further examined. Carriers with rs414171TT homozygotes and rs809451GC heterozygotes had a 1.78-fold (95% CI, 1.16-2.74) and 1.86-fold (95% CI, 1.26-2.74) excess risk of developing TB compared to those with wild-type genotypes. A greater risk of TB disease was observed in population carrying C-809451-T-414171-C-622502 haplotype (OR 3.66, 95% CI: 2.12-6.32). The G(-809451)-A(-414171)-C-622502-containing CISH promoter drove a 5.43-fold increased reporter expression compared to the C-809451-T-(414171)-C-622502-containing counterpart in Hela cell lines (P = 0.0009). PBMCs carrying rs414171TT homozygotes and rs809451GC heterozygotes showed a reduced CISH mRNA level compared to cells carrying wild type genotypes. Individuals with the rs414171TT genotype had significantly increased IL-12p40 and IL-10 production. In conclusion, CISH promoter rs414171 and rs809451 polymorphisms may play a vital role in mediating individual susceptibility to tuberculosis.	[Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children, Beijing, Peoples R China; Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, AD (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children, Beijing, Peoples R China.	shenad16@hotmail.com	shen, chen/AAC-2458-2020; 孙, 琳/HGE-6966-2022	Jin, Yaqiong/0000-0002-9318-6531	National Natural Science Foundation of China [81201263]; Beijing Natural Science Foundation [7121007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (No. 81201263) and Beijing Natural Science Foundation (No. 7121007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Bahari G, 2013, GENET MOL RES, V12, P160, DOI 10.4238/2013.January.24.8; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Endo TA, 1997, NATURE, V387, P924; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Gunsten S, 2009, IMMUNOLOGY, V126, P500, DOI 10.1111/j.1365-2567.2008.02923.x; Hanta I, 2012, BRATISL MED J, V113, P657, DOI 10.4149/BLL_2012_148; Hashimoto K, 2009, VIROLOGY, V391, P162, DOI 10.1016/j.virol.2009.06.026; Hu YM, 2002, TXB PEDIAT, P970; Ikeda T, 2002, J LEUKOCYTE BIOL, V72, P1198; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Kouhpayeh HR, 2012, GENET MOL RES, V11, P1075, DOI 10.4238/2012.April.27.6; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; MarfaingKoka A, 1996, INT IMMUNOL, V8, P1587, DOI 10.1093/intimm/8.10.1587; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Meenakshi P, 2013, SCAND J IMMUNOL, V78, P92, DOI 10.1111/sji.12055; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nolan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059461; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Shen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067816; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tong HV, 2012, IMMUNOGENETICS, V64, P261, DOI 10.1007/s00251-011-0584-y; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uchida K, 1997, CYTOGENET CELL GENET, V78, P209, DOI 10.1159/000134658; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao L, 2013, CELL BIOCH BIOPHYS	38	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92020	10.1371/journal.pone.0092020	http://dx.doi.org/10.1371/journal.pone.0092020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632804	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400132
J	Vera, NPM; Schmidt, R; Langer, K; Zlatev, I; Wronski, R; Auer, E; Havas, D; Windisch, M; von Briesen, H; Wagner, S; Stab, J; Deutsch, M; Pietrzik, C; Fazekas, F; Ropele, S				Vera, Naira P. Martinez; Schmidt, Reinhold; Langer, Klaus; Zlatev, Iavor; Wronski, Robert; Auer, Ewald; Havas, Daniel; Windisch, Manfred; von Briesen, Hagen; Wagner, Sylvia; Stab, Julia; Deutsch, Motti; Pietrzik, Claus; Fazekas, Franz; Ropele, Stefan			Tracking of Magnetite Labeled Nanoparticles in the Rat Brain Using MRI	PLOS ONE			English	Article							SATURATION-TRANSFER CEST; IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; ENGINEERED NANOPARTICLES; ALBUMIN NANOPARTICLES; HSA-NANOPARTICLES; NERVOUS-SYSTEM; AGENTS; FLUORESCENCE; CONTRAST	This study was performed to explore the feasibility of tracing nanoparticles for drug transport in the healthy rat brain with a clinical MRI scanner. Phantom studies were performed to assess the R-1 (= 1/T-1) relaxivity of different magnetically labeled nanoparticle (MLNP) formulations that were based on biodegradable human serum albumin and that were labeled with magnetite of different size. In vivo MRI measurements in 26 rats were done at 3T to study the effect and dynamics of MLNP uptake in the rat brain and body. In the brain, MLNPs induced T-1 changes were quantitatively assessed by T-1 relaxation time mapping in vivo and compared to post-mortem results from fluorescence imaging. Following intravenous injection of MLNPs, a visible MLNP uptake was seen in the liver and spleen while no visual effect was seen in the brain. However a histogram analysis of T-1 changes in the brain demonstrated global and diffuse presence of MLNPs. The magnitude of these T-1 changes scaled with post-mortem fluorescence intensity. This study demonstrates the feasibility of tracking even small amounts of magnetite labeled NPs with a sensitive histogram technique in the brain of a living rodent.	[Vera, Naira P. Martinez; Schmidt, Reinhold; Fazekas, Franz; Ropele, Stefan] Med Univ Graz, Dept Neurol, Graz, Austria; [Langer, Klaus; Zlatev, Iavor] Univ Munster, Inst Pharmaceut Technol & Biopharm, D-48149 Munster, Germany; [Wronski, Robert; Auer, Ewald; Havas, Daniel; Windisch, Manfred] JSW Live Sci GmbH, Grambach, Austria; [von Briesen, Hagen; Wagner, Sylvia; Stab, Julia] Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, St Ingbert, Germany; [Deutsch, Motti] Bar Ilan Univ, Schottenstein Ctr Res & Technol Cellome, Dept Phys, Ramat Gan, Israel; [Pietrzik, Claus] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55122 Mainz, Germany	Medical University of Graz; University of Munster; Fraunhofer Gesellschaft; Bar Ilan University; Johannes Gutenberg University of Mainz	Ropele, S (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	stefan.ropele@medunigraz.at	Schmidt, Reinhold/E-1137-2014	Langer, Klaus/0000-0002-0203-7478; Wagner, Sylvia/0000-0001-7922-977X	ERA-NET Neuron Call "Development and advancement in methods and technologies towards understanding of brain diseases"; Austrian Science Fund (FWF) [I453-B09, I454-B09]; Deutsches Bundesministerium fur Bildung und Forschung [01EW1009, 01EW1010]; Israel Ministry of Health [6694]; Austrian Science Fund (FWF) [I 453] Funding Source: researchfish	ERA-NET Neuron Call "Development and advancement in methods and technologies towards understanding of brain diseases"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsches Bundesministerium fur Bildung und Forschung; Israel Ministry of Health; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This collaborative work resulted from the NanoBrain project which was funded by the ERA-NET Neuron Call "Development and advancement in methods and technologies towards understanding of brain diseases". Grant sponsors: Austrian Science Fund (FWF): I453-B09 and I454-B09, Deutsches Bundesministerium fur Bildung und Forschung: 01EW1009 and 01EW1010, and Israel Ministry of Health: 6694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqudami A, 2007, PLASMONICS, V2, P5, DOI 10.1007/s11468-006-9019-2; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Birkl C, 2014, MAGN RESON MED, V71, P1575, DOI 10.1002/mrm.24799; Brisset JC, 2011, MOL IMAGING BIOL, V13, P672, DOI 10.1007/s11307-010-0402-1; Castelli DD, 2013, NMR BIOMED, V26, P839, DOI 10.1002/nbm.2974; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; GhoshMitra S, 2012, ADV DRUG DELIVER REV, V64, P110, DOI 10.1016/j.addr.2011.12.013; Gossuin Y, 2009, WIRES NANOMED NANOBI, V1, P299, DOI 10.1002/wnan.36; Herrmann KH, 2012, MAGN RESON MATER PHY, V25, P233, DOI 10.1007/s10334-011-0284-5; Huang J, 2012, THERANOSTICS, V2, P86, DOI 10.7150/thno.4006; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; Low K, 2011, NANOMED-NANOTECHNOL, V7, P454, DOI 10.1016/j.nano.2010.12.003; Marrache S, 2013, CURR MED CHEM, V20, P3500, DOI 10.2174/0929867311320280007; McMahon MT, 2006, MAGN RESON MED, V55, P836, DOI 10.1002/mrm.20818; Naahidi S, 2013, J CONTROL RELEASE, V166, P182, DOI 10.1016/j.jconrel.2012.12.013; Pelaz B, 2013, SMALL, V9, P1573, DOI 10.1002/smll.201201229; Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091; Re F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/7/073001; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Roohi F, 2012, INT J NANOMED, V7, P4447, DOI 10.2147/IJN.S33120; Rumenapp C, 2012, PHARM RES-DORDR, V29, P1165, DOI 10.1007/s11095-012-0711-y; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Silva GA, 2010, ANN NY ACAD SCI, V1199, P221, DOI 10.1111/j.1749-6632.2009.05361.x; Siwach OP, 2008, MATER SCI ENG B-ADV, V149, P99, DOI 10.1016/j.mseb.2007.12.007; Soesbe TC, 2013, NMR BIOMED, V26, P829, DOI 10.1002/nbm.2874; Stephen ZR, 2011, MATER TODAY, V14, P330, DOI 10.1016/S1369-7021(11)70163-8; Tu CQ, 2012, WIRES NANOMED NANOBI, V4, P448, DOI 10.1002/wnan.1170; von Storp B, 2012, J MICROENCAPSUL, V29, P138, DOI 10.3109/02652048.2011.635218; Wagner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032568; Wagner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014213; Wahajuddin, 2012, INT J NANOMED, V7, P3445, DOI 10.2147/IJN.S30320; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Weber C, 2000, INT J PHARM, V211, P67, DOI 10.1016/S0378-5173(00)00590-1; Weber C, 2000, INT J PHARM, V196, P197, DOI 10.1016/S0378-5173(99)00420-2; Xu S, 2013, ADV DRUG DELIVER REV, V65, P121, DOI 10.1016/j.addr.2012.09.041; Yokel R, 2013, WIRES NANOMED NANOBI, V5, P346, DOI 10.1002/wnan.1202; Zensi A, 2009, J CONTROL RELEASE, V137, P78, DOI 10.1016/j.jconrel.2009.03.002; Zhang LJ, 2011, J MAGN RESON IMAGING, V33, P194, DOI 10.1002/jmri.22412; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	41	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92068	10.1371/journal.pone.0092068	http://dx.doi.org/10.1371/journal.pone.0092068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633006	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400139
J	Perez-Mendoza, D; Aragon, IM; Prada-Ramirez, HA; Romero-Jimenez, L; Ramos, C; Gallegos, MT; Sanjuan, J				Perez-Mendoza, Daniel; Aragon, Isabel M.; Prada-Ramirez, Harold A.; Romero-Jimenez, Lorena; Ramos, Cayo; Gallegos, Maria-Trinidad; Sanjuan, Juan			Responses to Elevated c-di-GMP Levels in Mutualistic and Pathogenic Plant-Interacting Bacteria	PLOS ONE			English	Article							SAVASTANOI PV. SAVASTANOI; GRAM-NEGATIVE BACTERIA; RHIZOBIUM-LEGUMINOSARUM; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; DIGUANYLATE CYCLASE; CELLULOSE SYNTHESIS; CYCLIC DIGUANYLATE; ESCHERICHIA-COLI; PILZ DOMAIN	Despite a recent burst of research, knowledge on c-di-GMP signaling pathways remains largely fragmentary and molecular mechanisms of regulation and even c-di-GMP targets are yet unknown for most bacteria. Besides genomics or bioinformatics, accompanying alternative approaches are necessary to reveal c-di-GMP regulation in bacteria with complex lifestyles. We have approached this study by artificially altering the c-di-GMP economy of diverse pathogenic and mutualistic plant-interacting bacteria and examining the effects on the interaction with their respective host plants. Phytopathogenic Pseudomonas and symbiotic Rhizobium strains with enhanced levels of intracellular c-di-GMP displayed common free-living responses: reduction of motility, increased production of extracellular polysaccharides and enhanced biofilm formation. Regarding the interaction with the host plants, P. savastanoi pv. savastanoi cells containing high c-di-GMP levels formed larger knots on olive plants which, however, displayed reduced necrosis. In contrast, development of disease symptoms in P. syringae-tomato or P. syringae-bean interactions did not seem significantly affected by high c-di-GMP. On the other hand, increasing c-di-GMP levels in symbiotic R. etli and R. leguminosarum strains favoured the early stages of the interaction since enhanced adhesion to plant roots, but decreased symbiotic efficiency as plant growth and nitrogen contents were reduced. Our results remark the importance of c-di-GMP economy for plant-interacting bacteria and show the usefulness of our approach to reveal particular stages during plant-bacteria associations which are sensitive to changes in c-di-GMP levels.	[Perez-Mendoza, Daniel; Prada-Ramirez, Harold A.; Romero-Jimenez, Lorena; Gallegos, Maria-Trinidad; Sanjuan, Juan] CSIC, Dpto Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain; [Aragon, Isabel M.; Ramos, Cayo] Univ Malaga, Inst Hortofruticultura Subtrop & La Mayora, IHSM, Area Genet,CSIC,UMA, E-29071 Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Sanjuan, J (corresponding author), CSIC, Dpto Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain.	juan.sanjuan@eez.csic.es	RAMOS, CAYO/G-3818-2011; MENDOZA, DANIEL PEREZ/L-9353-2014; Gallegos, María-Trinidad M.T./K-6501-2014	RAMOS, CAYO/0000-0002-2362-5041; MENDOZA, DANIEL PEREZ/0000-0001-9918-5671; Gallegos, María-Trinidad M.T./0000-0001-7633-8807; Sanjuan, Juan/0000-0002-6404-8754	Andalusian Government (Junta de Andalucia); Spanish Plan Nacional I+D+i (Ministerio de Economia y Competitividad) [BIO2011-23032, AGL2011-30343-C02-01]; Fondo Europeo de Desarrollo Regional (FEDER); FPU; FPI fellowship (Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad, Spain); JAE-Pre fellowship; JAE-doc postdoctoral contract from Consejo Superior de Investigaciones Cientificas (CSIC); Junta de Andalucia	Andalusian Government (Junta de Andalucia)(Junta de Andalucia); Spanish Plan Nacional I+D+i (Ministerio de Economia y Competitividad); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); FPU(Spanish Government); FPI fellowship (Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad, Spain); JAE-Pre fellowship; JAE-doc postdoctoral contract from Consejo Superior de Investigaciones Cientificas (CSIC); Junta de Andalucia(Junta de Andalucia)	This work was supported by grant P10-CVI-5800 from the Andalusian Government (Junta de Andalucia) and by the Spanish Plan Nacional I+D+i grants BIO2011-23032 and AGL2011-30343-C02-01 (Ministerio de Economia y Competitividad), all co-financed by Fondo Europeo de Desarrollo Regional (FEDER). IMA was supported by FPU and HPR by an FPI fellowship (Ministerio de Ciencia e Innovacion/Ministerio de Economia y Competitividad, Spain). LRJ was supported by JAE-Pre fellowship and DPM by a JAE-doc postdoctoral contract from Consejo Superior de Investigaciones Cientificas (CSIC, 2009-2011) and by a postdoctoral contract from Junta de Andalucia (2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albareda M, 2006, FEMS MICROBIOL LETT, V259, P67, DOI 10.1111/j.1574-6968.2006.00244.x; Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; AMIKAM D, 1995, BIOCHEM J, V311, P921, DOI 10.1042/bj3110921; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Ausmees N, 1999, MICROBIOL-UK, V145, P1253, DOI 10.1099/13500872-145-5-1253; Barnhart DM, 2013, APPL ENVIRON MICROB, V79, P7188, DOI 10.1128/AEM.02148-13; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chatterjee S, 2010, MOL PLANT MICROBE IN, V23, P1356, DOI 10.1094/MPMI-03-10-0057; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Edmunds AC, 2013, J BACTERIOL, V195, P2155, DOI 10.1128/JB.02068-12; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; FETT WF, 1989, PLANT PHYSIOL, V89, P5, DOI 10.1104/pp.89.1.5; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hosni T, 2011, ISME J, V5, P1857, DOI 10.1038/ismej.2011.65; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Laus MC, 2005, MOL PLANT MICROBE IN, V18, P533, DOI 10.1094/MPMI-18-0533; LEYVA A, 1987, J BACTERIOL, V169, P4929, DOI 10.1128/jb.169.11.4929-4934.1987; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matas IM, 2012, NEW PHYTOL, V196, P1182, DOI 10.1111/j.1469-8137.2012.04357.x; Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x; MAY TB, 1994, METHOD ENZYMOL, V235, P295; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Moretti C, 2008, PSEUDOMONAS SYRINGAE, P321; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Penyalver R, 2006, PHYTOPATHOLOGY, V96, P313, DOI 10.1094/PHYTO-96-0313; Perez-Martinez I, 2007, RES MICROBIOL, V158, P60, DOI 10.1016/j.resmic.2006.09.008; Perez-Mendoza D, 2005, J BACTERIOL, V187, P7341, DOI 10.1128/JB.187.21.7341-7350.2005; Perez-Mendoza D, 2011, MICROBIOL-SGM, V157, P3340, DOI 10.1099/mic.0.050450-0; Perez-Mendoza D, 2011, MOL MICROBIOL, V82, P719, DOI 10.1111/j.1365-2958.2011.07849.x; QUINTO C, 1985, P NATL ACAD SCI USA, V82, P1170, DOI 10.1073/pnas.82.4.1170; RIGAUD J, 1975, J GEN MICROBIOL, V88, P223, DOI 10.1099/00221287-88-2-223; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Robertson M, 2013, ANTON LEEUW INT J G, V103, P251, DOI 10.1007/s10482-012-9796-x; Rodriguez-Moreno L, 2008, PHYTOPATHOLOGY, V98, P815, DOI 10.1094/PHYTO-98-7-0815; Rodriguez-Moreno L, 2009, MICROB BIOTECHNOL, V2, P476, DOI 10.1111/j.1751-7915.2009.00101.x; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMIT G, 1987, J BACTERIOL, V169, P4294, DOI 10.1128/jb.169.9.4294-4301.1987; Soto MJ, 2002, MOL MICROBIOL, V43, P371, DOI 10.1046/j.1365-2958.2002.02749.x; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Taylor JD, 1996, PLANT PATHOL, V45, P469, DOI 10.1046/j.1365-3059.1996.d01-147.x; Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x; Vargas P, 2011, MOL PLANT MICROBE IN, V24, P1207, DOI 10.1094/MPMI-03-11-0077; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Williams A, 2008, J BACTERIOL, V190, P4706, DOI 10.1128/JB.01694-07; Xu J, 2013, MOL MICROBIOL, V89, P929, DOI 10.1111/mmi.12321; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Yu J, 1999, MOL MICROBIOL, V33, P712, DOI 10.1046/j.1365-2958.1999.01516.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	82	46	48	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91645	10.1371/journal.pone.0091645	http://dx.doi.org/10.1371/journal.pone.0091645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626229	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300112
J	Smithson, C; Purdy, A; Verster, AJ; Upton, C				Smithson, Chad; Purdy, Alex; Verster, Adrian J.; Upton, Chris			Prediction of Steps in the Evolution of Variola Virus Host Range	PLOS ONE			English	Article							COMPLETE GENOMIC SEQUENCE; ECTROMELIA-VIRUS; CAUSATIVE AGENT; DNA-SEQUENCES; MYXOMA VIRUS; PROTEIN; LOCALIZATION; RESISTANT; ALIGNMENT; SMALLPOX	Variola virus, the agent of smallpox, has a severely restricted host range (humans) but a devastatingly high mortality rate. Although smallpox has been eradicated by a World Health Organization vaccination program, knowledge of the evolutionary processes by which human super-pathogens such as variola virus arise is important. By analyzing the evolution of variola and other closely related poxviruses at the level of single nucleotide polymorphisms we detected a hotspot of genome variation within the smallpox ortholog of the vaccinia virus O1L gene, which is known to be necessary for efficient replication of vaccinia virus in human cells. These mutations in the variola virus ortholog and the subsequent loss of the functional gene from camelpox virus and taterapox virus, the two closest relatives of variola virus, strongly suggest that changes within this region of the genome may have played a key role in the switch to humans as a host for the ancestral virus and the subsequent host-range restriction that must have occurred to create the phenotype exhibited by smallpox.	[Smithson, Chad; Purdy, Alex; Upton, Chris] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Verster, Adrian J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Victoria; University of Toronto	Upton, C (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	cupton@uvic.ca		Upton, Chris/0000-0002-9019-8967	Natural Sciences and Engineering Research Council [155125]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Sciences and Engineering Research Council Discovery Grant to CU (#155125; www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2006, J VIROL, V80, P4978, DOI 10.1128/JVI.80.10.4978-4991.2006; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Babkin IV, 2012, INFECT GENET EVOL, V12, P1597, DOI 10.1016/j.meegid.2012.07.011; Best SM, 2000, VIROLOGY, V277, P76, DOI 10.1006/viro.2000.0505; Brodie R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-96; Brunetti CR, 2003, J VIROL, V77, P13335, DOI 10.1128/JVI.77.24.13335-13347.2003; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Camus-Bouclainville C, 2011, EMERG INFECT DIS, V17, P633, DOI 10.3201/eid1704.101146; Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cottingham MG, 2013, VACCINE, V31, P4247, DOI 10.1016/j.vaccine.2013.03.021; Coulson D, 2011, VIRUS GENES, V42, P171, DOI 10.1007/s11262-010-0560-x; Cresawn SG, 2007, VIROLOGY, V363, P319, DOI 10.1016/j.virol.2007.02.005; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Esteban DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-261; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Furuse Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-52; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Hendrickson RC, 2010, VIRUSES-BASEL, V2, P1933, DOI 10.3390/v2091933; Hillary William, 2011, Microb Inform Exp, V1, P2, DOI 10.1186/2042-5783-1-2; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Johnston SC, 2009, J VIROL, V83, P1708, DOI 10.1128/JVI.01364-08; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kerr PJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002950; Kerr PJ, 2012, ANTIVIR RES, V93, P387, DOI 10.1016/j.antiviral.2012.01.009; Kerr PJ, 1998, REV SCI TECH OIE, V17, P256, DOI 10.20506/rst.17.1.1081; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HJ, 2001, VIROLOGY, V281, P170, DOI 10.1006/viro.2000.0761; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McFadden G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000727; Morales M, 2009, J VIROL, V83, P2397, DOI 10.1128/JVI.02189-08; Morgan GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000785; Nazarian SH, 2007, VIRUS RES, V129, P11, DOI 10.1016/j.virusres.2007.05.001; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Postigo A, 2009, CELL MICROBIOL, V11, P1208, DOI 10.1111/j.1462-5822.2009.01327.x; Qin L, 2011, J VIROL, V85, P13049, DOI 10.1128/JVI.05779-11; ROSEL J, 1985, J VIROL, V56, P830, DOI 10.1128/JVI.56.3.830-838.1985; Rosengard AM, 2002, P NATL ACAD SCI USA, V99, P8808, DOI 10.1073/pnas.112220499; Schweneker M, 2012, J VIROL, V86, P2323, DOI 10.1128/JVI.06166-11; Shchelkunov SN, 2011, VACCINE, V29, pD49, DOI 10.1016/j.vaccine.2011.05.037; Sleator RD, 2011, ARCH MICROBIOL, V193, P235, DOI 10.1007/s00203-011-0677-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yadav VN, 2012, J IMMUNOL, V189, P1431, DOI 10.4049/jimmunol.1200946; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186	48	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91520	10.1371/journal.pone.0091520	http://dx.doi.org/10.1371/journal.pone.0091520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626337	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300097
J	van Loon, JE; Sonneveld, MAH; Praet, SFE; de Maat, MPM; Leebeek, FWG				van Loon, Janine E.; Sonneveld, Michelle A. H.; Praet, Stephan F. E.; de Maat, Moniek P. M.; Leebeek, Frank W. G.			Performance Related Factors Are the Main Determinants of the von Willebrand Factor Response to Exhaustive Physical Exercise	PLOS ONE			English	Article							ABO BLOOD-GROUP; SINGLE-NUCLEOTIDE POLYMORPHISM; VONWILLEBRAND-FACTOR; FACTOR-VIII; CARDIOVASCULAR-DISEASE; PLATELET ACTIVATION; MAXIMAL EXERCISE; GENE PROMOTER; PLASMA-LEVELS; RISK	Background: Physical stress triggers the endothelium to release von Willebrand Factor (VWF) from the Weibel Palade bodies. Since VWF is a risk factor for arterial thrombosis, it is of great interest to discover determinants of VWF response to physical stress. We aimed to determine the main mediators of the VWF increase by exhaustive physical exercise. Methods: 105 healthy individuals (18-35 years) were included in this study. Each participant performed an incremental exhaustive exercise test on a cycle ergometer. Respiratory gas exchange measurements were obtained while cardiac function was continuously monitored. Blood was collected at baseline and directly after exhaustion. VWF antigen (VWF:Ag) levels, VWF collagen binding (VWF:CB) levels, ADAMTS13 activity and common variations in Syntaxin Binding Protein-5 (STXBP5, rs1039084 and rs9399599), Syntaxin-2 (STX2, rs7978987) and VWF (promoter, rs7965413) were determined. Results: The median VWF:Ag level at baseline was 0.94 IU/mL [IQR 0.8-1.1] and increased with 47% [IQR 25-73] after exhaustive exercise to a median maximum VWF:Ag of 1.38 IU/mL [IQR 1.1-1.8] (p<0.0001). VWF:CB levels and ADAMTS13 activity both also increased after exhaustive exercise (median increase 43% and 12%, both p<0.0001). The strongest determinants of the VWF:Ag level increase are performance related (p<0.0001). We observed a gender difference in VWF:Ag response to exercise (females 1.2 IU/mL; males 1.7 IU/mL, p = 0.001), which was associated by a difference in performance. Genetic variations in STXBP5, STX2 and the VWF promoter were not associated with VWF:Ag levels at baseline nor with the VWF:Ag increase. Conclusions:VWF:Ag levels strongly increase upon exhaustive exercise and this increase is strongly determined by physical fitness level and the intensity of the exercise, while there is no clear effect of genetic variation in STXBP5, STX2 and the VWF promoter.	[van Loon, Janine E.; Sonneveld, Michelle A. H.; de Maat, Moniek P. M.; Leebeek, Frank W. G.] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands; [Sonneveld, Michelle A. H.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Praet, Stephan F. E.] Erasmus Univ, Med Ctr, Dept Rehabil Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Leebeek, FWG (corresponding author), Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands.	leebeek@erasmusmc.nl			Dutch Thrombosis Foundation	Dutch Thrombosis Foundation	This work was supported by a grant of the Dutch Thrombosis Foundation (2010-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bladbjerg EM, 2006, J THROMB HAEMOST, V4, P599, DOI 10.1111/j.1538-7836.2005.01778.x; Casonato A, 2008, BRIT J HAEMATOL, V140, P230, DOI 10.1111/j.1365-2141.2007.06907.x; Claus RA, 2006, J THROMB HAEMOST, V4, P902, DOI 10.1111/j.1538-7836.2006.01837.x; Creighton BC, 2013, EUR J APPL PHYSIOL, V113, P2203, DOI 10.1007/s00421-013-2645-4; Daidone V, 2009, THROMB HAEMOSTASIS, V101, P298, DOI 10.1160/TH08-08-0501; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Delp MD, 2004, J APPL PHYSIOL, V97, P1112, DOI 10.1152/japplphysiol.00147.2003; El-Sayed MS, 2000, MED SCI SPORT EXER, V32, P918; ElSayed MS, 1995, BLOOD COAGUL FIBRIN, V6, P747, DOI 10.1097/00001721-199512000-00009; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; HANSEN JB, 1990, THROMB HAEMOSTASIS, V64, P385; Harvey PJ, 2000, BRIT J HAEMATOL, V109, P349, DOI 10.1046/j.1365-2141.2000.02000.x; Hickson N, 2011, J THROMB HAEMOST, V9, P603, DOI 10.1111/j.1538-7836.2010.04161.x; Hollestelle MJ, 2001, THROMB HAEMOSTASIS, V86, P855, DOI 10.1055/s-0037-1616143; Kanaji S, 2012, J THROMB HAEMOST, V10, P1646, DOI 10.1111/j.1538-7836.2012.04797.x; Keightley AM, 1999, BLOOD, V93, P4277, DOI 10.1182/blood.V93.12.4277.412k03_4277_4283; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; Lethagen S, 2008, THROMB HAEMOSTASIS, V99, P1013, DOI 10.1160/TH07-06-0419; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; Lippi G, 2005, BLOOD COAGUL FIBRIN, V16, P533, DOI 10.1097/01.mbc.0000183117.66605.a3; Lippi G, 2009, SEMIN THROMB HEMOST, V35, P269, DOI 10.1055/s-0029-1222605; Martinelli I, 2005, SEMIN HEMATOL, V42, P49, DOI 10.1053/j.seminhematol.2004.09.009; MAYADAS T, 1989, BLOOD, V73, P706; Middeldorp Saskia, 2005, Gend Med, V2 Suppl A, pS3, DOI 10.1016/S1550-8579(05)80059-2; MYERS J, 1990, J APPL PHYSIOL, V68, P404, DOI 10.1152/jappl.1990.68.1.404; Pinsky DJ, 1996, J CLIN INVEST, V97, P493, DOI 10.1172/JCI118440; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Reiter RA, 2003, BLOOD, V101, P946, DOI 10.1182/blood-2002-03-0814; Ribeiro J, 2007, J SCI MED SPORT, V10, P164, DOI 10.1016/j.jsams.2006.06.001; Ribeiro JL, 2008, CLIN APPL THROMB-HEM, V14, P454, DOI 10.1177/1076029607305530; Rock G, 1997, CLIN J SPORT MED, V7, P94, DOI 10.1097/00042752-199704000-00004; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SMALL M, 1984, HAEMOSTASIS, V14, P262; Smith NL, 2011, BLOOD, V117, P6007, DOI 10.1182/blood-2010-10-315473; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Souto JC, 2003, THROMB HAEMOSTASIS, V89, P468; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Stakiw J, 2008, J THROMB HAEMOST, V6, P90; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; van Loon JE, 2010, CIRC-CARDIOVASC GENE, V3, P507, DOI 10.1161/CIRCGENETICS.110.957407; van Schie MC, 2011, J THROMB HAEMOST, V9, P899, DOI 10.1111/j.1538-7836.2011.04243.x; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Weber CT, 1986, CARDIOPULMONARY EXER; WHINCUP PH, 1990, BMJ-BRIT MED J, V300, P1679, DOI 10.1136/bmj.300.6741.1679; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Wieberdink RG, 2010, STROKE, V41, P2151, DOI 10.1161/STROKEAHA.110.586289; Wu O, 2008, J THROMB HAEMOST, V6, P62; ZHANG YY, 1991, MED SCI SPORT EXER, V23, P625	51	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91687	10.1371/journal.pone.0091687	http://dx.doi.org/10.1371/journal.pone.0091687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626470	Green Published, gold			2022-12-27	WOS:000332851300121
J	Zhang, XY; Li, CX; Gong, ZY				Zhang, Xiaoyan; Li, Caixia; Gong, Zhiyuan			Development of a Convenient In Vivo Hepatotoxin Assay Using a Transgenic Zebrafish Line with Liver-Specific DsRed Expression	PLOS ONE			English	Article							OXIDATIVE STRESS; N-NITROSODIMETHYLAMINE; LINDANE TOXICITY; RAT HEPATOCYTES; DRINKING-WATER; DANIO-RERIO; INJURY; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; MODELS; CELLS	Previously we have developed a transgenic zebrafish line (LiPan) with liver-specific red fluorescent protein (DsRed) expression under the fabp10a promoter. Since red fluorescence in the liver greatly facilitates the observation of liver in live LiPan fry, we envision that the LiPan zebrafish may provide a useful tool in analyses of hepatotoxicity based on changes of liver red fluorescence intensity and size. In this study, we first tested four well-established hepatotoxins (acetaminophen, aspirin, isoniazid and phenylbutazone) in LiPan fry and demonstrated that these hepatotoxins could significantly reduce both liver red fluorescence and liver size in a dosage-dependent manner, thus the two measurable parameters could be used as indicators of hepatotoxicity. We then tested the LiPan fry with nine other chemicals including environmental toxicants and human drugs. Three (mefenamic acid, lindane, and arsenate) behave like hepatotoxins in reduction of liver red fluorescence, while three others (17 beta-estradiol, TCDD [2,3,7,8-tetrachlorodibenzo-p-dioxin] and NDMA [N-nitrosodimethylamine]) caused increase of liver red fluorescence and the liver size. Ethanol and two other chemicals, amoxicillin (antibiotics) and chlorphenamine (pain killer) did not resulted in significant changes of liver red fluorescence and liver size. By quantitative RT-PCR analysis, we found that the changes of red fluorescence intensity caused by different chemicals correlated to the changes of endogenous fabp10a RNA expression, indicating that the measured hepatotoxicity was related to fatty acid transportation and metabolism. Finally we tested a mixture of four hepatotoxins and observed a significant reduction of red fluorescence in the liver at concentrations below the lowest effective concentrations of individual hepatotoxins, suggesting that the transgenic zebrafish assay is capable of reporting compound hepatotoxicity effect from chemical mixtures. Thus, the LiPan transgenic fry provide a rapid and convenient in vivo hepatotoxicity assay that should be applicable to high-throughput hepatotoxicity test in drug screening as well as in biomonitoring environmental toxicants.	[Zhang, Xiaoyan; Li, Caixia; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260; Li, Caixia/0000-0003-2190-655X	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JA, 2011, EXPERT OPIN DRUG MET, V7, P817, DOI 10.1517/17425255.2011.574613; Aithal GP, 2011, NAT REV RHEUMATOL, V7, P139, DOI 10.1038/nrrheum.2010.214; Aronson JK., 2008, MEYLERS SIDE EFFECTS; Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001; Bhadauria S, 2007, CELL MOL BIOL, V53, P102, DOI 10.1170/T781; Bhadauria S, 2010, TOXICOL MECH METHOD, V20, P242, DOI 10.3109/15376511003793325; Bioulac-Sage P, 2008, HEPATOL INT, V2, P316, DOI 10.1007/s12072-008-9075-0; BOLL M, 1995, Z NATURFORSCH C, V50, P135; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlson P, 2013, AQUAT TOXICOL; Carlson P, 2013, TOXICOL SCI, V134, P83, DOI 10.1093/toxsci/kft086; Cheng TJ, 2011, TOXICOL APPL PHARM, V256, P146, DOI 10.1016/j.taap.2011.08.001; Cummings AM, 1996, TOXICOL APPL PHARM, V138, P131, DOI 10.1006/taap.1996.0106; Das J, 2010, FREE RADICAL RES, V44, P340, DOI 10.3109/10715760903513017; Greenhough S., 2012, Pharmaceutical Medicine, V26, P85; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Hill A, 2012, DRUG METAB REV, V44, P127, DOI 10.3109/03602532.2011.645578; Huang XQ, 2012, FUTURE ONCOL, V8, P21, DOI [10.2217/FON.11.137, 10.2217/fon.11.137]; Hussaini SH, 2007, EXPERT OPIN DRUG SAF, V6, P673, DOI 10.1517/14740338.6.6.673; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Kanungo J, 2011, NEUROTOXICOL TERATOL, V33, P618, DOI 10.1016/j.ntt.2011.08.013; Kasap E, 2012, EXP THER MED, V4, P33, DOI 10.3892/etm.2012.561; Katz J., 2005, ESSENTIALS PAIN MED, P141; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lewis JH, 2007, DRUG INDUCED LIVER D, P440; Liteplo RG, 2001, J ENVIRON SCI HEAL C, V19, P281, DOI 10.1081/GNC-100103588; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Matsumura F, 1997, BIOCHEM PHARMACOL, V53, P1397, DOI 10.1016/S0006-2952(97)00036-1; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Minigh J., 2008, XPHARM COMPREHENSIVE, P1; Mizgireuv IV, 2004, TOXICOL PATHOL, V32, P514, DOI 10.1080/01926230490496311; Mrema EJ, 2013, TOXICOLOGY, V307, P74, DOI 10.1016/j.tox.2012.11.015; Nadanaciva S, 2013, TOXICOL APPL PHARM, V272, P272, DOI 10.1016/j.taap.2013.06.019; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; Niemela O, 2010, SCAND J CLIN LAB INV, V70, P305, DOI 10.3109/00365513.2010.486442; Nolan K, 2012, PEDIATR DERMATOL, V29, P141, DOI 10.1111/j.1525-1470.2011.01519.x; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; Ohlsson C, 2000, BIOCHEM BIOPH RES CO, V278, P640, DOI 10.1006/bbrc.2000.3827; Okada M, 2010, INT J MOL SCI, V11, P4114, DOI 10.3390/ijms11104114; Padma VV, 2011, FOOD CHEM TOXICOL, V49, P991, DOI 10.1016/j.fct.2011.01.005; Patlolla AK, 2012, MICROCHEM J, V105, P101, DOI 10.1016/j.microc.2012.08.013; Radosavljevic T, 2009, HUM EXP TOXICOL, V28, P747, DOI 10.1177/0960327109353055; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Roth RA, 2011, CRIT REV TOXICOL, V41, P723, DOI 10.3109/10408444.2011.575765; Singh Amrit Pal, 2011, Toxicol Int, V18, P87, DOI 10.4103/0971-6580.84258; Soma LR, 2012, J VET PHARMACOL THER, V35, P1, DOI 10.1111/j.1365-2885.2011.01299.x; Somchit N., 2004, SMJ Singapore Medical Journal, V45, P530; Storch J, 2002, MOL CELL BIOCHEM, V239, P25, DOI 10.1023/A:1020546321508; Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197; Tafazoli S, 2005, DRUG METAB REV, V37, P311, DOI 10.1081/DMR-200055227; Tolman Keith G., 1998, American Journal of Medicine, V105, p13S, DOI 10.1016/S0002-9343(98)00070-9; Tolosa L, 2013, ARCH TOXICOL, V87, P1115, DOI 10.1007/s00204-013-1012-x; TOMATIS L, 1964, J NATL CANCER I, V33, P341; Ung CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027819; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Wauson EM, 2002, TOXICOL SCI, V65, P211, DOI 10.1093/toxsci/65.2.211; WEBER LWD, 1995, TOXICOL APPL PHARM, V131, P155, DOI 10.1006/taap.1995.1057; Weger BD, 2013, CHEM SCREENING PROCE; Zhang H, 2013, J LIPID RES, V54, P345, DOI 10.1194/jlr.M028969; Zhang M, 2003, DIGEST DIS SCI, V48, P926, DOI 10.1023/A:1023003730138; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055474; Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0; ZIMMERMAN HJ, 1993, DM-DIS MON, V39, P678; Zimmerman HJ, 1999, HEPATOTOXICITY ADVER, P126; Zucchini-Pascal N, 2011, FOOD CHEM TOXICOL, V49, P3128, DOI 10.1016/j.fct.2011.09.033	71	35	39	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91874	10.1371/journal.pone.0091874	http://dx.doi.org/10.1371/journal.pone.0091874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626481	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300143
J	Li, N; Liu, RM; Zhai, HX; Li, L; Yin, YX; Zhang, JJ; Xia, YF				Li, Na; Liu, Runmei; Zhai, Hongxia; Li, Liang; Yin, Yaxin; Zhang, Jinjin; Xia, Yunfeng			Polymorphisms of the LTA Gene May Contribute to the Risk of Myocardial Infarction: A Meta-Analysis	PLOS ONE			English	Article							LYMPHOTOXIN-ALPHA GENE; CORONARY-ARTERY-DISEASE; ASSOCIATION; SNPS; SUSCEPTIBILITY; HETEROGENEITY; INFLAMMATION; EXPRESSION; JAPANESE; CANCER	Objective: The lymphotoxin-alpha (LTA), as one of the mediators of inflammation, may play an important role in the pathogenesis of myocardial infarction (MI). Genetic association studies (GAS) that have investigated the association between three common polymorphisms (A252G, G10A and C804A) of the LTA gene and susceptibility to MI have produced contradictory and inconclusive results. The aim of this meta-analysis is to provide a relatively comprehensive account of the association of these polymorphisms with susceptibility to MI. Methods: A literature search for eligible GAS published before October 15, 2013 was conducted in the PubMed, Embase, Web of Science, Cochrane Library, and CNKI (China National Knowledge Infrastructure) databases. We performed a meta-analysis of fifteen case-control studies with a total of 22,549 MI patients and 16,105 healthy controls. Results: For LTA A252G, a borderline significant overall association was found, indicating that GG genotype may confer an increased susceptibility to MI compared to AA and AG genotypes. Based on an ethnicity stratification analysis, a significant association was observed in Asians, but not in Caucasians. For LTA G10A, no significant overall association was found. However, subgroup analysis based on ethnicity suggested that the 10A allele may confer a significant increased susceptibility to MI only in Asian populations. For LTA C804A, the combined results revealed a significantly increased susceptibility to MI for carriers of the 804A allele in both overall analysis and stratified analyses. Conclusion: This meta-analysis shows that LTA C804A may be associated with an increased susceptibility to MI, whereas LTA A252G and G10A may confer a significant increased susceptibility to MI only in Asians. Thus, these polymorphisms of the LTA gene can probably be used with other genetic markers together to identify individuals at high susceptibility to MI especially in Asians.	[Li, Na; Liu, Runmei; Zhai, Hongxia; Li, Liang; Yin, Yaxin; Zhang, Jinjin; Xia, Yunfeng] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Cadres Ward 1, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Xia, YF (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Cadres Ward 1, Beijing, Peoples R China.	xiayf_pla1h@163.com	zhang, jin/GXV-9154-2022					Asselbergs FW, 2007, CLIN SCI, V112, P291, DOI 10.1042/CS20060200; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Carpeggiani C, 2010, ATHEROSCLEROSIS, V211, P461, DOI 10.1016/j.atherosclerosis.2010.03.012; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Gigante B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011300; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang TC, 2011, SCAND J INFECT DIS, V43, P436, DOI 10.3109/00365548.2011.562528; Ianni M, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-14; Iwanaga Y, 2004, ATHEROSCLEROSIS, V172, P197, DOI 10.1016/j.atherosclerosis.2003.09.026; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Kimura A, 2007, TISSUE ANTIGENS, V69, P265, DOI 10.1111/j.1399-0039.2006.00798.x; Koch W, 2001, ATHEROSCLEROSIS, V159, P137, DOI 10.1016/S0021-9150(01)00467-1; Koch W, 2007, HUM MOL GENET, V16, P1821, DOI 10.1093/hmg/ddm130; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lu RQ, 2012, CANCER EPIDEMIOL, V36, pE380, DOI 10.1016/j.canep.2012.05.014; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Ozaki K, 2005, CELL MOL LIFE SCI, V62, P1804, DOI 10.1007/s00018-005-5098-z; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Padovani JC, 2000, THROMB RES, V100, P263, DOI 10.1016/S0049-3848(00)00315-7; Panoulas VF, 2008, ANN RHEUM DIS, V67, P1550, DOI 10.1136/ard.2007.082594; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Ryan AW, 2008, ATHEROSCLEROSIS, V197, P465, DOI 10.1016/j.atherosclerosis.2007.03.032; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Schurks M, 2011, CEPHALALGIA, V31, P1381, DOI 10.1177/0333102411419022; Sedlacek K, 2007, J MOL MED, V85, P997, DOI 10.1007/s00109-007-0211-4; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; Stoll LL, 2004, J IMMUNOL, V173, P1336, DOI 10.4049/jimmunol.173.2.1336; Tanaka T, 2006, J HUM GENET, V51, P595, DOI 10.1007/s10038-006-0411-8; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.014; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Wang YC, 2010, LABMEDICINE, V41, P220, DOI 10.1309/LM6NPRVF05SJBAVQ; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Xu Z, 2013, TUMOUR BIOL; Yamada A, 2004, J MOL MED, V82, P477, DOI 10.1007/s00109-004-0556-x; Yang M, 2012, RESPIROLOGY, V17, P1229, DOI 10.1111/j.1440-1843.2012.02243.x; Zhou P, 2012, ASIAN PAC J CANCER P, V13, P1949, DOI 10.7314/APJCP.2012.13.5.1949	50	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92272	10.1371/journal.pone.0092272	http://dx.doi.org/10.1371/journal.pone.0092272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642747	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900117
J	Rao, RP; Scheffer, L; Srideshikan, SM; Parthibane, V; Kosakowska-Cholody, T; Masood, MA; Nagashima, K; Gudla, P; Lockett, S; Acharya, U; Acharya, JK				Rao, Raghavendra Pralhada; Scheffer, Luana; Srideshikan, Sargur M.; Parthibane, Velayoudame; Kosakowska-Cholody, Teresa; Masood, M. Athar; Nagashima, Kunio; Gudla, Prabhakar; Lockett, Stephen; Acharya, Usha; Acharya, Jairaj K.			Ceramide Transfer Protein Deficiency Compromises Organelle Function and Leads to Senescence in Primary Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; STRUCTURAL BASIS; RAT-LIVER; LIFE-SPAN; GOLGI; TRAFFICKING; CERT; GLUCOSYLCERAMIDE; APOPTOSIS; TRANSPORT	Ceramide transfer protein (CERT) transfers ceramide from the endoplasmic reticulum (ER) to the Golgi complex. Its deficiency in mouse leads to embryonic death at E11.5. CERT deficient embryos die from cardiac failure due to defective organogenesis, but not due to ceramide induced apoptotic or necrotic cell death. In the current study we examined the effect of CERT deficiency in a primary cell line, namely, mouse embryonic fibroblasts (MEFs). We show that in MEFs, unlike in mutant embryos, lack of CERT does not lead to increased ceramide but causes an accumulation of hexosylceramides. Nevertheless, the defects due to defective sphingolipid metabolism that ensue, when ceramide fails to be trafficked from ER to the Golgi complex, compromise the viability of the cell. Therefore, MEFs display an incipient ER stress. While we observe that ceramide trafficking from ER to the Golgi complex is compromised, the forward transport of VSVG-GFP protein is unhindered from ER to Golgi complex to the plasma membrane. However, retrograde trafficking of the plasma membrane-associated cholera toxin B to the Golgi complex is reduced. The dysregulated sphingolipid metabolism also leads to increased mitochondrial hexosylceramide. The mitochondrial functions are also compromised in mutant MEFs since they have reduced ATP levels, have increased reactive oxygen species, and show increased glutathione reductase activity. Live-cell imaging shows that the mutant mitochondria exhibit reduced fission and fusion events. The mitochondrial dysfunction leads to an increased mitophagy in the CERT mutant MEFs. The compromised organelle function compromise cell viability and results in premature senescence of these MEFs.	[Rao, Raghavendra Pralhada; Scheffer, Luana; Srideshikan, Sargur M.; Parthibane, Velayoudame; Kosakowska-Cholody, Teresa; Acharya, Jairaj K.] NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA; [Masood, M. Athar] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Frederick, MD USA; [Nagashima, Kunio] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Frederick, MD USA; [Gudla, Prabhakar; Lockett, Stephen] Frederick Natl Lab Canc Res, Opt Microscopy & Anal Lab, Frederick, MD USA; [Acharya, Usha] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester	Acharya, JK (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA.	acharyaj@mail.nih.gov	Madabushi, Srideshikan Sargur/AAG-1208-2020	Madabushi, Srideshikan Sargur/0000-0002-1087-6044; Acharya, Jairaj/0000-0001-7366-4228	intramural division of the National Cancer Institute, National Institutes of Health, Department of Health and Human Resources; NATIONAL CANCER INSTITUTE [ZIABC011187] Funding Source: NIH RePORTER	intramural division of the National Cancer Institute, National Institutes of Health, Department of Health and Human Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole by the intramural division of the National Cancer Institute, National Institutes of Health, Department of Health and Human Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Fisher R, 2010, HIPR2 ADAPTIVE THRES; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2010, P JPN ACAD B-PHYS, V86, P426, DOI 10.2183/pjab.86.426; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Obeid LM, 2003, SCI AGING KNOWLEDGE, V2003, pPE27; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PAGANO RE, 1989, METHOD CELL BIOL, V29, P75; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIES H, 1991, KLIN WOCHENSCHR, V69, P965, DOI 10.1007/BF01645140; SIXMA TK, 1993, BIOCHEMISTRY-US, V32, P191, DOI 10.1021/bi00052a025; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309	36	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92142	10.1371/journal.pone.0092142	http://dx.doi.org/10.1371/journal.pone.0092142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642596	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900093
J	Sousa, MC; Varandas, R; Santos, RC; Santos-Rosa, M; Alves, V; Salvador, JAR				Sousa, Maria C.; Varandas, Raquel; Santos, Rita C.; Santos-Rosa, Manuel; Alves, Vera; Salvador, Jorge A. R.			Antileishmanial Activity of Semisynthetic Lupane Triterpenoids Betulin and Betulinic Acid Derivatives: Synergistic Effects with Miltefosine	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; LEISHMANIA-DONOVANI; IN-VITRO; CHEMOTHERAPY; APOPTOSIS; AGENTS; DRUGS; ASSAY	Leishmaniasis is a neglected tropical disease (NTDs), endemic in 88 countries, affecting more than 12 million people. The treatment consists in pentavalent antimony compounds, amphotericin B, pentamidine and miltefosine, among others. However, these current drugs are limited due to their toxicity, development of biological resistance, length of treatment and high cost. Thus, it is important to continue the search for new effective and less toxic treatments. The anti-Leishmania activity of sixteen semisynthetic lupane triterpenoids derivatives of betulin (BT01 to BT09) and betulinic acid (AB10 to AB16) were evaluated. Drug interactions between the active compounds and one current antileishmanial drug, miltefosine, were assessed using the fixed ratio isobologram method. In addition, effects on the cell cycle, apoptosis/necrosis events, morphology and DNA integrity were studied. The derivatives BT06 (3 beta-Hydroxy-(20R)-lupan-29-oxo-28-yl-1H-imidazole-1-carboxylate) and AB13 (28-(1H-imidazole-1-yl)-3,28-dioxo-lup-1,20(29)-dien-2-yl-1H-imidazole-1-carboxylate) were found to be the most active, with IC50 values of 50.8 mu M and 25.8 mu M, respectively. Interactions between these two compounds and miltefosine were classified as synergistic, with the most effective association being between AB13 and miltefosine, where decreases of IC50 values to 6 mM were observed, similar to the miltefosine activity alone. AB13 induced significant morphological changes, while both derivatives produced anti-proliferative activity through cell cycle arrest at the G0/G1 phase. Neither of these derivatives induced significant apoptosis/necrosis, as indicated by phosphatidylserine externalization and DNA fragmentation assays. In addition, neither of the derivatives induced death in macrophage cell lines. Thus, they do not present any potential risk of toxicity for the host cells. This study has identified the betulin derivative BT06 and the betulinic acid derivative AB13 as promising molecules in the development of new alternative therapies for leishmaniasis, including those involving combined-therapy with miltefosine.	[Sousa, Maria C.; Varandas, Raquel; Santos, Rita C.; Salvador, Jorge A. R.] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Sousa, Maria C.] Univ Coimbra CEF FFUC, Fac Pharm, Ctr Pharmaceut Studies, Coimbra, Portugal; [Salvador, Jorge A. R.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Santos-Rosa, Manuel; Alves, Vera] Univ Coimbra, Fac Med, Inst Immunol, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Sousa, MC (corresponding author), Univ Coimbra, Fac Pharm, Coimbra, Portugal.	mcsousa@ci.uc.pt; salvador@ci.uc.pt	Sousa, Maria/HCI-9642-2022; Sousa, Maria do Céu/AGQ-8739-2022; Alves, Vera/AAX-8195-2020; SALVADOR, JORGE A. R./N-7174-2017	Alves, Vera/0000-0002-2625-1671; SALVADOR, JORGE A. R./0000-0003-0779-6083; Varandas, Raquel/0000-0002-5985-2019; SOUSA, Maria do Ceu Rodrigues/0000-0003-4957-7831	"(POCI)/FEDER'' da Fundacao para a Ciencia e Tecnologia (FCT)	"(POCI)/FEDER'' da Fundacao para a Ciencia e Tecnologia (FCT)	This work was supported by "(POCI)/FEDER'' da Fundacao para a Ciencia e Tecnologia (FCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Alakurtti S, 2010, BIOORGAN MED CHEM, V18, P1573, DOI 10.1016/j.bmc.2010.01.003; Baglin I, 2003, MINI-REV MED CHEM, V3, P525, DOI 10.2174/1389557033487917; Carvalho L, 2011, ANTIMICROB AGENTS CH, V55, P4204, DOI 10.1128/AAC.00520-11; Chowdhury AR, 2003, MOL MED, V9, P26; Chowdhury S, 2011, MOL PHARMACOL, V80, P694, DOI 10.1124/mol.111.072785; Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; da Silva AA, 2009, FITOTERAPIA, V80, P478, DOI 10.1016/j.fitote.2009.06.007; Darzynkiewicz Z, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0804s01; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dominguez-Carmona DB, 2010, PHYTOMEDICINE, V17, P379, DOI 10.1016/j.phymed.2009.08.002; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; Fuertes MA, 2008, CURR MED CHEM, V15, P433; Gazanion E, 2011, PARASITOL INT, V60, P19, DOI 10.1016/j.parint.2010.09.005; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Kappagoda S, 2011, MAYO CLIN PROC, V86, P561, DOI 10.4065/mcp.2011.0203; Lakshmi V, 2007, PHYTOMEDICINE, V14, P36, DOI 10.1016/j.phymed.2005.10.002; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Moreira W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.83; Mukherjee Rama, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P271, DOI 10.2174/187152006776930846; Nakayama H, 2007, BIOMED PHARMACOTHER, V61, P186, DOI 10.1016/j.biopha.2007.02.001; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Prada CF, 2013, BIOCHEM PHARMACOL, V85, P1433, DOI 10.1016/j.bcp.2013.02.024; RajuGautam S, 2009, MED RES REV, V29, P767; Ryu SY, 2000, PLANTA MED, V66, P358, DOI 10.1055/s-2000-8531; Santin MR, 2009, PARASITOL RES, V105, P1489, DOI 10.1007/s00436-009-1578-7; Santos RC, 2011, BIOCHIMIE, V93, P1065, DOI 10.1016/j.biochi.2011.02.014; Santos RC, 2010, BIOORGAN MED CHEM, V18, P4385, DOI 10.1016/j.bmc.2010.04.085; Santos RC, 2009, BIOORGAN MED CHEM, V17, P6241, DOI 10.1016/j.bmc.2009.07.050; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P2064, DOI 10.1128/AAC.45.7.2064-2069.2001; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; van Zandbergen G, 2010, TRENDS PARASITOL, V26, P477, DOI 10.1016/j.pt.2010.06.008; Vermeersch M, 2009, ANTIMICROB AGENTS CH, V53, P3855, DOI 10.1128/AAC.00548-09; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wagenpfeil S, 2006, ARTIF INTELL MED, V37, P65, DOI 10.1016/j.artmed.2005.01.011; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1; Xiong JA, 2010, BIOORGAN MED CHEM, V18, P6451, DOI 10.1016/j.bmc.2010.06.092; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214	43	45	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e89939	10.1371/journal.pone.0089939	http://dx.doi.org/10.1371/journal.pone.0089939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643019	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900005
J	Khonmee, J; Brown, JL; Rojanasthien, S; Aunsusin, A; Thumasanukul, D; Kongphoemphun, A; Siriaroonrat, B; Tipkantha, W; Punyapornwithaya, V; Thitaram, C				Khonmee, Jaruwan; Brown, Janine L.; Rojanasthien, Suvichai; Aunsusin, Anurut; Thumasanukul, Dissakul; Kongphoemphun, Adisorn; Siriaroonrat, Boripat; Tipkantha, Wanlaya; Punyapornwithaya, Veerasak; Thitaram, Chatchote			Gender, Season and Management Affect Fecal Glucocorticoid Metabolite Concentrations in Captive Goral (Naemorhedus griseus) in Thailand	PLOS ONE			English	Article							BLACK-FOOTED FERRET; ADRENAL ACTIVITY; ENVIRONMENTAL ENRICHMENT; CORTISOL METABOLITES; SEX-DIFFERENCES; ADRENOCORTICAL ACTIVITY; DOMESTIC LIVESTOCK; ZOO VISITORS; STRESS; BEHAVIOR	Chinese goral (Naemorhedus griseus) are a threatened species in Thailand and the focus of captive breeding for possible reintroduction. However, little is known of their biology or what factors in the captive environment affect welfare. Our objective was to determine the impact of gender, season, and management on goral adrenal activity. We hypothesized that differences in fecal glucocorticoid concentrations would be related to animal density. Fecal samples were collected 3 days/week for 1 year from 63 individuals (n = 32 males, 31 females) at two facilities that house the majority of goral in Thailand: Omkoi Wildlife Sanctuary (Omkoi), an off-exhibit breeding center that houses goral in individual pens (16 pens; n = 8 males, 8 females) and in small family groups (8 pens; n = 8 males, 8 females); and the Chiang Mai Night Safari (NS), a zoo that maintains 31 goral (n = 17 males, 14 females) in one large pen. Glucocorticoid metabolite concentrations were higher in male than female goral at Omkoi throughout the year, and there was a seasonal effect on adrenal activity (p<0.05). Goral at Omkoi and NS were used to test the effect of animal density on fecal glucocorticoid excretion of goral housed in similar-sized enclosures. Overall, the highest levels were found at NS (n = 31 adults/pen; 27 m(2) per animal) compared to Omkoi (n = 2 adults/pen; 400 m(2) per animal) (p<0.05). Overall findings support our hypothesis that animal density and aspects of the captive environment impact adrenal steroid activity in captive goral. In addition, gender and season also had significant effects on glucocorticoid metabolite production. Potential stressors pertaining to the welfare of this species were identified, which will guide future efforts to improve management and create self-sustaining and healthy populations of this threatened species.	[Khonmee, Jaruwan; Rojanasthien, Suvichai; Punyapornwithaya, Veerasak; Thitaram, Chatchote] Chiang Mai Univ, Fac Vet Med, Chiang Mai 50000, Thailand; [Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Aunsusin, Anurut] Chiang Mai Night Safari, Chiang Mai, Thailand; [Thumasanukul, Dissakul; Kongphoemphun, Adisorn] Omkoi Wildlife Sanctuary, Dept Natl Pk Wildlife & Plant Conservat, Chiang Mai, Thailand; [Siriaroonrat, Boripat; Tipkantha, Wanlaya] Zool Pk Org, Conservat Res & Educ Div, Bangkok, Thailand	Chiang Mai University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Khonmee, J (corresponding author), Chiang Mai Univ, Fac Vet Med, Chiang Mai 50000, Thailand.	jaruwan.khonmee@cmu.ac.th; chatchote.thitaram@cmu.ac.th	Punyapornwithaya, Veerasak/ABE-5119-2020; Punyapornwithaya, Verasak/V-9323-2019; Thitaram, Chatchote/AHD-1584-2022	Punyapornwithaya, Verasak/0000-0001-9870-7773; 	National Research Council of Thailand (NRCT)	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT))	This study was funded by National Research Council of Thailand (NRCT). All laboratory analyses and additional lab support was provided by Faculty of Veterinary Medicine, Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Brown JL, 2001, ZOO BIOL, V20, P463, DOI 10.1002/zoo.10028; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Bubenik GA, 1998, COMP BIOCHEM PHYS C, V120, P307, DOI 10.1016/S0742-8413(98)10010-5; BUIRSKI P, 1978, ANIM BEHAV, V26, P123, DOI 10.1016/0003-3472(78)90011-8; Carlstead K, 1999, ZOO BIOL, V18, P35, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;35::AID-ZOO5&gt;3.0.CO;2-L; CARLSTEAD K, 1994, ZOO BIOL, V13, P447, DOI 10.1002/zoo.1430130507; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Chaiyarat Rattanawat, 1999, Natural History Bulletin of the Siam Society, V47, P191; CHRISTISON GI, 1972, J ANIM SCI, V35, P1005; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Cyr NE, 2008, GEN COMP ENDOCR, V158, P20, DOI 10.1016/j.ygcen.2008.05.001; Davis N, 2005, APPL ANIM BEHAV SCI, V90, P131, DOI 10.1016/j.applanim.2004.08.020; DOBSON H, 1995, J REPROD FERTIL, P451; Duckworth J.W., 2008, NAEMORHEDUS GRISEUS, DOI [10.2305/IUCN.UK.2008.RLTS.T14303A4430834.en, DOI 10.2305/IUCN.UK.2008.RLTS.T14303A4430834.EN]; ERIKSSON H, 1970, EUR J BIOCHEM, V15, P132, DOI 10.1111/j.1432-1033.1970.tb00987.x; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Harper JM, 2001, GEN COMP ENDOCR, V123, P337, DOI 10.1006/gcen.2001.7682; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; HORTON GMJ, 1991, APPL ANIM BEHAV SCI, V32, P197, DOI 10.1016/S0168-1591(05)80043-7; Hosey GR, 2005, APPL ANIM BEHAV SCI, V90, P107, DOI 10.1016/j.applanim.2004.08.015; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; Li CW, 2007, GEN COMP ENDOCR, V151, P202, DOI 10.1016/j.ygcen.2007.01.014; LIPTRAP RM, 1993, ANN NY ACAD SCI, V697, P275, DOI 10.1111/j.1749-6632.1993.tb49941.x; MELLEN JD, 1991, ZOO BIOL, V10, P95, DOI 10.1002/zoo.1430100202; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Moreira N, 2007, ZOO BIOL, V26, P441, DOI 10.1002/zoo.20139; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Morrow CJ, 2002, GEN COMP ENDOCR, V126, P229, DOI 10.1006/gcen.2002.7797; Mostl E, 1999, J VET MED A, V46, P621, DOI 10.1046/j.1439-0442.1999.00256.x; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MULLER CJC, 1994, S AFR J ANIM SCI, V24, P56; OTTENWELLER JE, 1979, ACTA ENDOCRINOL-COP, V91, P150, DOI 10.1530/acta.0.0910150; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; Palme R, 1997, Z SAUGETIERKD, V62, P192; Patton ML, 2000, J ZOO WILDLIFE MED, V31, P228, DOI 10.1638/1042-7260(2000)031[0228:SCIAHO]2.0.CO;2; PERKINS LA, 1992, ZOO BIOL, V11, P177, DOI 10.1002/zoo.1430110306; Pinheiro J., 2019, NLME LINEAR NONLINEA; Poessel SA, 2011, GEN COMP ENDOCR, V172, P526, DOI 10.1016/j.ygcen.2011.04.018; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabinowitz A, 1998, ORYX, V32, P201, DOI 10.1046/j.1365-3008.1998.d01-37.x; Rajagopal T, 2011, J APPL ANIM WELF SCI, V14, P18, DOI 10.1080/10888705.2011.527598; Raminelli JLF, 2001, BIOL RHYTHM RES, V32, P159; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; Saito TR, 1996, CONTEMP TOP LAB ANIM, V35, P80; Scarlata CD, 2013, ANIM WELFARE, V22, P357, DOI 10.7120/09627286.22.3.357; Schatz S, 2001, VET RES COMMUN, V25, P271, DOI 10.1023/A:1010626608498; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; Shepherdson DJ, 2004, ANIM WELFARE, V13, pS105; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; Strier KB, 1999, HORM BEHAV, V35, P125, DOI 10.1006/hbeh.1998.1505; Tan HM, 2013, RES VET SCI, V94, P228, DOI 10.1016/j.rvsc.2012.09.024; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Teskey-Gerstl A, 2000, J COMP PHYSIOL B, V170, P163, DOI 10.1007/s003600050271; Thai Meteorological Department, 2013, THAI MET DEP CHIANG; Thitaram C, 2008, THERIOGENOLOGY, V69, P237, DOI 10.1016/j.theriogenology.2007.09.018; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; van Lier E, 2003, ANIM REPROD SCI, V79, P81, DOI 10.1016/S0378-4320(03)00083-6; VANDENHEEDE M, 1993, APPL ANIM BEHAV SCI, V37, P39, DOI 10.1016/0168-1591(93)90069-2; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; WOODWARD CJH, 1991, BRIT J NUTR, V66, P117, DOI 10.1079/BJN19910015; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Young KM, 2001, ZOO BIOL, V20, P517, DOI 10.1002/zoo.10001	66	14	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91633	10.1371/journal.pone.0091633	http://dx.doi.org/10.1371/journal.pone.0091633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637886	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100049
J	Sato, M; Kondo, M; Tateishi, R; Fujiwara, N; Kato, N; Yoshida, H; Taguri, M; Koike, K				Sato, Masaya; Kondo, Mayuko; Tateishi, Ryosuke; Fujiwara, Naoto; Kato, Naoya; Yoshida, Haruhiko; Taguri, Masataka; Koike, Kazuhiko			Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENOME-WIDE ASSOCIATION; RIBAVIRIN COMBINATION THERAPY; PEGYLATED INTERFERON-ALPHA; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; INTERLEUKIN 28B; GENOTYPE; PROGRESSION; POLYMORPHISMS	Background & Aims: IL28B polymorphisms were shown to be strongly associated with the response to interferon therapy in chronic hepatitis C (CHC) and spontaneous viral clearance. However, little is known about how these polymorphisms affect the natural course of the disease. Thus, we conducted the present meta-analysis to assess the impact of IL28B polymorphisms on disease progression. Methods: A literature search was conducted using MEDLINE, EMBASE, and the Cochrane Library. Integrated odds ratios (OR) were calculated with a fixed-effects or random-effects model based on heterogeneity analyses. Results: We identified 28 studies that included 10,024 patients. The pooled results indicated that the rs12979860 genotype CC was significantly associated (vs. genotype CT/TT; OR, 1.122; 95% CI, 1.003-1.254; P = 0.044), and that the rs8099917 genotype TT tended to be (vs. genotype TG/GG; OR, 1.126; 95% CI, 0.988-1.284; P = 0.076) associated, with an increased possibility of severe fibrosis. Both rs12979860 CC (vs. CT/TT; OR, 1.288; 95% CI, 1.050-1.581; P = 0.015) and rs8099917 TT (vs. TG/GG; OR, 1.324; 95% CI, 1.110-1.579; P = 0.002) were significantly associated with a higher possibility of severe inflammation activity. Rs8099917 TT was also significantly associated with a lower possibility of severe steatosis (vs. TG/GG; OR, 0.580; 95% CI, 0.351-0.959; P = 0.034), whereas rs12979860 CC was not associated with hepatic steatosis (vs. CT/TT; OR, 1.062; 95% CI, 0.415-2.717; P = 0.901). Conclusions: IL28B polymorphisms appeared to modify the natural course of disease in patients with CHC. Disease progression seems to be promoted in patients with the rs12979860 CC and rs8099917 TT genotypes.	[Sato, Masaya; Kondo, Mayuko; Tateishi, Ryosuke; Fujiwara, Naoto; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan; [Kato, Naoya] Univ Tokyo, Inst Med Sci, Unit Dis Control Genome Med, Minato Ku, Tokyo, Japan; [Taguri, Masataka] Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan	University of Tokyo; University of Tokyo; Yokohama City University	Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Fujiwara, Naoto/Y-5938-2019; Tateishi, Ryosuke/G-7758-2014	Fujiwara, Naoto/0000-0002-4109-3421; Tateishi, Ryosuke/0000-0003-3021-2517	Global COE Program, "Center of Education and Research for Advanced Genome-Based Medicine: For personalized medicine and the control of worldwide infectious diseases"; Ministry of Education, Culture, Sports, Science and Technology, Japan; Leading Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Health and Labor Sciences Research Grants for Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan	Global COE Program, "Center of Education and Research for Advanced Genome-Based Medicine: For personalized medicine and the control of worldwide infectious diseases"; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leading Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Health and Labor Sciences Research Grants for Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Global COE Program, "Center of Education and Research for Advanced Genome-Based Medicine: For personalized medicine and the control of worldwide infectious diseases"; the Ministry of Education, Culture, Sports, Science and Technology, Japan; by grants from the Leading Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan; and by Health and Labor Sciences Research Grants for Research on Hepatitis from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Andrade RJ, 2000, ALIMENT PHARM THER, V14, P929; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Asahina Y, 2011, J HEPATOL, V54, pS37, DOI 10.1016/S0168-8278(11)60084-6; Asahina Y, 2011, HEPATOLOGY; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; BARRERA JM, 1995, HEPATOLOGY, V21, P639, DOI 10.1016/0270-9139(95)90511-1; Bau DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016374; Bochud PY, 2011, J HEPATOL, V55, P980, DOI 10.1016/j.jhep.2011.01.050; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; Borenstein M, 2009, INTRO META ANAL; Cai T, 2011, J HEPATOL; De Nicola S, 2009, J HEPATOL, V51, P964, DOI 10.1016/j.jhep.2009.08.001; de Rueda PM, 2011, AM J GASTROENTEROL; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EHNHOLM C, 1982, ARTERIOSCLEROSIS, V2, P68, DOI 10.1161/01.ATV.2.1.68; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Falleti E, 2011, J CLIN IMMUNOL, V31, P891, DOI 10.1007/s10875-011-9547-1; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hourigan LF, 1999, HEPATOLOGY, V29, P1215, DOI 10.1002/hep.510290401; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Joshita S, 2012, HUM IMMUNOL, V73, P298, DOI 10.1016/j.humimm.2011.12.021; Kato N, 2005, HEPATOLOGY, V42, P846, DOI 10.1002/hep.20860; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Li CZ, 2009, LIVER INT, V29, P1413, DOI 10.1111/j.1478-3231.2009.02061.x; Li JH, 2010, HEPATOLOGY, V51, P1904, DOI 10.1002/hep.23592; Lindh M, 2011, J VIRAL HEPATITIS, V18, pE325, DOI 10.1111/j.1365-2893.2010.01425.x; Lindh M, 2011, J INFECT DIS, V203, P1748, DOI 10.1093/infdis/jir193; Lotrich FE, 2010, J INTERFERON CYTOKIN; Mach T, 2012, PRZ GASTROENTEROL, V7, P38, DOI 10.5114/pg.2012.27221; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marabita F, 2011, HEPATOLOGY, V54, P1127, DOI 10.1002/hep.24503; Massard J, 2006, J HEPATOL, V44, pS19, DOI 10.1016/j.jhep.2005.11.009; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Miura M, 2011, HEPATOL INT; Miyamura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028617; Miyashita M, 2012, J VIRAL HEPATITIS, V19, P608, DOI 10.1111/j.1365-2893.2011.01580.x; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; Moriyama M, 2007, HEPATOL INT, V1, P302, DOI 10.1007/s12072-007-9003-8; Nakaya M, 2006, BIOSCI BIOTECH BIOCH, V70, P47, DOI 10.1271/bbb.70.47; Ohnishi M, 2012, J GASTROENTEROL, V47, P834, DOI 10.1007/s00535-012-0550-y; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Pradat P, 2007, J VIRAL HEPATITIS, V14, P556, DOI 10.1111/j.1365-2893.2006.00829.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; SCHECTMAN G, 1992, ARTERIOSCLER THROMB, V12, P1053, DOI 10.1161/01.ATV.12.9.1053; Shinohara E, 1997, HEPATOLOGY, V25, P1502, DOI 10.1002/hep.510250632; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thursz M, 1999, LANCET, V354, P2119, DOI 10.1016/S0140-6736(99)91443-5; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Tolmane I, 2012, HEPAT RES TREAT; Toyoda H, 2012, J MED VIROL, V84, P61, DOI 10.1002/jmv.22272; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Urabe Y, 2013, J HEPATOL, V58, P875, DOI 10.1016/j.jhep.2012.12.024; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	72	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91822	10.1371/journal.pone.0091822	http://dx.doi.org/10.1371/journal.pone.0091822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637774	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100065
J	Tuteja, A; Siddiqui, AB; Madan, K; Goyal, R; Shalimar; Sreenivas, V; Kaur, N; Panda, SK; Narayanasamy, K; Subodh, S; Acharya, SK				Tuteja, Amit; Siddiqui, Abu Baker; Madan, Kaushal; Goyal, Rohit; Shalimar; Sreenivas, Vishnubhatla; Kaur, Navkiran; Panda, Subrat K.; Narayanasamy, Krishnamoorthy; Subodh, Swati; Acharya, Subrat K.			Mutation Profiling of the Hepatitis B Virus Strains Circulating in North Indian Population	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; BASAL CORE PROMOTER; HEPATOCELLULAR-CARCINOMA; HBV GENOTYPES; VIROLOGICAL CHARACTERISTICS; SURFACE-ANTIGEN; EASTERN INDIA; PHYLOGENETIC RELATEDNESS; SEQUENTIAL ACCUMULATION; MOLECULAR EPIDEMIOLOGY	Aims: The aim of this study was to investigate the genomic mutations in the circulating Hepatitis B virus strains causing infection in the Indian population. Further, we wanted to analyze the biological significance of these mutations in HBV mediated disease. Methods: 222 HBsAg positive patients were enrolled in the study. The genotype and mutation profile was determined for the infecting HBV isolate by sequencing overlapping fragments. These sequences were analyzed by using different tools and compared with previously available HBV sequence information. Mutation Frequency Index (MFI) for the Genes and Diagnosis group was also calculated. Results: HBV Genotype D was found in 55% (n = 121) of the patient group and genotype A was found in 30% (n = 66) of samples. The majority (52%) of the HBV-infected individuals in the present study were HBeAg-negative in all the age groups studied. Spontaneous drug associated mutations implicated in resistance to antiviral therapy were also identified in about quarter of our patients, which is of therapeutic concern. The MFI approach used in the study indicated that Core peptide was the most conserved region in both genotypes and Surface peptide had highest mutation frequency. Few mutations in X gene (T36A and G50R) showed high frequency of association with HCC. A rare recombinant strain of HBV genotype A and D was also identified in the patient group. Conclusions: HBV genotype D was found out to be most prevalent. More than half of the patients studied had HBeAg negative disease. Core region was found to be most conserved. Drug Associated mutations were detected in 22% of the patient group and T36A and G50R mutations in X gene were found to be associated with HCC.	[Tuteja, Amit; Siddiqui, Abu Baker; Narayanasamy, Krishnamoorthy; Subodh, Swati] Inst Mol Med, New Delhi, India; [Tuteja, Amit; Kaur, Navkiran] Amity Univ, Amity Inst Biotechnol, Noida, India; [Subodh, Swati] CSIR, Open Source Drug Discovery Unit, New Delhi, India; [Madan, Kaushal; Goyal, Rohit; Shalimar; Acharya, Subrat K.] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Panda, Subrat K.] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Stat, New Delhi, India	Amity University Noida; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Subodh, S (corresponding author), Inst Mol Med, New Delhi, India.	swatisubodh@yahoo.com; subratacharya@hotmail.com	kaur, Navkiran/AAR-2942-2021; , .Shalimar/J-5686-2016	, .Shalimar/0000-0003-1247-437X; Kaur, Navkiran/0000-0003-2522-7044	Rapid Grant for Young Investigator (RGYI) Scheme of Department of Biotechnology, Government of India [BT/PR8942/GBD/27/44/2006]	Rapid Grant for Young Investigator (RGYI) Scheme of Department of Biotechnology, Government of India	The work was funded under the Rapid Grant for Young Investigator (RGYI) Scheme of Department of Biotechnology, Government of India (Websitehttp://dbtindia.nic.in) awarded to Dr. Swati Subodh (Grant number - BT/PR8942/GBD/27/44/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1999, J CLIN MICROBIOL, V37, P2899, DOI 10.1128/JCM.37.9.2899-2903.1999; Acharya SK, 2006, NATL MED J INDIA, V19, P203; Alam MM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-115; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; BLUM HE, 1991, J VIROL, V65, P1836, DOI 10.1128/JVI.65.4.1836-1842.1991; BLUM HE, 1995, DIGESTION, V56, P85, DOI 10.1159/000201226; Borkakoty BJ, 2008, INDIAN J MED RES, V127, P65; Borroto-Esoda K, 2007, J HEPATOL, V47, P492, DOI 10.1016/j.jhep.2007.06.011; Bozkaya H, 1997, J HEPATOL, V26, P508, DOI 10.1016/S0168-8278(97)80415-1; Brunetto MR, 2003, J HEPATOL, V39, pS164, DOI 10.1016/S0168-8278(03)00329-5; Chattopadhyay S, 2006, WORLD J GASTROENTERO, V12, P6702, DOI 10.3748/wjg.v12.i41.6702; Chaudhuri V, 2004, GASTROENTEROLOGY, V127, P1356, DOI 10.1053/j.gastro.2004.08.003; Choi CS, 2009, J MED VIROL, V81, P1721, DOI 10.1002/jmv.21591; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Fujiwara K, 2005, WORLD J GASTROENTERO, V11, P6410, DOI 10.3748/wjg.v11.i41.6410; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; Gandhe SS, 2003, J MED VIROL, V69, P324, DOI 10.1002/jmv.10292; Ghosh S, 2013, J VIRAL HEPATITIS, V20, P209, DOI 10.1111/j.1365-2893.2012.01655.x; Guo X, 2008, J HEPATOL, V49, P718, DOI 10.1016/j.jhep.2008.06.026; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; HAWKINS AE, 1994, J MED VIROL, V43, P5, DOI 10.1002/jmv.1890430103; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Ijaz S, 2003, J GEN VIROL, V84, P269, DOI 10.1099/vir.0.18667-0; Jeantet D, 2002, HEPATOLOGY, V35, P1215, DOI 10.1053/jhep.2002.32710; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kajiya Y, 2001, DIGEST DIS SCI, V46, P509, DOI 10.1023/A:1005582812466; Karayiannis P, 1995, HEPATOLOGY, V22, P1628, DOI 10.1016/0270-9139(95)90183-3; Kew MC, 2005, J MED VIROL, V75, P513, DOI 10.1002/jmv.20311; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; KIDDLJUNGGREN K, 1995, J GEN VIROL, V76, P2119, DOI 10.1099/0022-1317-76-9-2119; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Kuang SY, 2004, P NATL ACAD SCI USA, V101, P3575, DOI 10.1073/pnas.0308232100; Kumar Ashish, 2005, Indian J Gastroenterol, V24, P19; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Lin X, 2005, WORLD J GASTROENTERO, V11, P4703, DOI 10.3748/wjg.v11.i30.4703; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Liu WC, 2007, VIRUS RES, V129, P212, DOI 10.1016/j.virusres.2007.07.016; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077; Madan K, 2009, HEPATOL RES, V39, P157, DOI 10.1111/j.1872-034X.2008.00417.x; Mizokami M, 1999, INTERVIROLOGY, V42, P159, DOI 10.1159/000024975; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Orito E, 2001, HEPATOLOGY, V34, P590, DOI 10.1053/jhep.2001.27221; Pastor R, 2009, WORLD J GASTROENTERO, V15, P753, DOI 10.3748/wjg.15.753; Sarin SK, 2001, J GASTROEN HEPATOL, V16, P666, DOI 10.1046/j.1440-1746.2001.02476.x; Scheiblauer H, 2010, VOX SANG, V98, P403, DOI 10.1111/j.1423-0410.2009.01272.x; Sen U, 2002, INT J CANCER, V100, P86, DOI 10.1002/ijc.10446; Shin YC, 2011, FEBS LETT, V585, P3964, DOI 10.1016/j.febslet.2011.11.003; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Simon B, 2013, J CLIN MICROBIOL, V51, P163, DOI 10.1128/JCM.01630-12; Song BC, 2006, INTERVIROLOGY, V49, P266, DOI 10.1159/000093456; Sugauchi F, 2004, J GEN VIROL, V85, P811, DOI 10.1099/vir.0.79811-0; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Suwannakarn K, 2005, J GEN VIROL, V86, P3027, DOI 10.1099/vir.0.81241-0; Tacke F, 2004, J VIROL, V78, P8524, DOI 10.1128/JVI.78.16.8524-8535.2004; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thakur V, 2002, J GASTROEN HEPATOL, V17, P165, DOI 10.1046/j.1440-1746.2002.02605.x; Tong Shuping, 2005, Int J Med Sci, V2, P2; Utsumi T, 2009, J CLIN MICROBIOL, V47, P1842, DOI 10.1128/JCM.02328-08; Villet S, 2007, J HEPATOL, V46, P531, DOI 10.1016/j.jhep.2006.11.016; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Wang ZH, 2007, J CLIN MICROBIOL, V45, P1491, DOI 10.1128/JCM.02157-06; Warner N, 2007, ANTIMICROB AGENTS CH, V51, P2285, DOI 10.1128/AAC.01499-06; Zekri ARN, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-74; Zhang DK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-271	76	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91150	10.1371/journal.pone.0091150	http://dx.doi.org/10.1371/journal.pone.0091150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637457	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100018
J	Zhou, R; Sun, YX; Yang, WJ; Yang, F				Zhou, Rong; Sun, Yu-Xia; Yang, Wei-Jun; Yang, Fan			Identification and Characterization of a Ste20-Like Kinase in Artemia and Its Role in the Developmental Regulation and Resistance to Environmental Stress	PLOS ONE			English	Article							SHOCK/ALPHA-CRYSTALLIN PROTEIN; MITOGEN-ACTIVATED PROTEIN; RIBOSOMAL S6 KINASE; CHAPERONE ACTIVITY; MOLECULAR CHARACTERIZATION; ENCYSTED EMBRYOS; BRINE SHRIMP; FRANCISCANA; SLK; P26	Background: To adapt to extreme environments, the crustacean Artemia has evolved two alternative reproductive pathways. During ovoviviparous (direct) development, nauplius larvae are produced. In contrast, Artemia females release encysted diapause embryos (cysts) via the oviparous pathway. To date, the cellular mechanisms that regulate stress resistance of Artemia remain largely unknown. Ste20-like kinase (SLK) participates in multiple biological processes, including stress responses, apoptosis, and cell cycle progression. Principal Finding: We isolated and characterized a member of the SLK superfamily termed ArSLK from Artemia parthenogenetica. The ArSLK gene is transcribed throughout both ovoviviparous and oviparous development; however, the protein is located mainly in the nuclei of stress-resistant diapause cysts, unlike the nauplii and nauplius-destined embryos where it is cytoplasmic. Interestingly, exposure of nauplii to heat shock, acidic pH, and UV irradiation induced the translocation of ArSLK from cytoplasm to nucleus. This translocation was reversed following stress removal. Moreover, under physiologically-stressful conditions, the nauplius larvae produced by adults after gene knockdown of endogenous ArSLK by RNAi, lost the ability of free-swimming much earlier than those of control larvae from females injected with GFP dsRNA. Conclusions/Significance: Taken together, this study demonstrated that trafficking of ArSLK between the cytoplasm and the nucleus participates in regulating the stress resistance of Artemia. Our findings may provide significant insight into the functions of members of the SLK superfamily.	[Yang, Fan] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, F (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China.	fan_yang@zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830	National Natural Science Foundation of China [31270424 1/4 CE31370394]; National Basic Research Program of China (863 Program) [2012AA092205]; Scientific Research Fund of Zhejiang Provincial Education Department [N20080103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (863 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); Scientific Research Fund of Zhejiang Provincial Education Department	This work was supported by the National Natural Science Foundation of China (31270424 1/4 CE31370394), National Basic Research Program of China (863 Program, 2012AA092205) and the Scientific Research Fund of Zhejiang Provincial Education Department (N20080103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; Alves PS, 2006, EXP CELL RES, V312, P308, DOI 10.1016/j.yexcr.2005.10.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browne RA, 1990, ARTEMIA BIOL; Chen T, 2003, EUR J BIOCHEM, V270, P137, DOI 10.1046/j.1432-1033.2003.03373.x; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Clegg JS, 1999, AM ZOOL, V39, P836; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; CLEGG JS, 1974, T AM MICROSC SOC, V93, P481, DOI 10.2307/3225153; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Day RM, 2003, CELL STRESS CHAPERON, V8, P183, DOI 10.1379/1466-1268(2003)008<0183:ASHCPF>2.0.CO;2; Delarosa S, 2011, AM J PHYSIOL-RENAL, V301, pF554, DOI 10.1152/ajprenal.00062.2011; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Herbert NA, 2005, MAR BIOL, V147, P1403, DOI 10.1007/s00227-005-0003-8; Li R, 2012, J BIOL CHEM, V287, P15923, DOI 10.1074/jbc.M111.312413; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; Manzerra P, 1996, EXP CELL RES, V229, P35, DOI 10.1006/excr.1996.0341; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Qian YW, 1998, SCIENCE, V282, P1701, DOI 10.1126/science.282.5394.1701; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; Sun Y, 2004, J BIOL CHEM, V279, P39999, DOI 10.1074/jbc.M406999200; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Warner AH, 2004, ARCH BIOCHEM BIOPHYS, V424, P189, DOI 10.1016/j.abb.2004.02.022; Willsie JK, 2001, J EXP BIOL, V204, P2339; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	37	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92234	10.1371/journal.pone.0092234	http://dx.doi.org/10.1371/journal.pone.0092234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637947	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100131
J	De Jesus, M; Ostroff, GR; Levitz, SM; Bartling, TR; Mantis, NJ				De Jesus, Magdia; Ostroff, Gary R.; Levitz, Stuart M.; Bartling, Toni R.; Mantis, Nicholas J.			A Population of Langerin-Positive Dendritic Cells in Murine Peyer's Patches Involved in Sampling beta-Glucan Microparticles	PLOS ONE			English	Article							C-TYPE LECTIN; SUBEPITHELIAL DOME; IMMUNE-RESPONSES; INNATE IMMUNITY; T-CELL; RECOGNITION; PATHOGEN; LOCALIZATION; IMMUNIZATION; CD11B(+)	Glucan particles (GPs) are 2-4 mu m hollow, porous shells composed of 1,3-beta-D-glucan that have been effectively used for oral targeted-delivery of a wide range of payloads, including small molecules, siRNA, DNA, and protein antigens. While it has been demonstrated that the transepithelial transport of GPs is mediated by Peyer's patch M cells, the fate of the GPs once within gut-associated lymphoid tissue (GALT) is not known. Here we report that fluorescently labeled GPs administered to mice by gavage accumulate in CD11c(+) DCs situated in Peyer's patch sub-epithelial dome (SED) regions. GPs appeared in DCs within minutes after gavage and remained within the SED for days afterwards. The co-administration or sequential administration of GPs with differentially labeled GPs or poly(lactic-co-glycolic acid) nanoparticles demonstrated that the SED DC subpopulation in question was capable of internalizing particles of different sizes and material compositions. Phenotypic analysis identified the GP-containing DCs as being CD8(alpha-) and CD11b(lo/-), suggesting they are the so-called myeloid and/or double negative (DN) subset(s) of PP DCs. A survey of C-type lectin receptors (CLRs) known to be expressed by leukocytes within the intestinal mucosa revealed that GP-containing SED DCs were positive for Langerin (CD207), a CLR with specificity for beta-D-glucan and that has been shown to mediate the internalization of a wide range of microbial pathogens, including bacteria, viruses and fungi. The presence of Langerin(+) DCs in the SED as determined by immunofluorescence was confirmed using Langerin E-GFP transgenic mice. In summary, our results demonstrate that following M cell-mediated transepithelial transport, GPs (and other micro/nanoparticles) are sampled by a population of SED DCs distinguished from other Peyer's patch DC subsets by their expression of Langerin. Future studies will be aimed at defining the role of Langerin in antigen sampling and antigen presentation within the context of the GALT.	[De Jesus, Magdia; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12237 USA; [Ostroff, Gary R.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Bartling, Toni R.] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA; [Mantis, Nicholas J.] Univ Albany, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12237 USA.	nmantis@wadsworth.org		Mantis, Nicholas/0000-0002-5083-8640	Life Sciences Research Foundation, Howard Hughes Medical Institute (HHMI); American Society for Microbiology; National Institutes of Health [HD061916, GM082978, AI025780, AI102618, HL112671];  [R01DK085753];  [1R21AI094074]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102618, R01AI025780, R21AI094074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082978] Funding Source: NIH RePORTER	Life Sciences Research Foundation, Howard Hughes Medical Institute (HHMI); American Society for Microbiology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MDJ was supported by the Life Sciences Research Foundation, Howard Hughes Medical Institute (HHMI) sponsored fellowship. MDJ also acknowledges the generous support of a 2012 Career Development award for Postdoctoral Women from the American Society for Microbiology. This work was supported in part by National Institutes of Health grants HD061916 and GM082978 to NJM. GRO was supported in part by R01DK085753 and 1R21AI094074. SML was supported in part by National Institutes of Health grants AI025780, AI102618, and HL112671. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; BENACH JL, 1982, INFECT IMMUN, V35, P947, DOI 10.1128/IAI.35.3.947-951.1982; Chang SY, 2010, IMMUNOL REV, V234, P233, DOI 10.1111/j.0105-2896.2009.00878.x; De Jesus M, 2013, JOVE-J VIS EXP, DOI 10.3791/50167; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; De Smet R, 2013, J CONTROL RELEASE, V172, P671, DOI 10.1016/j.jconrel.2013.09.007; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Hopkins SA, 1997, ADV EXP MED BIOL, V417, P105; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Huang H, 2013, CLIN VACCINE IMMUNOL; Huang HB, 2012, J IMMUNOL, V189, P312, DOI 10.4049/jimmunol.1200603; Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Igyarto BZ, 2013, CURR OPIN IMMUNOL, V25, P115, DOI 10.1016/j.coi.2012.11.007; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lelouard H, 2010, GASTROENTEROLOGY, V138, P173, DOI 10.1053/j.gastro.2009.09.051; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; Lopatin U, 2013, J VIROL, V87, P524, DOI 10.1128/JVI.01801-12; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Preza GC, 2013, AIDS RES HUM RETROVI; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rochereau N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001658; Rochereau N, 2011, VACCINE, V29, P3655, DOI 10.1016/j.vaccine.2011.03.012; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; Shin MK, 2013, MICROBIOL IMMUNOL, V57, P417, DOI 10.1111/1348-0421.12053; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Soto ER, 2008, BIOCONJUGATE CHEM, V19, P840, DOI 10.1021/bc700329p; Soto ER, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/143524; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; van den Berg LM, 2013, ADV EXP MED BIOL, V762, P45, DOI 10.1007/978-1-4614-4433-6_2	42	44	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91002	10.1371/journal.pone.0091002	http://dx.doi.org/10.1371/journal.pone.0091002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632738	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400031
J	Rossegger, A; Endrass, J; Gerth, J; Singh, JP				Rossegger, Astrid; Endrass, Jerome; Gerth, Juliane; Singh, Jay P.			Replicating the Violence Risk Appraisal Guide: A Total Forensic Cohort Study	PLOS ONE			English	Article							PREDICTIVE-VALIDITY; RECIDIVISM; OFFENDERS; INSTRUMENTS; PERFORMANCE; ACCURACY; SIZES; VRAG	Introduction: The performance of violence risk assessment instruments can be primarily investigated by analysing two psychometric properties: discrimination and calibration. Although many studies have examined the discrimination capacity of the Violence Risk Appraisal Guide (VRAG) and other actuarial risk assessment tools, few have evaluated how well calibrated these instruments are. The aim of the present investigation was to replicate the development study of the VRAG in Europe including measurements of discrimination and calibration. Method: Using a prospective study design, we assessed a total cohort of violent offenders in the Zurich Canton of Switzerland using the VRAG prior to discharge from prisons, secure facilities, and outpatient clinics. Assessors adhered strictly to the assessment protocol set out in the instrument's manual. After controlling for attrition, 206 offenders were followed in the community for a fixed period of 7 years. We used charges and convictions for subsequent violent offenses as the outcomes. Receiver operating characteristic analysis was conducted to measure discrimination, and Sanders' decomposition of the Brier score as well as Bayesian credible intervals were calculated to measure calibration. Results: The discrimination of the VRAG's risk bins was modest (area under the curve = 0.72, 95% CI = 0.63-0.81, p<0.05). However, the calibration of the tool was poor, with Sanders' calibration score suggesting an average assessment error of 21% in the probabilistic estimates associated with each bin. The Bayesian credible intervals revealed that in five out of nine risk bins the intervals did not contain the expected risk rates. Discussion: Measurement of the calibration validity of risk assessment instruments needs to be improved, as has been done with respect to discrimination. Additional replication studies that focus on the calibration of actuarial risk assessment instruments are needed. Meanwhile, we recommend caution when using the VRAG probabilistic risk estimates in practice.	[Rossegger, Astrid; Endrass, Jerome; Gerth, Juliane; Singh, Jay P.] Dept Mental Hlth Serv, Off Correct, Zurich, Switzerland; [Rossegger, Astrid; Endrass, Jerome; Gerth, Juliane] Univ Konstanz, Dept Psychol, Constance, Germany; [Singh, Jay P.] Molde Univ Coll, Inst Hlth Sci, Molde, Norway	University of Konstanz; Molde University College	Endrass, J (corresponding author), Dept Mental Hlth Serv, Off Correct, Zurich, Switzerland.	jerome.endrass@ji.zh.ch		Endrass, Jerome/0000-0001-9961-6734; Rossegger, Astrid/0000-0003-0207-732X				Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Association AP, 1978, 14 ASS AP; Association AP, 1974, 8 ASS AP; Breslow N, 1990, STAT SCI, V5, P269; Carlin BP, 2009, CH CRC TEXT STAT SCI, V78, P1; Donaldson T, 2008, SEX ABUSE-J RES TR, V20, P206, DOI 10.1177/1079063208317734; EDWARDS W, 1963, PSYCHOL REV, V70, P193, DOI 10.1037/h0044139; Endrass J, 2007, ZURCHER FORENSIK STU; Fazel S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4692; Ferro CAT, 2007, WEATHER FORECAST, V22, P1076, DOI 10.1175/WAF1034.1; Fleiss JL., 2003, STAT METHODS RATES P; Hanson RK, 2010, LAW HUMAN BEHAV, V34, P275, DOI 10.1007/s10979-010-9227-3; Hare R.D, 2003, MANUAL REVISED PSYCH, V2nd; Harris GT, 2003, PSYCHOL ASSESSMENT, V15, P413, DOI 10.1037/1040-3590.15.3.413; HARRIS GT, 1993, CAN J BEHAV SCI, V25, P267, DOI 10.1037/h0078783; Harris GT, 2002, LAW HUMAN BEHAV, V26, P377, DOI 10.1023/A:1016347320889; Hart SD, 2007, BRIT J PSYCHIAT, V190, pS60, DOI 10.1192/bjp.190.5.s60; Hastings ME, 2011, PSYCHOL ASSESSMENT; Helmus L, 2012, CRIM JUSTICE BEHAV, V39, P1148, DOI 10.1177/0093854812443648; Higgins J, 2008, COCHRANE BOOK SERIES, P48; Jacoby Joseph E., 1979, CRIMINALLY INSANE CO; Kass RE, 1996, J AM STAT ASSOC, V91, P1343, DOI 10.2307/2291752; Kroner Carolin, 2007, Crim Behav Ment Health, V17, P89, DOI 10.1002/cbm.644; Mills JF, 2005, CRIM JUSTICE BEHAV, V32, P565, DOI 10.1177/0093854805278417; Monahan J., 1981, PREDICTING VIOLENT B; Mossman D, 2006, SEX ABUSE-J RES TR, V18, P41, DOI 10.1007/s11194-006-9001-8; Nuffield J., 1982, REPORT NO JS 22 6519; Quinsey V. L., 2006, VIOLENT OFFENDERS AP, V2nd, DOI 10.1037/11367-000; REDELMEIER DA, 1991, J CLIN EPIDEMIOL, V44, P1141, DOI 10.1016/0895-4356(91)90146-Z; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Rogers W, 1992, STATA TECHNICAL B, V10, P20; Rossegger A, 2009, FORTSCHR NEUROL PSYC, V77, P577, DOI 10.1055/s-0028-1109705; Rossegger A, 2013, BEHAV SCI LAW, V31, P154, DOI 10.1002/bsl.2044; Rufibach K, 2010, J CLIN EPIDEMIOL, V63, P938, DOI 10.1016/j.jclinepi.2009.11.009; Schmid CH., 2005, ENCY BIOSTATISTICS, V2, DOI [10.1002/0470011815.b2a13049, DOI 10.1002/0470011815.b2a13049]; Singh J. P., 2013, SEXUAL OFFENDER TREA, V7, P44; Singh JP, 2013, BEHAV SCI LAW, V31, P55, DOI 10.1002/bsl.2053; Singh JP, 2013, BEHAV SCI LAW, V31, P8, DOI 10.1002/bsl.2052; Singh JP, 2014, BRIT J PSYC IN PRESS; Snowden RJ, 2007, PSYCHOL MED, V37, P1539, DOI 10.1017/S0033291707000876; SPIEGELHALTER DJ, 1986, STAT MED, V5, P421, DOI 10.1002/sim.4780050506; Stata Corp, 2012, STAT STAT SOFTW REL; Steadman Henry J., 1974, CAREERS CRIMINALLY I; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Tengstrom A, 2001, NORD J PSYCHIAT, V55, P243, DOI 10.1080/080394801681019093; Urbaniok F, 2008, FORTSCHR NEUROL PSYC, V76, P470, DOI 10.1055/s-2008-1038228; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Viljoen JL, 2010, ASSESSMENT, V17, P377, DOI 10.1177/1073191109359587; Yessine AK, 2006, CAN J CRIMINOL CRIM, V48, P573, DOI 10.1353/ccj.2006.0045	51	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91845	10.1371/journal.pone.0091845	http://dx.doi.org/10.1371/journal.pone.0091845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632561	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400106
J	Sugiura, T; Kawaguchi, Y; Goto, K; Hayashi, Y; Gono, T; Furuya, T; Nishino, I; Yamanaka, H				Sugiura, Tomoko; Kawaguchi, Yasushi; Goto, Kanako; Hayashi, Yukiko; Gono, Takahisa; Furuya, Takefumi; Nishino, Ichizo; Yamanaka, Hisashi			Association between a C8orf13-BLK Polymorphism and Polymyositis/Dermatomyositis in the Japanese Population: An Additive Effect with STAT4 on Disease Susceptibility	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IDIOPATHIC INFLAMMATORY MYOPATHY; RHEUMATOID-ARTHRITIS; EXPRESSION; HAPLOTYPE; MYOSITIS; REGION; RISK; GENE	Background: Accumulating evidence has shown that several non-HLA genes are involved in the susceptibility to polymyositis/dermatomyositis. This study aimed to investigate the involvement of C8orf13-BLK, one of the strongest candidate genes for autoimmune diseases, in susceptibility to polymyositis/dermatomyositis in the Japanese population. A possible gene-gene interaction between C8orf13-BLK and STAT4, which we recently showed to be associated with Japanese polymyositis/dermatomyositis, was also analyzed. Methods: A single-nucleotide polymorphism in C8orf13-BLK (dbSNP ID: rs13277113) was investigated in the Japanese population using a TaqMan assay in 283 polymyositis patients, 194 dermatomyositis patients, and 656 control subjects. Results: The C8orf13-BLK rs13277113A allele was associated with overall polymyositis/dermatomyositis (P<0.001, odds ratio [OR] 1.44, 95% confidence interval [CI] 1.19-1.73), as well as polymyositis (P = 0.011, OR 1.32, 95% CI 1.06-1.64) and dermatomyositis (P<0.001, OR 1.64, 95% CI 1.26-2.12). No association was observed between the C8orf13-BLK rs13277113A allele and either interstitial lung disease or anti-Jo-1 antibody positivity. The C8orf13-BLK rs13277113 A and STAT4 rs7574865 T alleles had an additive effect on polymyositis/ dermatomyositis susceptibility. The strongest association was observed in dermatomyositis, with an OR of 3.07 (95% CI; 1.57-6.02) for the carriers of four risk alleles at the two SNP sites, namely, rs1327713 and rs7574865. Conclusions: This study established C8orf13-BLK as a new genetic susceptibility factor for polymyositis/ dermatomyositis. Both C8orf13-BLK and STAT4 exert additive effects on disease susceptibility. These observations suggested that C8orf13-BLK, in combination with STAT4, plays a pivotal role in creating genetic susceptibility to polymyositis/ dermatomyositis in Japanese individuals.	[Sugiura, Tomoko; Kawaguchi, Yasushi; Gono, Takahisa; Furuya, Takefumi; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Goto, Kanako; Hayashi, Yukiko; Nishino, Ichizo] Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Goto, Kanako; Hayashi, Yukiko; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Dev, Tokyo, Japan	Tokyo Women's Medical University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Kawaguchi, Y (corresponding author), Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan.	y-kawa@ior.twmu.ac.jp	Nishino, Ichizo/G-2676-2010	Nishino, Ichizo/0000-0001-9452-112X	Ministry of Health, Labor, and Welfare, Japan; National Center of Neurology and Psychiatry [23-4, 23-5]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan)	This study was supported by autoimmune disease research grants from the Ministry of Health, Labor, and Welfare, Japan and was partly supported by an Intramural Research Grant (23-4, 23-5) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Chinoy H, 2008, ARTHRITIS RHEUM-US, V58, P3247, DOI 10.1002/art.23900; Chinoy H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3327; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; DYMECKI SM, 1992, J BIOL CHEM, V267, P4815; Fan Y, 2011, MOL BIOL REP, V38, P4445, DOI 10.1007/s11033-010-0573-5; Furuya T, 2004, J RHEUMATOL, V31, P1768; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ito I, 2010, ARTHRITIS RHEUM-US, V62, P890, DOI 10.1002/art.27303; Ito I, 2009, ARTHRITIS RHEUM-US, V60, P553, DOI 10.1002/art.24246; Kawasaki A, 2008, ARTHRITIS RHEUM-US, V58, P826, DOI 10.1002/art.23216; Kawasaki A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2516; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; Koga M, 2011, J HUM GENET, V56, P503, DOI 10.1038/jhg.2011.49; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Liang YL, 2012, MOL BIOL REP, V39, P8873, DOI 10.1007/s11033-012-1754-1; Miller FW, 2013, ARTHRITIS RHEUM-US, V65, P3239, DOI 10.1002/art.38137; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Orozco G, 2011, ANN RHEUM DIS, V70, P463, DOI 10.1136/ard.2010.137174; Ramesha KN, 2010, ANN INDIAN ACAD NEUR, V13, P250, DOI 10.4103/0972-2327.74190; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rider LG, 1999, ARTHRITIS RHEUM, V42, P1285, DOI 10.1002/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1; Samuelson EM, 2012, IMMUNOL CELL BIOL, V90, P620, DOI 10.1038/icb.2011.76; Simpfendorfer KR, 2012, HUM MOL GENET, V21, P3918, DOI 10.1093/hmg/dds220; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Sugiura T, 2012, ANN RHEUM DIS, V71, P1646, DOI 10.1136/annrheumdis-2011-200839; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x	28	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90019	10.1371/journal.pone.0090019	http://dx.doi.org/10.1371/journal.pone.0090019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632671	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400009
J	Bakshi, K; Parihar, R; Goswami, SK; Walsh, M; Friedman, E; Wang, HY				Bakshi, Kalindi; Parihar, Raminder; Goswami, Satindra K.; Walsh, Melissa; Friedman, Eitan; Wang, Hoau-Yan			RETRACTED: Prenatal Cocaine Exposure Uncouples mGluR1 from Homer1 and Gq Proteins (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							METABOTROPIC GLUTAMATE RECEPTORS; D-1 DOPAMINE-RECEPTOR; ACETYLCHOLINE-RELEASE; ACTIVATION; INHIBITION; EXPRESSION; TOLERANCE; CORTEX; BINDS	Cocaine exposure during gestation causes protracted neurobehavioral changes consistent with a compromised glutamatergic system. Although cocaine profoundly disrupts glutamatergic neurotransmission and in utero cocaine exposure negatively affects metabotropic glutamate receptor-type 1 (mGluR1) activity, the effect of prenatal cocaine exposure on mGluR1 signaling and the underlying mechanism responsible for the prenatal cocaine effect remain elusive. Using brains of the 21-day-old (P21) prenatal cocaine-exposed rats, we show that prenatal cocaine exposure uncouples mGluR1s from their associated synaptic anchoring protein, Homer1 and signal transducer, Gq/11 proteins leading to markedly reduced mGluR1-mediated phosphoinositide hydrolysis in frontal cortex (FCX) and hippocampus. This prenatal cocaine-induced effect is the result of a sustained protein kinase C (PKC)-mediated phosphorylation of mGluR1 on the serine residues. In support, phosphatase treatment of prenatal cocaine-exposed tissues restores whereas PKC-mediated phosphorylation of saline-treated synaptic membrane attenuates mGluR1 coupling to both Gq/11 and Homer1. Expression of mGluR1, Homer1 or G alpha proteins was not altered by prenatal cocaine exposure. Collectively, these data indicate that prenatal cocaine exposure triggers PKC-mediated hyper-phosphorylation of the mGluR1 leading to uncoupling of mGluR1 from its signaling components. Hence, blockade of excessive PKC activation may alleviate abnormalities in mGluR1 signaling and restores mGluR1-regulated brain functions in prenatal cocaine-exposed brains.	[Wang, Hoau-Yan] CUNY, Sch Med, Sophie Davis Sch Biomed Educ, Dept Physiol, New York, NY 10031 USA; CUNY, Sch Med, Sophie Davis Sch Biomed Educ, Dept Pharmacol, New York, NY 10031 USA; CUNY, Sch Med, Sophie Davis Sch Biomed Educ, Dept Neurosci, New York, NY 10031 USA	City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education	Wang, HY (corresponding author), CUNY, Sch Med, Sophie Davis Sch Biomed Educ, Dept Physiol, New York, NY 10031 USA.	hywang@med.cuny.edu			National Institute on Drug Abuse [MIDARP R24-DA018055]; CUNY collaborative grant; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA018055] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); CUNY collaborative grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by public service grant, MIDARP R24-DA018055 from the National Institute on Drug Abuse (EF, HYW), CUNY collaborative grant (HYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Bakshi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025019; Bakshi K, 2009, J NEUROSCI, V29, P6308, DOI 10.1523/JNEUROSCI.5485-08.2009; Bandstra ES, 2002, NEUROTOXICOL TERATOL, V24, P297, DOI 10.1016/S0892-0362(02)00192-7; Bellone C, 2011, NAT NEUROSCI, V14, P1439, DOI 10.1038/nn.2930; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Booze RM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-33; DelaneyBlack V, 1996, PEDIATRICS, V98, P735; DOWEDWARDS DL, 1991, NEUROTOXICOL TERATOL, V13, P347, DOI 10.1016/0892-0362(91)90082-8; Friedman E, 1996, NEUROSCIENCE, V70, P739, DOI 10.1016/S0306-4522(96)83011-9; Ghasemzadeh MB, 2003, EUR J NEUROSCI, V18, P1645, DOI 10.1046/j.1460-9568.2003.02880.x; Hahn CG, 2005, J PSYCHIATR RES, V39, P355, DOI 10.1016/j.jpsychires.2004.10.007; Harvey JA, 2001, NEUROTOX RES, V3, P117, DOI 10.1007/BF03033234; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; Jones LB, 2000, J NEUROSCI, V20, P4606, DOI 10.1523/JNEUROSCI.20-12-04606.2000; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; MAYES LC, 1995, PEDIATRICS, V95, P539; Morrow CE, 2006, DEV NEUROPSYCHOL, V30, P905, DOI 10.1207/s15326942dn3003_8; Murphy EH, 1997, PHYSIOL BEHAV, V62, P597, DOI 10.1016/S0031-9384(97)00170-4; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Price CJ, 2005, NEUROPHARMACOLOGY, V49, P45, DOI 10.1016/j.neuropharm.2005.05.009; Romano AG, 1996, PHARMACOL BIOCHEM BE, V53, P617, DOI 10.1016/0091-3057(95)02061-6; ROMANO AG, 1995, PHARMACOL BIOCHEM BE, V52, P415, DOI 10.1016/0091-3057(95)00129-K; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Stanwood GD, 2003, NEUROSCIENCE, V122, P579, DOI 10.1016/j.neuroscience.2003.08.029; Swanson CJ, 2001, J NEUROSCI, V21, P9043, DOI 10.1523/JNEUROSCI.21-22-09043.2001; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Thompson BL, 2005, BEHAV BRAIN RES, V164, P107, DOI 10.1016/j.bbr.2005.06.010; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Wang HY, 2005, NEUROSCIENCE, V135, P247, DOI 10.1016/j.neuroscience.2005.06.003; Wang HY, 1999, NEUROPEPTIDES, V33, P197, DOI 10.1054/npep.1999.0024; WANG HY, 1995, J PHARMACOL EXP THER, V273, P492; WANG HY, 1994, J NEUROCHEM, V63, P1720; Wang HY, 1993, SOC NEUR ABSTR, V19; WANG XH, 1995, BRAIN RES, V689, P32, DOI 10.1016/0006-8993(95)00528-X; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yablonsky-Alter E, 2005, J PHARMACOL EXP THER, V312, P297, DOI 10.1124/jpet.104.074062; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016; Zhen XC, 2001, J NEUROSCI, V21, P9160, DOI 10.1523/JNEUROSCI.21-23-09160.2001	40	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91671	10.1371/journal.pone.0091671	http://dx.doi.org/10.1371/journal.pone.0091671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626340	Green Published, gold			2022-12-27	WOS:000332851300118
J	Rao, XG; Huang, DF; Sui, XX; Liu, GF; Song, XH; Xie, JL; Huang, DY				Rao, Xuguang; Huang, Daofu; Sui, Xuxia; Liu, Gefei; Song, Xuhong; Xie, Jinglian; Huang, Dongyang			Overexpression of WRAP53 Is Associated with Development and Progression of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; EXPRESSION; GENE; P53; REGULATOR; ANTIGEN; TARGET; ROLES; RISK	Background: Esophageal squamous cell carcinoma (ESCC) is a highly aggressive cancer whose underlying molecular mechanisms are poorly understood. The natural antisense transcript (NAT) WRAP53 regulates p53 expression and WRAP53 protein is a component of telomerase. NATs play key roles in carcinogenesis, and although WRAP53 is known to increase cancer cell survival, its role in ESCC clinicopathology is unknown. The aim of this study was to investigate WRAP53 expression in ESCC and to correlate it with clinicopathological characteristics. Methods: WRAP53 mRNA and protein expression was measured by quantitative PCR (qRT-PCR) and western blotting, respectively, in 4 ESSC cells lines and in 45 paired ESCC and non-neoplastic esophageal mucosa tissues. To correlate WRAP53 protein expression with clinicopathological characteristics, immunohistochemistry (IHC) was performed on 134 ESCC and 85 non-neoplastic esophageal mucosa tissues. Results: Expression of WRAP53 was detected in all ESCC cell lines and was upregulated in the ESCC tissues compared with the corresponding non-neoplastic tissues (P<0.01). More cells expressed WRAP53 protein in the ESCC tissues than in the non-neoplastic tissues (P<0.01). Overexpression of WRAP53 was significantly correlated with tumor infiltration depth (P = 0.000), clinical stage (P = 0.001), and lymph node metastasis (P = 0.025). Wrap53 expression was not correlated with age, gender, or tumor differentiation. Conclusion: This report indicates increased expression of WRAP53 in ESCC and that WRAP53 overexpression is correlated with tumor progression. WRAP53 may play a significant role in ESCC; accordingly, WRAP53 could be a useful biomarker for ESCC.	[Rao, Xuguang; Huang, Daofu; Xie, Jinglian] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Thorac & Cardiovasc Surg, Shantou, Guangdong, Peoples R China; [Rao, Xuguang] Guangzhou Med Univ, Affiliated Canc Hosp, Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China; [Sui, Xuxia; Liu, Gefei; Song, Xuhong; Huang, Dongyang] Shantou Univ, Coll Med, Dept Cell Biol, Key Lab High Canc Incidence Coastal Chaoshan Area, Shantou, Guangdong, Peoples R China	Shantou University; Guangzhou Medical University; Shantou University	Huang, DY (corresponding author), Shantou Univ, Coll Med, Dept Cell Biol, Key Lab High Canc Incidence Coastal Chaoshan Area, Shantou, Guangdong, Peoples R China.	huangdy@stu.edu.cn			Guangdong Natural Science Foundation [10151503102000049, S2012030006289]; Natural Scientific Foundation of China [31371333]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Guangdong Natural Science Foundation (No. 10151503102000049 and No. S2012030006289) and Natural Scientific Foundation of China (31371333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; Cancer Institute of the Chinese Academy of Medical Sciences (CICAMS), 1976, CHIN MED J, V2, P357; Dolnick BJ, 2003, CANCER BIOL THER, V2, P364, DOI 10.4161/cbt.2.4.424; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Farnebo M, 2009, CELL CYCLE, V8, P2343, DOI 10.4161/cc.8.15.9223; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; Lam AKY, 2000, CRIT REV ONCOL HEMAT, V33, P71, DOI 10.1016/S1040-8428(99)00054-2; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Lin M, 2012, CHINESE SCI BULL, V57, P959, DOI 10.1007/s11434-011-4917-x; Lu XF, 2010, CELL MOL LIFE SCI, V67, P3313, DOI 10.1007/s00018-010-0382-y; Mahmoudi S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.90; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Metindir J, 2008, EUR J GYNAECOL ONCOL, V29, P489; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Oto OA, 2007, LEUKEMIA RES, V31, P1495, DOI 10.1016/j.leukres.2007.01.005; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Rossignol F, 2002, GENE, V299, P135, DOI 10.1016/S0378-1119(02)01049-1; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, CELL CYCLE, V8, P1329, DOI 10.4161/cc.8.9.8288; Wang LD, 2002, DIS ESOPHAGUS, V15, P80, DOI 10.1046/j.1442-2050.2002.00228.x; Wang N, 2009, MOL BIOL REP, V36, P357, DOI 10.1007/s11033-007-9187-y; Xu Xiao-chun, 2009, V471, P335, DOI 10.1007/978-1-59745-416-2_17; Yao XQ, 2004, WORLD J GASTROENTERO, V10, P1262; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhang SC, 2007, J MOL MED, V85, P1215, DOI 10.1007/s00109-007-0219-9; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	31	21	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91670	10.1371/journal.pone.0091670	http://dx.doi.org/10.1371/journal.pone.0091670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626331	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300117
J	Porolak, G; Dabek, L; Krockenberger, AK				Porolak, Gabriel; Dabek, Lisa; Krockenberger, Andrew K.			Spatial Requirements of Free-Ranging Huon Tree Kangaroos, Dendrolagus matschiei (Macropodidae), in Upper Montane Forest	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HOME-RANGE; HABITAT FRAGMENTATION; REPRODUCTIVE SUCCESS; BODY-SIZE; SPACE USE; FOOD; MAMMALS; ORGANIZATION; POPULATIONS	Tree kangaroos (Macropodidae, Dendrolagus) are some of Australasia's least known mammals. However, there is sufficient evidence of population decline and local extinctions that all New Guinea tree kangaroos are considered threatened. Understanding spatial requirements is important in conservation and management. Expectations from studies of Australian tree kangaroos and other rainforest macropodids suggest that tree kangaroos should have small discrete home ranges with the potential for high population densities, but there are no published estimates of spatial requirements of any New Guinea tree kangaroo species. Home ranges of 15 Huon tree kangaroos, Dendrolagus matschiei, were measured in upper montane forest on the Huon Peninsula, Papua New Guinea. The home range area was an average of 139.6 +/- 26.5 ha (100% MCP; n = 15) or 81.8 +/- 28.3 ha (90% harmonic mean; n = 15), and did not differ between males and females. Home ranges of D. matschiei were 40-100 times larger than those of Australian tree kangaroos or other rainforest macropods, possibly due to the impact of hunting reducing density, or low productivity of their high altitude habitat. Huon tree kangaroos had cores of activity within their range at 45% (20.9 +/- 4.1 ha) and 70% (36.6 +/- 7.5 ha) harmonic mean isopleths, with little overlap (4.8 +/- 2.9%; n = 15 pairs) between neighbouring females at the 45% isopleth, but, unlike the Australian species, extensive overlap between females (20.8 +/- 5.5%; n = 15 pairs) at the complete range (90% harmonic mean). Males overlapped each other and females to a greater extent than did pairs of females. From core areas and overlap, the density of female D. matschiei was one per 19.4 ha. Understanding the cause of this low density is crucial in gaining greater understanding of variations in density of tree kangaroos across the landscape. We consider the potential role of habitat fragmentation, productivity and hunting pressure in limiting tree kangaroo density in New Guinea rainforests.	[Porolak, Gabriel; Krockenberger, Andrew K.] James Cook Univ, Ctr Trop Biodivers & Climate Change, Cairns, Australia; [Porolak, Gabriel; Krockenberger, Andrew K.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Australia; [Porolak, Gabriel; Dabek, Lisa] Woodland Pk Zoo, Dept Field Conservat, Seattle, WA USA	James Cook University; James Cook University	Porolak, G (corresponding author), James Cook Univ, Ctr Trop Biodivers & Climate Change, Cairns, Australia.	gabriel.porolak@my.jcu.edu.au		Krockenberger, Andrew/0000-0003-2872-9939	National Geographic Society; Conservation International; Woodland Park Zoo; Roger Williams Park Zoo; American Zoo and Aquarium Association's (AZA) Tree Kangaroo Species Survival Plan	National Geographic Society(National Geographic Society); Conservation International; Woodland Park Zoo; Roger Williams Park Zoo; American Zoo and Aquarium Association's (AZA) Tree Kangaroo Species Survival Plan	The authors would like to acknowledge in-kind and financial support from the following institutions, the National Geographic Society (Grant of $19,900-Determining Activity Patterns, Home Range Size, and Habitat Use by the Matschie's Tree Kangaroo (Dendrolagus matschiei) on the Huon Peninsula, Papua New Guinea through Radiotelemetry), Conservation International, Woodland Park Zoo, Roger Williams Park Zoo, and the American Zoo and Aquarium Association's (AZA) Tree Kangaroo Species Survival Plan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bennett E., 2002, Conservation in Practice, V3, P28; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; BERGER J, 1990, CONSERV BIOL, V4, P91, DOI 10.1111/j.1523-1739.1990.tb00271.x; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; CLUTTONBROCK TH, 1989, NATURE, V337, P70, DOI 10.1038/337070a0; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; Coombes KE, 2005, THESIS J COOK U; Davies NB, 1991, BEHAV ECOLOGY EVOLUT; DIFFENDORFER JE, 1995, ECOLOGY, V76, P827, DOI 10.2307/1939348; DWYER PD, 1991, HUM ECOL, V19, P187, DOI 10.1007/BF00888745; DWYER PD, 1985, MAN, V20, P243, DOI 10.2307/2802383; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Evans M, 1996, WILDLIFE RES, V23, P547, DOI 10.1071/WR9960547; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Fisher DO, 2000, J ANIM ECOL, V69, P1083, DOI 10.1046/j.1365-2656.2000.00450.x; Flannery TF, 1996, TREE KANGAROOS CURIO, P84; FLEHARTY E D, 1973, Southwestern Naturalist, V18, P21, DOI 10.2307/3669907; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Fowler J., 1998, PRACTICAL STAT FIELD, P130; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; IMS RA, 1987, J ANIM ECOL, V56, P585, DOI 10.2307/5070; IMS RA, 1995, MOSAIC LANDSCAPES EC; IUCN, 2013, RED LIST THREAT SPEC; Jensen R, 2005, GEN COLLECTION FLORA; JOHNSON CN, 1986, BEHAV ECOL SOCIOBIOL, V19, P143, DOI 10.1007/BF00299949; Jonsson P, 2002, EVOL ECOL, V16, P455, DOI 10.1023/A:1020854525220; Kenward R., 1996, RANGES 5 ANAL SYSTEM; Kenward RE., 2000, MANUAL WILDLIFE RADI; Leary T, 2009, IUCN RED LIST THREAT; Lieth H, 1975, PRIMARY PRODUCTIVITY; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; Mack LA, 2005, 61 RES MAN AS PAC, P1; MARES MA, 1976, OECOLOGIA, V25, P1, DOI 10.1007/BF00345029; Martin R., 1992, Australian Natural History, V24, P22; Martin R, 2005, AUSTRAL NAT HIST SER, P1; Martin RW, 1996, TREE KANGAROOS CURIO, P36; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; METZGAR LH, 1979, J MAMMAL, V60, P129, DOI 10.2307/1379764; Newell GR, 1999, BIOL CONSERV, V91, P181, DOI 10.1016/S0006-3207(99)00083-X; Newell GR, 1999, WILDLIFE RES, V26, P129, DOI 10.1071/WR98016; Pellissier L, 2012, ECOL EVOL, V2, P1818, DOI 10.1002/ece3.296; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Procter-Gray E., 1984, P129; Rapp JM, 2012, ECOLOGY, V93, P2061, DOI 10.1890/11-1725.1; Robinson EJ, 2000, HUNTING SUSTAINABILI; ROLSTAD J, 1991, BIOL J LINN SOC, V42, P149, DOI 10.1111/j.1095-8312.1991.tb00557.x; ROSENZWEIG ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Schradin C, 2010, ANIM BEHAV, V79, P195, DOI 10.1016/j.anbehav.2009.10.027; SCOTT JM, 1993, WILDLIFE MONOGR, P1; SLOBODCHIKOFF CN, 1984, NEW ECOLOGY NOVEL AP; Steadman DW, 2002, HUM ECOL, V30, P339, DOI 10.1023/A:1016520602698; TAITT MJ, 1981, J ANIM ECOL, V50, P125, DOI 10.2307/4036; Terborgh J, 1980, CONSERVATION BIOL EC; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; van der Ree R, 2003, J ZOOL, V259, P327, DOI 10.1017/S0952836902003229; van der Ree R, 2001, WILDLIFE RES, V28, P517, DOI 10.1071/WR00051; White G.C., 1990, ANAL WILDLIFE RADIO; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wittenberger JF, 1981, ANIMAL SOCIAL BEHA; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959; Yahner RH, 1997, CONSERV BIOL, V11, P569, DOI 10.1046/j.1523-1739.1997.96322.x	63	4	4	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91870	10.1371/journal.pone.0091870	http://dx.doi.org/10.1371/journal.pone.0091870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642914	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000333259900042
J	Sartorius, T; Peter, A; Schulz, N; Drescher, A; Bergheim, I; Machann, J; Schick, F; Siegel-Axel, D; Schurmann, A; Weigert, C; Haring, HU; Hennige, AM				Sartorius, Tina; Peter, Andreas; Schulz, Nadja; Drescher, Andrea; Bergheim, Ina; Machann, Juergen; Schick, Fritz; Siegel-Axel, Dorothea; Schuermann, Annette; Weigert, Cora; Haering, Hans-Ulrich; Hennige, Anita M.			Cinnamon Extract Improves Insulin Sensitivity in the Brain and Lowers Liver Fat in Mouse Models of Obesity	PLOS ONE			English	Article							FASTING BLOOD-GLUCOSE; IN-VITRO; ANTIOXIDANT ACTIVITY; ESSENTIAL OILS; GLYCOGEN; EUGENOL; CINNAMALDEHYDE; INFLAMMATION; INHIBITION; OVERWEIGHT	Objectives: Treatment of diabetic subjects with cinnamon demonstrated an improvement in blood glucose concentrations and insulin sensitivity but the underlying mechanisms remained unclear. This work intends to elucidate the impact of cinnamon effects on the brain by using isolated astrocytes, and an obese and diabetic mouse model. Methods: Cinnamon components (eugenol, cinnamaldehyde) were added to astrocytes and liver cells to measure insulin signaling and glycogen synthesis. Ob/ob mice were supplemented with extract from cinnamomum zeylanicum for 6 weeks and cortical brain activity, locomotion and energy expenditure were evaluated. Insulin action was determined in brain and liver tissues. Results: Treatment of primary astrocytes with eugenol promoted glycogen synthesis, whereas the effect of cinnamaldehyde was attenuated. In terms of brain function in vivo, cinnamon extract improved insulin sensitivity and brain activity in ob/ob mice, and the insulin-stimulated locomotor activity was improved. In addition, fasting blood glucose levels and glucose tolerance were greatly improved in ob/ob mice due to cinnamon extracts, while insulin secretion was unaltered. This corresponded with lower triglyceride and increased liver glycogen content and improved insulin action in liver tissues. In vitro, Fao cells exposed to cinnamon exhibited no change in insulin action. Conclusions: Together, cinnamon extract improved insulin action in the brain as well as brain activity and locomotion. This specific effect may represent an important central feature of cinnamon in improving insulin action in the brain, and mediates metabolic alterations in the periphery to decrease liver fat and improve glucose homeostasis.	[Sartorius, Tina; Peter, Andreas; Drescher, Andrea; Siegel-Axel, Dorothea; Weigert, Cora; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany; [Sartorius, Tina; Schulz, Nadja; Machann, Juergen; Schuermann, Annette; Weigert, Cora; Haering, Hans-Ulrich; Hennige, Anita M.] German Ctr Diabet Res DZD, Tubingen, Germany; [Sartorius, Tina; Machann, Juergen; Weigert, Cora; Haering, Hans-Ulrich; Hennige, Anita M.] Univ Tuebingen IDM, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Tubingen, Germany; [Schulz, Nadja; Schuermann, Annette] German Inst Human Nutr, Dept Expt Diabetol, Potsdam, Germany; [Bergheim, Ina] Univ Jena, Dept Nutr Sci, SD Model Syst Mol Nutr, Jena, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Sartorius, T (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany.	tina.sartorius@med.uni-tuebingen.de		Schick, Fritz/0000-0002-4231-3406; Schurmann, Annette/0000-0002-4113-4377	German Federal Ministry of Education and Research (BMBF) [01GI0925]; University of Tuebingen	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); University of Tuebingen	The project was supported in part by grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.; 01GI0925). Additional parts of the funding are internal department funds of the University of Tuebingen (employment of people at the University of Tuebingen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler JA, 2007, DIABETES CARE, V30, P813, DOI 10.2337/dc06-1871; Anand P, 2010, CHEM-BIOL INTERACT, V186, P72, DOI 10.1016/j.cbi.2010.03.044; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Chericoni S, 2005, J AGR FOOD CHEM, V53, P4762, DOI 10.1021/jf050183e; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Couturier K, 2011, METABOLISM, V60, P1590, DOI 10.1016/j.metabol.2011.03.016; Davis PA, 2011, J MED FOOD, V14, P884, DOI 10.1089/jmf.2010.0180; Deepa B, 2013, TOXICOL MECH METHOD, V23, P223, DOI 10.3109/15376516.2012.743638; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Gruenwald J, 2010, CRIT REV FOOD SCI, V50, P822, DOI 10.1080/10408390902773052; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Hennige AM, 2006, DIABETOLOGIA, V49, P1274, DOI 10.1007/s00125-006-0192-9; Hennige AM, 2005, DIABETES, V54, P361, DOI 10.2337/diabetes.54.2.361; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Ho YS, 2010, AGEING RES REV, V9, P354, DOI 10.1016/j.arr.2009.10.001; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215; Kleinridders A, 2009, CURR OPIN PHARMACOL, V9, P794, DOI 10.1016/j.coph.2009.10.006; Lu T, 2012, NUTR RES, V32, P408, DOI 10.1016/j.nutres.2012.05.003; Lungarini S, 2008, FOOD ADDIT CONTAM A, V25, P1297, DOI 10.1080/02652030802105274; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Nagababu E, 2010, METHODS MOL BIOL, V610, P165, DOI 10.1007/978-1-60327-029-8_10; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Rafehi H, 2012, DIABETES OBES METAB, V14, P493, DOI 10.1111/j.1463-1326.2011.01538.x; Ranasinghe P, 2012, DIABETIC MED, V29, P1480, DOI 10.1111/j.1464-5491.2012.03718.x; Roussel AM, 2009, J AM COLL NUTR, V28, P16, DOI 10.1080/07315724.2009.10719756; Sartorius T, 2012, CELL PHYSIOL BIOCHEM, V30, P238, DOI 10.1159/000339060; Sartorius T, 2012, DIABETES, V61, P1669, DOI 10.2337/db11-1521; Sartorius T, 2012, FASEB J, V26, P1799, DOI 10.1096/fj.11-191023; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; Sebai H, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-189; Shimada Y, 2000, PHYTOTHER RES, V14, P466, DOI 10.1002/1099-1573(200009)14:6&lt;466::AID-PTR614&gt;3.0.CO;2-Z; Simic A, 2004, PHYTOTHER RES, V18, P713, DOI 10.1002/ptr.1516; Singh G, 2007, FOOD CHEM TOXICOL, V45, P1650, DOI 10.1016/j.fct.2007.02.031; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Suppapitiporn Suchat, 2006, J Med Assoc Thai, V89 Suppl 3, pS200; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Tschritter O, 2009, J CLIN ENDOCR METAB, V94, P4600, DOI 10.1210/jc.2009-0469; Tsou RC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00192; Usta J, 2003, HUM EXP TOXICOL, V22, P355, DOI 10.1191/0960327103ht379oa; Usta J, 2002, FOOD CHEM TOXICOL, V40, P935, DOI 10.1016/S0278-6915(02)00071-6; Vuksan V, 2005, NUTR METAB CARDIOVAS, V15, P149, DOI 10.1016/j.numecd.2005.05.001; Wickenbere J, 2012, BRIT J NUTR, V107, P1845, DOI 10.1017/S0007114511005113; Wie MB, 1997, NEUROSCI LETT, V225, P93, DOI 10.1016/S0304-3940(97)00195-X; Yu IC, 2013, DIABETES, V62, P411, DOI 10.2337/db12-0135; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	54	61	64	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92358	10.1371/journal.pone.0092358	http://dx.doi.org/10.1371/journal.pone.0092358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643026	Green Published, gold			2022-12-27	WOS:000333259900125
J	Binder, M; Roberts, C; Spencer, N; Antoine, D; Cartwright, C				Binder, Michaela; Roberts, Charlotte; Spencer, Neal; Antoine, Daniel; Cartwright, Caroline			On the Antiquity of Cancer: Evidence for Metastatic Carcinoma in a Young Man from Ancient Nubia (c. 1200BC)	PLOS ONE			English	Article							MYELOMA BONE-DISEASE; EPIDEMIOLOGIC TRANSITION; TUMOR; RISK; DIAGNOSIS; KNOWLEDGE; PATTERNS; SKELETON; HUMANS; ORIGIN	Cancer, one of the world's leading causes of death today, remains almost absent relative to other pathological conditions, in the archaeological record, giving rise to the conclusion that the disease is mainly a product of modern living and increased longevity. This paper presents a male, young-adult individual from the archaeological site of Amara West in northern Sudan (c. 1200BC) displaying multiple, mainly osteolytic, lesions on the vertebrae, ribs, sternum, clavicles, scapulae, pelvis, and humeral and femoral heads. Following radiographic, microscopic and scanning electron microscopic (SEM) imaging of the lesions, and a consideration of differential diagnoses, a diagnosis of metastatic carcinoma secondary to an unknown soft tissue cancer is suggested. This represents the earliest complete example in the world of a human who suffered metastatic cancer to date. The study further draws its strength from modern analytical techniques applied to differential diagnoses and the fact that it is firmly rooted within a well-documented archaeological and historical context, thus providing new insights into the history and antiquity of the disease as well as its underlying causes and progression.	[Binder, Michaela; Roberts, Charlotte] Univ Durham, Dept Archaeol, Durham, England; [Spencer, Neal; Antoine, Daniel] British Museum, Dept Ancient Egypt & Sudan, London WC1B 3DG, England; [Cartwright, Caroline] British Museum, Dept Conservat & Sci Res, London WC1B 3DG, England	Durham University; Natural History Museum London; Natural History Museum London	Binder, M (corresponding author), Univ Durham, Dept Archaeol, Durham, England.	michaela.binder@durham.ac.uk	Roberts, Charlotte Ann/H-2622-2019	Roberts, Charlotte Ann/0000-0002-2259-807X; Spencer, Neal/0000-0002-3443-2341; Binder, Michaela/0000-0002-3105-5878; Antoine, Daniel/0000-0002-7262-8812	Leverhulme Trust [F/00 052/C]; Institute for Bioarchaeology at the British Museum	Leverhulme Trust(Leverhulme Trust); Institute for Bioarchaeology at the British Museum	Funding for the project was provided by a research grant (Grant number F/00 052/C) of the Leverhulme Trust http://www.leverhulme.ac.uk/. Additional funding was obtained from the Institute for Bioarchaeology at the British Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2010, J CLIN ONCOL, V28, P232, DOI 10.1200/JCO.2009.23.8162; Aufderheide A.C., 2003, SCI STUDY MUMMIES; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Awadelkarim KD, 2012, SCI TOTAL ENVIRON, V423, P214, DOI 10.1016/j.scitotenv.2010.09.010; BAKER BJ, 2012, GLOBAL HIST PALEOPAT, P209; Barrett R, 1998, ANNU REV ANTHROPOL, V27, P247, DOI 10.1146/annurev.anthro.27.1.247; Bartsch Helmut, 2007, V174, P19; Bertram John S., 2000, Molecular Aspects of Medicine, V21, P167, DOI 10.1016/S0098-2997(00)00007-8; Binder M, REGARDING D IN PRESS; Binder M., 2011, SUDAN NUBIA, V15, P39; Binder M, 2011, BRIT MUSEUM STUDIES, P16; Binet S, 2002, SCI TOTAL ENVIRON, V300, P37, DOI 10.1016/S0048-9697(02)00279-6; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P95, DOI 10.1590/S0074-02762003000900015; Boyle P, 2008, WORLD CANC REPORT 20; Breasted J.H., 1930, EDWIN SMITH SURG PAP; Brickley M., 2004, GUIDELINES STANDARDS, P23; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brothwell D, 2012, BLACKW COMPANION ANT, P420; Brown PJ, 2011, BLACKW COMPANION ANT, P253; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Buikstra J.E., 2012, GLOBAL HIST PALEOPAT; Buikstra J. E., 1994, STANDARDS DATA COLLE; Buzdar Aman U, 2003, Oncology (Williston Park), V17, P1361; Capasso LL, 2005, INT J CANCER, V113, P2, DOI 10.1002/ijc.20610; Chamberlain A.T., 2006, DEMOGRAPHY ARCHAEOLO; Cox M, 2000, HUMAN OSTEOLOGY ARCH, P61; David AR, 2010, NAT REV CANCER, V10, P728, DOI 10.1038/nrc2914; Delgado J, 2005, CHEST, V128, P124, DOI 10.1378/chest.128.1.124; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Dorfman H.D., 1998, BONE TUMORS; Dupras T, 2014, 41 ANN M PAL ASS; Esche E, 2010, ANTHROPOLOGIE, V48, P33; Fornaciari G, 1999, INT J OSTEOARCHAEOL, V9, P302; Franceschi S, 2013, MOL ONCOL, V7, P1, DOI 10.1016/j.molonc.2012.10.010; Frank SA, 2004, NAT REV GENET, V5, P764, DOI 10.1038/nrg1450; Gabler K, 2009, THESIS LUDWIG MAXIMI; Gladykowska-Rzeczycka J., 1991, HUMAN PALEOPATHOLOGY, P251; Hershkovitz I, 1998, AM J PHYS ANTHROPOL, V106, P47, DOI 10.1002/(SICI)1096-8644(199805)106:1<47::AID-AJPA4>3.0.CO;2-A; Hibbs AC, 2011, AM J PHYS ANTHROPOL, V145, P290, DOI 10.1002/ajpa.21493; Ho J H, 1972, Adv Cancer Res, V15, P57, DOI 10.1016/S0065-230X(08)60372-3; Huchet JB, 2013, J ARCHAEOL SCI, V40, P3793, DOI 10.1016/j.jas.2013.04.025; Huchet JB, 2011, INT J OSTEOARCHAEOL, V21, P92, DOI 10.1002/oa.1110; HUEPER WC, 1963, ANN NY ACAD SCI, V108, P963, DOI 10.1111/j.1749-6632.1963.tb13433.x; Karpozilos A, 2004, EUR J CANCER, V40, P2033, DOI 10.1016/j.ejca.2004.04.036; Layer G., 2005, HDB DIAGNOSTISCHE RA, V2, P327, DOI [10.1007/b137523, DOI 10.1007/B137523]; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Manderson L, 2011, BLACKW COMPANION ANT, P323; Marks MK, 2007, INT J OSTEOARCHAEOL, V17, P217, DOI 10.1002/oa.874; McKeown RE, 2009, AM J LIFESTYLE MED, V3, p19S, DOI 10.1177/1559827609335350; MILLER RL, 1992, BRIT MED J, V304, P555, DOI 10.1136/bmj.304.6826.555; Mukherjee S., 2012, J POSTGRAD MED ED RE, V46, P112, DOI [10.5005/jp-journals-10028-1025, DOI 10.5005/JP-JOURNALS-10028-1025]; Mustacchi P, 2003, HOLLAND FREI CANC ME; Nerlich AG, 2006, ONCOL REP, V16, P197; Nesse R.M., 1994, WHY WE GET SICK NEW; Nunn JF., 2002, ANCIENT EGYPTIAN MED; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Pahl W. M., 1986, INT J ANTHR, V1, P267, DOI [10.1007/BF02442041, DOI 10.1007/BF02442041]; Parkin Tim G., 2003, OLD AGE ROMAN WORLD; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Prates C, 2011, INT J PALEOPATHOL, V1, P98, DOI 10.1016/j.ijpp.2011.09.002; Resnick D, 1995, DIAGNOSIS BONE JOINT; REYMAN TA, 1977, CAN MED ASSOC J, V117, P470; Rokhlin D, 1966, DIS ANCIENT MAN; Rothschild BM, 1998, AM J PHYS ANTHROPOL, V105, P241, DOI 10.1002/(SICI)1096-8644(199802)105:2<241::AID-AJPA10>3.0.CO;2-0; ROTHSCHILD BM, 1995, AM J PHYS ANTHROPOL, V96, P357, DOI 10.1002/ajpa.1330960404; Ryan P., 2012, BRIT MUS TECHN RES B, V6, P97; Sanchez G.M., 2012, EDWIN SMITH PAPYRUS; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Schlott T, 2007, ANTICANCER RES, V27, P4117; Schultz M, 2007, INT J CANCER, V121, P2591, DOI 10.1002/ijc.23073; Serpico M., 2000, ANCIENT EGYPTIAN MAT; Sezer O, 2009, ONCOLOGIST, V14, P276, DOI 10.1634/theoncologist.2009-0003; Sitas F, 2008, LANCET ONCOL, V9, P786, DOI 10.1016/S1470-2045(08)70198-0; SMITH S, 2003, WRETCHED KUSH; Spencer N, P 12 INT C IN PRESS; Spencer N., 2012, SUDAN NUBIA, V16, P37; Spencer N., 2012, ANTIKE SUDAN, V23, P21; Spencer P, 1997, ARCHITECTURAL REPORT; Stearns SC, 2012, P ROY SOC B-BIOL SCI, V279, P4305, DOI 10.1098/rspb.2012.1326; STROUHAL E, 1976, AM J PHYS ANTHROPOL, V45, P613, DOI 10.1002/ajpa.1330450328; Strouhal E, 1993, Anthropol Anz, V51, P97; STROUHAL E, 1981, Ossa, V8, P165; STROUHAL E, 1978, B NEW YORK ACAD MED, V54, P290; Strouhal E, 1994, PALEOPATHOLOGY NEW S, V85, P1; STROUHAL E., 2001, P 13 EUR M PAL ASS, P265; Strouhal E, 1991, J PALEOPATHOLOGY, V3, P51; Strouhal E, 1990, ANTHROPOLOGIE, V28, P78; Strouhal E., 1982, OSSA, V8, P165; Strouhal E., 1991, INT J OSTEOARCHAEOL, V1, P219, DOI DOI 10.1002/OA.1390010314; Van Pelt WP, CAMBRIDGE ARCHAEOLOG, V23; Wells C., 1963, J LARYNGOL OTOL, V77, P261, DOI [10.1017/S0022215100060606, DOI 10.1017/S0022215100060606]; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Yaccoby S, 2010, BRIT J HAEMATOL, V149, P311, DOI 10.1111/j.1365-2141.2010.08141.x; Zuckerman MK, 2012, BLACKW COMPANION ANT, P34; [No title captured]	95	48	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90924	10.1371/journal.pone.0090924	http://dx.doi.org/10.1371/journal.pone.0090924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AD4XD	24637948	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000333254100013
J	Lehmann, A; Kliewer, A; Martens, JC; Nagel, F; Schulz, S				Lehmann, Andreas; Kliewer, Andrea; Maertens, Jan Carlo; Nagel, Falko; Schulz, Stefan			Carboxyl-Terminal Receptor Domains Control the Differential Dephosphorylation of Somatostatin Receptors by Protein Phosphatase 1 Isoforms	PLOS ONE			English	Article							ARRESTIN BINDING; CUSHINGS-DISEASE; INTERNALIZATION; PHOSPHORYLATION	We have recently identified protein phosphatase 1 beta (PP1 beta) as G protein-coupled receptor (GPCR) phosphatase for the sst(2) somatostatin receptor using siRNA knockdown screening. By contrast, for the sst(5) somatostatin receptor we identified protein phosphatase 1 gamma (PP1 gamma) as GPCR phosphatase using the same approach. We have also shown that sst(2) and sst(5) receptors differ substantially in the temporal dynamics of their dephosphorylation and trafficking patterns. Whereas dephosphorylation and recycling of the sst(2) receptor requires extended time periods of similar to 30 min, dephosphorylation and recycling of the sst(5) receptor is completed in less than 10 min. Here, we examined which receptor domains determine the selection of phosphatases for receptor dephosphorylation. We found that generation of tail-swap mutants between sst(2) and sst(5) was required and sufficient to reverse the patterns of dephosphorylation and trafficking of these two receptors. In fact, siRNA knockdown confirmed that the sst(5) receptor carrying the sst(2) tail is predominantly dephosphorylated by PP1 beta, whereas the sst(2) receptor carrying the sst(5) tail is predominantly dephosphorylated by PP1 gamma. Thus, the GPCR phosphatase responsible for dephosphorylation of individual somatostatin receptor subtypes is primarily determined by their different carboxyl-terminal receptor domains. This phosphatase specificity has in turn profound consequences for the dephosphorylation dynamics and trafficking patterns of GPCRs.	[Lehmann, Andreas; Kliewer, Andrea; Maertens, Jan Carlo; Nagel, Falko; Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, Jena Univ Hosp, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Schulz, S (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Jena Univ Hosp, Lobderstr 1, D-07743 Jena, Germany.	Stefan.Schulz@mti.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885	Deutsche Forschungsgemeinschaft [SCHU924/10-3]; Deutsche Krebshilfe grant [109952]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe grant(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft grant SCHU924/10-3 and the Deutsche Krebshilfe grant 109952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choy MS, 2012, BIOCHEM SOC T, V40, P969, DOI 10.1042/BST20120094; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Doll C, 2012, BRIT J PHARMACOL, V167, P1259, DOI 10.1111/j.1476-5381.2012.02080.x; Donangelo I, 2005, ENDOCRINE, V28, P131, DOI 10.1385/ENDO:28:2:131; Feelders RA, 2013, J CLIN ENDOCR METAB, V98, P425, DOI 10.1210/jc.2012-3126; Gatto F, 2013, J CLIN ENDOCR METAB, V98, pE66, DOI 10.1210/jc.2012-2609; Gehret AU, 2013, ACS CHEM BIOL, V8, P588, DOI 10.1021/cb3004513; Krueger KM, 1997, J BIOL CHEM, V272, P5; Liu Q, 2008, MOL PHARMACOL, V73, P292, DOI 10.1124/mol.107.038570; Oberg KE, 2010, GASTROENTEROLOGY, V139, P742, DOI 10.1053/j.gastro.2010.07.002; Petrich A, 2013, MOL ENDOCRINOL, V24, P436; Peverelli E, 2008, MOL ENDOCRINOL, V22, P676, DOI 10.1210/me.2007-0068; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; Poll F, 2011, J BIOL CHEM, V286, P32931, DOI 10.1074/jbc.M111.224899; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200	15	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91526	10.1371/journal.pone.0091526	http://dx.doi.org/10.1371/journal.pone.0091526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637622	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100041
J	Mussolin, C; Nys, J; Content, A; Leybaert, J				Mussolin, Christophe; Nys, Julie; Content, Alain; Leybaert, Jacqueline			Symbolic Number Abilities Predict Later Approximate Number System Acuity in Preschool Children	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; SENSE; REPRESENTATIONS; DISCRIMINATION; DISABILITIES; ACHIEVEMENT; SUBTRACTION; JUDGMENTS; KNOWLEDGE	An ongoing debate in research on numerical cognition concerns the extent to which the approximate number system and symbolic number knowledge influence each other during development. The current study aims at establishing the direction of the developmental association between these two kinds of abilities at an early age. Fifty-seven children of 3-4 years performed two assessments at 7 months interval. In each assessment, children's precision in discriminating numerosities as well as their capacity to manipulate number words and Arabic digits was measured. By comparing relationships between pairs of measures across the two time points, we were able to assess the predictive direction of the link. Our data indicate that both cardinality proficiency and symbolic number knowledge predict later accuracy in numerosity comparison whereas the reverse links are not significant. The present findings are the first to provide longitudinal evidence that the early acquisition of symbolic numbers is an important precursor in the developmental refinement of the approximate number representation system.	[Mussolin, Christophe; Nys, Julie; Content, Alain; Leybaert, Jacqueline] Univ Libre Bruxelles, Ctr Res Cognit & Neurosci, Lab Cognit Language Dev, Brussels, Belgium	Universite Libre de Bruxelles	Mussolin, C (corresponding author), Univ Libre Bruxelles, Ctr Res Cognit & Neurosci, Lab Cognit Language Dev, Brussels, Belgium.	christophe.mussolin@ulb.ac.be		Content, Alain/0000-0003-4170-463X	National Fund for Scientific Research (Belgium)	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The first author is supported by a grant from the National Fund for Scientific Research (Belgium). The authors declare no conflict of interest that might be interpreted as influencing the research, and APA ethical standards were followed in the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Brannon EM, 2002, COGNITION, V83, P223, DOI 10.1016/S0010-0277(02)00005-7; Brannon EM, 2001, COGNITIVE PSYCHOL, V43, P53, DOI 10.1006/cogp.2001.0756; Briars D.J., 1988, CHILDRENS COUNTING C, P63; Brunswick N, 2012, J EXP CHILD PSYCHOL, V111, P268, DOI 10.1016/j.jecp.2011.08.001; Carey S, 2001, MIND LANG, V16, P37, DOI 10.1111/1468-0017.00155; Carey S, 2004, DAEDALUS-US, V133, P59, DOI 10.1162/001152604772746701; Carey Susan, 2009, OXFORD SERIES COGNIT; Chevrie-Muller C., 2001, NOUVELLES EPREUVES E; Coquet F, 2007, REEDUCATION ORTHOPHO, V231, P203; Corsi PM, 1972, THESIS MONTREAL; CRANO WD, 1978, J EDUC PSYCHOL, V70, P39, DOI 10.1037/0022-0663.70.1.39; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; Dehaene S, 1997, NUMBER SENSE MIND CR; DeWind NK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00068; ELLIS N, 1988, APPL COGNITIVE PSYCH, V2, P47, DOI 10.1002/acp.2350020106; Elzhov TV, 2012, R INTERFACE LEVENBER; Gallistel C. R., 2005, CAMBRIDGE HDB THINKI, P559, DOI [DOI 10.1037/002775, 10.1037/002775]; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Gelman R., 1978, CHILDS UNDERSTANDING; Gilmore CK, 2007, NATURE, V447, P589, DOI 10.1038/nature05850; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Huntley-Fenner G, 2000, PSYCHOL SCI, V11, P147, DOI 10.1111/1467-9280.00230; Inglis M, 2014, ACTA PSYCHOL, V145, P147, DOI 10.1016/j.actpsy.2013.11.009; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2012, ACTA PSYCHOL, V141, P373, DOI 10.1016/j.actpsy.2012.09.009; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lindskog M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00510; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lonnemann J, 2011, J NEUROLINGUIST, V24, P583, DOI 10.1016/j.jneuroling.2011.02.004; Luo YLL, 2011, LEARN INDIVID DIFFER, V21, P710, DOI 10.1016/j.lindif.2011.09.001; Lyons IM, 2011, COGNITION, V121, P256, DOI 10.1016/j.cognition.2011.07.009; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2009, 5 LOOKS 6 DEFICIT NU; Mussolin C, 2012, TRENDS NEUROSCI EDUC, V1, P21, DOI 10.1016/j.tine.2012.09.003; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Noel MP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00165; Nys J, 2013, TRENDS NEUROSCI EDUC, V2, P13, DOI 10.1016/j.tine.2013.01.001; Ostad SA, 1997, BRIT J EDUC PSYCHOL, V67, P345, DOI 10.1111/j.2044-8279.1997.tb01249.x; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Price GR, 2012, ACTA PSYCHOL, V140, P50, DOI 10.1016/j.actpsy.2012.02.008; Quartana PJ, 2010, PAIN, V149, P325, DOI 10.1016/j.pain.2010.02.029; Raven J.C., 1977, RAVENS COLOURED PROG; ROGOSA D, 1980, PSYCHOL BULL, V88, P245, DOI 10.1037/0033-2909.88.2.245; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Schneider W., 2002, E PRIME VERSION 20 C; SEKULER R, 1977, CHILD DEV, V48, P630, DOI 10.1111/j.1467-8624.1977.tb01208.x; Shalev R. S., 2007, WHY IS MATH SO HARD, P49; Sikora P, 2008, WORK STRESS, V22, P51, DOI 10.1080/02678370801999651; Slaughter V, 2006, DEVELOPMENTAL SCI, V9, P33, DOI 10.1111/j.1467-7687.2005.00460.x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Temple E, 1998, P NATL ACAD SCI USA, V95, P7836, DOI 10.1073/pnas.95.13.7836; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Van Nieuwenhoven C., 2001, TEST DIAGNOSTIQUE CO; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; von Aster M., 2006, ZAREKI R BATTERIE EV; Wagner JB, 2011, COGNITION, V119, P10, DOI 10.1016/j.cognition.2010.11.014; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	74	58	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91839	10.1371/journal.pone.0091839	http://dx.doi.org/10.1371/journal.pone.0091839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637785	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100066
J	Sanghera, S; Roberts, TE; Barton, P; Frew, E; Daniels, J; Middleton, L; Gennard, L; Kai, J; Gupta, JK				Sanghera, Sabina; Roberts, Tracy Elizabeth; Barton, Pelham; Frew, Emma; Daniels, Jane; Middleton, Lee; Gennard, Laura; Kai, Joe; Gupta, Janesh Kumar			Levonorgestrel-Releasing Intrauterine System vs. Usual Medical Treatment for Menorrhagia: An Economic Evaluation Alongside a Randomised Controlled Trial	PLOS ONE			English	Article							COST-EFFECTIVENESS; HYSTERECTOMY; WOMEN; ABLATION; THERAPY; HEALTH; SF-6D; EQ-5D	Objective: To undertake an economic evaluation alongside the largest randomised controlled trial comparing Levonorgestrel-releasing intrauterine device ('LNG-IUS') and usual medical treatment for women with menorrhagia in primary care; and compare the cost-effectiveness findings using two alternative measures of quality of life. Methods: 571 women with menorrhagia from 63 UK centres were randomised between February 2005 and July 2009. Women were randomised to having a LNG-IUS fitted, or usual medical treatment, after discussing with their general practitioner their contraceptive needs or desire to avoid hormonal treatment. The treatment was specified prior to randomisation. For the economic evaluation we developed a state transition (Markov) model with a 24 month follow-up. The model structure was informed by the trial women's pathway and clinical experts. The economic evaluation adopted a UK National Health Service perspective and was based on an outcome of incremental cost per Quality Adjusted Life Year (QALY) estimated using both EQ-5D and SF-6D. Results: Using EQ-5D, LNG-IUS was the most cost-effective treatment for menorrhagia. LNG-IUS costs pound 100 more than usual medical treatment but generated 0.07 more QALYs. The incremental cost-effectiveness ratio for LNG-IUS compared to usual medical treatment was 1600 pound per additional QALY. Using SF-6D, usual medical treatment was the most cost-effective treatment. Usual medical treatment was both less costly (100) pound and generated 0.002 more QALYs. Conclusion: Impact on quality of life is the primary indicator of treatment success in menorrhagia. However, the most cost-effective treatment differs depending on the quality of life measure used to estimate the QALY. Under UK guidelines LNG-IUS would be the recommended treatment for menorrhagia. This study demonstrates that the appropriate valuation of outcomes in menorrhagia is crucial.	[Sanghera, Sabina; Roberts, Tracy Elizabeth; Barton, Pelham; Frew, Emma] Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England; [Daniels, Jane; Gupta, Janesh Kumar] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Daniels, Jane; Middleton, Lee; Gennard, Laura] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Kai, Joe] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Kai, Joe] Univ Nottingham, Natl Inst Hlth Res, Nottingham NG7 2RD, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Nottingham; University of Nottingham	Roberts, TE (corresponding author), Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England.	T.E.Roberts@bham.ac.uk	Frew, Emma/AAO-5141-2021; Roberts, Tracy/AAO-4610-2021	Frew, Emma/0000-0002-5462-1158; Roberts, Tracy/0000-0002-0624-0537; Middleton, Lee/0000-0003-4621-1922; Kai, Joe/0000-0001-9040-9384; Sanghera, Sabina/0000-0001-8387-3103	NIHR Health Technology Assessment Programme; National Institute for Health Research [02/06/02] Funding Source: researchfish	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding provided by the NIHR Health Technology Assessment Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal PD, 2006, CONTRACEPTION, V74, P249, DOI 10.1016/j.contraception.2006.03.024; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Curtis L, 2015, UNIT COSTS HLTH SOCI; Daniels JP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2564; Endrikat J, 2012, ARCH GYNECOL OBSTET, V285, P117, DOI 10.1007/s00404-011-1902-1; Gupta J, 2013, NEW ENGL J MED, V368, P128, DOI 10.1056/NEJMoa1204724; Hurskainen R, 2004, JAMA-J AM MED ASSOC, V291, P1456, DOI 10.1001/jama.291.12.1456; Joint formulary committee, 2011, BRIT NAT FORM 62; National Collaborating Centre for Women's and Children's Health, 2007, HEAV MENSTR BLEED; National Institute for Health and Clinical Excellence, 2008, GUID METH TECHN APPR; Office of Population Censuses and Surveys, 1995, MORB STAT GEN PRACT; Roberts TE, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2202; Royal College of Obstetricians and Gynaecologists, 1998, IN MAN MEN; Sanghera S, 2013, SOC SCI MED, V98, P149, DOI 10.1016/j.socscimed.2013.09.016; Shapley M, 2002, BRIT J GEN PRACT, V52, P108; Stewart A, 2001, BRIT J OBSTET GYNAEC, V108, P74, DOI 10.1016/S0306-5456(00)00020-6; Whitehurst DGT, 2011, VALUE HEALTH, V14, P531, DOI 10.1016/j.jval.2010.09.002; You JHS, 2006, HUM REPROD, V21, P1878, DOI 10.1093/humrep/del088	20	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91891	10.1371/journal.pone.0091891	http://dx.doi.org/10.1371/journal.pone.0091891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638071	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100075
J	Plaganyi, EE; van Putten, I; Thebaud, O; Hobday, AJ; Innes, J; Lim-Camacho, L; Norman-Lopez, A; Bustamante, RH; Farmery, A; Fleming, A; Frusher, S; Green, B; Hoshino, E; Jennings, S; Pecl, G; Pascoe, S; Schrobback, P; Thomas, L				Plaganyi, Eva E.; van Putten, Ingrid; Thebaud, Olivier; Hobday, Alistair J.; Innes, James; Lim-Camacho, Lilly; Norman-Lopez, Ana; Bustamante, Rodrigo H.; Farmery, Anna; Fleming, Aysha; Frusher, Stewart; Green, Bridget; Hoshino, Eriko; Jennings, Sarah; Pecl, Gretta; Pascoe, Sean; Schrobback, Peggy; Thomas, Linda			A Quantitative Metric to Identify Critical Elements within Seafood Supply Networks	PLOS ONE			English	Article							ASYMMETRIC PRICE TRANSMISSION; CHAIN MANAGEMENT; CLIMATE-CHANGE; EQUILIBRIUM; ECOSYSTEM; COST	A theoretical basis is required for comparing key features and critical elements in wild fisheries and aquaculture supply chains under a changing climate. Here we develop a new quantitative metric that is analogous to indices used to analyse food-webs and identify key species. The Supply Chain Index (SCI) identifies critical elements as those elements with large throughput rates, as well as greater connectivity. The sum of the scores for a supply chain provides a single metric that roughly captures both the resilience and connectedness of a supply chain. Standardised scores can facilitate cross-comparisons both under current conditions as well as under a changing climate. Identification of key elements along the supply chain may assist in informing adaptation strategies to reduce anticipated future risks posed by climate change. The SCI also provides information on the relative stability of different supply chains based on whether there is a fairly even spread in the individual scores of the top few key elements, compared with a more critical dependence on a few key individual supply chain elements. We use as a case study the Australian southern rock lobster Jasus edwardsii fishery, which is challenged by a number of climate change drivers such as impacts on recruitment and growth due to changes in large-scale and local oceanographic features. The SCI identifies airports, processors and Chinese consumers as the key elements in the lobster supply chain that merit attention to enhance stability and potentially enable growth. We also apply the index to an additional four real-world Australian commercial fishery and two aquaculture industry supply chains to highlight the utility of a systematic method for describing supply chains. Overall, our simple methodological approach to empirically-based supply chain research provides an objective method for comparing the resilience of supply chains and highlighting components that may be critical.	[Plaganyi, Eva E.; Thebaud, Olivier; Innes, James; Lim-Camacho, Lilly; Norman-Lopez, Ana; Bustamante, Rodrigo H.; Pascoe, Sean] Climate Adaptat Flagship, Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia; [van Putten, Ingrid; Hobday, Alistair J.; Fleming, Aysha] Climate Adaptat Flagship, Commonwealth Sci & Ind Res Org, Hobart, Tas, Australia; [Farmery, Anna; Frusher, Stewart; Green, Bridget; Hoshino, Eriko; Jennings, Sarah; Pecl, Gretta] Univ Tasmania, Hobart, Tas, Australia; [Schrobback, Peggy] Queensland Univ Technol, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; Queensland University of Technology (QUT)	Plaganyi, EE (corresponding author), Climate Adaptat Flagship, Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia.	Eva.Plaganyi-lloyd@csiro.au	Fleming, Aysha/E-8753-2011; Innes, James/D-9424-2011; Hoshino, Eriko/N-7557-2013; Schrobback, Peggy/X-4697-2019; van putten, ingrid/AAV-1301-2021; Thomas, Linda/Q-2521-2018; Pecl, Gretta/D-7267-2011; Jennings, Sarah/J-7888-2014; Hobday, Alistair/A-1460-2012; Frusher, Stewart/G-5117-2014; Green, Bridget/G-3368-2014; Farmery, Anna/H-9696-2014; Plaganyi, Eva E/C-5130-2011; Lim-Camacho, Lilly/A-7502-2015; Thebaud, Olivier/D-9792-2011; Pascoe, Sean/D-9710-2011	Fleming, Aysha/0000-0001-9895-1928; Innes, James/0000-0003-1975-6062; Hoshino, Eriko/0000-0001-7110-4251; Schrobback, Peggy/0000-0003-0526-1659; van putten, ingrid/0000-0001-8397-9768; Thomas, Linda/0000-0001-8989-8109; Pecl, Gretta/0000-0003-0192-4339; Jennings, Sarah/0000-0002-5760-4193; Hobday, Alistair/0000-0002-3194-8326; Frusher, Stewart/0000-0003-2493-3676; Green, Bridget/0000-0001-8214-6430; Farmery, Anna/0000-0002-8938-0040; Plaganyi, Eva E/0000-0002-4740-4200; Lim-Camacho, Lilly/0000-0002-4897-1186; Thebaud, Olivier/0000-0001-8665-3827; Pascoe, Sean/0000-0001-6581-2649	Australia's CSIRO Climate Adaptation Flagship; Fisheries Research and Development Corporation - Department of Climate Change and Energy Efficiency on behalf of the Australian Government (FRDC-DCCEE Marine National Adaptation Program) [2011/233]	Australia's CSIRO Climate Adaptation Flagship; Fisheries Research and Development Corporation - Department of Climate Change and Energy Efficiency on behalf of the Australian Government (FRDC-DCCEE Marine National Adaptation Program)	This work was supported by funding from Australia's CSIRO Climate Adaptation Flagship (www.csiro.au) and the Fisheries Research and Development Corporation - Department of Climate Change and Energy Efficiency on behalf of the Australian Government (FRDC-DCCEE Marine National Adaptation Program 2011/233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; [Anonymous], 1992, MARINE RESOURCE EC; Asche F, 2007, APPL ECON, V39, P2535, DOI 10.1080/00036840500486524; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Carter CR, 2008, INT J PHYS DISTR LOG, V38, P360, DOI 10.1108/09600030810882816; Chen IJ, 2004, J OPER MANAG, V22, P119, DOI 10.1016/j.jom.2003.12.007; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 2011, ECOL MODEL, V222, P857, DOI 10.1016/j.ecolmodel.2010.09.030; Christopher M., 1992, LOGISTICS SUPPLY CHA; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; DPIPWE, 2013, TOX ALG BLOOM UPD FI; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Essington T. E., 2012, MODEL DATA ADEQUACY; Essington TE, 2013, ICES J MAR SCI, DOI [10.1093/icesjms/fst047., DOI 10.1093/ICESJMS/FST047.E]; Fackler PL, 2001, HANDB ECON, V18, P971; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Harland C.M., 1996, BRIT J MANAGE, V7, pS63, DOI [10.1111/j.1467-8551.1996.tb00148.x, DOI 10.1111/J.1467-8551.1996.TB00148.X]; Hobday A. J., 2008, IMPLICATIONS CLIMATE; Hobday A.J., 2013, GROWTH OPPORTUNITIES; Jaffry SA, 1999, APPL ECON, V31, P473, DOI 10.1080/000368499324183; James SJ, 2010, FOOD RES INT, V43, P1944, DOI 10.1016/j.foodres.2010.02.001; Levermann A, 2014, NATURE, V506, P27, DOI 10.1038/506027a; Linnane A, 2010, FISH RES, V105, P163, DOI 10.1016/j.fishres.2010.04.001; Meyer J, 2004, J AGR ECON, V55, P581, DOI 10.1111/j.1477-9552.2004.tb00116.x; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Mullon C, 2009, NAT RESOUR MODEL, V22, P564, DOI 10.1111/j.1939-7445.2009.00053.x; Nagurney A, 2010, INT J PROD ECON, V128, P200, DOI 10.1016/j.ijpe.2010.07.020; Nielsen M., 2005, MAR RESOUR ECON, V20, P185, DOI [DOI 10.1086/MRE.20.2.42629468, https://doi.org/10.1086/mre.20.2.42629468]; Nielsen M, 2012, MAR RESOUR ECON, V27, P165, DOI 10.5950/0738-1360-27.2.165; Norman-Lopez A, 2013, AUSTR J AGR RESOURCE, V57, P1; Oshita Y, 2012, ENERG ECON, V34, P1041, DOI 10.1016/j.eneco.2011.08.013; Pecl G, 2009, E COAST TASMANIAN RO; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Plaganyi EE, 2013, P NATL ACAD SCI USA, V110, P3639, DOI 10.1073/pnas.1217822110; Samuelson PA, 1952, AM ECON REV, V42, P283; Simioni M, 2013, CAN J AGR ECON, V61, P37, DOI 10.1111/j.1744-7976.2012.01257.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith ADM, 2011, SCIENCE, V334, P39; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; TAKAYAMA T, 1964, J FARM ECON, V46, P67, DOI 10.2307/1236473; van Putten IE, 2013, REG ENVIRON CHANGE, V13, P1313, DOI 10.1007/s10113-013-0456-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wohlgenant MK, 2001, HANDB ECON, V18, P933	46	26	28	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91833	10.1371/journal.pone.0091833	http://dx.doi.org/10.1371/journal.pone.0091833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633147	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000332858400104
J	Tran, MV; O'Grady, M; Colborn, J; Van Ness, K; Hill, RW				Tran, Mark V.; O'Grady, Matthew; Colborn, Jeremiah; Van Ness, Kimberly; Hill, Richard W.			Aggression and Food Resource Competition between Sympatric Hermit Crab Species	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; INTERSPECIFIC COMPETITION; VERTICAL ZONATION; COEXISTENCE; INTERFERENCE; EXPLOITATION; DISPLACEMENT; POPULATIONS; COMPONENTS; PHYSIOLOGY	The vertical zonation patterns of intertidal organisms have been topics of interest to marine ecologists for many years, with interspecific food competition being implicated as a contributing factor to intertidal community organization. In this study, we used behavioral bioassays to examine the potential roles that interspecific aggression and food competition have on the structuring of intertidal hermit crab assemblages. We studied two ecologically similar, sympatric hermit crab species, Clibanarius digueti [1] and Paguristes perrieri [2], which occupy adjacent zones within the intertidal region of the Gulf of California. During the search phase of foraging, C. digueti showed higher frequencies of aggressive behaviors than P. perrieri. In competition assays, C. digueti gained increased access to food resources compared to P. perrieri. The results suggest that food competition may play an important role in structuring intertidal hermit crab assemblages, and that the zonation patterns of Gulf of California hermit crab species may be the result of geographical displacement by the dominant food competitor (C. digueti).	[Tran, Mark V.; O'Grady, Matthew; Colborn, Jeremiah; Van Ness, Kimberly; Hill, Richard W.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Tran, Mark V.; Hill, Richard W.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Tran, MV (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	mvtran27@gmail.com			Dr. Marvin Hensley Endowed Scholarship in Zoology; Zoology Department at Michigan State University	Dr. Marvin Hensley Endowed Scholarship in Zoology; Zoology Department at Michigan State University	This research was funded by the Dr. Marvin Hensley Endowed Scholarship in Zoology awarded to Mark V. Tran by the Zoology Department at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayon-Parente Manuel, 2010, Nauplius, V18, P1; BERTNESS MD, 1981, J EXP MAR BIOL ECOL, V49, P189, DOI 10.1016/0022-0981(81)90070-8; BERTNESS MD, 1981, AM NAT, V118, P432, DOI 10.1086/283835; BERTNESS MD, 1981, ECOLOGY, V62, P411, DOI 10.2307/1936715; Bouvier E. L., 1895, B MUS NATL HIST NAT, V1, P6; Bouvier E.L, 1898, B MUSEUM HIST NATURE, V4, P371; BRITTON JC, 1994, OCEANOGR MAR BIOL, V32, P369; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; DEBACH P, 1966, ANNU REV ENTOMOL, V11, P183, DOI 10.1146/annurev.en.11.010166.001151; Gherardi F, 1997, CRUSTACEANA, V70, P608, DOI 10.1163/156854097X00717; Gherardi F, 2005, ETHOLOGY, V111, P271, DOI 10.1111/j.1439-0310.2004.01060.x; GHERARDI F, 1990, J EXP MAR BIOL ECOL, V143, P221, DOI 10.1016/0022-0981(90)90072-K; Harvey AW, 1988, THESIS U ARIZONA; HAZLETT BA, 1981, ANNU REV ECOL SYST, V12, P1, DOI 10.1146/annurev.es.12.110181.000245; HELLER HC, 1971, ECOLOGY, V52, P312, DOI 10.2307/1934590; Kaiser MJ, 1998, J NAT HIST, V32, P521, DOI 10.1080/00222939800770281; Kellog CW, 1996, J EXP MAR BIOL ECOL, V22, P101; Laidre ME, 2012, J ZOOL, V288, P33, DOI 10.1111/j.1469-7998.2012.00921.x; Laidre ME, 2013, MAR ECOL-EVOL PERSP, V34, P80, DOI 10.1111/j.1439-0485.2012.00527.x; Laidre ME, 2011, J EXP MAR BIOL ECOL, V397, P65, DOI 10.1016/j.jembe.2010.10.024; Lee PG, 1996, AQUACULT NUTR, V2, P157, DOI 10.1111/j.1365-2095.1996.tb00055.x; Lohrer AM, 2000, J EXP MAR BIOL ECOL, V244, P203, DOI 10.1016/S0022-0981(99)00139-2; McKillup SC, 1997, MAR ECOL PROG SER, V148, P109, DOI 10.3354/meps148109; McNatty A, 2009, OECOLOGIA, V160, P187, DOI 10.1007/s00442-009-1279-z; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Morton B, 2000, J EXP MAR BIOL ECOL, V246, P1, DOI 10.1016/S0022-0981(99)00170-7; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Peiman KS, 2010, Q REV BIOL, V85, P133, DOI 10.1086/652374; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Ramsay K, 1997, ESTUAR COAST SHELF S, V44, P213, DOI 10.1006/ecss.1996.0213; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; SCULLY EP, 1983, J EXP MAR BIOL ECOL, V71, P221, DOI 10.1016/0022-0981(83)90116-8; SNYDERCONN E, 1980, MAR BEHAV PHYSIOL, V7, P135, DOI 10.1080/10236248009386977; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Stillman JH, 1996, J EXP BIOL, V199, P1845; Tran MV, 2013, J CRUSTACEAN BIOL, V33, P512, DOI 10.1163/1937240X-00002154; Tricarico E, 2008, J EXP MAR BIOL ECOL, V354, P150, DOI 10.1016/j.jembe.2007.11.001; Turra A, 2004, MAR BIOL, V145, P251, DOI 10.1007/s00227-004-1323-9; Turra A, 2004, J EXP MAR BIOL ECOL, V310, P183, DOI 10.1016/j.jembe.2004.04.008; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	41	22	23	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91823	10.1371/journal.pone.0091823	http://dx.doi.org/10.1371/journal.pone.0091823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632897	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400100
J	Wang, QW; Ren, J; Morgan, S; Liu, ZJ; Dou, CL; Liu, B				Wang, Qiwei; Ren, Jun; Morgan, Stephanie; Liu, Zhenjie; Dou, Changlin; Liu, Bo			Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BOUND FAS LIGAND; INDUCED APOPTOSIS; INDUCE APOPTOSIS; MICE; EXPRESSION; WALL; INFLAMMATION; POLARIZATION; PATHOGENESIS	Aims: In abdominal aortic aneurysm (AAA), macrophages are detected in the proximity of aortic smooth muscle cells (SMCs). We have previously demonstrated in a murine model of AAA that apoptotic SMCs attract monocytes and other leukocytes by producing MCP-1. Here we tested whether infiltrating macrophages also directly contribute to SMC apoptosis. Methods and Results: Using a SMC/RAW264.7 macrophage co-culture system, we demonstrated that MCP-1-primed RAWs caused a significantly higher level of apoptosis in SMCs as compared to control macrophages. Next, we detected an enhanced Fas ligand (FasL) mRNA level and membrane FasL protein expression in MCP-1-primed RAWs. Neutralizing FasL blocked SMC apoptosis in the co-culture. In situ proximity ligation assay showed that SMCs exposed to primed macrophages contained higher levels of receptor interacting protein-1 (RIP1)/Caspase 8 containing cell death complexes. Silencing RIP1 conferred apoptosis resistance to SMCs. In the mouse elastase injury model of aneurysm, aneurysm induction increased the level of RIP1/Caspase 8 containing complexes in medial SMCs. Moreover, TUNEL-positive SMCs in aneurysmal tissues were frequently surrounded by CD68(+)/FasL(+) macrophages. Conversely, elastase-treated arteries from MCP-1 knockout mice display a reduction of both macrophage infiltration and FasL expression, which was accompanied by diminished apoptosis of SMCs. Conclusion: Our data suggest that MCP-1-primed macrophages are more cytotoxic. MCP-1 appears to modulate macrophage cytotoxicity by increasing the level of membrane bound FasL. Thus, we showed that MCP-1-primed macrophages kill SMCs through a FasL/Fas-Caspase8-RIP1 mediated mechanism.	[Wang, Qiwei; Ren, Jun; Morgan, Stephanie; Liu, Zhenjie; Liu, Bo] Univ Wisconsin, Dept Surg, Div Vasc Surg, Madison, WI 53706 USA; [Dou, Changlin] Luye Pharma Grp, Yantai, Peoples R China	University of Wisconsin System; University of Wisconsin Madison	Liu, B (corresponding author), Univ Wisconsin, Dept Surg, Div Vasc Surg, Madison, WI 53706 USA.	liub@surgery.wisc.edu		Wang, Qiwei/0000-0003-3897-2529; REN, Jun/0000-0002-6358-0765	National Institute of Health [R01HL088447]; Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute [T32 HL 07936, T32 HL110853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088447, T32HL007936, T32HL110853] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health R01HL088447 (BL) and the Ruth L. Kirschstein National Research Service Award T32 HL 07936 and T32 HL110853 from the National Heart Lung and Blood Institute to the University of Wisconsin-Madison Cardiovascular Research Center and Department of Surgery (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhari BA, 2013, ONCOGENE, V32, P3263, DOI 10.1038/onc.2012.337; Boyle JJ, 2003, ARTERIOSCL THROM VAS, V23, P1553, DOI 10.1161/01.ATV.0000086961.44581.B7; Boyle JJ, 2002, ARTERIOSCL THROM VAS, V22, P1624, DOI 10.1161/01.ATV.0000033517.48444.1A; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; CLOWES AW, 1989, LAB INVEST, V60, P360; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; de Waard V, 2010, ATHEROSCLEROSIS, V211, P84, DOI 10.1016/j.atherosclerosis.2010.01.042; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; Iida Y, 2013, ARTERIOSCL THROM VAS, V33, P718, DOI 10.1161/ATVBAHA.112.300329; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; KOCH AE, 1993, AM J PATHOL, V142, P1423; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Middleton RK, 2007, J VASC SURG, V45, P574, DOI 10.1016/j.jvs.2006.11.020; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; Morgan MJ, 2009, J IMMUNOL, V183, P3278, DOI 10.4049/jimmunol.0803428; Morgan S, 2012, ARTERIOSCL THROM VAS, V32, P2493, DOI 10.1161/ATVBAHA.112.255661; Nahrendorf M, 2011, ARTERIOSCL THROM VAS, V31, P750, DOI 10.1161/ATVBAHA.110.221499; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Niu JL, 2006, J MOL CELL CARDIOL, V40, P810, DOI 10.1016/j.yjmcc.2006.03.010; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Nordon IM, 2009, VASCULAR, V17, P253, DOI 10.2310/6670.2009.00046; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Thompson RW, 1999, ANN NY ACAD SCI, V878, P159, DOI 10.1111/j.1749-6632.1999.tb07682.x; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Yamanouchi D, 2010, ARTERIOSCL THROM VAS, V30, P702, DOI 10.1161/ATVBAHA.109.200527; Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P6026, DOI 10.1167/iovs.10-7023; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	44	17	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92053	10.1371/journal.pone.0092053	http://dx.doi.org/10.1371/journal.pone.0092053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632850	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400136
J	Zhang, HS; Wei, JR; Huang, JP				Zhang, Huishu; Wei, Jianrong; Huang, Jiping			Scaling and Predictability in Stock Markets: A Comparative Study	PLOS ONE			English	Article							RETURNS; MODEL	Most people who invest in stock markets want to be rich, thus, many technical methods have been created to beat the market. If one knows the predictability of the price series in different markets, it would be easier for him/her to make the technical analysis, at least to some extent. Here we use one of the most basic sold-and-bought trading strategies to establish the profit landscape, and then calculate the parameters to characterize the strength of predictability. According to the analysis of scaling of the profit landscape, we find that the Chinese individual stocks are harder to predict than US ones, and the individual stocks are harder to predict than indexes in both Chinese stock market and US stock market. Since the Chinese (US) stock market is a representative of emerging (developed) markets, our comparative study on the markets of these two countries is of potential value not only for conducting technical analysis, but also for understanding physical mechanisms of different kinds of markets in terms of scaling.	[Huang, Jiping] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Huang, JP (corresponding author), Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.	jphuang@fudan.edu.cn	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137	National Natural Science Foundation of China [11075035, 11222544]; Fok Ying Tung Education Foundation [131008]; Program for New Century Excellent Talents in University [NCET-12-0121]; Shanghai Rising-Star Program [12QA1400200]; Chinese National Key Basic Research Special Fund [2011CB922004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Program; Chinese National Key Basic Research Special Fund(National Basic Research Program of China)	This work is supported by the National Natural Science Foundation of China under Grant Nos. 11075035 and 11222544 (http://www.nsfc.gov.cn/); the Fok Ying Tung Education Foundation under Grant No. 131008 (http://www.moe.edu.cn/); the Program for New Century Excellent Talents in University (NCET-12-0121) (http://www.moe.edu.cn/); the Shanghai Rising-Star Program (No. 12QA1400200) (http://www.stcsm.gov.cn/); and the Chinese National Key Basic Research Special Fund under Grant No. 2011CB922004 (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber BM, 2000, J FINANC, V55, P773, DOI 10.1111/0022-1082.00226; Biondo AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068344; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; BLUME L, 1994, J FINANC, V49, P153, DOI 10.2307/2329139; Brown DP, 1989, REV FINANC STUD, V2, P527, DOI 10.1093/rfs/2.4.527; Carbone A, 2004, PHYSICA A, V344, P267, DOI 10.1016/j.physa.2004.06.130; Caruso F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190501; Chen HL, 2000, J FINANC QUANT ANAL, V35, P343, DOI 10.2307/2676208; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dosi G, 2013, J ECON DYN CONTROL, V37, P1598, DOI 10.1016/j.jedc.2012.11.008; Eleswarapu VR, 2004, J BUS, V77, P275, DOI 10.1086/381275; FAMA EF, 1989, J FINANC ECON, V25, P23, DOI 10.1016/0304-405X(89)90095-0; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Garvey R., 2005, J APPL FINANCE, V15, P93; Gronlund A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033960; Harvey A.C., 1983, J BUSINESS EC STAT, V1, P299, DOI DOI 10.1080/07350015.1983.10509355; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Horiuchi S, 2012, POPUL ECOL, V54, P197, DOI 10.1007/s10144-011-0279-0; Malkiel B.G., 2004, JOURNALOFFINANCIALRE, V27, P449, DOI DOI 10.1111/J.1475-6803.2004.00102.X; Mantegna R. N., 2000, INTRO ECONOPHYSICS; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Masih AM, 1999, PACIFIC BASIN FINANC, V7, P251, DOI DOI 10.1016/S0927-538X(99)00013-X; Park C. - H., 2004, 200404 AGMAS; Wei JR, 2013, PHYSICA A, V392, P2728, DOI 10.1016/j.physa.2013.02.011	26	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91707	10.1371/journal.pone.0091707	http://dx.doi.org/10.1371/journal.pone.0091707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632944	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400080
J	Zheng, WL; Li, Z; Nguyen, AT; Li, CX; Emelyanov, A; Gong, ZY				Zheng, Weiling; Li, Zhen; Anh Tuan Nguyen; Li, Caixia; Emelyanov, Alexander; Gong, Zhiyuan			Xmrk, Kras and Myc Transgenic Zebrafish Liver Cancer Models Share Molecular Signatures with Subsets of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							COMPARATIVE FUNCTIONAL GENOMICS; GENE-EXPRESSION; EARLY RECURRENCE; CANDIDATE GENES; POOR-PROGNOSIS; MOUSE MODELS; PRAVASTATIN; ACTIVATION; STATHMIN; HEPATOCARCINOGENESIS	Previously three oncogene transgenic zebrafish lines with inducible expression of xmrk, kras or Myc in the liver have been generated and these transgenic lines develop oncogene-addicted liver tumors upon chemical induction. In the current study, comparative transcriptomic approaches were used to examine the correlation of the three induced transgenic liver cancers with human liver cancers. RNA profiles from the three zebrafish tumors indicated relatively small overlaps of significantly deregulated genes and biological pathways. Nevertheless, the three transgenic tumor signatures all showed significant correlation with advanced or very advanced human hepatocellular carcinoma (HCC). Interestingly, molecular signature from each oncogene-induced zebrafish liver tumor correlated with only a small subset of human HCC samples (24-29%) and there were conserved up-regulated pathways between the zebrafish and correlated human HCC subgroup. The three zebrafish liver cancer models together represented nearly half (47.2%) of human HCCs while some human HCCs showed significant correlation with more than one signature defined from the three oncogene-addicted zebrafish tumors. In contrast, commonly deregulated genes (21 up and 16 down) in the three zebrafish tumor models generally showed accordant deregulation in the majority of human HCCs, suggesting that these genes might be more consistently deregulated in a broad range of human HCCs with different molecular mechanisms and thus serve as common diagnosis markers and therapeutic targets. Thus, these transgenic zebrafish models with well-defined oncogene-induced tumors are valuable tools for molecular classification of human HCCs and for understanding of molecular drivers in hepatocarcinogenesis in each human HCC subgroup.	[Zheng, Weiling; Li, Zhen; Anh Tuan Nguyen; Li, Caixia; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Emelyanov, Alexander] Inst Cell & Mol Biol, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260; Li, Caixia/0000-0003-2190-655X; Emelyanov, Alexander/0000-0002-8693-794X	National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by a grant from National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, BJU INT, V107, P126, DOI 10.1111/j.1464-410X.2010.09344.x; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Foster J, 2007, ANN SURG ONCOL, V14, P752, DOI 10.1245/s10434-006-9123-8; GAN FY, 1993, J HISTOCHEM CYTOCHEM, V41, P1185, DOI 10.1177/41.8.7687263; Gan L, 2010, ONCOL REP, V23, P1037, DOI 10.3892/or_00000730; Goldman R, 2009, CLIN CANCER RES, V15, P1808, DOI 10.1158/1078-0432.CCR-07-5261; Gomez A, 2001, J BIOL CHEM, V276, P3333, DOI 10.1074/jbc.M006574200; Graf H, 2008, DIGESTION, V78, P34, DOI 10.1159/000156702; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh SY, 2010, MOL CARCINOGEN, V49, P476, DOI 10.1002/mc.20627; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kawata S, 2001, BRIT J CANCER, V84, P886, DOI 10.1054/bjoc.2000.1716; Kudo T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-32; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Lee JS, 2005, CARCINOGENESIS, V26, P1013, DOI 10.1093/carcin/bgi030; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Leenders MWH, 2008, WORLD J GASTROENTERO, V14, P6915, DOI 10.3748/wjg.14.6915; Lersch C, 2004, HEPATO-GASTROENTEROL, V51, P1099; Li Y, 2008, HEPATOL RES, V38, P85, DOI 10.1111/j.1872-034X.2007.00207.x; Li Z, 2012, DIS MODEL MECH; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Liu S, 2011, ANNU REV PATHOL-MECH, V6, P71, DOI 10.1146/annurev-pathol-011110-130330; Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Lu JW, 2011, BIRTH DEFECTS RES C, V93, P157, DOI 10.1002/bdrc.20205; Mavaddat N, 2009, CANCER EPIDEM BIOMAR, V18, P255, DOI 10.1158/1055-9965.EPI-08-0704; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Mirbahai L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-3; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Siegel AB, 2010, HEPATOLOGY, V52, P360, DOI 10.1002/hep.23633; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P705, DOI 10.1177/019262330002800511; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Wang X, 2009, PROTEOMICS, V9, P242, DOI 10.1002/pmic.200800155; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019	50	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91179	10.1371/journal.pone.0091179	http://dx.doi.org/10.1371/journal.pone.0091179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633177	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400045
J	Vato, A; Szymanski, FD; Semprini, M; Mussa-Ivaldi, FA; Panzeri, S				Vato, Alessandro; Szymanski, Francois D.; Semprini, Marianna; Mussa-Ivaldi, Ferdinando A.; Panzeri, Stefano			A Bidirectional Brain-Machine Interface Algorithm That Approximates Arbitrary Force-Fields	PLOS ONE			English	Article							CORTICAL-NEURONS; STIMULUS LOCATION; PARIETAL CORTEX; MOTOR CORTEX; MOVEMENT; MUSCLE; RAT; INFORMATION; PRIMITIVES; RESPONSES	We examine bidirectional brain-machine interfaces that control external devices in a closed loop by decoding motor cortical activity to command the device and by encoding the state of the device by delivering electrical stimuli to sensory areas. Although it is possible to design this artificial sensory-motor interaction while maintaining two independent channels of communication, here we propose a rule that closes the loop between flows of sensory and motor information in a way that approximates a desired dynamical policy expressed as a field of forces acting upon the controlled external device. We previously developed a first implementation of this approach based on linear decoding of neural activity recorded from the motor cortex into a set of forces (a force field) applied to a point mass, and on encoding of position of the point mass into patterns of electrical stimuli delivered to somatosensory areas. However, this previous algorithm had the limitation that it only worked in situations when the position-to-force map to be implemented is invertible. Here we overcome this limitation by developing a new non-linear form of the bidirectional interface that can approximate a virtually unlimited family of continuous fields. The new algorithm bases both the encoding of position information and the decoding of motor cortical activity on an explicit map between spike trains and the state space of the device computed with Multi-Dimensional-Scaling. We present a detailed computational analysis of the performance of the interface and a validation of its robustness by using synthetic neural responses in a simulated sensory-motor loop.	[Vato, Alessandro; Szymanski, Francois D.; Semprini, Marianna] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Mussa-Ivaldi, Ferdinando A.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Mussa-Ivaldi, Ferdinando A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Mussa-Ivaldi, Ferdinando A.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Panzeri, Stefano] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Rovereto, Italy; [Panzeri, Stefano] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Istituto Italiano di Tecnologia - IIT; Northwestern University; Northwestern University; Shirley Ryan AbilityLab; Istituto Italiano di Tecnologia - IIT; University of Glasgow	Vato, A (corresponding author), Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy.	alessandro.vato@iit.it	Semprini, Marianna/AAC-3059-2019; Vato, Alessandro/B-2651-2013; Panzeri, Stefano/L-5977-2013	Semprini, Marianna/0000-0001-5504-0251; Vato, Alessandro/0000-0002-7217-999X; Panzeri, Stefano/0000-0003-1700-8909	BMI project of the Robotics, Brain and Cognitive Sciences Department, Italian Institute of Technology Italy; NICHHD [1R01HD072080-01]; SI-CODE project of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission [FP7-284553]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072080] Funding Source: NIH RePORTER	BMI project of the Robotics, Brain and Cognitive Sciences Department, Italian Institute of Technology Italy; NICHHD; SI-CODE project of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the BMI project of the Robotics, Brain and Cognitive Sciences Department, Italian Institute of Technology Italy and NICHHD grant 1R01HD072080-01 to FAM-I. The authors acknowledge the financial support of the SI-CODE project of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: FP7-284553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bienenstock E., 1995, HDB BRAIN THEORY NEU, P223; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Black A.H., 1972, PSYCHOL LEARNING MOT, V6, P47; Chakrabarti S, 2008, J NEUROPHYSIOL, V100, P50, DOI 10.1152/jn.90327.2008; Chao ZC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; EVARTS EV, 1981, CAN J PHYSIOL PHARM, V59, P757, DOI 10.1139/y81-112; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GISZTER SF, 1993, J NEUROSCI, V13, P467; Golledge HDR, 2003, NEUROREPORT, V14, P1045, DOI 10.1097/00001756-200305230-00028; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P143, DOI 10.1113/jphysiol.1966.sp007908; Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927; GRILLNER S, 1991, NEURON, V7, P1, DOI 10.1016/0896-6273(91)90069-C; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; HOGAN N, 1985, J DYN SYST-T ASME, V107, P1, DOI 10.1115/1.3140702; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; Houghton C, 2008, NEURAL COMPUT, V20, P1495, DOI 10.1162/neco.2007.10-06-350; Jackson A, 2011, IEEE T NEUR SYS REH, V19, P534, DOI 10.1109/TNSRE.2011.2158586; Karnopp D., 1990, SYSTEM DYNAMICS UNIF; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; KHATIB O, 1986, INT J ROBOT RES, V5, P90, DOI 10.1177/027836498600500106; Kim HK, 2007, IEEE T BIO-MED ENG, V54, P1520, DOI 10.1109/TBME.2007.900818; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; Mussa-Ivaldi FA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.008.2010; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; MUSSAIVALDI FA, 1992, BIOL CYBERN, V67, P479, DOI 10.1007/BF00198755; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Panzeri S, 2003, CEREB CORTEX, V13, P45, DOI 10.1093/cercor/13.1.45; Patil PG, 2008, NEUROTHERAPEUTICS, V5, P137, DOI 10.1016/j.nurt.2007.11.002; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; RACK PMH, 1969, J PHYSIOL-LONDON, V204, P443, DOI 10.1113/jphysiol.1969.sp008923; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Scaglione A, 2011, P NATL ACAD SCI USA, V108, P14956, DOI 10.1073/pnas.1103168108; Schwartz AB, 2007, J PHYSIOL-LONDON, V579, P581, DOI 10.1113/jphysiol.2006.126698; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Szymanski FD, 2011, IEEE ENG MED BIO, P4592, DOI 10.1109/IEMBS.2011.6091137; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908; Vato A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002578; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Von Neumann J., 2012, COMPUTER BRAIN; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Zimmermann JB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/054001	56	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91677	10.1371/journal.pone.0091677	http://dx.doi.org/10.1371/journal.pone.0091677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626393	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000332851300119
J	Chou, AK; Yang, MC; Tsai, HP; Chai, CY; Tai, MH; Kwan, AL; Hong, YR				Chou, An-Kuo; Yang, Ming-Chang; Tsai, Hung-Pei; Chai, Chee-Yin; Tai, Ming-Hong; Kwan, Aij-Li; Hong, Yi-Ren			Adenoviral-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Has a Protective Effect on Sciatic Nerve Following Constriction-Induced Spinal Cord Injury	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AMYOTROPHIC-LATERAL-SCLEROSIS; ROOT GANGLION APOPTOSIS; SUPERFICIAL DORSAL HORN; NEUROPATHIC PAIN; ADENOASSOCIATED VIRUS; MECHANICAL ALLODYNIA; INDUCED HYPERALGESIA; RECEPTOR COMPONENTS; TISSUE-INJURY	Neuropathic pain due to peripheral nerve injury may be associated with abnormal central nerve activity. Glial cell-line-derived neurotrophic factor (GDNF) can help attenuate neuropathic pain in different animal models of nerve injury. However, whether GDNF can ameliorate neuropathic pain in the spinal cord dorsal horn (SCDH) in constriction-induced peripheral nerve injury remains unknown. We investigated the therapeutic effects of adenoviral-mediated GDNF on neuropathic pain behaviors, microglial activation, pro-inflammatory cytokine expression and programmed cell death in a chronic constriction injury (CCI) nerve injury animal model. In this study, neuropathic pain was produced by CCI on the ipsilateral SCDH. Mechanical allodynia was examined with von Frey filaments and thermal sensitivity was tested using a plantar test apparatus post-operatively. Target proteins GDNF-1, GDNFRa-1, MMP2, MMP9, p38, phospho-p38, ED1, IL6, IL1 beta, AIF, caspase-9, cleaved caspase-9, caspase-3, cleaved caspase-3, PARP, cleaved PARP, SPECTRIN, cleaved SPECTRIN, Beclin-1, PKC sigma, PKC gamma, iNOS, eNOS and nNOS were detected. Microglial activity was measured by observing changes in immunoreactivity with OX-42. NeuN and TUNEL staining were used to reveal whether apoptosis was attenuated by GDNF. Results showed that administrating GDNF began to attenuate both allodynia and thermal hyperalgesia at day 7. CCI-rats were found to have lower GDNF and GDNFRa-1 expression compared to controls, and GDNF re-activated their expression. Also, GDNF significantly down-regulated CCI-induced protein expression except for MMP2, eNOS and nNOS, indicating that the protective action of GDNF might be associated with anti-inflammation and prohibition of microglia activation. Immunocytochemistry staining showed that GDNF reduced CCI-induced neuronal apoptosis. In sum, GDNF enhanced the neurotrophic effect by inhibiting microglia activation and cytokine production via p38 and PKC signaling. GDNF could be a good therapeutic tool to attenuate programmed cell death, including apoptosis and autophagy, consequent to CCI-induced peripheral nerve injury.	[Chou, An-Kuo] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Chou, An-Kuo] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Yang, Ming-Chang; Hong, Yi-Ren] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Yang, Ming-Chang; Hong, Yi-Ren] Kaohsiung Med Univ, Fac Med, Coll Med, Dept Biochem, Kaohsiung, Taiwan; [Yang, Ming-Chang] Kaohsiung Armed Forces Gen Hosp, Lab Med Res, Kaohsiung, Taiwan; [Tsai, Hung-Pei; Kwan, Aij-Li; Hong, Yi-Ren] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Dept Pathol, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Kwan, Aij-Li] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kwan, AL (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.	aijliekwan@yahoo.com.tw; m835016@cc.kmu.edu.tw		Yang, Ming-Chang/0000-0001-8657-8708; Chai, Chee-Yin/0000-0003-0486-9742; Hong, Yi-Ren/0000-0001-5470-6090	National Science Council [96-2314-B-182A-018-MY2, 95-2314-B-182A-151]; Chang Gung Memorial Hospital [CMRP83031]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was sponsored by National Science Council-96-2314-B-182A-018-MY2, National Science Council-95-2314-B-182A-151, and Chang Gung Memorial Hospital grant CMRP83031 to AKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Bridges D, 2001, BRIT J ANAESTH, V87, P12, DOI 10.1093/bja/87.1.12; Calvo M, 2011, GLIA; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Clark AK, 2012, EXP NEUROL, V234, P283, DOI 10.1016/j.expneurol.2011.09.012; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Eslamboli A, 2005, REV NEUROSCIENCE, V16, P303; George A, 2004, NEUROSCI LETT, V372, P215, DOI 10.1016/j.neulet.2004.09.075; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; GIRAUD C, 1995, J VIROL, V69, P6917, DOI 10.1128/JVI.69.11.6917-6924.1995; Hao SL, 2003, MOL THER, V8, P367, DOI 10.1016/S1525-0016(03)00185-0; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Ji RR, 2009, TRENDS PHARMACOL SCI, V30, P336, DOI 10.1016/j.tips.2009.04.002; Jin SX, 2003, J NEUROSCI, V23, P4017; Katsura H, 2006, J NEUROSCI, V26, P8680, DOI 10.1523/JNEUROSCI.1771-06.2006; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Lekan HA, 1996, NEUROSCI LETT, V208, P147, DOI 10.1016/0304-3940(96)12566-0; Maione S, 2002, NEUROREPORT, V13, P101, DOI 10.1097/00001756-200201210-00024; Manabe Y, 2002, APOPTOSIS, V7, P329, DOI 10.1023/A:1016123413038; MAO JR, 1995, NEUROSCI LETT, V198, P75, DOI 10.1016/0304-3940(95)11975-3; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Schaeffer V, 2010, GLIA, V58, P169, DOI 10.1002/glia.20910; Sekiguchi M, 2008, SPINE, V33, P1163, DOI 10.1097/BRS.0b013e31817144fc; Shortland P, 1999, BRAIN RES, V815, P206, DOI 10.1016/S0006-8993(98)01152-4; Sung CS, 2005, J NEUROCHEM, V94, P742, DOI 10.1111/j.1471-4159.2005.03226.x; Svensson CI, 2005, J NEUROCHEM, V92, P1508, DOI 10.1111/j.1471-4159.2004.02996.x; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Svensson CI, 2005, NEUROSCI LETT, V379, P209, DOI 10.1016/j.neulet.2004.12.064; Tai MH, 2003, EXP NEUROL, V183, P508, DOI 10.1016/S0014-4886(03)00130-4; Tang QB, 2007, EUR J NEUROSCI, V25, P2964, DOI 10.1111/j.1460-9568.2007.05576.x; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Wang LJ, 2002, J NEUROSCI, V22, P6920; Wen YR, 2011, J FORMOS MED ASSOC, V110, P487, DOI 10.1016/S0929-6646(11)60074-0; Whiteside GT, 2001, J NEUROSCI RES, V64, P168, DOI 10.1002/jnr.1062; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; YAMAZAKI K, 1988, P SOC EXP BIOL MED, V187, P209; Zhang E, 2013, BRAIN RES, V1519, P31, DOI 10.1016/j.brainres.2013.04.055; Zhang W, 2013, PHARMACOL BIOCHEM BE, V111, P64, DOI 10.1016/j.pbb.2013.07.017; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	48	17	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92264	10.1371/journal.pone.0092264	http://dx.doi.org/10.1371/journal.pone.0092264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642655	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900114
J	de Sousa, JT; Milan, M; Bargelloni, L; Pauletto, M; Matias, D; Joaquim, S; Matias, AM; Quillien, V; Leitao, A; Huvet, A				de Sousa, Joana Teixeira; Milan, Massimo; Bargelloni, Luca; Pauletto, Marianna; Matias, Domitilia; Joaquim, Sandra; Matias, Ana Margarete; Quillien, Virgile; Leitao, Alexandra; Huvet, Arnaud			A Microarray-Based Analysis of Gametogenesis in Two Portuguese Populations of the European Clam Ruditapes decussatus	PLOS ONE			English	Article							VASA-LIKE GENE; CARPET SHELL CLAM; CRASSOSTREA-GIGAS; GONADAL DEVELOPMENT; REPRODUCTIVE-CYCLE; MATURATION; OYSTER; EXPRESSION; GERMLINE; MOLLUSK	The European clam, Ruditapes decussatus is a species with a high commercial importance in Portugal and other Southern European countries. Its production is almost exclusively based on natural recruitment, which is subject to high annual fluctuations. Increased knowledge of the natural reproductive cycle of R. decussatus and its molecular mechanisms would be particularly important in providing new highly valuable genomic information for better understanding the regulation of reproduction in this economically important aquaculture species. In this study, the transcriptomic bases of R. decussatus reproduction have been analysed using a custom oligonucleotide microarray representing 51,678 assembled contigs. Microarray analyses were performed in four gonadal maturation stages from two different Portuguese wild populations, characterized by different responses to spawning induction when used as progenitors in hatchery. A comparison between the two populations elucidated a specific pathway involved in the recognition signals and binding between the oocyte and components of the sperm plasma membrane. We suggest that this pathway can explain part of the differences in terms of spawning induction success between the two populations. In addition, sexes and reproductive stages were compared and a correlation between mRNA levels and gonadal area was investigated. The lists of differentially expressed genes revealed that sex explains most of the variance in gonadal gene expression. Additionally, genes like Foxl2, vitellogenin, condensing 2, mitotic apparatus protein p62, Cep57, sperm associated antigens 6, 16 and 17, motile sperm domain containing protein 2, sperm surface protein Sp17, sperm flagellar proteins 1 and 2 and dpy-30, were identified as being correlated with the gonad area and therefore supposedly with the number and/or the size of the gametes produced.	[de Sousa, Joana Teixeira; Quillien, Virgile; Huvet, Arnaud] UMR CNRS 6539, IFREMER, Lab Sci Environm Marin, Plouzane, France; [de Sousa, Joana Teixeira; Matias, Domitilia; Joaquim, Sandra; Matias, Ana Margarete; Leitao, Alexandra] IPMA, Olhao, Portugal; [Milan, Massimo; Bargelloni, Luca; Pauletto, Marianna] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Instituto Portugues do Mar e da Atmosfera; University of Padua	Huvet, A (corresponding author), UMR CNRS 6539, IFREMER, Lab Sci Environm Marin, Plouzane, France.	ahuvet@ifremer.fr	Pauletto, Marianna/K-5518-2019; MILAN, MASSIMO/ABE-6936-2021; Milan, Massimo/H-7428-2019	Pauletto, Marianna/0000-0002-2424-7484; MILAN, MASSIMO/0000-0003-0246-9008; Matias, Domitilia/0000-0002-2191-7497; Joaquim, Sandra/0000-0002-6324-5908; Huvet, Arnaud/0000-0001-6912-881X; Leitao-BenHamadou, Alexandra/0000-0001-8903-3797	European program REPROSEED EU [245119]	European program REPROSEED EU	This study was supported by the European program REPROSEED EU Grant No. 245119 (http://www.reproseed.eu/). The first author is a Ph.D. student financially supported by the same program. The authors are grateful to the REPROSEED partners JL Nicolas, R Robert and P Boudry for their support during the course as well as P Sourdaine, P Favrel and C Lelong for helpful discussion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter S, 2004, MOL REPROD DEV, V67, P127, DOI 10.1002/mrd.10384; Aji L.P., 2011, JURNAL PENELITIAN SA, V14, P33; Bobe J, 2003, MOL REPROD DEV, V66, P46, DOI 10.1002/mrd.10334; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Caskey JL, 2009, INVERTEBR REPROD DEV, V53, P93, DOI 10.1080/07924259.2009.9652295; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; Colas P, 1998, SEMIN CELL DEV BIOL, V9, P539, DOI 10.1006/scdb.1998.0248; Deguchi R, 2003, J CELL SCI, V116, P367, DOI 10.1242/jcs.00221; Delgado M, 2005, SCI MAR, V69, P87; Dheilly NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036353; Di Patrizi L, 2001, GLYCOCONJUGATE J, V18, P511, DOI 10.1023/A:1019617728660; Ernande B, 2004, J EVOLUTION BIOL, V17, P342, DOI 10.1046/j.1420-9101.2003.00674.x; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Evens JP, 2001, BIOESSAYS, V23, P628; Fabioux C, 2005, AQUACULTURE, V250, P458, DOI 10.1016/j.aquaculture.2005.02.038; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Fard Jahromi S.S., 2013, ISRN BIOINFORMATICS, V2013, P1; Fleury E, 2008, GENE, V410, P187, DOI 10.1016/j.gene.2007.12.017; GOBET I, 1994, DEV BIOL, V164, P540, DOI 10.1006/dbio.1994.1222; Goto M, 2010, HUM REPROD, V25, P1884, DOI 10.1093/humrep/deq138; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hidaka H, 1985, CALMODULIN ANTAGONIS; HSU DR, 1994, GENETICS, V137, P999; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Leite RB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-741; Li MWM, 2009, TRENDS MOL MED, V15, P159, DOI 10.1016/j.molmed.2009.02.002; Llera-Herrera R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073176; Martoja R, 1967, INITIATION TECHNIQUE; Matias D, 2013, AQUACULTURE, V406, P52, DOI 10.1016/j.aquaculture.2013.04.030; Matias D, 2009, AQUACULT INT, V17, P257, DOI 10.1007/s10499-008-9197-3; Moreira R, 2012, DEV COMP IMMUNOL, V36, P140, DOI 10.1016/j.dci.2011.06.012; Obata M, 2010, DEV GENES EVOL, V220, P139, DOI 10.1007/s00427-010-0335-3; Royer J, 2008, AQUACULTURE, V277, P313, DOI 10.1016/j.aquaculture.2008.02.033; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Serdar S, 2010, FRESEN ENVIRON BULL, V19, P1055; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Sperry AO, 2012, BIOL CELL, V104, P297, DOI 10.1111/boc.201100102; Tosti E, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-26; Ueishi S, 2009, CELL STRUCT FUNCT, V34, P61, DOI 10.1247/csf.08042; Venditti JJ, 2010, BIOL REPROD, V82, P572, DOI 10.1095/biolreprod.109.076695; Vilela H., 1950, Archivos do Museu Bocage, VNo, 21, P1; Wada T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks765; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Watson AJ, 2007, J ANIM SCI, V85, pE1, DOI 10.2527/jas.2006-432; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	47	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92202	10.1371/journal.pone.0092202	http://dx.doi.org/10.1371/journal.pone.0092202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643002	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900102
J	Wang, Z; Yu, GH; Shi, BB; Wang, XM; Qiang, HP; Gao, HW				Wang, Zan; Yu, Guohui; Shi, Binbin; Wang, Xuemin; Qiang, Haiping; Gao, Hongwen			Development and Characterization of Simple Sequence Repeat (SSR) Markers Based on RNA-Sequencing of Medicago sativa and In silico Mapping onto the M. truncatula Genome	PLOS ONE			English	Article							GENIC MICROSATELLITE MARKERS; EST-DERIVED SSR; GENETIC DIVERSITY; ALFALFA; TRANSFERABILITY; IDENTIFICATION; MAP; L.; VALIDATION; PROGRAM	Sufficient codominant genetic markers are needed for various genetic investigations in alfalfa since the species is an outcrossing autotetraploid. With the newly developed next generation sequencing technology, a large amount of transcribed sequences of alfalfa have been generated and are available for identifying SSR markers by data mining. A total of 54,278 alfalfa non-redundant unigenes were assembled through the Illumina HiSeqTM 2000 sequencing technology. Based on 3,903 unigene sequences, 4,493 SSRs were identified. Tri-nucleotide repeats (56.71%) were the most abundant motif class while AG/CT (21.7%), AGG/CCT (19.8%), AAC/GTT (10.3%), ATC/ATG (8.8%), and ACC/GGT (6.3%) were the subsequent top five nucleotide repeat motifs. Eight hundred and thirty-seven EST-SSR primer pairs were successfully designed. Of these, 527 (63%) primer pairs yielded clear and scored PCR products and 372 (70.6%) exhibited polymorphisms. High transferability was observed for ssp falcata at 99.2% (523) and 71.7% (378) in M. truncatula. In addition, 313 of 527 SSR marker sequences were in silico mapped onto the eight M. truncatula chromosomes. Thirty-six polymorphic SSR primer pairs were used in the genetic relatedness analysis of 30 Chinese alfalfa cultivated accessions generating a total of 199 scored alleles. The mean observed heterozygosity and polymorphic information content were 0.767 and 0.635, respectively. The codominant markers not only enriched the current resources of molecular markers in alfalfa, but also would facilitate targeted investigations in marker-trait association, QTL mapping, and genetic diversity analysis in alfalfa.	[Wang, Zan; Yu, Guohui; Shi, Binbin; Wang, Xuemin; Qiang, Haiping; Gao, Hongwen] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Yu, Guohui] Northwest A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Northwest A&F University - China	Wang, Z (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	wangzan@cas.cn; hongwengao@hotmail.com			National Natural Science Foundation of China [31272495]; Agricultural Science and Technology Innovation Program of China [ASTIP-TAS10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program of China	This research was funded by a grant from the National Natural Science Foundation of China (No. 31272495) and the Agricultural Science and Technology Innovation Program (ASTIP-TAS10) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; [Anonymous], 2009, BMC PLANT BIOL, DOI DOI 10.1186/1471-2229-9-118; ARMSTRONG JM, 1954, CAN J BOT, V32, P531, DOI 10.1139/b54-050; Barcaccia G., 1994, Journal of Genetics and Breeding, V48, P161; BLONDON F, 1994, GENOME, V37, P264, DOI 10.1139/g94-037; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Choi HK, 2004, GENETICS, V166, P1463, DOI 10.1534/genetics.166.3.1463; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Diwan N, 1997, GENOME, V40, P887, DOI 10.1139/g97-115; Doyle J. J., 1987, PHYTOCHEM B, P11; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Flajoulot S, 2005, THEOR APPL GENET, V111, P1420, DOI 10.1007/s00122-005-0074-4; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Gupta S, 2009, GENOME, V52, P761, DOI [10.1139/g09-051, 10.1139/G09-051]; He C, 2009, CROP SCI, V49, P2176, DOI 10.2135/cropsci2007.04.0456; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu LL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-522; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pan L, 2010, J HERED, V101, P71, DOI 10.1093/jhered/esp070; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Robins JG, 2008, CROP SCI, V48, P1780, DOI 10.2135/cropsci2008.02.0101; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Sakiroglu M, 2010, THEOR APPL GENET, V121, P403, DOI 10.1007/s00122-010-1319-4; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Silva PIT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-17; Sledge MK, 2005, THEOR APPL GENET, V111, P980, DOI 10.1007/s00122-005-0038-8; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; STANFORD EH, 1951, AGRON J, V43, P222, DOI 10.2134/agronj1951.00021962004300050004x; Teh SL, 2011, MOL BIOL REP, V38, P3903, DOI 10.1007/s11033-010-0506-3; Thrall PH, 2000, J HERED, V91, P348, DOI 10.1093/jhered/91.4.348; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang Z, 2013, MOL BIOL REP, V40, P3291, DOI 10.1007/s11033-012-2404-3; Wang ZY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-139; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xin DW, 2012, MOL BIOL REP, V39, P9047, DOI 10.1007/s11033-012-1776-8; Yi GB, 2006, THEOR APPL GENET, V114, P113, DOI 10.1007/s00122-006-0415-y; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891	54	31	38	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92029	10.1371/journal.pone.0092029	http://dx.doi.org/10.1371/journal.pone.0092029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642969	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900063
J	Wen, XJ; Huang, AM; Liu, ZL; Liu, YY; Hu, JY; Liu, J; Shuai, XT				Wen, Xiaojun; Huang, Amin; Liu, Zhonglin; Liu, Yunyun; Hu, Jingyang; Liu, Jun; Shuai, Xintao			Downregulation of ROCK2 through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA; GENE DELIVERY; IN-VITRO; APOPTOSIS; TUMORS; PROGRESSION; INHIBITOR; MIGRATION; INVASION; DISEASE	Objective: Rho-associated coiled-coil kinase 2 (ROCK2) is an attractive therapeutic target because it is overexpressed in many malignancies, including glioma. Therefore, we designed the current study to determine whether the downregulation of ROCK2 would sensitize the cytotoxic effect of temozolomide (TMZ) in U251 cells. Methods: Glycol-polyethyleneimine (PEG-PEI) was used to deliver siROCK2 to U251 cells, and the physical characteristics of the PEG-PEI/siROCK2 complex (referred to as the siROCK2 complex) were investigated. The transfection efficiency and cell uptake were determined by flow cytometry (FCM) and confocal laser microscopy (CLSM), respectively. U251 cells were then treated with 100 mM TMZ, siROCK2 complexes or their combination. The apoptosis rate and cell migration were measured by FCM and wound-healing assay, respectively. The levels of Bax, Bcl-2, cleaved caspase-3, MMP-2, and MMP-9 were detected to analyze the degrees of apoptosis and migration. Results: Our results revealed that the characteristics of the siROCK2 complexes depended closely on the N/P ratios. PEG-PEI served as a good vector for siROCK2 and exhibited low cytotoxicity toward U251 cells. The CLSM assay showed that the siROCK2 complexes were successfully uptaken and that both the protein and mRNA levels of ROCK2 were significantly suppressed. Furthermore, the combination treatment induced a higher apoptosis rate and markedly increased the gap distance of U251 cells in the wound-healing assay. Levels of the proapoptotic proteins Bax and cleaved caspase-3 were significantly increased, whereas levels of the antiapoptotic protein Bcl-2 and the migration-related proteins MMP-2 and MMP-9 were significantly reduced by the combination treatment compared with either treatment alone. Conclusions: In conclusion, our results demonstrate that the combination of TMZ and siROCK2 effectively induces apoptosis and inhibits the migration of U251 cells. Therefore, the combination of TMZ and siROCK2 complex is a potential therapeutic approach for human glioma.	[Wen, Xiaojun; Liu, Zhonglin; Hu, Jingyang; Liu, Jun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Amin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yunyun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Shuai, Xintao] Sun Yat Sen Univ, Zhongshan Sch Med, Ctr Biomed Engn, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Shuai, XT (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Ctr Biomed Engn, Guangzhou 510275, Guangdong, Peoples R China.	Zhonglinliu@126.com			Chinese National Natural Science Foundation [81000466]; Guangdong Province Natural Science Foundation [S2013010014550]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grants to Zhonglin Liu from the Chinese National Natural Science Foundation (No. 81000466) and Guangdong Province Natural Science Foundation (S2013010014550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Das A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-36; Deng L, 2010, CANCER BIOL THER, V9, P875, DOI 10.4161/cbt.9.11.11634; Erkutlu I, 2013, TUMOR BIOL, V34, P1139, DOI 10.1007/s13277-013-0655-9; Gabelloni P, 2010, NEUROSCIENCE, V168, P514, DOI 10.1016/j.neuroscience.2010.03.064; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kondraganti S, 2000, CANCER RES, V60, P6851; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Liang YR, 2012, BIOCHEM BIOPH RES CO, V421, P690, DOI 10.1016/j.bbrc.2012.03.155; Liu YY, 2013, BRAIN RES, V1490, P43, DOI 10.1016/j.brainres.2012.10.039; Neu M, 2007, J CONTROL RELEASE, V124, P69, DOI 10.1016/j.jconrel.2007.08.009; Oellers P, 2009, GLIA, V57, P499, DOI 10.1002/glia.20777; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schofield AV, 2013, CRIT REV BIOCHEM MOL, V48, P301, DOI 10.3109/10409238.2013.786671; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trog D, 2006, EUR J PHARMACOL, V542, P8, DOI 10.1016/j.ejphar.2006.05.026; Vishnubhotla R, 2007, LAB INVEST, V87, P1149, DOI 10.1038/labinvest.3700674; Wang J, 2013, INT J PHARMACEUT, V458, P48, DOI 10.1016/j.ijpharm.2013.10.017; Yan B, 2006, NEUROSCI LETT, V407, P124, DOI 10.1016/j.neulet.2006.08.032; Zhang SG, 2012, J MOL NEUROSCI, V47, P346, DOI 10.1007/s12031-012-9759-8; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	23	8	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92050	10.1371/journal.pone.0092050	http://dx.doi.org/10.1371/journal.pone.0092050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642531	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900072
J	Jiao, ZJ; Bedoui, S; Brady, JL; Walter, A; Chopin, M; Carrington, EM; Sutherland, RM; Nutt, SL; Zhang, YX; Ko, HJ; Wu, L; Lew, AM; Zhan, YF				Jiao, Zhijun; Bedoui, Sammy; Brady, Jamie L.; Walter, Anne; Chopin, Michael; Carrington, Emma M.; Sutherland, Robyn M.; Nutt, Stephen L.; Zhang, Yuxia; Ko, Hyun-Ja; Wu, Li; Lew, Andrew M.; Zhan, Yifan			The Closely Related CD103(+) Dendritic Cells (DCs) and Lymphoid-Resident CD8(+) DCs Differ in Their Inflammatory Functions	PLOS ONE			English	Article							ANTIGEN CROSS-PRESENTATION; NOD-LIKE RECEPTOR; GM-CSF; T-CELLS; CUTTING EDGE; INTERLEUKIN-17A AND-17F; IN-VIVO; EXPRESSION; CD8-ALPHA(+); DIFFERENTIATION	Migratory CD103(+) and lymphoid-resident CD8(+) dendritic cells (DCs) share many attributes, such as dependence on the same transcription factors, cross-presenting ability and expression of certain surface molecules, such that it has been proposed they belong to a common sub-lineage. The functional diversity of the two DC types is nevertheless incompletely understood. Here we reveal that upon skin infection with herpes simplex virus, migratory CD103(+) DCs from draining lymph nodes were more potent at inducing Th17 cytokine production by CD4(+) T cells than CD8(+) DCs. This superior capacity to drive Th17 responses was also evident in CD103(+) DCs from uninfected mice. Their differential potency to induce Th17 differentiation was reflected by higher production of IL-1 beta and IL-6 by CD103(+) DCs compared with CD8(+) DCs upon stimulation. The two types of DCs from isolated lymph nodes also differ in expression of certain pattern recognition receptors. Furthermore, elevated levels of GM-CSF, typical of those found in inflammation, substantially increased the pool size of CD103(+) DCs in lymph nodes and skin. We argue that varied levels of GM-CSF may explain the contrasting reports regarding the positive role of GM-CSF in regulating development of CD103(+) DCs. Together, we find that these two developmentally closely-related DC subsets display functional differences and that GM-CSF has differential effect on the two types of DCs.	[Jiao, Zhijun; Brady, Jamie L.; Chopin, Michael; Carrington, Emma M.; Sutherland, Robyn M.; Nutt, Stephen L.; Zhang, Yuxia; Ko, Hyun-Ja; Lew, Andrew M.; Zhan, Yifan] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Jiao, Zhijun] Jiangsu Univ, Key Lab Med Immunol, Zhenjiang, Peoples R China; [Jiao, Zhijun] Jiangsu Univ, Dept Lab Med, Affiliated Hosp, Zhenjiang, Peoples R China; [Bedoui, Sammy; Walter, Anne] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Brady, Jamie L.; Chopin, Michael; Carrington, Emma M.; Sutherland, Robyn M.; Nutt, Stephen L.; Zhang, Yuxia; Ko, Hyun-Ja; Lew, Andrew M.; Zhan, Yifan] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Wu, Li] Tsinghua Univ, Beijing 100084, Peoples R China; [Wu, Li] Peking Univ, Joint Ctr Life Sci, Beijing 100871, Peoples R China; [Wu, Li] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Jiangsu University; Jiangsu University; University of Melbourne; University of Melbourne; Tsinghua University; Peking University; Tsinghua University	Lew, AM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	lew@wehi.edu.au; zhan@wehi.edu.au	Chopin, Michael/AAD-3661-2020; Nutt, Stephen L/C-9256-2013; Lew, Andrew/C-7248-2013	Nutt, Stephen L/0000-0002-0020-6637; Lew, Andrew/0000-0002-2198-8164; Michael, Chopin/0000-0001-8812-2763; Zhan, Yifan/0000-0001-6974-0486; BEDOUI, SAMMY/0000-0002-7443-0543	National Health and Medical Research Council of Australia (NHMRC) [575543, 637324, 1007703]; Juvenile Diabetes Research Foundation; NHMRC Independent Research Institutes [361646]; Australian Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NHMRC Independent Research Institutes(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR)	This work was supported by National Health and Medical Research Council of Australia (NH&MRC) program and project grants (#575543, #637324 and #1007703), Juvenile Diabetes Research Foundation, NHMRC Independent Research Institutes Infrastructure Support Scheme grant #361646, and Victorian State Government Operational Infrastructure Support and the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Campbell IK, 2011, J IMMUNOL, V186, P5468, DOI 10.4049/jimmunol.1002923; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Davey GM, 2010, J IMMUNOL, V184, P2243, DOI 10.4049/jimmunol.0903013; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dresch C, 2011, EUR J IMMUNOL, V41, P2544, DOI 10.1002/eji.201041374; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eisenbarth SC, 2012, NATURE, V484, P510, DOI 10.1038/nature11012; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Ouyang WJ, 2010, CYTOKINE GROWTH F R, V21, P435, DOI 10.1016/j.cytogfr.2010.10.007; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Schon MP, 1999, J IMMUNOL, V162, P6641; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540; Zhan YF, 2010, J IMMUNOL, V185, P2125, DOI 10.4049/jimmunol.0903793	53	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91126	10.1371/journal.pone.0091126	http://dx.doi.org/10.1371/journal.pone.0091126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637385	Green Published, gold			2022-12-27	WOS:000333254100017
J	Konzmann, S; Lunau, K				Konzmann, Sabine; Lunau, Klaus			Divergent Rules for Pollen and Nectar Foraging Bumblebees - A Laboratory Study with Artificial Flowers Offering Diluted Nectar Substitute and Pollen Surrogate	PLOS ONE			English	Article							DIVISION-OF-LABOR; BOMBUS-TERRESTRIS; AMINO-ACIDS; HONEY-BEES; EVOLUTION; QUALITY; PREFERENCES; HYMENOPTERA; FORAGERS; BEHAVIOR	Almost all bees collect nectar and pollen from flowers. Female bees collect pollen to provision their nest cells, whereas they use nectar for individual energy supply and nest cell provisioning. Bees fine-tune nectar foraging to the amount and to the concentration of nectar, but the individual bees' response to variability of amount and concentration of pollen reward has not yet been studied thoroughly in laboratory settings. We developed an experimental set-up in which bumblebees simultaneously collected sugar solution and pollen from artificial flowers; natural pollen was mixed with cellulose powder or glass powder as a pollen surrogate. Here we show that bumblebee (Bombus terrestris) workers do not specialise in nectar or pollen collection, but regularly collect both rewards on the same day. When offered a fixed pollen reward and varied amounts and concentrations of sugar solution, the bumblebees fine-tuned sugar solution foraging dependent on both the volume and concentration, with strong preferences for the highest concentration and the greatest volume. In the reciprocal tests, when offered a fixed sugar reward and varied amounts and concentrations of pollen mixed with a nutrient-free pollen surrogate, the bumblebees follow more an all-or-none rule for pollen, accepting all amounts and concentrations except pure surrogate. It is discussed how the bumblebees' ability to sense sugar, and their apparent inability to sense the pollen protein content, shaped their foraging behaviour. It is argued that the rarity of nectar mimicry and the frequency of pollen mimicry in natural flowers might be interpreted in the context of divergent abilities of nectar and pollen recognition in bees.	[Konzmann, Sabine; Lunau, Klaus] Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Lunau, K (corresponding author), Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany.	lunau@uni-duesseldorf.de	Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201				Adeva JJG, 2012, BIOSYST ENG, V112, P304, DOI 10.1016/j.biosystemseng.2012.05.002; Arenas A, 2012, ANIM BEHAV, V83, P1023, DOI 10.1016/j.anbehav.2012.01.026; Bodi M, 2012, MATH COMP MODEL DYN, V18, P87, DOI 10.1080/13873954.2011.601420; Budde Julia, 2007, Entomologie Heute, V19, P173; BUTLER CG, 1945, J EXP BIOL, V21, P5; Calderone NW, 1996, ANIM BEHAV, V51, P631, DOI 10.1006/anbe.1996.0068; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Carter C, 2006, NATURWISSENSCHAFTEN, V93, P72, DOI 10.1007/s00114-005-0062-1; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; Davies KL, 2004, ANN BOT-LONDON, V93, P75, DOI 10.1093/aob/mch007; DAY S, 1990, J APICULT RES, V29, P138, DOI 10.1080/00218839.1990.11101210; de Brito Sanchez MG, 2011, CHEM SENSES, V36, P675, DOI 10.1093/chemse/bjr040; de Vries H, 1998, BEHAV ECOL SOCIOBIOL, V44, P109, DOI 10.1007/s002650050522; Dobson HEM, 1997, J INSECT PHYSIOL, V43, P89, DOI 10.1016/S0022-1910(96)00024-8; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Edwards JR, 2011, J THEOR BIOL, V271, P64, DOI 10.1016/j.jtbi.2010.11.027; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Goyret J, 2005, NATURWISSENSCHAFTEN, V92, P440, DOI 10.1007/s00114-005-0016-7; Hagbery J, 2012, NATURWISSENSCHAFTEN, V99, P821, DOI 10.1007/s00114-012-0964-7; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Heinrich B., 2004, BUMBLEBEE EC; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; King MJ, 1996, J EXP BIOL, V199, P2317; Kitaoka TK, 2009, BEHAV ECOL SOCIOBIOL, V63, P501, DOI 10.1007/s00265-008-0684-3; KOLTERMANN R, 1971, Z VERGL PHYSIOL, V75, P49, DOI 10.1007/BF00335137; Lehmann S, 2010, AMINO ACIDS, V39, P949, DOI 10.1007/s00726-010-0525-3; Leonhardt SD, 2012, APIDOLOGIE, V43, P449, DOI 10.1007/s13592-011-0112-y; Linander N, 2012, CHEM SENSES, V37, P631, DOI 10.1093/chemse/bjs044; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Lunau Klaus, 2006, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V127, P13, DOI 10.1127/0006-8152/2006/0127-0013; Mapalad KS, 2008, J EXP BIOL, V211, P2239, DOI 10.1242/jeb.016642; MICHENER C D, 1978, University of Kansas Science Bulletin, V51, P575; Michener C. D., 2000, The bees of the world; Molet M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1919, DOI 10.1007/s00265-008-0623-3; Neff JL, 2008, APIDOLOGIE, V39, P30, DOI 10.1051/apido:2007055; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; Plowright CMS, 1999, BEHAVIOUR, V136, P951, DOI 10.1163/156853999501667; R DEVELOPMENT CORE TEAM, 2009, R LANG ENV STAT COMP; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Robertson AW, 1999, ECOLOGY, V80, P2594, DOI 10.1890/0012-9658(1999)080[2594:BBSOMG]2.0.CO;2; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Schmickl T, 2012, NEURAL COMPUT APPL, V21, P251, DOI 10.1007/s00521-010-0357-9; Schmidt JO, 2006, J INSECT BEHAV, V19, P521, DOI 10.1007/s10905-006-9039-y; Sedivy C, 2008, EVOLUTION, V62, P2487, DOI 10.1111/j.1558-5646.2008.00465.x; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Siegel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033465; Smeets P, 2003, APIDOLOGIE, V34, P333, DOI 10.1051/apido:2003026; Stanley RG., 1974, POLLEN, DOI [10.1007/978-3-642-65905-8, DOI 10.1007/978-3-642-65905-8]; Thorp RW, 2000, PLANT SYST EVOL, V222, P211, DOI 10.1007/BF00984103; Townsend-Mehler JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P305, DOI 10.1007/s00265-010-1047-4; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Wacht S, 2000, J COMP PHYSIOL A, V186, P193, DOI 10.1007/s003590050019; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083	62	47	50	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91900	10.1371/journal.pone.0091900	http://dx.doi.org/10.1371/journal.pone.0091900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637406	Green Published, gold			2022-12-27	WOS:000333254100077
J	Myhrvold, CL; Janny, F; Nelson, D; Ladd, SN; Atwood, A; Sachs, JP				Myhrvold, Conor L.; Janny, Fran; Nelson, Daniel; Ladd, S. Nemiah; Atwood, Alyssa; Sachs, Julian P.			Holocene Closure of Lib Pond, Marshall Islands	PLOS ONE			English	Article							INTERTROPICAL CONVERGENCE ZONE; MODELS	Well-preserved sediment from closed water bodies of atolls such as Lib Pond are rare opportunities to reconstruct the past regional climate, which pieced together across a latitude and longitude range identify the range of movement patterns of wider scale climate phenomena such as the Intertropical Convergence Zone (ITCZ) and El Nino Southern Oscillation (ENSO). We conducted the first physico-chemical survey of Lib Pond, a shallow, closed-water saline lake located on remote and difficult to access Lib Island in the Marshall Islands at 8 degrees 18' 48.99 '' N, 167 22' 51.90 '' E in the Pacific Ocean, in July 2009. We performed a bathymetric survey, recorded salinity, dissolved oxygen, pH, and temperature profiles, monitored the tidal variability, and conducted a vegetation survey surrounding the lake. From bathymetric data we calculated the lake volume, which we used to estimate the lake's salt budget, and ultimately the residence time of water in the lake basin. We took a series of sediment cores from the lake, cores which indicate Lib Island's changing environment and climate. Radiocarbon measurements determined sediment age, and reveal significant mixing over the last 2 ka of deposition. We conclude that prior to 3 ka, Lib Island was an atoll with a central lagoon connected to the open ocean, which was then closed off from the open ocean to form the brackish system that exists today. We predict that the sediment accumulation in Lib Pond evident today will continue. As seawater is inhibited from exchanging with fresh water, Lib Pond will become a shallower lake with increasingly fresh water.	[Myhrvold, Conor L.; Janny, Fran; Nelson, Daniel; Ladd, S. Nemiah; Atwood, Alyssa; Sachs, Julian P.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Myhrvold, CL (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	conor.myhrvold@gmail.com		Ladd, S. Nemiah/0000-0002-0132-5785; Nelson, Daniel/0000-0002-2716-7770	US National Science Foundation [NSF-ESH-0639640, EAR-0745982, EAR-0823503]	US National Science Foundation(National Science Foundation (NSF))	Funding was provided to JPS by the US National Science Foundation under grants #NSF-ESH-0639640, EAR-0745982, and EAR-0823503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berner EK, 1987, GLOBAL WATER CYCLE G; CANE MA, 1984, J PHYS OCEANOGR, V14, P1864, DOI 10.1175/1520-0485(1984)014<1864:MSLDEN>2.0.CO;2; FOSBERG F R, 1990, Atoll Research Bulletin, P1; Hakanson L., 1983, PRINCIPLES LAKE SEDI; Haug G. H., 2001, Science, V293, P1304, DOI 10.1126/science.1059725; Killops SD, 2005, INTRO GEOCHEMISTRY; Knauss JA, 2005, INTRO PHYS OCEANOGRA; Kwajalein Climate Kwajalein Climate, 2007, RTS WEATH STN; Payne A. I., 1986, ECOLOGY TROPICAL LAK; Peterson FL, 1997, DEVEL SEDIM, V54, P611; PSZENNY AAP, 1982, GEOPHYS RES LETT, V9, P751, DOI 10.1029/GL009i007p00751; RASMUSSON EM, 1983, SCIENCE, V222, P1195, DOI 10.1126/science.222.4629.1195; RMI Embassy Individual Atolls-Lib Island, 2005, REP MARSH ISL EMB US; Sachs JP, 2011, SCI AM, V304, P60, DOI 10.1038/scientificamerican0311-60; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Saenger Casey, 2006, Saline Syst, V2, P8, DOI 10.1186/1746-1448-2-8; Sheldon JE, 2006, ESTUAR COAST, V29, P133, DOI 10.1007/BF02784705; Taylor JD, 2006, ZOOL J LINN SOC-LOND, V148, P421, DOI 10.1111/j.1096-3642.2006.00261.x; Trichet J, 2001, SEDIMENT GEOL, V140, P177, DOI 10.1016/S0037-0738(00)00177-9; Valencia MJ, 1977, ATOLL RES B, V197; Wetzel RG, 1972, NUTRIENTS EUTROPHICA, V1, P84; Wilcox C, 2005, J HYDROL, V301, P29, DOI 10.1016/j.jhydrol.2004.06.027; Wright VP, 1996, SEDIMENTARY ENV PROC	23	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90939	10.1371/journal.pone.0090939	http://dx.doi.org/10.1371/journal.pone.0090939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638020	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100014
J	Pina, M; Almecija, S; Alba, DM; O'Neill, MC; Moya-Sola, S				Pina, Marta; Almecija, Sergio; Alba, David M.; O'Neill, Matthew C.; Moya-Sola, Salvador			The Middle Miocene Ape Pierolapithecus catalaunicus Exhibits Extant Great Ape-Like Morphometric Affinities on Its Patella: Inferences on Knee Function and Evolution	PLOS ONE			English	Article							HISPANOPITHECUS-LAIETANUS; POSITIONAL BEHAVIOR; HIND-LIMB; LOCOMOTION; PRIMATES; QUADRUPEDALISM; CATALONIA; SKELETON; POSTURE; ISLAND	The mosaic nature of the Miocene ape postcranium hinders the reconstruction of the positional behavior and locomotion of these taxa based on isolated elements only. The fossil great ape Pierolapithecus catalaunicus (IPS 21350 skeleton; 11.9 Ma) exhibits a relatively wide and shallow thorax with moderate hand length and phalangeal curvature, dorsally-oriented metacarpophalangeal joints, and loss of ulnocarpal articulation. This evidence reveals enhanced orthograde postures without modern ape-like below-branch suspensory adaptations. Therefore, it has been proposed that natural selection enhanced vertical climbing (and not suspension per se) in Pierolapithecus catalaunicus. Although limb long bones are not available for this species, its patella (IPS 21350.37) can potentially provide insights into its knee function and thus on the complexity of its total morphological pattern. Here we provide a detailed description and morphometric analyses of IPS 21350.37, which are based on four external dimensions intended to capture the overall patellar shape. Our results reveal that the patella of Pierolapithecus is similar to that of extant great apes: proximodistally short, mediolaterally broad and anteroposteriorly thin. Previous biomechanical studies of the anthropoid knee based on the same measurements proposed that the modern great ape patella reflects a mobile knee joint while the long, narrow and thick patella of platyrrhine and especially cercopithecoid monkeys would increase the quadriceps moment arm in knee extension during walking, galloping, climbing and leaping. The patella of Pierolapithecus differs not only from that of monkeys and hylobatids, but also from that of basal hominoids (e.g., Proconsul and Nacholapithecus), which display slightly thinner patellae than extant great apes (the previously-inferred plesiomorphic hominoid condition). If patellar shape in Pierolapithecus is related to modern great ape-like knee function, our results suggest that increased knee mobility might have originally evolved in relation to enhanced climbing capabilities in great apes (such as specialized vertical climbing).	[Pina, Marta; Almecija, Sergio; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Almecija, Sergio; O'Neill, Matthew C.] SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA; [Almecija, Sergio] Univ Turin, NYCEP Morphometr Grp, Turin, Italy; [Alba, David M.] Univ Turin, Dipartimento Sci Terra, Turin, Italy; [Moya-Sola, Salvador] Univ Autonoma Barcelona, ICREA, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Unitat Antropol Biol, Dept BABVE, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Turin; University of Turin; Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona	Pina, M (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain.	marta.pina@icp.cat	Alba, David/G-9716-2015; Almécija, Sergio/ABG-8129-2020; Pina, Marta/G-5974-2018	Alba, David/0000-0002-8886-5580; Almécija, Sergio/0000-0003-1373-1497; Moya-Sola, Salvador/0000-0001-8506-1061; Pina, Marta/0000-0001-9762-6402	Spanish Ministerio de Educacion [AP2010-4579]; Spanish Ministerio de Economia y Competitividad [CGL2011-27343, CGL2011-28681, RYC-2009-04533]; Generalitat de Catalunya [2009 SGR 754 GRC, BP-A 00226]; AAPA Professional Development Grant; ICREA Funding Source: Custom	Spanish Ministerio de Educacion(Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); AAPA Professional Development Grant; ICREA(ICREA)	This work has been supported by the Spanish Ministerio de Educacion (AP2010-4579 to MP), the Spanish Ministerio de Economia y Competitividad [CGL2011-27343, CGL2011-28681, and RYC-2009-04533 (to DMA)], the Generalitat de Catalunya [2009 SGR 754 GRC, and BP-A 00226 (to SA)], and the AAPA Professional Development Grant (to SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba DM, 2012, EVOL ANTHROPOL, V21, P254, DOI 10.1002/evan.21312; Alba DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039617; Alba DM, 2010, J HUM EVOL, V59, P143, DOI 10.1016/j.jhevol.2010.02.002; Almecija S, 2007, P ROY SOC B-BIOL SCI, V274, P2375, DOI 10.1098/rspb.2007.0750; Almecija S, 2014, AM J PHYS A IN PRESS; Almecija S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3888; Almecija S, 2012, AM J PHYS ANTHROPOL, V148, P436, DOI 10.1002/ajpa.22071; Almecija S, 2009, J HUM EVOL, V57, P284, DOI 10.1016/j.jhevol.2009.02.008; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Badoux D.M., 1974, P1; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Begun DR, 2005, SCIENCE, V308, DOI 10.1126/science.1108139; Casanovas-Vilar I, 2008, J HUM EVOL, V55, P589, DOI 10.1016/j.jhevol.2008.05.004; Casanovas-Vilar I, 2011, P NATL ACAD SCI USA, V108, P5554, DOI 10.1073/pnas.1018562108; Channon AJ, 2010, AM J PHYS ANTHROPOL, V143, P403, DOI 10.1002/ajpa.21329; Channon AJ, 2010, J ANAT, V216, P446, DOI 10.1111/j.1469-7580.2009.01209.x; Crompton RH, 2010, PHILOS T R SOC B, V365, P3301, DOI 10.1098/rstb.2010.0035; Deane AS, 2008, J HUM EVOL, V55, P691, DOI 10.1016/j.jhevol.2008.05.005; Deane AS, 2010, J HUM EVOL, V59, P150, DOI 10.1016/j.jhevol.2010.04.003; Doran Diane M., 1996, P213, DOI 10.1017/CBO9780511752414.018; FLEAGLE JG, 1976, FOLIA PRIMATOL, V26, P245, DOI 10.1159/000155756; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gebo DL, 1996, AM J PHYS ANTHROPOL, V101, P55, DOI 10.1002/(SICI)1096-8644(199609)101:1<55::AID-AJPA5>3.0.CO;2-C; Hammond AS, 2013, J HUM EVOL, V64, P658, DOI 10.1016/j.jhevol.2013.03.002; HARRISON T, 1986, J HUM EVOL, V15, P541, DOI 10.1016/S0047-2484(86)80073-2; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; HUNT KD, 1991, INT J PRIMATOL, V12, P95, DOI 10.1007/BF02547576; Hurzeler J., 1958, Verhandlungen der Naturforschenden Gesellschaft in Basel, V69, P1; Isler K, 2005, AM J PHYS ANTHROPOL, V126, P66, DOI 10.1002/ajpa.10419; Isler K, 2003, THESIS U ZURICH; Jenkins F.A. Jr., 1975, P213; Jungers W.L., 1990, P87; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kohler M, 2002, AM J PHYS ANTHROPOL, V119, P297, DOI 10.1002/ajpa.10140; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McCrossin M.L., 1994, DISSERTATION; McCrossin ML, 1994, AM J PHYS ANTHR S18, V37, P142; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Moya-Sola S, 2005, SCIENCE, V308, DOI 10.1126/science.1108433; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 1999, P NATL ACAD SCI USA, V96, P313, DOI 10.1073/pnas.96.1.313; Moya-Sola S, 2009, AM J PHYS ANTHROPOL, V139, P126, DOI 10.1002/ajpa.20891; MoyaSola S, 1996, NATURE, V379, P156, DOI 10.1038/379156a0; Nakatsukasa M, 2012, ANTHROPOL SCI, V120, P235, DOI 10.1537/ase.120731; NISELL R, 1985, ACTA ORTHOP SCAND, V56, P1, DOI 10.3109/17453678509154159; O'Neill MC, 2013, J EXP BIOL, V216, P3709, DOI 10.1242/jeb.079665; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Patel BA, 2009, J HUM EVOL, V57, P763, DOI 10.1016/j.jhevol.2009.08.005; de los Rios MP, 2012, J HUM EVOL, V63, P497, DOI 10.1016/j.jhevol.2012.05.012; Pina M, 2012, AM J PHYS ANTHROPOL, V149, P142, DOI 10.1002/ajpa.22109; PREUSCHOFT H, 1971, FOLIA PRIMATOL, V14, P209, DOI 10.1159/000155351; Preuschoft H., 1970, THE CHIMPANZEE, V3, P221; ROSE MD, 1994, J HUM EVOL, V26, P387, DOI 10.1006/jhev.1994.1025; Rose Michael D., 1996, African Study Monographs Supplementary Issue, V24, P3; STERN JT, 1974, J BIOMECH, V7, P411, DOI 10.1016/0021-9290(74)90004-9; Susanna I, 2010, AM J PHYS ANTHROPOL, P227; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; Ward Carol V., 2007, P1011, DOI 10.1007/978-3-540-33761-4_34; WARD CV, 1993, AM J PHYS ANTHROPOL, V90, P77, DOI 10.1002/ajpa.1330900106; WARD CV, 1995, J HUM EVOL, V29, P1, DOI 10.1006/jhev.1995.1045; Ward S, 1999, SCIENCE, V285, P1382, DOI 10.1126/science.285.5432.1382; Zihlman AL, 2011, ANAT REC, V294, P1842, DOI 10.1002/ar.21449	64	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91944	10.1371/journal.pone.0091944	http://dx.doi.org/10.1371/journal.pone.0091944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637777	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000333254100086
J	Renwick, AR; Robinson, CJ; Martin, TG; May, T; Polglase, P; Possingham, HP; Carwardine, J				Renwick, Anna R.; Robinson, Catherine J.; Martin, Tara G.; May, Tracey; Polglase, Phil; Possingham, Hugh P.; Carwardine, Josie			Biodiverse Planting for Carbon and Biodiversity on Indigenous Land	PLOS ONE			English	Article							EMISSIONS; BENEFITS	Carbon offset mechanisms have been established to mitigate climate change through changes in land management. Regulatory frameworks enable landowners and managers to generate saleable carbon credits on domestic and international markets. Identifying and managing the associated co-benefits and dis-benefits involved in the adoption of carbon offset projects is important for the projects to contribute to the broader goal of sustainable development and the provision of benefits to the local communities. So far it has been unclear how Indigenous communities can benefit from such initiatives. We provide a spatial analysis of the carbon and biodiversity potential of one offset method, planting biodiverse native vegetation, on Indigenous land across Australia. We discover significant potential for opportunities for Indigenous communities to achieve carbon sequestration and biodiversity goals through biodiverse plantings, largely in southern and eastern Australia, but the economic feasibility of these projects depend on carbon market assumptions. Our national scale cost-effectiveness analysis is critical to enable Indigenous communities to maximise the benefits available to them through participation in carbon offset schemes.	[Renwick, Anna R.; Martin, Tara G.; Possingham, Hugh P.; Carwardine, Josie] Univ Queensland, ARC Ctr Excellence Environm Decis, NERP Environm Decis Hub, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Robinson, Catherine J.; Martin, Tara G.; Carwardine, Josie] CSIRO Ecosyst Sci, Brisbane, Qld, Australia; [Robinson, Catherine J.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [May, Tracey] CSIRO Ecosyst Sci, Alice Springs, NT, Australia; [Polglase, Phil] CSIRO Ecosyst Sci, Crace, ACT, Australia; [Possingham, Hugh P.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Imperial College London	Renwick, AR (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, NERP Environm Decis Hub, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia.	a.renwick@uq.edu.au	Carwardine, Josie/A-5801-2011; POSSINGHAM, HUGH/R-8310-2019; Martin, Tara/M-1897-2016; Possingham, Hugh/B-1337-2008; Robinson, Cathy/D-3349-2011	POSSINGHAM, HUGH/0000-0001-7755-996X; Martin, Tara/0000-0001-7165-9812; Possingham, Hugh/0000-0001-7755-996X; Robinson, Cathy/0000-0002-3453-572X; May, Tracey/0000-0002-2226-6251	CSIRO Climate Adaptation and Sustainable Agriculture Flagship; National Indigenous Climate Change Project (RIRDC) [PRJ-005438]; ARC Centre of Excellence for Environmental Decisions; NERP Research Hub for Environmental Decisions; Julius Career Award	CSIRO Climate Adaptation and Sustainable Agriculture Flagship; National Indigenous Climate Change Project (RIRDC); ARC Centre of Excellence for Environmental Decisions(Australian Research Council); NERP Research Hub for Environmental Decisions; Julius Career Award	This work was supported by the CSIRO Climate Adaptation and Sustainable Agriculture Flagship, the National Indigenous Climate Change Project (RIRDC Project No PRJ-005438), the ARC Centre of Excellence for Environmental Decisions, the NERP Research Hub for Environmental Decisions and a Julius Career Award to TGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Climate Commission, 2013, CRIT DEC GLOB ACT BU; Commonwealth of Australia (Department of Climate Change and Energy Efficiency), 2012, CARB FARM IN HDB; DCCEE, 2012, CFI METH ENV PLANT N; Dohan R, 2010, 1 NATIONS CARBON COL; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Gerrard E, 2012, ABORIG HIST MG SER, V24, P135; Goldtooth T, 2010, CARBON MARKETS VIOLA; Grainger A, 2009, CURR BIOL, V19, pR974, DOI 10.1016/j.cub.2009.10.001; Hulvey KB, 2013, NAT CLIM CHANGE, V3, P869, DOI [10.1038/nclimate1862, 10.1038/NCLIMATE1862]; Lindenmayer DB, 2012, CONSERV LETT, V5, P28, DOI 10.1111/j.1755-263X.2011.00213.x; NICC, 2011, SUMM NAT IND CLIM CH; Parker C, 2008, LITTLE GLOBAL CANOPY; Peters-Stanley M., 2012, DEV DIMENSION STATE; Polglase PJ, 2013, CLIMATIC CHANGE, V121, P161, DOI 10.1007/s10584-013-0882-5; Putz FE, 2009, GLOBAL ENVIRON CHANG, V19, P400, DOI 10.1016/j.gloenvcha.2009.07.005; Robinson C. J., 2011, INDIGENOUS IN PRESS; Robinson CJ, 2014, GEOGR RES-AUST, V52, P123, DOI 10.1111/1745-5871.12049; Robinson CJ, 2013, NICC OPPORTUNITIES R; Russell-Smith J, 2009, INT J WILDLAND FIRE, V18, P1, DOI 10.1071/WF08009; Whitehead P. J., 2009, Culture, ecology and economy of fire management in North Australian savannas: rekindling the Wurrk tradition, P287	22	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91281	10.1371/journal.pone.0091281	http://dx.doi.org/10.1371/journal.pone.0091281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637736	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100025
J	Roth, JK; Johnson, MK; Tokoglu, F; Murphy, I; Constable, RT				Roth, Jennifer K.; Johnson, Marcia K.; Tokoglu, Fuyuze; Murphy, Isabella; Constable, R. Todd			Modulating Intrinsic Connectivity: Adjacent Subregions within Supplementary Motor Cortex, Dorsolateral Prefrontal Cortex, and Parietal Cortex Connect to Separate Functional Networks during Task and Also Connect during Rest	PLOS ONE			English	Article							OBJECT WORKING-MEMORY; BRAIN ACTIVITY; DEFAULT MODE; NEURAL SYSTEM; FLUCTUATIONS; FMRI; PARCELLATION; REGIONS; ATTENTION; LOBE	Supplementary motor area (SMA), the inferior frontal junction (IFJ), superior frontal junction (SFJ) and parietal cortex are active in many cognitive tasks. In a previous study, we found that subregions of each of these major areas were differentially active in component processes of executive function during working memory tasks. In the present study, each of these subregions was used as a seed in a whole brain functional connectivity analysis of working memory and resting state data. These regions show functional connectivity to different networks, thus supporting the parcellation of these major regions into functional subregions. Many regions showing significant connectivity during the working memory residual data (with task events regressed from the data) were also significantly connected during rest suggesting that these network connections to subregions within major regions of cortex are intrinsic. For some of these connections, task demands modulate activity in these intrinsic networks. Approximately half of the connections significant during task were significant during rest, indicating that some of the connections are intrinsic while others are recruited only in the service of the task. Furthermore, the network connections to traditional 'task positive' and 'task negative' (a.k.a 'default mode') regions shift from positive connectivity to negative connectivity depending on task demands. These findings demonstrate that such task-identified subregions are part of distinct networks, and that these networks have different patterns of connectivity for task as they do during rest, engaging connections both to task positive and task negative regions. These results have implications for understanding the parcellation of commonly active regions into more specific functional networks.	[Roth, Jennifer K.] Concordia Coll New York, Dept Social Sci, Bronxville, NY 10708 USA; [Johnson, Marcia K.] Yale Univ, Dept Psychol, Sch Med, New Haven, CT 06520 USA; [Tokoglu, Fuyuze] Yale Univ, Sch Med, Dept Diagnost Radiol, Magnet Resonance Res Ctr, New Haven, CT 06510 USA; [Murphy, Isabella] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Constable, R. Todd] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Constable, R. Todd] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Roth, JK (corresponding author), Concordia Coll New York, Dept Social Sci, Bronxville, NY 10708 USA.	Jennifer.roth@concordia-ny.edu	Constable, R. Todd/ABE-8038-2021	Constable, R. Todd/0000-0001-5661-9521	NIH [R01 NS051622]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051622] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by an NIH grant, NIH R01 NS051622 (http://www.ncbi.nlm.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Dumontheil I, 2011, J COGNITIVE NEUROSCI, V23, P168, DOI 10.1162/jocn.2010.21439; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Gilbert SJ, 2010, J NEUROSCI, V30, P1233, DOI 10.1523/JNEUROSCI.3220-09.2010; Giove F, 2009, MAGN RESON IMAGING, V27, P1058, DOI 10.1016/j.mri.2009.06.004; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raye CL, 2007, CORTEX, V43, P135, DOI 10.1016/S0010-9452(08)70451-9; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; Rosenau BJ, 2009, J VISION, V9, p164a; Rosenau BJ, 2009, J VISION, V9, P164; Roth JK, 2007, NEUROIMAGE, V38, P617, DOI 10.1016/j.neuroimage.2007.06.037; Roth JK, 2006, CEREB CORTEX, V16, P1595, DOI 10.1093/cercor/bhj096; Roth JK, 2009, NEUROIMAGE, V48, P601, DOI 10.1016/j.neuroimage.2009.07.002; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Vandenberghe R, 2009, BEHAV BRAIN RES, V199, P171, DOI 10.1016/j.bbr.2008.12.005; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638	44	10	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90672	10.1371/journal.pone.0090672	http://dx.doi.org/10.1371/journal.pone.0090672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637793	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100007
J	Chung, YG; Tu, D; Franck, D; Gil, ES; Algarrahi, K; Adam, RM; Kaplan, DL; Estrada, CR; Mauney, JR				Chung, Yeun Goo; Tu, Duong; Franck, Debra; Gil, Eun Seok; Algarrahi, Khalid; Adam, Rosalyn M.; Kaplan, David L.; Estrada, Carlos R., Jr.; Mauney, Joshua R.			Acellular Bi-Layer Silk Fibroin Scaffolds Support Tissue Regeneration in a Rabbit Model of Onlay Urethroplasty	PLOS ONE			English	Article							URETHRAL STRICTURE REPAIR; BUCCAL MUCOSA GRAFT; COLLAGEN MATRIX; MURINE MODEL; BLADDER; SUBMUCOSA; MANAGEMENT; RECONSTRUCTION; BIOMATERIAL; PERFORMANCE	Acellular scaffolds derived from Bombyx mori silk fibroin were investigated for their ability to support functional tissue regeneration in a rabbit model of urethra repair. A bi-layer silk fibroin matrix was fabricated by a solvent-casting/salt leaching process in combination with silk fibroin film casting to generate porous foams buttressed by homogeneous silk fibroin films. Ventral onlay urethroplasty was performed with silk fibroin grafts (Group 1, N = 4) (WidthxLength, 1x2 cm(2)) in adult male rabbits for 3 m of implantation. Parallel control groups consisted of animals receiving small intestinal submucosa (SIS) implants (Group 2, N = 4) or urethrotomy alone (Group 3, N = 3). Animals in all groups exhibited 100% survival prior to scheduled euthanasia and achieved voluntary voiding following 7 d of initial catheterization. Retrograde urethrography of each implant group at 3 m post-op revealed wide urethral calibers and preservation of organ continuity similar to pre-operative and urethrotomy controls with no evidence of contrast extravasation, strictures, fistulas, or stone formation. Histological (hematoxylin and eosin and Masson's trichrome), immunohistochemical, and histomorphometric analyses demonstrated that both silk fibroin and SIS scaffolds promoted similar extents of smooth muscle and epithelial tissue regeneration throughout the original defect sites with prominent contractile protein (a-smooth muscle actin and SM22 alpha) and cytokeratin expression, respectively. De novo innervation and vascularization were also evident in all regenerated tissues indicated by synaptophysin-positive neuronal cells and vessels lined with CD31 expressing endothelial cells. Following 3 m post-op, minimal acute inflammatory reactions were elicited by silk fibroin scaffolds characterized by the presence of eosinophil granulocytes while SIS matrices promoted chronic inflammatory responses indicated by mobilization of mononuclear cell infiltrates. The results of this study demonstrate that bi-layer silk fibroin scaffolds represent promising biomaterials for onlay urethroplasty, capable of promoting similar degrees of tissue regeneration in comparison to conventional SIS scaffolds, but with reduced immunogenicity.	[Chung, Yeun Goo; Tu, Duong; Franck, Debra; Algarrahi, Khalid; Adam, Rosalyn M.; Estrada, Carlos R., Jr.; Mauney, Joshua R.] Boston Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA; [Tu, Duong; Adam, Rosalyn M.; Estrada, Carlos R., Jr.; Mauney, Joshua R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tufts University	Estrada, CR (corresponding author), Boston Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA.	carlos.estrada@childrens.harvard.edu; joshua.mauney@childrens.harvard.edu	Estrada, Carlos R/H-2199-2015	Estrada, Carlos R/0000-0003-0586-9832	NIH/NIDDK [R00 DK083616-01A2, T32-DK60442]; Tissue Engineering Resource Center, NIH/NIBIB [P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060442] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Tissue Engineering Resource Center, NIH/NIBIB; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the following sources: NIH/NIDDK R00 DK083616-01A2 (MAUNEY); Tissue Engineering Resource Center, NIH/NIBIB P41 EB002520 (KAPLAN); NIH/NIDDK T32-DK60442 (FREEMAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9; Bhatnagar A, 2012, INDIAN J PLAST SURG, V45, P563, DOI 10.4103/0970-0358.105979; Brandes S, 2006, UROL CLIN N AM, V33, P87, DOI 10.1016/j.ucl.2005.10.001; Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301; Chandrasekharam V V S, 2013, Indian J Urol, V29, P173, DOI [10.4103/0970-1591.109984, 10.4103/0970-1591.117269]; Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X; Cilento BG, 1995, J UROLOGY, V153, P371; Cimador M, 2013, NAT REV UROL, DOI [10.1038/nrurol.2013.164, DOI 10.1038/NRUR0L.2013.164]; El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8; Elgammal MAA, 2009, INT BRAZ J UROL, V35, P450, DOI 10.1590/S1677-55382009000400009; FINKELSTEIN LH, 1991, J UROLOGY, V146, P840, DOI 10.1016/S0022-5347(17)37937-5; Fu Q, 2011, UROLOGY, V79, P246, DOI [10.1016/j.urology.2011.08.043, DOI 10.1016/J.UR0L0GY.2011.08.043]; Gomez P, 2011, BIOMATERIALS, V32, P7562, DOI 10.1016/j.biomaterials.2011.06.067; Hauser S, 2006, UROLOGY, V68, P263, DOI 10.1016/j.urology.2006.02.044; Kadian Yogender Singh, 2011, Afr J Paediatr Surg, V8, P164, DOI 10.4103/0189-6725.86054; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Kozinn SI, 2013, UROLOGY, V82, P718, DOI 10.1016/j.urology.2013.03.081; Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9; Lee YJ, 2013, KOREAN J UROL, V54, P561, DOI 10.4111/kju.2013.54.9.561; Macedo A, 2012, CURR OPIN UROL, V22, P447, DOI 10.1097/MOU.0b013e328357bc62; Villoldo GM, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2013.02.023; Marzorati G, 2008, UROLOG J, V75, P177, DOI 10.1177/039156030807500306; Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051; Mawhinney M, 2013, PERIODONTOL 2000, V61, P232, DOI 10.1111/j.1600-0757.2011.00408.x; Meeks JJ, 2009, J UROLOGY, V182, P1266, DOI 10.1016/j.juro.2009.06.027; Mellon MJ, 2014, INT J UROL, V21, P190, DOI 10.1111/iju.12236; MONFORT G, 1992, J UROLOGY, V148, P1504, DOI 10.1016/S0022-5347(17)36950-1; OLESEN K P, 1975, International Urology and Nephrology, V7, P303, DOI 10.1007/BF02082120; OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220; Palmer BW, 2013, CURR UROL REP, V14, P327, DOI 10.1007/s11934-013-0329-6; Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016; Palminteri E, 2012, UROLOGY, V79, P695, DOI 10.1016/j.urology.2011.09.055; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038; Sievert KD, 2000, J UROLOGY, V163, P1958, DOI 10.1016/S0022-5347(05)67610-0; Siosaki MD, 2013, CUAJ-CAN UROL ASSOC, V7, pE499, DOI 10.5489/cuaj.399; Sugita Y, 2001, J UROLOGY, V166, P1051, DOI 10.1016/S0022-5347(05)65918-6; Tu DD, 2013, BIOMATERIALS, V34, P8681, DOI 10.1016/j.biomaterials.2013.08.001; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Xie LH, 2013, UROL INT, V91, P256, DOI 10.1159/000353101; Zinman L, 1997, UROL CLIN N AM, V24, P683, DOI 10.1016/S0094-0143(05)70408-0	42	39	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91592	10.1371/journal.pone.0091592	http://dx.doi.org/10.1371/journal.pone.0091592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632740	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400072
J	Hunter, PR; Risebro, H; Yen, M; Lefebvre, H; Lo, C; Hartemann, P; Longuet, C; Jaquenoud, F				Hunter, Paul R.; Risebro, Helen; Yen, Marie; Lefebvre, Helene; Lo, Chay; Hartemann, Philippe; Longuet, Christophe; Jaquenoud, Francois			Impact of the Provision of Safe Drinking Water on School Absence Rates in Cambodia: A Quasi-Experimental Study	PLOS ONE			English	Article							MORTALITY; CHILDREN; SANITATION; COUNTRIES; RISK	Background: Education is one of the most important drivers behind helping people in developing countries lift themselves out of poverty. However, even when schooling is available absenteeism rates can be high. Recently interest has focussed on whether or not WASH interventions can help reduce absenteeism in developing countries. However, none has focused exclusively on the role of drinking water provision. We report a study of the association between absenteeism and provision of treated water in containers into schools. Methods and Findings: We undertook a quasi-experimental longitudinal study of absenteeism rates in 8 schools, 4 of which received one 20 L container of treated drinking water per day. The water had been treated by filtration and ultraviolet disinfection. Weekly absenteeism rates were compared across all schools using negative binomial model in generalized estimating equations. There was a strong association with provision of free water and reduced absenteeism (Incidence rate ratio = 0.39 (95% Confidence Intervals 0.27-0.56)). However there was also a strong association with season (wet versus dry) and a significant interaction between receiving free water and season. In one of the intervention schools it was discovered that the water supplier was not fulfilling his contract and was not delivering sufficient water each week. In this school we showed a significant association between the number of water containers delivered each week and absenteeism (IRR = 0.98 95% CI 0.96-1.00). Conclusion: There appears to be a strong association between providing free safe drinking water and reduced absenteeism, though only in the dry season. The mechanism for this association is not clear but may in part be due to improved hydration leading to improved school experience for the children.	[Hunter, Paul R.; Risebro, Helen] Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England; [Yen, Marie; Lefebvre, Helene; Jaquenoud, Francois] 1001 Fontaines Demain, Caluire Et Cuire, France; [Lefebvre, Helene] Teuk Saat 1001, Phnom Penh, Cambodia; [Hartemann, Philippe] Univ Lorraine, Fac Med Nancy, Dept Environm & Sante Publ, Nancy, France; [Longuet, Christophe] Fdn Merieux, Lyon, France	University of East Anglia; Universite de Lorraine	Hunter, PR (corresponding author), Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England.	Paul.Hunter@uea.ac.uk	Hunter, Paul/N-9021-2019; Hunter, Paul/A-7172-2008; Risebro, Helen/S-5693-2016	Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144; Risebro, Helen/0000-0003-4389-748X	Fondation Ensemble; Danone Group; Agence Francaise de Developpement; Fondation Merieux; Fondation Avenir Finance	Fondation Ensemble; Danone Group(Danone Nutricia); Agence Francaise de Developpement; Fondation Merieux; Fondation Avenir Finance	The study received financial support as charitable donations from Fondation Ensemble, Danone Group, Agence Francaise de Developpement, Fondation Merieux, and Fondation Avenir Finance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadzi H, 2009, WORLD BANK RES OBSER, V24, P267, DOI 10.1093/wbro/lkp008; Bar-David Y, 2005, ACTA PAEDIATR, V94, P1667, DOI 10.1080/08035250500254670; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Benton D, 2009, APPETITE, V53, P143, DOI 10.1016/j.appet.2009.05.006; Doria MD, 2009, SCI TOTAL ENVIRON, V407, P5455, DOI 10.1016/j.scitotenv.2009.06.031; Fadda R, 2012, APPETITE, V59, P730, DOI 10.1016/j.appet.2012.07.005; Freeman MC, 2012, TROP MED INT HEALTH, V17, P380, DOI 10.1111/j.1365-3156.2011.02927.x; FULLER B, 1987, REV EDUC RES, V57, P255, DOI 10.3102/00346543057003255; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Heiner JD, 2011, WILD ENVIRON MED, V22, P329, DOI 10.1016/j.wem.2011.08.003; Huber AC, 2013, INT J ENVIRON HEAL R, V23, P96, DOI 10.1080/09603123.2012.699032; Hunter PR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1145; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Jasper C, 2012, INT J ENV RES PUB HE, V9, P2772, DOI 10.3390/ijerph9082772; Maughan RJ, 2012, NUTR REV, V70, pS152, DOI 10.1111/j.1753-4887.2012.00531.x; Ngai TKK, 2007, J ENVIRON SCI HEAL A, V42, P1879, DOI 10.1080/10934520701567148; Risebro HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042762; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Tamas A, 2011, HEALTH EDUC BEHAV, V38, P357, DOI 10.1177/1090198110374702; United Nations, 2011, MILL DEV GOALS REP 2	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91847	10.1371/journal.pone.0091847	http://dx.doi.org/10.1371/journal.pone.0091847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632573	Green Accepted, gold, Green Published			2022-12-27	WOS:000332858400107
J	Makai, P; Beckebans, F; van Exel, J; Brouwer, WBF				Makai, Peter; Beckebans, Franziska; van Exel, Job; Brouwer, Werner B. F.			Quality of Life of Nursing Home Residents with Dementia: Validation of the German Version of the ICECAP-O	PLOS ONE			English	Article							EQ-5D; CARE; INSTRUMENT; VALIDITY; HEALTH; RELIABILITY; PREVALENCE; CONSTRUCT; SCALE; INDEX	Objectives: To validate the ICECAP-O capability wellbeing measure's German translation in older people with dementia living in a nursing home, and to investigate the influence of proxy characteristics on responses. Method: Cross-sectional study. For 95 residents living in a German nursing home, questionnaires were completed by nursing professionals serving as proxy respondents. We investigated the convergent validity of the ICECAP-O with other Quality of Life (Qol) measures, the EQ-5D extended with a cognitive dimension (EQ-5D+C), the Alzheimer's Disease Related Quality of Life (ADRQL) measures, and the Barthel-index measure of Activities of Daily Living (ADL). Discriminant validity was investigated using bivariate and multivariate stepwise regression analysis, comparing ICECAP-O scores between subgroups varying in dementia severity, care dependency, ADL status and demographic characteristics. Results: Convergent validity between the ICECAP-O, EQ-5D+C, ADRQL and Barthel-Index scores was moderate to good (with correlations of 0.72, 0.69 and 0.53 respectively), but differed considerably between dimensions of the instruments. Discriminant validity was confirmed by finding differences in ICECAP-O scores between subgroups based on ADL scores (0.58 below 65 points on the Barthel-index and 0.80 above 65 points) and other characteristics. The ICECAP-O scores based on available tariffs were related to proxy characteristics gender (0.52 males versus 0.65 females) and work experience (0.61 below 2 years of experience versus 0.68 above 2 years). Discussion: The results of this study suggest that the ICECAP-O is a promising generic measure for general Qol and capability of people with dementia living in a nursing home. Validity tests generally yielded favorable results. Work experience and gender appeared to influence proxy response, which raises questions regarding appropriate proxies, especially since the ICECAP-O may be completed by proxies relatively often. Further research is necessary to validate the German version of the ICECAP-O, with specific attention to proxy completion for people with dementia.	[Makai, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr, NL-6525 ED Nijmegen, Netherlands; [Beckebans, Franziska] Siemens Hlth Insurance Fund, Munich, Germany; [van Exel, Job; Brouwer, Werner B. F.] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands	Radboud University Nijmegen; Siemens AG; Siemens Germany; Erasmus University Rotterdam	Makai, P (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Geriatr, NL-6525 ED Nijmegen, Netherlands.	Peter.Makai@radboudumc.nl	van Exel, Job/E-6191-2013; Makai, Peter/I-5278-2012	van Exel, Job/0000-0002-4178-1777; Makai, Peter/0000-0002-5332-1751; Brouwer, Werner/0000-0002-0476-8397				Al-Janabi H, 2011, QUALITY LIFE RES; Andersen Christian K, 2004, Health Qual Life Outcomes, V2, P52, DOI 10.1186/1477-7525-2-52; Ankri J, 2003, J CLIN EPIDEMIOL, V56, P1055, DOI 10.1016/S0895-4356(03)00175-6; [Anonymous], 2009, S3 LEITL DEM KURZV; [Anonymous], 2012, IICD10GM DTSCH I MED; Black B., 2009, ALZHEIMER DIS RELATE; Bowling A, 2007, AGEING SOC, V27, P827, DOI 10.1017/S0144686X07006423; Brod M, 1999, GERONTOLOGIST, V39, P25, DOI 10.1093/geront/39.1.25; Bryan S, 2005, QUAL LIFE RES, V14, P107, DOI 10.1007/s11136-004-1920-6; Carpenter CR, 2011, ACAD EMERG MED, V18, P374, DOI 10.1111/j.1553-2712.2011.01040.x; Coast J, 2008, QUAL LIFE RES, V17, P967, DOI 10.1007/s11136-008-9372-z; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Cohen-Mansfield J, 2010, AM J GERIAT PSYCHIAT, V18, P351, DOI 10.1097/JGP.0b013e3181c531fd; Cohen-Mansfield J, 2009, AM J GERIAT PSYCHIAT, V17, P299, DOI 10.1097/JGP.0b013e31818f3a52; Collin C, 1988, Int Disabil Stud, V10, P61; Comans TA, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-58; Coucill W, 2001, MED CARE, V39, P760, DOI 10.1097/00005650-200108000-00003; Couzner L, 2012, INT J PUBLIC HEALTH, P1; Couzner L, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-69; Davis JC, 2011, QUAL LIFE RES, P1; Davis JC, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-65; Dichter M, 2011, Z GERONTOL GERIATR, V44, P405, DOI 10.1007/s00391-011-0235-9; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ettema TP, 2007, INT J GERIATR PSYCH, V22, P424, DOI 10.1002/gps.1692; Ettema TP, 2005, QUAL LIFE RES, V14, P675, DOI 10.1007/s11136-004-1258-0; GKV-Spitzenverband, 2009, RICHTL GKV SPITZ BEG; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; Graske J, 2012, AGING MENT HEALTH, V16, P819, DOI 10.1080/13607863.2012.667782; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; GREINER W, 2007, GESUNDHEITSOKONOMISC, P403; Grewal I, 2006, SOC SCI MED, V62, P1891, DOI 10.1016/j.socscimed.2005.08.023; Hacher J RB, 2008, PFLEGEVERSICHERUNG K; Heuschmann PU, 2005, FORTSCHR NEUROL PSYC, V73, P74, DOI 10.1055/s-2004-830172; Jonker C, 2004, DEMENT GERIATR COGN, V18, P159, DOI 10.1159/000079196; Kasper JD, 2009, ALZ DIS ASSOC DIS, V23, P275, DOI 10.1097/WAD.0b013e31819b02bc; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Kunz S, 2010, QUAL LIFE RES, V19, P425, DOI 10.1007/s11136-010-9600-1; Kwasky A.N., 2010, ALZHEIMERS CARE TODA, V11, P186, DOI [10.1097/ACQ.0b013e3181ec00e1, DOI 10.1097/ACQ.0B013E3181EC00E1]; Lyketsos CG, 2003, INT J GERIATR PSYCH, V18, P275, DOI 10.1002/gps.796; MAHONEY F I, 1965, Md State Med J, V14, P61; Makai P, 2014, SOC SCI MED, V102, P83, DOI 10.1016/j.socscimed.2013.11.050; Makai P, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-57; Makai P, 2012, QUAL LIFE RES, V21, P801, DOI 10.1007/s11136-011-9997-1; McIlroy SP, 2001, ADV PSYCHIAT TREATME, V7, P24, DOI DOI 10.1192/APT.7.1.24; MENZIKUHN C, 2006, LEBENSQUALITAT MENSC; Merchant, 1999, J MENTAL HLTH AGING, V5, P49; Missotten P, 2008, DEMENT GERIATR COGN, V25, P564, DOI 10.1159/000137689; Mitchell PM, 2013, MED DECISION MAKING; Novella JL, 2001, QUAL LIFE RES, V10, P443, DOI 10.1023/A:1012522013817; Peralta Jaime, 2013, 2013 IEEE Power & Energy Society General Meeting, DOI 10.1109/PESMG.2013.6672356; Pickard AS, 2005, MED CARE, V43, P493, DOI 10.1097/01.mlr.0000160419.27642.a8; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rabins PV, 2007, INT PSYCHOGERIATR, V19, P401, DOI 10.1017/S1041610207004863; Rabins PV., 1999, J MENTAL HLTH AGING, V5, P33; Ready RE, 2002, ALZ DIS ASSOC DIS, V16, P109, DOI 10.1097/00002093-200204000-00008; Ready Rebecca E, 2007, Am J Alzheimers Dis Other Demen, V22, P528, DOI 10.1177/1533317507307032; Robert Koch Institut in Zusammenarbeit mit dem statistischen Bundesamt e, 2005, GES BUND ALT; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Selai CE, 2001, NEUROPSYCHOL REHABIL, V11, P219, DOI 10.1080/09602010042000033; Sen A.K., 1982, CHOICE WELFARE MEASU; Sloane PD, 2005, GERONTOLOGIST, V45, P37, DOI 10.1093/geront/45.suppl_1.37; Verbeek H, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-30; Voigt-Radloff S, 2012, EUR J NEUROL, V19, P376, DOI 10.1111/j.1468-1331.2011.03561.x; Weyerer S., 2004, Z GERONTOPSYCHOLOGIE, V17, P41; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolfs CAG, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-33	67	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92016	10.1371/journal.pone.0092016	http://dx.doi.org/10.1371/journal.pone.0092016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632775	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400131
J	Perez-Rivas, LG; Jerez, JM; Carmona, R; de Luque, V; Vicioso, L; Claros, MG; Viguera, E; Pajares, B; Sanchez, A; Ribelles, N; Alba, E; Lozano, J				Perez-Rivas, Luis G.; Jerez, Jose M.; Carmona, Rosario; de Luque, Vanessa; Vicioso, Luis; Gonzalo Claros, M.; Viguera, Enrique; Pajares, Bella; Sanchez, Alfonso; Ribelles, Nuria; Alba, Emilio; Lozano, Jose			A microRNA Signature Associated with Early Recurrence in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; TARGET RECOGNITION; PROGNOSTIC-FACTORS; TUMOR DORMANCY; HAZARD RATES; EXPRESSION; SURGERY; CYTOSCAPE; PATTERNS; REVEALS	Recurrent breast cancer occurring after the initial treatment is associated with poor outcome. A bimodal relapse pattern after surgery for primary tumor has been described with peaks of early and late recurrence occurring at about 2 and 5 years, respectively. Although several clinical and pathological features have been used to discriminate between low-and high-risk patients, the identification of molecular biomarkers with prognostic value remains an unmet need in the current management of breast cancer. Using microarray-based technology, we have performed a microRNA expression analysis in 71 primary breast tumors from patients that either remained disease-free at 5 years post-surgery (group A) or developed early (group B) or late (group C) recurrence. Unsupervised hierarchical clustering of microRNA expression data segregated tumors in two groups, mainly corresponding to patients with early recurrence and those with no recurrence. Microarray data analysis and RT-qPCR validation led to the identification of a set of 5 microRNAs (the 5-miRNA signature) differentially expressed between these two groups: miR-149, miR-10a, miR-20b, miR-30a-3p and miR-342-5p. All five microRNAs were down-regulated in tumors from patients with early recurrence. We show here that the 5-miRNA signature defines a high-risk group of patients with shorter relapse-free survival and has predictive value to discriminate non-relapsing versus early-relapsing patients (AUC = 0.993, p-value<0.05). Network analysis based on miRNA-target interactions curated by public databases suggests that down-regulation of the 5-miRNA signature in the subset of early-relapsing tumors would result in an overall increased proliferative and angiogenic capacity. In summary, we have identified a set of recurrence-related microRNAs with potential prognostic value to identify patients who will likely develop metastasis early after primary breast surgery.	[Perez-Rivas, Luis G.; de Luque, Vanessa; Pajares, Bella; Sanchez, Alfonso; Ribelles, Nuria; Alba, Emilio; Lozano, Jose] Hosp Univ Virgen Victoria, Inst Biomed Malaga IBIMA, Serv Oncol Med, Lab Oncol Mol, Malaga, Spain; [Jerez, Jose M.] Univ Malaga, Dept Lenguajes & Ciencias Computac, E-29071 Malaga, Spain; [Carmona, Rosario; Gonzalo Claros, M.] Univ Malaga, Plataforma Andaluza Bioinformat, E-29071 Malaga, Spain; [Vicioso, Luis] Hosp Univ Virgen Victoria, Inst Biomed Malaga IBIMA, Serv Anat Patol, Malaga, Spain; [Gonzalo Claros, M.; Lozano, Jose] Univ Malaga, Dept Bioquim & Biol Mol, E-29071 Malaga, Spain; [Viguera, Enrique] Univ Malaga, Dept Biol Celular Genet & Fisiol Anim, E-29071 Malaga, Spain	Hospital Virgen de la Victoria; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Hospital Virgen de la Victoria; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga	Lozano, J (corresponding author), Hosp Univ Virgen Victoria, Inst Biomed Malaga IBIMA, Serv Oncol Med, Lab Oncol Mol, Malaga, Spain.	jlozano@uma.es	Lozano, José/C-2760-2014; Jerez, José Manuel M/L-1801-2014; Mínguez, Enrique Viguera/H-4416-2015; Jerez, José/GYV-4500-2022; Ribelles, Nuria/ABH-2617-2020; Aragonés, José Manuel Jerez/ABF-7743-2020; Alba, Emilio/S-1435-2019; Claros, Manuel Gonzalo/K-2274-2014; Carmona, Rosario/K-9092-2014	Lozano, José/0000-0002-8187-2833; Jerez, José Manuel M/0000-0002-7858-2966; Mínguez, Enrique Viguera/0000-0001-5475-3807; Ribelles, Nuria/0000-0003-3194-7398; Aragonés, José Manuel Jerez/0000-0002-7858-2966; Alba, Emilio/0000-0002-3364-2603; Claros, Manuel Gonzalo/0000-0002-0112-3550; Carmona, Rosario/0000-0002-4235-2886	Spanish Society of Medical Oncology (SEOM); Spanish Ministerio de Economia [SAF2010-20203, TIN2010-16556]; Junta de Andalucia [TIN-4026]	Spanish Society of Medical Oncology (SEOM); Spanish Ministerio de Economia(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by a grant from the Spanish Society of Medical Oncology (SEOM, to NR) and by grants from the Spanish Ministerio de Economia, (SAF2010-20203 to J.L and TIN2010-16556 to J.J) and from the Junta de Andalucia (TIN-4026, to JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Caruso S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.33; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cox D. R., 1984, ANAL SURVIVAL DATA; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Demicheli R, 1996, BREAST CANCER RES TR, V41, P177, DOI 10.1007/BF01807163; Demicheli R, 2001, BRIT J CANCER, V85, P490, DOI 10.1054/bjoc.2001.1969; Demicheli R, 2007, ANN SURG ONCOL, V13, P776; Demicheli R, 2007, NAT CLIN PRACT ONCOL, V4, P699, DOI 10.1038/ncponc0999; Demicheli R, 2007, ANN SURG ONCOL, V14, P1519, DOI 10.1245/s10434-006-9279-2; Demicheli R, 2010, CANCER SCI, V101, P826, DOI 10.1111/j.1349-7006.2009.01472.x; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Dylla L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063032; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107; FISHER ER, 1978, HUM PATHOL, V9, P523, DOI 10.1016/S0046-8177(78)80133-6; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grammatikakis I, 2013, INT J MOL SCI, V14, P1822, DOI 10.3390/ijms14011822; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess KR, 2003, BREAST CANCER RES TR, V78, P105, DOI 10.1023/A:1022166517963; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iqbal J, 2012, BLOOD, V119, P4939, DOI 10.1182/blood-2011-07-370122; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Jatoi I, 2005, BREAST CANCER RES TR, V89, P173, DOI 10.1007/s10549-004-1722-0; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lumley T, 2007, SURVIVAL PACKAGE R H; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; McCarthy N, 2013, NAT REV CANCER, V13, P441; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perez-Rivas LG, 2012, INT J ONCOL, V41, P2200, DOI 10.3892/ijo.2012.1667; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietrowska M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-66; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Romero-Cordoba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031904; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spitale A, 2009, ANN ONCOL, V20, P628, DOI 10.1093/annonc/mdn675; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Takeshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059057; Tu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051606; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693; Wei YY, 2013, CIRCULATION, V127, P1609, DOI 10.1161/CIRCULATIONAHA.112.000736; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167	108	68	73	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91884	10.1371/journal.pone.0091884	http://dx.doi.org/10.1371/journal.pone.0091884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632820	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400115
J	Sala, M; Kroft, LJM; Roell, B; van der Grond, J; Slagboom, PE; Mooijaart, SP; de Roos, A; van Heemst, D				Sala, Michiel; Kroft, Lucia J. M.; Roell, Boudewijn; van der Grond, Jeroen; Slagboom, P. Eline; Mooijaart, Simon P.; de Roos, Albert; van Heemst, Diana			Association of Liver Enzymes and Computed Tomography Markers of Liver Steatosis with Familial Longevity	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; FATTY LIVER; HEPATIC STEATOSIS; ALANINE AMINOTRANSFERASE; NONAGENARIAN SIBLINGS; DIABETES-MELLITUS; DISEASE; PREVALENCE; RISK; POPULATION	Objective: Familial longevity is marked by enhanced peripheral but not hepatic insulin sensitivity. The liver has a critical role in the pathogenesis of hepatic insulin resistance. Therefore we hypothesized that the extent of liver steatosis would be similar between offspring of long-lived siblings and control subjects. To test our hypothesis, we investigated the extent of liver steatosis in non-diabetic offspring of long-lived siblings and age-matched controls by measuring liver enzymes in plasma and liver fat by computed tomography (CT). Research Design and Methods:: We measured nonfasting alanine transaminase (ALT), aspartate aminotransferase (AST), and U-glutamyl transferase (GGT) in 1625 subjects (736 men, mean age 59.1 years) from the Leiden Longevity Study, comprising offspring of long-lived siblings and partners thereof. In a random subgroup, fasting serum samples (n = 230) were evaluated and CT was performed (n = 268) for assessment of liver-spleen (L/S) ratio and the prevalence of moderate-to-severe non-alcoholic fatty liver disease (NAFLD). Linear mixed model analysis was performed adjusting for age, gender, body mass index, smoking, use of alcohol and hepatotoxic medication, and correlation of sibling relationship. Results: Offspring of long-lived siblings had higher nonfasting ALT levels as compared to control subjects (24.3 mmol/L versus 23.2 mmol/L, p = 0.03), while AST and GGT levels were similar between the two groups. All fasting liver enzyme levels were similar between the two groups. CT L/S ratio and prevalence of moderate-to-severe NAFLD was similar between groups (1.12 vs 1.14, p = 0.25 and 8% versus 8%, p = 0.91, respectively). Conclusions: Except for nonfasting levels of ALT, which were slightly higher in the offspring of long-lived siblings compared to controls, no differences were found between groups in the extent of liver steatosis, as assessed with liver biochemical tests and CT. Thus, our data indicate that the extent of liver steatosis is similar between offspring of long-lived siblings and control subjects.	[Sala, Michiel; Kroft, Lucia J. M.; Roell, Boudewijn; van der Grond, Jeroen; de Roos, Albert] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Mooijaart, Simon P.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [van der Grond, Jeroen; Mooijaart, Simon P.; van Heemst, Diana] Netherlands Consortium Healthy Ageing, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sala, M (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.	M.L.Sala@lumc.nl	Mooijaart, Simon P./A-5306-2008; Slagboom, P. Eline/R-4790-2016	Mooijaart, Simon P./0000-0003-3106-3568; Slagboom, P. Eline/0000-0002-2875-4723	Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (Netherlands Consortium for Healthy Aging) [05040202]; European Community [Health-2013-INNOVATION-1-602757]	Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (Netherlands Consortium for Healthy Aging); European Community(European Commission)	Funding was provided by Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (05040202 Netherlands Consortium for Healthy Aging) and by the European Community within the Seventh Framework Program under grant agreement no. Health-2013-INNOVATION-1-602757 (HUMAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; [Anonymous], 2013, GUID ATC CLASS DDD A; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Dick TJM, 2013, ATHEROSCLEROSIS, V226, P208, DOI 10.1016/j.atherosclerosis.2012.10.040; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Ford I, 2011, INT J EPIDEMIOL, V40, P1530, DOI 10.1093/ije/dyr172; Foster T, 2011, AM J GASTROENTEROL, V106, P71, DOI 10.1038/ajg.2010.299; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; JESSURUN N, 2013, PHARM WEEKBLAD, V148, P28; Kim LJ, 2011, OBESITY, V19, P1265, DOI 10.1038/oby.2010.291; Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Obika M, 2012, EXP DIABETES RES, DOI 10.1155/2012/145754; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Passtoors WM, 2013, AGING CELL, V12, P24, DOI 10.1111/acel.12015; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Reaven GM, 2005, ENDOCRIN METAB CLIN, V34, P49, DOI 10.1016/j.ecl.2004.12.001; Redgrave TG, 2004, BIOCHEM SOC T, V32, P79, DOI 10.1042/BST0320079; Rozing MP, 2011, AGE, V33, P623, DOI 10.1007/s11357-011-9206-8; Rozing MP, 2010, J AM GERIATR SOC, V58, P564, DOI 10.1111/j.1532-5415.2010.02725.x; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Speliotes EK, 2008, J GASTROEN HEPATOL, V23, P894, DOI 10.1111/j.1440-1746.2008.05420.x; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Targher G, 2006, J HEPATOL, V45, P879, DOI 10.1016/j.jhep.2006.09.005; Taylor R, 2008, DIABETOLOGIA, V51, P1781, DOI 10.1007/s00125-008-1116-7; Vaarhorst AAM, 2011, AGE, V33, P219, DOI 10.1007/s11357-010-9172-6; Vliegenthart R, 2002, AM J EPIDEMIOL, V155, P332, DOI 10.1093/aje/155.4.332; Voshol PJ, 2009, BBA-MOL CELL BIOL L, V1791, P479, DOI 10.1016/j.bbalip.2008.12.015; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2012, AM J PHYSIOL-ENDOC M, V302, pE344, DOI 10.1152/ajpendo.00455.2011; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91085	10.1371/journal.pone.0091085	http://dx.doi.org/10.1371/journal.pone.0091085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632889	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400040
J	Xiao, L; Zhang, CK; Li, XH; Gong, SC; Hu, RM; Balasubramanian, R; Crowley Jr, WF; Hastings, MH; Zhou, QY				Xiao, Ling; Zhang, Chengkang; Li, Xiaohan; Gong, Shiaoching; Hu, Renming; Balasubramanian, Ravikumar; Crowley, William F. W., Jr.; Hastings, Michael H.; Zhou, Qun-Yong			Signaling Role of Prokineticin 2 on the Estrous Cycle of Female Mice	PLOS ONE			English	Article							LUTEINIZING-HORMONE SURGE; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; EFFERENT PROJECTIONS; OLFACTORY-BULB; PREOPTIC AREA; NEURONS; KISSPEPTIN; RATS	The possible signaling role of prokineticin 2 (PK2) and its receptor, prokineticin receptor 2 (PKR2), on female reproduction was investigated. First, the expression of PKR2 and its co-localization with estrogen receptor (ER alpha) in the hypothalamus was examined. Sexually dimorphic expression of PKR2 in the preoptic area of the hypothalamus was observed. Compared to the male mice, there was more widespread PKR2 expression in the preoptic area of the hypothalamus in the female mice. The likely co-expression of PKR2 and ERa in the preoptic area of the hypothalamus was observed. The estrous cycles in female PK2-null, and PKR2-null heterozygous mice, as well as in PK2-null and PKR2-null compound heterozygous mice were examined. Loss of one copy of PK2 or PKR2 gene caused elongated and irregular estrous cycle in the female mice. The alterations in the estrous cycle were more pronounced in PK2-null and PKR2-null compound heterozygous mice. Consistent with these observations, administration of a small molecule PK2 receptor antagonist led to temporary blocking of estrous cycle at the proestrous phase in female mice. The administration of PKR2 antagonist was found to blunt the circulating LH levels. Taken together, these studies indicate PK2 signaling is required for the maintenance of normal female estrous cycles.	[Xiao, Ling; Zhang, Chengkang; Li, Xiaohan; Zhou, Qun-Yong] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Xiao, Ling] Fudan Univ, Jinshan Hosp, Dept Endocrinol, Shanghai 200433, Peoples R China; [Gong, Shiaoching] Rockefeller Univ, GENSAT Project, New York, NY 10021 USA; [Hu, Renming] Fudan Univ, Huashan Hosp, Inst Endocrinol & Diabetol, Shanghai 200433, Peoples R China; [Balasubramanian, Ravikumar; Crowley, William F. W., Jr.] Massachusetts Gen Hosp, Harvard Reprod Endocrine Sci Ctr, Boston, MA 02114 USA; [Balasubramanian, Ravikumar; Crowley, William F. W., Jr.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Hastings, Michael H.] Med Res Council Lab Mol Biol, Div Neurobiol, Cambridge, England	University of California System; University of California Irvine; Fudan University; Rockefeller University; Fudan University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Zhou, QY (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	qzhou@uci.edu		Hastings, Michael Harvey/0000-0001-8576-6651; Zhang, Chengkang/0000-0002-3746-2095	NIH [HD15788]; MRC [MC_U105170643] Funding Source: UKRI; Medical Research Council [MC_U105170643] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD015788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant HD15788. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Boden MJ, 2010, REPRODUCTION, V139, P1077, DOI 10.1530/REP-09-0523; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Cheng MY, 2006, J COMP NEUROL, V498, P796, DOI 10.1002/cne.21087; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chu A, 2013, ENDOCRINOLOGY, V154, P2924, DOI 10.1210/en.2013-1080; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; Colledge W. H., 2008, V46, P117, DOI 10.1007/400_2007_050; Curtis VF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054916; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; KALRA SP, 1993, ENDOCR REV, V14, P507, DOI 10.1210/er.14.5.507; Kim GL, 2010, ENDOCRINOLOGY, V151, P5038, DOI 10.1210/en.2010-0521; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Levine JE, 1997, BIOL REPROD, V56, P293, DOI 10.1095/biolreprod56.2.293; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; Miller BH, 2006, BIOL REPROD, V75, P778, DOI 10.1095/biolreprod.106.052845; Mitsushima D, 2003, NEUROSCI RES, V46, P399, DOI 10.1016/S0168-0102(03)00099-3; Mitsushima D, 2002, NEUROSCIENCE, V113, P109, DOI 10.1016/S0306-4522(02)00160-4; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Palm IF, 1999, NEUROSCIENCE, V93, P659, DOI 10.1016/S0306-4522(99)00106-2; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2010, FRONT HORM RES, V39, P142, DOI 10.1159/000312700; Prosser HM, 2007, P NATL ACAD SCI USA, V104, P648, DOI 10.1073/pnas.0606884104; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020263; SCHWARTZ WJ, 1985, J NEUROSCI, V5, P2771; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; vanderBeek EM, 1996, PROG BRAIN RES, V111, P295, DOI 10.1016/S0079-6123(08)60415-X; vanderBeek EM, 1997, BRAIN RES, V755, P101, DOI 10.1016/S0006-8993(97)00086-3; WATTS AG, 1989, J ENDOCRINOL, V122, P593, DOI 10.1677/joe.0.1220593; Xu Z, 2011, MOL CELL ENDOCRINOL, V339, P90, DOI 10.1016/j.mce.2011.03.020; Zhang CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007151	45	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90860	10.1371/journal.pone.0090860	http://dx.doi.org/10.1371/journal.pone.0090860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633064	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400022
J	Zhou, Y; Tao, SY; Chen, H; Huang, LL; Zhu, X; Li, YP; Wang, ZL; Lin, H; Hao, F; Yang, ZL; Wang, LY; Zhu, XJ				Zhou, Yu; Tao, Siyu; Chen, Hui; Huang, Lulin; Zhu, Xiong; Li, Youping; Wang, Zhili; Lin, He; Hao, Fang; Yang, Zhenglin; Wang, Liya; Zhu, Xianjun			Exome Sequencing Analysis Identifies Compound Heterozygous Mutation in ABCA4 in a Chinese Family with Stargardt Disease	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; MACULAR DYSTROPHY; GENE ABCR; FUNDUS-FLAVIMACULATUS; RETINITIS-PIGMENTOSA; TRANSPORTER GENE; RIM PROTEIN; DEGENERATION; LIPOFUSCIN; MICE	Stargardt disease is the most common cause of juvenile macular dystrophy. Five subjects from a two-generation Chinese family with Stargardt disease are reported in this study. All family members underwent complete ophthalmologic examinations. Patients of the family initiated the disease during childhood, developing progressively impaired central vision and bilateral atrophic macular lesions in the retinal pigmental epithelium (RPE) that resembled a "beaten-bronze'' appearance. Peripheral venous blood was obtained from all patients and their family members for genetic analysis. Exome sequencing was used to analyze the exome of two patients II1, II2. A total of 50709 variations shared by the two patients were subjected to several filtering steps against existing variation databases. Identified variations were verified in all family members by PCR and Sanger sequencing. Compound heterozygous variants p.Y808X and p.G607R of the ATP-binding cassette, sub-family A (ABC1), member 4 (ABCA4) gene, which encodes the ABCA4 protein, a member of the ATP-binding cassette (ABC) transport superfamily, were identified as causative mutations for Stargardt disease of this family. Our findings provide one novel ABCA4 mutation in Chinese patients with Stargardt disease.	[Zhou, Yu; Huang, Lulin; Zhu, Xiong; Li, Youping; Lin, He; Hao, Fang; Yang, Zhenglin; Zhu, Xianjun] Sichuan Acad Med Sci, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Sichuan, Peoples R China; [Zhou, Yu; Huang, Lulin; Zhu, Xiong; Li, Youping; Lin, He; Hao, Fang; Yang, Zhenglin; Zhu, Xianjun] Sichuan Acad Med Sci, Inst Lab Med, Chengdu, Sichuan, Peoples R China; [Zhou, Yu; Chen, Hui; Huang, Lulin; Zhu, Xiong; Li, Youping; Lin, He; Hao, Fang; Yang, Zhenglin; Zhu, Xianjun] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Tao, Siyu; Huang, Lulin; Zhu, Xiong; Li, Youping; Lin, He; Hao, Fang; Yang, Zhenglin; Zhu, Xianjun] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Sichuan, Peoples R China; [Tao, Siyu; Wang, Zhili; Wang, Liya] Zhengzhou Univ, Peoples Hosp, Henan Eye Hosp, Zhengzhou, Henan, Peoples R China; [Tao, Siyu; Wang, Zhili; Wang, Liya] Zhengzhou Univ, Peoples Hosp, Henan Eye Inst, Zhengzhou, Henan, Peoples R China; [Chen, Hui] Sichuan Acad Med Sci, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Chen, Hui] Sichuan Acad Med Sci, Inst Lab Anim, Chengdu, Sichuan, Peoples R China; [Zhou, Yu; Huang, Lulin; Zhu, Xiong; Yang, Zhenglin; Zhu, Xianjun] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Zhou, Yu; Huang, Lulin; Zhu, Xiong; Yang, Zhenglin; Zhu, Xianjun] Chinese Acad Sci, Sichuan Translat Med Res Hosp, Chengdu, Sichuan, Peoples R China; [Yang, Zhenglin; Zhu, Xianjun] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Sichuan, Peoples R China; [Zhu, Xianjun] Xinan Jiaotong Univ, Coll Life Sci & Engn, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Zhengzhou University; Zhengzhou University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Electronic Science & Technology of China	Wang, LY (corresponding author), Zhengzhou Univ, Peoples Hosp, Henan Eye Hosp, Zhengzhou, Henan, Peoples R China.	wangliya55@126.com; xjzhu2@gmail.com		Zhu, Xianjun/0000-0002-2531-7552	National Natural Science Foundation of China [81025006, 81170883, 81271007]; Department of Science and Technology of Sichuan Province, China [SZ20120209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province, China	This research was supported by the National Natural Science Foundation of China [81025006, 81170883 (Z.Y.), 81271007 (X.Z.)], and Department of Science and Technology of Sichuan Province, China (SZ20120209, Z.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Birch DG, 2001, EXP EYE RES, V73, P877, DOI 10.1006/exer.2001.1093; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Casals F, 2012, J NEUROIMMUNOL, V248, P10, DOI 10.1016/j.jneuroim.2011.12.017; Coco RM, 2010, EUR J OPHTHALMOL, V20, P724, DOI 10.1177/112067211002000413; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Edwards AO, 2001, INVEST OPHTH VIS SCI, V42, P2652; Edwards AO, 1999, AM J OPHTHALMOL, V127, P426, DOI 10.1016/S0002-9394(98)00331-6; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Franceschetti A, 1965, Arch Ophtalmol Rev Gen Ophtalmol, V25, P505; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Klevering BJ, 1999, BRIT J OPHTHALMOL, V83, P914, DOI 10.1136/bjo.83.8.914; Klevering BJ, 2005, GRAEF ARCH CLIN EXP, V243, P90, DOI 10.1007/s00417-004-1079-4; Ku CS, 2012, ANN NEUROL, V71, P5, DOI 10.1002/ana.22647; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Michaelides M, 2007, BRIT J OPHTHALMOL, V91, P1650, DOI 10.1136/bjo.2007.118356; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Poloschek CM, 2010, INVEST OPHTH VIS SCI, V51, P4253, DOI 10.1167/iovs.09-4655; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Rozet JM, 1996, GENOMICS, V36, P554, DOI 10.1006/geno.1996.0508; Sheffield VC, 2011, NEW ENGL J MED, V364, P1932, DOI 10.1056/NEJMra1012354; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STEINMETZ RL, 1991, OPHTHALMOLOGY, V98, P953; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Strom SP, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-67; Vasireddy V, 2010, PROG RETIN EYE RES, V29, P191, DOI 10.1016/j.preteyeres.2010.01.001; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; WELEBER RG, 1994, ARCH OPHTHALMOL-CHIC, V112, P752, DOI 10.1001/archopht.1994.01090180050033; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zernant J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/iovs.11-8182; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhong M, 2009, J BIOL CHEM, V284, P3640, DOI 10.1074/jbc.M806580200	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91962	10.1371/journal.pone.0091962	http://dx.doi.org/10.1371/journal.pone.0091962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632595	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400127
J	Zurek, G; Rybka, K; Pogrzeba, M; Krzyzak, J; Prokopiuk, K				Zurek, Grzegorz; Rybka, Krystyna; Pogrzeba, Marta; Krzyzak, Jacek; Prokopiuk, Kamil			Chlorophyll a Fluorescence in Evaluation of the Effect of Heavy Metal Soil Contamination on Perennial Grasses	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; PHOTOSYSTEM-II; HIGHER-PLANTS; CADMIUM; METABOLISM; TOXICITY; ZINC; PHYTOREMEDIATION; PHYTOEXTRACTION; INDUCTION	Chlorophyll a fluorescence gives information about the plant physiological status due to its coupling to the photosynthetic electron transfer chain and to the further biochemical processes. Environmental stresses, which acts synergistically, disturbs the photosynthesis. The OJIP test, elaborated by Strasser and co-workers, enables comparison of the physiological status of plants grown on polluted vs. control areas. The paper shows that the Chl a measurements are very useful tool in evaluating of heavy metal ions influence on perennial grasses, tested as potential phytoremediators. Among 5 cultivars tested, the highest concentration of Cd and Zn ions, not associated with the yield reduction, was detected in the biomass of tall fescue cv. Rahela. Chl a fluorescence interpreted as double normalized curves pointed out Rahela as the outstanding cultivar under the HM ions stress.	[Zurek, Grzegorz; Prokopiuk, Kamil] Plant Breeding & Acclimatizat Inst IHAR PIB, Dept Grasses Legumes & Energy Plants, Blonie, Poland; [Rybka, Krystyna] Plant Breeding & Acclimatizat Inst IHAR PIB, Dept Plant Physiol & Biochem, Blonie, Poland; [Pogrzeba, Marta; Krzyzak, Jacek] Inst Ecol Ind Areas, Dept Environm Biotechnol, Phytoremediat Team, Katowice, Poland	Institute of Plant Breeding & Acclimatization; Institute of Plant Breeding & Acclimatization; Institute for Ecology of Industrial Areas	Rybka, K (corresponding author), Plant Breeding & Acclimatizat Inst IHAR PIB, Dept Plant Physiol & Biochem, Blonie, Poland.	k.rybka@ihar.edu.pl	Zurek, Grzegorz/F-3493-2013; Krzyżak, Jacek/AAT-6515-2020	Krzyżak, Jacek/0000-0003-1606-8416; Pogrzeba, Marta/0000-0002-9934-094X; Rybka, Krystyna/0000-0002-4707-8492; Zurek, Grzegorz/0000-0003-2359-2232; Prokopiuk, Kamil/0000-0003-0308-3078	Ministry of Agriculture and Rural Development, Poland [PW3-3-00-0-03]	Ministry of Agriculture and Rural Development, Poland	The work was financed by the Ministry of Agriculture and Rural Development, Poland, as grant PW3-3-00-0-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak B., 2002, J WATER LAND DEV, V6, P29; Baker NR, 2004, ADV PHOTO RESPIRAT, V19, P65; Borjesson P, 1999, BIOMASS BIOENERG, V16, P137, DOI 10.1016/S0961-9534(98)00080-4; Bryson GM, 2007, COMMUN SOIL SCI PLAN, V38, P315, DOI 10.1080/00103620601172316; Buonasera K, 2011, ANAL BIOANAL CHEM, V401, P1139, DOI 10.1007/s00216-011-5166-1; Caldelas C, 2012, ACTA PHYSIOL PLANT, V34, P1217, DOI 10.1007/s11738-012-0956-4; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Gibson D. J., 2009, GRASSES GRASSLAND EC; Goltsev V, 2012, BBA-BIOENERGETICS, V1817, P1490, DOI 10.1016/j.bbabio.2012.04.018; Guha A, 2013, J PHOTOCH PHOTOBIO B, V119, P71, DOI 10.1016/j.jphotobiol.2012.12.006; Gururani MA, 2012, PLANT PHYSIOL BIOCH, V58, P182, DOI 10.1016/j.plaphy.2012.07.003; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Janik E, 2010, PLANT CELL PHYSIOL, V51, P1330, DOI 10.1093/pcp/pcq093; Joshi MK, 2004, ADV PHOTO RESPIRAT, V19, P637; Kalaji HM, 2007, PLANT SOIL ENVIRON, V53, P511, DOI 10.17221/2191-PSE; Kalaji HM, 2012, PHOTOSYNTH RES, V114, P69, DOI 10.1007/s11120-012-9780-3; Krupa Z, 1998, PLANT SCI, V138, P149, DOI 10.1016/S0168-9452(98)00159-9; Kucharski R, 2005, PLANT SOIL, V273, P291, DOI 10.1007/s11104-004-8068-6; Lin YF, 2012, CELL MOL LIFE SCI, V69, P3187, DOI 10.1007/s00018-012-1089-z; Molins H, 2013, PLANT CELL ENVIRON, V36, P804, DOI 10.1111/pce.12016; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Mysliwa-Kurdziel B., 2004, P146; Nedunuri KV, 2010, INT J PHYTOREMEDIAT, V12, P200, DOI 10.1080/15226510903213928; Oukarroum A, 2007, ENVIRON EXP BOT, V60, P438, DOI 10.1016/j.envexpbot.2007.01.002; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Sas-Nowosielska A, 2004, ENVIRON POLLUT, V128, P373, DOI 10.1016/j.envpol.2003.09.012; Schansker G, 2013, PHOTOSYNTH RES, V1, P1, DOI [10.1007/s11120-01309806-01309805, DOI 10.1007/S11120-01309806-01309805]; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Siedlecka A, 1999, PHOTOSYNTHETICA, V36, P321, DOI 10.1023/A:1007097518297; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Stirbet A, 1998, J THEOR BIOL, V193, P131, DOI 10.1006/jtbi.1998.0692; Stirbet A, 2012, PHOTOSYNTH RES, V113, P15, DOI 10.1007/s11120-012-9754-5; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; Tlustos P, 2006, PLANT SOIL ENVIRON, V52, P413, DOI 10.17221/3460-PSE; Toth SZ, 2007, BBA-BIOENERGETICS, V1767, P295, DOI 10.1016/j.bbabio.2007.02.019; Toth SZ, 2013, PHYSIOL PLANTARUM, V148, P161, DOI 10.1111/ppl.12006; Tsimilli-Michael M, 2008, MYCORRHIZA STATE ART, P679, DOI DOI 10.1007/978-3-540-78826-3_32; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wierzbicka MH, 2007, PROTOPLASMA, V231, P99, DOI 10.1007/s00709-006-0227-6; ZAGDANSKA B, 1995, ACTA BIOCHIM POL, V42, P281	42	68	68	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91475	10.1371/journal.pone.0091475	http://dx.doi.org/10.1371/journal.pone.0091475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633293	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400063
J	Prinja, S; Jeet, G; Verma, R; Kumar, D; Bahuguna, P; Kaur, M; Kumar, R				Prinja, Shankar; Jeet, Gursimer; Verma, Ramesh; Kumar, Dinesh; Bahuguna, Pankaj; Kaur, Manmeet; Kumar, Rajesh			Economic Analysis of Delivering Primary Health Care Services through Community Health Workers in 3 North Indian States	PLOS ONE			English	Article							COST	Background: We assessed overall annual and unit cost of delivering package of services and specific services at sub-centre level by CHWs and cost effectiveness of Government of India's policy of introducing a second auxiliary nurse midwife (ANM) at the sub-centre compared to scenario of single ANM sub-centre. Methods: We undertook an economic costing of health services delivered by CHWs, from a health system perspective. Bottom-up costing method was used to collect data on resources spent in 50 randomly selected sub-centres selected from 4 districts. Mean unit cost along with its 95% confidence intervals were estimated using bootstrap method. Multiple linear regression model was used to standardize cost and assess its determinants. Results: Annually it costs INR 1.03 million (USD 19,381), or INR 187 (USD 3.5) per capita per year, to provide a package of preventive, curative and promotive services through community health workers. Unit costs for antenatal care, postnatal care, DOTS treatment and immunization were INR 525 (USD 10) per full ANC care, INR 767 (USD 14) per PNC case registered, INR 974 (USD 18) per DOTS treatment completed and INR 97 (USD 1.8) per child immunized in routine immunization respectively. A 10% increase in human resource costs results in 6% rise in per capita cost. Similarly, 10% increment in the ANC case registered per provider through-put results in a decline in unit cost ranging from 2% in the event of current capacity utilization to 3% reduction in case of full capacity utilization. Incremental cost of introducing 2nd ANM at sub-centre level per unit percent increase ANC coverage was INR 23,058 (USD 432). Conclusion: Our estimates would be useful in undertaking full economic evaluations or equity analysis of CHW programs. Government of India's policy of hiring 2nd ANM at sub-centre level is very cost effective from Indian health system perspective.	[Prinja, Shankar; Jeet, Gursimer; Bahuguna, Pankaj; Kaur, Manmeet; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Verma, Ramesh] Pt BD Sharma Post Grad Inst Med Sci, Dept Community Med, Rohtak, Haryana, India; [Kumar, Dinesh] Dr Rajendra Prasad Govt Med Coll, Dept Community Med, Kangra, Himachal Prades, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Pt. B.D. Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	shankarprinja@gmail.com	KUMAR, DINESH/GRJ-5448-2022	KUMAR, DINESH/0000-0002-9641-6662; /0000-0003-3727-9941; Bahuguna, Pankaj/0000-0001-9952-6077	Research Grant of Post Graduate Institute of Medical Education and Research, Chandigarh, India	Research Grant of Post Graduate Institute of Medical Education and Research, Chandigarh, India	The study was funded by the Research Grant of Post Graduate Institute of Medical Education and Research, Chandigarh, India (http://pgimer.edu.in/PGIMER_PORTAL/PGIMERPORTAL/home.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Taghreed, 2008, Cost Eff Resour Alloc, V6, P22, DOI 10.1186/1478-7547-6-22; [Anonymous], 2021, J HEALTH RES, V41, P116; [Anonymous], 2013, EQUITY HOSP SERVICES; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bossert T, 1998, SOC SCI MED, V47, P1513, DOI 10.1016/S0277-9536(98)00234-2; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Folland Sherman, 2009, EC HLTH HLTH CARE; Fox-Rushby J, 2006, EC EVALUATION; IHP+, 2009, TASKF INN INT FIN HL; IIPS, 2007, NAT FAM HLTH SURV 3; Kaur Manmeet, 2012, WHO South East Asia J Public Health, V1, P94, DOI 10.4103/2224-3151.206920; Kuper H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015431; Lewin SA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub2; Makan B, 1997, EC ANAL COMMUNITY HL; McCord GC, 2013, B WORLD HEALTH ORGAN, V91, P244, DOI 10.2471/BLT.12.109660; McIntyre D, 2011, HEALTH POLICY PLANN, V26, P174, DOI 10.1093/heapol/czq031; Ministry of Health and Family Welfare (MoHFW) Government of India & UNICEF, 2019, NAT POP POL 2000; MOHFW, 2013, IND PUBL HLTH STAND; MOHFW, 2006, NAT HLTH ACC IND; MOHFW, 2013, RUR HLTH STAT IND 20; MOHFW, 2005, NAT RUR HLTH MISS IM; MoI&B, 2014, YOJ DEV MONTHL; Nordstrom A, 2007, B WORLD HEALTH ORGAN, V85, P246, DOI 10.2471/BLT.07.041467; Paulus A, 2002, PUBLIC MONEY MANAGE, V22, P25, DOI 10.1111/1467-9302.00315; Prinja S, 2013, J TROP PEDIATRICS, V59, P489, DOI 10.1093/tropej/fmt057; Prinja S, 2012, INDIAN J MED RES, V136, P421; Rannan-Elliya RP, 1997, HLTH ACCOUNTING COMP; UNICEF I, 2010, COV EV SURV 2009; Viswanathan M, 2010, MED CARE, V48, P792, DOI 10.1097/MLR.0b013e3181e35b51; Walker DG, 2005, J COMMUN HEALTH, V30, P221, DOI 10.1007/s10900-004-1960-4; WHO, 2013, INV TEND DEV COST EF; WHO, 2003, MAKING CHOICES HLTH; WHO, 2005, CHOOSING INT AR COST; World Health Organization, 2001, MACR HLTH INV HLTH E	35	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91781	10.1371/journal.pone.0091781	http://dx.doi.org/10.1371/journal.pone.0091781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626285	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300134
J	Suzuki, K; Nakamura, S; Morimoto, M; Fujii, K; Noda, NN; Inagaki, F; Ohsumi, Y				Suzuki, Kuninori; Nakamura, Shingo; Morimoto, Mayumi; Fujii, Kiyonaga; Noda, Nobuo N.; Inagaki, Fuyuhiko; Ohsumi, Yoshinori			Proteomic Profiling of Autophagosome Cargo in Saccharomyces cerevisiae	PLOS ONE			English	Article							UBIQUITIN PROTEASE; YEAST; PROTEINS; PATHWAYS; MUTANTS; VACUOLE; STARVATION; CYTOPLASM; RIBOSOMES; DELIVERY	Macroautophagy (autophagy) is a bulk protein-degradation system ubiquitously conserved in eukaryotic cells. During autophagy, cytoplasmic components are enclosed in a membrane compartment, called an autophagosome. The autophagosome fuses with the vacuole/lysosome and is degraded together with its cargo. Because autophagy is important for the maintenance of cellular homeostasis by degrading unwanted proteins and organelles, identification of autophagosome cargo proteins (i.e., the targets of autophagy) will aid in understanding the physiological roles of autophagy. In this study, we developed a method for monitoring intact autophagosomes ex vivo by detecting the fluorescence of GFP-fused aminopeptidase I, the best-characterized selective cargo of autophagosomes in Saccharomyces cerevisiae. This method facilitated optimization of a biochemical procedure to fractionate autophagosomes. A combination of LC-MS/MS with subsequent statistical analyses revealed a list of autophagosome cargo proteins; some of these are selectively enclosed in autophagosomes and delivered to the vacuole in an Atg11-independent manner. The methods we describe will be useful for analyzing the mechanisms and physiological significance of Atg11-independent selective autophagy.	[Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan; [Nakamura, Shingo; Fujii, Kiyonaga; Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Dept Biol Struct, Sapporo, Hokkaido, Japan; [Noda, Nobuo N.] Inst Microbial Chem BIKAKEN, Mol Struct Lab, Tokyo, Japan; [Morimoto, Mayumi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan	University of Tokyo; Hokkaido University; Tokyo Institute of Technology	Suzuki, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan.	kuninori@k.u-tokyo.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Noda, Nobuo/0000-0002-6940-8069	Hamaguchi Foundation for the Advancement of Biochemistry [H23-3]; Mishima Kaiun Memorial Foundation [H25-130]; NOVARTIS Foundation (Japan) [11-128]; Takeda Science Foundation; Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [24121707, 24657083, 25291040, 23000015]	Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); NOVARTIS Foundation (Japan)(Novartis); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Hamaguchi Foundation for the Advancement of Biochemistry (H23-3 to KS; http://www.hamaguchi-foundation.or.jp/); the Mishima Kaiun Memorial Foundation (H25-130 to KS; http://www.mishima-kaiun.or.jp/); the NOVARTIS Foundation (Japan) for the Promotion of Science (11-128 to KS; http://novartisfound.or.jp/); the Takeda Science Foundation (to KS; http://www.takeda-sci.or.jp/); the Yamada Science Foundation (to KS; http://www.yamadazaidan.jp/); and by Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24121707, 24657083, and 25291040 to KS; 23000015 to YO; http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; EGNER R, 1993, J BIOL CHEM, V268, P27269; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kirchberger J, 1999, BIOCHEM J, V341, P15, DOI 10.1042/0264-6021:3410015; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5	26	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91651	10.1371/journal.pone.0091651	http://dx.doi.org/10.1371/journal.pone.0091651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626240	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300114
J	Wang, XY; Fan, SL; Song, MZ; Pang, CY; Wei, HL; Yu, JW; Ma, QF; Yu, SX				Wang, Xiaoyan; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Yu, Jiwen; Ma, Qifeng; Yu, Shuxun			Upland Cotton Gene GhFPF1 Confers Promotion of Flowering Time and Shade-Avoidance Responses in Arabidopsis thaliana	PLOS ONE			English	Article							FLORAL INDUCTION; SALICYLIC-ACID; LOCUS-T; PHYTOCHROME; HOMOLOG; PROTEIN; VERNALIZATION; COMPETENCE; POLYPLOIDY; EXPRESSION	Extensive studies on floral transition in model species have revealed a network of regulatory interactions between proteins that transduce and integrate developmental and environmental signals to promote or inhibit the transition to flowering. Previous studies indicated FLOWERING PROMOTING FACTOR 1 (FPF1) gene was involved in the promotion of flowering, but the molecular mechanism was still unclear. Here, FPF1 homologous sequences were screened from diploid Gossypium raimondii L. (D-genome, n = 13) and Gossypium arboreum L. genome (A-genome, n = 13) databases. Orthologous genes from the two species were compared, suggesting that distinctions at nucleic acid and amino acid levels were not equivalent because of codon degeneracy. Six FPF1 homologous genes were identified from the cultivated allotetraploid Gossypium hirsutum L. (AD-genome, n = 26). Analysis of relative transcripts of the six genes in different tissues revealed that this gene family displayed strong tissue-specific expression. GhFPF1, encoding a 12.0-kDa protein (Accession No: KC832319) exerted more transcripts in floral apices of short-season cotton, hinting that it could be involved in floral regulation. Significantly activated APETALA 1 and suppressed FLOWERING LOCUS C expression were induced by over-expression of GhFPF1 in the Arabidopsis Columbia-0 ecotype. In addition, transgenic Arabidopsis displayed a constitutive shade-avoiding phenotype that is characterized by long hypocotyls and petioles, reduced chlorophyll content, and early flowering. We propose that GhFPF1 may be involved in flowering time control and shade-avoidance responses.	[Wang, Xiaoyan; Ma, Qifeng] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Wang, Xiaoyan; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Yu, Jiwen; Ma, Qifeng; Yu, Shuxun] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	yu@cricaas.com.cn		Wang, Xiaoyan/0000-0003-3222-2567	Earmarked Fund for China Agriculture Research System [CARS-18]; National High-tech Research and Development Projects of China [2011AA10A102]	Earmarked Fund for China Agriculture Research System; National High-tech Research and Development Projects of China(National High Technology Research and Development Program of China)	This research was supported by the Earmarked Fund for China Agriculture Research System (CARS-18) and funded by the National High-tech Research and Development Projects of China (2011AA10A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Attitalla Idress Hamad, 2011, Pak J Biol Sci, V14, P998, DOI 10.3923/pjbs.2011.998.999; Ballare CL, 1999, TRENDS PLANT SCI, V4, P97, DOI 10.1016/S1360-1385(99)01383-7; BALLARE CL, 1987, PLANT CELL ENVIRON, V10, P551, DOI 10.1111/1365-3040.ep11604091; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bernier G, 2002, RUSS J PLANT PHYSL+, V49, P445, DOI 10.1023/A:1016343421814; Borner Roland, 2000, 11 INT C AR RES JUN; Chen LG, 2010, MOL PLANT MICROBE IN, V23, P558, DOI 10.1094/MPMI-23-5-0558; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cronn RC, 1999, P NATL ACAD SCI USA, V96, P14406, DOI 10.1073/pnas.96.25.14406; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Ge L, 2004, PLANT PHYSIOL, V135, P1502, DOI 10.1104/pp.104.041996; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Havelange A, 2000, PHYSIOL PLANTARUM, V109, P343, DOI 10.1034/j.1399-3054.2000.100316.x; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kania T, 1997, PLANT CELL, V9, P1327, DOI 10.1105/tpc.9.8.1327; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Korves TM, 2003, PLANT PHYSIOL, V133, P339, DOI 10.1104/pp.103.027094; Lai DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028676; Li J, 2013, PLANT CELL REP, V32, P1675, DOI 10.1007/s00299-013-1479-1; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Melzer S, 1999, PLANT J, V18, P395, DOI 10.1046/j.1365-313X.1999.00461.x; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Pajerowska-Mukhtar KM, 2013, TRENDS PLANT SCI, V18, P402, DOI 10.1016/j.tplants.2013.04.004; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Ren GJ, 2000, ACTA BOT BOREALI-OCC, V20, P847; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Smykal P, 2004, PLANT MOL BIOL, V55, P253, DOI 10.1007/s11103-004-0557-8; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Wang GF, 2011, PLANT PHYSIOL, V156, P1508, DOI 10.1104/pp.111.176776; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Yang MW, 2002, CHINESE J SPECTROSCO, V19, P479; Zhang Y, 2008, BIOSCIENCE REP, V28, P7, DOI 10.1042/BSR20070028	48	12	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91869	10.1371/journal.pone.0091869	http://dx.doi.org/10.1371/journal.pone.0091869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626476	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300142
J	Akerberg, AA; Stewart, S; Stankunas, K				Akerberg, Alexander A.; Stewart, Scott; Stankunas, Kryn			Spatial and Temporal Control of Transgene Expression in Zebrafish	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; CELL FATES; ESTROGEN-RECEPTOR; BINDING DOMAINS; GAL4 GENE; EMBRYOS; TISSUE; NOTCH; SPECIFICATION; DROSOPHILA	Transgenic zebrafish research has provided valuable insights into gene functions and cell behaviors directing vertebrate development, physiology, and disease models. Most approaches use constitutive transgene expression and therefore do not provide control over the timing or levels of transgene induction. We describe an inducible gene expression system that uses new tissue-specific zebrafish transgenic lines that express the Gal4 transcription factor fused to the estrogen-binding domain of the human estrogen receptor. We show these Gal4-ERT driver lines confer rapid, tissue-specific induction of UAS-controlled transgenes following tamoxifen exposure in both embryos and adult fish. We demonstrate how this technology can be used to define developmental windows of gene function by spatiotemporal-controlled expression of constitutively active Notch1 in embryos. Given the array of existing UAS lines, the modular nature of this system will enable many previously intractable zebrafish experiments.	[Akerberg, Alexander A.; Stewart, Scott; Stankunas, Kryn] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Akerberg, Alexander A.; Stankunas, Kryn] Univ Oregon, Dept Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Stewart, S (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	sstewart@molbio.uoregon.edu; kryn@uoregon.edu		Akerberg, Alexander/0000-0001-9385-3739	Oregon Medical Research Foundation; NIH/NICHD; University of Oregon; NIH/NHLBI [5R00HL087598]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL087598] Funding Source: NIH RePORTER	Oregon Medical Research Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Oregon; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support came from the Oregon Medical Research Foundation (SS), a NIH/NICHD Developmental Biology Training Grant (AAA), the University of Oregon (KS), and the NIH/NHLBI (5R00HL087598) (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 1999, CURR BIOL, V9, P247, DOI 10.1016/S0960-9822(99)80113-4; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BRAND AH, 1993, DEVELOPMENT, V118, P401; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Gerety SS, 2013, DEVELOPMENT, V140, P2235, DOI 10.1242/dev.091520; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Latimer AJ, 2006, DEV BIOL, V298, P392, DOI 10.1016/j.ydbio.2006.05.039; LAUGHON A, 1984, MOL CELL BIOL, V4, P260, DOI 10.1128/MCB.4.2.260; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; MA J, 1988, NATURE, V334, P631, DOI 10.1038/334631a0; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Melby AE, 1996, DEVELOPMENT, V122, P2225; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Scott EK, 2009, J NEUROCHEM, V110, P441, DOI 10.1111/j.1471-4159.2009.06161.x; Stewart S, 2012, DEV BIOL, V365, P339, DOI 10.1016/j.ydbio.2012.02.031; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Wang YH, 2006, DIFFERENTIATION, V74, P186, DOI 10.1111/j.1432-0436.2006.00064.x; Wang YH, 2006, GENE EXPR PATTERNS, V6, P335, DOI 10.1016/j.modgep.2005.10.002; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; Yamamoto M, 2010, DEVELOPMENT, V137, P2527, DOI 10.1242/dev.051011	42	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92217	10.1371/journal.pone.0092217	http://dx.doi.org/10.1371/journal.pone.0092217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643048	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900105
J	Heinzelmann, G; Kuyucak, S				Heinzelmann, Germano; Kuyucak, Serdar			Molecular Dynamics Simulations of the Mammalian Glutamate Transporter EAAT3	PLOS ONE			English	Article							CONTROLS CATION INTERACTIONS; BINDING FREE-ENERGIES; ASPARTATE TRANSPORTER; SUBSTRATE INTERACTIONS; EXTRACELLULAR GATE; NA+ BINDING; RESIDUE; SODIUM; MECHANISM; HOMOLOG	Excitatory amino acid transporters (EAATs) are membrane proteins that enable sodium-coupled uptake of glutamate and other amino acids into neurons. Crystal structures of the archaeal homolog Glt(Ph) have been recently determined both in the inward-and outward-facing conformations. Here we construct homology models for the mammalian glutamate transporter EAAT3 in both conformations and perform molecular dynamics simulations to investigate its similarities and differences from Glt(Ph). In particular, we study the coordination of the different ligands, the gating mechanism and the location of the proton and potassium binding sites in EAAT3. We show that the protonation of the E374 residue is essential for binding of glutamate to EAAT3, otherwise glutamate becomes unstable in the binding site. The gating mechanism in the inward-facing state of EAAT3 is found to be different from that of Glt(Ph), which is traced to the relocation of an arginine residue from the HP1 segment in Glt(Ph) to the TM8 segment in EAAT3. Finally, we perform free energy calculations to locate the potassium binding site in EAAT3, and find a high-affinity site that overlaps with the Na1 and Na3 sites in Glt(Ph).	[Heinzelmann, Germano; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney	Kuyucak, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	serdar@physics.usyd.edu.au	Kuyucak, Serdar/AAH-8417-2021; Heinzelmann, Germano/C-3460-2016	Heinzelmann, Germano/0000-0001-7168-6941; Kuyucak, Serdar/0000-0003-4315-9532	Australian Research Council [DP1092729]	Australian Research Council(Australian Research Council)	This work was supported by a grant from the Australian Research Council (DP1092729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bergles DE, 2002, J NEUROSCI, V22, P10153; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Carlsson J, 2005, J PHYS CHEM B, V109, P6448, DOI 10.1021/jp046022f; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Erkens GB, 2013, NATURE, V502, P119, DOI 10.1038/nature12538; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Frillingos S, 1997, PROTEIN SCI, V6, P431; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Grazioso G, 2012, J AM CHEM SOC, V134, P453, DOI 10.1021/ja208485w; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Heinzelmann G, 2014, J PHYS CHEM B, V118, P1813, DOI 10.1021/jp412195m; Heinzelmann G, 2013, J PHYS CHEM B, V117, P5486, DOI 10.1021/jp4010423; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Jiang J, 2011, NEUROPHARMACOLOGY, V60, P172, DOI 10.1016/j.neuropharm.2010.07.019; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Lev B, 2013, PHYS CHEM CHEM PHYS, V15, P2397, DOI 10.1039/c2cp42860a; Limongelli V, 2013, P NATL ACAD SCI USA, V110, P6358, DOI 10.1073/pnas.1303186110; Minh DDL, 2005, BIOPHYS J, V89, pL25, DOI 10.1529/biophysj.105.069336; Mwaura J, 2012, ACS CHEM NEUROSCI, V3, P1073, DOI 10.1021/cn300163p; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Rosental N, 2011, J BIOL CHEM, V286, P41381, DOI 10.1074/jbc.M111.291021; Roux B, 2008, J CHEM PHYS, V126; Roux B, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2931568; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Stolzenberg S, 2012, J PHYS CHEM B, V116, P5372, DOI 10.1021/jp301726s; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2005, BIOCHEMISTRY-US, V44, P3466, DOI 10.1021/bi047812i; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Tao Z, 2008, BIOCHEMISTRY-US, V47, P12923, DOI 10.1021/bi8017174; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070947; Watzke N, 2000, J GEN PHYSIOL, V116, P609, DOI 10.1085/jgp.116.5.609; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zomot E, 2013, J BIOL CHEM, V288, P8231, DOI 10.1074/jbc.M112.438432	73	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92089	10.1371/journal.pone.0092089	http://dx.doi.org/10.1371/journal.pone.0092089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643009	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900082
J	de Mola, CL; Quispe, R; Valle, GA; Poterico, JA				Loret de Mola, Christian; Quispe, Renato; Valle, Giancarlo A.; Poterico, Julio A.			Nutritional Transition in Children under Five Years and Women of Reproductive Age: A 15-Years Trend Analysis in Peru	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DEVELOPING-COUNTRIES; OBESITY; OVERWEIGHT; UNDERWEIGHT; ANEMIA; GROWTH; BRAZIL; INCOME	Background: Rapid urbanization, increase in food availability, and changes in diet and lifestyle patterns have been changing nutritional profiles in developing nations. We aimed to describe nutritional changes in children under 5 years and women of reproductive age in Peru, during a 15-year period of rapid economic development and social policy enhancement. Materials and Methods: Trend analyses of anthropometric measures in children of preschool age and women between 1549 years, using the Peruvian National Demographic and Family Health Surveys (DHS) from 1996 to 2011. WHO growth curves were used to define stunting, underweight, wasting and overweight in children <5y. We employed the WHO BMI-age standardized curves for teenagers between 15-19y. In women >19 years, body mass index (BMI) was analyzed both categorically and as a continuous variable. To statistically analyze the trends, we used regression models: Linear and Poisson for continuous and binary outcomes, respectively. Results: We analyzed data from 123 642 women and 64 135 children, from 1996 to 2011. Decreases over time were evidenced for underweight (p<0.001), wasting (p<0.001), and stunting (p<0.001) in children under 5y. This effect was particularly noted in urban settings. Overweight levels in children reduced (p<0.001), however this reduction stopped, in urban settings, since 2005 (similar to 12%). Anemia decreased in children and women (p<0.001); with higher reduction in urban (down arrow 43%) than in rural children (down arrow 24%). BMI in women aged 15-19 years increased (p<0.001) across time, with noticeable BMI-curve shift in women older than 30 years. Moreover, obesity doubled during this period in women more than 19y. Conclusion: Nutrition transition in Peru shows different patterns for urban and rural populations. Public policies should emphasize targeting both malnutrition conditions-undernutrition/stunting, overweight/obesity and anemia-considering age and place of residence in rapid developing societies like Peru.	[Loret de Mola, Christian; Quispe, Renato; Valle, Giancarlo A.; Poterico, Julio A.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Loret de Mola, Christian] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Quispe, Renato] Univ Peruana Cayetano Heredia, CONEVID Unidad Conocimiento & Evidencia, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidade Federal de Pelotas; Universidad Peruana Cayetano Heredia	de Mola, CL (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	chlmz@yahoo.com	de Mola, Christian Loret/C-9534-2012	de Mola, Christian Loret/0000-0002-5264-5914; Valle, Giancarlo/0000-0002-4914-473X; Poterico, Julio A/0000-0001-7838-3505				Acosta A. M., 2011, IDS WORKING PAPERS, P2, DOI DOI 10.1111/j.2040-0209.2011.00367.x; Adel E, 2008, LIBYAN J MED, V3, P13, DOI 10.4176/071006; Álvarez-Dongo Doris, 2012, Rev. perú. med. exp. salud publica, V29, P303; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2008, WORLDW PREV AN 1993; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Baughcum AE, 2000, PEDIATRICS, V106, P1380, DOI 10.1542/peds.106.6.1380; Bermudez Odilia I., 2003, Cad. Saúde Pública, V19, pS87, DOI 10.1590/S0102-311X2003000700010; Creber RMM, 2010, REV PANAM SALUD PUBL, V28, P1, DOI 10.1590/S1020-49892010000700001; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; DEMOLA CL, 2012, PLOS ONE, V0007; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Eckhardt CL, 2008, EUR J CLIN NUTR, V62, P238, DOI 10.1038/sj.ejcn.1602727; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Assuncao MCF, 2007, REV SAUDE PUBL, V41, P539, DOI 10.1590/S0034-89102006005000031; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Instituto Nacional de Salud, 2012, EV IND PROGR ART NUT; Jacoby E, 2003, PREV MED, V37, P396, DOI 10.1016/S0091-7435(03)00159-2; Kain Juliana, 2003, Cad. Saúde Pública, V19, pS77, DOI 10.1590/S0102-311X2003000700009; Kimbro RT, 2010, HEALTH AFFAIR, V29, P411, DOI 10.1377/hlthaff.2009.0731; Macro ORC, 2006, DEM HLTH SURV INT MA; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mispireta ML, 2007, REV PERU MED EXP SAL, V24, P129; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/S0034-89102009000100005; Pajuelo-Ramírez Jaime, 2011, Rev. perú. med. exp. salud publica, V28, P222, DOI 10.1590/s1726-46342011000200008; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Poterico Julio A., 2012, Rev. perú. med. exp. salud publica, V29, P581; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Uauy R., 2001, Journal of Nutrition, V131, P893; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; WHO, 2006, WHO CHILD GROWTH STA; WHO U World Bank, 2012, LEV TRENDS CHILD MAL; WHO/UNICEF, 2013, PROGR SAN DRINK WAT; World Health Organization, 1995, PHYS STAT US INT ANT	44	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92550	10.1371/journal.pone.0092550	http://dx.doi.org/10.1371/journal.pone.0092550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24643049	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900145
J	Pani, AK; Jiao, Y; Sample, KJ; Smeyne, RJ				Pani, Amar K.; Jiao, Yun; Sample, Kenneth J.; Smeyne, Richard J.			Neurochemical Measurement of Adenosine in Discrete Brain Regions of Five Strains of Inbred Mice	PLOS ONE			English	Article							A(2A) RECEPTORS; ELECTROCHEMICAL DETECTION; ANTAGONISTIC INTERACTION; INDUCED SEIZURES; RAT-BRAIN; DOPAMINE; RELEASE; MODULATION; ACETYLCHOLINE; METABOLISM	Adenosine (ADO), a non-classical neurotransmitter and neuromodulator, and its metabolites adenosine triphosphate (ATP), adenosine diphosphate (ADP) and adenosine monophosphate (AMP), have been shown to play an important role in a number of biochemical processes. Although their signaling is well described, it has been difficult to directly, accurately and simultaneously quantitate these purines in tissue or fluids. Here, we describe a novel method for measuring adenosine (ADO) and its metabolites using high performance liquid chromatography with electrochemical detection (HPLC-ECD). Using this chromatographic technique, we examined baseline levels of ADO and ATP, ADP and AMP in 6 different brain regions of the C57BL/6J mouse: stratum, cortex, hippocampus, olfactory bulb, substantia nigra and cerebellum and compared ADO levels in 5 different strains of mice (C57BL/6J, Swiss-Webster, FVB/NJ, 129P/J, and BALB/c). These studies demonstrate that baseline levels of purines vary significantly among the brain regions as well as between different mouse strains. These dissimilarities in purine concentrations may explain the variable phenotypes among background strains described in neurological disease models.	[Pani, Amar K.; Jiao, Yun; Sample, Kenneth J.; Smeyne, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Smeyne, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Richard.smeyne@stjude.org		Smeyne, Richard/0000-0002-8459-5472	ALSAC	ALSAC(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by ALSAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLGAIER C, 1991, N-S ARCH PHARMACOL, V344, P187, DOI 10.1007/BF00167217; Andreescu CE, 2011, NEUROSCIENCE, V176, P274, DOI 10.1016/j.neuroscience.2010.12.024; [Anonymous], GLIA, V74, P73; Bao SW, 1998, BEHAV NEUROSCI, V112, P714; BARTRUP JT, 1990, BRAIN RES, V530, P330, DOI 10.1016/0006-8993(90)91305-Z; Berman RF, 2000, BRAIN RES, V872, P44, DOI 10.1016/S0006-8993(00)02441-0; Birbeck JA, 2012, PITTC 2012 ORL, P70; Birbeck JA, 2013, ANAL CHEM, V85, P7398, DOI 10.1021/ac4013144; Boison D, 2012, GLIA, V60, P1234, DOI 10.1002/glia.22285; Boison D, 2011, CURR TOP MED CHEM, V11, P1068, DOI 10.2174/156802611795347609; Borowiec A, 2006, ACTA BIOCHIM POL, V53, P269; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; CEBALLOS G, 1994, J NEUROCHEM, V62, P1144; Chen GX, 2000, BRAIN RES, V887, P144, DOI 10.1016/S0006-8993(00)03005-5; Dale N, 1998, J PHYSIOL-LONDON, V511, P265, DOI 10.1111/j.1469-7793.1998.265bi.x; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; DELUCA M, 1973, P NATL ACAD SCI USA, V70, P1664, DOI 10.1073/pnas.70.6.1664; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; Ferre S, 2007, PROG NEUROBIOL, V83, P332, DOI 10.1016/j.pneurobio.2007.04.002; FERRE S, 1991, EUR J PHARMACOL, V192, P31, DOI 10.1016/0014-2999(91)90065-X; Ferre S, 1996, NEUROSCI LETT, V208, P109, DOI 10.1016/0304-3940(96)12577-5; FERRE S, 1994, NEUROREPORT, V6, P73, DOI 10.1097/00001756-199412300-00020; FERRE S, 1991, P NATL ACAD SCI USA, V88, P7238, DOI 10.1073/pnas.88.16.7238; FERRE S, 1994, NEUROSCIENCE, V63, P765, DOI 10.1016/0306-4522(94)90521-5; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fuxe K, 2010, CNS NEUROSCI THER, V16, pe18, DOI 10.1111/j.1755-5949.2009.00126.x; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; GHARIB A, 1982, J NEUROCHEM, V38, P810, DOI 10.1111/j.1471-4159.1982.tb08702.x; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; GOODMAN RR, 1983, SCIENCE, V220, P967, DOI 10.1126/science.6302841; Hamre K, 1999, BRAIN RES, V828, P91, DOI 10.1016/S0006-8993(99)01273-1; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HARMS HH, 1979, NEUROPHARMACOLOGY, V18, P577, DOI 10.1016/0028-3908(79)90107-2; HENDERSON RJ, 1984, J CHROMATOGR, V298, P231, DOI 10.1016/S0021-9673(01)92718-9; Hickey P, 2012, CURR NEUROL NEUROSCI, V12, P376, DOI 10.1007/s11910-012-0279-2; Hohoff C, 2010, J PSYCHIATR RES, V44, P930, DOI 10.1016/j.jpsychires.2010.02.006; Howard M, 1998, INVEST OPHTH VIS SCI, V39, P1942; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Inoue T, 2000, ANAL CHEM, V72, P5755, DOI 10.1021/ac000716c; JACKISCH R, 1984, N-S ARCH PHARMACOL, V327, P319, DOI 10.1007/BF00506243; Jang H, 2012, J NEUROSCI, V32, P1545, DOI 10.1523/JNEUROSCI.5123-11.2012; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jenner P, 2009, PARKINSONISM RELAT D, V15, P406, DOI [10.1016/j.parkreldis.2008.12.006, 10.1016/S1353-8020(09)70829-6]; Jiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029447; Jin SY, 1997, N-S ARCH PHARMACOL, V355, P48; Kaelin-Lang A, 1999, NEUROSCI LETT, V261, P189, DOI 10.1016/S0304-3940(99)00022-1; KIRK IP, 1995, J NEUROCHEM, V64, P2801; Kloor D, 2000, CLIN CHEM, V46, P537; Kobayashi T, 1998, BRAIN RES, V787, P211, DOI 10.1016/S0006-8993(97)01481-9; Kovacs Z, 1998, Neurobiology (Bp), V6, P315; Lazarus M, 2011, J NEUROSCI, V31, P10067, DOI 10.1523/JNEUROSCI.6730-10.2011; Lee AW, 2003, NEUROSCIENCE, V118, P263, DOI 10.1016/S0306-4522(02)00950-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LeMoine C, 1997, J NEUROSCI, V17, P8038; MYERS S, 1986, BRAIN RES, V375, P193, DOI 10.1016/0006-8993(86)90975-3; Namba Kazunori, 2010, BMC Res Notes, V3, P323, DOI 10.1186/1756-0500-3-323; Nguyen MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087165; Pajski ML, 2010, ACS CHEM NEUROSCI, V1, P775, DOI 10.1021/cn100037d; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PEDATA F, 1983, NEUROPHARMACOLOGY, V22, P609, DOI 10.1016/0028-3908(83)90152-1; PHILLIS JW, 1981, PROG NEUROBIOL, V16, P187, DOI 10.1016/0301-0082(81)90014-9; Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005; Quarta D, 2004, J NEUROCHEM, V91, P873, DOI 10.1111/j.1471-4159.2004.02761.x; Restivo L, 2006, BEHAV GENET, V36, P923, DOI 10.1007/s10519-006-9088-1; Rodrigues RJ, 2005, J NEUROCHEM, V92, P433, DOI 10.1111/j.1471-4159.2004.02887.x; Salamone John D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS130, DOI 10.1016/j.parkreldis.2008.04.017; Salim H, 2000, J NEUROCHEM, V74, P432, DOI 10.1046/j.1471-4159.2000.0740432.x; Sanchez-Perez A, 2005, CEREBELLUM, V4, P162, DOI 10.1080/14734220510008003; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Sebastiao Ana M, 2009, Handb Exp Pharmacol, P471, DOI 10.1007/978-3-540-89615-9_16; Smeyne M, 2001, GLIA, V34, P73, DOI 10.1002/glia.1042; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Smith Y, 2000, TRENDS NEUROSCI, V23, pS28, DOI 10.1016/S1471-1931(00)00023-9; SNYDER SH, 1985, ANNU REV NEUROSCI, V8, P103; Sonsalla PK, 2012, EXP NEUROL, V234, P482, DOI 10.1016/j.expneurol.2012.01.022; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Srivastava S, 2012, J NEUROCHEM, V123, P668, DOI 10.1111/jnc.12026; Stone Trevor W, 2009, Handb Exp Pharmacol, P535, DOI 10.1007/978-3-540-89615-9_17; Takehara K, 2004, NEUROSCI LETT, V364, P43, DOI 10.1016/j.neulet.2004.04.024; Wardas J, 2002, POL J PHARMACOL, V54, P313; Wei CJ, 2011, LEARN MEMORY, V18, P459, DOI 10.1101/lm.2136011; WINN HR, 1980, CIRC RES, V47, P568, DOI 10.1161/01.RES.47.4.568; WOJCIK WJ, 1983, J NEUROCHEM, V41, P759, DOI 10.1111/j.1471-4159.1983.tb04805.x; WOOD PL, 1989, NEUROPHARMACOLOGY, V28, P21, DOI 10.1016/0028-3908(89)90062-2; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X	88	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92422	10.1371/journal.pone.0092422	http://dx.doi.org/10.1371/journal.pone.0092422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642754	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900136
J	Svobodova, I; Chaloupkova, H; Koncel, R; Bartos, L; Hradecka, L; Jebavy, L				Svobodova, Ivona; Chaloupkova, Helena; Koncel, Roman; Bartos, Ludek; Hradecka, Lenka; Jebavy, Lukas			Cortisol and Secretory Immunoglobulin A Response to Stress in German Shepherd Dogs	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; SALIVARY CORTISOL; IMMUNE-SYSTEM; COPING STYLES; BEHAVIOR; PUPPIES; IGA; PIGS; AGE; ANIMALS	The aim of the study was to determine whether cortisol and secretory Immunoglobulin A (sIgA) could be used as an indicator of acute stress in both young and adult dogs. Seventeen German shepherd puppies were exposed to the Puppy test (challenge test) at the age of seven weeks. This test has been routinely used to assess the future working ability of potential police dogs. In addition, ten adult females were subjected to 4 minutes of defense training under stressful conditions. Saliva was collected from the puppies and adult females before testing and 20 minutes after the start of testing, using a cotton swab held for 1-2 minutes in each dog's mouth. Cortisol concentrations increased after the test compared to the control sample both in puppies and the adult females. However adult females showed a significant decrease in sIgA after defense training while puppies showed a tendency of increase in sIgA. We propose that salivary cortisol could be used as an indicator of stress in puppies during early ontogeny. It is not yet clear whether sIgA could be used as a useful indicator of short-term stress in dogs.	[Svobodova, Ivona; Chaloupkova, Helena; Koncel, Roman; Bartos, Ludek; Hradecka, Lenka; Jebavy, Lukas] Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Prague 6, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Chaloupkova, H (corresponding author), Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Prague 6, Czech Republic.	chaloupkovah@af.czu.cz	Chaloupková, Helena/A-7683-2019; Svobodova, Ivona/U-7957-2018	Chaloupková, Helena/0000-0003-4894-0600; Svobodova, Ivona/0000-0003-3303-981X	 [MVCR VF 20112014012]		Funding provided by grant number MVCR VF 20112014012 (URL:http://www.mvcr.cz/dotace-a-granty.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi PA, 2008, GEN COMP ENDOCR, V155, P398, DOI 10.1016/j.ygcen.2007.07.002; Asher L, 2013, J VET BEHAV, V8, P431, DOI 10.1016/j.jveb.2013.08.004; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bennett A, 2010, DOMEST ANIM ENDOCRIN, V39, P171, DOI 10.1016/j.domaniend.2010.04.003; Bergamasco L, 2010, APPL ANIM BEHAV SCI, V125, P56, DOI 10.1016/j.applanim.2010.03.002; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Bosch JA, 2002, INT REV NEUROBIOL, V52, P213; Bosch JA, 1996, PSYCHOSOM MED, V58, P374, DOI 10.1097/00006842-199607000-00010; Chaloupkova H, 2007, J ANIM SCI, V85, P1741, DOI 10.2527/jas.2006-504; Dreschel NA, 2009, HORM BEHAV, V55, P163, DOI 10.1016/j.yhbeh.2008.09.010; Erber R, 2012, STRESS, V15, P184, DOI 10.3109/10253890.2011.606855; EVANS P, 1994, BRIT J CLIN PSYCHOL, V33, P575, DOI 10.1111/j.2044-8260.1994.tb01154.x; Fahlman MM, 2001, INT J SPORTS MED, V22, P284; Fan YX, 2009, STRESS HEALTH, V25, P189, DOI 10.1002/smi.1239; HARGREAVES AL, 1990, APPL ANIM BEHAV SCI, V26, P103, DOI 10.1016/0168-1591(90)90091-Q; Horvath Z, 2007, HORM BEHAV, V52, P621, DOI 10.1016/j.yhbeh.2007.08.001; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Hucklebridge F, 1998, INT J PSYCHOPHYSIOL, V31, P69, DOI 10.1016/S0167-8760(98)00042-7; Ishiwata T, 2006, ANIM SCI J, V77, P352, DOI 10.1111/j.1740-0929.2006.00359.x; Kikkawa A, 2005, J VET MED SCI, V67, P707, DOI 10.1292/jvms.67.707; Kikkawa A, 2003, J VET MED SCI, V65, P689, DOI 10.1292/jvms.65.689; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LEMAHO Y, 1992, AM J PHYSIOL, V263, pR775, DOI 10.1152/ajpregu.1992.263.4.R775; Lester SR, 2010, ANAT SCI EDUC, V3, P160, DOI 10.1002/ase.161; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Muneta Y, 2010, J VET MED SCI, V72, P1295, DOI 10.1292/jvms.10-0009; Ogra PL, 2010, AGEING RES REV, V9, P101, DOI 10.1016/j.arr.2009.07.007; PALAZZOLO DL, 1987, P SOC EXP BIOL MED, V185, P305; REIMERS TJ, 1990, AM J VET RES, V51, P454; Rooney NJ, 2007, PHYSIOL BEHAV, V92, P847, DOI 10.1016/j.physbeh.2007.06.011; Schafer-Somi S, 2005, RES VET SCI, V78, P143, DOI 10.1016/j.rvsc.2004.07.011; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Steiss JE, 2007, APPL ANIM BEHAV SCI, V106, P96, DOI 10.1016/j.applanim.2006.06.018; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Tomkins LM, 2011, J VET BEHAV, V6, P178, DOI 10.1016/j.jveb.2010.12.002; Tsai ML, 2012, J STRENGTH COND RES, V26, P2202, DOI 10.1519/JSC.0b013e31823a4246; van der Borg JAM, 2010, APPL ANIM BEHAV SCI, V128, P78, DOI 10.1016/j.applanim.2010.09.016; Veissier I, 1997, J ANIM SCI, V75, P356; Volkmann ER, 2006, STRESS HEALTH, V22, P11, DOI 10.1002/smi.1077; von Borell E, 2007, HORM BEHAV, V52, P130, DOI 10.1016/j.yhbeh.2007.03.014; Watamura SE, 2010, PSYCHONEUROENDOCRINO, V35, P1156, DOI 10.1016/j.psyneuen.2010.02.001; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Zaine L, 2011, BRIT J NUTR, V106, pS183, DOI 10.1017/S0007114511000559; Zeier H, 1996, BIOL PSYCHOL, V42, P413, DOI 10.1016/0301-0511(95)05170-8	46	30	30	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90820	10.1371/journal.pone.0090820	http://dx.doi.org/10.1371/journal.pone.0090820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637917	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100012
J	Symonds, MRE; Weston, MA; Robinson, RW; Guay, PJ				Symonds, Matthew R. E.; Weston, Michael A.; Robinson, Randall W.; Guay, Patrick-Jean			Comparative Analysis of Classic Brain Component Sizes in Relation to Flightiness in Birds	PLOS ONE			English	Article							INITIATION DISTANCE; PHYLOGENETIC-RELATIONSHIPS; INTERSPECIFIC VARIATION; MOLECULAR PHYLOGENY; LIFE-HISTORY; RISK-TAKING; AVIAN BRAIN; EYE SIZE; EVOLUTION; ECOLOGY	Increased encephalization has been linked to a range of behavioural traits and scenarios. However, studies of whole brain size in this context have been criticised for ignoring the role of specific brain areas in controlling behaviour. In birds, the response to potential threats is one such behaviour that may relate to the way in which the brain processes sensory information. We used a phylogenetic generalised least squares (PGLS) analyses, based on five different phylogenetic hypotheses, to analyse the relationship of relative sizes of whole brain and brain components with Flight-Initiation Distance (FID), the distance at which birds flee from an approaching human, for 41 bird species. Starting distance (the distance at which an approach to a bird commences), body mass and eye size have elsewhere been shown to be positively associated with FID, and consequently were included as covariates in our analysis. Starting distance and body mass were by far the strongest predictors of FID. Of all brain components, cerebellum size had the strongest predictor weight and was negatively associated with FID but the confidence intervals on the average estimate included zero and the overall predictor weight was low. Models featuring individual brain components were generally more strongly weighted than models featuring whole brain size. The PGLS analyses estimated there to be no phylogenetic signal in the regression models, and hence produced results equivalent to ordinary least squares regression analysis. However analyses that assumed strong phylogenetic signal produced substantially different results with each phylogeny, and overall suggest a negative relationship between forebrain size and FID. Our analyses suggest that the evolutionary assumptions of the comparative analysis, and consideration of starting distance make a profound difference to the interpretation of the effect of brain components on FID in birds.	[Symonds, Matthew R. E.; Weston, Michael A.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia; [Robinson, Randall W.; Guay, Patrick-Jean] Victoria Univ, Appl Ecol Res Grp, St Albans, Vic, Australia; [Robinson, Randall W.; Guay, Patrick-Jean] Victoria Univ, Inst Sustainabil & Innovat, Coll Engn & Sci, St Albans, Vic, Australia	Deakin University; Victoria University; Victoria University	Symonds, MRE (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia.	matthew.symonds@deakin.edu.au	Symonds, Matthew R.E./I-6020-2018	Symonds, Matthew R.E./0000-0002-9785-6045; Robinson, Randall/0000-0001-8425-0709; Weston, Michael/0000-0002-8717-0410	Melbourne Water Corporation; Victoria University; Faculty of Health Engineering and Science Collaborative Research Grant Scheme; Faculty of Science, Engineering and the Built Environment (Deakin University) Collaborative Research Grant	Melbourne Water Corporation; Victoria University; Faculty of Health Engineering and Science Collaborative Research Grant Scheme; Faculty of Science, Engineering and the Built Environment (Deakin University) Collaborative Research Grant	This research was supported by funding from Melbourne Water Corporation and a Victoria University Fellowship and a Faculty of Health Engineering and Science Collaborative Research Grant Scheme to PJG. Write up was supported by a Faculty of Science, Engineering and the Built Environment (Deakin University) Collaborative Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Bao XK, 2010, MOL PHYLOGENET EVOL, V56, P840, DOI 10.1016/j.ympev.2010.03.038; Barton K., 2012, MUMIN MULTIMODEL INF; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; BENNETT PM, 1985, J ZOOL, V207, P151; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Burish MJ, 2004, BRAIN BEHAV EVOLUT, V63, P107, DOI 10.1159/000075674; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Chamaille-Jammes S, 2012, BEHAV ECOL SOCIOBIOL, V66, P985, DOI 10.1007/s00265-012-1354-z; Davis KE, 2008, REWEAVING TAPESTRY S; Day LB, 2005, BRAIN BEHAV EVOLUT, V66, P62, DOI 10.1159/000085048; Dumont F, 2012, ETHOLOGY, V118, P1051, DOI 10.1111/eth.12006; Dunbar RIM, 1998, ETHOLOGY, V104, P695, DOI 10.1111/j.1439-0310.1998.tb00103.x; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Eason PK, 2006, J WILDLIFE MANAGE, V70, P1796, DOI 10.2193/0022-541X(2006)70[1796:FAFIDI]2.0.CO;2; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2007, MOL PHYLOGENET EVOL, V43, P515, DOI 10.1016/j.ympev.2007.02.015; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garamszegi LZ, 2005, P ROY SOC B-BIOL SCI, V272, P159, DOI 10.1098/rspb.2004.2940; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Glover HK, 2011, LANDSCAPE URBAN PLAN, V103, P326, DOI 10.1016/j.landurbplan.2011.08.006; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; Guay PJ, 2013, WILDLIFE RES, V40, P289, DOI 10.1071/WR13013; Guay PJ, 2013, AUSTRAL ECOL, V38, P516, DOI 10.1111/j.1442-9993.2012.02441.x; Guay PJ, 2008, AUST J ZOOL, V56, P311, DOI 10.1071/ZO08082; Guay PJ, 2013, ETHOLOGY, V119, P552, DOI 10.1111/eth.12094; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HEALY S, 1990, EVOLUTION, V44, P339, DOI 10.1111/j.1558-5646.1990.tb05203.x; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; HOCKIN D, 1992, J ENVIRON MANAGE, V36, P253, DOI 10.1016/S0301-4797(08)80002-3; Hugall AF, 2012, NATURE, V485, P631, DOI 10.1038/nature11050; Iwaniuk AN, 2009, CAN J EXP PSYCHOL, V63, P150, DOI 10.1037/a0015678; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johnson KP, 2001, AUK, V118, P874, DOI 10.1642/0004-8038(2001)118[0874:AMPOTD]2.0.CO;2; Kirsch JA, 2008, CONSCIOUS COGN, V17, P475, DOI 10.1016/j.concog.2008.03.018; Kolb EM, 2013, J EXP BIOL, V216, P515, DOI 10.1242/jeb.076000; Kubke MF, 2004, BRAIN BEHAV EVOLUT, V63, P169, DOI 10.1159/000076242; Lerner HRL, 2008, AUK, V125, P304, DOI 10.1525/auk.2008.06161; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; Maddison W., 2018, MESQUITE MODULAR SYS; Marchant S, 1990, HDB AUSTR NZ ANTAR B, V1; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McLeod EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082008; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2014, J EVOLUTION BIOL, V27, P34, DOI 10.1111/jeb.12272; Moller AP, 2010, J EVOLUTION BIOL, V23, P1689, DOI 10.1111/j.1420-9101.2010.02034.x; Moller AP, 2010, ETHOLOGY, V116, P458, DOI 10.1111/j.1439-0310.2010.01754.x; Moller AP, 2008, BEHAV ECOL, V19, P1095, DOI 10.1093/beheco/arn103; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2012, BEHAV ECOL, V23, P843, DOI 10.1093/beheco/ars040; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Orme D, 2012, CAPER COMP ANAL PHYL; Packert M, 2012, MOL PHYLOGENET EVOL, V63, P606, DOI 10.1016/j.ympev.2012.02.002; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; PORTMANN ADOLPHE, 1947, ALAUDA, V15, P1; PURVIS A, 1994, J THEOR BIOL, V167, P293, DOI 10.1006/jtbi.1994.1071; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Reiner A, 2005, BRAIN RES BULL, V66, P317, DOI 10.1016/j.brainresbull.2005.05.007; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Rezende EL, 2012, COMPR PHYSIOL, V2, P639, DOI 10.1002/cphy.c100079; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2007, P ROY SOC B-BIOL SCI, V274, P763, DOI 10.1098/rspb.2006.3765; Sol D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009617; Sol D, 2009, BIOL LETTERS, V5, P130, DOI 10.1098/rsbl.2008.0621; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Symonds MRE, 2002, SYST BIOL, V51, P541, DOI 10.1080/10635150290069977; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	78	18	19	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91960	10.1371/journal.pone.0091960	http://dx.doi.org/10.1371/journal.pone.0091960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637884	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100090
J	Belhassen-Garcia, M; Romero-Alegria, A; Velasco-Tirado, V; Alonso-Sardon, M; Lopez-Bernus, A; Alvela-Suarez, L; del Villar, LP; Carpio-Perez, A; Galindo-Perez, I; Cordero-Sanchez, M; Pardo-Lledias, J				Belhassen-Garcia, Moncef; Romero-Alegria, Angela; Velasco-Tirado, Virginia; Alonso-Sardon, Montserrat; Lopez-Bernus, Amparo; Alvela-Suarez, Lucia; Perez del Villar, Luis; Carpio-Perez, Adela; Galindo-Perez, Inmaculada; Cordero-Sanchez, Miguel; Pardo-Lledias, Javier			Study of Hydatidosis-Attributed Mortality in Endemic Area	PLOS ONE			English	Article							ECHINOCOCCUS-GRANULOSUS; CYST; INFECTION; SURGERY; SPAIN	Background: Cystic hydatid disease is still an important health problem in European Mediterranean areas. In spite of being traditionally considered as a "benign" pathology, cystic echinococcosis is an important cause of morbidity in these areas. Nevertheless, there are few analyses of mortality attributed to human hydatidosis. Objective: To describe the epidemiology, the mortality rate and the causes of mortality due to E. granulosus infection in an endemic area. Methodology: A retrospective study followed up over a period of 14 years (1998-2011). Principal Findings: Of the 567 patients diagnosed with hydatid disease over the period 1998-2011, eleven deaths directly related to hydatid disease complications were recorded. Ten patients (90.9%) died due to infectious complications and the remaining one (9.1%) died due to mechanical complications after a massive hemoptysis. We registered a case fatality rate of 1.94% and a mortality rate of 3.1 per 100.000 inhabitants. Conclusions: Hydatidosis is still a frequent parasitic disease that causes a considerable mortality. The main causes of mortality in patients with hydatidosis are complications related to the rupture of CE cysts with supurative collangitis. Therefore, an expectant management can be dangerous and it must be only employed in well-selected patients.	[Belhassen-Garcia, Moncef; Cordero-Sanchez, Miguel] Complejo Asistencial Univ Salamanca, CIETUS, IBSAL, Secc Enfermedades Infecciosas,Serv Med Interna, Salamanca, Spain; [Romero-Alegria, Angela; Lopez-Bernus, Amparo; Carpio-Perez, Adela] Complejo Asistencial Univ Salamanca, IBSAL, Serv Med Interna, Salamanca, Spain; [Velasco-Tirado, Virginia; Alvela-Suarez, Lucia] Complejo Asistencial Univ Salamanca, CIETUS, IBSAL, Serv Med Interna, Salamanca, Spain; [Alonso-Sardon, Montserrat] Univ Salamanca, Dept Med Prevent Salud Publ & Microbiol Med, E-37008 Salamanca, Spain; [Perez del Villar, Luis] Univ Salamanca, IBSAL, CIETUS, E-37008 Salamanca, Spain; [Galindo-Perez, Inmaculada] CAP Camargo, Jose Barros, Cantabria, Spain; [Pardo-Lledias, Javier] Hosp Gen Palencia Ri Carrion, Serv Med Interna, Palencia, Spain	University of Salamanca; University of Salamanca	Belhassen-Garcia, M (corresponding author), Complejo Asistencial Univ Salamanca, CIETUS, IBSAL, Secc Enfermedades Infecciosas,Serv Med Interna, Salamanca, Spain.	mbelhassen@hotmail.com	Alonso-Sardon, Montserrat/E-2185-2018	Velasco Tirado, Virginia/0000-0001-7175-1758; Alonso-Sardon, Montserrat/0000-0003-1829-5858; Belhassen-Garcia, Moncef/0000-0002-2230-1256				Garcia MB, 2010, AM J TROP MED HYG, V82, P376, DOI 10.4269/ajtmh.2010.09-0375; Bristow BN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001524; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Daali M, 2001, ANN CHIR, V126, P242, DOI 10.1016/S0003-3944(01)00507-7; DIAZ A, 1995, EXP PARASITOL, V80, P473, DOI 10.1006/expr.1995.1059; Ferreira AM, 2000, PARASITOL TODAY, V16, P168, DOI 10.1016/S0169-4758(99)01625-7; Ghoshal A G, 2012, J Assoc Physicians India, V60, P12; Gruttadauria S, 2003, DIGEST DIS SCI, V48, P358, DOI 10.1023/A:1021995914494; Gutierrez MP, 2003, ENFERM INFEC MICR CL, V21, P563, DOI 10.1157/13054549; Kocer NE, 2008, INT J INFECT DIS, V12, P248, DOI 10.1016/j.ijid.2007.08.005; Li YM, 2011, AM J TROP MED HYG, V85, P452, DOI 10.4269/ajtmh.2011.10-0448; Loinaz C, 2001, WORLD J SURG, V25, P1260, DOI 10.1007/s00268-001-0106-4; Martinez P, 2011, REV CHIL INFECTOL, V28, P585, DOI /S0716-10182011000700013; Pardo J, 2005, ENFERM INFEC MICR CL, V23, P266, DOI 10.1157/13074966; Rojo-Vazquez FA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000893; Tagliacozzo S, 2011, AM J SURG, V201, P797, DOI 10.1016/j.amjsurg.2010.02.011; Yilmaz M, 2012, INT SURG, V97, P239, DOI 10.9738/CC116.1; Zubiaurre Lizarralde Leire, 2006, Gastroenterol Hepatol, V29, P405, DOI 10.1157/13091454	18	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91342	10.1371/journal.pone.0091342	http://dx.doi.org/10.1371/journal.pone.0091342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632824	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400054
J	Derosiere, G; Dalhoumi, S; Perrey, S; Dray, G; Ward, T				Derosiere, Gerard; Dalhoumi, Sami; Perrey, Stephane; Dray, Gerard; Ward, Tomas			Towards a Near Infrared Spectroscopy-Based Estimation of Operator Attentional State	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CEREBRAL-BLOOD-FLOW; SUSTAINED ATTENTION; MENTAL WORKLOAD; MOTOR IMAGERY; FATIGUE; TIME; PERFORMANCE; CLASSIFICATION; ACTIVATION	Given the critical risks to public health and safety that can involve lapses in attention (e. g., through implication in workplace accidents), researchers have sought to develop cognitive-state tracking technologies, capable of alerting individuals engaged in cognitively demanding tasks of potentially dangerous decrements in their levels of attention. The purpose of the present study was to address this issue through an investigation of the reliability of optical measures of cortical correlates of attention in conjunction with machine learning techniques to distinguish between states of full attention and states characterized by reduced attention capacity during a sustained attention task. Seven subjects engaged in a 30 minutes duration sustained attention reaction time task with near infrared spectroscopy (NIRS) monitoring over the prefrontal and the right parietal areas. NIRS signals from the first 10 minutes of the task were considered as characterizing the 'full attention' class, while the NIRS signals from the last 10 minutes of the task were considered as characterizing the 'attention decrement' class. A two-class support vector machine algorithm was exploited to distinguish between the two levels of attention using appropriate NIRS-derived signal features. Attention decrement occurred during the task as revealed by the significant increase in reaction time in the last 10 compared to the first 10 minutes of the task (p<.05). The esults demonstrate relatively good classification accuracy, ranging from 65 to 90%. The highest classification accuracy results were obtained when exploiting the oxyhemoglobin signals (i.e., from 77 to 89%, depending on the cortical area considered) rather than the deoxyhemoglobin signals (i.e., from 65 to 66%). Moreover, the classification accuracy increased to 90% when using signals from the right parietal area rather than from the prefrontal cortex. The results support the feasibility of developing cognitive tracking technologies using NIRS and machine learning techniques.	[Derosiere, Gerard; Perrey, Stephane] Univ Montpellier I, EuroMov, Movement Hlth M2H, Montpellier, France; [Derosiere, Gerard; Dalhoumi, Sami; Ward, Tomas] Natl Univ Ireland Maynooth, BERG, Maynooth, Kildare, Ireland; [Dalhoumi, Sami; Dray, Gerard] Ecole Mines Ales, Lab Genie Informat & Ingn Prod LG2IP, Nimes, France	Universite de Montpellier; Maynooth University; IMT - Institut Mines-Telecom; IMT Mines Ales	Derosiere, G (corresponding author), Univ Montpellier I, EuroMov, Movement Hlth M2H, Montpellier, France.	gerard.derosiere@univ-montp1.fr	perrey, stephane/B-7483-2008; Ward, Tomas/AEN-2410-2022; Dray, Gerard/ACO-1836-2022	perrey, stephane/0000-0002-8741-629X; Dray, Gerard/0000-0003-1525-5682; Derosiere, Gerard/0000-0001-8283-1569; Ward, Tomas/0000-0002-6173-6607	LabEx "Numerisation and Modelisation for Health and Environment'' [ANR-10-LABX-20-01]; French University Institute [IUF -UM1 1195-UM2 110744]	LabEx "Numerisation and Modelisation for Health and Environment''; French University Institute	This work was supported by the LabEx "Numerisation and Modelisation for Health and Environment'' (ANR-10-LABX-20-01) and the French University Institute (IUF -UM1 1195-UM2 110744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletti F, 2012, COMPUT BIOL MED, V42, P282, DOI 10.1016/j.compbiomed.2011.06.001; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Beleites C, 2005, CHEMOMETR INTELL LAB, V79, P91, DOI 10.1016/j.chemolab.2005.04.008; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Bunce SC, 2006, IEEE ENG MED BIOL, V25, P54, DOI 10.1109/MEMB.2006.1657788; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Butti Michele, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1040; Butti Michele, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1944; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Caffier PP, 2003, EUR J APPL PHYSIOL, V89, P319, DOI 10.1007/s00421-003-0807-5; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coull JT, 1998, NEUROPSYCHOLOGIA, V36, P1325, DOI 10.1016/S0028-3932(98)00035-9; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Cui X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015474; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; De Joux N, 2013, BRAIN COGNITION, V81, P370, DOI 10.1016/j.bandc.2012.12.003; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Derosiere G, 2015, CEREB CORTEX, V25, P66, DOI 10.1093/cercor/bht206; Derosiere G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00583; Dinges DF, 1997, SLEEP, V20, P267; Dong YC, 2011, IEEE T INTELL TRANSP, V12, P596, DOI 10.1109/TITS.2010.2092770; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Fallgatter AJ, 1997, NEUROSCI LETT, V223, P89, DOI 10.1016/S0304-3940(97)13416-4; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; GRANDJEAN E, 1979, BRIT J IND MED, V36, P175; Helton WS, 2007, J CLIN EXP NEUROPSYC, V29, P545, DOI 10.1080/13803390600814757; Hoshi Y, 2005, INT REV NEUROBIOL, V66, P237, DOI 10.1016/S0074-7742(05)66008-4; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Izzetoglu K, 2004, P ANN INT IEEE EMBS, V26, P5333; Johnson RR, 2011, BIOL PSYCHOL, V87, P241, DOI 10.1016/j.biopsycho.2011.03.003; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Lal SKL, 2003, J SAFETY RES, V34, P321, DOI 10.1016/S0022-4375(03)00027-6; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Li ZY, 2009, EUR J APPL PHYSIOL, V107, P281, DOI 10.1007/s00421-009-1122-6; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Nambu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057174; Naseer N, 2014, EXP BRAIN RES, V232, P555, DOI 10.1007/s00221-013-3764-1; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parasuraman R, 2013, OXFORD HDB COGNITIVE, P159, DOI DOI 10.1093/0XF0RDHB/9780199757183.013.0010; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Perrey S, 2008, METHODS, V45, P289, DOI 10.1016/j.ymeth.2008.04.005; Posner M.I., 1987, NEUROPSYCHOL REHABIL, P182; Power SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037791; Re R, 2013, PROC SPIE, V8804, DOI 10.1117/12.2032512; Saager RB, 2011, NEUROIMAGE, V55, P1679, DOI 10.1016/j.neuroimage.2011.01.043; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x; Shaw TH, 2013, BRAIN COGNITION, V82, P265, DOI 10.1016/j.bandc.2013.05.003; Shen KQ, 2008, CLIN NEUROPHYSIOL, V119, P1524, DOI 10.1016/j.clinph.2008.03.012; Shen KQ, 2008, MACH LEARN, V70, P1, DOI 10.1007/s10994-007-5025-7; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yamanaka K, 2010, CEREB CORTEX, V20, P1037, DOI 10.1093/cercor/bhp163; Yang GS, 2010, INFORM SCIENCES, V180, P1942, DOI 10.1016/j.ins.2010.01.011	70	34	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92045	10.1371/journal.pone.0092045	http://dx.doi.org/10.1371/journal.pone.0092045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632819	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400133
J	Kneller, R; Mongeon, M; Cope, J; Garner, C; Ternouth, P				Kneller, Robert; Mongeon, Marcel; Cope, Jeff; Garner, Cathy; Ternouth, Philip			Industry-University Collaborations in Canada, Japan, the UK and USA - With Emphasis on Publication Freedom and Managing the Intellectual Property Lock-Up Problem	PLOS ONE			English	Article							TECHNOLOGY-TRANSFER; ENGAGEMENT; INVENTION; LINKAGES; SCIENCE; FIRMS	As industry-university collaborations are promoted to commercialize university research and foster economic growth, it is important to understand how companies benefit from these collaborations, and to ensure that resulting academic discoveries are developed for the benefit of all stakeholders: companies, universities and public. Lock up of inventions, and censoring of academic publications, should be avoided if feasible. This case-study analysis of interviews with 90 companies in Canada, Japan, the UK and USA assesses the scope of this challenge and suggests possible resolutions. The participating companies were asked to describe an important interaction with universities, and most described collaborative research. The most frequently cited tensions concerned intellectual property management and publication freedom. IP disagreements were most frequent in the context of narrowly-focused collaborations with American universities. However, in the case of exploratory research, companies accepted the IP management practices of US universities. It might make sense to let companies have an automatic exclusive license to IP from narrowly defined collaborations, but to encourage universities to manage inventions from exploratory collaborations to ensure development incentives. Although Canada, the UK and US have strong publication freedom guarantees, tensions over this issue arose frequently in focused collaborations, though were rare in exploratory collaborations. The UK Lambert Agreements give sponsors the option to control publications in return for paying the full economic cost of a project. This may offer a model for the other three countries. Uniquely among the four countries, Japan enables companies to control exclusively most collaborative inventions and to censor academic publications. Despite this high degree of control, the interviews suggest many companies do not develop university discoveries to their full potential. The steps suggested above may rebalance the situation in Japan. Overall, the interviews reveal the complexity of these issues and the need for flexibility on the part of universities and companies.	[Kneller, Robert] Univ Tokyo, RCAST, Tokyo, Japan; [Mongeon, Marcel] Ross Mongeon Covello & Co, London, ON, Canada; [Mongeon, Marcel] McMaster Univ, Off Res Contracts & Intellectual Property, Hamilton, ON, Canada; [Cope, Jeff] Res Triangle Inst, Res Triangle Pk, NC 27709 USA; [Garner, Cathy] Manchester Knowledge Capital Ltd, Manchester, Lancs, England; [Garner, Cathy; Ternouth, Philip] Council Ind & Higher Educ, London, England	University of Tokyo; McMaster University; Research Triangle Institute	Kneller, R (corresponding author), Univ Tokyo, RCAST, Tokyo, Japan.	kneller@tt.rcast.u-tokyo.ac.jp			Council for Industry and Higher Education (CIHE); UK Social Science Research Council; Centre for Business Research in Cambridge University; Sasakawa Peace Foundation of Japan; Japanese Ministry of Education, Culture, Sports, Science and Technology [B-18310103, C-116100000161]; Grants-in-Aid for Scientific Research [23590126] Funding Source: KAKEN	Council for Industry and Higher Education (CIHE); UK Social Science Research Council; Centre for Business Research in Cambridge University; Sasakawa Peace Foundation of Japan; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	UK data collection was funded by the Council for Industry and Higher Education (CIHE), with support from the UK Social Science Research Council and the Centre for Business Research in Cambridge University. Data collection in Canada, Japan and the USA was supported by a grant from the Sasakawa Peace Foundation of Japan. Robert Kneller's analysis of the interviews was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology under Grants-in-Aid project numbers B-18310103 and C-116100000161. The CIHE, in particular co-author Philip Ternouth, played a significant role in designing the study and data collection. However, this was done in the context of CIHE carrying out its mission as a neutral, not-for profit facilitator of communication between UK universities and industries and of academic research on the industry-university interface.	Ankrah SN, 2013, TECHNOVATION, V33, P50, DOI 10.1016/j.technovation.2012.11.001; [Anonymous], 2007, NIKKEI FINANCIA 0306; [Anonymous], 2012, TECHNOLOGY TRANS FEB, V6, p[17, 20]; Arora A, 2004, IND CORP CHANGE, V13, P451, DOI 10.1093/icc/dth018; Association of University Technology Managers (AUTM), 2013, AUTM US LIC ACT SURV; Association of University Technology Managers (AUTM), 2011, AUTM CAN LIC ACT SUR; Baird P, 2002, SCIENCE, V297, P2211; Barbolla AMB, 2009, TECHNOL ANAL STRATEG, V21, P599, DOI 10.1080/09537320902969133; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Brown R, 2006, INT COMPETITIVENESS; Bruneel J, 2010, RES POLICY, V39, P858, DOI 10.1016/j.respol.2010.03.006; Canadian Association of University Teachers, 2012, GUID PRINC U COLL; Christensen C. M., 2001, INNOVATORS DILEMMA N; CHRISTENSEN CM, 1993, BUS HIST REV, V67, P531, DOI 10.2307/3116804; Cohen WM, 2002, MANAGE SCI, V48, P1, DOI 10.1287/mnsc.48.1.1.14273; Cosh A., 2006, UK PLC JUST INNOVATI; Council for Industry and Higher Education (CIHE), 2009, U BUS INT COMP UNPUB, VII; Edwards MG, 2003, NAT BIOTECHNOL, V21, P618, DOI 10.1038/nbt0603-618; Eisenberg RS, 1996, VA LAW REV, V82, P1663, DOI 10.2307/1073686; Etzkowitz H, 2002, MIT RISE ENTREPRENEU; Florida R, 1999, INDUSTRIALIZING KNOWLEDGE, P589; Geiger RL, 2012, J TECHNOL TRANSFER, V37, P175, DOI 10.1007/s10961-010-9192-5; Geiger Roger L., 2008, CORPORATE SPONSORED; Hall B, 2003, RAND J ECON, V32, P101; Hall BH., 2001, J TECHNOLOGY TRANSFE, V26, P87, DOI [DOI 10.1023/A:1007888312792, 10.1023/A:1007888312792]; Henderson R, 2006, J PROD INNOVAT MANAG, V23, P5, DOI 10.1111/j.1540-5885.2005.00175.x; Hertzfeld HR, 2006, RES POLICY, V35, P825, DOI 10.1016/j.respol.2006.04.006; Higher Education Funding Council for England (HEFCE), 2012, UK U CONTR EC GROWTH; Jarvis L, 2008, CHEM ENG NEWS, V86, P13; Kneller R, 2003, U PA J INT ECON LAW, V24, P329; Kneller R, 2001, CLIN CANCER RES, V7, P761; Kneller R, 2013, FULFILLING PROMISE T, P23; Kneller R, 2007, BRIDGING ISLANDS VEN; Kneller R, 2007, IND HIGHER EDUC, V21, P211, DOI 10.5367/000000007781236925; Kneller R, 2011, NEW HORIZ ENTREP, P69; Kneller R, 2010, NAT REV DRUG DISCOV, V9, P867, DOI 10.1038/nrd3251; Kondro W., 2013, SCIENCE; Lach S, 2008, RAND J ECON, V39, P403, DOI 10.1111/j.0741-6261.2008.00020.x; LaFrance M, 2005, COMP STUDY US JAPANE; Lee YS, 2000, J TECHNOLOGY TRANSFE, V25, P111, DOI DOI 10.1023/A:1007895322042; Marshall Eliot, 1997, SCIENCE, V276, P523; MEXT, 2002, INT PROP WORK GROUP; Ministry of Education Culture Sports Science and Technology (MEXT), 2012, HEIS 23 NEND DAIG NI; Motohashi K, 2005, RES POLICY, V34, P583, DOI 10.1016/j.respol.2005.03.001; Naylor CD, 2002, CAN MED ASSOC J, V166, P453; NSB, 2014, SCI ENG IND 2014; Perkmann M, 2013, RES POLICY, V42, P423, DOI 10.1016/j.respol.2012.09.007; Plewa C, 2013, J ENG TECHNOL MANAGE, V30, P21, DOI 10.1016/j.jengtecman.2012.11.005; Rappert B, 1999, RES POLICY, V28, P873, DOI 10.1016/S0048-7333(99)00028-1; Roush W, 1997, SCIENCE, V276, P523; Russell S, 2000, SAN FRANCISCO C 1101; Santoro MD, 2002, RES POLICY, V31, P1163, DOI 10.1016/S0048-7333(01)00190-1; Sohn SY, 2012, J TECHNOL TRANSFER, V37, P532, DOI 10.1007/s10961-011-9220-0; Study Committee on Large Enterprise Ventures, 2008, PROP STUD COMM LARG; Van Eecke P, 2008, MONITORING ANAL TECH; VANDIERDONCK R, 1990, RES POLICY, V19, P551, DOI 10.1016/0048-7333(90)90012-U; Vogel G, 1997, SCIENCE, V276, P525; Watanabe Toshiya, 2012, WATANABE TOSHIYA; Wohlin C, 2012, IEEE SOFTWARE, V29, P67, DOI 10.1109/MS.2011.92; Wright M, 2008, RES POLICY, V37, P1205, DOI 10.1016/j.respol.2008.04.021; Zinner DE, 2009, HEALTH AFFAIR, V28, P1814, DOI 10.1377/hlthaff.28.6.1814	61	21	21	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90302	10.1371/journal.pone.0090302	http://dx.doi.org/10.1371/journal.pone.0090302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632805	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400013
J	Nieland, TJF; Logan, DJ; Saulnier, J; Lam, D; Johnson, C; Root, DE; Carpenter, AE; Sabatini, BL				Nieland, Thomas J. F.; Logan, David J.; Saulnier, Jessica; Lam, Daniel; Johnson, Caroline; Root, David E.; Carpenter, Anne E.; Sabatini, Bernardo L.			High Content Image Analysis Identifies Novel Regulators of Synaptogenesis in a High-Throughput RNAi Screen of Primary Neurons	PLOS ONE			English	Article							BETA-CATENIN; SCHIZOPHRENIA; EXPRESSION; PROTEINS; AUTISM; FAMILY; SCALE; AXIN	The formation of synapses, the specialized points of chemical communication between neurons, is a highly regulated developmental process fundamental to establishing normal brain circuitry. Perturbations of synapse formation and function causally contribute to human developmental and degenerative neuropsychiatric disorders, such as Alzheimer's disease, intellectual disability, and autism spectrum disorders. Many genes controlling synaptogenesis have been identified, but lack of facile experimental systems has made systematic discovery of regulators of synaptogenesis challenging. Thus, we created a high-throughput platform to study excitatory and inhibitory synapse development in primary neuronal cultures and used a lentiviral RNA interference library to identify novel regulators of synapse formation. This methodology is broadly applicable for high-throughput screening of genes and drugs that may rescue or improve synaptic dysfunction associated with cognitive function and neurological disorders.	[Nieland, Thomas J. F.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Lam, Daniel; Root, David E.] Broad Inst Harvard & MIT, RNAi Platform, Cambridge, MA USA; [Logan, David J.; Carpenter, Anne E.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Saulnier, Jessica; Johnson, Caroline; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Nieland, TJF (corresponding author), Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA.	tnieland@broadinstitute.org; bernardo_sabatini@hms.harvard.edu	Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261; Johnson, Caroline/0000-0001-5770-6176	National Institutes of Health [MH095096, R01 GM089652]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grants supported by National Institutes of Health (MH095096 to BLS and R01 GM089652 to AEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Boda B, 2010, CURR OPIN NEUROBIOL, V20, P519, DOI 10.1016/j.conb.2010.03.012; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen Y, 2013, IUBMB LIFE, V65, P685, DOI 10.1002/iub.1184; Fang WQ, 2011, J NEUROSCI, V31, P13613, DOI 10.1523/JNEUROSCI.3120-11.2011; Gejman PV, 2011, ANNU REV GENOM HUM G, V12, P121, DOI 10.1146/annurev-genom-082410-101459; Hempel CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025999; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lionel AC, 2013, HUM MOL GENET, V22, P2055, DOI 10.1093/hmg/ddt056; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Noh HJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003523; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wenzel A, 1997, J NEUROCHEM, V68, P469	30	30	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91744	10.1371/journal.pone.0091744	http://dx.doi.org/10.1371/journal.pone.0091744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633176	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400084
J	Zhang, XH; Yu, ZY; Zhang, SP; He, KW				Zhang, Xuehan; Yu, Zhengyu; Zhang, Shuping; He, Kongwang			Immunization with H7-HCP-Tir-Intimin Significantly Reduces Colonization and Shedding of Escherichia coli O157:H7 in Goats	PLOS ONE			English	Article							EPITHELIAL-CELLS; IN-VITRO; O157-H7; O157/H7; CATTLE; INFECTION; ADHERENCE; FLAGELLIN; VACCINATION; PROTEINS	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is the causative agent of hemorrhagic colitis and hemolytic uremic syndrome in humans. However, the bacterium can colonize the intestines of ruminants without causing clinical signs. EHEC O157:H7 needs flagella (H7) and hemorrhagic coli pili (HCP) to adhere to epithelial cells. Then the bacterium uses the translocated intimin receptor (Tir) and an outer membrane adhesion (Intimin) protein to colonize hosts. This leads to the attachment and effacement of (A/E) lesions. A tetravalent recombinant vaccine (H7-HCP-Tir-Intimin) composed of immunologically important portions of H7, HCP, Tir and Intimin proteins was constructed and its efficacy was evaluated using a caprine model. The results showed that the recombinant vaccine induced strong humoral and mucosal immune responses and protected the subjects from live challenges with EHEC O157:H7 86-24 stain. After a second immunization, the average IgG titer peaked at 7.2x10(5). Five days after challenge, E. coli O157:H7 was no longer detectable in the feces of vaccinated goats, but naive goats shed the bacterium throughout the course of the challenge. Cultures of intestinal tissues showed that vaccination of goats with H7-HCP-Tir-Intimin reduced the amount of intestinal colonization by EHEC O157:H7 effectively. Recombinant H7-HCP-Tir-Intimin protein is an excellent vaccine candidate. Data from the present study warrant further efficacy studies aimed at reducing EHEC O157:H7 load on farms and the contamination of carcasses by this zoonotic pathogen.	[Zhang, Xuehan; Yu, Zhengyu; He, Kongwang] Jiangsu Acad Agr Sci, Inst Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Xuehan; Yu, Zhengyu; He, Kongwang] Minist Agr, Key Lab Engn Res Vet Bioprod, Nanjing, Jiangsu, Peoples R China; [Zhang, Xuehan; Yu, Zhengyu; He, Kongwang] Natl Ctr Engn Res Vet Bioprod, Nanjing, Jiangsu, Peoples R China; [Zhang, Xuehan; Yu, Zhengyu; He, Kongwang] Jiangsu Coinnovat Ctr Prevent & Control Importan, Yangzhou, Peoples R China; [Zhang, Shuping] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; University of Missouri System; University of Missouri Columbia	Zhang, XH (corresponding author), Jiangsu Acad Agr Sci, Inst Vet Med, Nanjing, Jiangsu, Peoples R China.	liuxuehan1996@hotmail.com; kwh2003@263.net			National Science Fund for Young Scholars [31201919]	National Science Fund for Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Science Fund for Young Scholars (31201919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Amani J, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-28; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Ando H, 2007, MICROBIOL-SGM, V153, P464, DOI 10.1099/mic.0.2006/000893-0; Atef YM, 2011, VET IMMUN IMMUNO, V140, P42; Best A, 2006, VET MICROBIOL, V113, P63, DOI 10.1016/j.vetmic.2005.10.033; Daniel UT, 2009, FOODBORNE PATHOG DIS, V6, P871; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; Keskinen LA, 2011, INT J FOOD MICROBIOL, V147, P157, DOI 10.1016/j.ijfoodmicro.2011.04.002; La Ragione RM, 2006, J MED MICROBIOL, V55, P819, DOI 10.1099/jmm.0.46469-0; La Ragione RM, 2005, J MED MICROBIOL, V54, P485, DOI 10.1099/jmm.0.45897-0; Maria AL, 2011, PLOS ONE, V29, P3923; McNeilly TN, 2008, INFECT IMMUN, V76, P2594, DOI 10.1128/IAI.01452-07; McNeilly TN, 2010, VACCINE, V28, P1422, DOI 10.1016/j.vaccine.2009.10.076; McNeilly TN, 2010, VACCINE, V28, P1412, DOI 10.1016/j.vaccine.2009.10.148; Moxley RA, 2009, FOODBORNE PATHOG DIS, V6, P879, DOI 10.1089/fpd.2009.0297; Muehlherr JE, 2003, J DAIRY SCI, V86, P3849, DOI 10.3168/jds.S0022-0302(03)73992-7; Neville LF, 2005, INT J MOL MED, V16, P165; Potter AA, 2004, VACCINE, V22, P362, DOI 10.1016/j.vaccine.2003.08.007; Rich AR, 2010, VACCINATION REDUCE P, P94; Solomakos N, 2009, FOOD MICROBIOL, V26, P865, DOI 10.1016/j.fm.2009.06.002; Sukumar S, 2007, J IMMUNOL, V17, P1147; Vilte DA, 2012, VET IMMUNOL IMMUNOP, V146, P169, DOI 10.1016/j.vetimm.2012.03.002; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Yin XH, 2011, CAN J VET RES, V75, P81; Zhang XH, 2012, VET REC, V170, P178, DOI 10.1136/vr.100325; Zhang XH, 2010, SCI AGR SINICA, V43, P2070; Zhang XH, 2011, VACCINE, V29, P3923, DOI 10.1016/j.vaccine.2011.02.007; Zhang XueHan, 2012, Chinese Journal of Zoonoses, V28, P1065; Zhang XueHan, 2011, Jiangsu Journal of Agricultural Sciences, V27, P1021; Zhao PanDeng, 2011, Jiangsu Journal of Agricultural Sciences, V27, P1300	34	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91632	10.1371/journal.pone.0091632	http://dx.doi.org/10.1371/journal.pone.0091632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632795	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400074
J	Stapleton, DI; Lau, XZ; Flores, M; Trieu, J; Gehrig, SM; Chee, A; Naim, T; Lynch, GS; Koopman, R				Stapleton, David I.; Lau, Xianzhong; Flores, Marcelo; Trieu, Jennifer; Gehrig, Stefan M.; Chee, Annabel; Naim, Timur; Lynch, Gordon S.; Koopman, Rene			Dysfunctional Muscle and Liver Glycogen Metabolism in mdx Dystrophic Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; BRANCHING ENZYME; HEPATIC GLYCOGEN; SKELETAL-MUSCLE; STORAGE-DISEASE; EXERCISE; MOUSE; RESISTANCE; HEALTHY; BINDING	Background: Duchenne muscular dystrophy (DMD) is a severe, genetic muscle wasting disorder characterised by progressive muscle weakness. DMD is caused by mutations in the dystrophin (dmd) gene resulting in very low levels or a complete absence of the dystrophin protein, a key structural element of muscle fibres which is responsible for the proper transmission of force. In the absence of dystrophin, muscle fibres become damaged easily during contraction resulting in their degeneration. DMD patients and mdx mice (an animal model of DMD) exhibit altered metabolic disturbances that cannot be attributed to the loss of dystrophin directly. We tested the hypothesis that glycogen metabolism is defective in mdx dystrophic mice. Results: Dystrophic mdx mice had increased skeletal muscle glycogen (79%, (P<0.01)). Skeletal muscle glycogen synthesis is initiated by glycogenin, the expression of which was increased by 50% in mdx mice (P<0.0001). Glycogen synthase activity was 12% higher (P<0.05) but glycogen branching enzyme activity was 70% lower (P<0.01) in mdx compared with wild-type mice. The rate-limiting enzyme for glycogen breakdown, glycogen phosphorylase, had 62% lower activity (P<0.01) in mdx mice resulting from a 24% reduction in PKA activity (P<0.01). In mdx mice glycogen debranching enzyme expression was 50% higher (P<0.001) together with starch-binding domain protein 1 (219% higher; P<0.01). In addition, mdx mice were glucose intolerant (P<0.01) and had 30% less liver glycogen (P<0.05) compared with control mice. Subsequent analysis of the enzymes dysregulated in skeletal muscle glycogen metabolism in mdx mice identified reduced glycogenin protein expression (46% less; P<0.05) as a possible cause of this phenotype. Conclusion: We identified that mdx mice were glucose intolerant, and had increased skeletal muscle glycogen but reduced amounts of liver glycogen.	[Stapleton, David I.; Lau, Xianzhong; Flores, Marcelo; Trieu, Jennifer; Gehrig, Stefan M.; Chee, Annabel; Naim, Timur; Lynch, Gordon S.; Koopman, Rene] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia	University of Melbourne	Koopman, R (corresponding author), Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia.	rkoopman@unimelb.edu.au	Lynch, Gordon/G-9553-2015	Lynch, Gordon/0000-0001-9220-9810; Koopman, Rene/0000-0001-5359-0284; Lau, Xianzhong/0000-0001-7845-8933	Muscular Dystrophy Association [175821]	Muscular Dystrophy Association(Muscular Dystrophy Association)	Supported by the Muscular Dystrophy Association (project grant 175821 to Gordon S. Lynch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y, 1996, J CLIN INVEST, V97, P941, DOI 10.1172/JCI118517; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; CAUDWELL FB, 1980, EUR J BIOCHEM, V109, P391, DOI 10.1111/j.1432-1033.1980.tb04806.x; ELLIS DA, 1980, BRIT MED BULL, V36, P165, DOI 10.1093/oxfordjournals.bmb.a071633; FREIDENBERG GR, 1985, J CLIN ENDOCR METAB, V60, P320, DOI 10.1210/jcem-60-2-320; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; GIBSON WB, 1971, BIOCHEMISTRY-US, V10, P4253, DOI 10.1021/bi00799a016; Ham DJ, 2013, CLIN NUTR; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; KOUBI H, 1991, CAN J PHYSIOL PHARM, V69, P841, DOI 10.1139/y91-127; Lau X, 2013, DIABETOLOGIA, V56, P675, DOI 10.1007/s00125-012-2805-9; Lienenlueke B, 2007, HISTOCHEM CELL BIOL, V128, P371, DOI 10.1007/s00418-007-0327-1; MACLENNAN PA, 1991, BIOCHEM J, V275, P477, DOI 10.1042/bj2750477; Matsumura T, 2009, J NEUROL SCI, V276, P60, DOI 10.1016/j.jns.2008.08.037; MCARDLE A, 1995, NEUROMUSCULAR DISORD, V5, P445, DOI 10.1016/0960-8966(95)00001-4; Ortenblad N, 2011, J PHYSIOL-LONDON, V589, P711, DOI 10.1113/jphysiol.2010.195982; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roder IV, 2009, CELL SIGNAL, V21, P819, DOI 10.1016/j.cellsig.2009.01.029; Ros S, 2011, DIABETOLOGIA, V54, P2639, DOI 10.1007/s00125-011-2238-x; Rufo A, 2011, J BONE MINER RES, V26, P1891, DOI 10.1002/jbmr.410; Ryu JH, 2009, INT J BIOL MACROMOL, V45, P478, DOI 10.1016/j.ijbiomac.2009.08.006; Sharma U, 2003, MAGN RESON IMAGING, V21, P145, DOI 10.1016/S0730-725X(02)00646-X; Shearer J, 2011, AM J PHYSIOL-ENDOC M, V301, pE31, DOI 10.1152/ajpendo.00525.2010; SRIVASTAVA U, 1981, CAN J PHYSIOL PHARM, V59, P329, DOI 10.1139/y81-051; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Sullivan MA, 2011, BIOMACROMOLECULES, V12, P1983, DOI 10.1021/bm2006054; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; van Maanen MH, 1999, BBA-GENE STRUCT EXPR, V1447, P284, DOI 10.1016/S0167-4781(99)00159-1; WATKINS SC, 1987, J NEUROL SCI, V82, P181, DOI 10.1016/0022-510X(87)90017-7; Wineinger MA, 1998, AM J PHYS MED REHAB, V77, P20, DOI 10.1097/00002060-199801000-00004; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005	35	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91514	10.1371/journal.pone.0091514	http://dx.doi.org/10.1371/journal.pone.0091514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626262	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300095
J	Ambayya, A; Su, AT; Osman, NH; Nik-Samsudin, NR; Khalid, K; Chang, KM; Sathar, J; Rajasuriar, JS; Yegappan, S				Ambayya, Angeli; Su, Anselm Ting; Osman, Nadila Haryani; Nik-Samsudin, Nik Rosnita; Khalid, Khadijah; Chang, Kian Meng; Sathar, Jameela; Rajasuriar, Jay Suriar; Yegappan, Subramanian			Haematological Reference Intervals in a Multiethnic Population	PLOS ONE			English	Article							BLOOD; HEMOGLOBIN; COUNT	Introduction: Similar to other populations, full blood count reference (FBC) intervals in Malaysia are generally derived from non-Malaysian subjects. However, numerous studies have shown significant differences between and within populations supporting the need for population specific intervals. Methods: Two thousand seven hundred twenty five apparently healthy adults comprising all ages, both genders and three principal races were recruited through voluntary participation. FBC was performed on two analysers, Sysmex XE-5000 and Unicel DxH 800, in addition to blood smears and haemoglobin analysis. Serum ferritin, soluble transferrin receptor and C-reactive protein assays were performed in selected subjects. All parameters of qualified subjects were tested for normality followed by determination of reference intervals, measures of central tendency and dispersion along with point estimates for each subgroup. Results: Complete data was available in 2440 subjects of whom 56% (907 women and 469 men) were included in reference interval calculation. Compared to other populations there were significant differences for haemoglobin, red blood cell count, platelet count and haematocrit in Malaysians. There were differences between men and women, and between younger and older men; unlike in other populations, haemoglobin was similar in younger and older women. However ethnicity and smoking had little impact. 70% of anemia in premenopausal women, 24% in postmenopausal women and 20% of males is attributable to iron deficiency. There was excellent correlation between Sysmex XE-5000 and Unicel DxH 800. Conclusion: Our data confirms the importance of population specific haematological parameters and supports the need for local guidelines rather than adoption of generalised reference intervals and cut-offs.	[Ambayya, Angeli; Osman, Nadila Haryani; Nik-Samsudin, Nik Rosnita; Khalid, Khadijah; Chang, Kian Meng; Sathar, Jameela; Rajasuriar, Jay Suriar; Yegappan, Subramanian] Hosp Ampang, Dept Haematol, Ampang, Selangor, Malaysia; [Su, Anselm Ting] Univ Malaysia Sarawak, Dept Community Med & Publ Hlth, Kuching, Sarawak, Malaysia	University of Malaysia Sarawak	Yegappan, S (corresponding author), Hosp Ampang, Dept Haematol, Ampang, Selangor, Malaysia.	mani14141@gmail.com	AMBAYYA, ANGELI/J-7800-2017; Su, Anselm/E-8205-2010	Su, Anselm/0000-0001-8153-3244; ambayya, angeli/0000-0001-9294-0320	Ministry of Health, Malaysia [10-277-5480]	Ministry of Health, Malaysia	This project was funded by the Ministry of Health, Malaysia (Research ID 10-277-5480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2006, THROMB RES, V118, P463, DOI 10.1016/j.thromres.2005.09.007; Achie LN, 2011, ASIAN J MED SCI, V3, P154; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Bull B S, 2003, Lab Hematol, V9, P1; Department of Statistics Malaysia, 2011, POPULATION DISTRIBUT; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Hafiza Alauddin, 2012, Malays J Pathol, V34, P161; Hsieh MM, 2010, J CLIN ONCOL, V28, P1633, DOI 10.1200/JCO.2009.24.3881; Ittermann T, 2010, CLIN LAB, V56, P9; Jung H, 2010, KOREAN J LAB MED, V30, P451, DOI 10.3343/kjlm.2010.30.5.451; LEWIS SM, 1982, CLIN LAB HAEMATOL, V4, P83; Loh S P, 2010, MALAYSIAN J MED HLTH, V6, P63; Milman N, 2009, ANN HEMATOL, V88, P687, DOI 10.1007/s00277-008-0647-9; Mine M, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.5; Ministry of Health Malaysia, 2008, TRANSF PRACT GUID CL, P15; NHANES, 2007, LAB PROC MAN; Osei-Bimpong A, 2012, INT J LAB HEMATOL, V34, P91, DOI 10.1111/j.1751-553X.2011.01365.x; Pekelharing J, 2010, SYSMEX J INT, V20, P1; Roshan TM, 2009, INT J LAB HEMATOL, V31, P505, DOI 10.1111/j.1751-553X.2008.01068.x; Sirdah MM, 2008, J CLIN LAB ANAL, V22, P353, DOI 10.1002/jcla.20265; Subhashree AR, 2012, J CLIN DIAGN RES, V6, P1675, DOI 10.7860/JCDR/2012/4882.2630; Urrechaga E, 2013, INT J LAB HEMATOL, V35, P144, DOI 10.1111/ijlh.12013; Urrechaga E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/603786; Urrechaga E, 2010, ANEMIA, V2010, DOI 10.1155/2010/625919; Urrechaga E, 2009, CLIN CHEM LAB MED, V47, P1411, DOI 10.1515/CCLM.2009.301; World Health Organization, 2011, HAEM CONC DIAGN ASS; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP	29	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91968	10.1371/journal.pone.0091968	http://dx.doi.org/10.1371/journal.pone.0091968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642526	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000333259900052
J	Gates, KM; Molenaar, PCM; Iyer, SP; Nigg, JT; Fair, DA				Gates, Kathleen M.; Molenaar, Peter C. M.; Iyer, Swathi P.; Nigg, Joel T.; Fair, Damien A.			Organizing Heterogeneous Samples Using Community Detection of GIMME-Derived Resting State Functional Networks	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; EPISODIC RETRIEVAL; BRAIN NETWORKS; GLOBAL SIGNAL; CONNECTIVITY; FMRI; ARCHITECTURE; PSYCHIATRY; PATTERNS; CHILDREN	Clinical investigations of many neuropsychiatric disorders rely on the assumption that diagnostic categories and typical control samples each have within-group homogeneity. However, research using human neuroimaging has revealed that much heterogeneity exists across individuals in both clinical and control samples. This reality necessitates that researchers identify and organize the potentially varied patterns of brain physiology. We introduce an analytical approach for arriving at subgroups of individuals based entirely on their brain physiology. The method begins with Group Iterative Multiple Model Estimation (GIMME) to assess individual directed functional connectivity maps. GIMME is one of the only methods to date that can recover both the direction and presence of directed functional connectivity maps in heterogeneous data, making it an ideal place to start since it addresses the problem of heterogeneity. Individuals are then grouped based on similarities in their connectivity patterns using a modularity approach for community detection. Monte Carlo simulations demonstrate that using GIMME in combination with the modularity algorithm works exceptionally well - on average over 97% of simulated individuals are placed in the accurate subgroup with no prior information on functional architecture or group identity. Having demonstrated reliability, we examine resting-state data of fronto-parietal regions drawn from a sample (N = 80) of typically developing and attention-deficit/hyperactivity disorder (ADHD) - diagnosed children. Here, we find 5 subgroups. Two subgroups were predominantly comprised of ADHD, suggesting that more than one biological marker exists that can be used to identify children with ADHD based from their brain physiology. Empirical evidence presented here supports notions that heterogeneity exists in brain physiology within ADHD and control samples. This type of information gained from the approach presented here can assist in better characterizing patients in terms of outcomes, optimal treatment strategies, potential gene-environment interactions, and the use of biological phenomenon to assist with mental health.	[Gates, Kathleen M.] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27514 USA; [Molenaar, Peter C. M.] Penn State Univ, Dept Human Dev & Family Studies, State Coll, PA USA; [Iyer, Swathi P.; Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Fair, Damien A.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA	University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Gates, KM (corresponding author), Univ N Carolina, Dept Psychol, Chapel Hill, NC 27514 USA.	kmgates@unc.edu			NIH [R01 MH86654, K99/R00 MH091238, R01 MH096773, R21 EB015573]; Oregon Clinical and Translational Research Institute; Medical Research Foundation; NSF [1157220]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH091238, R01MH086654, R01MH096773] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1157220] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Clinical and Translational Research Institute; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported in part by NIH (http://grants.nih.gov/grants/oer.htm) grants R01 MH86654 (JTN), K99/R00 MH091238 (DAF), R01 MH096773 (DAF), and R21 EB015573 (KMG), the Oregon Clinical and Translational Research Institute (http://www.ohsu.edu/xd/research/centers-institutes/octri/) (DAF), the Medical Research Foundation (http://www.ohsu.edu/xd/about/foundation/about/medical-research-foundation/) (DAF), and and NSF grant 1157220 (http://www.nsf.gov/funding/) (PCMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltz AM, 2013, ADDICT BEHAV, V38, P2052, DOI 10.1016/j.addbeh.2012.12.023; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Conners C. K., 2008, CONNERS 3 EDITION CO, V3rd; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friedman BH, 2003, INTEGR PHYS BEH SCI, V38, P295, DOI 10.1007/BF02688859; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Gates KM, 2010, NEUROIMAGE, V50, P1118, DOI 10.1016/j.neuroimage.2009.12.117; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Karrer B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046119; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kherif F, 2003, NEUROIMAGE, V20, P2197, DOI 10.1016/j.neuroimage.2003.08.018; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; Kutner M. H., 2004, APPL LINEAR REGRESSI; LAMIELL JT, 1981, AM PSYCHOL, V36, P276, DOI 10.1037/0003-066X.36.3.276; Lancaster JL, 1995, HUM BRAIN MAPP, V3, P209, DOI 10.1002/hbm.460030305; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Miller MB, 2002, J COGNITIVE NEUROSCI, V14, P1200, DOI 10.1162/089892902760807203; Miller MB, 2007, INT J PSYCHOPHYSIOL, V63, P205, DOI 10.1016/j.ijpsycho.2006.03.019; Molenaar P.C.M., 2004, MEAS-INTERDISCIP RES, V2, P201, DOI [10.1207/s15366359mea0204_1, DOI 10.1207/S15366359MEA0204_1]; Molenaar PCM, 2008, DEV PSYCHOBIOL, V50, P60, DOI 10.1002/dev.20262; Mumford JA, 2014, NEUROIMAGE, V86, P573, DOI 10.1016/j.neuroimage.2013.10.020; Musser ED, 2013, J AM ACAD CHILD PSY, V52, P163, DOI 10.1016/j.jaac.2012.11.009; Nesselroade J. R., 1979, LONGITUDINAL RES STU; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nichols TT, ADDICT BIOL IN PRESS; Nikolas MA, 2013, NEUROPSYCHOLOGY, V27, P107, DOI 10.1037/a0030685; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Puig-Antich J., 1986, SCHEDULE AFFECTIVE D; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Satterthwaite TD, 2013, NEUROIMAGE, V83, P45, DOI 10.1016/j.neuroimage.2013.06.045; Seghier ML, 2008, HUM BRAIN MAPP, V29, P461, DOI 10.1002/hbm.20410; Silk T, 2005, BRIT J PSYCHIAT, V187, P282, DOI 10.1192/bjp.187.3.282; Silk TJ, 2008, BRAIN IMAGING BEHAV, V2, P123, DOI 10.1007/s11682-008-9021-8; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Talairach J., 1988, COPLANAR STEREOTAXIC; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Wechsler D, 1974, WECHSLER INTELLIGENC; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004	58	73	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91322	10.1371/journal.pone.0091322	http://dx.doi.org/10.1371/journal.pone.0091322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642753	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900018
J	Henrich, B; Rumming, M; Sczyrba, A; Velleuer, E; Dietrich, R; Gerlach, W; Gombert, M; Rahn, S; Stoye, J; Borkhardt, A; Fischer, U				Henrich, Birgit; Rumming, Madis; Sczyrba, Alexander; Velleuer, Eunike; Dietrich, Ralf; Gerlach, Wolfgang; Gombert, Michael; Rahn, Sebastian; Stoye, Jens; Borkhardt, Arndt; Fischer, Ute			Mycoplasma salivarium as a Dominant Coloniser of Fanconi Anaemia Associated Oral Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RIBOSOMAL-RNA; STREPTOCOCCUS-ANGINOSUS; PSEUDOMONAS-AERUGINOSA; MICROBIAL COMMUNITY; MOLECULAR ANALYSIS; BACTERIA PRESENT; INFECTION; HEAD; NECK	Mycoplasma salivarium belongs to the class of the smallest self-replicating Tenericutes and is predominantly found in the oral cavity of humans. In general it is considered as a non-pathogenic commensal. However, some reports point to an association with human diseases. M. salivarium was found e.g. as causative agent of a submasseteric abscess, in necrotic dental pulp, in brain abscess and clogged biliary stent. Here we describe the detection of M. salivarium on the surface of a squamous cell carcinoma of the tongue of a patient with Fanconi anaemia (FA). FA is an inherited bone marrow failure syndrome based on defective DNA-repair that increases the risk of carcinomas especially oral squamous cell carcinoma. Employing high coverage, massive parallel Roche/454-next-generation-sequencing of 16S rRNA gene amplicons we analysed the oral microbiome of this FA patient in comparison to that of an FA patient with a benign leukoplakia and five healthy individuals. The microbiota of the FA patient with leukoplakia correlated well with that of the healthy controls. A dominance of Streptococcus, Veillonella and Neisseria species was typically observed. In contrast, the microbiome of the cancer bearing FA patient was dominated by Pseudomonas aeruginosa at the healthy sites, which changed to a predominance of 98% M. salivarium on the tumour surface. Quantification of the mycoplasma load in five healthy, two tumour- and two leukoplakia-FA patients by TaqMan-PCR confirmed the prevalence of M. salivarium at the tumour sites. These new findings suggest that this mycoplasma species with its reduced coding capacity found ideal breeding grounds at the tumour sites. Interestingly, the oral cavity of all FA patients and especially samples at the tumour sites were in addition positive for Candida albicans. It remains to be elucidated in further studies whether M. salivarium can be used as a predictive biomarker for tumour development in these patients.	[Henrich, Birgit; Rahn, Sebastian] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany; [Rumming, Madis; Velleuer, Eunike; Gombert, Michael; Borkhardt, Arndt; Fischer, Ute] Univ Dusseldorf, Dept Paediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Fac Med, Dusseldorf, Germany; [Rumming, Madis; Sczyrba, Alexander; Gerlach, Wolfgang; Stoye, Jens] Univ Bielefeld, Fac Technol, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Dietrich, Ralf] German Fanconi Anemia Help eV, Unna, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Bielefeld	Henrich, B (corresponding author), Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany.	birgit.henrich@uni-duesseldorf.de	Velleuer, Eunike/U-6355-2019	Velleuer, Eunike/0000-0003-4328-9556; Sczyrba, Alexander/0000-0002-4405-3847				Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Alcaraz LD, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2012.03857.x; Baracaldo R, 2012, J CLIN MICROBIOL, V50, P1805, DOI 10.1128/JCM.06839-11; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Do T, 2013, CLIN COSMET INVESTIG, V5, P11, DOI 10.2147/CCIDE.S31005; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ENGEL L D, 1970, Journal of Periodontal Research, V5, P163; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Grisold AJ, 2008, J CLIN MICROBIOL, V46, P3860, DOI 10.1128/JCM.00807-08; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He X, 2011, MOL ORAL MICROBIOL, V26, P337, DOI 10.1111/j.2041-1014.2011.00622.x; Henrich B, 2010, J MED MICROBIOL, V59, P239, DOI 10.1099/jmm.0.013110-0; Hooper SJ, 2007, J MED MICROBIOL, V56, P1651, DOI 10.1099/jmm.0.46918-0; Hooper SJ, 2006, J CLIN MICROBIOL, V44, P1719, DOI 10.1128/JCM.44.5.1719-1725.2006; Hsiao WWL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-345; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; KUNDSIN RB, 1967, AM J EPIDEMIOL, V86, P579, DOI 10.1093/oxfordjournals.aje.a120767; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; LOWBURY EJL, 1970, J MED MICROBIOL, V3, P39, DOI 10.1099/00222615-3-1-39; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Magurran A., 2004, MEASURING BIOL DIVER, P1, DOI 10.2989/16085910409503825.; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nseir S, 2007, INTENS CARE MED, V33, P137, DOI 10.1007/s00134-006-0422-0; Orsted I, 2011, CLIN MICROBIOL INFEC, V17, P1047, DOI 10.1111/j.1469-0691.2011.03462.x; Panghal M, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-22; Park David R, 2005, Respir Care, V50, P742; Park DR, 2005, RESP CARE, V50, P763; Pushalkar S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-144; Pushalkar S, 2011, FEMS IMMUNOL MED MIC, V61, P269, DOI 10.1111/j.1574-695X.2010.00773.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sasaki M, 2005, ORAL DIS, V11, P151, DOI 10.1111/j.1601-0825.2005.01051.x; Schabereiter-Gurtner C, 2007, J CLIN MICROBIOL, V45, P906, DOI 10.1128/JCM.01344-06; Scheckenbach K, 2012, KLIN PADIATR, V224, P132, DOI 10.1055/s-0032-1308989; Shiga K, 2001, ONCOL REP, V8, P245; SO AKL, 1983, BRIT MED J, V286, P762, DOI 10.1136/bmj.286.6367.762; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Tateda M, 2000, INT J MOL MED, V6, P699; Vandecandelaere I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038401; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WATANABE T, 1986, J CLIN MICROBIOL, V23, P1034, DOI 10.1128/JCM.23.6.1034-1038.1986; Watanabe T, 1998, FEMS IMMUNOL MED MIC, V22, P241, DOI 10.1111/j.1574-695X.1998.tb01212.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	59	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92297	10.1371/journal.pone.0092297	http://dx.doi.org/10.1371/journal.pone.0092297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642836	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900119
J	Jonas, M; Eloka, O; Stephan, J; Franz, VH				Jonas, Melanie; Eloka, Owino; Stephan, Julia; Franz, Volker H.			Need for Space: The Key Distance Effect Depends on Spatial Stimulus Configurations	PLOS ONE			English	Article							S-R COMPATIBILITY; RESPONSE COMPATIBILITY; INTERFERENCE	In numerous psychological experiments, participants classify stimuli by pressing response keys. According to Lakens, Schneider, Jostmann, and Schubert (2011), classification performance is affected by physical distance between response keys - indicating a cognitive tendency to represent categories in spatial code. However, previous evidence for a key distance effect (KDE) from a color-naming Stroop task is inconclusive as to whether: (a) key separation automatically leads to an internal spatial representation of non-spatial stimulus characteristics in participants, or if the KDE rather depends on physical spatial characteristics of the stimulus configuration; (b) the KDE attenuates the Stroop interference effect. We therefore first adopted the original Stroop task in Experiment 1, confirming that wider key distance facilitated responses, but did not modulate the Stroop effect as was previously found. In Experiments 2 and 3 we controlled potential mediator variables in the original design. When we did not display instructions about stimulus-response mappings, thereby removing the unintended spatial context from the Stroop stimuli, no KDE emerged. Presenting the instructions at a central position in Experiment 4 confirmed that key separation alone is not sufficient for a KDE, but correspondence between spatial configurations of stimuli and responses is also necessary. Evidence indicates that the KDE on Stroop performance is due to known mechanisms of stimulus-response compatibility and response discriminability. The KDE does, however, not demonstrate a general disposition to represent any stimulus in spatial code.	[Jonas, Melanie; Eloka, Owino; Stephan, Julia; Franz, Volker H.] Univ Hamburg, Dept Psychol, Hamburg, Germany	University of Hamburg	Jonas, M (corresponding author), Univ Hamburg, Dept Psychol, Hamburg, Germany.	melanie.jonas@uni-hamburg.de	Franz, Volker H/K-4128-2012	Franz, Volker H/0000-0002-8457-0611	Hochschulpakt; University of Hamburg; International Graduate Research Training Group [IKG-1247]; Deutsche Forschungsgemeinschaft (DFG)	Hochschulpakt; University of Hamburg; International Graduate Research Training Group; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by funding of MJ through Hochschulpakt 2020 (HSP I, URL: http://www.bmbf.de/de/6142.php), a scholarship of the University of Hamburg (URL: http://www.uni-hamburg.de/forschung/nachwuchs/promotion/stipendienwegweiser/promotionsstipendien.html) to OE, and a research grant to VH within the International Graduate Research Training Group (No. IKG-1247) on Cross-Modal Interaction in Natural and Artificial Cognitive Systems (CINACS) from the Deutsche Forschungsgemeinschaft (DFG, URL: http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id = 968025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JJ, 2003, COGNITIVE PSYCHOL, V46, P302, DOI 10.1016/S0010-0285(02)00516-9; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Clark A, 2008, SUPERSIZING MIND EMB; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Houwer J, 2003, MEM COGNITION, V31, P353, DOI 10.3758/BF03194393; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Franz VH, 2012, PSYCHON B REV, V19, P395, DOI 10.3758/s13423-012-0230-1; Heister G., 1990, STIMULUS RESPONSE CO, DOI DOI 10.1016/S0166-4115(08)61220-0; Jostmann NB, 2007, J EXP PSYCHOL GEN, V136, P593, DOI 10.1037/0096-3445.136.4.593; Koch I, 2011, ACTA PSYCHOL, V136, P399, DOI 10.1016/j.actpsy.2011.01.006; Lakens D, 2011, PSYCHOL SCI, V22, P887, DOI 10.1177/0956797611412391; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MILLER J, 1985, J EXP PSYCHOL HUMAN, V11, P221; Nett N, 2014, EXP PSYCHOL, V61, P142, DOI 10.1027/1618-3169/a000234; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Proctor RW, 2012, ACTA PSYCHOL, V141, P39, DOI 10.1016/j.actpsy.2012.06.005; Shimizu H, 2002, BEHAV RES METH INS C, V34, P250, DOI 10.3758/BF03195452; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Stins JF, 2000, Q J EXP PSYCHOL-A, V53, P569, DOI 10.1080/027249800390619; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vu KPL, 2002, PERCEPT PSYCHOPHYS, V64, P815, DOI 10.3758/BF03194748; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892	24	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91432	10.1371/journal.pone.0091432	http://dx.doi.org/10.1371/journal.pone.0091432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642888	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900021
J	Oku, Y; Tareyanagi, C; Takaya, S; Osaka, S; Ujiie, H; Yoshida, K; Nishiya, N; Uehara, Y				Oku, Yusuke; Tareyanagi, Chiaki; Takaya, Shinichi; Osaka, Sayaka; Ujiie, Haruki; Yoshida, Kentaro; Nishiya, Naoyuki; Uehara, Yoshimasa			Multimodal Effects of Small Molecule ROCK and LIMK Inhibitors on Mitosis, and Their Implication as Anti-Leukemia Agents	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; AURORA-A; THERAPEUTIC TARGETS; MITOTIC CHECKPOINT; MIS-SEGREGATION; KINASE; CELLS; ANEUPLOIDY; IDENTIFICATION; REGULATOR	Accurate chromosome segregation is vital for cell viability. Many cancer cells show chromosome instability (CIN) due to aberrant expression of the genes involved in chromosome segregation. The induction of massive chromosome segregation errors in such cancer cells by small molecule inhibitors is an emerging strategy to kill these cells selectively. Here we screened and characterized small molecule inhibitors which cause mitotic chromosome segregation errors to target cancer cell growth. We screened about 300 chemicals with known targets, and found that Rho-associated coiled-coil kinase (ROCK) inhibitors bypassed the spindle assembly checkpoint (SAC), which delays anaphase onset until proper kinetochore-microtubule interactions are established. We investigated how ROCK inhibitors affect chromosome segregation, and found that they induced microtubule-dependent centrosome fragmentation. Knockdown of ROCK1 and ROCK2 revealed their additive roles in centrosome integrity. Pharmacological inhibition of LIMK also induced centrosome fragmentation similar to that by ROCK inhibitors. Inhibition of ROCK or LIMK hyper-stabilized mitotic spindles and impaired Aurora-A activation. These results suggested that ROCK and LIMK are directly or indirectly involved in microtubule dynamics and activation of Aurora-A. Furthermore, inhibition of ROCK or LIMK suppressed T cell leukemia growth in vitro, but not peripheral blood mononuclear cells. They induced centrosome fragmentation and apoptosis in T cell leukemia cells. These results suggested that ROCK and LIMK can be a potential target for anti-cancer drugs.	[Oku, Yusuke; Tareyanagi, Chiaki; Takaya, Shinichi; Osaka, Sayaka; Ujiie, Haruki; Yoshida, Kentaro; Nishiya, Naoyuki; Uehara, Yoshimasa] Iwate Med Univ, Sch Pharmaceut Sci, Dept Microbial Chem Biol & Drug Discovery, Yahaba, Iwate, Japan	Iwate Medical University	Uehara, Y (corresponding author), Iwate Med Univ, Sch Pharmaceut Sci, Dept Microbial Chem Biol & Drug Discovery, Yahaba, Iwate, Japan.	yuehara@iwate-med.ac.jp	Uehara, Yoshimasa/G-1060-2014	Nishiya, Naoyuki/0000-0003-1575-9944	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23501310, 221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is in part supported by a Grant-in-Aid for Strategic Medical Science Research Center from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2010-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Asteriti IA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-131; Bergnes G, 2005, CURR TOP MED CHEM, V5, P127, DOI 10.2174/1568026053507697; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; De Luca M, 2008, ONCOGENE, V27, P6539, DOI 10.1038/onc.2008.252; Fan LF, 2010, J CELL SCI, V123, P1247, DOI 10.1242/jcs.061754; Farrell P, 2013, MOL CANCER THER, V12, P460, DOI 10.1158/1535-7163.MCT-12-0657; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Hardwicke MA, 2009, MOL CANCER THER, V8, P1808, DOI 10.1158/1535-7163.MCT-09-0041; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Ikezoe T, 2007, MOL CANCER THER, V6, P1851, DOI 10.1158/1535-7163.MCT-07-0067; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Johnson EO, 2012, J CELL SCI, V125, P1204, DOI 10.1242/jcs.092304; Jones R, 2013, INVEST NEW DRUG, V31, P1001, DOI 10.1007/s10637-013-9926-y; Katayama H, 2012, CANCER CELL, V21, P196, DOI 10.1016/j.ccr.2011.12.025; Kelly KR, 2011, J CELL MOL MED, V15, P2057, DOI 10.1111/j.1582-4934.2010.01218.x; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Petrilli A, 2013, ONCOGENE; Ritchey L, 2012, CELL CYCLE, V11, P296, DOI 10.4161/cc.11.2.18734; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Sakaue-Sawano A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-2; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shan WW, 2012, CLIN CANCER RES, V18, P3352, DOI 10.1158/1078-0432.CCR-11-3058; Shimokawa H, 2002, J CARDIOVASC PHARM, V40, P749; Sumi T, 2006, EXP CELL RES, V312, P1021, DOI 10.1016/j.yexcr.2005.12.030; Tannous BA, 2013, J NATL CANC I; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tomita M, 2010, CANCER SCI, V101, P1204, DOI 10.1111/j.1349-7006.2010.01499.x; Torres JZ, 2011, CELL, V147, P1309, DOI 10.1016/j.cell.2011.11.020; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Wysong DR, 2009, CELL CYCLE, V8, P876, DOI 10.4161/cc.8.6.7897; Yang ZY, 2009, J CELL BIOL, V186, P675, DOI 10.1083/jcb.200906150	41	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92402	10.1371/journal.pone.0092402	http://dx.doi.org/10.1371/journal.pone.0092402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642638	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900133
J	Streb, S; Zeeman, SC				Streb, Sebastian; Zeeman, Samuel C.			Replacement of the Endogenous Starch Debranching Enzymes ISA1 and ISA2 of Arabidopsis with the Rice Orthologs Reveals a Degree of Functional Conservation during Starch Synthesis	PLOS ONE			English	Article							GRANULE INITIATION; ISOAMYLASE GENE; HOMO-OLIGOMER; AMYLOPECTIN; MUTANTS; BIOSYNTHESIS; MAIZE; METABOLISM; ENDOSPERM; BREAKDOWN	This study tested the interchangeability of enzymes in starch metabolism between dicotyledonous and monocotyledonous plant species. Amylopectin - a branched glucose polymer - is the major component of starch and is responsible for its semicrystalline property. Plants synthesize starch with distinct amylopectin structures, varying between species and tissues. The structure determines starch properties, an important characteristic for cooking and nutrition, and for the industrial uses of starch. Amylopectin synthesis involves at least three enzyme classes: starch synthases, branching enzymes and debranching enzymes. For all three classes, several enzyme isoforms have been identified. However, it is not clear which enzyme(s) are responsible for the large diversity of amylopectin structures. Here, we tested whether the specificities of the debranching enzymes (ISA1 and ISA2) are major determinants of species-dependent differences in amylopectin structure by replacing the dicotyledonous Arabidopsis isoamylases (AtISA1 and AtISA2) with the monocotyledonous rice (Oryza sativa) isoforms. We demonstrate that the ISA1 and ISA2 are sufficiently well conserved between these species to form heteromultimeric chimeric Arabidopsis/rice isoamylase enzymes. Furthermore, we were able to reconstitute the endosperm-specific rice OsISA1 homomultimeric complex in Arabidopsis isa1isa2 mutants. This homomultimer was able to facilitate normal rates of starch synthesis. The resulting amylopectin structure had small but significant differences in comparison to wild-type Arabidopsis amylopectin. This suggests that ISA1 and ISA2 have a conserved function between plant species with a major role in facilitating the crystallization of pre-amylopectin synthesized by starch synthases and branching enzymes, but also influencing the final structure of amylopectin.	[Streb, Sebastian; Zeeman, Samuel C.] ETH, Dept Biol, Inst Agr Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Streb, S (corresponding author), ETH, Dept Biol, Inst Agr Sci, Zurich, Switzerland.	sstreb@ethz.ch		Streb, Sebastian/0000-0002-9095-6596; Zeeman, Samuel/0000-0002-2791-0915	Swiss National Science Foundation [3100AO-116434/1, 31003A-131074]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	The work was funded by the Swiss National Science Foundation (Grant Nos. 3100AO-116434/1 and 31003A-131074) and ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof S, 2013, PLANT CELL, V25, P1400, DOI 10.1105/tpc.113.109793; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1723, DOI 10.1104/pp.125.4.1723; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Facon M, 2013, PLANT PHYSIOL, V163, P1363, DOI 10.1104/pp.113.225565; Fujita N, 1999, PLANTA, V208, P283, DOI 10.1007/s004250050560; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Hostettler C, 2011, METHODS MOL BIOL, V775, P387, DOI 10.1007/978-1-61779-237-3_21; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; MACGREGOR EA, 1993, STARCH-STARKE, V45, P232, DOI 10.1002/star.19930450705; Morell MK, 1998, ELECTROPHORESIS, V19, P2603, DOI 10.1002/elps.1150191507; Mouille G, 1996, PLANT CELL, V8, P1353; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 1997, PLANT J, V12, P143, DOI 10.1046/j.1365-313X.1997.12010143.x; Posewitz MC, 2004, PLANT CELL, V16, P2151, DOI 10.1105/tpc.104.021972; Rahman S, 2003, GENOME, V46, P496, DOI 10.1139/g02-130; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Sundberg M, 2013, PLOS ONE IN PRESS; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	34	19	19	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92174	10.1371/journal.pone.0092174	http://dx.doi.org/10.1371/journal.pone.0092174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642810	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900098
J	Terry, RL; Kaneb, HM; Wells, DJ				Terry, Rebecca L.; Kaneb, Hannah M.; Wells, Dominic J.			Poloxomer 188 Has a Deleterious Effect on Dystrophic Skeletal Muscle Function	PLOS ONE			English	Article							MEMBRANE SEALANT POLOXAMER; MDX MICE; MUSCULAR-DYSTROPHY; BLOCK-COPOLYMERS; MOUSE; PHARMACOKINETICS; CONTRACTION; SARCOLEMMA; INJECTION; PROTECTS	Duchenne muscular dystrophy (DMD) is an X-linked, fatal muscle wasting disease for which there is currently no cure and limited palliative treatments. Poloxomer 188 (P188) is a tri-block copolymer that has been proposed as a potential treatment for cardiomyopathy in DMD patients. Despite the reported beneficial effects of P188 on dystrophic cardiac muscle function, the effects of P188 on dystrophic skeletal muscle function are relatively unknown. Mdx mice were injected intraperitoneally with 460 mg/kg or 30 mg/kg P188 dissolved in saline, or saline alone (control). The effect of single-dose and 2-week daily treatment was assessed using a muscle function test on the Tibialis Anterior (TA) muscle in situ in anaesthetised mice. The test comprises a warm up, measurement of the force-frequency relationship and a series of eccentric contractions with a 10% stretch that have previously been shown to cause a drop in maximum force in mdx mice. After 2 weeks of P188 treatment at either 30 or 460 mg/kg/day the drop in maximum force produced following eccentric contractions was significantly greater than that seen in saline treated control mice (P = 0.0001). Two week P188 treatment at either dose did not significantly change the force-frequency relationship or maximum isometric specific force produced by the TA muscle. In conclusion P188 treatment increases susceptibility to contraction-induced injury following eccentric contractions in dystrophic skeletal muscle and hence its suitability as a potential therapeutic for DMD should be reconsidered.	[Terry, Rebecca L.; Kaneb, Hannah M.; Wells, Dominic J.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Kaneb, Hannah M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Cellular & Mol Neurosci, London, England	University of London; University of London Royal Veterinary College; Imperial College London	Wells, DJ (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, Royal Coll St, London, England.	dwells@rvc.ac.uk		Wells, Dominic/0000-0002-1425-6344	Wellcome Trust Integrated Veterinary Research Fellowship	Wellcome Trust Integrated Veterinary Research Fellowship	Dr Rebecca Terry was funded by a Wellcome Trust Integrated Veterinary Research Fellowship. http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdamsGraves P, 1997, BLOOD, V90, P2041, DOI 10.1182/blood.V90.5.2041; Alvarez-Lorenzo C, 2011, CURR DRUG TARGETS, V12, P1112, DOI 10.2174/138945011795906615; [Anonymous], 2013, PHAS 3 RAND STUD POL; Brockington M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014434; Broze GJ, 2001, THROMB HAEMOSTASIS, V85, P747; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Burns JW, 2011, RESUSCITATION, V82, P1453, DOI 10.1016/j.resuscitation.2011.06.007; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Chen YC, 2011, CELL BIOCHEM BIOPHYS, V60, P267, DOI 10.1007/s12013-010-9149-1; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Demina T, 2005, BIOCHEMISTRY-US, V44, P4042, DOI 10.1021/bi048373q; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; Greenebaum B, 2004, BURNS, V30, P539, DOI 10.1016/j.burns.2004.02.009; Grindel JM, 2002, BIOPHARM DRUG DISPOS, V23, P87, DOI 10.1002/bdd.297; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Jewell RC, 1997, J PHARM SCI, V86, P808, DOI 10.1021/js960491e; Kabanov AV, 2003, J CONTROL RELEASE, V91, P75, DOI 10.1016/S0168-3659(03)00211-6; Krylova OO, 2003, CHEM-EUR J, V9, P3930, DOI 10.1002/chem.200204621; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; MOKRI B, 1975, NEUROLOGY, V25, P1111, DOI 10.1212/WNL.25.12.1111; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Ng R, 2008, AM J PHYSIOL-CELL PH, V295, pC146, DOI 10.1152/ajpcell.00017.2008; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Quinlan JG, 2006, NEUROMUSCULAR DISORD, V16, P855, DOI 10.1016/j.nmd.2006.09.016; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Spurney CF, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-20; Townsend D, 2010, J CLIN INVEST, V120, P1140, DOI 10.1172/JCI41329; Wang JY, 2010, LANGMUIR, V26, P12953, DOI 10.1021/la101841a; Wooddell CI, 2010, MUSCLE NERVE, V41, P487, DOI 10.1002/mus.21527; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275	33	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91221	10.1371/journal.pone.0091221	http://dx.doi.org/10.1371/journal.pone.0091221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642557	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000333259900014
J	Yang, HJ; Kim, YE; Yun, JY; Kim, HJ; Jeon, BS				Yang, Hui-Jun; Kim, Young Eun; Yun, Ji Young; Kim, Han-Joon; Jeon, Beom Seok			Identifying the Clusters within Nonmotor Manifestations in Early Parkinson's Disease by Using Unsupervised Cluster Analysis	PLOS ONE			English	Article							OLFACTORY DYSFUNCTION; PREMOTOR PHASE; HETEROGENEITY; IDENTIFICATION; SUBTYPES; MOTOR; ASSOCIATION; PROGRESSION; FEATURES; RISK	Background: Classical and data-driven classifications of Parkinson's disease (PD) are based primarily on motor symptoms, with little attention being paid to the clustering of nonmotor manifestations. Methods: Clinical data on demographic, motor and nonmotor features, including the Korean version of the sniffin' stick (KVSS) test results, and responses to the screening questionnaire of the nonmotor features were collected from 56 PD patients with disease onset within 3 years. Nonmotor subgroups were classified using unsupervised hierarchical cluster analysis (HCA). In addition to unsupervised HCA, we performed a cross-sectional analysis comparing the performance on the KVSS olfactory test with other nonmotor manifestations of the patients. Results: Forty-nine patients (87.5%) had hyposmia based on the KVSS test. HCA suggested three nonmotor clusters for all PD patients and two nonmotor clusters in de novo PD patients, without a priori assumptions about the relatedness. In the cross-sectional analysis, dream-enactment behavior was more prevalent in patients with lower olfactory scores, implying impaired olfactory function (P = 0.029 for all PD patients; P = 0.046 for de novo PD patients). Conclusion: We propose the existence of different clusters of nonmotor manifestations in early PD by using unsupervised hierarchical clustering. To our knowledge, this study is the first to report the identification of nonmotor subgroups based on unsupervised HCA of multiple nonmotor manifestations in the early stage of the disease.	[Yang, Hui-Jun] Ulsan Univ Hosp, Dept Neurol, Ulsan, South Korea; [Kim, Young Eun; Kim, Han-Joon; Jeon, Beom Seok] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Kim, Young Eun; Kim, Han-Joon; Jeon, Beom Seok] Seoul Natl Univ Hosp, Movement Disorder Ctr, Parkinson Study Grp, Neurosci Res Inst, Seoul 110744, South Korea; [Yun, Ji Young] Ewha Womans Univ, Mokdong Hosp, Dept Neurol, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University	Jeon, BS (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	brain@snu.ac.kr	Yang, Hui-Jun/M-5881-2014	Yang, Hui-Jun/0000-0002-3593-1134; Kim, Han-Joon/0000-0001-8219-9663	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A101273, A110875]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by grants of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A101273 and A110875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2011, MOVEMENT DISORD, V26, P621, DOI 10.1002/mds.23602; Berendse HW, 2011, J NEUROL SCI, V310, P21, DOI 10.1016/j.jns.2011.06.020; Berg D, 2013, EUR J NEUROL, V20, P102, DOI 10.1111/j.1468-1331.2012.03798.x; Chen HL, 2013, ENVIRON HEALTH PERSP, V121, P1245, DOI 10.1289/ehp.1306967; Cho JH, 2009, AURIS NASUS LARYNX, V36, P280, DOI 10.1016/j.anl.2008.07.005; Cramer CK, 2010, PARKINSONISM RELAT D, V16, P124, DOI 10.1016/j.parkreldis.2009.09.004; Dujardin K, 2004, J NEUROL, V251, P1383, DOI 10.1007/s00415-004-0549-2; ezankova R., 2009, STAT-US, V46, P216; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Gasparoli E, 2002, NEUROL SCI, V23, pS77, DOI 10.1007/s100720200078; Goldstein DS, 2010, NEUROLOGY, V74, P245, DOI 10.1212/WNL.0b013e3181ca014c; Graham JM, 1999, MOVEMENT DISORD, V14, P10; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Hong S.C., 1999, KOREAN J OTORHINOLAR, V42, P855; Kim HJ, 2009, J NEUROL SCI, V287, P200, DOI 10.1016/j.jns.2009.07.026; Lemer A, 2008, MOVEMENT DISORD, V23, P1076, DOI 10.1002/mds.22066; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Liepelt-Scarfone I, 2013, NEUROEPIDEMIOLOGY, V41, P174, DOI 10.1159/000353560; Morley JF, 2011, J NEUROL SCI, V310, P228, DOI 10.1016/j.jns.2011.05.030; Morley JF, 2011, MOVEMENT DISORD, V26, P2051, DOI 10.1002/mds.23792; Lloret SP, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/473579; Post B, 2008, J NEUROL, V255, P716, DOI 10.1007/s00415-008-0782-1; Postuma RB, 2011, MOVEMENT DISORD, V27, P617; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Ravina B, 2013, MOVEMENT DISORD, V28, P122, DOI 10.1002/mds.25325; Reijnders JSAM, 2009, PARKINSONISM RELAT D, V15, P379, DOI 10.1016/j.parkreldis.2008.09.003; Schrag A, 2006, J NEUROL NEUROSUR PS, V77, P275; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Siderowf A, 2012, MOVEMENT DISORD, V27, P406, DOI 10.1002/mds.24892; Stiasny-Kolster K, 2005, BRAIN, V128, P126, DOI 10.1093/brain/awh322; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tolosa E, 2009, NEUROLOGY, V72, pS12, DOI 10.1212/WNL.0b013e318198db11; van Rooden SM, 2009, J NEUROL NEUROSUR PS, V80, P846, DOI 10.1136/jnnp.2008.166629; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; van Rooden SM, 2010, MOVEMENT DISORD, V25, P969, DOI 10.1002/mds.23116	36	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91906	10.1371/journal.pone.0091906	http://dx.doi.org/10.1371/journal.pone.0091906			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643014	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900044
J	Bavan, S; Sherman, B; Luetje, CW; Abaffy, T				Bavan, Selvan; Sherman, Benjamin; Luetje, Charles W.; Abaffy, Tatjana			Discovery of Novel Ligands for Mouse Olfactory Receptor MOR42-3 Using an In Silico Screening Approach and In Vitro Validation	PLOS ONE			English	Article							ODORANT RECEPTOR; MOLECULAR-BASIS; FUNCTIONAL EXPRESSION; SCORING FUNCTION; DOCKING; IDENTIFICATION; SPECIFICITY; VOMERONASAL; ANTAGONISTS; FAMILY	The ligands for many olfactory receptors remain largely unknown despite successful heterologous expression of these receptors. Understanding the molecular receptive range of olfactory receptors and deciphering the olfactory recognition code are hampered by the huge number of odorants and large number of olfactory receptors, as well as the complexity of their combinatorial coding. Here, we present an in silico screening approach to find additional ligands for a mouse olfactory receptor that allows improved definition of its molecular receptive range. A virtual library of 574 odorants was screened against a mouse olfactory receptor MOR42-3. We selected the top 20 candidate ligands using two different scoring functions. These 40 odorant candidate ligands were then tested in vitro using the Xenopus oocyte heterologous expression system and two-electrode voltage clamp electrophysiology. We experimentally confirmed 22 of these ligands. The candidate ligands were screened for both agonist and antagonist activity. In summary, we validated 19 agonists and 3 antagonists. Two of the newly identified antagonists were of low potency. Several previously known ligands (mono- and dicarboxylic acids) are also confirmed in this study. However, some of the newly identified ligands were structurally dissimilar compounds with various functional groups belonging to aldehydes, phenyls, alkenes, esters and ethers. The high positive predictive value of our in silico approach is promising. We believe that this approach can be used for initial deorphanization of olfactory receptors as well as for future comprehensive studies of molecular receptive range of olfactory receptors.	[Bavan, Selvan; Sherman, Benjamin; Luetje, Charles W.; Abaffy, Tatjana] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Abaffy, T (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	tabaffy@med.miami.edu	Abaffy, Tatjana/C-2071-2015		National Institutes of Health [R01 DC008119]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institutes of Health R01 DC008119 to CWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200; Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R., 2007, ICM MANUAL; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bush CF, 2007, J BIOL CHEM, V282, P19042, DOI 10.1074/jbc.M610781200; Cavasotto CN, 2006, BIOORG MED CHEM LETT, V16, P1969, DOI 10.1016/j.bmcl.2005.12.067; Charlier L, 2012, CELL MOL LIFE SCI, V69, P4205, DOI 10.1007/s00018-012-1116-0; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Launay G, 2012, PROTEIN ENG DES SEL, V25, P377, DOI 10.1093/protein/gzs037; Li JY, 2012, J NEUROCHEM, V121, P881, DOI 10.1111/j.1471-4159.2012.07740.x; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reed RR, 2004, CELL, V116, P329, DOI 10.1016/S0092-8674(04)00047-9; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Schapira M, 2000, P NATL ACAD SCI USA, V97, P1008, DOI 10.1073/pnas.97.3.1008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	37	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92064	10.1371/journal.pone.0092064	http://dx.doi.org/10.1371/journal.pone.0092064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637889	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100110
J	Bock, JO; Luppa, M; Brettschneider, C; Riedel-Heller, S; Bickel, H; Fuchs, A; Gensichen, J; Maier, W; Mergenthal, K; Schafer, I; Schon, G; Weyerer, S; Wiese, B; van den Bussche, H; Scherer, M; Konig, HH				Bock, Jens-Oliver; Luppa, Melanie; Brettschneider, Christian; Riedel-Heller, Steffi; Bickel, Horst; Fuchs, Angela; Gensichen, Jochen; Maier, Wolfgang; Mergenthal, Karola; Schaefer, Ingmar; Schoen, Gerhard; Weyerer, Siegfried; Wiese, Birgitt; van den Bussche, Hendrik; Scherer, Martin; Koenig, Hans-Helmut			Impact of Depression on Health Care Utilization and Costs among Multimorbid Patients - Results from the MultiCare Cohort Study	PLOS ONE			English	Article							SERVICE UTILIZATION; SYMPTOMS; OLDER; VALIDITY; GERMANY; ILLNESS; SCALE	Objective: The objective of this study was to describe and analyze the effects of depression on health care utilization and costs in a sample of multimorbid elderly patients. Method: This cross-sectional analysis used data of a prospective cohort study, consisting of 1,050 randomly selected multimorbid primary care patients aged 65 to 85 years. Depression was defined as a score of six points or more on the Geriatric Depression Scale (GDS-15). Subjects passed a geriatric assessment, including a questionnaire for health care utilization. The impact of depression on health care costs was analyzed using multiple linear regression models. A societal perspective was adopted. Results: Prevalence of depression was 10.7%. Mean total costs per six-month period were (sic)8,144 (95% CI: (sic)6,199-(sic)10,090) in patients with depression as compared to (sic)3,137 (95% CI: (sic)2,735-(sic)3,538; p<0.001) in patients without depression. The positive association between depression and total costs persisted after controlling for socio-economic variables, functional status and level of multimorbidity. In particular, multiple regression analyses showed a significant positive association between depression and pharmaceutical costs. Conclusion: Among multimorbid elderly patients, depression was associated with significantly higher health care utilization and costs. The effect of depression on costs was even greater than reported by previous studies conducted in less morbid patients.	[Bock, Jens-Oliver; Brettschneider, Christian; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany; [Luppa, Melanie; Riedel-Heller, Steffi] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Bickel, Horst] Tech Univ Munich, Dept Psychiat, D-80290 Munich, Germany; [Fuchs, Angela] Univ Dusseldorf, Med Ctr, Dept Gen Practice, Dusseldorf, Germany; [Gensichen, Jochen] Jena Univ Hosp, Dept Gen Practice, Jena, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Mergenthal, Karola] Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany; [Schaefer, Ingmar; van den Bussche, Hendrik; Scherer, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Schoen, Gerhard] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Weyerer, Siegfried] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Wiese, Birgitt] Hannover Med Sch, Inst Biometry, Hannover, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; Technical University of Munich; University of Munich; Heinrich Heine University Dusseldorf; Friedrich Schiller University of Jena; University of Bonn; Goethe University Frankfurt; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Hannover Medical School	Bock, JO (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany.	j.bock@uke.de	König, Hans-Helmut/P-1211-2018; Brettschneider, Christian/H-5920-2019; Luppa, Melanie/AAQ-7338-2021; Riedel-Heller, Steffi/ABG-1537-2021	König, Hans-Helmut/0000-0001-5711-6862; Brettschneider, Christian/0000-0002-5280-1075; 	German Federal Ministry of Education and Research [01ET0725-31, 01ET1006A-K]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by the German Federal Ministry of Education and Research (grant numbers 01ET0725-31 and 01ET1006A-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier AK, 2011, PSYCHIAT PRAX, V38, P280, DOI 10.1055/s-0030-1266105; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Brauns H, 1999, ZUMA NACHRICHTEN, V23, P7; Busch MA, 2013, PSYCHIAT PRAX, V40, P214, DOI 10.1055/s-0032-1333026; Chen J, 2000, J OFF STAT, V16, P113; Deutsche Krankenhausgesellschaft, 2009, BEST KRANK PLAN INV; Deutsche Rentenversicherung Bund, 2010, REH 2010, V184; Federal Statistical Office, 2008, GRUND KRANK; Federal Statistical Office, 2008, KOST KRANK; Federal Statistical Office, 2010, VERBR DEUTSCHL; Federal Statistical Office, 2008, PFLEG 2007; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Fydrich T., 2009, Z MED PSYCHOL, V18, P43, DOI DOI 10.1026//0012-1924.45.4.212; Gauggel S, 1999, Z KLIN PSYCHOL-FORSC, V28, P18, DOI 10.1026//0084-5345.28.1.18; GKV- Spitzenverband, 2007, FESTB; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Heinrich S, 2008, VALUE HEALTH, V11, P611, DOI 10.1111/j.1524-4733.2007.00285.x; Kassenzahnarztliche Bundesvereinigung, 2009, ABR FESTZ; Katon WJ, 2003, ARCH GEN PSYCHIAT, V60, P897, DOI 10.1001/archpsyc.60.9.897; Konig HH, 2009, BRIT J PSYCHIAT, V195, P308, DOI 10.1192/bjp.bp.108.058032; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; Krauth C, 2005, GESUNDHEITSWESEN, V67, P736, DOI 10.1055/s-2005-858698; Lacruz ME, 2012, AGE AGEING, V41, P183, DOI 10.1093/ageing/afr162; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Leicht H, 2011, ACTA PSYCHIAT SCAND, V124, P384, DOI 10.1111/j.1600-0447.2011.01741.x; Livingston G, 1997, BRIT J PSYCHIAT, V171, P56, DOI 10.1192/bjp.171.1.56; Luber MP, 2001, AM J GERIAT PSYCHIAT, V9, P169, DOI 10.1176/appi.ajgp.9.2.169; Luce BR, 1996, COST EFFECTIVENESS H, P176; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Luppa M, 2012, INT PSYCHOGERIATR; Luppa M, 2008, J AFFECT DISORDERS, V105, P195, DOI 10.1016/j.jad.2007.05.008; Luppa M, 2012, CURR PHARM DESIGN, V18, P5936, DOI 10.2174/138161212803523572; MAHONEY F I, 1965, Md State Med J, V14, P61; Rote Liste Service GmbH, 2008, ROT LIST 2008 ARZN D; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Schafer I, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-145; SCHUBERT DSP, 1995, GEN HOSP PSYCHIAT, V17, P326, DOI 10.1016/0163-8343(95)00065-Y; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; SOMMER G, 1991, DIAGNOSTICA, V37, P160; Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Verband der Ersatzkassen, 2007, VERG POD LEIST; Verband der Ersatzkassen, 2002, VERG ERG LEIST; Verband der Ersatzkassen, 2001, VERG LOG SPRACHT LEI; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	47	61	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91973	10.1371/journal.pone.0091973	http://dx.doi.org/10.1371/journal.pone.0091973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24638040	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100093
J	Chou, CL; Chou, CY; Hsu, CC; Chou, YC; Chen, TJ; Chou, LF				Chou, Chia-Lin; Chou, Chia-Yu; Hsu, Chia-Chen; Chou, Yueh-Ching; Chen, Tzeng-Ji; Chou, Li-Fang			Old Habits Die Hard: A Nationwide Utilization Study of Short-Acting Nifedipine in Taiwan	PLOS ONE			English	Article							SUBLINGUAL NIFEDIPINE; MANAGEMENT; RISK; GUIDELINES; MORTALITY; SOCIETY; HEALTH; SAFETY; ADULTS; DRUGS	Background: To investigate the nationwide trend of ambulatory prescriptions of short-acting nifedipine on a PRN (pro re nata) order over a fifteen-year period in Taiwan. Methods: The systematic sampling claims datasets (0.2% sampling ratio) of ambulatory care visits within Taiwan's National Health Insurance from 1997 to 2011 were analyzed. The prescriptions of short-acting capsule-form nifedipine on a PRN order were stratified by the patient's age, the prescribing physician's specialty, and the setting of healthcare facility for each year. Results: During the study period, 8,189,681 visits were analyzed. While the utilization rate of calcium channel blockers changed with time from 2.8% (13,767/489,636) in 1997 to 5.1% (31,349/614,719) in 2011, that of short-acting nifedipine were from 1.0% (n = 5,070) to 0.2% (n = 1,246). However, short-acting capsule-form nifedipine on a PRN order still existed (from 447 prescriptions in 1997 to 784 in 2011). More than one half of these PRN nifedipines were prescribed by the internists and to the elderly patients; almost four-fifths of PRN nifedipines were prescribed during non-emergent consultations. Conclusion: The physicians in Taiwan still had the habit of prescribing short-acting nifedipines for PRN use. The reason for such practices and the impact on patients' health deserve attention.	[Chou, Chia-Lin; Hsu, Chia-Chen; Chou, Yueh-Ching] Taipei Vet Gen Hosp, Dept Pharm, Taipei, Taiwan; [Chou, Chia-Yu; Chou, Yueh-Ching] Taipei Vet Gen Hosp, Dept Crit Care Med, Taipei, Taiwan; [Chou, Chia-Yu; Chou, Yueh-Ching] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chou, Chia-Yu] Taipei Med Univ, Coll Pharm, Taipei, Taiwan; [Chou, Chia-Yu] Natl Def Med Ctr, Sch Med, Dept Internal Med, Taipei, Taiwan; [Chou, Chia-Yu] Tzu Chi Univ, Dept Med, Hualien, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chou, Li-Fang] Natl Chengchi Univ, Dept Publ Finance, Taipei 11623, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; National Defense Medical Center; Tzu Chi University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Chengchi University	Chou, YC (corresponding author), Taipei Vet Gen Hosp, Dept Pharm, Taipei, Taiwan.	ycchou@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021; Hsu, Chia-Chen/AAB-3117-2019		Taipei Veterans General Hospital [V102C-160]; National Science Council in Taiwan [NSC99-2410-H-004-029-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Taipei Veterans General Hospital (V102C-160) and National Science Council in Taiwan (NSC99-2410-H-004-029-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Blaszak RT, 2001, J PEDIATR-US, V139, P34, DOI 10.1067/mpd.2001.114699; Bureau of National Health Insurance Department of Health Executive Yuan, 2011, EX YUAN NAT HLTH INS; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Egger DW, 2002, PEDIATR NEPHROL, V17, P35, DOI 10.1007/s004670200006; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fretheim A, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-21; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; Furmaga EM, 2005, ADV PATIENT SAFETY R, V3; GIFFORD RW, 1991, JAMA-J AM MED ASSOC, V266, P829, DOI 10.1001/jama.266.6.829; Grise EM, 2012, STROKE, V43, P557, DOI 10.1161/STROKEAHA.111.637983; Grossman E, 2004, PROG CARDIOVASC DIS, V47, P34, DOI 10.1016/j.pcad.2004.04.006; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Hemmelgarn BR, 2008, CAN J CARDIOL, V24, P507, DOI 10.1016/S0828-282X(08)70627-5; Ishibashi Y, 1999, CLIN EXP PHARMACOL P, V26, P404, DOI 10.1046/j.1440-1681.1999.03046.x; Jung SY, 2011, NEUROLOGY, V77, P1229, DOI 10.1212/WNL.0b013e318230201a; Kizer JR, 2000, PHARMACOEPIDEM DR S, V9, P25, DOI 10.1002/(SICI)1099-1557(200001/02)9:1<25::AID-PDS469>3.0.CO;2-E; Liu JY, 2001, EUR J CLIN PHARMACOL, V57, P505, DOI 10.1007/s002280100349; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marwick C, 1996, JAMA-J AM MED ASSOC, V275, P423, DOI 10.1001/jama.275.6.423; Maxwell CJ, 2000, PHARMACOEPIDEM DR S, V9, P11, DOI 10.1002/(SICI)1099-1557(200001/02)9:1<11::AID-PDS468>3.0.CO;2-U; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Messerli FH, 1999, ARCH INTERN MED, V159, P2259, DOI 10.1001/archinte.159.19.2259; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Rehman F, 1996, AM J HYPERTENS, V9, P1035, DOI 10.1016/0895-7061(96)00172-0; Saito M, 2005, EUR J CLIN PHARMACOL, V61, P531, DOI 10.1007/s00228-005-0974-x; Stafford RS, 2006, HYPERTENSION, V48, P213, DOI 10.1161/01.HYP.0000229653.73128.b6; Su Tung-Ping, 2002, Zhonghua Yi Xue Za Zhi (Taipei), V65, P378; Yiu V, 2004, PEDIATR NEPHROL, V19, P644, DOI 10.1007/s00467-004-1444-x	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91858	10.1371/journal.pone.0091858	http://dx.doi.org/10.1371/journal.pone.0091858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637880	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100070
J	Geng, P; Li, WL; Lin, L; de Miranda, JR; Emrich, S; An, LJ; Terenius, O				Geng, Peng; Li, Wenli; Lin, Lan; de Miranda, Joachim R.; Emrich, Scott; An, Lijia; Terenius, Olle			Genetic Characterization of a Novel Iflavirus Associated with Vomiting Disease in the Chinese Oak Silkmoth Antheraea pernyi	PLOS ONE			English	Article							PICORNA-LIKE VIRUS; DEFORMED-WING-VIRUS; PHYLOGENETIC ANALYSIS; ECTROPIS-OBLIQUA; SACBROOD VIRUS; SEQUENCE; VARROA-DESTRUCTOR-VIRUS-1; IDENTIFICATION; PREDICTION; TAXONOMY	Larvae of the Chinese oak silkmoth (Antheraea pernyi) are often affected by AVD (A. pernyi vomiting disease), whose causative agent has long been suspected to be a virus. In an unrelated project we discovered a novel positive sense single-stranded RNA virus that could reproduce AVD symptoms upon injection into healthy A. pernyi larvae. The genome of this virus is 10,163 nucleotides long, has a natural poly-A tail, and contains a single, large open reading frame flanked at the 5' and 3' ends by untranslated regions containing putative structural elements for replication and translation of the virus genome. The open reading frame is predicted to encode a 3036 amino acid polyprotein with four viral structural proteins (VP1-VP4) located in the N-terminal end and the non-structural proteins, including a helicase, RNA-dependent RNA polymerase and 3C-protease, located in the C-terminal end of the polyprotein. Putative 3C-protease and autolytic cleavage sites were identified for processing the polyprotein into functional units. The genome organization, amino acid sequence and phylogenetic analyses suggest that the virus is a novel species of the genus Iflavirus, with the proposed name of Antheraea pernyi Iflavirus (ApIV).	[Geng, Peng; Li, Wenli; Lin, Lan; An, Lijia] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China; [Lin, Lan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [de Miranda, Joachim R.; Terenius, Olle] Swedish Univ Agr Sci SLU, Dept Ecol, Uppsala, Sweden; [Emrich, Scott] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA	Dalian University of Technology; Shenyang Pharmaceutical University; Swedish University of Agricultural Sciences; University of Notre Dame	Terenius, O (corresponding author), Swedish Univ Agr Sci SLU, Dept Ecol, Uppsala, Sweden.	olle.terenius@slu.se		Terenius, Olle/0000-0002-9909-1859; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	Carl Trygger foundation; Swedish research council Formas	Carl Trygger foundation; Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas)	This project was supported by the Carl Trygger foundation and the Swedish research council Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-10; Berenyi O, 2007, APPL ENVIRON MICROB, V73, P3605, DOI 10.1128/AEM.00696-07; Berman J. J., 2012, TAXONOMIC GUIDE INFE, P237, DOI DOI 10.1016/B978-0-12-415895-5.00042-8; Bonning B, 2010, INSECT VIROLOGY; BREITBURD F, 1995, J VIROL, V69, P3959, DOI 10.1128/JVI.69.6.3959-3963.1995; Ce S, 2005, LIAONING AGR SCI, V4, P39; Choe SE, 2012, VET MICROBIOL, V157, P32, DOI 10.1016/j.vetmic.2011.12.007; Christian PD, 2005, J ECON ENTOMOL, V98, P1839, DOI 10.1603/0022-0493-98.6.1839; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2006, J VIROL, V80, P11528, DOI 10.1128/JVI.00754-06; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Hunter WB, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_28.1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu J, 2006, J GEN VIROL, V87, P3667, DOI 10.1099/vir.0.82090-0; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Millan-Leiva A, 2012, J INVERTEBR PATHOL, V109, P127, DOI 10.1016/j.jip.2011.10.009; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0; Roberts LO, 2009, VIRUS RES, V139, P157, DOI 10.1016/j.virusres.2008.07.017; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terio V, 2008, NEW MICROBIOL, V31, P439; van Oers MM, 2010, INSECT VIROLOGY, P231; Wang XC, 2004, J GEN VIROL, V85, P1145, DOI 10.1099/vir.0.19638-0; Wu TY, 2007, FEBS LETT, V581, P3120, DOI 10.1016/j.febslet.2007.05.070; Ye S, 2012, VIROLOGY, V428, P136, DOI 10.1016/j.virol.2012.04.002; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996	37	16	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92107	10.1371/journal.pone.0092107	http://dx.doi.org/10.1371/journal.pone.0092107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637949	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100112
J	Haller, C; Berthold, M; Wobser, D; Kropec, A; Lauriola, M; Schlensak, C; Huebner, J				Haller, Christoph; Berthold, Martin; Wobser, Dominique; Kropec, Andrea; Lauriola, Marinella; Schlensak, Christian; Huebner, Johannes			Cell-Wall Glycolipid Mutations and Their Effects on Virulence of E. faecalis in a Rat Model of Infective Endocarditis	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; RESISTANT ENTEROCOCCI; BIOFILM FORMATION; IN-VITRO; FAECIUM; DISEASE	Enterococci are among the major pathogens implicated in cardiac infections and biofilm formation. E. faecalis has been shown to play an important role in infectious endocarditis. Several distinct mechanisms for biofilm formation have been identified in E. faecalis. Our group has previously characterized two distinct bacterial glucosyltransferases playing key roles in the production of the major cell wall glycolipids and leading to reduced biofilm production. To assess if this mechanism is involved in the pathogenesis of enterococcal endocarditis we compared the wild-type strain of E. faecalis 12030 with two mutants in gene EF2891 and EF2890 respectively in a rat model of infective endocarditis. The results showed less endocarditic lesions and reduced colony counts per vegetation in the two mutants. indicating that the modification of bacterial surface lipids results in significantly reduced virulence in infective endocarditis. These results underscore the important role of biofilm formation in the pathogenicity of enterococcal endocarditis and may indicate an interesting target for novel therapeutic strategies.	[Haller, Christoph; Schlensak, Christian] Univ Med Ctr Tubingen, Dept Thorac & Cardiovasc Surg, Tubingen, Germany; [Berthold, Martin; Wobser, Dominique; Kropec, Andrea; Lauriola, Marinella] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany; [Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; University of Munich	Huebner, J (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany.	johannes.huebner@med.uni-muenchen.de		Huebner, Johannes/0000-0003-1232-4646; lauriola, marinella/0000-0001-9228-5389				Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Baldassarri L, 2001, MED MICROBIOL IMMUN, V190, P113, DOI 10.1007/s00430-001-0096-8; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; DURACK DT, 1972, BRIT J EXP PATHOL, V53, P44; Guo QY, 2006, FEMS MICROBIOL LETT, V264, P8, DOI 10.1111/j.1574-6968.2006.00378.x; Heikens E, 2011, MICROBES; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Joyanes P, 2000, EUR J CLIN MICROBIOL, V19, P124, DOI 10.1007/s100960050443; Joyanes Providencia, 1999, Clin Microbiol Infect, V5, P382, DOI 10.1111/j.1469-0691.1999.tb00160.x; Nallapareddy SR, 2011, RELATIVE CONTRIBUTIO; Paganelli F, 2011, TRENDS MICROBIOLOGY; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Sandoe JAT, 2003, J MED MICROBIOL, V52, P547, DOI 10.1099/jmm.0.05201-0; SANTORO J, 1978, INFECT IMMUN, V19, P915, DOI 10.1128/IAI.19.3.915-918.1978; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Su SH, 1998, ASAIO J, V44, P770, DOI 10.1097/00002480-199811000-00003; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Werner G., 2008, EURO SURVEILL, V13, P19046	23	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91863	10.1371/journal.pone.0091863	http://dx.doi.org/10.1371/journal.pone.0091863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637922	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100072
J	Karlas, T; Petroff, D; Garnov, N; Bohm, S; Tenckhoff, H; Wittekind, C; Wiese, M; Schiefke, I; Linder, N; Schaudinn, A; Busse, H; Kahn, T; Mossner, J; Berg, T; Troltzsch, M; Keim, V; Wiegand, J				Karlas, Thomas; Petroff, David; Garnov, Nikita; Boehm, Stephan; Tenckhoff, Hannelore; Wittekind, Christian; Wiese, Manfred; Schiefke, Ingolf; Linder, Nicolas; Schaudinn, Alexander; Busse, Harald; Kahn, Thomas; Moessner, Joachim; Berg, Thomas; Troeltzsch, Michael; Keim, Volker; Wiegand, Johannes			Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and H-1-MR Spectroscopy	PLOS ONE			English	Article							FATTY LIVER-DISEASE; VISCERAL ADIPOSE-TISSUE; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; FIBROSIS; DIAGNOSIS; CAP; QUANTIFICATION; MRI; ASSOCIATION	Introduction: Non-invasive assessment of steatosis and fibrosis is of growing relevance in non-alcoholic fatty liver disease (NAFLD). H-1-Magnetic resonance spectroscopy (H-1-MRS) and the ultrasound-based controlled attenuation parameter (CAP) correlate with biopsy proven steatosis, but have not been correlated with each other so far. We therefore performed a headto- head comparison between both methods. Methods: Fifty patients with biopsy-proven NAFLD and 15 healthy volunteers were evaluated with H-1-MRS and transient elastography (TE) including CAP. Steatosis was defined according to the percentage of affected hepatocytes: S1 5-33%, S2 34-66%, S3 >= 67%. Results: Steatosis grade in patients with NAFLD was S1 36%, S2 40% and S3 24%. CAP and H-1-MRS significantly correlated with histopathology and showed comparable accuracy for the detection of hepatic steatosis: areas under the receiveroperating characteristics curves were 0.93 vs. 0.88 for steatosis >= S1 and 0.94 vs. 0.88 for >= S2, respectively. Boot-strapping analysis revealed a CAP cut-off of 300 dB/m for detection of S2-3 steatosis, while retaining the lower cut-off of 215 dB/m for the definition of healthy individuals. Direct comparison between CAP and H-1-MRS revealed only modest correlation (total cohort: r = 0.63 [0.44, 0.76]; NAFLD cases: r = 0.56 [0.32, 0.74]). For detection of F2-4 fibrosis TE had sensitivity and specificity of 100% and 98.1% at a cut-off value of 8.85 kPa. Conclusion: Our data suggest a comparable diagnostic value of CAP and H-1-MRS for hepatic steatosis quantification. Combined with the simultaneous TE fibrosis assessment, CAP represents an efficient method for non-invasive characterization of NAFLD. Limited correlation between CAP and H-1-MRS may be explained by different technical aspects, anthropometry, and presence of advanced liver fibrosis.	[Karlas, Thomas; Petroff, David; Garnov, Nikita; Linder, Nicolas; Schaudinn, Alexander; Wiegand, Johannes] Leipzig Univ Med Ctr, IFB AdiposityDis, Leipzig, Germany; [Karlas, Thomas; Moessner, Joachim; Troeltzsch, Michael; Keim, Volker; Wiegand, Johannes] Univ Hosp Leipzig, Div Gastroenterol & Rheumatol, Dept Med Neurol & Dermatol, Leipzig, Germany; [Petroff, David] Univ Leipzig, Clin Trial Ctr, D-04109 Leipzig, Germany; [Garnov, Nikita; Linder, Nicolas; Schaudinn, Alexander; Busse, Harald; Kahn, Thomas] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany; [Boehm, Stephan; Tenckhoff, Hannelore; Wiese, Manfred; Berg, Thomas; Wiegand, Johannes] Univ Hosp Leipzig, Div Gastroenterol & Rheumatol, Sect Hepatol, Dept Med Neurol & Dermatol, Leipzig, Germany; [Wittekind, Christian] Univ Hosp Leipzig, Inst Pathol, Leipzig, Germany; [Schiefke, Ingolf] Klinikum St Georg, Clin Gastroenterol & Hepatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University	Wiegand, J (corresponding author), Leipzig Univ Med Ctr, IFB AdiposityDis, Leipzig, Germany.	johannes.wiegand@medizin.uni-leipzig.de	Karlas, Thomas/I-1782-2019	Karlas, Thomas/0000-0002-8109-8526; Berg, Thomas/0000-0003-0003-6241	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001, K7-40]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001 (Project No. K7-40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2013, EXPERT REV GASTROENT, V7, P205, DOI [10.1586/EGH.13.7, 10.1586/egh.13.7]; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bedossa P, 2009, J HEPATOL, V50, P1, DOI 10.1016/j.jhep.2008.10.014; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chon YE, 2014, LIVER INT, V34, P102, DOI 10.1111/liv.12282; Corwin A, 2012, EMERG RADIOL, V19, P141, DOI 10.1007/s10140-011-1010-3; Cournane S, 2012, PHYS MED BIOL, V57, P3901, DOI 10.1088/0031-9155/57/12/3901; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Dyson JK, 2013, J CLIN PATHOL, V66, P1033, DOI 10.1136/jclinpath-2013-201620; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Friedrich-Rust M, 2012, EUR J RADIOL, V81, pE325, DOI 10.1016/j.ejrad.2011.10.029; Guiu B, 2012, GUT, V61, P1369, DOI 10.1136/gutjnl-2011-301780; Guiu B, 2012, EUR RADIOL, V22, P855, DOI 10.1007/s00330-011-2326-9; Guiu B, 2009, J HEPATOL, V51, P1082, DOI 10.1016/j.jhep.2009.09.006; Hamilton G, 2009, J MAGN RESON IMAGING, V30, P145, DOI 10.1002/jmri.21809; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Iwasaki T, 2011, HEPATO-GASTROENTEROL, V58, P2103, DOI 10.5754/hge11263; Jin X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034198; Karlas T, 2013, BEST PRACT RES CL EN, V27, P195, DOI 10.1016/j.beem.2013.02.002; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Kumar M, 2013, J GASTROEN HEPATOL, V28, P1194, DOI 10.1111/jgh.12134; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Myers RP, 2012, J HEPATOL, V56, P564, DOI 10.1016/j.jhep.2011.10.007; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rosendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029433; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; So R, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-56; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Thormer G, 2013, J MAGN RESON IMAGING, V37, P1144, DOI 10.1002/jmri.23890; Thomas E Louise, 2007, Atherosclerosis, V195, pe181, DOI 10.1016/j.atherosclerosis.2007.03.043; Le TA, 2012, HEPATOLOGY, V56, P922, DOI 10.1002/hep.25731; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wong GLH, 2013, WORLD J HEPATOL, V5, P264, DOI 10.4254/wjh.v5.i5.264; Wong VWS, 2012, AM J GASTROENTEROL, V107, P1862, DOI 10.1038/ajg.2012.331; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; ZWEIG MH, 1993, CLIN CHEM, V39, P561	56	105	113	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91987	10.1371/journal.pone.0091987	http://dx.doi.org/10.1371/journal.pone.0091987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637477	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100097
J	Kwakkenbos, L; Willems, LM; Baron, M; Hudson, M; Cella, D; van den Ende, CHM; Thombs, BD				Kwakkenbos, Linda; Willems, Linda M.; Baron, Murray; Hudson, Marie; Cella, David; van den Ende, Cornelia H. M.; Thombs, Brett D.		Canadian Scleroderma Res Grp	The Comparability of English, French and Dutch Scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): An Assessment of Differential Item Functioning in Patients with Systemic Sclerosis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; VITALITY SUBSCALE; RESPONSE THEORY; DISEASE; SCALES; PROMIS; OCCUPATIONS; RELIABILITY; SEVERITY; SYMPTOMS	Objective: The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) is commonly used to assess fatigue in rheumatic diseases, and has shown to discriminate better across levels of the fatigue spectrum than other commonly used measures. The aim of this study was to assess the cross-language measurement equivalence of the English, French, and Dutch versions of the FACIT-F in systemic sclerosis (SSc) patients. Methods: The FACIT-F was completed by 871 English-speaking Canadian, 238 French-speaking Canadian and 230 Dutch SSc patients. Confirmatory factor analysis was used to assess the factor structure in the three samples. The Multiple-Indicator Multiple-Cause (MIMIC) model was utilized to assess differential item functioning (DIF), comparing English versus French and versus Dutch patient responses separately. Results: A unidimensional factor model showed good fit in all samples. Comparing French versus English patients, statistically significant, but small-magnitude DIF was found for 3 of 13 items. French patients had 0.04 of a standard deviation (SD) lower latent fatigue scores than English patients and there was an increase of only 0.03 SD after accounting for DIF. For the Dutch versus English comparison, 4 items showed small, but statistically significant, DIF. Dutch patients had 0.20 SD lower latent fatigue scores than English patients. After correcting for DIF, there was a reduction of 0.16 SD in this difference. Conclusions: There was statistically significant DIF in several items, but the overall effect on fatigue scores was minimal. English, French and Dutch versions of the FACIT-F can be reasonably treated as having equivalent scoring metrics.	[Kwakkenbos, Linda; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Kwakkenbos, Linda; Baron, Murray; Hudson, Marie; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Willems, Linda M.; van den Ende, Cornelia H. M.] Sint Maartensklin Nijmegen, Dept Rheumatol, Nijmegen, Netherlands; [Baron, Murray; Hudson, Marie; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Cella, David] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University; Sint Maartens Clinic; McGill University; Northwestern University; Feinberg School of Medicine; McGill University; McGill University; McGill University	Kwakkenbos, L (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	kwakkenbosL@gmail.com	Baron, Murray/AAF-9486-2019; Pope, Janet/G-3342-2011; Kwakkenbos, Linda/GXH-2756-2022; van den Ende, Cornelia/G-9559-2011; van den Ende, Cornelia/ABG-7626-2020	Pope, Janet/0000-0003-1479-5302; Kwakkenbos, Linda/0000-0002-1573-4504; van den Ende, Cornelia/0000-0002-4352-2824; 	Dutch patient organization for patients with systemic autoimmune diseases (NVLE); Canadian Scleroderma Research Group; Canadian Institutes of Health Research (CIHR) [FRN 83518]; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc. (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH (Neuried, Germany); FRSQ; Canadian Arthritis Network (CAN); Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer; Actelion pharmaceuticals; Fonds de la Recherche en Sante Quebec (FRSQ); Arthritis Society	Dutch patient organization for patients with systemic autoimmune diseases (NVLE); Canadian Scleroderma Research Group; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc. (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH (Neuried, Germany); FRSQ(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network (CAN); Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer(Pfizer); Actelion pharmaceuticals; Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Arthritis Society	This work was supported by the Dutch patient organization for patients with systemic autoimmune diseases (NVLE) and the Canadian Scleroderma Research Group which receives grant funding from the Canadian Institutes of Health Research (CIHR) (grant #FRN 83518), the Scleroderma Society of Canada and its provincial Chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, CA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), FRSQ, the Canadian Arthritis Network (CAN), and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC. The CSRG has also received educational grants from Pfizer and Actelion pharmaceuticals. Dr. Baron is the director of the Canadian Scleroderma Research Group. Dr. Kwakkenbos is supported by a Fonds de la Recherche en Sante Quebec (FRSQ) postdoctoral fellowship. Dr. Thombs is supported by an Investigator Salary Award from the Arthritis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, KELLEYS TXB RHEUMATO; Bassel M, 2011, RHEUMATOLOGY, V50, P762, DOI 10.1093/rheumatology/keq310; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bjorner JB, 2014, J CLIN EPIDEMIOL, V67, P108, DOI 10.1016/j.jclinepi.2013.07.016; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Cella D, 2005, J RHEUMATOL, V32, P811; Cella D, 2011, SUPPORT CARE CANCER, V19, P1441, DOI 10.1007/s00520-010-0971-1; Cohen J.E., 1988, STAT POWER ANAL BEHA; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Harel D, 2012, RHEUMATOLOGY, V51, P2177, DOI 10.1093/rheumatology/kes206; Hewlett S, 2007, ARTHRIT RHEUM-ARTHR, V57, P429, DOI 10.1002/art.22611; Hewlett S, 2011, ARTHRIT CARE RES, V63, pS263, DOI 10.1002/acr.20579; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Hoogeboom TJ, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2012-001161, 10.1136/bmjopen-2013-003563]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudson M, 2009, J RHEUMATOL, V36, P2481, DOI 10.3899/jrheum.081237; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; LEROY EC, 1988, J RHEUMATOL, V15, P202; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nikolaus S, 2013, J CLIN EPIDEMIOL, V66, P1175, DOI 10.1016/j.jclinepi.2013.05.010; Nikolaus S, 2013, ARTHRIT CARE RES, V65, P1128, DOI 10.1002/acr.21949; Olson K, 2007, ONCOL NURS FORUM, V34, P93, DOI 10.1188/07.ONF.93-99; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Richards HL, 2003, ARTHRIT RHEUM-ARTHR, V49, P689, DOI 10.1002/art.11385; Sandqvist G, 2008, RHEUMATOLOGY, V47, P1708, DOI 10.1093/rheumatology/ken359; Sandqvist G, 2008, DISABIL REHABIL, V30, P27, DOI 10.1080/09638280701190083; Sandusky SB, 2009, RHEUMATOLOGY, V48, P165, DOI 10.1093/rheumatology/ken455; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Strickland G, 2012, CLIN RHEUMATOL, V31, P1215, DOI 10.1007/s10067-012-1997-1; Suarez-Almazor ME, 2007, J RHEUMATOL, V34, P1718; Teresi JA, 2006, MED CARE, V44, pS39, DOI 10.1097/01.mlr.0000245452.48613.45; Thombs BD, 2008, RHEUMATOLOGY, V47, P1559, DOI 10.1093/rheumatology/ken331; Thombs BD, 2012, CLIN EXP RHEUMATOL, V30, pS23; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tyndall A, 2005, Ann Rheum Dis, V64, P1107, DOI 10.1136/ard.2005.036038; van Lankveld WGJM, 2007, RHEUMATOLOGY, V46, P872, DOI 10.1093/rheumatology/kem008; Wigley FM, RHEUMATOLOGY, P1463; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6; Zumbo BD, 1999, HDB THEORY METHODS D; ZWICK R, 1997, 9705 ED TEST SERV	43	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91979	10.1371/journal.pone.0091979	http://dx.doi.org/10.1371/journal.pone.0091979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24638101	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100095
J	Pyykko, OT; Lumela, M; Rummukainen, J; Nerg, O; Seppala, TT; Herukka, SK; Koivisto, AM; Alafuzoff, I; Puli, L; Savolainen, S; Soininen, H; Jaaskelainen, JE; Hiltunen, M; Zetterberg, H; Leinonen, V				Pyykko, Okko T.; Lumela, Miikka; Rummukainen, Jaana; Nerg, Ossi; Seppala, Toni T.; Herukka, Sanna-Kaisa; Koivisto, Anne M.; Alafuzoff, Irina; Puli, Lakshman; Savolainen, Sakari; Soininen, Hilkka; Jaaskelainen, Juha E.; Hiltunen, Mikko; Zetterberg, Henrik; Leinonen, Ville			Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MYELIN BASIC-PROTEIN; ALZHEIMERS-DISEASE; CSF BIOMARKERS; BETA; NEUROFILAMENT	Background: The significance of amyloid precursor protein (APP) and neuroinflammation in idiopathic normal pressure hydrocephalus (iNPH) and Alzheimer's disease (AD) is unknown. Objective: To investigate the role of soluble APP (sAPP) and amyloid beta (Ab) isoforms, proinflammatory cytokines, and biomarkers of neuronal damage in the cerebrospinal fluid (CSF) in relation to brain biopsy Ab and hyperphosphorylated tau (HPt) findings. Methods: The study population comprised 102 patients with possible NPH with cortical brain biopsies, ventricular and lumbar CSF samples, and DNA available. The final clinical diagnoses were: 53 iNPH (91% shunt-responders), 26 AD (10 mixed iNPH+AD), and 23 others. Biopsy samples were immunostained against Ab and HPt. CSF levels of AD-related biomarkers (Ab42, p-tau, total tau), non-AD-related Ab isoforms (Ab38, Ab40), sAPP isoforms (sAPPa, sAPPb), proinflammatory cytokines (several interleukins (IL), interferon-gamma, monocyte chemoattractant protein-1, tumor necrosis factor-alpha) and biomarkers of neuronal damage (neurofilament light and myelin basic protein) were measured. All patients were genotyped for APOE. Results: Lumbar CSF levels of sAPP alpha were lower (p<0.05) in patients with shunt-responsive iNPH compared to non-iNPH patients. sAPPb showed a similar trend (p = 0.06). CSF sAPP isoform levels showed no association to Ab or HPt in the brain biopsy. Quantified Ab load in the brain biopsy showed a negative correlation with CSF levels of Ab42 in ventricular (r = 20.295, p = 0.003) and lumbar (r = 20.356, p = 0.01) samples, while the levels of Ab38 and Ab40 showed no correlation. CSF levels of proinflammatory cytokines and biomarkers of neuronal damage did not associate to the brain biopsy findings, diagnosis, or shunt response. Higher lumbar/ventricular CSF IL-8 ratios (p<0.001) were seen in lumbar samples collected after ventriculostomy compared to the samples collected before the procedure. Conclusions: The role of sAPP isoforms in iNPH seems to be independent from the amyloid cascade. No neuroinflammatory background was observed in iNPH or AD.	[Pyykko, Okko T.; Lumela, Miikka; Savolainen, Sakari; Jaaskelainen, Juha E.; Leinonen, Ville] Kuopio Univ Hosp, Neurosurg NeuroCtr, SF-70210 Kuopio, Finland; [Nerg, Ossi; Herukka, Sanna-Kaisa; Koivisto, Anne M.; Soininen, Hilkka] Kuopio Univ Hosp, Neurol NeuroCtr, SF-70210 Kuopio, Finland; [Seppala, Toni T.; Herukka, Sanna-Kaisa; Koivisto, Anne M.; Puli, Lakshman; Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med, Dept Neurol, Kuopio, Finland; [Rummukainen, Jaana] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland; [Alafuzoff, Irina] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Clin Neurochem Lab, Gothenburg, Sweden	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Uppsala University; University of Gothenburg	Pyykko, OT (corresponding author), Kuopio Univ Hosp, Neurosurg NeuroCtr, SF-70210 Kuopio, Finland.	okko.pyykko@gmail.com	Seppälä, Toni T./D-4518-2015	Seppälä, Toni T./0000-0002-4940-3498; Nerg, Ossi/0000-0002-2401-9078; PULI, LAKSHMAN/0000-0001-9140-2360	Health Research Council of the Academy of Finland; The Finnish Medical Foundation; EVO/VTR grants, Kuopio University Hospital [5252614, 5772708]; University of Eastern Finland; Finnish Cultural Foundation's North Savo Regional Fund	Health Research Council of the Academy of Finland(Academy of Finland); The Finnish Medical Foundation; EVO/VTR grants, Kuopio University Hospital; University of Eastern Finland; Finnish Cultural Foundation's North Savo Regional Fund(Finnish Cultural Foundation)	This study was funded by the Health Research Council of the Academy of Finland, The Finnish Medical Foundation, EVO/VTR grants from the Kuopio University Hospital 5252614, 5772708, the strategic funding from the University of Eastern Finland, and Finnish Cultural Foundation's North Savo Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Agren-Wilsson A, 2007, ACTA NEUROL SCAND, V116, P333, DOI 10.1111/j.1600-0404.2007.00890.x; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P455; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Cusimano MD, 2011, CAN J NEUROL SCI, V38, P274, DOI 10.1017/S031716710001146X; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; Hamilton R, 2010, ANN NEUROL, V68, P535, DOI 10.1002/ana.22015; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Koivisto AM, 2013, NEUROSURGERY, V72, P1, DOI 10.1227/NEU.0b013e31827414b3; Leinonen V, 2012, NEUROPATH APPL NEURO, V38, P72, DOI 10.1111/j.1365-2990.2011.01195.x; Leinonen V, 2008, ARCH NEUROL-CHICAGO, V65, P1304, DOI 10.1001/archneur.65.10.noc80013; Leinonen Ville, 2011, Int J Alzheimers Dis, V2011, P312526, DOI 10.4061/2011/312526; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; McGirr A, 2012, J NEUROL SCI, V321, P82, DOI 10.1016/j.jns.2012.07.062; Miyajima M, 2013, EUR J NEUROL, V20, P236, DOI 10.1111/j.1468-1331.2012.03781.x; Patel S, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-7; Pyykko OT, 2012, J NEUROL NEUROSUR PS, V83, P1119, DOI [10.1136/jnnp-2012-303849, 10.1136/jnnp-2011-303849]; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ray B, 2011, J PSYCHIATR RES, V45, P539, DOI 10.1016/j.jpsychires.2010.07.011; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Rinne JO, 2012, ACTA NEUROPATHOL, V124, P833, DOI 10.1007/s00401-012-1051-z; Rota E, 2006, NEUROL SCI, V27, P33, DOI 10.1007/s10072-006-0562-6; Selnes P, 2010, CEREBROSPINAL FLUID, V7; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Stoeck K, 2005, ARCH NEUROL-CHICAGO, V62, P1591, DOI 10.1001/archneur.62.10.1591; Sundstrom N, 2010, J NEUROSURG, V113, P1294, DOI 10.3171/2010.8.JNS10157; SUTTON LN, 1983, J NEUROSURG, V59, P467, DOI 10.3171/jns.1983.59.3.0467; Tarkowski E, 2003, NEUROBIOL AGING, V24, P707, DOI 10.1016/S0197-4580(02)00187-2; Tarnaris A, 2011, J NEUROSURG, V115, P145, DOI 10.3171/2011.2.JNS101316; Tarnaris A, 2009, BIOMARK MED, V3, P787, DOI 10.2217/BMM.09.37; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; Tullberg M, 1998, NEUROLOGY, V50, P1122, DOI 10.1212/WNL.50.4.1122; Tullberg M, 2007, EUR J NEUROL, V14, P248, DOI 10.1111/j.1468-1331.2006.01553.x; Tullberg M, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-9; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Whitaker JN, 1998, MULT SCLER J, V4, P16, DOI 10.1191/135245898678909123; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102	44	66	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91974	10.1371/journal.pone.0091974	http://dx.doi.org/10.1371/journal.pone.0091974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638077	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100094
J	Tebbich, S; Teschke, I				Tebbich, Sabine; Teschke, Irmgard			Coping with Uncertainty: Woodpecker Finches (Cactospiza pallida) from an Unpredictable Habitat Are More Flexible than Birds from a Stable Habitat	PLOS ONE			English	Article							TOOL-USE; BEHAVIORAL DRIVE; EVOLUTION; INHIBITION; GALAPAGOS; SIZE	Behavioural flexibility is thought to be a major factor in evolution. It may facilitate the discovery and exploitation of new resources, which in turn may expose populations to novel selective forces and facilitate adaptive radiation. Darwin's finches are a textbook example of adaptive radiation. They are fast learners and show a range of unusual foraging techniques, probably as a result of their flexibility. In this study we aimed to test whether variability of the environment is correlated with flexibility. We compared woodpecker finches from a dry area (hereafter, Arid Zone), where food availability is variable, with individuals from a cloud forest (hereafter, Scalesia zone) where food abundance is stable. As parameters for flexibility, we measured neophilia and neophobia, which are two aspects of reaction to novelty, reversal learning and problem-solving. We found no differences in performance on a problem-solving task but, in line with our prediction, individuals from the Arid Zone were significantly faster reversal learners and more neophilic than their conspecifics from the Scalesia zone. The latter result supports the notion that environmental variability drives flexibility. In contrast to our prediction, Arid Zone birds were even more neophobic than birds from the Scalesia Zone. The latter result could be the consequence of differences in predation pressure between the two vegetation zones.	[Tebbich, Sabine] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Teschke, Irmgard] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany	University of Vienna; Max Planck Society	Tebbich, S (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	sabine.tebbich@univie.ac.at			FWF [V95-B17]; DFG [TE 628/1-1]; University of St. Andrews	FWF(Austrian Science Fund (FWF)); DFG(German Research Foundation (DFG)); University of St. Andrews	S. Tebbich was funded by the FWF (project number V95-B17) and I. Teschke by the DFG (project number TE 628/1-1). The University of St. Andrews provided additional funding for materials and travel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, ANIMAL SPECIES EVOLU; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Bond AB, 2007, J COMP PSYCHOL, V121, P372, DOI 10.1037/0735-7036.121.4.372; BOWMAN ROBERT L., 1965, LIVING BIRD, V4, P29; Day LB, 1999, ANIM BEHAV, V57, P393, DOI 10.1006/anbe.1998.1007; Duckworth RA, 2009, EVOL ECOL, V23, P513, DOI 10.1007/s10682-008-9252-6; Dukas Reuven, 1998, P129; Eibl-Eibesfeldt I., 1962, Journal fuer Ornithologie, V103, P92, DOI 10.1007/BF01670851; Eibl-Eibesfeldt I., 1961, Zeitschrift fuer Tierpsychologie, V18, P343; Grant P.R., 1999, RECOGNITION STATES L, V2; GRANT PR, 1985, BIOL J LINN SOC, V25, P1, DOI 10.1111/j.1095-8312.1985.tb00384.x; GRANT PR, 1980, AUK, V97, P227; GREENBERG R, 1984, J COMP PSYCHOL, V98, P131, DOI 10.1037/0735-7036.98.2.131; Greenberg R, 2001, CURR ORNITHOL; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Jackson MH, 1993, GALAPAGOS NATURAL HI; Kotrschal A, 2010, PLOS BIOL, V8; Lapiedra O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2893; Lefebvre L, 1997, BEHAV PROCESS, V40, P201, DOI 10.1016/S0376-6357(97)00783-3; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lefebvre Louis, 2003, P39; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Macphail EM, 1996, COGNITIVE BRAIN RES, V3, P279, DOI 10.1016/0926-6410(96)00013-4; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Odling-Smee L, 2003, ANIM BEHAV, V65, P701, DOI 10.1006/anbe.2003.2082; Plotkin H. C., 1988, ROLE BEHAV EVOLUTION; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Price T, 2008, SPECIATION BIRDS; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; Roth TC, 2010, P ROY SOC B-BIOL SCI, V277, P3187, DOI 10.1098/rspb.2010.0630; SCHLUTER D, 1984, AUK, V101, P59, DOI 10.1093/auk/101.1.59; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; Sol D, 2002, ANIM BEHAV, V64, P516, DOI 10.1006/anbe.2002.4005; Sol D, 2012, ANIM BEHAV, V83, P179, DOI 10.1016/j.anbehav.2011.10.024; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; SWARTH HARRY S., 1929, PROC CALIFORNIA ACAD SCI, V18, P29; Tebbich S, 2004, ANIM BEHAV, V67, P689, DOI 10.1016/j.anbehav.2003.08.003; Tebbich S, 2004, CONDOR, V106, P95, DOI 10.1650/7293; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; Teschke I, 2011, ANIM BEHAV, V82, P945, DOI 10.1016/j.anbehav.2011.07.032; Thorpe WH, 1956, LEARNING INSTINCT AN; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; West-Eberhard Mary Jane, 2003, pi	45	33	33	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91718	10.1371/journal.pone.0091718	http://dx.doi.org/10.1371/journal.pone.0091718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24638107	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100054
J	Wang, H; Megill, A; Wong, PC; Kirkwood, A; Lee, HK				Wang, Hui; Megill, Andrea; Wong, Philip C.; Kirkwood, Alfredo; Lee, Hey-Kyoung			Postsynaptic Target Specific Synaptic Dysfunctions in the CA3 Area of BACE1 Knockout Mice	PLOS ONE			English	Article							BETA-SECRETASE BACE1; NICOTINIC ACETYLCHOLINE-RECEPTORS; ALZHEIMERS-DISEASE; MOSSY FIBER; FEEDFORWARD INHIBITION; RAT HIPPOCAMPUS; A-BETA; GABAERGIC INTERNEURONS; SILENT SYNAPSES; AMYLOID-BETA	Beta-amyloid precursor protein cleaving enzyme 1 (BACE1), a major neuronal beta-secretase critical for the formation of beta-amyloid (A beta) peptide, is considered one of the key therapeutic targets that can prevent the progression of Alzheimer's disease (AD). Although a complete ablation of BACE1 gene prevents Ab formation, we previously reported that BACE1 knockouts (KOs) display presynaptic deficits, especially at the mossy fiber (MF) to CA3 synapses. Whether the defect is specific to certain inputs or postsynaptic targets in CA3 is unknown. To determine this, we performed whole-cell recording from pyramidal cells (PYR) and the stratum lucidum (SL) interneurons in the CA3, both of which receive excitatory MF terminals with high levels of BACE1 expression. BACE1 KOs displayed an enhancement of paired-pulse facilitation at the MF inputs to CA3 PYRs without changes at the MF inputs to SL interneurons, which suggests postsynaptic target specific regulation. The synaptic dysfunction in CA3 PYRs was not restricted to excitatory synapses, as seen by an increase in the paired-pulse ratio of evoked inhibitory postsynaptic currents from SL to CA3 PYRs. In addition to the changes in evoked synaptic transmission, BACE1 KOs displayed a reduction in the frequency of miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs) in CA3 PYRs without alteration in mEPSCs recorded from SL interneurons. This suggests that the impairment may be more global across diverse inputs to CA3 PYRs. Our results indicate that the synaptic dysfunctions seen in BACE1 KOs are specific to the postsynaptic target, the CA3 PYRs, independent of the input type.	[Wang, Hui; Megill, Andrea; Kirkwood, Alfredo; Lee, Hey-Kyoung] Johns Hopkins Univ, Mind Brain Inst, Dept Neurosci, Baltimore, MD 21218 USA; [Wang, Hui; Lee, Hey-Kyoung] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol & Neurosci, Baltimore, MD USA	Johns Hopkins University; University System of Maryland; University of Maryland College Park; Johns Hopkins University	Lee, HK (corresponding author), Johns Hopkins Univ, Mind Brain Inst, Dept Neurosci, Baltimore, MD 21218 USA.	heykyounglee@jhu.edu		Lee, Hey-Kyoung/0000-0002-5554-983X	National Institute of Health [P01-NS047308, R01-AG034606]; Robert and Florence Deutsch Graduate Award; Ann G. Wylie Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, R01AG034606] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Florence Deutsch Graduate Award; Ann G. Wylie Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Health grants (P01-NS047308 to PCW and H-KL; R01-AG034606 to AK), the Robert and Florence Deutsch Graduate Award (UMD to HW), and the Ann G. Wylie Dissertation Fellowship (UMD to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1998, J NEUROSCI, V18, P3386; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Chen YM, 2012, J NEUROSCI, V32, P11390, DOI 10.1523/JNEUROSCI.0757-12.2012; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Giusti-Rodriguez P, 2011, J NEUROSCI, V31, P15751, DOI 10.1523/JNEUROSCI.3588-11.2011; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; LANGDON RB, 1993, J PHYSIOL-LONDON, V472, P157, DOI 10.1113/jphysiol.1993.sp019941; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Le Magueresse C, 2006, J PHYSIOL-LONDON, V576, P533, DOI 10.1113/jphysiol.2006.117572; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Liu Y, 2001, J NEUROSCI, V21, P5660, DOI 10.1523/JNEUROSCI.21-15-05660.2001; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Maggi L, 2003, P NATL ACAD SCI USA, V100, P2059, DOI 10.1073/pnas.0437947100; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; SEGUELA P, 1993, J NEUROSCI, V13, P596; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Torborg CL, 2010, J NEUROSCI, V30, P15628, DOI 10.1523/JNEUROSCI.3099-10.2010; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Wang H, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/272374; Wang H, 2010, J NEUROSCI, V30, P13808, DOI 10.1523/JNEUROSCI.1070-10.2010; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Zhong CB, 2008, J NEUROSCI, V28, P9111, DOI 10.1523/JNEUROSCI.0381-08.2008	51	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92279	10.1371/journal.pone.0092279	http://dx.doi.org/10.1371/journal.pone.0092279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637500	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100137
J	Bu, Y; Jia, QA; Ren, ZG; Zhang, JB; Jiang, XM; Liang, L; Xue, TC; Zhang, QB; Wang, YH; Zhang, L; Xie, XY; Tang, ZY				Bu, Yang; Jia, Qing-An; Ren, Zheng-Gang; Zhang, Ju-Bo; Jiang, Xue-Mei; Liang, Lei; Xue, Tong-Chun; Zhang, Quan-Bao; Wang, Yan-Hong; Zhang, Lan; Xie, Xiao-Ying; Tang, Zhao-You			Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-INITIATING CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; I RECEPTOR; CANCER; INSULIN; CHEMORESISTANCE; METASTASIS	Background: Evidence suggests that many types of cancers are composed of different cell types, including cancer stem cells (CSCs). We have previously shown that the chemotherapeutic agent oxaliplatin induced epithelial-mesenchymal transition, which is thought to be an important mechanism for generating CSCs. In the present study, we investigate whether oxaliplatin-treated cancer tissues possess characteristics of CSCs, and explore oxaliplatin resistance in these tissues. Methods: Hepatocellular carcinoma cells (MHCC97H cells) were subcutaneously injected into mice to form tumors, and the mice were intravenously treated with either oxaliplatin or glucose. Five weeks later, the tumors were orthotopically xenografted into livers of other mice, and these mice were treated with either oxaliplatin or glucose. Metastatic potential, sensitivity to oxaliplatin, and expression of CSC-related markers in the xenografted tumor tissues were evaluated. DNA microarrays were used to measure changes in gene expression as a result of oxaliplatin treatment. Additionally, an oxaliplatin-resistant cell line (MHCC97H-OXA) was established to assess insulin-like growth factor 1 secretion, cell invasion, cell colony formation, oxaliplatin sensitivity, and expression of CSC-related markers. The effects of an insulin-like growth factor 1 receptor inhibitor were also assessed. Results: Oxaliplatin treatment inhibited subcutaneous tumor growth. Tumors from oxaliplatin-treated mice that were subsequently xenografted into livers of other mice exhibited that decreasing sensitivity to oxaliplatin and increasing pulmonary metastatic potential. Among the expression of CSC-related proteins, the gene for insulin-like growth factor 1, was up-regulated expecially in these tumor tissues. Additionally, MHCC97H-OXA cells demonstrated that increasing cell invasion, colony formation, and expression of insulin-like growth factor 1 and CSC-related markers, whereas treatment with an inhibitor of the insulin-like growth factor 1 receptor suppressed these effects. Conclusion: Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma cells is associated with increased autocrine of IGF1.	[Bu, Yang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Bu, Yang; Jia, Qing-An; Ren, Zheng-Gang; Zhang, Ju-Bo; Liang, Lei; Xue, Tong-Chun; Zhang, Quan-Bao; Wang, Yan-Hong; Zhang, Lan; Xie, Xiao-Ying; Tang, Zhao-You] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Liver Canc Inst,Zhongshan Hosp, Shanghai 200433, Peoples R China; [Jia, Qing-An] Shanxi Prov Peoples Hosp, Xian, Peoples R China; [Jiang, Xue-Mei] Haikou Peoples Hosp, Dept Gastroenterol, Haikou, Peoples R China	Fudan University; Fudan University; Shanxi People's Hospital	Tang, ZY (corresponding author), Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Liver Canc Inst,Zhongshan Hosp, Shanghai 200433, Peoples R China.	zytang88@163.com	wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022		Foundation of China National '211' Project for Higher Education [2007-353]; National Key Science, Technology Specific Project [2008ZX10002-019]; National Natural Science Foundation of China [81172275, 21272565]; National Basic Research Program of China (973 Program) [2009CB521700]	Foundation of China National '211' Project for Higher Education; National Key Science, Technology Specific Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research project was supported in part by grants from The Foundation of China National '211' Project for Higher Education (No. 2007-353); The National Key Science, Technology Specific Project (2008ZX10002-019); The National Natural Science Foundation of China (81172275 and 21272565); and The National Basic Research Program of China (973 Program, 2009CB521700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2006, CLIN CANCER RES, V12, P5611, DOI 10.1158/1078-0432.CCR-06-1564; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Bitelman C, 2013, CANC LETT; Bodzin AS, 2012, J CELL PHYSIOL, V227, P2947, DOI 10.1002/jcp.23041; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Costello RT, 2000, CANCER RES, V60, P4403; De Larco JE, 2001, CANCER RES, V61, P2857; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ford NA, 2013, ENDOCR-RELAT CANCER, V20, P39, DOI 10.1530/ERC-12-0329; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia QA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/908601; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; Kajiyama H, 2007, INT J ONCOL, V31, P277; Lee J, 2012, NUTR CANCER, V64, P153, DOI 10.1080/01635581.2012.630161; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Lee TKW, 2011, HEPATOLOGY, V53, P160, DOI 10.1002/hep.24000; Li Z, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-17; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu LL, 2011, STEM CELLS DEV, V20, P2023, DOI 10.1089/scd.2011.0012; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Plymate SR, 2007, CLIN CANCER RES, V13, P6429, DOI 10.1158/1078-0432.CCR-07-0648; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Pollak M, 2008, BEST PRACT RES CL EN, V22, P625, DOI 10.1016/j.beem.2008.08.004; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sivakumar R, 2009, INT J ONCOL, V34, P329, DOI 10.3892/ijo_00000155; Sun YG, 2012, INT J RADIAT ONCOL, V82, pE563, DOI 10.1016/j.ijrobp.2011.06.1999; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Tong CM, 2011, J GASTROEN HEPATOL, V26, P1229, DOI 10.1111/j.1440-1746.2011.06762.x; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Xiao YH, 2012, J IMMUNOL METHODS, V384, P148, DOI 10.1016/j.jim.2012.06.009; Xiong W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-219; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yamauchi K, 2008, CANCER RES, V68, P516, DOI 10.1158/0008-5472.CAN-07-3063; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Ye SL, 2010, ONCOLOGIST, V15, P34, DOI 10.1634/theoncologist.2010-S4-34; Yen Y, 2008, AM J CLIN ONCOL-CANC, V31, P317, DOI 10.1097/COC.0b013e318162f57d; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 ; Zhang T, 2005, CLIN CANCER RES, V11, P8557, DOI 10.1158/1078-0432.CCR-05-0944	52	25	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e89686	10.1371/journal.pone.0089686	http://dx.doi.org/10.1371/journal.pone.0089686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632571	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400007
J	Hammamieh, R; Chakraborty, N; Gautam, A; Miller, SA; Muhie, S; Meyerhoff, J; Jett, M				Hammamieh, Rasha; Chakraborty, Nabarun; Gautam, Aarti; Miller, Stacy-Ann; Muhie, Seid; Meyerhoff, James; Jett, Marti			Transcriptomic Analysis of the Effects of a Fish Oil Enriched Diet on Murine Brains	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SUPPLEMENTATION LOWERS INFLAMMATION; DEFICIENT MALE RATS; GENE-EXPRESSION; DOCOSAHEXAENOIC ACID; BIPOLAR DISORDER; OMEGA-3-FATTY-ACID SUPPLEMENTATION; OMEGA-3 SUPPLEMENTATION; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE	The health benefits of fish oil enriched with high omega-3 polyunsaturated fatty acids (n-3 PUFA) are widely documented. Fish oil as dietary supplements, however, show moderate clinical efficacy, highlighting an immediate scope of systematic in vitro feedback. Our transcriptomic study was designed to investigate the genomic shift of murine brains fed on fish oil enriched diets. A customized fish oil enriched diet (FD) and standard lab diet (SD) were separately administered to two randomly chosen populations of C57BL/6J mice from their weaning age until late adolescence. Statistical analysis mined 1,142 genes of interest (GOI) differentially altered in the hemibrains collected from the FD- and SD-fed mice at the age of five months. The majority of identified GOI (similar to 40%) encodes proteins located in the plasma membrane, suggesting that fish oil primarily facilitated the membrane-oriented biofunctions. FD potentially augmented the nervous system's development and functions by selectively stimulating the Src-mediated calcium-induced growth cascade and the downstream PI3K-AKT-PKC pathways. FD reduced the amyloidal burden, attenuated oxidative stress, and assisted in somatostatin activation-the signatures of attenuation of Alzheimer's disease, Parkinson's disease, and affective disorder. FD induced elevation of FKBP5 and suppression of BDNF, which are often linked with the improvement of anxiety disorder, depression, and post-traumatic stress disorder. Hence we anticipate efficacy of FD in treating illnesses such as depression that are typically triggered by the hypoactivities of dopaminergic, adrenergic, cholinergic, and GABAergic networks. Contrastingly, FD's efficacy could be compromised in treating illnesses such as bipolar disorder and schizophrenia, which are triggered by hyperactivities of the same set of neuromodulators. A more comprehensive investigation is recommended to elucidate the implications of fish oil on disease pathomechanisms, and the result-driven repositioning of fish oil utilization may revitalize its therapeutic efficacy.	[Hammamieh, Rasha; Chakraborty, Nabarun; Gautam, Aarti; Miller, Stacy-Ann; Muhie, Seid; Meyerhoff, James; Jett, Marti] United States Army, Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA		Hammamieh, R (corresponding author), United States Army, Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA.	Rasha.Hammamieh1@us.army.mil		Hammamieh, Rasha/0000-0001-8643-6232	Military and Operational Medicine Research Area Directorate III	Military and Operational Medicine Research Area Directorate III	Funding was provided by the Military and Operational Medicine Research Area Directorate III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Adams PB, 1996, LIPIDS, V31, pS157, DOI 10.1007/BF02637069; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Alkhalil A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-173; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Begg DP, 2012, HYPERTENS RES, V35, P381, DOI 10.1038/hr.2011.194; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bivens CLM, 2004, BIOL REPROD, V70, P1458, DOI 10.1095/biolreprod.103.026351; Blandini F, 2006, NEUROLOGY, V66, P529, DOI 10.1212/01.wnl.0000198511.09968.b3; Bloch MH, 2012, MOL PSYCHIATR, V17, P1272, DOI 10.1038/mp.2011.100; BOURRE JM, 1990, BIOCHIM BIOPHYS ACTA, V1043, P149, DOI 10.1016/0005-2760(90)90288-9; BOURRE JM, 1988, BIOCHIM BIOPHYS ACTA, V960, P458, DOI 10.1016/0005-2760(88)90055-0; BOURRE JM, 1990, LIPIDS, V25, P465, DOI 10.1007/BF02538090; Bousquet M, 2009, PROG NEURO-PSYCHOPH, V33, P1401, DOI 10.1016/j.pnpbp.2009.07.018; Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001; Bousquet M, 2011, J LIPID RES, V52, P263, DOI 10.1194/jlr.M011692; Brenna JT, 2007, PROSTAG LEUKOTR ESS, V77, P247, DOI 10.1016/j.plefa.2007.10.016; Burnashev N, 1998, CELL CALCIUM, V24, P325, DOI 10.1016/S0143-4160(98)90056-2; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066; Carlsen H, 2009, GENES NUTR, V4, P215, DOI 10.1007/s12263-009-0133-6; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Caughey GE, 1996, AM J CLIN NUTR, V63, P116, DOI 10.1093/ajcn/63.1.116; CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; CLARK WF, 1994, AM J KIDNEY DIS, V23, P644, DOI 10.1016/S0272-6386(12)70273-1; Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015; Conklin SM, 2007, PSYCHOSOM MED, V69, P932, DOI 10.1097/PSY.0b013e31815aaa42; Conner JM, 2010, CEREB CORTEX, V20, P2739, DOI 10.1093/cercor/bhq022; Cui HX, 2010, SCHIZOPHR RES, V121, P172, DOI 10.1016/j.schres.2010.05.003; CUNNANE SC, 1984, BRIT J NUTR, V51, P209, DOI 10.1079/BJN19840025; Curcic-Blake B, 2012, NEUROIMAGE, V59, P1540, DOI 10.1016/j.neuroimage.2011.08.036; Cysneiros RM, 2010, EPILEPSY BEHAV, V17, P33, DOI 10.1016/j.yebeh.2009.11.006; da Silva TM, 2008, J AFFECT DISORDERS, V111, P351, DOI 10.1016/j.jad.2008.03.008; De Roo M, 2008, PROG BRAIN RES, V169, P199, DOI 10.1016/S0079-6123(07)00011-8; Deckelbaum RJ, 2012, J NUTR, V142, p587S, DOI 10.3945/jn.111.148080; Duffy EM, 2004, J RHEUMATOL, V31, P1551; ENDRES S, 1993, J LEUKOCYTE BIOL, V54, P599, DOI 10.1002/jlb.54.6.599; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Freeman MP, 2006, PROSTAG LEUKOTR ESS, V75, P291, DOI 10.1016/j.plefa.2006.07.007; Freeman MP, 2006, ACTA PSYCHIAT SCAND, V113, P31, DOI 10.1111/j.1600-0447.2005.00660.x; Gao SF, 2012, CEREB CORTEX; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Gorjao R, 2009, PHARMACOL THERAPEUT, V122, P56, DOI 10.1016/j.pharmthera.2009.01.004; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Grassi-Oliveira R, 2008, BIOL PSYCHIAT, V64, P281, DOI 10.1016/j.biopsych.2008.02.023; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gulesserian T, 2001, J INVEST MED, V49, P41, DOI 10.2310/6650.2001.34089; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hammamieh R, 2007, OMICS, V11, P143, DOI 10.1089/omi.2007.4322; Hammamieh R, 2007, BREAST CANCER RES TR, V101, P7, DOI 10.1007/s10549-006-9269-x; Hammamieh R, 2012, BEHAV BRAIN RES, V235, P55, DOI 10.1016/j.bbr.2012.07.022; Harbeby E, 2012, PROSTAG LEUKOTR ESS, V86, P211, DOI 10.1016/j.plefa.2012.04.008; Hauck S, 2010, PROG NEURO-PSYCHOPH, V34, P459, DOI 10.1016/j.pnpbp.2010.01.010; Heck A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029337; Heerwagen MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067791; Hennebelle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042142; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Hooijmans CR, 2012, J ALZHEIMERS DIS, V28, P191, DOI 10.3233/JAD-2011-111217; Im DS, 2012, PROG LIPID RES, V51, P232, DOI 10.1016/j.plipres.2012.02.003; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kang JI, 2012, PSYCHONEUROENDOCRINO, V37, P1569, DOI 10.1016/j.psyneuen.2012.02.017; Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Kil TH, 2010, EUR J PAEDIATR NEURO, V14, P278, DOI 10.1016/j.ejpn.2009.08.004; Kitajka K, 2002, P NATL ACAD SCI USA, V99, P2619, DOI 10.1073/pnas.042698699; Kitajka K, 2004, P NATL ACAD SCI USA, V101, P10931, DOI 10.1073/pnas.0402342101; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Le-Niculescu H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.1; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lee Y, 2013, PSYCHIAT INVEST, V10, P56, DOI 10.4306/pi.2013.10.1.56; Lei X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070645; Lesperance F, 2011, J CLIN PSYCHIAT, V72, P1054, DOI 10.4088/JCP.10m05966blu; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lin CH, 2011, PARKINSONISM RELAT D, V17, P84, DOI 10.1016/j.parkreldis.2010.11.011; Liuzzi GM, 2007, NEUROCHEM RES, V32, P2184, DOI 10.1007/s11064-007-9415-9; Logan Alan C, 2004, Lipids Health Dis, V3, P25; Lorenzl S, 2003, NEUROCHEM INT, V43, P191, DOI 10.1016/S0197-0186(03)00004-4; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Lucas M, 2011, AM J CLIN NUTR, V93, P1337, DOI 10.3945/ajcn.111.011817; Maes M, 2000, BIOL PSYCHIAT, V47, P910, DOI 10.1016/S0006-3223(99)00268-1; Mann J. J., 2012, NEUROBIOLOGICAL BASI; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Matsuda Y, 1996, CYTOGENET CELL GENET, V74, P107, DOI 10.1159/000134393; Matsuoka Y, 2011, BIOPSYCHOSOC MED, V5, DOI 10.1186/1751-0759-5-3; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Menke A, 2013, GENES BRAIN BEHAV; Meyer JH, 2001, NEUROREPORT, V12, P4121, DOI 10.1097/00001756-200112210-00052; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Muhie S, 2013, GENES IMMUN, V14, P19, DOI 10.1038/gene.2012.49; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Post RM, 2010, NEUROTOX RES, V18, P256, DOI 10.1007/s12640-010-9182-2; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Puskas LG, 2004, BIOCHIMIE, V86, P817, DOI 10.1016/j.biochi.2004.10.004; Reif A, 2011, J ALZHEIMERS DIS, V23, P327, DOI 10.3233/JAD-2010-101491; Rizzo AM, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-82; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Ross BM, 2007, MED HYPOTHESES, V68, P515, DOI 10.1016/j.mehy.2006.07.054; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Rybakowski JK, 2013, J AFFECT DISORDERS, V146, P286, DOI 10.1016/j.jad.2012.07.019; Rybakowski JK, 2009, SCHIZOPHR RES, V109, P90, DOI 10.1016/j.schres.2009.02.005; Sanchez-Resendis O, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00033; Sarris J, 2012, J CLIN PSYCHIAT, V73, P81, DOI 10.4088/JCP.10r06710; Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Silberberg G, 2010, AM J MED GENET B, V153B, P1318, DOI 10.1002/ajmg.b.31112; Simopoulos AP, 2011, WORLD REV NUTR DIET, V102, P10, DOI 10.1159/000327785; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; SOMERVILLE MJ, 1991, MOL BRAIN RES, V9, P1, DOI 10.1016/0169-328X(91)90123-F; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Stomrud E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt44; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; Suk K, 2003, J PHARMACOL EXP THER, V305, P638, DOI 10.1124/jpet.102.047373; Takei S, 2011, J PSYCHIATR RES, V45, P460, DOI 10.1016/j.jpsychires.2010.08.009; Takuma K, 2012, NEUROSCIENCE, V207, P261, DOI 10.1016/j.neuroscience.2012.01.034; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Tuo JS, 2009, AM J PATHOL, V175, P799, DOI 10.2353/ajpath.2009.090089; Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; VONAU D, 1988, EUR J APPL PHYSIOL O, V58, P97, DOI 10.1007/BF00636610; Wakefield SL, 2008, AM J PHYSIOL-ENDOC M, V294, pE425, DOI 10.1152/ajpendo.00409.2007; Wang D, 2013, J BIOL CHEM; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Woodworth HL, 2010, CANCER RES, V70, P7960, DOI 10.1158/0008-5472.CAN-10-1396; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Xu H, 2011, HIPPOCAMPUS, V21, P495, DOI 10.1002/hipo.20767; Yon MA, 2013, BRIT J NUTR, V109, P1573, DOI 10.1017/S000711451200579X; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006	139	27	27	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90425	10.1371/journal.pone.0090425	http://dx.doi.org/10.1371/journal.pone.0090425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632812	Green Published, gold			2022-12-27	WOS:000332858400014
J	Ishikawa, M; Maekawa, K; Saito, K; Senoo, Y; Urata, M; Murayama, M; Tajima, Y; Kumagai, Y; Saito, Y				Ishikawa, Masaki; Maekawa, Keiko; Saito, Kosuke; Senoo, Yuya; Urata, Masayo; Murayama, Mayumi; Tajima, Yoko; Kumagai, Yuji; Saito, Yoshiro			Plasma and Serum Lipidomics of Healthy White Adults Shows Characteristic Profiles by Subjects' Gender and Age	PLOS ONE			English	Article							MASS-SPECTROMETRY; METABOLOMICS; ACID; BIOMARKERS; BLOOD; SPHINGOMYELIN; INFLAMMATION; RESOLUTION; MEDIATORS; REVEALS	Blood is a commonly used biofluid for biomarker discovery. Although blood lipid metabolites are considered to be potential biomarker candidates, their fundamental properties are not well characterized. We aimed to (1) investigate the matrix type (serum vs. plasma) that may be preferable for lipid biomarker exploration, (2) elucidate age-and gender-associated differences in lipid metabolite levels, and (3) examine the stability of lipid metabolites in matrix samples subjected to repeated freeze-thaw cycles. Using liquid chromatography-mass spectrometry, we performed lipidomic analyses for fasting plasma and serum samples for four groups (15 subjects/group) of young and elderly (25-34 and 55-64 years old, respectively) males and females and for an additional aliquot of samples from young males, which were subjected to repeated freeze-thaw cycles. Lysophosphatidylcholine and diacylglycerol levels were higher in serum than in plasma samples, suggesting that the clotting process influences serum lipid metabolite levels. Gender-associated differences highlighted that the levels of many sphingomyelin species were significantly higher in females than in males, irrespective of age and matrix (plasma and serum). Age-associated differences were more prominent in females than in males, and in both matrices, levels of many triacylglycerols were significantly higher in elderly females than in young females. Plasma and serum levels of most lipid metabolites were reduced by freeze-thawing. Our results indicate that plasma is an optimal matrix for exploring lipid biomarkers because it represents the original properties of an individual's blood sample. In addition, the levels of some blood lipid species of healthy adults showed gender-and age-associated differences; thus, this should be considered during biomarker exploration and its application in diagnostics. Our fundamental findings on sample selection and handling procedures for measuring blood lipid metabolites is important for ensuring the quality of biomarkers identified and its qualification process.	[Ishikawa, Masaki; Maekawa, Keiko; Saito, Kosuke; Senoo, Yuya; Urata, Masayo; Murayama, Mayumi; Tajima, Yoko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Tokyo, Japan; [Ishikawa, Masaki; Maekawa, Keiko; Saito, Kosuke; Senoo, Yuya; Urata, Masayo; Murayama, Mayumi; Tajima, Yoko; Saito, Yoshiro] Natl Inst Hlth Sci, Dis Metabolome Project, Tokyo, Tokyo, Japan; [Kumagai, Yuji] Kitasato Univ, East Hosp, Clin Trial Ctr, Sagamihara, Kanagawa 228, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Kitasato University	Maekawa, K (corresponding author), Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Tokyo, Japan.	maekawa@nihs.go.jp	Saito, Kosuke/AAI-2878-2020		Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare [028]; Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan [10-45]	Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare; Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan	This work was supported by the Health Labour Sciences Research Grants (Grant number 028) from the Ministry of Health, Labour and Welfare, and by the Advanced Research for Products Mining Program (Grant number 10-45) from the National Institute of Biomedical Innovation of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri JM, 2012, EUR J NUTR, V51, P199, DOI 10.1007/s00394-011-0208-1; Arana L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-15; Beger RD, 2010, TOXICOL APPL PHARM, V243, P154, DOI 10.1016/j.taap.2009.11.019; Ben-Amor N, 2006, J PHYSIOL-LONDON, V570, P309, DOI 10.1113/jphysiol.2005.100800; Bjornerem A, 2004, J CLIN ENDOCR METAB, V89, P6039, DOI 10.1210/jc.2004-0735; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Demirkan A, 2013, J PSYCHIATR RES, V47, P357, DOI 10.1016/j.jpsychires.2012.11.001; Denery JR, 2011, ANAL CHEM, V83, P1040, DOI 10.1021/ac102806p; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Ishikawa M, 2013, BIOL PHARM BULL, V36, P682; Jiang H, 2013, ANAL BIOANAL CHEM, V405, P7357, DOI 10.1007/s00216-013-7166-9; KNOPP RH, 1994, ATHEROSCLEROSIS, V110, pS83, DOI 10.1016/0021-9150(94)05379-W; Kogure R, 2011, BIOCHEM BIOPH RES CO, V416, P58, DOI 10.1016/j.bbrc.2011.10.141; Lagarde M, 2010, PROSTAG LEUKOTR ESS, V82, P227, DOI 10.1016/j.plefa.2010.02.017; Liu JY, 2010, P NATL ACAD SCI USA, V107, P17017, DOI 10.1073/pnas.1011278107; Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; McClay JL, 2013, METABOLOMICS, V9, P392, DOI 10.1007/s11306-012-0456-y; MERRILL AH, 1985, LIPIDS, V20, P252, DOI 10.1007/BF02534197; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Nikkila Janne, 2008, Mol Syst Biol, V4, P197, DOI 10.1038/msb.2008.34; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Parman T, 2011, TOXICOL SCI, V124, P487, DOI 10.1093/toxsci/kfr238; Rees D, 2006, AM J CLIN NUTR, V83, P331; Sangkuhl K, 2011, PHARMACOGENET GENOM, V21, P516, DOI 10.1097/FPC.0b013e3283406323; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; Schuchardt JP, 2013, PROSTAG LEUKOTR ESS, V89, P19, DOI 10.1016/j.plefa.2013.04.001; Seijo S, 2013, AM J GASTROENTEROL, V108, P926, DOI 10.1038/ajg.2013.11; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Subbaiah PV, 2012, BBA-MOL CELL BIOL L, V1821, P908, DOI 10.1016/j.bbalip.2012.02.007; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; Vouk K, 2012, HUM REPROD, V27, P2955, DOI 10.1093/humrep/des152; Walker CG, 2013, BR J NUTR, P1; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021230	42	117	118	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91806	10.1371/journal.pone.0091806	http://dx.doi.org/10.1371/journal.pone.0091806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632803	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400093
J	Kuhn, S; Lorenz, R; Banaschewski, T; Barker, GJ; Buechel, C; Conrod, PJ; Flor, H; Garavan, H; Ittermann, B; Loth, E; Mann, K; Nees, F; Artiges, E; Paus, T; Rietschel, M; Smolka, MN; Strohle, A; Walaszek, B; Schumann, G; Heinz, A; Gallinat, JR				Kuehn, Simone; Lorenz, Robert; Banaschewski, Tobias; Barker, Gareth J.; Buechel, Christian; Conrod, Patricia J.; Flor, Herta; Garavan, Hugh; Ittermann, Bernd; Loth, Eva; Mann, Karl; Nees, Frauke; Artiges, Eric; Paus, Tomas; Rietschel, Marcella; Smolka, Michael N.; Stroehle, Andreas; Walaszek, Bernadetta; Schumann, Gunter; Heinz, Andreas; Galliant, Juergen		Imagen Consortium	Positive Association of Video Game Playing with Left Frontal Cortical Thickness in Adolescents	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; PERCEPTUAL DECISION-MAKING; HUMAN CEREBRAL-CORTEX; NEURAL BASIS; SEGREGATION; EXPERIENCE; EFFICIENCY; MECHANISM; INFERENCE; DYNAMICS	Playing video games is a common recreational activity of adolescents. Recent research associated frequent video game playing with improvements in cognitive functions. Improvements in cognition have been related to grey matter changes in prefrontal cortex. However, a fine-grained analysis of human brain structure in relation to video gaming is lacking. In magnetic resonance imaging scans of 152 14-year old adolescents, FreeSurfer was used to estimate cortical thickness. Cortical thickness across the whole cortical surface was correlated with self-reported duration of video gaming (hours per week). A robust positive association between cortical thickness and video gaming duration was observed in left dorsolateral prefrontal cortex (DLPFC) and left frontal eye fields (FEFs). No regions showed cortical thinning in association with video gaming frequency. DLPFC is the core correlate of executive control and strategic planning which in turn are essential cognitive domains for successful video gaming. The FEFs are a key region involved in visuo-motor integration important for programming and execution of eye movements and allocation of visuo-spatial attention, processes engaged extensively in video games. The results may represent the biological basis of previously reported cognitive improvements due to video game play. Whether or not these results represent a-priori characteristics or consequences of video gaming should be studied in future longitudinal investigations.	[Kuehn, Simone; Stroehle, Andreas] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, B-9000 Ghent, Belgium; [Kuehn, Simone; Lorenz, Robert; Heinz, Andreas; Galliant, Juergen] Ghent Inst Funct & Metab Imaging, Ghent, Belgium; [Kuehn, Simone] Charite, Clin Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Banaschewski, Tobias] PTB, Berlin, Germany; [Barker, Gareth J.; Conrod, Patricia J.; Loth, Eva] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat, Mannheim, Germany; [Buechel, Christian; Schumann, Gunter] Kings Coll London, Inst Psychiat, London, England; [Flor, Herta; Nees, Frauke] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Garavan, Hugh] Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Mann, Karl] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Artiges, Eric] Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, Mannheim, Germany; [Artiges, Eric] Univ Paris Sud, INSERM Unit Imaging & Psychiat, Inst Natl Sante Rech Med, Orsay, France; [Paus, Tomas] Univ Paris 05, AP HP, Dept Adolescent Psychopathol & Med, Paris, France; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Rietschel, Marcella] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Smolka, Michael N.] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, D-01062 Dresden, Germany; [Galliant, Juergen] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, D-01062 Dresden, Germany; [Galliant, Juergen] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany	Ghent University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB); Central Institute of Mental Health; University of London; King's College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Trinity College Dublin; Central Institute of Mental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Baycrest; McGill University; University of Nottingham; Central Institute of Mental Health; Technische Universitat Dresden; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kuhn, S (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, B-9000 Ghent, Belgium.	kuehn@mpib-berlin.mpg.de	Vollstädt-Klein, Sabine/C-6744-2012; Rapp, Michael/ABB-7573-2020; Banaschewski, Tobias/ABE-5985-2020; Conrod, Patricia J/P-4187-2018; Artiges, Eric/AAT-7219-2021; Artiges, Eric/C-2815-2019; Nees, Frauke/AAZ-2150-2020; Kuehn, Simone/P-6145-2014; Ströhle, Andreas/E-4286-2012; Barker, Gareth J/C-9616-2009; Smolka, Michael/B-4865-2011; Heinz, Andreas/ABB-7736-2020	Vollstädt-Klein, Sabine/0000-0002-6210-672X; Rapp, Michael/0000-0003-0106-966X; Banaschewski, Tobias/0000-0003-4595-1144; Artiges, Eric/0000-0003-4461-7646; Artiges, Eric/0000-0003-4461-7646; Barker, Gareth J/0000-0002-5214-7421; Smolka, Michael/0000-0001-5398-5569; Heinz, Andreas/0000-0001-5405-9065; Nees, Frauke/0000-0002-7796-8234; Flor, Herta/0000-0003-4809-5398; Kuhn, Simone/0000-0001-6823-7969; Loth, Eva/0000-0001-9458-9167	European Community [LSHM-CT-2007-037286]; UK Department of Health NIHR-Biomedical Research Centre 'Mental Health'; MRC program grant "Developmental pathways into adolescents' substance abuse"; Berliner Senatsverwaltung "Implikationen biopsychosozialer Grundlagen der Spielsucht fur Pravention und Therapie" Vergabe [002-2008/ I B 35]; BMBF [01 GQ 0914]; MRC [G0901858] Funding Source: UKRI; Medical Research Council [G0901858, G9817803B] Funding Source: researchfish	European Community(European Commission); UK Department of Health NIHR-Biomedical Research Centre 'Mental Health'; MRC program grant "Developmental pathways into adolescents' substance abuse"(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Berliner Senatsverwaltung "Implikationen biopsychosozialer Grundlagen der Spielsucht fur Pravention und Therapie" Vergabe; BMBF(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The IMAGEN study receives research funding from the European Community's Sixth Framework Program (LSHM-CT-2007-037286) and is supported by the UK Department of Health NIHR-Biomedical Research Centre 'Mental Health' and the MRC program grant "Developmental pathways into adolescents' substance abuse." Project coordination: Gunter Schumann (Gunter.Schumann@iop.kcl.ac.uk), website: http://www.imagen-europe.com. Additional funding was provided by the Berliner Senatsverwaltung "Implikationen biopsychosozialer Grundlagen der Spielsucht fur Pravention und Therapie" Vergabe-Nr. 002-2008/ I B 35 and BMBF 01 GQ 0914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Cannonieri GC, 2007, NEUROREPORT, V18, P1063, DOI 10.1097/WNR.0b013e3281a030e5; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Goel V, 2000, J COGNITIVE NEUROSCI, V12, P110, DOI 10.1162/08989290051137639; GOLDBERG E, 1994, J COGNITIVE NEUROSCI, V6, P276, DOI 10.1162/jocn.1994.6.3.276; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2010, CURR BIOL, V20, P1573, DOI 10.1016/j.cub.2010.07.040; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Groussard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013225; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kirsh SJ, 2007, AGGRESSIVE BEHAV, V33, P353, DOI 10.1002/ab.20191; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kuhn S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.53; Kuhn S., 2013, MOL PSYCHIAT; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Lobel E, 2001, J NEUROSURG, V95, P804, DOI 10.3171/jns.2001.95.5.0804; Lovden M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.013; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Lynch J, 2010, J SURG EDUC, V67, P184, DOI 10.1016/j.jsurg.2010.02.010; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schlickum MK, 2009, WORLD J SURG, V33, P2360, DOI 10.1007/s00268-009-0151-y; Schmidt-Wilcke T, 2010, NEUROIMAGE, V51, P1234, DOI 10.1016/j.neuroimage.2010.03.042; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Smith ME, 1999, COGNITIVE BRAIN RES, V7, P389, DOI 10.1016/S0926-6410(98)00043-3; Spence I, 2009, J EXP PSYCHOL LEARN, V35, P1097, DOI 10.1037/a0015641; Talairach J., 1988, COPLANAR STEREOTAXIC; Wolfling K, 2011, PSYCHOTHER PSYCH MED, V61, P216, DOI 10.1055/s-0030-1263145; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053055	57	57	57	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91506	10.1371/journal.pone.0091506	http://dx.doi.org/10.1371/journal.pone.0091506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633348	Green Published, gold			2022-12-27	WOS:000332858400065
J	Lee, FY; Wang, SS; Tsai, MH; Huang, HC; Lin, HC; Lee, SD				Lee, Fa-Yauh; Wang, Sun-Sang; Tsai, Ming-Hung; Huang, Hui-Chun; Lin, Han-Chieh; Lee, Shou-Dong			Adrenal Dysfunction in Portal Hypertensive Rats with Acute Hemorrhage	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE; SEPTIC SHOCK; SPLANCHNIC HYPOSENSITIVITY; HYPERDYNAMIC CIRCULATION; VASCULAR HYPOREACTIVITY; ADRENALECTOMIZED RATS; ARTERIAL-PRESSURE; CIRRHOTIC RATS; INSUFFICIENCY	Nitric oxide (NO) participates in shock and poorer portal hypotensive effect to vasoconstrictors in portal hypertension with hemorrhage, the so-called splanchnic hyposensitivity. Relative adrenal insufficiency accompanies hemorrhagic shock and is found in liver disease, the 'hepatoadrenal syndrome', but the relevant interactions remain unsettled. Portal hypertensive rats were induced by partial portal vein ligation (PVL). Experiments were performed on the 14th day post PVL: (I) ACTH stimulation test for rats without or with hemorrhage; (II) Glypressin response (mean arterial pressure, MAP; portal pressure, PP) in rats (a) without hemorrhage or with hemorrhage, injected with (b) distilled water (DW), (c) dexamethasone 3 mg/kg; (III) To survey the dose-dependent effects of glucocorticoid without being confounded by endogenous adrenal hormone, glypressin response was surveyed in PVL rats with adrenalectomy: (a) without hemorrhage or with hemorrhage, injected with (b) DW; (c) dexamethasone 3 mg/kg; (d) dexamethasone 5 mg/kg. Plasma tumor necrosis factor-alpha (TNF-alpha) concentrations and abdominal aorta (AA), superior mesenteric artery (SMA) NO synthases (NOS) mRNA expressions were determined. The results showed that ACTH induced corticosterone release similarly in PVL rats with or without hemorrhage. In bleeding PVL rats, dexamethasone (1) down-regulated AA NOS and enhanced glypressin-induced MAP elevation; (2) did not influence glypressin-induced PP reduction; (3) reduced TNF-alpha. In bleeding PVL and adrenalectomized rats, high-dose dexamethasone (1) down-regulated AA/SMA NOS; (2) enhanced glypressin-induced MAP elevation and PP reduction; (3) reduced TNF-alpha. In conclusion, bleeding portal hypertensive rats failed to enhance corticosterone release, suggesting a relative adrenal insufficiency. High-dose dexamethasone reversed systemic hypotension and splanchnic hyporesponsiveness to glypressin in adrenalectomized PVL rats accompanied by TNF-alpha and NOS down-regulation, suggesting the importance of adequate adrenocorticoid supplement in portal hypertension with hemorrhage and adrenal dysfunction.	[Lee, Fa-Yauh; Wang, Sun-Sang; Huang, Hui-Chun; Lin, Han-Chieh; Lee, Shou-Dong] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Lee, Fa-Yauh; Huang, Hui-Chun; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Wang, Sun-Sang] Taipei Vet Gen Hosp, Dept Med Affair & Planning, Taipei, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Tsai, Ming-Hung] Chang Gung Mem Hosp, Div Digest Therapeut Endoscopy, Taipei 10591, Taiwan; [Tsai, Ming-Hung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Cheng Hsin General Hospital; Chang Gung Memorial Hospital; Chang Gung University	Tsai, MH (corresponding author), Chang Gung Mem Hosp, Div Digest Therapeut Endoscopy, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	mhtsai@adm.cgmh.org.tw; hchuang2@vghtpe.gov.tw			National Science Council, Taiwan [NSC 99-2314-B-182A-072-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC 99-2314-B-182A-072-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 1998, BRIT J CLIN PHARMACO, V46, P589; AYALA A, 1990, Cytokine, V2, P170, DOI 10.1016/1043-4666(90)90012-I; Bellissant E, 2000, CLIN PHARMACOL THER, V68, P293, DOI 10.1067/mcp.2000.109354; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; BUTLER DG, 1985, COMP BIOCHEM PHYS A, V81, P353; CATALANO RD, 1984, ARCH SURG-CHICAGO, V119, P145; Chan CC, 1999, HEPATOLOGY, V30, P630, DOI 10.1002/hep.510300317; Chen YC, 2005, J AM SOC NEPHROL, V16, P2864, DOI 10.1681/ASN.2004110944; Chu C J, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V59, P145; Chu CJ, 1998, CLIN SCI, V95, P629, DOI 10.1042/cs0950629; Chu CJ, 2000, CLIN SCI, V99, P475, DOI 10.1042/CS20000067; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145; DARLINGTON DN, 1989, AM J PHYSIOL, V256, pH1274, DOI 10.1152/ajpheart.1989.256.5.H1274; DORIN RI, 1988, CRIT CARE MED, V16, P296, DOI 10.1097/00003246-198803000-00019; Fernandez J, 2006, HEPATOLOGY, V44, P1288, DOI 10.1002/hep.21352; GRUNFELD JP, 1987, HYPERTENSION, V10, P608, DOI 10.1161/01.HYP.10.6.608; HADDY FJ, 1965, AM J PHYSIOL, V208, P169, DOI 10.1152/ajplegacy.1965.208.1.169; Hamet P, 1983, HYPERTENSION, P964; Huang HC, 2003, EUR J CLIN INVEST, V33, P505, DOI 10.1046/j.1365-2362.2003.01162.x; Huang Hui-Chun, 2004, J Chin Med Assoc, V67, P268; IMMS FJ, 1974, ARCH INT PHARMACOD T, V207, P9; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; KRAVETZ D, 1987, GASTROENTEROLOGY, V93, P170, DOI 10.1016/0016-5085(87)90330-1; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Liu LM, 2005, J SURG RES, V125, P128, DOI 10.1016/j.jss.2004.12.008; Marik PE, 2005, CRIT CARE MED, V33, P1254, DOI 10.1097/01.CCM.0000164541.12106.57; MONCADA S, 1991, PHARMACOL REV, V43, P109; PALLER MS, 1984, AM J PHYSIOL, V246, pH25, DOI 10.1152/ajpheart.1984.246.1.H25; PIZCUETA P, 1992, GASTROENTEROLOGY, V103, P1909, DOI 10.1016/0016-5085(92)91451-9; REINCKE M, 1993, J CLIN ENDOCR METAB, V77, P151, DOI 10.1210/jc.77.1.151; RUBANYI GM, 1990, BLOOD VESSELS, V27, P246; Rushing GD, 2006, AM SURGEON, V72, P552; Skimming JW, 2003, AM J PHYSIOL-LUNG C, V285, pL484, DOI 10.1152/ajplung.00433.2002; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; THIEMERMANN C, 1990, EUR J PHARMACOL, V182, P591, DOI 10.1016/0014-2999(90)90062-B; Tsai MH, 2006, HEPATOLOGY, V43, P673, DOI 10.1002/hep.21101; Tsai MH, 2005, UPDATE TREATMENT LIV, P3; WAAGE A, 1987, CLIN IMMUNOL IMMUNOP, V45, P348, DOI 10.1016/0090-1229(87)90087-0; Wagner C, 2007, AM J PHYSIOL-REG I, V293, pR1781, DOI 10.1152/ajpregu.00439.2007; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; Wang P, 1999, ARCH SURG-CHICAGO, V134, P394, DOI 10.1001/archsurg.134.4.394; Wiest R, 1999, J CLIN INVEST, V104, P1223, DOI 10.1172/JCI7458; YAGIL Y, 1988, HYPERTENSION, V11, P174, DOI 10.1161/01.HYP.11.2.174; Yang Shumei, 2004, Current Vascular Pharmacology, V2, P1, DOI 10.2174/1570161043476483; ZINGARELLI B, 1994, AM J PHYSIOL, V266, pH1512, DOI 10.1152/ajpheart.1994.266.4.H1512; ZINGARELLI B, 1994, SHOCK, V2, P210, DOI 10.1097/00024382-199409000-00009	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92093	10.1371/journal.pone.0092093	http://dx.doi.org/10.1371/journal.pone.0092093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633079	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400141
J	Mockett, RJ; Matsumoto, Y				Mockett, Robin J.; Matsumoto, Yuri			Effect of Prolonged Coldness on Survival and Fertility of Drosophila melanogaster	PLOS ONE			English	Article							TEMPERATURE; LIFE; CRYOPRESERVATION; DIAPAUSE; HISTORY; EMBRYOS; FLIES; RATES; SHOCK	The laboratory fruit fly, Drosophila melanogaster, is used widely in biological research, but the requirement to maintain stocks with a roughly biweekly generation time imposes substantial burdens of labor, potential cross-contamination and mutation accumulation. The purpose of this study was to assess the impact of prolonged cold stress or milder cooling on survivorship and fertility. The hypothesis was that cold storage would result in postponement of reproduction and a longer generation time. Flies of several genotypes were maintained continuously at 4-11 degrees C; recovery rates and subsequent yields of adult progeny were recorded. Adults and pupae of a relatively long-lived y w lineage were more resistant to severe cold stress than embryos and larvae. Adults exhibited minimal mortality up to at least 5 d at 4 degrees C, 20 d at 8 degrees C and 12 weeks at 11 degrees C. Reproduction did not occur at these temperatures, but progeny were obtained after recovery at 25 degrees C. At all temperatures, chilling caused a rapid, severe and progressive decrease in fertility during the first 2 d of recovery. The impact on fertility during the subsequent 2-4 d was much milder and it occurred only after prolonged incubation at low temperatures. The total reproductive output during the first 6 d of recovery was sufficient to replace the parental population after 12 weeks at 11 degrees C. Food spoilage had an unexpectedly low impact on survivorship and fertility, and the reproductive output of F1 progeny was not affected by storing parental flies at 11 degrees C for 8-10 weeks. In the case of w(1118) flies, replacement of the parents within 6 d of recovery was possible for up to 60 d at 11 degrees C. Among less fertile genotypes, replacement of the parents was possible within 18 d after 4-10 weeks at 11 degrees C. These results show that the 2-week maintenance interval of stocks of D. melanogaster can be extended 3-7 fold, at least for 1 generation, by storing adult flies at 11 degrees C.	[Mockett, Robin J.; Matsumoto, Yuri] Univ S Alabama, Dept Biomed Sci, Mobile, AL 36688 USA	University of South Alabama	Mockett, RJ (corresponding author), Univ S Alabama, Dept Biomed Sci, Mobile, AL 36688 USA.	mockett@southalabama.edu			College of Allied Health Professions, University of South Alabama	College of Allied Health Professions, University of South Alabama	This project was supported by the College of Allied Health Professions, University of South Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anxolabehere D, 1970, Bull. Soc. zool. Fr., V95, P61; Anxolabehere D, 1970, DROS INF SERV, V45, P78; ASHBURNER M, 1992, SCIENCE, V258, P1896, DOI 10.1126/science.1470912; Ashburner M., 2005, DROSOPHILA LAB HDB, P122; Ashburner M., 1978, GENETICS BIOL DROS A, P1; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; DAVID J, 1969, ANN SOC ENTOMOL FR, V5, P161; Dillon ME, 2007, J EXP BIOL, V210, P2897, DOI 10.1242/jeb.007591; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Houle D, 1997, GENET RES, V69, P209, DOI 10.1017/S0016672397002760; Kelty JD, 1999, J INSECT PHYSIOL, V45, P719, DOI 10.1016/S0022-1910(99)00040-2; Kim K, 2010, EXP GERONTOL, V45, P984, DOI 10.1016/j.exger.2010.08.033; KIMURA MT, 1988, EVOLUTION, V42, P1288, DOI 10.1111/j.1558-5646.1988.tb04188.x; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Lerman DN, 2001, J EXP BIOL, V204, P315; Lindsley DL, 1992, GENOME DROSOPHILA ME, P138; Loeb J, 1917, J BIOL CHEM, V32, P103; MacAlpine JLP, 2011, J INSECT PHYSIOL, V57, P35, DOI 10.1016/j.jinsphys.2010.09.003; MAZUR P, 1992, SCIENCE, V258, P1932, DOI 10.1126/science.1470915; Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Mitchell KA, 2013, NATURWISSENSCHAFTEN, V100, P281, DOI 10.1007/s00114-013-1023-8; Mockett RJ, 2012, MECH AGEING DEV, V133, P359, DOI 10.1016/j.mad.2012.04.002; Nilson TL, 2006, J INSECT PHYSIOL, V52, P1027, DOI 10.1016/j.jinsphys.2006.07.001; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Rako L, 2009, J EVOLUTION BIOL, V22, P2438, DOI 10.1111/j.1420-9101.2009.01852.x; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; STEPONKUS PL, 1990, NATURE, V345, P170, DOI 10.1038/345170a0; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Zajitschek F, 2013, AGE, V35, P1193, DOI 10.1007/s11357-012-9445-3	37	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92228	10.1371/journal.pone.0092228	http://dx.doi.org/10.1371/journal.pone.0092228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632815	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400154
J	Montiel, EE; Cabrero, J; Ruiz-Estevez, M; Burke, WD; Eickbush, TH; Camacho, JPM; Lopez-Leon, MD				Montiel, Eugenia E.; Cabrero, Josefa; Ruiz-Estevez, Mercedes; Burke, William D.; Eickbush, Thomas H.; Camacho, Juan Pedro M.; Lopez-Leon, Maria Dolores			Preferential Occupancy of R2 Retroelements on the B Chromosomes of the Grasshopper Eyprepocnemis plorans	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; NON-LTR RETROTRANSPOSONS; RDNA LOCUS; REVERSE TRANSCRIPTION; NUCLEOLAR ORGANIZER; CHROMATIN-STRUCTURE; NORTH-AFRICA; ELEMENTS; DNA; GENOME	R2 non-LTR retrotransposons exclusively insert into the 28S rRNA genes of their host, and are expressed by co-transcription with the rDNA unit. The grasshopper Eyprepocnemis plorans contains transcribed rDNA clusters on most of its A chromosomes, as well as non-transcribed rDNA clusters on the parasitic B chromosomes found in many populations. Here the structure of the E. plorans R2 element, its abundance relative to the number of rDNA units and its retrotransposition activity were determined. Animals screened from five populations contained on average over 12,000 rDNA units on their A chromosomes, but surprisingly only about 100 R2 elements. Monitoring the patterns of R2 insertions in individuals from these populations revealed only low levels of retrotransposition. The low rates of R2 insertion observed in E. plorans differ from the high levels of R2 insertion previously observed in insect species that have many fewer rDNA units. It is proposed that high levels of R2 are strongly selected against in E. plorans, because the rDNA transcription machinery in this species is unable to differentiate between R2-inserted and uninserted units. The B chromosomes of E. plorans contain an additional 7,000 to 15,000 rDNA units, but in contrast to the A chromosomes, from 150 to over 1,500 R2 elements. The higher concentration of R2 in the inactive B chromosomes rDNA clusters suggests these chromosomes can act as a sink for R2 insertions thus further reducing the level of insertions on the A chromosomes. These studies suggest an interesting evolutionary relationship between the parasitic B chromosomes and R2 elements.	[Montiel, Eugenia E.; Cabrero, Josefa; Ruiz-Estevez, Mercedes; Camacho, Juan Pedro M.; Lopez-Leon, Maria Dolores] Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain; [Burke, William D.; Eickbush, Thomas H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Granada; University of Rochester	Lopez-Leon, MD (corresponding author), Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain.	mdlopez@ugr.es	Jimenez, Eugenia E Montiel/I-2936-2015; Burke, William/C-1203-2012; Camacho, Juan Pedro M/L-6869-2014; Cabrero, Josefa/L-8899-2014; López-León, María Dolores/L-9026-2014	Jimenez, Eugenia E Montiel/0000-0002-2461-9268; Camacho, Juan Pedro M/0000-0002-2507-9814; Cabrero, Josefa/0000-0002-5848-6985; López-León, María Dolores/0000-0003-2337-7313	Spanish Ministerio de Ciencia y Tecnologia [CGL2009-11917]; Plan Andaluz de Investigacion [CVI-6649]; FEDER funds; National Institutes of Health [GM42790]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Andaluz de Investigacion; FEDER funds(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (CGL2009-11917) and Plan Andaluz de Investigacion (CVI-6649), and was partially performed by FEDER funds and a grant from the National Institutes of Health (GM42790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bachtrog D, 2003, MOL BIOL EVOL, V20, P173, DOI 10.1093/molbev/msg035; Bakkali M, 2004, HEREDITY, V92, P428, DOI 10.1038/sj.hdy.6800437; Bakkali M, 2002, HEREDITY, V88, P14, DOI 10.1038/sj.hdy.6800002; Bibillo A, 2002, J MOL BIOL, V316, P459, DOI 10.1006/jmbi.2001.5369; Burke WD, 1998, NATURE, V392, P141, DOI 10.1038/32330; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Cabrero J, 1999, HEREDITY, V83, P435, DOI 10.1038/sj.hdy.6885960; CABRERO J, 1987, GENOME, V29, P116, DOI 10.1139/g87-020; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Camacho JPM, 1997, AM NAT, V149, P1030, DOI 10.1086/286037; CAMACHO JPM, 1991, GENOME, V34, P638, DOI 10.1139/g91-097; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Christensen SM, 2005, MOL CELL BIOL, V25, P6617, DOI 10.1128/MCB.25.15.6617-6628.2005; DAMMANN R, 1995, MOL CELL BIOL, V15, P5294; Darlington CD., 1958, EVOLUTION GENETIC SY; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; Eickbush DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066441; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Eickbush MT, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-11; EICKBUSH TH, 1985, EMBO J, V4, P2281, DOI 10.1002/j.1460-2075.1985.tb03927.x; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feng JL, 2008, BIOTECHNIQUES, V44, P901, DOI 10.2144/000112750; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; George JA, 1996, GENETICS, V142, P853; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HENRIQUESGIL N, 1990, EVOLUTION, V44, P747, DOI [10.1111/j.1558-5646.1990.tb05952.x, 10.2307/2409449]; Herrera JA, 1996, HEREDITY, V76, P633, DOI 10.1038/hdy.1996.90; JAKUBCZAK JL, 1992, GENETICS, V131, P129; JAKUBCZAK JL, 1991, P NATL ACAD SCI USA, V88, P3295, DOI 10.1073/pnas.88.8.3295; Jamburuthugoda VK, 2011, J MOL BIOL, V407, P661, DOI 10.1016/j.jmb.2011.02.015; Jones RN, 1985, EVOLUTION GENOME SIZ, P397; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2005, GENOME RES, V15, P1106, DOI 10.1101/gr.3271405; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Lamb JC, 2007, CHROMOSOME RES, V15, P383, DOI 10.1007/s10577-007-1135-0; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; LOPEZLEON MD, 1993, HEREDITY, V71, P352, DOI 10.1038/hdy.1993.149; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; McAllister BF, 1997, MOL BIOL EVOL, V14, P69, DOI 10.1093/oxfordjournals.molbev.a025704; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Mingazzini V, 2011, HEREDITY, V106, P567, DOI 10.1038/hdy.2010.86; Montiel EE, 2012, GENETICA, V140, P365, DOI 10.1007/s10709-012-9686-1; NUR U, 1977, GENETICS, V87, P499; NUR U, 1966, GENETICS, V54, P1239; OSTERGREN G., 1945, Botaniska Notiser, P157; Parkin EJ, 2004, MOL BIOL EVOL, V21, P1595, DOI 10.1093/molbev/msh163; Perez-Gonzalez CE, 2002, GENETICS, V162, P799; Perez-Gonzalez CE, 2001, GENETICS, V158, P1557; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P338, DOI 10.1159/000079309; PLOWMAN AB, 1994, HEREDITY, V72, P587, DOI 10.1038/hdy.1994.81; Randolph L, 1928, ANAT REC, V41, P102; Rezende-Teixeira P, 2009, CHROMOSOME RES, V17, P455, DOI 10.1007/s10577-009-9038-x; ROIHA H, 1981, NATURE, V290, P749, DOI 10.1038/290749a0; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; RUFAS JS, 1982, ARCH BIOL, V93, P267; Ruiz-Estevez M, 2013, GENETICA, V141, P337, DOI 10.1007/s10709-013-9733-6; Ruiz-Estevez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036600; Ruiz-Ruano FJ, 2011, CYTOGENET GENOME RES, V134, P120, DOI 10.1159/000324690; SCHAFER M, 1987, DEV BIOL, V120, P418, DOI 10.1016/0012-1606(87)90245-4; Shaw M.W., 1990, Oxford Surveys in Evolutionary Biology, V7, P197; Teruel M, 2007, CHROMOSOME RES, V15, P755, DOI 10.1007/s10577-007-1159-5; Teruel M, 2009, CHROMOSOMA, V118, P291, DOI 10.1007/s00412-008-0197-x; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; Theuri J, 2005, CYTOGENET GENOME RES, V110, P203, DOI 10.1159/000084953; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; White W, 1973, ANIMAL CYTOLOGY EVOL; Wilson E, 1907, SCIENCE, V26, P870, DOI [10.1126/science.26.677.870-a, DOI 10.1126/SCIENCE.26.660.258]; Yang J, 1999, P NATL ACAD SCI USA, V96, P7847, DOI 10.1073/pnas.96.14.7847; Ye JQ, 2006, MOL CELL BIOL, V26, P8781, DOI 10.1128/MCB.01409-06; Zhang X, 2005, GENETICS, V170, P195, DOI 10.1534/genetics.104.038703; Zhang X, 2008, MOL BIOL EVOL, V25, P229, DOI 10.1093/molbev/msm250; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179; Zhou J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000386; Ziegler CG, 2003, CHROMOSOME RES, V11, P23, DOI 10.1023/A:1022053931308; Zurita S, 1998, EVOLUTION, V52, P274, DOI 10.1111/j.1558-5646.1998.tb05163.x	81	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91820	10.1371/journal.pone.0091820	http://dx.doi.org/10.1371/journal.pone.0091820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632855	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400099
J	Peters, I; Dubrowinskaja, N; Abbas, M; Seidel, C; Kogosov, M; Scherer, R; Gebauer, K; Merseburger, AS; Kuczyk, MA; Grunwald, V; Serth, J				Peters, Inga; Dubrowinskaja, Natalia; Abbas, Mahmoud; Seidel, Christoph; Kogosov, Michael; Scherer, Ralph; Gebauer, Kai; Merseburger, Axel S.; Kuczyk, Markus A.; Gruenwald, Viktor; Serth, Juergen			DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies	PLOS ONE			English	Article							FACTOR-TARGETED THERAPY; PROGNOSTIC-FACTORS; CARCINOMA; RECURRENCE; SUNITINIB; MODELS	VEGF-targeted therapy increases both the progression-free (PFS) and overall survival (OS) of patients with metastasized renal cell cancer (mRCC). Identification of molecular phenotypes of RCC could improve risk-stratification and the prediction of the clinical disease course. We investigated whether gene-specific DNA hypermethylation can predict PFS and OS among patients undergoing anti-VEGF-based therapy. Primary tumor tissues from 18 patients receiving targeted therapy were examined retrospectively using quantitative methylation-specific PCR analysis of CST6, LAD1, hsa-miR-124-3, and hsa-miR-91 CpG islands. PFS and OS were analyzed for first-line and sequential antiangiogenic therapies using the log rank statistics. Sensitivity and specificity were determined for predicting first-line therapy failure. Hypermethylation of CST6 and LAD1 was associated with both a shortened PFS (log rank p = 0.009 and p = 0.004) and OS (p = 0.011 and p = 0.043). The median PFS observed for the high and low methylation groups of CST6 and LAD1 was 2.0 vs. 11.4 months. LAD1 methylation had a specificity of 1.0 (95% CI 0.65-1.0) and a sensitivity of 0.73 (95% CI 0.43-0.90) for the prediction of first-line therapy. CST6 and LAD1 methylation are candidate epigenetic biomarkers showing unprecedented association with PFS and OS as well as specificity for the prediction of the response to therapy. DNA methylation markers should be considered for the prospective evaluation of larger patient cohorts in future studies.	[Peters, Inga; Dubrowinskaja, Natalia; Kogosov, Michael; Gebauer, Kai; Merseburger, Axel S.; Kuczyk, Markus A.; Serth, Juergen] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany; [Abbas, Mahmoud] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Seidel, Christoph] Univ Med Ctr Eppendorf, Dept Oncol Hematol Bone MarrowTransplantat Pneumo, Hamburg, Germany; [Scherer, Ralph] Hannover Med Sch, Dept Biometry, Hannover, Germany; [Gruenwald, Viktor] Hannover Med Sch, Clin Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany	Hannover Medical School; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Hannover Medical School	Serth, J (corresponding author), Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany.	serth.juergen@mh-hannover.de						Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Galsky MD, 2013, LANCET ONCOL, V14, P102, DOI 10.1016/S1470-2045(12)70581-8; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Gebauer K, 2013, BRIT J CANCER, V108, P131, DOI 10.1038/bjc.2012.537; Gigante M, 2012, ANTICANCER RES, V32, P5447; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Jemal A, 2011, CA CANC J CLIN; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Knox JJ, 2008, LANCET, V372, P427, DOI 10.1016/S0140-6736(08)61040-5; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Morris MR, 2003, ONCOGENE, V22, P6794, DOI 10.1038/sj.onc.1206914; Morris MR, 2010, ONCOGENE, V30, P1390; Motoki K, 1997, GENOMICS, V39, P323, DOI 10.1006/geno.1996.4507; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nickerson P, 2008, CLIN LAB MED, V28, P455, DOI 10.1016/j.cll.2008.09.003; Seidel C, 2012, EUR J CANCER, V48, P1023, DOI 10.1016/j.ejca.2012.02.048; Skolarikos AA, 2006, AM J NEPHROL, V26, P218, DOI 10.1159/000093631; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Sternberg CN, 2013, EUR J CANCER, V49, P1287, DOI 10.1016/j.ejca.2012.12.010; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Team R. D. C, 2011, R LANG ENV STAT COMP; van Vlodrop IJH, 2010, AM J PATHOL, V176, P575, DOI 10.2353/ajpath.2010.090442; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987	30	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91440	10.1371/journal.pone.0091440	http://dx.doi.org/10.1371/journal.pone.0091440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633192	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400062
J	Phan, JA; Kicic, A; Berry, LJ; Fernandes, LB; Zosky, GR; Sly, PD; Larcombe, AN				Phan, Jennifer A.; Kicic, Anthony; Berry, Luke J.; Fernandes, Lynette B.; Zosky, Graeme R.; Sly, Peter D.; Larcombe, Alexander N.			Rhinovirus Exacerbates House-Dust-Mite Induced Lung Disease in Adult Mice	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; SUBJECTS IN-VIVO; ASTHMATIC SUBJECTS; CHRONIC BRONCHITIS; EPITHELIAL-CELLS; INDUCED SPUTUM; MOUSE MODELS; MURINE MODEL; INFECTION; CHILDREN	Human rhinovirus is a key viral trigger for asthma exacerbations. To date, murine studies investigating rhinovirus-induced exacerbation of allergic airways disease have employed systemic sensitisation/intranasal challenge with ovalbumin. In this study, we combined human-rhinovirus infection with a clinically relevant mouse model of aero-allergen exposure using house-dust-mite in an attempt to more accurately understand the links between human-rhinovirus infection and exacerbations of asthma. Adult BALB/c mice were intranasally exposed to low-dose house-dust-mite (or vehicle) daily for 10 days. On day 9, mice were inoculated with human-rhinovirus-1B (or UV-inactivated human-rhinovirus-1B). Forty-eight hours after inoculation, we assessed bronchoalveolar cellular inflammation, levels of relevant cytokines/serum antibodies, lung function and responsiveness/sensitivity to methacholine. House-dust-mite exposure did not result in a classical TH2-driven response, but was more representative of noneosinophilic asthma. However, there were significant effects of house-dust-mite exposure on most of the parameters measured including increased cellular inflammation (primarily macrophages and neutrophils), increased total IgE and house-dust-mite-specific IgG(1) and increased responsiveness/sensitivity to methacholine. There were limited effects of human-rhinovirus-1B infection alone, and the combination of the two insults resulted in additive increases in neutrophil levels and lung parenchymal responses to methacholine (tissue elastance). We conclude that acute rhinovirus infection exacerbates house-dust-mite-induced lung disease in adult mice. The similarity of our results using the naturally occurring allergen house-dust-mite, to previous studies using ovalbumin, suggests that the exacerbation of allergic airways disease by rhinovirus infection could act via multiple or conserved mechanisms.	[Phan, Jennifer A.; Kicic, Anthony; Berry, Luke J.; Zosky, Graeme R.; Larcombe, Alexander N.] Univ Western Australia, Telethon Inst Child Hlth Res, Div Clin Sci, Subiaco, WA, Australia; [Phan, Jennifer A.; Fernandes, Lynette B.] Univ Western Australia, Sch Med & Pharmacol, Pharmacol Pharm & Anaesthesiol Unit, Crawley, WA, Australia; [Kicic, Anthony; Berry, Luke J.; Zosky, Graeme R.; Larcombe, Alexander N.] Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia; [Kicic, Anthony] Princess Margaret Hosp, Dept Resp Med, Perth, WA, Australia; [Kicic, Anthony] Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Crawley, WA, Australia; [Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Queensland	Larcombe, AN (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Div Clin Sci, Subiaco, WA, Australia.	alexanderl@ichr.uwa.edu.au	Larcombe, Alexander/AAG-8533-2019; Sly, Peter D/F-1486-2010; Kicic, Anthony/ABA-1252-2021; Fernandes, Lynette/H-9175-2014	Larcombe, Alexander/0000-0003-4196-4482; Sly, Peter D/0000-0001-6305-2201; Kicic, Anthony/0000-0002-0008-9733; Fernandes, Lynette/0000-0003-3768-1340; Zosky, Graeme/0000-0001-9039-0302	Australian Research Council [DP110101706]	Australian Research Council(Australian Research Council)	This project was supported by an Australian Research Council (www.arc.gov.au) Discovery Project Grant (DP110101706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bates JHT, 2003, J APPL PHYSIOL, V94, P1297, DOI 10.1152/japplphysiol.00706.2002; Bates JHT, 2002, J APPL PHYSIOL, V93, P705, DOI 10.1152/japplphysiol.01274.2001; Birrell MA, 2010, EUR RESPIR J, V36, P1220, DOI 10.1183/09031936.00069110; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busse WW, 1997, J ALLERGY CLIN IMMUN, V100, P147, DOI 10.1016/S0091-6749(97)70216-1; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; CHEUNG D, 1995, AM J RESP CRIT CARE, V152, P1490, DOI 10.1164/ajrccm.152.5.7582282; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; EADIE MB, 1966, BMJ-BRIT MED J, V2, P671, DOI 10.1136/bmj.2.5515.671; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408, DOI 10.1152/jappl.1989.67.6.2408; Gern JE, 1997, AM J RESP CRIT CARE, V155, P1159, DOI 10.1164/ajrccm.155.3.9117003; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Grunberg K, 1997, CLIN EXP ALLERGY, V27, P36, DOI 10.1111/j.1365-2222.1997.tb00670.x; HALPERIN SA, 1985, AM REV RESPIR DIS, V132, P976; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hershenson MB, 2013, SCIENTIFICA, V2013, P12; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL, 1997, J INFECT DIS, V175, P323, DOI 10.1093/infdis/175.2.323; Kimb KW, 1995, J ALLERGY CLIN IMMUN, V95, P843; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Kuypers J, 2010, EXPERT REV MOL DIAGN, V10, P395, DOI [10.1586/erm.10.38, 10.1586/ERM.10.38]; LAMBERT HP, 1972, BMJ-BRIT MED J, V3, P323, DOI 10.1136/bmj.3.5822.323; Larcombe AN, 2011, INFLUENZA OTHER RESP, V5, P334, DOI 10.1111/j.1750-2659.2011.00236.x; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Lloyd CM, 2007, CURR ALLERGY ASTHM R, V7, P231, DOI 10.1007/s11882-007-0077-0; Lundblad LKA, 2007, EUR RESPIR J, V30, P805, DOI 10.1183/09031936.00091307; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Norzila MZ, 2000, AM J RESP CRIT CARE, V161, P769, DOI 10.1164/ajrccm.161.3.9809071; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Pizzichini MMM, 1998, AM J RESP CRIT CARE, V158, P1178, DOI 10.1164/ajrccm.158.4.9712082; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; RUECKERT RR, 1996, FIELDS VIROLOGY, V1, P609; Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC; SHERRY B, 1985, J VIROL, V53, P137, DOI 10.1128/JVI.53.1.137-143.1985; STENHOUSE AC, 1967, BMJ-BRIT MED J, V3, P461, DOI 10.1136/bmj.3.5563.461; Tuthill TJ, 2003, J GEN VIROL, V84, P2829, DOI 10.1099/vir.0.19109-0; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wilder JA, 1999, AM J RESP CELL MOL, V20, P1326, DOI 10.1165/ajrcmb.20.6.3561; Zosky GR, 2009, AM J PHYSIOL-LUNG C, V297, pL373, DOI 10.1152/ajplung.00053.2009	63	25	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92163	10.1371/journal.pone.0092163	http://dx.doi.org/10.1371/journal.pone.0092163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632596	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400147
J	Fernandez, JA; Bankhead, P; Zhou, HY; McGeown, JG; Curtis, TM				Fernandez, Jose A.; Bankhead, Peter; Zhou, Huiyu; McGeown, J. Graham; Curtis, Tim M.			Automated Detection and Measurement of Isolated Retinal Arterioles by a Combination of Edge Enhancement and Cost Analysis	PLOS ONE			English	Article							COMPUTER-BASED METHOD; CEREBRAL-ARTERIES; PHOSPHORYLATION; PHYSIOLOGY; AGREEMENT; CHANNELS; KINASE; BRAIN; CELL	Pressure myography studies have played a crucial role in our understanding of vascular physiology and pathophysiology. Such studies depend upon the reliable measurement of changes in the diameter of isolated vessel segments over time. Although several software packages are available to carry out such measurements on small arteries and veins, no such software exists to study smaller vessels (<50 mu m in diameter). We provide here a new, freely available open-source algorithm, MyoTracker, to measure and track changes in the diameter of small isolated retinal arterioles. The program has been developed as an ImageJ plug-in and uses a combination of cost analysis and edge enhancement to detect the vessel walls. In tests performed on a dataset of 102 images, automatic measurements were found to be comparable to those of manual ones. The program was also able to track both fast and slow constrictions and dilations during intraluminal pressure changes and following application of several drugs. Variability in automated measurements during analysis of videos and processing times were also investigated and are reported. MyoTracker is a new software to assist during pressure myography experiments on small isolated retinal arterioles. It provides fast and accurate measurements with low levels of noise and works with both individual images and videos. Although the program was developed to work with small arterioles, it is also capable of tracking the walls of other types of microvessels, including venules and capillaries. It also works well with larger arteries, and therefore may provide an alternative to other packages developed for larger vessels when its features are considered advantageous.	[Fernandez, Jose A.; McGeown, J. Graham; Curtis, Tim M.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [Bankhead, Peter] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Zhou, Huiyu] Queens Univ Belfast, Sch Elect Elect Engn & Comp Sci, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Queens University Belfast	Fernandez, JA (corresponding author), Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland.	jfernandezgonzalez01@qub.ac.uk	Curtis, Tim/AEU-9750-2022; Zhou, Huiyu/O-2692-2014; Bankhead, Peter/AAA-7915-2020	Zhou, Huiyu/0000-0003-1634-9840; Bankhead, Peter/0000-0003-4851-8813; Curtis, Tim/0000-0003-1543-2781	British Heart Foundation [PG/11/94/29169]; Biotechnology and Biological Sciences Research Council [BB/I026359/1]; BBSRC [BB/I026359/1] Funding Source: UKRI; EPSRC [EP/H049606/1, EP/J006238/1, EP/G034303/1, EP/K004379/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G034303/1, EP/K004379/1, EP/H049606/1, EP/J006238/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the British Heart Foundation (Grant number: PG/11/94/29169) and the Biotechnology and Biological Sciences Research Council (Grant number: BB/I026359/1) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burke M, 2013, CURR VASC P IN PRESS; Chan SL, 2013, FASEB J IN PRESS; Chan YC, 2010, ARTERIOSCL THROM VAS, V30, P992, DOI 10.1161/ATVBAHA.110.203935; Chan YC, 2012, PHARMACOL RES, V65, P182, DOI 10.1016/j.phrs.2011.09.010; Czikora A, 2012, BRIT J PHARMACOL, V165, P1801, DOI 10.1111/j.1476-5381.2011.01645.x; Dabertrand F, 2012, CIRC RES, V110, P285, DOI 10.1161/CIRCRESAHA.111.258145; Davis Michael J., 2006, Lymphatic Research and Biology, V4, P3, DOI 10.1089/lrb.2006.4.3; Davis MJ, 2012, MICROCIRCULATION, V19, P99, DOI 10.1111/j.1549-8719.2011.00131.x; Davis MJ, 2005, MICROCIRCULATION, V12, P361, DOI 10.1080/10739680590934772; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Fike CD, 2012, NEONATOLOGY, V101, P28, DOI 10.1159/000326270; Gokina NI, 2002, AM J PHYSIOL-HEART C, V282, pH1410, DOI 10.1152/ajpheart.00441.2001; Grande G, 2013, CEPHALALGIA, V33, P152, DOI 10.1177/0333102412468340; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hein TW, 2012, INVEST OPHTH VIS SCI, V53, P7943, DOI 10.1167/iovs.12-11005; Hinds K, 2013, INVEST OPHT IN PRESS; Howitt L, 2011, AM J PHYSIOL-HEART C, V301, pH29, DOI 10.1152/ajpheart.00134.2011; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Izzard AS, 2013, CURR VASC P IN PRESS; Jackson WF, 2000, HYPERTENSION, V35, P173, DOI 10.1161/01.HYP.35.1.173; Kim S, 2006, MICROCIRCULATION, V13, P199, DOI 10.1080/10739680600556878; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; McGahon MK, 2007, AM J PHYSIOL-HEART C, V292, pH1001, DOI 10.1152/ajpheart.01003.2006; Nepiyushchikh ZV, 2011, J PHYSIOL-LONDON, V589, P5415, DOI 10.1113/jphysiol.2011.218446; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palomares SM, 2013, CURR VASC P IN PRESS; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Puro DG, 2012, PROG RETIN EYE RES, V31, P258, DOI 10.1016/j.preteyeres.2012.01.001; Scholfield CN, 2007, MICROCIRCULATION, V14, P11, DOI 10.1080/10739680601072115; SIMONS MA, 1987, INVEST RADIOL, V22, P562, DOI 10.1097/00004424-198707000-00006; Tanano I, 2013, INVEST OPHTH VIS SCI, V54, P1443, DOI 10.1167/iovs.12-10115; Zhong XZ, 2010, J PHYSIOL-LONDON, V588, P3277, DOI 10.1113/jphysiol.2010.192823	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91791	10.1371/journal.pone.0091791	http://dx.doi.org/10.1371/journal.pone.0091791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626349	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300137
J	Jalah, R; Kulkarni, V; Patel, V; Rosati, M; Alicea, C; Bear, J; Yu, L; Guan, YJ; Shen, XY; Tomaras, GD; LaBranche, C; Montefiori, DC; Prattipati, R; Pinter, A; Bess, J; Lifson, JD; Reed, SG; Sardesai, NY; Venzon, DJ; Valentin, A; Pavlakis, GN; Felber, BK				Jalah, Rashmi; Kulkarni, Viraj; Patel, Vainav; Rosati, Margherita; Alicea, Candido; Bear, Jenifer; Yu, Lei; Guan, Yongjun; Shen, Xiaoying; Tomaras, Georgia D.; LaBranche, Celia; Montefiori, David C.; Prattipati, Rajasekhar; Pinter, Abraham; Bess, Julian, Jr.; Lifson, Jeffrey D.; Reed, Steven G.; Sardesai, Niranjan Y.; Venzon, David J.; Valentin, Antonio; Pavlakis, George N.; Felber, Barbara K.			DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques	PLOS ONE			English	Article							T-CELL RESPONSES; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 VACCINE EFFICACY; RHESUS MACAQUES; GENE-TRANSFER; B-CELL; ELECTROPORATION; PLASMID; SIV; IL-12	We tested the concept of combining DNA with protein to improve anti-HIV Env systemic and mucosal humoral immune responses. Rhesus macaques were vaccinated with DNA, DNA&protein co-immunization or DNA prime followed by protein boost, and the magnitude and mucosal dissemination of the antibody responses were monitored in both plasma and mucosal secretions. We achieved induction of robust humoral responses by optimized DNA vaccination delivered by in vivo electroporation. These responses were greatly increased upon administration of a protein boost. Importantly, a co-immunization regimen of DNA&protein injected in the same muscle at the same time induced the highest systemic binding and neutralizing antibodies to homologous or heterologous Env as well as the highest Env-specific IgG in saliva. Inclusion of protein in the vaccine resulted in more immunized animals with Env-specific IgG in rectal fluids. Inclusion of DNA in the vaccine significantly increased the longevity of systemic humoral immune responses, whereas protein immunization, either as the only vaccine component or as boost after DNA prime, was followed by a great decline of humoral immune responses overtime. We conclude that DNA&protein co-delivery in a simple vaccine regimen combines the strength of each vaccine component, resulting in improved magnitude, extended longevity and increased mucosal dissemination of the induced antibodies in immunized rhesus macaques.	[Jalah, Rashmi; Kulkarni, Viraj; Alicea, Candido; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Frederick, MD 21701 USA; [Patel, Vainav; Rosati, Margherita; Bear, Jenifer; Valentin, Antonio; Pavlakis, George N.] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Yu, Lei; Guan, Yongjun] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Human Virol, Baltimore, MD 21201 USA; [Shen, Xiaoying; Tomaras, Georgia D.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Shen, Xiaoying; Tomaras, Georgia D.] Duke Univ, Dept Surg, Durham, NC USA; [Shen, Xiaoying; Tomaras, Georgia D.] Duke Univ, Dept Immunol Mol Genet & Microbiol, Durham, NC USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Prattipati, Rajasekhar; Pinter, Abraham] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Bess, Julian, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Sardesai, Niranjan Y.] Inovio Pharmaceut Inc, Blue Bell, PA USA; [Venzon, David J.] NCI, Biostat & Data Management Sect, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; Duke University; Duke University; Duke University; Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pavlakis, GN (corresponding author), NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA.	george.pavlakis@nih.gov; barbara.felber@nih.gov	Guan, Yongjun/V-8117-2019; Tomaras, Georgia/J-5041-2016	Guan, Yongjun/0000-0001-6546-2095; Sardesai, Niranjan/0000-0001-6920-1167	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); NCI/NIH [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases-NIH [HHSN27201100016C, R01AI102718]; Institute of Human Virology Faculty Development Fund; Bill and Melinda Gates Foundation [42387]; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102718] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute of Human Virology Faculty Development Fund; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH) (BKF and GNP); Federal funds from the NCI/NIH under Contract HHSN261200800001E (to JDL); National Institute of Allergy and Infectious Diseases-NIH Contract HHSN27201100016C (to GDT, XS, CL, and DCM), National Institute of Allergy and Infectious Diseases-NIH grant R01AI102718 (to AP), Institute of Human Virology Faculty Development Fund (to YG) and Bill and Melinda Gates Foundation Grant #42387 (to SGR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Bolton DL, 2012, MUCOSAL IMMUNOL, V5, P41, DOI 10.1038/mi.2011.45; Boyer JD, 2005, J MED PRIMATOL, V34, P262, DOI 10.1111/j.1600-0684.2005.00124.x; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Cristillo AD, 2008, BIOCHEM BIOPH RES CO, V366, P29, DOI 10.1016/j.bbrc.2007.11.052; Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106; Halwani R, 2008, J IMMUNOL, V180, P7969, DOI 10.4049/jimmunol.180.12.7969; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hirao LA, 2008, VACCINE, V26, P3112, DOI 10.1016/j.vaccine.2008.02.036; Hutnick NA, 2011, CURR OPIN VIROL, V1, P233, DOI 10.1016/j.coviro.2011.08.003; Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407; Jaworski JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031464; Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Kennedy JS, 2008, VACCINE, V26, P4420, DOI 10.1016/j.vaccine.2008.05.090; Kulkarni V, 2013, HUM VACC IMMUNOTHER, V9, P2081, DOI 10.4161/hv.25473; Kulkarni V, 2013, HUM VACC IMMUNOTHER, V9, P2069, DOI 10.4161/hv.25442; Kulkarni V, 2011, VACCINE, V29, P6742, DOI 10.1016/j.vaccine.2010.12.056; Li JY, 2013, VACCINE, V31, P3747, DOI 10.1016/j.vaccine.2013.04.037; Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; MOORE JP, 1989, AIDS, V3, P155, DOI 10.1097/00002030-198903000-00006; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Otten GR, 2006, VACCINE, V24, P4503, DOI 10.1016/j.vaccine.2005.08.017; Pal R, 2005, J MED PRIMATOL, V34, P226, DOI 10.1111/j.1600-0684.2005.00120.x; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Prud'homme GJ, 2006, CURR GENE THER, V6, P243, DOI 10.2174/156652306776359504; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rizzuto G, 1999, P NATL ACAD SCI USA, V96, P6417, DOI 10.1073/pnas.96.11.6417; Robinson TM, 2007, J MED PRIMATOL, V36, P276, DOI 10.1111/j.1600-0684.2007.00245.x; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Schadeck EB, 2006, VACCINE, V24, P4677, DOI 10.1016/j.vaccine.2005.10.035; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11	47	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91550	10.1371/journal.pone.0091550	http://dx.doi.org/10.1371/journal.pone.0091550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626482	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300103
J	Chaichana, P; Okabayashi, T; Puiprom, O; Sasayama, M; Sasaki, T; Yamashita, A; Ramasoota, P; Kurosu, T; Ikuta, K				Chaichana, Panjaporn; Okabayashi, Tamaki; Puiprom, Orapim; Sasayama, Mikiko; Sasaki, Tadahiro; Yamashita, Akifumi; Ramasoota, Pongrama; Kurosu, Takeshi; Ikuta, Kazuyoshi			Low Levels of Antibody-Dependent Enhancement in Vitro Using Viruses and Plasma from Dengue Patients	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; SECONDARY INFECTION; ENHANCING ACTIVITY; PERIPHERAL-BLOOD; IMMUNE-COMPLEXES; DISEASE SEVERITY; ACUTE-PHASE; CELLS; PATHOGENESIS	Background: The majority of dengue patients infected with any serotype of dengue virus (DENV) are asymptomatic, but the remainder may develop a wide spectrum of clinical symptoms, ranging from mild dengue fever (DF) to severe dengue hemorrhagic fever (DHF). Severe cases occur more often in patients who experience a secondary infection with a different virus serotype. A phenomenon called antibody-dependent enhancement (ADE) has been proposed to explain the onset of these severe cases, but the exact mechanism of ADE remains unclear. Methodology/Principal Finding: Virus neutralization and ADE assays were performed using ultracentrifugation supernatants of acute-phase sera from patients with secondary infections or human monoclonal antibodies (HuMAbs) as anti-DENV antibodies. Virus sources included infectious serum-derived viruses from the ultracentrifugation precipitates, laboratory-culture adapted DENV, or recombinant DENVs derived from patient sera. In contrast to the high levels of ADE observed with laboratory virus strains, low ADE was observed with autologous patient-derived viruses, when patient sera were used to provide the antibody component in the ADE assays. Similar results were obtained using samples from DF and DHF patients. Recombinant-viruses derived from DHF patients showed only minor differences in neutralization and ADE activity in the presence of HuMAbs or plasma derived from the same DHF patient. Conclusion/Significance: Serum or plasma taken from patients during the acute phase of a secondary infection showed high levels of ADE, but no neutralization activity, when assayed in the presence of laboratory-adapted virus strains. By contrast, serum or plasma from the same patient showed high levels of neutralization activity but failed to induce significant ADE when the assays were performed with autologous virus. These results demonstrate the significance of the virus source when measuring ADE. They also suggest that repeated passage of DENV in cell culture has endowed it with the capacity to induce high levels of ADE.	[Chaichana, Panjaporn; Okabayashi, Tamaki; Puiprom, Orapim; Sasayama, Mikiko] Mahidol Univ, Fac Trop Med, MOCID, Bangkok, Thailand; [Ramasoota, Pongrama] Mahidol Univ, Fac Trop Med, CEAR, Bangkok, Thailand; [Sasaki, Tadahiro; Yamashita, Akifumi; Kurosu, Takeshi; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Osaka, Japan; [Sasaki, Tadahiro; Yamashita, Akifumi; Ramasoota, Pongrama; Kurosu, Takeshi; Ikuta, Kazuyoshi] JST JICA, Sci & Technol Res Partnership Sustainable Dev SAT, Tokyo, Japan	Mahidol University; Mahidol University; Osaka University	Ikuta, K (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Virol, Osaka, Japan.	ikuta@biken.osaka-u.ac.jp	Ramasoota, Pongrama/W-3503-2019		Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; JST/JICA (SATREPS), Japan [08080924]	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; JST/JICA (SATREPS), Japan	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; and the JST/JICA (SATREPS; 08080924), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baclig MO, 2010, SE ASIAN J TROP MED, V41, P1352; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI 10.4049/jimmunol.1203052; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; da Silva Voorham JM, 2012, PLOS ONE, V7; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646; Garcia G, 2010, AM J TROP MED HYG, V82, P1153, DOI 10.4269/ajtmh.2010.09-0353; Guy B, 2004, VACCINE, V22, P3563, DOI 10.1016/j.vaccine.2004.03.042; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P276; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Hughes HR, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-115; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; King Alan D., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P718; Konishi E, 2010, J VIROL METHODS, V163, P360, DOI 10.1016/j.jviromet.2009.10.026; Kou ZH, 2011, VIROLOGY, V410, P240, DOI 10.1016/j.virol.2010.11.007; Kubota-Koketsu R, 2009, BIOCHEM BIOPH RES CO, V387, P180, DOI 10.1016/j.bbrc.2009.06.151; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kurosu T, 2010, BIOCHEM BIOPH RES CO, V394, P398, DOI 10.1016/j.bbrc.2010.02.181; Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10; Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924; Moi ML, 2013, T ROY SOC TROP MED H, V107, P51, DOI 10.1093/trstmh/trs007; Moi ML, 2011, J CLIN VIROL, V52, P225, DOI 10.1016/j.jcv.2011.07.009; Moi ML, 2011, J INFECT DIS, V203, P1405, DOI 10.1093/infdis/jir053; Paradkar PN, 2011, BIOSCIENCE REP, V31, P221, DOI 10.1042/BSR20100078; Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06; Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024; Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7; RUANGJIRACHUPORN W, 1979, CLIN EXP IMMUNOL, V36, P46; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Sasaki T, 2013, ANTIVIR RES, V98, P423, DOI 10.1016/j.antiviral.2013.03.018; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Setthapramote C, 2012, BIOCHEM BIOPH RES CO, V423, P867, DOI 10.1016/j.bbrc.2012.06.057; Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003; Srikiatkhachorn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051335; van der Schaar HM, 2009, IMMUNOBIOLOGY, V214, P613, DOI 10.1016/j.imbio.2008.11.008; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Yenchitsomanus Pa-Thai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P228	49	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92173	10.1371/journal.pone.0092173	http://dx.doi.org/10.1371/journal.pone.0092173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642752	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900097
J	Chen, YH; Tian, J; Tian, XY; Tang, XY; Rui, K; Tong, J; Lu, LW; Xu, HX; Wang, SJ				Chen, Yanhong; Tian, Jie; Tian, Xinyu; Tang, Xinyi; Rui, Ke; Tong, Jia; Lu, Liwei; Xu, Huaxi; Wang, Shengjun			Adipose Tissue Dendritic Cells Enhances Inflammation by Prompting the Generation of Th17 Cells	PLOS ONE			English	Article							DIET-INDUCED OBESITY; BODY-MASS INDEX; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; PROSPECTIVE COHORT; MICE; LEPTIN; RISK; PATHOGENESIS	Background: Obesity has become a global challenge for public health. It has been reported that obesity is associated with chronic inflammation. However, the mechanism for the chronic inflammation contributes to obesity remains elusive. Methodology/Principal Findings: In our study, we found a novel CD11c(+) dendritic cell subset existed in murine adipose tissues which was immature phenotype. Moreover, as compared to the lean controls, the number of CD11c(+) DCs and CD4(+)IL-17(+) T cells were higher in adipose tissue of high fat diet (HFD) mice. Adipose tissues derived dendritic cells (ATDCs) displayed lower levels of CD40, CD80, CD86, MHCI and MHCII expression than splenic DCs (SPDCs). However, ATDCs showed higher levels of IL-6, TGF-beta and IL-23 secretion. Moreover, our in vitro experiments demonstrated that ATDCs were capable of promoting Th17 cell generation. Conclusions/Significance: Our results indicate the existence of CD11c(+) DCs in adipose tissues, which displays an immature phenotype but possessing pro-inflammatory function.	[Chen, Yanhong; Tian, Jie; Tian, Xinyu; Tang, Xinyi; Rui, Ke; Tong, Jia; Xu, Huaxi; Wang, Shengjun] Jiangsu Univ, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Peoples R China; [Tian, Jie; Xu, Huaxi; Wang, Shengjun] Jiangsu Univ, Sch Med Sci & Lab Med, Inst Lab Med, Zhenjiang, Peoples R China; [Lu, Liwei] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Liwei] Univ Hong Kong, Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China	Jiangsu University; Jiangsu University; University of Hong Kong; University of Hong Kong	Wang, SJ (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Peoples R China.	sjwjs@mail.ujs.edu.cn	tian, jie/H-2497-2011; Lu, Liwei/C-4357-2009	Lu, Liwei/0000-0002-8634-0967	National Natural Science Foundation of China [31170849, 81072453, 31270947]; Specialized Research Fund for the Doctoral Program of Higher Education [20133227110008]; Health Department Foundation of Jiangsu Province [Z201313]; Graduate Student Research and Innovation Program of Jiangsu Province [CXZZ12_0710, CXZZ13_0700, CXLX11_0608]; Jiangsu Province "333" Project; "Qinglan" Project; Top Talent Program of Jiangsu University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Health Department Foundation of Jiangsu Province; Graduate Student Research and Innovation Program of Jiangsu Province; Jiangsu Province "333" Project; "Qinglan" Project(Jiangsu Polytech Institute); Top Talent Program of Jiangsu University	This work was supported by the National Natural Science Foundation of China (Grant No. 31170849, 81072453, 31270947), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20133227110008), Health Department Foundation of Jiangsu Province (Grant No. Z201313), Graduate Student Research and Innovation Program of Jiangsu Province (Grant No. CXZZ12_0710, CXZZ13_0700, CXLX11_0608), Jiangsu Province "333" Project and "Qinglan" Project, and Top Talent Program of Jiangsu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECH REP SER, V894, P1; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bernotiene E, 2004, ARTHRITIS RES THER, V6, pR256, DOI 10.1186/ar1174; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chamilos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012955; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fransen JH, 2009, ARTHRITIS RHEUM-US, V60, P2304, DOI 10.1002/art.24719; Govindarajan G, 2008, AM J MED, V121, P366, DOI 10.1016/j.amjmed.2008.01.032; Han JW, 2008, CIRC RES, V102, P546, DOI 10.1161/CIRCRESAHA.107.161653; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Lang JE, 2008, AM J PHYSIOL-LUNG C, V294, pL1013, DOI 10.1152/ajplung.00122.2007; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Pini M, 2008, ENDOCRINOLOGY, V149, P4080, DOI 10.1210/en.2008-0327; Pini M, 2010, J LEUKOCYTE BIOL, V87, P51, DOI 10.1189/jlb.0309188; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shimazu T, 2009, INT J OBESITY, V33, P490, DOI 10.1038/ijo.2009.29; Sterry W, 2007, BRIT J DERMATOL, V157, P649, DOI 10.1111/j.1365-2133.2007.08068.x; Sumarac-Dumanovic M, 2009, INT J OBESITY, V33, P151, DOI 10.1038/ijo.2008.216; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Wu H, 2009, CIRCULATION, V119, P2708; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zyromski NJ, 2008, AM J PHYSIOL-GASTR L, V295, pG552, DOI 10.1152/ajpgi.90278.2008	36	69	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92450	10.1371/journal.pone.0092450	http://dx.doi.org/10.1371/journal.pone.0092450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642966	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900142
J	Lin, CY; Li, RP; Cheng, HG; Wang, J; Shao, X				Lin, Chunye; Li, Ruiping; Cheng, Hongguang; Wang, Jing; Shao, Xiao			Tungsten Distribution in Soil and Rice in the Vicinity of the World's Largest and Longest-Operating Tungsten Mine in China	PLOS ONE			English	Article							BIOCHEMICAL-CONSTITUENTS; PLANTS; BIOAVAILABILITY; CONTAMINATION; MOLYBDENUM; SPECIATION; TOXICITY; GROWTH; METALS; MATTER	The objective of this study is to investigate tungsten (W) contamination in soil and its enrichment in rice in the area of the world's largest and longest-operating W mines in China. Root zone soil and rice plants were sampled at 15 sites in the agricultural field adjacent to W mines and analyzed for Al, Fe, Mn, Sc, and W contents and W chemical forms in the soil samples and W contents in the rice root, stem, leaf, and grain samples. Results showed that W content in the soil ranged from 3.99 to 43.7 mg kg(-1), with more than 90% of W in the residual fraction, showing its low mobility and bioavailability. Average W contents in the rice root, stem, leaf, and grain were 7.06, 2.34, 4.76, 0.17 mg kg(-1), respectively. In addition, they were linearly independent of W content and chemical forms in the soil. Average enrichment factor values were 0.39, 0.13, 0.28, and 0.01 for the root, stem, leaf, and grain, respectively. In can be concluded that W mining activity in the Dayu county contaminated the nearby agricultural soil and led to W bioaccumulation in the rice. This may pose a health risk to residents via food and soil ingestion, which should be a focus of scrutiny.	[Lin, Chunye; Li, Ruiping; Cheng, Hongguang; Shao, Xiao] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China; [Wang, Jing] Minist Land & Resources, China Land Surveying & Planning Inst, Key Lab Land Use, Beijing, Peoples R China	Beijing Normal University; Ministry of Natural Resources of the People's Republic of China	Lin, CY (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.	c.lin@bnu.edu.cn			National Natural Science Foundation of China [41371441]; Ministry of Environmental Protection [201309044, 201109064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Environmental Protection	This study was supported by the National Natural Science Foundation of China (41371441, http://www.nsfc.gov.cn/), and the Ministry of Environmental Protection Funded Project (201309044, 201109064; http://www.zhb.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamakis Ioannis-Dimosthenis S., 2012, Plants-Basel, V1, P82, DOI 10.3390/plants1020082; Bednar AJ, 2009, CHEMOSPHERE, V75, P1049, DOI 10.1016/j.chemosphere.2009.01.039; Bibak A, 1998, J AGR FOOD CHEM, V46, P3139, DOI 10.1021/jf971103c; Bowen H. J. M, 1979, ENV CHEM ELEMENTS; BOWEN HJM, 1960, BIOCHEM J, V77, P79, DOI 10.1042/bj0770079; Bruschweiler B, 2009, TOXICOL LETT, V189, pS219, DOI 10.1016/j.toxlet.2009.06.509; Cheng HG, 2013, POL J ENVIRON STUD, V22, P301; DAVIES EB, 1956, NATURE, V178, P866, DOI 10.1038/178866a0; Eriksson J.E, 2001, 5159 EPA; Fritsch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020682; FU MH, 1988, J ENVIRON QUAL, V17, P146, DOI 10.2134/jeq1988.00472425001700010024x; Huang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075007; Jiang F, 2007, PLANT SOIL, V301, P37, DOI 10.1007/s11104-007-9409-z; Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071176; Johnson D. R., 2009, Land Contamination & Reclamation, V17, P141, DOI 10.2462/09670513.939; Kabata-Pendias A., 2007, TRACE ELEMEN SOIL HU, DOI [10.1007/978-3-540-32714-1, DOI 10.1007/978-3-540-32714-1, 10.1007/978-3-540-32714-1_20]; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P9646, DOI 10.1021/es300606x; Koutsospyros A, 2006, J HAZARD MATER, V136, P1, DOI 10.1016/j.jhazmat.2005.11.007; Kumar A, 2011, PLANT SOIL ENVIRON, V57, P519, DOI 10.17221/345/2011-PSE; Kumar A, 2012, COMMUN SOIL SCI PLAN, V43, P1098, DOI 10.1080/00103624.2012.656171; Lin CY, 2008, J ENVIRON QUAL, V37, P1477, DOI 10.2134/jeq2007.0388; Lin CY, 2008, ENVIRON MONIT ASSESS, V137, P329, DOI 10.1007/s10661-007-9768-1; Pyatt F.B., 2004, J ENV HLTH RES, V3, P13; QUIN BF, 1976, PLANT SOIL, V45, P201, DOI 10.1007/BF00011142; QUIN BF, 1974, PLANT SOIL, V41, P177, DOI 10.1007/BF00017953; QUIN BF, 1972, NEW ZEAL J SCI, V15, P308; QUIN BF, 1972, PLANT SOIL, V37, P699, DOI 10.1007/BF01348530; Rodushkin I, 1999, SCI TOTAL ENVIRON, V231, P53, DOI 10.1016/S0048-9697(99)00080-7; Steinmaus C, 2004, ENVIRON HEALTH PERSP, V112, P766, DOI 10.1289/ehp.6592; Strigul N, 2005, CHEMOSPHERE, V61, P248, DOI 10.1016/j.chemosphere.2005.01.083; Strigul N, 2010, ECOTOX ENVIRON SAFE, V73, P1099, DOI 10.1016/j.ecoenv.2010.05.005; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; USEPA (United States Environmental Protection Agency), 2011, EXP FACT HDB 2011 ED; Wei F.S., 1990, BACKGROUND CONTENTS; Wilson B., 2009, Land Contamination & Reclamation, V17, P93, DOI 10.2462/09670513.935; Wilson B, 2006, SCI TOTAL ENVIRON, V370, P401, DOI 10.1016/j.scitotenv.2006.07.026; Wilson B, 2009, J TOXICOL ENV HEAL A, V72, P807, DOI 10.1080/15287390902800389; WILSON DO, 1966, NATURE, V209, P941, DOI 10.1038/209941a0; Zheng SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049664; Zhu HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050225	40	21	22	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91981	10.1371/journal.pone.0091981	http://dx.doi.org/10.1371/journal.pone.0091981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642612	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900054
J	Cann, CE; Adams, JE; Brown, JK; Brett, AD				Cann, Christopher E.; Adams, Judith E.; Brown, J. Keenan; Brett, Alan D.			CTXA Hip-An Extension of Classical DXA Measurements Using Quantitative CT	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CONTRAST-ENHANCED MDCT; X-RAY ABSORPTIOMETRY; PROXIMAL FEMUR; UNIVERSAL STANDARDIZATION; FEMORAL-NECK; DENSITOMETRY; OSTEOPOROSIS; CALIBRATION; SPINE	Bone mineral density (BMD) estimates for the proximal femur using Dual Energy X-ray Absorptiometry (DXA) are currently considered the standard for making a diagnosis of osteoporosis in an individual patient using BMD alone. We have compared BMD results from a commercial Quantitative CT (QCT) BMD analysis system, "CTXA Hip'', which provides clinical data for the proximal femur, to results from DXA. We have also used CTXA Hip to determine cortical and trabecular contributions to total BMD. Sixty-nine patients were scanned using 3D QCT and DXA. CTXA Hip BMD measurements for Total Hip and Femoral Neck were compared to DXA results. Twenty-two women were scanned at 0,1,2 years and CTXA Hip and DXA results analyzed for long-term reproducibility. Long-term reproducibility calculated as root-mean-square averages of SDs in vivo was 0.012 g/cm(2) (CV = 1.8%) for CTXA Total Hip and 0.011 g/cm(2) (CV = 2.0%) for CTXA Femoral Neck compared to 0.014 g/cm(2) (CV = 2.0%) and 0.016 g/cm(2) (CV = 2.7%), respectively, for DXA. The correlation of Total Hip BMD CTXA vs. DXA was R = 0.97 and for Femoral Neck was R = 0.95 (SEE 0.044 g/cm(2) in both cases). Cortical bone comprised 6265% (mean +/- SD) of total hipbone mass in osteoporotic women. CTXA Hip provides substantially the same clinical information as conventional DXA and in addition provides estimates of BMD in separate cortical and trabecular bone compartments, which may be useful in evaluation of bone strength.	[Cann, Christopher E.; Brown, J. Keenan; Brett, Alan D.] Mindways Software Inc, Austin, TX 78704 USA; [Cann, Christopher E.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Adams, Judith E.] Univ Manchester, Dept Clin Radiol, Manchester, Lancs, England	University of California System; University of California San Francisco; University of Manchester	Brett, AD (corresponding author), Mindways Software Inc, Austin, TX 78704 USA.	alan@qct.com		Brett, Alan/0000-0002-1671-9277				Adams JE, 2009, EUR J RADIOL, V71, P415, DOI 10.1016/j.ejrad.2009.04.074; [Anonymous], 2008, ACR PRACT GUID PERF; Bauer JS, 2007, AM J ROENTGENOL, V188, P1294, DOI 10.2214/AJR.06.1006; Binkley N, 2005, J BONE MINER RES, V20, P195, DOI 10.1359/JBMR.041115; Camp JJ, 2004, PRO BIOMED OPT IMAG, V5, P74, DOI 10.1117/12.535745; CANN CE, 1980, J COMPUT ASSIST TOMO, V4, P493, DOI 10.1097/00004728-198008000-00018; Curtis JR, 2008, J BONE MINER RES, V23, P1061, DOI [10.1359/jbmr.080232, 10.1359/JBMR.080232]; Damilakis J, 2010, EUR RADIOL, V20, P2707, DOI 10.1007/s00330-010-1845-0; Faulkner KG, 1999, J CLIN DENSITOM, V2, P343, DOI 10.1385/JCD:2:3:343; Genant HK, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken180; GENANT HK, 1994, J BONE MINER RES, V9, P1503; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; GOODSITT MM, 1992, BONE MINER, V19, P145, DOI 10.1016/0169-6009(92)90922-Z; Gruber M, 2013, EUR RADIOL, V23, P505, DOI 10.1007/s00330-012-2629-5; Guglielmi G, 2005, ACTA RADIOL, V46, P269, DOI 10.1080/02841850510012661; Hui SL, 1997, J BONE MINER RES, V12, P1463, DOI 10.1359/jbmr.1997.12.9.1463; Kang Y, 2005, COMPUT MED IMAG GRAP, V29, P533, DOI 10.1016/j.compmedimag.2005.05.002; Kang Y, 2003, IEEE T MED IMAGING, V22, P586, DOI 10.1109/TMI.2003.812265; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Keyak JH, 2011, BONE, V48, P1239, DOI 10.1016/j.bone.2011.03.682; Khoo BCC, 2012, OSTEOPOROSIS INT, V23, P1393, DOI 10.1007/s00198-011-1727-6; Khoo BCC, 2009, OSTEOPOROSIS INT, V20, P1539, DOI 10.1007/s00198-008-0820-y; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lang TF, 1997, BONE, V21, P101, DOI 10.1016/S8756-3282(97)00072-0; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Link TM, 2004, RADIOLOGY, V231, P805, DOI 10.1148/radiol.2313030325; Liu G, 1997, OSTEOPOROSIS INT, V7, P564, DOI 10.1007/BF02652563; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; Nelson HD, 2010, ANN INTERN MED, V153; Papadakis AE, 2009, EUR RADIOL, V19, P172, DOI 10.1007/s00330-008-1099-2; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; Poole KES, 2010, J BONE MINER RES, V25, P482, DOI 10.1359/jbmr.090734; Prior JC, 1997, J BONE MINER RES, V12, P1851, DOI 10.1359/jbmr.1997.12.11.1851; Siris ES, 2012, OSTEOPOROSIS INT, V23, P2093, DOI 10.1007/s00198-012-1991-0; Slosman DO, 1999, J CLIN DENSITOM, V2, P37, DOI 10.1385/JCD:2:1:37; Smith JA, 1999, J CLIN DENSITOM, V2, P181, DOI 10.1385/JCD:2:2:181; US Department of Health and Human Services, 2004, BON HLTH OST REP SUR, DOI [10.2165/00002018-200932030-00004, DOI 10.2165/00002018-200932030-00004]; WAHNER HW, 1994, J BONE MINER RES, V9, P951; Yu EW, 2012, J BONE MINER RES, V27, P119, DOI 10.1002/jbmr.506	40	33	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91904	10.1371/journal.pone.0091904	http://dx.doi.org/10.1371/journal.pone.0091904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637515	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100079
J	Diaz-Riquelme, J; Martinez-Zapater, JM; Carmona, MJ				Diaz-Riquelme, Jose; Martinez-Zapater, Jose M.; Carmona, Maria J.			Transcriptional Analysis of Tendril and Inflorescence Development in Grapevine (Vitis vinifera L.)	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL TRANSITION; MERISTEM IDENTITY; BUD DEVELOPMENT; FLOWERING-TIME; ARABIDOPSIS; EXPRESSION; INTEGRATION; MICROARRAY; SIGNALS	In grapevine (Vitis vinifera L.), the lateral meristem can give rise to either tendrils or inflorescences which are determined organs. To get insights into the processes of tendril and inflorescence development, we characterized the transcriptional variation taking place in both organs. The results of the global transcriptional analyses along tendril and inflorescence development suggested that these two homologous organs initially share a common transcriptional program related to cell proliferation and growth functions. In later developmental stages they showed organ specific gene expression programs related to the particular differentiation processes taking place in each organ. In this way, tendrils showed higher transcription of genes related to photosynthesis, hormone signaling and secondary metabolism than inflorescences, while inflorescences displayed higher transcriptional activity for genes encoding transcription factors, mainly those belonging to the MADS-box gene family. The expression profiles of selected transcription factors related with inflorescence and flower meristem identity and with flower organogenesis were generally conserved with respect to their homologs in model species. Regarding tendrils, it was interesting to find that genes related with reproductive development in other species were also recruited for grapevine tendril development. These results suggest a role for those genes in the regulation of basic cellular mechanisms common to both developmental processes.	[Diaz-Riquelme, Jose; Martinez-Zapater, Jose M.] Univ La Rioja, CSIC, Inst Ciencias Vid & Vino, Logrono, Spain; [Carmona, Maria J.] Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, Dept Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; Universidad Politecnica de Madrid	Carmona, MJ (corresponding author), Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, Dept Biotecnol, Madrid, Spain.	mariajose.carmona@upm.es	CARMONA, MARIA JOSÉ CARVALHO/G-3653-2014; Martinez Zapater, Jose/I-4892-2012	CARMONA, MARIA JOSÉ CARVALHO/0000-0002-3031-2924; Martinez Zapater, Jose/0000-0001-7217-4454	Spanish Ministry of Science and Innovation (MICINN) [BIO2008-03892, BIO2011-26229]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by Projects BIO2008-03892 and BIO2011-26229 from the Spanish Ministry of Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Baggiolini M., 1952, REV ROMANDE AGR VITI, V8, p4e6, DOI DOI 10.3354/CR01048; Boss P. K., 2000, Australian Journal of Grape and Wine Research, V6, P168, DOI 10.1111/j.1755-0238.2000.tb00176.x; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Boss PK, 2002, PLANT SCI, V162, P887, DOI 10.1016/S0168-9452(02)00034-1; Boss PK, 2001, PLANT MOL BIOL, V45, P541, DOI 10.1023/A:1010634132156; Burko Y, 2013, PLANT CELL, V25, P2070, DOI 10.1105/tpc.113.113035; Buttrose M. S., 1974, Horticultural Abstracts, V44, P319; Calonje M, 2004, PLANT PHYSIOL, V135, P1491, DOI 10.1104/pp.104.040832; Carmona MJ, 2007, CAN J BOT, V85, P701, DOI 10.1139/B07-059; Carmona MJ, 2002, PLANT PHYSIOL, V130, P68, DOI 10.1104/pp.002428; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Diaz-Riquelme J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-181; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Gerrath JM, 1993, HORTIC REV, V13, P315; Gerrath JM, 1998, PHYLLOTAXIS VITACEAE, P89; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Grimplet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008365; Guo AY, 2008, GENE, V418, P1, DOI 10.1016/j.gene.2008.03.016; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hou HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059358; Carmona MJ, 2008, J EXP BOT, V59, P2579, DOI 10.1093/jxb/ern160; Carmona MJ, 2007, PLANT MOL BIOL, V63, P637, DOI 10.1007/s11103-006-9113-z; Jung JH, 2012, PLANT J, V69, P577, DOI 10.1111/j.1365-313X.2011.04813.x; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Lehti-Shiu MD, 2005, PLANT MOL BIOL, V58, P89, DOI 10.1007/s11103-005-4546-3; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Mandaokar A, 2003, PLANT MOL BIOL, V52, P775, DOI 10.1023/A:1025045217859; May P., 2000, Australian Journal of Grape and Wine Research, V6, P82, DOI 10.1111/j.1755-0238.2000.tb00166.x; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; MORRISON JC, 1991, BOT GAZ, V152, P304, DOI 10.1086/337894; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Nagano Y, 2001, NUCLEIC ACIDS RES, V29, P4097, DOI 10.1093/nar/29.20.4097; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; PRATT C, 1974, AM J ENOL VITICULT, V25, P131; Rausch T, 2004, BBA-PROTEINS PROTEOM, V1696, P253, DOI 10.1016/j.bbapap.2003.09.017; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Shikata M, 2009, PLANT CELL PHYSIOL, V50, P2133, DOI 10.1093/pcp/pcp148; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; TUCKER SC, 1968, AM J BOT, V55, P1110, DOI 10.2307/2440479; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Viaene T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-148; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu GZ, 2010, PLANT CELL, V22, P3726, DOI 10.1105/tpc.110.075564; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yang SH, 2006, PLANT J, V45, P166, DOI 10.1111/j.1365-313X.2005.02585.x	63	27	29	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92339	10.1371/journal.pone.0092339	http://dx.doi.org/10.1371/journal.pone.0092339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637773	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100143
J	Edwards, FA; Edwards, DP; Sloan, S; Hamer, KC				Edwards, Felicity A.; Edwards, David P.; Sloan, Sean; Hamer, Keith C.			Sustainable Management in Crop Monocultures: The Impact of Retaining Forest on Oil Palm Yield	PLOS ONE			English	Article							RAIN-FOREST; SPECIES RICHNESS; TROPICAL FOREST; FUNCTIONAL DIVERSITY; HABITAT MANAGEMENT; ECOSYSTEM SERVICES; CONSERVATION VALUE; NATURAL ENEMIES; BIODIVERSITY; LANDSCAPE	Tropical agriculture is expanding rapidly at the expense of forest, driving a global extinction crisis. How to create agricultural landscapes that minimise the clearance of forest and maximise sustainability is thus a key issue. One possibility is protecting natural forest within or adjacent to crop monocultures to harness important ecosystem services provided by biodiversity spill-over that may facilitate production. Yet this contrasts with the conflicting potential that the retention of forest exports dis-services, such as agricultural pests. We focus on oil palm and obtained yields from 499 plantation parcels spanning a total of approximate to 23,000 ha of oil palm plantation in Sabah, Malaysian Borneo. We investigate the relationship between the extent and proximity of both contiguous and fragmented dipterocarp forest cover and oil palm yield, controlling for variation in oil palm age and for environmental heterogeneity by incorporating proximity to non-native forestry plantations, other oil palm plantations, and large rivers, elevation and soil type in our models. The extent of forest cover and proximity to dipterocarp forest were not significant predictors of oil palm yield. Similarly, proximity to large rivers and other oil palm plantations, as well as soil type had no significant effect. Instead, lower elevation and closer proximity to forestry plantations had significant positive impacts on oil palm yield. These findings suggest that if dipterocarp forests are exporting ecosystem service benefits or ecosystem dis-services, that the net effect on yield is neutral. There is thus no evidence to support arguments that forest should be retained within or adjacent to oil palm monocultures for the provision of ecosystem services that benefit yield. We urge for more nuanced assessments of the impacts of forest and biodiversity on yields in crop monocultures to better understand their role in sustainable agriculture.	[Edwards, Felicity A.; Hamer, Keith C.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Edwards, David P.; Sloan, Sean] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld, Australia; [Edwards, David P.; Sloan, Sean] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Edwards, David P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Leeds; James Cook University; James Cook University; University of Sheffield	Edwards, FA (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	bs08f2a@leeds.ac.uk	Sloan, Sean/A-8630-2012; Edwards, David/AAC-5091-2019	Sloan, Sean/0000-0002-7834-0203; Edwards, David/0000-0001-8562-3853; Edwards, Felicity/0000-0003-1742-2763	Biotechnology and Biological Sciences Research Council; Australian Research Council; Biotechnology and Biological Sciences Research Council [1087855] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Research Council(Australian Research Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	F.A.E was supported by a Biotechnology and Biological Sciences Research Council doctoral training grant studentship, and D. P. E and S. S. were supported by an Australian Research Council Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bhagwat SA, 2008, CONSERV BIOL, V22, P1368, DOI 10.1111/j.1523-1739.2008.01026.x; Bisseleua HBD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056115; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Corley R., 2003, OIL PALM; Director of National Mapping, 1974, TAW SOILS SAB SHEET; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Edwards DP, 2012, BIOL CONSERV, V151, P60, DOI 10.1016/j.biocon.2012.01.017; Edwards DP, 2012, CONSERV LETT, V5, P20, DOI 10.1111/j.1755-263X.2011.00209.x; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Edwards FA, 2013, IBIS, V155, P313, DOI 10.1111/ibi.12027; ESRI, 2011, ARCGIS DESKT REL 10; FAO website, WRB MAP WORLD SOIL R; Fayle TM, 2010, BASIC APPL ECOL, V11, P337, DOI 10.1016/j.baae.2009.12.009; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Food and Agriculture Organization of the United Nations, 2013, FAOSTAT STAT DAT; Foster WA, 2011, PHILOS T R SOC B, V366, P3277, DOI 10.1098/rstb.2011.0041; Garcia-Ulloa J, 2012, CONSERV LETT, V5, P366, DOI 10.1111/j.1755-263X.2012.00254.x; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hill JK, 2011, PHILOS T R SOC B, V366, P3265, DOI 10.1098/rstb.2011.0050; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Koh LP, 2008, J APPL ECOL, V45, P1002, DOI 10.1111/j.1365-2664.2008.01491.x; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Koh LP, 2009, TRENDS ECOL EVOL, V24, P431, DOI 10.1016/j.tree.2009.03.012; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lucey JM, 2012, BIOTROPICA, V44, P368, DOI 10.1111/j.1744-7429.2011.00824.x; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; Olschewski R, 2006, ECOL SOC, V11; Olschewski R, 2010, ECOL COMPLEX, V7, P314, DOI 10.1016/j.ecocom.2010.01.002; Perfecto I, 2004, ECOLOGY, V85, P2677, DOI 10.1890/03-3145; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Peterson EE, 2011, FRESHWATER BIOL, V56, P590, DOI 10.1111/j.1365-2427.2010.02507.x; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Ranganathan J, 2010, BIOL CONSERV, V143, P2909, DOI 10.1016/j.biocon.2010.04.018; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Rheinhardt R, 2012, ECOL INDIC, V23, P46, DOI 10.1016/j.ecolind.2012.03.017; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Sande SO, 2009, BIOL CONSERV, V142, P2703, DOI 10.1016/j.biocon.2009.06.023; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8349, DOI 10.1073/pnas.1210595110; Schroth G, 2011, ENVIRON MANAGE, V48, P229, DOI 10.1007/s00267-011-9708-2; Senior MJM, 2013, BIODIVERS CONSERV, V22, P253, DOI 10.1007/s10531-012-0419-7; Sheldon FH, 2010, BIOL CONSERV, V143, P399, DOI 10.1016/j.biocon.2009.11.004; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Styring AR, 2011, FOREST ECOL MANAG, V261, P531, DOI 10.1016/j.foreco.2010.11.003; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Woltz JM, 2012, AGR ECOSYST ENVIRON, V152, P40, DOI 10.1016/j.agee.2012.02.008; Woodcock P, 2011, PHILOS T R SOC B, V366, P3256, DOI 10.1098/rstb.2011.0031; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024; Zuur Alain F., 2009, P1	74	25	26	5	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91695	10.1371/journal.pone.0091695	http://dx.doi.org/10.1371/journal.pone.0091695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638038	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333254100052
J	Francis, DM; Koveal, D; Tortajada, A; Page, R; Peti, W				Francis, Dana M.; Koveal, Dorothy; Tortajada, Antoni; Page, Rebecca; Peti, Wolfgang			Interaction of Kinase-Interaction-Motif Protein Tyrosine Phosphatases with the Mitogen-Activated Protein Kinase ERK2	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; MAP KINASE; DIFFERENTIAL REGULATION; BINDING DOMAIN; PTP-SL; DOCKING INTERACTIONS; STRUCTURAL BASIS; P38-ALPHA; SPECIFICITY; P38	The mitogen-activation protein kinase ERK2 is tightly regulated by multiple phosphatases, including those of the kinase interaction motif (KIM) PTP family (STEP, PTPSL and HePTP). Here, we use small angle X-ray scattering (SAXS) and isothermal titration calorimetry (ITC) to show that the ERK2: STEP complex is compact and that residues outside the canonical KIM motif of STEP contribute to ERK2 binding. Furthermore, we analyzed the interaction of PTPSL with ERK2 showing that residues outside of the canonical KIM motif also contribute to ERK2 binding. The integration of this work with previous studies provides a quantitative and structural map of how the members of a single family of regulators, the KIM-PTPs, differentially interact with their corresponding MAPKs, ERK2 and p38 alpha.	[Francis, Dana M.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Koveal, Dorothy; Tortajada, Antoni; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Peti, W (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	Wolfgang_Peti@brown.edu	Peti, Wolfgang/L-3492-2014		American Cancer Society [RSG-08-067-01-LIB]; National Institute of Health [R01GM100910]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100910] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grant RSG-08-067-01-LIB from the American Cancer Society to R. P. and by R01GM100910 from the National Institute of Health to W. P. Use of NSLS at Brookhaven National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-98CH10886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasu MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005432; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Francis DM, 2014, BIOMOL NMR ASSIGN, V8, P185, DOI 10.1007/s12104-013-9480-8; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Francis DM, 2011, J AM CHEM SOC, V133, P17138, DOI 10.1021/ja2075136; Francis DM, 2013, STRUCTURE, V21, P1612, DOI 10.1016/j.str.2013.07.003; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar GS, 2013, J BIOL CHEM, V288, P28347, DOI 10.1074/jbc.M113.499178; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Piserchio A, 2012, BIOCHEMISTRY-US, V51, P8047, DOI 10.1021/bi3012725; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tarrega C, 2002, J BIOL CHEM, V277, P2629, DOI 10.1074/jbc.M108874200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang YY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002241; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	28	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91934	10.1371/journal.pone.0091934	http://dx.doi.org/10.1371/journal.pone.0091934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637728	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100084
J	Jing, XN; Shi, QY; Bi, W; Zeng, ZF; Liang, YR; Wu, X; Xiao, SH; Liu, J; Yang, LH; Tao, EX				Jing, Xiuna; Shi, Qiaoyun; Bi, Wei; Zeng, Zhifen; Liang, Yanran; Wu, Xia; Xiao, Songhua; Liu, Jun; Yang, Lianhong; Tao, Enxiang			Rifampicin Protects PC12 Cells from Rotenone-Induced Cytotoxicity by Activating GRP78 via PERK-eIF2 alpha-ATF4 Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-REGULATED PROTEIN; RENAL EPITHELIAL-CELLS; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; PARKINSONS-DISEASE; INDUCED APOPTOSIS; ER STRESS; DEATH; INDUCTION	Rifampicin has been proposed as a therapeutic candidate for Parkinson's disease (PD). We previously showed that rifampicin was neuroprotective in PD models in vivo and in vitro. However, the molecular mechanisms underlying are not fully elucidated. In this study, using the comprehensive proteomic analysis, we identified that the 78 kDa glucose-regulated protein (GRP78), a hallmark of the unfolded protein response (UPR), was upregulated in rifampicin-treated PC12 cells. Western blot analysis confirmed GRP78 activation. GRP78 functions cytoprotectively in stressed cells, therefore, we hypothesized that GRP78 mediated rifampicin-induced neuroprotection. Using RNA interference, we found that GRP78 gene knockdown significantly attenuated the neuroprotective effects of rifampicin. Next, we examined three UPR transducers, namely, protein kinase RNA-like endoplasmic reticulum kinase (PERK), inositol requiring kinase alpha (IRE alpha) and activating transcription factor 6 (ATF 6), and how they regulated rifampicin-stimulated GRP78 expression. Our results showed that PERK, eukaryotic initiation factor 2 alpha (eIF2 alpha), and activating transcription factor 4 (ATF4) were activated in rifampicin-treated PC12 cells. Silencing the ATF4 gene using RNAi inhibited GRP78 stimulation. Interestingly, we did not detect significant IRE alpha activation, X-box binding protein 1 mRNA splicing, or ATF6 cleavage up to 24 h after rifampicin treatment. Taken together, our data suggested that rifampicin induced GRP78 via the PERK-eIF2 alpha-ATF4 pathway to protect neurons against rotenone-induced cell damage. Targeting molecules in this pathway could be a novel therapeutic approach for PD treatment.	[Jing, Xiuna; Bi, Wei; Zeng, Zhifen; Liang, Yanran; Wu, Xia; Xiao, Songhua; Liu, Jun; Yang, Lianhong; Tao, Enxiang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Shi, Qiaoyun] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Bi, Wei] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Stanford University; Jinan University	Tao, EX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	taoenxiang@163.com			National Natural Science Foundation of China (NSFC) [81371391]; Guangdong Provincial Department of Science and Technology [7001599, S2012010010731]; Ph.D. Programs Foundation of Ministry of Education of China [20070558257]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Department of Science and Technology; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was funded by the the National Natural Science Foundation of China (NSFC, 81371391), and the Guangdong Provincial Department of Science and Technology (7001599; S2012010010731) and the Ph.D. Programs Foundation of Ministry of Education of China (No. 20070558257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi W, 2011, BRAIN RES, V1395, P12, DOI 10.1016/j.brainres.2011.04.019; Bradbury J, 2005, DRUG DISCOV TODAY, V10, P80, DOI 10.1016/S1359-6446(04)03340-9; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Chen SW, 2010, NEURAL REGEN RES, V5, P251, DOI 10.3969/j.issn.1673-5374.2010.04.002; Dong WJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2588; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Goldenberg-Cohen N, 2012, APOPTOSIS, V17, P278, DOI 10.1007/s10495-011-0678-x; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Hara H, 2011, NEUROCHEM INT, V58, P35, DOI 10.1016/j.neuint.2010.10.006; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Jankovic Joseph, 2008, Neuropsychiatr Dis Treat, V4, P743; Jessie K, 2010, INT J MOL SCI, V11, P4488, DOI 10.3390/ijms11114488; Jia Z, 2004, AM J PHYSIOL-RENAL, V287, pF1113, DOI 10.1152/ajprenal.00138.2004; Jiang YF, 2012, NEUROSCI LETT, V516, P182, DOI 10.1016/j.neulet.2012.03.074; Kilic U, 2004, ACTA NEUROPATHOL, V108, P65, DOI 10.1007/s00401-004-0867-6; Kong XC, 2011, BRAIN RES, V1383, P99, DOI 10.1016/j.brainres.2011.01.093; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010489; Lehotsky J, 2009, CELL MOL NEUROBIOL, V29, P917, DOI 10.1007/s10571-009-9376-4; Liu H, 1998, J BIOL CHEM, V273, P12858, DOI 10.1074/jbc.273.21.12858; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Oida Y, 2008, BRAIN RES, V1208, P217, DOI 10.1016/j.brainres.2008.02.068; Oida Y, 2006, BRAIN RES, V1082, P196, DOI 10.1016/j.brainres.2006.01.116; Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shen CX, 2008, CHEM-BIOL INTERACT, V176, P196, DOI 10.1016/j.cbi.2008.07.014; Sun YL, 2010, NEURAL REGEN RES, V5, P85, DOI 10.3969/j.issn.1673-5374.2010.02.001; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Wu HL, 2009, CARDIOVASC RES, V81, P148, DOI 10.1093/cvr/cvn262; Xu J, 2007, BRAIN RES, V1139, P220, DOI 10.1016/j.brainres.2006.12.074; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	38	22	23	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92110	10.1371/journal.pone.0092110	http://dx.doi.org/10.1371/journal.pone.0092110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638036	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100113
J	Song, IW; Li, WR; Chen, LY; Shen, LF; Liu, KM; Yen, JJY; Chen, YJ; Chen, YJ; Kraus, VB; Wu, JY; Lee, MTM; Chen, YT				Song, I-Wen; Li, Wei-Ru; Chen, Li-Ying; Shen, Li-Fen; Liu, Kai-Ming; Yen, Jeffrey J. Y.; Chen, Yi-Ju; Chen, Yu-Ju; Kraus, Virginia Byers; Wu, Jer-Yuarn; Lee, M. T. Michael; Chen, Yuan-Tsong			Palmitoyl Acyltransferase, Zdhhc13, Facilitates Bone Mass Acquisition by Regulating Postnatal Epiphyseal Development and Endochondral Ossification: A Mouse Model	PLOS ONE			English	Article							MT1-MMP; OSTEOPOROSIS; PROTEIN; IDENTIFICATION; ANGIOGENESIS; EXPRESSION; ISOFORMS; DISEASE; COMPLEX; 5P15.33	ZDHHC13 is a member of DHHC-containing palmitoyl acyltransferases (PATs) family of enzymes. It functions by post-translationally adding 16-carbon palmitate to proteins through a thioester linkage. We have previously shown that mice carrying a recessive Zdhhc13 nonsense mutation causing a Zdhcc13 deficiency develop alopecia, amyloidosis and osteoporosis. Our goal was to investigate the pathogenic mechanism of osteoporosis in the context of this mutation in mice. Body size, skeletal structure and trabecular bone were similar in Zdhhc13 WT and mutant mice at birth. Growth retardation and delayed secondary ossification center formation were first observed at day 10 and at 4 weeks of age, disorganization in growth plate structure and osteoporosis became evident in mutant mice. Serial microCT from 4-20 week-olds revealed that Zdhhc13 mutant mice had reduced bone mineral density. Through co-immunoprecipitation and acylbiotin exchange, MT1-MMP was identified as a direct substrate of ZDHHC13. In cells, reduction of MT1-MMP palmitoylation affected its subcellular distribution and was associated with decreased VEGF and osteocalcin expression in chondrocytes and osteoblasts. In Zdhhc13 mutant mice epiphysis where MT1-MMP was under palmitoylated, VEGF in hypertrophic chondrocytes and osteocalcin at the cartilage-bone interface were reduced based on immunohistochemical analyses. Our results suggest that Zdhhc13 is a novel regulator of postnatal skeletal development and bone mass acquisition. To our knowledge, these are the first data to suggest that ZDHHC13-mediated MT1-MMP palmitoylation is a key modulator of bone homeostasis. These data may provide novel insights into the role of palmitoylation in the pathogenesis of human osteoporosis.	[Song, I-Wen; Li, Wei-Ru; Chen, Li-Ying; Shen, Li-Fen; Liu, Kai-Ming; Yen, Jeffrey J. Y.; Wu, Jer-Yuarn; Lee, M. T. Michael; Chen, Yuan-Tsong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Song, I-Wen; Chen, Yuan-Tsong] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liu, Kai-Ming] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yi-Ju; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Kraus, Virginia Byers] Duke Univ, Med Ctr, Dept Med, Div Rheumatol, Durham, NC 27710 USA; [Lee, M. T. Michael] RIKEN, Ctr Integrat Med Sci, Lab Int Alliance Genom Res, Yokohama, Kanagawa, Japan; [Lee, M. T. Michael] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Academia Sinica - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Duke University; RIKEN; China Medical University Taiwan; Duke University	Lee, MTM (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	mikelee@ibms.sinica.edu.tw; chen0010@ibms.sinica.edu.tw	Chen, Yi-Ju/AAP-9052-2021; Song, I-Wen/AAW-9307-2020; Yen, Jeffrey Jong-Young/Q-5134-2018; Wu, Jer-Yuarn/S-7010-2018; Chen, Yu-Ju/E-9481-2015	Chen, Yi-Ju/0000-0002-7203-9188; Yen, Jeffrey Jong-Young/0000-0001-6299-1995; Chen, Yu-Ju/0000-0002-3178-6697; SONG, I-WEN/0000-0003-1579-4328	Academia Sinica Genomic Medicine Multicenter Study [40-05-GMM]; National Research Program for Genomic Medicine, National Science Council, Taiwan (National Center for Genome Medicine) [NSC101-2319-B-001-001]	Academia Sinica Genomic Medicine Multicenter Study(Academia Sinica - Taiwan); National Research Program for Genomic Medicine, National Science Council, Taiwan (National Center for Genome Medicine)	This study was supported by the Academia Sinica Genomic Medicine Multicenter Study (40-05-GMM), the National Research Program for Genomic Medicine, National Science Council, Taiwan (National Center for Genome Medicine, NSC101-2319-B-001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004; Chan KM, 2012, DEV CELL, V22, P1176, DOI 10.1016/j.devcel.2012.04.014; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Li Y, 2010, J BIOL CHEM, V285, P13022, DOI 10.1074/jbc.M109.079426; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Loro ML, 2000, J CLIN ENDOCR METAB, V85, P3908; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Manduca P, 2009, BONE, V44, P251, DOI 10.1016/j.bone.2008.10.046; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Oyama T, 2000, GENE CHROMOSOME CANC, V29, P9, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Tang Y, 2013, DEV CELL; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Yamamoto Y, 2007, ONCOLOGY-BASEL, V72, P132, DOI 10.1159/000111132; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	37	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92194	10.1371/journal.pone.0092194	http://dx.doi.org/10.1371/journal.pone.0092194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637783	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100125
J	Guicciardi, ME; Werneburg, NW; Bronk, SF; Franke, A; Yagita, H; Thomas, G; Gores, GJ				Guicciardi, Maria Eugenia; Werneburg, Nathan W.; Bronk, Steven F.; Franke, Adrian; Yagita, Hideo; Thomas, Gary; Gores, Gregory J.			Cellular Inhibitor of Apoptosis (cIAP)-Mediated Ubiquitination of Phosphofurin Acidic Cluster Sorting Protein 2 (PACS-2) Negatively Regulates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Cytotoxicity	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; LYSOSOMAL PATHWAY; DOWN-REGULATION; IAP PROTEINS; CIAP1; ACTIVATION; XIAP; DEGRADATION; BINDING	Lysosomal membrane permeabilization is an essential step in TRAIL-induced apoptosis of liver cancer cell lines. TRAIL-induced lysosomal membrane permeabilization is mediated by the multifunctional sorting protein PACS-2 and repressed by the E3 ligases cIAP-1 and cIAP-2. Despite the opposing roles for PACS-2 and cIAPs in TRAIL-induced apoptosis, an interaction between these proteins has yet to be examined. Herein, we report that cIAP-1 and cIAP-2 confer TRAIL resistance to hepatobiliary cancer cell lines by reducing PACS-2 levels. Under basal conditions, PACS-2 underwent K48-linked poly-ubiquitination, resulting in PACS-2 proteasomal degradation. Biochemical assays showed cIAP-1 and cIAP-2 interacted with PACS-2 in vitro and co-immunoprecipitation studies demonstrated that the two cIAPs bound PACS-2 in vivo. More importantly, both cIAP-1 and cIAP-2 directly mediated PACS-2 ubiquitination in a cell-free assay. Single c-Iap-1 or c-Iap-2 gene knock-outs in mouse hepatocytes did not lead to PACS-2 accumulation. However, deletion of both cIAP-1 and cIAP-2 reduced PACS-2 ubiquitination, which increased PACS-2 levels and sensitized HuH-7 cells to TRAIL-induced lysosomal membrane permeabilization and apoptosis. Correspondingly, deletion of cIAPs sensitized wild-type, but not PACS-2-deficient hepatocarcinoma cells or Pacs-2(-/-) mouse hepatocytes to TRAIL-induced apoptosis. Together, these data suggest cIAPs constitutively downregulate PACS-2 by polyubiquitination and proteasomal degradation, thereby restraining TRAIL-induced killing of liver cancer cells.	[Guicciardi, Maria Eugenia; Werneburg, Nathan W.; Bronk, Steven F.; Franke, Adrian; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Thomas, Gary] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Mayo Clinic; Juntendo University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	gores.gregory@mayo.edu			NIH [R01 DK63947, CA151564]; Mayo Foundation;  [DK84567]; NATIONAL CANCER INSTITUTE [R01CA151564, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK063947] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by NIH R01 DK63947 (to GJG), CA151564 (GT), Optical Microscopy Core DK84567 and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Arnt CR, 2002, J BIOL CHEM, V277, P44236, DOI 10.1074/jbc.M207578200; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Canbay A, 2003, J CLIN INVEST, V112, P152, DOI 10.1172/JCI200317740; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dynek JN, 2013, CANCER LETT, V332, P206, DOI 10.1016/j.canlet.2010.06.013; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635; Gao Z, 2007, J BIOL CHEM, V282, P30718, DOI 10.1074/jbc.M705258200; Garrison SP, 2012, CELL DEATH DIFFER, V19, P642, DOI 10.1038/cdd.2011.136; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Gores GJ, 2001, HEPATOLOGY, V34, P3, DOI 10.1053/jhep.2001.25173; Guicciardi ME, 2007, AM J PHYSIOL-GASTR L, V292, pG1337, DOI 10.1152/ajpgi.00497.2006; Guicciardi ME, 2011, EXP CELL RES, V317, P107, DOI 10.1016/j.yexcr.2010.10.005; Guicciardi ME, 2005, GASTROENTEROLOGY, V129, P269, DOI 10.1053/j.gastro.2005.05.022; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Takeda K, 2008, P NATL ACAD SCI USA, V105, P10895, DOI 10.1073/pnas.0802702105; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Werneburg NW, 2012, J BIOL CHEM, V287, P24427, DOI 10.1074/jbc.M112.342238; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016	44	20	20	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92124	10.1371/journal.pone.0092124	http://dx.doi.org/10.1371/journal.pone.0092124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633224	Green Accepted, Green Published, gold			2022-12-27	WOS:000332858400144
J	Verburgh, L; Scherder, EJA; van Lange, PAM; Oosterlaan, J				Verburgh, Lot; Scherder, Erik J. A.; van Lange, Paul A. M.; Oosterlaan, Jaap			Executive Functioning in Highly Talented Soccer Players	PLOS ONE			English	Article							PERCEPTUAL-COGNITIVE EXPERTISE; INTERVAL ENDURANCE CAPACITY; WORKING-MEMORY; SPORT; INHIBITION; BASEBALL; IDENTIFICATION; INTELLIGENCE; SKILL; TASK	Executive functions might be important for successful performance in sports, particularly in team sports requiring quick anticipation and adaptation to continuously changing situations in the field. The executive functions motor inhibition, attention and visuospatial working memory were examined in highly talented soccer players. Eighty-four highly talented youth soccer players (mean age 11.9), and forty-two age-matched amateur soccer players (mean age 11.8) in the age range 8 to 16 years performed a Stop Signal task (motor inhibition), the Attention Network Test (alerting, orienting, and executive attention) and a visuospatial working memory task. The highly talented soccer players followed the talent development program of the youth academy of a professional soccer club and played at the highest national soccer competition for their age. The amateur soccer players played at a regular soccer club in the same geographical region as the highly talented soccer players and play in a regular regional soccer competition. Group differences were tested using analyses of variance. The highly talented group showed superior motor inhibition as measured by stop signal reaction time (SSRT) on the Stop Signal task and a larger alerting effect on the Attention Network Test, indicating an enhanced ability to attain and maintain an alert state. No group differences were found for orienting and executive attention and visuospatial working memory. A logistic regression model with group (highly talented or amateur) as dependent variable and executive function measures that significantly distinguished between groups as predictors showed that these measures differentiated highly talented soccer players from amateur soccer players with 89% accuracy. Highly talented youth soccer players outperform youth amateur players on suppressing ongoing motor responses and on the ability to attain and maintain an alert state; both may be essential for success in soccer.	[Verburgh, Lot; Scherder, Erik J. A.; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Bt Amsterdam, Netherlands; [van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Bt Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Verburgh, L (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Bt Amsterdam, Netherlands.	l.verburgh@vu.nl		Van Lange, Paul/0000-0001-7774-6984				Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Alves H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00036; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cornelissen S, 2010, INT J HIST SPORT, V27, P3008, DOI 10.1080/09523367.2010.508306; de Kieviet JF, 2012, BRIT J NUTR, V108, P2215, DOI 10.1017/S0007114512000293; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Elferink-Gemser MT, 2006, BRIT J SPORT MED, V40, P340, DOI 10.1136/bjsm.2005.023044; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Furley P, 2010, PERCEPT MOTOR SKILL, V110, P801, DOI 10.2466/PMS.110.3.801-808; Gray R, 2009, J EXP PSYCHOL-APPL, V15, P91, DOI 10.1037/a0015591; Groth-Marnat G, 2001, CA CH AD PS, P29; Helsen WF, 2000, J SPORT SCI, V18, P727; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Hong Fan, 2005, International Journal of the History of Sport, V22, P510, DOI 10.1080/09523360500126336; Huertas F, 2011, J SPORT EXERCISE PSY, V33, P649, DOI 10.1123/jsep.33.5.649; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Meylan C, 2010, INT J SPORTS SCI COA, V5, P571, DOI 10.1260/1747-9541.5.4.571; Mezzacappa E, 2004, CHILD DEV, V75, P1373, DOI 10.1111/j.1467-8624.2004.00746.x; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Morris T, 2000, J SPORT SCI, V18, P715, DOI 10.1080/02640410050120096; Nakamoto H, 2008, PERCEPT MOTOR SKILL, V106, P163, DOI 10.2466/PMS.106.1.163-170; Nakamoto H, 2008, BRAIN RES, V1189, P179, DOI 10.1016/j.brainres.2007.10.096; Nakamoto H, 2012, BRAIN COGNITION, V80, P23, DOI 10.1016/j.bandc.2012.04.004; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Nouchi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055518; NOUGIER V, 1991, INT J SPORT PSYCHOL, V22, P307; Nutley SB, 2010, DEV NEUROPSYCHOL, V35, P81, DOI 10.1080/87565640903325741; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; Penner IK, 2012, NEUROPSYCHOL REHABIL, V22, P716, DOI 10.1080/09602011.2012.686883; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Salminen T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00166; Scheres A, 2004, ARCH CLIN NEUROPSYCH, V19, P569, DOI 10.1016/j.acn.2003.08.005; Sella F, 2012, PSYCHOL RES, V77, P204; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; SPSS, 2011, IBM SPSS STAT BAS 20; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Vaeyens R, 2007, J SPORT EXERCISE PSY, V29, P147, DOI 10.1123/jsep.29.2.147; van Hilvoorde I, 2010, INT REV SOCIOL SPORT, V45, P87, DOI 10.1177/1012690209356989; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Visscher C, 2006, PERCEPT MOTOR SKILL, V102, P81; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wang C, 2013, J MOT BEHAV; Wang CH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055773, 10.1371/journal.pone.0073985]; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002; Zwierko T, 2008, J HUM KINET, V19, P53, DOI 10.2478/v10078-008-0004-z	60	139	141	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91254	10.1371/journal.pone.0091254	http://dx.doi.org/10.1371/journal.pone.0091254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632735	Green Published, gold			2022-12-27	WOS:000332858400050
J	Bates, SR; Quake, SR				Bates, Steven R.; Quake, Stephen R.			Mapping of Protein-Protein Interactions of E. coli RNA Polymerase with Microfluidic Mechanical Trapping	PLOS ONE			English	Article							ESCHERICHIA-COLI; MASS-SPECTROMETRY; ALPHA-SUBUNIT; CONTACT SITE; SIGMA-FACTOR; TRANSCRIPTION ACTIVATORS; IN-VITRO; REGION 4; YEAST; COMPLEX	The biophysical details of how transcription factors and other proteins interact with RNA polymerase are of great interest as they represent the nexus of how structure and function interact to regulate gene expression in the cell. We used an in vitro microfluidic approach to map interactions between a set of ninety proteins, over a third of which are transcription factors, and each of the four subunits of E. coli RNA polymerase, and we compared our results to those of previous large-scale studies. We detected interactions between RNA polymerase and transcription factors that earlier high-throughput screens missed; our results suggest that such interactions can occur without DNA mediation more commonly than previously appreciated.	[Bates, Steven R.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, HHMI, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	quake@stanford.edu			National Science Foundation; National Institutes of Health; Howard Hughes Medical Institute	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the National Science Foundation, the National Institutes of Health, and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Arifuzzaman M, 2002, GENES CELLS, V7, P553, DOI 10.1046/j.1365-2443.2002.00545.x; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Borukhov S, 2003, CURR OPIN MICROBIOL, V6, P93, DOI 10.1016/S1369-5274(03)00036-5; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Causler B, 2004, MASS SPECTROM REV, V23, P350, DOI 10.1002/mas.10080; Collins MO, 2008, CURR OPIN BIOTECH, V19, P324, DOI 10.1016/j.copbio.2008.06.002; CUI YH, 1995, J BACTERIOL, V177, P4872, DOI 10.1128/jb.177.17.4872-4880.1995; Darwin AJ, 1998, J BACTERIOL, V180, P4192, DOI 10.1128/JB.180.16.4192-4198.1998; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Ilag LL, 2004, STRUCTURE, V12, P269, DOI 10.1016/j.str.2004.01.007; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kulkarni RD, 1999, BIOCHEMISTRY-US, V38, P3362, DOI 10.1021/bi982814m; Leonhartsberger S, 2001, J MOL BIOL, V307, P93, DOI 10.1006/jmbi.2000.4451; Lochowska A, 2004, MOL MICROBIOL, V53, P791, DOI 10.1111/j.1365-2958.2004.04161.x; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Mahren S, 2003, J BACTERIOL, V185, P1796, DOI 10.1128/JB.185.6.1796-1802.2003; Martin RG, 2002, MOL MICROBIOL, V43, P355, DOI 10.1046/j.1365-2958.2002.02748.x; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; Meier M, 2013, P NATL ACAD SCI USA, V110, P477, DOI 10.1073/pnas.1210634110; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Rhodius VA, 2000, J MOL BIOL, V299, P311, DOI 10.1006/jmbi.2000.3737; Shah IM, 2004, J MOL BIOL, V343, P513, DOI 10.1016/j.jmb.2004.08.057; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TOBIN JF, 1990, J MOL BIOL, V211, P75, DOI 10.1016/0022-2836(90)90012-B; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Weber KD, 2005, J BACTERIOL, V187, P1724, DOI 10.1128/JB.187.5.1724-1731.2005; Westblade LF, 2004, J MOL BIOL, V335, P685, DOI 10.1016/j.jmb.2003.11.004; Wickstrum JR, 2004, J BACTERIOL, V186, P6277, DOI 10.1128/JB.186.18.6277-6285.2004; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	37	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91542	10.1371/journal.pone.0091542	http://dx.doi.org/10.1371/journal.pone.0091542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643045	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900026
J	Chowdhury, FZ; Estrada, LD; Murray, S; Forman, J; Farrar, JD				Chowdhury, Fatema Z.; Estrada, Leonardo D.; Murray, Sean; Forman, James; Farrar, J. David			Pharmacological Inhibition of TPL2/MAP3K8 Blocks Human Cytotoxic T Lymphocyte Effector Functions	PLOS ONE			English	Article							HUMAN CD8(+) EFFECTOR; TNF-ALPHA PRODUCTION; PROTEIN-KINASE; RHEUMATOID-ARTHRITIS; MAP KINASE; CLONAL EXPANSION; GAMMA PRODUCTION; INNATE IMMUNITY; CENTRAL MEMORY; TPL2 KINASE	CD8(+) cytotoxic T lymphocytes (CTLs) play a major role in defense against intracellular pathogens. During development, antigen-presenting cells secrete innate cytokines such as IL-12 and IFN-alpha, which drive CTL differentiation into diverse populations of effector and long-lived memory cells. Using whole transcriptome analyses, the serine/threonine protein kinase Tpl2/MAP3K8 was found to be induced by IL-12 and selectively expressed by effector memory (T-EM) CTLs. Tpl2 regulates various inflammatory pathways by activating the ERK mediated MAP kinase pathway in innate immune cells such as macrophages and dendritic cells. In this study, we found that a specific small molecule Tpl2 inhibitor blocked IFN-gamma and TNF-alpha secretion as well as cytolytic activity of human CTLs. This pathway was specific for human effector CTLs, as the Tpl2 inhibitor did not block IFN-gamma and TNF-alpha secretion from murine effector CTLs. Further, IL-12 failed to induce expression of Tpl2 in murine CTLs, and Tpl2 deficient murine CTLs did not exhibit any functional deficiency either in vitro or in vivo in response to L. monocytogenes infection. In summary, we identified a species-specific role for Tpl2 in effector function of human CTLs, which plays a major role in adaptive immune responses to intracellular pathogens and tumors.	[Chowdhury, Fatema Z.; Estrada, Leonardo D.; Murray, Sean; Forman, James; Farrar, J. David] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Farrar, J. David] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Farrar, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	David.Farrar@UTSouthwestern.edu			National Institutes of Health [AI005284, AI045764, AI056222]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056222, R01AI045764, T32AI005284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by National Institutes of Health grants (AI005284, F.Z.C.; AI045764, J.F.; and AI056222, J.D.F.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang J, 2004, J IMMUNOL, V172, P2818, DOI 10.4049/jimmunol.172.5.2818; Chowdhury FZ, 2011, BLOOD, V118, P3890, DOI 10.1182/blood-2011-05-357111; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; Graham DB, 2006, J IMMUNOL, V177, P6098, DOI 10.4049/jimmunol.177.9.6098; Gugasyan R, 2012, EMBO J, V31, P692, DOI 10.1038/emboj.2011.435; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Hirata K, 2010, BIOL PHARM BULL, V33, P1233, DOI 10.1248/bpb.33.1233; Hirata K, 2010, BIOL PHARM BULL, V33, P133, DOI 10.1248/bpb.33.133; Hu YH, 2006, BIOORG MED CHEM LETT, V16, P6067, DOI 10.1016/j.bmcl.2006.08.102; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Lawrenz M, 2012, MUCOSAL IMMUNOL, V5, P129, DOI 10.1038/mi.2011.57; Lindstrom TM, 2010, RHEUM DIS CLIN N AM, V36, P367, DOI 10.1016/j.rdc.2010.02.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Ramos HJ, 2009, BLOOD, V113, P5516, DOI 10.1182/blood-2008-11-188458; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wu JJ, 2009, BIOORG MED CHEM LETT, V19, P3485, DOI 10.1016/j.bmcl.2009.05.009; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	36	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92187	10.1371/journal.pone.0092187	http://dx.doi.org/10.1371/journal.pone.0092187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642963	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900101
J	Ferrando, ML; van Baarlen, P; Orru, G; Piga, R; Bongers, RS; Wels, M; De Greeff, A; Smith, HE; Wells, JM				Ferrando, M. Laura; van Baarlen, Peter; Orru, Germano; Piga, Rosaria; Bongers, Roger S.; Wels, Michiel; De Greeff, Astrid; Smith, Hilde E.; Wells, Jerry M.			Carbohydrate Availability Regulates Virulence Gene Expression in Streptococcus suis	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; FIBRONECTIN-BINDING PROTEIN; BACILLUS-SUBTILIS; GLYCOGEN-METABOLISM; ESCHERICHIA-COLI; EPITHELIAL-CELLS; MOUSE INTESTINE; MOLECULAR CHARACTERIZATION; HYALURONAN CONCENTRATION; CATABOLITE REPRESSION	Streptococcus suis is a major bacterial pathogen of young pigs causing worldwide economic problems for the pig industry. S. suis is also an emerging pathogen of humans. Colonization of porcine oropharynx by S. suis is considered to be a high risk factor for invasive disease. In the oropharyngeal cavity, where glucose is rapidly absorbed but dietary alpha-glucans persist, there is a profound effect of carbohydrate availability on the expression of virulence genes. Nineteen predicted or confirmed S. suis virulence genes that promote adhesion to and invasion of epithelial cells were expressed at higher levels when S. suis was supplied with the alpha-glucan starch/pullulan compared to glucose as the single carbon source. Additionally the production of suilysin, a toxin that damages epithelial cells, was increased more than ten-fold when glucose levels were low and S. suis was growing on pullulan. Based on biochemical, bioinformatics and in vitro and in vivo gene expression studies, we developed a biological model that postulates the effect of carbon catabolite repression on expression of virulence genes in the mucosa, organs and blood. This research increases our understanding of S. suis virulence mechanisms and has important implications for the design of future control strategies including the development of anti-infective strategies by modulating animal feed composition.	[Ferrando, M. Laura; van Baarlen, Peter; Piga, Rosaria; Wells, Jerry M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Ferrando, M. Laura] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Orru, Germano] Univ Cagliari, Oral Biotechnol Lab, Cagliari, Italy; [Bongers, Roger S.; Wels, Michiel] NIZO Food Res BV, Ede, Netherlands; [De Greeff, Astrid; Smith, Hilde E.] Wageningen Univ, Anim Sci Grp, Cent Vet Inst, Lelystad, Netherlands	Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; University of Cagliari; NIZO Food Research; Animal Sciences Group of Wageningen UR; Wageningen University & Research	Wells, JM (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	jerry.wells@wur.nl	van Baarlen, Peter/B-8699-2009; Ferrando, Maria Laura/M-3026-2018	van Baarlen, Peter/0000-0003-3530-5472; Ferrando, Maria Laura/0000-0002-1398-8244; Orru, Germano/0000-0003-1032-4431	Netherlands Top Institute for Food and Nutrition	Netherlands Top Institute for Food and Nutrition	The work was funded by The Netherlands Top Institute for Food and Nutrition. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Allen AG, 2004, MICROB PATHOGENESIS, V36, P327, DOI 10.1016/j.micpath.2004.02.006; Allen AG, 2001, INFECT IMMUN, V69, P2732, DOI 10.1128/IAI.69.4.2732-2735.2001; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bakker GCM, 1998, VET QUART, V20, pS59; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Bonafonte MA, 2000, FEMS MICROBIOL LETT, V191, P31, DOI 10.1016/S0378-1097(00)00366-9; Bongaerts RJM, 2000, INFECT IMMUN, V68, P7141, DOI 10.1128/IAI.68.12.7141-7143.2000; Bonifait L, 2011, VET MICROBIOL, V148, P333, DOI 10.1016/j.vetmic.2010.09.024; Bourassa L, 2009, MOL MICROBIOL, V72, P124, DOI 10.1111/j.1365-2958.2009.06629.x; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chaptal V, 2006, PROTEINS, V64, P814, DOI 10.1002/prot.21001; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; EISENBERG RJ, 1974, BIOCHEM BIOPH RES CO, V57, P959, DOI 10.1016/0006-291X(74)90789-X; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; FERRARI M, 1993, MICROBIOLOGICA, V16, P381; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fontaine MC, 2004, INFECT IMMUN, V72, P774, DOI 10.1128/IAI.72.2.774-781.2004; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Ge JC, 2009, CURR MICROBIOL, V59, P248, DOI 10.1007/s00284-009-9425-8; Gopal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010349; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Gough H, 1996, ARCH ORAL BIOL, V41, P141, DOI 10.1016/0003-9969(95)00121-2; Henrissat B, 2002, TRENDS GENET, V18, P437, DOI 10.1016/S0168-9525(02)02734-8; Hui AY, 2012, WIRES SYST BIOL MED, V4, P15, DOI 10.1002/wsbm.157; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Jobin MC, 2003, FEMS MICROBIOL LETT, V220, P113, DOI 10.1016/S0378-1097(03)00088-0; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; Kouki A, 2011, J BIOL CHEM, V286, P38854, DOI 10.1074/jbc.M111.260992; Lalonde M, 2000, MICROBIOL-SGM, V146, P1913, DOI 10.1099/00221287-146-8-1913; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; MEURMAN JH, 1987, CARIES RES, V21, P353, DOI 10.1159/000261039; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Monedero V, 2008, RES MICROBIOL, V159, P94, DOI 10.1016/j.resmic.2007.10.002; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; MORMANN JE, 1981, CARIES RES, V15, P166; MORMANN JE, 1982, STARKE, V34, P121, DOI 10.1002/star.19820340406; Norton PM, 1999, FEMS IMMUNOL MED MIC, V26, P25, DOI 10.1111/j.1574-695X.1999.tb01369.x; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitsillides AA, 1999, RHEUMATOLOGY, V38, P1108, DOI 10.1093/rheumatology/38.11.1108; Praest BM, 1997, CLIN CHIM ACTA, V266, P117, DOI 10.1016/S0009-8981(97)00122-8; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Santi I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003787; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Schonert S, 2006, J BACTERIOL, V188, P3911, DOI 10.1128/JB.00213-06; Seitz M, 2013, VET MICROBIOL, V167, P584, DOI 10.1016/j.vetmic.2013.09.010; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Shelburne SA, 2008, MOL MICROBIOL, V69, P436, DOI 10.1111/j.1365-2958.2008.06290.x; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shim JH, 2009, J BACTERIOL, V191, P4835, DOI 10.1128/JB.00176-09; Si YH, 2009, VET MICROBIOL, V139, P80, DOI 10.1016/j.vetmic.2009.04.024; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HE, 2001, INFECT IMMUN, V69, P1961, DOI 10.1128/IAI.69.3.1961-1966.2001; Smith HJ, 1996, ACTA RADIOL, V37, P2; Tan C, 2008, VET MICROBIOL, V130, P363, DOI 10.1016/j.vetmic.2008.02.025; TARAVEL FR, 1983, EUR J BIOCHEM, V130, P147; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanier G, 2007, VET MICROBIOL; Vanier G, 2007, CAN J VET RES, V71, P81; VECHT U, 1989, AM J VET RES, V50, P1037; WALKER GJ, 1971, EUR J BIOCHEM, V20, P14, DOI 10.1111/j.1432-1033.1971.tb01356.x; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang AD, 2011, VET MICROBIOL, V148, P436, DOI 10.1016/j.vetmic.2010.09.027; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072285	92	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e89334	10.1371/journal.pone.0089334	http://dx.doi.org/10.1371/journal.pone.0089334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642967	Green Published, gold			2022-12-27	WOS:000333259900003
J	He, JZ; Deng, L; Na, FF; Xue, JX; Gao, H; Lu, Y				He, Jiazhuo; Deng, Lei; Na, Feifei; Xue, Jianxin; Gao, Hui; Lu, You			The Association between TGF-beta 1 Polymorphisms and Radiation Pneumonia in Lung Cancer Patients Treated with Definitive Radiotherapy: A Meta-Analysis	PLOS ONE			English	Article							NORMAL TISSUE COMPLICATIONS; GENE POLYMORPHISMS; RISK; TOXICITY; FIBROSIS; TGFB1	Background: Previous studies investigating the association between TGF-beta 1 polymorphisms and Radiation Pneumonia (RP) risk have provided inconsistent results. The aim of our study was to assess the association between the TGF-beta 1 genes C509T, G915C and T869C polymorphisms and risk of RP in lung cancer patients treated with definitive radiotherapy. Methods: Two investigators independently searched the Medline, Embase, CNKI, and Chinese Biomedicine Databases for studies published before September 2013. Summary odds ratios (ORs) and 95% confidence intervals (CIs) for TGF-beta 1 polymorphisms and RP were calculated in a fixed-effects model or a random-effects model when appropriate. Results: Ultimately, each 7 studies were found to be eligible for meta-analyses of C509T, G915C and T869C, respectively. Our analysis suggested that the variant genotypes of T869C were associated with a significantly increased RP risk in dominant model (OR = 0.59, 95% CI = 0.45-0.79) and CT vs. TT model (OR = 0.47, 95% CI = 0.32-0.69). In the subgroup analyses by ethnicity/country, a significantly increased risk was observed among Caucasians. For C509T and G915C polymorphism, no obvious associations were found for all genetic models. Conclusion: This meta-analysis suggests that T869C polymorphism of TGF-beta 1 may be associated with RP risk only in Caucasians, and there may be no association between C509T and G915C polymorphism and RP risk.	[He, Jiazhuo; Deng, Lei; Na, Feifei; Xue, Jianxin; Gao, Hui; Lu, You] Sichuan Univ, West China Hosp, Ctr Canc, Dept Thorac Oncol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Lu, Y (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Dept Thorac Oncol, Chengdu 610064, Sichuan, Peoples R China.	radyoulu@hotmail.com	gao, huile/G-8290-2012; Deng, Lei/I-7030-2018	gao, huile/0000-0002-5355-7238; Deng, Lei/0000-0001-8867-6635; Lu, You/0000-0003-1671-1408	National Major Project of China [2011ZX09302-001-01]; National Natural Science Fund of China [81101698]	National Major Project of China; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Major Project of China (2011ZX09302-001-01) and National Natural Science Fund of China (81101698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsbeih G, 2003, RADIOTHER ONCOL, V66, P341, DOI 10.1016/S0167-8140(02)00327-4; Alsbeih G, 2010, RADIAT RES, V173, P505, DOI 10.1667/RR1769.1; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Andreassen CN, 2005, ACTA ONCOL, V44, P801, DOI 10.1080/02841860500374513; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Burger A, 1998, INT J RADIAT BIOL, V73, P401, DOI 10.1080/095530098142239; Hakenjos L, 2000, INT J RADIAT BIOL, V76, P503, DOI 10.1080/095530000138501; Kong Feng-Ming, 2008, Cancer Control, V15, P140; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Niu XM, 2012, J THORAC ONCOL, V7, P1668, DOI 10.1097/JTO.0b013e318267cf5b; Shah R, 2006, HUM GENET, V120, P461, DOI 10.1007/s00439-006-0194-1; Voets AM, 2012, RADIOTHER ONCOL, V105, P296, DOI 10.1016/j.radonc.2012.09.016; Wang G, 2011, SINGLE NUCLEOTIDE PO; Wang LH, 2010, J CLIN ONCOL, V28, pE621, DOI 10.1200/JCO.2010.31.0458; Xue JX, 2013, MOL THER, V21, P456, DOI 10.1038/mt.2012.183; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763; Zhang L., 2008, CLIN LAB STUDY FACTO; Zhao LJ, 2009, INT J RADIAT ONCOL, V74, P1385, DOI 10.1016/j.ijrobp.2008.10.065; Zhao YC, 2005, P ANN INT IEEE EMBS, P6128, DOI 10.1109/IEMBS.2005.1615892	19	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91100	10.1371/journal.pone.0091100	http://dx.doi.org/10.1371/journal.pone.0091100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642488	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900012
J	Peeters, F; Oehlen, M; Ronner, J; van Os, J; Lousberg, R				Peeters, Frenk; Oehlen, Mare; Ronner, Jacco; van Os, Jim; Lousberg, Richel			Neurofeedback As a Treatment for Major Depressive Disorder - A Pilot Study	PLOS ONE			English	Article							FRONTAL EEG ASYMMETRY; ALPHA ASYMMETRY; ELECTROENCEPHALOGRAPHIC ASYMMETRY; BRAIN ASYMMETRY; ANXIETY; ANTIDEPRESSANT; ENDOPHENOTYPE; SEVERITY; EMOTION	Background: There is growing interest in neurofeedback as a treatment for major depressive disorder. Reduction of asymmetry of alpha-activity between left and right prefrontal areas with neurofeedback has been postulated as effective in earlier studies. Unfortunately, methodological shortcomings limit conclusions that can be drawn from these studies. In a pilot-study, we investigated the effectiveness of reduction of asymmetry of alpha-activity with neurofeedback in depressed participants with the use of a stringent methodological approach. Methods: Nine participants meeting DSM-IV criteria for major depressive disorder were treated with a maximum of 30 neurofeedback-sessions, aimed at reducing asymmetry of alpha-activity, over a 10-week period. No changes in the use of antidepressants were allowed 6 weeks before and during the intervention. Changes in depressive symptomatology were assessed with the Quick Inventory of Depressive Symptoms, self-report version. Results: We observed response in 1 and remission in 4 out of a total of 9 participants. The effectiveness appeared largest in female participants. The mean asymmetry of alpha-activity decreased significantly over sessions in a quadratic fashion. This decrease was associated with clinical response. Conclusions: This pilot study suggests that neurofeedback aimed at a reduction of frontal asymmetry of alpha-activity may be effective as a treatment for depression. However, this was an open label pilot study. Non-specific effects of the procedure and/or a beneficial natural course may have confounded the results. Randomized controlled trials will have to establish the efficacy of neurofeedback for depression.	[Peeters, Frenk; Oehlen, Mare; van Os, Jim; Lousberg, Richel] Maastricht Univ, EURON, Dept Psychiat & Psychol, South Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands; [Ronner, Jacco] Maastricht Univ, Fac Psychol & Neurosci, Dept Instrumentat, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Maastricht University; University of London; King's College London	Peeters, F (corresponding author), Maastricht Univ, EURON, Dept Psychiat & Psychol, South Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands.	f.peeters@maastrichtuniversity.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; Peeters, F/0000-0002-6167-8582				Allen JJB, 2004, PSYCHOPHYSIOLOGY, V41, P269, DOI 10.1111/j.1469-8986.2003.00149.x; Allen JJB, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00232; Baehr E., 1997, J NEUROTHERAPY, V2, P10, DOI DOI 10.1300/J184V02N03_02; Baehr E., 2001, J NEUROTHER, V4, P11, DOI [10.1300/J184v04n04_03, DOI 10.1300/J184V04N04_03]; BIRBAUMER N, 1988, INT J NEUROSCI, V39, P101, DOI 10.3109/00207458808985696; Blom MBJ, 2007, J AFFECT DISORDERS, V104, P119, DOI 10.1016/j.jad.2007.03.010; Bruder GE, 2001, BIOL PSYCHIAT, V49, P416, DOI 10.1016/S0006-3223(00)01016-7; Bruder GE, 1997, BIOL PSYCHIAT, V41, P939, DOI 10.1016/S0006-3223(96)00260-0; Bruder GE, 2004, NEUROPSYCHOPHARMACOL, V29, P1752, DOI 10.1038/sj.npp.1300519; Bruder GE, 2008, BIOL PSYCHIAT, V63, P1171, DOI 10.1016/j.biopsych.2007.10.009; Choi SW, 2011, NEUROPSYCHOBIOLOGY, V63, P43, DOI 10.1159/000322290; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Debener S, 2000, NEUROPSYCHOBIOLOGY, V41, P31, DOI 10.1159/000026630; Evans JR, 1999, INTRO QUANTITATIVE E; Hammond DC, 2005, J ADULT DEV, V12, P131, DOI 10.1007/s10804-005-7029-5; Hardman E, 1997, NEUROSCI LETT, V221, P117, DOI 10.1016/S0304-3940(96)13303-6; Herrington JD, 2010, PSYCHOPHYSIOLOGY, V47, P442, DOI 10.1111/j.1469-8986.2009.00958.x; Lofthouse N, 2012, CURR PSYCHIAT REP, V14, P536, DOI 10.1007/s11920-012-0301-z; Niedermeyer E., 2004, ELECTROENCEPHALOGRAP; Peeters F, INT J PSYCH IN PRESS; Pizzagalli DA, 2002, BIOL PSYCHIAT, V52, P73, DOI 10.1016/S0006-3223(02)01313-6; Reid SA, 1998, PSYCHOPHYSIOLOGY, V35, P389, DOI 10.1111/1469-8986.3540389; Rosenfeld JP, 1996, INT J PSYCHOPHYSIOL, V23, P137, DOI 10.1016/0167-8760(96)00037-2; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Stewart JL, 2011, J AFFECT DISORDERS, V129, P167, DOI 10.1016/j.jad.2010.08.029; Stewart JL, 2010, J ABNORM PSYCHOL, V119, P502, DOI 10.1037/a0019196; Thibodeau R, 2006, J ABNORM PSYCHOL, V115, P715, DOI 10.1037/0021-843X.115.4.715	29	27	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91837	10.1371/journal.pone.0091837	http://dx.doi.org/10.1371/journal.pone.0091837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642756	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900039
J	Chen, SC; Wei, DD; Shao, RF; Dou, W; Wang, JJ				Chen, Shi-Chun; Wei, Dan-Dan; Shao, Renfu; Dou, Wei; Wang, Jin-Jun			The Complete Mitochondrial Genome of the Booklouse, Liposcelis decolor: Insights into Gene Arrangement and Genome Organization within the Genus Liposcelis	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC INFERENCE; PSOCIDS PSOCOPTERA; WEB SERVER; SEQUENCE; INSECTA; LICE; EVOLUTION; REARRANGEMENTS; SUBGENOMES	Booklice in the genus Liposcelis are pests of stored grain products. They pose a considerable economic threat to global food security and safety. To date, the complete mitochondrial genome has only been determined for a single booklouse species Liposcelis bostrychophila. Unlike most bilateral animals, which have their 37 mt genes on one circular chromosome, approximate to 15 kb in size, the mt genome of L. bostrychophila has two circular chromosomes, 8 and 8.5 kb in size. Here, we report the mt genome of another booklouse, Liposcelis decolor. The mt genome of L. decolor has the typical mt chromosome of bilateral animals, 14,405 bp long with 37 genes (13 PCGs, 22 tRNAs and 2 rRNAs). However, the arrangement of these genes in L. decolor differs substantially from that observed in L. bostrychophila and other insects. With the exception of atp8-atp6, L. decolor differs from L. bostrychophila in the arrangement of all of the other 35 genes. The variation in the mt genome organization and mt gene arrangement between the two Liposcelis species is unprecedented for closely related animals in the same genus. Furthermore, our results indicate that the two-chromosome mt genome organization observed in L. bostrychophila likely evolved recently after L. bostrychophila and L. decolor split from their most recent common ancestor.	[Chen, Shi-Chun; Wei, Dan-Dan; Dou, Wei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China; [Shao, Renfu] Univ Sunshine Coast, Fac Sci Educ & Engn, GeneCol Res Ctr, Maroochydore, Qld, Australia	Southwest University - China; University of the Sunshine Coast	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	wangjinjun@swu.edu.cn		Shao, Renfu/0000-0002-1686-4968	National Natural Sciences Foundation [31000860]; Program for Innovative Research Team in University [IRT0976]; Specialized Research Fund for the Doctoral Program of Higher Education [20100182120022]; Fundamental Research Funds for the Central Universities [XDJK2013C051, XDJK2013A005]	National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in University; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Sciences Foundation (31000860), the Program for Innovative Research Team in University (IRT0976), the Specialized Research Fund for the Doctoral Program of Higher Education(20100182120022), and the Fundamental Research Funds for the Central Universities (XDJK2013C051, XDJK2013A005). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Athanassiou CG, 2012, J ECON ENTOMOL, V105, P282, DOI 10.1603/EC11209; Athanassiou CG, 2010, J FOOD PROTECT, V73, P2244, DOI 10.4315/0362-028X-73.12.2244; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Cheng WX, 2007, PESTIC BIOCHEM PHYS, V89, P151, DOI 10.1016/j.pestbp.2007.05.004; Covacin C, 2006, INSECT MOL BIOL, V15, P63, DOI 10.1111/j.1365-2583.2005.00608.x; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Gibson T, 2007, J MOL EVOL, V65, P308, DOI 10.1007/s00239-007-9007-y; Gibson T, 2007, J MOL EVOL, V64, P463, DOI 10.1007/s00239-006-0187-7; Grimaldi D, 2006, P ROY SOC B-BIOL SCI, V273, P625, DOI 10.1098/rspb.2005.3337; Hu F, 2009, MICRON, V40, P628, DOI 10.1016/j.micron.2009.02.006; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Li FS, 2002, PSOCOPTERA CHINA, P77; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; LIENHARD C, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P117; Liu GH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-45; Liu YG, 2013, COMP BIOCHEM PHYS D, V8, P72, DOI 10.1016/j.cbd.2012.12.003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LYAL CHC, 1985, SYST ENTOMOL, V10, P145; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satoh TP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-479; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2012, GENOME BIOL EVOL, V4, P1088, DOI 10.1093/gbe/evs088; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Sheffield NC, 2008, MOL BIOL EVOL, V25, P2499, DOI 10.1093/molbev/msn198; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIMON M, 1984, MOL GEN GENET, V196, P266, DOI 10.1007/BF00328059; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Watanabe KI, 1999, J MOL BIOL, V286, P645, DOI 10.1006/jmbi.1998.2523; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; Wei DD, 2011, J ECON ENTOMOL, V104, P1720, DOI 10.1603/EC11177; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yan DK, 2012, GENE, V506, P117, DOI 10.1016/j.gene.2012.06.022; Yang QQ, 2013, J ECON ENTOMOL, V106, P419, DOI 10.1603/EC12163; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	12	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91902	10.1371/journal.pone.0091902	http://dx.doi.org/10.1371/journal.pone.0091902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637476	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100078
J	Olsen, JA; Balle, T; Gajhede, M; Ahring, PK; Kastrup, JS				Olsen, Jeppe A.; Balle, Thomas; Gajhede, Michael; Ahring, Philip K.; Kastrup, Jette S.			Molecular Recognition of the Neurotransmitter Acetylcholine by an Acetylcholine Binding Protein Reveals Determinants of Binding to Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; DOMAIN	Despite extensive studies on nicotinic acetylcholine receptors (nAChRs) and homologues, details of acetylcholine binding are not completely resolved. Here, we report the crystal structure of acetylcholine bound to the receptor homologue acetylcholine binding protein from Lymnaea stagnalis. This is the first structure of acetylcholine in a binding pocket containing all five aromatic residues conserved in all mammalian nAChRs. The ligand-protein interactions are characterized by contacts to the aromatic box formed primarily by residues on the principal side of the intersubunit binding interface (residues Tyr89, Trp143 and Tyr185). Besides these interactions on the principal side, we observe a cation-p interaction between acetylcholine and Trp53 on the complementary side and a water-mediated hydrogen bond from acetylcholine to backbone atoms of Leu102 and Met114, both of importance for anchoring acetylcholine to the complementary side. To further study the role of Trp53, we mutated the corresponding tryptophan in the two different acetylcholine-binding interfaces of the widespread alpha 4 beta 2 nAChR, i.e. the interfaces alpha 4(+) beta 2(2) and alpha 4(+) alpha 4(2). Mutation to alanine (W82A on the beta 2 subunit or W88A on the alpha 4 subunit) significantly altered the response to acetylcholine measured by oocyte voltage-clamp electrophysiology in both interfaces. This shows that the conserved tryptophan residue is important for the effects of ACh at alpha 4 beta 2 nAChRs, as also indicated by the crystal structure. The results add important details to the understanding of how this neurotransmitter exerts its action and improves the foundation for rational drug design targeting these receptors.	[Olsen, Jeppe A.; Gajhede, Michael; Kastrup, Jette S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Olsen, Jeppe A.] NeuroSearch AS, Ballerup, Denmark; [Balle, Thomas; Ahring, Philip K.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Ahring, Philip K.] Aniona ApS, Ballerup, Denmark	University of Copenhagen; University of Sydney	Kastrup, JS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	jsk@sund.ku.dk		Gajhede, Michael/0000-0001-9864-2287; Kastrup, Jette Sandholm/0000-0003-2654-1510; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; Drug Research Academy at the University of Copenhagen, Denmark; DANSCATT; Novo Nordisk Foundation	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; Drug Research Academy at the University of Copenhagen, Denmark; DANSCATT; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The work of JAO has been co-funded by NeuroSearch A/S and the Danish Agency for Science, Technology and Innovation. Financial support has been granted from the Drug Research Academy at the University of Copenhagen, Denmark; DANSCATT and the Novo Nordisk Foundation. As an employee at NeuroSearch A/S 50% of their time, JAO participated in the following roles; study design, data collection and analysis, decision to publish, and preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blum AP, 2013, J BIOL CHEM, V288, P6991, DOI 10.1074/jbc.M112.439968; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Du J, 2012, TRENDS PHARMACOL SCI, V33, P482, DOI 10.1016/j.tips.2012.06.005; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P888, DOI 10.1016/j.jmgm.2011.01.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Nemecz A, 2011, J BIOL CHEM, V286, P42555, DOI 10.1074/jbc.M111.286583; Nielsen SF, 2000, J MED CHEM, V43, P2217, DOI 10.1021/jm990973d; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Ussing CA, 2013, J MED CHEM, V56, P940, DOI 10.1021/jm301409f; VERDONK ML, 1993, J COMPUT AID MOL DES, V7, P173, DOI 10.1007/BF00126443; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	35	31	31	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91232	10.1371/journal.pone.0091232	http://dx.doi.org/10.1371/journal.pone.0091232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637639	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100022
J	Zhou, XH; Liu, J				Zhou, Xionghui; Liu, Juan			Inferring Gene Dependency Network Specific to Phenotypic Alteration Based on Gene Expression Data and Clinical Information of Breast Cancer	PLOS ONE			English	Article							REGULATORY NETWORKS; MUTUAL INFORMATION; HISTOLOGIC GRADE; HIGH-RISK; B-CELLS; THERAPY; METASTASIS; MYC; SIGNATURE; SURVIVAL	Although many methods have been proposed to reconstruct gene regulatory network, most of them, when applied in the sample-based data, can not reveal the gene regulatory relations underlying the phenotypic change (e. g. normal versus cancer). In this paper, we adopt phenotype as a variable when constructing the gene regulatory network, while former researches either neglected it or only used it to select the differentially expressed genes as the inputs to construct the gene regulatory network. To be specific, we integrate phenotype information with gene expression data to identify the gene dependency pairs by using the method of conditional mutual information. A gene dependency pair (A, B) means that the influence of gene A on the phenotype depends on gene B. All identified gene dependency pairs constitute a directed network underlying the phenotype, namely gene dependency network. By this way, we have constructed gene dependency network of breast cancer from gene expression data along with two different phenotype states (metastasis and non-metastasis). Moreover, we have found the network scale free, indicating that its hub genes with high out-degrees may play critical roles in the network. After functional investigation, these hub genes are found to be biologically significant and specially related to breast cancer, which suggests that our gene dependency network is meaningful. The validity has also been justified by literature investigation. From the network, we have selected 43 discriminative hubs as signature to build the classification model for distinguishing the distant metastasis risks of breast cancer patients, and the result outperforms those classification models with published signatures. In conclusion, we have proposed a promising way to construct the gene regulatory network by using sample-based data, which has been shown to be effective and accurate in uncovering the hidden mechanism of the biological process and identifying the gene signature for phenotypic change.	[Zhou, Xionghui; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China	Wuhan University	Liu, J (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.	liujuan@whu.edu.cn		Zhou, Xionghui/0000-0003-1234-1091	National Science Foundation of China [61272274, 60970063]; program for New Century Excellent Talents in Universities [NCET-10-0644]; Fundamental Research Funds for the Central Universities [2012211020208]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Science Foundation of China (61272274, 60970063), the program for New Century Excellent Talents in Universities (NCET-10-0644), and the Fundamental Research Funds for the Central Universities (2012211020208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; CLARK GM, 1983, NEW ENGL J MED, V309, P1343, DOI 10.1056/NEJM198312013092240; Dehmer M, 2011, SYMMETRY-BASEL, V3, P767, DOI 10.3390/sym3040767; Dehmer M, 2011, COMPLEXITY, V17, P45, DOI 10.1002/cplx.20379; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Emmert-Streib F., 2008, INFORM THEORY STAT L; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hase T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000550; Hong SK, 2006, CELL CYCLE, V5, P801, DOI 10.4161/cc.5.8.2638; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; JOENSUU H, 1994, AM J PATHOL, V145, P1191; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Li J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1033; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moreto J, 2008, CELL SIGNAL, V20, P1092, DOI 10.1016/j.cellsig.2008.01.022; Nakagawa M, 2011, HAEMATOL-HEMATOL J, V96, P1318, DOI 10.3324/haematol.2011.041053; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2013, NUCLEIC ACIDS RES, V41, pD553, DOI 10.1093/nar/gks1244; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Qiu P, 2009, COMPUT METH PROG BIO, V94, P177, DOI 10.1016/j.cmpb.2008.11.003; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schubert A, 2008, GYNECOL ENDOCRINOL, V24, P331, DOI 10.1080/09513590802095845; Song JM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002910; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Wu M, 2012, BRIEF BIOINFORM, V13, P150, DOI 10.1093/bib/bbr029; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040918; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626; Zhang Y, 2009, CANCER RES, V69, p598S; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	59	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92023	10.1371/journal.pone.0092023	http://dx.doi.org/10.1371/journal.pone.0092023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637666	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100101
J	Buja, A; Damiani, G; Gini, R; Visca, M; Federico, B; Donato, D; Francesconi, P; Marini, A; Donatini, A; Brugaletta, S; Baldo, V; Bellentani, MD				Buja, Alessandra; Damiani, Gianfranco; Gini, Rosa; Visca, Modesta; Federico, Bruno; Donato, Daniele; Francesconi, Paolo; Marini, Alessandro; Donatini, Andrea; Brugaletta, Salvatore; Baldo, Vincenzo; Bellentani, Maria Donata		Valore Project	Systematic Age-Related Differences in Chronic Disease Management in a Population-Based Cohort Study: A New Paradigm of Primary Care Is Required	PLOS ONE			English	Article							HEALTH-CARE; QUALITY; INDICATORS; PROGRAMS; PROJECT	Background: Our interest in chronic conditions is due to the fact that, worldwide, chronic diseases have overtaken infectious diseases as the leading cause of death and disability, so their management represents an important challenge for health systems. The aim of this study was to compare the performance of primary health care services in managing diabetes, congestive heart failure (CHF) and coronary heart disease (CHD), by age group. Methods: This population-based retrospective cohort study was conducted in Italy, enrolling 1,948,622 residents >= 16 years old. A multilevel regression model was applied to analyze compliance to care processes with explanatory variables at both patient and district level, using age group as an independent variable, and adjusting for sex, citizenship, disease duration, and Charlson index on the first level, and for District Health Unit on the second level. Results: The quality of chronic disease management showed an inverted U-shaped relationship with age. In particular, our findings indicate lower levels for young adults (16-44 year-olds), adults (45-64), and oldest old (+85) than for patients aged 65-74 in almost all quality indicators of CHD, CHF and diabetes management. Young adults (16-44 y), adults (45-64 y), the very old (75-84 y) and the oldest old (+85 y) patients with CHD, CHF and diabetes are less likely than 65-74 year-old patients to be monitored and treated using evidence-based therapies, with the exceptions of echocardiographic monitoring for CHF in young adult patients, and renal monitoring for CHF and diabetes in the very old. Conclusion: Our study shows that more effort is needed to ensure that primary health care systems are sensitive to chronic conditions in the young and in the very elderly.	[Buja, Alessandra; Baldo, Vincenzo] Univ Padua, Dipartimento Med Mol, Sect Publ Hlth, Lab Publ Hlth & Populat Studies, Padua, Italy; [Damiani, Gianfranco] Univ Cattolica Sacro Cuore, Fac Med, Ist Sanita Pubbl, Rome, Italy; [Gini, Rosa; Francesconi, Paolo] Agenzia Reg Sanita Toscana, Osservatorio Epidemiol, Florence, Italy; [Visca, Modesta] Agenzia Nazl & Serv Sanit, Agenas, Sez OSS, Rome, Italy; [Federico, Bruno] Univ Cassino & Lazio Meridionale, Dipartimento Sci Umane Sociali & Salute, Cassino, Italy; [Donato, Daniele] ULSS 16 Padova, Padua, Italy; [Marini, Alessandro] Zona Terr Senigallia, Ancona, Italy; [Donatini, Andrea] Reg Emilia Romagna, Bologna, Italy; [Brugaletta, Salvatore] ASP 7 Ragusa, Ragusa, Italy	University of Padua; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Cassino	Buja, A (corresponding author), Univ Padua, Dipartimento Med Mol, Sect Publ Hlth, Lab Publ Hlth & Populat Studies, Padua, Italy.	alessandra.buja@unipd.it	Baldo, Vincenzo/V-4005-2019; Brugaletta, Salvatore/AAJ-2090-2020; Buja, Alessandra/AAN-8141-2020; Damiani, Gianfranco/K-2782-2016; Vincenzo, Baldo/D-7822-2018	Baldo, Vincenzo/0000-0001-6012-9453; Buja, Alessandra/0000-0003-2216-3807; Damiani, Gianfranco/0000-0003-3028-6188; Vincenzo, Baldo/0000-0001-6012-9453; Gini, Rosa/0000-0002-6250-877X	"La Valutazione dei nuovi modelli organizzativi della Medicina Generale," acronym VALORE; Italian Ministry of Health [art.12-bis, d. lgs. 502/1992]	"La Valutazione dei nuovi modelli organizzativi della Medicina Generale," acronym VALORE; Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by the project named "La Valutazione dei nuovi modelli organizzativi della Medicina Generale," acronym VALORE, funded by the Italian Ministry of Health in the context of regular health research (art.12-bis, d. lgs. 502/1992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Cardiology American Heart Association and American Medical Association, HEART FAIL WORK HEAR; American College of Cardiology American Heart Association and American Medical Association. Chronic Stable Coronary Artery Disease Work Group, CHRON STABL COR ART; [Anonymous], 2012, GU; [Anonymous], PIAN PREV 2010 2012; [Anonymous], 2008, B UFFICIALE REGIONE; Buja A, 2014, EUR J PREV CARDIOL, V21, P222, DOI 10.1177/2047487312462148; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Dahrouge S, 2011, CAN FAM PHYSICIAN, V57, P1300; Dall TM, 2010, AM J MANAG CARE, V16, P438; Delamater AM, 2006, CLIN DIABETES, V24, P71, DOI 10.2337/diaclin.24.2.71.; Direzione Generale Prevenzione Sanitaria Ufficio I n, 2009, DGPREV13488PF; Eduardo Sabate, 2008, ADHERENCE LONG TERM; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Funnell M.M., 2004, CLIN DIABETES, V22, P123, DOI [10.2337/diaclin.22.3.123, DOI 10.2337/DIACLIN.22.3.123]; Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15; Hill PL, 2011, HEALTH PSYCHOL, V30, P797, DOI 10.1037/a0023860; Institut National d'Excellence en Sante et en Services Sociaux, 2012, SUMM SUPP CONT QUAL; Krieger Nancy, 2003, American Journal of Public Health, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Kuzuya M, 2006, J AM GERIATR SOC, V54, P598, DOI 10.1111/j.1532-5415.2006.00659.x; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Linden A, 2007, J EVAL CLIN PRACT, V13, P400, DOI 10.1111/j.1365-2753.2006.00721.x; Lukas CV, 2007, HEALTH CARE MANAGE R, V32, P309, DOI 10.1097/01.HMR.0000296785.29718.5d; Maciocco G, 2007, Ann Ig, V19, P551; Magnezi R, 2013, AM J MANAG CARE, V19, pE140; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Ministero dell'Istruzione dell'Universita e della Ricerca, 2011, BUSS RIF ISTR TREND; Morandi I, 2010, ASSISTENZA GLI ANZIA; Nicolucci A, 2006, INT J QUAL HEALTH C, V18, P26, DOI 10.1093/intqhc/mzl023; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stark RG, 2011, DIABETES-METAB RES, V27, P383, DOI 10.1002/dmrr.1186; Visca M, 2013, HEALTH POLICY, V113, P188, DOI 10.1016/j.healthpol.2013.05.016; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner Edward H, 1996, MILBANK Q, V74, P511; WHO Library Cataloguing-in-Publication Data, WHO LIB CAT PUBL DAT; World Development Indicators, 2009, WORLD DEV IND	36	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91340	10.1371/journal.pone.0091340	http://dx.doi.org/10.1371/journal.pone.0091340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632818	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400053
J	Buturovic, L; Wong, M; Tang, GW; Altman, RB; Petkovic, D				Buturovic, Ljubomir; Wong, Mike; Tang, Grace W.; Altman, Russ B.; Petkovic, Dragutin			High Precision Prediction of Functional Sites in Protein Structures	PLOS ONE			English	Article							EXPRESSION PROFILE; CLASSIFICATION; IDENTIFICATION; VALIDATION; DISCOVERY	We address the problem of assigning biological function to solved protein structures. Computational tools play a critical role in identifying potential active sites and informing screening decisions for further lab analysis. A critical parameter in the practical application of computational methods is the precision, or positive predictive value. Precision measures the level of confidence the user should have in a particular computed functional assignment. Low precision annotations lead to futile laboratory investigations and waste scarce research resources. In this paper we describe an advanced version of the protein function annotation system FEATURE, which achieved 99% precision and average recall of 95% across 20 representative functional sites. The system uses a Support Vector Machine classifier operating on the microenvironment of physicochemical features around an amino acid. We also compared performance of our method with state-of-the-art sequence-level annotator Pfam in terms of precision, recall and localization. To our knowledge, no other functional site annotator has been rigorously evaluated against these key criteria. The software and predictive models are incorporated into the WebFEATURE service at http://feature.stanford.edu/wf4.0-beta.	[Buturovic, Ljubomir; Petkovic, Dragutin] San Francisco State Univ, Dept Comp Sci, San Francisco, CA 94132 USA; [Wong, Mike; Petkovic, Dragutin] San Francisco State Univ, Ctr Comp Life Sci, San Francisco, CA 94132 USA; [Tang, Grace W.; Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California State University System; San Francisco State University; California State University System; San Francisco State University; Stanford University	Buturovic, L (corresponding author), San Francisco State Univ, Dept Comp Sci, San Francisco, CA 94132 USA.	ljubomir@sfsu.edu		Altman, Russ/0000-0003-3859-2905	Amazon Web Services in Education Research Grant; NIH [LM05652, GM072970, GM102365]; NSFBIOX2 award [CNS-0619926]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970, R01GM102365] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005652, R29LM005652] Funding Source: NIH RePORTER	Amazon Web Services in Education Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFBIOX2 award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The computational resources of this research were supported through an Amazon Web Services in Education Research Grant to Center for Computing for Life Sciences at San Francisco State University, awarded June 18, 2012. RBA is supported by NIH grants LM05652, GM072970, GM102365 and the NSFBIOX2 award CNS-0619926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fetrow JS, 1998, J MOL BIOL, V281, P949, DOI 10.1006/jmbi.1998.1993; Glazer DS, 2009, STRUCTURE, V17, P919, DOI 10.1016/j.str.2009.05.010; Halperin I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S2; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Lal A, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-44; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Petrey D, 2009, CURR OPIN STRUC BIOL, V19, P363, DOI 10.1016/j.sbi.2009.02.001; Pillai R, 2011, J MOL DIAGN, V13, P48, DOI 10.1016/j.jmoldx.2010.11.001; Polacco BJ, 2006, BIOINFORMATICS, V22, P723, DOI 10.1093/bioinformatics/btk038; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Tang GW, 2011, STRUCTURE, V19, P461, DOI 10.1016/j.str.2011.02.007; Thornton Janet, 2001, Trends in Biochemical Sciences, V26, P88, DOI 10.1016/S0968-0004(00)01765-5; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Wang L, 2008, BIOINFORMATICS, V24, P412, DOI 10.1093/bioinformatics/btm579; Wei L, 1998, Pac Symp Biocomput, P497; Wei Liping, 2003, J Bioinform Comput Biol, V1, P119, DOI 10.1142/S0219720003000150; Wu TF, 2004, J MACH LEARN RES, V5, P975	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91240	10.1371/journal.pone.0091240	http://dx.doi.org/10.1371/journal.pone.0091240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632601	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400048
J	Chen, WS; Dong, N; Huang, CH; Zhang, ZH; Hu, JY; Xie, H; Pan, JX; Liu, ZG				Chen, Wensheng; Dong, Nuo; Huang, Caihong; Zhang, Zhenhao; Hu, Jiaoyue; Xie, Hui; Pan, Juxin; Liu, Zuguo			Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit	PLOS ONE			English	Article							BENZALKONIUM CHLORIDE; IN-VITRO; PROSTAGLANDIN ANALOGS; EPITHELIAL-CELLS; VIVO; CONJUNCTIVA; PERMEABILITY; RESISTANCE; PRESSURE; GLAUCOMA	Prostaglandin (PG) analogs, including latanoprost, travoprost, and bimatoprost, are currently the most commonly used topical ocular hypotensive medications. The purpose of this study was to investigate the corneal alterations in rabbits following exposure to commercial solution of latanoprost, travoprost and bimatoprost. A total of 64 New Zealand albino rabbits were used and four groups of treatments were constituted. Commercial latanoprost, travoprost, bimatoprost or 0.02% benzalkonium chloride (BAK) was applied once daily to one eye each of rabbits for 30 days. The contralateral untreated eyes used as controls. Schirmer test, tear break-up time (BUT), rose Bengal and fluorescein staining were performed on days 5, 10, 20, and 30. Central corneal changes were analyzed by in vivo confocal microscopy, and the corneal barrier function was evaluated by measurement of corneal transepithelial electrical resistance on day 5. Whole mount corneas were analyzed by using fluorescence confocal microscopy for the presence of tight-junction (ZO-1, occludin) and adherens-junction (E-cadherin, beta-catenin) proteins, actin cytoskeleton, proliferative marker Ki67 and cell apoptosis in the epithelium. Topical application of commercial PG analogs resulted in significant corneal epithelial and stromal defects while no significant changes in aqueous tear production, BUT, rose bengal and fluorescein staining scores on day 5. Commercial PG analogs induced dislocation of ZO-1 and occludin from their normal locus, disorganization of cortical actin cytoskeleton at the superficial layer, and disruption of epithelial barrier function. The eyes treated with 0.02% BAK and latanoprost exhibited significantly reduced Schirmer scores, BUT, and increased fluorescein staining scores on days 10 and 30, respectively. Topical application of commercial PG analogs can quickly impair the corneal epithelium and stroma without tear deficiency. Commercial PG analogs break down the barrier integrity of corneal epithelium, concomitant with the disruption of cell junction and actin cytoskeleton between superficial cells in the corneal epithelium in vivo.	[Chen, Wensheng] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Inst Eye, Fujian, Peoples R China; Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Affiliated Xiamen Eye Ctr, Fujian, Peoples R China	Xiamen University; Xiamen University	Chen, WS (corresponding author), Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Inst Eye, Fujian, Peoples R China.	cwensheng@hotmail.com; zuguoliu@xmu.edu.cn			National Natural Science Foundation of China, Beijing, China [81270978, U1205025, 81330022, 30973249, 81100638]; Medical Innovative Program of Fujian Province, China [2012-CXB-31]; Science and Technology Planning Projects of Xiamen [3502Z20094027, 3502Z20131017]; Health Department Project of Fujian [2013-2-112]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Medical Innovative Program of Fujian Province, China; Science and Technology Planning Projects of Xiamen; Health Department Project of Fujian	This work was supported by the National Natural Science Foundation of China, Beijing, China (grant no 81270978, U1205025, 81330022, 30973249, 81100638); Medical Innovative Program of Fujian Province, China (grnat no 2012-CXB-31); Science and Technology Planning Projects of Xiamen (No. 3502Z20094027, No. 3502Z20131017); and Health Department Project of Fujian (No. 2013-2-112). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Chen WS, 2013, CORNEA, V32, P1599, DOI 10.1097/ICO.0b013e3182a8196f; Chen WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040893; Chen WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026103; Cracknell KPB, 2009, EXP EYE RES, V88, P786, DOI 10.1016/j.exer.2008.08.022; Crichton ACS, 2013, ADV THER, V30, P260, DOI 10.1007/s12325-013-0014-7; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; Georgiev GA, 2011, INVEST OPHTH VIS SCI, V52, P4645, DOI 10.1167/iovs.10-6271; Guenoun JM, 2005, INVEST OPHTH VIS SCI, V46, P4594, DOI 10.1167/iovs.05-0776; Guenoun JM, 2005, INVEST OPHTH VIS SCI, V46, P2444, DOI 10.1167/iovs.04-1331; Guo Y, 2007, INVEST OPHTH VIS SCI, V48, P2001, DOI 10.1167/iovs.06-0613; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kimura K, 2013, INVEST OPHTH VIS SCI, V17, P2572; Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6; Kusano M, 2010, CORNEA, V29, P80, DOI 10.1097/ICO.0b013e3181a3c3e6; Liang H, 2011, BRIT J OPHTHALMOL, V95, P869, DOI 10.1136/bjo.2010.189449; McKee HDR, 2005, EYE, V19, P923, DOI 10.1038/sj.eye.6701674; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Nakagawa S, 2012, INVEST OPHTH VIS SCI, V53, P5154, DOI 10.1167/iovs.12-9685; Parrish RK, 2003, AM J OPHTHALMOL, V135, P688, DOI 10.1016/S0002-9394(03)00098-9; Pauly A, 2012, INVEST OPHTH VIS SCI, V53, P8172, DOI 10.1167/iovs.12-10766; Pisella PJ, 2004, INVEST OPHTH VIS SCI, V45, P1360, DOI 10.1167/iovs.03-1067; Prausnitz MR, 1998, J PHARM SCI, V87, P1479, DOI 10.1021/js9802594; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Yanai R, 2009, INVEST OPHTH VIS SCI, V50, P4605, DOI 10.1167/iovs.09-3407; Yu FF, 2013, INVEST OPHTH VIS SCI, V54, P3385, DOI 10.1167/iovs.12-11181	26	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e89205	10.1371/journal.pone.0089205	http://dx.doi.org/10.1371/journal.pone.0089205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632558	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400006
J	Kerkhof, E; Lakhanpaul, M; Ray, S; Verbakel, JY; Van den Bruel, A; Thompson, M; Berger, MY; Moll, HA; Oostenbrink, R				Kerkhof, Evelien; Lakhanpaul, Monica; Ray, Samiran; Verbakel, Jan Y.; Van den Bruel, Ann; Thompson, Matthew; Berger, Marjolein Y.; Moll, Henriette A.; Oostenbrink, Rianne		European Res Network Recognising S	The Predictive Value of the NICE "Red Traffic Lights" in Acutely Ill Children	PLOS ONE			English	Article							SERIOUS BACTERIAL-INFECTION; FEBRILE CHILDREN; EMERGENCY-DEPARTMENT; OBSERVATION SCALES; DECISION RULE; MANAGEMENT; FEVER; SYMPTOMS; SIGNS; CARE	Objective: Early recognition and treatment of febrile children with serious infections (SI) improves prognosis, however, early detection can be difficult. We aimed to validate the predictive rule-in value of the National Institute for Health and Clinical Excellence (NICE) most severe alarming signs or symptoms to identify SI in children. Design, Setting and Participants: The 16 most severe ("red") features of the NICE traffic light system were validated in seven different primary care and emergency department settings, including 6,260 children presenting with acute illness. Main Outcome Measures: We focussed on the individual predictive value of single red features for SI and their combinations. Results were presented as positive likelihood ratios, sensitivities and specificities. We categorised "general" and "disease-specific" red features. Changes in pre-test probability versus post-test probability for SI were visualised in Fagan nomograms. Results: Almost all red features had rule-in value for SI, but only four individual red features substantially raised the probability of SI in more than one dataset: "does not wake/stay awake", "reduced skin turgor", "non-blanching rash", and "focal neurological signs". The presence of >= 3 red features improved prediction of SI but still lacked strong rule-in value as likelihood ratios were below 5. Conclusions: The rule-in value of the most severe alarming signs or symptoms of the NICE traffic light system for identifying children with SI was limited, even when multiple red features were present. Our study highlights the importance of assessing the predictive value of alarming signs in clinical guidelines prior to widespread implementation in routine practice.	[Kerkhof, Evelien; Moll, Henriette A.; Oostenbrink, Rianne] Erasmus MC Sophia Childrens Hosp, Dept Gen Pediat, Rotterdam, Netherlands; [Lakhanpaul, Monica] UCL, Inst Child Hlth, Dept Gen & Adolescent Pediat, London, England; [Ray, Samiran] Great Ormond St Hosp Sick Children, Pediat Intens Care Unit, London, England; [Verbakel, Jan Y.] Katholieke Univ Leuven, Dept Gen Practice, Louvain, Belgium; [Van den Bruel, Ann; Thompson, Matthew] Univ Oxford, Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford, England; [Berger, Marjolein Y.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; KU Leuven; University of Oxford; University of Groningen	Oostenbrink, R (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Gen Pediat, Rotterdam, Netherlands.	r.oostenbrink@erasmusmc.nl	Ray, Samiran/AAZ-4916-2020; Van den Bruel, Ann/AAC-2442-2020; Verbakel, Jan/E-6758-2015	Ray, Samiran/0000-0002-3738-4672; Van den Bruel, Ann/0000-0001-9012-2009; Verbakel, Jan/0000-0002-7166-7211; Lakhanpaul, Monica/0000-0002-9855-2043	ZonMW, a Dutch organisation for health research and development; Europe Container Terminals B.V; European Society of Pediatric Infectious Diseases	ZonMW, a Dutch organisation for health research and development(Netherlands Organization for Health Research and Development); Europe Container Terminals B.V; European Society of Pediatric Infectious Diseases	EK is supported by ZonMW, a Dutch organisation for health research and development; RO is supported by an unrestricted grant of the Europe Container Terminals B.V and by a fellowship award of European Society of Pediatric Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon K, 2004, ARCH DIS CHILD, V89, P159, DOI 10.1136/adc.2002.024406; BAKER MD, 1990, PEDIATRICS, V85, P1040; Berger MY, 2008, GUIDELINE CHILDREN F; Bleeker SE, 2007, ACTA PAEDIATR, V96, P100, DOI 10.1111/j.1651-2227.2006.00033.x; Brent AJ, 2011, ARCH DIS CHILD, V96, P361, DOI 10.1136/adc.2010.183111; Bruijnzeels MA, 1998, BRIT J GEN PRACT, V48, P880; Chen SM, 2013, EMERG MED J, V30, P406, DOI 10.1136/emermed-2011-200808; Chiappini E, 2009, CLIN THER, V31, P1826, DOI 10.1016/j.clinthera.2009.08.006; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; De S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f866; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064; Kumar A, 2009, CRIT CARE CLIN, V25, P733, DOI 10.1016/j.ccc.2009.08.004; MCCARTHY PL, 1985, PEDIATRICS, V76, P167; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; Monteny M, 2008, BRIT J GEN PRACT, V58, P242, DOI 10.3399/bjgp08X279643; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; Oostenbrink R, 2004, EUR J EPIDEMIOL, V19, P109, DOI 10.1023/B:EJEP.0000017828.13995.76; Oostenbrink R, 2012, ARCH DIS CHILD, V97, P667, DOI 10.1136/archdischild-2011-300667; Roukema J, 2008, J AM MED INFORM ASSN, V15, P107, DOI 10.1197/jamia.M2164; TEACH SJ, 1995, J PEDIATR-US, V126, P877, DOI 10.1016/S0022-3476(95)70200-8; Thompson M, 2009, ARCH DIS CHILD, V94, P888, DOI 10.1136/adc.2009.159095; van Charante EPM, 2007, BMC FAM PRACT, V8, P1, DOI 10.1186/1471-2296-8-46; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Verbakel JY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-10	26	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90847	10.1371/journal.pone.0090847	http://dx.doi.org/10.1371/journal.pone.0090847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633015	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400021
J	Liu, ZT; Ning, HJ; Que, SP; Wang, LL; Qin, X; Peng, T				Liu, Zhengtao; Ning, Huaijun; Que, Shuping; Wang, Linlin; Qin, Xue; Peng, Tao			Complex Association between Alanine Aminotransferase Activity and Mortality in General Population: A Systematic Review and Meta-Analysis of Prospective Studies	PLOS ONE			English	Review							GAMMA-GLUTAMYL-TRANSFERASE; AGE-RELATED-CHANGES; INDIVIDUAL PATIENT DATA; METABOLIC SYNDROME; UNITED-STATES; CARDIOVASCULAR-DISEASE; ALL-CAUSE; PREDICT MORTALITY; UPPER LIMITS; LIVER	Objective: Controversy exists in using alanine aminotransferase (ALT) activity for predicting long-term survival. Therefore, this research study investigated the association between ALT activity and mortality through a systematic review and meta-analysis of previous prospective studies. Methods: Electronic literature databases, including PubMed, Embase, and the Institute for Scientific Information (ISI), were searched for relevant prospective observational studies (published before Dec 30, 2013) on the association between baseline ALT activity and ensuing all-cause/disease-specific mortality. Information on nationality, sample size, participant characteristics, follow-up duration, comparison, outcome assessment, hazard ratios (HRs) and adjusted covariates was extracted. Pooled HRs and corresponding 95% confidence intervals (CIs) were separately calculated for categorical risk estimates (highest vs. lowest ALT categories) and continuous risk estimates (per 5 U/l of ALT increment) in subgroups separated by age (<70/>= 70 years). Results: A total of twelve prospective cohort studies, totaling 206,678 participants and 16,249 deaths, were identified and analyzed. In the younger age group, the pooled HR for mortality related to liver-disease was about 1.24 (95% CI: 1.23-1.25) per 5 U/l of ALT increment. The dose-response HRs of all-cause mortality, cardiovascular (CV) disease-related mortality, and cancer-related mortality were 0.91 (0.88-0.94), 0.91 (0.85-0.96), 0.92 (0.86-0.98) respectively per 5 U/l of ALT elevation, with insignificant heterogeneity in the older population. There was an approximate decrease of 4% observed on HRs of all-cause, CV-related, and cancer-related mortality followed with one year's increment through meta-regression (all P < 0.05). Conclusions: The ALT-mortality association was inconsistent and seems particularly susceptible to age after synthesizing the previous prospective studies. In terms of the age, ALT activity was more valuable in predicting mortality in the older population; extremely low ALT levels indicated a higher all-cause, CV-related, and cancer-related mortality. ALT activity may therefore be a useful biomarker when predicting the long-term survival of elderly patients.	[Liu, Zhengtao; Peng, Tao] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Peoples R China; [Liu, Zhengtao] Guangxi Med Univ, Natl Ctr Int Res Biol Targeting Diag & Therapy, Nanning, Peoples R China; [Ning, Huaijun; Que, Shuping] Women & Childrens Hosp Guangxi, Dept Pediat, Nanning, Peoples R China; [Que, Shuping; Wang, Linlin] Guangxi Med Univ, Affiliated Hosp 1, Dept Pediat, Nanning, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Clin Lab Ctr, Nanning, Peoples R China; [Peng, Tao] Guangxi Med Univ, Guangxi Key Lab Biol Targeting Diag & Therapy Res, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Peng, T (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Peoples R China.	pengtaocn@hotmail.com			National Nature Science Foundation of China [NSFC 81072321, 30760243, 30460143, 30560133]; Program for New Century Excellent Talents in University (NCET); Guangxi Nature Sciences Grant [GuiKeGong 1104003A-7]; Guangxi Health Ministry Medicine Grant (Key-Scientific-Research-Grant) [Z201018]; Programs for Changjiang Scholars and Innovative Research Team in University [IRT1119]; Innovative Research Team in Guangxi Natural Science Foundation [2011GXNSFF018005]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET)); Guangxi Nature Sciences Grant; Guangxi Health Ministry Medicine Grant (Key-Scientific-Research-Grant); Programs for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovative Research Team in Guangxi Natural Science Foundation	This work was supported in part by the National Nature Science Foundation of China (NSFC 81072321, 30760243, 30460143 and 30560133), 2009 Program for New Century Excellent Talents in University (NCET), Guangxi Nature Sciences Grant (GuiKeGong 1104003A-7), Guangxi Health Ministry Medicine Grant (Key-Scientific-Research-Grant Z201018), grants from Programs for Changjiang Scholars and Innovative Research Team in University (No. IRT1119) and Innovative Research Team in Guangxi Natural Science Foundation (No. 2011GXNSFF018005). No funding body had any influence or input into the study design, data collection, analysis, data interpretation, or writing of the report.	Adams WL, 1990, J AM GERIATRICS SOC; Al-hamoudi W, 2013, DIGEST DIS SCI, P1; Arndt V, 1998, INT ARCH OCC ENV HEA, V71, P405, DOI 10.1007/s004200050299; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Chen CH, 2007, J GASTROEN HEPATOL, V22, P1482, DOI 10.1111/j.1440-1746.2006.04615.x; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong MH, 2012, CLIN GASTROENTEROL H, V10, P285, DOI 10.1016/j.cgh.2011.10.014; Dong MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014254; Du G, 2013, PREVENTIVE MED; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elinav E, 2005, AM J GASTROENTEROL, V100, P2201, DOI 10.1111/j.1572-0241.2005.41822.x; Elinav E, 2006, J AM GERIATR SOC, V54, P1719, DOI 10.1111/j.1532-5415.2006.00921.x; Ford I, 2011, INT J EPIDEMIOL, V40, P1530, DOI 10.1093/ije/dyr172; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Goessling W, 2008, GASTROENTEROLOGY, V135, P1935, DOI 10.1053/j.gastro.2008.09.018; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hovinen SM, 2010, J AM GERIATR SOC, V58, P1399, DOI 10.1111/j.1532-5415.2010.02901.x; Hui WS, 2010, EUR J EPIDEMIOL, V25, P375, DOI 10.1007/s10654-010-9459-z; Ioannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Koehler EM, 2013, LIVER INT; Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P712, DOI 10.1093/gerona/glq082; Lee BS, 2013, J MED VIROLOGY; Lee DH, 2009, EUR J CARDIOV PREV R, V16, P16, DOI 10.1097/HJR.0b013e32830aba5c; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; Limdi JK, 2003, POSTGRAD MED J, V79, P307, DOI 10.1136/pmj.79.932.307; Liu ZT, 2012, CLIN BIOCHEM, V45, P1683, DOI 10.1016/j.clinbiochem.2012.08.022; Liu ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066666, 10.1371/journal.pone.0055618]; Marchesini G, 2011, INT J EPIDEMIOL, V40, P1539, DOI 10.1093/ije/dyr187; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Molander RC, 2010, ALCOHOL CLIN EXP RES, V34, P1182, DOI 10.1111/j.1530-0277.2010.01195.x; Nakamura K, 2006, J EPIDEMIOL, V16, P15, DOI 10.2188/jea.16.15; Olynyk JK, 2009, AM J GASTROENTEROL, V104, P1715, DOI 10.1038/ajg.2009.229; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pendino GM, 2005, HEPATOLOGY, V41, P1151, DOI 10.1002/hep.20689; Polder JJ, 2002, EUR J PUBLIC HEALTH, V12, P57, DOI 10.1093/eurpub/12.1.57; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Program ESot TRotNCE, 2001, JAMA, V285; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Ruhl CE, 2012, HEPATOLOGY, V55, P447, DOI 10.1002/hep.24725; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009; Schooling CM, 2012, ANN EPIDEMIOLOGY; Sharp S, 2012, STATA TECHNICAL B, V7; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Singh GK, 2011, J CANCER EPIDEMIOL, V2011, DOI 10.1155/2011/107497; SLEE VN, 1978, ANN INTERN MED, V88, P424, DOI 10.7326/0003-4819-88-3-424; Steichen TJ, 1998, STATA TECHNICAL B, V7; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tolman KG, 2002, AM J CARDIOL, V89, P1374, DOI 10.1016/S0002-9149(02)02355-X; Turrell G, 2001, INT J EPIDEMIOL, V30, P231, DOI 10.1093/ije/30.2.231; Vento S, 2008, LANCET, V371, P1822, DOI 10.1016/S0140-6736(08)60778-3; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; Wells GA, 2011, NEWCASTLE OTTAWA SCA; WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002; Yang MC, 2002, PHARMACOL TOXICOL, V90, P203, DOI 10.1034/j.1600-0773.2002.900406.x; Yun JE, 2010, CIRCULATION J OFFICI, V75, P964; Yun KE, 2009, ATHEROSCLEROSIS, V205, P533, DOI 10.1016/j.atherosclerosis.2008.12.012	73	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91410	10.1371/journal.pone.0091410	http://dx.doi.org/10.1371/journal.pone.0091410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633141	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400061
J	Mirsaeidi, M; Machado, RF; Garcia, JGN; Schraufnagel, DE				Mirsaeidi, Mehdi; Machado, Roberto F.; Garcia, Joe G. N.; Schraufnagel, Dean E.			Nontuberculous Mycobacterial Disease Mortality in the United States, 1999-2010: A Population-Based Comparative Study	PLOS ONE			English	Article							LUNG-DISEASE; RESPIRATORY-DISEASE; AVIUM COMPLEX; RISK-FACTORS; PREVALENCE; IMMUNODEFICIENCY; VACCINATION; ONTARIO	Background: Environmental nontuberculous mycobacteria (NTM) are ubiquitous organisms with which humans commonly interact. The epidemiologic characteristics of NTM diseases including mortality rate and its associated factors remain largely unknown. In this study, we explored the geographical area of exposure and mortality and comorbid conditions of affected persons to determine environment, host, and host-pathogen interactive factors. Methods: We analyzed mortality related to nontuberculous mycobacterial infections from 1999 through 2010 by examining multiple-cause-of-death data from the National Center for Health Statistics. Among those who died with these diseases, we analyzed age-adjusted mortality rates, trends, associations with demographic variables, and comorbid conditions and correlated this information with similar data for tuberculosis-related mortality during the same time. Measurements and Mean Results: From 1999 through 2010, nontuberculous mycobacterial disease was reported as an immediate cause of death in 2,990 people in the United States with a combined overall mean age-adjusted mortality rate of 0.1 per 100,000 person-years. A significant increase in the number of NTM related deaths was seen from 1999 through 2010 (R-2 = 0.72, p<0.0001), but it was not significant after adjustment for age. Persons aged 55 years and older, women, those living in Hawaii and Louisiana, and those of non-Hispanic, white ethnicity had higher mortality rates. Compared to tuberculosis-related mortality, chronic obstructive pulmonary disease, bronchiectasis, HIV, interstitial lung diseases, and tobacco use were significantly more common in persons with nontuberculous mycobacteria-related deaths. Conclusions: Nontuberculous mycobacteria-related death numbers are rising and are unevenly distributed. The strong association of nontuberculous mycobacterial disease with age suggests that its prevalence will increase as the United States population ages.	[Mirsaeidi, Mehdi; Machado, Roberto F.; Schraufnagel, Dean E.] Univ Illinois, Div Pulm & Crit Care, Chicago, IL 60680 USA; [Garcia, Joe G. N.] Univ Arizona, Dept Med, Tucson, AZ USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona	Mirsaeidi, M (corresponding author), Univ Illinois, Div Pulm & Crit Care, Chicago, IL 60680 USA.	mmirsae@uic.edu		Mirsaeidi, Mehdi/0000-0001-5298-8442; Schraufnagel, Dean/0000-0003-0063-7223; Machado, Roberto/0000-0002-3722-5954	NHLBI NIH HHS [R01 HL111656, T32 HL082547] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111656, T32HL082547] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Al-Houqani M, 2012, CHEST, V141, P190, DOI 10.1378/chest.11-0089; Andrejak C, 2013, THORAX, V68, P256, DOI 10.1136/thoraxjnl-2012-201772; Bright P, 2013, CLIN EXP IMMUNOL, V171, P195, DOI 10.1111/cei.12010; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Chan ED, 2013, SEMIN RESP CRIT CARE, V34, P110, DOI 10.1055/s-0033-1333573; Falkinham JO, 2003, EMERG INFECT DIS, V9, P763; Falkinham Joseph O, 2003, Can J Infect Dis, V14, P281; Franco DDIaS, 2006, NCHS URB RUR CLASS S; GIRARD W M, 1976, Bulletin of the International Union Against Tuberculosis, V51, P263; Hoefsloot W, 2013, J INFECT; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; KATILA ML, 1987, TUBERCLE, V68, P291, DOI 10.1016/0041-3879(87)90070-5; Lee WI, 2011, J FORMOS MED ASSOC, V110, P750, DOI 10.1016/j.jfma.2011.11.004; LILIENFELD AM, 1983, ENVIRON HEALTH PERSP, V52, P3, DOI 10.2307/3429643; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Mirsaeidi M, 2013, INT J INFECT DIS IJI; Mirsaeidi S M, 2006, Monaldi Arch Chest Dis, V65, P106; OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Saleeb Paul, 2010, Curr Infect Dis Rep, V12, P198, DOI 10.1007/s11908-010-0103-6; SCHRAUFNAGEL DE, 1984, CAN MED ASSOC J, V130, P34; Tabarsi P, 2009, AM J MED SCI, V337, P182, DOI 10.1097/MAJ.0b013e318185d32f; Valadas E, 2004, CLIN INFECT DIS, V39, P457, DOI 10.1086/422326; VONREYN CF, 1993, J CLIN MICROBIOL, V31, P3227, DOI 10.1128/JCM.31.12.3227-3230.1993; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement; Wilsher M, 2012, RESP MED, V106, P1441, DOI 10.1016/j.rmed.2012.06.020; Winthrop KL, 2011, PHARMACOEPIDEM DR S, V20, P229, DOI 10.1002/pds.2049; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC	30	112	118	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91879	10.1371/journal.pone.0091879	http://dx.doi.org/10.1371/journal.pone.0091879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632814	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400114
J	Yuan, FR; Yosef, N; Reddy, CL; Huang, AL; Chiang, SC; Tithi, HR; Ubogu, EE				Yuan, Furong; Yosef, Nejla; Reddy, Chetan Lakshmana; Huang, Ailing; Chiang, Sharon C.; Tithi, Hafiza Rahman; Ubogu, Eroboghene E.			CCR2 Gene Deletion and Pharmacologic Blockade Ameliorate a Severe Murine Experimental Autoimmune Neuritis Model of Guillain-Barre Syndrome	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PERIPHERAL NERVOUS-SYSTEM; CHEMOKINE RECEPTOR CCR2; SCHWANN-CELLS; IN-VITRO; DISEASE; EXPRESSION; NERVES; MICE; INFLAMMATION	The molecular determinants and signaling pathways responsible for hematogenous leukocyte trafficking during peripheral neuroinflammation are incompletely elucidated. Chemokine ligand/receptor pair CCL2/CCR2 has been pathogenically implicated in the acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barre syndrome (GBS). We evaluated the role of CCR2 in peripheral neuroinflammation utilizing a severe murine experimental autoimmune neuritis (sm-EAN) model. Sm-EAN was induced in 8-12 week old female SJL CCR2 knockout (CCR2KO), heterozygote (CCR2HT) and wild type (CCR2WT) mice, and daily neuromuscular severity scores and weights recorded. In vitro and in vivo splenocyte proliferation and cytokine expression assays, and sciatic nerve Toll-like receptor (TLR) 2, TLR4 and CCL2 expression assays were performed to evaluate systemic and local innate immune activation at disease onset. Motor nerve electrophysiology and sciatic nerve histology were also performed to characterize the inflammatory neuropathy at expected peak severity. To further determine the functional relevance of CCR2 in sm-EAN, 20 mg/kg CCR2 antagonist, RS 102895 was administered daily for 5 days to a cohort of CCR2WT mice following sm-EAN disease onset, with efficacy compared to 400 mg/kg human intravenous immunoglobulin (IVIg). CCR2KO mice were relatively resistant to sm-EAN compared to CCR2WT and CCR2HT mice, associated with attenuated peripheral nerve demyelinating neuritis. Partial CCR2 gene deletion did not confer any protection against sm-EAN. CCR2KO mice demonstrated similar splenocyte activation or proliferation profiles, as well as TLR2, TLR4 and CCL2 expression to CCR2WT or CCR2HT mice, implying a direct role for CCR2 in sm-EAN pathogenesis. CCR2 signaling blockade resulted in rapid, near complete recovery from sm-EAN following disease onset. RS 102895 was significantly more efficacious than IVIg. CCR2 mediates pathogenic hematogenous monocyte trafficking into peripheral nerves, with consequential demyelination in sm-EAN. CCR2 is amenable to pharmacologic blockade, making it a plausible drug target for GBS.	[Yuan, Furong; Yosef, Nejla; Reddy, Chetan Lakshmana; Huang, Ailing; Tithi, Hafiza Rahman; Ubogu, Eroboghene E.] Baylor Coll Med, Dept Neurol, Neuromuscular Immunopathol Res Lab, Houston, TX 77030 USA; [Yosef, Nejla] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chiang, Sharon C.] Rice Univ, Dept Stat, Houston, TX 77251 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University	Ubogu, EE (corresponding author), Baylor Coll Med, Dept Neurol, Neuromuscular Immunopathol Res Lab, Houston, TX 77030 USA.	ubogu@uab.edu	Ubogu, Eroboghene/R-3894-2019	Ubogu, Eroboghene/0000-0002-8307-9994	Baylor College of Medicine New Investigator Start-Up program; Guillain-Barre syndrome/Chronic Inflammatory Demyelinating Polyradiculoneuropathy Foundation International; National Institutes of Health (NIH) [R21 NS073702, R21 NS078226, R01 NS075212, P30 AI27767]; NATIONAL CANCER INSTITUTE [T32CA096520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS078226, R01NS075212, R21NS073702] Funding Source: NIH RePORTER	Baylor College of Medicine New Investigator Start-Up program; Guillain-Barre syndrome/Chronic Inflammatory Demyelinating Polyradiculoneuropathy Foundation International; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Baylor College of Medicine New Investigator Start-Up program from 2007-2011 and a research grant from the Guillain-Barre syndrome/Chronic Inflammatory Demyelinating Polyradiculoneuropathy Foundation International from 2010-2012. Work in the Neuromuscular Immunopathology Research Laboratory at Baylor College of Medicine was supported by National Institutes of Health (NIH) grants R21 NS073702, R21 NS078226 and R01 NS075212, and a subaward P30 AI27767 to E.E.U. from 2011-2013. The funding sources had no involvement in the conduct of the research, manuscript preparation, data collection/analyses or decision to submit this work for publication.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bennett JL, 2007, VIRAL IMMUNOL, V20, P19, DOI 10.1089/vim.2006.0068; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Calida DM, 2000, J NEUROIMMUNOL, V107, P1, DOI 10.1016/S0165-5728(00)00249-6; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chiang S, 2013, MUSCLE NERVE, V48, P320, DOI 10.1002/mus.23829; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Duan RS, 2004, NEUROBIOL DIS, V16, P630, DOI 10.1016/j.nbd.2004.04.007; Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041; Hartung HP, 2002, CURR OPIN NEUROL, V15, P571, DOI 10.1097/00019052-200210000-00008; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; JESSEN KR, 1987, J NEUROSCI, V7, P3362; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2002, BRAIN, V125, P823, DOI 10.1093/brain/awf070; Kruisbeek Ada M, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0314s24; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Mitchell LA, 2013, INT IMMUNOPHARMACOL, V15, P357, DOI 10.1016/j.intimp.2012.11.016; Orlikowski D, 2003, J NEUROIMMUNOL, V134, P118, DOI 10.1016/S0165-5728(02)00393-4; Press R, 2003, J CLIN IMMUNOL, V23, P259, DOI 10.1023/A:1024532715775; Reddy CL, 2013, CELL MOL NEUROBIOL, V33, P789, DOI 10.1007/s10571-013-9946-3; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Ubogu Eroboghene E, 2013, Methods Mol Biol, V1013, P17, DOI 10.1007/978-1-62703-426-5_2; Ubogu EE, 2012, J PERIPHER NERV SYST, V17, P53, DOI 10.1111/j.1529-8027.2012.00375.x; Ubogu Eroboghene E., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P141; Viquez OM, 2007, CHEM RES TOXICOL, V20, P370, DOI 10.1021/tx6003453; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Xia RH, 2010, NEUROPATH APPL NEURO, V36, P388, DOI 10.1111/j.1365-2990.2010.01092.x; Xia RH, 2010, MUSCLE NERVE, V41, P850, DOI 10.1002/mus.21588; Xia RH, 2010, J NEUROIMMUNOL, V219, P54, DOI 10.1016/j.jneuroim.2009.11.019; Yao Y, 2010, J BIOL CHEM, V285, P31509, DOI 10.1074/jbc.M110.124891; Ydens E, 2013, NEUROBIOL DIS, V55, P95, DOI 10.1016/j.nbd.2013.03.005; Yosef N, 2013, CELL MOL NEUROBIOL, V33, P175, DOI 10.1007/s10571-012-9882-7; Yosef N, 2012, J CELL PHYSIOL, V227, P3857, DOI 10.1002/jcp.24100; Yosef N, 2012, MICROVASC RES, V83, P298, DOI 10.1016/j.mvr.2012.01.005; Yosef N, 2010, J NEUROPATH EXP NEUR, V69, P82, DOI 10.1097/NEN.0b013e3181c84a9a; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	41	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90463	10.1371/journal.pone.0090463	http://dx.doi.org/10.1371/journal.pone.0090463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632828	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400015
J	Ge, C; Song, JT; Chen, L; Wang, L; Chen, YF; Liu, XX; Zhang, Y; Zhang, LN; Zhang, M				Ge, Cheng; Song, Jiantao; Chen, Liang; Wang, Lin; Chen, Yifei; Liu, Xinxin; Zhang, Yu; Zhang, Lining; Zhang, Mei			Atheroprotective Pulsatile Flow Induces Ubiquitin-Proteasome-Mediated Degradation of Programmed Cell Death 4 in Endothelial Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PDCD4; ACTIVATED PROTEIN-KINASE; SHEAR-STRESS; DISTURBED FLOW; MESSENGER-RNA; TRANSLATION; EXPRESSION; PROLIFERATION; APOPTOSIS; MUSCLE	Objectives: We recently found low level of tumor suppressor programmed cell death 4 (PDCD4) associated with reduced atherosclerotic plaque area (unpublished). We investigated whether atheroprotective unidirectional pulsatile shear stress affects the expression of PDCD4 in endothelial cells. Methods and Results: En face co-immunostaining of the mouse aortic arch revealed a low level of PDCD4 in endothelial cells undergoing pulsatile shear stress. Application of unidirectional pulsatile shear stress to human umbilical vein endothelial cells (HUVECs) decreased PDCD4 protein but not mRNA level. Immunoprecipitation revealed that pulsatile shear stress induced the coupling of ubiquitin with PDCD4 expression. The phosphatidyl inositol 3-kinase (PI3K)/Akt pathway was involved in this ubiquitin-proteasome-mediated degradation of PDCD4. Gain of function and loss of function experiments showed that PDCD4 induced turnover (proliferation and apoptosis) of HUVECs. Low PDCD4 level was associated with reduced proliferation but not apoptosis or phosphorylation of endothelial nitric oxide synthase caused by pulsatile shear stress to help maintain the homeostasis of endothelial cells. Conclusions: Pulsatile shear stress induces ubiquitin-proteasome-mediated degradation of PDCD4 via a PI3K/Akt pathway in HUVECs. PDCD4 induces turnover (proliferation and apoptosis) of HUVECs. Low PDCD4 level is associated with reduced proliferation for maintenance of HUVEC homeostasis under pulsatile shear stress.	[Ge, Cheng; Song, Jiantao; Wang, Lin; Chen, Yifei; Liu, Xinxin; Zhang, Yu; Zhang, Mei] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Ge, Cheng; Song, Jiantao; Wang, Lin; Chen, Yifei; Liu, Xinxin; Zhang, Yu; Zhang, Mei] Shandong Univ, Chinese Minist Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Chen, Liang] Shandong Univ, Dept Emergency, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Zhang, Lining] Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Zhang, M (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	daixh@vip.sina.com	Chen, Yi/HIR-2608-2022		National Basic Research Program of China (973 Program) [2010CB732605, 2011CB503906]; National Natural Science Foundation of China [30970709, 81270404, 81172863]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Basic Research Program of China (973 Program, 2010CB732605, 2011CB503906) and the National Natural Science Foundation of China (No. 30970709, 81270404, 81172863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; ASAKURA T, 1990, CIRC RES, V66, P1045, DOI 10.1161/01.RES.66.4.1045; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Banjo T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2978; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eto K, 2012, CELL DEATH DIFFER, V19, P573, DOI 10.1038/cdd.2011.126; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Guo DL, 2007, CIRC RES, V100, P564, DOI 10.1161/01.RES.0000259561.23876.c5; Guo Xiaoling, 2011, Genes Cancer, V2, P818, DOI 10.1177/1947601911431082; Hayashi A, 2010, HUM PATHOL, V41, P1507, DOI 10.1016/j.humpath.2010.02.019; Jaitovich A, 2008, J BIOL CHEM, V283, P25348, DOI 10.1074/jbc.M801635200; Kadohama T, 2007, J CELL PHYSIOL, V212, P244, DOI 10.1002/jcp.21024; Kolpa HJ, 2013, DEVELOPMENT, V140, P2172, DOI 10.1242/dev.084475; Kraiss LW, 2001, J SURG RES, V97, P20, DOI 10.1006/jsre.2001.6091; Kroczynska B, 2012, MOL CELL BIOL, V32, P2809, DOI 10.1128/MCB.00310-12; Lankat-Buttgereit B, 2003, BIOL CELL, V95, P515, DOI 10.1016/j.biolcel.2003.09.003; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lee DY, 2012, P NATL ACAD SCI USA, V109, P1967, DOI 10.1073/pnas.1121214109; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu XJ, 2010, AM J PHYSIOL-CELL PH, V298, pC1481, DOI 10.1152/ajpcell.00413.2009; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Milkiewicz M, 2011, AM J PATHOL, V178, P935, DOI 10.1016/j.ajpath.2010.10.042; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Singh P, 2011, ONCOGENE, V30, P4864, DOI 10.1038/onc.2011.202; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Song XG, 2013, AUTOPHAGY, V9, P743, DOI 10.4161/auto.24069; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Wang F, 2012, J CELL BIOCHEM, V113, P2989, DOI 10.1002/jcb.24176; Wang XL, 2007, PROTEOMICS, V7, P588, DOI 10.1002/pmic.200600568; Waters LC, 2011, J BIOL CHEM, V286, P17270, DOI 10.1074/jbc.M110.166157; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030311; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	42	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91564	10.1371/journal.pone.0091564	http://dx.doi.org/10.1371/journal.pone.0091564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626527	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300104
J	Nagu, TJ; Spiegelman, D; Hertzmark, E; Aboud, S; Makani, J; Matee, MI; Fawzi, W; Mugusi, F				Nagu, Tumaini J.; Spiegelman, Donna; Hertzmark, Ellen; Aboud, Said; Makani, Julie; Matee, Mecky I.; Fawzi, Wafaie; Mugusi, Ferdinand			Anemia at the Initiation of Tuberculosis Therapy Is Associated with Delayed Sputum Conversion among Pulmonary Tuberculosis Patients in Dar-es-Salaam, Tanzania	PLOS ONE			English	Article							HIV; PREVALENCE; MORTALITY; SMEAR; BACILLI; DISEASE; MODELS; RISK; IRON	Background: Pulmonary tuberculosis and anemia are both prevalent in Tanzania. There is limited and inconsistent literature on the association between anemia and sputum conversion following tuberculosis treatment. Methods: Newly diagnosed sputum smear positive pulmonary tuberculosis patients aged >= 15 years initiating on standard anti tuberculosis therapy were recruited from 14 of 54 tuberculosis clinics in Dar es Salaam. Patients were receiving medication according to the recommended short course Directly Observed Therapy (DOT) strategy and were followed up prospectively until completion of treatment (six months). Patients were evaluated before initiation of TB treatment by performing the following; clinical history, physical examination, complete blood counts, serum biochemistry and sputum microscopy. Sputum smears were re-examined at two months of anti-tuberculosis therapy for presence of acid fast bacilli. Anemia was defined as hemoglobin < 13 g/dl (males) or < 12 g/dl (females). Log-binomial regression was used to assess the association between anemia and sputum conversion at two months. Results: Of the 1245 patients included in the study, 86% were anemic and 7% were sputum smear positive at two months of anti-tuberculosis therapy. Anemic patients were three times more likely to have sputum positive smear as compared to non-anemic patients at two months (RR = 3.05; 95% CI 1.11-8.40) p = 0.03. The risk for sputum positive smear results increased with severity of anemia (P for trend < 0.01). Conclusion: Baseline anemia is associated with increased risk for persistent positive sputum smears at two months of tuberculosis treatment. Future studies should evaluate the mechanisms for TB-associated anemia as well as the role of intervention for anemia among TB patients.	[Nagu, Tumaini J.; Mugusi, Ferdinand] MUHAS, Dept Internal Med, Dar Es Salaam, Tanzania; [Nagu, Tumaini J.] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Spiegelman, Donna; Hertzmark, Ellen] HSPH, Dept Epidemiol, Boston, MA USA; [Spiegelman, Donna] HSPH, Dept Biostat, Boston, MA USA; [Aboud, Said; Matee, Mecky I.] MUHAS, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Makani, Julie] MUHAS, Dept Hematol, Dar Es Salaam, Tanzania; [Fawzi, Wafaie] HSPH, Dept Global Hlth & Populat, Boston, MA USA	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Nagu, TJ (corresponding author), MUHAS, Dept Internal Med, Dar Es Salaam, Tanzania.	jtjoyce20@hotmail.com	Makani, Julie/N-9370-2013	Makani, Julie/0000-0002-4801-6250	MUHAS-HARVARD scholarship program	MUHAS-HARVARD scholarship program	This work was accomplished as part of MUHAS-HARVARD scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, World Health Forum, V14, P438; Bagaitkar J, 2008, TOB INDUC DIS, V4; Chien JY, 2013, CHEST, V143, P1725, DOI 10.1378/chest.12-2051; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127; Fortun J, 2007, J ANTIMICROB CHEMOTH, V59, P794, DOI 10.1093/jac/dkm025; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; Govindarajulu US, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1104; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Guglielmetti L, 2013, INT J TUBERC LUNG D, V17, P825, DOI 10.5588/ijtld.12.0361; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Hussain SF, 2004, INT J TUBERC LUNG D, V8, P493; Isanaka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037350; Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Karyadi E, 2000, J NUTR, V130, P2953, DOI 10.1093/jn/130.12.2953; Karzakova L M, 2005, Probl Tuberk Bolezn Legk, P36; Kourbatova EV, 2006, INT J TUBERC LUNG D, V10, P1224; Kwange SO, 2007, INDIAN J MED MICROBI, V28, P221; Lee SW, 2006, J KOREAN MED SCI, V21, P1028, DOI 10.3346/jkms.2006.21.6.1028; Long R, 2003, INFECT CONT HOSP EP, V24, P831, DOI 10.1086/502145; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mkopi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051828; MORRIS CDW, 1989, Q J MED, V73, P1151; Mugusi FM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-409; Olaniyi J A, 2003, Afr J Med Med Sci, V32, P239; Orofino RD, 2012, J BRAS PNEUMOL, V38, P88, DOI 10.1590/S1806-37132012000100013; Parikh Raunak, 2012, J Assoc Physicians India, V60, P22; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; Saathoff E, 2011, INT J TUBERC LUNG D, V15, P925, DOI 10.5588/ijtld.10.0477; Senkoro M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-210; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; Slama K, 2012, INT J TUBERC LUNG D, V11, P1049; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Tiwari Simmi, 2012, Indian J Tuberc, V59, P135; United Republic of Tanzania, 2011, MIN HLTH SOC WELF NA; United Republic of Tanzania, 2006, MAN NAT TUB LEPR PRO; United Republic of Tanzania, 2013, POP HOUS CENS POP DI; United Republic of Tanzania Ministry of Health and Social Welfare, 2012, NAT GUID MAN HIV AID; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weiss G, 2002, EUR J CLIN INVEST, V32, P70, DOI 10.1046/j.1365-2362.2002.0320s1070.x; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2011, SER FERR CONC ASS IR	46	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91229	10.1371/journal.pone.0091229	http://dx.doi.org/10.1371/journal.pone.0091229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642636	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900015
J	Young, DM; Levinson, JD; Sinnett, S				Young, Danielle M.; Levinson, Justin D.; Sinnett, Scott			Innocent until Primed: Mock Jurors' Racially Biased Response to the Presumption of Innocence	PLOS ONE			English	Article							VIDEOTAPED CONFESSIONS; POLICE OFFICERS; DECISION-MAKING; RACE; ATTENTION; THREAT; BLACK	Background: Research has shown that crime concepts can activate attentional bias to Black faces. This study investigates the possibility that some legal concepts hold similar implicit racial cues. Presumption of innocence instructions, a core legal principle specifically designed to eliminate bias, may instead serve as an implicit racial cue resulting in attentional bias. Methodology/Principal findings: The experiment was conducted in a courtroom with participants seated in the jury box. Participants first watched a video of a federal judge reading jury instructions that contained presumption of innocence instructions, or matched length alternative instructions. Immediately following this video a dot-probe task was administered to assess the priming effect of the jury instructions. Presumption of innocence instructions, but not the alternative instructions, led to significantly faster response times to Black faces when compared with White faces. Conclusions/Significance: These findings suggest that the core principle designed to ensure fairness in the legal system actually primes attention for Black faces, indicating that this supposedly fundamental protection could trigger racial stereotypes.	[Young, Danielle M.] Rutgers State Univ, Dept Psychol, New Brunswick, NJ 08903 USA; [Levinson, Justin D.] Univ Hawaii Manoa, William S Richardson Sch Law, Honolulu, HI 96822 USA; [Sinnett, Scott] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA	Rutgers State University New Brunswick; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Sinnett, S (corresponding author), Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA.	ssinnett@hawaii.edu		Levinson, Justin/0000-0003-3028-1598				Amodio DM, 2006, J PERS SOC PSYCHOL, V91, P652, DOI 10.1037/0022-3514.91.4.652; BODENHAUSEN GV, 1988, J PERS SOC PSYCHOL, V55, P726, DOI 10.1037/0022-3514.55.5.726; Correll J, 2006, J EXP SOC PSYCHOL, V42, P120, DOI 10.1016/j.jesp.2005.02.006; Correll J, 2002, J PERS SOC PSYCHOL, V83, P1314, DOI 10.1037//0022-3514.83.6.1314; Correll J, 2007, J PERS SOC PSYCHOL, V92, P1006, DOI 10.1037/0022-3514.92.6.1006; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; Goff PA, 2008, J PERS SOC PSYCHOL, V94, P292, DOI 10.1037/0022-3514.94.2.292; Graham S, 2004, LAW HUMAN BEHAV, V28, P483, DOI 10.1023/B:LAHU.0000046430.65485.1f; Haney C, 2003, DEPAUL LAW REV, V53, P1557; Hutchings VL, 2009, ANNU REV POLIT SCI, V12, P397, DOI 10.1146/annurev.polisci.12.060107.154208; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; Lassiter GD, 2001, ADV EXP SOC PSYCHOL, V33, P189, DOI 10.1016/S0065-2601(01)80006-X; Lassiter GD, 2002, PSYCHOL SCI, V13, P299, DOI 10.1111/1467-9280.00456; Levinson JD, 2005, U CINCI LAW REV, V73, P1059; Levinson JD., 2010, W VA LAW REV, V112, P307; Levinson JD, 2013, NEW YORK U LAW REV; Levinson JD, 2007, DUKE LAW J, V57, P345; Levinson Justin D., 2010, OHIO ST J CRIM L, V8, P187; MACLEOD C, 1988, Q J EXP PSYCHOL-A, V40, P653, DOI 10.1080/14640748808402292; Mendelberg T, 2008, PERSPECT POLIT, V6, P109, DOI 10.1017/S1537592708080092; Ogletree C, 2012, IMPLICIT RACIAL BIAS ACROSS THE LAW, P45; Payne BK, 2005, J EXP SOC PSYCHOL, V41, P36, DOI 10.1016/j.jesp.2004.05.001; Ratcliff JJ, 2010, PSYCHOL PUBLIC POL L, V16, P200, DOI 10.1037/a0018482; Trawalter S, 2008, J EXP SOC PSYCHOL, V44, P1322, DOI 10.1016/j.jesp.2008.03.006; Ware LJ, 2008, J EXP PSYCHOL-APPL, V14, P192, DOI 10.1037/1076-898X.14.2.192	27	3	3	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92365	10.1371/journal.pone.0092365	http://dx.doi.org/10.1371/journal.pone.0092365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24643050	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900126
J	Giachini, FR; Leite, R; Osmond, DA; Lima, VV; Inscho, EW; Webb, RC; Tostes, RC				Giachini, Fernanda R.; Leite, Romulo; Osmond, David A.; Lima, Victor V.; Inscho, Edward W.; Webb, R. Clinton; Tostes, Rita C.			Anti-Platelet Therapy with Clopidogrel Prevents Endothelial Dysfunction and Vascular Remodeling in Aortas from Hypertensive Rats	PLOS ONE			English	Article							CORONARY-ARTERY; INDUCED RELAXATION; PLATELET-FUNCTION; P2Y(1) RECEPTORS; THORACIC AORTA; ANGIOTENSIN-II; BLOOD-PRESSURE; ADP; MECHANISMS; ASPIRIN	The aim was to investigate the beneficial effects of clopidogrel in thoracic aorta function and structure and to characterize if P2Y(12) receptors contribute to these effects. Male Sprague Dawley rats were infused with angiotensin II [(Ang II) 60 ng.min(-1), 14 days] or saline (control rats) and were simultaneously treated with clopidogrel (10 mg.kg(-1).day(-1)) or vehicle. After 14 days, systolic blood pressure (mmHg) was similar in Ang II-hypertensive rats treated with clopidogrel or vehicle (199 +/- 9 vs. 190 +/- 11, respectively). Systolic blood pressure in control rats was not altered by clopidogrel treatment (128 +/- 1 vs. vehicle, 134 +/- 2). Endothelium-dependent relaxation induced by 2-MeS-ADP was decreased in aortas from vehicle-treated Ang II-hypertensive rats, compared to vehicle-treated control rats. This response was elicited via activation of P2Y(1) and P2Y(12) receptors. In the presence of L-NAME and indomethacin, 2-MeS-ADP induced contraction and this response was augmented in vehicle-treated Ang II-hypertensive rats, compared to vehicle-treated control rats. The contraction to 2-MeS-ADP was evoked by P2Y(13) and P2Y(12) receptor activation. Clopidogrel-treatment did not normalize relaxation or contractile responses induced by 2-MeS-ADP in aortas from Ang II-hypertensive rats. P2Y(1) and P2Y(12) protein expression was increased, whereas P2Y(13) receptor expression was reduced in aorta from vehicle-treated Ang II-hypertensive rats. Endothelium-dependent relaxation upon acetylcholine-stimulation was reduced in vehicle-treated Ang II-hypertensive rats, and clopidogrel treatment was effective in improving endothelial function. Clopidogrel also prevented vascular remodeling, evidenced by augmented media thickness in aortas from Ang II-hypertensive rats. Clopidogrel has beneficial effects on the aortic endothelium of Ang II-hypertensive rats, but its effects do not seem to be directly related to the presence of P2Y(12) receptors in this vessel.	[Giachini, Fernanda R.; Lima, Victor V.] Univ Fed Mato Grosso, Inst Biol Sci & Hlth, Barra Do Garcas, MT, Brazil; [Leite, Romulo] Univ Fed Ouro Preto, Sch Pharm, Ouro Preto, MG, Brazil; [Osmond, David A.; Inscho, Edward W.; Webb, R. Clinton] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Tostes, Rita C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ribeirao Preto, SP, Brazil	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Ouro Preto; University System of Georgia; Augusta University; Universidade de Sao Paulo	Giachini, FR (corresponding author), Univ Fed Mato Grosso, Inst Biol Sci & Hlth, Barra Do Garcas, MT, Brazil.	fernandagiachini@hotmail.com	Giachini, Fernanda R/J-7958-2012; Tostes, Rita C/C-1025-2012	Giachini, Fernanda R/0000-0003-2688-7204; Tostes, Rita C/0000-0002-9446-0707	National Institutes of Health [HL71138, DK83685, DK44628, HL098135]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado do Mato Grosso (FAPEMAT); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvmento Cientifico e Tecnologico (CNPq); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098135, R01HL071138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083685, R01DK044628, R29DK044628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvmento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health (HL71138, DK83685 and DK44628and HL098135), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Amparo a Pesquisa do Estado do Mato Grosso (FAPEMAT), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de Desenvolvmento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2006, DIABETES, V55, P780, DOI 10.2337/diabetes.55.03.06.db05-1394; Arazi HC, 2012, CURR PHARM DES; Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; Bautista LE, 2003, J HUM HYPERTENS, V17, P223, DOI 10.1038/sj.jhh.1001537; Bender SB, 2011, J APPL PHYSIOL, V111, P1744, DOI 10.1152/japplphysiol.00946.2011; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Boyer JL, 1998, BRIT J PHARMACOL, V124, P1, DOI 10.1038/sj.bjp.0701837; Brown NJ, 1996, TRENDS CARDIOVAS MED, V6, P239, DOI 10.1016/S1050-1738(96)00091-6; Dol-Gleizes F, 1999, EUR J PHARMACOL, V367, P247, DOI 10.1016/S0014-2999(98)00985-6; GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Giachini FR, 2009, CLIN SCI LOND; Gkaliagkousi E, 2010, AM J HYPERTENS, V23, P229, DOI 10.1038/ajh.2009.247; Graciano ML, 2008, AM J PHYSIOL-RENAL, V294, pF161, DOI 10.1152/ajprenal.00281.2007; Graff J, 2003, BRIT J CLIN PHARMACO, V56, P321, DOI 10.1046/j.0306-5251.2003.01873.x; Hamilos M, 2011, J THROMB THROMBOLYS, V32, P64, DOI 10.1007/s11239-011-0557-x; HELLEM AJ, 1967, THROMB DIATH HAEMOST, VS, P193; KAUL S, 1993, CIRC RES, V72, P737, DOI 10.1161/01.RES.72.4.737; Kim YC, 2005, BIOCHEM PHARMACOL, V70, P266, DOI 10.1016/j.bcp.2005.04.021; Klinkhardt U, 2003, CLIN PHARMACOL THER, V73, P232, DOI 10.1067/mcp.2003.13; LEACH CM, 1982, PROSTAGLANDINS, V24, P47, DOI 10.1016/0090-6980(82)90176-9; Lip GYH, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003186.pub3; Mitchell C, 2012, J PHARMACOL EXP THER, V343, P755, DOI 10.1124/jpet.112.198051; Palatini P, 2011, VASC HEALTH RISK MAN, V7, P725, DOI 10.2147/VHRM.S25270; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rayment SJ, 2007, FASEB J, V21, P577, DOI 10.1096/fj.06-7050com; Safar ME, 1998, HYPERTENSION, V32, P156, DOI 10.1161/01.HYP.32.1.156; Saiag B, 1996, BRIT J PHARMACOL, V118, P804, DOI 10.1111/j.1476-5381.1996.tb15471.x; Savoia C, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001815; Schafer A, 2011, BASIC RES CARDIOL, V106, P485, DOI 10.1007/s00395-011-0153-4; Shechter M, 2012, PLATELETS, V23, P202, DOI 10.3109/09537104.2011.604805; Simon J, 2002, J BIOL CHEM, V277, P31390, DOI 10.1074/jbc.M110714200; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2007, VASC MED, V12, P113, DOI 10.1177/1358863X07077462; Storey RF, 2002, PLATELETS, V13, P407, DOI 10.1080/0953710021000024402; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; UMEMURA K, 1995, JPN J PHARMACOL, V67, P253, DOI 10.1254/jjp.67.253; Virdis A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/916310; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Warnholtz A, 2007, ATHEROSCLEROSIS, V194, P439, DOI 10.1016/j.atherosclerosis.2006.08.034; Wihlborg AK, 2004, ARTERIOSCL THROM VAS, V24, P1810, DOI 10.1161/01.ATV.0000142376.30582.ed; YAO SK, 1993, CIRCULATION, V88, P2888, DOI 10.1161/01.CIR.88.6.2888; Zeng CY, 2010, CLIN SCI, V118, P459, DOI 10.1042/CS20090546	44	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91890	10.1371/journal.pone.0091890	http://dx.doi.org/10.1371/journal.pone.0091890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638017	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100074
J	Tan, PC; Zaidi, SN; Azmi, N; Omar, SZ; Khong, SY				Tan, Peng Chiong; Zaidi, Syeda Nureena; Azmi, Noor; Omar, Siti Zawiah; Khong, Su Yen			Depression, Anxiety, Stress and Hyperemesis Gravidarum: Temporal and Case Controlled Correlates	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; PREGNANCY; NAUSEA	Objective: To evaluate the temporal and case-controlled correlations of anxiety, depression and stress with hyperemesis gravidarum Study Design: We performed a longitudinal cohort study of women with hyperemesis gravidarum using the Depression, Anxiety and Stress Scale (DASS-21) to evaluate psychological distress at hospitalization and in the third trimester of pregnancy (from 28 weeks gestation). Third pregnancy trimester controls were recruited from routine antenatal clinic attendees who were matched to gestational age at the second DASS-21 assessment in the HG cohort. Results: The prevalences of nausea and vomiting, depression, anxiety and stress caseness in newly hospitalised hyperemesis gravidarum women were 100% and 100%, 19%, 69% and 21% which by the third trimester had fallen to 15.7% and 9.9%, 4%, 19% and 3% and in third trimester controls were 15.9% and 14.2%, 14%, 61% and 20% respectively. Within the hyperemesis gravidarum cohort, nausea, vomiting depression, anxiety and stress reduced significantly by an absolute 84.3% (95% CI 76.2%-89.8%), 90.1% (82.8%-94.2%), 14.9% (7.2%-23.0%), 49.6% (38.6%-58.7%) and 18.2% (10.4%-26.4%) respectively between hospitalization for hyperemesis gravidarum and at the third trimester. In the third trimester, when comparing the hyperemesis gravidarum cohort to controls, the risk of nausea or vomiting was similar but depression, anxiety and stress were significantly lower: adjusted odds ratio AOR 0.10 (95% CI 0.03-0.5), 0.11 (0.05-0.23) and 0.08 (0.02-0.33) respectively. Conclusion: Our study revealed a reassuring pattern of a strong rebound from depression, anxiety and stress in women with hyperemesis gravidarum such that by the third pregnancy trimester the level of psychological distress was even lower than in controls. This observation imply that much of the psychological distress in acute hyperemesis gravidarum is self-limiting and probably in the causal pathway of hyperemesis gravidarum. Care in women with hyperemesis gravidarum should focus on the relief of nausea and vomiting.	[Tan, Peng Chiong; Zaidi, Syeda Nureena; Azmi, Noor; Omar, Siti Zawiah; Khong, Su Yen] Univ Malaya, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia	Universiti Malaya	Tan, PC (corresponding author), Univ Malaya, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia.	pctan@um.edu.my	Tan, Peng/HGD-6812-2022; TAN, PENG CHIONG/B-9917-2010; Zaidi, Syeda/CAF-2671-2022; OMAR, SITI ZAWIAH BINTI/B-9817-2010; Zaidi, Syeda/CAH-8644-2022; Su Yen, Khong/G-5036-2011; Tan, Peng Chiong/AAM-8408-2021	TAN, PENG CHIONG/0000-0001-8713-6581; Zaidi, Syeda/0000-0003-2969-896X; Zaidi, Syeda/0000-0003-2969-896X; Tan, Peng Chiong/0000-0001-8713-6581	University of Malaya [UM.C/625/1/HIR/MOHE/MED/28, H20001-00-E000066]	University of Malaya(Universiti Malaya)	A covering block research grant (UM.C/625/1/HIR/MOHE/MED/28 account no. H20001-00-E000066) was provided by the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Einarson TR, 2013, J POPUL THER CLIN PH, V20, pE171; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; McCarthy FP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027678; Meades R, 2011, J AFFECT DISORDERS, V133, P1, DOI 10.1016/j.jad.2010.10.009; Munch S, 2002, SOC WORK HEALTH CARE, V36, P59, DOI 10.1300/J010v36n01_05; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Ramli M, 2012, ASEAN J PSYCHIAT, V12, pXX; Seng JS, 2007, J PSYCHOSOM OBST GYN, V28, P209, DOI 10.1080/01674820701262044; Simpson SW, 2001, J WOMEN HEALTH GEN-B, V10, P471, DOI 10.1089/152460901300233948; Tan PC, 2006, BJOG-INT J OBSTET GY, V113, P733, DOI 10.1111/j.1471-0528.2006.00947.x; Tan PC, 2011, CURR OPIN OBSTET GYN, V23, P87, DOI 10.1097/GCO.0b013e328342d208; Tan PC, 2010, EUR J OBSTET GYN R B, V149, P153, DOI 10.1016/j.ejogrb.2009.12.031; Uguz F, 2012, GEN HOSP PSYCHIAT, V34, P398, DOI 10.1016/j.genhosppsych.2012.03.021; Verberg MFG, 2005, HUM REPROD UPDATE, V11, P527, DOI 10.1093/humupd/dmi021	18	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92036	10.1371/journal.pone.0092036	http://dx.doi.org/10.1371/journal.pone.0092036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637791	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100106
J	Boudreaux, C; Chanthala, P; Lindelow, M				Boudreaux, Chantelle; Chanthala, Phetdara; Lindelow, Magnus			Assessing the Elimination of User Fees for Delivery Services in Laos	PLOS ONE			English	Article							HEALTH-CARE SERVICES; ABOLITION; MORTALITY	A pilot eliminating user fees associated with delivery at the point of services was introduced in two districts of Laos in March 2009. Following two years of implementation, an evaluation was conducted to assess the pilot impact, as well as to document the pilot design and implementation challenges. Study results show that, even in the presence of the substantial access and cultural barriers, user fees associated with delivery at health facilities act as a serious deterrent to care seeking behavior. We find a tripling of facility-based delivery rates in the intervention areas, compared to a 40% increase in the control areas. While findings from the control region suggest that facility-based delivery rates may be on the rise across the country, the substantially higher increase in the pilot areas highlight the impact of financial burden associated with facility-based delivery fees. These fees can play an important role in rapidly increasing the uptake of facility delivery to reach the national targets and, ultimately, to improve maternal and child health outcomes. The pilot achieved important gains while relying heavily on capacity and systems already in place. However, the high cost associated with monitoring and evaluation suggest broad-scale expansion of the pilot activities is likely to necessitate targeted capacity building initiatives, especially in areas with limited district level capacity to manage funds and deliver detailed and timely reports.	[Boudreaux, Chantelle] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Chanthala, Phetdara] World Bank, Human Dev Sect, Viangchan, Laos; [Lindelow, Magnus] World Bank, Human Dev Sect, Brasilia, DF, Brazil	Harvard University; Harvard T.H. Chan School of Public Health; The World Bank; The World Bank	Boudreaux, C (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	chantelle.boudreaux@gmail.com			World Bank	World Bank(The World Bank India)	This project and work was funded by the World Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin J.S., 1987, FINANCING HLTH SERVI; [Anonymous], 2013, MILLENNIUM DEV GOALS; Asante Fa, 2007, Ghana Med J, V41, P110; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cohen J, 2008, FREE DISTRIBUTION CO; Deininger K, 2005, J AFR ECON, V14, P55, DOI 10.1093/jae/ejh034; Department of Economic and Social Affairs, 2011, MILL DEV GOALS IND; Douangphachanh X, 2010, BIOSCI TRENDS, V4, P318; Douangvichit Daovieng, 2012, BMC Res Notes, V5, P30, DOI 10.1186/1756-0500-5-30; Dzakpasu S, 2013, HLTH POLICY PLAN; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Manithip C, 2012, MIDWIFERY; Ministry of Health and Lao Statistics Bureau and and ICF International, 2012, LAO SOC IND STUD LSI; Penfold Suzanne, 2007, Ghana Med J, V41, P100; Periscopic, 2013, US GUN DEATH DAT VIS; Ridde V, 2011, HEALTH POLICY PLANN, V26, pII30, DOI 10.1093/heapol/czr060; Ridde V, 2011, HEALTH POLICY PLANN, V26, P1, DOI 10.1093/heapol/czq021; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Steinhardt LC, 2011, HEALTH POLICY PLANN, V26, pII92, DOI 10.1093/heapol/czr069; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; Thome JM, 2009, LAO PEOPLES DEMOCRAT, P71; Wilkinson D, 2001, B WORLD HEALTH ORGAN, V79, P665; Witter S, 2011, HEALTH POLICY PLANN, V26, pII84, DOI 10.1093/heapol/czr066; World Bank, 2013, MAT HLTH OUT OF POCK	27	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e89784	10.1371/journal.pone.0089784	http://dx.doi.org/10.1371/journal.pone.0089784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632592	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400008
J	Jung, HR; Song, KH; Chang, JT; Doh, J				Jung, Hong-Ryul; Song, Kwang Hoon; Chang, John T.; Doh, Junsang			Geometrically Controlled Asymmetric Division of CD4+T Cells Studied by Immunological Synapse Arrays	PLOS ONE			English	Article							T-LYMPHOCYTE DIVISION; DENDRITIC CELLS; EFFECTOR; DIFFERENTIATION; MEMORY; ACTIVATION; RESPONSES; SURFACES; FATE; RECOGNITION	Similar to stem cells, naive T cells undergo asymmetric division following activation. While asymmetric division of T cells has been shown to be an important mechanism for the generation of lymphocyte fate diversity during immune responses, key factors that influence whether T cells will undergo symmetric or asymmetric divisions are not completely understood. Here, we utilized immunological synapse arrays (ISAs) to begin to dissect mechanisms of asymmetric T lymphocyte division. ISAs are protein micropatterned surfaces composed of two segregated regions, activation sites and adhesion fields. Activation sites are small spots presenting activation signals such as anti-CD3 and anti-CD28, and adhesion fields are the remaining regions surrounding activation sites immobilized with interintercel adhesion molecule 1 (ICAM-1). By varying the size and the distance between the activation sites and measuring the incidence of asymmetric cell divisions, we found that the distance between activation sites is an important regulator of asymmetric division. Further analysis revealed that more symmetric divisions occurred when two nascent daughter cells stably interacted with two distinct activation sites throughout and following cytokinesis. In contrast, more asymmetric divisions occurred when only one daughter cell remained anchored on an activation site while the other daughter became motile and moved away following cytokinesis. Together, these results indicate that TCR signaling events during cytokinesis may repolarize key molecules for asymmetric partitioning, suggesting the possibility that the density of antigen presenting cells that interact with T cells as they undergo cytokinesis may be a critical factor regulating asymmetric division in T cells.	[Jung, Hong-Ryul; Doh, Junsang] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn I Bio, Pohang, South Korea; [Song, Kwang Hoon; Doh, Junsang] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, South Korea; [Chang, John T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of California System; University of California San Diego	Chang, JT (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	changj@ucsd.edu; jsdoh@postech.ac.kr	Song, Kwanghoon/Q-6934-2016	Song, Kwanghoon/0000-0001-8143-7148; jung, hong ryul/0000-0001-7969-5885	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A121177/HI12C1079]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095277] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008469] Funding Source: NIH RePORTER	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (JD, Grant No. A121177/HI12C1079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2012, CURR OPIN CELL BIOL, V24, P526, DOI 10.1016/j.ceb.2012.05.002; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Doh J, 2010, BIOMATERIALS, V31, P3422, DOI 10.1016/j.biomaterials.2010.01.018; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Irvine DJ, 2007, CURR OPIN IMMUNOL, V19, P463, DOI 10.1016/j.coi.2007.05.003; Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.smim.2007.02.011; Jung HR, 2012, WILEY INTERDISCIPLIN; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mukai A, 2008, J CELL SCI, V121, P1325, DOI 10.1242/jcs.027417; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	31	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91926	10.1371/journal.pone.0091926	http://dx.doi.org/10.1371/journal.pone.0091926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632942	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400121
J	Kornmeier, J; Worner, R; Riedel, A; Bach, M; van Elst, LT				Kornmeier, Juergen; Woerner, Rike; Riedel, Andreas; Bach, Michael; van Elst, Ludger Tebartz			A Different View on the Checkerboard? Alterations in Early and Late Visually Evoked EEG Potentials in Asperger Observers	PLOS ONE			English	Article							FUNCTIONING AUTISM; ATTENTION; QUOTIENT; P300; RECOGNITION; DISORDERS; CHILDREN; BRAIN	Background: Asperger Autism is a lifelong psychiatric condition with highly circumscribed interests and routines, problems in social cognition, verbal and nonverbal communication, and also perceptual abnormalities with sensory hypersensitivity. To objectify both lower-level visual and cognitive alterations we looked for differences in visual event-related potentials (EEG) between Asperger observers and matched controls while they observed simple checkerboard stimuli. Methods: In a balanced oddball paradigm checkerboards of two checksizes (0.6 degrees and 1.2 degrees) were presented with different frequencies. Participants counted the occurrence times of the rare fine or rare coarse checkerboards in different experimental conditions. We focused on early visual ERP differences as a function of checkerboard size and the classical P3b ERP component as an indicator of cognitive processing. Results: We found an early (100-200 ms after stimulus onset) occipital ERP effect of checkerboard size (dominant spatial frequency). This effect was weaker in the Asperger than in the control observers. Further a typical parietal/central oddball-P3b occurred at 500 ms with the rare checkerboards. The P3b showed a right-hemispheric lateralization, which was more prominent in Asperger than in control observers. Discussion: The difference in the early occipital ERP effect between the two groups may be a physiological marker of differences in the processing of small visual details in Asperger observers compared to normal controls. The stronger lateralization of the P3b in Asperger observers may indicate a stronger involvement of the right-hemispheric network of bottom-up attention. The lateralization of the P3b signal might be a compensatory consequence of the compromised early checksize effect. Higher-level analytical information processing units may need to compensate for difficulties in low-level signal analysis.	[Kornmeier, Juergen] Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany; [Kornmeier, Juergen; Bach, Michael] Univ Freiburg, Ctr Eye, D-79106 Freiburg, Germany; [Woerner, Rike] PPD Germany GmbH & Co Kg, Karlsruhe, Germany; [Riedel, Andreas; van Elst, Ludger Tebartz] Univ Freiburg, Sect Expt Neuropsychiat, Clin Psychiat & Psychotherapy, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Kornmeier, J (corresponding author), Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany.	juergen.kornmeier@uni-freiburg.de	Bach, Michael/A-6637-2010	Bach, Michael/0000-0003-2028-535X	Deutsche Forschungsgemeinschaft [KO 4764/1-1, TE 280/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (KO 4764/1-1 & TE 280/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1995, PSYCHOPHYSIOLOGY, V32, P467, DOI 10.1111/j.1469-8986.1995.tb02098.x; American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P107; Bach M, 1998, FUNCTIONAL IMAGING, P391; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Boeschoten MA, 2007, CLIN NEUROPHYSIOL, V118, P2076, DOI 10.1016/j.clinph.2007.05.004; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Edgington E.S., 2007, RANDOMIZATION TESTS; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; HOLM S, 1979, SCAND J STAT, V6, P65; Jackson BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066797; Jarbrink K, 2007, AUTISM, V11, P453, DOI 10.1177/1362361307079602; Jemel B, 2010, J VISION, V10, DOI 10.1167/10.6.13; Jeste SS, 2009, J AUTISM DEV DISORD, V39, P495, DOI 10.1007/s10803-008-0652-9; Kornmeier J, 2009, J VISION, V9, DOI 10.1167/9.1.7; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI [10.1203/PDR.0b013e3182130c54, 10.1109/SPL.2011.5782616]; McCleery JP, 2007, BIOL PSYCHIAT, V62, P1007, DOI 10.1016/j.biopsych.2007.02.009; Milne E, 2009, BIOL PSYCHIAT, V65, P22, DOI 10.1016/j.biopsych.2008.07.017; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; PARKER DM, 1977, PERCEPTION, V6, P85, DOI 10.1068/p060085; PLANT GT, 1983, ELECTROEN CLIN NEURO, V56, P147, DOI 10.1016/0013-4694(83)90069-X; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Preiser D, 2013, INVEST OPHTH VIS SCI, V54, P1182, DOI 10.1167/iovs.12-11201; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shalom DB, 2009, NEUROSCIENTIST, V15, P589, DOI 10.1177/1073858409336371; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Tebartz van Elst L, 2013, ASPERGER SYNDROM ERW, P412; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; van Elst LT, 2013, EUR ARCH PSY CLIN N, V263, pS189, DOI 10.1007/s00406-013-0459-3; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	42	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90993	10.1371/journal.pone.0090993	http://dx.doi.org/10.1371/journal.pone.0090993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632708	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400030
J	Limpens, J; Holmgren, M; Jacobs, CMJ; Van der Zee, SEATM; Karofeld, E; Berendse, F				Limpens, Juul; Holmgren, Milena; Jacobs, Cor M. J.; Van der Zee, Sjoerd E. A. T. M.; Karofeld, Edgar; Berendse, Frank			How Does Tree Density Affect Water Loss of Peatlands? A Mesocosm Experiment	PLOS ONE			English	Article							CARBON-DIOXIDE; SPHAGNUM MOSSES; VASCULAR PLANTS; CLIMATE-CHANGE; SCOTS PINE; BOREAL; EVAPOTRANSPIRATION; EVAPORATION; VEGETATION; TABLE	Raised bogs have accumulated more atmospheric carbon than any other terrestrial ecosystem on Earth. Climate-induced expansion of trees and shrubs may turn these ecosystems from net carbon sinks into sources when associated with reduced water tables. Increasing water loss through tree evapotranspiration could potentially deepen water tables, thus stimulating peat decomposition and carbon release. Bridging the gap between modelling and field studies, we conducted a three-year mesocosm experiment subjecting natural bog vegetation to three birch tree densities, and studied the changes in subsurface temperature, water balance components, leaf area index and vegetation composition. We found the deepest water table in mesocosms with low tree density. Mesocosms with high tree density remained wettest (i.e. highest water tables) whereas the control treatment without trees had intermediate water tables. These differences are attributed mostly to differences in evapotranspiration. Although our mesocosm results cannot be directly scaled up to ecosystem level, the systematic effect of tree density suggests that as bogs become colonized by trees, the effect of trees on ecosystem water loss changes with time, with tree transpiration effects of drying becoming increasingly offset by shading effects during the later phases of tree encroachment. These density-dependent effects of trees on water loss have important implications for the structure and functioning of peatbogs.	[Limpens, Juul; Berendse, Frank] Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Holmgren, Milena] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; Alterra, Climate Change & Adapt Land & Water Management, Wageningen, Netherlands; [Van der Zee, Sjoerd E. A. T. M.] Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands; [Karofeld, Edgar] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Limpens, J (corresponding author), Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6700 AP Wageningen, Netherlands.	Juul.Limpens@wur.nl	Karofeld, Edgar/H-3628-2018	Karofeld, Edgar/0000-0001-6533-8473; Jacobs, Cor/0000-0003-4079-9067	Dutch Forest Service; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Foundation for Conservation of Irish Bogs; European development Fund (Centre of Excellence FIBIR);  [SF0180025s12]	Dutch Forest Service; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Foundation for Conservation of Irish Bogs; European development Fund (Centre of Excellence FIBIR); 	Grants from the Dutch Forest Service, the Dutch Ministry of Economic Affairs, Agriculture and Innovation and the Foundation for Conservation of Irish Bogs made the research possible. From the Estonian side, the study was supported by the target-financed research project SF0180025s12 and by the European development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyea LR, 2006, ECOL MONOGR, V76, P299, DOI 10.1890/0012-9615(2006)076[0299:BTLTPB]2.0.CO;2; Berg EE, 2009, CAN J FOREST RES, V39, P2033, DOI 10.1139/X09-121; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bragg OM, 2002, SCI TOTAL ENVIRON, V294, P111, DOI 10.1016/S0048-9697(02)00059-1; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Breeuwer A, 2009, BASIC APPL ECOL, V10, P330, DOI 10.1016/j.baae.2008.05.005; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; de Bruin HAR, 1998, HYDROL PROCESS, V12, P1053, DOI 10.1002/(SICI)1099-1085(19980615)12:7&lt;1053::AID-HYP639&gt;3.0.CO;2-E; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Elbers, 2009, GEMETEN ACTUELE VERD; Eppinga MB, 2009, PLANT ECOL, V200, P53, DOI 10.1007/s11258-007-9309-6; Fay E, 2009, CANADA MIRES PEAT, V5, P1; Frankl R, 2000, FLORA, V195, P267; GOUDRIAAN J, 1977, P249; Gunnarsson U, 1998, WETLANDS, V18, P133, DOI 10.1007/BF03161450; Hamaker P, 2000, WATERVERBRUIK BOSSEN; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Heijmans MMPD, 2004, AGR FOREST METEOROL, V123, P135, DOI 10.1016/j.agrformet.2003.12.006; Heijmans MMPD, 2013, GLOBAL CHANGE BIOL, V19, P2240, DOI 10.1111/gcb.12202; Holmgren M, 2012, OECOLOGIA, V169, P293, DOI 10.1007/s00442-011-2196-5; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Humphreys ER, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000111; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; Juutinen S, 2010, ECOSYSTEMS, V13, P874, DOI 10.1007/s10021-010-9361-2; Kapfer J, 2011, J ECOL, V99, P1179, DOI 10.1111/j.1365-2745.2011.01847.x; Kellner E, 2001, AGR FOREST METEOROL, V110, P101, DOI 10.1016/S0168-1923(01)00283-0; Kettridge N, 2013, J GEOPHYS RES-BIOGEO, V118, P422, DOI 10.1002/jgrg.20043; Kramer P.J., 1983, WATER RELATIONS PLAN; LAFLEUR P, 1990, CAN GEOGR-GEOGR CAN, V34, P79, DOI 10.1111/j.1541-0064.1990.tb01072.x; Lafleur PM, 2005, HYDROL PROCESS, V19, P3533, DOI 10.1002/hyp.5842; Limpens J, 2004, ECOSYSTEMS, V7, P793, DOI 10.1007/s10021-004-0274-9; Limpens J, 2009, ROL BERK BIJ HERSTEL; Limpens J, 2014, FUNCT ECOL, V28, P283, DOI 10.1111/1365-2435.12148; Linderholm HW, 2004, WETLANDS, V24, P357, DOI 10.1672/0277-5212(2004)024[0357:AAOTCT]2.0.CO;2; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Ohlson M, 2001, OIKOS, V94, P425, DOI 10.1034/j.1600-0706.2001.940305.x; Pellerin S, 2000, CAN J BOT, V78, P255, DOI 10.1139/cjb-78-2-255; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Pouliot R, 2011, ACTA OECOL, V37, P346, DOI 10.1016/j.actao.2011.04.001; Price JS, 2009, J HYDROL, V369, P175, DOI 10.1016/j.jhydrol.2009.02.044; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Proctor MCF, 2000, NEW PHYTOL, V148, P1, DOI 10.1111/j.1469-8137.2000.00751.x; Robroek BJM, 2009, GLOBAL CHANGE BIOL, V15, P680, DOI 10.1111/j.1365-2486.2008.01724.x; Sarkkola S, 2010, CAN J FOREST RES, V40, P1485, DOI 10.1139/X10-084; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2005, GLOBAL CHANGE BIOL, V11, P1003, DOI 10.1111/j.1365-2486.2005.00962.x; Scheffer M, 2012, P NATL ACAD SCI USA, V109, P21384, DOI 10.1073/pnas.1219844110; Stewart RIA, 2013, ADV ECOL RES, V48, P71, DOI 10.1016/B978-0-12-417199-2.00002-1; Strakova P, 2012, GLOBAL CHANGE BIOL, V18, P322, DOI 10.1111/j.1365-2486.2011.02503.x; Strilesky SL, 2012, AGR FOREST METEOROL, V153, P45, DOI 10.1016/j.agrformet.2011.06.006; Thompson DK, 2012, THESIS MCMASTER U HA; Turunen J, 2002, HOLOCENE, V12, P69, DOI 10.1191/0959683602hl522rp; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Weltzin JF, 2001, OECOLOGIA, V128, P557, DOI 10.1007/s004420100691; Wiedermann MM, 2007, ECOLOGY, V88, P454, DOI 10.1890/05-1823	57	25	26	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91748	10.1371/journal.pone.0091748	http://dx.doi.org/10.1371/journal.pone.0091748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632565	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400086
J	Lodh, N; Naples, JM; Bosompem, KM; Quartey, J; Shiff, CJ				Lodh, Nilanjan; Naples, Jean M.; Bosompem, Kwabena M.; Quartey, Joseph; Shiff, Clive J.			Detection of Parasite-Specific DNA in Urine Sediment Obtained by Filtration Differentiates between Single and Mixed Infections of Schistosoma mansoni and S. haematobium from Endemic Areas in Ghana	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DIAGNOSTIC-TESTS; FILTERED URINE; FRAGMENTS; CHILDREN; ADULTS	Differential diagnosis of Schistosoma mansoni and S. haematobium, which often occur sympatrically in Africa, requires both urine and stool and the procedures are low in sensitivity. The standard diagnostic tests, such as Kato-Katz (KK) for S. mansoni eggs and presence of haematuria for S. haematobium both lack sensitivity, produce false-negative results and show reduced accuracy with decreasing intensity of infection. The need for a single diagnostic test with high sensitivity and specificity for both parasites is important as many African countries are implementing Mass Drug Administration (MDA) following recommendations of the World Health Organization (WHO). Eighty-six samples of urine sediment obtained by filtration were collected from a group of 5-23 years old people from an endemic area of southern Ghana. DNA was extracted from the urine sediment on filter paper from which a species-specific repeat fragment was amplified by polymerase chain reaction (PCR) with specific primers for S. mansoni and for S. haematobium. Additionally, all participants were tested by KK (stool) and dipstick for haematuria. Diagnostic parameters for all three tests were analyzed statistically. Amplification of species-specific DNA by PCR showed much higher sensitivity (99%-100%) and specificity (100%) compared to KK and haematuria (sensitivity: 76% and 30% respectively) for both schistosome species. The same pattern was observed when the data were stratified for age group and sex specific analysis. In addition PCR amplification detected DNA from 11 individuals infected with both parasites who were negative by KK and haematuria. This approach of detecting parasite specific DNA from either or both species in a single urine specimen is a practical advantage that avoids the need for two specimens and is more effective than standard tests including those based on serology. This promises to improve the effectiveness of surveillance of MDA control programs of schistosomiasis.	[Lodh, Nilanjan; Naples, Jean M.; Shiff, Clive J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Bosompem, Kwabena M.; Quartey, Joseph] NMIMR, Dept Parasitol, Legon, Accra, Ghana	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lodh, N (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	nlodh@jhsph.edu			Department of Molecular Microbiology and Immunology of Johns Hopkins School of Public Health allocation; Open Access Promotion Fund of the Johns Hopkins University Libraries	Department of Molecular Microbiology and Immunology of Johns Hopkins School of Public Health allocation; Open Access Promotion Fund of the Johns Hopkins University Libraries	Financial support for the molecular work was from the Department of Molecular Microbiology and Immunology of Johns Hopkins School of Public Health allocation. Specimen collection and parasitological examination, Kato-Katz and haematuria kits were provided by Noguchi Memorial Institute for Medical Research. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GLOBAL BURDEN DIS CO; Chen M, 1989, TROP DIS B, V84, P1; DEVLAS SJ, 1992, PARASITOL TODAY, V8, P274, DOI 10.1016/0169-4758(92)90144-Q; Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947; Gelfand M, 1967, CLIN STUDY INTESTINA; Hamburger J, 2001, AM J TROP MED HYG, V65, P907, DOI 10.4269/ajtmh.2001.65.907; HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R; Hamilton JV, 1998, PARASITOLOGY, V117, pS41; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Ibironke O, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001464; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; KNIGHT WB, 1976, AM J TROP MED HYG, V25, P818, DOI 10.4269/ajtmh.1976.25.818; Koukounari A, 2009, AM J TROP MED HYG, V80, P435, DOI 10.4269/ajtmh.2009.80.435; Krampe A, 2007, COMPUT STAT DATA AN, V51, P4124, DOI 10.1016/j.csda.2007.01.021; Lodh N, 2013, AM J TROP MED HYG, V89, P46, DOI 10.4269/ajtmh.13-0104; Mharakurwa S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-103; Navaratnam AMD, 2012, T ROY SOC TROP MED H, V106, P400, DOI 10.1016/j.trstmh.2012.03.013; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; SHIFF CJ, 1968, J PARASITOL, V54, P1133, DOI 10.2307/3276977; Shiff C, 2006, T ROY SOC TROP MED H, V100, P847, DOI 10.1016/j.trstmh.2005.10.010; Shiff C, 2010, T ROY SOC TROP MED H, V104, P3, DOI 10.1016/j.trstmh.2009.05.013; Terer CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002106; Zhong XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059089	25	35	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91144	10.1371/journal.pone.0091144	http://dx.doi.org/10.1371/journal.pone.0091144			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632992	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400041
J	Su, Q; Xie, W; Wang, SL; Wu, QJ; Ghanim, M; Zhang, YJ				Su, Qi; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Ghanim, Murad; Zhang, Youjun			Location of Symbionts in the Whitefly Bemisia tabaci Affects Their Densities during Host Development and Environmental Stress	PLOS ONE			English	Article							LEAF CURL VIRUS; SECONDARY SYMBIONTS; INFECTION DENSITY; CYTOPLASMIC INCOMPATIBILITY; EVOLUTIONARY RELATIONSHIPS; TRANSOVARIAL TRANSMISSION; BACTERIAL SYMBIONTS; WOLBACHIA; RICKETTSIA; VECTOR	Bacterial symbionts often enhance the physiological capabilities of their arthropod hosts and enable their hosts to expand into formerly unavailable niches, thus leading to biological diversification. Many arthropods, including the worldwide invasive whitefly Bemisia tabaci, have individuals simultaneously infected with symbionts of multiple genera that occur in different locations in the host. This study examined the population dynamics of symbionts that are located in different areas within B. tabaci. While densities of Portiera and Hamiltonella (which are located in bacteriocytes) appeared to be well-regulated during host development, densities of Rickettsia (which are not located in bacteriocytes) were highly variable among individual hosts during host development. Host mating did not significantly affect symbiont densities. Infection by Tomato yellow leaf curl virus did not affect Portiera and Hamiltonella densities in either sex, but increased Rickettsia densities in females. High and low temperatures did not affect Portiera and Hamiltonella densities, but low temperature (15 degrees C) significantly suppressed Rickettsia densities whereas high temperature (35 degrees C) had little effect on Rickettsia densities. The results are consistent with the view that the population dynamics of bacterial symbionts in B. tabaci are regulated by symbiont location within the host and that the regulation reflects adaptation between the bacteria and insect.	[Su, Qi] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Su, Qi; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China; [Ghanim, Murad] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China.	zhangyoujun@caas.cn	Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2013CB127602]; National Natural Science Foundation of China [31171857]; Beijing Natural Science Foundation [6131002]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2013CB127602), the National Natural Science Foundation of China (31171857), the Beijing Natural Science Foundation (6131002), and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbutsu H, 2008, APPL ENVIRON MICROB, V74, P6053, DOI 10.1128/AEM.01503-08; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Brumin M, 2012, APPL ENVIRON MICROB, V78, P5565, DOI 10.1128/AEM.01184-12; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Bution ML, 2008, MICRON, V39, P1179, DOI 10.1016/j.micron.2008.05.003; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Caspi-Fluger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021096; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; Darby AC, 2001, FEMS MICROBIOL ECOL, V36, P43, DOI 10.1111/j.1574-6941.2001.tb00824.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2007, ARTHROPOD-PLANT INTE, V1, P195, DOI 10.1007/s11829-007-9018-z; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Ikeda T, 2003, J INVERTEBR PATHOL, V84, P1, DOI 10.1016/S0022-2011(03)00106-X; Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Macaluso KR, 2008, VECTOR-BORNE ZOONOT, V8, P391, DOI 10.1089/vbz.2007.0218; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; McGraw EA, 2001, P ROY SOC B-BIOL SCI, V268, P2565, DOI 10.1098/rspb.2001.1839; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pan HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02230; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Sinisterra XH, 2005, J GEN VIROL, V86, P1525, DOI 10.1099/vir.0.80665-0; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Su Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089002; Su Q, 2013, ENVIRON ENTOMOL, V42, P1265, DOI 10.1603/EN13182; Su Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01367; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Zhang H, 2009, VIRUS GENES, V39, P249, DOI 10.1007/s11262-009-0384-8	61	16	16	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91802	10.1371/journal.pone.0091802	http://dx.doi.org/10.1371/journal.pone.0091802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632746	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400091
J	Goychuk, I; Kharchenko, VO; Metzler, R				Goychuk, Igor; Kharchenko, Vasyl O.; Metzler, Ralf			How Molecular Motors Work in the Crowded Environment of Living Cells: Coexistence and Efficiency of Normal and Anomalous Transport	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; DYNAMICS; MOTION; VISCOELASTICITY; SUBDIFFUSION; DIFFUSION; KINETICS	Recent experiments reveal both passive subdiffusion of various nanoparticles and anomalous active transport of such particles by molecular motors in the molecularly crowded environment of living biological cells. Passive and active microrheology reveals that the origin of this anomalous dynamics is due to the viscoelasticity of the intracellular fluid. How do molecular motors perform in such a highly viscous, dissipative environment? Can we explain the observed co-existence of the anomalous transport of relatively large particles of 100 to 500 nm in size by kinesin motors with the normal transport of smaller particles by the same molecular motors? What is the efficiency of molecular motors in the anomalous transport regime? Here we answer these seemingly conflicting questions and consistently explain experimental findings in a generalization of the well-known continuous diffusion model for molecular motors with two conformational states in which viscoelastic effects are included.	[Goychuk, Igor; Kharchenko, Vasyl O.; Metzler, Ralf] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Kharchenko, Vasyl O.] Natl Acad Sci Ukraine, Inst Appl Phys, Sumy, Ukraine; [Metzler, Ralf] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	University of Potsdam; National Academy of Sciences Ukraine; Institute of Applied Physics, National Academy of Sciences of Ukraine; Tampere University	Goychuk, I (corresponding author), Univ Potsdam, Inst Phys & Astron, Potsdam, Germany.	igoychuk@uni-potsdam.de	Kharchenko, Vasyl/X-5475-2019; Kharchenko, Vasyl O./E-9432-2014; Metzler, Ralf/J-9088-2013; Goychuk, Igor/A-7103-2008	Kharchenko, Vasyl/0000-0002-0148-6001; Kharchenko, Vasyl O./0000-0002-0148-6001; Metzler, Ralf/0000-0002-6013-7020; Goychuk, Igor/0000-0002-6818-9159	Deutsche Forschungsgemeinschaft(DFG) [GO 2052/1-1, GO 2052/1-2]; Finland Distinguished Professor program, Academy of Finland	Deutsche Forschungsgemeinschaft(DFG)(German Research Foundation (DFG)); Finland Distinguished Professor program, Academy of Finland	Grants GO 2052/1-1, GO 2052/1-2 (IG), Deutsche Forschungsgemeinschaft(DFG); Finland Distinguished Professor program (RM), Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblard F, 1996, PHYS REV LETT, V77, P4470, DOI 10.1103/PhysRevLett.77.4470; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Astumian RD, 1996, BIOPHYS J, V70, P637, DOI 10.1016/S0006-3495(96)79605-4; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Bruno L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018332; Caspi A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011916; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; Franosch T, 2011, NATURE, V478, P85, DOI 10.1038/nature10498; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Goychuk I, 2013, MATH MODEL NAT PHENO, V8, P144, DOI 10.1051/mmnp/20138210; Goychuk I, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051131; Goychuk I, 2012, ADV CHEM PHYS, V150, P187; Goychuk I, 2010, CHEM PHYS, V375, P450, DOI 10.1016/j.chemphys.2010.04.009; Goychuk I, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046125; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; Holyst R, 2009, PHYS CHEM CHEM PHYS, V11, P9025, DOI 10.1039/b908386c; Huang RX, 2011, NAT PHYS, V7, P576, DOI [10.1038/NPHYS1953, 10.1038/nphys1953]; Jeon JH, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/4/045011; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Jones AT, 2003, ADV DRUG DELIVER REV, V55, P1353, DOI 10.1016/j.addr.2003.07.002; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; JULICHER F, 1999, LECT NOTES PHYS, V532, P46; Kharchenko V, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043042; Kharchenko VO, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052119; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Makhnovskii YA, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021102; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mattsson J, 2009, NATURE, V462, P83, DOI 10.1038/nature08457; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Nelson P, 2004, BIOLOGICAL PHYSICS E; Odijk T, 2000, BIOPHYS J, V79, P2314, DOI 10.1016/S0006-3495(00)76477-0; PALMER RG, 1984, PHYS REV LETT, V53, P958, DOI 10.1103/PhysRevLett.53.958; Perez-Carrasco R, 2010, BIOPHYS J, V98, P2591, DOI 10.1016/j.bpj.2010.02.027; Perrin J, 1909, ANN CHIM PHYS, V18, P5; Qian H, 2000, BIOPHYS J, V79, P137, DOI 10.1016/S0006-3495(00)76278-3; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; Robert D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010046; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Sekimoto K, 1997, J PHYS SOC JPN, V66, P1234, DOI 10.1143/JPSJ.66.1234; Szymanski J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038102; Tabei SMA, 2013, P NATL ACAD SCI USA, V110, P4911, DOI 10.1073/pnas.1221962110; Taylor MA, 2013, NAT PHOTONICS, V7, P229, DOI [10.1038/NPHOTON.2012.346, 10.1038/nphoton.2012.346]; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; WYMAN J, 1975, P NATL ACAD SCI USA, V72, P3983, DOI 10.1073/pnas.72.10.3983; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7	54	67	68	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91700	10.1371/journal.pone.0091700	http://dx.doi.org/10.1371/journal.pone.0091700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626511	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300124
J	Adachi, I				Adachi, Ikuma			Spontaneous Spatial Mapping of Learned Sequence in Chimpanzees: Evidence for a SNARC-Like Effect	PLOS ONE			English	Article							MENTAL REPRESENTATION; WORKING-MEMORY; NUMBERS; SPACE	In the last couple of decades, there has been a growing number of reports on space-based representation of numbers and serial order in humans. In the present study, to explore evolutionary origins of such representations, we examined whether our closest evolutionary relatives, chimpanzees, map an acquired sequence onto space in a similar way to humans. The subjects had been trained to perform a number sequence task in which they touched a sequence of "small'' to "large'' Arabic numerals presented in random locations on the monitor. This task was presented in sessions that also included test trials consisting of only two numerals (1 and 9) horizontally arranged. On half of the trials 1 was located to the left of 9, whereas on the other half 1 was to the right to 9. The Chimpanzees' performance was systematically influenced by the spatial arrangement of the stimuli; specifically, they responded quicker when 1 was on the left and 9 on the right compared to the other way around. This result suggests that chimpanzees, like humans, spontaneously map a learned sequence onto space.	Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 484, Japan	Kyoto University	Adachi, I (corresponding author), Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 484, Japan.	ikuma.adachi@gmail.com		Adachi, Ikuma/0000-0003-2856-8792	 [24000001];  [23220006];  [25730093]; Grants-in-Aid for Scientific Research [23220006] Funding Source: KAKEN	; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by Grant-in-Aids for Specially Promoted Research: No. 24000001 (PI: Tetsuro Matsuzawa), for Scientific Research (S): No. 23220006 (PI: Masaki Tomonaga) and for Young Scientists (B): No. 25730093 (Ikuma Adachi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biro D, 2001, Anim Cogn, V4, P193, DOI 10.1007/s100710100086; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chen Q, 2010, COGNITIVE PSYCHOL, V60, P218, DOI 10.1016/j.cogpsych.2010.01.001; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Fias W., 2005, HDB MATH COGNITION, P43; Fias W, 2011, ATTENTION PERFORM, P133, DOI 10.1016/B978-0-12-385948-8.00010-4; Fischer MH, 2003, VIS COGN, V10, P493, DOI 10.1080/13506280244000186; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Inoue S, 2007, CURR BIOL, V17, pR1004, DOI 10.1016/j.cub.2007.10.027; Kawai N, 2000, NATURE, V403, P39, DOI 10.1038/47405; Maass A, 2003, PSYCHOL SCI, V14, P296, DOI 10.1111/1467-9280.14421; Matsuzawa T, 2003, ANIM COGN, V6, P199, DOI 10.1007/s10071-003-0199-2; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P3, DOI 10.1007/4-431-30248-4_1; Matsuzawa T, 2009, CURR OPIN NEUROBIOL, V19, P92, DOI 10.1016/j.conb.2009.04.007; Muller D, 2007, MEM COGNITION, V35, P1151, DOI 10.3758/BF03193485; Shaki S, 2008, COGNITION, V108, P590, DOI 10.1016/j.cognition.2008.04.001; Tomonaga M., 1993, PRIMATE RES, V9, P67; van Dijck JP, 2013, PSYCHOL SCI, V24, P1854, DOI 10.1177/0956797613479610; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013	24	51	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e90373	10.1371/journal.pone.0090373	http://dx.doi.org/10.1371/journal.pone.0090373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643044	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900006
J	Carter, A; Min, JE; Chau, W; Lima, VD; Kestler, M; Pick, N; Money, D; Montaner, JSG; Hogg, RS; Kaida, A				Carter, Allison; Min, Jeong Eun; Chau, William; Lima, Viviane D.; Kestler, Mary; Pick, Neora; Money, Deborah; Montaner, Julio S. G.; Hogg, Robert S.; Kaida, Angela			Gender Inequities in Quality of Care among HIV-Positive Individuals Initiating Antiretroviral Treatment in British Columbia, Canada (2000-2010)	PLOS ONE			English	Article							PHYSICIAN SPECIALIZATION; UPDATED RECOMMENDATIONS; HEALTH-CARE; INFECTION; THERAPY; ADHERENCE; BARRIERS; WOMEN; EXPERIENCE; MORTALITY	Objectives: We measured gender differences in "Quality of Care" (QOC) during the first year after initiation of antiretroviral therapy and investigated factors associated with poorer QOC among women. Design: QOC was estimated using the Programmatic Compliance Score (PCS), a validated metric associated with all-cause mortality, among all patients (>= 19 years) who initiated ART in British Columbia, Canada (2000-2010). Methods: PCS includes six indicators of non-compliance with treatment initiation guidelines at baseline (not having drug resistance testing before treatment; starting on a non-recommended regimen; starting therapy at CD4<200 cells/mm(3)) and during first-year follow-up (receiving <3 CD4 tests; receiving <3 viral load tests; not achieving viral suppression within six months). Summary scores range from 0-6; higher scores indicate poorer QOC. Multivariable ordinal logistic regression was used to measure if female gender was an independent predictor of poorer QOC and factors associated with poorer QOC among women. Results: QOC was determined for 3,642 patients (20% women). At baseline: 42% of women (34% men) did not have resistance testing before treatment; 17% of women (9% men) started on a non-recommended regimen (all p < 0.001). At follow-up: 17% of women (11% men) received <3 CD4; 17% of women (11% men) received <3 VL; 50% of women (41% men) did not achieve viral suppression (all p < 0.001). Overall, QOC was better among men (mean PSC = 1.54 (SD = 1.30)) compared with women (mean = 1.89 (SD = 1.37); p < 0.001). In the multivariable model, female gender (AOR = 1.16 [95% CI: 0.99-1.35]; p = 0.062) remained associated with poorer QOC after covariate adjustment. Among women, those with injection drug use history, of Aboriginal ancestry, from Vancouver Island, and who initiated ART in earlier years were more likely to have poorer QOC. Conclusions: Poorer QOC among women, especially from marginalized communities, demands that barriers undermining women's access to high-quality care be addressed to improve treatment and health for women with HIV.	[Carter, Allison; Hogg, Robert S.; Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Carter, Allison; Min, Jeong Eun; Chau, William; Lima, Viviane D.; Montaner, Julio S. G.; Hogg, Robert S.; Kaida, Angela] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Kestler, Mary; Pick, Neora] BC Womens Hosp & Hlth Ctr, Oak Tree Clin, Vancouver, BC, Canada; [Money, Deborah] BC Womens Hosp & Hlth Ctr, Womens Hlth Res Inst, Vancouver, BC, Canada; [Money, Deborah] Univ British Columbia, Fac Med, Dept Obstet & Gynecol, Vancouver, BC, Canada; [Kestler, Mary; Pick, Neora; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia	Kaida, A (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	kangela@sfu.ca		Hogg, Robert/0000-0003-3463-5488; Carter, Allison/0000-0003-2151-2622	BC Ministry of Health (PharmaCare)	BC Ministry of Health (PharmaCare)	The Drug Treatment Program is funded by the BC Ministry of Health (PharmaCare). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad M, 2012, ANTIVIR THER, V18, P27; [Anonymous], HIV AIDS EP UPD; Backus LI, 2010, ARCH INTERN MED, V170, P1239, DOI 10.1001/archinternmed.2010.234; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; Benoit C, 2007, GENDERING POPULATION; British Columbia Centre for Excellence in HIV/AIDS, 2011, BC HIV AIDS THERAPEU; Burdge DR, 2003, CAN MED ASSOC J, V168, P1671; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carter AJ, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17433; Cescon AM, 2011, HIV MED, V12, P352, DOI 10.1111/j.1468-1293.2010.00890.x; Csete J, 2005, VECTORS VESSELS VICT; CUNNINGHAM WE, 1995, MED CARE, V33, P739, DOI 10.1097/00005650-199507000-00009; Gahagan J, 2001, CANADIAN WOMAN STUDI, V21, P118; Gallant JE, 2002, J CLIN VIROL, V25, P317, DOI 10.1016/S1386-6532(02)00024-0; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hirschhorn LR, 2006, WOMEN HEALTH ISS, V16, P104, DOI 10.1016/j.whi.2006.02.004; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kellington S, 1999, LISTEN WOMEN ARE TAL; Kerr C. A., 2012, AM J MED QUAL, DOI 1062860611425714; Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106; Korthuis PT, 2011, JAIDS-J ACQ IMM DEF, V56, pS83, DOI 10.1097/QAI.0b013e31820bc9a5; Landon BE, 2005, ARCH INTERN MED, V165, P1133, DOI 10.1001/archinte.165.10.1133; Landon BE, 2003, J GEN INTERN MED, V18, P233, DOI 10.1046/j.1525-1497.2003.20705.x; Lichtenstein B, 2006, AIDS PATIENT CARE ST, V20, P122, DOI 10.1089/apc.2006.20.122; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Lima VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047859; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McNeil D., 2011, NEW YORK TIMES; Moneyham L, 2010, J ASSOC NURSE AIDS C, V21, P467, DOI 10.1016/j.jana.2010.03.003; Moore AL, 2003, JAIDS-J ACQ IMM DEF, V32, P452, DOI 10.1097/00126334-200304010-00017; Moore AL, 2002, J ACQ IMMUN DEF SYND, V29, P197, DOI 10.1097/00042560-200202010-00015; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Nicastri E, 2007, J ANTIMICROB CHEMOTH, V60, P724, DOI 10.1093/jac/dkm302; Nichols F H, 2000, J Obstet Gynecol Neonatal Nurs, V29, P56, DOI 10.1111/j.1552-6909.2000.tb02756.x; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; Puskas CM, 2011, CURRENT HIV AIDS REP, P1; Quinn E, 2010, LEADERSHIP ENGAGEMEN; Sargeant Sheena, 2008, BARRIERS ACCESS PRIM; Schuster MA, 2000, AM J PUBLIC HEALTH, V90, P1074, DOI 10.2105/AJPH.90.7.1074; Sherr KH, 2010, AIDS, V24, pS59, DOI 10.1097/01.aids.0000366083.75945.07; Sowell RL, 1996, NURS CONNECT, V9, P5; Stein MD, 2000, AM J PUBLIC HEALTH, V90, P1138, DOI 10.2105/AJPH.90.7.1138; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; Tapp C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-86; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Turner BJ, 2003, J GEN INTERN MED, V18, P248, DOI 10.1046/j.1525-1497.2003.20122.x; Umeh OC, 2006, SEX DIFFERENCES PHAR; UNAIDS, 2010, ANN 1 HIV AIDS EST D; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; Wood E, 2003, J INFECT DIS, V188, P1164, DOI 10.1086/378703; Wuest Judith, 2002, Health Care Women Int, V23, P794, DOI 10.1080/07399330290112326; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	56	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92334	10.1371/journal.pone.0092334	http://dx.doi.org/10.1371/journal.pone.0092334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642949	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900122
J	Lui, G; Wong, RYK; Li, F; Lee, MKP; Lai, RWM; Li, TCM; Kam, JKM; Lee, N				Lui, Grace; Wong, Rity Y. K.; Li, Florence; Lee, May K. P.; Lai, Raymond W. M.; Li, Timothy C. M.; Kam, Joseph K. M.; Lee, Nelson			High Mortality in Adults Hospitalized for Active Tuberculosis in a Low HIV Prevalence Setting	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; DIAGNOSIS; DELAY; DEATH; IMPACT; CITY; TRANSMISSION; PREDICTORS; INPATIENTS	Background: This study aims to evaluate the outcomes of adults hospitalized for tuberculosis in a higher-income region with low HIV prevalence. Methods: A retrospective cohort study was conducted on all adults hospitalized for pulmonary and/or extrapulmonary tuberculosis in an acute-care hospital in Hong Kong during a two-year period. Microscopy and solid-medium culture were routinely performed. The diagnosis of tuberculosis was made by: (1) positive culture of M. tuberculosis, (2) positive M. tuberculosis PCR result, (3) histology findings of tuberculosis infection, and/or (4) typical clinico-radiological manifestations of tuberculosis which resolved after anti-TB treatment, in the absence of alternative diagnoses. Time to treatment ('early', started during initial admission; 'late', subsequent periods), reasons for delay, and short-and long-term survival were analyzed. Results: Altogether 349 patients were studied [median(IQR) age 62(48-77) years; non-HIV immunocompromised conditions 36.7%; HIV/AIDS 2.0%]. 57.9%, 16.3%, and 25.8% had pulmonary, extrapulmonary, and pulmonary-extrapulmonary tuberculosis respectively. 58.2% was smear-negative; 0.6% multidrug-resistant. 43.4% developed hypoxemia. Crude 90-day and 1-year all-cause mortality was 13.8% and 24.1% respectively. 57.6% and 35.8% received 'early' and 'late' treatment respectively, latter mostly culture-guided [median(IQR) intervals, 5(3-9) vs. 43(25-61) days]. Diagnosis was unknown before death in 6.6%. Smear-negativity, malignancy, chronic lung diseases, and prior exposure to fluoroquinolones (adjusted-OR 10.6, 95% CI 1.3-85.2) delayed diagnosis of tuberculosis. Failure to receive 'early' treatment independently predicted higher mortality (Cox-model, adjusted-HR 1.8, 95% CI 1.1-3.0). Conclusions: Mortality of hospitalized tuberculosis patients is high. Newer approaches incorporating methods for rapid diagnosis and initiation of anti-tuberculous treatment are urgently required to improve outcomes.	[Lui, Grace; Wong, Rity Y. K.; Li, Timothy C. M.; Lee, Nelson] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Li, Florence] Univ Sheffield, Fac Med, Sheffield, S Yorkshire, England; [Lee, May K. P.; Lai, Raymond W. M.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Kam, Joseph K. M.; Lee, Nelson] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; University of Sheffield; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong	Lee, N (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Infect Dis, Hong Kong, Hong Kong, Peoples R China.	leelsn@cuhk.edu.hk	Lee, Nelson/B-6418-2008; KAM, Kai Man/K-4546-2012; Lui, Chung Yan Grace/N-5178-2016; Lui, Grace/N-4498-2019; Hahn, Horst/G-9018-2011	Lee, Nelson/0000-0002-0783-6607; KAM, Kai Man/0000-0003-0579-0307; Lui, Chung Yan Grace/0000-0001-5242-2967; Hahn, Horst/0000-0001-9901-3861				Chen TC, 2011, INT J INFECT DIS, V15, pE211, DOI 10.1016/j.ijid.2010.11.008; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P705; Erhabor G E, 2006, Indian J Chest Dis Allied Sci, V48, P253; Farah MG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-33; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023715; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; Greenaway C, 2002, AM J RESP CRIT CARE, V165, P927, DOI 10.1164/ajrccm.165.7.2107040; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Harris TG, 2013, AM J INFECT CONTROL, V41, P155, DOI 10.1016/j.ajic.2012.02.015; Hui Z, 2012, BIOMED ENVIRON SCI, V25, P483, DOI 10.3967/0895-3988.2012.04.015; Jeon CY, 2011, INT J TUBERC LUNG D, V15, P77; Kim HJ, 2010, INT J TUBERC LUNG D, V14, P79; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lin CY, 2010, J FORMOS MED ASSOC, V109, P269, DOI 10.1016/S0929-6646(10)60052-6; Liu YC, 2010, INT J TUBERC LUNG D, V14, P72; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Malbasa Milica, 2011, Pneumologia, V60, P138; Marks SM, 2011, INT J TUBERC LUNG D, V15, P465, DOI 10.5588/ijtld.10.0259; MATHUR P, 1994, ARCH INTERN MED, V154, P306, DOI 10.1001/archinte.154.3.306; Porskrog A, 2011, INT J TUBERC LUNG D, V15, P459, DOI 10.5588/ijtld.10.0353; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Rao VK, 1999, ANN INTERN MED, V130, P404, DOI 10.7326/0003-4819-130-5-199903020-00004; Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129; Shen GH, 2012, INT J ANTIMICROB AG, V39, P201, DOI 10.1016/j.ijantimicag.2011.11.014; Shu CC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-46; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Surveillance Team Special Preventive Programme Centre for Health Protection, 2011, HIV SURV REP 2010 UP; Perrechi MCT, 2011, J BRAS PNEUMOL, V37, P783, DOI 10.1590/S1806-37132011000600012; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Tuberculosis and Chest Service Department of Health Hong Kong SAR Government, 2009, ANN REP 2009; van der Heijden YF, 2012, INT J TUBERC LUNG D, V16, P1162, DOI 10.5588/ijtld.12.0046; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; World Health Organization (WHO), 2011, WHO REP GLOB TUB CON; Yen YF, 2012, T ROY SOC TROP MED H, V106, P303, DOI 10.1016/j.trstmh.2012.01.011; Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849	37	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92077	10.1371/journal.pone.0092077	http://dx.doi.org/10.1371/journal.pone.0092077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642794	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900078
J	Ostermann, J; Njau, B; Brown, DS; Muhlbacher, A; Thielman, N				Ostermann, Jan; Njau, Bernard; Brown, Derek S.; Muehlbacher, Axel; Thielman, Nathan			Heterogeneous HIV Testing Preferences in an Urban Setting in Tanzania: Results from a Discrete Choice Experiment	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CONJOINT-ANALYSIS; RANDOMIZED-TRIAL; VOLUNTARY; ACCEPTABILITY; MOSHI; PREVENTION; CLIENTS; RISK; CARE	Background: Efforts to reduce Human Immunodeficiency Virus (HIV) transmission through treatment rely on HIV testing programs that are acceptable to broad populations. Yet, testing preferences among diverse at-risk populations in Sub-Saharan Africa are poorly understood. We fielded a population-based discrete choice experiment (DCE) to evaluate factors that influence HIV-testing preferences in a low-resource setting. Methods: Using formative work, a pilot study, and pretesting, we developed a DCE survey with five attributes: distance to testing, confidentiality, testing days (weekday vs. weekend), method for obtaining the sample for testing (blood from finger or arm, oral swab), and availability of HIV medications at the testing site. Cluster-randomization and Expanded Programme on Immunization (EPI) sampling methodology were used to enroll 486 community members, ages 18-49, in an urban setting in Northern Tanzania. Interviewer-assisted DCEs, presented to participants on iPads, were administered between September 2012 and February 2013. Results: Nearly three of five males (58%) and 85% of females had previously tested for HIV; 20% of males and 37% of females had tested within the past year. In gender-specific mixed logit analyses, distance to testing was the most important attribute to respondents, followed by confidentiality and the method for obtaining the sample for the HIV test. Both unconditional assessments of preferences for each attribute and mixed logit analyses of DCE choice patterns suggest significant preference heterogeneity among participants. Preferences differed between males and females, between those who had previously tested for HIV and those who had never tested, and between those who tested in the past year and those who tested more than a year ago. Conclusion: The findings suggest potentially significant benefits from tailoring HIV testing interventions to match the preferences of specific populations, including males and females and those who have never tested for HIV.	[Ostermann, Jan; Thielman, Nathan] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Ostermann, Jan; Brown, Derek S.; Muehlbacher, Axel] Duke Univ, Ctr Hlth Policy & Inequal Res, Durham, NC USA; [Njau, Bernard] Kilimanjaro Christian Med Coll, Dept Community Hlth, Moshi, Tanzania; [Brown, Derek S.] Washington Univ, Brown Sch, St Louis, MO USA; [Muehlbacher, Axel] Hsch Neubrandenburg, Stiftungsinst Gesundheitsokon & Med Management, Neubrandenburg, Germany; [Thielman, Nathan] Duke Univ, Sch Med, Durham, NC USA	Duke University; Duke University; Washington University (WUSTL); Duke University	Thielman, N (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	n.thielman@duke.edu	Brown, Derek S/J-3035-2013; Ostermann, Jan/GQB-4743-2022; Njau, Bernard/AAI-2152-2020; Thielman, Nathan/R-5142-2019; Mühlbacher, Axel/AAZ-6577-2020	Brown, Derek S/0000-0001-9908-9882; Thielman, Nathan/0000-0001-8152-2879; Mühlbacher, Axel/0000-0003-4402-9211; Ostermann, Jan/0000-0002-8236-9500	National Institute of Mental Health (NIMH) [R21 MH096631]; Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH) [5P30 AI064518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH096631] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This publication was made possible by Grant Number R21 MH096631 from the National Institute of Mental Health (NIMH), and supported by the Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program (5P30 AI064518). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIMH or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; [Anonymous], 2012, NGEN VERS 1 1 1; Baggaley R, 2012, B WORLD HEALTH ORGAN, V90, P652, DOI 10.2471/BLT.11.100818; Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Bond VA, 2010, AIDS CARE, V22, P6, DOI 10.1080/09540121003720994; Bridges J, CONJOINT ANAL HLTH S; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Brown DS, 2010, VACCINE, V28, P1702, DOI 10.1016/j.vaccine.2009.12.024; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Champ P.A., 2006, VALUING ENV AMENITIE; Cherutich P, 2013, CURR HIV-AIDS REP, V10, P134, DOI 10.1007/s11904-013-0158-8; Chu HY, 2005, INT J STD AIDS, V16, P691, DOI 10.1258/095646205774357307; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Cremin I, 2012, TROP MED INT HEALTH, V17, pe26, DOI 10.1111/j.1365-3156.2011.02937.x; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fiorillo SP, 2012, AIDS CARE, V24, P1264, DOI 10.1080/09540121.2012.658751; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Fylkesnes K, 1999, AIDS, V13, P2469, DOI 10.1097/00002030-199912030-00019; Glick P, 2005, EVALUATION REV, V29, P331, DOI 10.1177/0193841X05276437; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hole AR, 2007, STATA J, V7, P388, DOI 10.1177/1536867X0700700306; Houdmont J, 2013, AIDS CARE; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Jurgensen M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-2; Keeffe JE, 1996, B WORLD HEALTH ORGAN, V74, P525; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Knox SA, 2013, SOCIAL SCI MED; Kyaddondo D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-966; Landman Keren Z, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P24, DOI 10.1177/1545109706298479; Landman KZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003075; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Marshall DA, 2009, HEALTH ECON, V18, P1420, DOI 10.1002/hec.1437; Muhlbacher AC, 2008, PSYCHOSOC MED, V5; National Bureau of Statistics, 2011, TANZ DEM HLTH SURV 2; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Njau B, 2012, AIDS CARE, V24, P413, DOI 10.1080/09540121.2011.608796; Njeru MK, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-243; Ole-Nguyaine S, 2004, ANN TROP MED PARASIT, V98, P171, DOI 10.1179/000349804225003163; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Phillips KA, 2002, HEALTH SERV RES, V37, P1681, DOI 10.1111/1475-6773.01115; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Prabhu M, 2011, INT J GYNECOL OBSTET, V113, P63, DOI 10.1016/j.ijgo.2010.10.019; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Sadique MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054149; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Shorter MM, 2009, JAIDS-J ACQ IMM DEF, V52, P648, DOI 10.1097/QAI.0b013e3181b31a6a; StataCorp, 2011, STAT STAT SOFTW REL, P173; TACAIDS, 2013, HIV AIDS MAL IND SUR; Thielman NM, 2006, AM J PUBLIC HEALTH, V96, P114, DOI 10.2105/AJPH.2004.056796; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; Tribble AC, 2009, INT J TUBERC LUNG D, V13, P1260; Walensky RP, 2010, J ACQUIR IMMUNE DEFI; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Waters RC, 2011, JAIDS-J ACQ IMM DEF, V56, P443, DOI 10.1097/QAI.0b013e3182118f8c; WHO, 2008, MOD 7 EPI COV SURV T	62	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92100	10.1371/journal.pone.0092100	http://dx.doi.org/10.1371/journal.pone.0092100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24643047	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900085
J	Takemura, K; Uchida, Y; Yoshikawa, S				Takemura, Kosuke; Uchida, Yukiko; Yoshikawa, Sakiko			Roles of Extension Officers to Promote Social Capital in Japanese Agricultural Communities	PLOS ONE			English	Article								Social capital has been found to be correlated with community welfare, but it is not easy to build and maintain it. The purpose of the current study is to investigate the role of professional coordinators of social relationships to create and maintain social capital in a community. We focused on extension officers in Japanese agricultural communities, who help farmers in both technical and social matters. A large nation-wide survey of extension officers as well as two supplementary surveys were conducted. We found that (1) social capital-related activities (e. g., assistance for building organizations among farmers) were particularly effective for solving problems; (2) social capital (trust relationships) among community residents increased their life quality; (3) social capital in local communities was correlated with extension officers' own communication skills and harmonious relationships among their colleagues. In sum, social capital in local communities is maintained by coordinators with professional social skills.	[Takemura, Kosuke] Kyoto Univ, Grad Sch Management, Kyoto, Japan; [Uchida, Yukiko; Yoshikawa, Sakiko] Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan	Kyoto University; Kyoto University	Takemura, K (corresponding author), Kyoto Univ, Grad Sch Management, Kyoto, Japan.	boz.takemura@gmail.com		Uchida, Yukiko/0000-0002-8336-2423	Kokoro Research Center at Kyoto University, Japan [08-1-01, 10-1-07]; Japan Agricultural Development and Extension Personnel Association	Kokoro Research Center at Kyoto University, Japan; Japan Agricultural Development and Extension Personnel Association	This work was supported by grants from the Kokoro Research Center at Kyoto University, Japan (Project Number: 08-1-01, 10-1-07); and the Japan Agricultural Development and Extension Personnel Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson E., 1972, SOCIAL ANIMAL; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Coleman JS, 1990, FDN SOCIAL THEORY, P175; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fukuda K, 2007, J RURAL COMMUNITY ST, V105, P25; Fukuda K, 2003, J RURAL COMMUNITY ST, V97, P82; Fukushima S., 2012, Journal of Rural Planning, V31, P84, DOI 10.2750/arp.31.84; Fukushima S, 2012, ENV INF SCI, V40, P31; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Gyawali BR, 2010, J AGR EXT RURAL DEV, V2, P167; Harada H, 2011, JPN J EXP SOC PSYCHO, V50, P168; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Japan Agricultural Development and Extension Association, 1992, SUSU JIK KENSH SHOK; Matsushita K., 2007, Journal of Rural Economics, V79, P482; Ministry of Agriculture Forestry and Fisheries Japan, 2010, GUID MAN AGR EXT SER; Ministry of Agriculture Forestry and Fisheries Japan, WHAT IS EXT SERV; Ministry of Agriculture Forestry and Fisheries Japan, 2012, GUID MAN AGR EXT SER; Mulder LB, 2006, J EXP SOC PSYCHOL, V42, P147, DOI 10.1016/j.jesp.2005.03.002; Nonaka I, 1998, CALIF MANAGE REV, V40, P40, DOI 10.2307/41165942; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Putnam RD., 2000, BOWLING ALONE COLLAP; Puurtinen M, 2009, P ROY SOC B-BIOL SCI, V276, P355, DOI 10.1098/rspb.2008.1060; Research Group of Specialists in Extension Activities of Kinki, 2009, RES TRA METH JUN EXT; S. Fukushima, 2009, PAP ENV INF SCI, V23, P269; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Svendsen GLH, 2004, CREATING DESTURCTION; Tsutsui T, 2005, RES REP HLTH LAB SCI; Uchida Y, 2011, SOCIOTECHNICA, V8, P194; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Uskul AK, 2008, P NATL ACAD SCI USA, V105, P8552, DOI 10.1073/pnas.0803874105; Wilkinson RG, 1999, ANN NY ACAD SCI, V896, P48, DOI 10.1111/j.1749-6632.1999.tb08104.x; Wilson DS, 2009, EVOL HUM BEHAV, V30, P190, DOI 10.1016/j.evolhumbehav.2008.12.002; Yamabata N., 2010, J RURAL PLANNING ASS, V28, P273, DOI DOI 10.2750/ARP.28.273; Yamagishi T, 2011, SCI MIND, P1, DOI 10.1007/978-4-431-53936-0; Yamaguchi S., 2007, J RURAL PLAN ASS, V26, P287, DOI [10.2750/arp.26.287, DOI 10.2750/ARP.26.287]; Zakaria S, 2010, LIBR MANAGE, V31, P27, DOI 10.1108/01435121011013377	41	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91975	10.1371/journal.pone.0091975	http://dx.doi.org/10.1371/journal.pone.0091975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642575	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900053
J	Marcus, JL; Glidden, DV; McMahan, V; Lama, JR; Mayer, KH; Liu, AY; Montoya-Herrera, O; Casapia, M; Hoagland, B; Grant, RM				Marcus, Julia L.; Glidden, David V.; McMahan, Vanessa; Lama, Javier R.; Mayer, Kenneth H.; Liu, Albert Y.; Montoya-Herrera, Orlando; Casapia, Martin; Hoagland, Brenda; Grant, Robert M.			Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men	PLOS ONE			English	Article							HIGH-RISK; HIV; INFECTION; PREVALENCE; TENOFOVIR; WOMEN; ACQUISITION; ACYCLOVIR	Background: In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the effect of daily oral emtricitabine/tenofovir (FTC/TDF) PrEP on HSV-2 seroincidence and ulcer occurrence among men who have sex with men (MSM) in the iPrEx trial. Methods: HSV-2 serum testing was performed at screening and every six months. Among HSV-2-seronegative individuals, we used Cox regression models to estimate hazard ratios (HRs) of HSV-2 seroincidence associated with randomization to FTC/TDF. We used multiple imputation and Cox regression to estimate HRs for HSV-2 seroincidence accounting for drug exposure. We assessed ulcer occurrence among participants with prevalent or incident HSV-2 infection. Results: Of the 2,499 participants, 1383 (55.3%) tested HSV-2-seronegative at baseline, 892 (35.7%) tested positive, 223 (8.9%) had indeterminate tests, and one test was not done. Of the 1,347 HSV-2-seronegative participants with follow-up, 125 (9.3%) had incident HSV-2 infection (5.9 per 100 person-years). Compared with participants receiving placebo, there was no difference in HSV-2 seroincidence among participants receiving FTC/TDF (HR 1.1, 95% CI: 0.8-1.5; P = 0.64) or among participants receiving FTC/TDF with a concentration of tenofovir diphosphate >16 per million viable cells (HR 1.0, 95% CI: 0.3-3.5; P = 0.95). Among participants with HSV-2 infection, the proportion with >= 1 moderate or severe ulcer adverse event was twice as high in the placebo vs. active arm (5.9% vs. 2.9%, P = 0.02), but there were no differences in the proportions with >= 1 clinical examination during which perianal or groin ulcers were identified. Conclusions: Tenofovir in daily oral FTC/TDF PrEP may reduce the occurrence of ulcers in individuals with HSV-2 infection but does not protect against HSV-2 incidence among MSM.	[Marcus, Julia L.; McMahan, Vanessa; Grant, Robert M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Marcus, Julia L.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Glidden, David V.; Grant, Robert M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lama, Javier R.] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Liu, Albert Y.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Montoya-Herrera, Orlando] Fdn Ecuatoriana Equidad, Guayaquil, Guayas, Ecuador; [Casapia, Martin] Asociac Civil Selva Amazon, Iquitos, Peru; [Hoagland, Brenda] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; San Francisco Department of Public Health; Fundacao Oswaldo Cruz	Grant, RM (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	robert.grant@ucsf.edu	Glidden, David/AAD-4730-2020	Casapia Morales, Wilfredo Martin/0000-0002-5972-0948; Glidden, David/0000-0001-5888-1419; Grant, Robert/0000-0002-0851-7085	Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health [UO1 AI64002]; Bill and Melinda Gates Foundation; Gladstone Institutes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI064002, P30AI027763] Funding Source: NIH RePORTER	Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, as a cooperative agreement (UO1 AI64002, to Dr. Grant), by the Bill and Melinda Gates Foundation, and by the Gladstone Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; Boily MC, 2011, 18 C RETR OPP INF BO; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2013, 20 C RETR OPP INF AT; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Golden MR, 2005, SEX TRANSM DIS, V32, P771, DOI 10.1097/01.olq.0000175377.88358.f3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Hendrix CW, 2012, CURR OPIN HIV AIDS, V7, P498, DOI 10.1097/COH.0b013e32835847ae; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; LeGoff J, 2008, J CLIN MICROBIOL, V46, P1914, DOI 10.1128/JCM.02332-07; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lupi O, 2011, INT J DERMATOL, V50, P709, DOI 10.1111/j.1365-4632.2010.04863.x; Okuku HS, 2011, SEX TRANSM DIS, V38, P837, DOI 10.1097/OLQ.0b013e31821a6225; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Paz-Bailey G, 2007, SEX TRANSM INFECT, V83, P16, DOI 10.1136/sti.2006.020966; Rubin DB, 2004, MULTIPLE IMPUTATION; Tan DHS, 2012, INT J WOMENS HEALTH, V4, P341, DOI 10.2147/IJWH.S27601; Tan DHS, 2011, AIDS, V25, P207, DOI 10.1097/QAD.0b013e328341ddf7; van de Laar MJW, 1998, INT J EPIDEMIOL, V27, P127, DOI 10.1093/ije/27.1.127; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456	26	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91513	10.1371/journal.pone.0091513	http://dx.doi.org/10.1371/journal.pone.0091513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637511	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100039
J	Ramadas, P; Rajendran, PP; Krishnan, P; Alex, A; Siskind, E; Kadiyala, A; Jayaschandran, V; Basu, A; Bhaskaran, M; Molmenti, EP				Ramadas, Poornima; Rajendran, Prejith P.; Krishnan, Prathik; Alex, Asha; Siskind, Eric; Kadiyala, Aditya; Jayaschandran, Vivek; Basu, Amit; Bhaskaran, Madhu; Molmenti, Ernesto P.			Extended-Spectrum-Beta-Lactamase Producing Bacteria Related Urinary Tract Infection in Renal Transplant Recipients and Effect on Allograft Function	PLOS ONE			English	Article							ESCHERICHIA-COLI; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; KIDNEY-TRANSPLANTATION; UNITED-STATES; PREVALENCE; ENTEROBACTERIACEAE; SUSCEPTIBILITY; COMPLICATIONS; EPIDEMIOLOGY	Background: Urinary tract infection (UTI) is a well-recognized early complication in renal transplant recipients (RTR) and can have significant bearing on their outcome. The recent rise in incidence of extended spectrum beta lactamase (ESBL) producing bacteria causing UTI among RTR poses new and significant challenges in terms of management and outcome. Our aim is to analyze the effect of ESBL producing bacteria causing UTI in these patients and its impact on allograft function. Methods: We reviewed the medical records of 147 RTR who were followed at a tertiary care hospital affiliated transplant center between January 2007 and May 2013 and noted five RTR who developed episodes of ESBL producing bacteria related UTI during follow up. Multiple patient characteristics including demographics, immunosuppression, recurrences, allograft function and outcome were analyzed. Results: Five patients (3.4%) out of 147 had ESBL producing bacteria related UTI. We found all patients to be above 60 years of age, with three out of five being females, and all five patients had diabetes mellitus. We identified a total of 37 episodes of UTI among these five patients during this period. Two of these patients had elevated creatinine values during the episodes of UTI and three of them developed bacteremia. Of the five patients, four of them had a favorable outcome except for one patient who developed persistent allograft dysfunction. Conclusion: RTR are at a higher risk for developing ESBL producing bacteria associated UTI. Early diagnosis along with appropriate and judicious use of antibiotics will ensure long term success in allograft and patient outcome.	[Ramadas, Poornima; Rajendran, Prejith P.; Krishnan, Prathik; Alex, Asha; Jayaschandran, Vivek; Basu, Amit; Bhaskaran, Madhu; Molmenti, Ernesto P.] N Shore Univ Hosp, Transplant Program, Manhasset, NY 11030 USA; [Siskind, Eric] N Shore Univ Hosp, Dept Surg, Manhasset, NY USA; [Kadiyala, Aditya] N Shore Univ Hosp, Dept Nephrol, Manhasset, NY USA	Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital	Bhaskaran, M (corresponding author), N Shore Univ Hosp, Transplant Program, Manhasset, NY 11030 USA.	mbhaskar@nshs.edu	Kadiyala, Aditya/S-8056-2019	Kadiyala, Aditya/0000-0003-2553-5557; Krishnan, Prathik/0000-0001-7849-2621				Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Abbott KC, 2001, AM J NEPHROL, V21, P120, DOI 10.1159/000046234; Bloom RD, 2008, CLIN J AM SOC NEPHRO, V3, pS38, DOI 10.2215/CJN.02650707; Calbo E, 2006, J ANTIMICROB CHEMOTH, V57, P780, DOI 10.1093/jac/dkl035; Charfeddine Khaled, 2002, Saudi J Kidney Dis Transpl, V13, P195; Chuang P, 2005, CLIN TRANSPLANT, V19, P230, DOI 10.1111/j.1399-0012.2005.00327.x; Colodner R, 2004, EUR J CLIN MICROBIOL, V23, P163, DOI 10.1007/s10096-003-1084-2; Coskun AK, 2011, TRANSPL P, V43, P813, DOI 10.1016/j.transproceed.2010.11.016; COVESMITH A, 2007, TRENDS UROL GYNECOL, V12, P31, DOI DOI 10.1002/TRE.33; Dantas SRPE, 2006, J HOSP INFECT, V63, P117, DOI 10.1016/j.jhin.2005.10.018; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Domann E, 2003, J CLIN MICROBIOL, V41, P5500, DOI 10.1128/JCM.41.12.5500-5510.2003; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; FOX BC, 1990, AM J MED, V89, P255, DOI 10.1016/0002-9343(90)90337-D; Golebiewska J, 2011, TRANSPL P, V43, P2985, DOI 10.1016/j.transproceed.2011.07.010; Goya N, 1997, INFECTION, V25, P101, DOI 10.1007/BF02113586; Grover ML, 2009, J AM BOARD FAM MED, V22, P266, DOI 10.3122/jabfm.2009.03.080123; John U, 2006, NEPHROL DIAL TRANSPL, V21, P3269, DOI 10.1093/ndt/gfl464; Kader AA, 2005, ANN SAUDI MED, V25, P239, DOI 10.5144/0256-4947.2005.239; Kawecki D, 2011, TRANSPL P, V43, P2991, DOI 10.1016/j.transproceed.2011.09.002; Kee T, 2004, TRANSPL P, V36, P2001, DOI 10.1016/j.transproceed.2004.08.121; Khanna P, 2010, SAUDI J KIDNEY DIS T, V21, P876; Leggiadro RJ, 1997, INFECT DIS CLIN N AM, V11, P875, DOI 10.1016/S0891-5520(05)70395-0; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Muller V, 1998, J UROLOGY, V159, P1826, DOI 10.1016/S0022-5347(01)63165-3; Naber KG, 2001, EUR UROL, V40, P576, DOI 10.1159/000049840; Ozcakar ZB, 2011, ACTA PAEDIATR, V100, pE61, DOI 10.1111/j.1651-2227.2011.02262.x; Paterson DL, 2001, J CLIN MICROBIOL, V39, P2206, DOI 10.1128/JCM.39.6.2206-2212.2001; Patterson JE, 2000, INFECT CONT HOSP EP, V21, P455, DOI 10.1086/501787; Pinheiro HS, 2010, TRANSPL P, V42, P486, DOI 10.1016/j.transproceed.2010.02.002; Ranganathan M, 2009, TRANSPL P, V41, P162, DOI 10.1016/j.transproceed.2008.10.022; Rice JC, 2006, AM J TRANSPLANT, V6, P2375, DOI 10.1111/j.1600-6143.2006.01471.x; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V42, P37, DOI 10.1086/498519; Rodriguez-Bano J, 2008, EXPERT REV ANTI-INFE, V6, P671, DOI 10.1586/14787210.6.5.671; Rupp ME, 2003, DRUGS, V63, P353, DOI 10.2165/00003495-200363040-00002; Saemann M, 2008, EUR J CLIN INVEST, V38, P58, DOI 10.1111/j.1365-2362.2008.02014.x; TolkoffRubin NE, 1997, INFECT DIS CLIN N AM, V11, P707, DOI 10.1016/S0891-5520(05)70381-0; Valera B, 2006, TRANSPLANT P, V38, P2414, DOI 10.1016/j.transproceed.2006.08.018; Yilmaz E, 2008, J CHEMOTHERAPY, V20, P581, DOI 10.1179/joc.2008.20.5.581	39	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91289	10.1371/journal.pone.0091289	http://dx.doi.org/10.1371/journal.pone.0091289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637786	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100026
J	Yaligar, J; Gopalan, V; Kiat, OW; Sugii, S; Shui, GH; Lam, BD; Henry, CJ; Wenk, MR; Tai, ES; Velan, SS				Yaligar, Jadegoud; Gopalan, Venkatesh; Kiat, Ong Wee; Sugii, Shigeki; Shui, Guanghou; Lam, Buu Duyen; Henry, Christiani Jeyakumar; Wenk, Markus R.; Tai, E. Shyong; Velan, S. Sendhil			Evaluation of Dietary Effects on Hepatic Lipids in High Fat and Placebo Diet Fed Rats by In Vivo MRS and LC-MS Techniques	PLOS ONE			English	Article							CHOLESTEROL ESTER HYDROLASE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; LIVER-DISEASE; UNCOUPLING PROTEIN-2; METABOLIC SYNDROME; ACID UNSATURATION; OBESITY; LYSOPHOSPHATIDYLCHOLINE; ACCUMULATION	Background & Aims: Dietary saturated fatty acids contribute to the development of fatty liver and have pathogenic link to systemic inflammation. We investigated the effects of dietary fat towards the pathogenesis of non-alcoholic fatty liver disease by longitudinal in vivo magnetic resonance spectroscopy (MRS) and in vitro liquid chromatography coupled with mass spectrometry (LC-MS). Methods: All measurements were performed on rats fed with high fat diet (HFD) and chow diet for twenty four weeks. Longitudinal MRS measurements were performed at the 12th, 18th and 24th weeks. Liver tissues were analyzed by LC-MS, histology and gene transcription studies after terminal in vivo experiments. Results: Liver fat content of HFD rats for all ages was significantly (P<0.05) higher compared to their respective chow diet fed rats. Unsaturation indices estimated from MRS and LC-MS data of chow diet fed rats were significantly higher (P<0.05) than HFD fed rats. The concentration of triglycerides 48:1, 48:2, 50:1, 50:2, 50:3, 52:1, 52:2, 52:3, 54:3 and 54:2 was significantly higher (P<0.05) in HFD rats. The concentration for some polyunsaturated triglycerides 54:7, 56:8, 56:7, 58:11, 58:10, 58:9, 58:8 and 60:10 was significantly higher (P<0.05) in chow diet fed rats compared to HFD rats. Lysophospholipid concentrations including LPC and LPE were higher in HFD rats at 24 weeks indicating the increased risk of diabetes. The expression of CD36, PPAR alpha, SCD1, SREBF1 and UCP2 were significantly upregulated in HFD rats. Conclusions: We demonstrated the early changes in saturated and unsaturated lipid composition in fatty liver by in vivo MRS and ex vivo LC-MS. The higher LPC concentration in HFD rats indicated a higher risk of developing diabetes. Early metabolic perturbations causing changes in lipid composition can be evaluated by the unsaturation index and correlated to the non alcoholic fatty liver disease.	[Yaligar, Jadegoud; Gopalan, Venkatesh; Kiat, Ong Wee; Sugii, Shigeki; Velan, S. Sendhil] ASTAR, Lab Mol Imaging, Singapore Bioimaging Consortium, Singapore, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Lam, Buu Duyen; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Lam, Buu Duyen; Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Henry, Christiani Jeyakumar; Velan, S. Sendhil] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Velan, SS (corresponding author), ASTAR, Lab Mol Imaging, Singapore Bioimaging Consortium, Singapore, Singapore.	Sendhil_Velan@sbic.a-star.edu.sg	Henry, Christiani Jeyakumar/AHB-2632-2022; Wenk, Markus Rene/D-1441-2014; Velan, S. Sendhil/B-6374-2017	Henry, Christiani Jeyakumar/0000-0002-1602-0140; Velan, S. Sendhil/0000-0002-4096-0722; Sugii, Shigeki/0000-0002-2537-9534; Shui, Guanghou/0000-0002-1621-9643; Tai, E Shyong/0000-0003-2929-8966	Singapore Bioimaging Consortium, A*STAR, Singapore; National University of Singapore, Singapore	Singapore Bioimaging Consortium, A*STAR, Singapore; National University of Singapore, Singapore(National University of Singapore)	This research was supported by the intramural funding from Singapore Bioimaging Consortium, A*STAR, Singapore & National University of Singapore, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi Herve, 2010, WILEY INTERDISCIPLIN, V2; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Bordoni A, 1998, PROSTAG LEUKOTR ESS, V58, P417, DOI 10.1016/S0952-3278(98)90163-6; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Dorfman SE, 2009, OBESITY, V17, P1200, DOI 10.1038/oby.2008.662; Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x; Fabbrini E, 2009, OBESITY, V17, P25, DOI 10.1038/oby.2008.494; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; HORROBIN DF, 1993, AM J CLIN NUTR, V57, P732; IKAI E, 1995, J HUM HYPERTENS, V9, P101; KALOUS M, 1992, BIOCHIM BIOPHYS ACTA, V1098, P167, DOI 10.1016/S0005-2728(05)80332-9; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Manco M, 2000, METABOLISM, V49, P220, DOI 10.1016/S0026-0495(00)91377-5; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Nagarajan V, 2013, AM J PHYSIOL-HEART C, V304, pH1495, DOI 10.1152/ajpheart.00478.2012; Pamplona R, 2000, J GERONTOL A-BIOL, V55, pB286, DOI 10.1093/gerona/55.6.B286; Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x; Pipatpiboon N, 2012, ENDOCRINOLOGY, V153, P329, DOI 10.1210/en.2011-1502; Pratchayasakul W, 2011, LIFE SCI, V88, P619, DOI 10.1016/j.lfs.2011.02.003; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; REZNICK AZ, 1998, OXIDATIVE STRESS SKE; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Schober C, 2009, BIOORG CHEM, V37, P202, DOI 10.1016/j.bioorg.2009.09.002; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shui GH, 2013, METABOLOMICS, V9, P786, DOI 10.1007/s11306-013-0494-0; Shui GH, 2011, J CHROMATOGR A, V1218, P4357, DOI 10.1016/j.chroma.2011.05.011; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; SIMON JB, 1978, GASTROENTEROLOGY, V75, P470; SIMON JB, 1978, SCAND J CLIN LAB INV, V38, P218, DOI 10.3109/00365517809104929; Thomas MA, 2001, MAGNET RESON MED, V46, P58, DOI 10.1002/mrm.1160; Velan SS, 2008, AM J PHYSIOL-REG I, V295, pR1060, DOI 10.1152/ajpregu.90367.2008; Velan SS, 2007, J MAGN RESON IMAGING, V25, P192, DOI 10.1002/jmri.20786; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Wei Y, 2008, J HEPATOL, V49, P417, DOI 10.1016/j.jhep.2008.03.018; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; ZAVARONI I, 1992, J INTERN MED, V231, P235, DOI 10.1111/j.1365-2796.1992.tb00529.x; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	54	19	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91436	10.1371/journal.pone.0091436	http://dx.doi.org/10.1371/journal.pone.0091436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638096	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100034
J	Yeo, AJ; Becherel, OJ; Luff, JE; Cullen, JK; Wongsurawat, T; Jenjaroenpoon, P; Kuznetsov, VA; McKinnon, PJ; Lavin, MF				Yeo, Abrey J.; Becherel, Olivier J.; Luff, John E.; Cullen, Jason K.; Wongsurawat, Thidathip; Jenjaroenpoon, Piroon; Kuznetsov, Vladimir A.; McKinnon, Peter J.; Lavin, Martin F.			R-Loops in Proliferating Cells but Not in the Brain: Implications for AOA2 and Other Autosomal Recessive Ataxias	PLOS ONE			English	Article							STRAND BREAK REPAIR; OCULOMOTOR APRAXIA TYPE-2; DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; TOPOISOMERASE-I; NEURODEGENERATIVE DISEASE; CEREBELLAR ATAXIAS; ESCHERICHIA-COLI; PAUSE SITES; SENATAXIN	Disruption of the Setx gene, defective in ataxia oculomotor apraxia type 2 (AOA2) leads to the accumulation of DNA/RNA hybrids (R-loops), failure of meiotic recombination and infertility in mice. We report here the presence of R-loops in the testes from other autosomal recessive ataxia mouse models, which correlate with fertility in these disorders. R-loops were coincident in cells showing high basal levels of DNA double strand breaks and in those cells undergoing apoptosis. Depletion of Setx led to high basal levels of R-loops and these were enhanced further by DNA damage both in vitro and in vivo in tissues with proliferating cells. There was no evidence for accumulation of R-loops in the brains of mice where Setx, Atm, Tdp1 or Aptx genes were disrupted. These data provide further evidence for genome destabilization as a consequence of disrupted transcription in the presence of DNA double strand breaks arising during DNA replication or recombination. They also suggest that R-loop accumulation does not contribute to the neurodegenerative phenotype in these autosomal recessive ataxias.	[Yeo, Abrey J.; Becherel, Olivier J.; Luff, John E.; Cullen, Jason K.; Lavin, Martin F.] QIMR Berghofer Med Res Inst, Radiat Biol & Oncol Lab, Brisbane, Qld, Australia; [Yeo, Abrey J.; Lavin, Martin F.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Becherel, Olivier J.] Univ Queensland, Sch Chem & Mol Biol, St Lucia, Qld, Australia; [Wongsurawat, Thidathip; Jenjaroenpoon, Piroon; Kuznetsov, Vladimir A.] Bioinformat Inst, Dept Genome & Gene Express Data Anal, Singapore, Singapore; [Wongsurawat, Thidathip; Kuznetsov, Vladimir A.] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet & Tumour Cell Biol, Memphis, TN 38105 USA	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; St Jude Children's Research Hospital	Lavin, MF (corresponding author), QIMR Berghofer Med Res Inst, Radiat Biol & Oncol Lab, Brisbane, Qld, Australia.	martin.lavin@qimrberghofer.edu.au	Lavin, Martin F/F-5961-2014; Wongsurawat, Thidathip/K-5590-2019; Yeo, Abrey J/D-9695-2015	Lavin, Martin F/0000-0002-5940-4769; Yeo, Abrey J/0000-0003-4470-4854; Cullen, Jason/0000-0003-4961-1673	Australian Research Council (ARC); BrAshA-T Foundation; Department of Innovation, Australian Government; University of Queensland, Australia; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	Australian Research Council (ARC)(Australian Research Council); BrAshA-T Foundation; Department of Innovation, Australian Government; University of Queensland, Australia(University of Queensland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Australian Research Council (ARC) and the BrAshA-T Foundation to MFL. AJY is a recipient of the International Postgraduate Research Scholarship (IPRS) awarded by the Department of Innovation, Australian Government, and the UQCentennial and UQAdvantage scholarships awarded by the University of Queensland, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; Anheim M, 2009, BRAIN, V132, P2688, DOI 10.1093/brain/awp211; BARBI G, 1991, AM J MED GENET, V40, P44, DOI 10.1002/ajmg.1320400109; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Becherel OJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003435; Belzil VV, 2013, MOL CELL NEUROSCI, V56, P406, DOI 10.1016/j.mcn.2012.12.006; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cirillo D, 2013, RNA, V19, P129, DOI 10.1261/rna.034777.112; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Guichard S, 2001, CLIN CANCER RES, V7, P3222; Hanson KA, 2012, WIRES RNA, V3, P265, DOI 10.1002/wrna.111; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Hazelbaker DZ, 2013, MOL CELL, V49, P55, DOI 10.1016/j.molcel.2012.10.014; Kasiviswanathan R, 2013, J BIOL CHEM, V288, P14247, DOI 10.1074/jbc.M113.458802; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kollmannsberger C, 1999, ONCOLOGY-BASEL, V56, P1, DOI 10.1159/000011923; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 2013, DNA REPAIR, V12, P612, DOI 10.1016/j.dnarep.2013.04.014; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Ooi L, 2008, BIOCHEM J, V414, P327, DOI 10.1042/BJ20080963; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Richard P, 2013, GENE DEV, V27, P2227, DOI 10.1101/gad.224923.113; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rulten SL, 2013, DNA REPAIR, V12, P558, DOI 10.1016/j.dnarep.2013.04.008; Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Vantaggiato C, 2011, BRAIN, V134, P1808, DOI 10.1093/brain/awr084; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115; Wong ET, 2004, ONCOLOGIST, V9, P68, DOI 10.1634/theoncologist.9-1-68; Wongsurawat T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1075; Wu ZK, 2010, NUCLEIC ACIDS RES, V38, P2346, DOI 10.1093/nar/gkp1251; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	57	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90219	10.1371/journal.pone.0090219	http://dx.doi.org/10.1371/journal.pone.0090219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637776	Green Published, gold			2022-12-27	WOS:000333254100005
J	Alizadeh, H; Tripathi, T; Abdi, M; Smith, AD				Alizadeh, Hassan; Tripathi, Trivendra; Abdi, Mahshid; Smith, Ashley Dawn			Pathogenic Strains of Acanthamoeba Are Recognized by TLR4 and Initiated Inflammatory Responses in the Cornea	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; EPITHELIAL-CELLS; KERATITIS; MANNOSE; PROTEIN; EXPRESSION; FLAGELLIN; INNATE; CD14; DIFFERENTIATION	Free-living amoebae of the Acanthamoeba species are the causative agent of Acanthamoeba keratitis (AK), a sight-threatening corneal infection that causes severe pain and a characteristic ring-shaped corneal infiltrate. Innate immune responses play an important role in resistance against AK. The aim of this study is to determine if Toll-like receptors (TLRs) on corneal epithelial cells are activated by Acanthamoeba, leading to initiation of inflammatory responses in the cornea. Human corneal epithelial (HCE) cells constitutively expressed TLR1, TLR2, TLR3, TLR4, and TLR9 mRNA, and A. castellanii upregulated TLR4 transcription. Expression of TLR1, TLR2, TLR3, and TLR9 was unchanged when HCE cells were exposed to A. castellanii. IL-8 mRNA expression was upregulated in HCE cells exposed to A. castellanii. A. castellanii and lipopolysaccharide (LPS) induced significant IL-8 production by HCE cells as measured by ELISA. The percentage of total cells positive for TLR4 was higher in A. castellanii stimulated HCE cells compared to unstimulated HCE cells. A. castellanii induced upregulation of IL-8 in TLR4 expressing human embryonic kidney (HEK)-293 cells, but not TLR3 expressing HEK-293 cells. TLR4 neutralizing antibody inhibited A. castellanii-induced IL-8 by HCE and HEK-293 cells. Clinical strains but not soil strains of Acanthamoeba activated TLR4 expression in Chinese hamster corneas in vivo and in vitro. Clinical isolates but not soil isolates of Acanthamoeba induced significant (P< 0.05) CXCL2 production in Chinese hamster corneas 3 and 7 days after infection, which coincided with increased inflammatory cells in the corneas. Results suggest that pathogenic species of Acanthamoeba activate TLR4 and induce production of CXCL2 in the Chinese hamster model of AK. TLR4 may be a potential target in the development of novel treatment strategies in Acanthamoeba and other microbial infections that activate TLR4 in corneal cells.	[Alizadeh, Hassan] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA; North Texas Eye Res Inst, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Alizadeh, H (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	hassan.alizadeh@unthsc.edu	Tripathi, Trivendra/I-9595-2019; Smith, Ashley/GZB-0298-2022; TRIPATHI, TRIVENDRA/H-2759-2014	Tripathi, Trivendra/0000-0002-6006-1273; TRIPATHI, TRIVENDRA/0000-0002-6006-1273	Public Health Service [EY09756]; NATIONAL EYE INSTITUTE [R01EY009756] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Public Health Service Grant EY09756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh H., 1996, OCULAR INFECT IMMUNI, P1062; Alizadeh H, 2007, INVEST OPHTH VIS SCI, V48, P5597, DOI 10.1167/iovs.07-0407; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Blais DR, 2005, INVEST OPHTH VIS SCI, V46, P4235, DOI 10.1167/iovs.05-0543; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Clarke DW, 2006, MICROBES INFECT, V8, P1400, DOI 10.1016/j.micinf.2005.12.009; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Gadjeva M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000826; Garate M, 2004, J BIOL CHEM, V279, P29849, DOI 10.1074/jbc.M402334200; GARNER A, 1993, BRIT J OPHTHALMOL, V77, P366, DOI 10.1136/bjo.77.6.366; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; HE YG, 1992, INVEST OPHTH VIS SCI, V33, P126; Heine H, 1999, J IMMUNOL, V162, P6971; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Hurt M, 2003, INFECT IMMUN, V71, P6243, DOI 10.1128/IAI.71.11.6243-6255.2003; Hurt M, 2003, INVEST OPHTH VIS SCI, V44, P3424, DOI 10.1167/iovs.03-0019; Hurt M, 2003, J PARASITOL, V89, P565, DOI 10.1645/0022-3395(2003)089[0565:TIOACC]2.0.CO;2; Hurt M, 2001, INFECT IMMUN, V69, P2988, DOI 10.1128/IAI.69.5.2988-2995.2001; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson A, 2005, OCUL SURF, V3, pS187; Kumar A, 2007, INVEST OPHTH VIS SCI, V48, P4664, DOI 10.1167/iovs.07-0473; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Lang LL, 2011, INFLAMMATION, V34, P371, DOI 10.1007/s10753-010-9244-x; LARKIN DFP, 1991, EYE, V5, P70, DOI 10.1038/eye.1991.14; LARKIN DFP, 1991, BRIT J OPHTHALMOL, V75, P421, DOI 10.1136/bjo.75.7.421; Leher H, 1999, EXP EYE RES, V69, P75, DOI 10.1006/exer.1999.0678; MATHERS W, 1987, AM J OPHTHALMOL, V103, P626, DOI 10.1016/S0002-9394(14)74321-1; McDermott AM, 2005, OCUL SURF, V3, pS131; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Niederkorn JY, 2002, ARCH IMMUNOL THER EX, V50, P53; Niederkorn JY, 1999, SPRINGER SEMIN IMMUN, V21, P147, DOI 10.1007/BF00810247; Redfern RL, 2010, EXP EYE RES, V90, P679, DOI 10.1016/j.exer.2010.03.012; Ren MY, 2010, IMMUNOL CELL BIOL, V88, P529, DOI 10.1038/icb.2010.6; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song PI, 2001, INVEST OPHTH VIS SCI, V42, P2867; STEWART GL, 1994, INT J PARASITOL, V24, P739, DOI 10.1016/0020-7519(94)90129-5; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tripathi T, 2013, EXP EYE RES, V113, P182, DOI 10.1016/j.exer.2013.05.021; Tripathi T, 2012, INVEST OPHTH VIS SCI, V53, P7973, DOI 10.1167/iovs.12-10436; Ueta M, 2004, J IMMUNOL, V173, P3337, DOI 10.4049/jimmunol.173.5.3337; WILSON SE, 1995, INVEST OPHTH VIS SCI, V36, P32; Wu MH, 2009, J IMMUNOL, V182, P1609, DOI 10.4049/jimmunol.182.3.1609; WU XA, 1995, CURR EYE RES, V14, P969, DOI 10.3109/02713689508995137; Yang ZT, 1997, INFECT IMMUN, V65, P439, DOI 10.1128/IAI.65.2.439-445.1997; Yu FSX, 2006, INVEST OPHTH VIS SCI, V47, P1255, DOI 10.1167/iovs.05-0956	52	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92375	10.1371/journal.pone.0092375	http://dx.doi.org/10.1371/journal.pone.0092375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633052	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400159
J	Barcelos, QL; Pinto, JMA; Vaillancourt, LJ; Souza, EA				Barcelos, Quelen L.; Pinto, Joyce M. A.; Vaillancourt, Lisa J.; Souza, Elaine A.			Characterization of Glomerella Strains Recovered from Anthracnose Lesions on Common Bean Plants in Brazil	PLOS ONE			English	Article							MATING-TYPE LOCI; COLLETOTRICHUM-LINDEMUTHIANUM; VEGETATIVE COMPATIBILITY; FUNGAL EPIPHYTES; ASCOMYCETE; ENDOPHYTES; GENETICS; GRAMINICOLA; VARIABILITY; PATHOGENS	Anthracnose caused by Colletotrichum lindemuthianum is an important disease of common bean, resulting in major economic losses worldwide. Genetic diversity of the C. lindemuthianum population contributes to its ability to adapt rapidly to new sources of host resistance. The origin of this diversity is unknown, but sexual recombination, via the Glomerella teleomorph, is one possibility. This study tested the hypothesis that Glomerella strains that are frequently recovered from bean anthracnose lesions represent the teleomorph of C. lindemuthianum. A large collection of Glomerella isolates could be separated into two groups based on phylogenetic analysis, morphology, and pathogenicity to beans. Both groups were unrelated to C. lindemuthianum. One group clustered with the C. gloeosporioides species complex and produced mild symptoms on bean tissues. The other group, which belonged to a clade that included the cucurbit anthracnose pathogen C. magna, caused no symptoms. Individual ascospores recovered from Glomerella perithecia gave rise to either fertile (perithecial) or infertile (conidial) colonies. Some pairings of perithecial and conidial strains resulted in induced homothallism in the conidial partner, while others led to apparent heterothallic matings. Pairings involving two perithecial, or two conidial, colonies produced neither outcome. Conidia efficiently formed conidial anastomosis tubes (CATs), but ascospores never formed CATs. The Glomerella strains formed appressoria and hyphae on the plant surface, but did not penetrate or form infection structures within the tissues. Their behavior was similar whether the beans were susceptible or resistant to anthracnose. These same Glomerella strains produced thick intracellular hyphae, and eventually acervuli, if host cell death was induced. When Glomerella was co-inoculated with C. lindemuthianum, it readily invaded anthracnose lesions. Thus, the hypothesis was not supported: Glomerella strains from anthracnose lesions do not represent the teleomorphic phase of C. lindemuthianum, and instead appear to be bean epiphytes that opportunistically invade and sporulate in the lesions.	[Barcelos, Quelen L.; Souza, Elaine A.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Pinto, Joyce M. A.] Empresa Brasileira Pesquisa Agropecuaria Embrapa, Sinop, Mato Grosso, Brazil; [Vaillancourt, Lisa J.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA	Universidade Federal de Lavras; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Kentucky	Vaillancourt, LJ (corresponding author), Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA.	vaillan@uky.edu; easouza@dbi.ufla.br			Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais -FAPEMIG [CAG-APQ00635-12]; Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais -FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants and scholarships from the following Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais -FAPEMIG (CAG-APQ00635-12), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves Marcelo C., 2006, Fitopatologia Brasileira, V31, P557, DOI 10.1590/S0100-41582006000600004; Alvindia DG, 2008, CROP PROT, V27, P1200, DOI 10.1016/j.cropro.2008.02.007; Alzate-Marin A.L., 2004, ANN REPORT BEAN IMPR, V47, P241; Arie T, 1997, FUNGAL GENET BIOL, V21, P118, DOI 10.1006/fgbi.1997.0961; BAILEY JA, 1995, DISEASE ANALYSIS THROUGH GENETICS AND BIOTECHNOLOGY, P197; Bailey JA, 1996, PHYTOPATHOLOGY, V86, P1076, DOI 10.1094/Phyto-86-1076; Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; Batista UG, 1982, SCRIB FITOPATOLOGIA, V7, P285; Bryson RJ, 1990, SEXUAL HYBRIDIZATION; Camargo OA, 2007, GENET MOL RES, V6, P607; Davide LMC, 2009, CROP BREED APPL BIOT, V9, P23, DOI 10.12702/1984-7033.v09n01a04; CHILTON SJP, 1945, AM J BOT, V32, P549, DOI 10.2307/2437685; CHILTON SJP, 1949, AM J BOT, V36, P717, DOI 10.2307/2438224; CHILTON SJP, 1949, AM J BOT, V36, P270, DOI 10.2307/2437882; Cisar CR, 1999, CURR GENET, V35, P127, DOI 10.1007/s002940050441; de Souza BO, 2007, CIENC AGROTEC, V31, P1000, DOI 10.1590/S1413-70542007000400009; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DRIVER CH, 1955, MYCOLOGIA, V47, P311, DOI 10.2307/3755453; Du MZ, 2005, MYCOLOGIA, V97, P641, DOI 10.3852/mycologia.97.3.641; EDGERTON CW, 1945, AM J BOT, V32, P115, DOI 10.2307/2437529; Ferreira DF, 2011, CIENC AGROTEC, V35, P1039, DOI 10.1590/S1413-70542011000600001; Flowers JL, 2005, CURR GENET, V48, P380, DOI 10.1007/s00294-005-0034-1; Freeman S, 2001, PHYTOPATHOLOGY, V91, P986, DOI 10.1094/PHYTO.2001.91.10.986; Garcia-Serrano M, 2008, MYCOSCIENCE, V49, P312, DOI 10.1007/s10267-008-0424-6; Gioti A, 2012, MOL BIOL EVOL, V29, P3215, DOI 10.1093/molbev/mss132; HABGOOD RM, 1970, NATURE, V227, P1268, DOI 10.1038/2271268a0; Henry G, 1990, TRENDS CIAT COMM, P89; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Ishikawa F.H., 2012, ANN REP BEAN IMPROV, V55, P141; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Ishikawa FH, 2010, J PHYTOPATHOL, V158, P270, DOI 10.1111/j.1439-0434.2009.01608.x; Junqueira NTV, 1984, CERES, V31, P322; KIMATI H., 1970, Anais da Escola Superior de Agricultura ''Luiz de Queiroz'' (Brazil)., V27, P411; Latunde-Dada AO, 1999, PLANT PATHOL, V48, P777, DOI 10.1046/j.1365-3059.1999.00405.x; Leite TD, 2013, J MICROBIOL, V51, P56, DOI 10.1007/s12275-013-2356-x; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Liu B, 2007, PHYTOPATHOLOGY, V97, P1305, DOI 10.1094/PHYTO-97-10-1305; Liu F, 2013, MYCOLOGIA, V105, P844, DOI 10.3852/12-315; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; LUCAS GB, 1946, AM J BOT, V33, P802, DOI 10.2307/2437277; Lucas GB, 1944, AM J BOT, V31, P233, DOI 10.2307/2437611; MCGAHEN JW, 1951, AM J BOT, V38, P610, DOI 10.2307/2437771; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Mendes Costa M.C., 1996, REV BRASIL GENETICS, V19, P350; MENEZES JR, 1988, PHYTOPATHOLOGY, V78, P650, DOI 10.1094/Phyto-78-650; O'Connell R. J., 1992, Colletotrichum: biology, pathology and control., P67; Oliveira, 1991, THESIS U FEDERAL LAV; Osono T, 2008, MYCOLOGIA, V100, P387, DOI 10.3852/07-110R1; Peloso MJ, 1992, ANTRACNOSIS FRIJOL C, P86; Photita W, 2004, FUNGAL DIVERS, V16, P131; Pinto JMA, 2012, PHYTOPATHOLOGY, V102, P490, DOI 10.1094/PHYTO-06-11-0179; Poggeler S, 2011, FUNGAL BIOL-UK, V115, P615, DOI 10.1016/j.funbio.2011.03.003; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Rava AC, 1994, PRINCIPAIS DOENCAS F, P17; Rava C. A., 1993, Fitopatologia Brasileira, V18, P388; Redman RS, 1999, PLANT PHYSIOL, V119, P795, DOI 10.1104/pp.119.2.795; Roca MG, 2004, MYCOL RES, V108, P1320, DOI 10.1017/S0953756204000838; Rodriguez-Guerra R, 2005, MYCOLOGIA, V97, P793, DOI 10.3852/mycologia.97.4.793; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Saccardo PA, 1878, MICHELIA, V1, P117; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; Shear CL, 1913, STUDIES FUNGUS PARAS; SHERRIFF C, 1994, EXP MYCOL, V18, P121, DOI 10.1006/emyc.1994.1014; Silva KJDE, 2007, J PHYTOPATHOL, V155, P241; Souza EA, 2010, GENET MOL RES, V9, P1759, DOI 10.4238/vol9-3gmr863; Sreenivasaprasad S, 1996, GENOME, V39, P499, DOI 10.1139/g96-064; Starnes JH, 2012, GENETICS, V191, P389, DOI 10.1534/genetics.111.137950; SUTTON B, 1992, CL LIB APPL, P1; Talamini Viviane, 2006, Fitopatologia Brasileira, V31, P545, DOI 10.1590/S0100-41582006000600002; Thon MR, 2000, MOL PLANT MICROBE IN, V13, P1356, DOI 10.1094/MPMI.2000.13.12.1356; Vaillancourt L, 2000, COLLETOTRICHUM, P29; VAILLANCOURT LJ, 1994, EXP MYCOL, V18, P311, DOI 10.1016/S0147-5975(06)80004-6; Vargas WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/pp.111.190397; Von Arx, 1957, PHYTOPATHOL Z, V29, P413; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; WHEELER HE, 1959, AM J BOT, V46, P361, DOI 10.2307/2439196; WHEELER HE, 1948, AM J BOT, V35, P722, DOI 10.2307/2438153; WHEELER HE, 1956, AM J BOT, V43, P1, DOI 10.2307/2438406; WHEELER HE, 1950, AM J BOT, V37, P304, DOI 10.2307/2437851; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zaffarano PL, 2010, FUNGAL GENET BIOL, V47, P761, DOI 10.1016/j.fgb.2010.06.001	82	11	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90910	10.1371/journal.pone.0090910	http://dx.doi.org/10.1371/journal.pone.0090910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633173	Green Published, gold			2022-12-27	WOS:000332858400024
J	Covington, JD; Galgani, JE; Moro, C; LaGrange, JM; Zhang, ZY; Rustan, AC; Ravussin, E; Bajpeyi, S				Covington, Jeffrey D.; Galgani, Jose E.; Moro, Cedric; LaGrange, Jamie M.; Zhang, Zhengyu; Rustan, Arild C.; Ravussin, Eric; Bajpeyi, Sudip			Skeletal Muscle Perilipin 3 and Coatomer Proteins Are Increased following Exercise and Are Associated with Fat Oxidation	PLOS ONE			English	Article							INTRAMYOCELLULAR LIPID-CONTENT; INSULIN SENSITIVITY; TRIGLYCERIDE CONTENT; PLIN PROTEINS; DROPLETS; CONTRACTION; EXPRESSION; RESISTANCE; SPECTROSCOPY; INTENSITY	Lipid droplet-associated proteins such as perilipin 3 (PLIN3) and coatomer GTPase proteins (GBF1, ARF1, Sec23a, and ARFRP1) are expressed in skeletal muscle but little is known so far as to their regulation of lipolysis. We aimed here to explore the effects of lipolytic stimulation in vitro in primary human myotubes as well as in vivo following an acute exercise bout. In vitro lipolytic stimulation by epinephrine (100 mu M) or by a lipolytic cocktail (30 mu M palmitate, 4 mu M forskolin, and 0.5 mu M ionomycin, PFI) resulted in increases in PLIN3 protein content. Coatomer GTPases such as GBF1, ARF1, Sec23a, and ARFRP1 also increased in response to lipolytic stimuli. Furthermore, a long duration endurance exercise bout (20 males; age 24.0 +/- 4.5 y; BMI 23.6 +/- 1.8 kg/m(2)) increased PLIN3 protein in human skeletal muscle (p = 0.03) in proportion to ex vivo palmitate oxidation (r = 0.45, p = 0.04) and whole body in vivo fat oxidation (r = 0.52, p = 0.03). Protein content of ARF1 was increased (p = 0.04) while mRNA expression was increased for several other coatomers (GBF1, ARF1, and Sec23a, all p<0.05). These data provide novel observational insight into the possible relationships between lipolysis and PLIN3 along with these coatomoer GTPase proteins in human skeletal muscle.	[Covington, Jeffrey D.; LaGrange, Jamie M.; Zhang, Zhengyu; Ravussin, Eric; Bajpeyi, Sudip] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Galgani, Jose E.] Pontificia Univ Catolica Chile, Sch Med, Santiago, Chile; [Moro, Cedric] INSERM, UMR 1048, Inst Metab & Cardiovasc Dis, Toulouse, France; [Moro, Cedric] Univ Toulouse 3, F-31062 Toulouse, France; [Rustan, Arild C.] Univ Oslo, Dept Pharmaceut Biosci, Oslo, Norway; [Bajpeyi, Sudip] Univ Texas El Paso, Dept Kinesiol, El Paso, TX 79968 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Pontificia Universidad Catolica de Chile; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oslo; University of Texas System; University of Texas El Paso	Bajpeyi, S (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	sbajpeyi@utep.edu	Moro, Cedric/N-5754-2017; Ravussin, Eric/N-1985-2017	Ravussin, Eric/0000-0003-2129-547X; Bajpeyi, Sudip/0000-0002-5336-8330; Moro, Cedric/0000-0003-4294-0597	Obesity Society; Nutrition Obesity Research Center (NORC) [NIH 1P30 DK072476]; COBRE [NIH P20 RR021945]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	Obesity Society; Nutrition Obesity Research Center (NORC); COBRE; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This investigation was supported in part by a young investigator award from The Obesity Society (J.E.G.) and a Nutrition Obesity Research Center (NORC) grant NIH 1P30 DK072476 (E.R.). This work utilized the Genomics Core Facility and the Cell Biology and Bioimaging Core at Pennington Biomedical Research Center, which is supported in part by COBRE (NIH P20 RR021945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpeyi S, 2009, J APPL PHYSIOL, V106, P1079, DOI 10.1152/japplphysiol.91262.2008; Bosma M, 2013, BBA-MOL CELL BIOL L, V1831, P844, DOI 10.1016/j.bbalip.2013.01.007; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; de Wilde J, 2010, FEBS J, V277, P761, DOI 10.1111/j.1742-4658.2009.07525.x; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Galgani JE, 2012, OBESITY, V20, P1387, DOI 10.1038/oby.2011.166; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hommel A, 2010, MOL CELL BIOL, V30, P1231, DOI 10.1128/MCB.01269-09; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kovalik JP, 2011, DIABETES, V60, P1882, DOI 10.2337/db10-0427; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Louche K, 2013, J CLIN ENDOCR METAB, V98, P4863, DOI 10.1210/jc.2013-2058; MacPherson REK, 2013, AM J PHYSIOL-REG I, V304, pR644, DOI 10.1152/ajpregu.00418.2012; MacPherson REK, 2012, AM J PHYSIOL-REG I, V302, pR29, DOI 10.1152/ajpregu.00163.2011; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; Peters SJ, 2012, APPL PHYSIOL NUTR ME, V37, P724, DOI [10.1139/h2012-059, 10.1139/H2012-059]; Prats C, 2006, J LIPID RES, V47, P2392, DOI 10.1194/jlr.M600247-JLR200; Shimizu M, 2006, J BIOCHEM, V139, P563, DOI 10.1093/jb/mvj053; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Sparks LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021068; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; Watt MJ, 2004, FASEB J, V18, P1445, DOI 10.1096/fj.03-1067fje; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	32	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91675	10.1371/journal.pone.0091675	http://dx.doi.org/10.1371/journal.pone.0091675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632837	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400077
J	Nilsson, EM; Fainberg, HP; Choong, SS; Giles, TC; Sells, J; May, S; Stansfield, FJ; Allen, WR; Emes, RD; Mostyn, A; Mongan, NP; Yon, L				Nilsson, Emeli M.; Fainberg, Hernan P.; Choong, Siew S.; Giles, Thomas C.; Sells, James; May, Sean; Stansfield, Fiona J.; Allen, William R.; Emes, Richard D.; Mostyn, Alison; Mongan, Nigel P.; Yon, Lisa			Molecular Characterization of Adipose Tissue in the African Elephant (Loxodonta africana)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; C-FOS EXPRESSION; INSULIN-RESISTANCE; MISSENSE MUTATION; NORTH-AMERICA; OBESE GENE; MILK-FAT; LEPTIN; PROTEIN; RATS	Adipose tissue (AT) is a dynamic and flexible organ with regulatory roles in physiological functions including metabolism, reproduction and inflammation; secreted adipokines, including leptin, and fatty acids facilitate many of these roles. The African elephant (Loxodonta africana) is experiencing serious challenges to optimal reproduction in captivity. The physiological and molecular basis of this impaired fertility remains unknown. AT production of leptin is a crucial molecular link between nutritional status, adiposity and fertility in many species. We propose that leptin has a similar function in the African elephant. African elephant visceral and subcutaneous adipose tissue (AT) was obtained from both sexes and a range of ages including females with known pregnancy status. RNA was extracted and histological sections created and analyzed by microarray, PCR and immunohistochemistry respectively. Gas-chromatography was used to determine the fatty acid composition of AT. Microarray expression profiling was used to compare gene expression profiles of AT from pre-pubertal versus reproductively competent adult African elephants. This study demonstrates, for the first time, leptin mRNA and protein expression in African elephant AT. The derived protein sequence of the elephant leptin protein was exploited to determine its relationship within the class I helical cytokine superfamily, which indicates that elephant leptin is most closely related to the leptin orthologs of Oryctolagus cuniculus (European rabbit), Lepus oiostolus (woolly hare), and members of the Ochotonidae (Pika). Immunohistological analysis identified considerable leptin staining within the cytoplasm of adipocytes. Significant differences in fatty acid profiles between pregnant and non-pregnant animals were revealed, most notably a reduction in both linoleic and a linoleic acid in pregnant animals. This report forms the basis for future studies to address the effect of nutrient composition and body condition on reproduction in captive and wild elephants.	[Nilsson, Emeli M.; Fainberg, Hernan P.; Choong, Siew S.; Sells, James; Emes, Richard D.; Mostyn, Alison; Mongan, Nigel P.; Yon, Lisa] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Loughborough, England; [Giles, Thomas C.; Emes, Richard D.] Univ Nottingham, Adv Data Anal Ctr, Loughborough, England; [May, Sean] Univ Nottingham, Div Plant Sci, Nottingham Arabidopsis Stock Ctr, Loughborough, England; [Stansfield, Fiona J.] Save Valley Conservancy, Elephant Res & Conservat Unit, Harare, Zimbabwe; [Allen, William R.] Paul Mellon Lab, Newmarket, Suffolk, England	University of Nottingham; University of Nottingham; University of Nottingham	Emes, RD (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Sutton Bonington Campus, Loughborough, England.	richard.emes@nottingham.ac.uk; alison.mostyn@nottingham.ac.uk; nigel.mongan@nottingham.ac.uk; lisa.yon@nottingham.ac.uk	may, sean t/B-6838-2012; Emes, Richard D/C-5341-2008; Choong, Sandie/Q-2370-2019; Yon, Lisa K/G-4453-2011; Fainberg, Hernan/GQZ-6651-2022	may, sean t/0000-0001-5282-3250; Emes, Richard D/0000-0001-6855-5481; Yon, Lisa K/0000-0002-9765-3192; Choong, Siew Shean/0000-0003-2081-8099; Fainberg, Hernan Pablo/0000-0001-9330-9047; Mongan, Nigel/0000-0001-5438-1126	Society for Reproduction and Fertility Academic Scholarship Fund; University of Nottingham; BBSRC [BB/I001271/1, BB/E022758/1, BB/L010100/1, BB/J018961/1, BB/E01772X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J018961/1, G17764, BBS/B/1356X, G18881, BB/L010100/1, BB/I001271/1, BB/E01772X/1, BB/E022758/1] Funding Source: researchfish	Society for Reproduction and Fertility Academic Scholarship Fund; University of Nottingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Part of this work was supported by the Society for Reproduction and Fertility Academic Scholarship Fund, and part from internal funding from the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Akiyama S, 2010, BLOOD CELL MOL DIS, V44, P209, DOI 10.1016/j.bcmd.2010.02.013; AL MDM, 1995, BRIT J NUTR, V74, P55, DOI 10.1079/BJN19950106; Andres S, 2013, HORMONES CANC, P1; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Budak E, 2006, FERTIL STERIL, V85, P1563, DOI 10.1016/j.fertnstert.2005.09.065; Campfield LA, 1996, HORM METAB RES, V28, P619, DOI 10.1055/s-2007-979867; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chouinard PY, 1999, J DAIRY SCI, V82, P2737, DOI 10.3168/jds.S0022-0302(99)75530-X; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; DEMAN JM, 1963, J DAIRY RES, V30, P339, DOI 10.1017/S0022029900011523; DUNCAN WRH, 1968, COMP BIOCHEM PHYSIOL, V25, P319, DOI 10.1016/0010-406X(68)90939-0; Evans G.H, 1910, ELEPHANTS THEIR DIS; Fainberg HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049101; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Geary N, 2007, SEX DIFFERENCES ENER, P254; Graham NS, 2010, VET J, V186, P323, DOI 10.1016/j.tvjl.2009.08.030; Gulliver CE, 2012, ANIM REPROD SCI, V131, P9, DOI 10.1016/j.anireprosci.2012.02.002; Hamilton BS, 1998, CANADIAN J DIABETES, V22, pS13; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hausman GJ, 2012, BIOCHIMIE, V94, P2075, DOI 10.1016/j.biochi.2012.02.022; Hermes R, 2008, THERIOGENOLOGY, V70, P131, DOI 10.1016/j.theriogenology.2008.04.003; Hildebrandt T. B., 2006, International Zoo Yearbook, V40, P20, DOI 10.1111/j.1748-1090.2006.00020.x; Huan JN, 2003, J BIOL CHEM, V278, P45638, DOI 10.1074/jbc.M304165200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUERTALEIDENZ NO, 1993, J ANIM SCI, V71, P625, DOI 10.2527/1993.713625x; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; KNITTEL T, 1992, GASTROENTEROLOGY, V102, P1724, DOI 10.1016/0016-5085(92)91736-N; Lacasa D, 1997, ENDOCRINOLOGY, V138, P2729, DOI 10.1210/en.138.7.2729; Lavoie J-M, 2012, J NUTR METABOLISM, V2012; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Licinio J, 1998, J CLIN ENDOCR METAB, V83, P4140, DOI 10.1210/jc.83.11.4140; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; Marjeta Furman SM, 2010, ARCH ANIMAL BREEDING, V53, P73; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; MCCULLAGH KG, 1969, NATURE, V222, P493, DOI 10.1038/222493a0; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Nantermet P, 2008, ENDOCRINOLOGY, V149, P1551, DOI 10.1210/en.2007-1151; OLSON AL, 1994, ENDOCRINOLOGY, V134, P271, DOI 10.1210/en.134.1.271; Olson D, 2000, ZOO BIOL, V19, P311, DOI 10.1002/1098-2361(2000)19:5<311::AID-ZOO3>3.3.CO;2-F; PERRY JS, 1953, PHILOS T R SOC B, V237, P93, DOI 10.1098/rstb.1953.0001; Pietrzak-Fiecko R, 2009, CZECH J ANIM SCI, V54, P403, DOI 10.17221/1683-CJAS; Pinilla L, 1999, EUR J ENDOCRINOL, V140, P468, DOI 10.1530/eje.0.1400468; Poitout V., 2002, CURR OPIN ENDOCRINOL, V9, P152; Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; ROSENKRANZWEISS P, 1994, J MOL CELL CARDIOL, V26, P261, DOI 10.1006/jmcc.1994.1029; Sasaki Y, 2006, ANIM GENET, V37, P40, DOI 10.1111/j.1365-2052.2005.01380.x; Scantlebury M, 2006, P ROY SOC B-BIOL SCI, V273, P57, DOI 10.1098/rspb.2005.3280; SCHMIDT M, 1986, ZOO WILD ANIMAL MED, P884; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Suzuki R, 2005, J BIOL CHEM, V280, P3331, DOI 10.1074/jbc.M410955200; SWERDLOFF RS, 1976, ENDOCRINOLOGY, V98, P1359, DOI 10.1210/endo-98-6-1359; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; Wiese R. J., 2006, International Zoo Yearbook, V40, P80, DOI 10.1111/j.1748-1090.2006.00080.x; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291; WU Z, 1991, J DAIRY SCI, V74, P3035, DOI 10.3168/jds.S0022-0302(91)78489-0; Wu-Peng S, 1999, OBES RES, V7, P586, DOI 10.1002/j.1550-8528.1999.tb00718.x; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zonta E, 2013, NUCLEIC ACIDS RES, V41, P554, DOI 10.1093/nar/gks1046	73	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91717	10.1371/journal.pone.0091717	http://dx.doi.org/10.1371/journal.pone.0091717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633017	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400081
J	Doneva, SP; Cole, GG				Doneva, Silviya P.; Cole, Geoff G.			The Role of Attention in a Joint-Action Effect	PLOS ONE			English	Article							ACTION CO-REPRESENTATION; INFLUENCE FREDS ACTION; SELECTIVE ATTENTION; MIRROR NEURONS; INHIBITION; RETURN; TASK; APPEARANCE; PERCEPTION; EXECUTION	The most common explanation for joint-action effects has been the action co-representation account in which observation of another's action is represented within one's own action system. However, recent evidence has shown that the most prominent of these joint-action effects (i.e., the Social Simon effect), can occur when no co-actor is present. In the current work we examined whether another joint-action phenomenon (a movement congruency effect) can be induced when a participant performs their part of the task with a different effector to that of their co-actor and when a co-actor's action is replaced by an attention-capturing luminance signal. Contrary to what is predicted by the action co-representation account, results show that the basic movement congruency effect occurred in both situations. These findings challenge the action co-representation account of this particular effect and suggest instead that it is driven by bottom-up mechanisms.	[Doneva, Silviya P.; Cole, Geoff G.] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England	University of Essex	Doneva, SP (corresponding author), Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England.	sdoneva@essex.ac.uk						Atmaca S, 2008, SOC NEUROSCI-UK, V3, P410, DOI 10.1080/17470910801900908; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Cole GG, 2012, PSYCHOL RES-PSYCH FO, V76, P736, DOI 10.1007/s00426-011-0395-7; Cole GG, 2010, Q J EXP PSYCHOL, V63, P147, DOI 10.1080/17470210902853522; Cole GG, 2009, VIS COGN, V17, P755, DOI 10.1080/13506280802611582; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Dolk T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00084; Fine JM, 2013, J EXP PSYCHOL HUMAN, V39, P1541, DOI 10.1037/a0031953; Fine JM, 2011, EXP BRAIN RES, V211, P459, DOI 10.1007/s00221-011-2707-y; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frischen A, 2009, COGNITION, V111, P212, DOI 10.1016/j.cognition.2009.02.003; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Hayes SJ, 2010, PSYCHOL RES-PSYCH FO, V74, P302, DOI 10.1007/s00426-009-0250-2; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P208, DOI 10.1007/BF00419608; Hommel B, 1996, Q J EXP PSYCHOL-A, V49, P546, DOI 10.1080/027249896392496; Hommel B, 2009, PSYCHOL SCI, V20, P794, DOI 10.1111/j.1467-9280.2009.02367.x; Hopfinger JB, 2001, COGN AFFECT BEHAV NE, V1, P56, DOI 10.3758/CABN.1.1.56; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Kingstone A, 1999, PERCEPT PSYCHOPHYS, V61, P1046, DOI 10.3758/BF03207612; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lepsien J, 2002, J COGNITIVE NEUROSCI, V14, P127, DOI 10.1162/089892902317236795; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Liepelt R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00086; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Mayer AR, 2004, NEUROIMAGE, V23, P534, DOI 10.1016/j.neuroimage.2004.06.027; Mayer AR, 2004, J COGNITIVE NEUROSCI, V16, P1262, DOI 10.1162/0898929041920531; Muller NG, 2007, J COGNITIVE NEUROSCI, V19, P587, DOI 10.1162/jocn.2007.19.4.587; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Muller BCN, 2011, NEUROPSYCHOLOGIA, V49, P1373, DOI 10.1016/j.neuropsychologia.2011.01.022; Ondobaka S, 2012, PSYCHOL SCI, V23, P30, DOI 10.1177/0956797611424163; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Prime DJ, 2006, BRAIN RES, V1072, P161, DOI 10.1016/j.brainres.2005.11.081; Prime DJ, 2004, PSYCHOL SCI, V15, P272, DOI 10.1111/j.0956-7976.2004.00665.x; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; Richardson MJ, 2009, NEUROSCI LETT, V449, P117, DOI 10.1016/j.neulet.2008.10.092; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Romero V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044761; Ruz M., 2002, PSICOLOGICA, V23, P283, DOI DOI 10.1080/09084282.2010.547774; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Skarratt PA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00196; Skarratt PA, 2010, ACTA PSYCHOL, V134, P48, DOI 10.1016/j.actpsy.2009.12.003; Tsai CC, 2008, J COGNITIVE NEUROSCI, V20, P2015, DOI 10.1162/jocn.2008.20144; Van der Lubbe RHJ, 2005, J COGNITIVE NEUROSCI, V17, P1829, DOI 10.1162/089892905775008634; Vlainic E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00208; Wascher E, 2004, PSYCHOPHYSIOLOGY, V41, P716, DOI 10.1111/j.1469-8986.2004.00198.x; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Welsh TN, 2007, PSYCHON B REV, V14, P950, DOI 10.3758/BF03194127; Welsh TN, 2009, BRAIN COGNITION, V71, P64, DOI 10.1016/j.bandc.2009.04.001; Welsh TN, 2009, BRAIN RES, V1248, P141, DOI 10.1016/j.brainres.2008.10.077; Welsh TN, 2005, NEUROSCI LETT, V385, P99, DOI 10.1016/j.neulet.2005.05.013; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	62	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91336	10.1371/journal.pone.0091336	http://dx.doi.org/10.1371/journal.pone.0091336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642806	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000333259900019
J	Kumar, D; Srinivasan, N				Kumar, Devpriya; Srinivasan, Narayanan			Naturalizing Sense of Agency with a Hierarchical Event-Control Approach	PLOS ONE			English	Article							COGNITIVE SCIENCE; SELF; PERCEPTION; SIMULATION; MODEL	Unraveling the mechanisms underlying self and agency has been a difficult scientific problem. We argue for an event-control approach for naturalizing the sense of agency by focusing on the role of perception-action regularities present at different hierarchical levels and contributing to the sense of self as an agent. The amount of control at different levels of the control hierarchy determines the sense of agency. The current study investigates this approach in a set of two experiments using a scenario containing multiple agents sharing a common goal where one of the agents is partially controlled by the participant. The participant competed with other agents for achieving the goal and subsequently answered questions on identification (which agent was controlled by the participant), the degree to which they are confident about their identification (sense of identification) and the degree to which the participant believed he/she had control over his/her actions (sense of authorship). Results indicate a hierarchical relationship between goal-level control (higher level) and perceptual-motor control (lower level) for sense of agency. Sense of identification ratings increased with perceptual-motor control when the goal was not completed but did not vary with perceptual-motor control when the goal was completed. Sense of authorship showed a similar interaction effect only in experiment 2 that had only one competing agent unlike the larger number of competing agents in experiment 1. The effect of hierarchical control can also be seen in the misidentification pattern and misidentification was greater with the agent affording greater control. Results from the two studies support the event-control approach in understanding sense of agency as grounded in control. The study also offers a novel paradigm for empirically studying sense of agency and self.	[Kumar, Devpriya; Srinivasan, Narayanan] Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad 211002, Uttar Pradesh, India	University of Allahabad	Srinivasan, N (corresponding author), Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad 211002, Uttar Pradesh, India.	nsrini@cbcs.ac.in	Srinivasan, Narayanan/E-7882-2010; Kumar, Devpriya/AAH-2546-2020	Srinivasan, Narayanan/0000-0001-5342-0381; Kumar, Devpriya/0000-0001-7048-9006				Apps MAJ, 2014, NEUROSCI BIOBEHAV R, V41, P85, DOI 10.1016/j.neubiorev.2013.01.029; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Blackmore S, 2004, CONSCIOUSNESS INTRO; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cohen J., 1983, APPL MULTIPLE REGRES; Dennett D., 1992, SELF CONSCIOUSNESS M, P275; Desantis A, 2011, CONSCIOUS COGN, V20, P1211, DOI 10.1016/j.concog.2011.02.012; Dewey JA, 2010, CONSCIOUS COGN, V19, P48, DOI 10.1016/j.concog.2009.09.007; Ebert JP, 2010, CONSCIOUS COGN, V19, P481, DOI 10.1016/j.concog.2009.10.002; Feinberg TE, 2011, CONSCIOUS COGN, V20, P4, DOI 10.1016/j.concog.2010.09.016; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gao T, 2009, COGNITIVE PSYCHOL, V59, P154, DOI 10.1016/j.cogpsych.2009.03.001; Haggard P, 2003, CONSCIOUS COGN, V12, P695, DOI 10.1016/S1053-8100(03)00052-7; Hohwy J, 2007, PSYCHE, V13; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2010, EFFORTLESS ATTENTION, P121, DOI DOI 10.7551/MITPRESS/9780262013840.003.0006; Hommel B, 2007, J CONSCIOUSNESS STUD, V14, P155; Hommel B, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P113; Honaker J., 2009, AMELIA 2 PROGRAM MIS; Hood B., 2012, SELF ILLUSION SOCIAL; Hurley S, 2008, BEHAV BRAIN SCI, V31, P1, DOI 10.1017/S0140525X07003123; Ichikawa M, 2006, VISION RES, V46, P2192, DOI 10.1016/j.visres.2005.12.021; Jeannerod M, 2004, MIND LANG, V19, P113, DOI 10.1111/j.1468-0017.2004.00251.x; Jordan J. S., 1989, VOLITIONAL ACTION CO, P371; Jordan JS, 2003, CONSCIOUS COGN, V12, P633, DOI 10.1016/S1053-8100(03)00075-8; Kumar D, 2013, P 35 ANN C COGN SCI; Limanowski J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00547; Mansell W, 2011, TOP COGN SCI, V3, P257, DOI 10.1111/j.1756-8765.2011.01140.x; MARKEN RS, 1986, J EXP PSYCHOL HUMAN, V12, P267, DOI 10.1037/0096-1523.12.3.267; Metzinger T., 2005, PSYCHE, V11, P1; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moore JW, 2009, COGNITION, V110, P279, DOI 10.1016/j.cognition.2008.11.006; Moore JW, 2012, CONSCIOUS COGN, V21, P1211; Pacherie E., 2011, OXFORD HDB SELF, P442; Pacherie E., 2007, PSYCHE INTERDISCIPL, V13, P30, DOI DOI 10.1093/ACPR0F:0S0/9780199988341.003.0020; Powers, 2005, BEHAV CONTROL PERCEP; Schneider DW, 2006, J EXP PSYCHOL GEN, V135, P623, DOI 10.1037/0096-3445.135.4.623; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Wegner D., 2008, ARE WE FREE PSYCHOL, P226; WEGNER DM, 2005, NEW UNCONSCIOUS, P19	43	19	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92431	10.1371/journal.pone.0092431	http://dx.doi.org/10.1371/journal.pone.0092431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642834	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900138
J	Mountzios, G; Aivazi, D; Kostopoulos, I; Kourea, HP; Kouvatseas, G; Timotheadou, E; Zebekakis, P; Efstratiou, I; Gogas, H; Vamvouka, C; Chrisafi, S; Stofas, A; Pentheroudakis, G; Koutras, A; Galani, E; Bafaloukos, D; Fountzilas, G				Mountzios, Giannis; Aivazi, Dimitra; Kostopoulos, Ioannis; Kourea, Helen P.; Kouvatseas, George; Timotheadou, Eleni; Zebekakis, Pantelis; Efstratiou, Ioannis; Gogas, Helen; Vamvouka, Chrisanthi; Chrisafi, Sofia; Stofas, Anastasios; Pentheroudakis, George; Koutras, Angelos; Galani, Eleni; Bafaloukos, Dimitrios; Fountzilas, George			Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes	PLOS ONE			English	Article							FACTOR-I RECEPTOR; THERAPEUTIC TARGET; PHASE-III; RISK; SURVIVAL; IGF-1; CELLS; IGF1R; ASSOCIATION; EPIRUBICIN	Introduction: We sought to determine the level of protein expression of the critical components of the insulin-like growth factor receptor (IGFR) pathway and to evaluate their prognostic significance across the different early breast cancer subtypes. Patients and Methods: Archival tumor tissue from 1,021 women with early, node positive breast cancer, who were prospectively evaluated within two randomized clinical trials, was used to construct tissue microarrays that were stained for hormone receptors (HR), Ki67, HER2, epidermal growth factor receptor (EGFR) and cytokeratins 5/6, to classify tumors into five immunophenotypical subgroups. Immunohistochemical (IHC) expression of IGF1R-alpha and beta subunits, IGF2R and IGF-binding protein 2 (IGFBP2) was assessed using the immunoreactive score (IRS). Repeated internal cross-validation was performed to examine the statistical validity of the cut off points for all biomarkers. Results: After a median follow-up time of 105.4 months, overall 370 women (36.2%) had relapsed and 270 (26.4%) had died. Tumors expressing IGF1R-alpha above the median IRS were significantly more frequently HR positive (luminal A+B+HER2), as compared to HER2-enriched and triple negative ones (p<0.001 for both comparisons). IGF2R was overexpressed significantly more frequently in HR negative tumors (p = 0.001) and had an inverse correlation with all other biomarkers. Patients with luminal A and B tumors with high IGF1R-alpha and negative EGFR expression (N = 190) had significantly higher 4-year survival rates, as compared to the rest (log-rank p = 0.046), as did patients with luminal A and B tumors with high IGF1R-alpha and low IGF2R expression, as compared to the rest (N = 91), (log-rank p = 0.035). After adjustment for significant variables, patients in the latter group had a relative 45% reduction in the risk of death, as compared to the rest (p = 0.035). Conclusion: Aberrant expression of components of the IGF1R pathway is associated with better clinical outcomes in women with luminal A and B, node positive, early breast cancer.	[Mountzios, Giannis] 251 Airforce Gen Hosp, Dept Med Oncol, Athens, Greece; [Aivazi, Dimitra; Chrisafi, Sofia; Fountzilas, George] Aristotle Univ Thessaloniki, Mol Oncol Lab, Sch Med, Hellen Fdn Canc Res, GR-54006 Thessaloniki, Greece; [Kostopoulos, Ioannis] Aristotle Univ Thessaloniki, Dept Pathol, Sch Med, GR-54006 Thessaloniki, Greece; [Kourea, Helen P.] Univ Hosp Patras, Dept Pathol, Rion, Greece; [Kouvatseas, George] Hlth Data Specialists Ltd, Athens, Greece; [Timotheadou, Eleni; Fountzilas, George] Aristotle Univ Thessaloniki, Dept Med Oncol, Sch Med, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece; [Zebekakis, Pantelis] Aristotle Univ Thessaloniki, Dept Internal Med 1, Sch Med, AHEPA Hosp, GR-54006 Thessaloniki, Greece; [Efstratiou, Ioannis] Papageorgiou Hosp, Dept Pathol, Thessaloniki, Greece; [Gogas, Helen] Univ Athens, Sch Med, Dept Med 1, Laiko Gen Hosp, GR-11527 Athens, Greece; [Vamvouka, Chrisanthi] Evangelismos Med Ctr, Dept Pathol, Athens, Greece; [Stofas, Anastasios] Natl & Kapodistrian Univ Athens, Dept Pathol, Athens 11528, Greece; [Pentheroudakis, George] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Koutras, Angelos] Univ Patras, Sch Med, Dept Med, Div Oncol,Univ Hosp, GR-26110 Patras, Greece; [Galani, Eleni] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Bafaloukos, Dimitrios] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; University of Patras; Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki; Ahepa University Hospital; Papageorgiou Hospital; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Evangelismos Hospital; National & Kapodistrian University of Athens; University Hospital Ioannina; University of Patras	Mountzios, G (corresponding author), 251 Airforce Gen Hosp, Dept Med Oncol, Athens, Greece.	gmountzios@gmail.com	TIMOTHEADOU, ELENI/AAM-6301-2020; Fountzilas, George/ABF-2139-2020; Mountzios, Giannis/ABE-1197-2020; Chrisafi, Sofia/AAH-2823-2020	Fountzilas, George/0000-0001-8045-2186	internal Hellenic Co-operative Oncology Group (HeCOG) research grant [HE R_10/10]	internal Hellenic Co-operative Oncology Group (HeCOG) research grant	The study did not have any external funding. The study was supported in part by an internal Hellenic Co-operative Oncology Group (HeCOG) research grant (HE R_10/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNETERRE J, 1990, CANCER RES, V50, P6931; Browne BC, 2012, BREAST CANCER RES TR, V136, P717, DOI 10.1007/s10549-012-2260-9; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Diallo-Danebrock R, 2007, CLIN CANCER RES, V13, P488, DOI 10.1158/1078-0432.CCR-06-1842; Doyle SL, 2012, AM J GASTROENTEROL, V107, P196, DOI 10.1038/ajg.2011.417; Foulstone EJ, 2013, ENDOCRINOLOGY, V154, P1780, DOI 10.1210/en.2012-1970; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Fountzilas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037946; Franks SE, 2012, ONCOGENE, V31, P3298, DOI 10.1038/onc.2011.486; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Gallicchio L, 2013, J CANCER RES CLIN, V139, P837, DOI 10.1007/s00432-013-1391-7; Gogas H, 2012, BREAST CANCER RES TR, V132, P609, DOI 10.1007/s10549-011-1913-4; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hartog H, 2012, ANTICANCER RES, V32, P1309; Hermani A, 2013, CELL SIGNAL, V25, P1395, DOI 10.1016/j.cellsig.2013.02.018; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Khajah MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041847; Kim JS, 2012, CANCER-AM CANCER SOC, V118, P2454, DOI 10.1002/cncr.26492; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Lin MZ, 2014, ONCOGENE, V33, P85, DOI 10.1038/onc.2012.538; Llanos AA, 2013, BREAST CANCER RES TR, V138, P571, DOI 10.1007/s10549-013-2452-y; Maor S, 2007, CANCER LETT, V257, P236, DOI 10.1016/j.canlet.2007.07.019; Martin EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049067; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meyer F, 2010, CLIN CANCER RES, V16, P1008, DOI 10.1158/1078-0432.CCR-09-2014; Mountzios G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054048; Muendlein A, 2013, J CANCER RES CLIN, V139, P491, DOI 10.1007/s00432-012-1355-3; Nahta Rita, 2012, Chemother Res Pract, V2012, P648965, DOI 10.1155/2012/648965; Nielsen TO, 2004, CANCER RES, V64, P286, DOI 10.1158/0008-5472.CAN-03-1242; PAPA V, 1993, CANCER RES, V53, P3736; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; RAILO MJ, 1994, EUR J CANCER, V30A, P307, DOI 10.1016/0959-8049(94)90247-X; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Shimizu C, 2004, HUM PATHOL, V35, P1537, DOI 10.1016/j.humpath.2004.09.005; Shin AS, 2007, BREAST CANCER RES TR, V105, P55, DOI 10.1007/s10549-006-9427-1; Soria JC, 2013, EUR J CANCER, V49, P1799, DOI 10.1016/j.ejca.2013.01.003; Ueda S, 2006, CANCER SCI, V97, P597, DOI 10.1111/j.1349-7006.2006.00228.x; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Warner E, 2011, NEW ENGL J MED, V365, P1025, DOI 10.1056/NEJMcp1101540; Werner H, 2012, LANCET ONCOL, V13, pE537, DOI 10.1016/S1470-2045(12)70362-5; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yerushalmi R, 2012, BREAST CANCER RES TR, V132, P131, DOI 10.1007/s10549-011-1529-8	48	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91407	10.1371/journal.pone.0091407	http://dx.doi.org/10.1371/journal.pone.0091407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637962	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100032
J	Polzin, K; Rokas, A				Polzin, Kenneth; Rokas, Antonis			Evaluating Rare Amino Acid Substitutions (RGC_CAMs) in a Yeast Model Clade	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; REPLACEMENTS; PHYLOGENETICS; COELOMATA; SEQUENCES; HOMOPLASY; EVOLUTION; ANIMALS; GENUS	When inferring phylogenetic relationships, not all sites in a sequence alignment are equally informative. One recently proposed approach that takes advantage of this inequality relies on sites that contain amino acids whose replacement requires multiple substitutions. Identifying these so-called RGC_CAM substitutions (after Rare Genomic Changes as Conserved Amino acids-Multiple substitutions) requires that, first, at any given site in the amino acid sequence alignment, there must be a minimum of two different amino acids; second, each amino acid must be present in at least two taxa; and third, the amino acids must require a minimum of two nucleotide substitutions to replace each other. Although theory suggests that RGC_CAM substitutions are expected to be rare and less likely to be homoplastic, the informativeness of RGC_CAM substitutions has not been extensively evaluated in biological data sets. We investigated the quality of RGC_CAM substitutions by examining their degree of homoplasy and internode certainty in nearly 2.7 million aligned amino acid sites from 5,261 proteins from five species belonging to the yeast Saccharomyces sensu stricto clade whose phylogeny is well-established. We identified 2,647 sites containing RGC_CAM substitutions, a number that contrasts sharply with the 100,887 sites containing RGC_non-CAM substitutions (i.e., changes between amino acids that require only a single nucleotide substitution). We found that RGC_CAM substitutions had significantly lower homoplasy than RGC_non-CAM ones; specifically RGC_CAM substitutions showed a per-site average homoplasy index of 0.100, whereas RGC_non-CAM substitutions had a homoplasy index of 0.215. Internode certainty values were also higher for sites containing RGC_CAM substitutions than for RGC_non-CAM ones. These results suggest that RGC_ CAM substitutions possess a strong phylogenetic signal and are useful markers for phylogenetic inference despite their rarity.	[Polzin, Kenneth; Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Rokas, A (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	antonis.rokas@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551	Graduate Program in Biological Sciences at Vanderbilt University; National Science Foundation [DEB-0844968]	Graduate Program in Biological Sciences at Vanderbilt University; National Science Foundation(National Science Foundation (NSF))	KP was funded by the Graduate Program in Biological Sciences at Vanderbilt University. Research in AR's laboratory is supported by the National Science Foundation (DEB-0844968). This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Cracraft J., 2004, ASSEMBLING TREE LIFE; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hittinger CT, 2013, TRENDS GENET, V29, P309, DOI 10.1016/j.tig.2013.01.002; Irimia M, 2007, MOL BIOL EVOL, V24, P1604, DOI 10.1093/molbev/msm105; Kitching I. J., 1998, CLADISTICS THEORY PR; Rogozin IB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-7; Rogozin IB, 2007, MOL BIOL EVOL, V24, P2594, DOI 10.1093/molbev/msm218; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rokas A, 1999, INSECT MOL BIOL, V8, P527, DOI 10.1046/j.1365-2583.1999.00149.x; Rokas A, 2008, MOL BIOL EVOL, V25, P1943, DOI 10.1093/molbev/msn143; Salichos L, 2014, MOL BIOL EV IN PRESS; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; SANDERSON MJ, 1989, EVOLUTION, V43, P1781, DOI 10.1111/j.1558-5646.1989.tb02626.x; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92213	10.1371/journal.pone.0092213	http://dx.doi.org/10.1371/journal.pone.0092213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637883	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100128
J	Dolzycka, D; Herzmann, G; Sommer, W; Wilhelm, O				Dolzycka, Dominika; Herzmann, Grit; Sommer, Werner; Wilhelm, Oliver			Can Training Enhance Face Cognition Abilities in Middle-Aged Adults?	PLOS ONE			English	Article							FACIAL AFFECT RECOGNITION; INDIVIDUAL-DIFFERENCES; DEVELOPMENTAL PROSOPAGNOSIA; CONGENITAL PROSOPAGNOSIA; DETAILED EXPLORATION; WORKING-MEMORY; OLDER-ADULTS; SPEED; INFORMATION; PLASTICITY	Face cognition is a crucial skill for social interaction and shows large individual differences in healthy adults, suggesting a possibility for improvement in some. We developed and tested specific training procedures for the accuracy of face memory and the speed of face cognition. Two groups each of 20 healthy middle-aged trainees practiced for 29 daily sessions of 15 minutes duration with different computerized home-based training procedures. In addition, 20 matched and 59 non-matched controls were included. Face cognition speed training enhanced performance during the training and transferred to the latent factor level as measured in a pre-post comparison. Persistence of the training effect was evidenced at the manifest level after three months. However, the training procedure influenced the speed of processing object stimuli to the same extent as face stimuli and therefore seems to have affected a more general ability of processing complex visual stimuli and not only faces. No effects of training on the accuracy of face memory were found. This study demonstrates that face-specific abilities may be hard to improve but also shows the plasticity of the speed of processing complex visual stimuli - for the first time in middle-aged, normal adults.	[Dolzycka, Dominika; Sommer, Werner] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Herzmann, Grit] Coll Wooster, Dept Psychol, Wooster, OH 44691 USA; [Wilhelm, Oliver] Univ Ulm, Dept Psychol, D-89069 Ulm, Germany	Humboldt University of Berlin; College of Wooster; Ulm University	Dolzycka, D (corresponding author), Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany.	dominika.dolzycka@hu-berlin.de	Sommer, Werner/N-1945-2019; Wilhelm, Oliver/K-6455-2012; Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; Wilhelm, Oliver/0000-0001-7980-1166; Dolzycka, Dominika/0000-0002-6177-8815	Deutsche Forschungsgemeinschaft [Wi 2667/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by a grant from the Deutsche Forschungsgemeinschaft (Wi 2667/2-2) to OW and WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; BARNETT V, 1994, OUTLIERS STAT DATA; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P554, DOI 10.1162/0898929053467613; Belleville S, 2006, DEMENT GERIATR COGN, V22, P486, DOI 10.1159/000096316; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Brunsdon R, 2006, COGN NEUROPSYCHOL, V23, P822, DOI 10.1080/02643290500441841; Bruyer R, 2007, ACTA PSYCHOL, V124, P159, DOI 10.1016/j.actpsy.2006.03.001; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Caldara R, 2005, J COGNITIVE NEUROSCI, V17, P1652, DOI 10.1162/089892905774597254; Chen S, 2010, ENCY RES DESIGN, P185; Chiller-Glaus S, 2009, TESTING LIMITS FACE; Chiller-Glaus S, 2007, IDENTITY VERIFICATIO, P1327; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Danthiir V., 2005, PSYCHOL SCI, V47, P200; DeGutis J, 2011, NEUROPSYCHOLOGIA, V49, P2505, DOI 10.1016/j.neuropsychologia.2011.04.031; DeGutis JM, 2007, J COGNITIVE NEUROSCI, V19, P1790, DOI 10.1162/jocn.2007.19.11.1790; Duchaine BC, 2004, NEURON, V43, P469, DOI 10.1016/j.neuron.2004.08.006; Edwards JD, 2009, J GERONTOL A-BIOL, V64, P1262, DOI 10.1093/gerona/glp131; ELLIOTT ES, 1973, B PSYCHONOMIC SOC, V2, P71, DOI 10.3758/BF03327717; ELLIS HD, 1988, DEV NEUROPSYCHOL, V4, P283, DOI 10.1080/87565648809540412; Germine LT, 2011, COGNITION, V118, P201, DOI 10.1016/j.cognition.2010.11.002; GOLDMAN SR, 1989, J EDUC PSYCHOL, V81, P481, DOI 10.1037/0022-0663.81.4.481; GOLDSTEIN AG, 1985, B PSYCHONOMIC SOC, V23, P211; Gunther VK, 2003, AGING MENT HEALTH, V7, P200, DOI 10.1080/1360786031000101175; Hager W, 2000, EVALUATION PSYCHOL I, P41; Hair J.F., 2010, MULTIVARIATE DATA AN, P1; Harting C, 2000, WECHSLER MEMORY SCAL; Herzmann G, 2008, BEHAV RES METHODS, V40, P840, DOI 10.3758/BRM.40.3.840; Herzmann G, 2010, J COGNITIVE NEUROSCI, V22, P571, DOI 10.1162/jocn.2009.21249; Hildebrandt A, 2013, PSYCHOL AGING, V28, P243, DOI 10.1037/a0031490; Hildebrandt A, 2012, COGNITION EMOTION, V26, P650, DOI 10.1080/02699931.2011.602046; Hildebrandt A, 2011, PSYCHOL AGING, V26, P701, DOI 10.1037/a0023056; Hildebrandt A, 2010, PSYCHOL AGING, V25, P794, DOI 10.1037/a0019774; Hopkins IM, 2011, J AUTISM DEV DISORD, V41, P1543, DOI 10.1007/s10803-011-1179-z; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hussain Z, 2009, VISION RES, V49, P2273, DOI 10.1016/j.visres.2009.06.014; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Kaufmann JM, 2013, NEUROPSYCHOLOGIA, V51, P1310, DOI 10.1016/j.neuropsychologia.2013.03.015; Kaufmann JM, 2009, J COGNITIVE NEUROSCI, V21, P625, DOI 10.1162/jocn.2009.21080; Kesslak JP, 1997, BEHAV NEUROL, V10, P137, DOI 10.3233/BEN-1997-10407; Klauer KJ, 2001, HDB KOGNITIVES TRAIN, P3; Kliegl R, 2001, COMMUNICATION TECHNO, P169; Kliegl R, 2006, EXTENDING INTELLIGEN; Lander K, 2007, MEMORY, V15, P63, DOI 10.1080/09658210601108732; Lindenberger U, 1991, AGING PROFESSIONAL E; Maichle U, 1992, LERN DENKSTRATEGIEN, P167; Malpass R.S., 1981, PERCEIVING REMEMBERI, P271; MALPASS RS, 1973, PERCEPT PSYCHOPHYS, V14, P285, DOI 10.3758/BF03212392; McArdle J.J., 1994, LIFE SPAN DEV PSYCH, P223, DOI DOI 10.4324/9781315792712-10; McArdle JJ, 2008, PSYCHOL AGING, V23, P702, DOI 10.1037/a0014349; McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612; Meredith W, 2006, MED CARE, V44, pS69, DOI 10.1097/01.mlr.0000245438.73837.89; Moore S, 2001, NEUROPSYCHOL REHABIL, V11, P245, DOI 10.1080/09602010042000222; Mulaik SA, 2009, LINEAR CAUSAL MODELI; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Neta M, 2011, NEUROIMAGE, V56, P1685, DOI 10.1016/j.neuroimage.2011.02.051; O'Brien JL, 2011, PSYCHOPHYSIOLOGY, V48, pS39; Raven JC, 1979, MANUAL RAVENS PROGR; Russell R, 2012, NEUROPSYCHOLOGIA, V50, P334, DOI 10.1016/j.neuropsychologia.2011.12.004; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; Sandman CA, 1993, CLIN GERONTOLOGIST, V13, P19, DOI DOI 10.1300/J018V13N04_03; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Sekiguchi T, 2011, ACTA PSYCHOL, V137, P1, DOI 10.1016/j.actpsy.2011.01.014; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shiran A, 2011, J NEUROLINGUIST, V24, P524, DOI 10.1016/j.jneuroling.2010.12.001; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Sommer W, 2013, ACTA PSYCHOL, V142, P62, DOI 10.1016/j.actpsy.2012.11.001; SPORER SL, 1991, J EXP PSYCHOL LEARN, V17, P323, DOI 10.1037/0278-7393.17.2.323; Sporer SL, 1992, WIEDERERKENNEN GESIC; Wilhelm O, 2010, J PERS SOC PSYCHOL, V99, P530, DOI 10.1037/a0019972; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; Wolwer W, 2005, SCHIZOPHR RES, V80, P295, DOI 10.1016/j.schres.2005.07.018; Wong ACN, 2009, PSYCHOL SCI, V20, P1108, DOI 10.1111/j.1467-9280.2009.02430.x; WOODHEAD MM, 1979, ERGONOMICS, V22, P333, DOI 10.1080/00140137908924617; Yang LX, 2006, PSYCHOL AGING, V21, P372, DOI 10.1037/0882-7974.21.2.372; Yang LX, 2009, J GERONTOL B-PSYCHOL, V64, P608, DOI 10.1093/geronb/gbp063; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x	84	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90249	10.1371/journal.pone.0090249	http://dx.doi.org/10.1371/journal.pone.0090249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632743	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400011
J	Hang, J; Forshey, BM; Yang, Y; Solorzano, VF; Kuschner, RA; Halsey, ES; Jarman, RG; Kochel, TJ				Hang, Jun; Forshey, Brett M.; Yang, Yu; Solorzano, Victor Fiestas; Kuschner, Robert A.; Halsey, Eric S.; Jarman, Richard G.; Kochel, Tadeusz J.			Genomic Characterization of Group C Orthobunyavirus Reference Strains and Recent South American Clinical Isolates	PLOS ONE			English	Article							ARTHROPOD-BORNE VIRUSES; MOLECULAR EPIDEMIOLOGY; FAMILY BUNYAVIRIDAE; S SEGMENT; RNA; IDENTIFICATION; SEQUENCE; POLYMERASE; PROMALS; BIOLOGY	Group C orthobunyaviruses (family Bunyaviridae, genus Orthobunyavirus), discovered in the 1950s, are vector-borne human pathogens in the Americas. Currently there is a gap in genomic information for group C viruses. In this study, we obtained complete coding region sequences of reference strains of Caraparu (CARV), Oriboca (ORIV), Marituba (MTBV) and Madrid (MADV) viruses, and five clinical isolates from Peru and Bolivia, using an unbiased de novo approach consisting of random reverse transcription, random anchored PCR amplification, and high throughput pyrosequencing. The small, medium, and large segments encode for a 235 amino acid nucleocapsid protein, an approximately 1430 amino acid surface glycoprotein polyprotein precursor, and a 2248 amino acid RNA-dependent RNA polymerase, respectively. Additionally, the S segment encodes for an 83 amino acid non-structural protein, although this protein is truncated or silenced in some isolates. Phylogenetically, three clinical isolates clustered with CARV, one clustered with MTBV, and one isolate appeared to be a reassortant or a genetic drift resulted from the high variability of the medium segment which was also seen in a few other orthobunyaviruses. These data represent the first complete coding region sequences for this serocomplex of pathogenic orthobunyaviruses. The genome-wide phylogeny of reference strains is consistent with the antigenic properties of the viruses reported in the original serological studies conducted in the 1960s. Comparative analysis of conserved protein regions across group C virus strains and the other orthobunyavirus groups revealed that these group C viruses contain characteristic domains of potential structural and functional significance. Our results provide the basis for the developments of diagnostics, further genetic analyses, and future epidemiologic studies of group C viruses.	[Hang, Jun; Yang, Yu; Kuschner, Robert A.; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA; [Forshey, Brett M.; Jarman, Richard G.] US Naval Med Res Unit, Lima, Peru; [Solorzano, Victor Fiestas] Inst Nacl Salud, Ctr Nacl Salud Publ, Lima, Peru; [Kochel, Tadeusz J.] US Naval Med Res Ctr, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Instituto Nacional de Salud - Peru; Naval Medical Research Center (NMRC)	Hang, J (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.	jun.hang.ctr@mail.mil	Fiestas, Victor/J-6894-2019; Halsey, Eric/AAC-8110-2022	Fiestas, Victor/0000-0002-5554-3542; Halsey, Eric/0000-0001-6291-8923	Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center	Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center	This work was supported by the Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2010, AM J TROP MED HYG, V83, P714, DOI 10.4269/ajtmh.2010.10-0116; Ariza A, 2013, NUCLEIC ACIDS RES, V41, P5912, DOI 10.1093/nar/gkt268; Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; Briese T, 2007, ARCH VIROL, V152, P2237, DOI 10.1007/s00705-007-1069-z; Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030; CASALS J, 1961, AM J TROP MED HYG, V10, P250, DOI 10.4269/ajtmh.1961.10.250; Chowdhary R, 2012, J GEN VIROL, V93, P1023, DOI 10.1099/vir.0.039479-0; Coupeau D, 2013, J GEN VIROL, V94, P1168, DOI 10.1099/vir.0.051821-0; Magalhaes CLD, 2011, ARCH VIROL, V156, P1173, DOI 10.1007/s00705-011-0976-1; DERODANICHE E, 1964, AM J TROP MED HYG, V13, P839, DOI 10.4269/ajtmh.1964.13.839; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eifan S, 2013, VIRUSES-BASEL, V5, P2447, DOI 10.3390/v5102447; Eifan SA, 2009, J VIROL, V83, P11307, DOI 10.1128/JVI.01460-09; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Fischer M, 2013, J GEN VIROL, V94, P1161, DOI 10.1099/vir.0.049908-0; Forshey BM, 2014, J VIROL, V88, P3052, DOI 10.1128/JVI.03295-13; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; Hang Jun, 2012, J Biomol Tech, V23, P4, DOI 10.7171/jbt.12-2301-001; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Lambert AJ, 2009, J CLIN MICROBIOL, V47, P2398, DOI 10.1128/JCM.00182-09; Lanciotti RS, 2013, VIROLOGY, V444, P55, DOI 10.1016/j.virol.2013.05.031; Magalhaes CLD, 2007, VIRUS GENES, V35, P681, DOI 10.1007/s11262-007-0138-4; Mohamed M, 2009, J VIROL, V83, P7612, DOI 10.1128/JVI.02080-08; Mores CN, 2009, VECTOR-BORNE ZOONOT, V9, P25, DOI 10.1089/vbz.2008.0030; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Nunes MRT, 2005, J VIROL, V79, P10561, DOI 10.1128/JVI.79.16.10561-10570.2005; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pinheiro F, 1994, HDB ZOONOSES F, P212; Plyusnin A, 2012, VIRUS TAXONOMY, P725; Reguera J, 2013, P NATL ACAD SCI USA, V110, P7246, DOI 10.1073/pnas.1302298110; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Shi XH, 2009, J GEN VIROL, V90, P2483, DOI 10.1099/vir.0.013540-0; SHOPE RE, 1962, AM J TROP MED HYG, V11, P283, DOI 10.4269/ajtmh.1962.11.283; SRIHONGS.S, 1966, AM J TROP MED HYG, V15, P379, DOI 10.4269/ajtmh.1966.15.379; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2; Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Yanase T, 2012, ARCH VIROL, V157, P1611, DOI 10.1007/s00705-012-1341-8	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92114	10.1371/journal.pone.0092114	http://dx.doi.org/10.1371/journal.pone.0092114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633174	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400143
J	Lago, BV; Mello, FC; Ribas, FS; Valente, F; Soares, CC; Niel, C; Gomes, SA				Lago, Barbara V.; Mello, Francisco C.; Ribas, Flavia S.; Valente, Fatima; Soares, Caroline C.; Niel, Christian; Gomes, Selma A.			Analysis of Complete Nucleotide Sequences of Angolan Hepatitis B Virus Isolates Reveals the Existence of a Separate Lineage within Genotype E	PLOS ONE			English	Article							ANTI-HBS ANTIBODIES; SURFACE-ANTIGEN; PHYLOGENETIC ANALYSIS; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; BELGIAN PATIENTS; HIGH PREVALENCE; AFRICAN; EPIDEMIOLOGY; CARRIERS	Hepatitis B virus genotype E (HBV/E) is highly prevalent in Western Africa. In this work, 30 HBV/E isolates from HBsAg positive Angolans (staff and visitors of a private hospital in Luanda) were genetically characterized: 16 of them were completely sequenced and the pre-S/S sequences of the remaining 14 were determined. A high proportion (12/30, 40%) of subjects tested positive for both HBsAg and anti-HBs markers. Deduced amino acid sequences revealed the existence of specific substitutions and deletions in the B-and T-cell epitopes of the surface antigen (pre-S1- and pre-S2 regions) of the virus isolates derived from 8/12 individuals with concurrent HBsAg/anti-HBs. Phylogenetic analysis performed with 231 HBV/E full-length sequences, including 16 from this study, showed that all isolates from Angola, Namibia and the Democratic Republic of Congo (n = 28) clustered in a separate lineage, divergent from the HBV/E isolates from nine other African countries, namely Cameroon, Central African Republic, Cote d'Ivoire, Ghana, Guinea, Madagascar, Niger, Nigeria and Sudan, with a Bayesian posterior probability of 1. Five specific mutations, namely small S protein T57I, polymerase Q177H, G245W and M612L, and X protein V30L, were observed in 79-96% of the isolates of the separate lineage, compared to a frequency of 0-12% among the other HBV/E African isolates.	[Lago, Barbara V.; Mello, Francisco C.; Ribas, Flavia S.; Soares, Caroline C.; Niel, Christian; Gomes, Selma A.] Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil; [Valente, Fatima] Minist Hlth, Eduardo dos Santos Fdn, Luanda, Angola	Fundacao Oswaldo Cruz	Gomes, SA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil.	selma@ioc.fiocruz.br	Soares, Caroline Cordeiro/ABM-8961-2022; gomes, selma A/D-2762-2015; Niel, Christian/G-3712-2013	Gomes, Selma/0000-0003-0233-3370	Fiocruz; CNPq	Fiocruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Sources of funding that have supported the work: Fiocruz, CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Bottecchia M, 2008, J GASTROEN HEPATOL, V23, P67, DOI 10.1111/j.1440-1746.2007.05238.x; Bottecchia M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-11; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupinay T, 2010, J MED VIROL, V82, P1515, DOI 10.1002/jmv.21865; Fujiwara K, 2005, WORLD J GASTROENTERO, V11, P6410, DOI 10.3748/wjg.v11.i41.6410; Ganne-Carrie N, 2006, J MED VIROL, V78, P335, DOI 10.1002/jmv.20545; GUNTHER S, 1995, J VIROL, V69, P5437; HEIJTINK RA, 1982, J MED VIROL, V10, P83, DOI 10.1002/jmv.1890100202; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Jang JS, 2009, J MED VIROL, V81, P1531, DOI 10.1002/jmv.21577; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lee BS, 2013, J MED VIROL, V85, P1327, DOI 10.1002/jmv.23594; Margeridon S, 2005, J GEN VIROL, V86, P1687, DOI 10.1099/vir.0.80810-0; Martel N, 2013, J VIROL METHODS, V193, P653, DOI 10.1016/j.jviromet.2013.07.045; Mathet VL, 2006, J CLIN MICROBIOL, V44, P3435, DOI 10.1128/JCM.00866-06; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; Odemuyiwa SO, 2001, J MED VIROL, V65, P463, DOI 10.1002/jmv.2058; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pourkarim MR, 2011, J MED VIROL, V83, P1876, DOI 10.1002/jmv.22174; Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015; Pourkarim MR, 2010, J MED VIROL, V82, P379, DOI 10.1002/jmv.21726; Rambaut A, 2009, FIGTREE V1 3 1 TREE; SHIELS MT, 1987, GASTROENTEROLOGY, V93, P675, DOI 10.1016/0016-5085(87)90427-6; Sitnik R, 2007, BRAZ J MED BIOL RES, V40, P1689, DOI 10.1590/S0100-879X2007001200013; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSANG TK, 1986, DIGEST DIS SCI, V31, P620, DOI 10.1007/BF01318693; Valente F, 2010, MEM I OSWALDO CRUZ, V105, P970, DOI 10.1590/S0074-02762010000800004; Wang Y. M., 1996, Singapore Medical Journal, V37, P150; Wang YM, 1999, J GASTROENTEROL, V34, P600, DOI 10.1007/s005350050379; Zhang DK, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-307	47	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92223	10.1371/journal.pone.0092223	http://dx.doi.org/10.1371/journal.pone.0092223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632784	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400152
J	Nataraj, R; Evans, PJ; Seitz, WH; Li, ZM				Nataraj, Raviraj; Evans, Peter J.; Seitz, William H., Jr.; Li, Zong-Ming			Effects of Carpal Tunnel Syndrome on Reach-to-Pinch Performance	PLOS ONE			English	Article							PROPRIOCEPTIVE FEEDBACK; PREHENSION MOVEMENTS; INDEX FINGER; HAND; COORDINATION; DIAGNOSIS; SYMPTOMS; POSITION; GRASP; THUMB	Background: Carpal tunnel syndrome (CTS) compromises fine sensorimotor function during activities of daily living. Reach-to-pinch for a small object requires not only dexterity of the grasping digits, but also coordinated transport of the hand to the target. This study examined the effects of CTS on the kinematic performance of reach-to-pinch maneuver. Methods: Eleven CTS subjects and 11 able-bodied (ABL) controls donned markers for motion capture of the hand, thumb and index finger during reach-to-pinch. Subjects were presented with a virtual target they could see without seeing their reaching upper-extremity. Subjects were instructed to reach to and grasp a virtual object as accurately and precisely as possible. Performance was assessed by variability of the movement trajectories of the digits and hand, the accuracy relative to the target, and precision of pinch contact over repetitive trials. Findings: The CTS group demonstrated significantly increased movement variability in inter-pad distance, joint angles, and transport of the hand compared to ABL controls (p<0.01). CTS subjects also exhibited reductions in accuracy (41%) and precision (33%) of their pinch contact location (p<0.05). Interpretation: CTS adversely affects the ability to execute the reach-to-pinch maneuver. Reduced performance was shown in terms of increased variability for both grasp and transport and the ability to locate the grasping digits relative to a target-object. These performance indices could be used for diagnostic and evaluative purposes of CTS.	[Nataraj, Raviraj; Li, Zong-Ming] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Evans, Peter J.; Seitz, William H., Jr.; Li, Zong-Ming] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, ZM (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	liz4@ccf.org	Nataraj, Raviraj/G-4535-2010	Nataraj, Raviraj/0000-0002-5261-3031	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR056964]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056964] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR056964. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castiello U, 1998, EXP BRAIN RES, V120, P31, DOI 10.1007/s002210050375; Connolly JD, 1999, EXP BRAIN RES, V125, P281, DOI 10.1007/s002210050684; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; Domalain M, 2008, ERGONOMICS, V51, P1441, DOI 10.1080/00140130802130225; Dubrowski A, 2002, EXP BRAIN RES, V145, P365, DOI 10.1007/s00221-002-1120-y; Gay A, 2007, JOINT BONE SPINE, V74, P461, DOI 10.1016/j.jbspin.2006.10.010; Gehrmann S, 2008, J HAND SURG-AM, V33A, P1069, DOI 10.1016/j.jhsa.2008.02.030; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Hibbard PB, 2003, EXP BRAIN RES, V148, P196, DOI 10.1007/s00221-002-1295-2; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; JEANNEROD M, 1981, J PHYSIOLOGY PARIS, V77, pA54; Keith MW, 2009, J AM ACAD ORTHOP SUR, V17, P397, DOI 10.5435/00124635-200906000-00008; Keith MW, 2009, J AM ACAD ORTHOP SUR, V17, P389, DOI 10.5435/00124635-200906000-00007; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Napadow V, 2006, NEUROIMAGE, V31, P520, DOI 10.1016/j.neuroimage.2005.12.017; Nataraj R, 2013, COMPUTER METHODS BIO; Nataraj R, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024753; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PHALEN GS, 1966, J BONE JOINT SURG AM, VA 48, P211, DOI 10.2106/00004623-196648020-00001; Radwin RG, 2004, J BONE JOINT SURG AM, V86A, P2614, DOI 10.2106/00004623-200412000-00005; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; Shen ZLL, 2012, GAIT POSTURE, V36, P643, DOI 10.1016/j.gaitpost.2012.04.012; SILVERSTEIN BA, 1987, AM J IND MED, V11, P343, DOI 10.1002/ajim.4700110310; Stevens JC, 1999, MUSCLE NERVE, V22, P1448, DOI 10.1002/(SICI)1097-4598(199910)22:10<1448::AID-MUS17>3.3.CO;2-P	24	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92063	10.1371/journal.pone.0092063	http://dx.doi.org/10.1371/journal.pone.0092063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632925	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400138
J	Ng, KP; Stringer, SJ; Jesky, MD; Yadav, P; Athwal, R; Dutton, M; Ferro, CJ; Cockwell, P				Ng, Khai P.; Stringer, Stephanie J.; Jesky, Mark D.; Yadav, Punit; Athwal, Rajbir; Dutton, Mary; Ferro, Charles J.; Cockwell, Paul			Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study	PLOS ONE			English	Article							SERUM URIC-ACID; GLYCATION END-PRODUCTS; VASCULAR OXIDATIVE STRESS; ALL-CAUSE MORTALITY; MIDDLE-AGED MEN; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION; OXIDANT STRESS	Background: Arterial stiffness is increased in patients with CKD and is a powerful predictor of cardiovascular morbidity and mortality. Use of the xanthine oxidase inhibitor allopurinol has been shown to improve endothelial function, reduce left ventricular hypertrophy and possibly improve cardiovascular outcome. We explored the relationship between use of allopurinol and arterial stiffness in patients with chronic kidney disease (CKD). Methods: Cross-sectional observational study of 422 patients with CKD with evidence of, or at high risk of, renal disease progression. Arterial stiffness was determined by carotid-femoral pulse wave velocity (PWV). Results: The mean age was 63 +/- 16 years, median estimated glomerular filtration rate was 25 (interquartile range: 19-31) ml/min/1.73 m(2) and mean PWV was 10.2 +/- 2.4 m/s. Seventy-seven patients (18%) were receiving regular allopurinol, 61% at a dose of 100 mg/day (range: 50-400 mg/day). Patients receiving allopurinol had significantly lower peripheral pulse pressure, central pulse pressure, central systolic blood pressure, serum uric acid level tissue advanced glycation end product levels but comparable high-sensitivity C-reactive protein levels. Use of allopurinol was associated with lower PWV. After adjusting for age, gender, ethnicity, tissue advanced glycation end product level, peripheral pulse pressure, smoking pack years, presence of diabetes mellitus and use of angiotensin converting enzyme inhibitor or angiotensin II receptor blocker, the use of allopurinol remained a significant independent determinant of PWV (mean difference: -0.63 m/s; 95% CI, -0.09 to -1.17 m/s, p = 0.02). Conclusion: In patients with CKD, use of allopurinol is independently associated with lower arterial stiffness. This study provides further justification for a large definitive randomised controlled trial examining the therapeutic potential of allopurinol to reduce cardiovascular risk in people with CKD.	[Ng, Khai P.; Stringer, Stephanie J.; Jesky, Mark D.; Yadav, Punit; Athwal, Rajbir; Dutton, Mary; Ferro, Charles J.; Cockwell, Paul] Queen Elizabeth Hosp Birmingham, Dept Renal Med, Birmingham, W Midlands, England; [Stringer, Stephanie J.; Jesky, Mark D.; Yadav, Punit; Ferro, Charles J.; Cockwell, Paul] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Cockwell, P (corresponding author), Queen Elizabeth Hosp Birmingham, Dept Renal Med, Birmingham, W Midlands, England.	paul.cockwell@uhb.nhs.uk	Ferro, Charles J./O-8912-2016; Stefanadis, Christodoulos/ABH-2232-2020; ferro, charles/L-7250-2019	Ferro, Charles J./0000-0003-0577-7081; Stefanadis, Christodoulos/0000-0001-5974-6454; ferro, charles/0000-0003-0577-7081; Cockwell, Paul/0000-0003-1975-266X	JABBS foundation (Birmingham, United Kingdom); University Hospital Birmingham Charities; British Renal Society; National Institute for Health; National Institute for Health Research [PDF-2012-05-205] Funding Source: researchfish	JABBS foundation (Birmingham, United Kingdom); University Hospital Birmingham Charities; British Renal Society; National Institute for Health; National Institute for Health Research(National Institute for Health Research (NIHR))	The study is supported by JABBS foundation (Birmingham, United Kingdom) (URL: http://opencharities.org/charities/1128402), University Hospital Birmingham Charities (URL: http://qehb.org/) and the British Renal Society (URL: http://www.britishrenal.org/). CJF is supported through a National Institute for Health Research Fellowship (URL: http://www.nihrtcc.nhs.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2012, J CLIN HYPERTENSION; Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Altman DG., 1999, PRACTICAL STAT MED R; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Edwards N Lawrence, 2008, Cleve Clin J Med, V75 Suppl 5, pS13; ERCAN ZS, 1992, GEN PHARMACOL-VASC S, V23, P1149, DOI 10.1016/0306-3623(92)90303-2; Erdogan D, 2005, INT J CLIN PRACT, V59, P1276, DOI 10.1111/j.1742-1241.2005.00621.x; Eskurza I, 2004, AM J PHYSIOL-HEART C, V286, pH1528, DOI 10.1152/ajpheart.00879.2003; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Galley HF, 1997, CLIN SCI, V92, P361, DOI 10.1042/cs0920361; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hickson SS, 2009, HYPERTENS RES, V32, P1079, DOI 10.1038/hr.2009.154; Hozawa A, 2006, ATHEROSCLEROSIS, V187, P401, DOI 10.1016/j.atherosclerosis.2005.09.020; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Jia N, 2012, CARDIOVASC THER, V30, P117, DOI 10.1111/j.1755-5922.2010.00243.x; Kals J, 2006, AM J HYPERTENS, V19, P902, DOI 10.1016/j.amjhyper.2006.02.003; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kao MP, 2011, J AM SOC NEPHROL, V22, P1382, DOI 10.1681/ASN.2010111185; Kasal DAB, 2008, HISTOL HISTOPATHOL, V23, P1241, DOI 10.14670/HH-23.1241; Kostka-Jeziorny K, 2011, BLOOD PRESSURE, V20, P104, DOI 10.3109/08037051.2010.532323; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li Yu-lin, 2011, Zhonghua Nei Ke Za Zhi, V50, P555; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Miller E R 3rd, 1997, J Cardiovasc Risk, V4, P19; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Mottram P, 1999, ATHEROSCLEROSIS, V145, P399, DOI 10.1016/S0021-9150(99)00073-8; Mulder DJ, 2008, ATHEROSCLEROSIS, V197, P217, DOI 10.1016/j.atherosclerosis.2007.03.027; Mulder DJ, 2011, ATHEROSCLEROSIS, V218, P102, DOI 10.1016/j.atherosclerosis.2011.05.011; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Pucci G, 2013, J HYPERTENS, V31, P77, DOI 10.1097/HJH.0b013e32835a8eb1; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Schutte AE, 2004, INT J VITAM NUTR RES, V74, P285, DOI 10.1024/0300-9831.74.4.285; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wei L, 2011, BRIT J CLIN PHARMACO, V71, P600, DOI 10.1111/j.1365-2125.2010.03887.x; Wilkinson IB, 2000, J PHYSIOL-LONDON, V525, P263, DOI 10.1111/j.1469-7793.2000.t01-1-00263.x; Wray DW, 2009, CLIN SCI, V116, P433, DOI 10.1042/CS20080337; Wright JM, 2001, BLOOD PRESS MONIT, V6, P161, DOI 10.1097/00126097-200106000-00008; Yamagishi S, 2012, BBA-GEN SUBJECTS, V1820, P663, DOI 10.1016/j.bbagen.2011.03.014; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yelken B, 2012, CLIN NEPHROL, V77, P275, DOI 10.5414/CN107352; Zureik M, 2004, ARTERIOSCL THROM VAS, V24, P1485, DOI 10.1161/01.ATV.0000136648.62973.c8	60	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91961	10.1371/journal.pone.0091961	http://dx.doi.org/10.1371/journal.pone.0091961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632580	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400126
J	Obata, R; Yanagi, Y				Obata, Ryo; Yanagi, Yasuo			Quantitative Analysis of Cone Photoreceptor Distribution and Its Relationship with Axial Length, Age, and Early Age-Related Macular Degeneration	PLOS ONE			English	Article							OUTER NUCLEAR LAYER; ADAPTIVE OPTICS; PACKING DENSITY; FELLOW EYE; MACULOPATHY; IMAGES; ECCENTRICITY	Purpose: It has not been clarified whether early age-related macular degeneration (AMD) is associated with cone photoreceptor distribution. We used adaptive optics fundus camera to examine cone photoreceptors in the macular area of aged patients and quantitatively analyzed its relationship between the presence of early AMD and cone distribution. Methods: Sixty cases aged 50 or older were studied. The eyes were examined with funduscopy and spectral-domain optical coherence tomography to exclude the eyes with any abnormalities at two sites of measurement, 2 degrees superior and 5 degrees temporal to the fovea. High-resolution retinal images with cone photoreceptor mosaic were obtained with adaptive optics fundus camera (rtx1, Imagine Eyes, France). After adjusting for axial length, cone packing density was calculated and the relationship with age, axial length, or severity of early AMD based on the age-related eye disease study (AREDS) classification was analyzed. Results: Patient's age ranged from 50 to 77, and axial length from 21.7 to 27.5 mm. Mean density in metric units and that in angular units were 24,900 cells/mm(2), 2,170 cells/deg(2) at 2 degrees superior, and 18,500 cells/mm(2), 1,570 cels/deg(2) at 5 degrees temporal, respectively. Axial length was significantly correlated with the density calculated in metric units, but not with that in angular units. Age was significantly correlated with the density both in metric and angular units at 2 degrees superior. There was no significant difference in the density in metric and angular units between the eyes with AREDS category one and those with categories two or three. Conclusion: Axial length and age were significantly correlated with parafoveal cone photoreceptor distribution. The results do not support that early AMD might influence cone photoreceptor density in the area without drusen or pigment abnormalities.	[Obata, Ryo; Yanagi, Yasuo] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Obata, R (corresponding author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan.	robata-tky@umin.ac.jp	Yanagi, Yasuo/AAF-2670-2020; Yanagi, Yasuo/AAA-5441-2022	Obata, Ryo/0000-0002-1762-0797; Yanagi, Yasuo/0000-0002-0362-7285	Ministry of Education, Culture, Sports, Science and Technology of Japan [24791837]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant in Aid for scientific research (B) number 24791837 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Boretsky A, 2012, LASER SURG MED, V44, P603, DOI 10.1002/lsm.22070; BROWN B, 1986, AM J OPTOM PHYS OPT, V63, P450; Chui TYP, 2012, INVEST OPHTH VIS SCI, V53, P3545, DOI 10.1167/iovs.11-8694; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Cooper RF, 2013, OPHTHAL PHYSL OPT, V33, P540, DOI 10.1111/opo.12070; Curcio CA, 2000, INVEST OPHTH VIS SCI, V41, P2015; CURCIO CA, 1992, VISUAL NEUROSCI, V9, P169, DOI 10.1017/S0952523800009639; Curcio CA, 2001, EYE, V15, P376, DOI 10.1038/eye.2001.140; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; EISNER A, 1991, INVEST OPHTH VIS SCI, V32, P8; EISNER A, 1987, INVEST OPHTH VIS SCI, V28, P1832; Garrioch R, 2012, OPTOMETRY VISION SCI, V89, P632, DOI 10.1097/OPX.0b013e3182540562; GARTNER S, 1981, BRIT J OPHTHALMOL, V65, P23, DOI 10.1136/bjo.65.1.23; Godara P, 2010, OPTOMETRY VISION SCI, V87, P930, DOI 10.1097/OPX.0b013e3181ff9a8b; IWASAKI M, 1988, INVEST OPHTH VIS SCI, V29, P671; Jackson GR, 2002, AGEING RES REV, V1, P381, DOI 10.1016/S1568-1637(02)00007-7; Jackson GR, 2000, VISION RES, V40, P2467, DOI 10.1016/S0042-6989(00)00108-5; Johnson PT, 2003, INVEST OPHTH VIS SCI, V44, P4481, DOI 10.1167/iovs.03-0436; Kam JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013127; Kanis MJ, 2008, INVEST OPHTH VIS SCI, V49, P2077, DOI 10.1167/iovs.07-1181; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kitaguchi Y, 2007, JPN J OPHTHALMOL, V51, P456, DOI 10.1007/s10384-007-0477-7; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lombardo M, 2014, RETINA-J RET VIT DIS, V34, P546, DOI 10.1097/IAE.0b013e3182a10850; Lombardo M, 2013, SENSORS-BASEL, V13, P334, DOI 10.3390/s130100334; Lombardo M, 2012, OPHTHALMOLOGY, V119, P1498, DOI 10.1016/j.ophtha.2012.03.019; Miller DT, 1996, VISION RES, V36, P1067, DOI 10.1016/0042-6989(95)00225-1; Mrejen S, 2013, OPHTHALMOLOGY, DOI [10.1016/j.ophtha.2013.09.026, DOI 10.1016/J.0PHTHA.2013.09.026]; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Ooto S, 2010, OPHTHALMOLOGY, V117, P1800, DOI 10.1016/j.ophtha.2010.01.042; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; SANDBERG MA, 1993, INVEST OPHTH VIS SCI, V34, P3477; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Song HX, 2011, INVEST OPHTH VIS SCI, V52, P7376, DOI 10.1167/iovs.11-7199; SWANN PG, 1991, OPHTHAL PHYSL OPT, V11, P59, DOI 10.1111/j.1475-1313.1991.tb00196.x; Tojo N, 2013, CLIN OPHTHALMOL, V7, P203, DOI 10.2147/OPTH.S39879; TUCKER GS, 1986, INVEST OPHTH VIS SCI, V27, P708; Wolfing JI, 2006, OPHTHALMOLOGY, V113, P1014, DOI 10.1016/j.ophtha.2006.01.056; Wu ZC, 2013, INVEST OPHTH VIS SCI, V54, P2800, DOI 10.1167/iovs.13-11613	50	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91873	10.1371/journal.pone.0091873	http://dx.doi.org/10.1371/journal.pone.0091873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632778	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400112
J	Sato, M; Hiraoka, M; Suzuki, H; Sakima, M; Al Mamun, A; Yamane, Y; Fujita, T; Yokoyama, U; Okumura, S; Ishikawa, Y				Sato, Motohiko; Hiraoka, Masahiro; Suzuki, Hiroko; Sakima, Miho; Al Mamun, Abdullah; Yamane, Yukiko; Fujita, Takayuki; Yokoyama, Utako; Okumura, Satoshi; Ishikawa, Yoshihiro			Protection of Cardiomyocytes from the Hypoxia-Mediated Injury by a Peptide Targeting the Activator of G-Protein Signaling 8	PLOS ONE			English	Article							BETA-GAMMA-SUBUNITS; RECEPTOR-INDEPENDENT ACTIVATOR; REPERFUSION INJURY; COUPLED RECEPTORS; DRUG DISCOVERY; ISCHEMIC-HEART; RGS PROTEINS; ALPHA; REGULATORS; PHOSPHORYLATION	Signaling via heterotrimeric G-protein is involved in the development of human diseases including ischemia-reperfusion injury of the heart. We previously identified an ischemia-inducible G-protein activator, activator of G-protein signaling 8 (AGS8), which regulates G beta gamma signaling and plays a key role in the hypoxia-induced apoptosis of cardiomyocytes. Here, we attempted to intervene in the AGS8-G beta gamma signaling process and protect cardiomyocytes from hypoxia-induced apoptosis with a peptide that disrupted the AGS8-G beta gamma interaction. Synthesized AGS8-peptides, with amino acid sequences based on those of the G beta gamma-binding domain of AGS8, successfully inhibited the association of AGS8 with G beta gamma. The AGS8-peptide effectively blocked hypoxia-induced apoptosis of cardiomyocytes, as determined by DNA end-labeling and an increase in cleaved caspase-3. AGS8-peptide also inhibited the change in localization/permeability of channel protein connexin 43, which was mediated by AGS8-G beta gamma under hypoxia. Small compounds that inhibit a wide range of G beta gamma signals caused deleterious effects in cardiomyocytes. In contrast, AGS8-peptide did not cause cell damage under normoxia, suggesting an advantage inherent in targeted disruption of the AGS8-G beta gamma signaling pathway. These data indicate a pivotal role for the interaction of AGS8 with G beta gamma in hypoxia-induced apoptosis of cardiomyocytes, and suggest that targeted disruption of the AGS8-G beta gamma signal provides a novel approach for protecting the myocardium against ischemic injury.	[Sato, Motohiko; Suzuki, Hiroko; Sakima, Miho; Al Mamun, Abdullah] Aichi Med Univ, Dept Physiol, Nagakute, Aichi 48011, Japan; [Hiraoka, Masahiro; Yamane, Yukiko; Fujita, Takayuki; Yokoyama, Utako; Ishikawa, Yoshihiro] Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa, Japan; [Okumura, Satoshi] Tsurumi Univ, Sch Dent Med, Dept Physiol, Yokohama, Kanagawa, Japan	Aichi Medical University; Yokohama City University; Tsurumi University	Sato, M (corresponding author), Aichi Med Univ, Dept Physiol, Nagakute, Aichi 48011, Japan.	motosato@aichi-med-u.ac.jp	Yokoyama, Utako/AAD-1404-2022; Mamun, Abdullah/HHM-9898-2022	Yokoyama, Utako/0000-0003-1803-0155; Al Mamun, Md. Abdullah/0000-0003-3839-9603	Toyoaki Scholarship Foundation; Naito Foundation; Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S1101027]; Grants-in-Aid for Scientific Research [25293236] Funding Source: KAKEN	Toyoaki Scholarship Foundation(Toyoaki Scholarship Foundation); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Grant-in-Aid for Scientific Research on Innovative Areas of Japan (MS), Grant-in-Aid for Scientific Research of Japan (MS), the Toyoaki Scholarship Foundation (MS), The Naito Foundation (MS) and Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2011-2015 (S1101027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Clemons TD, 2013, ACS NANO, V7, P2212, DOI 10.1021/nn305211f; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Flores-Munoz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045564; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Jneid Hani, 2012, Methodist Debakey Cardiovasc J, V8, P26; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; McGrath MF, 2012, AM J PHYSIOL-HEART C, V302, pH1826, DOI 10.1152/ajpheart.01085.2011; New DC, 2007, FEBS J, V274, P6025, DOI 10.1111/j.1742-4658.2007.06116.x; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Roof RA, 2006, CHEM BIOL DRUG DES, V67, P266, DOI 10.1111/j.1747-0285.2006.00373.x; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; SATO M, 1995, AM J HYPERTENS, V8, P160, DOI 10.1016/0895-7061(94)00191-D; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 1996, J BIOL CHEM, V271, P30052, DOI 10.1074/jbc.271.47.30052; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Sato M, 2013, CIRC J; Sato M, 2011, J BIOL CHEM, V286, P17766, DOI 10.1074/jbc.M111.219816; Sato M, 2009, J BIOL CHEM, V284, P31431, DOI 10.1074/jbc.M109.014068; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Sjogren B, 2011, ADV PHARMACOL, V62, P315, DOI 10.1016/B978-0-12-385952-5.00002-6; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Thuc LC, 2010, APOPTOSIS, V15, P669, DOI 10.1007/s10495-010-0473-0; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Windecker S, 2013, LANCET, V382, P644, DOI 10.1016/S0140-6736(13)61452-X; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200; Zhang P, 2011, CIRC RES, V109, P320, DOI 10.1161/CIRCRESAHA.110.231423; Zhang SS, 2013, BBA-MOL CELL RES, V1833, P876, DOI 10.1016/j.bbamcr.2012.10.020	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91980	10.1371/journal.pone.0091980	http://dx.doi.org/10.1371/journal.pone.0091980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632710	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400129
J	Shi, YW; Zhang, L; Yang, T				Shi, Yawei; Zhang, Lei; Yang, Ting			Nuclear Export of L-Periaxin, Mediated by Its Nuclear Export Signal in the PDZ Domain	PLOS ONE			English	Article							MYELINATING SCHWANN-CELLS; MARIE-TOOTH-DISEASE; HUMAN CYCLIN-A; LIM-KINASE 1; CYTOPLASMIC LOCALIZATION; PROTEIN; NEUROPATHY; RETENTION; SEQUENCE; MUTATION	Myelinating Schwann cells specifically express L-periaxin (L-PRX) in the mammalian peripheral nervous system. Several loss-of-function mutations in periaxin have been described and linked to autosomal recessive Dejerine Sottas neuropathy and to demyelinating Charcot-Marie-Tooth disease. The localization of L-periaxin is developmentally regulated in the nucleus and the plasma membrane of Schwann cells. In this study, L-periaxin, which contains a PDZ domain, a nuclear localization signal (NLS) domain, a repeat domain, and an acidic domain, was localized in the cytoplasm of RSC96 cells. By contrast, a mutant L-periaxin with a deleted PDZ domain was localized mainly in the nucleus of RSC96 cells. After a nuclear cyclin A1, which is localized exclusively in the nucleus, was fused with the PDZ domain, cyclinA1 was found in the cytoplasm of RSC96 cells. Treatment with leptomycin B (LMB), a specific inhibitor of nuclear export mediated by leucine-rich nuclear export signal (NES), also causes nuclear accumulation of wild-type L-periaxin. Double leucine mutation (L83, 85Q) in the putative NES in the PDZ domain prevented L-periaxin nuclear export and induced nuclear accumulation. These results suggested that the localization of L-periaxin in the cytoplasm is supported by NES in the PDZ domain.	[Shi, Yawei; Zhang, Lei; Yang, Ting] Shanxi Univ, Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan, Shanxi, Peoples R China; [Zhang, Lei] Hubei Univ Med, Renmin Hosp, Inst Clin Med, Shiyan, Hubei, Peoples R China; [Zhang, Lei] Hubei Univ Med, Renmin Hosp, Dept Cardiol, Shiyan, Hubei, Peoples R China	Shanxi University; Hubei University of Medicine; Hubei University of Medicine	Shi, YW (corresponding author), Shanxi Univ, Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan, Shanxi, Peoples R China.	yaweishi@sxu.edu.cn	石, 亚伟/AAQ-4263-2020	石, 亚伟/0000-0001-5887-4366	National Sciences Foundation of China [31170748]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported National Sciences Foundation of China (Grant No. 31170748). http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; Everly DN, 2004, J VIROL, V78, P11648, DOI 10.1128/JVI.78.21.11648-11655.2004; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Gonzalez-Mariscal L, 2006, EXP CELL RES, V312, P3323, DOI 10.1016/j.yexcr.2006.07.006; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Kijima K, 2004, J HUM GENET, V49, P376, DOI 10.1007/s10038-004-0162-3; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Masaki T, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740403; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Sherman DL, 2012, J NEUROSCI, V32, P9419, DOI 10.1523/JNEUROSCI.1220-12.2012; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tovar C, 2011, VET PATHOL, V48, P1195, DOI 10.1177/0300985811400447; Wu LMN, 2012, CURR BIOL, V22, P1957, DOI 10.1016/j.cub.2012.08.025; Yang N, 1999, BIOCHEM J, V338, P793, DOI 10.1042/0264-6021:3380793; Yang N, 1998, EXP CELL RES, V241, P242, DOI 10.1006/excr.1998.4053	31	10	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91953	10.1371/journal.pone.0091953	http://dx.doi.org/10.1371/journal.pone.0091953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633211	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400125
J	Shimizu, Y; Boehm, H; Yamaguchi, K; Spatz, JP; Nakanishi, J				Shimizu, Yoshihisa; Boehm, Heike; Yamaguchi, Kazuo; Spatz, Joachim P.; Nakanishi, Jun			A Photoactivatable Nanopatterned Substrate for Analyzing Collective Cell Migration with Precisely Tuned Cell-Extracellular Matrix Ligand Interactions	PLOS ONE			English	Article							E-CADHERIN; SPATIOTEMPORAL CONTROL; N-CADHERIN; ADHESION; PROTEIN; MONOLAYER; FORCES; ROLES; BETA; FAK	Collective cell migration is involved in many biological and pathological processes. Various factors have been shown to regulate the decision to migrate collectively or individually, but the impact of cell-extracellular matrix (ECM) interactions is still debated. Here, we developed a method for analyzing collective cell migration by precisely tuning the interactions between cells and ECM ligands. Gold nanoparticles are arrayed on a glass substrate with a defined nanometer spacing by block copolymer micellar nanolithography (BCML), and photocleavable poly(ethylene glycol) (Mw = 12 kDa, PEG12K) and a cyclic RGD peptide, as an ECM ligand, are immobilized on this substrate. The remaining glass regions are passivated with PEG2K-silane to make cells interact with the surface via the nanoperiodically presented cyclic RGD ligands upon the photocleavage of PEG12K. On this nanostructured substrate, HeLa cells are first patterned in photo-illuminated regions, and cell migration is induced by a second photocleavage of the surrounding PEG12K. The HeLa cells gradually lose their cell-cell contacts and become disconnected on the nanopatterned substrate with 10-nm particles and 57-nm spacing, in contrast to their behavior on the homogenous substrate. Interestingly, the relationship between the observed migration collectivity and the cell-ECM ligand interactions is the opposite of that expected based on conventional soft matter models. It is likely that the reduced phosphorylation at tyrosine-861 of focal adhesion kinase (FAK) on the nanopatterned surface is responsible for this unique migration behavior. These results demonstrate the usefulness of the presented method in understanding the process of determining collective and non-collective migration features in defined micro-and nano-environments and resolving the crosstalk between cell-cell and cell-ECM adhesions.	[Shimizu, Yoshihisa; Nakanishi, Jun] Natl Inst Mat Sci, WPI Res Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki, Japan; [Boehm, Heike; Spatz, Joachim P.] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Boehm, Heike] Max Planck Inst Intelligent Syst, CSF Biomat & Cellular Biophys, Stuttgart, Germany; [Yamaguchi, Kazuo] Kanagawa Univ, Fac Sci, Res Inst Photofunctionalized Mat, Dept Chem, Hiratsuka, Kanagawa, Japan; [Boehm, Heike; Spatz, Joachim P.] Heidelberg Univ, Inst Phys Chem, Dept Biophys Chem, Heidelberg, Germany	National Institute for Materials Science; Max Planck Society; Max Planck Society; Kanagawa University; Ruprecht Karls University Heidelberg	Nakanishi, J (corresponding author), Natl Inst Mat Sci, WPI Res Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki, Japan.	NAKANISHI.Jun@nims.go.jp	Boehm, Heike/I-8473-2016; Spatz, Joachim P/A-1107-2017; NAKANISHI, Jun/H-2616-2011	Boehm, Heike/0000-0002-7124-4913; Spatz, Joachim P/0000-0003-3419-9807; NAKANISHI, Jun/0000-0003-4457-6581	World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics; Max Planck Society	World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Max Planck Society(Max Planck Society)	This work was supported in part by the World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics. The financial support of the Max Planck Society is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d; Bai CY, 2007, J CELL SCI, V120, P2828, DOI 10.1242/jcs.03477; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Doran MR, 2009, LAB CHIP, V9, P2364, DOI 10.1039/b900791a; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gonzalez-Rodriguez D, 2012, SCIENCE, V338, P910, DOI 10.1126/science.1226418; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; Liu S, 2009, BIOCONJUGATE CHEM, V20, P2199, DOI 10.1021/bc900167c; Lohmuller T, 2011, BIOINTERPHASES, V6, pMR1, DOI 10.1116/1.3536839; Luo W, 2011, J AM CHEM SOC, V133, P10780, DOI 10.1021/ja204893w; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Nakanishi J, 2004, J AM CHEM SOC, V126, P16314, DOI 10.1021/ja044684c; Nakanishi J, 2007, J AM CHEM SOC, V129, P6694, DOI 10.1021/ja070294p; Nakanishi J, 2006, ANAL CHIM ACTA, V578, P100, DOI 10.1016/j.aca.2006.04.059; Nakanishi J, 2014, CHEM-ASIAN J, V9, P406, DOI 10.1002/asia.201301325; Nakanishi J, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/4/044608; Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Raghavan S, 2010, LANGMUIR, V26, P17733, DOI 10.1021/la102955m; Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550; Rolli CG, 2012, BIOMATERIALS, V33, P2409, DOI 10.1016/j.biomaterials.2011.12.012; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schaller MD, 2004, J CELL BIOL, V166, P157, DOI 10.1083/jcb.200406151; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Shih WT, 2012, CELL ADHES MIGR, V6, P513, DOI 10.4161/cam.21766; Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toyoshima M, 2007, CANCER RES, V67, P5162, DOI 10.1158/0008-5472.CAN-06-2756; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Zheng YH, 2009, CELL CYCLE, V8, P3474, DOI 10.4161/cc.8.21.9846	39	30	30	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91875	10.1371/journal.pone.0091875	http://dx.doi.org/10.1371/journal.pone.0091875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632806	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400113
J	Koslicki, D; Foucart, S; Rosen, G				Koslicki, David; Foucart, Simon; Rosen, Gail			WGSQuikr: Fast Whole-Genome Shotgun Metagenomic Classification	PLOS ONE			English	Article							IDENTIFICATION	With the decrease in cost and increase in output of whole-genome shotgun technologies, many metagenomic studies are utilizing this approach in lieu of the more traditional 16S rRNA amplicon technique. Due to the large number of relatively short reads output from whole-genome shotgun technologies, there is a need for fast and accurate short-read OTU classifiers. While there are relatively fast and accurate algorithms available, such as MetaPhlAn, MetaPhyler, PhyloPythiaS, and PhymmBL, these algorithms still classify samples in a read-by-read fashion and so execution times can range from hours to days on large datasets. We introduce WGSQuikr, a reconstruction method which can compute a vector of taxonomic assignments and their proportions in the sample with remarkable speed and accuracy. We demonstrate on simulated data that WGSQuikr is typically more accurate and up to an order of magnitude faster than the aforementioned classification algorithms. We also verify the utility of WGSQuikr on real biological data in the form of a mock community. WGSQuikr is a Whole-Genome Shotgun QUadratic, Iterative, K-mer based Reconstruction method which extends the previously introduced 16S rRNA-based algorithm Quikr. A MATLAB implementation of WGSQuikr is available at: http://sourceforge.net/projects/wgsquikr.	[Koslicki, David] Oregon State Univ, Dept Math, Corvallis, OR 97331 USA; [Foucart, Simon] Univ Georgia, Dept Math, Athens, GA 30602 USA; [Rosen, Gail] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA	Oregon State University; University System of Georgia; University of Georgia; Drexel University	Koslicki, D (corresponding author), Oregon State Univ, Dept Math, Corvallis, OR 97331 USA.	david.koslicki@math.oregonstate.edu		Rosen, Gail/0000-0003-1763-5750	NSF [DMS-1120622]	NSF(National Science Foundation (NSF))	Funding was provided by NSF grant DMS-1120622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly F. E., 2012, NUCLEIC ACIDS RES, V40, P1; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Carlos N, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.41; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Davenport CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041224; Foucart S, 2013, IEEE SIGNAL IN PRESS; Jumpstart Consortium HMP Data Generation Working Group, 2012, PLOS ONE, V7; Koslicki D, 2013, BIOINFORMATICS, V29, P2096, DOI 10.1093/bioinformatics/btt336; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; MacDonald NJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks335; MATLAB, 2012, MATLAB; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rosen Gail, 2008, Advances in Bioinformatics, V2008, P205969, DOI 10.1155/2008/205969; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Srinivasan SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S4; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	19	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91784	10.1371/journal.pone.0091784	http://dx.doi.org/10.1371/journal.pone.0091784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626336	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300136
J	Varela, S; Gonzalez-Hernandez, J; Casabella, E; Barrientos, R				Varela, Sara; Gonzalez-Hernandez, Javier; Casabella, Eduardo; Barrientos, Rafael			rAvis: An R-Package for Downloading Information Stored in Proyecto AVIS, a Citizen Science Bird Project	PLOS ONE			English	Article							SUBURBAN NEW-YORK	Citizen science projects store an enormous amount of information about species distribution, diversity and characteristics. Researchers are now beginning to make use of this rich collection of data. However, access to these databases is not always straightforward. Apart from the largest and international projects, citizen science repositories often lack specific Application Programming Interfaces (APIs) to connect them to the scientific environments. Thus, it is necessary to develop simple routines to allow researchers to take advantage of the information collected by smaller citizen science projects, for instance, programming specific packages to connect them to popular scientific environments (like R). Here, we present rAvis, an R-package to connect R-users with Proyecto AVIS (http://proyectoavis.com), a Spanish citizen science project with more than 82,000 bird observation records. We develop several functions to explore the database, to plot the geographic distribution of the species occurrences, and to generate personal queries to the database about species occurrences (number of individuals, distribution, etc.) and birdwatcher observations (number of species recorded by each collaborator, UTMs visited, etc.). This new R-package will allow scientists to access this database and to exploit the information generated by Spanish birdwatchers over the last 40 years.	[Varela, Sara] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Varela, Sara] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Casabella, Eduardo] Actividades Consultoria & Telecomunicac, ACCONTE Grp, Tres Cantos, Spain; [Barrientos, Rafael] Univ Castilla La Mancha, Fac Medio Ambiente, Dept Ciencias Ambientales, Toledo, Spain	Charles University Prague; Universidade Federal de Goias; Universidad de Castilla-La Mancha	Varela, S (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic.	svarela@paleobiogeography.org	Barrientos, Rafael/I-2102-2015; Varela, Sara/J-7725-2016	Barrientos, Rafael/0000-0002-1677-3214; Varela, Sara/0000-0002-5756-5737	European Science Foundation and Czech Republic; Education for Competitiveness Operational Programme (ECOP) project "Support of establishment, development and mobility of quality research teams at the Charles University'' [CZ.1.07/2.3.00/30.0022]; Juan de la Cierva program from the Spanish Ministry of Competitiveness	European Science Foundation and Czech Republic; Education for Competitiveness Operational Programme (ECOP) project "Support of establishment, development and mobility of quality research teams at the Charles University''; Juan de la Cierva program from the Spanish Ministry of Competitiveness	Sara Varela and Rafael Barrientos have postdoctoral grants. SV is funded by the European Science Foundation and Czech Republic, from the Education for Competitiveness Operational Programme (ECOP) project "Support of establishment, development and mobility of quality research teams at the Charles University'' (CZ.1.07/2.3.00/30.0022)(http://www.cuni.cz/UKEN-88.html). RB received financial assistance from Juan de la Cierva program from the Spanish Ministry of Competitiveness (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/?vgnextoid=fdf669dad3f88310VgnVCM1000001d04140aRCRD). Javier Gonzalez-Hernandez and Eduardo Casabella-Cabana are freelance web-developers that worked on the project during their free time. They were involved in the design, programming and optimization of the R-package ravis and on the web interface of Proyectoavis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton RM, 2010, SCRAPER TOOLS SCRAPI; [Anonymous], 2013, MAPTOOLS TOOLS READI; Bivand R, 2013, RGDAL BINDINGS GEOSP; Boettiger C, 2013, RFISHBASE R INTERFAC; Chamberlain S., 2012, RVERTNET SEARCH VERT; Chamberlain S, 2013, RGBIF INTERFACE GLOB; Chambers JM, 2008, STAT COMPUT SER, P1; Cooper CB, 2012, ENVIRON MANAGE, V50, P11, DOI 10.1007/s00267-012-9866-x; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Duck G, 2013, BMC BIOINFORMATICS, V14; Fellows I, 2013, OPENSTREETMAP ACCESS; Gutierrez R., 2012, LISTA AVES ESPANA ED; Herrando S., 2012, SEO BIRDLIFE ATLAS A; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Joppa LN, 2013, SCIENCE, V340, P814, DOI 10.1126/science.1231535; Lang D. T., 2013, XML TOOLS PARSING GE; Lang DT, 2013, RCURL GEN NETWORK HT; Lepczyk CA, 2005, J APPL ECOL, V42, P672, DOI 10.1111/j.1365-2664.2005.01059.x; Maia R, 2012, REBIRD INTERFACE EBI; Moral JCd, 2002, ATLAS AVES REPROD ES; Moyer-Horner L, 2012, J WILDLIFE MANAGE, V76, P1472, DOI 10.1002/jwmg.373; Mulder RA, 2010, WILDLIFE RES, V37, P440, DOI 10.1071/WR10007; Nagy C, 2012, NORTHEAST NAT, V19, P143, DOI 10.1656/045.019.s611; Oberhauser K, 2012, FRONT ECOL ENVIRON, V10, P318, DOI 10.1890/110274; R Core Team, 2021, R LANGUAGE ENV STAT; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Sizling AL, 2011, AM NAT, V178, P602, DOI 10.1086/662176; Tjorve E, 2008, J ECOL, V96, P1141, DOI 10.1111/j.1365-2745.2008.01433.x; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Voulgaropoulou S, 2012, IEEE ANNU SOFTW ENG, P1, DOI 10.1109/SEW.2012.7; Warnes G., 2013, GDATA VARIOUS R PROG; Weckel ME, 2010, J WILDLIFE MANAGE, V74, P1163, DOI 10.2193/2008-512; White EP, 2013, IDEAS ECOL EVOL, V6, P1, DOI 10.4033/iee.2013.6b.6.f; Wickham H., 2012, STRINGR MAKE IT EASI; Wickham H., 2012, SCALES SCALE FUNCTIO; Wiersma YF, 2010, AVIAN CONSERV ECOL, V5; Worthington JP, 2012, METHODS ECOL EVOL, V3, P303, DOI 10.1111/j.2041-210X.2011.00164.x	38	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91650	10.1371/journal.pone.0091650	http://dx.doi.org/10.1371/journal.pone.0091650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626233	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300113
J	You, JC; Li, Y; Fang, NZ; Liu, B; Zu, LL; Chang, R; Li, XB; Zhou, QH				You, Jiacong; Li, Yang; Fang, Nianzhen; Liu, Bin; Zu, Lingling; Chang, Rui; Li, Xuebing; Zhou, Qinghua			MiR-132 Suppresses the Migration and Invasion of Lung Cancer Cells via Targeting the EMT Regulator ZEB2	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; DOWN-REGULATION; BREAST-CANCER; EXPRESSION; METHYLATION; METASTASIS; BIOGENESIS; ZEB1/ZEB2; MICRORNAS	MicroRNAs (miRNAs) are small, non-coding RNAs which can function as oncogenes or tumor suppressor genes in human cancers. Emerging evidence reveals that deregulation of miRNAs contributes to the human non-small cell lung cancer (NSCLC). In the present study, we demonstrated that the expression levels of miR-132 were dramatically decreased in examined NSCLC cell lines and clinical NSCLC tissue samples. Then, we found that introduction of miR-132 significantly suppressed the migration and invasion of lung cancer cells in vitro, suggesting that miR-132 may be a novel tumor suppressor. Further studies indicated that the EMT-related transcription factor ZEB2 was one direct target genes of miR-132, evidenced by the direct binding of miR-132 with the 3' untranslated region (3' UTR) of ZEB2. Further, miR-132 could decrease the expression of ZEB2 at the levels of mRNA and protein. Notably, the EMT marker E-cadherin or vimentin, a downstream of ZEB2, was also down-regulated or up-regulated upon miR-132 treatment. Additionally, over-expressing or silencing ZEB2 was able to elevate or inhibit the migration and invasion of lung cancer cells, parallel to the effect of miR-132 on the lung cancer cells. Meanwhile, knockdown of ZEB2 reversed the enhanced migration and invasion mediated by anti-miR-132. These results indicate that miR-132 suppresses the migration and invasion of NSCLC cells through targeting ZEB2 involving the EMT process. Thus, our finding provides new insight into the mechanism of NSCLC progression. Therapeutically, miR-132 may serve as a potential target in the treatment of human lung cancer.	[You, Jiacong; Li, Yang; Fang, Nianzhen; Liu, Bin; Zu, Lingling; Chang, Rui; Li, Xuebing; Zhou, Qinghua] Tianjin Med Univ, Tianjin Lung Canc Inst, Gen Hosp, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China	Tianjin Medical University	You, JC (corresponding author), Tianjin Med Univ, Tianjin Lung Canc Inst, Gen Hosp, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.	yyjjcc_nk@163.com; zhouqh1016@yahoo.com.cn	Zhou, Qinghua/A-4184-2008		Key Project from National Natural Science Foundation of China [81000950]; National 863 Program [2012AA02A201, 2012AA02A502]; National 973 Program [2010CB529405]; Tianjin Scientific Innovation System Program [07SYSYSF05000, 07SYSYJC27900]; China-Sweden Cooperative Foundation [09ZCZDSF04100]; Major Project of Tianjin Sci-Tech Support Program [06YFSZSF05300]	Key Project from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program(National High Technology Research and Development Program of China); National 973 Program(National Basic Research Program of China); Tianjin Scientific Innovation System Program; China-Sweden Cooperative Foundation; Major Project of Tianjin Sci-Tech Support Program	This study was partly supported by the grants from the Key Project from National Natural Science Foundation of China (No. 81000950), National 863 Program (No. 2012AA02A201, No. 2012AA02A502), National 973 Program (No. 2010CB529405), Tianjin Scientific Innovation System Program (No. 07SYSYSF05000, No. 07SYSYJC27900), China-Sweden Cooperative Foundation (No. 09ZCZDSF04100), and Major Project of Tianjin Sci-Tech Support Program (No. 06YFSZSF05300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Cai Mu-Yan, 2012, PLoS One, V7, pe32838, DOI 10.1371/journal.pone.0032838; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chu PY, 2013, ORAL ONCOL, V49, P34, DOI 10.1016/j.oraloncology.2012.07.012; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cong NN, 2013, ONCOL REP, V29, P1579, DOI 10.3892/or.2013.2267; Dai YH, 2012, DIGEST DIS SCI, V57, P1253, DOI 10.1007/s10620-012-2042-6; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Henrion M, 2013, HUM MOL GENET, V22, P825, DOI 10.1093/hmg/dds489; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053663; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koopmansch B, 2013, BIOCHEM BIOPH RES CO, V431, P652, DOI 10.1016/j.bbrc.2013.01.070; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Lee JY, 2013, ONCOGENE IN PRESS; Li CY, 2004, ACTA BIOCH BIOPH SIN, V36, P405, DOI 10.1093/abbs/36.6.405; Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Liu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034832; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miao LJ, 2013, FEBS LETT, V587, P1359, DOI 10.1016/j.febslet.2013.03.006; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Suzuki H, 2008, PHARMACOGENOMICS, V9, P1917, DOI 10.2217/14622416.9.12.1917; Usova E V, 2013, Dokl Biol Sci, V448, P61, DOI 10.1134/S001249661301016X; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Wang Qiu-Yu, 2012, Shengli Xuebao, V64, P403; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wu QH, 2011, GYNECOL ONCOL, V122, P149, DOI 10.1016/j.ygyno.2011.03.026; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105; Zhou Qinghua, 2003, Zhongguo Fei Ai Za Zhi, V6, P464, DOI 10.3779/j.issn.1009-3419.2003.06.13	43	95	104	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91827	10.1371/journal.pone.0091827	http://dx.doi.org/10.1371/journal.pone.0091827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626466	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300140
J	Khalaj, N; Abu Osman, NA; Mokhtar, AH; Mehdikhani, M; Abas, WAW				Khalaj, Nafiseh; Abu Osman, Noor Azuan; Mokhtar, Abdul Halim; Mehdikhani, Mahboobeh; Abas, Wan Abu Bakar Wan			Balance and Risk of Fall in Individuals with Bilateral Mild and Moderate Knee Osteoarthritis	PLOS ONE			English	Article							BIODEX STABILITY SYSTEM; POSTURAL SWAY; ELDERLY PERSONS; PROPRIOCEPTION; STRENGTH; PAIN; ARTHRITIS; GAIT	Balance is essential for mobility and performing activities of daily living. People with knee osteoarthritis display impairment in knee joint proprioception. Thus, the aim of this study was to evaluate balance and risk of fall in individuals with bilateral mild and moderate knee osteoarthritis. Sixty subjects aged between 50 and 70 years volunteered in this study. They were categorized into three groups which were healthy (n = 20), mild (n = 20) and moderate (n = 20) bilateral knee osteoarthritis groups. Dynamic and static balance and risk of fall were assessed using Biodex Stability System. In addition, Timed Up and Go test was used as a clinical test for balance. Results of this study illustrated that there were significant differences in balance (dynamic and static) and risk of fall between three groups. In addition, the main (most significant) difference was found to be between healthy group and moderate group. Furthermore, on clinical scoring of balance, the "Timed Up and Go" test, all three groups showed significant difference. In conclusion, bilateral knee osteoarthritis impaired the balance and increased the risk of fall, particularly in people with moderate knee osteoarthritis.	[Khalaj, Nafiseh; Abu Osman, Noor Azuan; Mehdikhani, Mahboobeh; Abas, Wan Abu Bakar Wan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia; [Mokhtar, Abdul Halim] Univ Malaya, Fac Med, Dept Sport Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Khalaj, N (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia.	nafisehkhalaj@hotmail.com	MOKHTAR, ABDUL HALIM/B-8102-2010; Khalaj, Nafiseh/P-4935-2016; ABU OSMAN, NOOR AZUAN/B-9265-2010	MOKHTAR, ABDUL HALIM/0000-0001-8057-313X; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421	UM/MOHE/HIR [D000010-16001]	UM/MOHE/HIR	This study was supported by UM/MOHE/HIR Project No. D000010-16001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BL, 1998, J ATHL TRAINING, V33, P323; Aydog E, 2006, CLIN RHEUMATOL, V25, P462, DOI 10.1007/s10067-005-0074-4; Baert IAC, 2013, CLIN RHEUMATOL, V32, P1365, DOI 10.1007/s10067-013-2285-4; Bascuas I, 2013, ORTHOPEDICS, V36, pE6, DOI 10.3928/01477447-20121217-11; Cachupe WJC, 2001, MEASUREMENTS PHYS ED, V5, P97, DOI [DOI 10.1207/S15327841MPEE0502_, 10.1207/S15327841MPEE0502_3, DOI 10.1207/S15327841MPEE0502_3]; Fisher NM, 1997, SCAND J REHABIL MED, V29, P213; Hassan BS, 2002, ANN RHEUM DIS, V61, P422, DOI 10.1136/ard.61.5.422; Hassan BS, 2001, ANN RHEUM DIS, V60, P612, DOI 10.1136/ard.60.6.612; Hill KD, 2013, J CLIN GERONTOL GERI, V4, P22, DOI 10.1016/j.jcgg.2012.10.003; Hinman RS, 2002, RHEUMATOLOGY, V41, P1388, DOI 10.1093/rheumatology/41.12.1388; Hsieh RL, 2013, ARCH PHYS MED REHAB, V94, P340, DOI 10.1016/j.apmr.2012.09.022; Hurley MV, 1997, ANN RHEUM DIS, V56, P641, DOI 10.1136/ard.56.11.641; Jadelis K, 2001, J AM GERIATR SOC, V49, P884, DOI 10.1046/j.1532-5415.2001.49178.x; Kiss RM, 2011, J ELECTROMYOGR KINES, V21, P695, DOI 10.1016/j.jelekin.2011.07.011; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Masui T, 2006, J ORTHOP SCI, V11, P353, DOI 10.1007/s00776-006-1034-9; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Morrow JR, 2010, MEASUREMENT EVALUATI; Pandya NK, 2007, GAIT POSTURE, V25, P106, DOI 10.1016/j.gaitpost.2006.02.001; Pandya NK, 2005, CLIN ORTHOP RELAT R, P150, DOI 10.1097/01.blo.0000150316.97009.f2; Petrella M, 2012, REV BRAS REUMATOL, V52, P507, DOI 10.1590/S0482-50042012000400004; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Sharma L, 2003, ARTHRITIS RHEUM-US, V48, P3359, DOI 10.1002/art.11420; Sharma L, 1997, ARTHRITIS RHEUM, V40, P1518, DOI 10.1002/art.1780400821; Sibley KM, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-33; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; Wegener L, 1997, J ORTHOP SPORT PHYS, V25, P13, DOI 10.2519/jospt.1997.25.1.13; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	28	68	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92270	10.1371/journal.pone.0092270	http://dx.doi.org/10.1371/journal.pone.0092270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642715	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900116
J	Milutinovic, PS; Englert, JM; Crum, LT; Mason, NS; Ramsgaard, L; Enghild, JJ; Sparvero, LJ; Lotze, MT; Oury, TD				Milutinovic, Pavle S.; Englert, Judson M.; Crum, Lauren T.; Mason, Neale S.; Ramsgaard, Lasse; Enghild, Jan J.; Sparvero, Louis J.; Lotze, Michael T.; Oury, Tim D.			Clearance Kinetics and Matrix Binding Partners of the Receptor for Advanced Glycation End Products	PLOS ONE			English	Article							CELL-SURFACE RECEPTOR; SOLUBLE RECEPTOR; REPERFUSION INJURY; RAGE; BLOCKADE; PURIFICATION; ACTIVATION; EXPRESSION; PROTEIN; HMGB1	Elucidating the sites and mechanisms of sRAGE action in the healthy state is vital to better understand the biological importance of the receptor for advanced glycation end products (RAGE). Previous studies in animal models of disease have demonstrated that exogenous sRAGE has an anti-inflammatory effect, which has been reasoned to arise from sequestration of pro-inflammatory ligands away from membrane-bound RAGE isoforms. We show here that sRAGE exhibits in vitro binding with high affinity and reversibly to extracellular matrix components collagen I, collagen IV, and laminin. Soluble RAGE administered intratracheally, intravenously, or intraperitoneally, does not distribute in a specific fashion to any healthy mouse tissue, suggesting against the existence of accessible sRAGE sinks and receptors in the healthy mouse. Intratracheal administration is the only effective means of delivering exogenous sRAGE to the lung, the organ in which RAGE is most highly expressed; clearance of sRAGE from lung does not differ appreciably from that of albumin.	[Milutinovic, Pavle S.; Crum, Lauren T.; Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Englert, Judson M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Mason, Neale S.] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA; [Ramsgaard, Lasse; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct, Aarhus, Denmark; [Sparvero, Louis J.; Lotze, Michael T.] Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Oury, TD (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	tdoury@pitt.edu		Enghild, Jan Johannes/0000-0001-9292-9172	NIH [R21 HL095495]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095495, T32HL094295] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant R21 HL095495 to Tim D. Oury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; BRETT J, 1993, AM J PATHOL, V143, P1699; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Chuong C, 2009, J CELL PHYSIOL, V221, P430, DOI 10.1002/jcp.21873; Dahlin K, 2004, AM J RESP CELL MOL, V31, P309, DOI 10.1165/rcmb.2003-0423OC; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Do T, 2008, PROTEIN EXPRES PURIF, V60, P147, DOI 10.1016/j.pep.2008.04.009; EFFROS RM, 1983, AM REV RESPIR DIS, V127, pS59; Englert J, 2009, THESIS U PITTSBURGH; Englert JM, 2008, PROTEIN EXPRES PURIF, V61, P99, DOI 10.1016/j.pep.2008.05.004; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fehrenbach H, 1998, CELL MOL BIOL, V44, P1147; Frommhold D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-56; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Hastings RH, 2004, AM J PHYSIOL-LUNG C, V286, pL679, DOI 10.1152/ajplung.00205.2003; HASTINGS RH, 1992, J APPL PHYSIOL, V73, P1310, DOI 10.1152/jappl.1992.73.4.1310; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; John TA, 2001, J PHYSIOL-LONDON, V533, P547, DOI 10.1111/j.1469-7793.2001.0547a.x; Kataoka K, 2012, ONCOL LETT, V3, P1149, DOI 10.3892/ol.2012.612; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Marsche G, 2007, FASEB J, V21, P3075, DOI 10.1096/fj.07-8316com; Miller AL, 2012, J INFECT DIS, V205, P1311, DOI 10.1093/infdis/jir826; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; NEEPER M, 1992, J BIOL CHEM, V267, P14998; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Pullerits R, 2006, ARTHRITIS RHEUM, V54, P3898, DOI 10.1002/art.22217; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Rippe B, 1993, Perit Dial Int, V13 Suppl 2, pS35; Sarkany Z, 2011, J BIOL CHEM, V286, P37525, DOI 10.1074/jbc.M111.223438; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Sourris KC, 2010, DIABETOLOGIA, V53, P2442, DOI 10.1007/s00125-010-1837-2; Steiner J, 2011, CLIN CHEM LAB MED, V49, P409, DOI 10.1515/CCLM.2011.083; Sternberg DI, 2008, J THORAC CARDIOV SUR, V136, P1576, DOI 10.1016/j.jtcvs.2008.05.032; Teismann P, 2012, NEUROBIOL AGING, V33, P2478, DOI 10.1016/j.neurobiolaging.2011.12.006; VLASSARA H, 1989, J CLIN INVEST, V84, P1813, DOI 10.1172/JCI114366; VLASSARA H, 1988, DIABETES, V37, P456, DOI 10.2337/diabetes.37.4.456; Volz HC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0250-z; WAUTIER JL, 1994, P NATL ACAD SCI USA, V91, P7742, DOI 10.1073/pnas.91.16.7742; Wendt T, 2006, ATHEROSCLEROSIS, V185, P70, DOI 10.1016/j.atherosclerosis.2005.06.013; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC	50	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e88259	10.1371/journal.pone.0088259	http://dx.doi.org/10.1371/journal.pone.0088259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642901	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000333259900002
J	Sauque, V; Rabal-Garces, R; Sola-Almagro, C; Cuenca-Bescos, G				Sauque, Victor; Rabal-Garces, Raquel; Sola-Almagro, Cristina; Cuenca-Bescos, Gloria			Bone Accumulation by Leopards in the Late Pleistocene in the Moncayo Massif (Zaragoza, NE Spain)	PLOS ONE			English	Article							CROCUTA-SPELAEA GOLDFUSS; PANTHERA-PARDUS LINNAEUS; MULTIPLE CARNIVORE TAXA; WOLVES CANIS-LUPUS; SPOTTED HYENA; MIDDLE PLEISTOCENE; FEEDING ECOLOGY; HAMMERSTONE PERCUSSION; FAUNAL ASSEMBLAGE; 1823 POPULATION	Eating habits of Panthera pardus are well known. When there are caves in its territory, prey accumulates inside them. This helps to prevent its kill from being stolen by other predators like hyenas. Although the leopard is an accumulator of bones in caves, few studies have been conducted on existing lairs. There are, however, examples of fossil vertebrate sites whose main collecting agent is the leopard. During the Late Pleistocene, the leopard was a common carnivore in European faunal associations. Here we present a new locality of Quaternary mammals with a scarce human presence, the cave of Los Rincones (province of Zaragoza, Spain); we show the leopard to be the main accumulator of the bones in the cave, while there are no interactions between humans and leopards. For this purpose, a taphonomic analysis is performed on different bone-layers of the cave.	[Sauque, Victor; Rabal-Garces, Raquel; Cuenca-Bescos, Gloria] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Sola-Almagro, Cristina] Univ Zaragoza, Fac Filosofia & Letras, Zaragoza, Spain	University of Zaragoza; University of Zaragoza	Sauque, V (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	vsauque@gmail.com	Gloria, Cuenca-Bescós/A-3616-2013	Gloria, Cuenca-Bescós/0000-0001-5125-9651; Sauque, Victor/0000-0001-5379-5087	Government of Aragon [Exp. 50/2006, 132/2010]	Government of Aragon(Gobierno de Aragon)	Victor Sauque is beneficiary of a predoctoral grant from the Government of Aragon. The Government of Aragon has partially subsidized our geological activities in Los Rincones (Exp. 50/2006, 132/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1975, J ZOOL, V175, P15; ALADOS CL, 1996, ECOLOGIA COMPORTAMIE; Altuna J., 1972, Munibe, V24, P1; Altuna J., 1980, Munibe, V32, P317; Altuna J, 1981, RESTOS OSEOS YACIMIE, V223, P269; [Anonymous], 2006, TRABAJOS PREHIST; [Anonymous], 2001, AFRICAN PREDATORS; [Anonymous], 2010, ZONA ARQUEOLOGICA; [Anonymous], [No title captured]; Ansorge H, 2006, ACTA THERIOL, V51, P99, DOI 10.1007/BF03192661; Arrizabalaga A., 2000, MUNIBE ANTROPOLOGIA, V42, P193; Azorit Concepcion, 2002, Anales de Biologia (Murcia), V24, P107; Barrientos Luis Mariano, 1997, Quercus, V139, P14; Ruiz CB, 2011, QUATERN INT, V243, P105, DOI 10.1016/j.quaint.2011.02.021; Binford L.R., 1981, BONES ANCIENT MEN MO; Blasco MF, 1997, J ANTHROPOL RES, V53, P177, DOI 10.1086/jar.53.2.3631276; Blasco MF, 1997, BOLSKAN REV ARQUEOLO, P9; Blasco R, 2011, J ARCHAEOL SCI, V38, P3373, DOI 10.1016/j.jas.2011.07.023; Blumenschine R.J., 1993, BONES BEHAV, DOI 10.1016/j.jhevol.2017.08.004; BLUMENSCHINE RJ, 1986, J HUM EVOL, V15, P639, DOI 10.1016/S0047-2484(86)80002-1; Brain C.K., 1993, Transvaal Museum Monograph, V8, P257; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; BRAIN CK, 1970, NATURE, V225, P1112, DOI 10.1038/2251112a0; BUNN HT, 1986, J HUM EVOL, V15, P673, DOI 10.1016/S0047-2484(86)80004-5; Burke A, 2003, QUATERNARY RES, V59, P459, DOI 10.1016/S0033-5894(03)00059-0; Caceres I., 2002, THESIS U ROVIRA VIRG; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Carranza J., 2011, ENCICLOPEDIA VIRTUAL; Carrion JS, 2001, PALAEOGEOGR PALAEOCL, V176, P193, DOI 10.1016/S0031-0182(01)00338-8; Castanos P, 1990, ANTROPOLOGIA ARKEOLO, V42, P253; Castel Jean-Christophe, 2004, Revue de Paleobiologie, V23, P675; Castel Jean-Christophe, 2010, Revue de Paleobiologie, V29, P411; Clevenger A.P., 1991, ECOLOGIA PARDO ESPAN; Clot A., 1980, THESIS U P SABATIER; Coard R, 1999, J ARCHAEOL SCI, V26, P1369, DOI 10.1006/jasc.1999.0438; Cooper SM, 1999, AFR J ECOL, V37, P149, DOI 10.1046/j.1365-2028.1999.00161.x; CRUZURIBE K, 1991, J FIELD ARCHAEOL, V18, P467, DOI 10.2307/530408; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; Curio E., 1976, ETHOLOGY PREDATION; D'Errico F, 2002, J ARCHAEOL SCI, V29, P211, DOI 10.1006/jasc.2001.0687; DAMUTH J, 1982, PALEOBIOLOGY, V8, P434, DOI 10.1017/S009483730000717X; Daura J, 2013, QUATERNARY SCI REV, V60, P26, DOI 10.1016/j.quascirev.2012.10.042; Davis S., 2002, REV PORTUGUESA ARQUE, V5, P29; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; de Ruiter DJ, 2000, J ARCHAEOL SCI, V27, P665, DOI 10.1006/jasc.1999.0470; Delaney-Rivera C, 2009, J ARCHAEOL SCI, V36, P2597, DOI 10.1016/j.jas.2009.08.001; DELIBES M, 1980, ACTA THERIOL, V25, P309, DOI 10.4098/AT.arch.80-28; Delpech F, 1980, B ASS FRANCAISE ET S, V1, P268; Diedrich CG, 2012, J ARCHAEOL SCI, V39, P1749, DOI 10.1016/j.jas.2012.01.013; Diedrich CG, 2011, QUATERN INT, V233, P171, DOI 10.1016/j.quaint.2010.02.027; Diedrich CG, 2013, QUATERNARY SCI REV, V76, P167, DOI 10.1016/j.quascirev.2013.05.009; Diedrich CG, 2012, HIST BIOL, V24, P161, DOI 10.1080/08912963.2011.591491; Diedrich CG, 2011, HIST BIOL, V23, P237, DOI 10.1080/08912963.2010.530348; Diedrich CG, 2012, HIST BIOL, V24, P63, DOI 10.1080/08912963.2011.552718; Diedrich CG, 2011, HIST BIOL, V23, P335, DOI 10.1080/08912963.2011.552719; Diedrich CG, 2009, QUATERNARY RES, V71, P361, DOI 10.1016/j.yqres.2008.12.006; Diez JC, 1999, J HUM EVOL, V37, P623, DOI 10.1006/jhev.1999.0346; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M., 1994, TRABAJOS PREHIST, V51, P15, DOI DOI 10.3989/TP.1994.V51.I1.462; Dominguez-Rodrigo M., 1994, QUADERNOS PREHISTORI, V16, P9; Dominguez-Rodrigo Manuel, 2010, Journal of Taphonomy, V8, P155; Dominguez-Rodrigo Manuel, 2007, P255; Eisenmann V., 1986, EQUIDS ANCIENT WORLD, V1, P67; Elosegui MM, 2009, PARDO PIRINEOS; Esteban-Nadal M, 2012, J ARCHAEOL SCI, V39, P3208, DOI 10.1016/j.jas.2012.05.004; Falgueres C., 2005, MUNIBE, V57, P93; Fernandez H., 2001, OSTEOLOGIE COMP PETI; Fitzgibbon C. D., 1995, SERENGETI, P274; FITZGIBBON CD, 1989, J ZOOL, V218, P99, DOI 10.1111/j.1469-7998.1989.tb02528.x; Fosse P., 2010, ZONA ARQUELOGICA ACT, V13, P108; Fosse P., 1997, PALEO, V9, P15, DOI [10.3406/pal.1997.1227, DOI 10.3406/PAL.1997.1227]; Garcia N, 2001, ANTHROPOLOGIE, V105, P83; Garcia N, 1998, GEOBIOS-LYON, V31, P659, DOI 10.1016/S0016-6995(98)80053-3; Gil-Sanchez JM, 2006, ACTA THERIOL, V51, P85, DOI 10.1007/BF03192659; Gisbert M., 2009, CUEVAS SIMAS PROVINC; Granados J.E., 2001, Galemys, V13, P3; HAYNES G, 1983, PALEOBIOLOGY, V9, P164, DOI 10.1017/S0094837300007545; HAYNES G, 1980, PALEOBIOLOGY, V6, P341, DOI 10.1017/S0094837300006849; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2006, J ZOOL LONDON, V270, P1; Hillson S., 1992, MAMMAL BONES TEETH I; Jackson P., 1996, BIOL CONSERVATION; Jedrzejewska B., 1998, PREDATION VERTEBRATE; JordaPardo J. F., 2011, Boletin de la Real Sociedad Espanola de Historia Natural, Seccion Geologica, V105, P137; Kingdon J., 1977, E AFRICAN MAMMALS A; Kruuk H., 1972, SPOTTED HYENA STUDY; Kuhn BF, 2010, INT J OSTEOARCHAEOL, V20, P15, DOI 10.1002/oa.996; Kurten B, 1976, CAVE BEAR STORY LIFE; LEROUX PG, 1989, AFR J ECOL, V27, P167; Arsuaga JL, 2012, QUATERN INT, V275, P55, DOI 10.1016/j.quaint.2012.04.019; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; LYMAN RL, 1984, J ANTHROPOL ARCHAEOL, V3, P259, DOI 10.1016/0278-4165(84)90004-7; Marchal F, 2009, CR PALEVOL, V8, P493, DOI 10.1016/j.crpv.2009.03.004; Marean CW, 1998, CURR ANTHROPOL, V39, pS79, DOI 10.1086/204691; MARIEZKURRENA K, 1983, Munibe, V35, P149; Mateos-Quesada P, 2000, TROFEO, V376, P124; Mateos-Quesada P., 2011, ENCICLOPEDIA VIRTUAL; Mech D., 2003, WOLVES BEHAV ECOLOGY; Mills G, 1998, HYANAS STATUS SURVEY; Mills MGL, 1990, KALAHARI HYAENAS COM; MITCHELL B. L., 1965, ZOOL AFRICANA, V1, P297; Monchot Herve, 2005, Paleorient, V31, P27; Monchot H, 2009, QUATERNAIRE, V20, P239, DOI 10.4000/quaternaire.5166; Montoya P., 1999, Estudios Geologicos (Madrid), V55, P127; MORRIS P, 1972, Mammal Review, V2, P69, DOI 10.1111/j.1365-2907.1972.tb00160.x; Morris P., 1978, P483; Myers N., 1986, P437; Naves J, 2006, J MAMMAL, V87, P899, DOI 10.1644/05-MAMM-A-318R2.1; Noe-Nygaard N, 2005, J ARCHAEOL SCI, V32, P855, DOI 10.1016/j.jas.2005.01.004; Nohemi Sala M. T., 2011, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V105, P67; Nowak RM, 1999, MAMMALS WORLD; Okarma H, 1997, WOLF OKOLOGIE VERHAL, P1; Pales L., 1971, ATLAS OSTEOLOGIQUE S; Perez Ripoll M., 1988, ARCH PREHISTORIA LEV, V18, P83; Perez-Barberia F.J., 2010, ENCICLOPEDIA VIRTUAL; PEREZBARBERIA FJ, 1994, J ZOOL, V233, P649; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; Pickering TR, 2002, INT J OSTEOARCHAEOL, V12, P127, DOI 10.1002/oa.594; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Pinto Llona AC, 2005, TAFONOMI PALEOECOLOG; POCOCK R. I., 1932, PROC ZOOL SOC LONDON, V1932, P543; Pons-Moya J., 1985, Paleontologia i Evolucio, V18, P39; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Prendergast Mary E., 2008, Journal of Taphonomy, V6, P301; Quam RM, 2001, J HUM EVOL, V41, P385, DOI 10.1006/jhev.2001.0486; Rabal-Garces R, 2013, THESIS U ZARAGOZA; Rabal-Garces R, 2012, LETHAIA, V45, P96, DOI 10.1111/j.1502-3931.2011.00260.x; Rivals F, 2006, INT J OSTEOARCHAEOL, V16, P249, DOI 10.1002/oa.822; RODRIGUEZ CF, 1995, J ARCHAEOL SCI, V22, P597, DOI 10.1016/S0305-4403(95)80145-6; Rodriguez-Hidalgo A, 2013, J ARCHAEOL SCI, V40, P3031, DOI 10.1016/j.jas.2013.03.006; ROGERS L, 1981, NAT HIST, V90, P64; ROGERS LL, 1987, WILDLIFE MONOGR, P1; Sala N., 2012, THESIS U COMPLUTENSE; Sala N, 2013, J ARCHAEOL SCI, V40, P1389, DOI 10.1016/j.jas.2012.10.018; Saladie P, 2009, THESIS U ROVIRA VIRG; Saladie P, 2011, INT J OSTEOARCHAEOL, DOI [10.1002/oa.1237, DOI 10.1002/0A.1237]; Salazar-Garcia DC, 2013, QUAT INT IN PRESS; Sauque V, 2013, QUATERNAIRE, V24, P35; Schaller G. B., 1972, SERENGETI LION STUDY; Selvaggio M.M., 1994, THESIS RUTGERS U; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Shipman P., 1983, BAR International Series, V163, P31; SHIPMAN P, 1984, PALEOBIOLOGY, V10, P358, DOI 10.1017/S0094837300008320; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Simons JW, 1966, KENYA B CAVE EXPLORA, V1, P51; Steyn V, 2006, S AFR J WILDL RES, V36, P189; Stiner Mary C., 2004, Revue de Paleobiologie, V23, P771; Stiner Mary C., 1999, Ursus, V11, P41; Stiner MC, 1998, J HUM EVOL, V34, P303, DOI 10.1006/jhev.1997.0198; Stiner MC., 1996, GEOARCHAEOLOGY, V11, P279, DOI [10.1002/(SICI)1520-6548(199607)11:43.0.CO;2-Z, DOI 10.1002/(SICI)1520-6548(199607)11:43.0.CO;2-Z, DOI 10.1002/(SICI)1520-6548(199607)11:4<279::AID-GEA1>3.0.CO;2-Z]; SUTCLIFFE AJ, 1970, NATURE, V227, P1110, DOI 10.1038/2271110a0; Sutcliffe AJ., 1973, T CAVE RES GROUP G B, V15, P41; Testu A., 2011, QUATERNAIRE, V4, P271; Torres T, 1988, SPECIAL PUBLICATION, V99, P1; Turner A., 1997, BIG CATS THEIR FOSSI; Utrilla P., 2010, ZONA ARQUEOL, V13, P376; Valdiosera CE, 2008, P NATL ACAD SCI USA, V105, P5123, DOI 10.1073/pnas.0712223105; VIGAL CR, 1988, CAN J ZOOL, V66, P2836, DOI 10.1139/z88-410; Vigne, 2003, ARCHAEOFAUNA, V12, P157; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Villa P, 2000, J ANTHROPOL RES, V56, P187, DOI 10.1086/jar.56.2.3631362; Villa Paola, 2004, Revue de Paleobiologie, V23, P705; Villa P, 2010, J ARCHAEOL SCI, V37, P919, DOI 10.1016/j.jas.2009.11.025; Villaluenga Aritza, 2009, Munibe (Antropologia - Arkeologia), V60, P17; Voorhies M, 1969, 1 NEBR CONTR GEOL, V1; Walker R., 1985, GUIDE POSTCRANIAL BO; Yravedra Jose, 2011, Journal of Taphonomy, V9, P37; Yravedra Jose, 2010, Journal of Taphonomy, V8, P301	171	28	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92144	10.1371/journal.pone.0092144	http://dx.doi.org/10.1371/journal.pone.0092144			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642667	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900095
J	Wenneras, C; Hagberg, L; Andersson, R; Hynsjo, L; Lindahl, A; Okroj, M; Blom, AM; Johansson, P; Andreasson, B; Gottfries, J; Wold, AE				Wenneras, Christine; Hagberg, Lars; Andersson, Rune; Hynsjo, Lars; Lindahl, Anders; Okroj, Marcin; Blom, Anna M.; Johansson, Peter; Andreasson, Bjorn; Gottfries, Johan; Wold, Agnes E.			Distinct Inflammatory Mediator Patterns Characterize Infectious and Sterile Systemic Inflammation in Febrile Neutropenic Hematology Patients	PLOS ONE			English	Article							SERUM ALPHA-FETOPROTEIN; C4B-BINDING PROTEIN; IMMUNE-SYSTEM; DISEASES; BLOOD; TRANSPLANTATION; BACTEREMIA; ACTIVATION; CITRULLINE; MORTALITY	Background: Invasive infections and sterile tissue damage can both give rise to systemic inflammation with fever and production of inflammatory mediators. This makes it difficult to diagnose infections in patients who are already inflamed, e.g. due to cell and tissue damage. For example, fever in patients with hematological malignancies may depend on infection, lysis of malignant cells, and/or chemotherapy-induced mucosal damage. We hypothesized that it would be possible to distinguish patterns of inflammatory mediators characterizing infectious and non-infectious causes of inflammation, respectively. Analysis of a broad range of parameters using a multivariate method of pattern recognition was done for this purpose. Methods: In this prospective study, febrile (>38 degrees C) neutropenic patients (n = 42) with hematologic malignancies were classified as having or not having a microbiologically defined infection by an infectious disease specialist. In parallel, blood was analyzed for 116 biomarkers, and 23 clinical variables were recorded for each patient. Using O-PLS (orthogonal projection to latent structures), a model was constructed based on these 139 variables that could separate the infected from the non-infected patients. Non-discriminatory variables were discarded until a final model was reached. Finally, the capacity of this model to accurately classify a validation set of febrile neutropenic patients (n = 10) as infected or non-infected was tested. Results: A model that could segregate infected from non-infected patients was achieved based on discrete differences in the levels of 40 variables. These variables included acute phase proteins, cytokines, measures of coagulation, metabolism, organ stress and iron turn-over. The model correctly identified the infectious status of nine out of ten subsequently recruited febrile neutropenic hematology patients. Conclusions: It is possible to separate patients with infectious inflammation from those with sterile inflammation based on inflammatory mediator patterns. This strategy could be developed into a decision-making tool for diverse clinical applications.	[Wenneras, Christine; Johansson, Peter; Andreasson, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Dept Hematol & Coagulat, Gothenburg, Sweden; [Wenneras, Christine; Hagberg, Lars; Andersson, Rune; Wold, Agnes E.] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Hynsjo, Lars; Lindahl, Anders] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden; [Okroj, Marcin; Blom, Anna M.] Lund Univ, Dept Lab Med, Malmo, Sweden; [Johansson, Peter; Andreasson, Bjorn] Uddevalla Cent Hosp, Dept Internal Med, Uddevalla, Sweden; [Gottfries, Johan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; Lund University; Voestalpine AG; University of Gothenburg	Wenneras, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Hematol & Coagulat, Gothenburg, Sweden.	christine.wenneras@microbio.gu.se	Lindahl, Anders/H-9550-2014; Blom, Anna/AFS-7369-2022; Gottfries, Johan/M-3445-2016; Blom, Anna/B-9607-2009	Lindahl, Anders/0000-0003-2871-5166; Gottfries, Johan/0000-0001-7135-4664; Blom, Anna/0000-0002-1348-1734; Wold, Agnes/0000-0001-9196-5040; Andersson, Rune/0000-0002-8133-1199	Vastra Gotaland Region Research Foundation [93900]; Cancer and Allergy Foundation [149781]; LUA-ALF [71580]; Strategic ALF Transplantation [74080]; IngaBritt and Arne Lundberg Foundation [332/07]	Vastra Gotaland Region Research Foundation; Cancer and Allergy Foundation; LUA-ALF; Strategic ALF Transplantation; IngaBritt and Arne Lundberg Foundation	This work was supported by grants from Vastra Gotaland Region Research Foundation (grant number: 93900); Cancer and Allergy Foundation (grant number: 149781); LUA-ALF (grant number: 71580); Strategic ALF Transplantation (grant number: 74080), and the IngaBritt and Arne Lundberg Foundation (grant number: 332/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuntas F, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-62; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; BLOOMER JR, 1977, GASTROENTEROLOGY, V72, P479; Bodey GP, 2009, J ANTIMICROB CHEMOTH, V63, pI3, DOI 10.1093/jac/dkp074; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; CHRISTIANSEN M, 1994, SCAND J CLIN LAB INV, V54, P215, DOI 10.3109/00365519409088427; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Feld R, 2008, INT J ANTIMICROB AG, V32, pS30, DOI 10.1016/j.ijantimicag.2008.06.017; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; Hamilton MA, 2012, MINERVA ANESTESIOL, V78, P1039; Hermans PWM, 2005, CLIN INFECT DIS, V41, pS453, DOI 10.1086/431996; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; Komori H, 2012, J BIOL CHEM, V287, P30688, DOI 10.1074/jbc.M112.353771; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Liamis G, 2011, J INFECTION, V63, P327, DOI 10.1016/j.jinf.2011.07.013; Lin MY, 2008, ANTIMICROB AGENTS CH, V52, P3188, DOI 10.1128/AAC.01553-07; Martin M, 2009, J VASC SURG, V50, P100, DOI 10.1016/j.jvs.2008.12.033; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Panel C, 1990, J INFECT DIS, V161, P397; Parkins MD, 2007, J ANTIMICROB CHEMOTH, V60, P613, DOI 10.1093/jac/dkm212; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Robertson CM, 2006, MICROBES INFECT, V8, P1382, DOI 10.1016/j.micinf.2005.12.016; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Skovbjerg S, 2009, CLIN MICROBIOL INFEC, V15, P680, DOI 10.1111/j.1469-0691.2009.02796.x; Trauner M, 1999, J GASTROEN HEPATOL, V14, P946, DOI 10.1046/j.1440-1746.1999.01982.x; van der Velden WJFM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015156; Vischer UM, 1999, CRIT REV ONCOL HEMAT, V30, P93, DOI 10.1016/S1040-8428(98)00045-6; Vokurka S, 2013, MED SCI MONITOR, V19, P81, DOI 10.12659/MSM.883755; Wold S., 1989, Intelligent Instruments & Computers, V7, P197	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92319	10.1371/journal.pone.0092319	http://dx.doi.org/10.1371/journal.pone.0092319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642872	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900120
J	Cai, JR; Yu, XF; Xu, RD; Fang, Y; Qian, XQ; Liu, SP; Teng, J; Ding, XQ				Cai, Jieru; Yu, Xiaofang; Xu, Rende; Fang, Yi; Qian, Xiaoqin; Liu, Shaopeng; Teng, Jie; Ding, Xiaoqiang			Maximum Efficacy of Mesenchymal Stem Cells in Rat Model of Renal Ischemia-Reperfusion Injury: Renal Artery Administration with Optimal Numbers	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; EFFICIENCY; SURVIVAL; DELIVERY; THERAPY; FAILURE	Backgrounds: Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion (I/R) injury is currently limited by low rates of cell engraftment after systemic delivery. In this study, we investigate whether locally administration through renal artery can enhance the migration and therapeutic potential of mesenchymal stem cells (MSCs) in ischemic kidney. Methods: The model of renal I/R injury was induced by 45 min occlusion of the left renal pedicle and right nephrectomy in rat. Followed by reperfusion, graded doses of CM-Dil labeled MSCs were implanted via three routes: tail vein (TV), carotid artery (CA), and renal artery (RA). Renal blood flow was evaluated by color and spectral Doppler ultrasound at 1 h and 24 h post-I/R. All the samples were collected for analysis at 24 h post-I/R. Results: After injection of 1x10(6) MSCs, RA group showed obviously increased renal retention of grafted MSCs compared with TV and CA group; however, the renal function was even further deteriorated. When graded doses of MSCs, the maximal therapeutic efficiency was achieved with renal artery injection of 1x10(5) MSCs, which was significantly better than TV and CA group of 1x10(6) MSCs. In addition, further fluorescent microscopic and ultrasonic examination confirmed that the aggravated renal dysfunction in RA group was due to renal hypoperfusion caused by cell occlusion. Conclusion: Administration route and dosage are two critical factors determining the efficiency of cell therapy and 1x10(5) MSCs injected through renal artery produces the most dramatic improvement in renal function and morphology in rat model of renal I/R injury.	[Cai, Jieru; Yu, Xiaofang; Fang, Yi; Liu, Shaopeng; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Xu, Rende] Shanghai Jiao Tong Univ, Renji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Qian, Xiaoqin] Fudan Univ, Zhongshan Hosp, Dept Ultrasonog, Shanghai 200433, Peoples R China; [Teng, Jie] Fudan Univ, Zhongshan Hosp, Blood Purificat Ctr, Shanghai 200433, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University	Teng, J (corresponding author), Fudan Univ, Zhongshan Hosp, Blood Purificat Ctr, Shanghai 200433, Peoples R China.	teng.jie@zs-hospital.sh.cn; ding.xiaoqiang@zs-hospital.sh.cn			Major Project of Basic Research of Technology Committee in Shanghai of China [12DJ1400200]; Mingdao Plan of Fudan University [EZF152404/001/004]	Major Project of Basic Research of Technology Committee in Shanghai of China; Mingdao Plan of Fudan University	This work was supported by Major Project of Basic Research of Technology Committee in Shanghai of China (12DJ1400200) and Mingdao Plan of Fudan University (Grant NO: EZF152404/001/004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2012, CELL TRANSPLANT, V21, P2009, DOI 10.3727/096368912X640448; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Burst VR, 2010, NEPHRON EXP NEPHROL, V114, pE107, DOI 10.1159/000262318; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; da Cunha MGMCM, 2013, EUR SURG RES, V51, P58, DOI 10.1159/000354389; De Martino M, 2010, TRANSPL P, V42, P1331, DOI 10.1016/j.transproceed.2010.03.079; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; Fiorina P, 2006, J AM SOC NEPHROL, V17, P716, DOI 10.1681/ASN.2005090954; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Hagiwara M, 2008, HUM GENE THER, V19, P807, DOI [10.1089/hum.2008.016, 10.1089/hgt.2008.016]; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Li SH, 2009, J THORAC CARDIOV SUR, V137, P1225, DOI 10.1016/j.jtcvs.2008.11.001; Mias C, 2008, STEM CELLS, V26, P1749, DOI 10.1634/stemcells.2007-1000; Shih YC, 2013, PLAST RECONSTR SURG, V132, p940E, DOI 10.1097/PRS.0b013e3182a806ce; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel F, 2008, AM J PHYSIOL-RENAL, V295, pF315, DOI 10.1152/ajprenal.00098.2008; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Turetschek K, 1996, J ULTRAS MED, V15, P517; Yu XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062703; Zhang QW, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/859643; Zhuo W, 2013, TRANSPL P, V45, P503, DOI 10.1016/j.transproceed.2012.07.162	29	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92347	10.1371/journal.pone.0092347	http://dx.doi.org/10.1371/journal.pone.0092347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637784	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100144
J	Woo, SL; Xu, H; Li, HG; Zhao, Y; Hu, X; Zhao, JJ; Guo, X; Guo, T; Botchlett, R; Qi, T; Pei, Y; Zheng, J; Xu, YM; An, XF; Chen, LL; Chen, LL; Li, QF; Xiao, XQ; Huo, YQ; Wu, CD				Woo, Shih-Lung; Xu, Hang; Li, Honggui; Zhao, Yan; Hu, Xiang; Zhao, Jiajia; Guo, Xin; Guo, Ting; Botchlett, Rachel; Qi, Ting; Pei, Ya; Zheng, Juan; Xu, Yiming; An, Xiaofei; Chen, Lulu; Chen, Lili; Li, Qifu; Xiao, Xiaoqiu; Huo, Yuqing; Wu, Chaodong			Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SYSTEMIC INSULIN-RESISTANCE; RECEPTOR-GAMMA ACTIVATION; GENE-EXPRESSION PROFILES; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; DIABETES-MELLITUS; GLUCOSE-PRODUCTION; MICE; TISSUE; GLUCONEOGENESIS	Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin resistance. To better understand the pathophysiology of obesity-associated NAFLD, the present study examined the involvement of liver and adipose tissues in metformin actions on reducing hepatic steatosis and inflammation during obesity. C57BL/6J mice were fed a high-fat diet (HFD) for 12 weeks to induce obesity-associated NAFLD and treated with metformin (150 mg/kg/d) orally for the last four weeks of HFD feeding. Compared with HFD-fed control mice, metformin-treated mice showed improvement in both glucose tolerance and insulin sensitivity. Also, metformin treatment caused a significant decrease in liver weight, but not adiposity. As indicated by histological changes, metformin treatment decreased hepatic steatosis, but not the size of adipocytes. In addition, metformin treatment caused an increase in the phosphorylation of liver AMP-activated protein kinase (AMPK), which was accompanied by an increase in the phosphorylation of liver acetyl-CoA carboxylase and decreases in the phosphorylation of liver c-Jun N-terminal kinase 1 (JNK1) and in the mRNA levels of lipogenic enzymes and proinflammatory cytokines. However, metformin treatment did not significantly alter adipose tissue AMPK phosphorylation and inflammatory responses. In cultured hepatocytes, metformin treatment increased AMPK phosphorylation and decreased fat deposition and inflammatory responses. Additionally, in bone marrow-derived macrophages, metformin treatment partially blunted the effects of lipopolysaccharide on inducing the phosphorylation of JNK1 and nuclear factor kappa B (NF-kappa B) p65 and on increasing the mRNA levels of proinflammatory cytokines. Taken together, these results suggest that metformin protects against obesity-associated NAFLD largely through direct effects on decreasing hepatocyte fat deposition and on inhibiting inflammatory responses in both hepatocytes and macrophages.	[Woo, Shih-Lung; Xu, Hang; Li, Honggui; Zhao, Yan; Hu, Xiang; Zhao, Jiajia; Guo, Xin; Guo, Ting; Botchlett, Rachel; Qi, Ting; Pei, Ya; Zheng, Juan; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Hu, Xiang; Zheng, Juan; Chen, Lulu] Huazhong Univ Sci & Technol, Dept Endocrinol, Union Hosp, Tongji Coll Med, Wuhan 430074, Hubei, Peoples R China; [Zhao, Jiajia; Chen, Lili] Huazhong Univ Sci & Technol, Dept Stomatol, Union Hosp, Tongji Coll Med, Wuhan 430074, Hubei, Peoples R China; [Xu, Yiming; Huo, Yuqing] Georgia Regents Univ, Vasc Biol Ctr, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, GA USA; [An, Xiaofei; Huo, Yuqing] Peking Univ, Ctr Drug Discovery, Key Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Li, Qifu; Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China; [Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing, Peoples R China	Texas A&M University System; Texas A&M University College Station; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Georgia; Augusta University; Peking University; University Town of Shenzhen; Chongqing Medical University; Chongqing Medical University	Huo, YQ (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, GA USA.	YHUO@gru.edu; cdwu@tamu.edu	zhao, yan/N-6096-2014; Xiao, Xiaoqiu/K-7672-2019	Xiao, Xiaoqiu/0000-0002-4568-8772; Xu, Yiming/0000-0002-9537-3664; Xu, Yiming/0000-0002-8866-7859; Li, Qifu/0000-0003-3904-410X	American Diabetes Association (ADA) [1-10-JF-54, 1-13-BS-214-BR, 1-10-BS-76]; American Heart Association (AHA) [12BGIA9050003, 10GRNT4400005]; National Institutes of Health (NIH) [1R01DK095828, 1R01DK095862, R01HL095556-01, R21HL108922]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108922, R01HL095556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095862, R01DK095828] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by American Diabetes Association (ADA) grants 1-10-JF-54, 1-13-BS-214-BR (to C. W.), and 1-10-BS-76 (to Y.H.), American Heart Association (AHA) 12BGIA9050003 (to C. W.), 10GRNT4400005 (to Y.H). and National Institutes of Health (NIH) grants 1R01DK095828 and 1R01DK095862 (to C. W.), R01HL095556-01 and R21HL108922 (to Y.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2006, GASTROENTEROLOGY, V130, P1848, DOI 10.1053/j.gastro.2006.03.041; Anthony J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077946; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen YM, 2013, NUTR RES, V33, P332, DOI 10.1016/j.nutres.2013.02.003; Collier CA, 2006, AM J PHYSIOL-ENDOC M, V291, pE182, DOI 10.1152/ajpendo.00272.2005; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Guo X, 2013, J NUTR BIOCHEM, V24, P770, DOI 10.1016/j.jnutbio.2012.04.007; Guo X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039286; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; Huo YQ, 2012, J BIOL CHEM, V287, P21492, DOI 10.1074/jbc.M112.370379; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Kim S, 2005, J NUTR, V135, P33, DOI 10.1093/jn/135.1.33; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Klein-Wieringa IR, 2013, J IMMUNOL, V191, P1356, DOI 10.4049/jimmunol.1203074; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Neuschwander-Tetri BA, 2010, NAT REV GASTRO HEPAT, V7, P243, DOI 10.1038/nrgastro.2010.50; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; PERRIELLO G, 1994, DIABETES, V43, P920, DOI 10.2337/diabetes.43.7.920; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P273, DOI 10.1038/ncpgasthep0186; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shin N. R., 2013, GUT; Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Tajima K, 2013, AM J PHYSIOL-ENDOC M, V305, pE987, DOI 10.1152/ajpendo.00133.2013; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tilg H, 2005, NAT CLIN PRACT GASTR, V2, P148, DOI 10.1038/ncpgasthep0116; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	48	120	132	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91111	10.1371/journal.pone.0091111	http://dx.doi.org/10.1371/journal.pone.0091111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638078	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100016
J	Azhar, GS; Mavalankar, D; Nori-Sarma, A; Rajiva, A; Dutta, P; Jaiswal, A; Sheffield, P; Knowlton, K; Hess, JJ				Azhar, Gulrez Shah; Mavalankar, Dileep; Nori-Sarma, Amruta; Rajiva, Ajit; Dutta, Priya; Jaiswal, Anjali; Sheffield, Perry; Knowlton, Kim; Hess, Jeremy J.		Ahmedabad HeatClimate Study Group	Heat-Related Mortality in India: Excess All-Cause Mortality Associated with the 2010 Ahmedabad Heat Wave	PLOS ONE			English	Article							CLIMATE-CHANGE; UNITED-STATES; PUBLIC-HEALTH; CITIES; TEMPERATURE; EXTREMES; IMPACTS; WEATHER; INTENSE; STRESS	Introduction: In the recent past, spells of extreme heat associated with appreciable mortality have been documented in developed countries, including North America and Europe. However, far fewer research reports are available from developing countries or specific cities in South Asia. In May 2010, Ahmedabad, India, faced a heat wave where the temperatures reached a high of 46.8 degrees C with an apparent increase in mortality. The purpose of this study is to characterize the heat wave impact and assess the associated excess mortality. Methods: We conducted an analysis of all-cause mortality associated with a May 2010 heat wave in Ahmedabad, Gujarat, India, to determine whether extreme heat leads to excess mortality. Counts of all-cause deaths from May 1-31, 2010 were compared with the mean of counts from temporally matched periods in May 2009 and 2011 to calculate excess mortality. Other analyses included a 7-day moving average, mortality rate ratio analysis, and relationship between daily maximum temperature and daily all-cause death counts over the entire year of 2010, using month-wise correlations. Results: The May 2010 heat wave was associated with significant excess all-cause mortality. 4,462 all-cause deaths occurred, comprising an excess of 1,344 all-cause deaths, an estimated 43.1% increase when compared to the reference period (3,118 deaths). In monthly pair-wise comparisons for 2010, we found high correlations between mortality and daily maximum temperature during the locally hottest "summer'' months of April (r = 0.69, p<0.001), May (r = 0.77, p<0.001), and June (r = 0.39, p<0.05). During a period of more intense heat (May 19-25, 2010), mortality rate ratios were 1.76 [95% CI 1.67-1.83, p<0.001] and 2.12 [95% CI 2.03-2.21] applying reference periods (May 12-18, 2010) from various years. Conclusion: The May 2010 heat wave in Ahmedabad, Gujarat, India had a substantial effect on all-cause excess mortality, even in this city where hot temperatures prevail through much of April-June.	[Azhar, Gulrez Shah; Mavalankar, Dileep; Nori-Sarma, Amruta; Rajiva, Ajit; Dutta, Priya] Indian Inst Publ Hlth, Ahmadabad, Gujarat, India; [Azhar, Gulrez Shah; Mavalankar, Dileep] Publ Hlth Fdn India, New Delhi, India; [Nori-Sarma, Amruta; Knowlton, Kim] Columbia Mailman Sch Publ Hlth, New York, NY USA; [Jaiswal, Anjali; Knowlton, Kim] Nat Resources Def Council, New York, NY USA; [Sheffield, Perry] Icahn Sch Med,Mt Sinai, New York, NY USA; [Hess, Jeremy J.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Hess, Jeremy J.] Emory Univ, Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA USA	Public Health Foundation of India; Icahn School of Medicine at Mount Sinai; Emory University; Emory University	Azhar, GS (corresponding author), Indian Inst Publ Hlth, Ahmadabad, Gujarat, India.	gsazhar@iiphg.org	Mavalankar, Dileep/AAX-6931-2020; Rajiva, Ajit/P-9869-2019	Mavalankar, Dileep/0000-0003-0498-3799; Knowlton, Kim/0000-0002-8075-7817; Dutta, DrPriya/0000-0003-1594-9529	Climate Knowledge Development Network; FOGARTY INTERNATIONAL CENTER [R21TW009535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023515] Funding Source: NIH RePORTER	Climate Knowledge Development Network; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is funded by a grant from the Climate Knowledge Development Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhyaru-Majithia P, 2010, 8 DIE WORST HEAT WAV; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2012, EPIDEMIOLOGY, V23, P189, DOI 10.1097/EDE.0b013e318245c61c; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Bush KF, 2011, ENVIRON HEALTH PERSP, V119, P765, DOI 10.1289/ehp.1003000; Centers for Disease Control and Prevention, 2004, EXTR HEAT PREV GUID; Dave J, 2010, DYING HEAT WAVE KILL; De US, 2005, J INDIAN GEOPHYS UNI, V9, P173; Dole R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046582; ELLIS FP, 1976, T ROY SOC TROP MED H, V70, P412, DOI 10.1016/0035-9203(76)90121-8; Fowler DR, 2013, MMWR-MORBID MORTAL W, V62, P433; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Ghosh P., 2009, NAT ACT PLAN CLIM CH; Government of India, 2011, CENS IND; Guttikunda SK, 2012, ATMOS ENVIRON, V62, P551, DOI 10.1016/j.atmosenv.2012.08.074; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456; IPCC, 2012, MAN RISKS EXTR EV DI; IPCC Working Group II, 2011, SPEC REP MAN RISKS E; Joubert D, 2011, AM J PUBLIC HEALTH, V101, P395, DOI 10.2105/AJPH.2009.189563; Kalsi SR, 2001, CURR SCI INDIA, V80, P867; Kamaljit Ray AT, 2012, CLIMATE AHMEDABAD; Khosla R., 2010, RELEVANCE ROOFTOPS A; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Lan L, 2012, ECOHEALTH, P1; Lan L, 2012, ECOHEALTH, V9, P310, DOI 10.1007/s10393-012-0790-6; Matthies FB., 2008, HEAT HLTH ACTION PLA; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Ministry of Environment & Forests Government of India, 2010, CLIM CHANG IND 4 4 A; National Oceanic and Atmospheric Administration, 2013, NAT WEATH SERV GLOSS; Parry ML, 2007, 8 2 1 1 HEATWAVES; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sidhu RK, 1998, CURRENT SCI, V75; Takahashi K, 2007, J RISK RES, V10, P339, DOI 10.1080/13669870701217375; Vandentorren S, 2004, AM J PUBLIC HEALTH, V94, P1518, DOI 10.2105/AJPH.94.9.1518; Wong KV, 2013, J ENERG RESOUR-ASME, V135, DOI 10.1115/1.4023176	47	135	136	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91831	10.1371/journal.pone.0091831	http://dx.doi.org/10.1371/journal.pone.0091831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633076	gold, Green Published			2022-12-27	WOS:000332858400103
J	Fu, YC; Lin, CC; Chang, JK; Chen, CH; Tai, IC; Wang, GJ; Ho, ML				Fu, Yin-Chih; Lin, Chih-Chun; Chang, Je-Ken; Chen, Chung-Hwan; Tai, I-Chun; Wang, Gwo-Jaw; Ho, Mei-Ling			A Novel Single Pulsed Electromagnetic Field Stimulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells and Bone Repair	PLOS ONE			English	Article							LOCAL FACTOR PRODUCTION; OSTEOBLAST-LIKE CELLS; MAGNETIC-FIELDS; FEMORAL-HEAD; EXPOSURE; DIFFERENTIATION; OSTEONECROSIS; SAFETY; MODEL; RATS	Pulsed electromagnetic field (PEMF) has been successfully applied to accelerate fracture repair since 1979. Recent studies suggest that PEMF might be used as a nonoperative treatment for the early stages of osteonecrosis. However, PEMF treatment requires a minimum of ten hours per day for the duration of the treatment. In this study, we modified the protocol of the single-pulsed electromagnetic field (SPEMF) that only requires a 3-minute daily treatment. In the in vitro study, cell proliferation and osteogenic differentiation was evaluated in the hBMSCs. In the in vivo study, new bone formation and revascularization were evaluated in the necrotic bone graft. Results from the in vitro study showed no significant cytotoxic effects on the hBMSCs after 5 days of SPEMF treatment (1 Tesla, 30 pulses per day). hBMSC proliferation was enhanced in the SPEMF-treated groups after 2 and 4 days of treatment. The osteogenic differentiation of hBMSCs was significantly increased in the SPEMF-treated groups after 3-7 days of treatment. Mineralization also increased after 10, 15, 20, and 25 days of treatment in SPEMF-treated groups compared to the control group. The 7-day short-course treatment achieved similar effects on proliferation and osteogenesis as the 25-day treatment. Results from the in vivo study also demonstrated that both the 7-day and 25-day treatments of SPEMF increased callus formation around the necrotic bone and also increased new vessel formation and osteocyte numbers in the grafted necrotic bone at the 2nd and 4th weeks after surgery. In conclusion, the newly developed SPEMF accelerates osteogenic differentiation of cultured hBMSCs and enhances bone repair, neo-vascularization, and cell growth in necrotic bone in mice. The potential clinical advantage of the SPEMF is the short daily application and the shorter treatment course. We suggest that SPEMF may be used to treat fractures and the early stages of osteonecrosis.	[Fu, Yin-Chih; Lin, Chih-Chun; Chang, Je-Ken; Chen, Chung-Hwan; Tai, I-Chun; Wang, Gwo-Jaw; Ho, Mei-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Fu, Yin-Chih; Chen, Chung-Hwan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Fu, Yin-Chih; Chang, Je-Ken; Chen, Chung-Hwan; Wang, Gwo-Jaw; Ho, Mei-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Orthopaed, Kaohsiung, Taiwan; [Fu, Yin-Chih; Chang, Je-Ken; Chen, Chung-Hwan; Wang, Gwo-Jaw] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Fu, Yin-Chih] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Lin, Chih-Chun; Tai, I-Chun; Ho, Mei-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Physiol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Ho, ML (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan.	homelin@cc.kmu.edu.tw	Chen, Chung-Hwan/D-4036-2009	Chen, Chung-Hwan/0000-0001-8941-4792; Ho, Mei-Ling/0000-0001-8064-8488				AARON RK, 1989, J BONE MINER RES, V4, P227, DOI 10.1002/jbmr.5650040215; BASSETT CAL, 1989, CLIN ORTHOP RELAT R, P172; Chang K, 2004, BIOELECTROMAGNETICS, V25, P134, DOI 10.1002/bem.10168; Chang K, 2003, BIOELECTROMAGNETICS, V24, P189, DOI 10.1002/bem.10078; Eyres KS, 1996, BONE, V18, P505, DOI 10.1016/8756-3282(96)00070-1; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; GOSSLING HR, 1992, ORTHOPEDICS, V15, P711; Gowland PA, 2005, PROG BIOPHYS MOL BIO, V87, P175, DOI 10.1016/j.pbiomolbio.2004.08.006; GUIZZARDI S, 1994, J SPINAL DISORD, V7, P36, DOI 10.1097/00002517-199407010-00005; Hannay G, 2005, BIOELECTROMAGNETICS, V26, P670, DOI 10.1002/bem.20166; HECKMAN JD, 1981, CLIN ORTHOP RELAT R, P58; Lin TM, 2005, STEM CELLS DEV, V14, P92, DOI 10.1089/scd.2005.14.92; Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417; Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7; Massari L, 2006, J BONE JOINT SURG AM, V88A, P56, DOI 10.2106/JBJS.F.00536; MCLEOD KJ, 1992, J BONE JOINT SURG AM, V74A, P920, DOI 10.2106/00004623-199274060-00014; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Nakahara T, 2002, RADIOLOGY, V224, P817, DOI 10.1148/radiol.2243011300; Sakurai T, 2008, BIOELECTROMAGNETICS, V29, P118, DOI 10.1002/bem.20370; Schenck J F, 1998, Magn Reson Imaging Clin N Am, V6, P715; Schenck JF, 2000, J MAGN RESON IMAGING, V12, P2, DOI 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V; Schiffer IB, 2003, BIOELECTROMAGNETICS, V24, P241, DOI 10.1002/bem.10097; Silva AKA, 2006, RADIAT ENVIRON BIOPH, V45, P245, DOI 10.1007/s00411-006-0065-0; Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472; Taylor KF, 2006, J ORTHOP RES, V24, P2, DOI 10.1002/jor.20014; TROCK DH, 1994, J RHEUMATOL, V21, P1903; Tsai MT, 2009, J ORTHOP RES; Wang CK, 2009, BIOMATERIALS, V30, P4178, DOI 10.1016/j.biomaterials.2009.04.029; Yeh CH, 2009, CLIN ORTHOP RELAT R, V467, P2159, DOI 10.1007/s11999-009-0803-0; Zmyslony Marek, 2006, Medycyna Pracy, V57, P29	30	51	58	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91581	10.1371/journal.pone.0091581	http://dx.doi.org/10.1371/journal.pone.0091581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632682	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400070
J	Lee, KJ; Suh, GY; Chung, MP; Kim, H; Kwon, OJ; Han, J; Um, SW				Lee, Kyung Jong; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung; Han, Joungho; Um, Sang-Won			Combined Endobronchial and Transesophageal Approach of an Ultrasound Bronchoscope for Mediastinal Staging of Lung Cancer	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; 7TH EDITION; NODE; ULTRASONOGRAPHY; CLASSIFICATION; PROJECT	Background: We evaluated the utility of a combined approach using endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and transesophageal bronchoscopic ultrasound-guided fine-needle aspiration (EUS-FNA-B/E) for mediastinal staging of lung cancer. Methods: An EBUS-TBNA database was analyzed retrospectively. EUS-FNA-B/E was performed after EBUS-TBNA when mediastinal lymph nodes were not accessible using EBUS-TBNA or when tissue sampling using EBUS-TBNA alone was inadequate. Results: During the study period, 44 patients were enrolled. EBUS-TBNA and EUS-FNA-B/E were performed on 79 and 52 lymph nodes, respectively. The sensitivity, specificity, and accuracy of mediastinal N-staging using EBUS-TBNA alone were 79%, 100%, and 84%, respectively. The sensitivity, specificity, and accuracy of mediastinal N-staging using a combination of EBUS-TBNA and EUS-FNA-B/E were 100%, 100%, and 100%, respectively. Significant differences in sensitivity (P = 0.008) and accuracy (P = 0.004) of mediastinal N-staging were evident when EBUS-TBNA alone and the combined procedure were compared. The nodal stage shifted higher after use of the EUS-FNA-B/E procedure in six cases (13%). No serious complication associated with the procedures was noted. Conclusions: Use of a combination of EBUS-TBNA and EUS-FNA-B/E can afford better sensitivity and accuracy of mediastinal N-staging compared with use of EBUS-TBNA alone. Such combined procedures should be considered for examination of lesions that are inaccessible or difficult to access by EBUS-TBNA.	[Lee, Kyung Jong; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung; Um, Sang-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Han, Joungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Um, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.	sangwonum@skku.edu	Suh, Gee Young/O-3676-2019; Um, Sang Won/F-4610-2014	Suh, Gee Young/0000-0001-5473-1712; 				BENNETT BM, 1972, BIOMETRICS, V28, P793, DOI 10.2307/2528763; De Leyn P, 2007, J THORAC ONCOL, V2, P357, DOI 10.1097/01.JTO.0000263722.22686.1c; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Herth FJF, 2010, CHEST, V138, P790, DOI 10.1378/chest.09-2149; Hwangbo B, 2010, CHEST, V138, P795, DOI 10.1378/chest.09-2100; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jhun BW, 2012, J KOREAN MED SCI, V27, P46, DOI 10.3346/jkms.2012.27.1.46; Konge L, 2012, ENDOSCOPY, V44, P928, DOI 10.1055/s-0032-1309892; Lv YL, 2011, J THORAC ONCOL, V6, P1350, DOI 10.1097/JTO.0b013e31821d4384; Ohnishi R, 2011, ENDOSCOPY, V43, P1082, DOI 10.1055/s-0030-1256766; Rusch VW, 2007, J THORAC ONCOL, V2, P603, DOI 10.1097/JTO.0b013e31807ec803; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Szlubowski A, 2010, EUR J CARDIO-THORAC, V37, P1175, DOI 10.1016/j.ejcts.2009.11.015; Tournoy KG, 2012, LANCET ONCOL, V13, pE221, DOI 10.1016/S1470-2045(11)70407-7; Tournoy KG, 2009, J THORAC ONCOL, V4, P1576, DOI 10.1097/JTO.0b013e3181c1274f; Verma A, 2012, THORAC CANCER, V3, P280, DOI 10.1111/j.1759-7714.2011.00090.x; Vilmann P, 2005, ENDOSCOPY, V37, P833, DOI 10.1055/s-2005-870276; Wallace MB, 2008, JAMA-J AM MED ASSOC, V299, P540, DOI 10.1001/jama.299.5.540; Yasufuku K, 2011, J THORAC CARDIOV SUR, V142, P1393, DOI 10.1016/j.jtcvs.2011.08.037	21	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91893	10.1371/journal.pone.0091893	http://dx.doi.org/10.1371/journal.pone.0091893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632834	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400117
J	Lei, YP; Zhu, HP; Yang, W; Ross, ME; Shaw, GM; Finnell, RH				Lei, Yunping; Zhu, Huiping; Yang, Wei; Ross, M. Elizabeth; Shaw, Gary M.; Finnell, Richard H.			Identification of Novel CELSR1 Mutations in Spina Bifida	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; PLANAR-CELL-POLARITY; PHI-29 DNA-POLYMERASE; LOOP-TAIL; MOUSE; GENE; INITIATION; EXTENSION; RISK	Spina bifida is one of the most common neural tube defects (NTDs) with a complex etiology. Variants in planar cell polarity (PCP) genes have been associated with NTDs including spina bifida in both animal models and human cohorts. In this study, we sequenced all exons of CELSR1 in 192 spina bifida patients from a California population to determine the contribution of CELSR1 mutations in the studied population. Novel and rare variants identified in these patients were subsequently genotyped in 190 ethnically matched control individuals. Six missense mutations not found in controls were predicted to be deleterious by both SIFT and PolyPhen. Two TG dinucleotide repeat variants were individually detected in 2 spina bifida patients but not detected in controls. In vitro functional analysis showed that the two TG dinucleotide repeat variants not only changed subcellular localization of the CELSR1 protein, but also impaired the physical association between CELSR1 and VANGL2, and thus diminished the ability to recruit VANGL2 for cell-cell contact. In total, 3% of our spina bifida patients carry deleterious or predicted to be deleterious CELSR1 mutations. Our findings suggest that CELSR1 mutations contribute to the risk of spina bifida in a cohort of spina bifida patients from California.	[Lei, Yunping; Zhu, Huiping; Finnell, Richard H.] Univ Texas Austin, Dell Pediat Res Inst, Dept Nutrit Sci, Austin, TX 78712 USA; [Finnell, Richard H.] Univ Texas Austin, Dept Chem, Coll Nat Sci, Austin, TX 78712 USA; [Yang, Wei; Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Div Neonatol, Stanford, CA 94305 USA; [Ross, M. Elizabeth] Weill Cornell Med Coll, Ctr Neurogenet, Brain & Mind Res Inst, New York, NY USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Stanford University; Cornell University	Finnell, RH (corresponding author), Univ Texas Austin, Dell Pediat Res Inst, Dept Nutrit Sci, Austin, TX 78712 USA.	rfinnell@austin.utexas.edu	Lei, Yunping/B-6322-2009; Finnell, Richard/D-8174-2018	Lei, Yunping/0000-0003-1504-0884; Shaw, Gary/0000-0001-7438-4914; Finnell, Richard/0000-0002-5962-8754	NIH [HD067244, NS076465, ES021006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH grants HD067244, NS076465, and ES021006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allache R, 2012, BIRTH DEFECTS RES A, V94, P176, DOI 10.1002/bdra.23002; Bosoi CM, 2011, HUM MUTAT, V32, P1371, DOI 10.1002/humu.21589; Croen L A, 1991, Paediatr Perinat Epidemiol, V5, P423, DOI 10.1111/j.1365-3016.1991.tb00728.x; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; De Marco P, 2013, J MOL NEUROSCI, V49, P582, DOI 10.1007/s12031-012-9871-9; De Marco P, 2012, HUM MUTAT, V33, P384, DOI 10.1002/humu.21643; Deak KL, 2008, BIRTH DEFECTS RES A, V82, P662, DOI 10.1002/bdra.20511; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Devenport D, 2011, NAT CELL BIOL, V13, P893, DOI 10.1038/ncb2284; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Formstone CJ, 2005, DEV BIOL, V282, P320, DOI 10.1016/j.ydbio.2005.03.026; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Group M. V. S. R., 1991, LANCET, V338, P131, DOI DOI 10.1016/0140-6736(91)90133-A; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P824, DOI 10.1002/bdra.23079; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Lei YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069262; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Nelson JR, 2002, BIOTECHNIQUES, P44; Olshan AF, 2005, AM J MED GENET A, V135A, P268, DOI 10.1002/ajmg.a.30713; Robinson A, 2012, HUM MUTAT, V33, P440, DOI 10.1002/humu.21662; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Tran PX, 2011, BIRTH DEFECTS RES A, V91, P39, DOI 10.1002/bdra.20744; Yang XY, 2013, HUM MUTAT; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380	29	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92207	10.1371/journal.pone.0092207	http://dx.doi.org/10.1371/journal.pone.0092207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632739	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400150
J	Goh, LK; Liem, N; Vijayaraghavan, A; Chen, GB; Lim, PL; Tay, KJ; Chang, M; Low, JSW; Joshi, A; Huang, HH; Kalaw, E; Tan, PH; Hsieh, WS; Yong, WP; Alumkal, J; Sim, HG				Goh, Liang Kee; Liem, Natalia; Vijayaraghavan, Aadhitthya; Chen, Gengbo; Lim, Pei Li; Tay, Kae-Jack; Chang, Michelle; Low, John Soon Wah; Joshi, Adita; Huang, Hong Hong; Kalaw, Emarene; Tan, Puay Hoon; Hsieh, Wen-Son; Yong, Wei Peng; Alumkal, Joshi; Sim, Hong Gee			Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer	PLOS ONE			English	Article							TERTIARY GLEASON PATTERN-5; ACUTE MYELOID-LEUKEMIA; METHYLATION; EXPRESSION; REVEALS; KIT; BIOMARKERS; MANAGEMENT; CELLS; STAGE	We aimed to identify a prostate cancer DNA hypermethylation microarray signature (denoted as PHYMA) that differentiates prostate cancer from benign prostate hyperplasia (BPH), high from low-grade and lethal from non-lethal cancers. This is a non-randomized retrospective study in 111 local Asian men (87 prostate cancers and 24 BPH) treated from 1995 to 2009 in our institution. Archival prostate epithelia were laser-capture microdissected and genomic DNA extracted and bisulfite-converted. Samples were profiled using Illumina GoldenGate Methylation microarray, with raw data processed by GenomeStudio. A classification model was generated using support vector machine, consisting of a 55-probe DNA methylation signature of 46 genes. The model was independently validated on an internal testing dataset which yielded cancer detection sensitivity and specificity of 95.3% and 100% respectively, with overall accuracy of 96.4%. Second validation on another independent western cohort yielded 89.8% sensitivity and 66.7% specificity, with overall accuracy of 88.7%. A PHYMA score was developed for each sample based on the state of methylation in the PHYMA signature. Increasing PHYMA score was significantly associated with higher Gleason score and Gleason primary grade. Men with higher PHYMA scores have poorer survival on univariate (p = 0.0038, HR = 3.89) and multivariate analyses when controlled for (i) clinical stage (p = 0.055, HR = 2.57), and (ii) clinical stage and Gleason score (p = 0.043, HR = 2.61). We further performed bisulfite genomic sequencing on 2 relatively unknown genes to demonstrate robustness of the assay results. PHYMA is thus a signature with high sensitivity and specificity for discriminating tumors from BPH, and has a potential role in early detection and in predicting survival.	[Goh, Liang Kee; Vijayaraghavan, Aadhitthya] Duke Natl Univ Singapore, Grad Sch Med, Ctr Quantitat Med, Singapore, Singapore; [Goh, Liang Kee; Chen, Gengbo] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Liem, Natalia; Lim, Pei Li; Low, John Soon Wah; Hsieh, Wen-Son; Yong, Wei Peng] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Tay, Kae-Jack; Chang, Michelle; Joshi, Adita; Huang, Hong Hong; Sim, Hong Gee] Singapore Gen Hosp, Dept Urol, Singapore, Singapore; [Kalaw, Emarene; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Alumkal, Joshi] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital; Oregon Health & Science University	Goh, LK (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Ctr Quantitat Med, Singapore, Singapore.	liang.goh@duke-nus.edu.sg; sim.hong.gee@sgh.com.sg	Yong, Wei-Peng/Y-7260-2018; Tay, Kae Jack/N-6526-2016	Yong, Wei-Peng/0000-0003-4404-3777; Tay, Kae Jack/0000-0003-0365-1899	Singapore National Medical Research Council [NMRC NIG/0033/2008]; Khoo Discovery Awards [KDP/2008/0002, KDP/2009/0006]; Duke-NUS Signature Research Program Phase 1; Agency for Science, Technology and Research (A*STAR); Ministry of Health, Singapore; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER	Singapore National Medical Research Council(National Medical Research Council, Singapore); Khoo Discovery Awards; Duke-NUS Signature Research Program Phase 1; Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by the Singapore National Medical Research Council (NMRC NIG/0033/2008) to HGS, Khoo Discovery Awards (KDP/2008/0002 and KDP/2009/0006) and Duke-NUS Signature Research Program Phase 1 funded by the Agency for Science, Technology and Research (A*STAR), and the Ministry of Health, Singapore, to LKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albany C, 2012, PROSTATE CANC, V2011; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Baden J, 2011, J UROLOGY, V186, P2101, DOI 10.1016/j.juro.2011.06.052; Bailar J C 3rd, 1966, Cancer Chemother Rep, V50, P129; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bratt O, 2006, EUR UROL, V50, P410, DOI 10.1016/j.eururo.2006.03.066; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074775; Chiam K, 2014, CANCER LETT, V342, P248, DOI 10.1016/j.canlet.2012.02.011; Di Lorenzo G, 2004, EJSO-EUR J SURG ONC, V30, P987, DOI 10.1016/j.ejso.2004.07.017; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fiorentino M, 2010, UROL CLIN N AM, V37, P131, DOI 10.1016/j.ucl.2009.11.006; Gallick GE, 2012, FUTURE MED CHEM, V4, P107, DOI [10.4155/FMC.11.161, 10.4155/fmc.11.161]; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Goh Liang, 2005, Journal of Bioinformatics and Computational Biology, V3, P1107, DOI 10.1142/S0219720005001533; Goh L, 2007, BIOINFORMATICS, V23, P281, DOI 10.1093/bioinformatics/btl620; Gupta Aditi, 2013, Cancers (Basel), V5, P617, DOI 10.3390/cancers5020617; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Harkin DP, 2006, ONCOLOGIST, V11, P988, DOI 10.1634/theoncologist.11-9-988; Hewitt KJ, 2012, J CELL SCI, V125, P2276, DOI 10.1242/jcs.099192; Howlader N, 2013, SEER CANC STAT REV 1; Irsoy O, 2012, IEEE ACM T COMPUT BI, V9, P1663, DOI 10.1109/TCBB.2012.117; Jeronimo C, 2014, CANCER LETT, V342, P264, DOI 10.1016/j.canlet.2011.12.026; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Krishnamoorthy S, 2010, EXP CELL RES, V316, P1706, DOI 10.1016/j.yexcr.2010.03.005; Kron K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004830; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Lowrance William T, 2009, Rev Urol, V11, P117; Mazaris Evangelos, 2013, Nephrourol Mon, V5, P792, DOI 10.5812/numonthly.9430; McLean M, 1997, Clin Oncol (R Coll Radiol), V9, P222, DOI 10.1016/S0936-6555(97)80005-2; Mosse CA, 2004, AM J SURG PATHOL, V28, P394, DOI 10.1097/00000478-200403000-00014; Napieralski R, 2007, CLIN CANCER RES, V13, P5095, DOI 10.1158/1078-0432.CCR-07-0241; Nordlund J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034513; Ohgami RS, 2012, BRIT J HAEMATOL, V159, P182, DOI 10.1111/bjh.12029; Oue N, 2006, CANCER-AM CANCER SOC, V106, P1250, DOI 10.1002/cncr.21754; Pavlidis P, 2004, BIOINFORMATICS, V20, P586, DOI 10.1093/bioinformatics/btg461; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Raffoux E, 2010, ONCOTARGET, V1, P34, DOI 10.18632/oncotarget.106; Risk MC, 2010, CLIN CANCER RES, V16, P5414, DOI 10.1158/1078-0432.CCR-10-0272; Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467; Schwartzman J, 2011, EPIGENETICS-US, V6, P1248, DOI 10.4161/epi.6.10.17727; Sim HG, 2008, J UROLOGY, V179, P1775, DOI 10.1016/j.juro.2008.01.016; Sirma H, 2013, ONCOL LETT, V6, P1245, DOI 10.3892/ol.2013.1563; Tawadros T, 2012, BRIT J CANCER, V107, P1737, DOI 10.1038/bjc.2012.457; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; Vener T, 2008, CLIN CHEM, V54, P874, DOI 10.1373/clinchem.2007.094912; Verma Mukesh, 2011, Cancers (Basel), V3, P3773, DOI 10.3390/cancers3043773; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yang B, 2007, J INVEST DERMATOL, V127, P2123, DOI 10.1038/sj.jid.5700836; Yu YP, 2005, CARCINOGENESIS, V26, P471, DOI 10.1093/carcin/bgh310; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zam NABM, 2008, PATHOLOGY, V40, P586, DOI 10.1080/00313020802320671; Zawada AM, 2012, CIRC-CARDIOVASC GENE, V5, P611, DOI 10.1161/CIRCGENETICS.112.963207	65	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91666	10.1371/journal.pone.0091666	http://dx.doi.org/10.1371/journal.pone.0091666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626295	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300116
J	Maguire, S; Estabel, J; Ingham, N; Pearson, S; Ryder, E; Carragher, DM; Walker, N; Bussell, J; Chan, WI; Keane, TM; Adams, DJ; Scudamore, CL; Lelliott, CJ; Ramirez-Solis, R; Karp, NA; Steel, KP; White, JK; Gerdin, AK				Maguire, Simon; Estabel, Jeanne; Ingham, Neil; Pearson, Selina; Ryder, Edward; Carragher, Damian M.; Walker, Nicolas; Bussell, James; Chan, Wai-In; Keane, Thomas M.; Adams, David J.; Scudamore, Cheryl L.; Lelliott, Christopher J.; Ramirez-Solis, Ramiro; Karp, Natasha A.; Steel, Karen P.; White, Jacqueline K.; Gerdin, Anna-Karin		Sanger MGP Slc25a21 Project Team	Targeting of Slc25a21 Is Associated with Orofacial Defects and Otitis Media Due to Disrupted Expression of a Neighbouring Gene	PLOS ONE			English	Article							ALPHA-AMINOADIPIC ACIDURIA; TRANSPORTER FAMILY SLC25; LOCUS-CONTROL REGION; REGULATORY ELEMENTS; MOLAR OLIGODONTIA; GENOME-WIDE; PAX9 GENE; MOUSE; IDENTIFICATION; MICE	Homozygosity for Slc25a21(tm1a(KOMP)Wtsi) results in mice exhibiting orofacial abnormalities, alterations in carpal and rugae structures, hearing impairment and inflammation in the middle ear. In humans it has been hypothesised that the 2oxoadipate mitochondrial carrier coded by SLC25A21 may be involved in the disease 2-oxoadipate acidaemia. Unexpectedly, no 2-oxoadipate acidaemia-like symptoms were observed in animals homozygous for Slc25a21(tm1a(KOMP)Wtsi) despite confirmation that this allele reduces Slc25a21 expression by 71.3%. To study the complete knockout, an allelic series was generated using the loxP and FRT sites typical of a Knockout Mouse Project allele. After removal of the critical exon and neomycin selection cassette, Slc25a21 knockout mice homozygous for the Slc25a21(tm1b(KOMP)Wtsi) and Slc25a21(tm1d(KOMP)Wtsi) alleles were phenotypically indistinguishable from wild-type. This led us to explore the genomic environment of Slc25a21 and to discover that expression of Pax9, located 3' of the target gene, was reduced in homozygous Slc25a21(tm1a(KOMP)Wtsi) mice. We hypothesize that the presence of the selection cassette is the cause of the down regulation of Pax9 observed. The phenotypes we observed in homozygous Slc25a21(tm1a(KOMP)Wtsi) mice were broadly consistent with a hypomorphic Pax9 allele with the exception of otitis media and hearing impairment which may be a novel consequence of Pax9 down regulation. We explore the ramifications associated with this particular targeted mutation and emphasise the need to interpret phenotypes taking into consideration all potential underlying genetic mechanisms.	[Maguire, Simon; Estabel, Jeanne; Ingham, Neil; Pearson, Selina; Ryder, Edward; Carragher, Damian M.; Walker, Nicolas; Bussell, James; Keane, Thomas M.; Adams, David J.; Lelliott, Christopher J.; Ramirez-Solis, Ramiro; Karp, Natasha A.; Steel, Karen P.; White, Jacqueline K.; Gerdin, Anna-Karin; Sanger MGP Slc25a21 Project Team] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Walker, Nicolas] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, Cambs, England; [Chan, Wai-In] Cambridge Inst Med Res, Dept Haematol, Cambridge, Cambs, England; [Scudamore, Cheryl L.] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of London; University of London Royal Veterinary College	White, JK (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.	jkw@sanger.ac.uk	Ryder, Edward/AAK-1243-2021; Ismail, Ozama/AFQ-9517-2022; Carragher, Damian/E-6673-2016; Carragher, Damian/O-4183-2019	Ryder, Edward/0000-0002-1799-9899; Carragher, Damian/0000-0003-4341-4943; Carragher, Damian/0000-0003-4341-4943; Adams, David/0000-0001-9490-0306; Scudamore, Cheryl/0000-0002-7101-1714; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Keane, Thomas/0000-0001-7532-6898; Ismail, Ozama/0000-0002-0871-3924; Vancollie, Valerie/0000-0003-1547-1975; Karp, Natasha/0000-0002-8404-2907	Wellcome Trust [098051]; European Union [282510]; Medical Research Council [G0901338, MC_UP_1502/1, G0300212, MC_qA137918] Funding Source: researchfish; MRC [G0300212, MC_qA137918, MC_UP_1502/1, G0901338] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant no 098051 to WTSI) (http://www.wellcome.ac.uk/) and the European Union's Seventh Framework program under grant agreement number 282510 - BLUEPRINT (NW) (www.blueprint-epigenome.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Das P, 2003, AM J MED GENET A, V118A, P35, DOI 10.1002/ajmg.a.10011; DURAN M, 1984, J INHERIT METAB DIS, V7, P61, DOI 10.1007/BF01805803; FIERING S, 1993, P NATL ACAD SCI USA, V90, P8469, DOI 10.1073/pnas.90.18.8469; Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200; FISCHER MH, 1980, AM J MED GENET, V5, P35, DOI 10.1002/ajmg.1320050106; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Ingham Neil J, 2011, Curr Protoc Mouse Biol, V1, P279, DOI 10.1002/9780470942390.mo110059; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kist R, 2005, HUM MOL GENET, V14, P3605, DOI 10.1093/hmg/ddi388; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Kleinjan Dirk-Jan, 2009, Briefings in Functional Genomics & Proteomics, V8, P317, DOI 10.1093/bfgp/elp022; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Mataki S, 1991, STUDIES TRANSPORT ME, P298; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Ovchinnikov D, 2009, COLD SPRING HARB PRO; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Peters H, 1997, MAMM GENOME, V8, P62, DOI 10.1007/s003359900351; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; PRZYREMBEL H, 1976, CLIN CHIM ACTA, V66, P227, DOI 10.1016/0009-8981(76)90060-7; Ryder E, 2013, MAMM GENOME, V24, P286, DOI 10.1007/s00335-013-9467-x; Santagati F, 2003, GENETICS, V165, P235; Sasaki Y, 2007, ARCH ORAL BIOL, V52, P260, DOI 10.1016/j.archoralbio.2006.09.012; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tyrer HE, 2013, CURR ALLERGY ASTHM R, V13, P501, DOI 10.1007/s11882-013-0360-1; van der Weyden L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-224; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; WILSON RW, 1975, PEDIATR RES, V9, P522, DOI 10.1203/00006450-197506000-00002	38	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91807	10.1371/journal.pone.0091807	http://dx.doi.org/10.1371/journal.pone.0091807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642684	Green Submitted, gold, Green Published			2022-12-27	WOS:000333259900037
J	Maurya, SR; Mahalakshmi, R				Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan			Cysteine Residues Impact the Stability and Micelle Interaction Dynamics of the Human Mitochondrial beta-Barrel Anion Channel hVDAC-2	PLOS ONE			English	Article							MEMBRANE-PROTEIN VDAC; DETERGENT CONCENTRATION; ESCHERICHIA-COLI; BAK ACTIVATION; APOPTOSIS; ISOFORMS; SINGLE; UREA; TARGET; ENERGY	The anti-apoptotic 19-stranded transmembrane human voltage dependent anion channel isoform 2 (hVDAC-2) beta-barrel stability is crucial for anion transport in mitochondria. The role of the unusually high number of cysteine residues in this isoform is poorly understood. Using a Cys-less construct of hVDAC-2, we haveinvestigated the contribution of cysteines to channel function, barrel stability and its influence on the strength of protein-micelle interactions. We observe that despite the overall preservation in barrel structure upon cysteine mutation, subtle local variations in the mode of interaction of the barrel with its refolded micellar environment arise, which may manifest itself in the channel activity of both the proteins. Fluorescence measurements of the Trp residues in hVDAC-2 point to possible differences in the association of the barrel with lauryldimethylamine oxide (LDAO) micelles. Upon replacement of cysteines in hVDAC-2, our data suggests greater barrel rigidity by way of intra-protein interactions. This, in turn, lowers the equilibrium barrel thermodynamic parameters in LDAO by perturbingthe stability of the protein-micelle complex. In addition to this, we also find a difference in the cooperativity of unfolding upon increasing the LDAO concentration, implying the importance of micelle concentration and micelle-protein ratios on the stability of this barrel. Our results indicate that the nine cysteine residues of hVDAC-2 are the key in establishing strong(er) barrel interactions with its environment and also impart additional malleability to the barrel scaffold.	[Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India.	maha@iiserb.ac.in	Maurya, Svetlana/H-3664-2018; Mahalakshmi, Radhakrishnan/B-3143-2008	Maurya, Svetlana/0000-0002-4700-2711; Mahalakshmi, Radhakrishnan/0000-0003-1549-7550	Department of Biotechnology (DBT), Govt. of India [BT/01/IYBA/2009]; Council of Scientific and Industrial Research, India; DBT, Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); DBT, Govt. of India(Department of Biotechnology (DBT) India)	This work is supported by the Department of Biotechnology (DBT), Govt. of India award number BT/01/IYBA/2009. SRM is supported by a senior research fellowship from Council of Scientific and Industrial Research, India. R. M. is a recipient of the Ramalingaswami Fellowship from DBT, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1986, BIOPOLYMERS, V25, P1623, DOI 10.1002/bip.360250906; Andersen KK, 2012, BIOCHEMISTRY-US, V51, P8371, DOI 10.1021/bi300974y; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Bathori G, 1998, BIOCHEM BIOPH RES CO, V243, P258, DOI 10.1006/bbrc.1997.7926; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; CALHOUN D B, 1986, Proteins Structure Function and Genetics, V1, P109, DOI 10.1002/prot.340010202; Canchi DR, 2013, ANNU REV PHYS CHEM, V64, P273, DOI 10.1146/annurev-physchem-040412-110156; Chaturvedi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079351; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2007, METHOD CELL BIOL, V80, P241, DOI 10.1016/S0091-679X(06)80012-9; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1438, DOI 10.1016/j.bbamem.2011.11.014; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107; Franzin CM, 2007, J AM CHEM SOC, V129, P8078, DOI 10.1021/ja0728371; GREENE RF, 1974, J BIOL CHEM, V249, P5388; HERRMANN KW, 1962, J PHYS CHEM-US, V66, P295, DOI 10.1021/j100808a025; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193; Kaufmann TC, 2006, DETERGENT PROTEIN DE; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065, DOI 10.1110/ps.8.10.2065; Lakowicz J.R., 1991, TOPICS FLUORESCENCE, V2; Lazarou M, 2010, J BIOL CHEM, V285, P36876, DOI 10.1074/jbc.M110.159301; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Maurya SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087701; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989; Menzel VA, 2009, BIOSCIENCE REP, V29, P351, DOI 10.1042/BSR20080123; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Moon CP, 2011, J MOL BIOL, V413, P484, DOI 10.1016/j.jmb.2011.08.041; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Mudiyanselage APKKK, 2013, BIOCHEMISTRY-US, V52, P6127, DOI 10.1021/bi4007176; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Plotz M, 2012, CELL DEATH DIFFER, V19, P1928, DOI 10.1038/cdd.2012.71; Pocanschi CL, 2013, EUR BIOPHYS J BIOPHY, V42, P103, DOI 10.1007/s00249-013-0887-z; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003; Ren DC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000274; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schlebach JP, 2013, BIOCHEMISTRY-US, V52, P3229, DOI 10.1021/bi301635f; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Sheshadri S, 1999, PROTEIN SCI, V8, P1689, DOI 10.1110/ps.8.8.1689; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Stangl M, 2012, BIOPHYS J, V103, P2455, DOI 10.1016/j.bpj.2012.11.004; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Tan EHL, 1996, BIOPHYS J, V70, P2385, DOI 10.1016/S0006-3495(96)79806-5; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Venkatesu P, 2007, ARCH BIOCHEM BIOPHYS, V466, P106, DOI 10.1016/j.abb.2007.07.004; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhang XP, 2012, PROTEIN CELL, V3, P790, DOI 10.1007/s13238-012-2069-7	71	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92183	10.1371/journal.pone.0092183	http://dx.doi.org/10.1371/journal.pone.0092183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642864	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900099
J	Thompson, AA; Byrne, PA; Henriques, DYP				Thompson, Aidan A.; Byrne, Patrick A.; Henriques, Denise Y. P.			Visual Targets Aren't Irreversibly Converted to Motor Coordinates: Eye-Centered Updating of Visuospatial Memory in Online Reach Control	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; REFERENCE FRAMES; HAND COORDINATION; GUIDED REACH; MOVEMENTS; SPACE; TRANSFORMATIONS; GAZE; INFORMATION; REPRESENTATION	Counter to current and widely accepted hypotheses that sensorimotor transformations involve converting target locations in spatial memory from an eye-fixed reference frame into a more stable motor-based reference frame, we show that this is not strictly the case. Eye-centered representations continue to dominate reach control even during movement execution; the eye-centered target representation persists after conversion to a motor-based frame and is continuously updated as the eyes move during reach, and is used to modify the reach plan accordingly during online control. While reaches are known to be adjusted online when targets physically shift, our results are the first to show that similar adjustments occur in response to changes in representations of remembered target locations. Specifically, we find that shifts in gaze direction, which produce predictable changes in the internal (specifically eye-centered) representation of remembered target locations also produce mid-transport changes in reach kinematics. This indicates that representations of remembered reach targets (and visuospatial memory in general) continue to be updated relative to gaze even after reach onset. Thus, online motor control is influenced dynamically by both the external and internal updating mechanisms.	[Thompson, Aidan A.; Byrne, Patrick A.; Henriques, Denise Y. P.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Thompson, Aidan A.; Henriques, Denise Y. P.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Henriques, DYP (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	deniseh@yorku.ca		Byrne, Patrick/0000-0002-5276-5393	Natural Sciences and Engineering Research Council; Canadian Foundation for Innovation New Opportunities Fund; Ontario Graduate Scholarships Science and Technology program	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation New Opportunities Fund(Canada Foundation for Innovation); Ontario Graduate Scholarships Science and Technology program	This work was funded by the Natural Sciences and Engineering Research Council (through a Discovery Grant to DYPH and a post-graduate scholarship to AAT), the Canadian Foundation for Innovation New Opportunities Fund (DYPH), and the Ontario Graduate Scholarships Science and Technology program (AAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Byrne PA, 2010, J NEUROPHYSIOL, V103, P3054, DOI 10.1152/jn.01008.2009; Chen Y, 2011, NEUROPSYCHOLOGIA, V49, P49, DOI 10.1016/j.neuropsychologia.2010.10.031; Crawford JD, 2011, ANNU REV NEUROSCI, V34, P309, DOI 10.1146/annurev-neuro-061010-113749; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2002, PROG BRAIN RES, V140, P329; HOGAN N, 1984, J NEUROSCI, V4, P2745; Izawa J, 2008, J NEUROSCI, V28, P11360, DOI 10.1523/JNEUROSCI.3063-08.2008; Jones SAH, 2010, NEUROPSYCHOLOGIA, V48, P3782, DOI 10.1016/j.neuropsychologia.2010.10.001; Khan AZ, 2001, VISION RES, V41, P1743, DOI 10.1016/S0042-6989(01)00079-7; McGovern NN, 2011, J IMMUNOL, V186, P453, DOI 10.4049/jimmunol.1002213; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Medendorp WP, 2002, NEUROREPORT, V13, P633, DOI 10.1097/00001756-200204160-00019; Poljac E, 2003, EXP BRAIN RES, V151, P501, DOI 10.1007/s00221-003-1498-1; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Sorrento GU, 2008, J NEUROPHYSIOL, V99, P2968, DOI 10.1152/jn.90225.2008; Thompson AA, 2008, J NEUROPHYSIOL, V100, P2507, DOI 10.1152/jn.90599.2008; Van Pelt S, 2007, J NEUROPHYSIOL, V97, P1209, DOI 10.1152/jn.00882.2006	26	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92455	10.1371/journal.pone.0092455	http://dx.doi.org/10.1371/journal.pone.0092455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643008	gold, Green Published			2022-12-27	WOS:000333259900143
J	Gyllensten, H; Hakkarainen, KM; Hagg, S; Carlsten, A; Petzold, M; Rehnberg, C; Jonsson, AK				Gyllensten, Hanna; Hakkarainen, Katja M.; Hagg, Staffan; Carlsten, Anders; Petzold, Max; Rehnberg, Clas; Jonsson, Anna K.			Economic Impact of Adverse Drug Events - A Retrospective Population-Based Cohort Study of 4970 Adults	PLOS ONE			English	Article							COSTS; ADMISSIONS	Background: The aim was to estimate the direct costs caused by ADEs, including costs for dispensed drugs, primary care, other outpatient care, and inpatient care, and to relate the direct costs caused by ADEs to the societal COI (direct and indirect costs), for patients with ADEs and for the entire study population. Methods: We conducted a population-based observational retrospective cohort study of ADEs identified from medical records. From a random sample of 5025 adults in a Swedish county council, 4970 were included in the analyses. During a three-month study period in 2008, direct and indirect costs were estimated from resource use identified in the medical records and from register data on costs for resource use. Results: Among 596 patients with ADEs, the average direct costs per patient caused by ADEs were USD 444.9 [95% CI: 264.4 to 625.3], corresponding to USD 21 million per 100 000 adult inhabitants per year. Inpatient care accounted for 53.9% of all direct costs caused by ADEs. For patients with ADEs, the average societal cost of illness was USD 6235.0 [5442.8 to 7027.2], of which direct costs were USD 2830.1 [2260.7 to 3399.4] (45%), and indirect costs USD 3404.9 [2899.3 to 3910.4] (55%). The societal cost of illness was higher for patients with ADEs compared to other patients. ADEs caused 9.5% of all direct healthcare costs in the study population. Conclusions: Healthcare costs for patients with ADEs are substantial across different settings; in primary care, other outpatient care and inpatient care. Hence the economic impact of ADEs will be underestimated in studies focusing on inpatient ADEs alone. Moreover, the high proportion of indirect costs in the societal COI for patients with ADEs suggests that the observed costs caused by ADEs would be even higher if including indirect costs. Additional studies are needed to identify interventions to prevent and manage ADEs.	[Gyllensten, Hanna; Hakkarainen, Katja M.; Carlsten, Anders] Nord Sch Publ Hlth NHV, Gothenburg, Sweden; [Gyllensten, Hanna; Hakkarainen, Katja M.] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Sect Social Med, Gothenburg, Sweden; [Hagg, Staffan; Jonsson, Anna K.] Linkoping Univ, Fac Hlth Sci, Dept Drug Res Clin Pharmacol, Linkoping, Sweden; [Hagg, Staffan] Jonkoping Cty Council, Futurum Acad Hlth & Care, Jonkoping, Sweden; [Carlsten, Anders] Med Prod Agcy, Uppsala, Sweden; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat Occupat & Environm Med, Akad Stat, Gothenburg, Sweden; [Rehnberg, Clas] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Jonsson, Anna K.] Cty Council Ostergotland, Dept Clin Pharmacol, Linkoping, Sweden	University of Gothenburg; Linkoping University; Futurum; Medical Products Agency; University of Gothenburg; Karolinska Institutet; City Council Ostergotland	Gyllensten, H (corresponding author), Nord Sch Publ Hlth NHV, Gothenburg, Sweden.	hanna.gyllensten@nhv.se	Hägg, Staffan/G-5612-2013; Gyllensten, Hanna/H-7378-2016	Hägg, Staffan/0000-0002-5137-8420; Gyllensten, Hanna/0000-0001-6890-5162; Rehnberg, Clas/0000-0001-5326-450X	National Corporation of Swedish Pharmacies (Apoteket AB); Region Vastra Gotaland; Ostergotland County Council	National Corporation of Swedish Pharmacies (Apoteket AB); Region Vastra Gotaland; Ostergotland County Council	The research was funded by an unrestricted grant from the National Corporation of Swedish Pharmacies (Apoteket AB). Additional funding was received from Region Vastra Gotaland and Ostergotland County Council. The study sponsor had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The research was conducted independently from the sponsor.	Anell Anders, 2012, Health Syst Transit, V14, P1; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Gyllensten H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002574; Gyllensten H, 2012, DRUG SAFETY, V35, P207, DOI 10.2165/11597090-000000000-00000; Hakkarainen KM, 2013, BR J CLIN P IN PRESS, DOI [10.1111/bcp.12314, DOI 10.1111/BCP.12314:IN]; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Hohl CM, 2011, ANN EMERG MED, V58, P270, DOI 10.1016/j.annemergmed.2011.01.003; Hoonhout LHF, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-27; Howard RL, 2003, QUAL SAF HEALTH CARE, V12, P280, DOI 10.1136/qhc.12.4.280; Hug BL, 2012, JT COMM J QUAL PATIE, V38, P120, DOI 10.1016/S1553-7250(12)38016-1; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Nordic Centre for Classifications in Health Care, NORD CTR CLASS HLTH; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; Rodriguez-Monguio R, 2003, PHARMACOECONOMICS, V21, P623, DOI 10.2165/00019053-200321090-00002; Segel J. E., 2006, RTI UNC CTR EXCELLEN, P1; Statistics Sweden, STAT FOLKM EFT REG C; Statistics Sweden, 2013, STAT GEN GRUND MAN S; Sveriges Riksbank, SVER RIKSB ARSG VAL; Swedish Tax Agency, 2007, SKATT SVER SKATT ARS; Tafreshi MJ, 1999, ANN PHARMACOTHER, V33, P1252, DOI 10.1345/aph.19062	21	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92061	10.1371/journal.pone.0092061	http://dx.doi.org/10.1371/journal.pone.0092061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637879	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100109
J	Preti, MG; Makris, N; Papadimitriou, G; Lagana, MM; Griffanti, L; Clerici, M; Nemni, R; Westin, CF; Baselli, G; Baglio, F				Preti, Maria Giulia; Makris, Nikos; Papadimitriou, George; Lagana, Maria Marcella; Griffanti, Ludovica; Clerici, Mario; Nemni, Raffaello; Westin, Carl-Fredrik; Baselli, Giuseppe; Baglio, Francesca			A Novel Approach of Groupwise fMRI-Guided Tractography Allowing to Characterize the Clinical Evolution of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; BRAIN ACTIVATION; DIFFUSION; DTI; RECOMMENDATIONS; DISCONNECTION; DEMENTIA	Guiding diffusion tract-based anatomy by functional magnetic resonance imaging (fMRI), we aim to investigate the relationship between structural connectivity and functional activity in the human brain. To this purpose, we introduced a novel groupwise fMRI-guided tractographic approach, that was applied on a population ranging between prodromic and moderate stages of Alzheimer's disease (AD). The study comprised of 15 subjects affected by amnestic mild cognitive impairment (aMCI), 14 diagnosed with AD and 14 elderly healthy adults who were used as controls. By creating representative (ensemble) functionally guided tracts within each group of participants, our methodology highlighted the white matter fiber connections involved in verbal fluency functions for a specific population, and hypothesized on brain compensation mechanisms that potentially counteract or reduce cognitive impairment symptoms in prodromic AD. Our hope is that this fMRI-guided tractographic approach could have potential impact in various clinical studies, while investigating white/gray matter connectivity, in both health and disease.	[Preti, Maria Giulia; Lagana, Maria Marcella; Griffanti, Ludovica; Clerici, Mario; Nemni, Raffaello; Baglio, Francesca] Fdn Don Carlo Gnocchi ONLUS, IRCCS, Milan, Italy; [Preti, Maria Giulia; Griffanti, Ludovica; Baselli, Giuseppe] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Makris, Nikos; Papadimitriou, George] Harvard Univ, Sch Med, Dept Psychiat,Massachusetts Gen Hosp, Ctr Neural Syst Invest,Ctr Morphometr Anal,Athino, Boston, MA 02115 USA; [Makris, Nikos; Papadimitriou, George] Harvard Univ, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging,Dept Neur, Ctr Neural Syst Invest,Ctr Morphometr Anal,Sch Me, Boston, MA USA; [Makris, Nikos] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat,Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Makris, Nikos] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Clerici, Mario; Nemni, Raffaello] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Westin, Carl-Fredrik] Brigham & Womens Hosp, Dept Radiol, Lab Math Imaging, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	IRCCS Fondazione Don Carlo Gnocchi Onlus; Polytechnic University of Milan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; University of Milan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Preti, MG (corresponding author), Fdn Don Carlo Gnocchi ONLUS, IRCCS, Milan, Italy.	gpreti@dongnocchi.it	Lagana, Maria Marcella/L-8050-2016; Griffanti, Ludovica/ABA-4218-2020; Preti, Maria Giulia/X-9430-2019; Baglio, Francesca/K-2808-2016; baglio, francesca/AAX-6298-2020	Lagana, Maria Marcella/0000-0001-7848-1711; Griffanti, Ludovica/0000-0002-0540-9353; Preti, Maria Giulia/0000-0002-5323-5327; Baglio, Francesca/0000-0002-6145-5274; baglio, francesca/0000-0002-6145-5274; Clerici, Mario/0000-0001-5920-6191	Ricerca Corrente; Italian Ministry of Health; National Institutes of Health (NIH) [R01MH074794, P41EB015902, R01AG042512, R01DA027804, R21NS079905, R21NS077059]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077059, R21NS079905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027804] Funding Source: NIH RePORTER	Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Italian Ministry of Health(Ministry of Health, Italy); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by 2011-2012 Ricerca Corrente, Italian Ministry of Health (http://www.salute.gov.it/portale/temi/p2_5. jsp?lingua = italiano&area = Ricerca%20sanita ria&menu = corrente), National Institutes of Health (NIH) R01MH074794, NIH P41EB015902, NIH R01AG042512, NIH R01DA027804, NIH R21NS079905 and NIH R21NS077059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Basho S, 2007, NEUROPSYCHOLOGIA, V45, P1697, DOI 10.1016/j.neuropsychologia.2007.01.007; Bonzano L, 2009, NEUROIMAGE, V44, P9, DOI 10.1016/j.neuroimage.2008.08.015; Booth JR, 2007, BRAIN RES, V1133, P136, DOI 10.1016/j.brainres.2006.11.074; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haugrud N, 2011, J INT NEUROPSYCH SOC, V17, P1153, DOI 10.1017/S1355617711001196; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jackowski M, 2005, MED IMAGE ANAL, V9, P427, DOI 10.1016/j.media.2005.05.008; Jansen A, 2005, HUM BRAIN MAPP, V24, P165, DOI 10.1002/hbm.20077; Kim DS, 2005, ANN NY ACAD SCI, V1064, P1, DOI 10.1196/annals.1340.005; Kleiser R, 2010, NEURORADIOLOGY, V52, P37, DOI 10.1007/s00234-009-0539-2; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lagana M., 2010, COMPUT INTEL NEUROSC; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Magni E, 1996, EUR J NEUROL, V3, P98; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Neufang S, 2011, J ALZHEIMERS DIS, V25, P309, DOI 10.3233/JAD-2011-102154; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pihlajamaki M, 2008, AM J GERIAT PSYCHIAT, V16, P283, DOI 10.1097/JGP.0b013e318162a0a9; Preti MG, 2012, IEEE ENG MED BIO, P2283, DOI 10.1109/EMBC.2012.6346418; Preti MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035856; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Schlosser RGM, 2007, SCHIZOPHR RES, V89, P1, DOI 10.1016/j.schres.2006.09.007; Smits M, 2007, AM J NEURORADIOL, V28, P1354, DOI 10.3174/ajnr.A0538; Staempfli P, 2008, NEUROIMAGE, V39, P119, DOI 10.1016/j.neuroimage.2007.08.025; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058887	39	15	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92026	10.1371/journal.pone.0092026	http://dx.doi.org/10.1371/journal.pone.0092026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637718	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100102
J	Stahl-Pehe, A; Lange, K; Bachle, C; Castillo, K; Holl, RW; Rosenbauer, J				Stahl-Pehe, Anna; Lange, Karin; Baechle, Christina; Castillo, Katty; Holl, Reinhard W.; Rosenbauer, Joachim			Mental Health Problems among Adolescents with Early-Onset and Long-Duration Type 1 Diabetes and Their Association with Quality of Life: A Population-Based Survey	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; GERMAN HEALTH; CHILD HEALTH; SELF-REPORTS; PARENT; PREVALENCE; INTERVIEW; STRENGTHS; IMPACT	Objective: To evaluate mental health problems and associations between mental health problems and health-related quality of life in adolescents with type 1 diabetes in comparison with the general population. Method: A total of 629 11-to 17-year-olds with early-onset and long-lasting type 1 diabetes and their parents completed comprehensive questionnaires. Mental health was assessed using the parent-and self-report versions of the Strengths and Difficulties Questionnaire (SDQ). The Revised Children's Quality of Life Questionnaire (KINDL-R) was used to measure quality of life. The comparison group (n = 6,813) was a representative sample from the German KiGGS study. Results: The proportion of youths with mental health problems (defined as abnormal SDQ total difficulties score) was, based on self-reports, 4.4% in the patient group and 2.9% in the general population (adjusted OR = 1.61, p = 0.044); and based on proxy reports, 7.9% in the patient group and 7.2% in the general population (OR = 1.05, p = 0.788). Youths with type 1 diabetes and self-reported mental health problems scored worse in the KINDL-R subscales of physical well-being (adjusted average difference beta = -16.74, p < 0.001) and family (beta = -11.09, p = 0.017), and in the KINDL-R total score (beta = -8.09, p < 0.001), than peers with self-reported mental health problems. The quality of life of diabetic adolescents and proxy-reported mental health problems did not differ from peers with proxy-reported mental health problems adjusted for confounders. Conclusions: Compared with the general population with mental health problems, the quality of life of adolescents with type 1 diabetes who report mental health problems is more severely impaired. This observation calls for early prevention and intervention as part of pediatric diabetes long-term care.	[Stahl-Pehe, Anna; Baechle, Christina; Castillo, Katty; Rosenbauer, Joachim] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr DDZ, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Lange, Karin] Hannover Med Sch, Med Psychol Unit, Hannover, Germany; [Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Hannover Medical School; Ulm University	Stahl-Pehe, A (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr DDZ, Inst Biometr & Epidemiol, Dusseldorf, Germany.	anna.stahl@ddz.uni-duesseldorf.de		Holl, Reinhard/0000-0003-1395-4842; Stahl-Pehe, Anna/0000-0002-5281-6023	Competence Network for Diabetes Mellitus; Federal Ministry of Education and Research [01GI0802, 01GI1109A]; German Ministry of Health; Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia	Competence Network for Diabetes Mellitus; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry of Health; Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia	The study was supported by the Competence Network for Diabetes Mellitus (www.kompetenznetz-diabetes-mellitus.net/index.php/en) funded by the Federal Ministry of Education and Research (support code 01GI0802, 01GI1109A). The German Diabetes Center is institutionally funded by the German Ministry of Health and the Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2012, J AM ACAD CHILD PSY, V51, P1261, DOI 10.1016/j.jaac.2012.09.010; Becker A, 2004, EUR CHILD ADOLES PSY, V13, P11, DOI 10.1007/s00787-004-2003-5; Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950; Boe T, 2012, SOC PSYCH PSYCH EPID, V47, P1557, DOI 10.1007/s00127-011-0462-9; Bot M, 2011, EPIDEMIOL PSYCH SCI, V20, P357, DOI 10.1017/S2045796011000540; Bullinger M, 2008, EUR CHILD ADOLES PSY, V17, P125, DOI 10.1007/s00787-008-1014-z; de Wit M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-10; Delamater AM, 2009, PEDIATR DIABETES, V10, P175, DOI 10.1111/j.1399-5448.2009.00580.x; Erhart M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-77; Essau CA, 2012, INT J METH PSYCH RES, V21, P232, DOI 10.1002/mpr.1364; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Goodman R, 2012, SDQ SCORING INSTRUCT; Graue M, 2003, ACTA PAEDIATR, V92, P1190, DOI 10.1080/08035250310005657; Helgeson VS, 2007, J PEDIATR PSYCHOL, V32, P794, DOI 10.1093/jpepsy/jsm020; Helm Dieter, 2010, Central European Journal of Public Health, V18, P3; Holling H, 2008, EUR CHILD ADOLES PSY, V17, P34, DOI 10.1007/s00787-008-1004-1; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kulzer B, 2013, DIABETOL STOFFWECHS, V8, P198, DOI 10.1055/s-0033-1335785; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lange M, 2007, BUNDESGESUNDHEITSBLA, V50, P578, DOI 10.1007/s00103-007-0219-5; Marzelli MJ, 2014, DIABETES, V63, P343, DOI 10.2337/db13-0179; Moore SM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-50; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Perna L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-199; Persson S, 2013, DIABETOLOGIA, V56, P1254, DOI 10.1007/s00125-013-2870-8; Rajmil L, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-103; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P22, DOI 10.1007/s00787-008-1003-2; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Rothenberger A, 2008, EUR CHILD ADOLES PSY, V17, P99, DOI 10.1007/s00787-008-1011-2; Salardi S, 2012, DIABETES CARE, V35, P829, DOI 10.2337/dc11-1489; Speight J, 2013, MED J AUSTRALIA, V198, P16, DOI 10.5694/mja12.11489; Stahl A, 2012, DIABETES CARE, V35, P1736, DOI 10.2337/dc11-2438; Stahl-Pehe A, 2014, PEDIATR DIABETES, V15, P436, DOI 10.1111/pedi.12096; Stevanovic D, 2013, QUAL LIFE RES, V22, P333, DOI 10.1007/s11136-012-0158-y; Olives EV, 2013, QUAL LIFE RES, V22, P613, DOI 10.1007/s11136-012-0167-x; Wake M, 2000, DIABETIC MED, V17, P700, DOI 10.1046/j.1464-5491.2000.00360.x	41	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92473	10.1371/journal.pone.0092473	http://dx.doi.org/10.1371/journal.pone.0092473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637957	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100150
J	Tanabe, K; Yamazaki, H; Inaguma, Y; Asada, A; Kimura, T; Takahashi, J; Taoka, M; Ohshima, T; Furuichi, T; Isobe, T; Nagata, K; Shirao, T; Hisanaga, S				Tanabe, Kazuya; Yamazaki, Hiroyuki; Inaguma, Yutaka; Asada, Akiko; Kimura, Taeko; Takahashi, Junya; Taoka, Masato; Ohshima, Toshio; Furuichi, Teiichi; Isobe, Toshiaki; Nagata, Koh-ichi; Shirao, Tomoaki; Hisanaga, Shin-ichi			Phosphorylation of Drebrin by Cyclin-Dependent Kinase 5 and Its Role in Neuronal Migration	PLOS ONE			English	Article							REGULATES ACTIN POLYMERIZATION; CDK5 ACTIVATOR P35; BIPOLAR TRANSITION; PROTEIN; COMPLEX; GROWTH; BINDING; CELLS	Cyclin-dependent kinase 5 (Cdk5)-p35 is a proline-directed Ser/Thr kinase which plays a key role in neuronal migration, neurite outgrowth, and spine formation during brain development. Dynamic remodeling of cytoskeletons is required for all of these processes. Cdk5-p35 phosphorylates many cytoskeletal proteins, but it is not fully understood how Cdk5-p35 regulates cytoskeletal reorganization associated with neuronal migration. Since actin filaments are critical for the neuronal movement and process formation, we aimed to find Cdk5 substrates among actin-binding proteins. In this study, we isolated actin gels from mouse brain extracts, which contain many actin-binding proteins, and phosphorylated them by Cdk5-p35 in vitro. Drebrin, a side binding protein of actin filaments and well known for spine formation, was identified as a phosphorylated protein. Drebrin has two isoforms, an embryonic form drebrin E and an adult type long isoform drebrin A. Ser142 was identified as a common phosphorylation site to drebrin E and A and Ser342 as a drebrin A-specific site. Phosphorylated drebrin is localized at the distal area of total drebrin in the growth cone of cultured primary neurons. By expressing nonphosphorylatable or phosphorylation mimicking mutants in developing neurons in utero, the reversible phosphorylation/dephosphorylation reaction of drebrin was shown to be involved in radial migration of cortical neurons. These results suggest that Cdk5-p35 regulates neuronal migration through phosphorylation of drebrin in growth cone processes.	[Tanabe, Kazuya; Asada, Akiko; Kimura, Taeko; Takahashi, Junya; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan; [Yamazaki, Hiroyuki; Shirao, Tomoaki] Gunma Univ, Grad Sch Med, Dept Neurobiol & Behav, Maebashi, Gunma, Japan; [Inaguma, Yutaka; Nagata, Koh-ichi] Inst Dev Res, Kasugai, Aichi, Japan; [Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 19203, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Furuichi, Teiichi] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan	Tokyo Metropolitan University; Gunma University; Tokyo Metropolitan University; Waseda University; Tokyo University of Science	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan.	hisanaga-shinichi@tmu.ac.jp	Furuichi, Teiichi/B-5086-2014; Isobe, Toshiaki/Q-9279-2017; Shirao, Tomoaki/I-9257-2016	Furuichi, Teiichi/0000-0002-9676-1888; Taoka, Masato/0000-0001-5554-4951; Shirao, Tomoaki/0000-0003-4323-028X	Ministry of Education, Science and Culture, Japan [19057007, 20370047]	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants-in-aid from the Ministry of Education, Science and Culture, Japan (19057007 and 20370047 to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chew CS, 2005, AM J PHYSIOL-GASTR L, V289, pG320, DOI 10.1152/ajpgi.00002.2005; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dun XP, 2012, MOL CELL NEUROSCI, V49, P341, DOI 10.1016/j.mcn.2012.01.006; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; Heng JIT, 2010, TRENDS NEUROSCI, V33, P38, DOI 10.1016/j.tins.2009.09.003; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Honda T, 2011, NEUROCHEM RES, V36, P1270, DOI 10.1007/s11064-011-0407-4; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Ishikawa R, 2007, BIOCHEM BIOPH RES CO, V359, P398, DOI 10.1016/j.bbrc.2007.05.123; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2013, GENES CELLS, V18, P176, DOI 10.1111/gtc.12029; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Mizui T, 2009, J NEUROCHEM, V109, P611, DOI 10.1111/j.1471-4159.2009.05993.x; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishimura YV, 2012, MED MOL MORPHOL, V45, P1, DOI 10.1007/s00795-011-0557-0; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Paglini G, 1998, J NEUROSCI, V18, P9858; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shiraishi Y, 2003, MOL CELL NEUROSCI, V22, P188, DOI 10.1016/S1044-7431(03)00037-X; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; Shirao T, 2013, J NEUROCHEM, V126, P155, DOI 10.1111/jnc.12313; Taguchi K, 2005, J NEUROSCI RES, V81, P218, DOI 10.1002/jnr.20555; Takahashi H, 2003, J NEUROSCI, V23, P6586; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Taoka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp732; Tsutsumi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010260; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Xie MJ, 2013, CEREB CORTEX, V23, P1410, DOI 10.1093/cercor/bhs123; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007	50	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92291	10.1371/journal.pone.0092291	http://dx.doi.org/10.1371/journal.pone.0092291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637538	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100138
J	Zhang, GY; Zou, XY; Miao, S; Chen, JJ; Du, T; Zhong, L; Ju, GQ; Liu, GH; Zhu, YJ				Zhang, Guangyuan; Zou, Xiangyu; Miao, Shuai; Chen, Jinjun; Du, Tao; Zhong, Liang; Ju, Guanqun; Liu, Guohua; Zhu, Yingjian			The Anti-Oxidative Role of Micro-Vesicles Derived from Human Wharton-Jelly Mesenchymal Stromal Cells through NOX2/gp91(phox) Suppression in Alleviating Renal Ischemia-Reperfusion Injury in Rats	PLOS ONE			English	Article							GENERATING NADPH OXIDASES; ACUTE KIDNEY INJURY; STEM-CELLS; OXIDATIVE STRESS; IN-VIVO; MICROVESICLES; PROTECT; MICROPARTICLES; INDUCTION; INCREASES	Oxidative stress is known as one of the main contributors in renal ischemia/reperfusion injury (IRI). Here we hypothesized that Micro-vesicles (MVs) derived from human Wharton Jelly mesenchymal stromal cells (hWJMSCs) could protect kidney against IRI through mitigating oxidative stress. MVs isolated from hWJMSCs conditioned medium were injected intravenously in rats immediately after unilateral kidney ischemia for 60 min. The animals were sacrificed at 24h, 48h and 2 weeks respectively after reperfusion. Our results show that the expression of NOX2 and reactive oxygen species (ROS) in injured kidney tissues was declined and the oxidative stress was alleviated in MVs group at 24h and 48h in parallel with the reduced apoptosis and enhanced proliferation of cells. IRI-initiated fibrosis was abrogated by MVs coincident with renal function amelioration at 2 weeks. NOX2 was also found down-regulated by MVs both in human umbilical vein endothelial cells (HUVEC) and NRK-52E cell line under hypoxia injury model in vitro. In conclusion, a single administration of hWJMSC-MVs might protect the kidney by alleviation of the oxidative stress in the early stage of kidney IRI through suppressing NOX2 expression. Moreover, it could reduce the fibrosis and improved renal function.	[Zhang, Guangyuan; Zou, Xiangyu; Miao, Shuai; Du, Tao; Ju, Guanqun; Liu, Guohua; Zhu, Yingjian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Chen, Jinjun] Shanghai Jiao Tong Univ, Sch Med, Tissue Engn Ctr, Shanghai Key Lab Tissue Engn, Shanghai 200030, Peoples R China; [Du, Tao] Henan Prov Peoples Hosp, Dept Urol, Zhengzhou, Peoples R China; [Zhong, Liang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Zhengzhou University; Shanghai Jiao Tong University	Liu, GH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China.	liuguohua_sjtu@163.com; zhuyingjian_sjtu@126.com	Zhang, Guangyuan/AAD-5494-2020		Research Program of Science and Technology Commission of Shanghai Municipality [10411967200]; Shanghai Song-Jiang Health Bureau [2011PD06]; National Natural Science Foundation of China [81170642]; Shanghai Shen Kang Plat-form Grant [SHDC12007206]	Research Program of Science and Technology Commission of Shanghai Municipality; Shanghai Song-Jiang Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Shen Kang Plat-form Grant	This study is supported by grants from the Research Program of Science and Technology Commission of Shanghai Municipality (10411967200) and Shanghai Song-Jiang Health Bureau (2011PD06) and National Natural Science Foundation of China(81170642) and Shanghai Shen Kang Plat-form Grant (SHDC12007206). The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy VE, 2002, CRIT CARE CLIN, V18, P203, DOI 10.1016/S0749-0704(01)00002-1; Armitage ME, 2009, J MOL MED, V87, P1071, DOI 10.1007/s00109-009-0544-2; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bernard A, 2010, J TRAUMA, V69, P320, DOI 10.1097/TA.0b013e3181e401f0; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen XP, 2010, FREE RADICAL RES, V44, P587, DOI 10.3109/10715761003709802; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Cho KA, 2012, CELL BIOL INT, V36, P1267, DOI 10.1042/CBI20110634; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Driver AS, 2000, NEUROTOXICOL TERATOL, V22, P175, DOI 10.1016/S0892-0362(99)00069-0; Du T, 2012, CYTOTHERAPY, V14, P1215, DOI 10.3109/14653249.2012.711471; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kalinowski L, 2004, ACTA BIOCHIM POL, V51, P459; Kaminski KA, 2002, INT J CARDIOL, V86, P41, DOI 10.1016/S0167-5273(02)00189-4; Kleikers PWM, 2012, J MOL MED, V90, P1391, DOI 10.1007/s00109-012-0963-3; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; LEDWOZYW A, 1986, CLIN CHIM ACTA, V155, P275, DOI 10.1016/0009-8981(86)90247-0; Liu L, 2010, NEUROSCIENCE, V167, P1115, DOI 10.1016/j.neuroscience.2010.01.057; Looi YH, 2008, HYPERTENSION, V51, P319, DOI 10.1161/HYPERTENSIONAHA.107.101980; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Milwid JM, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/392050; Modlinger P, 2006, HYPERTENSION, V47, P238, DOI 10.1161/01.HYP.0000200023.02195.73; Mokarizadeh A, 2012, IMMUNOL LETT, V147, P47, DOI 10.1016/j.imlet.2012.06.001; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Shinomol GK, 2007, NEUROTOXICOLOGY, V28, P798, DOI 10.1016/j.neuro.2007.03.002; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Siriussawakul A, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/819382; Steinberg BE, 2007, SCI STKE 2007, V2007, DOI 10.1126/stke.3792007pe11; Sukpat S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/459196; Tsuda H, 2013, CELL TRANSPLANT; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Villanueva S, 2013, CLIN SCI, V125, P199, DOI 10.1042/CS20120644; Wang FW, 2013, J CELL BIOCH; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061366; Xagorari A, 2013, INT J CLIN EXP PATHO, V6, P831; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194; Zhuo WL, 2011, UROL INT, V86, P191, DOI 10.1159/000319366	59	97	101	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92129	10.1371/journal.pone.0092129	http://dx.doi.org/10.1371/journal.pone.0092129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637475	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100117
J	Lover, AA; Hartman, M; Chia, KS; Heymann, DL				Lover, Andrew A.; Hartman, Mikael; Chia, Kee Seng; Heymann, David L.			Demographic and Spatial Predictors of Anemia in Women of Reproductive Age in Timor-Leste: Implications for Health Program Prioritization	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; HEMOGLOBIN CONCENTRATION; INFANT-MORTALITY; PREGNANT-WOMEN; RISK-FACTORS; MALARIA; INTERVENTIONS; INFECTIONS; PREVALENCE; CHILDREN	Anemia is a significant risk factor for poor health outcomes for both the mother and neonate; however, the determinants of anemia in many epidemiological settings are poorly understood. Using a subset of a nationally representative cluster survey (2010 Demographic and Health Survey) in combination with other non-contemporaneous survey data, the epidemiology of anemia among women of reproductive age in Timor-Leste has been explored. Logistic regression was used to identify risk factors, population-level impacts were estimated as population attributable fractions and spatial analytics were used to identify regions of highest risk. The DHS survey found that similar to 21% of adult women in Timor-Leste are anemic (49,053; 95% CI: 37,095 to 61,035), with hemoglobin <12.0 g/dL. In this population, the main risk factors (adjusted odds ratio; 95% CI) are: currently abstaining from sex for any reason (2.25; 1.50 to 3.38); illiteracy (2.04; 1.49 to 2.80); giving birth within the previous year (1.80; 1.29 to 2.51); consumption of fruits/vegetables low in vitamin A (1.57; 1.13 to 2.20); and the district-level confirmed malaria incidence (1.31; 1.15 to 1.49). A review of prior soil-transmitted helminth surveys in Timor-Leste indicates low-to-moderate prevalence with generally low egg counts, suggesting a limited impact on anemia in this setting, although comprehensive survey data are lacking. Examination of the population-level effects highlights the impacts of both recent births and malaria on anemia, with more limited impacts from diet; the evidence does not suggest a large contribution from geohelminths within Timor-Leste. These patterns are divergent from some other settings in the Asia-Pacific region and highlight the need for further focused research. Targeting high-burden districts and by increasing access to pre/postnatal care, raising literacy levels, increasing access to family planning, and improving malaria control should be prioritized to maximize inherently limited health budgets in reaching these populations.	[Lover, Andrew A.; Hartman, Mikael; Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael] Natl Univ Singapore Hosp, Dept Surg, Singapore, Singapore; [Hartman, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Heymann, David L.] Publ Hlth England, Dept Hlth, London, England; [Heymann, David L.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England	National University of Singapore; National University of Singapore; Karolinska Institutet; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Lover, AA (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	andrew.a.lover@gmail.com	; Hartman, Mikael/B-4324-2011	Lover, Andrew/0000-0002-2181-3559; Hartman, Mikael/0000-0001-5726-9965				Agho KE, 2008, J HEALTH POPUL NUTR, V26, P200; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2008, WORLDW PREV AN 1993; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Bhutta ZA, 2012, INT J GYNECOL OBSTET, V119, pS13, DOI 10.1016/j.ijgo.2012.04.001; Boel M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000887; Deen J, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-8; Douglas NM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-135; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Ezzati M, 2004, COMP QUANTIFICATION; Friedman JF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000295; Haider BA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S19; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hotez PJ, 2010, ADV PARASIT, V72, P31, DOI 10.1016/S0065-308X(10)72002-9; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Klemm R, 2011, ARE WE MAKING PROR R; Lover AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-199; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Magalhaes RJS, 2013, GEOSPATIAL HEALTH, V7, P341; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; McClure EM, 2013, INT J GYNECOL OBSTET, V121, P103, DOI 10.1016/j.ijgo.2012.12.014; Melrose W, 2002, SURVEY GLUCOSE 6 PHO; Ministry of Health and National Statistics Office Timor-Leste University of Newcastle The Australian National University and ACIL Australia, 2004, TIM LEST 2003 DEM HL; Ministry of Health Timor-Leste, 2010, GLOB AIDS PROGR REP; Ministry of Health Timor-Leste World Health Organization AusAID, 2012, TIM LEST NAT PAR SUR; Morrow M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-85; Muhangi L, 2007, T ROY SOC TROP MED H, V101, P899, DOI 10.1016/j.trstmh.2007.03.017; National Statistics Directorate [Timor-Leste] Ministry of Finance [Timor-Leste] and ICF Macro, 2010, TIM LEST DEM HLTH SU; National Statistics Directorate Timor-Leste United National Development Program, 2011, POP HOUS CENS TIM LE; National Statistics Directorate Timor-Leste United National Development Program, TIM LEST GIS MAPS PO; Newson R., 2012, PUNAF STATA MODULE C; Nguyen Phuong H., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1213; Noronha JA, 2010, J OBSTET GYNAECOL, V30, P132, DOI 10.3109/01443610903267457; Nurdiati Detty Siti, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P14; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; PRITCHARD DI, 1990, PARASITOLOGY, V100, P317, DOI 10.1017/S0031182000061333; Pulford J, 2012, SOC SCI MED, V75, P2283, DOI 10.1016/j.socscimed.2012.08.030; Reeve DM, 2010, THESIS J COOK U AUST; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Senn N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009375; Shamah-Levy T, 2003, SALUD PUBLICA MEXICO, V45, pS499; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Tatala S, 1998, AM J CLIN NUTR, V68, P171, DOI 10.1093/ajcn/68.1.171; Timor-Leste Ministry of Health, 2007, ANN HLTH STAT RE JAN; Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44; United National Development Program, 2009, MILL DEV GOALS TIM L; van den Broek N, 1998, BRIT J OBSTET GYNAEC, V105, P385; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2011, SER FERR CONC ASS IR	49	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91252	10.1371/journal.pone.0091252	http://dx.doi.org/10.1371/journal.pone.0091252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632676	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000332858400049
J	Yeh, JR; Hsu, LC; Lin, C; Chang, FL; Lo, MT				Yeh, Jia-Rong; Hsu, Li-Chi; Lin, Chen; Chang, Fu-Ling; Lo, Men-Tzung			Nonlinear Analysis of Sensory Organization Test for Subjects with Unilateral Vestibular Dysfunction	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; EVALUATING POSTURAL CONTROL; APPROXIMATE ENTROPY; COMPENSATION	Vestibular disorder is the cause of approximately 50% of dizziness in older people. The vestibular system is a critical postural control mechanism, and posturography analysis is helpful for diagnosing vestibular disorder. In clinical practice, the sensory organization test (SOT) is used to quantify postural control in an upright stance under different test conditions. However, both aging and vestibular disorder cause declines of postural control mechanisms. The aim of this study was to enhance the performance of the SOT using a nonlinear algorithm of empirical mode decomposition (EMD) and to verify the differences of effects caused by aging and/or illnesses benefits to clinical diagnosis. A total of 51 subjects belonging to 3 groups-healthy-young, healthy-elderly and dizzy-were recruited for this study. New dynamic parameters of the SOT were derived from the center of pressure (COP) signals. EMD served as an adaptive filter bank to derive the low-and high-frequency components of the COP. The effects on four ratios of sensory analysis caused by aging and vestibular disorder can be investigated for the specific frequency bands. According to our findings, new SOT parameters derived from the component with the specific frequency band more sensitively reflect the functional condition of vestibular dysfunction. Furthermore, both aging and vestibular dysfunction caused an increase in magnitude for the low-frequency component of the AP-direction COP time series. In summary, the low-frequency fluctuation reflects the stability of postural control, while the high-frequency fluctuation is sensitive to the functional condition of the sensory system. EMD successfully improved the accuracy of SOT measurements in this investigation.	[Yeh, Jia-Rong; Lin, Chen; Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan; [Yeh, Jia-Rong; Lin, Chen; Lo, Men-Tzung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Tao Yuan, Taiwan; [Hsu, Li-Chi] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsu, Li-Chi] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chang, Fu-Ling] Taiwan Text Res Inst, New Taipei City, Taiwan; [Chang, Fu-Ling] Natl Yunlin Univ Sci & Technol, Grad Sch Design, Yunlin, Taiwan	National Central University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yunlin University Science & Technology	Lo, MT (corresponding author), Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan.	mzlo@ncu.edu.tw	huang, yuting/T-4341-2019	Lin, Chen/0000-0001-6261-8509	NSC Taiwan, ROC [99-2627-B-008-003, 97-2314-B-038-002-MY3]; NCU [CNJRF-101CGH-NCU-A4, VGHUST103-G1-3-3]; NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 102-2911-I-008-001]; Taipei Veterans General Hospital [V99C1-194, V100C-205, V101C-200]	NSC Taiwan, ROC(Ministry of Science and Technology, Taiwan); NCU; NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The authors wish to thank the support from NSC (http://web1.nsc.gov.tw/mp.aspx?mp=7 Taiwan, ROC), Grant No. 99-2627-B-008-003, and 97-2314-B-038-002-MY3, joint foundation of NCU (http://www.ncu.edu.tw), Grant No. CNJRF-101CGH-NCU-A4, VGHUST103-G1-3-3, NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 102-2911-I-008-001) and grants from Taipei Veterans General Hospital (http://www.vghtpe.gov.tw/doce/ V99C1-194, V100C-205 and V101C-200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoud H, 2007, IEEE SIGNAL PROC LET, V14, P297, DOI 10.1109/LSP.2006.888089; Amoud H, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/657391; Ator GA, 2010, VERTIGO EVALUATION T; Brown P, 1997, MOVEMENT DISORD, V12, P977, DOI 10.1002/mds.870120622; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Colnat-Coulbois S, 2005, J NEUROL NEUROSUR PS, V76, P780, DOI 10.1136/jnnp.2004.047829; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Dettmer M, 2013, HUM MOVEMENT SCI, V32, P214, DOI 10.1016/j.humov.2012.12.002; DIENER HC, 1984, J NEUROL NEUROSUR PS, V47, P679, DOI 10.1136/jnnp.47.7.679; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Fife TD, 2008, NEUROLOGY, V168, P2118; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; HASAN SS, 1992, IEEE ENG MED BIOL, V11, P35, DOI 10.1109/51.256956; Horak FB, 2010, RESTOR NEUROL NEUROS, V28, P57, DOI 10.3233/RNN-2010-0515; Horak FB, 2009, ANN NY ACAD SCI, V1164, P76, DOI 10.1111/j.1749-6632.2008.03708.x; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Li L-P, 2011, RES J APPL SCI ENG T, V3, P1014; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Marigold DS, 2004, NEUROREHAB NEURAL RE, V18, P222, DOI 10.1177/1545968304271171; Mease KD, 2003, J GUID CONTROL DYNAM, V26, P318, DOI 10.2514/2.5049; Monsell EM, 1997, OTOLARYNG HEAD NECK, V117, P394, DOI 10.1016/S0194-5998(97)70132-3; Nashner LM, 2008, PRACTICAL MANAGEMENT; NEIMAN J, 1990, NEUROLOGY, V40, P741, DOI 10.1212/WNL.40.5.741; Oie KS, 2001, NEUROSCI LETT, V315, P113, DOI 10.1016/S0304-3940(01)02348-5; Pachori RB, 2009, INT CONF ACOUST SPEE, P537, DOI 10.1109/ICASSP.2009.4959639; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pilkar R, 2011, MATH BIOSCI ENG, V8, P1085, DOI 10.3934/mbe.2011.8.1085; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Reid V A, 2002, Neurol Clin Neurophysiol, V2002, P2, DOI 10.1162/153840902760213658; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Sasaki O, 2001, NEUROSCI RES, V41, P185, DOI 10.1016/S0168-0102(01)00276-0; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sullivan EV, 2010, BIOL PSYCHIAT, V67, P44, DOI 10.1016/j.biopsych.2009.08.008; Turnock MJE, 2010, J MOTOR BEHAV, V42, P61, DOI 10.1080/00222890903397103; Yeh JR, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/943431	38	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91230	10.1371/journal.pone.0091230	http://dx.doi.org/10.1371/journal.pone.0091230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632582	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400047
J	Zhang, XA; Chen, X; Zhai, Y; Cui, Y; Cao, PB; Zhang, HX; Wu, ZH; Li, PY; Yu, LX; Xia, X; He, FC; Zhou, GQ				Zhang, Xiaoai; Chen, Xi; Zhai, Yun; Cui, Ying; Cao, Pengbo; Zhang, Hongxing; Wu, Zhihao; Li, Peiyao; Yu, Lixa; Xia, Xia; He, Fuchu; Zhou, Gangqiao			Combined Effects of Genetic Variants of the PTEN, AKT1, MDM2 and p53 Genes on the Risk of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PI3K/PTEN/AKT/MTOR PATHWAY; ASSOCIATION; CANCER; OVEREXPRESSION; METASTASIS; PROGNOSIS; REGION	Phosphatase and tensin homolog (PTEN), v-akt murine thymoma viral oncogene homolog 1 (AKT1), mouse double minute 2 (MDM2) and p53 play important roles in the development of cancer. We examined whether the single nucleotide polymorphisms (SNPs) in the PTEN, AKT1, MDM2 and p53 genes were related to the risk and severity of nasopharyngeal carcinoma (NPC) in the Chinese population. Seven SNPs [p53 rs1042522, PTEN rs11202592, AKT1 SNP1-5 (rs3803300, rs1130214, rs3730358, rs1130233 and rs2494732)] were genotyped in 593 NPC cases and 480 controls by PCR direct sequencing or PCR-RFLP analysis. Multivariate logistic regression analysis was used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). None of the polymorphisms alone was associated with the risk or severity of NPC. However, haplotype analyses indicated that a two-SNP core haplotype (SNP4-5, AA) in AKT1 was associated with a significantly increased susceptibility to NPC risk (adjusted OR = 3.87, 95% CI = 1.96-7.65; P<0.001). Furthermore, there was a significantly increased risk of NPC associated with the combined risk genotypes (i.e., p53 rs1042522 Arg/Pro + Pro/Pro, MDM2 rs2279244 G/T + G/G, PTEN rs11202592 C/C, AKT1 rs1130233 A/A). Compared with the low-risk group (0-2 combined risk genotypes), the high-risk group (3-4 combined risk genotypes) was associated with a significantly increased susceptibility to NPC risk (adjusted OR = 1.67, 95% CI = 1.12-2.50; P = 0.012). Our results suggest that genetic variants in the PTEN, AKT1, MDM2 and p53 tumor suppressor-oncoprotein network may play roles in mediating the susceptibility to NPC in Chinese populations.	[Zhang, Xiaoai; Chen, Xi; Zhai, Yun; Cao, Pengbo; Zhang, Hongxing; Wu, Zhihao; Li, Peiyao; Yu, Lixa; Xia, Xia; He, Fuchu; Zhou, Gangqiao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Cui, Ying] Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Peoples R China; [Zhang, Xiaoai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Guangxi Medical University; Beijing Institute of Microbiology & Epidemiology	He, FC (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	hefc@nic.bmi.ac.cn; zhougq114@gmail.com		Liu, Wei/0000-0002-9302-8170; Cao, Pengbo/0000-0002-7820-114X	China National Funds for Distinguished Young Scientists [81125017]; National Natural Science Foundation of China [81222027, 30901707, 30901231]	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by China National Funds for Distinguished Young Scientists (No. 81125017) and National Natural Science Foundation of China (No. 81222027, 30901707 and 30901231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2004, IN VIVO, V18, P555; Ashton KA, 2009, GYNECOL ONCOL, V113, P109, DOI 10.1016/j.ygyno.2008.12.036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Faratian D, 2009, CANC RES; Guo SL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3544; Harris SL, 2005, P NATL ACAD SCI USA, V102, P16297, DOI 10.1073/pnas.0508390102; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Hildesheim A, 2012, SEMIN CANCER BIOL, V22, P107, DOI 10.1016/j.semcancer.2012.01.007; Ishihara H, 2003, FEBS LETT, V554, P450, DOI 10.1016/S0014-5793(03)01225-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Ma J, 2012, J HUM GENET, V57, P261, DOI 10.1038/jhg.2012.15; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; Pegtel DM, 2005, J VIROL, V79, P15430, DOI 10.1128/JVI.79.24.15430-15442.2005; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Singh V, 2008, ANN EPIDEMIOL, V18, P48, DOI 10.1016/j.annepidem.2007.06.006; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Taweevisit Mana, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P136; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Xu JL, 2012, ASIAN PAC J CANCER P, V13, P2157, DOI 10.7314/APJCP.2012.13.5.2157; Xu Xijin, 2004, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V18, P658; Yang M, 2007, CARCINOGENESIS, V28, P1996, DOI 10.1093/carcin/bgm168; Yang Y, 2013, PROTEIN CELL, V4, P71, DOI 10.1007/s13238-012-2067-9; Yip WK, 2008, ONCOL REP, V19, P319; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang L, 2013, DRUG DES DEV THER, V7, P37, DOI 10.2147/DDDT.S30753; Zhou GQ, 2007, CLIN CANCER RES, V13, P2627, DOI 10.1158/1078-0432.CCR-06-2281	38	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92135	10.1371/journal.pone.0092135	http://dx.doi.org/10.1371/journal.pone.0092135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632578	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400146
J	Zhang, YF; Zheng, YF; Hu, JW; Du, N; Chen, F				Zhang, Yifei; Zheng, Yunfei; Hu, Jianwei; Du, Ning; Chen, Feng			Functional Diversity of the Microbial Community in Healthy Subjects and Periodontitis Patients Based on Sole Carbon Source Utilization	PLOS ONE			English	Article							BACTERIAL DIVERSITY; PROFILES; PATTERNS; BIOMASS; SHIFTS; PLAQUE; SOILS	Chronic periodontitis is one of the most common forms of biofilm-induced diseases. Most of the recent studies were focus on the dental plaque microbial diversity and microbiomes. However, analyzing bacterial diversity at the taxonomic level alone limits deeper comprehension of the ecological relevance of the community. In this study, we compared the metabolic functional diversity of the microbial community in healthy subjects and periodontitis patients in a creative way-to assess the sole carbon source utilization using Biolog assay, which was first applied on oral micro-ecology assessment. Pattern analyses of 95-sole carbon sources catabolism provide a community-level phenotypic profile of the microbial community from different habitats. We found that the microbial community in the periodontitis group had greater metabolic activity compared to the microbial community in the healthy group. Differences in the metabolism of specific carbohydrates (e. g. beta-methyl-D-glucoside, stachyose, maltose, D-mannose, beta-methyl-D-glucoside and pyruvic acid) were observed between the healthy and periodontitis groups. Subjects from the healthy and periodontitis groups could be well distinguished by cluster and principle component analyses according to the utilization of discriminate carbon sources. Our results indicate significant difference in microbial functional diversity between healthy subjects and periodontitis patients. We also found Biolog technology is effective to further our understanding of community structure as a composite of functional abilities, and it enables the identification of ecologically relevant functional differences among oral microbial communities.	[Zhang, Yifei; Hu, Jianwei; Du, Ning; Chen, Feng] Peking Univ, Sch Stomatol, Cent Lab, Beijing 100871, Peoples R China; [Zheng, Yunfei] Peking Univ, Sch Stomatol, Dept Periodontol, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, F (corresponding author), Peking Univ, Sch Stomatol, Cent Lab, Beijing 100871, Peoples R China.	moleculecf@gmail.com	zheng, yunfei/M-4172-2018		National Natural Science Foundation of China [81300880, 81200762]; Peking University School of Stomatology [PKUSS20110301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University School of Stomatology	This work was supported by grants 81300880 and 81200762 from National Natural Science Foundation of China, and by funding from Peking University School of Stomatology (PKUSS20110301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Anderson SA, 2002, APPL ENVIRON MICROB, V68, P5779, DOI 10.1128/AEM.68.11.5779-5783.2002; [Anonymous], 2009, ORAL MICROBIOLOGY; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Derry AM, 1998, WORLD J MICROB BIOT, V14, P571, DOI 10.1023/A:1008812821516; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Fisk MC, 2003, SOIL BIOL BIOCHEM, V35, P591, DOI 10.1016/S0038-0717(03)00053-1; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Glimm E, 1997, J MICROBIOL METH, V30, P71, DOI 10.1016/S0167-7012(97)00046-8; GRENIER D, 1986, INFECT IMMUN, V53, P616, DOI 10.1128/IAI.53.3.616-620.1986; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Krebs CJ, 1994, ECOLOGY EXPT ANAL DI; Kuhn I, 1996, SYST APPL MICROBIOL, V19, P442, DOI 10.1016/S0723-2020(96)80075-0; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Marsh P D, 1994, Adv Dent Res, V8, P263; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; MINAH GE, 1985, ARCH ORAL BIOL, V30, P397, DOI 10.1016/0003-9969(85)90066-4; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Rusznyak A, 2008, AQUAT BOT, V88, P211, DOI 10.1016/j.aquabot.2007.10.007; Schutter M, 2001, SOIL BIOL BIOCHEM, V33, P1481, DOI 10.1016/S0038-0717(01)00057-8; SHAH HN, 1989, ORAL MICROBIOL IMMUN, V4, P19, DOI 10.1111/j.1399-302X.1989.tb00401.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Staddon WJ, 1997, MICROB ECOL, V34, P125, DOI 10.1007/s002489900042; Stingu CS, 2008, J MED MICROBIOL, V57, P495, DOI 10.1099/jmm.0.47649-0; THEILADE ELSE, 1966, J PERIODONTAL RES, V1, P1, DOI 10.1111/j.1600-0765.1966.tb01842.x; WHITE DC, 1988, HYDROBIOLOGIA, V159, P119, DOI 10.1007/BF00007373; Zhang SM, 2011, EXP THER MED, V2, P1023, DOI 10.3892/etm.2011.311	31	11	13	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91977	10.1371/journal.pone.0091977	http://dx.doi.org/10.1371/journal.pone.0091977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632674	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400128
J	Zhu, S; Oremo, JA; Li, SQ; Zhen, MH; Tang, Y; Du, Y				Zhu, Sha; Oremo, Judith Apondi; Li, Sanqiang; Zhen, Minghui; Tang, Yue; Du, Ying			Synergistic Antitumor Activities of Docetaxel and Octreotide Associated with Apoptotic-Upregulation in Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOMATOSTATIN ANALOGS; RECEPTOR; CELLS; VEGF; OVEREXPRESSION; CHEMOTHERAPY; ACTIVATION; EXPRESSION; MECHANISM	Androgen deprivation therapy has become the fist-line treatment of metastatic prostate cancer; however, progression to castrate resistance disease occurs in the majority of patients. Thus, there is an urgent need for improvements in therapy for castration-resistant prostate cancer. The aims of the present study were to determine the efficacy somatostatin analogue octreotide (OCT) combined with a low dose of docetaxel (DTX) using castration resistant prostate cancer cells and to investigate the involved molecular mechanisms in vitro. The anti-proliferative and synergism potential effects were determined by MTT assay. Induction of apoptosis was analyzed employing annexing V and propidium iodide staining and flow cytometry. VEGFA, CASP9, CASP3 and ABCB1 gene expression was evaluated by RT-PCR and Q-RT-PCR analysis. OCT in combination with DTX treatments on DU145 cell migration was also evaluated. Investigation revealed that combined administration of DTX and OCT had significant, synergistically greater cytotoxicity than DTX or OCT treatment alone. The combination of the two drugs caused a more marked increase in apoptosis and resulted in greater suppression of invasive potential than either individual agent. There was obvious increase in caspase 3 expression in the OCT alone and two-drug combined treatment groups, however, VEGFA expression was markedly suppressed in them. These results support the conclusion that somatostatin analogues combined with docetaxel may enhance the chemotherapy efficacies through multiple mechanisms in castration-resistant PCa cell line. This work provides a preclinical rationale for the therapeutic strategies to improve the treatment in castrate resistance disease.	[Zhu, Sha; Oremo, Judith Apondi; Zhen, Minghui; Tang, Yue; Du, Ying] Zhengzhou Univ, Coll Basic Med Sci, Dept Microbiol & Immunol, Zhengzhou 450052, Peoples R China; [Li, Sanqiang] Henan Univ Sci & Technol, Coll Med, Dept Biochem & Mol Biol, Luoyang, Peoples R China	Zhengzhou University; Henan University of Science & Technology	Zhu, S (corresponding author), Zhengzhou Univ, Coll Basic Med Sci, Dept Microbiol & Immunol, Zhengzhou 450052, Peoples R China.	zsha@zzu.edu.cn			National Natural Science Foundation of China [81041102]; Scientific Research Preferred Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Preferred Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	This study was supported in parts by a grant from the National Natural Science Foundation of China (81041102) and Scientific Research Preferred Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appetecchia M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-19; Atmaca A, 2013, BRIT J CANCER, V108, P265, DOI 10.1038/bjc.2012.555; Avramis IA, 2001, ANTICANCER RES, V21, P2281; Bousquet C, 2006, EMBO J, V25, P3943, DOI 10.1038/sj.emboj.7601279; Bousquet C, 2012, J CLIN ENDOCR METAB, V97, P727, DOI 10.1210/jc.2011-2088; Caraglia M, 2005, FRONT BIOSCI, V10, P2566, DOI 10.2741/1720; Casar-Borota O, 2013, J CLIN ENDOCR METAB, V98, pE1730, DOI 10.1210/jc.2013-2145; Choi JH, 2002, BRIT J CANCER, V86, P1578, DOI 10.1038/sj.bjc.6600305; Engels FK, 2005, BRIT J CANCER, V93, P173, DOI 10.1038/sj.bjc.6602698; Goldberg AA, 2011, ONCOTARGET, V2, P761; Huang SM, 2013, ENDOCR RELAT CANC; Januchowski R, 2013, BIOMED PHARMACOTHER, V8; Jiang CC, 2009, NEOPLASIA, V11, P436, DOI 10.1593/neo.09208; Kaliszczak M, 2013, BRIT J CANCER, V109, P2356, DOI 10.1038/bjc.2013.584; Lattanzio L, 2013, ANTI-CANCER DRUG, V24, P120, DOI 10.1097/CAD.0b013e328358d1dc; Lu RC, 2013, ONCOL LETT, V5, P845, DOI 10.3892/ol.2013.1113; Maggioni D, 2010, J NEUROSCI RES, V88, P3171, DOI 10.1002/jnr.22465; Mentlein R, 2001, INT J CANCER, V92, P545, DOI 10.1002/ijc.1223; Nakabayashi M, 2010, BJU INT, V105, P1392, DOI 10.1111/j.1464-410X.2009.08971.x; Parrondo R, 2013, PEERJ, V1, DOI 10.7717/peerj.144; Perrot-Applanat M, 2012, CELL ADHES MIGR, V6, P547, DOI 10.4161/cam.23332; Ploussard G, 2010, CANCER RES, V70, P9253, DOI 10.1158/0008-5472.CAN-10-1447; Ruscica M, 2013, MOL CELL ENDOCRINOL, V5, P860; Schmid H A, 2005, J Endocrinol Invest, V28, P28; Shen HC, 2009, CANCER CELL, V15, P461, DOI 10.1016/j.ccr.2009.05.005; Shen L, 2013, EUR UROL; Stattin P, 2003, BRIT J CANCER, V89, P1814, DOI 10.1038/sj.bjc.6601351; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Suarez C, 2014, BJU INT, V113, P367, DOI 10.1111/bju.12110; Tsagarakis NJ, 2011, WORLD J GASTROENTERO, V17, P313, DOI 10.3748/wjg.v17.i3.313; Vainas O, 2012, BRIT J CANCER, V107, P814, DOI 10.1038/bjc.2012.316; Wang XL, 2013, INT J CLIN EXP PATHO, V6, P586; Wilson C, 2008, BRIT J CANCER, V99, P2054, DOI 10.1038/sj.bjc.6604804; Yang J, 2013, TRANSPL P, V45, P2433, DOI 10.1016/j.transproceed.2013.02.112	34	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91817	10.1371/journal.pone.0091817	http://dx.doi.org/10.1371/journal.pone.0091817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632829	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400097
J	Iwasaki, K; Sudo, H; Yamada, K; Ito, M; Iwasaki, N				Iwasaki, Koji; Sudo, Hideki; Yamada, Katsuhisa; Ito, Manabu; Iwasaki, Norimasa			Cytotoxic Effects of the Radiocontrast Agent Iotrolan and Anesthetic Agents Bupivacaine and Lidocaine in Three-Dimensional Cultures of Human Intervertebral Disc Nucleus Pulposus Cells: Identification of the Apoptotic Pathways	PLOS ONE			English	Article							LUMBAR DISC; CASPASE 3; DEGENERATION; TOXICITY; PUNCTURE	Background: Discography and discoblock are imaging procedures used to diagnose discogenic low back pain. Although needle puncture of the intervertebral disc (IVD) itself induces disc degeneration, the agents used in these procedures may also have harmful effects on IVD cells. The purpose of this study was to analyze whether radiocontrast agents and local anesthetic agents have detrimental effects on human nucleus pulposus (NP) cells. Methods: Healthy human NP cells were cultured for 7 days in three-dimensional (3D) cell-alginate bead composites, and were then exposed to clinically relevant doses of a radiocontrast agent (iotrolan) or local anesthetic (lidocaine or bupivacaine). Cell viability and apoptosis were measured by confocal microscopy and flow cytometry. On the basis of caspase expression profiles, the apoptotic pathways activated by the agents were identified by Western blot analysis. Results: The radiocontrast agent iotrolan did not affect NP cell viability or induce apoptosis. In contrast, both the anesthetic agents significantly decreased cell viability and increased the apoptotic cell number in a time-and dose-dependent manner. After 120 min, 2% lidocaine and 0.5% bupivacaine decreased percent live cells to 13% and 10%, respectively (p<0.05). The number of apoptotic cells was doubled by increasing lidocaine dosage from 1% to 2% (23% and 42%) and bupivacaine from 0.25% to 0.50% (25% and 48%) (p<0.05). Western blot analysis revealed that both anesthetic agents upregulated cleaved caspase-3 and caspase-8, whereas only bupivacaine upregulated cleaved caspase-9. Conclusions/Significance: The present study demonstrates that iotrolan does not affect the viability of healthy human NP cells. In contrast, the two anesthetic agents commonly used in discography or discoblock may cause extensive damage to IVDs by inducing apoptotic cell death.	[Iwasaki, Koji; Yamada, Katsuhisa; Iwasaki, Norimasa] Hokkaido Univ, Dept Orthopaed Surg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Sudo, Hideki; Ito, Manabu] Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Sudo, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan.	hidekisudo@yahoo.co.jp	Sudo, Hideki/G-2748-2012	Iwasaki, Koji/0000-0002-4525-9150	Nakatomi Foundation; Takeda Science Foundation	Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants from the Nakatomi Foundation and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayda-Bruno M, 2013, EUR SPINE J; Cai XY, 2014, SPINE J, V14, P483, DOI 10.1016/j.spinee.2013.06.041; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Chu CR, 2006, ARTHROSCOPY, V22, P693, DOI 10.1016/j.arthro.2006.05.006; Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2; GMEINWIESER JK, 1995, EUR RADIOL, V5, pS30, DOI 10.1007/BF02343258; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; Gruber HE, 2012, SPINE J, V12, P329, DOI 10.1016/j.spinee.2012.02.003; Lee H, 2010, SPINE J, V10, P159, DOI 10.1016/j.spinee.2009.08.445; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Masuda K, 2003, J ORTHOP RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2; McLure H A, 2005, Minerva Anestesiol, V71, P59; Miyazaki T, 2011, KNEE SURG SPORT TR A, V19, P1198, DOI 10.1007/s00167-010-1369-9; MIYAZAWA T, 1990, INVEST RADIOL, V25, P999, DOI 10.1097/00004424-199009000-00008; Moon JH, 2012, SPINE J, V12, P665, DOI 10.1016/j.spinee.2012.06.009; Ohtori Seiji, 2009, Spine (Phila Pa 1976), V34, P1345, DOI 10.1097/BRS.0b013e3181a401bf; Park JB, 2005, J BONE JOINT SURG AM, V87A, P1338, DOI 10.2106/JBJS.D.02527; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Press W R, 1989, Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd, V128, P126; Quero L, 2011, SPINE J, V11, P46, DOI 10.1016/j.spinee.2010.11.001; Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3; Ringel K, 1989, Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd, V128, P153; Singh J, 2008, J NUCL MED TECHNOL, V36, P69, DOI 10.2967/jnmt.107.047621; Sudo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058806; Sudo H, 2011, ARTHRITIS RHEUM-US, V63, P1648, DOI 10.1002/art.30251; Sudo H, 2010, J ORTHOP RES, V28, P1608, DOI 10.1002/jor.21185; WEINSTEIN J, 1988, SPINE, V13, P1344, DOI 10.1097/00007632-198812000-00002; Yamada K, 2014, AM J PATHOL, V184, P753, DOI 10.1016/j.ajpath.2013.11.010	29	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92442	10.1371/journal.pone.0092442	http://dx.doi.org/10.1371/journal.pone.0092442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642945	Green Published, gold			2022-12-27	WOS:000333259900141
J	Balasanyan, V; Arnold, DB				Balasanyan, Varuzhan; Arnold, Don B.			Actin and Myosin-Dependent Localization of mRNA to Dendrites	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; ZIPCODE-BINDING-PROTEIN; AXON INITIAL SEGMENT; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; CYTOPLASMIC DYNEIN; STAUFEN PROTEIN; KINESIN MOTOR; TRANSPORT; VA	The localization of mRNAs within axons and dendrites allows neurons to manipulate protein levels in a time and location dependent manner and is essential for processes such as synaptic plasticity and axon guidance. However, an essential step in the process of mRNA localization, the decision to traffic to dendrites and/or axons, remains poorly understood. Here we show that Myosin Va and actin filaments are necessary for the dendritic localization of the mRNA binding protein Staufen 1 and of mRNA encoding the microtubule binding protein Map2. Blocking the function or expression of Myosin Va or depolymerizing actin filaments leads to localization of Staufen 1 and of Map2 mRNA in both axons and dendrites. Furthermore, interaction with Myosin Va plays an instructive role in the dendritic localization of Hermes 1, an RNA binding protein. Wild-type Hermes 1 localizes to both axons and dendrites, whereas Hermes 1 fused with a Myosin Va binding peptide, localizes specifically to dendrites. Thus, our results suggest that targeting of mRNAs to the dendrites is mediated by a mechanism that is dependent on actin and Myosin Va.	[Balasanyan, Varuzhan; Arnold, Don B.] Univ So Calif, Dept Biol, Program Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Southern California	Arnold, DB (corresponding author), Univ So Calif, Dept Biol, Program Mol & Computat Biol, Los Angeles, CA 90089 USA.	darnold@usc.edu			NIH [NS041963]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant NS041963 to DBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam S, 2012, CELL REPORTS, V2, P89, DOI 10.1016/j.celrep.2012.05.018; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Arnold DB, 2013, J NEUROCHEM; Arnold DB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.283pe49; Aronov S, 2002, J CELL SCI, V115, P3817, DOI 10.1242/jcs.00058; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bassell GJ, 1998, J NEUROSCI, V18, P251; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bianco A, 2010, CURR BIOL, V20, P1487, DOI 10.1016/j.cub.2010.07.016; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Doyle M, 2012, GENE DEV, V26, P110, DOI 10.1101/gad.184945.111; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kim-Ha Jeongsil, 1993, Development (Cambridge), V119, P169; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Monshausen M, 2001, J NEUROCHEM, V76, P155, DOI 10.1046/j.1471-4159.2001.00061.x; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nalavadi VC, 2012, J NEUROSCI, V32, P15133, DOI 10.1523/JNEUROSCI.2006-12.2012; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Salerno VP, 2008, CELL MOTIL CYTOSKEL, V65, P422, DOI 10.1002/cm.20272; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Watanabe K, 2012, CELL REP, V2, P1546, DOI 10.1016/j.celrep.2012.11.015; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	57	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92349	10.1371/journal.pone.0092349	http://dx.doi.org/10.1371/journal.pone.0092349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637809	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100145
J	el Barzouhi, A; Vleggeert-Lankamp, CLAM; Nijeholt, GJLA; Van der Kallen, BF; van den Hout, WB; Koes, BW; Peul, WC				el Barzouhi, Abdelilah; Vleggeert-Lankamp, Carmen L. A. M.; Nijeholt, Geert J. Lycklama A.; Van der Kallen, Bas F.; van den Hout, Wilbert B.; Koes, Bart W.; Peul, Wilco C.		Leiden-Hague Spine Intervention Pr	Influence of Low Back Pain and Prognostic Value of MRI in Sciatica Patients in Relation to Back Pain	PLOS ONE			English	Article							LUMBAR DISC HERNIATION; PROLONGED CONSERVATIVE TREATMENT; EARLY SURGERY; RADICULOPATHY; MANAGEMENT; SYMPTOMS; OUTCOMES	Background: Patients with sciatica frequently complain about associated back pain. It is not known whether there are prognostic relevant differences in Magnetic Resonance Imaging (MRI) findings between sciatica patients with and without disabling back pain. Methods: The study population contained patients with sciatica who underwent a baseline MRI to assess eligibility for a randomized trial designed to compare the efficacy of early surgery with prolonged conservative care for sciatica. Two neuroradiologists and one neurosurgeon independently evaluated all MR images. The MRI readers were blinded to symptom status. The MRI findings were compared between sciatica patients with and without disabling back pain. The presence of disabling back pain at baseline was correlated with perceived recovery at one year. Results: Of 379 included sciatica patients, 158 (42%) had disabling back pain. Of the patients with both sciatica and disabling back pain 68% did reveal a herniated disc with nerve root compression on MRI, compared to 88% of patients with predominantly sciatica (P<0.001). The existence of disabling back pain in sciatica at baseline was negatively associated with perceived recovery at one year (Odds ratio [OR] 0.32, 95% Confidence Interval 0.18-0.56, P<0.001). Sciatica patients with disabling back pain in absence of nerve root compression on MRI at baseline reported less perceived recovery at one year compared to those with predominantly sciatica and nerve root compression on MRI (50% vs 91%, P<0.001). Conclusion: Sciatica patients with disabling low back pain reported an unfavorable outcome at one-year follow-up compared to those with predominantly sciatica. If additionally a clear herniated disc with nerve root compression on MRI was absent, the results were even worse.	[el Barzouhi, Abdelilah; Vleggeert-Lankamp, Carmen L. A. M.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Nijeholt, Geert J. Lycklama A.; Van der Kallen, Bas F.] Med Ctr Haaglanden, Dept Radiol, The Hague, Netherlands; [van den Hout, Wilbert B.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Koes, Bart W.] Univ Med Ctr, Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Peul, Wilco C.] Med Ctr Haaglanden, Dept Neurosurg, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Haaglanden Medical Center	el Barzouhi, A (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands.	A.el_barzouhi@lumc.nl	Koes, Bart w/K-4614-2016; Vleggeert-Lankamp, Carmen/AGX-9660-2022	Koes, Bart w/0000-0002-0450-9969; Vleggeert-Lankamp, Carmen/0000-0001-9597-7225; van den Hout, Wilbert B./0000-0002-6425-0135	Health Care Efficiency Research Program of Netherlands Organisation for Health Research and Development (ZonMw); Hoelen Foundation, The Hague	Health Care Efficiency Research Program of Netherlands Organisation for Health Research and Development (ZonMw); Hoelen Foundation, The Hague	This study was funded by grants from the Health Care Efficiency Research Program of Netherlands Organisation for Health Research and Development (ZonMw) and the Hoelen Foundation, The Hague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert HB, 2008, MED HYPOTHESES, V70, P361, DOI 10.1016/j.mehy.2007.05.014; Andrade P, 2011, PAIN, V152, P2645, DOI 10.1016/j.pain.2011.08.012; Atlas SJ, 2005, SPINE, V30, P927, DOI 10.1097/01.brs.0000158954.68522.2a; Beattie PF, 2000, SPINE, V25, P819, DOI 10.1097/00007632-200004010-00010; Beurskens AJHM, 1996, PAIN, V65, P71, DOI 10.1016/0304-3959(95)00149-2; Boos N, 1995, SPINE, V20, P2613, DOI 10.1097/00007632-199512150-00002; BRANTZAWADZKI MN, 1995, SPINE, V20, P1257, DOI 10.1097/00007632-199506000-00010; Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016; Chen CY, 1997, SPINE, V22, P1057, DOI 10.1097/00007632-199705150-00002; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Cotugnio D, 1764, ISCHIADE NERVOSA COM; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Deyo RA, 2013, NEW ENGL J MED, V368, P1056, DOI 10.1056/NEJMe1215599; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; Haugen AJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-183; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; Jarvik JG, 1996, ACAD RADIOL, V3, P537, DOI 10.1016/S1076-6332(96)80214-5; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Koes BW, 2007, BMJ-BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223.428495.BE; Konstantinou K, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-4; Mixter W.J., 1934, NEW ENGL J MED, V211, P210, DOI [10.1056/NEJM193408022110506, DOI 10.1056/NEJM193408022110506]; Mixter WJ, 1935, NEW ENGL J MED, V213, P385, DOI 10.1056/NEJM193508292130901; MODIC MT, 1995, RADIOLOGY, V195, P429, DOI 10.1148/radiology.195.2.7724762; Modic MT, 2005, RADIOLOGY, V237, P597, DOI 10.1148/radiol.2372041509; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Peters ML, 2007, ANN SURG, V245, P487, DOI 10.1097/01.sla.0000245495.79781.65; Peul WC, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-8; Peul WC, 2008, PAIN, V138, P180, DOI 10.1016/j.pain.2007.12.014; Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; ROBINSON JS, 1983, SOUTHERN MED J, V76, P232, DOI 10.1097/00007611-198302000-00022; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; STRATFORD PW, 1994, PHYS THER, V74, P528, DOI 10.1093/ptj/74.6.528; Vroomen PCAJ, 2002, NEURORADIOLOGY, V44, P59, DOI 10.1007/s002340100650; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; Yamashita K, 2006, SPINE, V31, P2602, DOI 10.1097/01.brs.0000240717.25787.7d	39	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90800	10.1371/journal.pone.0090800	http://dx.doi.org/10.1371/journal.pone.0090800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637890	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100011
J	Reaves, DK; Fagan-Solis, KD; Dunphy, K; Oliver, SD; Scott, DW; Fleming, JM				Reaves, Denise K.; Fagan-Solis, Katerina D.; Dunphy, Karen; Oliver, Shannon D.; Scott, David W.; Fleming, Jodie M.			The Role of Lipolysis Stimulated Lipoprotein Receptor in Breast Cancer and Directing Breast Cancer Cell Behavior	PLOS ONE			English	Article							PROTEIN; LEPTIN	The claudin-low molecular subtype of breast cancer is of particular interest for clinically the majority of these tumors are poor prognosis, triple negative, invasive ductal carcinomas. Claudin-low tumors are characterized by cancer stem cell-like features and low expression of cell junction and adhesion proteins. Herein, we sought to define the role of lipolysis stimulated lipoprotein receptor (LSR) in breast cancer and cancer cell behavior as LSR was recently correlated with tumor-initiating features. We show that LSR was expressed in epithelium, endothelium, and stromal cells within the healthy breast tissue, as well as in tumor epithelium. In primary breast tumor bioposies, LSR expression was significantly correlated with invasive ductal carcinomas compared to invasive lobular carcinomas, as well as ER alpha positive tumors and breast cancer cell lines. LSR levels were significantly reduced in claudin-low breast cancer cell lines and functional studies illustrated that reintroduction of LSR into a claudin-low cell line suppressed the EMT phenotype and reduced individual cell migration. However, our data suggest that LSR may promote collective cell migration. Re-introduction of LSR in claudin-low breast cancer cell lines reestablished tight junction protein expression and correlated with transepithelial electrical resistance, thereby reverting claudin-low lines to other intrinsic molecular subtypes. Moreover, overexpression of LSR altered gene expression of pathways involved in transformation and tumorigenesis as well as enhanced proliferation and survival in anchorage independent conditions, highlighting that reestablishment of LSR signaling promotes aggressive/tumor initiating cell behaviors. Collectively, these data highlight a direct role for LSR in driving aggressive breast cancer behavior.	[Reaves, Denise K.; Fagan-Solis, Katerina D.; Oliver, Shannon D.; Fleming, Jodie M.] N Carolina Cent Univ, Dept Biol, Durham, NC 27707 USA; [Dunphy, Karen] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Scott, David W.] Univ N Carolina, Dept Cell Physiol & Cell Biol, Chapel Hill, NC USA	University of North Carolina; North Carolina Central University; University of Massachusetts System; University of Massachusetts Amherst; University of North Carolina; University of North Carolina Chapel Hill	Fleming, JM (corresponding author), N Carolina Cent Univ, Dept Biol, Durham, NC 27707 USA.	Jodie.fleming@nccu.edu		Fleming, Jodie/0000-0003-0297-5197	NIGMS Support of Competitive Research (SCORE) Pilot Project Award [5SC2CA176585-02]; NCI Comprehensive Minority Institution/Cancer Center Partnership [U54 CA156735-03]; NATIONAL CANCER INSTITUTE [R21CA175783, U54CA156735, SC2CA176585, T32CA009156] Funding Source: NIH RePORTER	NIGMS Support of Competitive Research (SCORE) Pilot Project Award; NCI Comprehensive Minority Institution/Cancer Center Partnership; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIGMS Support of Competitive Research (SCORE) Pilot Project Award (5SC2CA176585-02) and the NCI Comprehensive Minority Institution/Cancer Center Partnership (U54 CA156735-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, FEBS J, V279, P4361, DOI 10.1111/febs.12026; Allred DC, 2004, BREAST CANCER RES, V6, P240, DOI 10.1186/bcr938; Biglia N, 2013, EJSO-EUR J SURG ONC, V39, P455, DOI 10.1016/j.ejso.2013.02.007; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Delort L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066284; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Dunphy KA, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-74; Fleming JM, 2013, J MOL ENDOCRINOL, V50, P79, DOI 10.1530/JME-12-0201; Fleming JM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-46; Fleming JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3215; Fleming JM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-266; Fleming JM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-27; Furuse M, 2012, ANN NY ACAD SCI, V1257, P54, DOI 10.1111/j.1749-6632.2012.06486.x; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Iwamoto N, 2013, CELL STRUCT FUNCT; Korhonen T, 2013, BREAST; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Macek R, 2003, CELL MOL BIOL, V49, P1; Martin TA, 2007, J CELL BIOCHEM, V101, P155, DOI 10.1002/jcb.21162; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Neal-Perry G, 2010, MATURITAS, V67, P34, DOI 10.1016/j.maturitas.2010.04.016; Papatheodorou P, 2013, MBIO, V4, DOI 10.1128/mBio.00244-13; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Perou CM, 2011, COLD SPRING HARB PER, V3; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Rouzier R, 2005, J CLIN ONCOL, V23, P8331, DOI 10.1200/JCO.2005.01.2898; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Scully S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025819; Spina A, 2013, FRONT BIOSCI-LANDMRK, V18, P133, DOI 10.2741/4092; Stenger C, 2010, FASEB J, V24, P4218, DOI 10.1096/fj.10-160440; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Webb PG, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-19; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017	41	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91747	10.1371/journal.pone.0091747	http://dx.doi.org/10.1371/journal.pone.0091747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637461	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100058
J	Zenger, M; Schaefert, R; van der Feltz-Cornelis, C; Brahler, E; Hauser, W				Zenger, Markus; Schaefert, Rainer; van der Feltz-Cornelis, Christina; Braehler, Elmar; Haeuser, Winfried			Validation of the Patient-Doctor-Relationship Questionnaire (PDRQ-9) in a Representative Cross-Sectional German Population Survey	PLOS ONE			English	Article							FIT INDEXES; ALLIANCE; COMMUNICATION; VARIABLES; MODELS; CARE; PAIN	The patient-doctor relationship (PDR) as perceived by the patient is an important concept in primary care and psychotherapy. The PDR Questionnaire (PDRQ-9) provides a brief measure of the therapeutic aspects of the PDR in primary care. We assessed the internal and external validity of the German version of the PDRQ-9 in a representative cross-sectional German population survey that included 2,275 persons aged >= 14 years who reported consulting with a primary care physician (PCP). The acceptance of the German version of this questionnaire was good. Confirmatory factor analysis demonstrated that the PRDQ-9 was unidimensional. The internal reliability (Cronbach's alpha) of the total score was .95. The corrected item-total correlations were >=.94. The mean satisfaction index of persons with a probable depressive disorder was lower than that of persons without a probable depressive disorder, indicating good discriminative concurrent criterion validity. The correlation coefficient between satisfaction with PDR and satisfaction with pain therapy was r=.51 in 489 persons who reported chronic pain, indicating good convergent validity. Despite the limitation of low variance in the PDRQ-9 total scores, the results indicate that the German version of the PDRQ-9 is a brief questionnaire with good psychometric properties to assess German patients' perceived therapeutic alliance with PCPs in public health research.	[Zenger, Markus] Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany; [Schaefert, Rainer] Heidelberg Univ, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [van der Feltz-Cornelis, Christina] Tilburg Univ, Fac Social Sci, Tranzo Dept, NL-5000 LE Tilburg, Netherlands; [van der Feltz-Cornelis, Christina] Clin Ctr Body Mind & Hlth, Tilburg, Netherlands; [van der Feltz-Cornelis, Christina] Trimbos Inst, Utrecht, Netherlands; [Braehler, Elmar] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Haeuser, Winfried] Klinikum Saarbrucken, Dept Internal Med 1, Saarbrucken, Germany; [Haeuser, Winfried] Tech Univ Munich, Dept Psychosomat Med, D-80290 Munich, Germany	Leipzig University; Ruprecht Karls University Heidelberg; Tilburg University; Trimbos Institute; Johannes Gutenberg University of Mainz; Technical University of Munich	Zenger, M (corresponding author), Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany.	Markus.Zenger@medizin.uni-leipzig.de	Häuser, Winfried/AAH-6633-2021; Häuser, Winfried/AAX-6231-2021; Braehler, Elmar/C-6535-2009; Van der Feltz-Cornelis, Christina/R-7107-2016	Braehler, Elmar/0000-0002-2648-2728; Van der Feltz-Cornelis, Christina/0000-0001-6925-8956; Hauser, Winfried/0000-0002-3742-729X				Arbuckle JL, 2009, AMOS TM 18 USERS GUI; Beck A, 1979, COGNITIVE THERAPY DE; BENSING JM, 1991, THESIS NIVEL UTRECHT; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Eveleigh RM, 2012, J CLIN EPIDEMIOL, V65, P10, DOI 10.1016/j.jclinepi.2011.05.011; Farin E, 2013, J BEHAV MED, V36, P246, DOI 10.1007/s10865-012-9419-z; Federal Statistical Office, 2011, ZENS 2011; Fletcher Astrid, 1992, British Medical Journal, V305, P1145; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Fuertes JN, 2007, PATIENT EDUC COUNS, V66, P29, DOI 10.1016/j.pec.2006.09.013; Gregorich SE, 2006, MED CARE, V44, pS78, DOI 10.1097/01.mlr.0000245454.12228.8f; Hauser W, 2012, PAIN, V153, P2466, DOI 10.1016/j.pain.2012.09.006; Hambleton RK, 2005, ADAPTING EDUCATIONAL AND PSYCHOLOGICAL TESTS FOR CROSS- CULTURAL ASSESSMENT, P3; Harlow LL., 2005, ESSENCE MULTIVARIATE; Horvath A., 1993, PSYCHODYNAMIC TREATM, P247; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; IASP, 1986, PAIN S, V3, pS1; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Martin-Fernandez J, 2010, ATEN PRIM, V42, P196, DOI 10.1016/j.aprim.2009.09.026; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mergen H, 2012, HEALTHMED, V6, P1763; Adan JCM, 2009, ACTAS ESP PSIQUIATRI, V37, P94; Ridd M, 2009, BRIT J GEN PRACT, V59, P268, DOI 10.3399/bjgp09X420248; Schenker Y, 2009, J GEN INTERN MED, V24, P550, DOI 10.1007/s11606-009-0937-5; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Thompson L, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-87; Van der Feltz-Cornelis CM, 2004, GEN HOSP PSYCHIAT, V26, P115, DOI 10.1016/j.genhosppsych.2003.08.010	29	25	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91964	10.1371/journal.pone.0091964	http://dx.doi.org/10.1371/journal.pone.0091964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637904	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100091
J	Cheng, XR; Yang, Q; Han, YQ; Ding, XF; Fan, Z				Cheng, Xiaorong; Yang, Qi; Han, Yaqian; Ding, Xianfeng; Fan, Zhao			Capacity Limit of Simultaneous Temporal Processing: How Many Concurrent 'Clocks' in Vision?	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; NEURAL MECHANISMS; MULTIPLE TARGETS; FRONTAL-CORTEX; TIME; ATTENTION; TRACKING; NUMBER; DISCRIMINATION	A fundamental ability for humans is to monitor and process multiple temporal events that occur at different spatial locations simultaneously. A great number of studies have demonstrated simultaneous temporal processing (STP) in human and animal participants, i.e., multiple 'clocks' rather than a single 'clock'. However, to date, we still have no knowledge about the exact limitation of the STP in vision. Here we provide the first experimental measurement to this critical parameter in human vision by using two novel and complementary paradigms. The first paradigm combines merits of a temporal oddball-detection task and a capacity measurement widely used in the studies of visual working memory to quantify the capacity of STP (CSTP). The second paradigm uses a two-interval temporal comparison task with various encoded spatial locations involved in the standard temporal intervals to rule out an alternative, 'object individuation'-based, account of CSTP, which is measured by the first paradigm. Our results of both paradigms indicate consistently that the capacity limit of simultaneous temporal processing in vision is around 3 to 4 spatial locations. Moreover, the binding of the 'local clock' and its specific location is undermined by bottom-up competition of spatial attention, indicating that the time-space binding is resource-consuming. Our finding that the capacity of STP is not constrained by the capacity of visual working memory (VWM) supports the idea that the representations of STP are likely stored and operated in units different from those of VWM. A second paradigm confirms further that the limited number of location-bound 'local clocks' are activated and maintained during a time window of several hundreds milliseconds.	[Cheng, Xiaorong; Yang, Qi; Han, Yaqian; Ding, Xianfeng; Fan, Zhao] CCNU, Key Lab Adolescent Cyberpsychol & Behav, Minist Educ, Wuhan, Peoples R China; [Cheng, Xiaorong; Yang, Qi; Han, Yaqian; Ding, Xianfeng; Fan, Zhao] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Cheng, Xiaorong; Yang, Qi; Han, Yaqian; Ding, Xianfeng; Fan, Zhao] Key Lab Human Dev & Mental Hlth Hubei Prov, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Fan, Z (corresponding author), CCNU, Key Lab Adolescent Cyberpsychol & Behav, Minist Educ, Wuhan, Peoples R China.	zfan@mail.edu.cn	?, ?/AAU-8474-2021; Ding, Xianfeng/B-8931-2016		SRF for ROCS, SEM; China Postdoctoral Science Foundation [20110491179]; Humanities and Social Sciences Foundation of the Ministry of Education, China [11YJC190006]; Key Laboratory of Adolescent Cyberpsychology and Behavior (CCNU), Ministry of Education, China [2012A03]; National Natural Science Foundation of China [31170979]; National Social Science Foundation of China [13CSH075]	SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Humanities and Social Sciences Foundation of the Ministry of Education, China; Key Laboratory of Adolescent Cyberpsychology and Behavior (CCNU), Ministry of Education, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	This work was made possible by grants from SRF for ROCS, SEM, the China Postdoctoral Science Foundation (20110491179), the Humanities and Social Sciences Foundation of the Ministry of Education, China (11YJC190006), the open funds of Key Laboratory of Adolescent Cyberpsychology and Behavior (CCNU), Ministry of Education, China (2012A03), the National Natural Science Foundation of China (31170979) and the National Social Science Foundation of China (13CSH075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayhan I, 2009, J VISION, V9, DOI 10.1167/9.11.2; Bahrami B, 2003, VISUAL COGNITION, V10; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; BERGEN JR, 1983, IEEE T SYST MAN CYB, V13, P857, DOI 10.1109/TSMC.1983.6313080; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bravo MJ, 1992, PERCEPTION PSYCHOPHY, V51; BROWN SW, 1990, ACTA PSYCHOL, V75, P103, DOI 10.1016/0001-6918(90)90081-P; Buhusi CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006268; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Cicchini GM, 2009, J VISION, V9, DOI 10.1167/9.1.9; COLTHEART M, 1980, PHILOS T ROY SOC B, V290, P57, DOI 10.1098/rstb.1980.0082; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dormal V, 2012, HUM BRAIN MAPP, V33, P1490, DOI 10.1002/hbm.21300; Fougnie D, 2006, PSYCHOL SCI, V17, P526, DOI 10.1111/j.1467-9280.2006.01739.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hartshorne JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002716; Helson H, 1930, Science, V71, P536, DOI 10.1126/science.71.1847.536; Hyde DC, 2011, J COGNITIVE NEUROSCI, V23, P2336, DOI 10.1162/jocn.2010.21581; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Johnston A, 2011, J VISION, V10, P1; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Klapproth F, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00071; Kline SR, 2013, ATTEN PERCEPT PSYCHO, V75, P161, DOI 10.3758/s13414-012-0370-4; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Magen H, 2009, NEUROPSYCHOLOGIA, V47, P1790, DOI 10.1016/j.neuropsychologia.2009.02.015; Matell MS, 2004, BEHAV NEUROSCI, V118, P150, DOI 10.1037/0735-7044.118.1.150; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; McPeek RM, 1999, VISION RES, V39, P1555, DOI 10.1016/S0042-6989(98)00228-4; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; MECK WH, 1984, J EXP PSYCHOL ANIM B, V10, P1, DOI 10.1037/0097-7403.10.1.1; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Morgan M, 2008, J VISION, V8, DOI 10.1167/8.11.9; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; New JJ, 2009, J VISION, V9, DOI 10.1167/9.2.4; OLTON DS, 1988, NEUROPSYCHOLOGIA, V26, P307, DOI 10.1016/0028-3932(88)90083-8; Pagano S, 2012, NEUROPSYCHOLOGIA, V50, P754, DOI 10.1016/j.neuropsychologia.2012.01.009; PALMER J, 1993, J EXP PSYCHOL HUMAN, V19, P108, DOI 10.1037/0096-1523.19.1.108; Pang KCH, 2001, NEUROSCIENCE, V103, P615, DOI 10.1016/S0306-4522(01)00018-5; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; PRICEWILLIAMS DR, 1954, NATURE, V173, P363, DOI 10.1038/173363a0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Rousseau L, 1996, PERCEPT PSYCHOPHYS, V58, P434, DOI 10.3758/BF03206819; SAGI D, 1985, PERCEPTION, V14, pA27; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; Staddon JER, 1999, J EXP ANAL BEHAV, V71, P215, DOI 10.1901/jeab.1999.71-215; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; van Rijn H, 2008, ACTA PSYCHOL, V129, P365, DOI 10.1016/j.actpsy.2008.09.002; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2; Yumoto N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019168	64	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91797	10.1371/journal.pone.0091797	http://dx.doi.org/10.1371/journal.pone.0091797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9MJ	24632675	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400089
J	Horstmann, JT; Henningsson, P; Thomas, ALR; Bomphrey, RJ				Horstmann, Jan T.; Henningsson, Per; Thomas, Adrian L. R.; Bomphrey, Richard J.			Wake Development behind Paired Wings with Tip and Root Trailing Vortices: Consequences for Animal Flight Force Estimates	PLOS ONE			English	Article							PARTICLE IMAGE VELOCIMETRY; VORTEX WAKE; KINEMATICS; BAT; REVEAL; FISH; LIFT	Recent experiments on flapping flight in animals have shown that a variety of unrelated species shed a wake behind left and right wings consisting of both tip and root vortices. Here we present an investigation using Particle Image Velocimetry (PIV) of the behaviour and interaction of trailing vortices shed by paired, fixed wings that simplify and mimic the wake of a flying animal with a non-lifting body. We measured flow velocities at five positions downstream of two adjacent NACA 0012 aerofoils and systematically varied aspect ratio, the gap between the wings (corresponding to the width of a non-lifting body), angle of attack, and the Reynolds number. The range of aspect ratios and Reynolds number where chosen to be relevant to natural fliers and swimmers, and insect flight in particular. We show that the wake behind the paired wings deformed as a consequence of the induced flow distribution such that the wingtip vortices convected downwards while the root vortices twist around each other. Vortex interaction and wake deformation became more pronounced further downstream of the wing, so the positioning of PIV measurement planes in experiments on flying animals has an important effect on subsequent force estimates due to rotating induced flow vectors. Wake deformation was most severe behind wings with lower aspect ratios and when the distance between the wings was small, suggesting that animals that match this description constitute high-risk groups in terms of measurement error. Our results, therefore, have significant implications for experimental design where wake measurements are used to estimate forces generated in animal flight. In particular, the downstream distance of the measurement plane should be minimised, notwithstanding the animal welfare constraints when measuring the wake behind flying animals.	[Horstmann, Jan T.] Bremen Univ Appl Sci, Bremen, Germany; [Horstmann, Jan T.; Henningsson, Per; Thomas, Adrian L. R.; Bomphrey, Richard J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Henningsson, Per] Lund Univ, Dept Biol, Lund, Sweden; [Bomphrey, Richard J.] Royal Vet Coll, Struct & Mot Lab, London, England	Bremen University of Applied Sciences; University of Oxford; Lund University; University of London; University of London Royal Veterinary College	Bomphrey, RJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	rbomphrey@rvc.ac.uk	Bomphrey, Richard/I-6272-2013	Bomphrey, Richard/0000-0002-4748-0510; Horstmann, Jan Tobias/0000-0001-6922-4756	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [EP/H004025/1, BB/J001244/1]; Swedish Research Council [2013-4838]; EPSRC Career Acceleration Fellowship; BBSRC [BB/J001244/1, BB/J000523/1, BB/J001244/2] Funding Source: UKRI; EPSRC [EP/H004025/2, EP/H004025/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J000523/1, BB/J001244/2] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H004025/2, EP/H004025/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); EPSRC Career Acceleration Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) and the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) grants to RJB (EP/H004025/1 and BB/J001244/1) and by the Swedish Research Council (www.vr.se) to PH (2013-4838). RJB holds an EPSRC Career Acceleration Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2009, EXP FLUIDS, V46, P835, DOI 10.1007/s00348-008-0602-5; Bomphrey RJ, 2012, J R SOC INTERFACE, V9, P3378, DOI 10.1098/rsif.2012.0418; Bomphrey RJ, 2012, EVOL BIOL, V39, P1, DOI 10.1007/s11692-011-9134-7; Bomphrey RJ, 2009, EXP FLUIDS, V46, P811, DOI 10.1007/s00348-009-0631-8; Bomphrey RJ, 2006, J R SOC INTERFACE, V3, P311, DOI 10.1098/rsif.2005.0090; Bomphrey RJ, 2005, J EXP BIOL, V208, P1079, DOI 10.1242/jeb.01471; Crow S. C., 1970, AIAA J, V8, P2172, DOI DOI 10.2514/3.6083; Drucker EG, 1999, J EXP BIOL, V202, P2393; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Hedenstrom A, 2009, EXP FLUIDS, V46, P923, DOI 10.1007/s00348-009-0634-5; Henningsson P, 2008, J EXP BIOL, V211, P717, DOI 10.1242/jeb.012146; Henningsson P, 2011, J R SOC INTERFACE, V8, P807, DOI 10.1098/rsif.2010.0533; Henningsson P, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0099; Henningsson P, 2012, J R SOC INTERFACE, V9, P1177, DOI 10.1098/rsif.2011.0749; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; Hubel TY, 2009, EXP FLUIDS, V46, P933, DOI 10.1007/s00348-009-0624-7; Johansson LC, 2009, J EXP BIOL, V212, P3365, DOI 10.1242/jeb.034454; Kundu PK, 2012, FLUID MECHANICS, 5TH EDITION, P1; Lack D., 1956, SWIFTS TOWER; MILNETHOMPSON LM, 1966, THEORETICAL AERODYNA; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Muijres FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037335; Muijres FT, 2011, EXP FLUIDS, V51, P511, DOI 10.1007/s00348-011-1067-5; Muller UK, 1997, J EXP BIOL, V200, P2893; Nauen JC, 2002, J EXP BIOL, V205, P3271; Nauen JC, 2002, J EXP BIOL, V205, P1709; Ortega JM, 2002, AIAA J, V40, P709, DOI 10.2514/2.1703; RAYNER JMV, 1979, J FLUID MECH, V91, P697, DOI 10.1017/S0022112079000410; RAYNER JMV, 1979, J FLUID MECH, V91, P731, DOI 10.1017/S0022112079000422; Rosen M, 2004, J EXP BIOL, V207, P4255, DOI 10.1242/jeb.01283; SPEDDING GR, 1984, J EXP BIOL, V111, P81; Stepniewski WZ, 1979, ROTARY WING AERODYNA; Taylor GI, 1938, PROC R SOC LON SER-A, V164, P0476, DOI 10.1098/rspa.1938.0032; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; THOMAS PJ, 1994, J FLUID MECH, V265, P289, DOI 10.1017/S0022112094000844; Waldman RM, 2012, EXP FLUIDS, V53, P1487, DOI 10.1007/s00348-012-1368-3	36	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91040	10.1371/journal.pone.0091040	http://dx.doi.org/10.1371/journal.pone.0091040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632825	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400037
J	Kendall, EJ; Flynn, MT				Kendall, Edward J.; Flynn, Matthew T.			Automated Breast Image Classification Using Features from Its Discrete Cosine Transform	PLOS ONE			English	Article							COMPUTER-AIDED DETECTION; DIAGNOSIS CAD; PERFORMANCE	Purpose: This work aimed to improve breast screening program accuracy using automated classification. The goal was to determine if whole image features represented in the discrete cosine transform would provide a basis for classification. Priority was placed on avoiding false negative findings. Methods: Online datasets were used for this work. No informed consent was required. Programs were developed in Mathematica and, where necessary to improve computational performance ported to C++. The use of a discrete cosine transform to separate normal from cancerous breast tissue was tested. Features (moments of the mean) were calculated in square sections of the transform centered on the origin. K-nearest neighbor and naive Bayesian classifiers were tested. Results: Forty-one features were generated and tested singly, and in combination of two or three. Using a k-nearest neighbor classifier, sensitivities as high as 98% with a specificity of 66% were achieved. With a naive Bayesian classifier, sensitivities as high as 100% were achieved with a specificity of 64%. Conclusion: Whole image classification based on discrete cosine transform (DCT) features was effectively implemented with a high level of sensitivity and specificity achieved. The high sensitivity attained using the DCT generated feature set implied that these classifiers could be used in series with other methods to increase specificity. Using a classifier with near 100% sensitivity, such as the one developed in this project, before applying a second classifier could only boost the accuracy of that classifier.	[Kendall, Edward J.; Flynn, Matthew T.] Mem Univ Newfoundland, Discipline Radiol, St John, NF, Canada	Memorial University Newfoundland	Kendall, EJ (corresponding author), Mem Univ Newfoundland, Discipline Radiol, St John, NF, Canada.	edward.kendall@mun.ca			Canadian Breast Cancer Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was funded in part by the Canadian Breast Cancer Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Azavedo E, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-22; BIRD RE, 1992, RADIOLOGY, V184, P613, DOI 10.1148/radiology.184.3.1509041; Coldman AJ, 2006, RADIOLOGY, V238, P809, DOI 10.1148/radiol.2382041684; Cupples TE, 2005, AM J ROENTGENOL, V185, P944, DOI 10.2214/AJR.04.1300; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dromain C, 2013, EUR J RADIOL, V82, P417, DOI 10.1016/j.ejrad.2012.03.005; Evans KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064366; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Fenton JJ, 2011, J NATL CANCER I, V103, P1152, DOI 10.1093/jnci/djr206; Gilbert FJ, 2008, NEW ENGL J MED, V359, P1675, DOI 10.1056/NEJMoa0803545; Gur D, 2004, RADIOLOGY, V233, P418, DOI 10.1148/radiol.2332040277; Gur D, 2003, RADIOLOGY, V228, P10, DOI 10.1148/radiol.2281020709; Gur D, 2008, RADIOLOGY, V249, P47, DOI 10.1148/radiol.2491072025; Heath M, 1998, COMP IMAG VIS, V13, P457; Heath M., 2000, P 5 INT WORKSH DIG M, P212; Houssami N, 2009, J MED IMAG RADIAT ON, V53, P171, DOI 10.1111/j.1754-9485.2009.02062.x; Houssami N, 2009, MED J AUSTRALIA, V190, P493, DOI 10.5694/j.1326-5377.2009.tb02526.x; Jiang YL, 2006, ACAD RADIOL, V13, P84, DOI 10.1016/j.acra.2005.09.086; Kendall EJ, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-43; Liu S, 1998, 1998 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL 1, P727, DOI 10.1109/ICIP.1998.723599; Liu S, 2001, IEEE T IMAGE PROCESS, V10, P874, DOI 10.1109/83.923284; Oliver A, 2010, MED IMAGE ANAL, V14, P87, DOI 10.1016/j.media.2009.12.005; Pisano ED, 2001, IWDM 2000: 5TH INTERNATIONAL WORKSHOP ON DIGITAL MAMMOGRAPHY, P504; Sato M, 2012, BREAST CANC; Scott HJ, 2005, P SOC PHOTO-OPT INS, V5749, P557, DOI 10.1117/12.596892; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; Suckling J, 1994, MAMMOGRAPHIC IMAGE A; Taylor-Phillips S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3279; The Breast Cancer Surveillance Consortium, 2005, NCI FUND BREAST CANC; Wolfe JM, 2010, CURR BIOL, V20, P121, DOI 10.1016/j.cub.2009.11.066	31	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91015	10.1371/journal.pone.0091015	http://dx.doi.org/10.1371/journal.pone.0091015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632807	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400034
J	Mittal, R; Grati, M; Gerring, R; Blackwelder, P; Yan, D; Li, JD; Liu, XZ				Mittal, Rahul; Grati, M'hamed; Gerring, Robert; Blackwelder, Patricia; Yan, Denise; Li, Jian-Dong; Liu, Xue Zhong			In Vitro Interaction of Pseudomonas aeruginosa with Human Middle Ear Epithelial Cells	PLOS ONE			English	Article							SUPPURATIVE OTITIS-MEDIA; SENSORINEURAL HEARING-LOSS; OUTER-MEMBRANE PROTEINS; SENSITIVITY PATTERN; HOST INNATE; INVASION; DEATH; COMPLICATIONS; MANIPULATION; PATHOGENESIS	Background: Otitis media (OM) is an inflammation of the middle ear which can be acute or chronic. Acute OM is caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis whereas Pseudomonas aeruginosa is a leading cause of chronic suppurative otitis media (CSOM). CSOM is a chronic inflammatory disorder of the middle ear characterized by infection and discharge. The survivors often suffer from hearing loss and neurological sequelae. However, no information is available regarding the interaction of P. aeruginosa with human middle ear epithelial cells (HMEECs). Methodology and Findings: In the present investigation, we demonstrate that P. aeruginosa is able to enter and survive inside HMEECs via an uptake mechanism that is dependent on microtubule and actin microfilaments. The actin microfilament disrupting agent as well as microtubule inhibitors exhibited significant decrease in invasion of HMEECs by P. aeruginosa. Confocal microscopy demonstrated F-actin condensation associated with bacterial entry. This recruitment of F-actin was transient and returned to normal distribution after bacterial internalization. Scanning electron microscopy demonstrated the presence of bacteria on the surface of HMEECs, and transmission electron microscopy confirmed the internalization of P. aeruginosa located in the plasma membrane-bound vacuoles. We observed a significant decrease in cell invasion of OprF mutant compared to the wild-type strain. P. aeruginosa induced cytotoxicity, as demonstrated by the determination of lactate dehydrogenase levels in culture supernatants of infected HMEECs and by a fluorescent dye-based assay. Interestingly, OprF mutant showed little cell damage compared to wild-type P. aeruginosa. Conclusions and Significance: This study deciphered the key events in the interaction of P. aeruginosa with HMEECs in vitro and highlighted the role of bacterial outer membrane protein, OprF, in this process. Understanding the molecular mechanisms in the pathogenesis of CSOM will help in identifying novel targets to design effective therapeutic strategies and to prevent hearing loss.	[Mittal, Rahul; Grati, M'hamed; Gerring, Robert; Yan, Denise; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Blackwelder, Patricia] Univ Miami, Ctr Adv Microscopy, Coral Gables, FL 33124 USA; [Blackwelder, Patricia] RSMAS, Key Biscayne, FL USA; [Li, Jian-Dong] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Li, Jian-Dong] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA	University of Miami; University of Miami; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University of Miami	Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.	xliu@med.miami.edu		Li, Jian-Dong/0000-0002-5593-050X; Grati, Mhamed/0000-0001-5149-3245; Grati, M'hamed/0000-0002-4490-1682; Blackwelder, Patricia/0000-0003-0989-2976	National Institutes of Health [R01DC005575, R01DC012546, R01DC012115]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC012546, R01DC005843, R01DC005575, R01DC012115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research work in Dr. Liu's laboratory is supported by the National Institutes of Health grants R01DC005575, R01DC012546, and R01DC012115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi OA, 2012, AFR HEALTH SCI, V12, P362, DOI 10.4314/ahs.v12i3.18; Allen Matthew, 1994, Clinical Materials, V16, P189; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Bluestone C.D, 1996, PEDIAT OTOLARYNGOLOG; Bluestone CD, 1998, INT J PEDIATR OTORHI, V42, P207, DOI 10.1016/S0165-5876(97)00147-X; Brauweiler AM, 2013, J ALLERGY CLIN IMMUN, V131, P421, DOI 10.1016/j.jaci.2012.10.030; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Carabeo R, 2011, CELL MICROBIOL, V13, P1460, DOI 10.1111/j.1462-5822.2011.01651.x; Carayol N, 2013, CURR OPIN MICROBIOL, V16, P32, DOI 10.1016/j.mib.2012.11.010; Chew Yok Kuan, 2012, Ear Nose Throat J, V91, P430; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Cureoglu S, 2004, LARYNGOSCOPE, V114, P622, DOI 10.1097/00005537-200404000-00006; da Costa SS, 2009, EUR ARCH OTO-RHINO-L, V266, P221, DOI 10.1007/s00405-008-0739-0; Dayasena RP, 2011, AUSTRALAS MED J, V4, P101, DOI 10.4066/AMJ.2011.549; FINNEN RL, 1992, J BACTERIOL, V174, P4977, DOI 10.1128/JB.174.15.4977-4985.1992; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Guthrie OW, 2008, TOXICOLOGY, V249, P91, DOI 10.1016/j.tox.2008.04.015; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hicks SW, 2013, NAT REV MICROBIOL, V11, P316, DOI 10.1038/nrmicro3009; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Horsington J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003239; Huang M, 1990, Ann Otol Rhinol Laryngol Suppl, V148, P35; JANDA JM, 1991, INFECT IMMUN, V59, P154, DOI 10.1128/IAI.59.1.154-161.1991; Jensen RG, 2013, INT J PEDIATR OTORHI, V77, P1530, DOI 10.1016/j.ijporl.2013.06.025; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Kim BG, 2014, LARYNGOSCOPE, V124, pE27, DOI 10.1002/lary.24397; Kolo ES, 2012, INDIAN J OTOLARYNGOL, V64, P59, DOI 10.1007/s12070-011-0251-5; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2674; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Lim DJ, 2012, ADV EXP MED BIOL, V720, P15, DOI 10.1007/978-1-4614-0254-1_2; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Madana J, 2011, INT J PEDIATR OTORHI, V75, P1104, DOI 10.1016/j.ijporl.2011.05.025; Matz G, 2004, OTOLARYNG HEAD NECK, V130, pS79, DOI 10.1016/j.otohns.2003.12.007; McClean S, 2012, PROTEIN PEPTIDE LETT, V19, P1013, DOI 10.2174/092986612802762688; MILIOTIS MD, 1995, INFECT IMMUN, V63, P4959, DOI 10.1128/IAI.63.12.4959-4963.1995; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; MORIZONO T, 1991, OTOLARYNG CLIN N AM, V24, P835; Morris P, 2013, AM FAM PHYSICIAN, V88, P694; Morris Peter S, 2009, Pediatr Clin North Am, V56, P1383, DOI 10.1016/j.pcl.2009.09.007; Mujeeb A, 2013, ACTA BIOMATER, V9, P4609, DOI 10.1016/j.actbio.2012.08.044; Nair MKM, 2009, FOODBORNE PATHOG DIS, V6, P495, DOI 10.1089/fpd.2008.0228; Navarro-Garcia F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/374395; Nestorovich EM, 2006, J BIOL CHEM, V281, P16230, DOI 10.1074/jbc.M600650200; Oelschlaeger Tobias A, 2000, BACTERIAL INVASION E, DOI [10.1007/978-1-4757-4580-1, DOI 10.1007/978-1-4757-4580-1]; Olatoke Fatai, 2008, Ear Nose Throat J, V87, pE19; Park HY, 2012, INT J PEDIATR OTORHI, V76, P475, DOI 10.1016/j.ijporl.2011.12.028; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Posselt G, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-77; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Qureishi A, 2014, INFECT DRUG RESIST, V7, P15, DOI 10.2147/IDR.S39637; RAWLING EG, 1995, INFECT IMMUN, V63, P38, DOI 10.1128/IAI.63.1.38-42.1995; RICHARDSON WP, 1988, INFECT IMMUN, V56, P2512, DOI 10.1128/IAI.56.9.2512-2514.1988; Saini Santosh, 2005, Indian J Pathol Microbiol, V48, P413; Sattar A, 2012, JCPSP-J COLL PHYSICI, V22, P128, DOI 02.2012/JCPSP.128129; STGEME JW, 1990, INFECT IMMUN, V58, P4036, DOI 10.1128/IAI.58.12.4036-4044.1990; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Villenave R, 2013, TRENDS MICROBIOL, V21, P238, DOI 10.1016/j.tim.2013.02.004; WOODRUFF WA, 1988, J BACTERIOL, V170, P2592, DOI 10.1128/jb.170.6.2592-2598.1988; Wu HH, 2009, J NEUROPATH EXP NEUR, V68, P677, DOI 10.1097/NEN.0b013e3181a77d1e; Wu J, 2013, DIGEST DIS SCI, V58, P1830, DOI 10.1007/s10620-013-2589-x; Wu JF, 2012, ACTA OTO-LARYNGOL, V132, P261, DOI 10.3109/00016489.2011.643239; Yeo SG, 2007, ACTA OTO-LARYNGOL, V127, P1062, DOI 10.1080/00016480601126978; Yorgancilar E, 2013, B-ENT, V9, P17; Yorgancilar E, 2013, EUR ARCH OTO-RHINO-L, V270, P69, DOI 10.1007/s00405-012-1924-8; Zou YN, 2013, BIOSCI BIOTECH BIOCH, V77, P345, DOI 10.1271/bbb.120764	75	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91885	10.1371/journal.pone.0091885	http://dx.doi.org/10.1371/journal.pone.0091885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632826	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400116
J	O'Mara, ML; Mark, AE				O'Mara, Megan L.; Mark, Alan E.			Structural Characterization of Two Metastable ATP-Bound States of P-Glycoprotein	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; NUCLEOTIDE-BINDING DOMAIN; MULTIDRUG ABC TRANSPORTER; TRANSMEMBRANE SEGMENTS; CROSS-LINKING; DRUG-BINDING; CASSETTE TRANSPORTER; CRYSTAL-STRUCTURE; LINKER REGION; ENVIRONMENT	ATP Binding Cassette (ABC) transporters couple the binding and hydrolysis of ATP to the transport of substrate molecules across the membrane. The mechanism by which ATP binding and/or hydrolysis drives the conformational changes associated with substrate transport has not yet been characterized fully. Here, changes in the conformation of the ABC export protein P-glycoprotein on ATP binding are examined in a series of molecular dynamics simulations. When one molecule of ATP is placed at the ATP binding site associated with each of the two nucleotide binding domains (NBDs), the membrane-embedded P-glycoprotein crystal structure adopts two distinct metastable conformations. In one, each ATP molecule interacts primarily with the Walker A motif of the corresponding NBD. In the other, the ATP molecules interacts with both Walker A motif of one NBD and the Signature motif of the opposite NBD inducing the partial dimerization of the NBDs. This interaction is more extensive in one of the two ATP binding site, leading to an asymmetric structure. The overall conformation of the transmembrane domains is not altered in either of these metastable states, indicating that the conformational changes associated with ATP binding observed in the simulations in the absence of substrate do not lead to the outward-facing conformation and thus would be insufficient in themselves to drive transport. Nevertheless, the metastable intermediate ATP-bound conformations observed are compatible with a wide range of experimental cross-linking data demonstrating the simulations do capture physiologically important conformations. Analysis of the interaction between ATP and its cofactor Mg2+ with each NBD indicates that the coordination of ATP and Mg2+ differs between the two NBDs. The role structural asymmetry may play in ATP binding and hydrolysis is discussed. Furthermore, we demonstrate that our results are not heavily influenced by the crystal structure chosen for initiation of the simulations.	[O'Mara, Megan L.; Mark, Alan E.] Univ Queensland, IMB, SCMB, Brisbane, Qld, Australia; [O'Mara, Megan L.] Univ Queensland, IMB, SMB, Brisbane, Qld, Australia; [Mark, Alan E.] Univ Queensland, IMB, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	O'Mara, ML (corresponding author), Univ Queensland, IMB, SCMB, Brisbane, Qld, Australia.	m.omara@uq.edu.au	O'Mara, Megan/ABF-8913-2020; O'Mara, Megan/AAY-5934-2021; Mark, Alan E/A-8799-2011; O'Mara, Megan L/A-4962-2011	O'Mara, Megan/0000-0002-8764-1585; Mark, Alan E/0000-0001-5880-4798; O'Mara, Megan L/0000-0002-8764-1585	Australian Research Council [DP110100327]; National Health and Medical Research Council [APP1049685]; Merit Allocation Scheme on the NCI National Facility at the ANU	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Merit Allocation Scheme on the NCI National Facility at the ANU	This work was supported by grants from the Australian Research Council (DP110100327), the National Health and Medical Research Council (APP1049685) and the Merit Allocation Scheme on the NCI National Facility at the ANU. MLO is an ARC Discovery Early Career Researcher (DE120101550). AEM is an ARC Discovery Outstanding Researcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AN, 2012, PROTEIN SCI, V21, P107, DOI 10.1002/pro.767; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Callaghan R, 2006, FEBS LETT, V580, P1056, DOI 10.1016/j.febslet.2005.11.083; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Ferreira RJ, 2012, J CHEM THEORY COMPUT, V8, P1853, DOI 10.1021/ct300083m; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Liang J, 2012, BIOCH BIOPHYSICA ACT; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loo TW, 2007, BIOCHEMISTRY-US, V46, P9328, DOI 10.1021/bi700837y; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2004, J BIOL CHEM, V279, P38395, DOI 10.1074/jbc.M405623200; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LOO TW, 1994, J BIOL CHEM, V269, P7750; Ma J, 2013, PROTEINS, V81, P1653, DOI 10.1002/prot.24324; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Modok S, 2004, J LIPID RES, V45, P1910, DOI 10.1194/jlr.M400220-JLR200; Nuti SL, 2000, BIOCHEMISTRY-US, V39, P3424, DOI 10.1021/bi992392w; Nuti SL, 2002, J BIOL CHEM, V277, P29417, DOI 10.1074/jbc.M204054200; O'Mara ML, 2012, J CHEM THEORY COMPUT, V8, P3964, DOI 10.1021/ct300254y; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Romsicki Y, 1998, EUR J BIOCHEM, V256, P170, DOI 10.1046/j.1432-1327.1998.2560170.x; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sato T, 2009, FEBS J, V276, P3504, DOI 10.1111/j.1742-4658.2009.07072.x; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Oliveira AS, 2011, PROTEINS, V79, P1977, DOI 10.1002/prot.23023; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378	64	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91916	10.1371/journal.pone.0091916	http://dx.doi.org/10.1371/journal.pone.0091916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632881	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400120
J	Gergs, A; Preuss, TG; Palmqvist, A				Gergs, Andre; Preuss, Thomas G.; Palmqvist, Annemette			Double Trouble at High Density: Cross-Level Test of Resource-Related Adaptive Plasticity and Crowding-Related Fitness	PLOS ONE			English	Article							DAPHNIA-MAGNA; FEEDING RATE; POPULATION-DYNAMICS; AMPLITUDE CYCLES; OFFSPRING SIZE; FILTER SCREENS; BODY-SIZE; FOOD; MODEL; REPRODUCTION	Population size is often regulated by negative feedback between population density and individual fitness. At high population densities, animals run into double trouble: they might concurrently suffer from overexploitation of resources and also from negative interference among individuals regardless of resource availability, referred to as crowding. Animals are able to adapt to resource shortages by exhibiting a repertoire of life history and physiological plasticities. In addition to resource-related plasticity, crowding might lead to reduced fitness, with consequences for individual life history. We explored how different mechanisms behind resource-related plasticity and crowding-related fitness act independently or together, using the water flea Daphnia magna as a case study. For testing hypotheses related to mechanisms of plasticity and crowding stress across different biological levels, we used an individual-based population model that is based on dynamic energy budget theory. Each of the hypotheses, represented by a sub-model, is based on specific assumptions on how the uptake and allocation of energy are altered under conditions of resource shortage or crowding. For cross-level testing of different hypotheses, we explored how well the sub-models fit individual level data and also how well they predict population dynamics under different conditions of resource availability. Only operating resource-related and crowding-related hypotheses together enabled accurate model predictions of D. magna population dynamics and size structure. Whereas this study showed that various mechanisms might play a role in the negative feedback between population density and individual life history, it also indicated that different density levels might instigate the onset of the different mechanisms. This study provides an example of how the integration of dynamic energy budget theory and individual-based modelling can facilitate the exploration of mechanisms behind the regulation of population size. Such understanding is important for assessment, management and the conservation of populations and thereby biodiversity in ecosystems.	[Gergs, Andre; Palmqvist, Annemette] Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark; [Preuss, Thomas G.] Rhein Westfal TH Aachen, Inst Environm Res, Aachen, Germany	Roskilde University; RWTH Aachen University	Gergs, A (corresponding author), Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark.	andre.gergs@bio5.rwth-aachen.de	; Preuss, Thomas G./A-7926-2009	Palmqvist, Annemette/0000-0003-3422-0063; Preuss, Thomas G./0000-0001-6249-6003	European Union [266712: ModNanoTox]	European Union(European Commission)	AG has received funding by the European Union (project no 266712: ModNanoTox). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Alvarez OA, 2006, ENVIRON TOXICOL CHEM, V25, P3230, DOI 10.1897/06-097R.1; Bassar RD, 2013, AM NAT, V181, P25, DOI 10.1086/668590; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Boersma M, 1997, EVOL ECOL, V11, P439, DOI 10.1023/A:1018484824003; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Bohrer RN, 1988, FUNCT ECOL, V2, P463, DOI 10.2307/2389389; BRADLEY MC, 1991, OECOLOGIA, V86, P414, DOI 10.1007/BF00317610; BRAND GW, 1985, MAR BIOL, V88, P67, DOI 10.1007/BF00393045; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; BURNS CW, 1995, OECOLOGIA, V101, P234, DOI 10.1007/BF00317289; Burns CW, 2000, FRESHWATER BIOL, V43, P19, DOI 10.1046/j.1365-2427.2000.00510.x; Chamberlin TC, 1931, J GEOL, V39, P155, DOI 10.1086/623804; Cleuvers M, 1997, OECOLOGIA, V110, P337, DOI 10.1007/s004420050167; DODSON SI, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432405; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284; Gergs A, 2014, J ANIM ECOL, V83, P758, DOI 10.1111/1365-2656.12195; GLAZIER DS, 1992, ECOLOGY, V73, P910, DOI 10.2307/1940168; GOPHEN M, 1984, OECOLOGIA, V64, P408, DOI 10.1007/BF00379140; GOSER B, 1994, OECOLOGIA, V98, P354, DOI 10.1007/BF00324224; GOSER B, 1997, DICHTEABHANGIGE ANDE; GOULDEN CE, 1980, P NATL ACAD SCI-BIOL, V77, P1716, DOI 10.1073/pnas.77.3.1716; GUISANDE C, 1992, J PLANKTON RES, V14, P997, DOI 10.1093/plankt/14.7.997; Hammers-Wirtz M, 2003, 36003024 FKZ FED ENV; HAYWARD RS, 1976, ARCH HYDROBIOL, V77, P139; Hazlerigg CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037550; HELGEN JC, 1987, HYDROBIOLOGIA, V154, P113, DOI 10.1007/BF00026835; HOBAEK A, 1990, ECOLOGY, V71, P2255, DOI 10.2307/1938637; Jager T, 2013, ECOL MODEL, DOI [10.1016/j.ecolmodel.2013.06.024, DOI 10.1016/J.EC0LM0DEL.2013.06.024]; Jager T, 2013, MAKING SENSE CHEM ST; Jager T, 2011, J SEA RES, V66, P456, DOI 10.1016/j.seares.2011.04.003; Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Kirk KL, 1998, ECOLOGY, V79, P2456, DOI 10.1890/0012-9658(1998)079[2456:ECSPDA]2.0.CO;2; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Lampert W, 1996, LIMNOL OCEANOGR, V41, P216, DOI 10.4319/lo.1996.41.2.0216; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P997, DOI 10.4319/lo.1994.39.5.0997; Lampert W, 2006, POL J ECOL, V54, P607; Lehmann T, 2006, INFECT GENET EVOL, V6, P410, DOI 10.1016/j.meegid.2006.01.007; Marshall DJ, 2009, ECOLOGY, V90, P487, DOI 10.1890/08-0320.1; Martin BT, 2013, AM NAT, V181, P506, DOI 10.1086/669904; MATVEEV V, 1993, FRESHWATER BIOL, V29, P99, DOI 10.1111/j.1365-2427.1993.tb00748.x; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCCAULEY E, 1987, AM NAT, V129, P97, DOI 10.1086/284624; MCCAULEY E, 1990, ECOLOGY, V71, P703, DOI 10.2307/1940324; McCauley E, 2008, NATURE, V455, P1240, DOI 10.1038/nature07220; MCMAHON JW, 1963, CAN J ZOOLOG, V41, P321, DOI 10.1139/z63-027; MILLER RICHARD S., 1967, ADVAN ECOL RESADVANCES IN ECOLOGICAL, V4, P1, DOI 10.1016/S0065-2504(08)60319-0; Moe SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2133, DOI 10.1098/rspb.2005.3184; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Nisbet RM, 2010, PHILOS T R SOC B, V365, P3541, DOI 10.1098/rstb.2010.0167; Plath K, 1998, LIMNOL OCEANOGR, V43, P593, DOI 10.4319/lo.1998.43.4.0593; POP M, 1991, HYDROBIOLOGIA, V225, P169, DOI 10.1007/BF00028394; Post JR, 1997, CAN J FISH AQUAT SCI, V54, P867, DOI 10.1139/cjfas-54-4-867; Preuss TG, 2009, ECOL MODEL, V220, P310, DOI 10.1016/j.ecolmodel.2008.09.018; Renault D, 2003, J ZOOL, V259, P381, DOI 10.1017/S0952836902003382; Repka S, 1999, J PLANKTON RES, V21, P971, DOI 10.1093/plankt/21.5.971; Ricklefs RE., 1999, ECOLOGY; RIGLER FH, 1961, CAN J ZOOLOG, V39, P857, DOI 10.1139/z61-080; Roff DA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P358, DOI 10.1086/518012; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; SEITZ A, 1984, OECOLOGIA, V62, P94, DOI 10.1007/BF00377380; Semlitsch RD, 2000, OECOLOGIA, V125, P179, DOI 10.1007/s004420000443; Sibly RM, 1999, ECOL APPL, V9, P496, DOI 10.1890/1051-0761(1999)009[0496:EEDFSS]2.0.CO;2; Siehoff S, 2009, FRESHWATER BIOL, V54, P15, DOI 10.1111/j.1365-2427.2008.02087.x; SOKULLKLUETTGEN B, 1998, KOMBINIERTE WIRKUNG; Sousa T, 2012, PHILOS T ROY SOC LON, V365, P3413; Sousa T, 2008, PHILOS T R SOC B, V363, P2453, DOI 10.1098/rstb.2007.2230; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stelzer CP, 2012, FUNCT ECOL, V26, P180, DOI 10.1111/j.1365-2435.2011.01918.x; THRELKELD ST, 1976, FRESHWATER BIOL, V6, P489, DOI 10.1111/j.1365-2427.1976.tb01640.x; Urabe J, 2001, FUNCT ECOL, V15, P165, DOI 10.1046/j.1365-2435.2001.00511.x; van der Meer J, 2006, J SEA RES, V56, P85, DOI 10.1016/j.seares.2006.03.001; Wogram J, 2001, B ENVIRON CONTAM TOX, V67, P360	83	17	17	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91503	10.1371/journal.pone.0091503	http://dx.doi.org/10.1371/journal.pone.0091503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626228	Green Published, gold			2022-12-27	WOS:000332851300092
J	Katz, J; Wu, LA; Mullany, LC; Coles, CL; Lee, ACC; Kozuki, N; Tielsch, JM				Katz, Joanne; Wu, Lauren A.; Mullany, Luke C.; Coles, Christian L.; Lee, Anne C. C.; Kozuki, Naoko; Tielsch, James M.			Prevalence of Small-for-Gestational-Age and Its Mortality Risk Varies by Choice of Birth-Weight-for-Gestation Reference Population	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; MIDDLE-INCOME COUNTRIES; FETAL-GROWTH; NEONATAL-MORTALITY; REFERENCE-STANDARDS; RANDOMIZED-TRIAL; INFANTS BORN; OUTCOMES; PRETERM; CALIFORNIA	Background: We use data from rural Nepal and South India to compare the prevalence of small-for-gestational-age (SGA) and neonatal mortality risk associated with SGA using different birth-weight-for-gestation reference populations. Methods: We identified 46 reference populations in low-, middle-, and high-income countries, of which 26 met the inclusion criteria of being commonly cited and having numeric 10th percentile cut points published. Those reference populations were then applied to populations from two community-based studies to determine SGA prevalence and its relative risk of neonatal mortality. Results: The prevalence of SGA ranged from 10.5% to 72.5% in Nepal, and 12.0% to 78.4% in India, depending on the reference population. Females had higher rates of SGA than males using reference populations that were not sex specific. SGA prevalence was lowest when using reference populations from low-income countries. Infants who were both preterm and SGA had much higher mortality risk than those who were term and appropriate-for-gestational-age. Risk ratios for those who are both preterm and SGA ranged from 7.34-17.98 in Nepal and 5.29-11.98 in India, depending on the reference population. Conclusions: These results demonstrate the value of a common birth-weight-for-gestation reference population that will facilitate comparisons of SGA prevalence and mortality risk across research studies.	[Katz, Joanne; Wu, Lauren A.; Mullany, Luke C.; Coles, Christian L.; Kozuki, Naoko] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Lee, Anne C. C.] Brigham & Womens Hosp, Dept Newborn Med, Boston, MA 02115 USA; [Tielsch, James M.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Global Hlth, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Brigham & Women's Hospital; George Washington University	Katz, J (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	jkatz@jhsph.edu		Tielsch, James/0000-0002-1151-060X; Katz, Joanne/0000-0002-5997-7823	Bill and Melinda Gates Foundation [810-2054]; National Institutes of Health [HD 44004, HD 38753]; JHU; Office of Health and Nutrition; US Agency for International Development [HRN-A-00-97-00015-00, GHS-A-00-03-000019-00]; Johns Hopkins University Libraries; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044004, R01HD038753] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JHU; Office of Health and Nutrition(United States Agency for International Development (USAID)); US Agency for International Development(United States Agency for International Development (USAID)); Johns Hopkins University Libraries(Johns Hopkins University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by the Bill and Melinda Gates Foundation to the US Fund for UNICEF to support the work of the Child Health Epidemiology Reference Group. The India Vitamin A and Nepal Chlorhexidine studies were supported by the National Institutes of Health [HD 44004, HD 38753], the Bill and Melinda Gates Foundation [810-2054], Cooperative Agreements between JHU and the Office of Health and Nutrition, and US Agency for International Development [HRN-A-00-97-00015-00, GHS-A-00-03-000019-00]. Procter and Gamble Company provided commodity support for the Nepal Chlorhexidine study. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; BABSON SG, 1970, PEDIATRICS, V45, P937; BHATIA B D, 1981, Indian Pediatrics, V18, P647; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BOERSMA ER, 1979, TROP GEOGR MED, V31, P7; BRENNER WE, 1976, AM J OBSTET GYNECOL, V126, P555, DOI 10.1016/0002-9378(76)90748-1; Callaghan WM, 2010, AM J EPIDEMIOL, V171, P826, DOI 10.1093/aje/kwp468; Charkaluk ML, 2012, J PEDIATR-US, V161, P1053, DOI 10.1016/j.jpeds.2012.05.037; CHENG MCE, 1972, J OBSTET GYN BR COMM, V79, P149; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Dietz PM, 2007, PAEDIATR PERINAT EP, V21, P62, DOI 10.1111/j.1365-3016.2007.00862.x; FREEMAN MG, 1969, OBSTET GYNECOL, V34, P648; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Gardosi J, 2009, AM J OBSTET GYNECOL, V201; Gibbons K, 2013, J PAEDIATR CHILD H, V49, P380, DOI 10.1111/jpc.12189; GOLDENBERG RL, 1989, AM J OBSTET GYNECOL, V161, P271, DOI 10.1016/0002-9378(89)90497-3; Gonzalez R, 2004, REV MED CHILE, V132, P1155; GRUENWALD P, 1966, AM J OBSTET GYNECOL, V94, P1112, DOI 10.1016/0002-9378(66)90774-5; Hong JS, 2007, PAEDIATR PERINAT EP, V21, P397, DOI 10.1111/j.1365-3016.2007.00850.x; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kloosterman G J, 1969, Ned Tijdschr Verloskd Gynaecol, V69, P349; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P61; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; MILNER RDG, 1974, J OBSTET GYN BR COMM, V81, P956; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; NISHIDA H, 1985, ACTA PAEDIATR SCAND, P62; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; OTT WJ, 1993, AM J OBSTET GYNECOL, V168, P1710, DOI 10.1016/0002-9378(93)90681-8; Parazzini F, 1991, Ann Ostet Ginecol Med Perinat, V112, P203; Prada JA, 1998, EUR J CLIN NUTR, V52, pS21; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; THOMSON A M, 1968, Journal of Obstetrics and Gynaecology of the British Commonwealth, V75, P903; Tielsch JM, 2007, PEDIATRICS, V119, pE330, DOI 10.1542/peds.2006-1192; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; Verhoeff FH, 2001, EUR J CLIN NUTR, V55, P682, DOI 10.1038/sj.ejcn.1601200; Villar J, 2013, BJOG; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2006, WHO CHILD GROWTH STA; WILCOX M, 1993, BRIT MED J, V307, P588, DOI 10.1136/bmj.307.6904.588; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; WOO JSK, 1986, AUST NZ J OBSTET GYN, V26, P54, DOI 10.1111/j.1479-828X.1986.tb01529.x; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E	50	47	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92074	10.1371/journal.pone.0092074	http://dx.doi.org/10.1371/journal.pone.0092074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642757	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900077
J	Lu, X; Zhang, FY; Shen, Q; Jiang, WM; Pan, QF; Lv, ZY; Yan, TX; Fu, XQ; Wang, YL; Qian, HM; Tang, KX				Lu, Xu; Zhang, Fangyuan; Shen, Qian; Jiang, Weimin; Pan, Qifang; Lv, Zongyou; Yan, Tingxiang; Fu, Xueqing; Wang, Yuliang; Qian, Hongmei; Tang, Kexuan			Overexpression of Allene Oxide Cyclase Improves the Biosynthesis of Artemisinin in Artemisia annua L.	PLOS ONE			English	Article							JASMONIC ACID; ARABIDOPSIS-THALIANA; TRANSGENIC TOBACCO; ENZYME; CHROMATOGRAPHY; INDUCTION; DEFENSE; PLANTS	Jasmonates (JAs) are important signaling molecules in plants and play crucial roles in stress responses, secondary metabolites' regulation, plant growth and development. In this study, the promoter of AaAOC, which was the key gene of jasmonate biosynthetic pathway, had been cloned. GUS staining showed that AaAOC was expressed ubiquitiously in A. annua. AaAOC gene was overexpressed under control of 35S promoter. RT-Q-PCR showed that the expression levels of AaAOC were increased from 1.6- to 5.2-fold in AaAOC-overexpression transgenic A. annua. The results of GC-MS showed that the content of endogenous jasmonic acid (JA) was 2- to 4.7-fold of the control level in AaAOC-overexpression plants. HPLC showed that the contents of artemisinin, dihydroartemisinic acid and artemisinic acid were increased significantly in AaAOC-overexpression plants. RT-Q-PCR showed that the expression levels of FPS (farnesyl diphosphate synthase), CYP71AV1 (cytochrome P450 dependent hydroxylase) and DBR2 (double bond reductase 2) were increased significantly in AaAOC-overexpression plants. All data demonstrated that increased endogenous JA could significantly promote the biosynthesis of artemisinin in AaAOC-overexpression transgenic A. annua.	[Lu, Xu; Zhang, Fangyuan; Shen, Qian; Jiang, Weimin; Pan, Qifang; Lv, Zongyou; Yan, Tingxiang; Fu, Xueqing; Wang, Yuliang; Qian, Hongmei; Tang, Kexuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Lu, Xu] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China	Shanghai Jiao Tong University; China Pharmaceutical University	Tang, KX (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China.	kxtang@sjtu.edu.cn	Tang, Kexuan/E-3555-2013; SHEN, QIAN/O-6347-2015	Tang, Kexuan/0000-0002-8748-9624; Wang, Yuliang/0000-0001-6174-6365; SHEN, QIAN/0000-0002-4621-4659; Jiang, Weimin/0000-0002-2546-5256	China "863" Program [2011AA100605]	China "863" Program(National High Technology Research and Development Program of China)	China "863" Program (grant no. 2011AA100605), the URL of funder's website: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2006, J BIOL CHEM, V281, P31528, DOI 10.1074/jbc.M604820200; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Engelberth J, 2003, ANAL BIOCHEM, V312, P242, DOI 10.1016/S0003-2697(02)00466-9; Ferreira JFS, 2009, PHYTOCHEM ANALYSIS, V20, P91, DOI 10.1002/pca.1101; Gu XC, 2012, PLANT CELL REP, V31, P2247, DOI 10.1007/s00299-012-1334-9; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang KJ, 2009, PLANTA, V229, P1057, DOI 10.1007/s00425-009-0896-4; Koo AJK, 2006, J BIOL CHEM, V281, P33511, DOI 10.1074/jbc.M607854200; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liu DH, 2010, RUSS J PLANT PHYSL+, V57, P882, DOI 10.1134/S102144371006018X; Liu WS, 2013, PLANT BIOTECHNOL J, V11, P43, DOI 10.1111/pbi.12005; Lu X, 2012, MOL BIOL REP, V39, P9521, DOI 10.1007/s11033-012-1816-4; Maes L, 2011, NEW PHYTOL, V189, P176, DOI 10.1111/j.1469-8137.2010.03466.x; Muller A, 2002, PLANTA, V216, P44, DOI 10.1007/s00425-002-0866-6; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Tretner C, 2008, J EXP BOT, V59, P2847, DOI 10.1093/jxb/ern145; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Weathers PJ, 2006, IN VITRO CELL DEV-PL, V42, P309, DOI 10.1079/IVP2006782; Yang DH, 2011, J EXP BOT, V62, P641, DOI 10.1093/jxb/erq298; Zhang L, 2009, BIOTECHNOL APPL BIOC, V52, P199, DOI 10.1042/BA20080068; Ziegler J, 2000, J BIOL CHEM, V275, P19132, DOI 10.1074/jbc.M002133200	29	19	19	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91741	10.1371/journal.pone.0091741	http://dx.doi.org/10.1371/journal.pone.0091741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642483	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900032
J	Bi, N; Cao, JZ; Song, YM; Shen, J; Liu, WY; Fan, J; He, J; Shi, YK; Zhang, X; Lu, N; Zhan, QM; Wang, LH				Bi, Nan; Cao, Jianzhong; Song, Yongmei; Shen, Jie; Liu, Wenyang; Fan, Jing; He, Jie; Shi, Yuankai; Zhang, Xun; Lu, Ning; Zhan, Qimin; Wang, Luhua			A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy	PLOS ONE			English	Article							REDUCED EXPRESSION; PROGNOSTIC VALUE; GROWTH; OVEREXPRESSION; MIR-150; CLUSTER; TUMORS	Small-cell lung cancer (SCLC) is one of the most aggressive cancers, yet the molecular mechanisms underlying its devastating clinical outcome remain elusive. In this study, we investigated whether microRNA (miRNA) expression profiles can predict the clinical outcomes of SCLC patients. A total of 82 patients with limited SCLC, who were treated with surgical resection and adjuvant chemotherapy, were enrolled in this study. First, we surveyed the expression of 924 miRNAs from 42 SCLC patients to discover survival-relevant miRNAs and develop prognostic models, which were then validated in an independent cohort of 40 cases using quantitative real-time PCR. We found that the miR-150/miR-886-3p signature was significantly correlated with the overall survival (OS) of SCLC patients (p = 0.02) in the training set, and both miRNA expression levels were much lower in the SCLC samples than normal lung samples. The miRNA signature also proved to be a significant predictor of survival in the validation set. Patients with high-risk miRNA signatures had poor overall survival (p = 0.005) and progression-free survival (p = 0.017) compared with those with low-risk scores. These findings retained statistical significance after adjusting for age, gender and smoking status (HR: 0.26, 95%: CI 0.10-0.69, p = 0.007), which suggested it may be an independent predictor of survival. In summary, we developed a prognostic miR-150/miR-886-3p signature and validated expression in an independent dataset of resectable SCLC. These preliminary results indicated that miRNAs may serve as promising molecular prognostic markers and new therapeutic targets for SCLC.	[Bi, Nan; Cao, Jianzhong; Shen, Jie; Liu, Wenyang; Wang, Luhua] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Radiat Oncol, Beijing 100730, Peoples R China; [Bi, Nan; Cao, Jianzhong; Song, Yongmei; Shen, Jie; Liu, Wenyang; Fan, Jing; He, Jie; Shi, Yuankai; Zhang, Xun; Lu, Ning; Zhan, Qimin; Wang, Luhua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Song, Yongmei; Fan, Jing; Zhan, Qimin] Chinese Acad Med Sci, Canc Hosp & Inst, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [He, Jie] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Thorac Surg, Beijing 100730, Peoples R China; [Shi, Yuankai] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Med Oncol, Beijing 100730, Peoples R China; [Zhang, Xun; Lu, Ning] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Hosp & Inst, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhanqimin@pumc.edu.cn; wlhwq@yahoo.com	bi, nan/GWV-5745-2022; Zhang, Xun/HHM-9059-2022; Liu, Wen-Yang/AAI-7264-2020	Zhang, Xun/0000-0001-5411-2727; Liu, Wen-Yang/0000-0002-6978-7169; song, yongmei/0000-0002-7789-0158	973 National Key Fundamental Research Program of China [2009CB521801, 2010CB912800]; National Natural Science Foundation of China [81021061, 81071830]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 National Key Fundamental Research Program of China (2009CB521801, 2010CB912800) and the National Natural Science Foundation of China (81021061, 81071830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JA, CLIN CANC RES, V16, P610; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cao J, 2013, CANC RES; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; COOK RM, 1993, CURR PROB CANCER, V17, P71; Crivellari G, 2007, ONCOLOGIST, V12, P79, DOI 10.1634/theoncologist.12-1-79; Eder M, 2005, NEW ENGL J MED, V352, P2446, DOI 10.1056/NEJMcibr051201; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lee HW, 2012, PATHOL INT, V62, P583, DOI 10.1111/j.1440-1827.2012.02845.x; Lee JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021300; Li YJ, 2012, ONCOL REP, V27, P129, DOI 10.3892/or.2011.1466; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Ma YL, 2012, GUT, V61, P1447, DOI 10.1136/gutjnl-2011-301122; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Ou SHI, 2009, J THORAC ONCOL, V4, P300, DOI 10.1097/JTO.0b013e318194a355; Pizzini S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-589; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Ranade AR, 2010, J THORAC ONCOL, V5, P1273, DOI 10.1097/JTO.0b013e3181dea6be; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Shiao TH, 2011, J THORAC ONCOL, V6, P195, DOI 10.1097/JTO.0b013e3181f94abb; Simon G, 2001, Chest Surg Clin N Am, V11, P165; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Treppendahl MB, 2012, BLOOD, V119, P206, DOI 10.1182/blood-2011-06-362541; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Xiong Y, PLOS ONE, V6; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhao LJ, 2009, INT J RADIAT ONCOL, V74, P1385, DOI 10.1016/j.ijrobp.2008.10.065; Zhu H, 2011, CANCER-AM CANCER SOC, V117, P5423, DOI 10.1002/cncr.26206	45	30	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91388	10.1371/journal.pone.0091388	http://dx.doi.org/10.1371/journal.pone.0091388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637927	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100031
J	Gupta, D; Rani, M; Khan, N; Jameel, S				Gupta, Deepti; Rani, Manjusha; Khan, Nabab; Jameel, Shahid			HIV-1 Infected Peripheral Blood Mononuclear Cells Modulate the Fibrogenic Activity of Hepatic Stellate Cells through Secreted TGF-beta and JNK Signaling	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GROWTH-FACTOR-BETA; C-VIRUS; LIVER FIBROSIS; HIV; PROLIFERATION; EXPRESSION; TRANSDUCTION; ACTIVATION; MECHANISMS	Background and Aims: Patients with liver disease infected with the human immunodeficiency virus (HIV) exhibit accelerated progression of hepatic fibrosis and liver cirrhosis compared to uninfected individuals. We studied the effects of soluble factors secreted by HIV-infected peripheral blood mononuclear cells (PBMCs) on hepatic stellate cells (HSCs), which are central mediators of liver fibrosis. Methods: An in vitro model was used in which a HSC line, LX2, was treated with culture supernatants of human PBMCs infected with macrophage tropic (R5) or T cell tropic (X4) strains of HIV-1. Quantitative reverse transcription PCR (qRT-PCR) and western blotting were used to assess the expression of fibrogenic and proinflammatory markers; LX2 proliferation and intracellular signaling pathways were also studied. A qRT-PCR based miRNome array was used for comparative miRNA profiling of LX2 cells treated with infected PBMC culture supernatants. Results: Pro-fibrogenic, angiogenic and proinflammatory markers, and proliferation of LX2 cells were increased following exposure to culture supernatants from HIV-1 infected PBMCs. The profiling of miRNAs in LX2 cells treated with culture supernatants from HIV-1 R5- or X4-infected PBMCs showed 66 and 22 miRNAs respectively, to be significantly altered compared to mock-treated LX2 cells. While different sets of miRNAs were altered in the two cases, bioinformatics analyses predicted these to be associated with common pathways, including TGF-beta signaling and extracellular matrix receptor interaction pathways. Conclusions: HIV infection creates a favorable milieu for the activation of hepatic stellate cells and increased hepatic fibrosis. We identify some regulatory molecules important for these effects.	[Gupta, Deepti; Rani, Manjusha; Khan, Nabab; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Jameel, S (corresponding author), Wellcome Trust DBT India Alliance, Hyderabad, Andhra Pradesh, India.	shahid@icgeb.res.in	khan, Nabab/Z-3970-2019; Gupta, Deepti/U-1777-2019	khan, Nabab/0000-0002-8563-5341; Gupta, Deepti/0000-0001-7931-0017	Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This work was funded by grants from the Department of Biotechnology (DBT) and Indian Council of Medical Research (ICMR). Senior Research Fellowship was awarded the ICMR to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RD, 2009, J INFECT DIS, V200, P619, DOI 10.1086/600107; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; BREEN EC, 1990, J IMMUNOL, V144, P480; Breitkopf K, 2005, ALCOHOL CLIN EXP RES, V29, p121S, DOI 10.1097/01.alc.0000189284.98684.22; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Guo GH, 2009, HEPATOB PANCREAT DIS, V8, P59; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hong F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033659; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Hung KS, 2005, BIOCHEM BIOPH RES CO, V336, P324, DOI 10.1016/j.bbrc.2005.08.085; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kawada N, 2011, HEPATOL RES, V41, P199, DOI 10.1111/j.1872-034X.2011.00776.x; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Kluwe J, 2007, OCTOBER, V13, P1324, DOI [10.1038/nm1663, DOI 10.1038/NM1663]; Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOTZ M, 1993, ANN NY ACAD SCI, V685, P501, DOI 10.1111/j.1749-6632.1993.tb35912.x; Marra F, 1997, GASTROENTEROLOGY, V112, P1297, DOI 10.1016/S0016-5085(97)70144-6; MOLINA JM, 1989, J CLIN INVEST, V84, P733, DOI 10.1172/JCI114230; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Nunoya J-J, 2013, J INFECT DIS, P1; Patel P, 2014, PLOS ONE IN PRESS; Roe Barbara, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000847; Roe B, 2007, J INFECT DIS, V196, P1053, DOI 10.1086/520935; Ryo A, 2000, AIDS RES HUM RETROV, V16, P995, DOI 10.1089/08892220050058416; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Sherman KE, 2007, HEPATOLOGY, V45, P1566, DOI 10.1002/hep.21722; Tahiri M, 2013, WORLD J HEPATOL, V5, P584, DOI 10.4254/wjh.v5.i10.584; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Ueberham E, 2003, HEPATOLOGY, V37, P1067, DOI 10.1053/jhep.2003.50196; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wiercinska-Drapalo A, 2004, VIRAL IMMUNOL, V17, P109, DOI 10.1089/088282404322875502; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoshida K, 2005, AM J PATHOL, V166, P1029, DOI 10.1016/S0002-9440(10)62324-3; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	48	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91569	10.1371/journal.pone.0091569	http://dx.doi.org/10.1371/journal.pone.0091569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637780	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100045
J	Wang, F; Li, DL; Wang, ZY; Dong, AR; Liu, LH; Wang, BY; Chen, QL; Liu, XH				Wang, Feng; Li, Danlei; Wang, Zhiying; Dong, Airong; Liu, Lihong; Wang, Buyong; Chen, Qiaoli; Liu, Xiaohan			Transcriptomic Analysis of the Rice White Tip Nematode, Aphelenchoides besseyi (Nematoda: Aphelenchoididae)	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; HORIZONTAL GENE-TRANSFER; ROOT-LESION NEMATODE; RNA INTERFERENCE; PHARYNGEAL GLAND; EFFECTOR PROTEIN; IDENTIFICATION; SEQUENCE; CLASSIFICATION; EXPRESSION	Background: The rice white tip nematode Aphelenchoides besseyi, a devastating nematode whose genome has not been sequenced, is distributed widely throughout almost all the rice-growing regions of the world. The aims of the present study were to define the transcriptome of A. besseyi and to identify parasite-related, mortality-related or host resistance-overcoming genes in this nematode. Methodology and Principal Findings: Using Solexa/Illumina sequencing, we profiled the transcriptome of mixed-stage populations of A. besseyi. A total of 51,270 transcripts without gaps were produced based on high-quality clean reads. Of all the A. besseyi transcripts, 9,132 KEGG Orthology assignments were annotated. Carbohydrate-active enzymes of glycoside hydrolases (GHs), glycosyltransferases (GTs), carbohydrate esterases (CEs) and carbohydrate-binding modules (CBMs) were identified. The presence of the A. besseyi GH45 cellulase gene was verified by in situ hybridization. Given that 13 unique A. besseyi potential effector genes were identified from 41 candidate effector homologs, further studies of these homologs are merited. Finally, comparative analyses were conducted between A. besseyi contigs and Caenorhabditis elegans genes to look for orthologs of RNAi phenotypes, neuropeptides and peptidases. Conclusions and Significance: The present results provide comprehensive insight into the genetic makeup of A. besseyi. Many of this species' genes are parasite related, nematode mortality-related or necessary to overcome host resistance. The generated transcriptome dataset of A. besseyi reported here lays the foundation for further studies of the molecular mechanisms related to parasitism and facilitates the development of new control strategies for this species.	[Wang, Feng; Li, Danlei; Wang, Zhiying; Dong, Airong; Liu, Lihong; Wang, Buyong; Chen, Qiaoli; Liu, Xiaohan] Northeast Forestry Univ, Coll Forestry, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Li, DL (corresponding author), Northeast Forestry Univ, Coll Forestry, Harbin, Heilongjiang, Peoples R China.	danleili@nefu.edu.cn	liu, li/HGC-0900-2022		Research Fund for the Doctoral Program of Higher Education of China [20100062120002]; Heilongjiang Postdoctoral Fund (China) [LBH-Z11248]; China State Scholarship Fund [2009660509]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Heilongjiang Postdoctoral Fund (China); China State Scholarship Fund	This work was financed by the Research Fund for the Doctoral Program of Higher Education of China (project 20100062120002), the Heilongjiang Postdoctoral Fund (China; project LBH-Z11248) and the China State Scholarship Fund (2009660509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Bakhetia M, 2005, TRENDS PLANT SCI, V10, P362, DOI 10.1016/j.tplants.2005.06.007; Cantacessi C, 2011, BIOTECHNOL ADV, V29, P261, DOI 10.1016/j.biotechadv.2010.11.005; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Cheng X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066011; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; de Boer JM, 1998, J NEMATOL, V30, P309; De Meutter J, 2003, MOL PLANT PATHOL, V4, P271, DOI [10.1046/j.1364-3703.2003.00176.x, 10.1046/J.1364-3703.2003.00176.X]; Duncan LW, 2006, PLANT NEMATOLOGY, P123, DOI [10.1079/9781845930561.0123, 10.1079/9781780641515.0144]; Elling AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-58; FORTUNER R, 1975, PLANT NEMATOLOGY, V44, P1; Fu Z, 2012, PHYTOPATHOLOGY, V102, P804, DOI 10.1094/PHYTO-12-11-0336; Geldhof P, 2007, PARASITOLOGY, V134, P609, DOI 10.1017/S0031182006002071; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haegeman A, 2013, MOL PLANT PATHOL, V14, P379, DOI 10.1111/mpp.12014; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jacob J, 2008, MOL GENET GENOMICS, V280, P1, DOI 10.1007/s00438-008-0340-7; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Jones JT, 2005, NEMATOLOGY, V7, P641, DOI 10.1163/156854105775142919; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karim N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-525; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2014, NEMATOLOGY, V16, P99, DOI 10.1163/15685411-00002748; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 2008, WORMBOOK, V25, P1, DOI [10.1895/wormbook.1.142.1, DOI 10.1895/W0RMB00K.1.142.1]; Lin BR, 2013, MOL PLANT MICROBE IN, V26, P55, DOI 10.1094/MPMI-05-12-0114-FI; Lin M.S., 2004, RICE SCI, V12, P289; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martin J, 2012, NUCLEIC ACIDS RES, V40, pD720, DOI 10.1093/nar/gkr1194; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rajan, 1990, Indian Journal of Nematology, V19, P10; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Rosso MN, 2005, MOL PLANT MICROBE IN, V18, P615, DOI 10.1094/MPMI-18-0615; Roze E, 2008, MOL PLANT PATHOL, V9, P1, DOI [10.1111/j.1364-3703.2007.00435.x, 10.1111/J.1364-3703.2007.00435.X]; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Silva G. S. da, 1992, Informe Agropecuario (Belo Horizonte), V16, P57; Tiwari S. P., 2003, Advances in nematology, P103; Togashi K, 2001, NEMATOLOGY, V3, P17, DOI 10.1163/156854101300106847; Tsay T. T., 1995, Plant Pathology Bulletin, V4, P180; Tytgat T, 2004, MOL PLANT MICROBE IN, V17, P846, DOI 10.1094/MPMI.2004.17.8.846; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Wang F, 2012, INT J MOL SCI, V13, P8819, DOI 10.3390/ijms13078819; Wang K. M., 1993, Plant Protection Bulletin (Taichung), V35, P14; Yoshida K, 2009, J NEMATOL, V41, P17; Yu P. C., 2004, Plant Pathology Bulletin, V13, P35	63	27	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91591	10.1371/journal.pone.0091591	http://dx.doi.org/10.1371/journal.pone.0091591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637831	gold, Green Submitted, Green Published			2022-12-27	WOS:000333254100047
J	Alaimo, A; Gorojod, RM; Beauquis, J; Munoz, MJ; Saravia, F; Kotler, ML				Alaimo, Agustina; Gorojod, Roxana M.; Beauquis, Juan; Munoz, Manuel J.; Saravia, Flavia; Kotler, Monica L.			Deregulation of Mitochondria-Shaping Proteins Opa-1 and Drp-1 in Manganese-Induced Apoptosis	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION; FISSION; FUSION; FRAGMENTATION; CRISTAE; NEURODEGENERATION; MODULATION; INHIBITION	Mitochondria are dynamic organelles that undergo fusion and fission processes. These events are regulated by mitochondria-shaping proteins. Changes in the expression and/or localization of these proteins lead to a mitochondrial dynamics impairment and may promote apoptosis. Increasing evidence correlates the mitochondrial dynamics disruption with the occurrence of neurodegenerative diseases. Therefore, we focused on this topic in Manganese (Mn)-induced Parkinsonism, a disorder associated with Mn accumulation preferentially in the basal ganglia where mitochondria from astrocytes represent an early target. Using MitoTracker Red staining we observed increased mitochondrial network fission in Mn-exposed rat astrocytoma C6 cells. Moreover, Mn induced a marked decrease in fusion protein Opa-1 levels as well as a dramatic increase in the expression of fission protein Drp-1. Additionally, Mn provoked a significant release of high MW Opa-1 isoforms from the mitochondria to the cytosol as well as an increased Drp-1 translocation to the mitochondria. Both Mdivi-1, a pharmacological Drp-1 inhibitor, and rat Drp-1 siRNA reduced the number of apoptotic nuclei, preserved the mitochondrial network integrity and prevented cell death. CsA, an MPTP opening inhibitor, prevented mitochondrial Delta psi m disruption, Opa-1 processing and Drp-1 translocation to the mitochondria therefore protecting Mn-exposed cells from mitochondrial disruption and apoptosis. The histological analysis and Hoechst 33258 staining of brain sections of Mn-injected rats in the striatum showed a decrease in cellular mass paralleled with an increase in the occurrence of apoptotic nuclei. Opa-1 and Drp-1 expression levels were also changed by Mn-treatment. Our results demonstrate for the first time that abnormal mitochondrial dynamics is implicated in both in vitro and in vivo Mn toxicity. In addition we show that the imbalance in fusion/fission equilibrium might be involved in Mn-induced apoptosis. This knowledge may provide new therapeutic tools for the treatment of Manganism and other neurodegenerative diseases.	[Alaimo, Agustina; Gorojod, Roxana M.; Kotler, Monica L.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Apoptosis El Sistema Nervioso & Nanooncol, Buenos Aires, DF, Argentina; [Alaimo, Agustina; Gorojod, Roxana M.; Kotler, Monica L.] Inst Quim Biol Ciencias Exactas Nat IQUIBICEN CON, Buenos Aires, DF, Argentina; [Beauquis, Juan; Saravia, Flavia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Neurobiol Lab, Buenos Aires, DF, Argentina; [Beauquis, Juan; Saravia, Flavia] Inst Biol & Med Expt IBYME CONICET, Buenos Aires, DF, Argentina; [Munoz, Manuel J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Munoz, Manuel J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias IFIBYNE CONI, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; University of Buenos Aires	Kotler, ML (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Apoptosis El Sistema Nervioso & Nanooncol, Buenos Aires, DF, Argentina.	moniquekotler@gmail.com	Beauquis, Juan/AAT-5042-2020	Beauquis, Juan/0000-0003-1404-5632; Saravia, Flavia/0000-0002-0781-0140; Kotler, Monica Lidia/0000-0002-3555-7621; Munoz, Manuel J./0000-0002-1152-5449; Gorojod, Roxana Mayra/0000-0002-9820-3978	Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP) [5406, 0356]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP No 5406 and 0356, www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo A, 2011, NEUROCHEM INT, V59, P297, DOI 10.1016/j.neuint.2011.06.001; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; ASCHNER M, 1992, J NEUROCHEM, V58, P730, DOI 10.1111/j.1471-4159.1992.tb09778.x; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Bette S, 2005, ACTA NEUROPATHOL, V109, P393, DOI 10.1007/s00401-004-0970-8; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cereghetti GM, 2010, CELL DEATH DIFFER, V17, P1785, DOI 10.1038/cdd.2010.61; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Corrado Mauro, 2012, Int J Cell Biol, V2012, P729290, DOI 10.1155/2012/729290; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Ganapathy PS, 2011, INVEST OPHTH VIS SCI, V52, P5551, DOI 10.1167/iovs.11-7256; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Gonzalez LE, 2008, NEUROCHEM INT, V53, P408, DOI 10.1016/j.neuint.2008.09.008; Gray JJ, 2013, BRAIN RES, V1494, P28, DOI 10.1016/j.brainres.2012.12.001; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Gunter TE, 2006, NEUROTOXICOLOGY, V27, P765, DOI 10.1016/j.neuro.2006.05.002; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Jain P, 2011, P NATL ACAD SCI USA, V108, P16032, DOI 10.1073/pnas.1105175108; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Ju WK, 2005, J COMP NEUROL, V488, P1, DOI 10.1002/cne.20586; Ju WK, 2008, INVEST OPHTH VIS SCI, V49, P4903, DOI 10.1167/iovs.07-1661; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Landes T, 2011, BBA-MOL CELL RES, V1813, P540, DOI 10.1016/j.bbamcr.2011.01.021; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Loucks FA, 2009, BRAIN RES, V1250, P63, DOI 10.1016/j.brainres.2008.10.081; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Maltecca F, 2012, HUM MOL GENET, V21, P3858, DOI 10.1093/hmg/dds214; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Men XL, 2009, INT J BIOCHEM CELL B, V41, P879, DOI 10.1016/j.biocel.2008.08.031; Milatovic D, 2007, TOXICOL SCI, V98, P198, DOI 10.1093/toxsci/kfm095; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quintanar L, 2012, EXP NEUROL, V233, P182, DOI 10.1016/j.expneurol.2011.09.032; Rao KVR, 2004, J BIOL CHEM, V279, P32333, DOI 10.1074/jbc.M402096200; Roth JA, 2009, NEUROMOL MED, V11, P281, DOI 10.1007/s12017-009-8088-8; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; SUZUKI H, 1983, TOXICOL APPL PHARM, V71, P422, DOI 10.1016/0041-008X(83)90030-3; Tan AR, 2011, CELL CALCIUM, V49, P108, DOI 10.1016/j.ceca.2010.12.002; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xu B, 2009, NEUROTOXICOLOGY, V30, P941, DOI 10.1016/j.neuro.2009.07.011; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yin ZB, 2008, BRAIN RES, V1203, P1, DOI 10.1016/j.brainres.2008.01.079; Zhao F, 2009, TOXICOL SCI, V107, P156, DOI 10.1093/toxsci/kfn213	66	55	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91848	10.1371/journal.pone.0091848	http://dx.doi.org/10.1371/journal.pone.0091848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632637	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400108
J	Buono, C; Alvarez-Zuzek, LG; Macri, PA; Braunstein, LA				Buono, Camila; Alvarez-Zuzek, Lucila G.; Macri, Pablo A.; Braunstein, Lidia A.			Epidemics in Partially Overlapped Multiplex Networks	PLOS ONE			English	Article							PREDICTABILITY	Many real networks exhibit a layered structure in which links in each layer reflect the function of nodes on different environments. These multiple types of links are usually represented by a multiplex network in which each layer has a different topology. In real-world networks, however, not all nodes are present on every layer. To generate a more realistic scenario, we use a generalized multiplex network and assume that only a fraction q of the nodes are shared by the layers. We develop a theoretical framework for a branching process to describe the spread of an epidemic on these partially overlapped multiplex networks. This allows us to obtain the fraction of infected individuals as a function of the effective probability that the disease will be transmitted T. We also theoretically determine the dependence of the epidemic threshold on the fraction q>0 of shared nodes in a system composed of two layers. We find that in the limit of q -> 0 the threshold is dominated by the layer with the smaller isolated threshold. Although a system of two completely isolated networks is nearly indistinguishable from a system of two networks that share just a few nodes, we find that the presence of these few shared nodes causes the epidemic threshold of the isolated network with the lower propagating capacity to change discontinuously and to acquire the threshold of the other network.	[Buono, Camila; Alvarez-Zuzek, Lucila G.; Macri, Pablo A.; Braunstein, Lidia A.] Univ Nacl Mar Del Plata, Fac Ciencias Exactas & Nat, Inst Invest Fis Mar Del Plata, Dept Fis, Mar Del Plata, Argentina; [Braunstein, Lidia A.] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA	National University of Mar del Plata; Boston University	Buono, C (corresponding author), Univ Nacl Mar Del Plata, Fac Ciencias Exactas & Nat, Inst Invest Fis Mar Del Plata, Dept Fis, Mar Del Plata, Argentina.	cbuono@mdp.edu.ar						Alligood K., 1997, CHAOS INTRO DYNAMICA; Bailey NTJ, 1975, MATH THEORY INFECT D; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Baxter GJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248701; Braunstein LA, 2007, INT J BIFURCAT CHAOS, V17, P2215, DOI 10.1142/S0218127407018361; Brummitt CD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.045102; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; Cardillo A, 2013, EUR PHYS J-SPEC TOP, V215, P23, DOI 10.1140/epjst/e2013-01712-8; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Cozzo E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050801; Cozzo E, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036115; Dickison M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066109; Dong GG, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052804; Erez T, 2005, NEW ECON WINDOWS, P201, DOI 10.1007/88-470-0344-X_12; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gao J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092002; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Granell C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.128701; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Kim JY, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058702; Kivela M, 2013, MULTILAYER NETWORKS; Lagorio C, 2009, PHYSICA A, V388, P755, DOI 10.1016/j.physa.2008.10.045; Lee KM, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033027; Marceau V, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026105; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Sahneh FD, 2013, P AMER CONTR CONF, P2307; Saumell-Mendiola A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026106; Valdez LD, 2013, FRACTALS, V21, DOI 10.1142/S0218348X13500199; Valdez LD, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050803; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Yagan O, 2013, IEEE J SEL AREA COMM, V31, P1038, DOI 10.1109/JSAC.2013.130606	40	104	105	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92200	10.1371/journal.pone.0092200	http://dx.doi.org/10.1371/journal.pone.0092200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632709	gold, Green Submitted, Green Published			2022-12-27	WOS:000332858400149
J	Qu, AL; Du, LT; Yang, YM; Liu, H; Li, J; Wang, LL; Liu, YM; Dong, ZG; Zhang, X; Jiang, XM; Wang, HY; Li, ZW; Zheng, GX; Wang, CX				Qu, Ailin; Du, Lutao; Yang, Yongmei; Liu, Hui; Li, Juan; Wang, Lili; Liu, Yimin; Dong, Zhaogang; Zhang, Xin; Jiang, Xiumei; Wang, Haiyan; Li, Zewu; Zheng, Guixi; Wang, Chuanxin			Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer	PLOS ONE			English	Article							POOR SURVIVAL; TUMOR HYPOXIA; EXPRESSION; MICRORNA-210; HSA-MIR-210; ASSOCIATION; STATISTICS; CARCINOMA; MIRNAS; CELLS	MicroRNA-210 (miR-210), the master hypoxamir, plays pleiotropic roles in certain cancers; however, its role in the development of human colorectal cancer remains unclear. Herein, we report that miR-210 is frequently up-regulated in colorectal cancer tissues, with high miR-210 expression significantly correlating with large tumor size, lymph node metastasis, advanced clinical stage and poor prognosis. Functionally, miR-210 overexpression promotes the migration and invasion of colorectal cancer cells. Furthermore, miR-210 can be induced by hypoxia and mediates the hypoxia-induced metastasis of colorectal cancer cells. In addition, vacuole membrane protein 1 (VMP1) is identified as the direct and functional target of miR-210. Thus, miR-210 is a useful biomarker for hypoxic tumor cells and a prognostic factor that plays an essential role in colorectal cancer metastasis.	[Qu, Ailin; Du, Lutao; Yang, Yongmei; Liu, Hui; Li, Juan; Wang, Lili; Liu, Yimin; Dong, Zhaogang; Zhang, Xin; Jiang, Xiumei; Wang, Haiyan; Li, Zewu; Zheng, Guixi; Wang, Chuanxin] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan, Shandong, Peoples R China	Shandong University	Wang, CX (corresponding author), Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan, Shandong, Peoples R China.	cxwang@sdu.edu.cn	wang, lili/HDL-7210-2022	ZHENG, GUIXI/0000-0003-2856-9592	National Natural Science Foundation of China [81271916, 81301506]; Shandong Province Natural Science Foundation of China [ZR2010H004]; Research Fund for the Doctoral Program of Higher Education of China [20120131110055]; National Key Clinical Medical Specialties Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Clinical Medical Specialties Foundation	This study was supported by National Natural Science Foundation of China (No. 81271916; 81301506); Shandong Province Natural Science Foundation of China (No. ZR2010H004); Research Fund for the Doctoral Program of Higher Education of China (No. 20120131110055) and National Key Clinical Medical Specialties Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050165; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Brown JM, 1998, CANCER RES, V58, P1408; Cai HQ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0499-6; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-432; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Crosby ME, 2009, CURR PHARM DESIGN, V15, P3861, DOI 10.2174/138161209789649367; Fan LF, 2008, INT J COLORECTAL DIS, V23, P1057, DOI 10.1007/s00384-008-0511-3; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Greither T, 2012, INT J CANCER, V130, P1230, DOI 10.1002/ijc.26109; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hockel M, 1996, CANCER RES, V56, P4509; Hong L, 2012, GENE, V507, P135, DOI 10.1016/j.gene.2012.07.025; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Kobayashi Masanobu, 2010, Gan To Kagaku Ryoho, V37, P2047; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lan KL, 2011, INT J RADIAT BIOL, V87, P579, DOI 10.3109/09553002.2011.568572; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Noman MZ, 2012, CANCER RES, V72, P4629, DOI 10.1158/0008-5472.CAN-12-1383; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Redova M, 2013, TUMOR BIOL, V34, P481, DOI 10.1007/s13277-012-0573-2; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Sauermann M, 2008, ONCOGENE, V27, P1320, DOI 10.1038/sj.onc.1210743; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Tsuchiya S, 2012, YAKUGAKU ZASSHI, V132, P1069, DOI 10.1248/yakushi.132.1069; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Vaccaro MI, 2003, PANCREATOLOGY, V3, P69, DOI 10.1159/000069150; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Voss MJ, 2010, CURR MOL MED, V10, P381, DOI 10.2174/156652410791317020; Williams KJ, 2005, RADIOTHER ONCOL, V75, P89, DOI 10.1016/j.radonc.2005.01.009; Wotschofsky Z, 2013, CLIN CHIM ACTA, V416, P5, DOI 10.1016/j.cca.2012.11.010; Ying Q, 2011, HEPATOLOGY, V54, P2064, DOI 10.1002/hep.24614	41	61	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90952	10.1371/journal.pone.0090952	http://dx.doi.org/10.1371/journal.pone.0090952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632577	Green Submitted, gold, Green Published			2022-12-27	WOS:000332858400027
J	Rao, W; Xie, GH; Zhang, Y; Wang, SJ; Wang, Y; Zhang, HZ; Song, FF; Zhang, RF; Yin, QQ; Shen, LS; Ge, HL				Rao, Wei; Xie, Guohua; Zhang, Yong; Wang, Shujun; Wang, Ying; Zhang, Huizhen; Song, Feifei; Zhang, Renfeng; Yin, Qinqin; Shen, Lisong; Ge, Hailiang			OVA66, a Tumor Associated Protein, Induces Oncogenic Transformation of NIH3T3 Cells	PLOS ONE			English	Article							ANTIGEN; PROLIFERATION; KINASE; CML66	The tumor associated antigen OVA66 has been demonstrated to be highly expressed in malignant tumors and implicated in various cellular processes. To further elucidate its oncogenic character, we established an OVA66 stably overexpressed NIH3T3 cell line and a vector transfected control, named NIH3T3-flagOVA66 and NIH3T3-mock, respectively. NIH3T3-flagOVA66 cells showed faster cell cycling, proliferation, cell migration and more resistance to 5-fluorouracil-induced apoptosis. When NIH3T3-flagOVA66 and NIH3T3-mock cells were injected into nude mice for xenograft tumorigenicity assays, the NIH3T3-flagOVA66 cells formed tumors whereas no tumors were observed in mice inoculated with NIH3T3-mock cells. Analysis of PI3K/AKT and ERK1/2 MAPK signaling pathways by serum stimulation indicated hyperactivation of AKT and ERK1/2 in NIH3T3-flagOVA66 cells compared with NIH3T3-mock cells, while a decreased level of p-AKT and p-ERK1/2 were observed in OVA66 knocked down HeLa cells. To further validate if the p-AKT or p-ERK1/2 is essential for OVA66 induced oncogenic transformation, we treated the cells with the PI3K/AKT specific inhibitor LY294002 and the ERK1/2 MAPK specific inhibitor PD98059 and found either inhibitor can attenuate the cell colony forming ability in soft agar and the cell viability of NIH3T3-flagOVA66 cells, suggesting aberrantly activated AKT and ERK1/2 signaling be indispensible of the tumorigenic role of OVA66. Our results indicate that OVA66 is important in oncogenic transformation, promoting proliferation, cell migration and reducing apoptosis via hyperactivating PI3K/AKT and ERK1/2 MAPK signaling pathway. Thus, OVA66 might be a novel target for early detection, prevention and treatment of tumors in the future.	[Rao, Wei; Zhang, Yong; Wang, Shujun; Wang, Ying; Zhang, Huizhen; Song, Feifei; Zhang, Renfeng; Yin, Qinqin; Ge, Hailiang] Shanghai Jiaotong Univ SJTU, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China; [Xie, Guohua; Shen, Lisong] Shanghai Jiaotong Univ SJTU, Sch Med, Xinhua Hosp, Dept Clin Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ge, HL (corresponding author), Shanghai Jiaotong Univ SJTU, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China.	gehl@shsmu.edu.cn	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022; rao, wei/AAM-1288-2021	, wei/0000-0002-2975-7045	National Natural Science Foundation of China [30371598, 81272328]; Scientific Research Project of Shanghai Institute of Immunology [08A03]; Innovative Program of Shanghai Municipal Education Commission [08YZ39]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Shanghai Institute of Immunology; Innovative Program of Shanghai Municipal Education Commission	This study was supported by grants from the National Natural Science Foundation of China (Nos. 30371598, 81272328), Scientific Research Project of Shanghai Institute of Immunology (No. 08A03) and Innovative Program of Shanghai Municipal Education Commission (No. 08YZ39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chari NS, 2009, APOPTOSIS, V14, P336, DOI 10.1007/s10495-009-0327-9; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jin S, 2008, CANCER SCI, V99, P1670, DOI 10.1111/j.1349-7006.2008.00860.x; Jin Shu, 2005, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V21, P233; Kadomatsu K, 1997, BRIT J CANCER, V75, P354, DOI 10.1038/bjc.1997.58; Li Mei-xing, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P185; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liu MY, 2002, CANCER RES, V62, P6475; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mufson RA, 2006, FRONT BIOSCI-LANDMRK, V11, P337, DOI 10.2741/1801; [荣婷婷 Rong Tingting], 2011, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V31, P1129; Sahin U, 1997, CURR OPIN IMMUNOL, V9, P709, DOI 10.1016/S0952-7915(97)80053-2; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Wang QF, 2008, CANCER LETT, V269, P127, DOI 10.1016/j.canlet.2008.04.035; Yang XF, 2001, P NATL ACAD SCI USA, V98, P7492, DOI 10.1073/pnas.131590998; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	19	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e85705	10.1371/journal.pone.0085705	http://dx.doi.org/10.1371/journal.pone.0085705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633332	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400001
J	Wang, HL; Zhou, PY; Liu, P; Zhang, Y				Wang, He-Ling; Zhou, Ping-Yi; Liu, Peng; Zhang, Yu			ALDH2 and ADH1 Genetic Polymorphisms May Contribute to the Risk of Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							ALCOHOL-DEHYDROGENASE ISOENZYMES; ALDEHYDE-DEHYDROGENASE; STOMACH-CANCER; ACETALDEHYDE; CONSUMPTION; ASSOCIATION; METABOLISM; DRINKING	Aim: We conducted a meta-analysis of case-control studies to determine whether ALDH2, ADH1 and ADH2 genetic polymorphisms contribute to the pathogenesis of gastric cancer. Methods: The PubMed, CISCOM, CINAHL, Web of Science, Google Scholar, EBSCO, Cochrane Library, and CBM databases were searched for relevant articles published before November 1st, 2013 without any language restrictions. Meta-analysis was conducted using the STATA 12.0 software. We calculated crude odds ratios (ORs) with their 95% confidence intervals (95% CI) to evaluate their relationships under five genetic models. Seven case-control studies with a total of 2,563 gastric cancer patients and 4,192 healthy controls met the inclusion criteria. Nine common polymorphisms were evaluated, including rs671, rs16941667 and rs886205 in the ALDH2 gene, rs1230025, rs13123099, rs698 and rs1693482 in the ADH1 gene, and rs1229984 and rs17033 in the ADH2 gene. Results: The results of our meta-analysis suggested that ALDH2 genetic polymorphisms might be strongly correlated with an increased risk of gastric cancer (allele model: OR = 1.21, 95% CI: 1.11 similar to 1.32, P<0.001; dominant model: OR = 1.23, 95% CI: 1.09 similar to 1.39, P = 0.001; respectively), especially for rs671 polymorphism. Furthermore, we observed significant associations between ADH1 genetic polymorphisms and an increased risk of gastric cancer (allele model: OR = 1.21, 95% CI: 1.08 similar to 1.36, P = 0.001; dominant model: OR = 10.52, 95% CI: 3.04 similar to 36.41, P<0.001; respectively), especially for rs1230025 polymorphism. Nevertheless, no positive relationships were found between ADH2 genetic polymorphisms and gastric cancer risk (all P>0.05). Conclusion: The current meta-analysis suggests that ALDH2 and ADH1 genetic polymorphisms may play crucial roles in the pathogenesis of gastric cancer. However, ADH2 genetic polymorphisms may not be important dominants of susceptibility to gastric cancer.	[Wang, He-Ling; Zhou, Ping-Yi; Liu, Peng; Zhang, Yu] Shengjing Hosp China Med Univ, Dept Gen Surg, Shenyang, Peoples R China		Wang, HL (corresponding author), Shengjing Hosp China Med Univ, Dept Gen Surg, Shenyang, Peoples R China.	wangheling1127@126.com			Research Foundation of Science and Technology Agency of Liaoning Province [2011408004]	Research Foundation of Science and Technology Agency of Liaoning Province	This work was supported by the Research Foundation of Science and Technology Agency of Liaoning Province (No. 2011408004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Budas GR, 2010, J MOL CELL CARDIOL, V48, P757, DOI 10.1016/j.yjmcc.2009.10.030; Cao HX, 2010, ASIAN PAC J CANCER P, V11, P1073; Chung CS, 2012, DIS ESOPHAGUS; den Hoed CM, 2011, EUR J CANCER, V47, P1211, DOI 10.1016/j.ejca.2010.12.012; Ding JH, 2011, CHINA CANC, V20, P579; Duell EJ, 2012, CARCINOGENESIS, V33, P361, DOI 10.1093/carcin/bgr285; Duell EJ, 2011, AM J CLIN NUTR, V94, P1266, DOI 10.3945/ajcn.111.012351; Dunagan M, 2012, AM J PHYSIOL-GASTR L, V303, pG1356, DOI 10.1152/ajpgi.00526.2011; Gonzalez CA, 2013, HELICOBACTER, V18, P34, DOI 10.1111/hel.12082; Haseba T, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/408190; Jelski W, 2008, CLIN CHIM ACTA, V395, P1, DOI 10.1016/j.cca.2008.05.001; Jelski W, 2008, DIGEST DIS SCI, V53, P2101, DOI 10.1007/s10620-007-0135-4; Jelski W, 2007, DIGEST DIS SCI, V52, P531, DOI 10.1007/s10620-006-9454-0; Jelski W, 2010, CLIN EXP MED, V10, P215, DOI 10.1007/s10238-010-0097-2; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Lai CL, 2013, CHEM-BIOL INTERACT, V202, P275, DOI 10.1016/j.cbi.2012.11.016; Lao-Sirieix P, 2010, CURR OPIN GENET DEV, V20, P210, DOI 10.1016/j.gde.2010.03.002; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011752; Linderborg K, 2011, ALCOHOL CLIN EXP RES, V35, P516, DOI 10.1111/j.1530-0277.2010.01368.x; Liu P, 2012, GENET MOL RES, V11, P3497, DOI 10.4238/2012.September.26.5; Matsumoto M, 2011, ALCOHOL CLIN EXP RES, V35, P28, DOI 10.1111/j.1530-0277.2010.01319.x; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Nagayoshi H, 2009, MUTAT RES-GEN TOX EN, V673, P74, DOI 10.1016/j.mrgentox.2008.11.009; Oelze M, 2011, J BIOL CHEM, V286, P8893, DOI 10.1074/jbc.M110.190017; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Piazuelo MB, 2010, INFECT DIS CLIN N AM, V24, P853, DOI 10.1016/j.idc.2010.07.010; Reidy J, 2011, SURG-J R COLL SURG E, V9, P278, DOI 10.1016/j.surge.2011.01.010; Sakamoto T, 2006, INT J CANCER, V118, P1501, DOI 10.1002/ijc.21505; Salaspuro M, 2011, J DIGEST DIS, V12, P51, DOI 10.1111/j.1751-2980.2011.00480.x; Sasako M, 2010, JPN J CLIN ONCOL, V40, pi28, DOI 10.1093/jjco/hyq124; Seitz HK, 2010, GENES NUTR, V5, P121, DOI 10.1007/s12263-009-0154-1; Shin CM, 2011, INT J EPIDEMIOL, V40, P1047, DOI 10.1093/ije/dyr067; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Yang YF, 2006, CHIN J PUBLIC HLTH, V22, P435; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang FF, 2007, INT J CANCER, V121, P2060, DOI 10.1002/ijc.22973; Zhou ZY, 2010, SHANGHAI J PREV MED, V22, P207; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	41	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e88779	10.1371/journal.pone.0088779	http://dx.doi.org/10.1371/journal.pone.0088779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633362	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400003
J	Case, AJ; Naruoka, Y; Chen, XM; Garland-Campbell, KA; Zemetra, RS; Carter, AH				Case, Austin J.; Naruoka, Yukiko; Chen, Xianming; Garland-Campbell, Kimberly A.; Zemetra, Robert S.; Carter, Arron H.			Mapping Stripe Rust Resistance in a BrundageXCoda Winter Wheat Recombinant Inbred Line Population	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; F-SP TRITICI; PUCCINIA-STRIIFORMIS; HIGH-TEMPERATURE; CHROMOSOMAL LOCATION; SEEDLING RESISTANCE; COMMON WHEAT; LINKAGE MAPS; AESTIVUM L.; GENE SR2	A recombinant inbred line (RIL) mapping population developed from a cross between winter wheat (Triticum aestivum L.) cultivars Coda and Brundage was evaluated for reaction to stripe rust (caused by Puccinia striiformis f. sp. tritici). Two hundred and sixty eight RIL from the population were evaluated in replicated field trials in a total of nine site-year locations in the U. S. Pacific Northwest. Seedling reaction to stripe rust races PST-100, PST-114 and PST-127 was also examined. A linkage map consisting of 2,391 polymorphic DNA markers was developed covering all chromosomes of wheat with the exception of 1D. Two QTL on chromosome 1B were associated with adult plant and seedling reaction and were the most significant QTL detected. Together these QTL reduced adult plant infection type from a score of seven to a score of two reduced disease severity by an average of 25% and provided protection against race PST-100, PST-114 and PST-127 in the seedling stage. The location of these QTL and the race specificity provided by them suggest that observed effects at this locus are due to a complementation of the previously known but defeated resistances of the cultivar Tres combining with that of Madsen (the two parent cultivars of Coda). Two additional QTL on chromosome 3B and one on 5B were associated with adult plant reaction only, and a single QTL on chromosome 5D was associated with seedling reaction to PST-114. Coda has been resistant to stripe rust since its release in 2000, indicating that combining multiple resistance genes for stripe rust provides durable resistance, especially when all-stage resistance genes are combined in a fashion to maximize the number of races they protect against. Identified molecular markers will allow for an efficient transfer of these genes into other cultivars, thereby continuing to provide excellent resistance to stripe rust.	[Case, Austin J.; Naruoka, Yukiko; Carter, Arron H.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Chen, Xianming; Garland-Campbell, Kimberly A.] ARS, Wheat Genet Qual Physiol & Dis Res Unit, USDA, Pullman, WA USA; [Zemetra, Robert S.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	Washington State University; United States Department of Agriculture (USDA); Oregon State University	Carter, AH (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ahcarter@wsu.edu	Carter, Arron/E-9631-2019	Carter, Arron/0000-0002-8019-6554; Garland-Campbell, Kimberly/0000-0003-4747-3270	Washington State University Hatch Project [0232]; Washington Grain Alliance; National Research Initiative Competitive Grants CAP project from the USDA National Institute of Food and Agriculture [2011-68002-30029]	Washington State University Hatch Project; Washington Grain Alliance; National Research Initiative Competitive Grants CAP project from the USDA National Institute of Food and Agriculture	This project was supported by Washington State University Hatch Project 0232, the Washington Grain Alliance, and the National Research Initiative Competitive Grants CAP project 2011-68002-30029 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Allan RE, 2000, CROP SCI, V40, P578, DOI 10.2135/cropsci2000.0028rcv; Bansal UK, 2011, THEOR APPL GENET, V122, P1461, DOI 10.1007/s00122-011-1545-4; Bariana HS, 2007, DEV PLANT BREED, V12, P723; Bariana HS, 2010, EUPHYTICA, V176, P251, DOI 10.1007/s10681-010-0240-x; Basten J.C., 1997, QTL CARTOGRAPHER REF; Carter AH, 2009, THEOR APPL GENET, V119, P1119, DOI 10.1007/s00122-009-1114-2; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Chen X. M., 1994, Phytopathology, V84, P1116; Chen XM, 2010, CAN J PLANT PATHOL, V32, P315, DOI 10.1080/07060661.2010.499271; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1993, PHYTOPATHOLOGY, V83, P382, DOI 10.1094/Phyto-83-382; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P1428, DOI 10.1094/Phyto-82-1428; Chen XM, 2002, PLANT DIS, V86, P39, DOI 10.1094/PDIS.2002.86.1.39; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P573, DOI 10.1094/Phyto-85-573; Chen XM, 1996, PHYTOPATHOLOGY, V86, P1228, DOI 10.1094/Phyto-86-1228; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P1362, DOI 10.1094/Phyto-85-1362; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P567, DOI 10.1094/Phyto-85-567; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; GALLUN RL, 1977, J HERED, V68, P223, DOI 10.1093/oxfordjournals.jhered.a108818; GERECHTERAMITAI ZK, 1989, EUPHYTICA, V43, P187, DOI 10.1007/BF00037912; Gustafson P., 2009, WHEAT SCI TRADE, P3, DOI DOI 10.1002/9780813818832.CH1; Haldane JBS, 1919, J GENET, V8, P299; Holland JB, 2002, PL BRED RE, V22, P9; Johnson EB, 2008, EUPHYTICA, V163, P193, DOI 10.1007/s10681-007-9628-7; Kolmer JA., 2009, WHEAT SCI TRADE, P89, DOI [10.1002/9780813818832.ch5, DOI 10.1002/9780813818832.CH5]; Kong L, 2005, PLANT BREEDING, V124, P525, DOI 10.1111/j.1439-0523.2005.01139.x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kota R, 2006, THEOR APPL GENET, V112, P492, DOI 10.1007/s00122-005-0151-8; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Leonard JM, 2008, THEOR APPL GENET, V116, P261, DOI 10.1007/s00122-007-0664-4; Li GQ, 2006, THEOR APPL GENET, V112, P1434, DOI 10.1007/s00122-006-0245-y; Li Q, 2011, THEOR APPL GENET, V122, P189, DOI 10.1007/s00122-010-1435-1; Lin F, 2008, THEOR APPL GENET, V116, P797, DOI 10.1007/s00122-008-0713-7; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Line R. F., 1992, USDA TECHNICAL B, V1788; LINE RF, 1995, PLANT DIS, V79, P1254; Liu XM, 2005, THEOR APPL GENET, V110, P1473, DOI 10.1007/s00122-005-1982-z; Lowe I, 2011, THEOR APPL GENET, V123, P143, DOI 10.1007/s00122-011-1573-0; Luo P.G., 2007, CAN J PLANT PATHOL, V30, P1; MACER RCF, 1975, T BRIT MYCOL SOC, V65, P351; Mago R, 2011, THEOR APPL GENET, V122, P735, DOI 10.1007/s00122-010-1482-7; McIntosh RA, 1996, EUPHYTICA, V89, P401; McIntosh RA, 2011, ANN WHEAT NEWSLETTER; Melichar JPE, 2008, THEOR APPL GENET, V117, P391, DOI 10.1007/s00122-008-0783-6; METZGER RJ, 1970, CROP SCI, V10, P567, DOI 10.2135/cropsci1970.0011183X001000050035x; Murphy LR, 2009, CROP SCI, V49, P1786, DOI 10.2135/cropsci2008.10.0621; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Pahalawatta V, 2005, PHYTOPATHOLOGY, V95, P427, DOI 10.1094/PHYTO-95-0427; PAN C. L., 1940, JOUR AMER SOC AGRON, V32, P107; PAYNE P I, 1986, Genetica Agraria, V40, P231; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Quincke MC, 2011, THEOR APPL GENET, V122, P1339, DOI 10.1007/s00122-011-1535-6; Riera-Lizarazu O, 2000, GENETICS, V156, P327; Saari EE, 1985, DIS DISTRIBUTION EPI, P259, DOI DOI 10.1016/B978-0-12-148402-6.50017-1; Santra DK, 2008, THEOR APPL GENET, V117, P793, DOI 10.1007/s00122-008-0820-5; Singh Ravi Prakash, 2005, Turkish Journal of Agriculture and Forestry, V29, P121; Singh RP, 2000, CROP SCI, V40, P1148, DOI 10.2135/cropsci2000.4041148x; SORRELLS ME, 1987, CROP SCI, V27, P1314, DOI 10.2135/cropsci1987.0011183X002700060060x; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Spielmeyer W, 2003, CROP SCI, V43, P333, DOI 10.2135/cropsci2003.0333; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Vazquez MD, 2012, THEOR APPL GENET, V124, P1, DOI 10.1007/s00122-011-1681-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan AM, 2012, PLANT DIS, V96, P67, DOI 10.1094/PDIS-02-11-0119; Wang LM, 2009, CEREAL RES COMMUN, V37, P209, DOI 10.1556/CRC.37.2009.2.7; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; Wang S, 2012, WINDOWS QTL CARTOGRA; William HM, 2006, GENOME, V49, P977, DOI 10.1139/G06-052; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; Zemetra RS, 1998, CROP SCI, V38, P1404, DOI 10.2135/cropsci1998.0011183X003800050056x; Zemetra RS, 2003, CROP SCI, V43, P1884, DOI 10.2135/cropsci2003.1884; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; [No title captured]	78	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91758	10.1371/journal.pone.0091758	http://dx.doi.org/10.1371/journal.pone.0091758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642574	Green Submitted, gold, Green Published			2022-12-27	WOS:000333259900035
J	Fernandez-Higuero, JA; Salvador, AM; Martin, C; Milicua, JCG; Arrondo, JLR				Fernandez-Higuero, Jose A.; Salvador, Ana M.; Martin, Cesar; Milicua, Jose Carlos G.; Arrondo, Jose L. R.			Human LDL Structural Diversity Studied by IR Spectroscopy	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; TRANSFORM INFRARED-SPECTROSCOPY; DEFECTIVE APOLIPOPROTEIN B-100; PLASMA-LIPOPROTEINS; SECONDARY STRUCTURE; RISK-FACTOR; PARTICLE; CHOLESTEROL; RECEPTOR	Lipoproteins are responsible for cholesterol traffic in humans. Low density lipoprotein (LDL) delivers cholesterol from liver to peripheral tissues. A misleading delivery can lead to the formation of atherosclerotic plaques. LDL has a single protein, apoB-100, that binds to a specific receptor. It is known that the failure associated with a deficient protein-receptor binding leads to plaque formation. ApoB-100 is a large single lipid-associated polypeptide difficulting the study of its structure. IR spectroscopy is a technique suitable to follow the different conformational changes produced in apoB-100 because it is not affected by the size of the protein or the turbidity of the sample. We have analyzed LDL spectra of different individuals and shown that, even if there are not big structural changes, a different pattern in the intensity of the band located around 1617 cm 21 related with strands embedded in the lipid monolayer, can be associated with a different conformational rearrangement that could affect to a protein interacting region with the receptor.	[Fernandez-Higuero, Jose A.; Salvador, Ana M.; Martin, Cesar; Arrondo, Jose L. R.] Univ Basque Country, CSIC, Unidad Biofis, EHU, E-48080 Bilbao, Spain; [Fernandez-Higuero, Jose A.; Salvador, Ana M.; Martin, Cesar; Milicua, Jose Carlos G.; Arrondo, Jose L. R.] Univ Basque Country, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Arrondo, JLR (corresponding author), Univ Basque Country, CSIC, Unidad Biofis, EHU, E-48080 Bilbao, Spain.	joseluis.arrondo@ehu.es	martin, cesar/L-1303-2014	martin, cesar/0000-0002-4087-8729; Salvador Ibanez, Ana Maria/0000-0003-2170-6419; Fernandez-Higuero, Jose Angel/0000-0002-4143-5532	MINECO [BFU 2006-14423]; Programa INNPACTO [NuIPT-2011-0817-010000]	MINECO(Spanish Government); Programa INNPACTO	This work has been supported in part by MINECO grant (BFU 2006-14423) and Programa INNPACTO (grant NuIPT-2011-0817-010000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; BANEULOS S, 1995, J BIOL CHEM, V270, P9192; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; Carmena R, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000131511.50734.44; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; CHAIT A, 1993, AM J MED, V94, P350, DOI 10.1016/0002-9343(93)90144-E; Chapman MJ, 1998, EUR HEART J, V19, pA24; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; Ensign W, 2006, CLIN CHEM, V52, P1722, DOI 10.1373/clinchem.2005.059949; Fernandez-Higuero JA, 2011, ANAL BIOCHEM, V417, P283, DOI 10.1016/j.ab.2011.06.004; Fruchart JC, 1997, CURR MED RES OPIN, V13, P603, DOI 10.1185/03007999709113334; GOORMAGHTIGH E, 1993, BIOCHEMISTRY-US, V32, P6104, DOI 10.1021/bi00074a023; GRIFFIN BA, 1994, ATHEROSCLEROSIS, V106, P241, DOI 10.1016/0021-9150(94)90129-5; Griffin BA, 1999, P NUTR SOC, V58, P163, DOI 10.1079/PNS19990022; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Koivuniemi A, 2008, BBA-PROTEINS PROTEOM, V1784, P1668, DOI 10.1016/j.bbapap.2008.06.007; KRAUSS RM, 1982, J LIPID RES, V23, P97; Krilov D, 2009, SPECTROCHIM ACTA A, V73, P701, DOI 10.1016/j.saa.2009.03.015; Kumar V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018841; LAGGNER P, 1981, J BIOL CHEM, V256, P1832; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Lamarche B, 1999, DIABETES METAB, V25, P199; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lund-Katz S, 1998, BIOCHEMISTRY-US, V37, P12867, DOI 10.1021/bi980828m; Lunin VY, 2001, ACTA CRYSTALLOGR D, V57, P108, DOI 10.1107/S0907444900014608; McNamara JR, 1996, J LIPID RES, V37, P1924; MISEREZ AR, 1995, ARTERIOSCL THROM VAS, V15, P1719, DOI 10.1161/01.ATV.15.10.1719; MUSLINER TA, 1988, CLIN CHEM, V34, pB78; Nara M, 2002, CHEM PHYS LIPIDS, V117, P1, DOI 10.1016/S0009-3084(02)00003-8; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NIGON F, 1991, J LIPID RES, V32, P1741; OTVOS JD, 1991, CLIN CHEM, V37, P377; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Prassl R, 2009, EUR BIOPHYS J BIOPHY, V38, P145, DOI 10.1007/s00249-008-0368-y; Rajman I, 1996, ATHEROSCLEROSIS, V125, P231; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Segrest JP, 1999, J LIPID RES, V40, P1401; Segrest JP, 2001, J LIPID RES, V42, P1346; Sninsky JJ, 2013, J INVESTIG MED; SPIN JM, 1995, BIOPHYS J, V68, P2115, DOI 10.1016/S0006-3495(95)80392-9; Tanfani F, 1997, BIOCHEM J, V322, P765, DOI 10.1042/bj3220765; TYBJAERGHANSEN A, 1995, SCAND J CLIN LAB INV, V55, P57; Vakkilainen J, 2003, CIRCULATION, V107, P1733, DOI 10.1161/01.CIR.0000057982.50167.6E; Vecino AJ, 2012, BBA-BIOMEMBRANES, V1818, P3158, DOI 10.1016/j.bbamem.2012.08.015; Vieira OV, 1996, J LIPID RES, V37, P2715; Wang L, 2006, P NATL ACAD SCI USA, V103, P6871, DOI 10.1073/pnas.0602213103; Wang XY, 2000, ARTERIOSCL THROM VAS, V20, P1301, DOI 10.1161/01.ATV.20.5.1301; Werner RM, 1998, CAN J CARDIOL, V14, p3B	58	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92426	10.1371/journal.pone.0092426	http://dx.doi.org/10.1371/journal.pone.0092426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642788	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900137
J	Johansson, SE; Larsen, SS; Povlsen, GK; Edvinsson, L				Johansson, Sara Ellinor; Larsen, Stine Schmidt; Povlsen, Gro Klitgaard; Edvinsson, Lars			Early MEK1/2 Inhibition after Global Cerebral Ischemia in Rats Reduces Brain Damage and Improves Outcome by Preventing Delayed Vasoconstrictor Receptor Upregulation	PLOS ONE			English	Article							TRANSIENT FOREBRAIN ISCHEMIA; CARDIAC-ARREST; BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; NEURONAL DAMAGE; CO2 REACTIVITY; ADULT RATS; RECOVERY; DEATH; ACTIVATION	Background: Global cerebral ischemia following cardiac arrest is associated with increased cerebral vasoconstriction and decreased cerebral blood flow, contributing to delayed neuronal cell death and neurological detriments in affected patients. We hypothesize that upregulation of contractile ETB and 5-HT1B receptors, previously demonstrated in cerebral arteries after experimental global ischemia, are a key mechanism behind insufficient perfusion of the post-ischemic brain, proposing blockade of this receptor upregulation as a novel target for prevention of cerebral hypoperfusion and delayed neuronal cell death after global cerebral ischemia. The aim was to characterize the time-course of receptor upregulation and associated neuronal damage after global ischemia and investigate whether treatment with the MEK1/2 inhibitor U0126 can prevent cerebrovascular receptor upregulation and thereby improve functional outcome after global cerebral ischemia. Incomplete global cerebral ischemia was induced in Wistar rats and the time-course of enhanced contractile responses and the effect of U0126 in cerebral arteries were studied by wire myography and the neuronal cell death by TUNEL. The expression of ETB and 5-HT1B receptors was determined by immunofluorescence. Results: Enhanced vasoconstriction peaked in fore-and midbrain arteries 3 days after ischemia. Neuronal cell death appeared initially in the hippocampus 3 days after ischemia and gradually increased until 7 days post-ischemia. Treatment with U0126 normalised cerebrovascular ETB and 5-HT1B receptor expression and contractile function, reduced hippocampal cell death and improved survival rate compared to vehicle treated animals. Conclusions: Excessive cerebrovascular expression of contractile ETB and 5-HT1B receptors is a delayed response to global cerebral ischemia peaking 3 days after the insult, which likely contributes to the development of delayed neuronal damage. The enhanced cerebrovascular contractility can be prevented by treatment with the MEK1/2 inhibitor U0126, diminishes neuronal damage and improves survival rate, suggesting MEK1/2 inhibition as a novel strategy for early treatment of neurological consequences following global cerebral ischemia.	[Johansson, Sara Ellinor; Larsen, Stine Schmidt; Povlsen, Gro Klitgaard; Edvinsson, Lars] Glostrup Cty Hosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Edvinsson, Lars] Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Lund, Sweden	University of Copenhagen; Lund University	Johansson, SE (corresponding author), Glostrup Cty Hosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	sara.ellinor.johansson@regionh.dk		Edvinsson, Lars/0000-0002-1805-1346	Lundbeck Foundation (Lundbeck Foundation Center for Neurovascular Signaling, LUCENS); Danish Research Council for Health and Disease	Lundbeck Foundation (Lundbeck Foundation Center for Neurovascular Signaling, LUCENS)(Lundbeckfonden); Danish Research Council for Health and Disease	This work was financially supported by the Lundbeck Foundation (Lundbeck Foundation Center for Neurovascular Signaling, LUCENS) and Danish Research Council for Health and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg SAS, 2006, J CEREBR BLOOD F MET, V26, P846, DOI 10.1038/sj.jcbfm.9600236; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Buunk G, 1996, INTENS CARE MED, V22, P1191, DOI 10.1007/BF01709335; Dragancea I, 2013, RESUSCITATION, V84, P337, DOI 10.1016/j.resuscitation.2012.09.015; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; Hosomi Naohisa, 2007, J Stroke Cerebrovasc Dis, V16, P103, DOI 10.1016/j.jstrokecerebrovasdis.2006.12.001; HOSSMANN KA, 1973, Z NEUROL, V204, P281, DOI 10.1007/BF00316009; Hossmann KA, 1997, SHOCK, V8, P95, DOI 10.1097/00024382-199708000-00004; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041852; KAGSTROM E, 1983, J CEREBR BLOOD F MET, V3, P170, DOI 10.1038/jcbfm.1983.24; KARLSSON BR, 1994, ACTA ANAESTH SCAND, V38, P248, DOI 10.1111/j.1399-6576.1994.tb03883.x; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; Larsen CC, 2011, J NEUROSURG, V114, P1143, DOI 10.3171/2010.6.JNS1018; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Maddahi A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-85; MATSUMOTO M, 1990, STROKE, V21, P1470, DOI 10.1161/01.STR.21.10.1470; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; MILLER CL, 1980, STROKE, V11, P542, DOI 10.1161/01.STR.11.5.542; MRSULJA BB, 1976, ACTA NEUROPATHOL, V36, P1, DOI 10.1007/BF00685142; NEMOTO EM, 1975, STROKE, V6, P425, DOI 10.1161/01.STR.6.4.425; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Petrovic M, 2011, VOJNOSANIT PREGL, V68, P495, DOI 10.2298/VSP1106495P; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Povlsen GK, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-34; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Safar P, 2002, CRIT CARE MED, V30, pS140, DOI 10.1097/00003246-200204001-00004; Satoh K, 2011, BRAIN RES, V1382, P266, DOI 10.1016/j.brainres.2011.01.049; SCHMIDTKASTNER R, 1986, J NEUROL, V233, P367, DOI 10.1007/BF00313924; Schmitz B, 1997, J CEREBR BLOOD F MET, V17, P1202, DOI 10.1097/00004647-199711000-00009; Schwartz BG, 2012, AM J CARDIOL, V110, P461, DOI 10.1016/j.amjcard.2012.03.048; SMITH ML, 1988, ACTA NEUROPATHOL, V76, P253, DOI 10.1007/BF00687772; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; TAKASU A, 1995, RESUSCITATION, V30, P69, DOI 10.1016/0300-9572(95)00864-P; WISNIEWSKI HM, 1995, ACTA NEUROPATHOL, V90, P432; Zeng YS, 2000, NEUROSCI RES, V37, P113, DOI 10.1016/S0168-0102(00)00107-3; Zhan LX, 2013, MOL NEUROBIOL, V48, P109, DOI 10.1007/s12035-013-8436-4; Zhan LX, 2012, NEUROPHARMACOLOGY, V63, P873, DOI 10.1016/j.neuropharm.2012.06.035	38	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92417	10.1371/journal.pone.0092417	http://dx.doi.org/10.1371/journal.pone.0092417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642693	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900134
J	Laventie, BJ; Guerin, F; Mourey, L; Tawk, MY; Jover, E; Maveyraud, L; Prevost, G				Laventie, Benoit-Joseph; Guerin, Frederic; Mourey, Lionel; Tawk, Mira Y.; Jover, Emmanuel; Maveyraud, Laurent; Prevost, Gilles			Residues Essential for Panton-Valentine Leukocidin S Component Binding to Its Cell Receptor Suggest Both Plasticity and Adaptability in Its Interaction Surface	PLOS ONE			English	Article							PORE-FORMING TOXINS; STAPHYLOCOCCAL ALPHA-TOXIN; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HEPTAMERIC TRANSMEMBRANE PORE; GAMMA-HEMOLYSIN; CRYSTAL-STRUCTURE; LUKE-LUKD; CONFORMATIONAL-CHANGES; NECROTIZING PNEUMONIA; LEUKOTOXIN FAMILY	Panton-Valentine leukocidin (PVL), a bicomponent staphylococcal leukotoxin, is involved in the poor prognosis of necrotizing pneumonia. The present study aimed to elucidate the binding mechanism of PVL and in particular its cell-binding domain. The class S component of PVL, LukS-PV, is known to ensure cell targeting and exhibits the highest affinity for the neutrophil membrane (K-d similar to 10(-10) M) compared to the class F component of PVL, LukF-PV (K-d similar to 10(-9) M). Alanine scanning mutagenesis was used to identify the residues involved in LukS-PV binding to the neutrophil surface. Nineteen single alanine mutations were performed in the rim domain previously described as implicated in cell membrane interactions. Positions were chosen in order to replace polar or exposed charged residues and according to conservation between leukotoxin class S components. Characterization studies enabled to identify a cluster of residues essential for LukS-PV binding, localized on two loops of the rim domain. The mutations R73A, Y184A, T244A, H245A and Y250A led to dramatically reduced binding affinities for both human leukocytes and undifferentiated U937 cells expressing the C5a receptor. The three-dimensional structure of five of the mutants was determined using X-ray crystallography. Structure analysis identified residues Y184 and Y250 as crucial in providing structural flexibility in the receptor-binding domain of LukS-PV.	[Laventie, Benoit-Joseph; Tawk, Mira Y.; Jover, Emmanuel; Prevost, Gilles] Univ Strasbourg CHRU, Federat Med Translat Strasbourg, EA Virulence Bacterienne Precoce 7290, Inst Bacteriol, Strasbourg, France; [Guerin, Frederic; Mourey, Lionel; Maveyraud, Laurent] CNRS, IPBS, Toulouse, France; [Guerin, Frederic; Mourey, Lionel; Maveyraud, Laurent] Univ Toulouse 3, Univ Toulouse, IPBS, F-31062 Toulouse, France	CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Maveyraud, L (corresponding author), CNRS, IPBS, Toulouse, France.	laurent.maveyraud@ipbs.fr; prevost@unistra.fr	LAVENTIE, Benoît-Joseph/H-5260-2011; Maveyraud, Laurent/C-6066-2011; Mourey, Lionel/B-5662-2009	LAVENTIE, Benoît-Joseph/0000-0003-0205-0944; Maveyraud, Laurent/0000-0003-4610-8319; Mourey, Lionel/0000-0002-8259-1259	Direction de la Recherche et des Etudes Doctorales [EA4438]; French Ministery of Superior Education and Research	Direction de la Recherche et des Etudes Doctorales; French Ministery of Superior Education and Research	This work was supported by grants from EA4438 to GP (Direction de la Recherche et des Etudes Doctorales, and BJL was awarded by the French Ministery of Superior Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Aman MJ, 2010, J BIOMOL STRUCT DYN, V28, P1; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cheung GYC, 2012, EXPERT OPIN THER TAR, V16, P601, DOI 10.1517/14728222.2012.682573; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; COONEY J, 1993, INFECT IMMUN, V61, P768, DOI 10.1128/IAI.61.2.768-771.1993; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DuMont AL, 2014, INFECT IMMUN, V82, P1268, DOI 10.1128/IAI.01444-13; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; Freer JH., 2006, COMPREHENSIVE SOURCE, P590, DOI 10.1016/B978-012088445-2/50037-8; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Girgis DO, 2005, INVEST OPHTH VIS SCI, V46, P2064, DOI 10.1167/iovs.04-0897; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Gravet A, 2001, J CLIN MICROBIOL, V39, P4349, DOI 10.1128/JCM.39.12.4349-4356.2001; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Joubert O, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/25935; Joubert O, 2006, BIOCHEM J, V396, P381, DOI 10.1042/BJ20051878; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P541, DOI 10.1271/bbb.61.541; Kew RR, 1997, J LEUKOCYTE BIOL, V61, P329, DOI 10.1002/jlb.61.3.329; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEUNIER O, 1995, CYTOMETRY, V21, P241, DOI 10.1002/cyto.990210304; Meyer F, 2009, INFECT IMMUN, V77, P266, DOI 10.1128/IAI.00402-08; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Morinaga N, 2003, MICROBIOL IMMUNOL, V47, P81, DOI 10.1111/j.1348-0421.2003.tb02789.x; Moussa LB, 1999, FEBS LETT, V461, P280, DOI 10.1016/S0014-5793(99)01453-2; Nariya H, 1997, FEBS LETT, V415, P96, DOI 10.1016/S0014-5793(97)01100-9; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; PREVOST G, 1995, FEBS LETT, V376, P135, DOI 10.1016/0014-5793(95)01260-9; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Roblin P, 2008, PROTEINS, V71, P485, DOI 10.1002/prot.21900; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Supersac G, 1998, MICROB PATHOGENESIS, V24, P241, DOI 10.1006/mpat.1997.0192; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; VecseySemjen B, 1997, J BIOL CHEM, V272, P5709, DOI 10.1074/jbc.272.9.5709; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Viero G, 2008, CELL MOL LIFE SCI, V65, P312, DOI 10.1007/s00018-007-7491-2; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Watkins RR, 2012, J MED MICROBIOL, V61, P1179, DOI 10.1099/jmm.0.043513-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOODIN AM, 1960, BIOCHEM J, V75, P158, DOI 10.1042/bj0750158; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	59	15	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92094	10.1371/journal.pone.0092094	http://dx.doi.org/10.1371/journal.pone.0092094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643034	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900084
J	Martin, PKM; Stilhano, RS; Samoto, VY; Takiya, CM; Peres, GB; Michelacci, YMCD; da Silva, FH; Pereira, VG; D'Almeida, V; Marques, FLN; Otake, AH; Chammas, R; Han, SW				Matsumoto Martin, Priscila Keiko; Stilhano, Roberta Sessa; Samoto, Vivian Yochiko; Takiya, Christina Maeda; Peres, Giovani Bravin; Correa da Silva Michelacci, Yara Maria; da Silva, Flavia Helena; Pereira, Vanessa Goncalves; D'Almeida, Vania; Navarro Marques, Fabio Luiz; Otake, Andreia Hanada; Chammas, Roger; Han, Sang Won			Mesenchymal Stem Cells Do Not Prevent Antibody Responses against Human alpha-L-Iduronidase when Used to Treat Mucopolysaccharidosis Type I	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; IMMUNE-RESPONSE; GENE-THERAPY; LYSOSOMAL STORAGE; INDOLEAMINE 2,3-DIOXYGENASE; NITRIC-OXIDE; BLOOD-CELLS; MICE; PROLIFERATION; IMPROVES	Mucopolysaccharidosis type I (MPSI) is an autosomal recessive disease that leads to systemic lysosomal storage, which is caused by the absence of alpha-L-iduronidase (IDUA). Enzyme replacement therapy is recognized as the best therapeutic option for MPSI; however, high titers of anti-IDUA antibody have frequently been observed. Due to the immunosuppressant properties of MSC, we hypothesized that MSC modified with the IDUA gene would be able to produce IDUA for a long period of time. Sleeping Beauty transposon vectors were used to modify MSC because these are basically less-immunogenic plasmids. For cell transplantation, 4x10(6) MSC-KO-IDUA cells (MSC from KO mice modified with IDUA) were injected into the peritoneum of KO-mice three times over intervals of more than one month. The total IDUA activities from MSC-KO-IDUA before cell transplantation were 9.6, 120 and 179 U for the first, second and third injections, respectively. Only after the second cell transplantation, more than one unit of IDUA activity was detected in the blood of 3 mice for 2 days. After the third cell transplantation, a high titer of anti-IDUA antibody was detected in all of the treated mice. Anti-IDUA antibody response was also detected in C57Bl/6 mice treated with MSC-WT-IDUA. The antibody titers were high and comparable to mice that were immunized by electroporation. MSC-transplanted mice had high levels of TNF-alpha and infiltrates in the renal glomeruli. The spreading of the transplanted MSC into the peritoneum of other organs was confirmed after injection of In-111-labeled MSC. In conclusion, the antibody response against IDUA could not be avoided by MSC. On the contrary, these cells worked as an adjuvant that favored IDUA immunization. Therefore, the humoral immunosuppressant property of MSC is questionable and indicates the danger of using MSC as a source for the production of exogenous proteins to treat monogenic diseases.	[Matsumoto Martin, Priscila Keiko; Stilhano, Roberta Sessa; da Silva, Flavia Helena; Han, Sang Won] Univ Fed Sao Paulo, Res Ctr Gene Therapy, Sao Paulo, Brazil; [Matsumoto Martin, Priscila Keiko; Stilhano, Roberta Sessa; Han, Sang Won] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Samoto, Vivian Yochiko; Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Peres, Giovani Bravin; Correa da Silva Michelacci, Yara Maria] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [da Silva, Flavia Helena] Univ Fed Rio Grande do Sul, Dept Genet, Sao Paulo, Brazil; [Pereira, Vanessa Goncalves; D'Almeida, Vania] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Navarro Marques, Fabio Luiz] Univ Sao Paulo, Nucl Med Ctr, Sao Paulo, Brazil; [Otake, Andreia Hanada; Chammas, Roger] Univ Sao Paulo, Sch Med, Dept Radiol & Oncol, Expt Oncol Lab, Sao Paulo, Brazil; [Otake, Andreia Hanada; Chammas, Roger] Canc Inst Sao Paulo State, Translat Invest Ctr Oncol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Sul; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Han, SW (corresponding author), Univ Fed Sao Paulo, Res Ctr Gene Therapy, Sao Paulo, Brazil.	sang.han@unifesp.br	Peres, Giovani B/D-4553-2013; D'Almeida, Vânia/AAV-3955-2020; STILHANO, roberta/F-6923-2015; Marques, Fabio LN/C-4153-2012; Otake, Andréia H./F-5131-2016; D'Almeida, Vania/AAB-7115-2020; Chammas, Roger/A-8004-2011; Takiya, Christina/AAU-5959-2021; Navarro Marques, Fabio Luiz/ABI-7774-2020	Peres, Giovani B/0000-0003-3890-5334; D'Almeida, Vânia/0000-0003-0947-5312; STILHANO, roberta/0000-0002-0653-5968; Marques, Fabio LN/0000-0001-7383-926X; Otake, Andréia H./0000-0003-1303-1220; Chammas, Roger/0000-0003-0342-8726; Takiya, Christina/0000-0002-8019-628X; Navarro Marques, Fabio Luiz/0000-0001-7383-926X	FAPESP [08/56529-1, 2008/56530-0, 2009/52235-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	PKMM and RSS were recipients of FAPESP scholarships (08/56529-1 and 2008/56530-0, respectively), and this work was financially supported by FAPESP (grant # 2009/52235-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronovich EL, 2007, J GENE MED, V9, P403, DOI 10.1002/jgm.1028; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Baldo G, 2013, MOL GENET METAB, V109, P33, DOI 10.1016/j.ymgme.2013.03.005; BECKER W, 1986, KLIN WOCHENSCHR, V64, P141, DOI 10.1007/BF01732640; Behmer O.A., 1976, MANUAL TECNICAS HIST, V1st; Belay E, 2010, STEM CELLS, V28, P1760, DOI 10.1002/stem.501; Bhaumik S, 2001, EXP CELL RES, V266, P44, DOI 10.1006/excr.2001.5201; Brooks DA, 2003, TRENDS MOL MED, V9, P450, DOI 10.1016/j.molmed.2003.08.004; Chung S, 2007, MOL GENET METAB, V90, P181, DOI 10.1016/j.ymgme.2006.08.001; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; Comoli P, 2008, NEPHROL DIAL TRANSPL, V23, P1196, DOI 10.1093/ndt/gfm740; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; da Silva Flavia Helena, 2012, Genet Vaccines Ther, V10, P2, DOI 10.1186/1479-0556-10-2; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Di Domenico C, 2006, HUM GENE THER, V17, P1112; Dickson P, 2008, J CLIN INVEST, V118, P2868, DOI 10.1172/JCI34676; Dierenfeld AD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001380; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; GOEDEMANS WT, 1987, J NUCL MED, V28, P1020; Grassel Susanne, 2012, Methods Mol Biol, V879, P203, DOI 10.1007/978-1-61779-815-3_14; HOPPER KE, 1986, J LEUKOCYTE BIOL, V39, P435, DOI 10.1002/jlb.39.4.435; Jin Z, 2011, GENE THER, V18, P849, DOI 10.1038/gt.2011.40; Kakavanos R, 2003, LANCET, V361, P1608, DOI 10.1016/S0140-6736(03)13311-9; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kobayashi H, 2005, MOL THER, V11, P776, DOI 10.1016/j.ymthe.2004.10.006; MCKUSICK VA, 1965, MEDICINE, V44, P445, DOI 10.1097/00005792-196511000-00001; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Parise CB, 2008, VACCINE, V26, P3812, DOI 10.1016/j.vaccine.2008.05.029; Ponder KP, 2008, J CLIN INVEST, V118, P2686, DOI 10.1172/JCI36521; Rafei M, 2008, BLOOD, V112, P4991, DOI 10.1182/blood-2008-07-166892; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Roca M, 2010, EUR J NUCL MED MOL I, V37, P835, DOI 10.1007/s00259-010-1393-5; Sacramento CB, 2010, J GENE MED, V12, P310, DOI 10.1002/jgm.1434; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Scriver C.R., 1995, METABOLIC MOL BASES; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Wraith JE, 2007, PEDIATRICS, V120, pE37, DOI 10.1542/peds.2006-2156; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Yoshida H, 2002, ARTHRITIS RHEUM, V46, P2235, DOI 10.1002/art.10441; Youd M, 2010, CLIN EXP IMMUNOL, V161, P176, DOI 10.1111/j.1365-2249.2010.04158.x; Zhang HY, 2010, EXPERT OPIN BIOL TH, V10, P701, DOI 10.1517/14712591003769816	44	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92420	10.1371/journal.pone.0092420	http://dx.doi.org/10.1371/journal.pone.0092420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642723	Green Submitted, gold, Green Published			2022-12-27	WOS:000333259900135
J	May, O; Yu, HY; Riederer, B; Manns, MP; Seidler, U; Bachmann, O				May, Oliver; Yu, Haoyang; Riederer, Brigitte; Manns, Michael P.; Seidler, Ursula; Bachmann, Oliver			Short-Term Regulation of Murine Colonic NBCe1-B (Electrogenic Na+/HCO3- Cotransporter) Membrane Expression and Activity by Protein Kinase C	PLOS ONE			English	Article							MUCOSAL BICARBONATE SECRETION; RENAL NA-HCO3 COTRANSPORTER; /OH-EXCHANGE ACTIVITY; PKC-EPSILON; NA+-HCO3-COTRANSPORTER; SURFACE EXPRESSION; DOWN-REGULATION; CACO-2 CELLS; CAMP; INHIBITION	The colonic mucosa actively secretes HCO3-, and several lines of evidence point to an important role of Na+/HCO3- cotransport (NBC) as a basolateral HCO3- import pathway. We could recently demonstrate that the predominant NBC isoform in murine colonic crypts is electrogenic NBCe1-B, and that secretagogues cause NBCe1 exocytosis, which likely represents a component of NBC activation. Since protein kinase C (PKC) plays a key role in the regulation of ion transport by trafficking events, we asked whether it is also involved in the observed NBC activity increase. Crypts were isolated from murine proximal colon to assess PKC activation as well as NBC function and membrane abundance using fluorometric pH(i) measurements and cell surface biotinylation, respectively. PKC isoform translocation and phosphorylation occurred in response to PMA-, as well as secretagogue stimulation. The conventional and novel PKC inhibitors Go6976 or Go6850 did not alter NBC function or surface expression by themselves, but stimulation with forskolin (10(-5) M) or carbachol (10(-4) M) in their presence led to a significant decrease in NBC-mediated proton flux, and biotinylated NBCe1. Our data thus indicate that secretagogues lead to PKC translocation and phosphorylation in murine colonic crypts, and that PKC is necessary for the increase in NBC transport rate and membrane abundance caused by cholinergic and cAMP-dependent stimuli.	[May, Oliver; Yu, Haoyang; Riederer, Brigitte; Manns, Michael P.; Seidler, Ursula; Bachmann, Oliver] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Hannover Medical School	Bachmann, O (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	bachmann.oliver@mh-hannover.de	Bachmann, Oliver/AAV-4258-2021; Seidler, Ursula/HII-8049-2022	Bachmann, Oliver/0000-0002-6830-2975; Seidler, Ursula/0000-0002-9600-2769	Deutsche Forschungsgemeinschaft [SFB621-C10];  [SFB621-C9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (www.dfg.de) to O. Bachmann (SFB621-C10). Brigitte Riederer was funded by the SFB621-C9 grant to U. Seidler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Alvarez BV, 2005, EMBO J, V24, P2499, DOI 10.1038/sj.emboj.7600736; Bachmann O, 2006, AM J PHYSIOL-GASTR L, V291, pG650, DOI 10.1152/ajpgi.00376.2005; Bachmann O, 2003, AM J PHYSIOL-GASTR L, V284, pG37, DOI 10.1152/ajpgi.00209.2002; Bachmann O, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-70; Broughman JR, 2006, AM J PHYSIOL-GASTR L, V291, pG318, DOI 10.1152/ajpgi.00355.2005; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chen M, 2012, J PHYSL; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Del Castillo IC, 2005, AM J PHYSIOL-CELL PH, V289, pC1332, DOI 10.1152/ajpcell.00580.2004; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Edelstein J, 2011, CELL SIGNAL, V23, P239, DOI 10.1016/j.cellsig.2010.09.008; Espiritu DJD, 2004, J MEMBRANE BIOL, V199, P39, DOI 10.1007/s00232-004-0675-x; Glaser S, 2003, AM J PHYSIOL-GASTR L, V284, pG683, DOI 10.1152/ajpgi.00302.2002; Gross E, 2003, J PHYSIOL-LONDON, V549, P673, DOI 10.1113/jphysiol.2003.042226; Gross E, 2002, AM J PHYSIOL-RENAL, V283, pF876, DOI 10.1152/ajprenal.00148.2002; Hegyi P, 2005, AM J PHYSIOL-CELL PH, V288, pC1030, DOI 10.1152/ajpcell.00430.2003; Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x; Hong JH, 2013, P NATL ACAD SCI USA, V110, P4105, DOI 10.1073/pnas.1221410110; Jacob P, 2000, GASTROENTEROLOGY, V119, P406, DOI 10.1053/gast.2000.9358; Kim HW, 2010, MOL CELL BIOL, V30, P5406, DOI 10.1128/MCB.00217-10; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MATTHEWS JB, 1993, AM J PHYSIOL, V265, pC1109, DOI 10.1152/ajpcell.1993.265.4.C1109; Odes HS, 1996, PHARMACOLOGY, V53, P60, DOI 10.1159/000139415; Orsenigo MN, 2002, EXP PHYSIOL, V87, P299, DOI 10.1113/eph8702319; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Perry C, 2006, AM J PHYSIOL-RENAL, V290, pF417, DOI 10.1152/ajprenal.00395.2004; Perry C, 2008, AMJPHYSIOL CELL PHYS; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; Qu F, 2011, J CELL BIOCHEM, V112, P902, DOI 10.1002/jcb.22999; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Ruiz OS, 1997, KIDNEY INT, V51, P1069, DOI 10.1038/ki.1997.149; Ruiz OS, 1996, KIDNEY INT, V49, P696, DOI 10.1038/ki.1996.98; RUIZ OS, 1992, AM J PHYSIOL, V262, pF560, DOI 10.1152/ajprenal.1992.262.4.F560; Saksena S, 2005, J BIOL CHEM, V280, P11859, DOI 10.1074/jbc.M411553200; Saksena S, 2002, AM J PHYSIOL-CELL PH, V283, pC1492, DOI 10.1152/ajpcell.00473.2001; Schmitt BM, 1999, AM J PHYSIOL-RENAL, V276, pF27, DOI 10.1152/ajprenal.1999.276.1.F27; SINGH AK, 2013, J PHYSL; Song JC, 1999, AM J PHYSIOL-CELL PH, V277, pC1239, DOI 10.1152/ajpcell.1999.277.6.C1239; Tang J, 2010, J BIOL CHEM, V285, P34072, DOI 10.1074/jbc.M110.137380; Tuo BG, 2004, AM J PHYSIOL-GASTR L, V286, pG814, DOI 10.1152/ajpgi.00251.2003; Yamada H, 1996, AM J PHYSIOL-RENAL, V271, pF1068, DOI 10.1152/ajprenal.1996.271.5.F1068; Yu HY, 2009, AM J PHYSIOL-GASTR L, V297, pG1223, DOI 10.1152/ajpgi.00157.2009	45	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92275	10.1371/journal.pone.0092275	http://dx.doi.org/10.1371/journal.pone.0092275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642792	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900118
J	Coste, J; Quinquis, L; D'Almeida, S; Audureau, E				Coste, Joel; Quinquis, Laurent; D'Almeida, Samuel; Audureau, Etienne			Smoking and Health-Related Quality of Life in the General Population. Independent Relationships and Large Differences According to Patterns and Quantity of Smoking and to Gender	PLOS ONE			English	Article							EPIDEMIOLOGIC ANALYSIS; TOBACCO USE; DEPRESSION; CESSATION; IMPACT; LIGHT; DEPENDENCE; INITIATION; DISORDERS; ALCOHOL	Background: Relationships between smoking and health-related quality of life (HRQoL) in the general population remain unclear. Objectives: To quantify the independent associations between smoking patterns and HRQoL and to identify any threshold or non-linear tendencies in these associations. Methods: A national representative, cross-sectional household survey of the French general non institutionalized population included 7525 men and 8486 women, aged 25-64 year in 2003. Scores on the eight subscales of the Medical Outcomes Study 36-item Short Form were the primary outcomes. Linear regression analyses were used to evaluate the associations between HRQoL and smoking history, quantity of smoking and smoking cessation while controlling for various socio-economic variables, depression, alcohol dependence and pathological conditions. Analyses were conducted in 2013. Results: Independent associations between smoking and HRQoL were found, including small positive associations for occasional or light smoking (up to 5 cigarettes per day), and larger and diffuse negative associations above this threshold. Much weaker associations and higher thresholds for negative HRQoL were found for women than for men. For ex-smokers of both genders, HRQoL was found to be better between 2 and 5 years after quitting. Conclusions: Smoking was independently related to HRQoL, with large differences according to the pattern and quantity of smoking, and to gender. These results may have considerable relevance both for public health action and care of smokers.	[Coste, Joel; Quinquis, Laurent; D'Almeida, Samuel; Audureau, Etienne] Hop Hotel Dieu, AP HP, Biostat & Epidemiol Unit, Paris, France; [Coste, Joel] Lorraine Univ, Univ Paris Descartes, Res Unit APEMAC, Sorbonne Paris Cite,EA 4360, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine	Coste, J (corresponding author), Hop Hotel Dieu, AP HP, Biostat & Epidemiol Unit, Paris, France.	joel.coste@htd.aphp.fr	Audureau, Etienne/R-4359-2018; Audureau, Etienne/AHE-2826-2022	Audureau, Etienne/0000-0002-6166-149X; Audureau, Etienne/0000-0002-6166-149X; d'Almeida, Samuel/0000-0002-5837-6057	French National Institute for Statistics and Economic Studies	French National Institute for Statistics and Economic Studies	This study was funded and performed by the French National Institute for Statistics and Economic Studies. The funding source had no role in the analysis, manuscript preparation, interpretation, or decision to submit the manuscript for publication.	Amos A, 2012, TOB CONTROL, V21, P236, DOI 10.1136/tobaccocontrol-2011-050280; [Anonymous], 2008, WHO REP GLOB TOB EPI; Anthony JC, 2000, ALCOHOL RES HEALTH, V24, P201; Beck F, 2010, PREMIERS RESULTATS B, P10; Bellido-Casado J, 2004, Eur J Intern Med, V15, P511, DOI 10.1016/j.ejim.2004.06.015; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P161, DOI 10.1001/archpsyc.55.2.161; Chaiton MO, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-356; Coggins CRE, 2009, PSYCHOPHARMACOLOGY, V207, P343, DOI 10.1007/s00213-009-1675-4; Coste J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-44; Davila EP, 2011, AM J HEALTH BEHAV, V35, P280, DOI 10.5993/AJHB.35.3.3; Diez JD, 2010, LUNG, V188, P393, DOI 10.1007/s00408-010-9256-1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Falk DE, 2006, ALCOHOL RES HEALTH, V29, P162; Funahashi K, 2011, QUAL LIFE RES, V20, P199, DOI 10.1007/s11136-010-9748-8; Gan HP, 2013, J PUBLIC HEALTH-HEID, V21, P389, DOI 10.1007/s10389-013-0567-6; Guiterrez-Bedmar M, 2009, INT J ENV RES PUB HE, V6, P310, DOI 10.3390/ijerph6010310; Haukkala A, 2000, ADDICT BEHAV, V25, P311, DOI 10.1016/S0306-4603(98)00125-7; HAYS RD, 1995, ARCH GEN PSYCHIAT, V52, P11; Heikkinen H, 2008, NICOTINE TOB RES, V10, P1199, DOI 10.1080/14622200802163142; Hurley LL, 2012, NEUROTOX RES, V21, P57, DOI 10.1007/s12640-011-9275-6; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; King MT, 2011, EXPERT REV PHARM OUT, V11, P171, DOI [10.1586/ERP.11.9, 10.1586/erp.11.9]; Lang I, 2007, PUBLIC HEALTH, V121, P518, DOI 10.1016/j.puhe.2007.01.005; Lanoe JL., 2005, ETUDES RESULTATS, V436, P1; Legleye S, 2011, DRUG ALCOHOL DEPEN, V117, P233, DOI 10.1016/j.drugalcdep.2011.02.004; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Mody RR, 2006, AM J HEALTH PROMOT, V20, P251, DOI 10.4278/0890-1171-20.4.251; Mucha Lisa, 2006, Gend Med, V3, P279, DOI 10.1016/S1550-8579(06)80216-0; Mulder I, 2001, PREV MED, V33, P653, DOI 10.1006/pmed.2001.0941; NAKAMURA T, 1986, COMPUT METH PROG BIO, V23, P53, DOI 10.1016/0169-2607(86)90080-5; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518; Pauly JR, 2008, FRONT BIOSCI-LANDMRK, V13, P505, DOI 10.2741/2696; Perkins K A, 1999, Nicotine Tob Res, V1, P301, DOI 10.1080/14622299050011431; Perneger, 2001, QUESTIONNAIRE MOS SF; Peto R, 2013, MORTALITY SMOKING DE; Peyre H, 2011, QUAL LIFE RES, V20, P287, DOI 10.1007/s11136-010-9740-3; Pisinger C, 2009, PREV MED, V49, P418, DOI 10.1016/j.ypmed.2009.08.011; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RUEFF B, 1989, PRESSE MED, V18, P1654; Schane RE, 2010, CIRCULATION, V121, P1518, DOI 10.1161/CIRCULATIONAHA.109.904235; Shiffman S, 2009, NICOTINE TOB RES, V11, P122, DOI 10.1093/ntr/ntn020; Strine TW, 2005, AM J PREV MED, V28, P182, DOI 10.1016/j.amepre.2004.10.002; Tsuang MT, 2012, HUM GENET, V131, P905, DOI 10.1007/s00439-012-1170-6; Vogl M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-203; Ware J., 1993, SF 36 HLTH SURVEY MA; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wilson D, 1999, PREV MED, V29, P139, DOI 10.1006/pmed.1999.0523; Zillich AJ, 2002, PHARMACOTHERAPY, V22, P759, DOI 10.1592/phco.22.9.759.34073	51	47	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91562	10.1371/journal.pone.0091562	http://dx.doi.org/10.1371/journal.pone.0091562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637739	gold, Green Published, Green Submitted			2022-12-27	WOS:000333254100044
J	Liu, ZS; Jiang, RF; Yuan, ST; Wang, N; Feng, Y; Hu, GL; Zhu, XM; Huang, K; Ma, JL; Xu, GT; Liu, QH; Xue, ZG; Fan, GP				Liu, Zhenshan; Jiang, Rongfeng; Yuan, Songtao; Wang, Na; Feng, Yun; Hu, Ganlu; Zhu, Xianmin; Huang, Kevin; Ma, Jieliang; Xu, Guotong; Liu, Qinghuai; Xue, Zhigang; Fan, Guoping			Integrated Analysis of DNA Methylation and RNA Transcriptome during In Vitro Differentiation of Human Pluripotent Stem Cells into Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							GENOME-WIDE MAPS; GENE-EXPRESSION; PROGENITOR CELLS; VISUAL FUNCTION; RPE; STATES; DEMETHYLATION; INACTIVATION; INSTABILITY; RESTRICTION	Using the paradigm of in vitro differentiation of hESCs/iPSCs into retinal pigment epithelial (RPE) cells, we have recently profiled mRNA and miRNA transcriptomes to define a set of RPE mRNA and miRNA signature genes implicated in directed RPE differentiation. In this study, in order to understand the role of DNA methylation in RPE differentiation, we profiled genome-scale DNA methylation patterns using the method of reduced representation bisulfite sequencing (RRBS). We found dynamic waves of de novo methylation and demethylation in four stages of RPE differentiation. Integrated analysis of DNA methylation and RPE transcriptomes revealed a reverse-correlation between levels of DNA methylation and expression of a subset of miRNA and mRNA genes that are important for RPE differentiation and function. Gene Ontology (GO) analysis suggested that genes undergoing dynamic methylation changes were related to RPE differentiation and maturation. We further compared methylation patterns among human ESC- and iPSC-derived RPE as well as primary fetal RPE (fRPE) cells, and discovered that specific DNA methylation pattern is useful to classify each of the three types of RPE cells. Our results demonstrate that DNA methylation may serve as biomarkers to characterize the cell differentiation process during the conversion of human pluripotent stem cells into functional RPE cells.	[Liu, Zhenshan; Jiang, Rongfeng; Wang, Na; Feng, Yun; Hu, Ganlu; Zhu, Xianmin; Ma, Jieliang; Xue, Zhigang] Tongji Univ, Sch Med, Tongji Hosp, Dept Regenerat Med,Translat Ctr Stem Cell Res, Shanghai 200092, Peoples R China; [Huang, Kevin; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Yuan, Songtao; Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Xu, Guotong] Tongji Univ, Sch Med, Tongji Eye Inst, Shanghai 200092, Peoples R China; [Xu, Guotong] Tongji Univ, Sch Med, Dept Regenerat Med, Shanghai 200092, Peoples R China; [Fan, Guoping] Tongji Univ, Sch Life Sci & Technol, Adv Inst Translat Med, Shanghai 200092, Peoples R China; [Liu, Zhenshan; Xue, Zhigang] Tongji Univ, Suzhou Inst, Suzhou, Jiangsu, Peoples R China	Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nanjing Medical University; Tongji University; Tongji University; Tongji University; Tongji University	Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn; Xuezhigang75@gmail.com; Gfan@mednet.ucla.edu	Albertini, David/AAD-3856-2021; Zhu, Xianmin/M-6437-2017	Albertini, David/0000-0001-6536-2828; Zhu, Xianmin/0000-0003-1405-9700; Liu, Qinghuai/0000-0003-1605-1964	NIH [GM081621]; International Science & Technology Cooperation Program of China [2011DFB30010]; National Natural Science Foundation of China [81271258]; Natural Science Foundation of Jiangsu Province of China [DK2011321]; Ministry of Science and Technology 973 Basic Research program in China [2011CB965102, 2011CB966204, 2012CB966303]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Ministry of Science and Technology 973 Basic Research program in China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM081621, International Science & Technology Cooperation Program of China (2011DFB30010), National Natural Science Foundation of China (81271258), Natural Science Foundation of Jiangsu Province of China (DK2011321), and Ministry of Science and Technology 973 Basic Research program in China (2011CB965102, 2011CB966204, and 2012CB966303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Ghazi NG, 2002, EYE, V16, P411, DOI 10.1038/sj.eye.6700197; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037224; Huang K, 2014, STEM CELL REP, V2, P36, DOI 10.1016/j.stemcr.2013.11.003; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Khavari DA, 2010, CELL CYCLE, V9, P3880, DOI 10.4161/cc.9.19.13385; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kokkinaki M, 2011, STEM CELLS, V29, P825, DOI 10.1002/stem.635; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao RR, 2004, BIOL REPROD, V71, P1772, DOI 10.1095/biolreprod.104.030395; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P4979, DOI 10.1167/iovs.10-5386; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tompkins JD, 2012, P NATL ACAD SCI USA, V109, P12544, DOI 10.1073/pnas.1209620109; Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	66	19	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91416	10.1371/journal.pone.0091416	http://dx.doi.org/10.1371/journal.pone.0091416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638073	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100033
J	Zafra, MP; Mazzeo, C; Gamez, C; Marco, AR; de Zulueta, A; Sanz, V; Bilbao, I; Ruiz-Cabello, J; Zubeldia, JM; del Pozo, V				Paz Zafra, Ma; Mazzeo, Carla; Gamez, Cristina; Rodriguez Marco, Ainara; de Zulueta, Ana; Sanz, Veronica; Bilbao, Izaskun; Ruiz-Cabello, Jesus; Zubeldia, Jose M.; del Pozo, Victoria			Gene Silencing of SOCS3 by siRNA Intranasal Delivery Inhibits Asthma Phenotype in Mice	PLOS ONE			English	Article							SMALL INTERFERING RNA; AIRWAY HYPERRESPONSIVENESS; IMMUNE-RESPONSES; INFLAMMATION; SUPPRESSOR; EXPRESSION; CELLS; THERAPY; RHOA	Suppresors of cytokine signaling (SOCS) proteins regulate cytokine responses and control immune balance. Several studies have confirmed that SOCS3 is increased in asthmatic patients, and SOCS3 expression is correlated with disease severity. The objective of this study was to evaluate if delivering of SOCS3 short interfering RNA (siRNA) intranasally in lungs could be a good therapeutic approach in an asthma chronic mouse model. Our results showed that intranasal treatment with SOCS3-siRNA led to an improvement in the eosinophil count and the normalization of hyperresponsiveness to methacholine. Concomitantly, this treatment resulted in an improvement in mucus secretion, a reduction in lung collagen, which are prominent features of airway remodeling. The mechanism implies JAK/STAT and RhoA/Rho-kinase signaling pathway, because we found a decreasing in STAT3 phosphorylation status and down regulation of RhoA/Rho-kinase protein expression. These results might lead to a new therapy for the treatment of chronic asthma.	[Paz Zafra, Ma; Mazzeo, Carla; Gamez, Cristina; Rodriguez Marco, Ainara; de Zulueta, Ana; Sanz, Veronica; del Pozo, Victoria] IIS Fdn Jimenez Diaz, Dept Immunol, Madrid, Spain; [Paz Zafra, Ma; Mazzeo, Carla; Gamez, Cristina; de Zulueta, Ana; Sanz, Veronica; Bilbao, Izaskun; Ruiz-Cabello, Jesus; del Pozo, Victoria] CIBER Enfermedades Resp, Madrid, Spain; [Bilbao, Izaskun; Ruiz-Cabello, Jesus] Ctr Nacl Invest Cardiovasc, Adv Imaging Unit, Madrid, Spain; [Bilbao, Izaskun; Ruiz-Cabello, Jesus] Univ Complutense Madrid, Madrid, Spain; [Zubeldia, Jose M.] Hosp Gen Gregorio Maranon, Allergy Sect, Madrid, Spain; [Zubeldia, Jose M.] Hosp Gen Gregorio Maranon, Expt Med Unit, Madrid, Spain	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital	del Pozo, V (corresponding author), IIS Fdn Jimenez Diaz, Dept Immunol, Madrid, Spain.	vpozo@fjd.es	Zafra, Maria Paz/ABH-4756-2020; Ruiz-Cabello, Jesus/A-9570-2012; Zubeldia, Jose M./H-3518-2016; Mazzeo, Carla/M-1976-2014; Gamez, Cristina/AAA-6000-2021	Zafra, Maria Paz/0000-0001-9303-0097; Ruiz-Cabello, Jesus/0000-0001-8681-5056; Zubeldia, Jose M./0000-0003-3110-274X; Mazzeo, Carla/0000-0001-7916-8209; Gamez, Cristina/0000-0001-5412-9318	CIBER de Enfermedades Respiratorias; Spain's Health Research Fund, a Carlos III Institute of Health initiative; Conchita Rabago Foundation;  [PS09/00153];  [PI12/00691]	CIBER de Enfermedades Respiratorias; Spain's Health Research Fund, a Carlos III Institute of Health initiative; Conchita Rabago Foundation; ; 	This study was supported by grants PS09/00153 and PI12/00691 and CIBER de Enfermedades Respiratorias; from Spain's Health Research Fund, a Carlos III Institute of Health initiative; and fellowship grants from the Conchita Rabago Foundation (PZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa S, 2004, CLIN EXP IMMUNOL, V135, P505, DOI 10.1111/j.1365-2249.2004.02405.x; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bonifazi P, 2010, MUCOSAL IMMUNOL, V3, P193, DOI 10.1038/mi.2009.130; Chiba Y, 2010, J PHARMACOL SCI, V114, P239, DOI 10.1254/jphs.10R03CR; Chiba Y, 2010, PHARMACOL RES, V61, P188, DOI 10.1016/j.phrs.2009.10.003; Chiba Y, 2009, AM J RESP CELL MOL, V40, P159, DOI 10.1165/rcmb.2008-0162OC; Collison A, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-29; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; Goto K, 2010, PHARMACOL RES, V61, P466, DOI 10.1016/j.phrs.2009.12.001; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hausding M, 2011, INT IMMUNOL, V23, P1, DOI 10.1093/intimm/dxq451; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Horiuchi Y, 2006, CLIN EXP DERMATOL, V31, P100, DOI 10.1111/j.1365-2230.2005.01979.x; Kasaian MT, 2013, AM J RESP CELL MOL, V49, P37, DOI 10.1165/rcmb.2012-0500OC; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Korideck H, 2009, J PHARMACOL EXP THER, V329, P882, DOI 10.1124/jpet.108.147579; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LoGrasso PV, 2009, CURR TOP MED CHEM, V9, P704, DOI 10.2174/156802609789044452; Lopez E, 2006, J IMMUNOL, V176, P1943, DOI 10.4049/jimmunol.176.3.1943; Lopez E, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/917015; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Madonna S, 2008, FASEB J, V22, P3287, DOI 10.1096/fj.08-106831; Manuyakorn W, 2013, ASIAN PAC J ALLERGY, V31, P3; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Moriwaki A, 2011, AM J RESP CELL MOL, V44, P448, DOI 10.1165/rcmb.2009-0051OC; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020; Zhu M, 2011, EUR RESPIR J, V38, P841, DOI 10.1183/09031936.00125010	33	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91996	10.1371/journal.pone.0091996	http://dx.doi.org/10.1371/journal.pone.0091996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637581	Green Published, gold			2022-12-27	WOS:000333254100099
J	Schuler, N; Palm, J; Kaiser, M; Betten, D; Furtwangler, R; Rube, C; Graf, N; Rube, CE				Schuler, Nadine; Palm, Jan; Kaiser, Mareike; Betten, Dominik; Furtwaengler, Rhoikos; Ruebe, Christian; Graf, Norbert; Ruebe, Claudia E.			DNA-Damage Foci to Detect and Characterize DNA Repair Alterations in Children Treated for Pediatric Malignancies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SQUAMOUS-CELL CARCINOMA; STRAND BREAK REPAIR; FANCONI-ANEMIA; NORMAL-TISSUES; RADIOSENSITIVITY; PATHWAY; ATM; HETEROCHROMATIN; REPLICATION	Purpose: In children diagnosed with cancer, we evaluated the DNA damage foci approach to identify patients with double-strand break (DSB) repair deficiencies, who may overreact to DNA-damaging radio-and chemotherapy. In one patient with Fanconi anemia (FA) suffering relapsing squamous cell carcinomas of the oral cavity we also characterized the repair defect in biopsies of skin, mucosa and tumor. Methods and Materials: In children with histologically confirmed tumors or leukemias and healthy control-children DSB repair was investigated by counting gamma H2AX-, 53BP1- and pATM-foci in blood lymphocytes at defined time points after ex-vivo irradiation. This DSB repair capacity was correlated with treatment-related normal-tissue responses. For the FA patient the defective repair was also characterized in tissue biopsies by analyzing DNA damage response proteins by light and electron microscopy. Results: Between tumor-children and healthy control-children we observed significant differences in mean DSB repair capacity, suggesting that childhood cancer is based on genetic alterations affecting DNA repair. Only 1 out of 4 patients with grade-4 normal-tissue toxicities revealed an impaired DSB repair capacity. The defective DNA repair in FA patient was verified in irradiated blood lymphocytes as well as in non-irradiated mucosa and skin biopsies leading to an excessive accumulation of heterochromatin-associated DSBs in rapidly cycling cells. Conclusions: Analyzing human tissues we show that DSB repair alterations predispose to cancer formation at younger ages and affect the susceptibility to normal-tissue toxicities. DNA damage foci analysis of blood and tissue samples allows one to detect and characterize DSB repair deficiencies and enables identification of patients at risk for high-grade toxicities. However, not all treatment-associated normal-tissue toxicities can be explained by DSB repair deficiencies.	[Schuler, Nadine; Palm, Jan; Kaiser, Mareike; Betten, Dominik; Ruebe, Christian; Ruebe, Claudia E.] Univ Saarland, Dept Radiat Oncol, Homburg, Germany; [Furtwaengler, Rhoikos; Graf, Norbert] Univ Saarland, Dept Pediat Hematol & Oncol, Homburg, Germany	Saarland University; Saarland University	Rube, CE (corresponding author), Univ Saarland, Dept Radiat Oncol, Homburg, Germany.	claudia.ruebe@uks.eu	Graf, Norbert/H-1328-2011; Furtwängler, Rhoikos/V-3519-2018	Graf, Norbert/0000-0002-2248-323X; Furtwängler, Rhoikos/0000-0002-1967-8343; Palm, Jan/0000-0003-1122-1557	Deutsche Krebshilfe [109774]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by "Deutsche Krebshilfe'' (grant no. 109774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolling T, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-10; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2012, MUTAT RES-FUND MOL M, V736, P39, DOI 10.1016/j.mrfmmm.2011.05.017; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; Holthausen JT, 2010, DNA REPAIR, V9, P1264, DOI 10.1016/j.dnarep.2010.09.014; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Knoch J, 2012, EUR J DERMATOL, V22, P443, DOI 10.1684/ejd.2012.1654; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lorat Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038165; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Marinoglou Konstantina, 2012, Yale Journal of Biology and Medicine, V85, P469; Martin OA, 2013, DNA REPAIR, V12, P844, DOI 10.1016/j.dnarep.2013.07.002; Nikkila J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3578; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; Raabe A, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-65; Romick-Rosendale LE, 2013, MUTAT RES-FUND MOL M, V743, P78, DOI 10.1016/j.mrfmmm.2013.01.001; Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Rube CE, 2011, DNA REPAIR, V10, P427, DOI 10.1016/j.dnarep.2011.01.012; Rube CE, 2010, INT J RADIAT ONCOL, V78, P359, DOI 10.1016/j.ijrobp.2009.08.052; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Stracker Travis H., 2013, Frontiers in Genetics, V4, P37, DOI 10.3389/fgene.2013.00037; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016	30	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91319	10.1371/journal.pone.0091319	http://dx.doi.org/10.1371/journal.pone.0091319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637877	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100028
J	Tsai, HC; Huang, CY; Su, HL; Tang, CH				Tsai, Hsiao-Chi; Huang, Chun-Yin; Su, Hong-Lin; Tang, Chih-Hsin			CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; FOCAL ADHESION KINASE; DRUG-RESISTANCE; SURVIVIN EXPRESSION; MALIGNANT-MELANOMA; PROGNOSTIC-FACTOR; FACTOR CTGF/CCN2; GENE-EXPRESSION; CANCER CELLS; LUNG-CANCER	Osteosarcoma (OS) is the most common form of malignant bone tumor and is an aggressive malignant neoplasm exhibiting osteoblastic differentiation. Cisplatin is one of the most efficacious antitumor drugs for osteosarcoma patients. However, treatment failures are common due to the development of chemoresistance. CCN2 (also known as CTGF), is a secreted protein that binds to integrins, modulates the invasive behavior of certain human cancer cells. However, the effect of CCN2 in cisplatin-mediated chemotherapy is still unknown. Here, we found that CCN2 was upregulated in human osteosarcoma cells after treatment with cisplatin. Moreover, overexpression of CCN2 increased the resistance to cisplatin-mediated cell apoptosis. In contrast, reduction of CCN2 by CCN2 shRNA promoted the chemotherapeutic effect of cisplatin. We also found that CCN2 provided resistance to cisplatin-induced apoptosis through upregulation of Bcl-xL and survivin. Knockdown of Bcl-xL or survivin removed the CCN2-mediated resistance to apoptosis induced by cisplatin. On the other hand, CCN2 also promoted FAK, MEK, and ERK survival signaling pathways to enhance tumor survival during cisplatin treatment. In a mouse xenograft model, overexpression of CCN2 promoted resistance to cisplatin. However, knockdown of CCN2 increased the therapeutic effect of cisplatin. Therefore, our data suggest that CCN2 might be a critical oncogene of human osteosarcoma for cisplatin-resistance and supported osteosarcoma cell growth in vivo and in vitro.	[Tsai, Hsiao-Chi; Su, Hong-Lin] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Huang, Chun-Yin] China Med Univ, Beigang Hosp, Dept Orthopaed Surg, Taichung, Yun Lin County, Taiwan; [Huang, Chun-Yin] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Su, HL (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	suhonglin@gmail.com; chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Anninga JK, 2011, EUR J CANCER, V47, P2431, DOI 10.1016/j.ejca.2011.05.030; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Demers MJ, 2009, J CELL BIOCHEM, V107, P639, DOI 10.1002/jcb.22131; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gimenez-Bonafe P, 2009, CURR CANCER DRUG TAR, V9, P320, DOI 10.2174/156800909788166600; Hou CH, 2009, BONE, V44, P233, DOI 10.1016/j.bone.2008.09.021; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Huang WC, 2011, BIOMEDICINE-TAIWAN, V1, P2, DOI 10.1016/j.biomed.2011.10.001; Janeway KA, 2010, LANCET ONCOL, V11, P670, DOI 10.1016/S1470-2045(10)70062-0; Karczmarek-Borowska B, 2005, FOLIA HISTOCHEM CYTO, V43, P237; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kubo M, 1998, BRIT J DERMATOL, V139, P192; Liang XJ, 2009, CELL BIOL INT, V33, P119, DOI 10.1016/j.cellbi.2008.10.013; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Moritani NH, 2003, CANCER LETT, V192, P205, DOI 10.1016/S0304-3835(02)00718-8; Osaka E, 2006, ACTA HISTOCHEM CYTOC, V39, P95, DOI 10.1267/ahc.06005; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; Shakunaga T, 2000, CANCER, V89, P1466, DOI 10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Spina A, 2013, J CELL PHYSIOL, V228, P198, DOI 10.1002/jcp.24124; Sridhar SS, 2005, MOL CANCER THER, V4, P677, DOI 10.1158/1535-7163.MCT-04-0297; Trieb K, 2003, EUR J SURG ONCOL, V29, P379, DOI 10.1053/ejso.2002.1415; Wang MY, 2009, CANCER RES, V69, P3482, DOI 10.1158/0008-5472.CAN-08-2524; Wang WJ, 2006, J SURG ONCOL, V93, P578, DOI 10.1002/jso.20507; Wang ZX, 2010, BONE, V47, P445, DOI 10.1016/j.bone.2010.05.027; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Wilkins RM, 2003, ANN SURG ONCOL, V10, P498, DOI 10.1245/ASO.2003.03.061; Xie D, 2001, CANCER RES, V61, P8917; Yatomi M, 2007, ANTICANCER RES, V27, P3235; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Zaffaroni N, 2002, DRUG RESIST UPDATE, V5, P65, DOI 10.1016/S1368-7646(02)00049-3; Zuo GW, 2010, HISTOL HISTOPATHOL, V25, P795, DOI 10.14670/HH-25.795	44	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90159	10.1371/journal.pone.0090159	http://dx.doi.org/10.1371/journal.pone.0090159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637722	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100003
J	Xu, SG; Zhu, JZ; Wu, ZY				Xu, Shuguang; Zhu, Jingzhi; Wu, Zhiyong			Loss of Dab2 Expression in Breast Cancer Cells Impairs Their Ability to Deplete TGF-beta and Induce Tregs Development via TGF-beta	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; TUMOR-SUPPRESSOR; TRANSFORMING GROWTH-FACTOR-BETA-1; MEDIATED ENDOCYTOSIS; PERIPHERAL-BLOOD; DOWN-REGULATION; CUTTING EDGE; RECEPTOR; MECHANISMS	Dab2 is a multifunctional adapter protein which is frequently under-expressed in a variety of cancers. It is implicated in many critical functions, including several signaling pathways, cell arrangement, differentiation of stem cells, and receptor endocytosis. Transforming growth factor-beta (TGF-beta) is a secreted multifunctional protein that controls several developmental processes and pathogenesis of many diseases. It has been documented that Dab2 played an important role in TGF-beta receptors endocytosis. Here, we present evidence that re-expression of Dab2 in SK-BR-3 cell partially restored its ability to deplete TGF-beta in surrounding medium by normalizing the trafficking of TGF-beta receptors. We also demonstrate that the difference in TGF-beta depletions produced by Dab2 expression was sufficient to impact on the conversion of naive CD4+ T cells to regulatory T cells (Tregs), and thus inhibited the proliferation of T cells. This work revealed a critical result that breast cancer cell was deficient in Dab2 expression and related receptor endocytosis-mediated TGF-beta depletion, which may contribute to the accumulation of TGF-beta in tumor microenvironment and the induction of immune tolerance.	[Xu, Shuguang; Zhu, Jingzhi; Wu, Zhiyong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wu, ZY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Surg, Shanghai, Peoples R China.	zhiyongwu@gmail.com						ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Anders RA, 1996, J BIOL CHEM, V271, P21758, DOI 10.1074/jbc.271.36.21758; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; cells T, J IMMUNOL, V173, P6526; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08; DALAL BI, 1993, AM J PATHOL, V143, P381; Desruisseau S, 2006, BRIT J CANCER, V94, P239, DOI 10.1038/sj.bjc.6602920; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Dumont N, 2000, BREAST CANCER RES, V2, P125, DOI 10.1186/bcr44; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Fulop V, 1998, ONCOGENE, V17, P419, DOI 10.1038/sj.onc.1201955; GORSCH SM, 1992, CANCER RES, V52, P6949; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grau AM, 2008, BREAST CANCER RES TR, V112, P335, DOI 10.1007/s10549-007-9845-8; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Ivanovic V, 2006, CLIN CHIM ACTA, V371, P191, DOI 10.1016/j.cca.2006.02.027; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Koumoundourou D, 2007, ANTICANCER RES, V27, P2613; LAIHO M, 1987, J BIOL CHEM, V262, P17467; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; MACCALLUM J, 1994, BRIT J CANCER, V69, P1006, DOI 10.1038/bjc.1994.197; Marrogi AJ, 1997, INT J CANCER, V74, P492, DOI 10.1002/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z; Martin JC, 2010, BRIT J CANCER, V103, P1716, DOI 10.1038/sj.bjc.6605975; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MASSAGUE J, 1986, J CELL PHYSIOL, V128, P216, DOI 10.1002/jcp.1041280212; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayorga ME, 2011, STEM CELLS DEV, V20, P681, DOI 10.1089/scd.2010.0151; MCCUNE BK, 1992, HUM PATHOL, V23, P13, DOI 10.1016/0046-8177(92)90004-M; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; O'Brien PJ, 2008, BIOL-TARGETS THER, V2, P563; Oluwadara O, 2011, BIOINFORMATION, V5, P285, DOI 10.6026/97320630005285; Paiva CE, 2010, ANN ONCOL, V21, P734, DOI 10.1093/annonc/mdp518; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Penheiter SG, 2010, MOL BIOL CELL, V21, P4009, DOI 10.1091/mbc.E09-12-1019; Petrausch U, 2009, J IMMUNOL, V183, P3682, DOI 10.4049/jimmunol.0900560; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Sheng ZJ, 2000, GENOMICS, V70, P381, DOI 10.1006/geno.2000.6383; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Tong JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-253; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Tseng CP, 1998, ENDOCRINOLOGY, V139, P3542, DOI 10.1210/en.139.8.3542; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; WALKER RA, 1992, EUR J CANCER, V28A, P641, DOI 10.1016/S0959-8049(05)80116-9; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Wang ZK, 2012, CANCER IMMUNOL IMMUN, V61, P911, DOI 10.1007/s00262-011-1158-4; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22; Zwaagstra JC, 2001, J BIOL CHEM, V276, P27237, DOI 10.1074/jbc.M100033200	69	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91709	10.1371/journal.pone.0091709	http://dx.doi.org/10.1371/journal.pone.0091709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638085	Green Submitted, Green Published, gold			2022-12-27	WOS:000333254100053
J	Cornet, AD; Groeneveld, ABJ; Hofstra, JJ; Vlaar, AP; Tuinman, PR; van Lingen, A; Levi, M; Girbes, ARJ; Schultz, MJ; Beishuizen, A				Cornet, Alexander D.; Groeneveld, A. B. Johan; Hofstra, Jorrit J.; Vlaar, Alexander P.; Tuinman, Pieter R.; van Lingen, Arthur; Levi, Marcel; Girbes, Armand R. J.; Schultz, Marcus J.; Beishuizen, Albertus			Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial	PLOS ONE			English	Article							ACUTE LUNG INJURY; PULMONARY LEAK INDEX; SEVERE SEPSIS; PERMEABILITY; COAGULOPATHY; INFLAMMATION; COAGULATION; PNEUMONIA; SEVERITY; SAFETY	Rationale: Pulmonary coagulopathy may play a pathogenetic role in acute respiratory distress syndrome (ARDS), by contributing to alveolocapillary inflammation and increased permeability. Recombinant human activated protein C (rh-APC) may inhibit this process and thereby improve patient outcome. Methods: A prospective randomized, saline-controlled, single-blinded clinical trial was performed in the intensive care units of two university hospitals, and patients with ARDS were included within 24 h after meeting inclusion criteria. Intervention: A 4-day course of intravenous rh-APC (24 mcg/kg/h) (n = 33) versus saline (n = 38). Outcomes: The primary outcome parameter was the pulmonary leak index (PLI) of (67)Gallium-transferrin as a measure of alveolocapillary permeability and secondary outcomes were disease severity scores and ventilator-free days, among others. Results: Baseline characteristics were similar; in 87% of patients the PLI was above normal and in 90% mechanical or non-invasive ventilation was instituted at a median lung injury score of 2.5. There was no evidence that Rh-APC treatment affected the PLI or attenuated lung injury and sequential organ failure assessment scores. Mean ventilator-free days amounted to 14 (rh-APC) and 12 days (saline, P = 0.35). 28-day mortality was 6% in rh-APC- and 18% in saline-treated patients (P = 0.12). There was no difference in bleeding events. The study was prematurely discontinued because rh-APC was withdrawn from the market. Conclusion: There is no evidence that treatment with intravenous rh-APC during 4 days for infectious or inflammatory ARDS ameliorates increased alveolocapillary permeability or the clinical course of ARDS patients. We cannot exclude underpowering.	[Cornet, Alexander D.; Groeneveld, A. B. Johan; Girbes, Armand R. J.; Beishuizen, Albertus] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Cornet, Alexander D.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Cornet, Alexander D.; Groeneveld, A. B. Johan; Girbes, Armand R. J.; Beishuizen, Albertus] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands; [Groeneveld, A. B. Johan] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [Hofstra, Jorrit J.; Vlaar, Alexander P.; Tuinman, Pieter R.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [Hofstra, Jorrit J.; Vlaar, Alexander P.; Tuinman, Pieter R.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Vlaar, Alexander P.; Levi, Marcel] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [van Lingen, Arthur] Vrije Univ Amsterdam, Med Ctr, Dept Nucl Med, Amsterdam, Netherlands; [Beishuizen, Albertus] Medisch Spectrum Twente, Dept Intens Care, Enschede, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Medical Spectrum Twente	Cornet, AD (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands.	cornet@vumc.nl	Levi, Marcel/AAZ-8559-2020; Tuinman, Pieter/AAN-2572-2020; Tuinman, Pieter/W-8624-2019; Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792; Cornet, Alexander/0000-0002-9917-5251; Tuinman, Pieter Roel/0000-0003-4335-5568; Vlaar, Alexander/0000-0002-3453-7186	Eli Lilly Inc. (Indianapolis, IN, USA)	Eli Lilly Inc. (Indianapolis, IN, USA)(Eli Lilly)	This trial has been supported via an unrestricted research grant from Eli Lilly Inc. (Indianapolis, IN, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Bae JS, 2010, J THROMB HAEMOST, V8, P1107, DOI 10.1111/j.1538-7836.2010.03812.x; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bir N, 2011, AM J RESP CELL MOL, V45, P632, DOI 10.1165/rcmb.2010-0397OC; Cepkova Magda, 2006, J Intensive Care Med, V21, P119, DOI 10.1177/0885066606287045; Choi G, 2007, CRIT CARE MED, V35, P1362, DOI 10.1097/01.CCM.0000261888.32654.6D; Cornet AD, 2013, J THROMB HAEMOST, V11, P894, DOI 10.1111/jth.12179; Cornet AD, 2009, EXPERT OPIN DRUG DIS, V4, P219, DOI 10.1517/17460440902721204; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ely EW, 2003, CRIT CARE MED, V31, P12, DOI 10.1097/00003246-200301000-00002; Finigan JH, 2009, AM J PHYSIOL-LUNG C, V296, pL1002, DOI 10.1152/ajplung.90555.2008; Groeneveld ABJ, 2006, INTENS CARE MED, V32, P1315, DOI 10.1007/s00134-006-0212-8; Groeneveld AB, 1994, THROMB HAEMOSTASIS, V78, P1444; Groeneveld ABJ, 1996, CRIT CARE MED, V24, P1467, DOI 10.1097/00003246-199609000-00007; Hofstra JJ, 2010, J AEROSOL MED PULM D, V23, P105, DOI 10.1089/jamp.2009.0779; Kalil AC, 2012, LANCET INFECT DIS, V12, P678, DOI 10.1016/S1473-3099(12)70157-3; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Nick JA, 2004, BLOOD, V104, P3878, DOI 10.1182/blood-2004-06-2140; Raijmakers PGHM, 1996, J NUCL MED, V37, P1316; RAIJMAKERS PGHM, 1993, CHEST, V104, P1825, DOI 10.1378/chest.104.6.1825; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Schultz MJ, 2006, CRIT CARE MED, V34, P871, DOI 10.1097/01.CCM.0000202136.91651.34; Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; van der Poll T, 2005, AM J RESP CRIT CARE, V171, P1125, DOI 10.1164/rccm.200411-1483OC; Verheij J, 2005, J CRIT CARE, V20, P162, DOI 10.1016/j.jcrc.2004.12.002; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 2003, CRIT CARE MED, V31, P834, DOI 10.1097/01.CCM.0000051515.56179.E1; Ware LB, 2007, CRIT CARE MED, V35, P1821, DOI 10.1097/01.CCM.0000275386.95968.5F; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wind J, 2007, RESP MED, V101, P2091, DOI 10.1016/j.rmed.2007.05.021	40	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90983	10.1371/journal.pone.0090983	http://dx.doi.org/10.1371/journal.pone.0090983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632673	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400029
J	Kakeya, H; Seki, M; Izumikawa, K; Kosai, K; Morinaga, Y; Kurihara, S; Nakamura, S; Imamura, Y; Miyazaki, T; Tsukamoto, M; Yanagihara, K; Tashiro, T; Kohno, S				Kakeya, Hiroshi; Seki, Masafumi; Izumikawa, Koichi; Kosai, Kosuke; Morinaga, Yoshitomo; Kurihara, Shintaro; Nakamura, Shigeki; Imamura, Yoshifumi; Miyazaki, Taiga; Tsukamoto, Misuzu; Yanagihara, Katsunori; Tashiro, Takayoshi; Kohno, Shigeru			Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; VENTILATOR-ASSOCIATED PNEUMONIA; SEASONAL INFLUENZA; BACTERIAL PNEUMONIA; ORAL OSELTAMIVIR; VIRUS-INFECTION; LUNG INJURY; CLARITHROMYCIN; OUTCOMES; COMPLICATIONS	Background: Macrolides have antibiotic and immunomodulatory activities, which may have a favorable effect on the clinical outcome of patients with infections, including influenza. This study aimed to evaluate the effects of combination therapy with an anti-influenza agent, oseltamivir, and a single-dose formulation of azithromycin (AZM), which has been used for influenza-related secondary pneumonia, on influenza patients. The primary endpoint was a change in the expression levels of inflammatory cytokines. Secondary endpoints were the time required for resolution of influenza-related symptoms, incidence of complications, and adverse reactions. Methods: Patients with seasonal influenza were enrolled in this multicenter, open-label, randomized study. Patients were stratified according to the presence of a high risk factor and were randomized to receive combination therapy with oseltamivir plus an extended-release formulation of AZM (combo-group) or oseltamivir monotherapy (mono-group). Results: We enrolled 107 patients and randomized them into the mono-group (56 patients) or the combo-group (51 patients). All patients were diagnosed with influenza A infection, and none of the patients had comorbid pneumonia. Statistically significant differences were not observed in the expression levels of inflammatory cytokines and chemokines between the 2 groups. The maximum temperature in the combo-group was lower than that in the mono-group on day 3 through day 5 (p = 0.048), particularly on day 4 (p = 0.037). Conclusion: To our knowledge, this is the first prospective, randomized, clinical trial of oseltamivir and AZM combination therapy for influenza. Although the difference in inflammatory cytokine expression level was not statistically significant, combination therapy showed an early resolution of some symptoms.	[Kakeya, Hiroshi] Osaka City Univ, Grad Sch Med, Dept Infect Control Sci, Osaka 558, Japan; [Kakeya, Hiroshi; Izumikawa, Koichi; Nakamura, Shigeki; Imamura, Yoshifumi; Miyazaki, Taiga; Kohno, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Seki, Masafumi] Osaka Univ Hosp, Div Infect & Control & Prevent, Osaka 553, Japan; [Izumikawa, Koichi; Kosai, Kosuke; Kurihara, Shintaro; Tsukamoto, Misuzu] Nagasaki Univ Hosp, Infect Control & Educ Ctr, Nagasaki, Japan; [Morinaga, Yoshitomo; Yanagihara, Katsunori] Nagasaki Univ Hosp, Dept Lab Med, Nagasaki, Japan; [Tashiro, Takayoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hlth Sci, Nagasaki 852, Japan	Osaka Metropolitan University; Nagasaki University; Osaka University; Nagasaki University; Nagasaki University; Nagasaki University	Kakeya, H (corresponding author), Osaka City Univ, Grad Sch Med, Dept Infect Control Sci, Osaka 558, Japan.	kakeya-ngs@umin.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [23591151, 25461516]; Japanese Ministry of Health, Labour and Welfare Sciences Research Grants [H25-Shinko-ippan-006]; nonprofit corporation Nagasaki Evaluation Organization for Clinical Interventions (NEOCI; Nagasaki, Japan); Pfizer Inc.	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare Sciences Research Grants; nonprofit corporation Nagasaki Evaluation Organization for Clinical Interventions (NEOCI; Nagasaki, Japan); Pfizer Inc.(Pfizer)	This study was supported by a Grant-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (No. 23591151 and No. 25461516) as well as by the Japanese Ministry of Health, Labour and Welfare Sciences Research Grants (H25-Shinko-ippan-006). The nonprofit corporation Nagasaki Evaluation Organization for Clinical Interventions (NEOCI; Nagasaki, Japan) and Pfizer Inc. also provided grants for this study, but the sponsors were not involved in the design of the study; enrollment of patients; data collection, analysis, and interpretation; or preparation of the manuscript.	Beigelman A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-90; Brown RB, 2003, CHEST, V123, P1503, DOI 10.1378/chest.123.5.1503; Deng R, 2008, J PATHOL, V216, P328, DOI 10.1002/path.2417; Giamarellos-Bourboulis EJ, 2008, CLIN INFECT DIS, V46, P1157, DOI 10.1086/529439; Ishii H, 2012, J INFECTION, V64, P343, DOI 10.1016/j.jinf.2011.12.002; Karlstrom A, 2009, J INFECT DIS, V199, P311, DOI 10.1086/596051; Kido H, 2007, CURR PHARM DESIGN, V13, P405, DOI 10.2174/138161207780162971; Kikuchi Y, 2009, PULM PHARMACOL THER, V22, P333, DOI 10.1016/j.pupt.2008.12.021; Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P2803, DOI 10.1128/AAC.01718-10; Konstantinos AP, 2001, RESP PHYSIOL, V128, P71, DOI 10.1016/S0034-5687(01)00266-3; Kosai K, 2008, SCAND J INFECT DIS, V40, P338, DOI 10.1080/00365540701660486; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3977, DOI 10.1128/AAC.00006-07; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martin C, 2001, INT CONGR SER, V1219, P807, DOI 10.1016/S0531-5131(01)00359-4; Martin-Loeches I, 2013, INTENS CARE MED, V39, P693, DOI 10.1007/s00134-013-2829-8; Martin-Loeches I, 2010, INTENS CARE MED, V36, P612, DOI 10.1007/s00134-009-1730-y; Meyer M, 2009, AM J RESP CELL MOL, V41, P590, DOI 10.1165/rcmb.2008-0155OC; Pocock S. J., 1975, BIOMETRICS, V31, P102; Sato K, 1998, AM J RESP CRIT CARE, V157, P853, DOI 10.1164/ajrccm.157.3.9703098; Sawabuchi T, 2009, RESPIROLOGY, V14, P1173, DOI 10.1111/j.1440-1843.2009.01639.x; Shimizu T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/265714; Spyridaki A, 2012, ANTIMICROB AGENTS CH, V56, P3819, DOI 10.1128/AAC.05798-11; Takahashi E, 2010, MICROBES INFECT, V12, P778, DOI 10.1016/j.micinf.2010.04.013; Tamaoki J, 1997, AM J PHYSIOL-LUNG C, V272, pL15, DOI 10.1152/ajplung.1997.272.1.L15; Viasus D, 2011, J INFECTION, V62, P193, DOI 10.1016/j.jinf.2011.01.014; Walkey AJ, 2012, CHEST, V141, P1153, DOI 10.1378/chest.11-1908; WHITMAN MS, 1992, INFECT CONT HOSP EP, V13, P357; Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705; Zarogoulidis P, 2012, EUR J CLIN PHARMACOL, V68, P479, DOI 10.1007/s00228-011-1161-x	30	36	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91293	10.1371/journal.pone.0091293	http://dx.doi.org/10.1371/journal.pone.0091293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632748	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400051
J	Nadkarni, MA; Chen, ZL; Wilkins, MR; Hunter, N				Nadkarni, Mangala A.; Chen, Zhiliang; Wilkins, Marc R.; Hunter, Neil			Comparative Genome Analysis of Lactobacillus rhamnosus Clinical Isolates from Initial Stages of Dental Pulp Infection: Identification of a New Exopolysaccharide Cluster	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; COLLAGEN-BINDING PROTEIN; GENE CLUSTERS; MOLECULAR CHARACTERIZATION; LISTERIA-MONOCYTOGENES; ADHESION; CASEI; GG; BIOSYNTHESIS; EVOLUTION	The human oral microbiome has a major role in oral diseases including dental caries. Our studies on progression of caries infection through dentin and more recently, the invasion of vital dental pulp, detected Lactobacillus rhamnosus in the initial stages of infection of vital pulp tissue. In this study employing current high-throughput next generation sequencing technology we sought to obtain insight into genomic traits of tissue invasive L. rhamnosus, to recognise biomarkers that could provide an understanding of pathogenic potential of lactobacilli, generally regarded as safe. Roche GS FLX+ technology was used to generate whole genome sequences of two clinical isolates of L. rhamnosus infecting vital pulp. Detailed genome-wide comparison of the genetic profiles of tissue invasive L. rhamnosus with probiotic L. rhamnosus was performed to test the hypothesis that specific strains of L. rhamnosus possessing a unique gene complement are selected for the capacity to invade vital pulp tissue. Analysis identified 264 and 258 genes respectively, from dental pulp-invasive L. rhamnosus strains LRHMDP2 and LRHMDP3 isolated from two different subjects that were not present in the reference probiotic L. rhamnosus strain ATCC 53103 (GG). Distinct genome signatures identified included the presence of a modified exopolysaccharide cluster, a characteristic confirmed in a further six clinical isolates. Additional features of LRHMDP2 and LRHMDP3 were altered transcriptional regulators from RpoN, NtrC, MutR, ArsR and zinc-binding Cro/CI families, as well as changes in the two-component sensor kinase response regulator and ABC transporters for ferric iron. Both clinical isolates of L. rhamnosus contained a single SpaFED cluster, as in L. rhamnosus Lc705, instead of the two Spa clusters (SpaCBA and SpaFED) identified in L. rhamnosus ATCC 53103 (GG). Genomic distance analysis and SNP divergence confirmed a close relationship of the clinical isolates but segregation from the reference probiotic L. rhamnosus strain ATCC 53103 (GG).	[Nadkarni, Mangala A.; Hunter, Neil] Westmead Ctr Oral Hlth, Inst Dent Res, Westmead, NSW, Australia; [Nadkarni, Mangala A.; Hunter, Neil] Westmead Millennium Inst, Westmead, NSW, Australia; [Nadkarni, Mangala A.; Hunter, Neil] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia; [Chen, Zhiliang; Wilkins, Marc R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of New South Wales Sydney	Nadkarni, MA (corresponding author), Westmead Ctr Oral Hlth, Inst Dent Res, Westmead, NSW, Australia.	mangala.nadkarni@sydney.edu.au			NIDCR [R01 DE015272-07]; Westmead Centre for Oral Health; Australian Government Super Science Scheme; New South Wales State Government Science Leveraging Fund (SLF); University of New South Wales; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015272] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Westmead Centre for Oral Health; Australian Government Super Science Scheme(Australian Government); New South Wales State Government Science Leveraging Fund (SLF); University of New South Wales; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported partially by NIDCR grant R01 DE015272-07, by the Westmead Centre for Oral Health, by the Australian Government Super Science Scheme, the New South Wales State Government Science Leveraging Fund (SLF) and by the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Chen Z, 2013, GENOME ANNOUNC, V1; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Fiocco D, 2010, J BACTERIOL, V192, P896, DOI 10.1128/JB.01122-09; Francl AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-77; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubble TS, 2003, ORAL MICROBIOL IMMUN, V18, P121, DOI 10.1034/j.1399-302X.2003.00059.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; Jolly L, 2001, INT DAIRY J, V11, P733, DOI 10.1016/S0958-6946(01)00117-0; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Laws A, 2001, BIOTECHNOL ADV, V19, P597, DOI 10.1016/S0734-9750(01)00084-2; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Love RM, 2002, CRIT REV ORAL BIOL M, V13, P171, DOI 10.1177/154411130201300207; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2007, J BACTERIOL, V189, P1199, DOI 10.1128/JB.01351-06; Monedero V, 2008, RES MICROBIOL, V159, P94, DOI 10.1016/j.resmic.2007.10.002; Monedero V, 2007, J MOL MICROB BIOTECH, V12, P20, DOI 10.1159/000096456; Nadkarni MA, 2010, J CLIN MICROBIOL, V48, P1732, DOI 10.1128/JCM.01912-09; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Paster BJ, 2009, PERIODONTOL 2000, V51, P38, DOI 10.1111/j.1600-0757.2009.00316.x; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Schaudinn C, 2009, J MICROSC-OXFORD, V235, P124, DOI 10.1111/j.1365-2818.2009.03201.x; Schroeder K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007567; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Song J, 2005, BIOINFORMATICS, V21, P2083, DOI 10.1093/bioinformatics/bti176; Stevens MJA, 2010, MICROBIOL-SGM, V156, P695, DOI 10.1099/mic.0.034165-0; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Welman AD, 2003, TRENDS BIOTECHNOL, V21, P269, DOI 10.1016/S0167-7799(03)00107-0; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	48	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e90643	10.1371/journal.pone.0090643	http://dx.doi.org/10.1371/journal.pone.0090643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632842	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400017
J	Pilipow, K; Basso, V; Migone, N; Mondino, A				Pilipow, Karolina; Basso, Veronica; Migone, Nicola; Mondino, Anna			Monoallelic Germline TSC1 Mutations Are Permissive for T Lymphocyte Development and Homeostasis in Tuberous Sclerosis Complex Individuals	PLOS ONE			English	Article							GENE INACTIVATION; ALLELIC LOSS; MOUSE MODEL; PATHOGENESIS; TUMORS; QUIESCENCE; MAINTAINS; SURVIVAL; LESIONS	Germline and somatic biallelic mutations of the Tuberous sclerosis complex (TSC) 1 and TSC2 gene products cause TSC, an autosomal dominant multifocal hamartomatosis with variable neurological manifestations. The consequences of TSC1 or TSC2 loss in cells of hematopoietic origin have recently started to be unveiled in mice and showed to hinder the development of proper T cell immunity. To date, the consequences of germline TSC1 mutations and/or its loss in mature human T cells remain to be determined. To address these issues, we analyzed subset representation, phenotype and responsiveness to mitogens in T cells from patients with inherited monoallelic TSC1 mutations, and induced shRNA-mediated TSC1 down-regulation in primary and transformed human T cells. We report that, the distribution of peripheral CD4 and CD8 T cell subsets, their cytokine-secretion profile, and responsiveness to in vitro stimulation were largely preserved in TSC subjects with monoallelic TSC1 germline mutations when compared to healthy controls. Sufficient levels of hamartin and tuberin and proper control of mTOR-dependent signaling in primary T cells from TSC subjects best explained this. In contrast, shRNA-induced down-regulation of TSC1, likely mimicking biallelic inactivation of TSC1, compromised hamartin and tuberin expression and mTORC2/AKT/FoxO1/3 signaling causing both primary and transformed T cells to die by apoptosis. Thus, our results indicate that, while one functional TSC1 allele preserves human T lymphocytes development and homeostasis, TSC1 acute down-regulation is detrimental to the survival of both primary and transformed T cells.	[Pilipow, Karolina; Basso, Veronica; Mondino, Anna] Ist Sci San Raffaele, Immunol Transplantat & Infect Dis Div, Lymphocyte Activat Unit, I-20132 Milan, Italy; [Pilipow, Karolina] Univ Vita Salute San Raffaele, Milan, Italy; [Migone, Nicola] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Migone, Nicola] Univ San Giovanni Battista, Azienda Osped, Turin, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Turin	Mondino, A (corresponding author), Ist Sci San Raffaele, Immunol Transplantat & Infect Dis Div, Lymphocyte Activat Unit, I-20132 Milan, Italy.	anna.mondino@hsr.it	Basso, Veronica/AAC-8131-2019; Mondino, Anna/K-9434-2016	Mondino, Anna/0000-0003-0833-6927; basso, veronica/0000-0003-1880-8406	Associazione Italiana Ricerca sul Cancro; San Raffaele Vita-Salute University; FIRC	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); San Raffaele Vita-Salute University; FIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Associazione Italiana Ricerca sul Cancro to AM. KP benefited of fellowships from the San Raffaele Vita-Salute University (2010-2012) and from FIRC (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLSEN G, 1994, ARCH NEUROL-CHICAGO, V51, P76, DOI 10.1001/archneur.1994.00540130110018; Borkowska J, 2011, INT J DERMATOL, V50, P13, DOI 10.1111/j.1365-4632.2010.04727.x; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Colombetti S, 2002, J IMMUNOL, V169, P6178, DOI 10.4049/jimmunol.169.11.6178; Crino PB, 2010, NEUROLOGY, V74, P1716, DOI 10.1212/WNL.0b013e3181e04325; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Hayashi T, 2010, MODERN PATHOL, V23, P1251, DOI 10.1038/modpathol.2010.114; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Henske EP, 1996, AM J HUM GENET, V59, P400; Henske EP, 1997, AM J PATHOL, V151, P1639; Hoogeveen-Westerveld M, 2011, HUM MUTAT, V32, P424, DOI 10.1002/humu.21451; Hoogeveen-Westerveld M, 2010, BBA-MOL BASIS DIS, V1802, P774, DOI 10.1016/j.bbadis.2010.06.004; Jentarra GM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-29; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; O'Brien TF, 2011, EUR J IMMUNOL, V41, P3361, DOI 10.1002/eji.201141411; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwartz RA, 2007, J AM ACAD DERMATOL, V57, P189, DOI 10.1016/j.jaad.2007.05.004; Song W, 2012, J NEUROCHEM, V123, P325, DOI 10.1111/j.1471-4159.2012.07914.x; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tucker T, 2002, CLIN GENET, V62, P345, DOI 10.1034/j.1399-0004.2002.620501.x; Weiner DM, 1998, J AM COLL SURGEONS, V187, P548, DOI 10.1016/S1072-7515(98)00239-7; Wolf HK, 1997, ACTA NEUROPATHOL, V93, P93, DOI 10.1007/s004010050587; Wu Q, 2011, J IMMUNOL, V187, P1106, DOI 10.4049/jimmunol.1003968; Yang K, 2011, NAT IMMUNOL; Zeng LH, 2011, HUM MOL GENET, V20, P445, DOI 10.1093/hmg/ddq491; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030249, 10.1371/journal.pone.0030592]	39	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91952	10.1371/journal.pone.0091952	http://dx.doi.org/10.1371/journal.pone.0091952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24633152	Green Published, gold, Green Submitted			2022-12-27	WOS:000332858400124
J	Sigurgeirsson, B; Emanuelsson, O; Lundeberg, J				Sigurgeirsson, Benjamin; Emanuelsson, Olof; Lundeberg, Joakim			Sequencing Degraded RNA Addressed by 3 ' Tag Counting	PLOS ONE			English	Article							SEQ; QUANTIFICATION; TRANSCRIPTION; DEGRADATION; INTEGRITY	RNA sequencing has become widely used in gene expression profiling experiments. Prior to any RNA sequencing experiment the quality of the RNA must be measured to assess whether or not it can be used for further downstream analysis. The RNA integrity number (RIN) is a scale used to measure the quality of RNA that runs from 1 (completely degraded) to 10 (intact). Ideally, samples with high RIN (>8) are used in RNA sequencing experiments. RNA, however, is a fragile molecule which is susceptible to degradation and obtaining high quality RNA is often hard, or even impossible when extracting RNA from certain clinical tissues. Thus, occasionally, working with low quality RNA is the only option the researcher has. Here we investigate the effects of RIN on RNA sequencing and suggest a computational method to handle data from samples with low quality RNA which also enables reanalysis of published datasets. Using RNA from a human cell line we generated and sequenced samples with varying RINs and illustrate what effect the RIN has on the basic procedure of RNA sequencing; both quality aspects and differential expression. We show that the RIN has systematic effects on gene coverage, false positives in differential expression and the quantification of duplicate reads. We introduce 3' tag counting (3TC) as a computational approach to reliably estimate differential expression for samples with low RIN. We show that using the 3TC method in differential expression analysis significantly reduces false positives when comparing samples with different RIN, while retaining reasonable sensitivity.	[Sigurgeirsson, Benjamin; Emanuelsson, Olof; Lundeberg, Joakim] Royal Inst Technol KTH, Sch Biotechnol, Sci Life Lab, Solna, Sweden	Royal Institute of Technology	Lundeberg, J (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Sci Life Lab, Solna, Sweden.	joakim.lundeberg@scilifelab.se	Sigurgeirsson, Bárður/B-6130-2011	Sigurgeirsson, Bardur/0000-0002-9733-9742	Swedish Research Council; Knut and Alice Wallenberg Foundation; Science for Life Laboratories, National Genomics Infrastructure (NGI), Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Science for Life Laboratories, National Genomics Infrastructure (NGI), Sweden	This work was supported by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, and Science for Life Laboratories, National Genomics Infrastructure (NGI), Sweden. The computations were performed on resources provided by SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2013, NATURE METHODS; Anders S, 2013, HTSEQ COUNT; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brisco MJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks588; Derti A, 2012, GENOME RES; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Felix K., 2013, TRIM GALORE; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Li W, 2012, BIOINFORMATICS, V28, P2914, DOI 10.1093/bioinformatics/bts559; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Solnestam BW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-574; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wan L, 2012, BIOSTATISTICS, V13, P734, DOI 10.1093/biostatistics/kxs001; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wu ZP, 2011, BIOINFORMATICS, V27, P502, DOI 10.1093/bioinformatics/btq696; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16	29	59	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91851	10.1371/journal.pone.0091851	http://dx.doi.org/10.1371/journal.pone.0091851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632678	Green Published, Green Submitted, gold			2022-12-27	WOS:000332858400109
J	Zhang, Q; Chen, W; Wu, XB; Su, YL; Hou, ZY; Zhang, YZ				Zhang, Qi; Chen, Wei; Wu, Xiaobo; Su, Yanling; Hou, Zhiyong; Zhang, Yingze			Comparative Study of W-Shaped Angular Plate and Reconstruction Plate in Treating Posterior Wall Fractures of the Acetabulum	PLOS ONE			English	Article							INTRAOPERATIVE FLUOROSCOPY; INTERNAL-FIXATION; SURGERY; REDUCTION; ACCURACY	Objective: This study aims to assess the medium-term results of the reconstruction of posterior wall fractures using a W-shaped acetabular angular plate (WAAP) compared to those fixed using a reconstruction plate. Methods: Between July 2006 and March 2009, we performed a retrospective study, which collected data for any patient treated for a posterior acetabular wall fracture. At the time of treatment, patients were either treated using a WAAP or a pelvic reconstruction plate. The intraoperative fluoroscopic images for both groups were compared. The quality of reduction and radiological grading were assessed according to the criteria developed by Matta. The clinical assessment was based on a modified Merle d'Aubigne and Postel scoring. Results: 53 patients met the inclusion criteria and were followed up for an average of 38 months. 25 patients were treated with a WAAP (study group), and 28 patients were treated with a pelvic reconstruction plate (control group). The intraoperative fluoroscopic images of the study group confirmed extra-articular screw placement in all cases. In the control group, intra-articular screw placement was observed intraoperatively in 5 patients (17.86%), and the definitive location of the periarticular hardware could not be determined in 4 patients (14.29%) during the operation. The differences between the two groups were statistically significant (p = 0.002). In contrast, the quality of fracture reduction, clinical outcomes, and radiological grading in the study group were not significantly different from those of the control group (p>0.05). The radiographic grade was strongly associated with the clinical outcomes in both the study and control groups (p<0.05). Conclusion: Reconstruction of posterior wall fractures of the acetabulum using a WAAP can help avoid screw penetration of the hip joint, provide a stable fixation of the posterior wall, and ensure good clinical outcomes.	[Zhang, Qi; Chen, Wei; Su, Yanling; Hou, Zhiyong; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China; [Wu, Xiaobo] Second Hosp Tangshan, Dept Orthopaed Surg, Tangshan, Hebei, Peoples R China	Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China.	dryzzhang@126.com	Chen, Wei/GRX-2231-2022	Zhang, YIngze/0000-0001-8042-6105; Hou, Zhiyong/0000-0001-5838-4025				Briffa N, 2011, J BONE JOINT SURG BR, V93B, P229, DOI 10.1302/0301-620X.93B2.24056; Carmack DB, 2001, J BONE JOINT SURG AM, V83A, P1370, DOI 10.2106/00004623-200109000-00012; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001; Ebraheim N A, 1992, J Orthop Trauma, V6, P146, DOI 10.1097/00005131-199206000-00003; Ebraheim NA, 2007, INT ORTHOP, V31, P671, DOI 10.1007/s00264-006-0246-0; Ficat RP, 1980, ISCHEMIA NECROSIS BO, P171; Gansslen A, 2009, OPER ORTHOPADE TRAUM, V21, P283, DOI 10.1007/s00064-009-1805-5; Giannoudis PV, 2007, J BONE JOINT SURG BR, V89B, P503, DOI 10.1302/0301-620X.89B4.18380; GOULET JA, 1994, J BONE JOINT SURG AM, V76A, P1457, DOI 10.2106/00004623-199410000-00004; Kendoff D, 2008, ARCH ORTHOP TRAUM SU, V128, P599, DOI 10.1007/s00402-007-0411-y; Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002; McMaster J, 2005, CURR ORTHOPAED, V19, P140, DOI 10.1016/j.cuor.2005.03.001; Moed BR, 2007, J TRAUMA, V62, pS63, DOI 10.1097/TA.0b013e318065adb4; Moed BR, 1996, J ORTHOP TRAUMA, V10, P93, DOI 10.1097/00005131-199602000-00004; Norris BL, 1999, J ORTHOP TRAUMA, V13, P414, DOI 10.1097/00005131-199908000-00004; Olson SA, 2007, J ORTHOP TRAUMA, V21, P608, DOI 10.1097/BOT.0b013e3181591397; Oransky M, 1993, J Orthop Trauma, V7, P28, DOI 10.1097/00005131-199302000-00006; Osgood GM, 2009, CURR ORTHOP PRACT, V20, P511, DOI 10.1097/BCO.0b013e3181b3a5f2; Porter SE, 2008, J ORTHOP TRAUMA, V22, P165, DOI 10.1097/BOT.0b013e318165918b; Richter H, 2004, J ORTHOP TRAUMA, V18, P179, DOI 10.1097/00005131-200403000-00010; RUESCH PD, 1994, CLIN ORTHOP RELAT R, P38; Stockle U, 2007, INJURY, V38, P450, DOI 10.1016/j.injury.2007.01.024; Tadros AMA, 2010, J TRAUMA, V68, P478, DOI 10.1097/TA.0b013e3181b28aee; Wu XB, 2010, J TRAUMA, V69, P423, DOI 10.1097/TA.0b013e3181ca05f6	24	10	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e92210	10.1371/journal.pone.0092210	http://dx.doi.org/10.1371/journal.pone.0092210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632754	gold, Green Published, Green Submitted			2022-12-27	WOS:000332858400151
J	Wu, H; Jiang, TL; Huang, XB; Lin, HJ; Wang, HW; Wang, L; Niu, HX; Feng, J				Wu, Hui; Jiang, Tinglei; Huang, Xiaobin; Lin, Hongjun; Wang, Hongwei; Wang, Lei; Niu, Hongxing; Feng, Jiang			A Test of Rensch's Rule in Greater Horseshoe Bat (Rhinolophus ferrumequinum) with Female-Biased Sexual Size Dimorphism	PLOS ONE			English	Article							WING MORPHOLOGY; WATER STRIDER; BODY-SIZE; ALLOMETRY; SELECTION; CHIROPTERA; EVOLUTION; MAMMALIA; BERGMANN; FAILS	Sexual size dimorphism (SSD) is widespread within the animal kingdom. Rensch's rule describes a relationship between SSD and body size: SSD increases with body size when males are the larger sex, and decreases with body size when females are the larger sex. Rensch's rule is well supported for taxa that exhibit male-biased SSD but patterns of allometry among taxa with female-biased size dimorphism are mixed, there is evidence both for and against the rule. Furthermore, most studies have investigated Rensch's rule across a variety of taxa; but among-population studies supporting Rensch's rule are lacking, especially in taxa that display only slight SSD. Here, we tested whether patterns of intraspecific variation in SSD in greater horseshoe bats conform to Rensch's rule, and evaluated the contribution of latitude to Rensch's rule. Our results showed SSD was consistently female-biased in greater horseshoe bats, although female body size was only slightly larger than male body size. The slope of major axis regression of log(10) (male) on log(10) (female) was significantly different from 1. Forearm length for both sexes of greater horseshoe bats was significantly negatively correlated with latitude, and males displayed a slightly but nonsignificant steeper latitudinal cline in body size than females. We suggest that variation in patterns of SSD among greater horseshoe bat populations is consistent with Rensch's rule indicating that males were the more variable sex. Males did not have a steeper body size-latitude relationship than females suggesting that sex-specific latitudinal variation in body size may not be an important contributing factor to Rensch's rule. Future research on greater horseshoe bats might best focus on more comprehensive mechanisms driving the pattern of female-biased SSD variation.	[Wu, Hui; Jiang, Tinglei; Huang, Xiaobin; Lin, Hongjun; Wang, Hongwei; Wang, Lei; Feng, Jiang] NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchu, Peoples R China; [Wu, Hui; Jiang, Tinglei; Feng, Jiang] NE Normal Univ, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Niu, Hongxing] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Henan Normal University	Jiang, TL (corresponding author), NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchu, Peoples R China.	jiangtl730@nenu.edu.cn; fengj@nenu.edu.cn	Lin, Hongjun/G-8462-2011; Jiang, Tinglei/GQQ-9485-2022; Wu, Hao/AGE-4639-2022	Lin, Hongjun/0000-0003-1125-0681; Yang, Xiaofei/0000-0002-5118-7755; Wu, Hao/0000-0003-2340-9258	National Natural Science Foundation of China [31030011, 31100280, 31270414]; Research Fund for the Doctoral Program of Higher Education of China [20110043120015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This project was supported by grants from the National Natural Science Foundation of China (Grant No. 31030011, 31100280, 31270414), Research Fund for the Doctoral Program of Higher Education of China (20110043120015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Altingham J., 1996, BATS BIOL BEHAV; ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; Andersson Malte, 1994; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Benda Petr, 2007, Acta Societatis Zoologicae Bohemicae, V71, P71; Benda Petr, 2011, Acta Societatis Zoologicae Bohemicae, V75, P159; Benda Pets, 2006, Acta Societatis Zoologicae Bohemicae, V70, P1; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Brunet-Rossinni Anja K., 2009, P315; CLUTTONBROCK TH, 1977, NATURE, V269, P797, DOI 10.1038/269797a0; Cox Robert M., 2007, P38; Dale J, 2007, P ROY SOC B-BIOL SCI, V274, P2971, DOI 10.1098/rspb.2007.1043; Darwin C, 1990, DESCENT MAN SELECTIO; Davis CM, 2008, BIOL J LINN SOC, V95, P141, DOI 10.1111/j.1095-8312.2008.01035.x; de Camargo NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049734; DeBlase A, 1980, FIELD M NAT HIST; Dietz C, 2006, J MAMMAL, V87, P1241, DOI 10.1644/05-MAMM-A-299R2.1; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FINDLEY JS, 1972, J MAMMAL, V53, P429, DOI 10.2307/1379035; Frydlova P, 2010, BIOL J LINN SOC, V100, P293, DOI 10.1111/j.1095-8312.2010.01430.x; GEIST V, 1987, CAN J ZOOL, V65, P1035, DOI 10.1139/z87-164; Hayssen V, 1996, J MAMMAL, V77, P476, DOI 10.2307/1382823; Herczeg G, 2010, J ANIM ECOL, V79, P581, DOI 10.1111/j.1365-2656.2010.01665.x; HUGHES PM, 1991, J EXP BIOL, V161, P285; KAWAI K, 2007, MAMMAL SCI, V47, P239; KOENIG WD, 1986, AM NAT, V127, P403, DOI 10.1086/284491; KRYSTUFEK B, 1993, ACTA THERIOL, V38, P67, DOI 10.4098/AT.arch.93-6; Kunz TH, 2006, BAT ECOLOGY; Lengkeek W, 2008, CAN J ZOOL, V86, P1173, DOI 10.1139/Z08-103; Liao WB, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-10; Lindenfors P, 2007, SEX SIZE GENDER ROLE, P19; Lison F, 2014, ACTA ZOOL-STOCKHOLM, V95, P137, DOI 10.1111/azo.12012; Mateju J, 2013, FRONT ZOOL, V10, P1, DOI 10.1186/1742-9994-10-27; Matthews LH, 1937, ZOOL SOC LOND, P224; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Polak J, 2010, EVOL ECOL, V24, P1255, DOI 10.1007/s10682-010-9354-9; Preatoni D, 2000, ATTI MUS CIV ST NAT, V11, P89; R Core Team, 2021, R LANGUAGE ENV STAT; Raihani G, 2006, ANIM BEHAV, V71, P833, DOI 10.1016/j.anbehav.2005.06.013; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; Ransome R.D., 1991, P88; RANSOME RD, 1968, J ZOOL, V154, P77; Rossiter SJ, 2006, MOL ECOL, V15, P3035, DOI 10.1111/j.1365-294X.2006.02987.x; Serrano-Meneses MA, 2008, J EVOLUTION BIOL, V21, P1259, DOI 10.1111/j.1420-9101.2008.01567.x; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; SINHA Y P, 1973, Mammalia, V37, P603, DOI 10.1515/mamm.1973.37.4.603; Smith AT, 2010, GUIDE ESTIMATES PRB; Smith RJ, 2002, INT J PRIMATOL, V23, P1095, DOI 10.1023/A:1019654100876; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Stefen C, 2012, ACTA THERIOL, P1; Stephens PR, 2009, EVOLUTION, V63, P910, DOI 10.1111/j.1558-5646.2008.00597.x; Stevens RD, 2013, ACTA CHIROPTEROL, V15, P163, DOI 10.3161/150811013X667966; Storz JF, 2001, BIOL J LINN SOC, V72, P17, DOI 10.1006/bijl.2000.0482; Stuart-Fox D, 2009, EVOL ECOL, V23, P425, DOI 10.1007/s10682-008-9242-8; Szekely T, 2000, EVOLUTION, V54, P1404, DOI 10.1111/j.0014-3820.2000.tb00572.x; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tubaro PL, 2003, BIOL J LINN SOC, V80, P519, DOI 10.1046/j.1095-8312.2003.00252.x; Webb TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000897; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; Wu Y., 2009, FAUNA HEBEI; Xiao Z, 1988, FAUNA LIAONING	68	49	55	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86085	10.1371/journal.pone.0086085	http://dx.doi.org/10.1371/journal.pone.0086085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465886	Green Submitted, gold, Green Published			2022-12-27	WOS:000330240500109
J	Tang, Y; He, H; Cheng, N; Song, YL; Ding, WJ; Zhang, YF; Zhang, WH; Zhang, J; Peng, H; Jiang, H				Tang, Yi; He, Hua; Cheng, Ning; Song, Yanling; Ding, Weijin; Zhang, Yingfan; Zhang, Wenhao; Zhang, Jie; Peng, Heng; Jiang, Hua			PDGF, NT-3 and IGF-2 in Combination Induced Transdifferentiation of Muscle-Derived Stem Cells into Schwann Cell-Like Cells	PLOS ONE			English	Article							DIFFERENTIATION; REGENERATION	Muscle-derived stem cells (MDSCs) are multipotent stem cells with a remarkable long-term self-renewal and regeneration capacity. Here, we show that postnatal MDSCs could be transdifferentiated into Schwann cell-like cells upon the combined treatment of three neurotrophic factors (PDGF, NT-3 and IGF-2). The transdifferentiation of MDSCs was initially induced by Schwann cell (SC) conditioned medium. MDSCs adopted a spindle-like morphology similar to SCs after the transdifferentiation. Immunocytochemistry and immunoblot showed clearly that the SC markers S100, GFAP and p75 were expressed highly only after the transdifferentiation. Flow cytometry assay showed that the portion of S100 expressed cells was more than 60 percent and over one fourth of the transdifferentiated cells expressed all the three SC markers, indicating an efficient transdifferentiation. We then tested neurotrophic factors in the conditioned medium and found it was PDGF, NT-3 and IGF-2 in combination that conducted the transdifferentiation. Our findings demonstrate that it is possible to use specific neurotrophic factors to transdifferentiate MDSCs into Schwann cell-like cells, which might be therapeutically useful for clinical applications.	[Tang, Yi; Song, Yanling; Ding, Weijin; Zhang, Yingfan; Zhang, Jie; Jiang, Hua] Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai, Peoples R China; [Tang, Yi] 411 Hosp CPLA, Dept Plast Surg, Shanghai, Peoples R China; [He, Hua] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Cheng, Ning] Second Mil Med Univ, Changhai Hosp, Dept Transfus, Shanghai, Peoples R China; [Zhang, Wenhao] Shanghai Jiao Tong Univ, XinHua Hosp, Dept Hematol, Sch Med, Shanghai 200030, Peoples R China; [Peng, Heng] Hong Kong Baptist Univ, Dept Math, Kowloon, Hong Kong, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Hong Kong Baptist University	Jiang, H (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai, Peoples R China.	lmiao.simm@gmail.com	Peng, Heng/B-7152-2009; Johnson, William/N-1972-2017	Peng, Heng/0000-0001-7807-8527; Johnson, William/0000-0002-3823-4094	National Natural Science Foundation of China [81100950]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81100950. Website http://www.nsfc.gov.cn no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; Cheng HL, 1999, ENDOCRINOLOGY, V140, P4478, DOI 10.1210/en.140.10.4478; Cohen RI, 1999, J EXP BIOL, V202, P461; Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463; Deasy BM, 2005, MOL BIOL CELL, V16, P3323, DOI 10.1091/mbc.E05-02-0169; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006; GUENARD V, 1992, J NEUROSCI, V12, P3310; Ide C, 1996, NEUROSCI RES, V25, P101; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Keilhoff G, 2000, NEUROREPORT, V11, P3805, DOI 10.1097/00001756-200011270-00042; Keilhoff G, 1999, J NEUROSCI METH, V89, P17, DOI 10.1016/S0165-0270(99)00034-5; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192; Mosahebi A, 2001, GLIA, V34, P8, DOI 10.1002/glia.1035; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008; Zhao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041506	22	62	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e73402	10.1371/journal.pone.0073402	http://dx.doi.org/10.1371/journal.pone.0073402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24637790	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800001
J	Costa, P; Alves, R; Neto, I; Marvao, P; Portela, M; Costa, MJ				Costa, Patricio; Alves, Raquel; Neto, Isabel; Marvao, Pedro; Portela, Miguel; Costa, Manuel Joao			Associations between Medical Student Empathy and Personality: A Multi-Institutional Study	PLOS ONE			English	Article							JOB-PERFORMANCE; 5-FACTOR MODEL; CONSCIENTIOUSNESS; AGREEABLENESS; SATISFACTION; DIMENSIONS; PHYSICIANS; BEHAVIOR	Background: More empathetic physicians are more likely to achieve higher patient satisfaction, adherence to treatments, and health outcomes. In the context of medical education, it is thus important to understand how personality might condition the empathetic development of medical students. Single institutional evidence shows associations between students' personality and empathy. This multi-institutional study aimed to assess such associations across institutions, looking for personality differences between students with high empathy and low empathy levels. Methods: Participants were 472 students from three medical schools in Portugal. They completed validated adaptations to Portuguese of self-report measures of the NEO-Five Factor Inventory(NEO-FFI) and the Jefferson Scale of Physician Empathy(JSPE-spv). Students were categorized into two groups: "Bottom" (low empathy, N = 165) and "Top" (high empathy, N = 169) according to their empathy JSPE-spv total score terciles. Correlation analysis, binary logistic regression analysis and ROC curve analysis were conducted. Results: A regression model with gender, age and university had a predictive power (pseudo R2) for belonging to the top or bottom group of 6.4%. The addition of personality dimensions improved the predictive power to 16.8%. Openness to experience and Agreeableness were important to predict top or bottom empathy scores when gender, age and university were considered." Based on the considered predictors the model correctly classified 69.3% of all students. Conclusions: The present multi-institutional cross-sectional study in Portugal revealed across-school associations between the Big5 dimensions Agreeableness and Openness to experience and the empathy of medical students and that personality made a significant contribution to identify the more empathic students. Therefore, medical schools may need to pay attention to the personality of medical students to understand how to enhance the empathy of medical students.	[Costa, Patricio; Alves, Raquel; Costa, Manuel Joao] Univ Minho, Sch Hlth Sci, Braga, Portugal; [Neto, Isabel] Univ Beira Interior, Fac Hlth Sci, Covilha, Portugal; [Marvao, Pedro] Univ Algarve, Dept Biomed Sci & Med, Faro, Portugal; [Alves, Raquel; Portela, Miguel] Univ Minho, Sch Econ & Management, Braga, Portugal	Universidade do Minho; Universidade da Beira Interior; Universidade do Algarve; Universidade do Minho	Costa, MJ (corresponding author), Univ Minho, Sch Hlth Sci, Braga, Portugal.	mmcosta@ecsaude.uminho.pt	Costa, Manuel Joao/C-3900-2009; Portela, Miguel/C-4509-2008; Costa, Patrício/A-3072-2013; Marvão, Pedro/ABE-2524-2020; Foucart, Alice/B-4552-2012; costa, albert/D-2850-2009	Costa, Manuel Joao/0000-0001-5255-4257; Portela, Miguel/0000-0002-4721-2081; Costa, Patrício/0000-0002-1201-9177; Marvão, Pedro/0000-0002-2030-0516; Foucart, Alice/0000-0001-5690-0735; Aparici, Melina/0000-0001-9015-0974; Neto, Isabel/0000-0001-5805-9759; costa, albert/0000-0002-8477-5609; Hayakawa, Sayuri/0000-0001-9863-1406				BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Batt-Rawden S, 2013, ACAD MED IN PRESS; Burch GSJ, 2008, INT REV IND ORGAN PS, V23, P261; Carmel S, 1996, SOC SCI MED, V43, P1253, DOI 10.1016/0277-9536(95)00445-9; Costa P, 2012, ADV HLTH SC IN PRESS; Costa P, 1992, REVISED NEO PI NEO F; COSTA PT, 1991, PERS INDIV DIFFER, V12, P887, DOI 10.1016/0191-8869(91)90177-D; DasGupta S, 2004, ACAD MED, V79, P351, DOI 10.1097/00001888-200404000-00013; Dudley NM, 2006, J APPL PSYCHOL, V91, P40, DOI 10.1037/0021-9010.91.1.40; GOUGH HG, 1991, PSYCHOL REP, V68, P979, DOI 10.2466/pr0.1991.68.3.979; Hegazi I, 2013, MED TEACH IN PRESS; Helle L, 2010, MED EDUC, V44, P621, DOI 10.1111/j.1365-2923.2010.03625.x; Hemmerdinger Joanne M, 2007, BMC Med Educ, V7, P24, DOI 10.1186/1472-6920-7-24; Hojat M, 2005, PERS INDIV DIFFER, V39, P1205, DOI 10.1016/j.paid.2005.04.007; Hojat M, 2007, EMPATHY PATIENT CARE; Hojat M, 2013, MED TEACH IN PRESS; Hojat M, 2013, MED TEACH, V35, pE1267, DOI 10.3109/0142159X.2013.785654; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; JOHN OP, 1994, CHILD DEV, V65, P160, DOI 10.2307/1131373; Johnson J. A., 1990, EMPATHY HELPING RELA, P49; Kataoka HU, 2009, ACAD MED, V84, P1192, DOI 10.1097/ACM.0b013e3181b180d4; Kim SS, 2004, EVAL HEALTH PROF, V27, P237, DOI 10.1177/0163278704267037; LePine JA, 2000, PERS PSYCHOL, V53, P563, DOI 10.1111/j.1744-6570.2000.tb00214.x; Lievens F, 2002, MED EDUC, V36, P1050, DOI 10.1046/j.1365-2923.2002.01328.x; Lievens F, 2009, J APPL PSYCHOL, V94, P1514, DOI 10.1037/a0016137; Magalhaes E, 2010, NAT S PSYCH RES PORT, P77; Magalhaes E, 2014, PSICOL-REFLEX CRIT, V27, P642, DOI 10.1590/1678-7153.201427405; Magalhaes E, 2012, MED TEACH, V34, P807, DOI 10.3109/0142159X.2012.702248; Misra-Hebert AD, 2012, INT J MED EDUC, V3, P71, DOI 10.5116/ijme.4f7e.e332; Nettle D, 2008, EUR J PERSONALITY, V22, P323, DOI 10.1002/per.672; Nunes P, 2011, INT J MED EDUC, V2, P12, DOI 10.5116/ijme.4d47.ddb0; Rahimi-Madiseh M, 2010, MED TEACH, V32, pE471, DOI 10.3109/0142159X.2010.509419; Rakel D, 2011, PATIENT EDUC COUNS, V85, P390, DOI 10.1016/j.pec.2011.01.009; Rolland JP, 1998, J PERS ASSESS, V71, P269, DOI 10.1207/s15327752jpa7102_13; Salgado JF, 1998, HUM PERFORM, V11, P271, DOI 10.1207/s15327043hup1102&3_8; Shen HK, 1997, ACAD MED, V72, P781, DOI 10.1097/00001888-199709000-00013; Stepien KA, 2006, J GEN INTERN MED, V21, P524, DOI 10.1111/j.1525-1497.2006.00443.x; SUCHMAN AL, 1993, MED CARE, V31, P1083, DOI 10.1097/00005650-199312000-00002; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; von Fragstein M, 2008, MED EDUC, V42, P1100, DOI 10.1111/j.1365-2923.2008.03137.x; Wilson I, 2013, MED TEACHER IN PRESS	42	116	124	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e89254	10.1371/journal.pone.0089254	http://dx.doi.org/10.1371/journal.pone.0089254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637613	Green Published, Green Submitted, gold			2022-12-27	WOS:000333254100001
J	Liang, XH; Chen, J; Liu, YX; He, CL; Li, TY				Liang, Xiaohua; Chen, Jie; Liu, Youxue; He, Chunling; Li, Tingyu			The Effect of Hypertension and Diabetes Management in Southwest China: A Before- and After-Intervention Study	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SYSTEMATIC ANALYSIS; HUMAN-RESOURCES; HEALTH; CARE; CHOLESTEROL; PREVALENCE; BURDEN; TRENDS	Background: Non-communicable diseases are leading causes of disease burden in middle income countries. Little evidence exists to determine if the primary healthcare system can effectively manage non-communicable diseases. The purpose of this study was to examine the effectiveness of hypertension and diabetes management by the primary healthcare system. Methods: We used individual level data from the 2009 National Basic Public Health Services System to assess the effectiveness of hypertension and diabetes interventions on fasting plasma glucose, and blood pressure. We analyzed the associations between fasting plasma glucose, systolic or diastolic blood pressure and risk factors. The estimated average intervention effect on data balanced with confounding variables was assessed. Results: 9543 individuals who had data for fasting plasma glucose, systolic blood pressure and diastolic blood pressure were included in this analysis. This study included 6681 patients with hypertension and 2222 with diabetes. The intervention lowered mean fasting plasma glucose by 0.5 mmol/L (0.4-0.6), lowered mean systolic blood pressure by 3.5 mm Hg (3.2-3.7), and lowered diastolic blood pressure by 2.9 mm Hg (2.7-3.2). Individuals who received medicinal treatment had 1.3 mmHg (0.8 to 1.8, P<0.01) lower diastolic blood pressure and 0.6 mmol/L (0.5-0.8, P<0.01) lower fasting plasma glucose than those who did not receive medicine. Generalized linear model indicated that medicinal treatment and baseline systolic blood pressure were significant positive predictors of change in systolic blood pressure. Age, living in urban areas and diabetic complications were significant negative predictors of change for systolic blood pressure. Conclusion: The National Basic Public Health Services System in China using trained community healthcare workers and well-established guidelines can be effectively implement non-communicable disease prevention and management care paradigms.	[Liang, Xiaohua; Chen, Jie; Liu, Youxue; Li, Tingyu] Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing,Minist Educ Key Lab Chil, Chongqing, Peoples R China; [Liang, Xiaohua; He, Chunling] Ctr Dis Control & Prevent Jiulongpo Dist, Chongqing, Peoples R China	Chongqing Medical University	Li, TY (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing,Minist Educ Key Lab Chil, Chongqing, Peoples R China.	tyli@vip.sina.com		Liu, Youxue/0000-0003-4493-4350	Chongqing Municipal Health Bureau [2012-2-453, 2012-2-518, 2009-1-39]; Biomedical Project from Chongqing Jiulongpo Science and Technology Commission [2012-1, 2013-1]	Chongqing Municipal Health Bureau; Biomedical Project from Chongqing Jiulongpo Science and Technology Commission	This work was supported by three grants [2012-2-453/2012-2-518/2009-1-39, http://www.cqwsj.gov.cn/] from Chongqing Municipal Health Bureau, and by two grants [2012-1/2013-1] of Biomedical Project from Chongqing Jiulongpo Science and Technology Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JK, 2013, J CARDIOVASC NURS; American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Corrao MA, 2000, B WORLD HEALTH ORGAN, V78, P884; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Cuddy Mary Linda Stotter, 2005, J Pract Nurs, V55, P17; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659; Frankenberg E, 1995, Health Transit Rev, V5, P143; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Huizinga MM, 2006, INDIAN J MED RES, V124, P481; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Linnet K, 1999, CLIN CHEM, V45, P314; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Low W H H, 2013, Med J Malaysia, V68, P129; Mitchell AD, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-29; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Omboni S, 2013, J HYPERTENS, V31, P455, DOI 10.1097/HJH.0b013e32835ca8dd; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Schmidt B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1017; Stewart S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7156; Thyregod HMaP, 2011, INTR GEN GEN LIN MOD; Tussing-Humphreys L, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120286; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	33	50	58	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91801	10.1371/journal.pone.0091801	http://dx.doi.org/10.1371/journal.pone.0091801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632720	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400090
J	Liang, XS; Gao, YA; Zhang, XY; Tian, YQ; Zhang, ZX; Gao, LH				Liang, Xinshu; Gao, Yinan; Zhang, Xiaoying; Tian, Yongqiang; Zhang, Zhenxian; Gao, Lihong			Effect of Optimal Daily Fertigation on Migration of Water and Salt in Soil, Root Growth and Fruit Yield of Cucumber (Cucumis sativus L.) in Solar-Greenhouse	PLOS ONE			English	Article							USE EFFICIENCY; PHOSPHORUS LEVEL; NITROGEN; IRRIGATION; NITRATE; FREQUENCY; TOMATO; ARCHITECTURE; MANAGEMENT; CHLORIDE	Inappropriate and excessive irrigation and fertilization have led to the predominant decline of crop yields, and water and fertilizer use efficiency in intensive vegetable production systems in China. For many vegetables, fertigation can be applied daily according to the actual water and nutrient requirement of crops. A greenhouse study was therefore conducted to investigate the effect of daily fertigation on migration of water and salt in soil, and root growth and fruit yield of cucumber. The treatments included conventional interval fertigation, optimal interval fertigation and optimal daily fertigation. Generally, although soil under the treatment optimal interval fertigation received much lower fertilizers than soil under conventional interval fertigation, the treatment optimal interval fertigation did not statistically decrease the economic yield and fruit nutrition quality of cucumber when compare to conventional interval fertigation. In addition, the treatment optimal interval fertigation effectively avoided inorganic nitrogen accumulation in soil and significantly (P < 0.05) increased the partial factor productivity of applied nitrogen by 88% and 209% in the early-spring and autumn-winter seasons, respectively, when compared to conventional interval fertigation. Although soils under the treatments optimal interval fertigation and optimal daily fertigation received the same amount of fertilizers, the treatment optimal daily fertigation maintained the relatively stable water, electrical conductivity and mineral nitrogen levels in surface soils, promoted fine root (< 1.5 mm diameter) growth of cucumber, and eventually increased cucumber economic yield by 6.2% and 8.3% and partial factor productivity of applied nitrogen by 55% and 75% in the early-spring and autumn-winter seasons, respectively, when compared to the treatment optimal interval fertigation. These results suggested that optimal daily fertigation is a beneficial practice for improving crop yield and the water and fertilizers use efficiency in solar greenhouse.	[Liang, Xinshu; Gao, Yinan; Zhang, Xiaoying; Tian, Yongqiang; Zhang, Zhenxian; Gao, Lihong] China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China	China Agricultural University	Gao, LH (corresponding author), China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China.	gaolh@cau.edu.cn		Liu, Youxue/0000-0003-4493-4350	earmarked fund for Modern Agro-industry Technology Research System in China [CARS-25]; Chinese Ministry of Water Resources [201001061]	earmarked fund for Modern Agro-industry Technology Research System in China; Chinese Ministry of Water Resources	This work was supported by the earmarked fund for Modern Agro-industry Technology Research System in China (CARS-25) and the Special Fund for Research in the Public Interest provided by the Chinese Ministry of Water Resources (201001061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 2010, ACTA AGR BOREALI OCC, P188; Belder P, 2005, FIELD CROP RES, V93, P169, DOI 10.1016/j.fcr.2004.09.022; Boomsma CR, 2009, AGRON J, V101, P1426, DOI 10.2134/agronj2009.0082; Cabello MJ, 2009, AGR WATER MANAGE, V96, P866, DOI 10.1016/j.agwat.2008.11.006; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Chen Qing, 2005, China Vegetables, P57; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; Gao LH, 2010, HORTTECHNOLOGY, V20, P626, DOI 10.21273/HORTTECH.20.3.626; [高艳明 Gao Yanming], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P121; Garnett T, 2009, PLANT CELL ENVIRON, V32, P1272, DOI 10.1111/j.1365-3040.2009.02011.x; Guo RY, 2008, ENVIRON POLLUT, V151, P443, DOI 10.1016/j.envpol.2007.04.008; He FF, 2007, NUTR CYCL AGROECOSYS, V77, P1, DOI 10.1007/s10705-006-6275-7; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; Houba VJG, 2000, COMMUN SOIL SCI PLAN, V31, P1299, DOI 10.1080/00103620009370514; Hvistendahl M, 2010, SCIENCE, V327, P801, DOI 10.1126/science.327.5967.801; JACKSON TL, 1966, SOIL SCI SOC AM PRO, V30, P70, DOI 10.2136/sssaj1966.03615995003000010026x; Jokinen K, 2011, SCI HORTIC-AMSTERDAM, V130, P808, DOI 10.1016/j.scienta.2011.09.008; KOCH GW, 1988, PLANT CELL ENVIRON, V11, P755, DOI 10.1111/j.1365-3040.1988.tb01160.x; Li HS, 2000, PRINCIPLES TECHNIQUE, P274; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2012, PHILOS T R SOC B, V367, P1598, DOI 10.1098/rstb.2011.0243; Mahajan G, 2006, AGR WATER MANAGE, V84, P202, DOI 10.1016/j.agwat.2006.03.003; Matsuo N, 2009, PLANT PROD SCI, V12, P514, DOI 10.1626/pps.12.514; Mi GH, 2010, SCI CHINA LIFE SCI, V53, P1369, DOI 10.1007/s11427-010-4097-y; Pei XB, 2002, ZHONGGUO NONG YE KE, V35, P1510; Rajput TBS, 2006, AGR WATER MANAGE, V79, P293, DOI 10.1016/j.agwat.2005.03.009; Shen J, 2012, J EXP BOT; Shi WM, 2009, NUTR CYCL AGROECOSYS, V83, P73, DOI 10.1007/s10705-008-9201-3; Silber A, 2005, PLANT SOIL, V270, P135, DOI 10.1007/s11104-004-1311-3; Silber A, 2003, PLANT SOIL, V253, P467, DOI 10.1023/A:1024857814743; [孙丽萍 SUN Liping], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P173; Thompson RB, 2007, AGR WATER MANAGE, V89, P261, DOI 10.1016/j.agwat.2007.01.013; Tian YQ, 2010, NUTR CYCL AGROECOSYS, V88, P429, DOI 10.1007/s10705-010-9367-3; Wang H, 2006, CRIT REV PLANT SCI, V25, P279, DOI 10.1080/07352680600709917; [汪建飞 Wang Jianfei], 2005, [土壤通报, Journal of Soil Science], V36, P708; WANG XZ, 1991, CHINESE B BOT, V8, P34; Wang YS, 2010, FUNCT PLANT BIOL, V37, P175, DOI 10.1071/FP09181; Wei Yan, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P67; Xu G, 2004, PLANT SOIL, V263, P297, DOI 10.1023/B:PLSO.0000047743.19391.42; Yoshida Chie, 2011, Horticultural Research (Japan), V10, P325, DOI 10.2503/hrj.10.325; Yu ShuFang, 2000, China Vegetables, P10; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang LD, 2012, SCI HORTIC-AMSTERDAM, V138, P43, DOI 10.1016/j.scienta.2012.02.003; Zhao ShuMei, 2001, Transactions of the Chinese Society of Agricultural Engineering, V17, P171; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	46	50	58	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86975	10.1371/journal.pone.0086975	http://dx.doi.org/10.1371/journal.pone.0086975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24632720	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300122
J	Chen, C; Sia, I; Ma, HM; Tai, BC; Cheong, A; Fong, NP; Tan, SYJ; Chan, KM; Tan, BY; Menon, E; Ee, CH; Lee, KK; Ng, YS; Teo, YY; Ma, S; Heng, D; Koh, GCH				Chen, Cynthia; Sia, Isaac; Ma, Hon-Ming; Tai, Bee Choo; Cheong, Angela; Fong, Ngan Phoon; Tan, Shi Yu Julia; Chan, Kin Ming; Tan, Boon Yeow; Menon, Edward; Ee, Chye Hua; Lee, Kok Keng; Ng, Yee Sien; Teo, Yik Ying; Ma, Stefan; Heng, Derrick; Koh, Gerald Choon-Huat			The Synergistic Effect of Functional Status and Comorbidity Burden on Mortality: A 16-Year Survival Analysis	PLOS ONE			English	Article							NURSING-HOME USE; OLDER-ADULTS; BARTHEL INDEX; HIP FRACTURE; FRAILTY; PREVALENCE; DISABILITY; ACCUMULATION; MORBIDITY; DISEASES	Objectives: The relationship between disability and comorbidity on mortality is widely perceived as additive in clinical models of frailty. Design: National data were retrospectively extracted from medical records of community hospital. Data Sources: There were of 12,804 acutely-disabled patients admitted for inpatient rehabilitation in Singapore rehabilitation community hospitals from 1996 through 2005 were followed up for death till 31 December 2011. Outcome Measure: Cox proportional-hazards regression to assess the interaction of comorbidity and disability at discharge on all-cause mortality. Results: During a median follow-up of 10.9 years, there were 8,565 deaths (66.9%). The mean age was 73.0 (standard deviation: 11.5) years. Independent risk factors of mortality were higher comorbidity (p<0.001), severity of disability at discharge (p<0.001), being widowed (adjusted hazard ratio [aHR]: 1.38, 95% confidence interval [CI]:1.25-1.53), low socioeconomic status (aHR: 1.40, 95%CI:1.29-1.53), discharge to nursing home (aHR: 1.14, 95%CI:1.05-1.22) and re-admission into acute care (aHR: 1.54, 95%CI:1.45-1.65). In the main effects model, those with high comorbidity had an aHR = 2.41 (95%CI:2.13-2.72) whereas those with total disability had an aHR = 2.28 (95%CI:2.12-2.46). In the interaction model, synergistic interaction existed between comorbidity and disability (p<0.001) where those with high comorbidity and total disability had much higher aHR = 6.57 (95%CI:5.15-8.37). Conclusions: Patients with greater comorbidity and disability at discharge, discharge to nursing home or re-admission into acute care, lower socioeconomic status and being widowed had higher mortality risk. Our results identified predictive variables of mortality that map well onto the frailty cascade model. Increasing comorbidity and disability interacted synergistically to increase mortality risk.	[Chen, Cynthia; Tai, Bee Choo; Cheong, Angela; Fong, Ngan Phoon; Teo, Yik Ying; Koh, Gerald Choon-Huat] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Sia, Isaac] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Ma, Hon-Ming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ma, Hon-Ming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Therapeut, Hong Kong, Hong Kong, Peoples R China; [Tan, Shi Yu Julia; Koh, Gerald Choon-Huat] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Chan, Kin Ming] Ang Mo Kio Thye Hua Kwan Hosp, Med Serv, Singapore, Singapore; [Tan, Boon Yeow] St Lukes Hosp, Med Serv, Singapore, Singapore; [Menon, Edward] St Andrews Community Hosp, Med Serv, Singapore, Singapore; [Ee, Chye Hua; Lee, Kok Keng] Bright Vis Hosp, Singapore, Singapore; [Ng, Yee Sien] Singapore Gen Hosp, Dept Rehabil Med, Singapore, Singapore; [Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Ma, Stefan; Heng, Derrick] Minist Hlth, Singapore, Singapore	National University of Singapore; State University System of Florida; University of Florida; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; National University of Singapore; Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Ministry of Health-Singapore	Koh, GCH (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	gerald_koh@nuhs.edu.sg	CHEN, CYNTHIA/O-6203-2016; Chen, Chien-Yi/A-9680-2015; Chou, Hung-Chieh/AGZ-5161-2022; Rogawski, Michael/B-6353-2009	Chen, Chien-Yi/0000-0002-6030-2655; CHOU, HUNG-CHIEH/0000-0002-8932-9472; Chang, Mei Hwei/0000-0002-3648-9261; HSIEH, WU-SHIUN/0000-0002-0609-3311; Koh, Choon Huat Gerald/0000-0002-6453-6897; TSAO, PO-NIEN/0000-0002-6114-1769; Matt, Lucas/0000-0003-3235-5140; Rogawski, Michael/0000-0002-3296-8193; Sia, Isaac/0000-0001-8449-1799; Ng, Yee-Sien/0000-0003-1377-5852	National University of Singapore (NUS) Start-Up Grant; NUS Provost Matching Grant; NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research [HSRG/0006/2013]; Singapore National Medical Research Council Research Fellowship; Schulich Graduate Scholarship, University of Western Ontario	National University of Singapore (NUS) Start-Up Grant(National University of Singapore); NUS Provost Matching Grant; NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research(Ministry of Education, SingaporeNational University of Singapore); Singapore National Medical Research Council Research Fellowship(National Medical Research Council, Singapore); Schulich Graduate Scholarship, University of Western Ontario	This study was supported by a National University of Singapore (NUS) Start-Up Grant, the NUS Provost Matching Grant, the NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research Grant Number HSRG/0006/2013, Singapore National Medical Research Council Research Fellowship and Schulich Graduate Scholarship, University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, PRINCIPLES GERIATRIC; Bernardini Judith, 2004, Adv Perit Dial, V20, P125; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P356, DOI 10.1016/j.jamda.2009.11.008; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; Lee J, 2007, NEUROCHEM RES, V32, P635, DOI 10.1007/s11064-006-9138-3; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Ministry of Health (MOH), 2004, HEALTHC SERV ELD INF; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Ravindrarajah R, ARCH GERONTOLOGY GER; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rochon PA, 1996, MED CARE, V34, P1093, DOI 10.1097/00005650-199611000-00004; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; ROY CW, 1988, INT J REHABIL RES, V11, P67, DOI 10.1097/00004356-198803000-00010; Rudberg MA, 1996, J GERONTOL A-BIOL, V51, pM189, DOI 10.1093/gerona/51A.5.M189; Schiller JS, 2012, VITAL HLTH STAT, V10, P67; Seo Nam Sook, 2006, Taehan Kanho Hakhoe Chi, V36, P514; Shah S, 2000, CLIN REHABIL, V14, P551, DOI 10.1191/0269215500cr360oa; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHINAR D, 1987, ARCH PHYS MED REHAB, V68, P723; Slot KB, 2008, BRIT MED J, V336, P376, DOI 10.1136/bmj.39456.688333.BE; Song XW, 2007, AGING CLIN EXP RES, V19, P145; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; van Kan GA, 2008, J AM MED DIR ASSOC, V9, P71, DOI 10.1016/j.jamda.2007.11.005; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Woo J, 2014, AGE, V36, P923, DOI 10.1007/s11357-013-9590-3	41	94	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106248	10.1371/journal.pone.0106248	http://dx.doi.org/10.1371/journal.pone.0106248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25229608	Green Published, gold, Green Submitted			2022-12-27	WOS:000341127500134
J	Hu, YS; Young, AJ; Ehli, EA; Nowotny, D; Davies, PS; Droke, EA; Soundy, TJ; Davies, GE				Hu, Yueshan; Young, Alan J.; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Droke, Elizabeth A.; Soundy, Timothy J.; Davies, Gareth E.			Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPRESSION; FATTY LIVER-DISEASE; DOUBLE-BLIND; BODY-WEIGHT; INSULIN-RESISTANCE; METABOLIC SYNDROME; SCHIZOPHRENIA; CLOZAPINE; GLUCOSE	Olanzapine is a first line medication for the treatment of schizophrenia, but it is also one of the atypical antipsychotics carrying the highest risk of weight gain. Metformin was reported to produce significant attenuation of antipsychotic-induced weight gain in patients, while the study of preventing olanzapine-induced weight gain in an animal model is absent. Berberine, an herbal alkaloid, was shown in our previous studies to prevent fat accumulation in vitro and in vivo. Utilizing a well-replicated rat model of olanzapine-induced weight gain, here we demonstrated that two weeks of metformin or berberine treatment significantly prevented the olanzapine-induced weight gain and white fat accumulation. Neither metformin nor berberine treatment demonstrated a significant inhibition of olanzapine-increased food intake. But interestingly, a significant loss of brown adipose tissue caused by olanzapine treatment was prevented by the addition of metformin or berberine. Our gene expression analysis also demonstrated that the weight gain prevention efficacy of metformin or berberine treatment was associated with changes in the expression of multiple key genes controlling energy expenditure. This study not only demonstrates a significant preventive efficacy of metformin and berberine treatment on olanzapine-induced weight gain in rats, but also suggests a potential mechanism of action for preventing olanzapine-reduced energy expenditure.	[Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA; [Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Univ Hlth Ctr, Sioux Falls, SD USA; [Hu, Yueshan; Ehli, Erik A.; Soundy, Timothy J.; Davies, Gareth E.] Univ S Dakota, Dept Psychiat, Sanford Sch Med, Sioux Falls, SD USA; [Young, Alan J.] S Dakota State Univ, Dept Vet & Biomed Sci, Coll Agr & Biol Sci, Brookings, SD 57007 USA; [Droke, Elizabeth A.] S Dakota State Univ, Dept Hlth & Nutr Sci, Coll Educ & Human Sci, Brookings, SD 57007 USA; [Davies, Gareth E.] S Dakota State Univ, Coll Pharm, Dept Pharm Practice, Brookings, SD 57007 USA	University of South Dakota; South Dakota State University; South Dakota State University; South Dakota State University	Hu, YS (corresponding author), Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA.	Yueshan.Hu@avera.org		Xiang, Zou/0000-0003-3925-0296	Avera Research Institute	Avera Research Institute	Avera Research Institute sponsored this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Blouin M, 2008, OBESITY, V16, P1780, DOI 10.1038/oby.2008.277; Boyda HN, 2014, PROG NEURO-PSYCHOPH, V48, P170, DOI 10.1016/j.pnpbp.2013.10.006; Boyda HN, 2012, J PSYCHIATR NEUROSCI, V37, P407, DOI 10.1503/jpn.110140; Case M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-72; Chen CH, 2008, PROG NEURO-PSYCHOPH, V32, P925, DOI 10.1016/j.pnpbp.2007.11.013; Citrome L, 2011, CLIN DRUG INVEST, V31, P455, DOI 10.2165/11589060-000000000-00000; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; De Hert MA, 2006, SCHIZOPHR RES, V83, P87, DOI 10.1016/j.schres.2005.12.855; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; Faulkner G, 2006, CAN J PSYCHIAT, V51, P502, DOI 10.1177/070674370605100805; Fell MJ, 2007, PSYCHOPHARMACOLOGY, V194, P221, DOI 10.1007/s00213-007-0833-9; Feng S, 2012, NEUROENDOCRINOL LETT, V33, P493; Gilles M, 2010, CLIN NEUROPHARMACOL, V33, P248, DOI 10.1097/WNF.0b013e3181f0ec33; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Haupt DW, 2006, EUR NEUROPSYCHOPHARM, V16, pS149, DOI 10.1016/j.euroneuro.2006.06.003; Hu Y, 2012, PHARMACOGENOMICS J, V12, P372, DOI 10.1038/tpj.2011.24; Hu Y, 2009, PHYTOMEDICINE, V16, P864, DOI 10.1016/j.phymed.2009.03.002; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Hu YS, 2010, PHYTOTHER RES, V24, P1831, DOI 10.1002/ptr.3204; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Hu YS, 2010, FITOTERAPIA, V81, P259, DOI 10.1016/j.fitote.2009.09.012; Ikegami M, 2013, EUR J PHARM; Jarskog LF, 2007, ANNU REV MED, V58, P49, DOI 10.1146/annurev.med.58.060904.084114; Jassim G, 2012, PSYCHOPHARMACOLOGY, V219, P783, DOI 10.1007/s00213-011-2397-y; Kluge M, 2007, J CLIN PSYCHOPHARM, V27, P662, DOI 10.1097/jcp.0b013e31815a8872; Kreuzer P, 2012, NERVENARZT, V83, P630, DOI 10.1007/s00115-011-3310-y; Kudoh A, 2004, ANESTH ANALG, V98, P111, DOI 10.1213/01.ANE.0000093313.16711.5E; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lee MS, 2011, J NUTR, V141, P1947, DOI 10.3945/jn.111.146050; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Liebig M, 2010, OBESITY, V18, P1952, DOI 10.1038/oby.2010.17; Lindenmayer JP, 2003, AM J PSYCHIAT, V160, P290, DOI 10.1176/appi.ajp.160.2.290; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Makino T, 2009, BIOL PHARM BULL, V32, P1741, DOI 10.1248/bpb.32.1741; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Muench J, 2010, AM FAM PHYSICIAN, V81, P617; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Newcomer JW, 2006, CAN J PSYCHIAT, V51, P480, DOI 10.1177/070674370605100803; Newcomer JW, 2004, CLIN THER, V26, P1936, DOI 10.1016/j.clinthera.2004.12.003; Oh JE, 2012, EXP MOL MED, V44, P545, DOI 10.3858/emm.2012.44.9.062; Praharaj SK, 2011, BRIT J CLIN PHARMACO, V71, P377, DOI 10.1111/j.1365-2125.2010.03783.x; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Saddichha S, 2008, SCHIZOPHR RES, V101, P266, DOI 10.1016/j.schres.2008.01.004; Schreiner A, 2012, J CLIN PSYCHOPHARM, V32, P449, DOI 10.1097/JCP.0b013e31825cccad; Sejima E, 2011, CELL MOL NEUROBIOL, V31, P985, DOI 10.1007/s10571-011-9663-8; Shirzadi AA, 2006, HARVARD REV PSYCHIAT, V14, P152, DOI 10.1080/10673220600748486; Skrede S, 2012, INT J NEUROPSYCHOPH, V15, P163, DOI 10.1017/S1461145711001271; Smith G. C., 2011, Archives of Physiology and Biochemistry, V117, P241, DOI 10.3109/13813455.2011.576681; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Thakore JH, 2004, BRIT J PSYCHIAT, V184, pS76, DOI 10.1192/bjp.184.47.s76; Toalson Patrick, 2004, Prim Care Companion J Clin Psychiatry, V6, P152; Tschoner A, 2007, INT J CLIN PRACT, V61, P1356, DOI 10.1111/j.1742-1241.2007.01416.x; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang YW, 2011, METABOLISM, V60, P298, DOI 10.1016/j.metabol.2010.02.005; Wu RR, 2008, AM J PSYCHIAT, V165, P352, DOI 10.1176/appi.ajp.2007.07010079; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang QH, 2011, CHIN J INTEGR MED, V17, P205, DOI 10.1007/s11655-011-0668-4; Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404	66	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93310	10.1371/journal.pone.0093310	http://dx.doi.org/10.1371/journal.pone.0093310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24676355	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600170
J	Chen, CY; Chen, HL; Chou, HC; Tsao, PN; Hsieh, WS; Chang, MH				Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei			Weight-Based Policy of Hepatitis B Vaccination in Very Low Birth Weight Infants in Taiwan: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; IMMUNE-RESPONSE; PRETERM INFANTS; INFECTION; PREVENTION; EFFICACY; IMMUNOGENICITY; GLOBULIN; BORN	Background: The current recommendation of giving the first dose of hepatitis B vaccine to very low birth weight (VLBW) infants at 30 days of chronologic age usually is not practical, because most VLBW infants are not medically stable at that age. We use an alternative body-weight-based protocol, and evaluate its efficacy in an endemic area under a universal immunization program. Methods: The immunogenicity of the current hepatitis B vaccination strategy in 155 VLBW preterm infants was evaluated at age 2 to 13 years, with parental consent. All of the infants were born between 1995 and 2006, and received their first dose of hepatitis B vaccine when they reached 2,000-2,200 g, irrespective of chronological age. Hepatitis B immunoglobulin (HBIG) was given at birth to infants born to HBsAg(+)/HBeAg(+) mothers. Results: All 155 of the recruited children were HBsAg and anti-HBc negative. The anti-HBs seropositivity rate (geometric mean titer) was 84.1% (146.5 mIU/mL) for children under 3 years, 73.5% (68.8 mIU/mL) for 4-to 7-year-olds, 27.7% (55.4 mIU/mL) for 8-to 11-year-olds and 20% (6.0 mIU/mL) for children >= 12 years of age. More than 90% of these children received the first vaccination after 30 days of age, half (51%) at 60 to 90 days, and 29 children (18.6%) after 90 days of age. Of the 26 infants born to HBsAg(+) mothers, 6/6 infants of HBeAg(+) mothers received HBIG at birth, and 12/20 infants of HBeAg(-) mothers received HBIG. None of the 26 infants became infected. Conclusions: Delaying hepatitis B vaccinations in VLBW preterm infants until they reach a weight of 2,000 g, with the administration of HBIG at birth for infants of HBsAg(+) mothers provided adequate immunogenicity and protection in a highly endemic area. Weight-based policy of hepatitis B vaccination is an effective and practical alternative strategy for VLBW infants.	[Chen, Chien-Yi] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, MH (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	changmh@ntu.edu.tw	CHEN, CYNTHIA/O-6203-2016; Chen, Chien-Yi/A-9680-2015; Chou, Hung-Chieh/AGZ-5161-2022; Rogawski, Michael/B-6353-2009	Chen, Chien-Yi/0000-0002-6030-2655; CHOU, HUNG-CHIEH/0000-0002-8932-9472; Chang, Mei Hwei/0000-0002-3648-9261; HSIEH, WU-SHIUN/0000-0002-0609-3311; Koh, Choon Huat Gerald/0000-0002-6453-6897; TSAO, PO-NIEN/0000-0002-6114-1769; Matt, Lucas/0000-0003-3235-5140; Rogawski, Michael/0000-0002-3296-8193; Sia, Isaac/0000-0001-8449-1799; Ng, Yee-Sien/0000-0003-1377-5852	National Taiwan University Hospital [NTUH.98-M1230]; Center for Disease Control, Department of Health, Taiwan [DOH98-DC-10181]	National Taiwan University Hospital(National Taiwan University); Center for Disease Control, Department of Health, Taiwan	This study was supported by grant from the National Taiwan University Hospital (NTUH.98-M1230), and partially from the Center for Disease Control, Department of Health, Taiwan (DOH98-DC-10181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1983, HEPATOLOGY, V3, P135; BEASLEY RP, 1983, LANCET, V2, P1099; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; HALL CB, 1994, PEDIATRICS, V94, P403; HALL CB, 1992, PEDIATRICS, V89, P795; Hsu HM, 1999, J INFECT DIS, V179, P367, DOI 10.1086/314585; Huang FY, 1997, ARCH DIS CHILD-FETAL, V77, pF135, DOI 10.1136/fn.77.2.F135; Kesler K, 1998, PEDIATR INFECT DIS J, V17, P116, DOI 10.1097/00006454-199802000-00007; Khalak R, 1998, PEDIATRICS, V101, P597, DOI 10.1542/peds.101.4.597; Kim SC, 1997, PEDIATRICS, V99, P534, DOI 10.1542/peds.99.4.534; Kirmani KI, 2002, PEDIATRICS, V109, P498, DOI 10.1542/peds.109.3.498; LAU YL, 1992, J PEDIATR-US, V121, P962, DOI 10.1016/S0022-3476(05)80352-X; LEE CY, 1991, PEDIATR INFECT DIS J, V10, P299, DOI 10.1097/00006454-199104000-00007; LEE PI, 1995, J PEDIATR-US, V126, P716, DOI 10.1016/S0022-3476(95)70398-5; Linder N, 2002, INFECTION, V30, P136, DOI 10.1007/s15010-002-2068-3; Linder N, 2000, ARCH DIS CHILD-FETAL, V83, pF24, DOI 10.1136/fn.83.1.F24; Losonsky GA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e14; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Ni YH, 2012, J HEPATOL, V57, P730, DOI 10.1016/j.jhep.2012.05.021; Patel DM, 1997, J PEDIATR-US, V131, P641, DOI 10.1016/S0022-3476(97)70078-7; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Saari TN, 2003, PEDIATRICS, V112, P193, DOI 10.1542/peds.112.1.193	24	94	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92271	10.1371/journal.pone.0092271	http://dx.doi.org/10.1371/journal.pone.0092271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	25229608	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100136
J	Hu, Y; Zhu, Q; Tang, LL				Hu, Yu; Zhu, Qin; Tang, Lili			MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression	PLOS ONE			English	Article							DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; S6 KINASE; MICRORNA; PATHWAY; GROWTH; AKT; TRANSLATION; APOPTOSIS	MicroRNAs (miRNAs) play an important role in human tumorigenesis as oncogenes or tumor suppressors. miR-99a has been reported as a tumor suppressor gene in various cancers in humans. However, only limited information about the function of miR-99a in human breast cancers is available. Here we investigated the expression of miR-99a in breast cancer tissue specimens and its antitumor activity in breast cancer cells. We initially identified that the expression of miR-99a was significantly reduced in four breast cancer cell lines. More importantly, we found downregulation of miR-99a in breast cancer specimens from ten different patients. We then analyzed the mechanism of miR-99a in inhibiting tumorigenesis. Cell-based assays that showed overexpression of miR-99a not only reduced breast cancer cell viability by inducing accumulation of cells at sub-G1 phase and cell apoptosis, but also inhibited tumorigenicity in vivo. As a critical miR-99a target, we have shown that the function of mammalian target of rapamycin (mTOR) was greatly inhibited by miR-99a-based Luciferase report assay; overexpression of miR-99a reduced the expression of mTOR and its downstream phosphorylated proteins (p-4E-BP1 and p-S6K1). Similar to restoring miR-99a expression, mTOR downregulation suppressed cell viability and increased cell apoptosis, whereas restoration of mTOR expression significantly reversed the inhibitory effects of miR-99a on the mTOR/p-4E-BP1/p-S6K1 signal pathway and the miR-99a antitumor activity. In clinical specimens and cell lines, mTOR was commonly overexpressed and its protein levels were statistically inversely correlated with miR-99a expression. Taken together, these results have demonstrated that miR-99a antitumor activity is achieved by targeting the mTOR/p-4E-BP1/p-S6K1 pathway in human breast cancer cells. This study suggests a potential therapeutic strategy to effectively control breast cancer development.	[Hu, Yu; Tang, Lili] Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China; [Zhu, Qin] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tang, LL (corresponding author), Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China.	lilitangxy@126.com		Xiang, Zou/0000-0003-3925-0296				Bose S, 2006, MODERN PATHOL, V19, P238, DOI 10.1038/modpathol.3800525; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cui L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-546; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Ekman S, 2012, J THORAC ONCOL, V7, P947, DOI 10.1097/JTO.0b013e31825581bd; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heinonen H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-348; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li M, 2012, ONCOL LETT, V4, P1213, DOI 10.3892/ol.2012.930; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; TELFORD WG, 1992, CYTOMETRY, V13, P137, DOI 10.1002/cyto.990130205; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zhou J, 2010, MOL MED REP, V3, P387, DOI 10.3892/mmr_00000269	45	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92099	10.1371/journal.pone.0092099	http://dx.doi.org/10.1371/journal.pone.0092099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24676355	Green Submitted, gold, Green Published			2022-12-27	WOS:000333254100111
J	Chen, XX; Shi, Y; Chai, WM; Feng, HL; Zhuang, JX; Chen, QX				Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Zhuang, Jiang-Xing; Chen, Qing-Xi			Condensed Tannins from Ficus virens as Tyrosinase Inhibitors: Structure, Inhibitory Activity and Molecular Mechanism	PLOS ONE			English	Article							TOF MS ANALYSIS; MUSHROOM TYROSINASE; SKIN; PIGMENTATION; DOPAMINE; KINETICS; LEAVES; IONS; HPLC; NMR	Condensed tannins from Ficus virens leaves, fruit, and stem bark were isolated and their structures characterized by C-13 nuclear magnetic resonance spectrometry, high performance liquid chromatography electrospray ionization mass spectrometry, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The results showed that the leaves, fruit, and stem bark condensed tannins were complex mixtures of homo-and heteropolymers of B-type procyanidins and prodelphinidins with degrees of polymerization up to hexamer, dodecamer, and pentadecamer, respectively. Antityrosinase activities of the condensed tannins were studied. The results indicated that the condensed tannins were potent tyrosinase inhibitors. The concentrations for the leaves, fruit, and stem bark condensed tannins leading to 50% enzyme activity were determined to be 131.67, 99.89, and 106.22 mu g/ml on monophenolase activity, and 128.42, 43.07, and 74.27 mu g/ml on diphenolase activity. The inhibition mechanism, type, and constants of the condensed tannins on the diphenolase activity were further investigated. The results indicated that the condensed tannins were reversible and mixed type inhibitors. Fluorescence quenching, copper interacting, and molecular docking techniques were utilized to unravel the molecular mechanisms of the inhibition. The results showed that the hydroxyl group on the B ring of the condensed tannins could chelate the dicopper irons of the enzyme. Moreover, the condensed tannins could reduce the enzyme product o-quinones into colourless compounds. These results would contribute to the development and design of antityrosinase agents.	[Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Chen, Qing-Xi] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Zhuang, Jiang-Xing] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhuang, JX (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	jiangxingzhuang@xmu.edu.cn; chenqx@xmu.edu.cn	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Natural Science Foundation of China [31071611, 31070522]; National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027/J0106]; Science and Technology Foundation of Fujian Province [2010N5013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China; Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The present investigation was supported by the Natural Science Foundation of China (No. 31071611; No. 31070522), the National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (Grant No. J1310027/J0106) and by the Science and Technology Foundation of Fujian Province (No. 2010N5013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed ESS, 2009, FOOD CHEM, V114, P1271, DOI 10.1016/j.foodchem.2008.11.005; Anandjiwala S, 2008, INDIAN J PHARM SCI, V70, P31, DOI 10.4103/0250-474X.40328; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Baby Joseph, 2010, International Journal of Pharma and Bio Sciences, V1, pP; Bawadi HA, 2005, CANCER LETT, V218, P153, DOI 10.1016/j.canlet.2004.06.021; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chauhan S, 2013, J MED PLANTS STUD, V1, P3846; Chen QX, 2005, FOOD CHEM, V91, P269, DOI 10.1016/j.foodchem.2004.01.078; Chen XX, 2014, FOOD CHEM, V155, P1, DOI 10.1016/j.foodchem.2014.01.011; Chen XX, 2013, INT J BIOL MACROMOL, V62, P726, DOI 10.1016/j.ijbiomac.2013.09.052; Chen XX, 2013, J ZHEJIANG UNIV-SC B, V14, P903, DOI 10.1631/jzus.B1200365; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Espin JC, 2001, BBA-PROTEIN STRUCT M, V1544, P289, DOI 10.1016/S0167-4838(00)00230-2; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; Haslam E., 1989, Plant polyphenols: vegetable tannins revisited.; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; Khatib S, 2007, J MED CHEM, V50, P2676, DOI 10.1021/jm061361d; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Lee N, 2012, ACS CHEM BIOL, V7, P1687, DOI 10.1021/cb300222b; Lim YY, 2007, LWT-FOOD SCI TECHNOL, V40, P1664, DOI 10.1016/j.lwt.2006.12.013; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; Niranjan S, 2012, GLOBAL J PHARM RES, V1, P318; Sanjust E, 2003, ARCH BIOCHEM BIOPHYS, V412, P272, DOI 10.1016/S0003-9861(03)00053-5; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sisti M, 2008, LWT-FOOD SCI TECHNOL, V41, P946, DOI 10.1016/j.lwt.2007.05.012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Takahashi S, 2010, BIOORGAN MED CHEM, V18, P8112, DOI 10.1016/j.bmc.2010.08.056; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Xiang P, 2006, CHINESE J ANAL CHEM, V34, P1019, DOI 10.1016/S1872-2040(06)60047-9; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhang LL, 2008, MOLECULES, V13, P2986, DOI 10.3390/molecules13122986; Zhuang JX, 2010, J AGR FOOD CHEM, V58, P12993, DOI 10.1021/jf103723k	38	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91809	10.1371/journal.pone.0091809	http://dx.doi.org/10.1371/journal.pone.0091809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24622390	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100063
J	Chen, XH; Scholl, TO				Chen, Xinhua; Scholl, Theresa O.			Maternal Biomarkers of Endothelial Dysfunction and Preterm Delivery	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADHESION MOLECULE-1; RETROSPECTIVE COHORT; HEART-DISEASE; UNITED-STATES; SE-SELECTIN; PREECLAMPSIA; RISK; WOMEN; INFLAMMATION	Background: Endothelial dysfunction is key to the development of atherosclerosis. Preterm delivery foreshadows later maternal cardiovascular disease (CVD), but it is not known if endothelial dysfunction also occurs. We prospectively measured circulating biomarkers of endothelial dysfunction in pregnant women with preterm or term delivery. Methods: We conducted a case-control study nested within a large prospective epidemiological study of young, generally healthy pregnant women. Women who delivered preterm (, 37 completed weeks gestation, n = 240) and controls who delivered at term (n = 439) were included. Pregnancies complicated by preeclampsia were analyzed separately. Circulating endothelial dysfunction biomarkers included soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). Results: Elevated levels of sICAM-1 and sVCAM-1 were positively associated with preterm delivery independent of usual risk factors. At entry (similar to 16 wks), the adjusted odds ratio (AOR) was 1.73 (95% confidence interval (CI) 1.09-2.74) for the highest quartile of sICAM-1 versus the lowest quartile and for sVCAM-1 the AOR was 2.17 (95% CI 1.36-3.46). When analysis was limited to cases with a spontaneous preterm delivery, the results were unchanged. Similar results were obtained for the 3rd trimester (similar to 30 wks). Elevated sE-selectin was increased only in preterm delivery complicated by preeclampsia; risk was increased at entry (AOR 2.32, 95% CI 1.22-4.40) and in the 3rd trimester (AOR 3.37, 95% CI 1.78-6.39). Conclusions: Impaired endothelial function as indicated by increased levels of soluble molecules commonly secreted by endothelial cells is a pathogenic precursor to CVD that is also present in women with preterm delivery. Our findings underscore the need for follow-up studies to determine if improving endothelial function prevents later CVD risk in women.	[Chen, Xinhua; Scholl, Theresa O.] Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Chen, XH (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA.	chenx1@rowan.edu	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	National Institute of Child Health and Human Development [HD061763, HD18269, HD38329]; National Institute on Minority Health and Health Disparities [1R01MD007828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants from the National Institute of Child Health and Human Development (HD061763 to Chen; HD18269 and HD38329 to Scholl) and the National Institute on Minority Health and Health Disparities (1R01MD007828 to Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; [Anonymous], 2006, INCOME EARNINGS POVE; Bartha JL, 2012, J WOMENS HEALTH, V21, P643, DOI 10.1089/jwh.2011.3013; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P19; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Hastie CE, 2011, INT J EPIDEMIOL, V40, P914, DOI 10.1093/ije/dyq270; Hediger ML, 1997, ANN EPIDEMIOL, V7, P400, DOI 10.1016/S1047-2797(97)00046-X; Jenny NS, 2006, J THROMB HAEMOST, V4, P107, DOI 10.1111/j.1538-7836.2005.01678.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Marvin KW, 2000, AM J REPROD IMMUNOL, V43, P264, DOI 10.1111/j.8755-8920.2000.430504.x; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Pina IL, 2011, CARDIOL REV, V19, P71, DOI 10.1097/CRD.0b013e318209c233; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Steinborn A, 2000, OBSTET GYNECOL, V95, P671, DOI 10.1016/S0029-7844(99)00604-3; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Velez DR, 2009, AJOG, V200; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	33	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85716	10.1371/journal.pone.0085716	http://dx.doi.org/10.1371/journal.pone.0085716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24622390	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100065
J	Chen, XK; May, B; Di, YM; Zhang, AL; Lu, CJ; Xue, CC; Lin, L				Chen, Xiankun; May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Lu, Chuanjian; Xue, Charlie Changli; Lin, Lin			Oral Chinese Herbal Medicine Combined with Pharmacotherapy for Stable COPD: A Systematic Review of Effect on BODE Index and Six Minute Walk Test	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CORDYCEPS-SINENSIS; ASTRAGALUS-MEMBRANACEUS; DISTANCE; COMPLEMENTARY; MANAGEMENT; PREDICTOR; CAPACITY; OUTCOMES	This systematic review evaluated the effects of Chinese herbal medicine (CHM) plus routine pharmacotherapy (RP) on the objective outcome measures BODE index, 6-minute walk test (6MWT), and 6-minute walk distance (6MWD) in individuals with stable chronic obstructive pulmonary disease (COPD). Searches were conducted of six English and Chinese databases (PubMed, EMBASE, CENTRAL, CINAHL, CNKI and CQVIP) from their inceptions until 18th November 2013 for randomized controlled trials involving oral administration of CHM plus RP compared to the same RP, with BODE Index and/or 6MWT/D as outcomes. Twenty-five studies were identified. BODE Index was used in nine studies and 6MWT/D was used in 22 studies. Methodological quality was assessed using the Cochrane Risk of Bias tool. Weaknesses were identified in most studies. Six studies were judged as 'low' risk of bias for randomisation sequence generation. Twenty-two studies involving 1,834 participants were included in the meta-analyses. The main meta-analysis results showed relative benefits for BODE Index in nine studies (mean difference [MD] -0.71, 95% confidence interval [CI] -0.94, -0.47) and 6MWT/D in 17 studies (MD 54.61 meters, 95% CI 33.30, 75.92) in favour of the CHM plus RP groups. The principal plants used were Astragalus membranaceus, Panax ginseng and Cordyceps sinensis. A. membranaceus was used in combination with other herbs in 18 formulae in 16 studies. Detailed sub-group and sensitivity analyses were conducted. Clinically meaningful benefits for BODE Index and 6MWT were found in multiple studies. These therapeutic effects were promising but need to be interpreted with caution due to variations in the CHMs and RPs used and methodological weakness in the studies. These issues should be addressed in future trials.	[Chen, Xiankun] Guangdong Prov Acad Chinese Med Sci, Evidence Based Med & Clin Res Serv Grp, Guangzhou, Guangdong, Peoples R China; [Chen, Xiankun; Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Xue, Charlie Changli] RMIT Univ, Sch Hlth Sci, Hlth Innovat Res Inst, Tradit & Complementary Med Res Program, Melbourne, Vic, Australia; [Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Lin] Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Royal Melbourne Institute of Technology (RMIT); Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lin, L (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	drlinlin620@163.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China [2012DFA31760]; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study is funded by a project grant from the International Science & Technology Cooperation Project of the Ministry of Science and Technology of China (Project Grant Number: 2012DFA31760, Project Title: Evaluation of Traditional and Scientific Evidence of Chinese Medicine). The project is partially supported by the China-Australia International Research Centre for Chinese Medicine, funded by Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS & GPHCM), Guangdong China, and RMIT University, Australia. The authors also acknowledge the support provided by the GPHCM and the School of Health Sciences, RMIT University to the first author (XKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; An XD, 2011, RESP MED, V105, P165, DOI 10.1016/j.rmed.2010.11.007; Brown Cynthia D, 2007, COPD, V4, P217; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen GC, 2012, SHANGHAI J TRADITION, V46, P42; Chen Ning, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P105, DOI 10.3736/jcim20090202; Chen Q, 2009, J FUJIAN U TRAD CHIN, V19, P12; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Cote CG, 2005, EUR RESPIR J, V26, P630, DOI 10.1183/09031936.05.00045505; CSRD, 2007, CHIN J INRERN MED, V46, P254; Cui Peng, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3451; Cui Zhao-bo, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P885; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Faganello MM, 2010, AM J MED SCI, V339, P10, DOI 10.1097/MAJ.0b013e3181bb8111; Fan BD, 2012, J SICHUAN TRADITIONA, P83; George J, 2004, MED J AUSTRALIA, V181, P248, DOI 10.5694/j.1326-5377.2004.tb06262.x; Glaab T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-79; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Guo WX, 2008, HEBEI J TRADITIONAL, V30, P121; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028696; Hu QG, 2012, J GUIYANG COLLAGE TR, V34, P135; [黄东晖 Huang Donghui], 2005, [第四军医大学学报, Journal of the Fourth Military Medical University], V26, P1611; Imfeld S, 2006, CHEST, V129, P873, DOI 10.1378/chest.129.4.873; Jian XY, 2012, J BEIJING U TRADITIO, V19, P32; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040824; Li SY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-197; Liang AW, 2013, J EMERGENCY TRADITIO, P1125; Liao Y.L., 2011, HERALD MED, V30, P63; Lin YZ, 2013, CHINESE MANIPULATION, P103; Liu CS, 2009, GUIDING J TRADITIONA, V11, P10; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mansori F, 2010, CLIN RESPIR J, V4, P241, DOI 10.1111/j.1752-699X.2010.00185.x; Marin JM, 2011, RESP MED, V105, P916, DOI 10.1016/j.rmed.2011.01.007; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Peng ZQ, 2013, THESIS FUJIAN U TRAD; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Shan LN, 2011, J GUANGZHOU U TRADIT, V28, P590; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Vickers A, 1999, BRIT MED J, V319, P1050, DOI 10.1136/bmj.319.7216.1050; Wise Robert A, 2005, COPD, V2, P125; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Xu JZ, 2012, YUNNAN J TRADITIONAL, V33, P31; Xu TingZhen, 2012, Chinese Archives of Traditional Chinese Medicine, V30, P570; Yang CM, 2013, MODERN J INTEGRATED, P729; Yu JY, 2011, J MED INFORM, P4019; Zeng JQ, 2013, J NEW CHINESE MED, P32; Zhang FY, 2007, SHANXI ZHONGYI J, V28, P1594; Zhang FY, 2007, J EMERGENCY TRADITIO, V19, P198; Zhang R.Z., 2011, CHINA PRACTICAL MED, V6, P118; Zhao YL, 2012, J TRADIT CHIN MED, V32, P203, DOI 10.1016/S0254-6272(13)60012-6; 茅蓉, 2009, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V29, P362	70	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91830	10.1371/journal.pone.0091830	http://dx.doi.org/10.1371/journal.pone.0091830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300132
J	Chen, XF; Li, LZ; Zhou, T; Li, ZZ				Chen, Xiaofang; Li, Lezhi; Zhou, Tao; Li, Zhanzhan			Prevalence of Hypertension in Rural Areas of China: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; MEN; AWARENESS; MORTALITY	Background: Hypertension is one of the leading causes of disease burden across the world. In China, the latest nationwide survey of prevalence of hypertension was ten year ago, and data in rural areas is little known. More information about hypertension prevalence could help to improve overall antihypertensive health care. We aimed to estimate the pooled prevalence of hypertension in rural areas of China. Methods: Comprehensive electronic searches of PubMed, Web of Knowledge, Chinese Web of Knowledge, Wangfang, Weipu and SinoMed databases were conducted to identify any study in each database published from January 1, 2004 to December 31, 2013, reporting the prevalence of hypertension in Chinese rural areas. Prevalence estimates were stratified by age, area, sex, publication year, and sample size. All statistical calculations were made using the Stata Version 11.0 (College Station, Texas) and Statsdirect Version 2.7.9. Results: We identified 124 studies with a total population of 3,735,534 in the present meta-analysis. Among people aged 18 years old in Chinese rural areas, the summarized prevalence is 22.81% (19.41%-26.41%). Subgroup analysis shows the following results: for male 24.46% (21.19%-27.89%, for female 22.17% (18.25%-26.35%). For 2004-2006: 18.94% (14.41%-23.94%), for 2007-2009, 21.24% (15.98%-27.01%) for 2010-2013: 26.68%, (20.79%-33.02%). For Northern region 25.76% (22.36%-29.32%), for Southern region 19.30%, (15.48%-24.08%). Conclusions: The last decade witnessed the growth in prevalence of hypertension in rural areas of China compared with the fourth national investigation, which has climbed the same level as the urban area. Guidelines for screening and treatment of hypertension in rural areas need to be given enough attention.	[Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hostipal 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Lezhi] Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhou, Tao] Southern Med Univ, Dept Cardiol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University; Southern Medical University - China; Central South University; Southern Medical University - China; Central South University	Li, LZ (corresponding author), Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	lilz1988@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Chen B, 2008, MOEDERN PREV MED, V35, P2823; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Department of Disease Control and Prevention Ministry of Health, 2006, REP CHRON DIS CHIN; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz AA, 2014, RURAL REMOTE HEALTH, V14; Dong CX, 2013, J INT MED RES, V41, P1291, DOI 10.1177/0300060513488498; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Gong Jie, 2011, Chinese Preventive Medicine, V12, P227; Han B, 2009, J ZHENGZHOU U MED SC, V44, P337; He F, 2012, CHIN J DIS CONTROL P, V16, P560; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu HH, 2008, PREV TREATMENT CARDI, V8, P195; Hu XJ, 2013, CHIN HLTH SERVICE MA, V5, P391; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kokiwar Prashant R, 2012, J Assoc Physicians India, V60, P26; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li LM, 2008, CHINESE REDIDENTS NU; Li Y, 2011, J SHENYANG MED COLL, V13, P228; Lin Kang, 2014, Wuhan Daxue Xuebao (Yixue Ban), V35, P114; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; Ministry of Health of the People's Republic of China, 2005, CHIN PREV CONTR HYP; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Ni GH, 2013, FOOD NUTR CHIN, V19, P70; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENS, V3, P1; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Stuart A, 1996, KENDALLS ADV THEORY; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; [王克伟 Wang Kewei], 2011, [中国公共卫生, China Public Health], V27, P1291; Wang YM., 2013, J BENBU MED COLL, V38, P321; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Xia YiYin, 2013, Journal of Tropical Medicine (Guangzhou), V13, P350; Xin RB, 2011, GUANGXI MED, V33, P963; Yang HJ, 2010, CHIN J GEN PRAC, V8, P896; Ye HaoFeng, 2005, China Tropical Medicine, V5, P1114; Ye ZW, 2011, ANHUI J PREV MED, V17, P190; Yin CG, 2009, PREV TREATMENT CARDI, V9, P137; Yu QH, 2011, WORLD HLTH DIG MED P, V8, P13; Yu YX, 2009, MED J CHIN PEOPLE HL, V21, P2364; Zhang AH, 2009, PREV MED TRIB, V15, P720; Zhang G, 2009, GONG GONG WEI SHENG, V20, P24; Zhang LJ, 2010, OCCUP HLTH, V26, P1872; Zhang Y., 2011, NINGXIA MED J, V33, P1222; Zhao JiQing, 2013, Bulletin of Disease Control and Prevention, V28, P27; Zheng YT, 2011, CHIN MED J METALL IN, V28, P573; Zheng ZH, 2010, CHINA CHLIN PRAC MED, V4, P219; Zhong DC, 2009, SICHUAN MED J, V30, P1056; Zhou YX, 2011, PRE MED TRIB, V17, P909	59	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115462	10.1371/journal.pone.0115462	http://dx.doi.org/10.1371/journal.pone.0115462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	24622390	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600050
J	Chen, XL; Chen, XZ; Lu, ZH; Wang, L; Yang, K; Hu, JK; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG				Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Wang, Li; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang			Comparison of Ultrasonic Scalpel versus Conventional Techniques in Open Gastrectomy for Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVATED SHEARS; CANCER; LYMPHADENECTOMY	Objectives: To compare surgical efficacy and postoperative recovery of ultrasonic scalpel (USS) with conventional techniques for the resection of gastric carcinoma. Methods: A systematic search of major medical databases (PubMed, Embase, CCRT and CNKI) was conducted. Both randomized and non-randomized controlled trials (RCTs and nRCTs) were considered eligible. Operation time (OT), intraoperative blood loss (BL) and postoperative complications (POC) rates as well as postoperative hospitalization days, number of dissected lymph nodes, abdominal drainage volume and time for recovery of gastrointestinal functions were synthesized and compared. Results: Nineteen studies were included (7 RCTs and 12 nRCTs), in which 1930 patients were enrolled totally (946 in the USS group and 984 in the conventional group). Monopolar electrocautery and ligation were used as the conventional methods. Comparative meta-analysis showed perioperative outcomes were significantly improved using USS compared with conventional surgical instrumentation. OT was reduced from a weighted mean of 185.3 min in the conventional group to 151.0 min in the USS group (MD = -33.30, 95% CI [-41.75, -24.86], p<0.001) and intraoperative BL was decreased from a weighted mean of 217.9 ml in the conventional group to 111.6 ml in the USS group (MD = -113.42, 95% CI [-142.05, -84.79], p<0.001). Results from RCTs subgroup were consistent with those from nRCTs subgroup. The weighted cumulative risk of POC accounted for 8.9% (0%-25%) and 12.9% (5.5%-45%) in the USS and conventional groups, respectively. Pooled estimated results from nRCTs (OR = 0.54, 95% CI [0.27, 1.06], p = 0.07) and RCTs (RR = 0.75, 95% CI [0.44, 1.26], p = 0.27) showed no significant difference between the USS and control groups. Analysis of secondary outcomes showed the improvements of the USS group over control group regarding the number of dissected lymph nodes, postoperative hospitalization days, abdominal drainage volume and time for recovery of gastrointestinal functions. Conclusion: Compared with conventional electrosurgery, the USS is a safe and effective technique with more short-term advantages in open surgery for gastric cancer.	[Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Li] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	hujkwch@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; Ministry of Education of China [2012SCU-NCET-11-0343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Domestic support from (1) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (No. 2011SCU04B19); and (2) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Chen CP, 2012, GUID CHIN MED, V10, P345; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chen Z, 2009, CHIN J MOD OPER SURG, V13, P257; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fu YM, 2011, CONT MED, V17, P104; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Hu JK, 2008, CHIN J BASES CLIN GE, V15, P718; Inoue K, 2012, J GASTROINTEST SURG, V16, P1840, DOI 10.1007/s11605-012-1970-y; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li G, 2010, J MED POSTGRA, V23, P1050; Li P, 2011, CHIN MED HERALD, V8, P177; Li ZR, 2009, CHIN ARCH GEN SURG E, V3, P510; Lin YH, 2011, CHIN J CLIN ELECT ED, V5, P975; [陆维祺 LU Weiqi], 2008, [中国实用外科杂志, Chinese Journal of Practical Surgery], V28, P203; Mahabaleshwar V, 2012, CAN J SURG, V55, P307, DOI 10.1503/cjs.000411; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mohri Y, 2007, SURG TODAY, V37, P1060, DOI 10.1007/s00595-007-3551-3; Pons Y, 2009, HEAD NECK ONCOL, V24, P1; Shi YF, 2012, GUID CHIN MED, V10, P154; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tou S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007886.pub2; Tsimoyiannis EC, 2002, WORLD J SURG, V26, P158; Tu JC, 2010, MED J COMMUN, V24, P60; Tu XH, 2009, CHIN J MOD OPER SURG, V13, P407; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Wei ZM, 2010, J MINI INVA MED, V5, P445; Wells G, 2009, OTTAWA HOSP RES I NE; Xu L, 2010, PEOPLES MIL SURG, V53, P490; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang ZY, 2012, CHIN J MOD DRUG APPL, V6, P3; Zhong L, 2012, ANN ACAD MED SINGAP, V41, P161; 尹蓓, 2011, [江苏医药, Jiangsu Medical Journal], V37, P2877; 宋小平, 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P590; 刘磊, 2010, [中国癌症杂志, China Oncology], V20, P799	41	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103330	10.1371/journal.pone.0103330	http://dx.doi.org/10.1371/journal.pone.0103330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800038
